Citrus Sinensis ID: 003368
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.978 | 0.799 | 0.452 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.976 | 0.781 | 0.432 | 1e-176 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.972 | 0.782 | 0.444 | 1e-168 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.88 | 0.740 | 0.358 | 1e-112 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.913 | 0.642 | 0.345 | 1e-107 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.893 | 0.588 | 0.343 | 1e-104 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.934 | 0.700 | 0.321 | 1e-102 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.913 | 0.673 | 0.333 | 1e-101 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.933 | 0.736 | 0.320 | 5e-99 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.852 | 0.562 | 0.325 | 2e-97 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 665 bits (1715), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/845 (45%), Positives = 522/845 (61%), Gaps = 38/845 (4%)
Query: 9 VLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI 68
VL+SWN S C+W+G+TC +++RVT L+L L G +SP IGNLSFL + L N
Sbjct: 43 VLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFF 102
Query: 69 QGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLY 128
G IP E+G+L RLE L + N L G IP L CSRL+ L L N+L GS+PSE SL
Sbjct: 103 GGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLT 162
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL----- 183
NL +L + NN+ G +P LGN+T LE ++L++N+L G IPS + QL ++ SL L
Sbjct: 163 NLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNF 222
Query: 184 GGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNA 243
G PP++YNLS L + N G L P LG+ L NL F + N+F+GS P SN
Sbjct: 223 SGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNI 282
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
S L+ L + NN G + FG++ +L L + N+LGS S ++ F+ SL NC+ L L
Sbjct: 283 STLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETL 341
Query: 304 NLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKI 347
+ N+ G LP SI +SGSIP +IG L++L + +D N G +
Sbjct: 342 GIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPL 401
Query: 348 PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407
P + +L NL++L++ N+LSG IP+ GN++ L L L NN G++P+SLGN L
Sbjct: 402 PTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLE 461
Query: 408 LHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
L + N L+G IP EI I + L+ + N L+GS+P IG L+ L + N LSG+
Sbjct: 462 LWIGDNKLNGTIPLEIMKIQQLL-RLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGK 520
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLE 526
+P +G+C ++ +++ N F G IP L L ++E+DLS N+LSG IP LE
Sbjct: 521 LPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLE 579
Query: 527 YLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGV 586
YLNLSFN+LEG+VP KGIF NA+ +S+ GN N LCGGI QL C K +
Sbjct: 580 YLNLSFNNLEGKVPVKGIFENATTVSIVGN-NDLCGGIMGFQLKPCLSQAPSVVKKHSSR 638
Query: 587 LKVIISTCSVFSGLLLGSFF---IFYWLRRRGGSGKE--PSEPILRRALRKVSYESLLKA 641
LK ++ SV LLL F WLR+R + + P+ L K+SY L A
Sbjct: 639 LKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNA 698
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN 701
T+GFSS++++G GSFG+VYK + +VA+KVLN+Q +GA KSF AEC +L++IRHRN
Sbjct: 699 TNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRN 758
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
LV+++T+CSSIDFQGN+F+AL+Y++MPNGSL+ WLHP+ + +E + R LTLLER++
Sbjct: 759 LVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV---EEIHRPSRTLTLLERLN 815
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL----RQEVPNNQ 817
IAIDVAS +DYLH HC EP HCDLKPSN+LLD++LTAHV DFGLARL +E NQ
Sbjct: 816 IAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQ 875
Query: 818 SSSVG 822
SS G
Sbjct: 876 LSSAG 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 367/849 (43%), Positives = 517/849 (60%), Gaps = 43/849 (5%)
Query: 9 VLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI 68
VL SWN S FC+W G+TC R RV L+L L G +SP IGNLSFLR ++L++N+
Sbjct: 50 VLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSF 109
Query: 69 QGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLY 128
IP ++GRLFRL+ L +S+N L G IP +LS CSRL + L N L +PSE SL
Sbjct: 110 GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG---- 184
L L + +NNLTG P LGN+TSL+ + AYN + G IP + +L ++ +
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229
Query: 185 -GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNA 243
G PP++YN+S L + S+ +N G+L G L NL+ + N F+G+ P +N
Sbjct: 230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
S+L+ +I N G + ++FG +++L +L + N+LG+ S + FI ++ANC+ L +L
Sbjct: 290 SSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYL 349
Query: 304 NLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKI 347
++ N+ G LP SI +SG+IP +IG LVSL + ++ N G++
Sbjct: 350 DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409
Query: 348 PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407
P +L NLQ +++ N +SGEIPS FGN++ L KL L +N+ G IP SLG + L
Sbjct: 410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469
Query: 408 LHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
L + N L+G IP+EI I ++ ++ + N L G P ++G L++L S N LSG+
Sbjct: 470 LWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIP--SSLVSLKDLREIDLSQNNLSGKIPISLERLP- 524
+P IG C ++ ++M N F G+IP S LVSLK+ +D S NNLSG+IP L LP
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKN---VDFSNNNLSGRIPRYLASLPS 585
Query: 525 LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNS-RNHKVY 583
L LNLS N EG+VPT G+F NA+A+SV GN+N +CGG+ E+QL C S R K
Sbjct: 586 LRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN-ICGGVREMQLKPCIVQASPRKRKPL 644
Query: 584 RGVLKVIISTCSVFSGLLLGSFF--IFYWLRRRGGSGKEPSEPILRRAL----RKVSYES 637
KV+ C + LLL + ++++R+ + P L KVSYE
Sbjct: 645 SVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEE 704
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI 697
L AT FSST+LIG G+FG+V+KG + +VA+KVLNL GA+KSF AEC + I
Sbjct: 705 LHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGI 764
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
RHRNLV++IT CSS+D +GNDF+ALVY++MP GSL+ WL + + + ND R+LT
Sbjct: 765 RHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERV---NDHSRSLTPA 821
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL----RQEV 813
E+++IAIDVASA++YLH HC +P HCD+KPSNILLD++LTAHV DFGLA+L +E
Sbjct: 822 EKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRES 881
Query: 814 PNNQSSSVG 822
NQ SS G
Sbjct: 882 FLNQFSSAG 890
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 592 bits (1525), Expect = e-168, Method: Compositional matrix adjust.
Identities = 372/836 (44%), Positives = 500/836 (59%), Gaps = 34/836 (4%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
+++ VL SWNDS C W G+ C +HRRVT +DL L G +SP +GNLSFLR +
Sbjct: 51 VSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSL 110
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
+L++N G IP E+G LFRL+ L +S+N G IP LS CS L L L N LE +P
Sbjct: 111 NLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVP 170
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
EF SL L L++ NNLTG P LGN+TSL+ + YN + G IP + +LK++
Sbjct: 171 LEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFF 230
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
+ G PP IYNLS L S+ N G+L P G L NLQ+ + N F+G+
Sbjct: 231 RIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTI 290
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P SN S+L+ L+I N+ GK+ ++FG +++L L + N+LG+ S ++ F+ +L N
Sbjct: 291 PETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTN 350
Query: 297 CSNLSFLNLVANQFKGALP----------------HSIVSGSIPSEIGKLVSLYLIEMDH 340
CS L +LN+ N+ G LP +++SGSIP IG LVSL +++
Sbjct: 351 CSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGE 410
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
N GK+P + L L+ + + N LSGEIPSS GN+S L L L NN+ G IPSSLG
Sbjct: 411 NLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLG 470
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
+ L L+L N L+G+IP E+ + + LN + N LVG + IG LK L VS
Sbjct: 471 SCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALDVS 529
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N LSG+IP + +C L+ + + N F G IP + L LR +DLS+NNLSG IP +
Sbjct: 530 YNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYM 588
Query: 521 ERL-PLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRN 579
L+ LNLS N+ +G VPT+G+F N SA+SV GN N LCGGIP LQL C R
Sbjct: 589 ANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNIN-LCGGIPSLQLQPCSVELPRR 647
Query: 580 HKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGK------EPSEPILRRALRKV 633
H R ++ + +S LL W + R S + + S ++ K+
Sbjct: 648 HSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKI 707
Query: 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRA 693
SY+ L K T GFSS++LIG G+FG+V+KG VAIKVLNL +GA+KSF AEC A
Sbjct: 708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767
Query: 694 LRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN 753
L IRHRNLV+++T CSS DF+GNDF+ALVY++MPNG+L+ WLHPD I +E + R
Sbjct: 768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI---EETGNPSRT 824
Query: 754 LTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
L L R++IAIDVASA+ YLH +C P HCD+KPSNILLD +LTAHV DFGLA+L
Sbjct: 825 LGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQL 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 302/843 (35%), Positives = 431/843 (51%), Gaps = 117/843 (13%)
Query: 20 CDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRL 79
C+W G+ C+ +V LD+ + L G +SP I NL+ L + LS N GKIP EIG L
Sbjct: 54 CNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSL 113
Query: 80 FR-LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138
L+ L LS N L G IP L +RL+ L LG N+L GSIP +
Sbjct: 114 HETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCN----------- 162
Query: 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSL-GQLKELKSL-----GLGGTIPPSIY 192
G+ +SL+ I L+ NSL G IP + LKEL+ L L GT+P S+
Sbjct: 163 ----------GSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLS 212
Query: 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG--------SFPLAFSNAS 244
N + L + N L G LP + + LQ +S N F F + +N+S
Sbjct: 213 NSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSS 272
Query: 245 NLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLN 304
+LQ LE+ GN+ G+++ S+ +L+V NL ++
Sbjct: 273 DLQELELAGNSLGGEIT------SSVRHLSV-----------------------NLVQIH 303
Query: 305 LVANQFKGALPHSIVS---------------GSIPSEIGKLVSLYLIEMDHNQFEGKIPE 349
L N+ G++P I + G IP E+ KL L + + +N G+IP
Sbjct: 304 LDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPM 363
Query: 350 EMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLH 409
E+ + L L++ N LSG IP SFGNLS L +L+L N+LSG +P SLG L +L
Sbjct: 364 ELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILD 423
Query: 410 LFQNDLSGAIPEEIF-NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
L N+L+G IP E+ N+ ++ LN + NHL G IP ++ + ++ +SSN LSG+I
Sbjct: 424 LSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKI 483
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLER-LPLEY 527
P ++GSC L+ + ++ N F ++PSSL L L+E+D+S N L+G IP S ++ L++
Sbjct: 484 PPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKH 543
Query: 528 LNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGVL 587
LN SFN L G V KG F+ + S G+S LCG I +Q C K + + +L
Sbjct: 544 LNFSFNLLSGNVSDKGSFSKLTIESFLGDS-LLCGSIKGMQ--ACKKKHKYPSVLLPVLL 600
Query: 588 KVIISTCSVFSGLLL------GSFFIFYWLRRRGGSGKE----PSEPILRRALRKVSYES 637
+I + G L G Y K+ P P ++SY+
Sbjct: 601 SLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP-------RISYQQ 653
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRN 696
L+ AT GF+++ LIG G FG VYKG R+ T VA+KVL+ + S SF EC+ L+
Sbjct: 654 LIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKR 712
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
RHRNL+R+IT+CS F ALV MPNGSLE L+P +NL L
Sbjct: 713 TRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHLYPGEYSS--------KNLDL 759
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN 816
++ ++I DVA + YLHH+ +HCDLKPSNILLD+ +TA V DFG++RL Q V
Sbjct: 760 IQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEET 819
Query: 817 QSS 819
S+
Sbjct: 820 VST 822
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 296/857 (34%), Positives = 445/857 (51%), Gaps = 103/857 (12%)
Query: 44 LIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYC 103
L GS+ IG L+ L ++ LS N + GKIP + G L L++L L+ N L G+IP + C
Sbjct: 204 LTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 104 SRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS 163
S L+ L L N+L G IP+E +L L+ L I +N LT IP L +T L + L+ N
Sbjct: 264 SSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENH 323
Query: 164 LGGNIPSSLGQLKELKSLGL-----GGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLT 218
L G I +G L+ L+ L L G P SI NL L +V N + G LP LGL
Sbjct: 324 LVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL- 382
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
L+NL+ +N +G P + SN + L+ L++ N G++ FG M +L ++++ N
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRN 441
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALP---------------HSIVSGSI 323
+ +GE + F NCSNL L++ N G L ++ ++G I
Sbjct: 442 HF-TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPI 495
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQ------------------------F 359
P EIG L L ++ + N F G+IP EMS L LQ
Sbjct: 496 PREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSV 555
Query: 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
L++ +N+ SG+IP+ F L SL L L N +G IP+SL +L L + N L+G I
Sbjct: 556 LDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTI 615
Query: 420 PEEIF-NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC--- 475
P E+ ++ +M LNF+ N L G+IP ++G L++++ +S+N SG IP + +C
Sbjct: 616 PGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNV 675
Query: 476 FYLQ------------EIY----------MAENFFRGSIPSSLVSLKDLREIDLSQNNLS 513
F L E++ ++ N F G IP S ++ L +DLS NNL+
Sbjct: 676 FTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLT 735
Query: 514 GKIPISLERL-PLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKC 572
G+IP SL L L++L L+ N+L+G VP G+F N +A + GN++ LCG L+
Sbjct: 736 GEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTD-LCGSKKPLKPCTI 794
Query: 573 PKNNSRNHKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRG-GSGKEPSEPILRRALR 631
+ +S K R +L ++ S ++ LLL + + + E S P L AL+
Sbjct: 795 KQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALK 854
Query: 632 KVSYE--SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSF 687
+E L +ATD F+S ++IG S +VYKG + DGT++A+KVLNL+ A K F
Sbjct: 855 LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE-DGTVIAVKVLNLKEFSAESDKWF 913
Query: 688 AAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE 747
E + L ++HRNLV+++ ++ KALV +M NG+LE+ +H A P
Sbjct: 914 YTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG--- 966
Query: 748 NDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+LLE+I + + +AS +DYLH P +HCDLKP+NILLD++ AHV DFG A
Sbjct: 967 -------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTA 1019
Query: 808 RL---RQEVPNNQSSSV 821
R+ R++ S+S
Sbjct: 1020 RILGFREDGSTTASTSA 1036
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 379 bits (972), Expect = e-104, Method: Compositional matrix adjust.
Identities = 273/794 (34%), Positives = 408/794 (51%), Gaps = 57/794 (7%)
Query: 39 LKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPG 98
L L G + +I N L+ + LSNNT+ G+IP + +L L LYL++NSL G +
Sbjct: 344 LSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSS 403
Query: 99 NLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAIS 158
++S + L L N LEG +P E L L+ + + EN +G +P +GN T L+ I
Sbjct: 404 SISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEID 463
Query: 159 LAYNSLGGNIPSSLGQLKELKSLGLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPP 213
N L G IPSS+G+LK+L L L G IP S+ N + + +N+L GS+P
Sbjct: 464 WYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPS 523
Query: 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273
S G L+ L+LF I NN G+ P + N NL + N F G +S G S +YL
Sbjct: 524 SFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCG---SSSYL 579
Query: 274 NVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSL 333
+ + G E L +NL L L NQF +G IP GK+ L
Sbjct: 580 SFDVTENGF----EGDIPLELGKSTNLDRLRLGKNQF---------TGRIPRTFGKISEL 626
Query: 334 YLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSG 393
L+++ N G IP E+ + L +++ +N LSG IP+ G L L +L L +N G
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686
Query: 394 VIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKV 453
+P+ + +L + L L N L+G+IP+EI N+ + ++LN N L G +P IG L
Sbjct: 687 SLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQAL-NALNLEENQLSGPLPSTIGKLSK 745
Query: 454 LRMFVVSSNNLSGEIPSEIGSCFYLQE-IYMAENFFRGSIPSSLVSLKDLREIDLSQNNL 512
L +S N L+GEIP EIG LQ + ++ N F G IPS++ +L L +DLS N L
Sbjct: 746 LFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQL 805
Query: 513 SGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPK 571
G++P + + L YLNLS+N+LEG++ K F+ A + GN+ LCG L
Sbjct: 806 VGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAG-LCGS----PLSH 858
Query: 572 CPKNNSRNHKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRR--------RGG------S 617
C + S+N + VIIS S + + L I + ++ RGG +
Sbjct: 859 CNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSN 918
Query: 618 GKEPSEPILRR--ALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV 675
P+ A + ++ +++AT + +IG G G VYK TI K+
Sbjct: 919 SSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI 978
Query: 676 LNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENW 735
L ++KSF E + L IRHR+LV+++ CSS + + L+Y+YM NGS+ +W
Sbjct: 979 LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDW 1035
Query: 736 LHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795
LH +E + L R+ IA+ +A V+YLH+ C P +H D+K SN+LLD+
Sbjct: 1036 LH------ANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDS 1089
Query: 796 NLTAHVGDFGLARL 809
N+ AH+GDFGLA++
Sbjct: 1090 NIEAHLGDFGLAKI 1103
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 373 bits (958), Expect = e-102, Method: Compositional matrix adjust.
Identities = 302/939 (32%), Positives = 432/939 (46%), Gaps = 168/939 (17%)
Query: 8 GVLNSWND-SHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNN 66
G L SWN + C+W GI C+ R VT +DL L G+LSP I L LR++++S N
Sbjct: 43 GYLASWNQLDSNPCNWTGIACT-HLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTN 101
Query: 67 TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVS 126
I G IP ++ LE L L N G IP L+ L LYL N L GSIP + +
Sbjct: 102 FISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGN 161
Query: 127 LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG-- 184
L +L+EL I NNLTG IP + + L I N G IPS + + LK LGL
Sbjct: 162 LSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAEN 221
Query: 185 ---GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFS 241
G++P + L L + + +NRL G +PPS+G +S L++ + N+F+GS P
Sbjct: 222 LLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVG-NISRLEVLALHENYFTGSIPREIG 280
Query: 242 NASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLS 301
+ ++ L + N G++ G++ A ++ + N L E F H L NL
Sbjct: 281 KLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKE--FGHIL----NLK 334
Query: 302 FLNLVANQFKGALPHSI---------------VSGSIPSEIGKLVSLYLIEMDHNQFEGK 346
L+L N G +P + ++G+IP E+ L L +++ NQ EGK
Sbjct: 335 LLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGK 394
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406
IP + N L+M N LSG IP+ F +L+ L LG+N LSG IP L K L
Sbjct: 395 IPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLT 454
Query: 407 LLHLFQNDLSGAIPEEIFNISHMS-----------------------DSLNFARNHLVGS 443
L L N L+G++P E+FN+ +++ + L A N+ G
Sbjct: 455 KLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGE 514
Query: 444 IPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC------------------------FYLQ 479
IPP+IGNL + F +SSN L+G IP E+GSC YL+
Sbjct: 515 IPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLE 574
Query: 480 EIYMAENFFRGSIPSSLVSLKDLREIDL-------------------------SQNNLSG 514
+ +++N G IP S L L E+ L S NNLSG
Sbjct: 575 ILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSG 634
Query: 515 KIPIS---LERLPLEYLN----------------------LSFNDLEGQVPTKGIFANAS 549
IP S L+ L + YLN +S N+L G VP +F
Sbjct: 635 TIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMD 694
Query: 550 AISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGV--LKVIISTCSVFSGLLLGSFFI 607
+ + +GN LC P P ++S+ + + G K++ TC V + L +F
Sbjct: 695 SSNFAGNHG-LCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLG 753
Query: 608 FYWLRRRGGSGKEPSEPILRRALRK------------VSYESLLKATDGFSSTHLIGIGS 655
W +R +EP+ L + +Y+ L+ AT FS ++G G+
Sbjct: 754 LCWTIKR----REPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGA 809
Query: 656 FGSVYKGTFDRDGTIVAIKVLNLQLQGASK--SFAAECRALRNIRHRNLVRVITSCSSID 713
G+VYK G ++A+K LN + +GAS SF AE L IRHRN+V++ C
Sbjct: 810 CGTVYKAEMS-GGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFC---- 864
Query: 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE---RISIAIDVASAV 770
+ N L+Y+YM GSL L Q E+N LL+ R IA+ A +
Sbjct: 865 YHQNS-NLLLYEYMSKGSLGEQL------QRGEKN------CLLDWNARYRIALGAAEGL 911
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
YLHH C+ +H D+K +NILLD AHVGDFGLA+L
Sbjct: 912 CYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL 950
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 286/858 (33%), Positives = 422/858 (49%), Gaps = 104/858 (12%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
+ + VL L L G + P++GN+ + ++ LS N + G IP +G L L LYL N
Sbjct: 198 KNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENY 257
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
L G IP + + L L +NKL GSIPS +L NL L++ +N LTGGIP LGNI
Sbjct: 258 LTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNI 317
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNLSLLANFSVPENR 206
S+ + L+ N L G+IPSSLG LK L L L G IPP + N+ + + + N+
Sbjct: 318 ESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNK 377
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
L GS+P S G L NL + N+ +G P N ++ +L++ N G + +FG+
Sbjct: 378 LTGSIPSSFG-NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGN 436
Query: 267 MKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI-------- 318
L L + +N+L + +AN S+L+ L L N F G P ++
Sbjct: 437 FTKLESLYLRVNHLSG------AIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQN 490
Query: 319 -------VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI 371
+ G IP + SL N+F G I E +L F++ HN+ GEI
Sbjct: 491 ISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEI 550
Query: 372 PSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSD 431
S++ L LI+ NNN++G IP+ + N+ QL L L N+L G +PE I N++++S
Sbjct: 551 SSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLS- 609
Query: 432 SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGS 491
L N L G +P + L L +SSNN S EIP S L ++ ++ N F GS
Sbjct: 610 RLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGS 669
Query: 492 -----------------------IPSSLVSLKDLREIDLSQNNLSGKIPISLE-RLPLEY 527
IPS L SL+ L ++DLS NNLSG IP + E + L
Sbjct: 670 IPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTN 729
Query: 528 LNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKC-----PKNNSRNHKV 582
+++S N LEG +P F A+A ++ N LC IP+ +L C PK N N V
Sbjct: 730 VDISNNKLEGPLPDTPTFRKATADALEENIG-LCSNIPKQRLKPCRELKKPKKNG-NLVV 787
Query: 583 Y-----RGVLKVIISTCS-VFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALR----- 631
+ GVL VI+S C+ F+ Y +R+R ++P +
Sbjct: 788 WILVPILGVL-VILSICANTFT----------YCIRKRKLQNGRNTDPETGENMSIFSVD 836
Query: 632 -KVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------AS 684
K Y+ ++++T+ F THLIG G + VY+ TI+A+K L+ +
Sbjct: 837 GKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL--QDTIIAVKRLHDTIDEEISKPVVK 894
Query: 685 KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQT 744
+ F E +AL IRHRN+V++ CS + + F L+Y+YM GSL L D
Sbjct: 895 QEFLNEVKALTEIRHRNVVKLFGFCS---HRRHTF--LIYEYMEKGSLNKLLAND----- 944
Query: 745 DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804
+E + LT +RI++ VA A+ Y+HH P +H D+ NILLDN+ TA + DF
Sbjct: 945 ----EEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDF 1000
Query: 805 GLARLRQEVPNNQSSSVG 822
G A+L + +N S+ G
Sbjct: 1001 GTAKLLKTDSSNWSAVAG 1018
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 362 bits (930), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 268/837 (32%), Positives = 412/837 (49%), Gaps = 67/837 (8%)
Query: 26 TCSP---RHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRL 82
T SP R ++ DL L+G + P++G+LS L +HL N + G IP EIGRL ++
Sbjct: 133 TISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKV 192
Query: 83 EALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG 142
+ + N L G IP + ++L+ LYL N L GSIPSE +L NL+EL + NNLTG
Sbjct: 193 TEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTG 252
Query: 143 GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLG-----LGGTIPPSIYNLSLL 197
IP GN+ ++ +++ N L G IP +G + L +L L G IP ++ N+ L
Sbjct: 253 KIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTL 312
Query: 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257
A + N+L+GS+PP LG S + L +IS N +G P +F + L+ L + N
Sbjct: 313 AVLHLYLNQLNGSIPPELGEMESMIDL-EISENKLTGPVPDSFGKLTALEWLFLRDNQLS 371
Query: 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317
G + + L L + NN D + L N L L N F+G +P S
Sbjct: 372 GPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLEN------LTLDDNHFEGPVPKS 425
Query: 318 I---------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNM 362
+ SG I G +L I++ +N F G++ + Q L +
Sbjct: 426 LRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFIL 485
Query: 363 RHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEE 422
+N ++G IP N++ L +L L +N ++G +P S+ N+ +++ L L N LSG IP
Sbjct: 486 SNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSG 545
Query: 423 IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIY 482
I ++++ + L+ + N IPP + NL L +S N+L IP + LQ +
Sbjct: 546 IRLLTNL-EYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLD 604
Query: 483 MAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL-ERLPLEYLNLSFNDLEGQVPT 541
++ N G I S SL++L +DLS NNLSG+IP S + L L ++++S N+L+G +P
Sbjct: 605 LSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPD 664
Query: 542 KGIFANASAISVSGNSNRLCGGIPELQ-LPKCPKNNSRNHKVYRGVLKVIISTCSVFSGL 600
F NA + GN + LCG + Q L C +S+ R ++ I+ + +
Sbjct: 665 NAAFRNAPPDAFEGNKD-LCGSVNTTQGLKPCSITSSKKSHKDRNLIIYIL--VPIIGAI 721
Query: 601 LLGSFF--IFYWLRRRGGSGKEPSEP-------ILRRALRKVSYESLLKATDGFSSTHLI 651
++ S IF R+R +E ++ + KV Y+ ++KAT F +LI
Sbjct: 722 IILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLI 781
Query: 652 GIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA------SKSFAAECRALRNIRHRNLVRV 705
G G G VYK I+A+K LN + + F E RAL IRHRN+V++
Sbjct: 782 GTGGHGKVYKAKL--PNAIMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKL 839
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
CS + N F LVY+YM GSL L E +DE + L +RI++
Sbjct: 840 FGFCS---HRRNTF--LVYEYMERGSLRKVL---------ENDDEAKKLDWGKRINVVKG 885
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
VA A+ Y+HH +H D+ NILL + A + DFG A+L + +N S+ G
Sbjct: 886 VAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAG 942
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 357 bits (916), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 262/804 (32%), Positives = 393/804 (48%), Gaps = 101/804 (12%)
Query: 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
+T L L + L G+LSP I NL+ L+ + L +N ++GK+P EI L +LE L+L N
Sbjct: 385 ELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRF 444
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
GEIP + C+ L + + N EG IP L L L +++N L GG+P LGN
Sbjct: 445 SGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCH 504
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNLSLLANFSVPENRL 207
L + LA N L G+IPSS G LK L+ L L G +P S+ +L L ++ NRL
Sbjct: 505 QLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRL 564
Query: 208 HGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267
+G++ P G S+ F ++NN F PL N+ NL L + N GK+ G +
Sbjct: 565 NGTIHPLCGS--SSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKI 622
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
+ L+ L+++ N L + L C L+ ++L N +SG IP +
Sbjct: 623 RELSLLDMSSNALTG------TIPLQLVLCKKLTHIDLNNN---------FLSGPIPPWL 667
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
GKL L +++ NQF +P E+ L L++ N L+G IP GNL +L L L
Sbjct: 668 GKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLD 727
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
N SG +P ++G L +L L L +N L+G IP EI + + +L+ + N+ G IP
Sbjct: 728 KNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPST 787
Query: 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL 507
IG L L +S N L+GE+P +G +K L +++
Sbjct: 788 IGTLSKLETLDLSHNQLTGEVPGSVG------------------------DMKSLGYLNV 823
Query: 508 SQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPEL 567
S NNL GK+ R P A S GN+ LCG P
Sbjct: 824 SFNNLGGKLKKQFSRWP-------------------------ADSFLGNTG-LCGS-PLS 856
Query: 568 QLPKCPKNNSRNHKVYRGVLKVIISTCSVFS--GLLLGSFFIFYWLR----RRGGSG--- 618
+ + NN + R V VIIS S + GL++ +F+ R ++ G G
Sbjct: 857 RCNRVRSNNKQQGLSARSV--VIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTA 914
Query: 619 --------KEPSEPILRRALRK--VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDG 668
+ +P+ R K + +E +++AT S +IG G G VYK +
Sbjct: 915 YTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGE 974
Query: 669 TIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMP 728
T+ K+L ++KSF+ E + L IRHR+LV+++ CSS + L+Y+YM
Sbjct: 975 TVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMK 1031
Query: 729 NGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788
NGS+ +WLH D P +++ + L R+ IA+ +A V+YLHH C P +H D+K
Sbjct: 1032 NGSIWDWLHEDK-PVLEKKK---KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKS 1087
Query: 789 SNILLDNNLTAHVGDFGLARLRQE 812
SN+LLD+N+ AH+GDFGLA++ E
Sbjct: 1088 SNVLLDSNMEAHLGDFGLAKVLTE 1111
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.782 | 0.527 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.986 | 0.427 | 0.526 | 0.0 | |
| 224115346 | 1017 | predicted protein [Populus trichocarpa] | 0.964 | 0.782 | 0.534 | 0.0 | |
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.958 | 0.819 | 0.523 | 0.0 | |
| 224090977 | 1034 | predicted protein [Populus trichocarpa] | 0.985 | 0.786 | 0.505 | 0.0 | |
| 224141953 | 1026 | predicted protein [Populus trichocarpa] | 0.983 | 0.790 | 0.510 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.970 | 0.779 | 0.509 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.986 | 0.796 | 0.501 | 0.0 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.986 | 0.794 | 0.501 | 0.0 | |
| 255585471 | 963 | serine-threonine protein kinase, plant-t | 0.953 | 0.817 | 0.495 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/849 (52%), Positives = 580/849 (68%), Gaps = 35/849 (4%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
ITQ P G+ SWNDS HFC+W G+TC RH+RV L+L S L+GSLSP IGNL+FL +
Sbjct: 51 ITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLNSLHLVGSLSPSIGNLTFLTGL 110
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
+L N G+IP E+GRL RL AL L++NS GEIP NLS CS L+ LG N L G IP
Sbjct: 111 NLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIP 170
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
S S + + + NNLTG +P LGN+TS++++S A N L G+IP +LGQL+ L+ +
Sbjct: 171 SWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFM 230
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
GLG G IP S+YN+S L FS+P N+L+GSLP L TL NLQ+ I NN F+GS
Sbjct: 231 GLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSL 290
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P + SNASNL +I +NF GK+S++FG M +L L +A N LG GE+D++SF++SL
Sbjct: 291 PSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMK 350
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
C L L+L +QF G LP+SI +SG+IP IG LV+L + + +
Sbjct: 351 CRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILAN 410
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
N F G IP + LQ L +++ NQLSG IPSS GN++ L L L NN+LSG IPSS G
Sbjct: 411 NDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFG 470
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
NL L L L N L+G IPE++ ++ ++ SLN ARN L G +P ++ LK L VS
Sbjct: 471 NLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVS 530
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N LSGEIP +GSC L+ ++M NFF+GSIP S +SL+ L ++DLS+NNLSG+IP L
Sbjct: 531 ENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFL 590
Query: 521 ERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNH 580
++L L LNLSFN+ EGQ+PTKG+F NA++ SV+GN N+LCGGIPEL LP CP +
Sbjct: 591 QQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGN-NKLCGGIPELHLPACPVTKPKTG 649
Query: 581 KVYRGVLKVIISTCSVFSGL-LLGSFFIFYWLRRRGGSGKEPSEPIL--RRALRKVSYES 637
+ RG LK++I + F GL L+ S + LRR +EPS+ + + VSY+
Sbjct: 650 ESKRG-LKLMIGLLTGFLGLVLIMSLLVINRLRR---VKREPSQTSASSKDLILNVSYDG 705
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI 697
L KAT GFSS +LIG G FGSVYKG +D T+VA+KV+ L +GA KSF AEC ALRNI
Sbjct: 706 LFKATGGFSSANLIGTGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNI 765
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
RHRNLV+V+T+CSS+D+QGNDFKALVY++MPNGSLENWLHP +P DE ND +R L+L
Sbjct: 766 RHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHP--VPTPDEINDVLRILSLP 823
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN-- 815
+R++IAIDVASA+DYLHHHC +P +HCDLKPSNILLDN++TAHVGDFGLAR E
Sbjct: 824 QRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRS 883
Query: 816 --NQSSSVG 822
+QSSS+G
Sbjct: 884 HPSQSSSIG 892
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/849 (52%), Positives = 579/849 (68%), Gaps = 35/849 (4%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
ITQ P G+ SWNDS HFC+W G+TC RH+RV L+L S L+GSLSP IGNL+FL +
Sbjct: 82 ITQDPLGITTSWNDSVHFCNWTGVTCGHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGL 141
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
+L N G+IP E+GRL RL AL L++NS GEIP NLS CS L+ LG N L G IP
Sbjct: 142 NLELNNFHGQIPQELGRLSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIP 201
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
S S + + + NNLTG +P LGN+TS++++S A N L G+IP +LGQL+ L+ +
Sbjct: 202 SWLGSYPKVVRMQLHYNNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFM 261
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
GLG G IP S+YN+S L FS+P N+L+GSLP L TL NLQ+ I NN F+G
Sbjct: 262 GLGMNGFSGIIPSSVYNMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPL 321
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P + SNASNL +I +NF GK+S++FG M +L L +A N LG GE+D++SF++SL
Sbjct: 322 PSSLSNASNLLEFDITMSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMK 381
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
C L L+L +QF G LP+SI +SG+IP IG LV+L + + +
Sbjct: 382 CRALKVLDLSGSQFGGVLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILAN 441
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
N F G IP + LQ L +++ NQLSG IPSS GN++ L L L NN+LSG IPSS G
Sbjct: 442 NDFTGSIPVLIGNLQMLGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFG 501
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
NL L L L N L+G IPE++ ++ ++ SLN ARN L G +P ++ LK L VS
Sbjct: 502 NLLYLQELDLSYNSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVS 561
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N LSGEIP +GSC L+ ++M NFF+GSIP S +SL+ L ++DLS+NNLSG+IP L
Sbjct: 562 ENKLSGEIPDGLGSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFL 621
Query: 521 ERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNH 580
++L L LNLSFN+ EGQ+PTKG+F NA++ SV+GN N+LCGGIPEL LP CP +
Sbjct: 622 QQLSLSNLNLSFNNFEGQLPTKGVFNNATSTSVAGN-NKLCGGIPELHLPACPVTKPKTG 680
Query: 581 KVYRGVLKVIISTCSVFSGL-LLGSFFIFYWLRRRGGSGKEPSEPIL--RRALRKVSYES 637
+ RG LK++I + F GL L+ S + LRR +EPS+ + + VSY+
Sbjct: 681 ESKRG-LKLMIGLLTGFLGLVLIMSLLVINRLRR---VKREPSQTSASSKDLILNVSYDG 736
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI 697
L KAT GFSS +LIG G FGSVYKG +D T+VA+KV+ L +GA KSF AEC ALRNI
Sbjct: 737 LFKATGGFSSANLIGTGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNI 796
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
RHRNLV+V+T+CSS+D+QGNDFKALVY++MPNGSLENWLHP +P DE ND +R L+L
Sbjct: 797 RHRNLVKVLTTCSSVDYQGNDFKALVYEFMPNGSLENWLHP--VPTPDEINDVLRILSLP 854
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN-- 815
+R++IAIDVASA+DYLHHHC +P +HCDLKPSNILLDN++TAHVGDFGLAR E
Sbjct: 855 QRLNIAIDVASALDYLHHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRS 914
Query: 816 --NQSSSVG 822
+QSSS+G
Sbjct: 915 HPSQSSSIG 923
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115346|ref|XP_002317009.1| predicted protein [Populus trichocarpa] gi|222860074|gb|EEE97621.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2087), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/835 (53%), Positives = 583/835 (69%), Gaps = 39/835 (4%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
I P+ + SWNDS HFC W+G+ C RH RVTVL L+S GL+GS+SP +GNLSFL +
Sbjct: 50 IIHDPQNIFGSWNDSLHFCQWQGVRCGRRHERVTVLKLESSGLVGSISPALGNLSFLWGL 109
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
LSNNT+QGKIP +GRLFRL+ L L++NS VGEIPGNLS+CS+L L L N L G IP
Sbjct: 110 DLSNNTLQGKIPDGLGRLFRLQILVLNNNSFVGEIPGNLSHCSKLDYLGLASNNLVGKIP 169
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
+E VSL L++L I +NNL+G IP F+GN+TSL +IS A N+ G IP +LGQLK L+SL
Sbjct: 170 AELVSLSKLEKLVIHKNNLSGAIPPFIGNLTSLNSISAAANNFQGRIPDTLGQLKNLESL 229
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
GLG GTIP IYNLS L+ S+ EN+L G LP +G++L NLQ QI N FSGS
Sbjct: 230 GLGTNFLSGTIPLPIYNLSTLSILSLSENQLQGYLPSDIGVSLPNLQYIQIRANQFSGSI 289
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
PL+ SN+SNLQ LE N+F GKLSVNFG +K LA ++++ N +GSGE E+SF+ SL N
Sbjct: 290 PLSISNSSNLQVLEAGDNSFSGKLSVNFGGLKHLAVVSLSFNKMGSGEPGELSFLDSLIN 349
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
C++L +++V N F+G LP+S+ + G I S IG L++L + ++
Sbjct: 350 CTSLYAIDIVGNHFEGMLPNSLGNLSTGLTFLGLGQNQLFGGIHSGIGNLINLNTLGLEF 409
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
NQ G IP ++ +L+ LQ ++ +N+LSG IPSS GNL+ L++ L N L G IPSS+G
Sbjct: 410 NQLSGPIPLDIGKLRMLQRFSLSYNRLSGHIPSSIGNLTLLLEFDLQGNQLQGTIPSSIG 469
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
N ++L LLHL +N+LSG P+E+F IS +S SL+ ++N+ GS+P +IG+LK L VS
Sbjct: 470 NCQKLLLLHLSRNNLSGNAPKELFAISSLSVSLDLSQNYFNGSLPSEIGSLKSLAKLNVS 529
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N SGEIPS + SC L+ +YM NFF+GSIPSS +L+ ++++DLS NNLSG+IP L
Sbjct: 530 YNEFSGEIPSTLASCTSLEYLYMQHNFFQGSIPSSFSTLRGIQKLDLSHNNLSGQIPKFL 589
Query: 521 ERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNH 580
+ L LNLSFND EG+VPTKG F NA+AISV GN +LCGGI EL+LPKC S+
Sbjct: 590 DTFALLTLNLSFNDFEGEVPTKGAFGNATAISVDGN-KKLCGGISELKLPKCNFKKSKKW 648
Query: 581 KVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESLLK 640
K+ ++ ++ C F G+ + SF + Y RR+ ++ SE L+ L KVSYE LLK
Sbjct: 649 KIPLWLILLLTIACG-FLGVAVVSFVLLYLSRRK--RKEQSSELSLKEPLPKVSYEMLLK 705
Query: 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHR 700
AT+GFSS +LIG G FGSVY+G D+D T+VAIKVLNLQ +GASKSF AEC ALRN+RHR
Sbjct: 706 ATNGFSSDNLIGEGGFGSVYRGILDQDDTVVAIKVLNLQTRGASKSFVAECEALRNVRHR 765
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGS---LENWLHPDAIPQTDEENDEIRNLTLL 757
NL+++ITSCSS+DFQGN+FKALVY++MPNGS LE WL+ L LL
Sbjct: 766 NLLKIITSCSSVDFQGNEFKALVYEFMPNGSLEILEKWLYSHN-----------YFLDLL 814
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+R++I IDVASA++YLHH +HCDLKPSNILLD N+ AHV DFG+A+L E
Sbjct: 815 QRLNIMIDVASALEYLHHGNATLVVHCDLKPSNILLDENMVAHVSDFGIAKLLGE 869
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/825 (52%), Positives = 566/825 (68%), Gaps = 34/825 (4%)
Query: 24 GITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLE 83
G+ C RH+RVT+LDL+S+ L+GS+SP IGNLSFLR + L N +IP EIG L RL+
Sbjct: 1 GVKCGRRHQRVTMLDLQSQKLVGSISPHIGNLSFLRVLQLEENGFNHEIPPEIGHLRRLQ 60
Query: 84 ALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG 143
L+LS+NSL GEIP NLS CS+L+ +Y+G N+L G IP+E SL L+ L I N+L+GG
Sbjct: 61 MLFLSNNSLSGEIPANLSSCSKLMYIYVGWNRLVGKIPAELGSLSKLQYLFIHANSLSGG 120
Query: 144 IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNLSLLA 198
IP GN++SLE +S N++ G IP+SL QL L + GL GTIPPS+ NLS L
Sbjct: 121 IPRSFGNLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLSSLI 180
Query: 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258
F+V N LHG+LP +LG+TL NLQ +S N F+GS P++ SNASNL+ GNN G
Sbjct: 181 FFAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTG 240
Query: 259 KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI 318
K+ + ++ L + +V NNLG+GE +++ F+ SL N SNL L L N F G LP SI
Sbjct: 241 KVP-SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESI 299
Query: 319 ----------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNM 362
+ GSIP+ IG LVSL +EM NQ G IP ++ +LQNL+ L +
Sbjct: 300 GNWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLML 359
Query: 363 RHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEE 422
N+LSG +PSS GNL +L++L+LG N G IPSSLG + L L L N+LSG IP +
Sbjct: 360 IKNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQ 419
Query: 423 IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIY 482
+ ++S +S SL+ + N L G++P ++GNLK L + VS+N LSG IPS +GSC L+ +
Sbjct: 420 VVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLS 479
Query: 483 MAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTK 542
M NFF+GSIPSS SL+ +R +DLS NNLSGKIP L+ + + +NLS+ND EG +PT+
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTE 539
Query: 543 GIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGVLKVIISTCS-VFSGLL 601
G+F N SA S+ GNS +LCGGIPE QLPKC + + LK+II+T S + +
Sbjct: 540 GVFKNVSATSIMGNS-KLCGGIPEFQLPKCNLQEPKKRGLSLA-LKIIIATVSGLLAITC 597
Query: 602 LGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYK 661
+ SF IF WLR++ G EP+ ++L KVSY+SLL+ATDGFSS++LIG+GSFGSVYK
Sbjct: 598 VLSFLIFLWLRKKKG---EPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYK 654
Query: 662 GTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721
G D DGT +A+KVLNL +GASKSF AEC ALRNIRHRNLV+V+T+CS +D+QGNDFKA
Sbjct: 655 GILDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKA 714
Query: 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPT 781
+VY++M NGSLE WLHP P T E + R L L+R++IAIDVA A+DYLHH CQ P
Sbjct: 715 VVYEFMVNGSLEQWLHPT--PTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPI 772
Query: 782 IHCDLKPSNILLDNNLTAHVGDFGLARLRQE----VPNNQSSSVG 822
+HCDLKPSN+LLD +T HVGDFG+A+ E VP QSSS+G
Sbjct: 773 VHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIG 817
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/843 (50%), Positives = 574/843 (68%), Gaps = 30/843 (3%)
Query: 6 PEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSN 65
P G+++SWNDS HFC+W GI C H+RV L+L GL+GSLSPQIGN+SFLR I L
Sbjct: 53 PLGLMSSWNDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSLSPQIGNMSFLRGISLEQ 112
Query: 66 NTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV 125
N G+IP EIGRL RL+ + S+NS GEIP NLS CS L+ L LG NKL G IP +
Sbjct: 113 NYFHGEIPQEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLMLRLGFNKLTGQIPYQLG 172
Query: 126 SLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG- 184
SL L+ + + NNL G +P LGNI+S+ ++SL+ N+ G+IP +LG+LK L LGLG
Sbjct: 173 SLQKLERVQLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRLKTLNFLGLGL 232
Query: 185 ----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAF 240
G IPP+I+NLS L F++P N+LHG+LP LGLTL NLQ+ I +NFFSG P++
Sbjct: 233 NNLSGMIPPTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPLPVSI 292
Query: 241 SNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNL 300
SNASNL L+I +NF K++++FG + +L L ++ N LG GE+D++SFI SL C NL
Sbjct: 293 SNASNLLELDIDTSNF-TKVTIDFGGLPNLWSLALSSNPLGKGEADDLSFIDSLTKCRNL 351
Query: 301 SFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDHNQFE 344
L+L + F G +P SI +SGSIP+ I L++L + ++ N
Sbjct: 352 RLLDLSNSHFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLAELTVEKNYLS 411
Query: 345 GKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQ 404
G IP + L+ LQ L++ N+LSG IPSS GN++ L + L N + G IPSS GNLK
Sbjct: 412 GSIPSVLGNLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGSIPSSFGNLKY 471
Query: 405 LALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNL 464
L L L QN LSG IP+E+ +S ++ SLN A+N L G +PP+ NL L VS N L
Sbjct: 472 LQNLDLSQNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKL 531
Query: 465 SGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP 524
G+IPS +GSC L++++M NFF G+IP S SL+ LR++DLS+NNLSG+IP L+RL
Sbjct: 532 YGQIPSSLGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLA 591
Query: 525 LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYR 584
L LNLSFN EG+VP +G F NA+AIS+SGN RLCGGIP+L+LP+C N S+N K R
Sbjct: 592 LISLNLSFNHFEGEVPREGAFLNATAISLSGNK-RLCGGIPQLKLPRCVVNRSKNGKTSR 650
Query: 585 GVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRA-LRKVSYESLLKATD 643
V +I + + + S + LR++ S ++ L KVSY +L KAT
Sbjct: 651 RVKLMIAILTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATA 710
Query: 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLV 703
GFSS +LIG GSFGSVY+G D + T+VA+KVL ++ + KSF AEC L+NIRHRNLV
Sbjct: 711 GFSSANLIGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLV 770
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+++T+CSS+DFQGNDFKALVY++MPNG+LE+WLH + P+T+ N++++ L+ +R++IA
Sbjct: 771 KILTACSSVDFQGNDFKALVYEFMPNGTLESWLH--SFPRTNGINEDLKILSFHQRLNIA 828
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN----NQSS 819
IDVA+A++YLH+ C +P +HCDLKPSN+LLDN++TAHVGDFGLAR +E N N+SS
Sbjct: 829 IDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFIEEAINPSHRNESS 888
Query: 820 SVG 822
SVG
Sbjct: 889 SVG 891
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/837 (51%), Positives = 563/837 (67%), Gaps = 26/837 (3%)
Query: 9 VLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI 68
L+SWNDS FC+W GITC RH RV +++L + L G+LSP +GN+SFLREI L+NNTI
Sbjct: 51 TLSSWNDSLDFCNWPGITCGRRHGRVRIINLVDQKLAGTLSPYVGNISFLREIRLANNTI 110
Query: 69 QGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLY 128
G+IP E+GRL RL L L++NS+ G+IP NLS CS L LY+ RNKL G IP+E L
Sbjct: 111 HGEIPPEVGRLLRLRVLMLTNNSIEGKIPANLSGCSSLAELYIDRNKLGGEIPTELGFLS 170
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG---- 184
L L+ ++NNL G IPH +GN+TSLE++SL N L G IP SLG+LK L SL LG
Sbjct: 171 KLTILSFRQNNLLGKIPHSIGNLTSLESLSLKRNVLEGTIPDSLGRLKRLTSLLLGENKL 230
Query: 185 -GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNA 243
G IPPS+YNLSL+ F + N GSLP +LGL+ +LQ + N FSG P + +NA
Sbjct: 231 SGFIPPSLYNLSLITTFYLGGNGFRGSLPSNLGLSFPHLQWLALWQNQFSGPIPGSLTNA 290
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
S LQ + N+ GK+ FG + L+ L+ NNLG+G DEM+F+ SL NCS L +
Sbjct: 291 SELQIVSFTYNSLTGKIPDIFGKLHHLSGLHFGSNNLGTGGDDEMAFLASLTNCSMLKVV 350
Query: 304 NLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKI 347
++ N+ +G+LP ++ + G IPS IG LV+L + MD N F G+I
Sbjct: 351 SINNNRLEGSLPITVGNLSTYMVYFGLSGNHIVGRIPSGIGNLVNLTFLYMDRNHFTGEI 410
Query: 348 PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407
P L+ L+ ++ N+LSG+IPSS GNLS L L L +N L IP+SLG K L
Sbjct: 411 PTSFGNLRKLEQFSLFSNRLSGKIPSSLGNLSLLSVLYLDDNKLKDTIPASLGGCKNLVS 470
Query: 408 LHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
L L + +L+G+IPE++F S + SLN + N GS+P IG+LK L VS N LSGE
Sbjct: 471 LGLSRKNLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPSTIGSLKGLSELDVSWNMLSGE 530
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEY 527
IP+ G C L+ ++M +NFF+GSIPSS SL+ ++ +DLS NNLSG++P L +P
Sbjct: 531 IPTSFGGCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDLSCNNLSGQLPNFLVTIPFIS 590
Query: 528 LNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGVL 587
LNLS+N+ EG+VP KG+F N SA+SV GN ++LCGGI EL LP+CP + K+
Sbjct: 591 LNLSYNNFEGEVPRKGVFTNESAVSVVGN-DKLCGGILELHLPECPNKEPKKTKMSHLQY 649
Query: 588 KVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSS 647
+ I+ G + S F+F W +++ + S+ +L+ + ++SYE L KATDGFS+
Sbjct: 650 LLAITIPCALVGAITVSSFLFCWFKKK--RKEHSSDTLLKESFPQISYERLFKATDGFST 707
Query: 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVIT 707
T+LIG+GSF SVYKG D DGT+VAIKVLNLQ +GASKSF EC ALRNIRHRNLV++IT
Sbjct: 708 TNLIGVGSFSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFKDECEALRNIRHRNLVKIIT 767
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
SCSSIDFQGN+FKALVY+YMP GSLE WLHP D++ ++++ LLERI+IAIDVA
Sbjct: 768 SCSSIDFQGNNFKALVYEYMPKGSLEKWLHPTQETHDDQQINQVQRPNLLERINIAIDVA 827
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV--PNNQSSSVG 822
+A+DYLHHHC P IHCD+KPSNILLD ++ H+GDFGLAR+ QE P+ +SSS G
Sbjct: 828 AALDYLHHHCHSPIIHCDVKPSNILLDKDMIGHLGDFGLARIFQEFSEPSLESSSAG 884
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1987), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/831 (50%), Positives = 557/831 (67%), Gaps = 30/831 (3%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
IT P +L+SWN+S HFC W GITC RH+RV +DL+S L GSL+ IGNLSFLR +
Sbjct: 46 ITDDPLHILSSWNESLHFCKWSGITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVL 105
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
+L NN++ IP EIGRLFRL L L NS GEIP N+SYCS L+ L LGRN L G +P
Sbjct: 106 NLQNNSLSHYIPQEIGRLFRLRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLP 165
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
+E SL L+ + N LTG I N++SLE I N+ G IP+S+GQLK L++
Sbjct: 166 AELKSLSKLQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTF 225
Query: 182 GLGGT-----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
LGG+ IPPSI+NLS L SVP N+LHG+LPP LG +L L++ ++ N FSGS
Sbjct: 226 SLGGSNFSGVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSI 285
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P SNASNL +L++ NNF GK+ + + +L+Y+ + NNLG+GE D++SF+++LAN
Sbjct: 286 PPTISNASNLVALDVSQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLAN 344
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
+NL L + N G LP + + G IPSEI L+ L + +
Sbjct: 345 NTNLEILAITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFER 404
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
N+ G IP + +L+NL L + N +SG IPSS GN++SL + L NNL G IPSSLG
Sbjct: 405 NELTGSIPSSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLG 464
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
N +Q+ L+ L +N+LSG IP+E+ +I +S SL+ + N GS+P ++G L L VS
Sbjct: 465 NCQQMLLMDLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVS 524
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIP-IS 519
N LSGEIP +GSC L+ +Y+ N F+G+IP SL SL+ + +++LS NNL+G+IP
Sbjct: 525 KNKLSGEIPKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFF 584
Query: 520 LERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRN 579
E LE L+LS+ND EG+VP +G+F NASA S+SGN N LCGGIPE+ LP+C N S
Sbjct: 585 AEFKSLEKLDLSYNDFEGEVPAEGVFKNASAFSISGNKN-LCGGIPEINLPRCTLNKSMK 643
Query: 580 HKV-YRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESL 638
K ++ L ++++ C V LLL S +F L+ R KE S L +KVSY++L
Sbjct: 644 PKTSHKLRLIIVVACCGVVGVLLLTSALLFCCLKMR--KNKEASGSSLDIFFQKVSYQNL 701
Query: 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR 698
LKATDGFSS +LIG GSFGSVYKG D TI+A+KVLNLQ +GAS+SF EC+AL N+R
Sbjct: 702 LKATDGFSSANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVR 761
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
HRNLV+V+T+CSS DF+ NDFKALVY+YM NGSLE WLHP P D+ R L+L+E
Sbjct: 762 HRNLVKVLTACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPP---RILSLIE 818
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
R+SI+IDVASA+DYLH+ CQ P +HCDLKPSNILLD+++TAHVGDFGLAR
Sbjct: 819 RLSISIDVASALDYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLARF 869
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/844 (50%), Positives = 556/844 (65%), Gaps = 30/844 (3%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
IT P G L+SWN+S FC W G+TC RH+RV LDL S L+GSLSP IGNLSFLR +
Sbjct: 46 ITGDPLGKLSSWNESSQFCQWSGVTCGRRHQRVVELDLHSYQLVGSLSPHIGNLSFLRIL 105
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
+L+NN++ IP E+GRLFRLE L L +N+ G IP N+S C+ L L R L G +P
Sbjct: 106 NLANNSLSLYIPQELGRLFRLEELVLRNNTFDGGIPANISRCANLRILDFSRGNLTGKLP 165
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
+E L L+ L I+ NN G IP+ GN++++ AI + N+L G+IP+ GQLK LK L
Sbjct: 166 AELGLLSKLQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKIL 225
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
LG G IPPSI+NLS L S P N+L+GSLP +LGLTL NLQ+F I N F G
Sbjct: 226 SLGANNLSGMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLI 285
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLA- 295
P FSNASNL S +I NNF GK+ L L V NNLG GE+++++F++ LA
Sbjct: 286 PATFSNASNLLSFQIGSNNFNGKVPP-LSSSHDLQVLGVGDNNLGKGENNDLNFVYPLAN 344
Query: 296 NCSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMD 339
N ++L L+ N F G LP + + GSIP++IG L++L + ++
Sbjct: 345 NMTSLEALDTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLE 404
Query: 340 HNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSL 399
NQ G IP M +LQ L L + N++SG IPSS GN++SL ++ + NNL G IP SL
Sbjct: 405 TNQLTGMIPSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSL 464
Query: 400 GNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVV 459
GN ++L L L QN+LSG IP+E+ +I +S L + N L GS+P ++ L L V
Sbjct: 465 GNWQKLLSLALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDV 524
Query: 460 SSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPIS 519
S N SGEIP +GSC L+ +++ ENF +G IP +L SL+ ++E++LS NNL+G+IP
Sbjct: 525 SKNRFSGEIPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEF 584
Query: 520 LERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSR 578
LE LE LNLSFND EG+VP +G F N SAIS+ GN +LCGGIP+L L +CP +
Sbjct: 585 LEDFKLLESLNLSFNDFEGEVPVQGAFQNTSAISIFGNK-KLCGGIPQLNLTRCPSSEPT 643
Query: 579 NHKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESL 638
N K ++ +I S C +L+ SF +FY R++ S+P L + +V+YE L
Sbjct: 644 NSKSPTKLIWIIGSVCGFLGVILIISFLLFYCFRKKKDK-PAASQPSLETSFPRVAYEDL 702
Query: 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR 698
L ATDGFSS +LIG GSFGSV+KG D +VA+KVLNL +GASKSF AEC AL++IR
Sbjct: 703 LGATDGFSSANLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASKSFMAECEALKSIR 762
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
HRNLV+++T+CSSIDFQGNDFKALVY++M NG+LE WLHP QT +E + + L L+
Sbjct: 763 HRNLVKLLTTCSSIDFQGNDFKALVYEFMVNGNLEEWLHP---VQTSDEANGPKALDLMH 819
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
R++IAI +ASA++YLHH CQ P IHCDLKPSNILLD N+TAHVGDFGLAR E +NQ+
Sbjct: 820 RLNIAIHMASALNYLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLARFHSEA-SNQT 878
Query: 819 SSVG 822
SSVG
Sbjct: 879 SSVG 882
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/847 (50%), Positives = 555/847 (65%), Gaps = 33/847 (3%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
IT P G+L+SWN+S HFCDW G+ C RHRRV +DL S L+GSLSP IGNLSFLR +
Sbjct: 46 ITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGSLSPHIGNLSFLRIL 105
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
L NN IP E+G LFRL L L +N+ G+IP N+S+CS L+ L L N L G +P
Sbjct: 106 KLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLLILSLSGNNLTGKLP 165
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
E SL L+ Q N L GGIP GN++++ I A N L G IP+S+GQLK LKS
Sbjct: 166 IELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQGGIPNSIGQLKSLKSF 225
Query: 182 GLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
G G IPPSIYNLS L F+VP N+LHG+LPP LGLTL NL++ +S N FSGS
Sbjct: 226 SFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPNLEILLMSFNRFSGSI 285
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P FSNAS + +E+ NN G++ + + L +L V +N LG+G D++SF+ LAN
Sbjct: 286 PPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDVNYLGNGNDDDLSFLPPLAN 344
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
++L L++ N F G LP I + GSIPS IG L+ L + ++
Sbjct: 345 KTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPSGIGNLIGLDTLGLEM 404
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
NQ G IP + +LQNL L + N++SG IPSS GN++SL+++ L NNL G IPSSLG
Sbjct: 405 NQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVYLSANNLQGRIPSSLG 464
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
N + L +LHL QN+LSG+IP+E+ +I S L + N L GS+P ++G L L F +S
Sbjct: 465 NCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLPLEVGKLANLGYFNLS 524
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N LSGEIP +GSC L+ +YM N F+G IP SL SL+ L+ ++LS NNLSG+IP L
Sbjct: 525 HNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQILNLSHNNLSGEIPKFL 584
Query: 521 ERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRN 579
L L L+LSFN+LEG+VP +GIFA AS S+ GN +LCGG+P+L L +C SR
Sbjct: 585 AELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGN-KKLCGGMPQLNLSRCTSKKSRK 643
Query: 580 HKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESLL 639
K + +I C +L+ S+ +F++L+ + + S ++V+YE LL
Sbjct: 644 LKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEK--KSRPASGSPWESTFQRVAYEDLL 701
Query: 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH 699
+AT+GFS +LIG GSFGSVYKG DG VA+KV NL +GASKSF AEC AL NIRH
Sbjct: 702 QATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSFMAECAALINIRH 761
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
RNLV+V+T+CS IDFQGNDFKALVY++M NGSLE WLHP Q +E R+L+LL+R
Sbjct: 762 RNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHP---AQISDEAHRRRDLSLLQR 818
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN---- 815
++IAIDVASA+DYLH+HCQ +HCDLKPSN+LLD +LTAHVGDFGLARL + +
Sbjct: 819 LNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCL 878
Query: 816 NQSSSVG 822
+Q+SS+G
Sbjct: 879 DQTSSIG 885
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/847 (49%), Positives = 557/847 (65%), Gaps = 60/847 (7%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
IT P VL SWN++ HFC W+G+TC HRRVTVLDL S + GS+SP IGNLSFLR +
Sbjct: 51 ITHDPFQVLRSWNETIHFCQWQGVTCGLLHRRVTVLDLHSLKISGSISPYIGNLSFLRAL 110
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
++ NN+ +IP +IG L RLE L L++NS+ G+IP N+S CS L+ + LG+NKLEG++P
Sbjct: 111 NIQNNSFGHEIPQQIGYLRRLEELRLNNNSVGGKIPTNISRCSNLVFISLGKNKLEGNVP 170
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
E L NL+ L+I N LTG IPH LGN++ L+ +SLA N + G +P+SLG L+ L L
Sbjct: 171 EELGVLSNLQVLSIFGNKLTGSIPHSLGNLSQLQRLSLAENRMVGEVPNSLGWLRNLTFL 230
Query: 182 G-----LGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
L GTIP S++NLS + N + EN HG+LP +G L N++ F IS+N F+G
Sbjct: 231 SLRSNRLSGTIPSSLFNLSSIRNLDIGENNFHGNLPSDIGFLLPNIRWFAISSNEFTGKI 290
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296
P++ SNA+NL+SL +L NN G++ + + L ++ NNLG+G++D++SF+HSL N
Sbjct: 291 PVSLSNATNLESLLLLQNNLTGEVP-SLAKLDRLRVFSLTSNNLGTGKADDLSFLHSLTN 349
Query: 297 CSNLSFLNLVANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDH 340
+ L L + N F G LP SI + GSIPS I LVSL E+ +
Sbjct: 350 TTALEELGVNGNNFGGMLPDSIANLSTTLRILLLDNNRIIGSIPSGIENLVSLEDFEVWN 409
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
NQ G IP+ + +LQNL L + N LSG IPSS GNL++L++L++ +NNLSG IPS LG
Sbjct: 410 NQLSGFIPDSIGKLQNLVVLALNSNMLSGHIPSSLGNLTNLIQLLVEDNNLSGRIPSDLG 469
Query: 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
+ + L L QN+ SG+IP E+ +IS +S L+ ++N+L G++P ++GNLK L F VS
Sbjct: 470 RCQNMLGLSLSQNNFSGSIPPEVISISSLSIYLDLSQNNLTGTLPMEVGNLKSLSEFDVS 529
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
N LSGEIP +GSC L+ + MA N F+G IPSSL SL+ L+ +DLS N+LS
Sbjct: 530 GNKLSGEIPRTLGSCISLEILNMAGNNFQGLIPSSLSSLRALQILDLSNNHLS------- 582
Query: 521 ERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNH 580
G VP+KGIF NASA SV GN N LCGGIPE QLP C NS H
Sbjct: 583 ----------------GMVPSKGIFKNASATSVEGN-NMLCGGIPEFQLPVC---NSARH 622
Query: 581 KVYR--GVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRALRKVSYESL 638
K R VLK +IS S + L+L +W R++ E + + + ++SY++L
Sbjct: 623 KKNRLTPVLKTVISAISGMAFLIL--MLYLFWFRQK--KVNETTADFSEKKIMELSYQNL 678
Query: 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR 698
KATDGFSS ++IG+GSFGSVYKG DR+GT++A+KV NL +G KSF AEC ALRNIR
Sbjct: 679 HKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVFNLMRRGGFKSFLAECEALRNIR 738
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
HRNL++V+T+CSS+D+ GNDFKALVY++M NGSLE WLHP T+E E R L L+
Sbjct: 739 HRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWLHPPV--ATNEAELETRKLNFLQ 796
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN-- 816
R++IAIDVASA+ YLHHHC+ +HCDLKPSNILLD LT HVGDFGLAR + N
Sbjct: 797 RLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELTGHVGDFGLARFLLDATQNHY 856
Query: 817 -QSSSVG 822
QSSS+G
Sbjct: 857 TQSSSIG 863
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 825 | ||||||
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.896 | 0.721 | 0.439 | 1e-155 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.876 | 0.889 | 0.425 | 1.5e-145 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.929 | 0.759 | 0.402 | 6.3e-140 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.934 | 0.764 | 0.401 | 5.6e-139 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.913 | 0.731 | 0.402 | 2.9e-135 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.923 | 0.753 | 0.371 | 1.2e-131 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.907 | 0.730 | 0.406 | 1.3e-130 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.873 | 0.735 | 0.366 | 1.8e-103 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.896 | 0.630 | 0.332 | 2.6e-102 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.923 | 0.610 | 0.332 | 3.9e-99 |
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1518 (539.4 bits), Expect = 1.0e-155, P = 1.0e-155
Identities = 348/792 (43%), Positives = 468/792 (59%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
LDL L G + P++ LS L+ + LS+N+IQG IP IG +L +L LSHN L G I
Sbjct: 108 LDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMI 167
Query: 97 PGNL-SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLE 155
P + + L LYL +N L G IPS +L +L+E + N L+G IP LG ++SL
Sbjct: 168 PREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLL 227
Query: 156 AISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRXXXXXXXXX 215
++L N+L G IP+S I+NLS L FSV EN+
Sbjct: 228 TMNLGQNNLSGMIPNS-------------------IWNLSSLRAFSVRENKLGGMIPTNA 268
Query: 216 XXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275
++ + N F G P + +NAS+L ++I GN F G ++ FG +++L L +
Sbjct: 269 FKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYL 328
Query: 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI----------------V 319
N + E D+ FI L NCS L LNL N G LP+S +
Sbjct: 329 WRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKI 388
Query: 320 SGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLS 379
+GSIP +IG L+ L + + +N F G +P + RL+NL L N LSG IP + GNL+
Sbjct: 389 TGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLT 448
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439
L L+LG N SG IP +L NL L L L N+LSG IP E+FNI +S +N ++N+
Sbjct: 449 ELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNN 508
Query: 440 LVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
L GSIP +IG+LK L F SN LSG+IP+ +G C L+ +Y+ N GSIPS+L L
Sbjct: 509 LEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQL 568
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSN 558
K L +DLS NNLSG+IP SL + L LNLSFN G+VPT G FA AS IS+ GN+
Sbjct: 569 KGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNA- 627
Query: 559 RLCGGIPELQLPKC-PKNNSRNHKVYRGVLKVIISTCSVXXXXXXXXXXIFYWLRRRGGS 617
+LCGGIP+L LP+C P +R H VL + +S + I + R + G+
Sbjct: 628 KLCGGIPDLHLPRCCPLLENRKHFP---VLPISVSLAAALAILSSLYLLITWHKRTKKGA 684
Query: 618 GKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN 677
PS ++ VSY L+KATDGF+ T+L+G GSFGSVYKG + VA+KVL
Sbjct: 685 ---PSRTSMK-GHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH-VAVKVLK 739
Query: 678 LQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH 737
L+ A KSF AEC ALRN+RHRNLV+++T CSSID +GNDFKA+VY +MPNGSLE+W+H
Sbjct: 740 LENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIH 799
Query: 738 PDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797
P+ Q D+ R+L L R++I +DVA A+DYLH H EP +HCD+K SN+LLD+++
Sbjct: 800 PETNDQADQ-----RHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDM 854
Query: 798 TAHVGDFGLARL 809
AHVGDFGLAR+
Sbjct: 855 VAHVGDFGLARI 866
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
Identities = 330/776 (42%), Positives = 448/776 (57%)
Query: 10 LNSWNDSHH--FCDWEGITCSPRH-RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNN 66
L SWN S H C W G+ C RH RV L L+S L G +SP +GNLSFLR + LS+N
Sbjct: 53 LASWNTSGHGQHCTWVGVVCGRRHPHRVVKLRLRSSNLAGIISPSLGNLSFLRTLQLSDN 112
Query: 67 TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVS 126
+ GKIP E+ RL RL+ L L+ NSL GEIP L + L L L N L G+IPS
Sbjct: 113 HLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSLGK 172
Query: 127 LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT 186
L L +LA+ EN L+G IP G + L +SLA+N+L G IP
Sbjct: 173 LTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLSGAIPD---------------- 216
Query: 187 IPPSIYNLSLLANFSVPENRXXXXXXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNL 246
P I+N+S L F V N+ Q + N F G P + NASN+
Sbjct: 217 -P--IWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIGNASNI 273
Query: 247 QSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLV 306
I N+F G + G M++L L + + E+++ F+ +L NCSNL + L
Sbjct: 274 SIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVELG 333
Query: 307 ANQFKGALPHSI----------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
+F G LP S+ +SGS+P +IG LV+L + + +N G +P
Sbjct: 334 GCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNSLTGSLPSS 393
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
S+L+NL+ L + +N+L G +P + GNL+ L + + N G IPS+LGNL +L ++L
Sbjct: 394 FSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINL 453
Query: 411 FQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPS 470
N+ G IP EIF+I +S+ L+ + N+L GSIP +IG LK + F SN LSGE PS
Sbjct: 454 GHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPS 513
Query: 471 EIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEY-LN 529
IG C LQ +++ NF GSIP +L LK L +DLS NNLSG+IP+SL +PL + LN
Sbjct: 514 TIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLN 573
Query: 530 LSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGVLKV 589
LSFN G+VPT G+FANAS I + GN++ +CGGIPEL LP C SR K ++ +L +
Sbjct: 574 LSFNSFHGEVPTNGVFANASEIYIQGNAH-ICGGIPELHLPTCSLK-SRKKKKHQ-ILLL 630
Query: 590 IISTCSVXXXXXXXXXXIFYWLRRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTH 649
++ C V + +R KE + ++Y+ L+KATDGFSS+H
Sbjct: 631 VVVICLVSTLAVFSLLYMLLTCHKR--RKKEVPATTSMQGHPMITYKQLVKATDGFSSSH 688
Query: 650 LIGIGSFGSVYKGTFD-RDGTI---VAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
L+G GSFGSVYKG FD +DG I VA++VL L+ A KSF AEC LRN RHRNLV++
Sbjct: 689 LLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKI 748
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+T CSSID +GNDFKA+VY +MPNGSLE+WLHP+ Q ++ R+LTL +R+S
Sbjct: 749 VTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQ-----RHLTLHQRVS 799
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1369 (487.0 bits), Expect = 6.3e-140, P = 6.3e-140
Identities = 324/805 (40%), Positives = 454/805 (56%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
LDL G++ ++G LS L + + N ++G IP + RL L L N L G +
Sbjct: 95 LDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSV 154
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA 156
P L + L+ L L N + G +P+ +L L++LA+ NNL G IP + +T + +
Sbjct: 155 PSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWS 214
Query: 157 ISLAYNSLGGNIPSSLGQLKELKSLGLG-----GTIPPSI-YNLSLLANFSVPENRXXXX 210
+ L N+ G P +L L LK LG+G G + P + L L +F++ N
Sbjct: 215 LQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGS 274
Query: 211 XXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270
+L NN +GS P F N NL+ L L N G S D++ L
Sbjct: 275 IPTTLSNISTLERLGMNENNL-TGSIP-TFGNVPNLKLL-FLHTNSLGSDSSR--DLEFL 329
Query: 271 AYLN--VAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
L + LG G + L +S NL A L +++SGSIP +IG
Sbjct: 330 TSLTNCTQLETLGIGRN-------RLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIG 382
Query: 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGN 388
L++L + +D N G +P + +L NL++L++ N+LSG IP+ GN++ L L L N
Sbjct: 383 NLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSN 442
Query: 389 NNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI 448
N G++P+SLGN L L + N L+G IP EI I + L+ + N L+GS+P I
Sbjct: 443 NGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL-RLDMSGNSLIGSLPQDI 501
Query: 449 GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLS 508
G L+ L + N LSG++P +G+C ++ +++ N F G IP L L ++E+DLS
Sbjct: 502 GALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPD-LKGLVGVKEVDLS 560
Query: 509 QNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPEL 567
N+LSG IP LEYLNLSFN+LEG+VP KGIF NA+ +S+ GN N LCGGI
Sbjct: 561 NNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGN-NDLCGGIMGF 619
Query: 568 QLPKCPKNNSRNHKVYRGVLKVIISTCSVXXXXXXX---XXXIFYWLRRRGGSGKEPSEP 624
QL C K + LK ++ SV WLR+R KE + P
Sbjct: 620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRK-KNKETNNP 678
Query: 625 I---LRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ 681
L K+SY L AT+GFSS++++G GSFG+VYK + +VA+KVLN+Q +
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738
Query: 682 GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAI 741
GA KSF AEC +L++IRHRNLV+++T+CSSIDFQGN+F+AL+Y++MPNGSL+ WLHP+ +
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798
Query: 742 PQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801
+E + R LTLLER++IAIDVAS +DYLH HC EP HCDLKPSN+LLD++LTAHV
Sbjct: 799 ---EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHV 855
Query: 802 GDFGLARLR----QEVPNNQSSSVG 822
DFGLARL +E NQ SS G
Sbjct: 856 SDFGLARLLLKFDEESFFNQLSSAG 880
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 321/800 (40%), Positives = 451/800 (56%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
LDL + G++ ++GNL L+ + + N ++G+IP + RL L L N+L +
Sbjct: 95 LDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGV 154
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA 156
P L +L+ LYLG N L+G P +L +L L + N+L G IP + ++ + +
Sbjct: 155 PSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVS 214
Query: 157 ISLAYNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNL-SLLANFSVPENRXXXX 210
++L N+ G P + L L++L G G + P NL + S+ N
Sbjct: 215 LTLTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGN-FLTG 273
Query: 211 XXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270
++F I N +GS F NL LE L NN G S +FGD L
Sbjct: 274 AIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLE-LANNSLG--SYSFGD---L 327
Query: 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKL 330
A+L+ A+ N +S+ + L S +N+ L +++ GSIP +IG L
Sbjct: 328 AFLD-ALTNCSHLHGLSVSY-NRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNL 385
Query: 331 VSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNN 390
+ L + + N G +P + L L L + N+ SGEIPS GNL+ LVKL L NN+
Sbjct: 386 IGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNS 445
Query: 391 LSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGN 450
G++P SLG+ + L + N L+G IP+EI I + LN N L GS+P IG
Sbjct: 446 FEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVH-LNMESNSLSGSLPNDIGR 504
Query: 451 LKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQN 510
L+ L ++ +NNLSG +P +G C ++ IY+ EN F G+IP + L ++ +DLS N
Sbjct: 505 LQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPD-IKGLMGVKNVDLSNN 563
Query: 511 NLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQL 569
NLSG I E LEYLNLS N+ EG+VPT+GIF NA+ +SV GN N LCG I EL+L
Sbjct: 564 NLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGNKN-LCGSIKELKL 622
Query: 570 PKCPKNNSRNHKVYRGVLKVIISTCSVXXXXXXXXXXI-FYWLRRRGGSGK-EPSEPILR 627
C + +LK + SV + W ++R + K S P
Sbjct: 623 KPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTL 682
Query: 628 RALR-KVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS 686
K+SY L ATDGFSS++++G GSFG+V+K + IVA+KVLN+Q +GA KS
Sbjct: 683 EIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKS 742
Query: 687 FAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE 746
F AEC +L++IRHRNLV+++T+C+SIDFQGN+F+AL+Y++MPNGSL+ WLHP+ + +E
Sbjct: 743 FMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEV---EE 799
Query: 747 ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
+ R LTLLER++IAIDVAS +DYLH HC EP HCDLKPSNILLD++LTAHV DFGL
Sbjct: 800 IHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGL 859
Query: 807 ARLR----QEVPNNQSSSVG 822
ARL QE NQ SS G
Sbjct: 860 ARLLLKFDQESFFNQLSSAG 879
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1325 (471.5 bits), Expect = 2.9e-135, P = 2.9e-135
Identities = 324/804 (40%), Positives = 449/804 (55%)
Query: 46 GSLSPQ-IGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS 104
GS PQ +G L L+ +++S N ++G+IP + RL + LS N L +P L S
Sbjct: 110 GSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHGVPSELGSLS 169
Query: 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164
+L L L +N L G+ P+ +L +L++L N + G IP + +T + +A NS
Sbjct: 170 KLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSF 229
Query: 165 GGNIPSSLGQLKELKSLGLG-----GTIPPSI-YNLSLLANFSVPENRXXXXXXXXXXXX 218
G P +L + L+SL L G + Y L L + N+
Sbjct: 230 SGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANI 289
Query: 219 XXXXQLFQISNNFFSGSFPLAFSNASNLQSLEI----LGNNFFGKLSV--NFGDMKSLAY 272
+ F IS+N+ SGS PL+F NL L I LGNN L + L Y
Sbjct: 290 SSLER-FDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEY 348
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVS 332
L+V N LG GE A+ +NLS + + F G +++SG+IP +IG LVS
Sbjct: 349 LDVGYNRLG-GELP--------ASIANLS--TTLTSLFLG---QNLISGTIPHDIGNLVS 394
Query: 333 LYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
L + ++ N G++P +L NLQ +++ N +SGEIPS FGN++ L KL L +N+
Sbjct: 395 LQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFH 454
Query: 393 GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLK 452
G IP SLG + L L + N L+G IP+EI I ++ ++ + N L G P ++G L+
Sbjct: 455 GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLE 513
Query: 453 VLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIP--SSLVSLKDLREIDLSQN 510
+L S N LSG++P IG C ++ ++M N F G+IP S LVSLK+ +D S N
Sbjct: 514 LLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKN---VDFSNN 570
Query: 511 NLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQL 569
NLSG+IP L LP L LNLS N EG+VPT G+F NA+A+SV GN+N +CGG+ E+QL
Sbjct: 571 NLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTN-ICGGVREMQL 629
Query: 570 PKCPKNNS-RNHKVYRGVLKVIISTC-SVXXXXXXXXXXIFYWLRRR----GGSGKEPSE 623
C S R K KV+ C + W +R S PS+
Sbjct: 630 KPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSD 689
Query: 624 PI-LRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG 682
L KVSYE L AT FSST+LIG G+FG+V+KG + +VA+KVLNL G
Sbjct: 690 STTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHG 749
Query: 683 ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIP 742
A+KSF AEC + IRHRNLV++IT CSS+D +GNDF+ALVY++MP GSL+ WL +
Sbjct: 750 ATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ---LE 806
Query: 743 QTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802
+ ND R+LT E+++IAIDVASA++YLH HC +P HCD+KPSNILLD++LTAHV
Sbjct: 807 DLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVS 866
Query: 803 DFGLARLRQEVPN----NQSSSVG 822
DFGLA+L + NQ SS G
Sbjct: 867 DFGLAQLLYKYDRESFLNQFSSAG 890
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1291 (459.5 bits), Expect = 1.2e-131, P = 1.2e-131
Identities = 301/811 (37%), Positives = 447/811 (55%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
LDL G + ++GNL L ++++ N+++G IP + RL L L N L +
Sbjct: 95 LDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGV 154
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA 156
P L ++L+ L LGRN L+G +P +L +LK L +NN+ G +P L ++ +
Sbjct: 155 PSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVG 214
Query: 157 ISLAYNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNL-SLLANFSVPENRXXXX 210
+ L+ N G P ++ L L+ L G G++ P NL + ++ EN
Sbjct: 215 LGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGEN-DLVG 273
Query: 211 XXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEI----LGNNFFGKLSV--NF 264
Q F I+ N +G F +LQ L++ LG+ FG L +
Sbjct: 274 AIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSL 333
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN-LSFLNLVANQFKGALPHSIVSGSI 323
+ L L+V LG + S+AN S L LNL+ N F GSI
Sbjct: 334 TNCTHLQLLSVGYTRLGG------ALPTSIANMSTELISLNLIGNHF---------FGSI 378
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383
P +IG L+ L +++ N G +P + +L L L++ N++SGEIPS GNL+ L
Sbjct: 379 PQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEI 438
Query: 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGS 443
L L NN+ G++P SLG + L + N L+G IP+EI I + + L+ N L GS
Sbjct: 439 LYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVN-LSMEGNSLSGS 497
Query: 444 IPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLR 503
+P IG+L+ L + +N SG +P +G+C ++++++ N F G+IP+ + L +R
Sbjct: 498 LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPN-IRGLMGVR 556
Query: 504 EIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCG 562
+DLS N+LSG IP LEYLNLS N+ G+VP+KG F N++ + V GN N LCG
Sbjct: 557 RVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKN-LCG 615
Query: 563 GIPELQLPKCPKNN---SRNHKVYRGVLKVIISTCSVXXXXXXXXXXIFYWLRRRGGSGK 619
GI +L+L C H + + +++S + W R+R + +
Sbjct: 616 GIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQ 675
Query: 620 E----PSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV 675
PS+ L K+SY L AT+GFSS++++G GSFG+V+K + IVA+KV
Sbjct: 676 TNNLVPSK--LEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKV 733
Query: 676 LNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENW 735
LN+Q +GA KSF AEC +L++ RHRNLV+++T+C+S DFQGN+F+AL+Y+Y+PNGS++ W
Sbjct: 734 LNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMW 793
Query: 736 LHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795
LHP+ + +E R LTLLER++I IDVAS +DYLH HC EP HCDLKPSN+LL++
Sbjct: 794 LHPEEV---EEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLED 850
Query: 796 NLTAHVGDFGLARLRQEVPN----NQSSSVG 822
+LTAHV DFGLARL + NQ SS G
Sbjct: 851 DLTAHVSDFGLARLLLKFDKESFLNQLSSAG 881
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
Identities = 323/795 (40%), Positives = 434/795 (54%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
L+L G++ ++GNL L+ +++SNN G IP + L L LS N L +
Sbjct: 110 LNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGV 169
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA 156
P S+L+ L LGRN L G P+ +L +L+ L N + G IP + + +
Sbjct: 170 PLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIF 229
Query: 157 ISLAYNSLGGNIPSSLGQLKELKSLGL-----GGTIPPSIYNLSLLANFSVPE---NRXX 208
+A N G P + L L L + GT+ P SLL N + N
Sbjct: 230 FRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG--SLLPNLQILYMGINSFT 287
Query: 209 XXXXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS---VNF- 264
QL I +N +G PL+F NL L L NN G S ++F
Sbjct: 288 GTIPETLSNISSLRQL-DIPSNHLTGKIPLSFGRLQNLLLLG-LNNNSLGNYSSGDLDFL 345
Query: 265 GDMKS---LAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321
G + + L YLNV N LG G+ FI +L+ + L+ L+L N ++SG
Sbjct: 346 GALTNCSQLQYLNVGFNKLG-GQLPV--FIANLS--TQLTELSLGGN---------LISG 391
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
SIP IG LVSL +++ N GK+P + L L+ + + N LSGEIPSS GN+S L
Sbjct: 392 SIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGL 451
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L NN+ G IPSSLG+ L L+L N L+G+IP E+ + + LN + N LV
Sbjct: 452 TYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLV-VLNVSFNLLV 510
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKD 501
G + IG LK L VS N LSG+IP + +C L+ + + N F G IP + L
Sbjct: 511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPD-IRGLTG 569
Query: 502 LREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRL 560
LR +DLS+NNLSG IP + L+ LNLS N+ +G VPT+G+F N SA+SV GN N L
Sbjct: 570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNIN-L 628
Query: 561 CGGIPELQLPKCPKNNSRNHKVYRGVLKVIISTCSVXXXXXXXXXXIFYW--LR----RR 614
CGGIP LQL C R H R ++ + +S W LR R
Sbjct: 629 CGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRA 688
Query: 615 GGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIK 674
+ + S ++ K+SY+ L K T GFSS++LIG G+FG+V+KG VAIK
Sbjct: 689 NNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIK 748
Query: 675 VLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLEN 734
VLNL +GA+KSF AEC AL IRHRNLV+++T CSS DF+GNDF+ALVY++MPNG+L+
Sbjct: 749 VLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDM 808
Query: 735 WLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794
WLHPD I +T + R L L R++IAIDVASA+ YLH +C P HCD+KPSNILLD
Sbjct: 809 WLHPDEIEETGNPS---RTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLD 865
Query: 795 NNLTAHVGDFGLARL 809
+LTAHV DFGLA+L
Sbjct: 866 KDLTAHVSDFGLAQL 880
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.8e-103, P = 1.8e-103
Identities = 290/792 (36%), Positives = 417/792 (52%)
Query: 60 EIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNL-SYCSRLIGLYLGRNKLEG 118
E+ +S + G+I I L L L LS N VG+IP + S L L L N L G
Sbjct: 70 ELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHG 129
Query: 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFL---GNITSLEAISLAYNSLGGNIPSSLG-Q 174
+IP E L L L + N L G IP L G+ +SL+ I L+ NSL G IP +
Sbjct: 130 NIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCH 189
Query: 175 LKELKSL-----GLGGTIPPSIYNLSLLANFSVPENRXXXXXXXXXXXXXXXXQLFQIS- 228
LKEL+ L L GT+P S+ N + L + N Q +S
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249
Query: 229 NNFFSGS-------FPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK-SLAYLNVAINNL 280
N+F S + F + +N+S+LQ LE+ GN+ G+++ + + +L +++ N +
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRI 309
Query: 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDH 340
E+S N NL+ LNL +N ++SG IP E+ KL L + + +
Sbjct: 310 HGSIPPEIS------NLLNLTLLNLSSN---------LLSGPIPRELCKLSKLERVYLSN 354
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
N G+IP E+ + L L++ N LSG IP SFGNLS L +L+L N+LSG +P SLG
Sbjct: 355 NHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLG 414
Query: 401 NLKQLALLHLFQNDLSGAIPEEIF-NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVV 459
L +L L N+L+G IP E+ N+ ++ LN + NHL G IP ++ + ++ +
Sbjct: 415 KCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDL 474
Query: 460 SSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPIS 519
SSN LSG+IP ++GSC L+ + ++ N F ++PSSL L L+E+D+S N L+G IP S
Sbjct: 475 SSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPS 534
Query: 520 LERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSR 578
++ L++LN SFN L G V KG F+ + S G+S LCG I +Q C K
Sbjct: 535 FQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDS-LLCGSIKGMQA--CKKK--- 588
Query: 579 NHKVYRGVLKVIISTCSVXXXXXXXXXXIFYWLRRRGGSG-----KEPSEPILRRALR-- 631
HK +L V++S + + R R G KE E ++
Sbjct: 589 -HKYPSVLLPVLLSLIATPVLCVFGYPLV---QRSRFGKNLTVYAKEEVEDEEKQNQNDP 644
Query: 632 ---KVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSF 687
++SY+ L+ AT GF+++ LIG G FG VYKG R+ T VA+KVL+ + S SF
Sbjct: 645 KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSF 703
Query: 688 AAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE 747
EC+ L+ RHRNL+R+IT+CS G F ALV MPNGSLE L+P
Sbjct: 704 KRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPGEYSS---- 754
Query: 748 NDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+NL L++ ++I DVA + YLHH+ +HCDLKPSNILLD+ +TA V DFG++
Sbjct: 755 ----KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGIS 810
Query: 808 RLRQEVPNNQSS 819
RL Q V S+
Sbjct: 811 RLVQGVEETVST 822
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 265/796 (33%), Positives = 414/796 (52%)
Query: 44 LIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYC 103
L G + +IGN S L ++ L +N + GKIP E+G L +L+AL + N L IP +L
Sbjct: 252 LEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRL 311
Query: 104 SRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS 163
++L L L N L G I E L +L+ L + NN TG P + N+ +L +++ +N+
Sbjct: 312 TQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNN 371
Query: 164 LGGNIPSSLGQLKELKSLG-----LGGTIPPSIYNLSLLANFSVPENRXXXXXXXXXXXX 218
+ G +P+ LG L L++L L G IP SI N + L + N+
Sbjct: 372 ISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM 431
Query: 219 XXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
I N F+G P N SNL++L + NN G L G ++ L L V+ N
Sbjct: 432 NLT--FISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYN 489
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI---------------VSGSI 323
+L +G + N +L+ L L +N F G +P + + G I
Sbjct: 490 SL-TGPIPR-----EIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPI 543
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383
P E+ + L ++++ +N+F G+IP S+L++L +L+++ N+ +G IP+S +LS L
Sbjct: 544 PEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNT 603
Query: 384 LILGNNNLSGVIPSSL-GNLKQLALLHLFQNDL-SGAIPEEIFNISHMSDSLNFARNHLV 441
+ +N L+G IP L +LK + L F N+L +G IP+E+ + M ++ + N
Sbjct: 604 FDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLE-MVQEIDLSNNLFS 662
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCF-YLQEIYMAENFFRGSIPSSLVSLK 500
GSIP + K + S NNLSG IP E+ + + ++ N F G IP S ++
Sbjct: 663 GSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMT 722
Query: 501 DLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNR 559
L +DLS NNL+G+IP SL L L++L L+ N+L+G VP G+F N +A + GN++
Sbjct: 723 HLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTD- 781
Query: 560 LCGGIPELQLPKCPKNNSRNHKVYRGVLKVIISTCSVXXXXXXXXXXIFYWLRRRGG--S 617
LCG L+ P K S + V+ +I+ + + + ++ +
Sbjct: 782 LCGSKKPLK-PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIEN 840
Query: 618 GKEPSEPILRRALRKVSYE--SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV 675
E S P L AL+ +E L +ATD F+S ++IG S +VYKG + DGT++A+KV
Sbjct: 841 SSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLE-DGTVIAVKV 899
Query: 676 LNLQLQGAS--KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLE 733
LNL+ A K F E + L ++HRNLV+++ ++ KALV +M NG+LE
Sbjct: 900 LNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLE 955
Query: 734 NWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793
+ +H A P +LLE+I + + +AS +DYLH P +HCDLKP+NILL
Sbjct: 956 DTIHGSAAPIG----------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILL 1005
Query: 794 DNNLTAHVGDFGLARL 809
D++ AHV DFG AR+
Sbjct: 1006 DSDRVAHVSDFGTARI 1021
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 3.9e-99, P = 3.9e-99
Identities = 273/821 (33%), Positives = 414/821 (50%)
Query: 27 CSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALY 86
CS + + L L L G + ++ L+++ LSNN++ G IP + L L LY
Sbjct: 332 CS-NNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLY 390
Query: 87 LSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPH 146
L +N+L G + ++S + L L L N LEG +P E +L L+ L + EN +G IP
Sbjct: 391 LHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQ 450
Query: 147 FLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG-----GTIPPSIYNLSLLANFS 201
+GN TSL+ I + N G IP S+G+LKEL L L G +P S+ N L
Sbjct: 451 EIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILD 510
Query: 202 VPENRXXXXXXXXXXXXXXXXQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS 261
+ +N+ QL + NN G+ P + + NL + + N G +
Sbjct: 511 LADNQLSGSIPSSFGFLKGLEQLM-LYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIH 569
Query: 262 VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321
G S +YL+ + N +G DE+ L N NL L L NQ ++G
Sbjct: 570 PLCG---SSSYLSFDVTN--NGFEDEIPL--ELGNSQNLDRLRLGKNQ---------LTG 613
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
IP +GK+ L L++M N G IP ++ + L +++ +N LSG IP G LS L
Sbjct: 614 KIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQL 673
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
+L L +N +P+ L N +L +L L N L+G+IP+EI N+ ++ LN +N
Sbjct: 674 GELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALN-VLNLDKNQFS 732
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQE-IYMAENFFRGSIPSSLVSLK 500
GS+P +G L L +S N+L+GEIP EIG LQ + ++ N F G IPS++ +L
Sbjct: 733 GSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLS 792
Query: 501 DLREIDLSQNNLSGKIPISL-ERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNR 559
L +DLS N L+G++P S+ + L YLN+SFN+L G++ K F+ A S GN+
Sbjct: 793 KLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTG- 849
Query: 560 LCGGIPELQLPKCPKNNSRNHKVYRGVLKVIISTCSVXXXXXXXXXXIFYWLRRR----- 614
LCG P + + NN + R V VIIS S I + ++R
Sbjct: 850 LCGS-PLSRCNRVRSNNKQQGLSARSV--VIISAISALTAIGLMILVIALFFKQRHDFFK 906
Query: 615 ------------GGSGKEPSEPILRRALRK--VSYESLLKATDGFSSTHLIGIGSFGSVY 660
S + +P+ R K + +E +++AT S +IG G G VY
Sbjct: 907 KVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVY 966
Query: 661 KGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720
K + T+ K+L ++KSF+ E + L IRHR+LV+++ CSS +
Sbjct: 967 KAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLN 1023
Query: 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEP 780
L+Y+YM NGS+ +WLH D P +++ + L R+ IA+ +A V+YLHH C P
Sbjct: 1024 LLIYEYMKNGSIWDWLHEDK-PVLEKKK---KLLDWEARLRIAVGLAQGVEYLHHDCVPP 1079
Query: 781 TIHCDLKPSNILLDNNLTAHVGDFGLAR-LRQEVPNNQSSS 820
+H D+K SN+LLD+N+ AH+GDFGLA+ L + N S+
Sbjct: 1080 IVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSN 1120
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_VI000800 | hypothetical protein (1034 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 825 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-105 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-30 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.001 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.001 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.003 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.003 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.004 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.004 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 345 bits (886), Expect = e-105
Identities = 259/830 (31%), Positives = 394/830 (47%), Gaps = 93/830 (11%)
Query: 4 QYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHL 63
P L++WN S C W+GITC+ RV +DL K + G +S I L +++ I+L
Sbjct: 42 NDPLKYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100
Query: 64 SNNTIQGKIPGEI-----------------------GRLFRLEALYLSHNSLVGEIPGNL 100
SNN + G IP +I G + LE L LS+N L GEIP ++
Sbjct: 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDI 160
Query: 101 SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160
S L L LG N L G IP+ +L +L+ L + N L G IP LG + SL+ I L
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220
Query: 161 YNSLGGNIPSSLGQLKELKSL-----GLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSL 215
YN+L G IP +G L L L L G IP S+ NL L + +N+L G +PPS+
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
Query: 216 GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275
+L L +S+N SG P NL+ L + NNF GK+ V + L L +
Sbjct: 281 -FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339
Query: 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYL 335
N SGE + +L +NL+ L+L N G +P + S G L L L
Sbjct: 340 WSNKF-SGEIPK-----NLGKHNNLTVLDLSTNNLTGEIPEGLCSS------GNLFKLIL 387
Query: 336 IEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVI 395
N EG+IP+ + ++L+ + ++ N SGE+PS F L + L + NNNL G I
Sbjct: 388 FS---NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
Query: 396 PSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLR 455
S ++ L +L L +N G +P+ S ++L+ +RN G++P K+G+L L
Sbjct: 445 NSRKWDMPSLQMLSLARNKFFGGLPD--SFGSKRLENLDLSRNQFSGAVPRKLGSLSELM 502
Query: 456 MFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGK 515
+S N LSGEIP E+ SC L + ++ N G IP+S + L ++DLSQN LSG+
Sbjct: 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGE 562
Query: 516 IPISLERL-PLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPK 574
IP +L + L +N+S N L G +P+ G F +A +V+GN LCGG LP C
Sbjct: 563 IPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN-IDLCGGDTTSGLPPC-- 619
Query: 575 NNSRNHKVYRGVLKVIISTCSVFSGLLLG-SFFIFYWLRRRGGS---------GKEPSEP 624
+V + TC++ + L+L F F ++R R G +
Sbjct: 620 -----KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF 674
Query: 625 ILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS 684
+ + ++ +L + ++I G G+ YKG ++G +K +N +
Sbjct: 675 FDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIP 730
Query: 685 KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQT 744
S A+ + ++H N+V++I C S L+++Y+ +L L
Sbjct: 731 SSEIAD---MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVL-------- 774
Query: 745 DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794
RNL+ R IAI +A A+ +LH C + +L P I++D
Sbjct: 775 -------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK-SFAAECRALRNIRHRNLVRVITSC 709
+G G FG+VY + G VAIK++ + + E L+ + H N+V++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
+ LV +Y GSL++ L + L+ E + I + +
Sbjct: 61 ED-----ENHLYLVMEYCEGGSLKDLLK-----------ENEGKLSEDEILRILLQILEG 104
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVGDFGLARLRQEVPNNQSSSVG 822
++YLH + IH DLKP NILLD+ N + DFGL++L + + VG
Sbjct: 105 LEYLHSNGI---IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 58/177 (32%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK--SFAAECRALRNIRHRNLVRVITS 708
+G GSFG+VYK G IVA+K+L + + + K + E R LR + H N+VR+I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
F+ D LV +Y G L ++L L+ E IA+ +
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRG------------GPLSEDEAKKIALQILR 109
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDLE 825
++YLH + IH DLKP NILLD N + DFGLA+ + ++ ++ VG
Sbjct: 110 GLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPW 163
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 22/174 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITS 708
+G GSFG VY + G +VAIKV+ + + E + L+ ++H N+VR+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
F+ D LV +Y G L + L + L+ E + S
Sbjct: 66 -----FEDEDKLYLVMEYCEGGDLFDLLK------------KRGRLSEDEARFYLRQILS 108
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A++YLH +H DLKP NILLD + + DFGLAR ++ VG
Sbjct: 109 ALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVG 158
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 32/168 (19%)
Query: 651 IGIGSFGSVYKGT----FDRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNL 702
+G G+FG VYKGT + T VA+K L +GAS + F E ++ + H N+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
VR++ C+ QG +V +YMP G L ++L LTL + + +
Sbjct: 64 VRLLGVCT----QGEPLY-IVTEYMPGGDLLDFLR-----------KHGEKLTLKDLLQM 107
Query: 763 AIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
A+ +A ++YL + +H DL N L+ NL + DFGL+R
Sbjct: 108 ALQIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRD 151
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTI----VAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG VYKG G VA+K L + + F E R +R + H N+V++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C+ + + +V +YM G L ++L L+L + +S A+
Sbjct: 67 LGVCTE---EEPLY--IVMEYMEGGDLLSYLR-----------KNRPKLSLSDLLSFALQ 110
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A ++YL IH DL N L+ NL + DFGL+R
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG VYKGT G VA+K L + + F E R +R + H N+V++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C+ + +V +YMP G L ++L + + L+L + +S A+
Sbjct: 67 LGVCTE---EEPLM--IVMEYMPGGDLLDYLR----------KNRPKELSLSDLLSFALQ 111
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A ++YL IH DL N L+ NL + DFGL+R
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 651 IGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRVI 706
+G G+FG VYKG T VA+K L + F E R ++ + H N+VR++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C+ + + LV +YM G L ++L + + E L+L + +S AI +
Sbjct: 63 GVCTE---EEPLY--LVLEYMEGGDLLDYLR---KSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A ++YL +H DL N L+ +L + DFGL+R
Sbjct: 115 AKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 20/173 (11%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVI 706
L+G GSFGSVY G ++A+K + L + ++ E R L +++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S + + + +Y+ GSL + L + E IR T +
Sbjct: 66 GSERDEE---KNTLNIFLEYVSGGSLSSLLK--KFGKLPE--PVIRKYT--------RQI 110
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
+ YLH + +H D+K +NIL+D++ + DFG A+ ++ + +
Sbjct: 111 LEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 27/169 (15%)
Query: 646 SSTHL---IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHR 700
S L +G G FG V+ GT+ T VA+K L G ++F E + ++ +RH
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHD 61
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
LV++ CS + +V +YM GSL ++L + E + L L + +
Sbjct: 62 KLVQLYAVCS----EEEPI-YIVTEYMSKGSLLDFLK----------SGEGKKLRLPQLV 106
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A +A + YL IH DL NIL+ NL + DFGLARL
Sbjct: 107 DMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G FG VYK R G VAIKV+ L+ + + E + L+ +H N+V+ S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS-- 65
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-IAIDVASA 769
+ D +V ++ GSL++ L + QT E+ I+ + ++
Sbjct: 66 ---YLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQ----------IAYVCKELLKG 110
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++YLH + IH D+K +NILL ++ + DFGL+
Sbjct: 111 LEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGLS 145
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 36/168 (21%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVR---V 705
IG G++G VYK + G +VA+K + ++ +G + E + L+ +RH N+VR +
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 706 ITSCSSIDFQGNDFKALVYQYMP---NGSLENWLHPDAIPQTDEENDEIRNLT--LLERI 760
+TS +G+ + +V++YM G L++ Q I+ LLE
Sbjct: 67 VTSKG----KGSIY--MVFEYMDHDLTGLLDSPEVKFTESQ-------IKCYMKQLLE-- 111
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ YLH + +H D+K SNIL++N+ + DFGLAR
Sbjct: 112 --------GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
IG G FG V G + G VA+K L A+++F AE + +RH NLV+++
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLL--- 66
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
+ QGN +V +YM GSL ++L + +TL +++ A+DV
Sbjct: 67 -GVVLQGNPL-YIVTEYMAKGSLVDYL----------RSRGRAVITLAQQLGFALDVCEG 114
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YL ++ +H DL N+L+ +L A V DFGLA+
Sbjct: 115 MEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVL-NLQLQGASKSFAAECRALRNIRHRNLVR 704
+G G+FG V+ G + D +VA+K L A K F E L N +H N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---PDAIPQTDEENDEIRNLTLLERIS 761
C+ +G D +V++YM +G L +L PDA ++ LTL + +
Sbjct: 73 FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQ 126
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
IA+ +AS + YL + +H DL N L+ +L +GDFG++R
Sbjct: 127 IAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 19/162 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V++G + ++ VAIK+L + F E +AL+ +RH++L+ + CS
Sbjct: 14 LGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ ++ + M GSL +L + E + L + I +A VA +
Sbjct: 73 -----VGEPVYIITELMEKGSLLAFL----------RSPEGQVLPVASLIDMACQVAEGM 117
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
YL ++ +IH DL NIL+ +L V DFGLARL +E
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 24/165 (14%)
Query: 651 IGIGSFGSVYKGTFD--RDGT--IVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G FG V +D D T VA+K LN + +S F E LR + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C G L+ +Y+P+GSL ++L D+I LL +
Sbjct: 72 KGVCEK---PGGRSLRLIMEYLPSGSLRDYLQ--------RHRDQINLKRLL---LFSSQ 117
Query: 766 VASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ +DYL IH DL NIL+++ + DFGLA++
Sbjct: 118 ICKGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 5e-17
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKSFA-AECRALRNIRHRNLVRVIT 707
IG GSFG VY DG + +K ++L + + A E + L+ + H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S F+ +V +Y G L I + +E +L+ + +
Sbjct: 67 S-----FEEKGKLCIVMEYADGGDLS-----QKIKKQKKEGKPFPEEQILD---WFVQLC 113
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A+ YLH +H D+KP NI L +N +GDFG+++
Sbjct: 114 LALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISK 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V++G ++ + T VA+K L K F AE + ++ +RH L+++ C+
Sbjct: 14 LGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ +V + M GSL +L R L L + I +A VAS +
Sbjct: 72 L-----EEPIYIVTELMKYGSLLEYLQ----------GGAGRALKLPQLIDMAAQVASGM 116
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
YL IH DL N+L+ N V DFGLAR+ +E
Sbjct: 117 AYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 28/169 (16%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV--LNLQLQGASKSFAAECRALRNIRHRNL 702
+ +G G++G VYK + G IVA+K L+ + +G + E L+ ++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 703 VR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
V+ VI + + LV++Y L+ +L D P N I+
Sbjct: 61 VKLLDVIHTERKL--------YLVFEYCDM-DLKKYL--DKRPGPLSPN-LIK------- 101
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
SI + + Y H H +H DLKP NIL++ + + DFGLAR
Sbjct: 102 -SIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-16
Identities = 41/108 (37%), Positives = 61/108 (56%)
Query: 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397
+D+ G IP ++S+L++LQ +N+ N + G IP S G+++SL L L N+ +G IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 398 SLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP 445
SLG L L +L+L N LSG +P + S NF N + IP
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 26/177 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVIT 707
LIG G+FG VYKG G VAIK ++L+ + A KS E L+N++H N+V+ I
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA--ID 765
S + +D ++ +Y NGSL + + E +
Sbjct: 67 S-----IETSDSLYIILEYAENGSLRQIIK--------------KFGPFPESLVAVYVYQ 107
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
V + YLH ++ IH D+K +NIL + + DFG+A +V + +S VG
Sbjct: 108 VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 27/168 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVL---NLQLQGASKSFAAECRALRNIRHRNLVRV 705
H +G G +G VY+G + + VA+K L +++ + F E ++ I+H NLV++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNLVQL 67
Query: 706 ITSCS-SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ C+ F ++ ++M G+L ++L + + + E+ + LL +A
Sbjct: 68 LGVCTREPPFY------IITEFMTYGNLLDYLR-----ECNRQ--EVNAVVLLY---MAT 111
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
++SA++YL ++ IH DL N L+ N V DFGL+RL
Sbjct: 112 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 48/168 (28%), Positives = 69/168 (41%), Gaps = 25/168 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKS-FAAECRALRNIRHRNLVRVITS 708
IG GSFG+V K DG I+ K ++ + K +E LR ++H N+VR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY--- 64
Query: 709 CSSIDFQGNDFKALVYQYMP---NGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIA 763
D + +Y M G L I + +E I E I
Sbjct: 65 ---YDRIIDRSNQTLYIVMEYCEGGDLAQ-----LIQKCKKERKYIE-----EEFIWRIL 111
Query: 764 IDVASAVDYLHH--HCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ A+ H+ +H DLKP+NI LD N +GDFGLA++
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-15
Identities = 45/123 (36%), Positives = 63/123 (51%), Gaps = 19/123 (15%)
Query: 108 GLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGN 167
GL L L G IP++ L +L+ + + N++ G IP LG+ITSLE + L+YNS G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 168 IPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI 227
IP SLGQL L+ L L G N L G +P +LG L + F
Sbjct: 482 IPESLGQLTSLRILNLNG-------------------NSLSGRVPAALGGRLLHRASFNF 522
Query: 228 SNN 230
++N
Sbjct: 523 TDN 525
|
Length = 623 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.9 bits (185), Expect = 2e-14
Identities = 57/165 (34%), Positives = 81/165 (49%), Gaps = 25/165 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS---FAAECRALRNIRH-RNLVRV 705
+G GSFG VY RD +VA+KVL +L+ SK F E + L ++ H N+V++
Sbjct: 7 KLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
FQ LV +Y+ GSLE+ L + L+ E + I
Sbjct: 64 YDF-----FQDEGSLYLVMEYVDGGSLEDLLK---------KIGRKGPLSESEALFILAQ 109
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT-AHVGDFGLARL 809
+ SA++YLH IH D+KP NILLD + + DFGLA+L
Sbjct: 110 ILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKL 151
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 29/165 (17%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVR-- 704
IG G FG V +G + VAIK L + F E + H N++R
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 705 -VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
V+T + ++ +YM NGSL+ +L END T+ + + +
Sbjct: 72 GVVTKSRPV--------MIITEYMENGSLDKFL---------RENDG--KFTVGQLVGML 112
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+AS + YL +H DL NIL+++NL V DFGL+R
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 30/166 (18%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIRHRNLVRVIT 707
++G GS G VYK G I A+K +++ K E + LR+ +V+
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK--- 63
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPD-AIPQTDEENDEIRNLTLLERI--SIAI 764
C ++ + ++V +YM GSL + L IP E + IA
Sbjct: 64 -CYGAFYKEGEI-SIVLEYMDGGSLADLLKKVGKIP---------------EPVLAYIAR 106
Query: 765 DVASAVDYLH--HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +DYLH H IH D+KPSN+L+++ + DFG+++
Sbjct: 107 QILKGLDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISK 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 23/167 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR---HRNLVR 704
IG G++G+VYK G VA+K + + L +G S E L+ + H N+VR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISI 762
++ C LV++++ + L +L P+ + I++L LL
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKDLMRQLL----- 117
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
VD+LH H +H DLKP NIL+ ++ + DFGLAR+
Sbjct: 118 -----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 51/164 (31%), Positives = 73/164 (44%), Gaps = 28/164 (17%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVI 706
+ IG G+FG VY G ++A+K + +Q K A E + L ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63
Query: 707 TSCSSIDFQGNDFKALVYQYMP---NGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
++ VY +M G+LE L I DE + L LLE
Sbjct: 64 --YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLE----- 110
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ YLH H +H D+KP+NI LD+N +GDFG A
Sbjct: 111 -----GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 26/181 (14%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
+ + IG G+ G VYK T G VAIK + L+ Q + E +++ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-IA 763
S + D +V +YM GSL D I Q +E +I+ +
Sbjct: 80 YYDS-----YLVGDELWVVMEYMDGGSLT-----DIITQNFVRMNE-------PQIAYVC 122
Query: 764 IDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQSSSV 821
+V ++YLH + IH D+K NILL + + + DFG A+L +E ++S V
Sbjct: 123 REVLQGLEYLHSQNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV 177
Query: 822 G 822
G
Sbjct: 178 G 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVL-NLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG+VYKG + +G VAIKVL A+K E + ++ H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C S Q L+ Q MP G L +++ D I + LL + +
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYVR--------NHKDNIGSQYLL---NWCVQ 117
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A + YL +H DL N+L+ + DFGLA+L
Sbjct: 118 IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG V+ ++D +VA+K L + A + F E L ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---PDAIPQTDEENDEIRNLTLLERISI 762
C+ +V++YM +G L +L PDA E+ LTL + ++I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 763 AIDVASAVDY---LHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A +AS + Y LH +H DL N L+ L +GDFG++R
Sbjct: 128 ASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 651 IGIGSFGSV-----YKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG V Y + +D +VA+K L A K F E L N++H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---PDAIPQTDEENDEIR-NLTLLERIS 761
C D +V++YM +G L +L PDA+ D + + + L L + +
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
IA +AS + YL + +H DL N L+ NL +GDFG++R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 33/168 (19%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL-----QLQGASKSFAAECRALRNIRHRNLVR 704
L+G GSFGSVY+G DG A+K ++L Q A K E L ++H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 705 VITSCSSIDFQGNDFKALVY-QYMPNGSLENWLHP-DAIPQTDEENDEIRNLT--LLERI 760
+ + D ++ + +P GSL L + P+ IR T +L
Sbjct: 67 YLGTEREED------NLYIFLELVPGGSLAKLLKKYGSFPEP-----VIRLYTRQIL--- 112
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YLH T+H D+K +NIL+D N + DFG+A+
Sbjct: 113 -------LGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIV--AIKVLN-LQLQGASKSFAAECRALRNI-RHRNLVRV 705
+IG G+FG V + +DG + AIK+L + + FA E L + H N++ +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERIS 761
+ +C + + + +Y P G+L ++L + +TD +E+ LT + +
Sbjct: 69 LGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A DVA+ + YL ++ IH DL N+L+ NL + + DFGL+R
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 650 LIGIGSFGSVYKGTFDR-DGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRNLVR 704
++G G FGSV +G + DG+ + + V ++L + S F +E +++ H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 705 VITSCSSIDFQGNDFKAL-----VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
+I C F+ + + + + +M +G L ++L + E L L
Sbjct: 66 LIGVC----FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL----GGLPE--KLPLQTL 115
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +D+A ++YL IH DL N +L ++T V DFGL++
Sbjct: 116 LKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 24/174 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRAL-RNIRHRNLVRV 705
+IG GSF +V AIK+L+ L + K E L R H ++++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ FQ + V +Y PNG L ++ DE+ R A +
Sbjct: 68 YYT-----FQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKC--TRF--------YAAE 110
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
+ A++YLH + IH DLKP NILLD ++ + DFG A++ + +S+
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 43/124 (34%), Positives = 64/124 (51%)
Query: 431 DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRG 490
D L L G IP I L+ L+ +S N++ G IP +GS L+ + ++ N F G
Sbjct: 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 491 SIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTKGIFANASA 550
SIP SL L LR ++L+ N+LSG++P +L L + +F D G G+ A
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH 540
Query: 551 ISVS 554
+SV
Sbjct: 541 LSVG 544
|
Length = 623 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 24/163 (14%)
Query: 651 IGIGSFGSV----YKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRV 705
+G G FG V Y D G +VA+K L + Q + + E L+ + H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
CS QG L+ +Y+P GSL ++L P+ L L + + A
Sbjct: 72 KGCCSE---QGGKGLQLIMEYVPLGSLRDYL-----PK--------HKLNLAQLLLFAQQ 115
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + YLH + IH DL N+LLDN+ +GDFGLA+
Sbjct: 116 ICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 37/171 (21%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK---SFAA--ECRALRNIRHRN-- 701
+G G++ VYK G IVAIK + L + +K +F A E + L+ ++H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 702 -LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE---NDEIRNLTLL 757
L+ V S+I+ LV+++M TD E D+ LT
Sbjct: 66 GLLDVFGHKSNIN--------LVFEFME---------------TDLEKVIKDKSIVLTPA 102
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ S + ++YLH + +H DLKP+N+L+ ++ + DFGLAR
Sbjct: 103 DIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 21/159 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V+ GT++ + T VA+K L + +SF E + ++ +RH LV++ S
Sbjct: 14 LGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+V +YM GSL ++L ++ E R L L + +A VA+ +
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL----------KDGEGRALKLPNLVDMAAQVAAGM 115
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
Y+ + IH DL+ +NIL+ + L + DFGLARL
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 34/175 (19%)
Query: 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHRNLV 703
IG G++G V R G VAIK ++ A E + LR++RH N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENII 62
Query: 704 R---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLE 758
++ S DF ND +V + M L + PQ +D I+ +L
Sbjct: 63 GLLDILRPPSPEDF--NDV-YIVTELMET-DLHKVIKS---PQ-PLTDDHIQYFLYQIL- 113
Query: 759 RISIAIDVASAVDYLHH-HCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ YLH + IH DLKPSNIL+++N + DFGLAR
Sbjct: 114 ---------RGLKYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G+ G V+K G VA+K + L+ G E +AL+ +H +V+++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ G+ F LV +YMP L L DE R L + S +
Sbjct: 66 --DVFPHGSGF-VLVMEYMP-SDLSEVLR-----------DEERPLPEAQVKSYMRMLLK 110
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
V Y+H +H DLKP+N+L+ + + DFGLARL
Sbjct: 111 GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARL 148
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 34/173 (19%)
Query: 651 IGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G GSFG VY+G T VAIK +N + AS F E ++ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 702 LVRVITSCSSIDFQGNDFKALV-YQYMPNGSLENWLHPDAIPQTDEENDEIRNL---TLL 757
+VR++ S G LV + M G L+++L E + L TL
Sbjct: 71 VVRLLGVVS----TGQ--PTLVVMELMAKGDLKSYLR-----SRRPEAENNPGLGPPTLQ 119
Query: 758 ERISIAIDVASAVDYLH--HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ I +A ++A + YL H DL N ++ +LT +GDFG+ R
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFV-----HRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 651 IGIGSFGSV-----YKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG V Y ++D +VA+K L A K F E L N++H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---PDAIPQTDEENDEIRNLTLLERISI 762
C D +V++YM +G L +L PDA+ E + LT + + I
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA--EGNRPAELTQSQMLHI 125
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A +A+ + YL + +H DL N L+ NL +GDFG++R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-12
Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 321 GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
G IP++I KL L I + N G IP + + +L+ L++ +N +G IP S G L+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLH 409
L L L N+LSG +P++LG LLH
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR----LLH 516
|
Length = 623 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G++G VYK G IVAIK + L + +G K+ E + L+ + H N+++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ D LV+++M + Q I++ +
Sbjct: 65 --DVFRHKGDL-YLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQ--------LLQ 109
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + H H +H DLKP N+L++ + DFGLAR
Sbjct: 110 GLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARS 147
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 31/164 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVR---V 705
+G G FG V+ G + T VAIK L QG+ ++F AE ++ ++H LVR V
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+T + ++ +YM NGSL ++L + E LT+ + I +A
Sbjct: 70 VT---------QEPIYIITEYMENGSLVDFL----------KTPEGIKLTINKLIDMAAQ 110
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A + ++ ++ IH DL+ +NIL+ L + DFGLARL
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 37/168 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
+G GSFG V G + A+KVL + + + E L I H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE---RISIAI 764
+ FQ + LV +Y P G L + L + E R A
Sbjct: 59 HYA---FQTEEKLYLVLEYAPGGELFSHLS--------------KEGRFSEERARFYAA- 100
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNN----LTAHVGDFGLAR 808
++ A++YLH I+ DLKP NILLD + LT DFGLA+
Sbjct: 101 EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLT----DFGLAK 141
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIV--AIKVL-NLQLQGASKSFAAECRALRNI-RHRNLVRV 705
+IG G+FG V K +DG + AIK + + + FA E L + H N++ +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE----NDEIRNLTLLERIS 761
+ +C + + L +Y P+G+L ++L + +TD N L+ + +
Sbjct: 74 LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813
A DVA +DYL Q+ IH DL NIL+ N A + DFGL+R QEV
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV 176
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 48/167 (28%), Positives = 71/167 (42%), Gaps = 35/167 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIR-------HRN 701
+G G+FGSVY G +VAIK + K F + EC LR ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V++ F+ ND V++YM G+L + E IR+
Sbjct: 60 IVKLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES--VIRS-------- 103
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I + + ++H H H DLKP N+L+ + DFGLAR
Sbjct: 104 IIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 21/160 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITS 708
IG G+FG VYKG + T VA+K L + F E L+ H N+V++I
Sbjct: 2 KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C +V + +P GSL +L ++ + + LL+ +++D A+
Sbjct: 61 CVQ-----KQPIYIVMELVPGGSLLTFLR--------KKKNRLTVKKLLQ---MSLDAAA 104
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YL IH DL N L+ N + DFG++R
Sbjct: 105 GMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 28/178 (15%)
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTI----VAIKVLNLQLQG--ASKSFAAEC 691
+LK T+ ++G G+FG+VYKG + +G VAIK+LN + G A+ F E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 60
Query: 692 RALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI 751
+ ++ H +LVR++ C S Q LV Q MP+G L +++H E D I
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVH--------EHKDNI 106
Query: 752 RNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ LL + + +A + YL + +H DL N+L+ + + DFGLARL
Sbjct: 107 GSQLLL---NWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 44/157 (28%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G++G VYK G +VAIKV+ L+ + E L+ RH N+V S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +Y GSL++ P ++ + + TL +
Sbjct: 69 ---YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK-----------GL 114
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
YLH + IH D+K +NILL + + DFG++
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVR 704
+G G+FG VYKG T VAIK L + + F E + +++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWL---HPDAIPQTDEENDEIRN-LTLLERI 760
++ C+ ++++Y+ +G L +L P + + ++ +++ L + +
Sbjct: 73 LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 761 SIAIDVASAVDYL--HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
IAI +A+ ++YL HH H DL N L+ LT + DFGL+R
Sbjct: 128 HIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRD 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-12
Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 22 WEGITC----SPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIG 77
W G C + + L L ++GL G + I L L+ I+LS N+I+G IP +G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 78 RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPS 122
+ LE L LS+NS G IP +L + L L L N L G +P+
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDG--TI-VAIKVL-NLQLQGASKSFAAECRALRNIRHRNLVR- 704
+G GSFG V +G + G I VA+K L + +L F E + ++ H NL+R
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V+ + + +V + P GSL + L DA+ ++ L ++
Sbjct: 62 YGVVLTHPLM---------MVTELAPLGSLLDRLRKDALGHF--------LISTLCDYAV 104
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I A+ + YL + IH DL NILL ++ +GDFGL R
Sbjct: 105 QI--ANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 25/159 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G FG+V +G + G VA+K N++ +++F E + + H+NLVR++
Sbjct: 14 IGEGEFGAVLQGEYT--GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL---G 66
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNL-TLLERISIAIDVASA 769
I G +V + M G+L N+L R L ++++ + ++DVA
Sbjct: 67 VILHNG---LYIVMELMSKGNLVNFLRTRG-----------RALVSVIQLLQFSLDVAEG 112
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YL + +H DL NIL+ + A V DFGLAR
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRN 701
IG G+FG V++ T+VA+K+L + AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---PDAIPQTDEENDEIR------ 752
+V+++ C+ G L+++YM G L +L P A R
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 753 -NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L+ E++ IA VA+ + YL + +H DL N L+ N+ + DFGL+R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V+ GT++ T VAIK L + ++F E + ++ +RH LV++ S
Sbjct: 14 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+V +YM GSL ++L + + + L L + + +A +AS +
Sbjct: 72 EEPIY------IVTEYMSKGSLLDFL----------KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
Y+ + +H DL+ +NIL+ NL V DFGLARL ++
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 33/182 (18%)
Query: 650 LIGIGSFGSVYKGTFDRDG---TIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVR- 704
+IG G FG V++G G VAIK L + + F +E + H N++R
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 705 --VITSCSSIDFQGNDFK--ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
V+T FK ++ +YM NG+L+ +L D E + + +L I
Sbjct: 72 EGVVTK----------FKPAMIITEYMENGALDKYLR-----DHDGEFSSYQLVGMLRGI 116
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ + S ++Y+H DL NIL+++NL V DFGL+R+ ++ P ++
Sbjct: 117 AAGMKYLSDMNYVHR---------DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 821 VG 822
G
Sbjct: 168 SG 169
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 55/175 (31%), Positives = 80/175 (45%), Gaps = 29/175 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVITS 708
+G G FG V+ G + R VAIK++ +GA F E + + + H NLV++
Sbjct: 12 LGSGQFGVVHLGKW-RGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C+ Q F +V +YM NG L N+L E L + + DV
Sbjct: 68 CTK---QRPIF--IVTEYMANGCLLNYL---------RERKGKLGTEWL--LDMCSDVCE 111
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ-SSSVG 822
A++YL + IH DL N L+ + V DFGLAR V ++Q +SS G
Sbjct: 112 AMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 33/173 (19%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRH 699
D F +IG G+FG V+ G + A+KVL + + AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE- 758
+V++ S FQ + LV +YMP G L N L IR E
Sbjct: 61 PWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLL--------------IRKDVFPEE 101
Query: 759 --RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
R IA ++ A+D +H + IH D+KP NIL+D H+ DFGL
Sbjct: 102 TARFYIA-ELVLALDSVH---KLGFIHRDIKPDNILIDA--DGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 33/164 (20%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
+G GS+GSVYK G +VAIKV+ ++ + E L+ +V+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK----- 62
Query: 710 SSIDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER-IS-IA 763
+ G+ FK +V +Y GS+ D + +I N TL E I+ I
Sbjct: 63 ----YYGSYFKNTDLWIVMEYCGAGSVS-----DIM--------KITNKTLTEEEIAAIL 105
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++YLH + IH D+K NILL+ A + DFG++
Sbjct: 106 YQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 51/172 (29%), Positives = 71/172 (41%), Gaps = 31/172 (18%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL---QLQGASKSFAAECRALRNIRHRN 701
F+ IG GSFG+VY R +VAIK ++ Q + E R L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 702 LVRVITSCSSIDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+I+++G + LV +Y GS + L P L +
Sbjct: 77 ---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP-----------LQEV 115
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
E +I + YLH H IH D+K NILL T + DFG A L
Sbjct: 116 EIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 31/174 (17%)
Query: 650 LIGIGSFGSVYKGT---FDRDGT---IVAIKVLNLQLQGAS----KSFAAECRALRNIRH 699
+G G+FG VY+GT G+ VA+K L +GA+ K F E + N H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFNH 58
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
N+V+++ C N+ + ++ + M G L ++L DA + LTL E
Sbjct: 59 PNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLR-DARVERFGPP----LLTLKEL 108
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL-----DNNLTAHVGDFGLAR 808
+ I +DVA YL Q IH DL N L+ D + +GDFGLAR
Sbjct: 109 LDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 650 LIGIGSFGSVYKGTF-DRDG--TIVAIKVLN--LQLQGASKSFAAECRALRNIRHRNLVR 704
+IG G FG VY GT D DG A+K LN L+ + F E +++ H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVLS 60
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
++ C + +G+ +V YM +G L N++ E N T+ + I +
Sbjct: 61 LLGIC--LPSEGSPL--VVLPYMKHGDLRNFIR-----------SETHNPTVKDLIGFGL 105
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
VA ++YL + +H DL N +LD + T V DFGLAR
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 52/187 (27%), Positives = 75/187 (40%), Gaps = 36/187 (19%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNL 702
F + IG G++G VY+ G IVA+K + + + G S E L N+RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 703 VR---VIT--SCSSIDFQGNDFKALVYQYMPN--GSL-ENWLHPDAIPQTDEENDEIRNL 754
V V+ SI F LV +Y SL +N P + Q
Sbjct: 69 VELKEVVVGKHLDSI------F--LVMEYCEQDLASLLDNMPTPFSESQVK--------- 111
Query: 755 TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVP 814
+ + + + YLH + IH DLK SN+LL + + DFGLAR
Sbjct: 112 ------CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 815 NNQSSSV 821
+ V
Sbjct: 163 KPMTPKV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--------LQGASKSFAAECRALRN 696
F+ IG GSFG VYK R +VAIKV++L+ +Q E + L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ-------QEIQFLSQ 55
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
R + + S F ++ +Y GS + L P + +T
Sbjct: 56 CRSPYITKYYGS-----FLKGSKLWIIMEYCGGGSCLDLLKPGKLDET------------ 98
Query: 757 LERISIAI---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
IA +V ++YLH +E IH D+K +NILL + DFG++
Sbjct: 99 ----YIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR---HRNLVRV 705
IG+G++G+VYK G VA+K + +Q G S E L+ + H N+VR+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C++ LV++++ + L +L D +P + I++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL--DKVPPPGLPAETIKDLMR--------Q 116
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+D+LH +C +H DLKP NIL+ + + DFGLAR+
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK-SFAAECRALRNIRHRNLVRVITS 708
L+G G+FG V+KGT +D T VA+K L K F +E R L+ H N+V++I
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C+ +V + +P G ++L ++ DE++ L++ A+D A+
Sbjct: 61 CTQ-----RQPIYIVMELVPGGDFLSFLR--------KKKDELKTKQLVK---FALDAAA 104
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ YL + IH DL N L+ N + DFG++ RQE SSS
Sbjct: 105 GMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMS--RQEDDGIYSSS 151
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 16/167 (9%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIV--AIKVLN-LQLQGASKSFAAECRALRNI-RHRNLVRV 705
+IG G+FG V K +DG + AIK + + + FA E L + H N++ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERIS 761
+ +C + + L +Y P+G+L ++L + +TD N L+ + +
Sbjct: 62 LGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A DVA +DYL Q+ IH DL NIL+ N A + DFGL+R
Sbjct: 117 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 36/181 (19%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRNIRHR 700
D F IG G++G VYK G +VA+K + L + +G + E + LR + HR
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 701 NLVR----VITSCSSIDF---QGNDFKALVYQYMPN---GSLENWLHPDAIPQTDEENDE 750
N+V V ++DF +G + LV++YM + G LE+ L D
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGL-------VHFSEDH 117
Query: 751 IRNL--TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I++ LLE ++Y H ++ +H D+K SNILL+N + DFGLAR
Sbjct: 118 IKSFMKQLLE----------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164
Query: 809 L 809
L
Sbjct: 165 L 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 23/161 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
I G++G V+ G I AIKV+ + + E L + +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S FQG LV +Y+P G L + L + DE+ RI IA ++
Sbjct: 61 S-----FQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDV---------ARIYIA-EIV 103
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A++YLH + IH DLKP NIL+D+N + DFGL++
Sbjct: 104 LALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTI---VAIKVL-NLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FGSV KG + VA+K L + K F E + + H +VR+I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C +G LV + P G L +L ++ EI L E +A V
Sbjct: 63 GVC-----KGEPL-MLVMELAPLGPLLKYL---------KKRREIPVSDLKE---LAHQV 104
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A + YL + +H DL N+LL N A + DFG++R
Sbjct: 105 AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 36/176 (20%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECRALRNIRHRNLVRV 705
++G G++G V K G IVAIK + + K+ E + LR +RH N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLE------NWLHPDAIPQTDEENDEIRNLTLLER 759
+ +G + LV++Y+ LE L PDA+
Sbjct: 66 KEAFRR---KGRLY--LVFEYVERTLLELLEASPGGLPPDAVR----------------- 103
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
S + A+ Y H H IH D+KP NIL+ + + DFG AR + P
Sbjct: 104 -SYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 29/180 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDG---TIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVR- 704
+IG G FG V G G VAIK L + + F +E + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V+T + +V +YM NGSL+ +L ++D T+++ + +
Sbjct: 71 EGVVTKSKPV--------MIVTEYMENGSLDAFL---------RKHDG--QFTVIQLVGM 111
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+AS + YL +H DL NIL+++NL V DFGL+R+ ++ P ++ G
Sbjct: 112 LRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 651 IGIGSFGSV----YKGTFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVRV 705
+G G FG V Y D G VA+K L + G E LRN+ H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C+ + GN K L+ +++P+GSL+ +L P+ + L +++ A+
Sbjct: 72 KGICT--EDGGNGIK-LIMEFLPSGSLKEYL-----PRN------KNKINLKQQLKYAVQ 117
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +DYL +H DL N+L+++ +GDFGL +
Sbjct: 118 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 50/164 (30%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK-VLNLQLQGASKSFAA-ECRALRNIRHRNLVRVITS 708
IG GS+G V+K G IVAIK + + K A E R L+ ++H NLV +I
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLTLLERISIAIDV 766
F+ LV++Y + ++ N L +P +P+ I+ +
Sbjct: 69 -----FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPE-----HLIKKIIW--------QT 109
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
AV++ H H+C IH D+KP NIL+ + DFG AR+
Sbjct: 110 LQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 645 FSSTHLI---GIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHR 700
F HL G+ F FD +VA+K+L + + A F E + + +++
Sbjct: 18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP 77
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
N++R++ C S +D ++ +YM NG L +L I T + I ++++ +
Sbjct: 78 NIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A+ +AS + YL +H DL N L+ N+ T + DFG++R
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 48/182 (26%), Positives = 85/182 (46%), Gaps = 31/182 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDG---TIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVR- 704
+IG G FG V +G G VAIK L + + F +E + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V+T + ++ ++M NG+L+++L Q D + I+ + +L I+
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFLR-----QNDGQFTVIQLVGMLRGIAA 117
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN--QSSS 820
+ S ++Y+H DL NIL+++NL V DFGL+R ++ ++ +SS
Sbjct: 118 GMKYLSEMNYVHR---------DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 821 VG 822
+G
Sbjct: 169 LG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNL 702
++ IG G++G VYKG + G IVA+K + L+ + G + E L+ ++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V + + Q + L+++++ S++ + D++P+ + + L++ S
Sbjct: 62 VCLQ----DVLMQESRL-YLIFEFL---SMDLKKYLDSLPK-----GQYMDAELVK--SY 106
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + H +H DLKP N+L+DN + DFGLAR
Sbjct: 107 LYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 40/186 (21%)
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI 697
L T F +IG G++G VYK + G +VAIK++++ + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59
Query: 698 -RHRNLVRVITSCSSIDFQGNDFKA----------LVYQYMPNGSLENWLHPDAIPQTDE 746
H N+ F G K LV + GS+ D + +
Sbjct: 60 SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLVKGLRK 105
Query: 747 ENDEIRNLTLLERIS-IAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVG-- 802
+ ++ E I+ I + + YLH + IH D+K NILL N A V
Sbjct: 106 KGKRLKE----EWIAYILRETLRGLAYLHENKV----IHRDIKGQNILLTKN--AEVKLV 155
Query: 803 DFGLAR 808
DFG++
Sbjct: 156 DFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V+ GT++ T VAIK L ++F E + ++ +RH LV + S
Sbjct: 14 LGQGCFGEVWMGTWN-GTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+V ++M GSL ++L +E D + L L + + +A +A +
Sbjct: 72 EEPIY------IVTEFMGKGSLLDFL---------KEGDG-KYLKLPQLVDMAAQIADGM 115
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
Y+ + IH DL+ +NIL+ +NL + DFGLARL ++
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVIT 707
IG G+FG V + A+K +N Q +G+ ++ E R L+ + H LV +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL-- 65
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S FQ + LV + G L H + Q + ++E + E +
Sbjct: 66 -WYS--FQDEENMYLVVDLLLGGDLR--YH---LSQKVKFSEEQVKFWICE-------IV 110
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
A++YLH IH D+KP NILLD H+ DF +A S+S
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 33/177 (18%)
Query: 651 IGIGSFGSV----YKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G FG V ++G +D VAIK++ + + F E + + + H LV++
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C+ Q + +V +YM NG L N+L + + + + + DV
Sbjct: 66 GVCTK---QRPIY--IVTEYMSNGCLLNYLR-----------EHGKRFQPSQLLEMCKDV 109
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ-SSSVG 822
+ YL IH DL N L+D+ V DFGL+R V +++ +SSVG
Sbjct: 110 CEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVG 160
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G FG V G D G VA+K + + +++F AE + +RH NLV+++
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE---RISIAID 765
++ +G + +V +YM GSL ++L R ++L + ++D
Sbjct: 68 I--VEEKGGLY--IVTEYMAKGSLVDYLRS-------------RGRSVLGGDCLLKFSLD 110
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
V A++YL + +H DL N+L+ + A V DFGL + E + Q +
Sbjct: 111 VCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR---VIT 707
+G G FG V+ G ++ + T VA+K L ++F E ++ ++H LVR V+T
Sbjct: 14 LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
I ++ +YM GSL ++L ++DE + L + I + +A
Sbjct: 72 KEEPI--------YIITEYMAKGSLLDFL----------KSDEGGKVLLPKLIDFSAQIA 113
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ Y+ ++ IH DL+ +N+L+ +L + DFGLAR+
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARV 152
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 31/183 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK--VLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G G+FG VYK + G +VA+K +++ + G + E + L+ ++H N+V +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 709 CSSIDFQGNDFKALVYQYMP------NGSLENWLHPDAIPQTDEENDEIRN--LTLLERI 760
+ + VY P +G LEN P +I+ L LLE I
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQLLEGI 128
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL-RQEVPNNQSS 819
+ YLH + +H D+K +NIL+DN + DFGLAR PN +
Sbjct: 129 N----------YLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 820 SVG 822
G
Sbjct: 176 GGG 178
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 34/178 (19%)
Query: 645 FSSTHLI-----GIGSFGSV----YKGTFDRDGTIVAIKVLNLQLQGASKS----FAAEC 691
F HL G G+FGSV Y D G +VA+K +LQ ++ F E
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK----KLQHSTAEHLRDFEREI 56
Query: 692 RALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI 751
L++++H N+V+ C S G LV +Y+P GSL ++L Q E +
Sbjct: 57 EILKSLQHDNIVKYKGVCYS---AGRRNLRLVMEYLPYGSLRDYL------QKHRERLDH 107
Query: 752 RNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
R L L A + ++YL + +H DL NIL+++ +GDFGL ++
Sbjct: 108 RKLLLY-----ASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 26/166 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK--VLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G+FG V+K + IVA+K ++ + +G + E + L+ ++H N+V +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 709 CSSIDFQGNDFKALVYQYMP------NGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
C + N +K Y G L N TL E +
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-------KNVK--------FTLSEIKKV 124
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + Y+H + +H D+K +NIL+ + + DFGLAR
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 35/170 (20%)
Query: 650 LIGIGSFGSVYKGTFDRDGTI----VAIKVLNLQLQGASKSFAA---ECRALRNIRHRNL 702
L+G G FG+V+KG + +G VAIK + Q + ++F A+ ++ H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAI-PQTDEENDEIRNLTLLER 759
VR++ C Q LV Q P GSL + + H D++ PQ L
Sbjct: 72 VRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQ------------RL-- 111
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
++ + +A + YL H +H +L NILL ++ + DFG+A L
Sbjct: 112 LNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADL 158
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 34/170 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
F+ IG GSFG V+KG +R +VAIK+++L+ AE + +I+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 705 VITSCSS---IDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
V++ C S + G+ K ++ +Y+ GS + L P + DE + T+L
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL-------DETQIATIL 107
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++ +DYLH E IH D+K +N+LL + + DFG+A
Sbjct: 108 R------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIRHRNLVRVITSC 709
IG+G+ VY + VAIK ++L+ S E +A+ H N+V+ TS
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
F D LV Y+ GSL + + + P+ DE T+L+ +V
Sbjct: 68 ----FVVGDELWLVMPYLSGGSLLD-IMKSSYPR--GGLDEAIIATVLK------EVLKG 114
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++YLH + Q IH D+K NILL + + + DFG++
Sbjct: 115 LEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 31/165 (18%)
Query: 651 IGIGSFGSV----YKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLV 703
+G GSFG V +KG+ G A+K+L+ K E R L++IRH LV
Sbjct: 9 LGTGSFGRVMLVRHKGS----GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ S FQ + LV +Y+P G L + L + A
Sbjct: 65 NLYGS-----FQDDSNLYLVMEYVPGGELFSHL------------RKSGRFPEPVARFYA 107
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V A++YLH ++ DLKP N+LLD++ + DFG A+
Sbjct: 108 AQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG GS G V T G VA+K ++L+ Q + E +R+ +H N+V + +S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +++ G+L D + T ++I ++ + V A+
Sbjct: 85 ---YLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQI--------ATVCLAVLKAL 128
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQS 818
+LH IH D+K +ILL ++ + DFG A++ +EVP +S
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIRHRN 701
F +G GS+GSVYK D A+K ++L + A E R L ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ + +D GN +V +Y P G L + + EI
Sbjct: 61 IISY--KEAFLD--GNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR-------- 107
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
I I + + LH ++ +H DLK +NILL N +GD G++++
Sbjct: 108 IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV 152
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 35/167 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVR---V 705
IG G++G VYK G IVA+K + L+ +G + E L+ + H N+VR V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 706 ITSCSSI----DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+ S + + +F D K +YM D+ P T + I+ S
Sbjct: 67 VHSENKLYLVFEFLDLDLK----KYM-----------DSSPLTGLDPPLIK--------S 103
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + Y H H +H DLKP N+L+D + DFGLAR
Sbjct: 104 YLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 42/163 (25%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRNLVRVI 706
+G G FGSV +G ++D +I+ + V +++ ++S F +E ++ H N++R+I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 707 TSC-SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C +++ +G ++ +M +G L ++L + D + L + D
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL------GDCPQYLPTQMLVKFMTD 120
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+AS ++YL + IH DL N +L+ N+ V DFGL++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 34/185 (18%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ-LQGASKSFAAECRALRNIRHRN 701
D + +G GS+ +VYKG +G +VA+KV+ LQ +G + E L+ ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 702 LV---RVITSCSSIDFQGNDFKALVYQYM---PNGSLENWLHPDAIPQTDEENDEIRNLT 755
+V +I + ++ + QYM P G LHP+ N ++
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPE--------NVKLFLFQ 111
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
LL +S Y+H Q +H DLKP N+L+ + + DFGLAR + VP+
Sbjct: 112 LLRGLS----------YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS-VPS 157
Query: 816 NQSSS 820
+ S+
Sbjct: 158 HTYSN 162
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/177 (27%), Positives = 83/177 (46%), Gaps = 26/177 (14%)
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQ-GASKSFAAECR 692
+LK T+ F ++G G+FG+VYKG + +G VAIK L A+K E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 693 ALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
+ ++ + ++ R++ C + Q L+ Q MP G L +++ E D I
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVR--------EHKDNIG 107
Query: 753 NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ LL + + +A ++YL + +H DL N+L+ + DFGLA+L
Sbjct: 108 SQYLL---NWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLV 703
+ LIG G++G+VY+G G +VA+K++NL S E L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ S +G ++ +Y GS+ + I + + ++++ R
Sbjct: 63 NITKYYGSY-LKGPRL-WIIMEYAEGGSVRTLMKAGPIAE--------KYISVIIR---- 108
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+V A+ Y+H IH D+K +NIL+ N + DFG+A L + + +S+ VG
Sbjct: 109 -EVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVG 163
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 34/170 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
F+ IG GSFG V+KG +R +VAIK+++L+ AE + +I+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 705 VITSCSS---IDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
V++ C S + G+ K ++ +Y+ GS + L DE + T+L
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF-------DEFQIATML 107
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ I +DYLH E IH D+K +N+LL + DFG+A
Sbjct: 108 KEI------LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 34/168 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK-----SFAAECRALRNIRHRNLVRV 705
IG G FG V G R G A +V+ +L+ ++ F E + R + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHR-GMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 706 ITSC-SSIDFQGNDFKALVYQYMPNGSLENWL-----HPDAIPQTDEENDEIRNLTLLER 759
+ C SI + LV ++ P G L+N+L + Q D +L+R
Sbjct: 61 LGQCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKD----------VLQR 104
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ A +VAS + +LH Q IH DL N L +L+ +GD+GLA
Sbjct: 105 M--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 27/169 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV--LNLQLQGASKSFAAECRALRNIRHRNL 702
F IG G++G VYK G +VA+K L+ + +G + E L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 703 VRVITSCSSIDFQGNDFKA-LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLER 759
V+++ D + K LV++++ + L+ ++ DA P + I++ LL+
Sbjct: 62 VKLL------DVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQG 112
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++ + H H +H DLKP N+L++ + DFGLAR
Sbjct: 113 LA----------FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 42/161 (26%), Positives = 65/161 (40%), Gaps = 20/161 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIRHRNLVRVITS 708
IG GSFG V+K D + A+K ++L + A E R L + ++R S
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
F +V +Y NG L L E+ + R I I +
Sbjct: 68 -----FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ--------VWRFFIQILLG- 113
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ +LH + +H D+K N+ LD +GD G+A+L
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 42/181 (23%)
Query: 654 GSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRNIRHRNLVRV--ITSC 709
G++G VY+ + G IVA+K L + + +G + E L ++H N+V V +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 710 SSID-------FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERI 760
S++D + +D K+L +E P E++ L LL
Sbjct: 76 SNLDKIYMVMEYVEHDLKSL---------METMKQPFLQS-------EVKCLMLQLL--- 116
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
S V +LH + +H DLK SN+LL+N + DFGLAR +
Sbjct: 117 -------SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166
Query: 821 V 821
V
Sbjct: 167 V 167
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 34/170 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
F+ IG GSFG VYKG +R +VAIK+++L+ AE + +I+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAE-DEIEDIQQE--IT 54
Query: 705 VITSCSS---IDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
V++ C S + G+ K ++ +Y+ GS + L P + +E T+L
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPL-------EETYIATIL 107
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
I +DYLH E IH D+K +N+LL + DFG+A
Sbjct: 108 REI------LKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-09
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 25/114 (21%)
Query: 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
L + + L G IP+ L L + L N++ G IP SLG++ L +L L N +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIG 473
PE +G L LR+ ++ N+LSG +P+ +G
Sbjct: 483 PES-------------------------LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 55/174 (31%), Positives = 81/174 (46%), Gaps = 35/174 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHR 700
++S +G G++GSV R G VAIK L+ Q S+ FA E L++++H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHE 74
Query: 701 NLVR---VITSCSSID-FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
N++ V TS S D FQ DF LV YM QTD + +I L
Sbjct: 75 NVIGLLDVFTSAVSGDEFQ--DF-YLVMPYM---------------QTDLQ--KIMGHPL 114
Query: 757 LE-RISIAI-DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
E ++ + + + Y+H IH DLKP N+ ++ + + DFGLAR
Sbjct: 115 SEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA---SKSFAAECRALRNIRHRNLVRVIT 707
IG G FG V G + T + V L++ + F E + R+++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 708 SCSS-IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR-NLTLLERISIAID 765
C+ + LV ++ P G L+ +L ++ + + + + T L+R+ A +
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYL------RSCRKAELMTPDPTTLQRM--ACE 108
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
+A + +LH + IH DL N LL +LT +GD+GL+ +
Sbjct: 109 IALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNK 150
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 651 IGIGSFGSVYKGTF-DRDGTI----VAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVR 704
+G G+FG VY+G + RDG VA+K L +S F E + H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+I + F+ + ++ + M G L+++L + + +LT+ + + A
Sbjct: 74 LI----GVSFERLP-RFILLELMAGGDLKSFLR-----ENRPRPERPSSLTMKDLLFCAR 123
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
DVA YL + IH D+ N LL A + DFG+AR
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 28/172 (16%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHR 700
D + IG G++G VYK +A+K + L+ + G + E L+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 701 NLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
N+VR V+ S + LV++Y L D D D +N L+
Sbjct: 62 NIVRLQDVVHSEKRL--------YLVFEY---------LDLDLKKHMDSSPDFAKNPRLI 104
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA-HVGDFGLAR 808
+ + + + Y H H +H DLKP N+L+D A + DFGLAR
Sbjct: 105 K--TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 650 LIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
IG G FG VY+G + + + VA+K + + F E +R H ++V++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
I + + +V + P G L ++L Q ++ + ++ +L L +
Sbjct: 73 IGVIT------ENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILY-----SYQ 115
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+++A+ YL + +H D+ N+L+ + +GDFGL+R
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 15/91 (16%)
Query: 286 DEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEG 345
+++S + L + +NL N +G +P S+ GSI S L ++++ +N F G
Sbjct: 436 NDISKLRHLQS------INLSGNSIRGNIPPSL--GSITS-------LEVLDLSYNSFNG 480
Query: 346 KIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376
IPE + +L +L+ LN+ N LSG +P++ G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 649 HLIGIGSFGSVYKGTF----DRDGTI-VAIKVLNLQLQGASKSFA---AECRALRNI-RH 699
+G G+FG V K + + T VA+K+L + K + +E ++ I +H
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR----NLT 755
+N++ ++ C+ +G + +V +Y +G+L ++L P D+ R LT
Sbjct: 76 KNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +S A VA +++L + IH DL N+L+ + + DFGLAR
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 651 IGIGSFGSVYKG-TFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR---HRNLVR 704
IG G++G V+K G VA+K + +Q +G S E LR++ H N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ C+ LV++++ + L +L D +P+ + I+++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMF-------- 117
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ +D+LH H +H DLKP NIL+ ++ + DFGLAR+
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/162 (28%), Positives = 66/162 (40%), Gaps = 26/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRVITSC 709
IG G+FG V+ G D T VA+K L K+ F E R L+ H N+VR+I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 710 SSIDFQGNDFKALVYQYMP---NGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ K +Y M G +L E L + E I + +
Sbjct: 63 TQ--------KQPIYIVMELVQGGDFLTFLR-----------TEGPRLKVKELIQMVENA 103
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A+ ++YL IH DL N L+ + DFG++R
Sbjct: 104 AAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 49/175 (28%), Positives = 76/175 (43%), Gaps = 29/175 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVITS 708
IG G FG V+ G + VAIK + +GA + F E + + + H LV++
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C+ LV+++M +G L ++L + + TLL + +DV
Sbjct: 68 CTE-----RSPICLVFEFMEHGCLSDYLR--------AQRGKFSQETLLG---MCLDVCE 111
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ-SSSVG 822
+ YL IH DL N L+ N V DFG+ R V ++Q +SS G
Sbjct: 112 GMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTG 160
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V+ T+++ T VA+K + +F AE ++ ++H LV++ +
Sbjct: 14 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
++ ++M GSL ++L ++DE L + I + +A +
Sbjct: 72 KEPIY------IITEFMAKGSLLDFL----------KSDEGSKQPLPKLIDFSAQIAEGM 115
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
++ Q IH DL+ +NIL+ +L + DFGLAR+ ++
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 29/88 (32%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFP 237
L + GL G IP I L L + ++ N + G++PPSLG ++++L++ +S N F+GS P
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG-SITSLEVLDLSYNSFNGSIP 483
Query: 238 LAFSNASNLQSLEILGNNFFGKLSVNFG 265
+ ++L+ L + GN+ G++ G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA-ECRALRNIRHRNLVR---VI 706
+G G++ +VYKG G IVA+K ++L + + S A E ++ ++H N+VR VI
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + + LV++YM + L+ ++ + + L S +
Sbjct: 68 HTENKL--------MLVFEYM-DKDLKKYM---------DTHGVRGALDPNTVKSFTYQL 109
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H + +H DLKP N+L++ + DFGLAR
Sbjct: 110 LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQ-GASKSFAAECR 692
+LK T+ ++G G+FG+VYKG + DG VAIKVL A+K E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 693 ALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
+ + + R++ C + Q LV Q MP G L +++ E D I
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVR--------ENKDRIG 107
Query: 753 NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ LL + + +A + YL + +H DL N+L+ + + DFGLARL
Sbjct: 108 SQDLL---NWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVRVITSC 709
IG G+ G+VYK G + A+KV+ + + E LR++ H N+V+ C
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----C 137
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
+ + + L+ ++M GSLE DE +A + S
Sbjct: 138 HDMFDHNGEIQVLL-EFMDGGSLEG----------THIADE------QFLADVARQILSG 180
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ YLH + +H D+KPSN+L+++ + DFG++R+ + + +SSVG
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVG 230
|
Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 57/194 (29%), Positives = 81/194 (41%), Gaps = 63/194 (32%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA---ECRALRNIR--------- 698
+G G++G V+K R +VA+K K F A A R R
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 699 -HRNLVRVITSCSSIDFQGNDFKA-------LVYQYMPNGSLENWLHPDAIPQTDEENDE 750
H N+V+++ N KA LV++YM E LH A+
Sbjct: 65 DHPNIVKLL----------NVIKAENDKDIYLVFEYM-----ETDLH--AV--------- 98
Query: 751 IRNLTLLERI---SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
IR +LE + I + A+ Y+H IH DLKPSNILL+++ + DFGLA
Sbjct: 99 IRA-NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
Query: 808 RLRQEVPNNQSSSV 821
R E+ N + V
Sbjct: 155 RSLSELEENPENPV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIRHRNL 702
+ ++G G+FG V+ D +V IK + ++ + AA EC+ L+ + H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
+ + F + +V +Y P G+L ++ + + DE L +I +
Sbjct: 62 IEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQK----RCNSLLDEDTILHFFVQILL 112
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT-AHVGDFGLARL 809
A LHH + +H DLK NILLD + +GDFG++++
Sbjct: 113 A---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 31/169 (18%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---------KSFAAECRALRNIRHR 700
LIG GSFGSVY G G ++A+K + L AS + A E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHP-DAIPQTDEENDEIRNLTLLER 759
N+V+ + S D + +Y+P GS+ L+ A +T +RN
Sbjct: 67 NIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEET-----LVRNFVR--- 113
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ ++YLH IH D+K +NIL+DN + DFG+++
Sbjct: 114 -----QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVRVITSC 709
+G G+ G V K G I+A+K + L++ A K E L +V +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
+ D ++ +YM GSL+ L + + E +L +I++A V
Sbjct: 69 ----YNNGDI-SICMEYMDGGSLDKIL-KEVQGRIPER--------ILGKIAVA--VLKG 112
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ YLH + IH D+KPSNIL+++ + DFG++
Sbjct: 113 LTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKV-LNLQLQGASKSFAA-ECRALRNIRHRNLVRVIT 707
L+G GS+G V K G IVAIK L + K A E R L+ +RH NLV +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLH-PDAIPQTDEENDEIRNLTLLERISIAIDV 766
F+ LV++++ + L++ P+ + DE R L +
Sbjct: 68 V-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGL-------DESRVRKYL------FQI 109
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+++ H H IH D+KP NIL+ + + DFG AR
Sbjct: 110 LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 645 FSSTHLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRH 699
F+ ++G G FGSV + D VA+K+L + +S + F E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 700 RNLVRVI-TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
N++++I S S ++ +M +G L +L I +E L L
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI------GEEPFTLPLQT 114
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ ID+AS ++YL + IH DL N +L+ N+T V DFGL++
Sbjct: 115 LVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 54/162 (33%), Positives = 70/162 (43%), Gaps = 24/162 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN----LQLQGASKSFAAECRALRNIRHRNLVRVI 706
IG GSFG V DG A+KVL L+ + A L+N++H LV +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S FQ D V Y+ G L L Q + E R R A ++
Sbjct: 63 YS-----FQTADKLYFVLDYVNGGELFFHL------QRERSFPEPR-----ARF-YAAEI 105
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
ASA+ YLH I+ DLKP NILLD+ + DFGL +
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 57/182 (31%), Positives = 78/182 (42%), Gaps = 28/182 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN----LQLQGASKSFAAECRALRNIRHRNLVRV 705
+IG GSFG V DG+ A+KVL L+ + + A L+N++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS--IA 763
S FQ + V Y+ G L + H R LE + A
Sbjct: 62 HYS-----FQTAEKLYFVLDYVNGGEL--FFHLQ------------RERCFLEPRARFYA 102
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGD 823
+VASA+ YLH I+ DLKP NILLD+ + DFGL + E S+ G
Sbjct: 103 AEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159
Query: 824 LE 825
E
Sbjct: 160 PE 161
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G+ G+VY G VAIK +NLQ Q + E +R +H N+V + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +Y+ GSL D + +T + +I ++ + A+
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQI--------AAVCRECLQAL 128
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQSSSVG 822
++LH IH D+K NILL + + + DFG A++ E + +S+ VG
Sbjct: 129 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVG 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFA---AECRALRNI-RHRN 701
+G G FG V D+ V + V L+ K + +E ++ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR----NLTLL 757
++ ++ +C+ Q LV +Y G+L +L P D D + LT
Sbjct: 80 IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +S A VA ++YL + IH DL N+L+ + + DFGLAR
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 48/170 (28%), Positives = 69/170 (40%), Gaps = 39/170 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA---------ECRALRNIRHRN 701
IG G++G V R G VAIK + +F E + LR+ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 702 LVRVITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIRN-LTLLE 758
++ + G DFK +V M E+ LH + IR L L
Sbjct: 66 IIAIRDILRP---PGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
R + Y+H IH DLKPSN+L++ + +GDFG+AR
Sbjct: 118 R---------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 24/161 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G++G+V+K IVA+K + L +G S E L+ ++H+N+VR+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 64
Query: 709 CSSIDFQGNDFK-ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
D +D K LV++Y + L+ + D N +I + S +
Sbjct: 65 ---YDVLHSDKKLTLVFEYC-DQDLKKYF--------DSCNGDIDPEIVK---SFMFQLL 109
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H H +H DLKP N+L++ N + DFGLAR
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 32/179 (17%)
Query: 651 IGIGSFGSVYKGT-FDRDG----TIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G G FG V K T F G T VA+K+L + AS S +E L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH------------PDAIPQTDEEND 749
++++ +CS + L+ +Y GSL ++L + +N
Sbjct: 65 VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 750 EIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ R LT+ + IS A ++ + YL + +H DL N+L+ + DFGL+R
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 37/140 (26%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 670 IVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMP 728
+VA+K+L + A F E + + ++ N++R++ C + +D ++ +YM
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYME 102
Query: 729 NGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788
NG L +L PQ E ++ ++ I +A +AS + YL +H DL
Sbjct: 103 NGDLNQFLSRHE-PQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLAT 158
Query: 789 SNILLDNNLTAHVGDFGLAR 808
N L+ N T + DFG++R
Sbjct: 159 RNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 31/185 (16%)
Query: 650 LIGIGSFGSVYKGTF-DRDGTIVAIKVLNLQ-------LQGASKSFA---AECRALR-NI 697
+G G+FG VYK + ++A+K +N+ + KS +E ++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
RH N+VR + F ND +V + L H +++ + + E
Sbjct: 67 RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE------- 112
Query: 758 ERI-SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN 816
ERI +I + + A+ YLH ++ +H DL P+NI+L + + DFGLA +Q+ P +
Sbjct: 113 ERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA--KQKQPES 168
Query: 817 QSSSV 821
+ +SV
Sbjct: 169 KLTSV 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/167 (30%), Positives = 73/167 (43%), Gaps = 30/167 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRN---LVRV 705
+G G++G V + G VAIK L+ Q A +K E R L+++ H N L+ V
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 706 ITSCSSI-DFQGNDFKALVYQYMP--NGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
T SS+ DFQ VY L N + + +D D I+ L
Sbjct: 83 FTPASSLEDFQD------VYLVTHLMGADLNNIVKCQKL--SD---DHIQFL-------- 123
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + Y+H IH DLKPSNI ++ + + DFGLAR
Sbjct: 124 VYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTF-DRDGTI---VAIKVLNLQLQGASKS----FAAECRAL 694
D + + L+ G+FG ++ G D V +K + AS+ E L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLL 62
Query: 695 RNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNL 754
+ H+N++ ++ C + + ++Y YM G+L+ +L + E N+ + L
Sbjct: 63 YGLSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQ---QCRLGEANNP-QAL 114
Query: 755 TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + +AI +A + YLH IH D+ N ++D L + D L+R
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 19/170 (11%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVA---IKVLNLQLQGASKSFAAECRALRNIR 698
F IG G F VYK DG +VA +++ + A + E L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
H N+++ + S F N+ +V + G L I ++ I T+ +
Sbjct: 61 HPNVIKYLAS-----FIENNELNIVLELADAGDLSR-----MIKHFKKQKRLIPERTIWK 110
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + SA++++H +H D+KP+N+ + +GD GL R
Sbjct: 111 YF---VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 34/177 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLV---RVI 706
+G GS+ +VYKG +G +VA+KV++++ + G + E L+ ++H N+V +I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 707 TSCSSIDFQGNDFKALVYQYM---PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ ++ F + QYM P G LHP N + LL ++
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHP--------YNVRLFMFQLLRGLA-- 117
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
Y+H + +H DLKP N+L+ + DFGLAR + +P+ SS
Sbjct: 118 --------YIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS-IPSQTYSS 162
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGT----IVAIKVL----NLQLQGASKSFAAECRALRNIRHRNL 702
+G +FG +YKG G +VAIK L N Q G F E + + H N+
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL-----HPDAIPQTDEENDEIRNLTLL 757
V ++ + ++++Y+ G L +L H D +DE+ +L
Sbjct: 70 VCLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + IAI +A+ ++YL H +H DL NIL+ L + D GL+R
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 51/170 (30%), Positives = 71/170 (41%), Gaps = 29/170 (17%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI---RH 699
D F S +IG G+FG V G I A+K L + + K A RA R+I
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEAD 59
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE- 758
V V S FQ ++ L+ +Y+P G + L ++ T E
Sbjct: 60 NPWV-VKLYYS---FQDENYLYLIMEYLPGGDMMTLL--------------MKKDTFTEE 101
Query: 759 --RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
R IA + A+D +H IH D+KP N+LLD + DFGL
Sbjct: 102 ETRFYIA-ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 26/163 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVL---NLQLQGASKSFAAECRALRNIRHR-NLVRVI 706
I G+FGSVY G AIKVL ++ + + AE + + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHP-DAIPQTDEENDEIRNLTLLERISIAID 765
S FQ D+ LV +Y+ G + + +P+ D + +
Sbjct: 64 YS-----FQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-----DWAKQY--------IAE 105
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V V+ LH Q IH D+KP N+L+D + DFGL+R
Sbjct: 106 VVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 23/176 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRA--LRNIRHRNLVRVITS 708
+G GS+G V DG IK LNL+ + AAE A L ++H N+V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIAIDV 766
++G D L+Y M G E D + E+ ++ L E + + +
Sbjct: 68 -----WEGED--GLLYIVM--GFCEG---GDLYHKLKEQKGKL----LPENQVVEWFVQI 111
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A A+ YLH ++ +H DLK N+ L VGD G+AR+ + + S+ +G
Sbjct: 112 AMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 30/175 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVR---VI 706
+G G++ +V+KG +VA+K + L+ +GA + E L+N++H N+V +I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI-D 765
+ + LV++Y+ + L+ +L D NL + + I +
Sbjct: 73 HTERCL--------TLVFEYLDS-DLKQYL------------DNCGNLMSMHNVKIFMFQ 111
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ + Y H +H DLKP N+L++ + DFGLAR + VP S+
Sbjct: 112 LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKS-VPTKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 7e-07
Identities = 20/60 (33%), Positives = 32/60 (53%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
NL+ L++ +N+L+ +F L +L L L NNL+ + P + L L L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
+ S IG GS G V T G VA+K ++L+ Q + E +R+ H N+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V + S + D +V +++ G+L D + T ++I ++
Sbjct: 82 VDMYNS-----YLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQI--------ATV 123
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQS 818
+ V A+ YLH + IH D+K +ILL ++ + DFG A++ +EVP +S
Sbjct: 124 CLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 52/163 (31%), Positives = 74/163 (45%), Gaps = 24/163 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRAL-RNIRHRNLVRV 705
+IG GSFG V DG A+KVL ++ + K AE L +N++H LV +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
S FQ + V ++ G L + H Q + E R R A +
Sbjct: 62 HYS-----FQTTEKLYFVLDFVNGGEL--FFHL----QRERSFPEPR-----ARFYAA-E 104
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ASA+ YLH ++ DLKP NILLD+ + DFGL +
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 31/173 (17%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL-------QLQGASKSFAAECRALR 695
D +G G+FG V+ A+KV+ + Q Q E R L+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN----EKRVLK 56
Query: 696 NIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
+ H ++R+ + D F ++ +Y+P G L ++L + N T
Sbjct: 57 EVSHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYL---------RNSGRFSNST 102
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L A ++ A++YLH ++ DLKP NILLD + DFG A+
Sbjct: 103 GL---FYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 21/171 (12%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFA---AECRALRNI-RHRN 701
+G G FG V D+ V + V L+ K + +E ++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR----NLTLL 757
++ ++ +C+ Q +V +Y G+L +L P + D R +T
Sbjct: 83 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ +S VA ++YL + IH DL N+L+ N + DFGLAR
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASK----SFAAECRALRNIRHRN 701
+G GSFG VY+G D T VAIK +N + AS F E ++ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNL-TLLERI 760
+VR++ S QG ++ + M G L+++L + + EN+ ++ +L + I
Sbjct: 71 VVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRS---LRPEMENNPVQAPPSLKKMI 122
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A ++A + YL+ + +H DL N ++ + T +GDFG+ R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG GS G V T G +VA+K ++L+ Q + E +R+ +H N+V + S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +++ G+L D + T ++I ++ + V A+
Sbjct: 86 ---YLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIA--------AVCLAVLKAL 129
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQS 818
LH + IH D+K +ILL ++ + DFG A++ +EVP +S
Sbjct: 130 SVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 48/170 (28%), Positives = 69/170 (40%), Gaps = 31/170 (18%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL---QLQGASKSFAAECRALRNIRHRN 701
F H IG GSFG+VY T +VA+K ++ Q + E + L+ ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 702 LVRVITSCSSIDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+I+++G K LV +Y GS + L P L +
Sbjct: 83 ---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP-----------LQEV 121
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
E +I + YLH H IH D+K NILL + DFG A
Sbjct: 122 EIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 32/178 (17%)
Query: 651 IGIGSFGSVY---------------KGTFDRDG-TIVAIKVLNLQLQGASKS----FAAE 690
+G G FG V+ + D +VA+KVL AS + F E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKE 69
Query: 691 CRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDE 750
+ L + N+ R++ C+ + ++ +YM NG L +L + +T
Sbjct: 70 VKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQ-KHVAETSGLACN 123
Query: 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++L+ + +A +AS + YL +H DL N L+ N T + DFG++R
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVITS 708
+G G FG V+ G + R VAIK +N +GA + F E + + + H LV++
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C+ Q + +V ++M NG L N+L + ++ LL S+ DV
Sbjct: 68 CTQ---QKPLY--IVTEFMENGCLLNYLR--------QRQGKLSKDMLL---SMCQDVCE 111
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YL + IH DL N L+ + V DFG+ R
Sbjct: 112 GMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 40/171 (23%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHRN---LV 703
+G G++G+V R G VAIK L Q S+ FA E R L++++H N L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-- 761
V T S+D + +DF Y MP TD + L E++S
Sbjct: 81 DVFTPDLSLD-RFHDF----YLVMP------------FMGTD-----LGKLMKHEKLSED 118
Query: 762 ----IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + Y+H IH DLKP N+ ++ + + DFGLAR
Sbjct: 119 RIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK---SFAAECRALRNIRHRNLVRVIT 707
IG G FG V D + + V L+ +SK F + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 708 SC-SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C +I + LV++Y G L+++L +E RN LL +A ++
Sbjct: 63 QCVEAIPY------LLVFEYCELGDLKSYLS--------QEQWHRRNSQLLLLQRMACEI 108
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
A+ V ++H H +H DL N L ++LT VGD+G+ R
Sbjct: 109 AAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSR 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 21/172 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G+ G+VY G VAIK +NLQ Q + E +R ++ N+V + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +Y+ GSL D + +T + +I ++ + A+
Sbjct: 85 ---YLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQI--------AAVCRECLQAL 128
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
D+LH + IH D+K NILL + + + DFG + +S+ VG
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 27/169 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI----RHRNLVRVI 706
I G+FG VY G + + A+KV+ + +K+ + +A R+ + +V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S Q + LV +Y+ G +++ LH DEE ++ IS +V
Sbjct: 71 YS-----LQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEE-------MAVKYIS---EV 113
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR--LRQEV 813
A A+DYLH H IH DLKP N+L+ N + DFGL++ L +E+
Sbjct: 114 ALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 18/183 (9%)
Query: 628 RALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSF 687
R+L + +L F ++G G++G VYKG + G + AIKV+++ + +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEI 59
Query: 688 AAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKA-LVYQYMPNGSLENWLHPDAIPQTD 745
E L+ HRN+ + G+D + LV ++ GS+ TD
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSV-----------TD 108
Query: 746 EENDEIRNLTLLERIS-IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804
+ N + I+ I ++ + +LH H IH D+K N+LL N + DF
Sbjct: 109 LVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDF 165
Query: 805 GLA 807
G++
Sbjct: 166 GVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 27/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
+G G +G V+ G IVA+K + L + E L + LV+++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
+ FQ +++ L +Y+P G L+ + D R +A ++
Sbjct: 69 A-----FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-----------RFYMA-EMF 111
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
AVD LH + IH DLKP N L+D + H+ DFGL+
Sbjct: 112 EAVDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 13/193 (6%)
Query: 631 RKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAE 690
+ + ++S +D + IG G++G V+K ++G+ A+K+L+ + + AE
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAE 64
Query: 691 CRALRNIR-HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEND 749
L+ + H N+V+ D + D LV + GS+ TD
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----------TDLVKG 113
Query: 750 EIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
++ +E IA + A+ L H TIH D+K +NILL + DFG++
Sbjct: 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 810 RQEVPNNQSSSVG 822
+++SVG
Sbjct: 174 LTSTRLRRNTSVG 186
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 45/172 (26%), Positives = 67/172 (38%), Gaps = 31/172 (18%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVL----NLQLQGASKSFAAECRALRNIR 698
+ +G G+ GSV K G I A+K + N LQ K E ++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ---KQILRELEINKSCK 57
Query: 699 HRNLVRVITSC-----SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN 753
+V+ + SSI + +Y GSL D+I + ++
Sbjct: 58 SPYIVKYYGAFLDESSSSI--------GIAMEYCEGGSL------DSIYKKVKKRGGRIG 103
Query: 754 LTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+L +I A V + YLH IH D+KPSNILL + DFG
Sbjct: 104 EKVLGKI--AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 5e-06
Identities = 49/180 (27%), Positives = 72/180 (40%), Gaps = 47/180 (26%)
Query: 651 IGIGSFGSVYKGTFD--RDGTIVAIKVL---NLQLQGASKSFAAECRALRNIRHRN---L 702
IG G++G VYK +DG AIK Q G S+S E LR ++H N L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 703 VRVITSCSS------IDFQGNDFKALV-YQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
V V + D+ +D ++ + +IP + +++L
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV--------SIPPS-----MVKSLL 114
Query: 756 --LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL--DNNLTAHV--GDFGLARL 809
+L + YLH +H DLKP+NIL+ + V GD GLARL
Sbjct: 115 WQILNGVH----------YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 33/173 (19%)
Query: 650 LIGIGSFGSVYKGTFDRD-GTIVAIKVLNL-----QLQGASKSFAAECRALRNIRHRNLV 703
L+G G+FG VY +D D G +A+K + + + + E + L+N++H +V
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI-RNLT--LLERI 760
+ C D + F +YMP GS++ D + + + R T +LE
Sbjct: 68 QYY-GCLRDDETLSIF----MEYMPGGSVK-----DQLKAYGALTETVTRKYTRQILE-- 115
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813
V+YLH + +H D+K +NIL D+ +GDFG ++ Q +
Sbjct: 116 --------GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 23/162 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVI 706
L+G G+FG V G A+K+L ++ A A E R L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S FQ D V +Y+ G L L + + D ++
Sbjct: 62 YS-----FQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR------------FYGAEI 104
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
SA+DYLH ++ DLK N++LD + + DFGL +
Sbjct: 105 VSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 31/197 (15%)
Query: 636 ESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALR 695
ESL TD + IG G++G VYK T +DG++ A+K+L+ + + AE L+
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQ 73
Query: 696 NI-RHRNLVRVITSCSSIDFQGNDFKA---------LVYQYMPNGSLENWLHPDAIPQTD 745
++ H N+V+ F G +KA LV + GS+ T+
Sbjct: 74 SLPNHPNVVK---------FYGMFYKADKLVGGQLWLVLELCNGGSV-----------TE 113
Query: 746 EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+ L+ I+ + A+ L H IH D+K +NILL + DFG
Sbjct: 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173
Query: 806 LARLRQEVPNNQSSSVG 822
++ +++SVG
Sbjct: 174 VSAQLTSTRLRRNTSVG 190
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVR---VI 706
+G G++ +VYKG +VA+K + L+ + GA + E L++++H N+V +I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI-D 765
+ S+ LV++Y+ + L+ +L D+ N + + + +
Sbjct: 74 HTEKSL--------TLVFEYL-DKDLKQYL------------DDCGNSINMHNVKLFLFQ 112
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ ++Y H + +H DLKP N+L++ + DFGLAR + +P S+
Sbjct: 113 LLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 23/72 (31%), Positives = 40/72 (55%)
Query: 29 PRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLS 88
+ R + ++L + G++ P +G+++ L + LS N+ G IP +G+L L L L+
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498
Query: 89 HNSLVGEIPGNL 100
NSL G +P L
Sbjct: 499 GNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 651 IGIGSFGSVYKGTFDRD------GTIVAIKVLNLQLQGASK----SFAAECRALRNIRHR 700
+G GSFG VY+G RD T VA+K +N + AS F E ++
Sbjct: 14 LGQGSFGMVYEGN-ARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCH 69
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNL-TLLER 759
++VR++ S +V + M +G L+++L + + EN+ R TL E
Sbjct: 70 HVVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRS---LRPEAENNPGRPPPTLQEM 121
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I +A ++A + YL+ + +H DL N ++ ++ T +GDFG+ R
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 23/162 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVI 706
L+G G+FG V G A+K+L ++ A A E R L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S FQ +D V +Y G L L + + D R A ++
Sbjct: 62 YS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-----------RFYGA-EI 104
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
SA+ YLH ++ DLK N++LD + + DFGL +
Sbjct: 105 VSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 40/180 (22%), Positives = 79/180 (43%), Gaps = 30/180 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL----------QLQGASKSFAAECRALRNIRH 699
LIG G++G VY G ++A+K + L + + K+ +E L+++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
N+V+ + ++ ++ +Y+P GS+ + L E +R T
Sbjct: 68 LNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTE--- 115
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
V + YLH + +H DLK N+L+D + + DFG+++ ++ +N +
Sbjct: 116 -----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 36/177 (20%)
Query: 645 FSSTHL-----IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIR 698
F++ L IG G+FG+V K GTI+A+K + + K + + +R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58
Query: 699 HRNLVRVITSCSSIDFQGNDFK---ALVYQYMPNGSLENW---LHPDAIPQTDEENDEIR 752
+ ++ F G F+ + + + SL+ + ++ E+
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELMDISLDKFYKYVY------------EVL 100
Query: 753 NLTLLERI--SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ E I IA+ A++YL + IH D+KPSNILLD N + DFG++
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 20/169 (11%)
Query: 651 IGIGSFGSVYKG-----TFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVR 704
+G FG VYKG VAIK L + +G + F E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWL-----HPDAIPQTDEENDEIRNLTLLER 759
++ + ++++ Y + L +L H D + TD++ L +
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSD-VGSTDDDKTVKSTLEPADF 126
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ I +A+ +++L H +H DL N+L+ + L + D GL R
Sbjct: 127 VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVI 706
L+G G+FG V G A+K+L ++ A A E R L+N RH L +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S FQ +D V +Y G L L + + D ++
Sbjct: 62 YS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR------------FYGAEI 104
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
SA+DYLH ++ ++ DLK N++LD + + DFGL +
Sbjct: 105 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--ASKSFAAECRALRNIRHRNLVRV--I 706
IG G+FG V+ T RDG VA+K + Q + K E + L +H N++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
ID F+ + Y+ +++ LH + +D ++ +
Sbjct: 68 LQPPHIDP----FEEI---YVVTELMQSDLHKIIVSPQPLSSDHVKVFLY--------QI 112
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ YLH +H D+KP N+L+++N + DFGLAR+
Sbjct: 113 LRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 31/165 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
+G+G FG V A+K + + G + +E L H +V++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE----RISIA 763
+ F+ + ++ +Y G L W +R+ L + R IA
Sbjct: 61 T-----FKDKKYIYMLMEYCLGGEL--W-------------TILRDRGLFDEYTARFYIA 100
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V A +YLH+ I+ DLKP N+LLD+N + DFG A+
Sbjct: 101 C-VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 51/164 (31%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G+FG VY+ I A+KVL+ + A K A RNI LVR + S
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE-VAHTIGERNI----LVRTLLDES 55
Query: 711 ------SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
FQ + LV YM G L L + D I L L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL-------- 107
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A+++LH + ++ DLKP NILLD + DFGL++
Sbjct: 108 ----ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 35/172 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK-VLNLQLQGASKS-----------FAA--ECRALRN 696
+G G++G V K G IVAIK V +++ F E + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
I+H N++ ++ + DF LV M L+ + + +IR LT
Sbjct: 77 IKHENIMGLVDV-----YVEGDFINLVMDIM-ASDLKKVV-----------DRKIR-LTE 118
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ I + + + ++ LH +H DL P+NI +++ + DFGLAR
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 20/165 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
+ F IG G++G VYK G + AIKV+ L+ E +++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V S + D + ++ GSL++ H L+ + +
Sbjct: 69 VAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTG------------PLSESQIAYV 111
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ + + YLH + +H D+K +NILL +N + DFG++
Sbjct: 112 SRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLV 703
F L+G G++G VYKG + G + AIKV+++ + E L+ HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66
Query: 704 RVITSCSSIDFQGNDFKA-LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--I 760
+ + G D + LV ++ GS+ D I T + TL E
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT-----DLIKNT-------KGNTLKEEWIA 114
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
I ++ + +LH H IH D+K N+LL N + DFG++
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 21/172 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G+ G+V+ G VAIK +NLQ Q + E ++ +++ N+V + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
F D +V +Y+ GSL D + +T + +I ++ + A+
Sbjct: 85 ---FLVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQI--------AAVCRECLQAL 128
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
++LH + IH D+K N+LL + + + DFG + +S+ VG
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 16/147 (10%)
Query: 670 IVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMP 728
+VA+K+L + A F E + L ++ N++R++ C D ++ +YM
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYME 102
Query: 729 NGSLENWL-HPDAIPQTDEENDEIRNLTLLERIS------IAIDVASAVDYLHHHCQEPT 781
NG L +L + + ND + L IS +A+ +AS + YL
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159
Query: 782 IHCDLKPSNILLDNNLTAHVGDFGLAR 808
+H DL N L+ NLT + DFG++R
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 21/172 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G+ G+VY G VAI+ +NLQ Q + E +R ++ N+V + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ D +V +Y+ GSL D + +T + +I ++ + A+
Sbjct: 86 ---YLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQI--------AAVCRECLQAL 129
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
++LH + IH D+K NILL + + + DFG + +S+ VG
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 49/165 (29%), Positives = 72/165 (43%), Gaps = 26/165 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS--FAAECRALRNIRHRNLVRV-- 705
+IG GS+G V G VAIK +N + S + E + LR +RH ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 706 ITSCSSIDFQGNDFKAL--VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
I S +FK + V++ M E+ LH I D+ E L + +
Sbjct: 67 IMLPPS----RREFKDIYVVFELM-----ESDLH-QVIKANDDLTPEHHQFFLYQLLR-- 114
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A+ Y+H H DLKP NIL + + + DFGLAR
Sbjct: 115 -----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 85/349 (24%), Positives = 138/349 (39%), Gaps = 48/349 (13%)
Query: 54 NLSFLREIHLSNNTIQG--KIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111
+LS L + L + + + L L +L L+ N L I L + L L L
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDL 123
Query: 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSS 171
N + P + NLKEL + +N + ++PS
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE-------------------------SLPSP 158
Query: 172 LGQLKELKSLGLGGT----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI 227
L L LK+L L +P + NLS L N + N++ LPP + L LS L+ +
Sbjct: 159 LRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSALEELDL 216
Query: 228 SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
SNN + SN NL LE L NN L + G++ +L L+++ N +
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLE-LSNNKLEDLPESIGNLSNLETLDLSNNQI------- 267
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM---DHNQFE 344
S I SL + +NL L+L N ALP I + E+ + L L + ++
Sbjct: 268 -SSISSLGSLTNLRELDLSGNSLSNALP-LIALLLLLLELLLNLLLTLKALELKLNSILL 325
Query: 345 GKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSG 393
+ + L++ + + + + S+L + I+ N N G
Sbjct: 326 NNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIG 374
|
Length = 394 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 37/179 (20%)
Query: 651 IGIGSFGSVYKGT---FDRDG----TIVAIKVLNLQLQGASKS-FAAECRALRNI-RHRN 701
+G G FG V D++ T VA+K+L S +E ++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL------------HPDAIPQTDEEND 749
++ ++ +C+ Q +V +Y G+L +L +P +P EE
Sbjct: 86 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVP---EEQL 137
Query: 750 EIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++L +S A VA ++YL + IH DL N+L+ + + DFGLAR
Sbjct: 138 SFKDL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 50/172 (29%), Positives = 71/172 (41%), Gaps = 31/172 (18%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL---QLQGASKSFAAECRALRNIRHRN 701
FS IG GSFG+VY R+ +VAIK ++ Q + E R L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 702 LVRVITSCSSIDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+I ++G + LV +Y GS + L P L +
Sbjct: 77 ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-----------LQEV 115
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
E ++ + YLH H IH D+K NILL +GDFG A +
Sbjct: 116 EIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG GS G V G VA+K+++L+ Q + E +R+ +H+N+V + S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
G + L+ +++ G+L D + QT ++I ++ V A+
Sbjct: 88 ---LVGEELWVLM-EFLQGGALT-----DIVSQTRLNEEQI--------ATVCESVLQAL 130
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQEVPNNQS 818
YLH + IH D+K +ILL + + DFG A++ ++VP +S
Sbjct: 131 CYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 21/187 (11%)
Query: 651 IGIGSFGSV-----YKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNI-RHRN 701
+G G FG V Y R V + V L+ K A +E ++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR----NLTLL 757
++ ++ C+ Q +V +Y G+L +L P D D + L+
Sbjct: 80 IINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ 817
+ +S A VA ++YL IH DL N+L+ + + DFGLAR ++ +
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 818 SSSVGDL 824
+S G L
Sbjct: 192 KTSNGRL 198
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 25/168 (14%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN- 701
D F S +IG G+FG V G I A+K+L + K A RA R+I
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 702 ---LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
+V++ S FQ L+ +++P G + L + D ++E + E
Sbjct: 60 GAWVVKMFYS-----FQDKRNLYLIMEFLPGGDMMTLLM-----KKDTLSEEATQFYIAE 109
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
+ A+D +H Q IH D+KP N+LLD + DFGL
Sbjct: 110 TVL-------AIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/175 (24%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVR---VI 706
+G G++ +V+KG +VA+K + L+ + GA + E L++++H N+V ++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI-D 765
+ S+ LV++Y+ + L+ ++ D+ N+ + + I +
Sbjct: 74 HTDKSL--------TLVFEYL-DKDLKQYM------------DDCGNIMSMHNVKIFLYQ 112
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ + Y H + +H DLKP N+L++ + DFGLAR + VP S+
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS-VPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 52/177 (29%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN----LQLQGASKSFAAECRALRNIRHRNLVRV 705
+IG GSFG V + A+KVL L+ + + L+N++H LV +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS--IA 763
S FQ D V Y+ G L L R LE + A
Sbjct: 62 HFS-----FQTADKLYFVLDYINGGELFYHLQ--------------RERCFLEPRARFYA 102
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
++ASA+ YLH ++ DLKP NILLD+ + DFGL + E N +S+
Sbjct: 103 AEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTST 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 54/178 (30%), Positives = 73/178 (41%), Gaps = 28/178 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA---ECRALRNIRHRNLVRVIT 707
+G G FG V G + A K LN + K + E R L + R +V +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN---DEIRNLTLLERISIAI 764
+ FQ LV M G L H I DEEN E R +I
Sbjct: 61 A-----FQTKTDLCLVMTIMNGGDLR--YH---IYNVDEENPGFPEPRACFYTAQI---- 106
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
S +++LH Q I+ DLKP N+LLDN+ + D GLA E+ + QS + G
Sbjct: 107 --ISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQSKTKG 156
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D F +IG G+FG V I A+K+LN + + ++ A R RN+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGD 59
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHP--DAIPQTDEENDEIRNLTLLERI 760
+ IT+ FQ ++ LV Y G L L D +P+ + R
Sbjct: 60 CQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED------------MARF 106
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
IA ++ A+ +H Q +H D+KP N+LLD N + DFG
Sbjct: 107 YIA-EMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVR---VI 706
+G GS+ +VYKG G +VA+K + L+ +GA + E L++++H N+V +I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLTLLERISIAI 764
+ ++ LV++Y+ + L+ ++ + N + LL
Sbjct: 73 HTKKTL--------TLVFEYL-DTDLKQYMDDCGGGL---SMHNVRLFLFQLLR------ 114
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ Y H +H DLKP N+L+ + DFGLAR + VP+ S+
Sbjct: 115 ----GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKS-VPSKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 19/175 (10%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK---VLNLQLQGASKSFAAECRALRNIRHRNLVRVIT 707
IG G F VY+ T DG VA+K + +L A E L+ + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S F ++ +V + G L I ++ I T+ + + +
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSR-----MIKHFKKQKRLIPEKTVWKYF---VQLC 116
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
SA++++H +H D+KP+N+ + +GD GL R S VG
Sbjct: 117 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVI 706
L+G G+FG V G A+K+L ++ A A E R L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ FQ +D V +Y G L L + + + R A ++
Sbjct: 62 YA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-----------RFYGA-EI 104
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
SA++YLH ++ D+K N++LD + + DFGL +
Sbjct: 105 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 25/166 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN--- 701
F IGIG+FG V + A+K L + ++ AA +A R+I
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEADNE 61
Query: 702 -LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
+V++ S FQ D V Y+P G + + L I + D L R
Sbjct: 62 WVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED-----------LARF 105
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
IA ++ A++ +H + IH D+KP NIL+D + + DFGL
Sbjct: 106 YIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 23/169 (13%)
Query: 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRN 696
+KA D F +IG G+FG V + A+K+L+ ++ + +F E R +
Sbjct: 40 MKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-- 96
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+ H N ++ + FQ + + +V +YMP G L N + IP+
Sbjct: 97 MAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK------------ 142
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
R A +V A+D +H IH D+KP N+LLD + + DFG
Sbjct: 143 WARFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 29/164 (17%)
Query: 651 IGIGSFGSVYKGTFD-RDGTI-VAIKVLNLQLQGASKSFAAECRALRNIRHR----NLVR 704
+G G+FG V KG + R I VAIKVL KS E I H+ +VR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+I C + LV + G L +L + DEI ++E +
Sbjct: 60 MIGVCEAEALM------LVMEMASGGPLNKFL--------SGKKDEITVSNVVELMH--- 102
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V+ + YL + +H DL N+LL N A + DFGL++
Sbjct: 103 QVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 650 LIGIGSFGSVYKGTFDRD-GTIVAIKVLNLQLQG--ASKSFAA---ECRALRNIRHRNLV 703
L+G G+FG VY +D D G +A K + + SK +A E + L+N++H
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE--- 64
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
R++ + + + +YMP GS+++ L A E +LE +S
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMS-- 120
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813
YLH + +H D+K +NIL D+ +GDFG ++ Q +
Sbjct: 121 --------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 34/190 (17%)
Query: 627 RRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--S 684
R+ L K +E + + + +G G++GSV + G VA+K L+ Q +
Sbjct: 5 RQELNKTIWE----VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 685 KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQT 744
K E R L++++H N++ L+ + P SLE + D T
Sbjct: 61 KRTYRELRLLKHMKHENVI-----------------GLLDVFTPARSLEEF--NDVYLVT 101
Query: 745 DEENDEIRNLTLLERIS------IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798
++ N+ ++++ + + + Y+H IH DLKPSN+ ++ +
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 158
Query: 799 AHVGDFGLAR 808
+ DFGLAR
Sbjct: 159 LKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 31/180 (17%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
NL+ L++ N++ +PS NL +L L L N+LS +P L NL L L L N +
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
S +P EI +S + L+ + N ++ + + NLK L +S+N L
Sbjct: 199 S-DLPPEIELLSALE-ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE---------- 245
Query: 476 FYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDL 535
+P S+ +L +L +DLS N +S I L L+LS N L
Sbjct: 246 ---------------DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSL 289
|
Length = 394 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 54/185 (29%), Positives = 81/185 (43%), Gaps = 14/185 (7%)
Query: 47 SLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRL 106
L + NLS L + LS N I +P EI L LE L LS+NS++ E+ +LS L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 107 IGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG 166
GL L NKLE +P +L NL+ L + N ++ LG++T+L + L+ NSL
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291
Query: 167 NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQ 226
+P L L+ L L L + N + + S+ +
Sbjct: 292 ALPLIALLLLLLELLLN---------LLLTLKALELKLNSILLNNNILSNGETSSPEALS 342
Query: 227 ISNNF 231
I +
Sbjct: 343 ILESL 347
|
Length = 394 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 20/163 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G+FG VYK G A K++ ++ + + F E L +H N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---- 68
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
F N L+ ++ G+L++ + T+ +IR + + A+
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIMLELERGLTE---PQIR--------YVCRQMLEAL 116
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL-ARLRQE 812
++LH H IH DLK NILL + + DFG+ A+ +
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 44/205 (21%)
Query: 614 RGGSGKEP--SEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIV 671
R GS K+P +E + K+ F+ IG GSFG+VY R +V
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKL-----------FTDLREIGHGSFGAVYFARDVRTNEVV 53
Query: 672 AIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVITSCSSIDFQGNDFKA----LVY 724
AIK ++ + +++ + E + L+ I+H N SI+++G + LV
Sbjct: 54 AIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN---------SIEYKGCYLREHTAWLVM 104
Query: 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHC 784
+Y GS + L P L +E +I + YLH H IH
Sbjct: 105 EYCL-GSASDLLEVHKKP-----------LQEVEIAAITHGALQGLAYLHSH---NMIHR 149
Query: 785 DLKPSNILLDNNLTAHVGDFGLARL 809
D+K NILL + DFG A +
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 47/165 (28%), Positives = 69/165 (41%), Gaps = 23/165 (13%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVL---NLQLQGASKSFAAECRALRNIRHRN 701
F +GIG+FG V + A+K L ++ L+ AE L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+VR+ S FQ D V Y+P G + + L I D L R
Sbjct: 63 VVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED-----------LARFY 106
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
IA ++ AV+ +H + IH D+KP NIL+D + + DFGL
Sbjct: 107 IA-ELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 45/175 (25%)
Query: 650 LIGIGSFGSVY---KGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI----RHRNL 702
++G G +G V+ K T G I A+KVL ++ A +A RNI +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V +I + FQ L+ +Y+ G L LER I
Sbjct: 63 VDLIYA-----FQTGGKLYLILEYLSGGEL---------------------FMHLEREGI 96
Query: 763 AI-DVAS--------AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ D A A+++LH Q+ I+ DLKP NILLD + DFGL +
Sbjct: 97 FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 39/184 (21%)
Query: 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRAL 694
++ + T+ + +G+G+FG V G VAIK + +K E + L
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63
Query: 695 RNIRHRNLVRV----ITSCSSIDF----QGNDFKALVYQYMPNGSLENWLHPDAIPQTDE 746
+++RH N++ + I+ I F G D L + + LE Q +
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLE--------KQFIQ 111
Query: 747 ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
+ + Y+H +H DLKPSNIL++ N + DFGL
Sbjct: 112 --------------YFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL 154
Query: 807 ARLR 810
AR++
Sbjct: 155 ARIQ 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 25/169 (14%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN- 701
+ F + +IG G+FG V G I A+K L L+ + K A +A R++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 702 ---LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
+V + S FQ + L+ +++P G L L + D ++++ + E
Sbjct: 60 SPWVVSLYYS-----FQDAQYLYLIMEFLPGGDLMTML-----IKYDTFSEDVTRFYMAE 109
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ +AI+ + + IH D+KP NIL+D + DFGL+
Sbjct: 110 CV-LAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 19/172 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G+FG VYK G + A KV+ + + + + E L H +V+++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
F + ++ ++ P G++ DAI E D R LT + I + A+
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAV------DAIML---ELD--RGLTEPQIQVICRQMLEAL 123
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
YLH IH DLK N+LL + + DFG++ + + S +G
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIG 172
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 650 LIGIGSFGSVYKGTFDRD-GTIVAIKVLNLQ--LQGASKSF-AAEC--RALRNIRHRNLV 703
L+G G+FG VY +D D G +A+K + Q SK A EC + L+N+RH +V
Sbjct: 9 LLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-- 761
+ C D + V +YMP GS+++ L L E ++
Sbjct: 68 QYY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQLKAYG--------------ALTENVTRR 110
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813
+ V YLH + +H D+K +NIL D+ +GDFG ++ Q +
Sbjct: 111 YTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 25/168 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G GS G V+ VA+K + L + K E + +R + H N+V+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDA--IPQTDEENDEIRNLTLLERIS------I 762
G+D + + ++ I Q E D + N+ +S
Sbjct: 73 P---SGSDL---------TEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHARLF 119
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARL 809
+ + Y+H +H DLKP+N+ ++ +L +GDFGLAR+
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 30/166 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVITS 708
+G G++GSV R VA+K L+ Q ++ E R L++++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVI----- 77
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS------I 762
L+ + P S+EN+ + T+ ++ N+ +++S +
Sbjct: 78 ------------GLLDVFTPATSIENF--NEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + Y+H IH DLKPSN+ ++ + + DFGLAR
Sbjct: 124 IYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D F +IG G+FG V G + A+K+LN + + ++ A R R++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-KWEMLKRAETACFREERDVLVNGD 59
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHP--DAIPQTDEENDEIRNLTLLERI 760
R IT+ FQ + LV Y G L L D +P+ + R
Sbjct: 60 RRWITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED------------MARF 106
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+A ++ A+D +H Q +H D+KP N+LLD N + DFG
Sbjct: 107 YLA-EMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 41/166 (24%), Positives = 82/166 (49%), Gaps = 29/166 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAA---ECRALRNIRHRNLV 703
++G G++G+VY G ++ G ++A+K + L A K + E L++++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHP-DAIPQTDEENDEIRNLTLLERISI 762
+ + +C N ++ +++P GS+ + L+ +P+ + + +
Sbjct: 66 QYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEP-----------VFCKYTK 109
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I V YLH++C +H D+K +N++L N + DFG AR
Sbjct: 110 QI--LDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 40/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G+FG VYK G + A KV++ + + + + E L + H N+V+++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ N+ L+ ++ G+++ + P T+ + + TL A+
Sbjct: 72 ---YYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----------EAL 116
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+YLH + IH DLK NIL + + DFG++ + S +G
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 165
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
++G G++G VY +AIK + + + E ++HRN+V+ + S
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI-RNLTLLERISIAIDVAS 768
S + FK + Q +P GSL L P D E I +LE
Sbjct: 75 S----ENGFFKIFMEQ-VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE---------- 119
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVGDFGLAR 808
+ YLH +H D+K N+L++ + + DFG ++
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 31/167 (18%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS------KSFAAECRALRNIRHRNLV 703
+G G+F S Y+ + GT++A+K + +S ++ E R + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
R + + F V ++M GS+ + L + + L
Sbjct: 67 R----MLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR------- 114
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH---VGDFGLA 807
+ YLH + IH D+K +N+L+D+ T + DFG A
Sbjct: 115 -----GLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAA 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 27/176 (15%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHR 700
D + IG G++G VYK G +VA+K L++ +G + E L+ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 701 N-LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL------HPDAIPQTDEENDEIRN 753
+VR++ + G LV++Y+ + L+ ++ +P I++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAK-----TIKS 114
Query: 754 LTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA-HVGDFGLAR 808
+A + H H +H DLKP N+L+D + D GL R
Sbjct: 115 FMYQLLKGVA--------HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G++G VYK G + A+K++ L+ E ++ +H N+V S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ + + +Y GSL++ H L+ L+ + + +
Sbjct: 75 ---YLSREKLWICMEYCGGGSLQDIYHVTG------------PLSELQIAYVCRETLQGL 119
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
YLH + +H D+K +NILL +N + DFG+A
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 28/68 (41%), Positives = 36/68 (52%), Gaps = 5/68 (7%)
Query: 743 QTDEENDEIRN--LTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800
+ DEE DE+ LTL + IS + VA +++L IH DL NILL N
Sbjct: 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 213
Query: 801 VGDFGLAR 808
+ DFGLAR
Sbjct: 214 ICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 16/28 (57%), Positives = 21/28 (75%)
Query: 782 IHCDLKPSNILLDNNLTAHVGDFGLARL 809
+H DLKPSN+LL+ N + DFGLAR+
Sbjct: 128 LHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
+ F +IG G+FG V + A+K+LN + + ++ A R R++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGD 59
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHP--DAIPQTDEENDEIRNLTLLERI 760
+ IT+ FQ + LV Y G L L D +P+ ++ L E +
Sbjct: 60 NQWITTLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE------DMARFYLAEMV 112
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
IAID +V LH+ +H D+KP NIL+D N + DFG
Sbjct: 113 -IAID---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 47/161 (29%), Positives = 68/161 (42%), Gaps = 21/161 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIRHRNLVRVITS 708
IG GSFG +Y D IK ++L + A+ E L ++H N+V S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
FQ N +V +Y G L ++ E D+I L+ +IS+
Sbjct: 68 -----FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE--DQI--LSWFVQISLG----- 113
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNN-LTAHVGDFGLAR 808
L H +H D+K NI L N + A +GDFG+AR
Sbjct: 114 ----LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 25/168 (14%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN- 701
+ F S +IG G+FG V G + A+K+L + K RA R+I
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEAD 59
Query: 702 ---LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
+V++ S FQ L+ +++P G + L + D +E + E
Sbjct: 60 SLWVVKMFYS-----FQDKLNLYLIMEFLPGGDMMTLLM-----KKDTLTEEETQFYIAE 109
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
+ A+D +H Q IH D+KP N+LLD+ + DFGL
Sbjct: 110 TVL-------AIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 55/187 (29%), Positives = 78/187 (41%), Gaps = 29/187 (15%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK--SFAAECRALRNIRHR 700
F L+G G FG V G I A+KV+ + A + SF E R+I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILSI 57
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLTLLE 758
+ I FQ D LV +Y P G L + L + D Q DE+ +
Sbjct: 58 SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDED---------MA 104
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFG-LARLRQEVPN 815
+ +A ++ A+ +H Q +H D+KP N+L+D T H+ DFG ARL
Sbjct: 105 QFYLA-ELVLAIHSVH---QMGYVHRDIKPENVLIDR--TGHIKLADFGSAARLTANKMV 158
Query: 816 NQSSSVG 822
N VG
Sbjct: 159 NSKLPVG 165
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 23/161 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G++GSVYK G +A+K + L+L + F L +I H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMEL-DILHKAVSPYI---- 61
Query: 711 SIDFQGNDF-KALVY---QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+DF G F + VY +YM GSL+ + E+ +L RI+ A V
Sbjct: 62 -VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED-------VLRRITYA--V 111
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ +L + IH D+KP+N+L++ N + DFG++
Sbjct: 112 VKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 81 RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNL 140
L++L LS+N L G L L L N L P F L +L+ L + NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 9e-04
Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 478 LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
L+ + ++ N + L +L+ +DLS NNL+ P + LP L L+LS N+L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 24/78 (30%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
L G +P + L +LQ +S N G+ P + + ++L+ L++ N+F G + + G
Sbjct: 430 LRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 267 MKSLAYLNVAINNLGSGE 284
+ SL LN+ N+L SG
Sbjct: 489 LTSLRILNLNGNSL-SGR 505
|
Length = 623 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 34/173 (19%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D F +G G+ G V+K + G I+A K+++L+++ A+RN R L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK----------PAIRNQIIREL 54
Query: 703 VRVITSCSS---IDFQGNDFK----ALVYQYMPNGSLENWLHPDA-IPQTDEENDEIRNL 754
+V+ C+S + F G + ++ ++M GSL+ L IP+
Sbjct: 55 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------- 103
Query: 755 TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+L ++SIA V + YL + +H D+KPSNIL+++ + DFG++
Sbjct: 104 -ILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 18/46 (39%), Positives = 30/46 (65%), Gaps = 2/46 (4%)
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
IA+ + A++YLH + IH D+KPSN+L++ N + DFG++
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 21/160 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
+G G FG V G + A K L+ L+ + + E + L + R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
+ F+ D LV M G L+ ++ P E I A +
Sbjct: 57 -SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA----------RAIFYAAQII 105
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+++LH Q ++ DLKP N+LLD++ + D GLA
Sbjct: 106 CGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 35/170 (20%)
Query: 651 IGIGSFGSVYKGT---FDRDGTI--VAIKVLNLQLQGASK-SFAAECRALRNI-RHRNLV 703
+G G+FG V + T + + VA+K+L + + + +E + + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN----LTLLER 759
++ +C+ G ++ +Y G L N+L R LTL +
Sbjct: 103 NLLGACTI---GGPIL--VITEYCCYGDLLNFLR--------------RKRESFLTLEDL 143
Query: 760 ISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+S + VA + +L +C IH DL N+LL + + DFGLAR
Sbjct: 144 LSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 49/166 (29%), Positives = 70/166 (42%), Gaps = 33/166 (19%)
Query: 651 IGIGSFGSV----YKGTFDRDGTIVAIKVLNLQLQGASKS---FAAECRALRNIRHRNLV 703
+G GSFG V +KGT G AIK L + K A E L + H +V
Sbjct: 26 LGTGSFGRVRIAKHKGT----GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDA-IPQTDEENDEIRNLTLLERISI 762
++ S FQ + + +++ G L L P ND + +
Sbjct: 82 NMMCS-----FQDENRVYFLLEFVVGGELFTHLRKAGRFP-----ND-------VAKFYH 124
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A ++ A +YLH + I+ DLKP N+LLDN V DFG A+
Sbjct: 125 A-ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 21/55 (38%), Positives = 31/55 (56%), Gaps = 5/55 (9%)
Query: 758 ERI--SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA-RL 809
E I + + + A+ YL + IH D+KPSNILLD + + DFG++ RL
Sbjct: 113 EDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 42/156 (26%), Positives = 62/156 (39%), Gaps = 28/156 (17%)
Query: 654 GSFGSVYKGTF--DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSS 711
GS G V+ T D V +K + K+ E L+ I HR ++ +I +
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR- 156
Query: 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVD 771
+K+ V MP + + + D L L + I+I + A+
Sbjct: 157 -------WKSTVCMVMPKYKCDLFTYVDR----------SGPLPLEQAITIQRRLLEALA 199
Query: 772 YLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
YLH IH D+K NI LD A +GDFG A
Sbjct: 200 YLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 31/166 (18%)
Query: 651 IGIGSFGSV---YKGTFDRDGTIVAIKVLN--LQLQGASKSFAAECRALRNIRHRNLVRV 705
IG G+ G V Y DR+ VAIK L+ Q Q +K E ++ + H+N++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII-- 79
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN-DEIRNLTL-LERISIA 763
+L+ + P SLE + + + + N ++ + L ER+S
Sbjct: 80 ---------------SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 764 I-DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 125 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN--LQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G+ G V G VA+K L+ Q Q +K E L+ + H+N++ ++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN-DEIRNLTL-LERISIAI-D 765
+ P SLE + + + + N ++ ++ L ER+S +
Sbjct: 89 -----------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 42/172 (24%), Positives = 68/172 (39%), Gaps = 26/172 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECRALRNIRHRNLVRVI 706
LIG G G VY VA+K + L K F E + ++ H +V V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 707 TSCSSIDFQGNDFKALVYQYMP-------NGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
+ CS D VY MP L++ +++ + E +
Sbjct: 69 SICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF----- 115
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811
+SI + + ++Y+H + +H DLKP NILL + D+G A ++
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164
|
Length = 932 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 42/167 (25%), Positives = 70/167 (41%), Gaps = 23/167 (13%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL----QGASKSFAAECRALRNIRHR 700
F ++G G FG V G + A K L + +G S + E + L + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
+V + + ++ D LV M G L+ ++ P +EE +
Sbjct: 61 FVVNLAYA-----YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE----------RAL 105
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
A ++ ++ LH +E T++ DLKP NILLD+ + D GLA
Sbjct: 106 FYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 628 RALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASK 685
R +RK+ +KA D + +IG G+FG V + A+K+L+ ++ +
Sbjct: 33 RKIRKLQ----MKAED-YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 686 SFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD 745
+F E R + + V V C+ FQ + + +V +YMP G L N + +P+
Sbjct: 88 AFFWEERDIMAFANSPWV-VQLFCA---FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK- 142
Query: 746 EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+ A +V A+D +H IH D+KP N+LLD + + DFG
Sbjct: 143 -----------WAKFYTA-EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 12/24 (50%), Positives = 14/24 (58%), Gaps = 1/24 (4%)
Query: 6 PEGVLNSWNDSH-HFCDWEGITCS 28
P G L+SWN S C W G+TC
Sbjct: 19 PSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 35/167 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA-AECRALRNIR-HRNLVRVI-- 706
IG G+F V K + G AIK + + + E +ALR + H N++R+I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 707 -----TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
T ++ F+ D +Y+ + + P E R + + ++
Sbjct: 67 LFDRKTGRLALVFELMDMN--LYELI-----KGRKRP---------LPEKRVKSYMYQL- 109
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++D++H + H D+KP NIL+ ++ + DFG R
Sbjct: 110 -----LKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 31/172 (18%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN--LQLQGASKSFAAECRALRNIRHRNL 702
+ + IG G+ G V G VAIK L+ Q +K E ++ + H+N+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 703 VR---VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+ V T S++ +F+ LV + M + +L + D D E
Sbjct: 78 IGLLNVFTPQKSLE----EFQDVYLVMELM-DANLCQVIQMD----LDHE---------- 118
Query: 758 ERISIAI-DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
R+S + + + +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 119 -RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 650 LIGIGSFGSVYKGTFDRD-GTIVAIKVLNLQLQGASKS---FAAEC--RALRNIRHRNLV 703
L+G G+FG VY +D D G +A+K + + S A EC + L+N+ H +V
Sbjct: 9 LLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-- 761
+ D ++ ++MP GS+++ L L E ++
Sbjct: 68 QYYGCLR--DPMERTL-SIFMEHMPGGSIKDQLKSYG--------------ALTENVTRK 110
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813
+ V YLH + +H D+K +NIL D+ +GDFG ++ Q +
Sbjct: 111 YTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRN 696
+KA D + +IG G+FG V + A+K+L+ ++ + +F E R +
Sbjct: 40 MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+ V + FQ + + +V +YMP G L N + +P+
Sbjct: 99 FANSPWVVQLFYA----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK------------ 142
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
R A +V A+D +H IH D+KP N+LLD + + DFG
Sbjct: 143 WARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 19/175 (10%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK---VLNLQLQGASKSFAAECRALRNIRHRNLVRVIT 707
IG G F VY+ T D VA+K + + A + E L+ + H N+++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S F ++ +V + G L I ++ I T+ + + +
Sbjct: 70 S-----FIEDNELNIVLELADAGDLSQ-----MIKYFKKQKRLIPERTVWKYF---VQLC 116
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
SAV+++H +H D+KP+N+ + +GD GL R S VG
Sbjct: 117 SAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 16/27 (59%), Positives = 20/27 (74%)
Query: 782 IHCDLKPSNILLDNNLTAHVGDFGLAR 808
+H DLKPSN+LL+ N + DFGLAR
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 44/162 (27%), Positives = 62/162 (38%), Gaps = 27/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECR---ALRNIRHRNLVR 704
+G G FG V + + G + AIK L A +S E R + RH LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ +C FQ D V +Y G L +H D + + A
Sbjct: 67 LF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-------------RAVFYAA 108
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
V + YLH + ++ DLK N+LLD + DFGL
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 21/126 (16%)
Query: 682 GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAI 741
G A E LR I H +++++ + F N F L+ +P + + + A
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGT-----FTYNKFTCLI---LPRYKTDLYCYLAAK 176
Query: 742 PQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801
RN+ + + ++I V A+ YLH + IH D+K NI +++ +
Sbjct: 177 ----------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL 223
Query: 802 GDFGLA 807
GDFG A
Sbjct: 224 GDFGAA 229
|
Length = 391 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHRNL 702
F ++G G++G V K IVAIK + + + ++ E + LR ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL-HPDAIPQTDEENDEIRNLTLLERIS 761
V + + F+ LV++Y+ LE P+ +P +++R S
Sbjct: 63 VELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-----EKVR--------S 104
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ A+ + H + +H D+KP N+L+ +N + DFG AR
Sbjct: 105 YIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 35/166 (21%)
Query: 650 LIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNL 702
++G G FG + +G + VAI L G S + F AE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 703 VR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
VR VIT +++ +V +YM NG+L+++L L +
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHE-----------GQLVAGQL 109
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+ + +AS + YL + +H L +L++++L + F
Sbjct: 110 MGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 15/33 (45%), Positives = 21/33 (63%)
Query: 782 IHCDLKPSNILLDNNLTAHVGDFGLARLRQEVP 814
+H DLKP N+L++ + + DFGLAR E P
Sbjct: 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGT--IVAIKVL--NLQLQGAS-KSFAAECRALRNIRHRNLVR 704
++G GSFG V + GT + AIKVL ++ LQ E R L +
Sbjct: 2 VLGKGSFGKVMLA--ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ C FQ D V +Y+ G L + Q + DE R+ A
Sbjct: 60 ALHCC----FQTKDRLFFVMEYVNGGDLMFQI------QRSRKFDEPRSRFY------AA 103
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+V A+ +LH H I+ DLK NILLD + DFG+ +
Sbjct: 104 EVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.97 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.94 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.94 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.9 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.9 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.9 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.9 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.9 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.9 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.9 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.9 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.9 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.9 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.89 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.89 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.89 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.89 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.89 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.88 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.88 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.88 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.88 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.88 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.88 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.88 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.88 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.87 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.87 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.87 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.87 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.87 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.87 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.87 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.87 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.87 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.87 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.87 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.87 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.87 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.87 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.87 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.86 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.86 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.86 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.86 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.86 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.86 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.86 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.86 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.86 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.86 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.86 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.86 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.86 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.86 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.86 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.86 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.86 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.86 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.86 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.85 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.85 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.85 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.85 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.85 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.85 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.85 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.85 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.85 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.85 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.85 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.85 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.85 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.85 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.85 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.85 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.85 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.85 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.85 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.85 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.85 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.85 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.84 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.84 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.84 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.84 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.84 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.84 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.84 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.84 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.84 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.84 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.84 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.84 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.84 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.84 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.84 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.84 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.84 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.84 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.84 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.84 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.84 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.83 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.83 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.83 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.83 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.83 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.83 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.83 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.83 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.83 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.83 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.83 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.83 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.83 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.83 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.82 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.82 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.82 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.82 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.82 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.82 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.82 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.82 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.82 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.82 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.82 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.82 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.81 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.81 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.81 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.81 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.81 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.81 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.81 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.81 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.81 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.81 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.8 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.8 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.8 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.8 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.8 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.8 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.79 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.79 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.79 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.79 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.79 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.78 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.78 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.78 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.77 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.77 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.77 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.76 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.7 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.69 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.65 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.6 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.59 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.47 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.43 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.2 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.13 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.07 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.03 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.97 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.96 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.81 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.81 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.71 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.45 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.29 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.25 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.21 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.18 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.18 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.16 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-95 Score=901.33 Aligned_cols=758 Identities=33% Similarity=0.532 Sum_probs=602.7
Q ss_pred CCcccccCCCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCcccc-CCCCCC
Q 003368 5 YPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIG-RLFRLE 83 (825)
Q Consensus 5 ~~~~~~~~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~ 83 (825)
||.+++.+|..+++||.|.|++|.. ..+|+.|||++|++.+.+++.+..+++|+.|+|++|++++.+|..+. .+++|+
T Consensus 43 ~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~ 121 (968)
T PLN00113 43 DPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121 (968)
T ss_pred CCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCC
Confidence 6888899998888999999999985 46899999999999999999999999999999999999988887755 899999
Q ss_pred EEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCc
Q 003368 84 ALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS 163 (825)
Q Consensus 84 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 163 (825)
+|+|++|++++.+|. ..+++|++|+|++|.+++.+|..|+++++|++|+|++|.+++.+|..|+++++|++|+|++|+
T Consensus 122 ~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199 (968)
T ss_pred EEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCC
Confidence 999999999887775 457888888888888888888888888888888888888888888888888888888888888
Q ss_pred CcccCCcccccccccceecCcC-----cCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCc
Q 003368 164 LGGNIPSSLGQLKELKSLGLGG-----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL 238 (825)
Q Consensus 164 l~~~~p~~~~~l~~L~~L~L~~-----~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~ 238 (825)
+++.+|..|+++++|+.|+|++ .+|..+.+++.|+.|++++|++++.+|..+. .+++|+.|+|++|.+++.+|.
T Consensus 200 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~ 278 (968)
T PLN00113 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPP 278 (968)
T ss_pred CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCch
Confidence 8888888888888888888764 4677788888888888888888887887776 788888888888888888888
Q ss_pred cccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCc
Q 003368 239 AFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI 318 (825)
Q Consensus 239 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 318 (825)
.+.++++|+.|+|++|++.+.+|..+..+++|+.|+++.|.+.... |..+..+++|+.|++++|.+++.+|..+
T Consensus 279 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~l~~L~~L~L~~n~l~~~~p~~l 352 (968)
T PLN00113 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI------PVALTSLPRLQVLQLWSNKFSGEIPKNL 352 (968)
T ss_pred hHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC------ChhHhcCCCCCEEECcCCCCcCcCChHH
Confidence 8888888888888888888888888888888888888888775422 4455666667777777666665433211
Q ss_pred ---------------ccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcE
Q 003368 319 ---------------VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383 (825)
Q Consensus 319 ---------------~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 383 (825)
+.+.+|..+..+.+|+.|++++|.+.+.+|..++.+++|+.|+|++|++++.+|..|..+++|+.
T Consensus 353 ~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 432 (968)
T PLN00113 353 GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432 (968)
T ss_pred hCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCE
Confidence 12356666677777777777777777777777788888888888888888888888888888888
Q ss_pred EEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCce
Q 003368 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNN 463 (825)
Q Consensus 384 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 463 (825)
|++++|.+++.+|..+..+++|+.|++++|++.|.+|..+. ...+ +.|++++|++++.+|..+.+++.|+.|++++|+
T Consensus 433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 510 (968)
T PLN00113 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510 (968)
T ss_pred EECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccc-eEEECcCCccCCccChhhhhhhccCEEECcCCc
Confidence 88888888888887788888888888888888887777543 3444 689999999999999999999999999999999
Q ss_pred ecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCC
Q 003368 464 LSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTK 542 (825)
Q Consensus 464 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~ 542 (825)
++|.+|..++.+++|++|++++|.++|.+|..+..+++|+.|||++|+++|.+|..+..+ .|+++++++|+++|.+|..
T Consensus 511 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~ 590 (968)
T PLN00113 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590 (968)
T ss_pred ceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence 999999999999999999999999999999999999999999999999999999999888 6999999999999999999
Q ss_pred CccCccccccccCCCCCCCCCCCCcCCCCCCCCCCCCcccccceeEEEEeehhhhhhHHHHHHHHhhhhhhcCCC--CCC
Q 003368 543 GIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGVLKVIISTCSVFSGLLLGSFFIFYWLRRRGGS--GKE 620 (825)
Q Consensus 543 ~~~~~~~~~~~~~n~~~lc~~~~~~~~~~~~~~~~~~~~~~~~~~~iii~~~~v~~~l~~~~~~~~~~~r~~~~~--~~~ 620 (825)
++|.++...++.||+ .+|+..+....++|.... +. .. ...++++++++++ ++++++++++++|+|+.. ...
T Consensus 591 ~~~~~~~~~~~~~n~-~lc~~~~~~~~~~c~~~~--~~-~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 663 (968)
T PLN00113 591 GAFLAINASAVAGNI-DLCGGDTTSGLPPCKRVR--KT-PS--WWFYITCTLGAFL-VLALVAFGFVFIRGRNNLELKRV 663 (968)
T ss_pred chhcccChhhhcCCc-cccCCccccCCCCCcccc--cc-ce--eeeehhHHHHHHH-HHHHHHHHHHHHHhhhccccccc
Confidence 999999999999998 899876555566775321 11 11 1111111111111 122222222222222211 110
Q ss_pred CC-chHHh------hhcccccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHH
Q 003368 621 PS-EPILR------RALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRA 693 (825)
Q Consensus 621 ~~-~~~~~------~~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~ 693 (825)
+. ..... .....++++++. ..|...++||+|+||.||+|++..+|+.||||+++..... ..+|++.
T Consensus 664 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~ 736 (968)
T PLN00113 664 ENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIAD 736 (968)
T ss_pred ccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHH
Confidence 00 00000 011223444443 3567788999999999999999889999999998644321 2356889
Q ss_pred hhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHH
Q 003368 694 LRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYL 773 (825)
Q Consensus 694 l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yL 773 (825)
+++++|||||+++|+|.. ++..++||||+++|+|.++++ .++|.++.+||.|+|+|++||
T Consensus 737 l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~---------------~l~~~~~~~i~~~ia~~L~yL 796 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR---------------NLSWERRRKIAIGIAKALRFL 796 (968)
T ss_pred HhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh---------------cCCHHHHHHHHHHHHHHHHHh
Confidence 999999999999999753 456899999999999999983 378999999999999999999
Q ss_pred HhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 774 HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 774 H~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
|+.+.++|+|||+||+||+++.++.+++. ||.++.
T Consensus 797 H~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred ccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 98877899999999999999999988876 666544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=574.07 Aligned_cols=496 Identities=34% Similarity=0.538 Sum_probs=444.8
Q ss_pred CcEEEEECCCCCCccccCcCCC-CCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIG-NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+++.|||++|++.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..|+++++|++|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 170 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence 5799999999999999998765 999999999999999988885 4688999999999999999999999999999999
Q ss_pred cCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcC-----
Q 003368 111 LGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----- 185 (825)
Q Consensus 111 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~----- 185 (825)
|++|.+.+.+|..|+++++|++|+|++|++++.+|..|+++++|+.|+|++|++++.+|..|+++++|++|++++
T Consensus 171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 250 (968)
T PLN00113 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250 (968)
T ss_pred CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence 999999989999999999999999999999999999999999999999999999999999999999999999874
Q ss_pred cCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcC
Q 003368 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFG 265 (825)
Q Consensus 186 ~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 265 (825)
.+|..+.+++.|+.|++++|++++.+|..+. .+++|++|+|++|.+++.+|..+.++++|+.|++++|.+.+..|..+.
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 329 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHh
Confidence 5788899999999999999999988888887 889999999999999999999999999999999999999999998899
Q ss_pred CCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCc---------------ccccCCccccCC
Q 003368 266 DMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI---------------VSGSIPSEIGKL 330 (825)
Q Consensus 266 ~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------------~~~~ip~~l~~l 330 (825)
.+++|+.|+++.|.+... .|..+..+++|+.|++++|++++.+|..+ +.+.+|..+..+
T Consensus 330 ~l~~L~~L~L~~n~l~~~------~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~ 403 (968)
T PLN00113 330 SLPRLQVLQLWSNKFSGE------IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403 (968)
T ss_pred cCCCCCEEECcCCCCcCc------CChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCC
Confidence 999999999999888642 25566777888888888888887666532 234788889999
Q ss_pred CCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeec
Q 003368 331 VSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410 (825)
Q Consensus 331 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 410 (825)
++|+.|++++|++++.+|..|..+++|++|++++|.+.+.+|..+..+++|++|+|++|++.+.+|..+ ..++|+.|++
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 999999999999999999999999999999999999999999999999999999999999999999866 4689999999
Q ss_pred CCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCC
Q 003368 411 FQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRG 490 (825)
Q Consensus 411 ~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 490 (825)
++|+++|.+|..+.++..+ ..|++++|++.+.+|..++++++|+.|++++|.++|.+|..++.+++|+.|+|++|+++|
T Consensus 483 s~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 561 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561 (968)
T ss_pred cCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence 9999999999999888887 689999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccccCCCCCCEEECCCCccccccCcccccccCceeeCCCCc-ceec
Q 003368 491 SIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFND-LEGQ 538 (825)
Q Consensus 491 ~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~L~~l~ls~N~-l~g~ 538 (825)
.+|..+..+++|+.||+++|+++|.+|..-.-..+....+.+|. ++|.
T Consensus 562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~ 610 (968)
T PLN00113 562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610 (968)
T ss_pred cCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCC
Confidence 99999999999999999999999999965322234444556664 4543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=358.20 Aligned_cols=455 Identities=26% Similarity=0.422 Sum_probs=299.8
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
.++.+++++|.+. .+.+.+.+|..|+.|++++|++. ..|++++.+..++.|+.|+|+++ .+|..+..+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 5777889999885 56667889999999999999998 78899999999999999999998 888999999999999999
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCc----CcCC
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG----GTIP 188 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~----~~~p 188 (825)
+|.+. ..|+.++.+..|..|+..+|+++ ..|+.+.++.+|..|++.+|+++...|..+. ++.|+.|+.. +.+|
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP 199 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLP 199 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCC
Confidence 99998 67888999999999999999999 6788888999999999999999865555555 9999999876 3678
Q ss_pred ccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCC
Q 003368 189 PSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268 (825)
Q Consensus 189 ~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 268 (825)
+.++.+..|..|++..|++. .+| ++. ..+.|.+|+++.|+|+-......+++++|.+|||.+|++. ..|+.+.-+.
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr 275 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR 275 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence 88888888888888888887 677 444 6777888888888887433344558888888888888875 5677777888
Q ss_pred CCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCccc----------------------------
Q 003368 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS---------------------------- 320 (825)
Q Consensus 269 ~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~---------------------------- 320 (825)
+|.+||+|+|.++.. |..++++ .|++|-+.+|.+.. +...+++
T Consensus 276 sL~rLDlSNN~is~L-------p~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 276 SLERLDLSNNDISSL-------PYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred hhhhhcccCCccccC-------Ccccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 888888888888764 5567777 78888888887652 1111100
Q ss_pred -ccCCc----cccCCCCcCEEEcccCcccccCCccccCCCC---CCEEEccccccccccCccccCCCCCcE-EEcccCcc
Q 003368 321 -GSIPS----EIGKLVSLYLIEMDHNQFEGKIPEEMSRLQN---LQFLNMRHNQLSGEIPSSFGNLSSLVK-LILGNNNL 391 (825)
Q Consensus 321 -~~ip~----~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l 391 (825)
+..|+ ....+.+.+.|+++.-+++ .+|+....... .+..+++.|++. ++|..+..+..+.+ +.+++|.+
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 01111 1122334445555555555 33433322222 455555555555 45554444444332 23333333
Q ss_pred ccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCcc
Q 003368 392 SGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSE 471 (825)
Q Consensus 392 ~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 471 (825)
+-+|..++.+++|..|+|++|-+. .+|.+++.+..+ +.+|++.|+|. .+|..+-.+..++.+-.++|++...-|+.
T Consensus 425 -sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L-q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 425 -SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL-QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG 500 (565)
T ss_pred -ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhh-heecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence 244555555555555555555554 455554444443 44444444443 34444444444444444444444322233
Q ss_pred ccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccc
Q 003368 472 IGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLS 513 (825)
Q Consensus 472 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~ 513 (825)
+.++..|..|||.+|.+. .+|+.+++|++|++|++++|.|.
T Consensus 501 l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 444444444444444444 44444444444444444444444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=352.25 Aligned_cols=431 Identities=25% Similarity=0.422 Sum_probs=370.1
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.-++.++++.|++. .+|++++.+..++.|+.++|++. .+|..++.+.+|..|+.++|.+. ..|+.++.+..|+.|+.
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 35788999999986 78889999999999999999999 89999999999999999999998 88889999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCc----C
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT----I 187 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~----~ 187 (825)
.+|+|+ ..|+++.++.+|..|++.+|+++...|..+. ++.|++||...|-++ .+|..++.+.+|..|+|..+ +
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l 221 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL 221 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC
Confidence 999999 7899999999999999999999955555554 999999999999996 88999999999999999853 4
Q ss_pred CccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCC
Q 003368 188 PPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267 (825)
Q Consensus 188 p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 267 (825)
| .|..++.|.+++++.|.+. .+|...+..++++.+|||.+|+++ ..|..+..+.+|++||+|+|.+++ +|..+++|
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 5 8899999999999999998 899999999999999999999998 578899999999999999999875 67889999
Q ss_pred CCCcEEEcccccCCCCCCC-------------------------------cccc----ccccccCCCCCEEEcccccccc
Q 003368 268 KSLAYLNVAINNLGSGESD-------------------------------EMSF----IHSLANCSNLSFLNLVANQFKG 312 (825)
Q Consensus 268 ~~L~~L~ls~N~l~~~~~~-------------------------------~~~~----~~~~~~l~~L~~L~L~~N~l~~ 312 (825)
.|+.|-+.+|.+..+..+ ..+. ......+.+.+.|+++.-+++
T Consensus 298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt- 375 (565)
T KOG0472|consen 298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT- 375 (565)
T ss_pred -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-
Confidence 999999999987532110 0000 011223446778888888887
Q ss_pred cCCCCcccccCCccccCCCC---cCEEEcccCcccccCCccccCCCCCCE-EEccccccccccCccccCCCCCcEEEccc
Q 003368 313 ALPHSIVSGSIPSEIGKLVS---LYLIEMDHNQFEGKIPEEMSRLQNLQF-LNMRHNQLSGEIPSSFGNLSSLVKLILGN 388 (825)
Q Consensus 313 ~~~~~~~~~~ip~~l~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (825)
.+|.+...... .+..+++.|++. .+|..+..++.+.+ +.+++|.++ .+|..++.+++|..|+|++
T Consensus 376 ---------~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~N 444 (565)
T KOG0472|consen 376 ---------LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSN 444 (565)
T ss_pred ---------cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeeccc
Confidence 78887665555 788999999998 78888877776554 566777776 8999999999999999999
Q ss_pred CccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccC
Q 003368 389 NNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468 (825)
Q Consensus 389 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~ 468 (825)
|-+. .+|.+++.+..|+.|+++.|+|. .+|+.+.....+ +.+-.++|++...-|..+.++.+|.+|||.+|.+. .|
T Consensus 445 N~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~l-Etllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~I 520 (565)
T KOG0472|consen 445 NLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTL-ETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QI 520 (565)
T ss_pred chhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHH-HHHHhccccccccChHHhhhhhhcceeccCCCchh-hC
Confidence 9998 68999999999999999999998 899987766555 45556668887666666999999999999999999 89
Q ss_pred CccccCCCCCCEEEccCCcCC
Q 003368 469 PSEIGSCFYLQEIYMAENFFR 489 (825)
Q Consensus 469 p~~~~~l~~L~~L~l~~N~l~ 489 (825)
|+.+|+|++|++|.+++|.|+
T Consensus 521 Pp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 521 PPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ChhhccccceeEEEecCCccC
Confidence 999999999999999999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=345.37 Aligned_cols=393 Identities=21% Similarity=0.238 Sum_probs=276.2
Q ss_pred cEEEEECCCCCCccccCcCCCC-C-CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGN-L-SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~-l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
+...||.+.+.+...-...+.. | +.-+.||+|+|+++.+.+..|.++++|+.++|.+|.++ .+|.......+|+.|+
T Consensus 53 ~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~ 131 (873)
T KOG4194|consen 53 NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD 131 (873)
T ss_pred CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence 4566777777665422222221 1 23467999999999888888899999999999999998 7777666667799999
Q ss_pred cCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcc
Q 003368 111 LGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPS 190 (825)
Q Consensus 111 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~ 190 (825)
|.+|.|+.+-.+++.-++.|+.||||.|.|+.+.-..|..=.++++|+|++|+|+......|.++.+|..|
T Consensus 132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl--------- 202 (873)
T KOG4194|consen 132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL--------- 202 (873)
T ss_pred eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee---------
Confidence 99999988778888888899999999999987666778777889999999999987777777777666666
Q ss_pred ccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCC
Q 003368 191 IYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270 (825)
Q Consensus 191 i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 270 (825)
.|+.|+++ .+|...|.+|++|+.|+|..|+|.-..-.+|..+++|+.|.|..|.+...-...|..|.
T Consensus 203 ----------kLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-- 269 (873)
T KOG4194|consen 203 ----------KLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-- 269 (873)
T ss_pred ----------ecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec--
Confidence 56677776 67777776677777777777777644345566666666666666666555555444444
Q ss_pred cEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc
Q 003368 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350 (825)
Q Consensus 271 ~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~ 350 (825)
++++|+|+.|+++. .-..++..+++|+.|+||+|.|..+-++.
T Consensus 270 ----------------------------kme~l~L~~N~l~~---------vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 270 ----------------------------KMEHLNLETNRLQA---------VNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred ----------------------------ccceeecccchhhh---------hhcccccccchhhhhccchhhhheeecch
Confidence 44555555555442 11124566777777777777777777777
Q ss_pred ccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccc
Q 003368 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS 430 (825)
Q Consensus 351 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 430 (825)
++-.++|++|+|++|+|+...+.+|..+..|+.|+|++|++...-..+|..+++|+.|||++|.+++.|.+..
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa------- 385 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAA------- 385 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecch-------
Confidence 7778888888888888887777788888888888888888877767778888888888888888876654421
Q ss_pred cccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECC
Q 003368 431 DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLS 508 (825)
Q Consensus 431 ~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls 508 (825)
..|..++.|+.|++.+|++....-.+|..+..|+.|+|.+|.+...-|.+|..| .|+.|-++
T Consensus 386 ---------------~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 386 ---------------VAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ---------------hhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 123445666666666776663333456666666666666666655555666555 55555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.32 Aligned_cols=362 Identities=23% Similarity=0.242 Sum_probs=299.8
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
.++.||+++|.+...-+..|-++++|+++++.+|.++ .||...+-..+|+.|+|.+|.|+.+-...++.++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 5788999999999988999999999999999999999 789877778889999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCC----
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIP---- 188 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p---- 188 (825)
.|.|+.+.-.+|..-.++++|+|++|+|+..--..|.++.+|..|.|+.|+++...+.+|.+|++|+.|+|..+..
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 9999977778888888999999999999988899999999999999999999988889999999999998876543
Q ss_pred -ccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCC
Q 003368 189 -PSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267 (825)
Q Consensus 189 -~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 267 (825)
-.+..|.+|+.|.|..|.+. .+.+..|..+.++++|+|+.|+++..-..++.+++.|+.|+||+|.+..+-++.+...
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 24567777888888888887 6667777778888888888888887777778888888888888888887777788888
Q ss_pred CCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCccccc
Q 003368 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGK 346 (825)
Q Consensus 268 ~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~ 346 (825)
++|++|+|++|+|++.. +.+|..++.|+.|+|++|+++. +- ..|..+++|+.|||++|.++..
T Consensus 317 qkL~~LdLs~N~i~~l~------~~sf~~L~~Le~LnLs~Nsi~~----------l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLD------EGSFRVLSQLEELNLSHNSIDH----------LAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred ccceeEeccccccccCC------hhHHHHHHHhhhhcccccchHH----------HHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 88888888888887765 3356667778888888887762 22 2456677888888888888776
Q ss_pred CCc---cccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCC
Q 003368 347 IPE---EMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413 (825)
Q Consensus 347 ~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 413 (825)
+.+ .|.+|++|+.|+|.+|+|..+.-..|..+..|++|||.+|.|..+-|.+|..+ .|+.|.+..-
T Consensus 381 IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 381 IEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred EecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 654 46778888888888888875555677888888888888888887778888777 7777766543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=334.61 Aligned_cols=168 Identities=46% Similarity=0.775 Sum_probs=151.3
Q ss_pred hcccccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeec
Q 003368 629 ALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708 (825)
Q Consensus 629 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 708 (825)
....|+++++.+||++|+..++||+|+||.||+|.. .+|+.||||++.....+..++|.+|++++++++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 456799999999999999999999999999999999 5779999998876543315679999999999999999999999
Q ss_pred ccccccCCCC-eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 709 CSSIDFQGND-FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 709 ~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
|.+ .+ ..+||||||++|+|.++|+... .. .++|.+|++||.++|+||+|||+.+.++|||||||
T Consensus 140 C~e-----~~~~~~LVYEym~nGsL~d~L~~~~---------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK 204 (361)
T KOG1187|consen 140 CLE-----GGEHRLLVYEYMPNGSLEDHLHGKK---------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK 204 (361)
T ss_pred Eec-----CCceEEEEEEccCCCCHHHHhCCCC---------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence 975 33 5899999999999999998641 11 78999999999999999999999999999999999
Q ss_pred CCCeeecCCCcEEEcccCccccccc
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
|+|||||+++++||+|||+|+..+.
T Consensus 205 ssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 205 SSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred HHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999999999988765
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=356.36 Aligned_cols=463 Identities=27% Similarity=0.348 Sum_probs=331.2
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
.++.|+++.|-+...+-+.+.+--+|+.||+++|++. ..|..+..+.+|+.|++|.|.|. ..|.+..++.+|++|+|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 4667777777666544444555555788888888776 67777777778888888888777 666777777788888888
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcccc
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIY 192 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~ 192 (825)
+|++. ..|..+..+++|++|+++.|++. .+|..+..++.++.++.++|......+...-..-.|+...+++.++..+.
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~ 177 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY 177 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence 88777 67777888888888888888877 67777777777777778777322233333322233444445566666676
Q ss_pred CCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcE
Q 003368 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272 (825)
Q Consensus 193 ~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 272 (825)
++.. .++|.+|++. .+.. ..+.+|+.|....|+++... -.-++|+.|+.++|.+.... .-.-..+|++
T Consensus 178 ~l~~--~ldLr~N~~~-~~dl---s~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~--~~p~p~nl~~ 245 (1081)
T KOG0618|consen 178 NLTH--QLDLRYNEME-VLDL---SNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLD--VHPVPLNLQY 245 (1081)
T ss_pred hhhe--eeecccchhh-hhhh---hhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeec--ccccccccee
Confidence 6666 6788888876 2222 26678888888888876432 24577888888888887322 2334568889
Q ss_pred EEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcccc
Q 003368 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMS 352 (825)
Q Consensus 273 L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 352 (825)
+++++|++... |.+++.|.+|+.++..+|+|+ .+|.++..+++|+.|+..+|.+. -+|+...
T Consensus 246 ~dis~n~l~~l-------p~wi~~~~nle~l~~n~N~l~----------~lp~ri~~~~~L~~l~~~~nel~-yip~~le 307 (1081)
T KOG0618|consen 246 LDISHNNLSNL-------PEWIGACANLEALNANHNRLV----------ALPLRISRITSLVSLSAAYNELE-YIPPFLE 307 (1081)
T ss_pred eecchhhhhcc-------hHHHHhcccceEecccchhHH----------hhHHHHhhhhhHHHHHhhhhhhh-hCCCccc
Confidence 99999988764 567788999999999999997 78888888889999999999988 6777788
Q ss_pred CCCCCCEEEccccccccccCc-cccCCCC-CcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccc
Q 003368 353 RLQNLQFLNMRHNQLSGEIPS-SFGNLSS-LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS 430 (825)
Q Consensus 353 ~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~ 430 (825)
+++.|++|+|..|+|. ..|. .|..+.. |..|+.+.|++....-..=..++.|+.|++.+|.|+...=+-+-+..++
T Consensus 308 ~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL- 385 (1081)
T KOG0618|consen 308 GLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL- 385 (1081)
T ss_pred ccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccce-
Confidence 8899999999999988 4444 3333333 6677777777763321112245677888888888876555555556666
Q ss_pred cccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCC
Q 003368 431 DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQN 510 (825)
Q Consensus 431 ~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N 510 (825)
+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..++.|+.+|+|.|
T Consensus 386 KVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 386 KVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred eeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccc
Confidence 67888888886444456677888888888888887 77888888888888888888887 666 7788888888888888
Q ss_pred ccccc-cCcccccccCceeeCCCCc
Q 003368 511 NLSGK-IPISLERLPLEYLNLSFND 534 (825)
Q Consensus 511 ~l~~~-~p~~~~~l~L~~l~ls~N~ 534 (825)
+|+.. +|.....-.|++||+++|.
T Consensus 463 ~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 463 NLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhhhhhhCCCcccceeeccCCc
Confidence 88753 4544443458888888885
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.81 Aligned_cols=480 Identities=27% Similarity=0.359 Sum_probs=392.7
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
+|++..++ ..||..+..-..++.|++..|-+-...-+...+-.+|+.||||+|++. ..|..+..+.+|+.|+++.|.|
T Consensus 3 vd~s~~~l-~~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQL-ELIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccC-cccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 45555555 467888877777999999999887433334455566999999999997 8999999999999999999999
Q ss_pred CCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCc-CCccccCCC
Q 003368 117 EGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT-IPPSIYNLS 195 (825)
Q Consensus 117 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~-~p~~i~~l~ 195 (825)
. ..|.+..++.+|++|.|.+|+++ ..|..+..+.+|++||+|+|++. .+|..+..++.+..+..+++ ....++...
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ 157 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTS 157 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcccc
Confidence 9 68899999999999999999999 88999999999999999999996 89999999999999988887 233344444
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
.+.+++..|.+.+.++..+. .++. .|+|+.|.+. -..+.++.+|+.|....|++.... -..++|+.|+.
T Consensus 158 -ik~~~l~~n~l~~~~~~~i~-~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a 226 (1081)
T KOG0618|consen 158 -IKKLDLRLNVLGGSFLIDIY-NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYA 226 (1081)
T ss_pred -chhhhhhhhhcccchhcchh-hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeee
Confidence 77888889998888887766 4444 6999999887 234678888999998888875433 23467888888
Q ss_pred ccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCC
Q 003368 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355 (825)
Q Consensus 276 s~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 355 (825)
++|.+...... ..-.+|++++++.|+++ .+|.+++.+.+|+.++..+|+++ .+|..+....
T Consensus 227 ~~n~l~~~~~~--------p~p~nl~~~dis~n~l~----------~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~ 287 (1081)
T KOG0618|consen 227 DHNPLTTLDVH--------PVPLNLQYLDISHNNLS----------NLPEWIGACANLEALNANHNRLV-ALPLRISRIT 287 (1081)
T ss_pred ccCcceeeccc--------cccccceeeecchhhhh----------cchHHHHhcccceEecccchhHH-hhHHHHhhhh
Confidence 88888733211 12347999999999998 68889999999999999999996 7888899999
Q ss_pred CCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCc-cceeecCCCCCccccchhhhcccccccccc
Q 003368 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQ-LALLHLFQNDLSGAIPEEIFNISHMSDSLN 434 (825)
Q Consensus 356 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~ 434 (825)
+|+.|+..+|.++ -+|.....+++|++|+|..|+|...++..+..+.. |..|+.+.|++. ..|..-......++.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHH
Confidence 9999999999998 78888888999999999999998554444444443 778888888887 56643333334447899
Q ss_pred cCCCccccCCCccccccccccEEeecCceecccCCc-cccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccc
Q 003368 435 FARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPS-EIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLS 513 (825)
Q Consensus 435 l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~ 513 (825)
+.+|.++...-+.+-+.+.|+.|+|++|+|. .+|+ .+.++..|++|+||+|+++ .+|+++..++.|++|..-+|++.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence 9999999988888999999999999999998 6665 5688999999999999999 89999999999999999999998
Q ss_pred cccCcccccc-cCceeeCCCCcceec-CCCCCccCccccccccCCC
Q 003368 514 GKIPISLERL-PLEYLNLSFNDLEGQ-VPTKGIFANASAISVSGNS 557 (825)
Q Consensus 514 ~~~p~~~~~l-~L~~l~ls~N~l~g~-~p~~~~~~~~~~~~~~~n~ 557 (825)
..| .+..+ .|+.+|+|.|+|+-. +|..-..++++..+++||.
T Consensus 444 -~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 444 -SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred -ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 667 55566 699999999999854 3443334778888999998
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.03 Aligned_cols=367 Identities=27% Similarity=0.441 Sum_probs=232.6
Q ss_pred CCCCEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 56 SFLREIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
+..+-.|+++|.++ +..|.+...+++++.|-|...++. .+|+.++.|.+|+.|.+++|++. .+-+.+..|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 33344444444444 234444444444444444444444 44444444444444444444444 2334444555555555
Q ss_pred ccccccc-cccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCc
Q 003368 135 IQENNLT-GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPP 213 (825)
Q Consensus 135 L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~ 213 (825)
+.+|+|. .-+|..+..|..|..||||+|+++ ..|..+...+++.+| +||+|++. .||.
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVL-------------------NLS~N~Ie-tIPn 143 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVL-------------------NLSYNNIE-TIPN 143 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEE-------------------EcccCccc-cCCc
Confidence 5555553 123444445555555555555554 445444444444444 44555554 6677
Q ss_pred hhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccc
Q 003368 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHS 293 (825)
Q Consensus 214 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~ 293 (825)
.++.+++.|-.||||+|++. .+|.....+.+|++|+|++|.+....-..+..
T Consensus 144 ~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPs--------------------------- 195 (1255)
T KOG0444|consen 144 SLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPS--------------------------- 195 (1255)
T ss_pred hHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCcc---------------------------
Confidence 77777777777788888776 45556677777888888888764433222233
Q ss_pred cccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCc
Q 003368 294 LANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS 373 (825)
Q Consensus 294 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 373 (825)
+++|+.|.+++.+=+- ..+|+.+..+.+|..+|+|.|.+. .+|+.+-++++|+.|+||+|+|+ .+..
T Consensus 196 ---mtsL~vLhms~TqRTl--------~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~ 262 (1255)
T KOG0444|consen 196 ---MTSLSVLHMSNTQRTL--------DNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNM 262 (1255)
T ss_pred ---chhhhhhhcccccchh--------hcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeec
Confidence 3344455555443321 156777777777777888888776 77777778888888888888887 5555
Q ss_pred cccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCcccccccc
Q 003368 374 SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKV 453 (825)
Q Consensus 374 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~ 453 (825)
..+.+.+|+.|+||.|+++ .+|++++.++.|+.|.+.+|+++= ..||..+|.|.+
T Consensus 263 ~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F------------------------eGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 263 TEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF------------------------EGIPSGIGKLIQ 317 (1255)
T ss_pred cHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc------------------------cCCccchhhhhh
Confidence 5666777888888888887 677778888888777777777651 246777788888
Q ss_pred ccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccc
Q 003368 454 LRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLS 513 (825)
Q Consensus 454 L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~ 513 (825)
|+.+..++|++. .+|..++.|..|+.|.|++|++- .+|+.+.-++.|+.||+..|.--
T Consensus 318 Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 318 LEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred hHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 888888888877 77888888888888888888877 67888888888888888888543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.55 Aligned_cols=365 Identities=26% Similarity=0.399 Sum_probs=288.2
Q ss_pred CcEEEEECCCCCCc-cccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLI-GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.-|.-.|+++|.++ +..|.++..++.++.|-|..-++. .+|..++.+.+|++|.+++|++. .+-+.++.++.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 45788999999999 578999999999999999999998 89999999999999999999998 5667889999999999
Q ss_pred cCCCCCCC-CCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCc
Q 003368 111 LGRNKLEG-SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPP 189 (825)
Q Consensus 111 Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~ 189 (825)
+..|++.. -+|..+-.+..|..||||+|+|+ ..|..+..-+++-+|+||+|+|..++...|.+|+.|-.|
T Consensus 85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL-------- 155 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL-------- 155 (1255)
T ss_pred hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh--------
Confidence 99999863 36777889999999999999999 889999999999999999999985554557777777776
Q ss_pred cccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccc-cCccccCcCCCC
Q 003368 190 SIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF-FGKLSVNFGDMK 268 (825)
Q Consensus 190 ~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l-~~~~~~~~~~l~ 268 (825)
|||+|++. .+|+.+- .+.+|++|+|++|.+.-..-..+-.+++|++|.+++.+- ...+|.++.+|.
T Consensus 156 -----------DLS~NrLe-~LPPQ~R-RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~ 222 (1255)
T KOG0444|consen 156 -----------DLSNNRLE-MLPPQIR-RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLH 222 (1255)
T ss_pred -----------ccccchhh-hcCHHHH-HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhh
Confidence 67777776 6777765 677788888888766532223344566677777776653 244667777777
Q ss_pred CCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCC
Q 003368 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIP 348 (825)
Q Consensus 269 ~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p 348 (825)
+|..+|+|.|++... |+.+.++++|+.|+||+|+++ .+.-..+.+.+|+.|+||.|+++ .+|
T Consensus 223 NL~dvDlS~N~Lp~v-------Pecly~l~~LrrLNLS~N~it----------eL~~~~~~W~~lEtLNlSrNQLt-~LP 284 (1255)
T KOG0444|consen 223 NLRDVDLSENNLPIV-------PECLYKLRNLRRLNLSGNKIT----------ELNMTEGEWENLETLNLSRNQLT-VLP 284 (1255)
T ss_pred hhhhccccccCCCcc-------hHHHhhhhhhheeccCcCcee----------eeeccHHHHhhhhhhccccchhc-cch
Confidence 777777777777543 667777778888888888877 45556667777888888888887 777
Q ss_pred ccccCCCCCCEEEccccccc-cccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhccc
Q 003368 349 EEMSRLQNLQFLNMRHNQLS-GEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNIS 427 (825)
Q Consensus 349 ~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~ 427 (825)
+++.++++|+.|.+.+|++. .-+|+.++.+.+|+.+..++|++. ..|..++.|..|+.|.|+.|++. ++|+.+--+.
T Consensus 285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~ 362 (1255)
T KOG0444|consen 285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLP 362 (1255)
T ss_pred HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcC
Confidence 88888888888888888774 346777888888888888888876 67778888888888888888877 6777776666
Q ss_pred ccccccccCCCccc
Q 003368 428 HMSDSLNFARNHLV 441 (825)
Q Consensus 428 ~l~~~l~l~~N~l~ 441 (825)
.+ +.||+..|.-.
T Consensus 363 ~l-~vLDlreNpnL 375 (1255)
T KOG0444|consen 363 DL-KVLDLRENPNL 375 (1255)
T ss_pred Cc-ceeeccCCcCc
Confidence 66 57777777543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=275.60 Aligned_cols=163 Identities=31% Similarity=0.515 Sum_probs=142.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
...+|...+.||+|+||+||+|+++.++..||||.+.+. .....+-...|+++++.++|||||++++++. .++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCC
Confidence 345788888899999999999999999999999999876 3445567889999999999999999999854 467
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-- 796 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-- 796 (825)
..|||||||.||+|.+|++.. +.+++.....++.|+|.|+++||+. +||||||||.|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~------------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~ 147 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR------------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTAR 147 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCC
Confidence 899999999999999999643 4788999999999999999999985 99999999999999764
Q ss_pred ----CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 ----LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ----~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
-.+||+|||+||.+.+. ....+.+|+|
T Consensus 148 ~~~~~~LKIADFGfAR~L~~~-~~a~tlcGSp 178 (429)
T KOG0595|consen 148 NDTSPVLKIADFGFARFLQPG-SMAETLCGSP 178 (429)
T ss_pred CCCCceEEecccchhhhCCch-hHHHHhhCCc
Confidence 46899999999999754 3456778875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.49 Aligned_cols=165 Identities=31% Similarity=0.415 Sum_probs=149.0
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
..++|+..++||+|+||+||.++.+.+++.+|+|+++++. ....+...+|..++.+++||+||+++.. ||+.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence 3567999999999999999999999999999999998764 2345678899999999999999999876 8999
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+.+|+|+||+.||.|..+|.. .+.+++..+.-++.+|+.||.|||+. +|||||+||+|||+|++|
T Consensus 98 ~kLylVld~~~GGeLf~hL~~------------eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~G 162 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQR------------EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQG 162 (357)
T ss_pred CeEEEEEeccCCccHHHHHHh------------cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCC
Confidence 999999999999999999953 25788888999999999999999985 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccCC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+++++||||+|..........+.+||+|
T Consensus 163 Hi~LtDFgL~k~~~~~~~~t~tfcGT~e 190 (357)
T KOG0598|consen 163 HIKLTDFGLCKEDLKDGDATRTFCGTPE 190 (357)
T ss_pred cEEEeccccchhcccCCCccccccCCcc
Confidence 9999999999988777777888999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=261.71 Aligned_cols=159 Identities=28% Similarity=0.393 Sum_probs=139.6
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC-eeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND-FKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~-~~~l 722 (825)
++..+.||+|..|+|||++++.+++.+|+|.+....+ ...+++.+|++++++++||+||+++|++.. .. ...+
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~isI 155 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEISI 155 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEEe
Confidence 4457889999999999999999999999999965543 346789999999999999999999999643 33 6899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
+||||.+|+|++++... +++++...-+||.+|++||.|||+. .+||||||||+|||+...|++|||
T Consensus 156 ~mEYMDgGSLd~~~k~~------------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV------------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred ehhhcCCCCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 99999999999998432 4688999999999999999999974 589999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||.++.+... .+.+.+||-
T Consensus 222 DFGVS~~lvnS--~a~tfvGT~ 241 (364)
T KOG0581|consen 222 DFGVSGILVNS--IANTFVGTS 241 (364)
T ss_pred cccccHHhhhh--hcccccccc
Confidence 99999998766 567888874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=261.05 Aligned_cols=161 Identities=29% Similarity=0.429 Sum_probs=136.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-------hHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
+.|...+.+|+|+||.|-+|..+.+|+.||||+++++... ......+|+++|++++|||||+++++ |+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----FE 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----ee
Confidence 3466789999999999999999999999999999765311 12235699999999999999999998 56
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
..++.|+|||||+||+|.+++-+. +.+.+..-..++.|++.|+.|||+. +|+||||||+|||+..
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~n------------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVAN------------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSN 311 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhc------------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEecc
Confidence 678889999999999999998654 2344455577999999999999996 9999999999999965
Q ss_pred C---CcEEEcccCcccccccCCCCCccccccC
Q 003368 796 N---LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~---~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+ ..+||+|||+||...+ .....+.+|||
T Consensus 312 ~~e~~llKItDFGlAK~~g~-~sfm~TlCGTp 342 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGE-GSFMKTLCGTP 342 (475)
T ss_pred CCcceEEEecccchhhcccc-ceehhhhcCCc
Confidence 4 7899999999999875 45778899997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=269.78 Aligned_cols=163 Identities=26% Similarity=0.404 Sum_probs=150.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
..|...+.||+|+|+.||+++...+|+.||+|++.+.. ....+...+||++-+.++|||||+++++ |++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence 45889999999999999999998999999999998642 3456778899999999999999999998 788999
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|.|+|++|+|.+++.. .+.+++.++..+.+||+.|+.|||+. +|||||||-.|+++++++++
T Consensus 93 VYivLELC~~~sL~el~Kr------------rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~V 157 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR------------RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNV 157 (592)
T ss_pred eEEEEEecCCccHHHHHHh------------cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcE
Confidence 9999999999999999852 35799999999999999999999996 89999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccCC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
||+|||||..++.++++..+.+|||+
T Consensus 158 KIgDFGLAt~le~~~Erk~TlCGTPN 183 (592)
T KOG0575|consen 158 KIGDFGLATQLEYDGERKKTLCGTPN 183 (592)
T ss_pred EecccceeeeecCcccccceecCCCc
Confidence 99999999999988888999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=269.22 Aligned_cols=161 Identities=38% Similarity=0.602 Sum_probs=134.1
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeE-EEEEEeecccchh--HHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTI-VAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~-vAvK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+...+.+|+|+||+||+|.+ .|+. ||||++....... .++|.+|+.+|++++|||||+++|+|... ....+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~----~~~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP----PGSLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC----CCceE
Confidence 34456699999999999999 4455 9999997654322 56899999999999999999999998752 11579
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeeecCCC-cE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEP-TIHCDLKPSNILLDNNL-TA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~-ivHrdlk~~NILl~~~~-~~ 799 (825)
+|||||++|+|.++++.. ....++|..++++|.|||+||.|||+. . ||||||||+|||++.++ ++
T Consensus 117 iVtEy~~~GsL~~~l~~~----------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~ 183 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK----------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTL 183 (362)
T ss_pred EEEEeCCCCcHHHHHhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEE
Confidence 999999999999999742 235799999999999999999999997 4 99999999999999998 99
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+++.........+...||+
T Consensus 184 KI~DFGlsr~~~~~~~~~~~~~GT~ 208 (362)
T KOG0192|consen 184 KIADFGLSREKVISKTSMTSVAGTY 208 (362)
T ss_pred EECCCccceeeccccccccCCCCCc
Confidence 9999999998765433334456765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.37 Aligned_cols=164 Identities=30% Similarity=0.445 Sum_probs=134.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhh--cCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALR--NIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.......++||+|.||.||||++ +++.||||++..+ ..+.|++|-++.+ .++|+||++++++-...+.. .-+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccc
Confidence 34556678999999999999998 5689999999854 3466777777766 46899999999986543322 346
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCCCCCeee
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH------CQEPTIHCDLKPSNILL 793 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~------~~~~ivHrdlk~~NILl 793 (825)
++||+||.+.|+|.+||... .++|....+||..+|+||+|||+. ..|+|+|||||++|||+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv 349 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV 349 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence 89999999999999999644 689999999999999999999975 35689999999999999
Q ss_pred cCCCcEEEcccCcccccccCCCC--CccccccC
Q 003368 794 DNNLTAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
.+|+++.|+|||||..+..+..- .-..|||.
T Consensus 350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~ 382 (534)
T KOG3653|consen 350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTR 382 (534)
T ss_pred ccCCcEEeeccceeEEecCCCCCcchhhhhhhh
Confidence 99999999999999988754321 22246663
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=242.28 Aligned_cols=161 Identities=30% Similarity=0.422 Sum_probs=144.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.+|.|+||+|..++.+.+|..+|+|++.++.- .+.+...+|..+++.+.||+++++++. +++.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence 3568889999999999999999999999999999987642 344567789999999999999999987 56678
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..||||||++||.|..+|+.. +++++..+..+|.||+.|++|||+. .|++||+||+|||+|.+|.
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~------------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~ 182 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKS------------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGH 182 (355)
T ss_pred eEEEEEeccCCccHHHHHHhc------------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCc
Confidence 999999999999999999643 5789999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccCC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+||+|||+||.... +..+.+||||
T Consensus 183 iKitDFGFAK~v~~---rT~TlCGTPe 206 (355)
T KOG0616|consen 183 IKITDFGFAKRVSG---RTWTLCGTPE 206 (355)
T ss_pred EEEEeccceEEecC---cEEEecCCcc
Confidence 99999999998643 4789999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=259.04 Aligned_cols=157 Identities=29% Similarity=0.431 Sum_probs=135.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.+.|+..+.||+|.||.||||+...+|+.||+|+++.+. .+......+||.+|++++||||++|.+...+. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 355788899999999999999999999999999998764 44556778999999999999999999986542 2457
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|||+|||+. +|.-.+.. ....++..+...|+.|++.||+|+|+. +|+|||||.+|||||.+|.+
T Consensus 193 iYlVFeYMdh-DL~GLl~~-----------p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~L 257 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSS-----------PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVL 257 (560)
T ss_pred EEEEEecccc-hhhhhhcC-----------CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCE
Confidence 8999999987 67655532 224689999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCC
Q 003368 800 HVGDFGLARLRQEVPNN 816 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~ 816 (825)
||+|||||+++......
T Consensus 258 KiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSA 274 (560)
T ss_pred EeccccceeeccCCCCc
Confidence 99999999988766543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=245.08 Aligned_cols=160 Identities=27% Similarity=0.351 Sum_probs=133.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+.|+....+|+|+||+||||+.+.+|+.||||++..... ...+...+|++++++++|||+|.+++.|. .....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 457778899999999999999999999999999965433 33567889999999999999999999954 46788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
+||+||++.--|++.= .....++.....+|+.|+++|+.|+|++ .||||||||+|||+..++.+|
T Consensus 77 hLVFE~~dhTvL~eLe------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELE------------RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred EEEeeecchHHHHHHH------------hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEE
Confidence 9999999874444332 1123567778899999999999999997 899999999999999999999
Q ss_pred EcccCcccccccCCCCCccccc
Q 003368 801 VGDFGLARLRQEVPNNQSSSVG 822 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~g 822 (825)
+||||+||.+.......+.+|.
T Consensus 142 LCDFGFAR~L~~pgd~YTDYVA 163 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDNYTDYVA 163 (396)
T ss_pred eccchhhHhhcCCcchhhhhhh
Confidence 9999999998765555555444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-30 Score=247.54 Aligned_cols=169 Identities=26% Similarity=0.381 Sum_probs=146.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe-
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF- 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~- 719 (825)
.+|+..+.||.|+||+|||+....+|+.||.|.++-.. ....++...|+.++++++|||||++++.- |.++..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~----f~~~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS----FIEDNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh----hhccchh
Confidence 45788899999999999999999999999999987432 34567789999999999999999998853 344444
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEP--TIHCDLKPSNILLDNNL 797 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~--ivHrdlk~~NILl~~~~ 797 (825)
.++||||+..|+|...+... +...+.+++...+++..|+++||.++|... ++ |+||||||.||+++.+|
T Consensus 95 lnivmE~c~~GDLsqmIk~~--------K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHF--------KKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred hHHHHHhhcccCHHHHHHHH--------HhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCC
Confidence 89999999999999988532 344567899999999999999999999843 34 89999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+|++|||++|+.....+.+.+.||||
T Consensus 166 vvKLGDfGL~r~l~s~~tfA~S~VGTP 192 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKTTFAHSLVGTP 192 (375)
T ss_pred ceeeccchhHhHhcchhHHHHhhcCCC
Confidence 999999999999998888889999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=234.10 Aligned_cols=157 Identities=28% Similarity=0.460 Sum_probs=135.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+.|...+.+|+|.||.||+|++..+|+.||||+++... .+......+||+.++.++|+||++++++ |...+..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence 35777889999999999999999999999999997653 2335678999999999999999999998 4446678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
-||+|||+. +|+..++. ....++-.+...++.++.+|++|+|.. .|+|||+||.|+|++++|.+|
T Consensus 77 ~lVfEfm~t-dLe~vIkd-----------~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKD-----------KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred EEEEEeccc-cHHHHhcc-----------cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEE
Confidence 899999986 89888853 334678888999999999999999986 899999999999999999999
Q ss_pred EcccCcccccccCCCCCcc
Q 003368 801 VGDFGLARLRQEVPNNQSS 819 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~ 819 (825)
|+|||+||......+....
T Consensus 142 iADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQTH 160 (318)
T ss_pred eecccchhccCCCCccccc
Confidence 9999999998876555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=257.49 Aligned_cols=155 Identities=30% Similarity=0.447 Sum_probs=138.5
Q ss_pred HhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 639 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.+...+|.-++.||+|+|++||+|+.+.++++||||++.+.. ....+...+|-++|.++ .||.||+|+.. |
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence 445677888999999999999999999999999999997653 23345677899999999 79999999976 8
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
+++..+|.|+||+++|+|.++++. .+.+++..+..+|.+|+.|++|||+. +||||||||+|||+|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K------------~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd 208 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKK------------YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLD 208 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHH------------hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEc
Confidence 999999999999999999999953 35788999999999999999999986 999999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
+||++||+|||.|+.+.+.
T Consensus 209 ~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 209 KDGHIKITDFGSAKILSPS 227 (604)
T ss_pred CCCcEEEeeccccccCChh
Confidence 9999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=237.44 Aligned_cols=163 Identities=25% Similarity=0.338 Sum_probs=135.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.+.|+..+.|++|+||.||||+.+.+++.||+|+++.... +-.-.-.+||.++.+++|||||.+........ -+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cce
Confidence 3568889999999999999999999999999999987642 22234689999999999999999988765422 345
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|||||+. +|...++.- ..++...++..++.|+++|++|||+. .|+|||+|++|+|+...|.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m-----------~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM-----------KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc-----------cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcE
Confidence 8999999987 888877532 24678889999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccc
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVG 822 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~g 822 (825)
||+|||+||.+.+.....+..|-
T Consensus 217 KiaDFGLAR~ygsp~k~~T~lVV 239 (419)
T KOG0663|consen 217 KIADFGLAREYGSPLKPYTPLVV 239 (419)
T ss_pred EecccchhhhhcCCcccCcceEE
Confidence 99999999999876444444343
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=251.97 Aligned_cols=149 Identities=32% Similarity=0.566 Sum_probs=129.8
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+...+.||+|-||.||.|++. ....||||.++.. .-..++|.+|+++|.+++|++||+++|+|.. ++..||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEEE
Confidence 455788999999999999993 4458999999765 3345789999999999999999999999864 34689999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
|||+.|+|.+||+.. ....+...+.+.+|.|||+||+||++. .+|||||.++||||+++..+||+||
T Consensus 281 E~m~~GsLl~yLr~~----------~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR----------EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred EecccCcHHHHhhhc----------CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence 999999999999641 335688889999999999999999986 9999999999999999999999999
Q ss_pred CcccccccC
Q 003368 805 GLARLRQEV 813 (825)
Q Consensus 805 Gla~~~~~~ 813 (825)
|+||...++
T Consensus 348 GLAr~~~d~ 356 (468)
T KOG0197|consen 348 GLARLIGDD 356 (468)
T ss_pred ccccccCCC
Confidence 999955444
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=242.30 Aligned_cols=160 Identities=26% Similarity=0.404 Sum_probs=141.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch---hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|+..+.+|+|.||+|-+|..+..|+.||||.+++.... +.-.+.+||++|+.++||||++++.. |+..+..
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdKI 128 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDKI 128 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCceE
Confidence 466778899999999999999889999999999876433 33467899999999999999999998 6778889
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
.+||||..+|.|++|+..+ +.+++.++.++.+||..|+.|+|.+ ++||||+|-+|||+|.++++|
T Consensus 129 vivMEYaS~GeLYDYiSer------------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER------------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred EEEEEecCCccHHHHHHHh------------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence 9999999999999999543 5799999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||++-++.+. ..-++++|+|
T Consensus 194 IADFGLSNly~~~-kfLqTFCGSP 216 (668)
T KOG0611|consen 194 IADFGLSNLYADK-KFLQTFCGSP 216 (668)
T ss_pred eeccchhhhhccc-cHHHHhcCCc
Confidence 9999999998764 4556777765
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=241.54 Aligned_cols=167 Identities=26% Similarity=0.366 Sum_probs=135.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------------hhHHHHHHHHHHhhcCCCCCceeEe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------------GASKSFAAECRALRNIRHRNLVRVI 706 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 706 (825)
..+.|...+.||+|.||+|.+|+...+++.||||++.+... ...+...+||++|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35678999999999999999999999999999999975421 0124678999999999999999999
Q ss_pred ecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003368 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDL 786 (825)
Q Consensus 707 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdl 786 (825)
++-- -...+..|||+|||..|.+...= .....++..++.+|.++|..||+|||.+ +||||||
T Consensus 175 EvLD---DP~s~~~YlVley~s~G~v~w~p------------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDI 236 (576)
T KOG0585|consen 175 EVLD---DPESDKLYLVLEYCSKGEVKWCP------------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDI 236 (576)
T ss_pred Eeec---CcccCceEEEEEeccCCccccCC------------CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 9743 23456799999999998875221 1112289999999999999999999986 9999999
Q ss_pred CCCCeeecCCCcEEEcccCcccccccC-----CCCCccccccCC
Q 003368 787 KPSNILLDNNLTAHVGDFGLARLRQEV-----PNNQSSSVGDLE 825 (825)
Q Consensus 787 k~~NILl~~~~~~ki~DFGla~~~~~~-----~~~~~~~~gt~~ 825 (825)
||+|+|++++|++||+|||.+-..... +.--+..+|||+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPA 280 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPA 280 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCcc
Confidence 999999999999999999998866322 111244688874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-29 Score=251.88 Aligned_cols=288 Identities=22% Similarity=0.189 Sum_probs=201.2
Q ss_pred CCceeeceeecCCC--CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCC-CcCCC
Q 003368 18 HFCDWEGITCSPRH--RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSH-NSLVG 94 (825)
Q Consensus 18 ~~C~~~g~~c~~~~--~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~ 94 (825)
-.|+..|.+-+|.. ...+.++|..|+|...+|.+|+.+++|+.||||+|+|+.+.|++|.++.+|..|-+-+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 34556666666653 6889999999999988888999999999999999999999999999999987766555 99998
Q ss_pred CCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCc---------
Q 003368 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG--------- 165 (825)
Q Consensus 95 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--------- 165 (825)
...+.|.+|..|+.|.+.-|++.-+..++|..+++|..|.+.+|.+..+.-..|..+.+++.+.+..|.+-
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla 210 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA 210 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence 88899999999999999999999888899999999999999999999555558999999999999999842
Q ss_pred ---ccCCcccccccccceecCcC----cCC-cccc-CCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCC
Q 003368 166 ---GNIPSSLGQLKELKSLGLGG----TIP-PSIY-NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236 (825)
Q Consensus 166 ---~~~p~~~~~l~~L~~L~L~~----~~p-~~i~-~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~ 236 (825)
...|..++...-..-..+.. .++ ..+. .+..+..--.+.....+.-|..-+..+++|+.|+|++|+++++.
T Consensus 211 ~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 211 DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIE 290 (498)
T ss_pred hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhh
Confidence 12222232222211111100 000 0000 01111111112222333455555666777777777777777777
Q ss_pred CccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEccccccc
Q 003368 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFK 311 (825)
Q Consensus 237 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 311 (825)
+.+|..+..++.|.|..|++...-...|.++..|+.|+|..|+|+.+. |-+|..+..|..|+|-.|.+.
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~------~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVA------PGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEe------cccccccceeeeeehccCccc
Confidence 777777777777777777776666666777777777777777776544 334555666666666666544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.79 Aligned_cols=159 Identities=30% Similarity=0.424 Sum_probs=128.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
.|...+++|+|+||.||+|+..++++.||||+....... --+|+++|++++|||||++.-++....-.++-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466789999999999999999999999999998655332 2479999999999999999988765322223356789
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CcEEEc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-LTAHVG 802 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-~~~ki~ 802 (825)
|||||. +|.++++.. ......++.....-++.|+.+|++|||+. +|+||||||.|+|+|.+ |.+|||
T Consensus 101 leymP~-tL~~~~r~~--------~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHY--------TRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred HHhchH-HHHHHHHHH--------hhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEec
Confidence 999987 888888521 01123566667778999999999999985 99999999999999976 899999
Q ss_pred ccCcccccccCCCCCc
Q 003368 803 DFGLARLRQEVPNNQS 818 (825)
Q Consensus 803 DFGla~~~~~~~~~~~ 818 (825)
|||.||.+...+++.+
T Consensus 169 DFGSAK~L~~~epniS 184 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNIS 184 (364)
T ss_pred cCCcceeeccCCCcee
Confidence 9999999987766543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=246.45 Aligned_cols=161 Identities=34% Similarity=0.466 Sum_probs=142.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|...+.||+|+||.||||+.+.+.+.||+|.+.+..+ ...+...+|++++++++|||||+++++ |+...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence 467788999999999999999999999999999976543 335678999999999999999999998 6778899
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+|.||+.| +|+.+|. ..+.+++..+..|+.+++.||.|||+. +|+|||+||.|||++..+++|
T Consensus 77 ~vVte~a~g-~L~~il~------------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE------------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred EEEehhhhh-hHHHHHH------------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCcee
Confidence 999999987 9999994 335789999999999999999999996 999999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||||+||-+.....-.++..|||
T Consensus 141 lcdFg~Ar~m~~~t~vltsikGtP 164 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTSVLTSIKGTP 164 (808)
T ss_pred echhhhhhhcccCceeeeeccCcc
Confidence 999999999877544456667776
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=242.99 Aligned_cols=151 Identities=27% Similarity=0.408 Sum_probs=136.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
..++|+...+||+|+||.||.|+-+.+|+.+|+|++++.. .++.+....|-.+|....+|+||+|+.+ |++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecCC
Confidence 4578999999999999999999999999999999998653 3456778899999999999999999987 8999
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+++||||||++||++...|... ..+++.++..++.+.+-|++-+|.. ++|||||||+|+|||..|
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~------------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~G 278 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRK------------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKG 278 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhc------------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCC
Confidence 9999999999999999998533 4688888899999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
++|++||||++-..
T Consensus 279 HiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLD 292 (550)
T ss_pred CEeeccccccchhh
Confidence 99999999996543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=247.43 Aligned_cols=165 Identities=27% Similarity=0.380 Sum_probs=142.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc----cc-hhHHHHHHHHHHhhcCC-CCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ----LQ-GASKSFAAECRALRNIR-HRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 714 (825)
....|...+.||+|+||+||.|++..+|+.||||++..+ .. ...+...+|+.++++++ ||||++++.+.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----- 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----- 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-----
Confidence 345788999999999999999999999999999987654 11 23456678999999999 99999999984
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
......++||||+.||+|.+++.. ..++.+.++.+++.|++.|++|+|+. +|+||||||+|||+|
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~------------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld 154 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN------------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLD 154 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH------------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEec
Confidence 446679999999999999999953 35678889999999999999999985 999999999999999
Q ss_pred CC-CcEEEcccCcccccccCCCCCccccccCC
Q 003368 795 NN-LTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 795 ~~-~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
.+ +++||+|||+++..........+.+||+.
T Consensus 155 ~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~ 186 (370)
T KOG0583|consen 155 GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPA 186 (370)
T ss_pred CCCCCEEEeccccccccCCCCCcccCCCCCcc
Confidence 99 99999999999998533445678888873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=246.17 Aligned_cols=161 Identities=27% Similarity=0.385 Sum_probs=147.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
..|...+.||+|+.|.||.|+...+++.||||++....+...+-..+|+.+|+..+|+|||+++..+.. .+..|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-----~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-----GDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-----cceeEE
Confidence 346777889999999999999999999999999998877777788999999999999999999998654 478999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|||||+||+|.|.+... .+++.+...||+++++||+|||.. +|+|||||+.|||++.+|.+||+
T Consensus 348 VMEym~ggsLTDvVt~~-------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKlt 411 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLT 411 (550)
T ss_pred EEeecCCCchhhhhhcc-------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEe
Confidence 99999999999988533 488999999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||++..+.+.....++.||||
T Consensus 412 DFGFcaqi~~~~~KR~TmVGTP 433 (550)
T KOG0578|consen 412 DFGFCAQISEEQSKRSTMVGTP 433 (550)
T ss_pred eeeeeeccccccCccccccCCC
Confidence 9999999988887889999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=255.94 Aligned_cols=171 Identities=28% Similarity=0.493 Sum_probs=144.4
Q ss_pred ccccHHHHHhhccc---------ccccceeccCCeeEEEEEEEcCCC---eEEEEEEeecccch-hHHHHHHHHHHhhcC
Q 003368 631 RKVSYESLLKATDG---------FSSTHLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQG-ASKSFAAECRALRNI 697 (825)
Q Consensus 631 ~~~~~~~~~~~~~~---------f~~~~~ig~G~~g~Vy~~~~~~~g---~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l 697 (825)
..++|++--+|... ....++||.|.||.||+|+++..| ..||||.++....+ +.++|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 44566654444332 355789999999999999997766 57999999977654 467899999999999
Q ss_pred CCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC
Q 003368 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC 777 (825)
Q Consensus 698 ~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~ 777 (825)
.||||++|.|... .....++|.|||++|+|+.||+.. .+.++|.+.+.+.++||.|+.||-+.
T Consensus 688 dHPNIIrLEGVVT-----ks~PvMIiTEyMENGsLDsFLR~~-----------DGqftviQLVgMLrGIAsGMkYLsdm- 750 (996)
T KOG0196|consen 688 DHPNIIRLEGVVT-----KSKPVMIITEYMENGSLDSFLRQN-----------DGQFTVIQLVGMLRGIASGMKYLSDM- 750 (996)
T ss_pred CCCcEEEEEEEEe-----cCceeEEEhhhhhCCcHHHHHhhc-----------CCceEeehHHHHHHHHHHHhHHHhhc-
Confidence 9999999999854 356789999999999999999643 25699999999999999999999986
Q ss_pred CCCeeecCCCCCCeeecCCCcEEEcccCcccccccCCCCCccc
Q 003368 778 QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820 (825)
Q Consensus 778 ~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~ 820 (825)
+.|||||.++|||++.+..+||+|||++|.++++++..++.
T Consensus 751 --~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt 791 (996)
T KOG0196|consen 751 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 791 (996)
T ss_pred --CchhhhhhhhheeeccceEEEeccccceeecccCCCccccc
Confidence 99999999999999999999999999999998877544443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=247.64 Aligned_cols=164 Identities=27% Similarity=0.384 Sum_probs=143.9
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 716 (825)
..++|...+++|+|+||+|+.|..+.+++.+|||.+++.. ....+....|.+++.... ||.+++++.+ |++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence 4567999999999999999999999999999999998764 344567778888877765 9999999987 899
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.++.|.||||+.||++..+.+. ..+++..+.-||..|+.||+|||++ +|||||||-+|||||.+
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~-------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~e 504 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHT-------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTE 504 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEec-------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEccc
Confidence 9999999999999996655542 3689999999999999999999996 99999999999999999
Q ss_pred CcEEEcccCcccccccCCCCCccccccCC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|++||+|||++|.-.-....+++.+||||
T Consensus 505 Gh~kiADFGlcKe~m~~g~~TsTfCGTpe 533 (694)
T KOG0694|consen 505 GHVKIADFGLCKEGMGQGDRTSTFCGTPE 533 (694)
T ss_pred CcEEecccccccccCCCCCccccccCChh
Confidence 99999999999976544457899999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=222.34 Aligned_cols=164 Identities=27% Similarity=0.414 Sum_probs=142.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+.++|+.++.+|+|.||.||.|+.+.++-.||+|++-+.. .+..+++.+|+++-+.++||||++++++ |.++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence 3467999999999999999999999999999999986542 2345789999999999999999999999 5667
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...||++||.++|+++..|.+. ...+++......++.|+|.|+.|+|. +.||||||||+|+|++.++
T Consensus 95 ~riyLilEya~~gel~k~L~~~----------~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~ 161 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEG----------RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAG 161 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhc----------ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCC
Confidence 8899999999999999999643 22456777788899999999999997 5999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
..||+|||.+-..+ ....++.+||+
T Consensus 162 ~lkiAdfGwsV~~p--~~kR~tlcgt~ 186 (281)
T KOG0580|consen 162 ELKIADFGWSVHAP--SNKRKTLCGTL 186 (281)
T ss_pred CeeccCCCceeecC--CCCceeeeccc
Confidence 99999999988754 34567888986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=242.62 Aligned_cols=154 Identities=28% Similarity=0.451 Sum_probs=132.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh-HHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC-
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND- 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~- 718 (825)
.++|...+.+|.|+||.||+|+-..+|+.||||+++...... .-.=.||+..++++. |||||++.+... +.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~-----d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR-----DNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-----ccCc
Confidence 356788899999999999999999999999999997654332 223468999999999 999999999853 344
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+|||||+. +|++.+.. +.+.+++.+...|+.||.+||+|+|.+ |+.|||+||+|||+.....
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~-----------R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~ 148 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKD-----------RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDV 148 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhh-----------cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccce
Confidence 89999999965 89999853 246799999999999999999999997 9999999999999998899
Q ss_pred EEEcccCcccccccCCC
Q 003368 799 AHVGDFGLARLRQEVPN 815 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~ 815 (825)
+||+|||+||.....++
T Consensus 149 iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 149 IKIADFGLAREVRSKPP 165 (538)
T ss_pred eEecccccccccccCCC
Confidence 99999999998876543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=256.20 Aligned_cols=163 Identities=28% Similarity=0.490 Sum_probs=135.8
Q ss_pred cccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+....+.||+|+||+||+|+.. .+...||||.++..... ..++|++|++++++++|||||+|+|.|.. +
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence 3445678999999999999863 23467999999887665 67899999999999999999999999975 6
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCc--ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTD--EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+.+++|+|||..|+|.+||....-.... ...+...+++..+.+.||.|||.||+||-++ .+|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 7899999999999999999754211111 1111145699999999999999999999986 8999999999999999
Q ss_pred CCcEEEcccCcccccccCC
Q 003368 796 NLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~ 814 (825)
+..|||+|||++|-.-..+
T Consensus 639 ~l~VKIsDfGLsRdiYssD 657 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSD 657 (774)
T ss_pred ceEEEecccccchhhhhhh
Confidence 9999999999999654443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=233.25 Aligned_cols=165 Identities=33% Similarity=0.517 Sum_probs=137.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.++...+.||+|+||.||.+....+|+..|||.+........+.+.+|+.+|++++|||||+.+|.... .+...+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~---~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS---RENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc---ccCeeeEe
Confidence 346678899999999999999988899999999987643335678999999999999999999997432 11136899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcEEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ki 801 (825)
.|||+++|+|.+++... . ..+++....++++||++||+|||++ +||||||||+|||++. ++.+||
T Consensus 94 ~mEy~~~GsL~~~~~~~----------g-~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kl 159 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY----------G-GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKL 159 (313)
T ss_pred eeeccCCCcHHHHHHHc----------C-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEe
Confidence 99999999999998532 1 1689999999999999999999985 9999999999999999 799999
Q ss_pred cccCccccccc---CCCCCccccccC
Q 003368 802 GDFGLARLRQE---VPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~---~~~~~~~~~gt~ 824 (825)
+|||+|+.... .........||+
T Consensus 160 aDFG~a~~~~~~~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 160 ADFGLAKKLESKGTKSDSELSVQGTP 185 (313)
T ss_pred ccCccccccccccccccccccccCCc
Confidence 99999998763 112244567775
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=245.72 Aligned_cols=154 Identities=33% Similarity=0.545 Sum_probs=132.3
Q ss_pred HHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccc
Q 003368 636 ESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSID 713 (825)
Q Consensus 636 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 713 (825)
+++....+.+...+.||+|+||+||||+|.. .||||.++.... +..++|+.|+.++++-||.||+=++|||..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-- 459 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-- 459 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--
Confidence 4444444556678899999999999999965 499999987653 456789999999999999999999999864
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
...++|+.+|+|-+|+.++|-. ...++..+...||.|||+|+.|||. +.|||||+|+.||++
T Consensus 460 ----p~~AIiTqwCeGsSLY~hlHv~-----------etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl 521 (678)
T KOG0193|consen 460 ----PPLAIITQWCEGSSLYTHLHVQ-----------ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFL 521 (678)
T ss_pred ----CceeeeehhccCchhhhhccch-----------hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEE
Confidence 2349999999999999999743 2468899999999999999999998 499999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+++++|||+|||+|..-..
T Consensus 522 ~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 522 HEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ccCCcEEEecccceeeeee
Confidence 9999999999999876433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=229.79 Aligned_cols=170 Identities=25% Similarity=0.411 Sum_probs=136.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCC-ceeEeecccccc-cCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRN-LVRVITSCSSID-FQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~-~~~~ 717 (825)
.+.|+..+.||+|+||+||+|+.+.+|+.||+|+++.... +......+|+.++.+++|+| ||++++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456677889999999999999999999999999986643 34556789999999999999 999999875421 1122
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+.. +|.+|+....... ..++-.....+++|+++|++|||++ +|+||||||.|||++++|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP--------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSG 157 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCC
Confidence 368899999965 8999986432110 2455578899999999999999997 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCcccccc
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
.+||+|||+||...-+....+.-++|
T Consensus 158 ~lKlaDFGlAra~~ip~~~yt~evvT 183 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMRTYTPEVVT 183 (323)
T ss_pred cEeeeccchHHHhcCCcccccccEEE
Confidence 99999999999776554444555555
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=244.90 Aligned_cols=155 Identities=28% Similarity=0.472 Sum_probs=131.8
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCe---E-EEEEEeecc---cchhHHHHHHHHHHhhcCCCCCceeEeeccc
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGT---I-VAIKVLNLQ---LQGASKSFAAECRALRNIRHRNLVRVITSCS 710 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~---~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 710 (825)
++-..++....+.||+|+||.||+|+++..+. . ||||..+.. .....++|.+|+++|+.++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33344455566999999999999999865422 3 899998852 2455779999999999999999999999975
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
. +...++|||+|+||+|.+||... ...+++.+++.++.++|+||+|||.. .+|||||.++|
T Consensus 232 ~-----~~Pl~ivmEl~~gGsL~~~L~k~-----------~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARN 292 (474)
T KOG0194|consen 232 L-----EEPLMLVMELCNGGSLDDYLKKN-----------KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARN 292 (474)
T ss_pred C-----CCccEEEEEecCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHH
Confidence 4 56789999999999999999643 12689999999999999999999985 99999999999
Q ss_pred eeecCCCcEEEcccCcccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~ 811 (825)
+|++.++.+||+|||+++.-.
T Consensus 293 cL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 293 CLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred heecCCCeEEeCccccccCCc
Confidence 999999999999999988753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=230.42 Aligned_cols=165 Identities=28% Similarity=0.393 Sum_probs=141.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..++||.|..++||+|+..++++.||||++..+... ..+++.+|+..|+.++|||||+++.. |..+...
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence 35688999999999999999999999999999999876543 35789999999999999999999887 4457889
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||.||.+|++.+.+... ....+++..+..|.+++++||.|||.+ +-||||||+.|||+|++|.+|
T Consensus 100 WvVmpfMa~GS~ldIik~~----------~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTY----------YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred EEeehhhcCCcHHHHHHHH----------ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEE
Confidence 9999999999999998643 123478888999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCCCC----ccccccC
Q 003368 801 VGDFGLARLRQEVPNNQ----SSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~----~~~~gt~ 824 (825)
|+|||.+--+-+...++ .+.+|||
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTP 194 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcc
Confidence 99999877665544443 3447776
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=242.41 Aligned_cols=415 Identities=24% Similarity=0.267 Sum_probs=252.0
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC-CC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR-NK 115 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~ 115 (825)
.|-+..++. ++|..+- ..-++++|..|+|+.+.|++|+.+++|+.||||+|+|+.+-|++|.++.+|.+|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344445553 3444331 2358999999999999999999999999999999999999999999999987776665 99
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCC
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLS 195 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~ 195 (825)
|+.+..++|++|..|+.|.+.-|++.-+..+.|..|++|..|.+..|.+..+.-.+|..+..++.+.+..+..-...+++
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 99877789999999999999999999888899999999999999999998444448888988888866544322333333
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
-++... . ..|..++......-..+.++++...-+..|..- ++.+
T Consensus 208 wla~~~--------------------------a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl-- 251 (498)
T KOG4237|consen 208 WLADDL--------------------------A------MNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESL-- 251 (498)
T ss_pred hhhhHH--------------------------h------hchhhcccceecchHHHHHHHhcccchhhhhhh--HHhH--
Confidence 222211 1 112223333333333333333322222211110 0000
Q ss_pred ccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCcccccCCccccCC
Q 003368 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSRL 354 (825)
Q Consensus 276 s~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 354 (825)
+.. + .+....-+ .-| ..|..+++|+.|+|++|+++++-+.+|.++
T Consensus 252 ---------------~s~---------~-~~~d~~d~---------~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~ 297 (498)
T KOG4237|consen 252 ---------------PSR---------L-SSEDFPDS---------ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGA 297 (498)
T ss_pred ---------------HHh---------h-ccccCcCC---------cChHHHHhhcccceEeccCCCccchhhhhhhcch
Confidence 000 0 00000000 111 135666777777777777777777777777
Q ss_pred CCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccc----------------
Q 003368 355 QNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGA---------------- 418 (825)
Q Consensus 355 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~---------------- 418 (825)
..++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+..|..|.|-.|.+.-.
T Consensus 298 a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~ 377 (498)
T KOG4237|consen 298 AELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVV 377 (498)
T ss_pred hhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCC
Confidence 7777777777777655556677777777777777777777777777777777777766655311
Q ss_pred -cchhhhcccccccccccCCCccc---cCCCcccc---------ccccccEE-eecCceecccCCccccCCCCCCEEEcc
Q 003368 419 -IPEEIFNISHMSDSLNFARNHLV---GSIPPKIG---------NLKVLRMF-VVSSNNLSGEIPSEIGSCFYLQEIYMA 484 (825)
Q Consensus 419 -ip~~~~~~~~l~~~l~l~~N~l~---~~~p~~~~---------~l~~L~~L-~ls~N~l~g~~p~~~~~l~~L~~L~l~ 484 (825)
.|.. ..+..+..+.++.+.+. ..-|++.+ .++-+.+. .-|++.++ .+|..+.. ...++++.
T Consensus 378 ~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~ 452 (498)
T KOG4237|consen 378 GNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--DVTELYLD 452 (498)
T ss_pred CCCCC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--hhHHHhcc
Confidence 1110 00111122333322221 11111111 11112211 12222222 44443321 34567888
Q ss_pred CCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCC
Q 003368 485 ENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFN 533 (825)
Q Consensus 485 ~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N 533 (825)
+|.++ .+|.. .+..| .+|+|+|+++..--..|.++ .+.+|-+|+|
T Consensus 453 gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 453 GNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 88887 67766 56677 78888888775444556666 4677777665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-23 Score=261.46 Aligned_cols=61 Identities=28% Similarity=0.250 Sum_probs=36.5
Q ss_pred CCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCC
Q 003368 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415 (825)
Q Consensus 354 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 415 (825)
.++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|... ++++|+.|++++|..
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR 837 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc
Confidence 3556666666666555666666666666666666654333555444 566666666666543
|
syringae 6; Provisional |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=234.14 Aligned_cols=156 Identities=27% Similarity=0.349 Sum_probs=130.8
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
++||+|+||.||+|+...+|+.||||+++... ......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999998899999999997542 22345678899999999999999999874 44678999999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG 140 (323)
T cd05571 76 YANGGELFFHLSRE------------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred CCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence 99999999888532 3678999999999999999999985 99999999999999999999999999
Q ss_pred cccccccCCCCCccccccC
Q 003368 806 LARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 806 la~~~~~~~~~~~~~~gt~ 824 (825)
+|+............+||+
T Consensus 141 ~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 141 LCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CCcccccCCCcccceecCc
Confidence 9986433322333445554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=224.21 Aligned_cols=160 Identities=29% Similarity=0.439 Sum_probs=129.9
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhc--CCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRN--IRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
....+.||+|.||.||+|+| .|+.||||++... +++.+.+|.++.+. ++|+||+.++++-.. +-..-.++||
T Consensus 213 I~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQLwL 286 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQLWL 286 (513)
T ss_pred eEEEEEecCccccceeeccc--cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEEEEE
Confidence 45678999999999999999 6789999999744 34667788877775 699999999987321 0011135799
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeecCCC
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH-----CQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~-----~~~~ivHrdlk~~NILl~~~~ 797 (825)
|.||.+.|||+|||.. ..++....+++|..+|.||+|||.+ ..|.|.|||||+.|||+.+++
T Consensus 287 vTdYHe~GSL~DyL~r-------------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-------------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred eeecccCCcHHHHHhh-------------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 9999999999999954 3678889999999999999999953 467899999999999999999
Q ss_pred cEEEcccCcccccccCC----CCCcccccc
Q 003368 798 TAHVGDFGLARLRQEVP----NNQSSSVGD 823 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~----~~~~~~~gt 823 (825)
.+.|+|+|||-...++. ......|||
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccce
Confidence 99999999998776542 134555676
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=238.01 Aligned_cols=149 Identities=28% Similarity=0.363 Sum_probs=131.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+...+++.||||+++... ....+.+.+|++++.+++||||+++++++ ++...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 46888999999999999999998899999999997542 22345678899999999999999999874 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~v 140 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK------------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHV 140 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCE
Confidence 99999999999999998532 3688999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||+|+...
T Consensus 141 kL~DFGla~~~~ 152 (363)
T cd05628 141 KLSDFGLCTGLK 152 (363)
T ss_pred EEeeccCccccc
Confidence 999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=232.32 Aligned_cols=156 Identities=28% Similarity=0.371 Sum_probs=130.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
++||+|+||.||+|+...+|+.||||++.... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999998899999999997542 23345788999999999999999999874 45678999999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 76 y~~~g~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG 140 (328)
T cd05593 76 YVNGGELFFHLSRE------------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG 140 (328)
T ss_pred CCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence 99999999888432 3588999999999999999999985 99999999999999999999999999
Q ss_pred cccccccCCCCCccccccC
Q 003368 806 LARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 806 la~~~~~~~~~~~~~~gt~ 824 (825)
+++............+||+
T Consensus 141 ~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 141 LCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CCccCCCcccccccccCCc
Confidence 9986543322233344554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=236.75 Aligned_cols=165 Identities=24% Similarity=0.332 Sum_probs=138.0
Q ss_pred HhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 639 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
....++|+..+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+++++.++||||+++++++ .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----Q 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence 334577999999999999999999998899999999986532 22345688999999999999999999874 4
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+++..++||||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+|||+++
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~-------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~ 177 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY-------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDK 177 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECC
Confidence 567899999999999999988422 467788899999999999999985 9999999999999999
Q ss_pred CCcEEEcccCcccccccCCC-CCccccccC
Q 003368 796 NLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
++.+||+|||+|+....... ...+.+||+
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~ 207 (370)
T cd05621 178 HGHLKLADFGTCMKMDETGMVRCDTAVGTP 207 (370)
T ss_pred CCCEEEEecccceecccCCceecccCCCCc
Confidence 99999999999997654322 223455664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=237.52 Aligned_cols=167 Identities=28% Similarity=0.409 Sum_probs=137.2
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCCeeeEE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGNDFKALV 723 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~~lv 723 (825)
...+.+|+|+||.||+|+.+.+|+.||||.++... ....+...+|++++++++|||||++++.--... ..-.+...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34578999999999999999999999999998654 234567889999999999999999988622100 0013456899
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCC--cE
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD--NNL--TA 799 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~--~~~--~~ 799 (825)
||||.+|+|+..|... +....+++.+.+.+..+++.||.|||++ +||||||||.||++- ++| --
T Consensus 96 mEyC~gGsL~~~L~~P---------EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSP---------ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred EeecCCCcHHHHhcCc---------ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence 9999999999999643 3456799999999999999999999986 999999999999993 334 46
Q ss_pred EEcccCcccccccCCCCCccccccCC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
||+|||.||-.++.+ -..+.+||+|
T Consensus 164 KLtDfG~Arel~d~s-~~~S~vGT~~ 188 (732)
T KOG4250|consen 164 KLTDFGAARELDDNS-LFTSLVGTEE 188 (732)
T ss_pred eeecccccccCCCCC-eeeeecCchh
Confidence 999999999987765 5688899975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=236.78 Aligned_cols=149 Identities=29% Similarity=0.395 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 46888999999999999999998899999999997542 23345678999999999999999999884 45778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 140 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKK------------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHI 140 (364)
T ss_pred EEEEECCCCCcHHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCE
Confidence 99999999999999998532 3588899999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||+++.+.
T Consensus 141 kl~Dfg~~~~~~ 152 (364)
T cd05599 141 KLSDFGLCTGLK 152 (364)
T ss_pred EEeecccceecc
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=234.46 Aligned_cols=161 Identities=26% Similarity=0.401 Sum_probs=140.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|+.++.+|+|+-|.|..|++..||+.+|||++.++.. .....+.+|+.+|+-+.||||+++++. +.+..++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCceE
Confidence 46788999999999999999999999999999987632 223457899999999999999999998 4567889
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+|.||+++|.|.+++..+ +++++.++.++..||+.|+.|+|+. +|+|||+||+|+|+|....+|
T Consensus 88 ylvlEyv~gGELFdylv~k------------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRK------------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred EEEEEecCCchhHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence 9999999999999999533 5788999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccCC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|+|||+|.+-.++ .--.+.+|+|+
T Consensus 153 IADFGMAsLe~~g-klLeTSCGSPH 176 (786)
T KOG0588|consen 153 IADFGMASLEVPG-KLLETSCGSPH 176 (786)
T ss_pred eeccceeecccCC-ccccccCCCcc
Confidence 9999999985443 23466677763
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-26 Score=220.07 Aligned_cols=160 Identities=24% Similarity=0.378 Sum_probs=143.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
-|+..+.+|+|+||.||||.++++|+.||||.+..+ .+.+++.+|+.+|++++.|++|++||.+. . ....|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF----K-~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF----K-HSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc----c-CCceEee
Confidence 477788999999999999999999999999998754 35678999999999999999999999853 2 4458999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
||||-.|+..+.++. ..+.+++.+...|.+..++||+|||.. +-||||||+.|||+..+|.+|++|
T Consensus 107 MEYCGAGSiSDI~R~-----------R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLAD 172 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA-----------RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLAD 172 (502)
T ss_pred hhhcCCCcHHHHHHH-----------hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhh
Confidence 999999999999853 346788999999999999999999986 678999999999999999999999
Q ss_pred cCcccccccCCCCCccccccC
Q 003368 804 FGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 804 FGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|..+.+......+.+|||
T Consensus 173 FGVAGQLTDTMAKRNTVIGTP 193 (502)
T KOG0574|consen 173 FGVAGQLTDTMAKRNTVIGTP 193 (502)
T ss_pred ccccchhhhhHHhhCccccCc
Confidence 999999988877788888987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=228.40 Aligned_cols=150 Identities=25% Similarity=0.429 Sum_probs=131.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 36888899999999999999998899999999987532 12345688999999999999999999874 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~ 140 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNS------------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHI 140 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence 89999999999999998532 3578889999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 141 kl~Dfg~~~~~~~ 153 (291)
T cd05612 141 KLTDFGFAKKLRD 153 (291)
T ss_pred EEEecCcchhccC
Confidence 9999999987644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=231.66 Aligned_cols=165 Identities=25% Similarity=0.384 Sum_probs=145.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+++|+|+||.++..+++.+++.||+|.+..... ...+...+|+.++++++|||||.+.+.+ .+++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCc
Confidence 3568889999999999999999999999999999987643 2345788999999999999999999984 33444
Q ss_pred -eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 720 -KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 720 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
.++||+|++||++.+.+... .+..+++.+.+++..|++.|+.|||+. .|+|||||++||++..+..
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~----------k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~ 144 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQ----------KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKK 144 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHH----------hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCc
Confidence 99999999999999998532 245788889999999999999999975 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||++|||+||.+..+...+++.+|||
T Consensus 145 VkLgDfGlaK~l~~~~~~a~tvvGTp 170 (426)
T KOG0589|consen 145 VKLGDFGLAKILNPEDSLASTVVGTP 170 (426)
T ss_pred eeecchhhhhhcCCchhhhheecCCC
Confidence 99999999999998877889999997
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=230.68 Aligned_cols=142 Identities=28% Similarity=0.404 Sum_probs=124.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
++||+|+||.||+|+...+|+.||+|++.... ......+.+|++++++++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999998899999999997642 22345678899999999999999999874 44678899999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 140 (323)
T cd05595 76 YANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred CCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence 99999999887422 3588999999999999999999985 99999999999999999999999999
Q ss_pred ccccc
Q 003368 806 LARLR 810 (825)
Q Consensus 806 la~~~ 810 (825)
+++..
T Consensus 141 ~~~~~ 145 (323)
T cd05595 141 LCKEG 145 (323)
T ss_pred Hhccc
Confidence 99864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=229.89 Aligned_cols=154 Identities=27% Similarity=0.330 Sum_probs=129.8
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999998899999999997532 23345688999999999999999999874 3467889999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|
T Consensus 76 ~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~ 140 (312)
T cd05585 76 NGGELFHHLQRE------------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLC 140 (312)
T ss_pred CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccc
Confidence 999999998532 3578899999999999999999985 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccC
Q 003368 808 RLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 808 ~~~~~~~~~~~~~~gt~ 824 (825)
+............+||+
T Consensus 141 ~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 141 KLNMKDDDKTNTFCGTP 157 (312)
T ss_pred ccCccCCCccccccCCc
Confidence 87544333334445654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=231.66 Aligned_cols=150 Identities=27% Similarity=0.367 Sum_probs=131.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++||||+++++++ .+++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence 56888999999999999999998899999999997542 22345788999999999999999999984 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKA------------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEEcCCCCChHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCE
Confidence 99999999999999998532 3577888899999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++...+
T Consensus 158 kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 158 KVTDFGFAKKVPD 170 (329)
T ss_pred EEeeccCceEcCC
Confidence 9999999987644
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=256.97 Aligned_cols=346 Identities=21% Similarity=0.227 Sum_probs=194.9
Q ss_pred CcCCCCCCCCCEEEcCCCc------ccccCCccccCCC-CCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCC
Q 003368 49 SPQIGNLSFLREIHLSNNT------IQGKIPGEIGRLF-RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121 (825)
Q Consensus 49 ~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 121 (825)
+.+|..+++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .+|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 4457778888888886553 3334666666653 5788888877776 556666 4577778888877777 456
Q ss_pred hhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceee
Q 003368 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFS 201 (825)
Q Consensus 122 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~ 201 (825)
..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..++.+++|+.|+
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~------------------- 687 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD------------------- 687 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe-------------------
Confidence 6677777777777777654445553 66777777777777665556666666666666664
Q ss_pred cCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCC
Q 003368 202 VPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLG 281 (825)
Q Consensus 202 l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 281 (825)
+++|...+.+|..+ ++++|+.|+|++|...+.+|.. .++|+.|+|++|.+.. +|..+ .+++|+
T Consensus 688 L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~---------- 750 (1153)
T PLN03210 688 MSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLD---------- 750 (1153)
T ss_pred CCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccc----------
Confidence 44433333455433 4566666666665443333321 2345555555555432 22211 233333
Q ss_pred CCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEE
Q 003368 282 SGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLN 361 (825)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 361 (825)
.|++.++.... +.... ....|......++|+.|++++|...+.+|.+++++++|+.|+
T Consensus 751 --------------------~L~l~~~~~~~-l~~~~-~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~ 808 (1153)
T PLN03210 751 --------------------ELILCEMKSEK-LWERV-QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE 808 (1153)
T ss_pred --------------------cccccccchhh-ccccc-cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEE
Confidence 33333221110 00000 000111122235666777777766666777777777777777
Q ss_pred ccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccc
Q 003368 362 MRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441 (825)
Q Consensus 362 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~ 441 (825)
+++|..-+.+|..+ ++++|+.|++++|.....+|.. .++|+.|+|++|.++ .+|..+..+..+ ..|++++++-.
T Consensus 809 Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L-~~L~L~~C~~L 882 (1153)
T PLN03210 809 IENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNL-SFLDMNGCNNL 882 (1153)
T ss_pred CCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCC-CEEECCCCCCc
Confidence 77765444566654 5677777777776544444442 245666677766665 455555444444 34455442222
Q ss_pred cCCCccccccccccEEeecCc
Q 003368 442 GSIPPKIGNLKVLRMFVVSSN 462 (825)
Q Consensus 442 ~~~p~~~~~l~~L~~L~ls~N 462 (825)
..+|..+..++.|+.+++++|
T Consensus 883 ~~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 883 QRVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CccCcccccccCCCeeecCCC
Confidence 234445555555555555544
|
syringae 6; Provisional |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=228.73 Aligned_cols=157 Identities=27% Similarity=0.358 Sum_probs=129.9
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
++||+|+||.||+|+...+|+.||||++.... ......+.+|+++++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999998899999999997642 22345678899999999999999999874 44678999999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.+++... ..+++.++..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 76 YANGGELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred CCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCC
Confidence 99999999888432 3588999999999999999999963 389999999999999999999999999
Q ss_pred cccccccCCCCCccccccC
Q 003368 806 LARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 806 la~~~~~~~~~~~~~~gt~ 824 (825)
+|+.............||+
T Consensus 142 ~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 142 LCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred CCeecCCCCcccccccCCc
Confidence 9986543322233334553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=234.23 Aligned_cols=163 Identities=25% Similarity=0.335 Sum_probs=135.9
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
..++|+..+.||+|+||.||+|+...+++.||||++.... ....+.+.+|+++++.++||||+++++++ .++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 4567899999999999999999998899999999997532 22345578999999999999999999874 456
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~ 179 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCC
Confidence 7899999999999999988432 467778889999999999999985 999999999999999999
Q ss_pred cEEEcccCcccccccCCC-CCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
.+||+|||+++....... .....+||+
T Consensus 180 ~~kL~DfG~~~~~~~~~~~~~~~~~gt~ 207 (370)
T cd05596 180 HLKLADFGTCMKMDANGMVRCDTAVGTP 207 (370)
T ss_pred CEEEEeccceeeccCCCcccCCCCCCCc
Confidence 999999999987644322 223445654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=230.24 Aligned_cols=151 Identities=25% Similarity=0.375 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC-eEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG-TIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g-~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|...+.||+|+||.||+|++..++ ..||||++.... ....+.+.+|+++++.++|||||++++++ .++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence 356888999999999999999875554 789999986532 23345788999999999999999999985 346
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~ 168 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRN------------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDG 168 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCC
Confidence 7899999999999999998532 3578889999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 169 ~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 169 FIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEecCCCCeecCC
Confidence 999999999987643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=231.55 Aligned_cols=165 Identities=27% Similarity=0.405 Sum_probs=131.4
Q ss_pred hcccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
+.++|...+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+++++++ +|||||+++++|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 345788899999999999999975 23457899999975432 3346789999999999 89999999998743
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCc------------------------------------------------
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTD------------------------------------------------ 745 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------ 745 (825)
.....++||||+++|+|.+++.........
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 244679999999999999998643210000
Q ss_pred --ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 746 --EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 746 --~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
........++|.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 0000123588999999999999999999985 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-24 Score=229.79 Aligned_cols=149 Identities=27% Similarity=0.398 Sum_probs=131.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+|+..+.||+|+||.||+|+...+|+.||||+++... ....+.+.+|++++..++||||+++++++ ..++..
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 5888999999999999999998889999999997543 22345788999999999999999999884 446789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 ~lv~e~~~g~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL------------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEE
Confidence 9999999999999998532 3578889999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 142 L~Dfg~a~~~~~ 153 (333)
T cd05600 142 LTDFGLSKGIVT 153 (333)
T ss_pred EEeCcCCccccc
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=209.61 Aligned_cols=162 Identities=25% Similarity=0.437 Sum_probs=140.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCC-CCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIR-HRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 712 (825)
.+.|...+.+|.|..++|.++.++++|+++|+|++..... ...++-.+|+++++++. ||+|+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---- 91 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---- 91 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence 3557788999999999999999999999999999964321 12356678999999985 9999999998
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
|+.....++|+|.|+.|.|.|||.+. ..+++.+..+|++|+..|++|||.. .|||||+||+|||
T Consensus 92 -yes~sF~FlVFdl~prGELFDyLts~------------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENIL 155 (411)
T KOG0599|consen 92 -YESDAFVFLVFDLMPRGELFDYLTSK------------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENIL 155 (411)
T ss_pred -ccCcchhhhhhhhcccchHHHHhhhh------------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhhee
Confidence 56677899999999999999999643 4688899999999999999999985 8999999999999
Q ss_pred ecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|++.++||+|||+|..+++++ .-...+|||
T Consensus 156 lddn~~i~isDFGFa~~l~~Ge-kLrelCGTP 186 (411)
T KOG0599|consen 156 LDDNMNIKISDFGFACQLEPGE-KLRELCGTP 186 (411)
T ss_pred eccccceEEeccceeeccCCch-hHHHhcCCC
Confidence 9999999999999999987753 456678886
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=223.36 Aligned_cols=150 Identities=25% Similarity=0.316 Sum_probs=129.5
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|+..+.||+|+||.||+|....+|+.||||.+..... .....+.+|++++++++|+||+++++++ .+.+..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 6778999999999999999988999999999875432 2234678999999999999999999885 3466889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+|||+++++.+||
T Consensus 77 lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNM----------GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred EEEEecCCCcHHHHHHhh----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEE
Confidence 999999999998887422 123588999999999999999999985 9999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 144 ~Dfg~~~~~~~ 154 (285)
T cd05631 144 SDLGLAVQIPE 154 (285)
T ss_pred eeCCCcEEcCC
Confidence 99999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=233.56 Aligned_cols=147 Identities=25% Similarity=0.318 Sum_probs=129.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|...+.||+|+||+||+|+...+++.||||++.... ....+.+.+|++++++++|||||++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5788899999999999999999999999999997542 23345788999999999999999999985 446789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||.. +|+||||||+|||++.++.+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~k 141 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRM------------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIK 141 (381)
T ss_pred EEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEE
Confidence 9999999999999998532 3578888899999999999999985 999999999999999999999
Q ss_pred EcccCccccc
Q 003368 801 VGDFGLARLR 810 (825)
Q Consensus 801 i~DFGla~~~ 810 (825)
|+|||+++..
T Consensus 142 L~DFGl~~~~ 151 (381)
T cd05626 142 LTDFGLCTGF 151 (381)
T ss_pred EeeCcCCccc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=233.68 Aligned_cols=148 Identities=26% Similarity=0.334 Sum_probs=129.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++|||||++++++ .+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 36888899999999999999999999999999986532 22345688999999999999999999984 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~ 140 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY------------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHI 140 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCE
Confidence 99999999999999998532 3577888889999999999999985 99999999999999999999
Q ss_pred EEcccCccccc
Q 003368 800 HVGDFGLARLR 810 (825)
Q Consensus 800 ki~DFGla~~~ 810 (825)
|++|||+|+..
T Consensus 141 kl~DfGla~~~ 151 (377)
T cd05629 141 KLSDFGLSTGF 151 (377)
T ss_pred EEeeccccccc
Confidence 99999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=231.48 Aligned_cols=168 Identities=24% Similarity=0.318 Sum_probs=139.3
Q ss_pred HHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeeccccc
Q 003368 636 ESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSI 712 (825)
Q Consensus 636 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 712 (825)
.++....++|...+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+++++.++||||+++++++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--- 112 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--- 112 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE---
Confidence 344455688999999999999999999999999999999986432 22345678999999999999999999884
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.++...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+. +|+||||||+|||
T Consensus 113 --~~~~~~~lv~Ey~~gg~L~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIl 174 (371)
T cd05622 113 --QDDRYLYMVMEYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNML 174 (371)
T ss_pred --EcCCEEEEEEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEE
Confidence 456789999999999999998842 2467778889999999999999985 9999999999999
Q ss_pred ecCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
++.++.+||+|||+|+....... ...+.+||+
T Consensus 175 l~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~ 207 (371)
T cd05622 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207 (371)
T ss_pred ECCCCCEEEEeCCceeEcCcCCcccccCcccCc
Confidence 99999999999999987654322 223445664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=213.73 Aligned_cols=164 Identities=29% Similarity=0.380 Sum_probs=143.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh---HHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA---SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+-.+++|+|.||+|-.++-+.+|+.+|||+++++..-+ ...-..|-++++..+||.+..+... |+..+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence 467999999999999999999999999999999998764322 3345678999999999999988654 78899
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|.||||+.||.|.-+|... +.+++.....+..+|..||.|||+. .||+||+|.+|.|+|.+|+
T Consensus 242 rlCFVMeyanGGeLf~HLsre------------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGH 306 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRE------------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGH 306 (516)
T ss_pred eEEEEEEEccCceEeeehhhh------------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCc
Confidence 999999999999999888543 4577777788999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccCC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+||+|||++|.-........+.+||||
T Consensus 307 IKitDFGLCKE~I~~g~t~kTFCGTPE 333 (516)
T KOG0690|consen 307 IKITDFGLCKEEIKYGDTTKTFCGTPE 333 (516)
T ss_pred eEeeecccchhcccccceeccccCChh
Confidence 999999999977666666788899986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=222.66 Aligned_cols=150 Identities=25% Similarity=0.466 Sum_probs=128.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|...+.||+|+||.||+|+...+++.||||.++.... .....+.+|++++++++||||+++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 3568889999999999999999988999999999875432 2345678999999999999999999984 446678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 79 ~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~k 143 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNC-----------GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELK 143 (288)
T ss_pred EEEEeCCCc-CHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence 999999975 898888422 12468889999999999999999985 999999999999999999999
Q ss_pred EcccCcccccc
Q 003368 801 VGDFGLARLRQ 811 (825)
Q Consensus 801 i~DFGla~~~~ 811 (825)
|+|||+++...
T Consensus 144 l~DfG~~~~~~ 154 (288)
T cd07871 144 LADFGLARAKS 154 (288)
T ss_pred ECcCcceeecc
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=229.89 Aligned_cols=157 Identities=27% Similarity=0.428 Sum_probs=129.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|++++++++|+||+++++++ ...+..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence 345667889999999999999988999999999865433 3346789999999999999999999984 4467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+.. ..++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||
T Consensus 149 lv~e~~~~~~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL 209 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKI 209 (353)
T ss_pred EEEecCCCCcccccc----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEE
Confidence 999999999986432 234567788999999999999985 8999999999999999999999
Q ss_pred cccCcccccccCCCCCcccccc
Q 003368 802 GDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt 823 (825)
+|||+++............+||
T Consensus 210 ~DfG~~~~~~~~~~~~~~~~gt 231 (353)
T PLN00034 210 ADFGVSRILAQTMDPCNSSVGT 231 (353)
T ss_pred cccccceecccccccccccccC
Confidence 9999998765433222333444
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=220.10 Aligned_cols=158 Identities=29% Similarity=0.455 Sum_probs=133.6
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
.+++|+|-||+||-|+++.+|+.||||++.+.+ ..+..+..+|+++++.++||.||.+... ++..+..+.|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence 589999999999999999999999999997653 3455788999999999999999999876 566788999999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CcEEEc
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN---LTAHVG 802 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~---~~~ki~ 802 (825)
.+.|.=|+-.|. ...+++++.....+..||+.||.|||.. .|||.|+||+|||+.+. -.+|+|
T Consensus 644 Kl~GDMLEMILS-----------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 644 KLHGDMLEMILS-----------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred hhcchHHHHHHH-----------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeec
Confidence 996544444442 2345788888888999999999999985 99999999999999643 279999
Q ss_pred ccCcccccccCCCCCccccccCC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|||+||++.+. ....+.+|||+
T Consensus 710 DFGfARiIgEk-sFRrsVVGTPA 731 (888)
T KOG4236|consen 710 DFGFARIIGEK-SFRRSVVGTPA 731 (888)
T ss_pred cccceeecchh-hhhhhhcCCcc
Confidence 99999999885 45688899985
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=226.34 Aligned_cols=156 Identities=22% Similarity=0.314 Sum_probs=129.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|+...+++.||||+++... ....+.+.+|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 47999999999999998899999999997642 22345688899999988 699999999984 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 e~~~~g~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Df 140 (329)
T cd05588 76 EFVSGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 140 (329)
T ss_pred eCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcC
Confidence 999999999887422 4689999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++..........+.+||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 141 GMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred ccccccccCCCccccccCCc
Confidence 99985433222333445554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=214.92 Aligned_cols=156 Identities=28% Similarity=0.383 Sum_probs=131.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeec--ccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL--QLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
....|...+.||+|+||.|..|+.+.+|+.||||++.. ...-..+...+|+..++.++|+||+.+...........-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34456667899999999999999999999999999973 3334456788999999999999999999986542333344
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+|+|+| +-+|...++.. ..++......+..|+++||.|+|+. +|+|||+||+|++++.+..
T Consensus 100 DvYiV~elM-etDL~~iik~~------------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~ 163 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ------------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCD 163 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC------------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCC
Confidence 589999999 55899888543 2377788889999999999999986 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
.||+|||+||....
T Consensus 164 lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 164 LKICDFGLARYLDK 177 (359)
T ss_pred EEeccccceeeccc
Confidence 99999999999854
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=226.50 Aligned_cols=152 Identities=26% Similarity=0.312 Sum_probs=131.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+++...+++.||||.+.... ....+.+.+|+.++..++|+||+++++++ .+++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46888999999999999999998899999999987532 22345688899999999999999999884 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~ 141 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF-----------EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHI 141 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCE
Confidence 99999999999999998531 13578889999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 142 kl~DfG~a~~~~~~ 155 (331)
T cd05624 142 RLADFGSCLKMNQD 155 (331)
T ss_pred EEEeccceeeccCC
Confidence 99999999876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=229.55 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=130.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+...+|+.||||+++... ....+.+.+|++++..++||+|++++++ +++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence 46888999999999999999998899999999997532 2234568889999999999999999987 445778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~v 140 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK------------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHV 140 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 99999999999999998532 3578889999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||+|+...
T Consensus 141 kL~DfG~~~~~~ 152 (360)
T cd05627 141 KLSDFGLCTGLK 152 (360)
T ss_pred EEeeccCCcccc
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=240.65 Aligned_cols=265 Identities=26% Similarity=0.326 Sum_probs=143.6
Q ss_pred EEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 34 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
-..|||+.+++. .+|+.+. ++|+.|++++|+|+ .+|.. .++|++|+|++|+|+. +|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence 445777777776 4666654 36777777777777 35532 4667777777777773 3432 24667777777
Q ss_pred CCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccC
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYN 193 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~ 193 (825)
|.|+. +|..+ .+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|... .+|+.
T Consensus 272 N~L~~-Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~------------- 326 (788)
T PRK15387 272 NPLTH-LPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCK------------- 326 (788)
T ss_pred Cchhh-hhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccc-------------
Confidence 77763 44322 45666777777776 33432 3567777777777663 23211 11222
Q ss_pred CCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEE
Q 003368 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273 (825)
Q Consensus 194 l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 273 (825)
|++++|+++ .+|.. ..+|+.|+|++|+|++ +|.. ..
T Consensus 327 ------L~Ls~N~L~-~LP~l----p~~Lq~LdLS~N~Ls~-LP~l---p~----------------------------- 362 (788)
T PRK15387 327 ------LWAYNNQLT-SLPTL----PSGLQELSVSDNQLAS-LPTL---PS----------------------------- 362 (788)
T ss_pred ------cccccCccc-ccccc----ccccceEecCCCccCC-CCCC---Cc-----------------------------
Confidence 244444444 23321 1234444444444442 1211 11
Q ss_pred EcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccC
Q 003368 274 NVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSR 353 (825)
Q Consensus 274 ~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 353 (825)
+|+.|++++|+++ .+|.. ..+|+.|++++|+|++ +|..
T Consensus 363 -------------------------~L~~L~Ls~N~L~----------~LP~l---~~~L~~LdLs~N~Lt~-LP~l--- 400 (788)
T PRK15387 363 -------------------------ELYKLWAYNNRLT----------SLPAL---PSGLKELIVSGNRLTS-LPVL--- 400 (788)
T ss_pred -------------------------ccceehhhccccc----------cCccc---ccccceEEecCCcccC-CCCc---
Confidence 2333344444443 22221 1234555555555553 3322
Q ss_pred CCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhc
Q 003368 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425 (825)
Q Consensus 354 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 425 (825)
.++|+.|++++|+|+ .+|..+ .+|+.|++++|+|+ .+|..++++++|+.|+|++|.|+|..|..+..
T Consensus 401 ~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~ 467 (788)
T PRK15387 401 PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE 467 (788)
T ss_pred ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence 245666677777666 355432 35666777777776 56666777777777777777777766665533
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=225.73 Aligned_cols=156 Identities=24% Similarity=0.324 Sum_probs=128.6
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999998899999999997642 22345677899888776 799999999984 4467899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 E~~~~~~L~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~Df 140 (329)
T cd05618 76 EYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 140 (329)
T ss_pred eCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999887422 3688999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++.............||+
T Consensus 141 G~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 141 GMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CccccccCCCCccccccCCc
Confidence 99986433222233344543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-24 Score=225.46 Aligned_cols=150 Identities=29% Similarity=0.480 Sum_probs=128.3
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
....+.||+|-||+|..|.. ..+..||||.++..... .+++|.+|+++|++++|||||+++|.|.. ++..++|
T Consensus 540 L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-----DePicmI 613 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-----DDPLCMI 613 (807)
T ss_pred eehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-----CCchHHH
Confidence 34467899999999999998 55799999999877654 45899999999999999999999999975 5678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
+|||++|+|.+|+.+...+. ..-..-++||.|||.|++||.+. .+||||+.++|+|+|.++++||+|
T Consensus 614 ~EYmEnGDLnqFl~aheapt----------~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT----------AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc----------cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecC
Confidence 99999999999997653222 22234567999999999999986 899999999999999999999999
Q ss_pred cCcccccccC
Q 003368 804 FGLARLRQEV 813 (825)
Q Consensus 804 FGla~~~~~~ 813 (825)
||++|-+-..
T Consensus 681 fgmsR~lysg 690 (807)
T KOG1094|consen 681 FGMSRNLYSG 690 (807)
T ss_pred cccccccccC
Confidence 9999955443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-25 Score=210.65 Aligned_cols=162 Identities=25% Similarity=0.367 Sum_probs=136.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++.|+..++||+|+|+.||++.++++|+.+|+|++... .....+++.+|+.+.+.++|||||++... +....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccce
Confidence 45678889999999999999999999999999998644 23456788999999999999999999987 455788
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD---NN 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~---~~ 796 (825)
.|+|+|+|.||+|..-+. .....++..+-.+++||+.|+.|+|.. +|||||+||+|+++. ..
T Consensus 85 ~ylvFe~m~G~dl~~eIV------------~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIV------------AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKG 149 (355)
T ss_pred eEEEEecccchHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCC
Confidence 999999999999976552 124578888999999999999999986 999999999999994 34
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
..+|++|||+|.... +....-..+|||
T Consensus 150 A~vKL~~FGvAi~l~-~g~~~~G~~GtP 176 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVN-DGEAWHGFAGTP 176 (355)
T ss_pred CceeecccceEEEeC-CccccccccCCC
Confidence 578999999999887 333445567776
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=226.29 Aligned_cols=162 Identities=27% Similarity=0.391 Sum_probs=141.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch---hHHHHHHHHHHhhcCC-CCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 717 (825)
.+.|+..+.||+|.||+||+|+.+.+|+.+|+|.+.+.... ..+.+.+|+++|+++. |||||+++++ |++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEcC
Confidence 34577789999999999999999999999999999876543 3468899999999999 9999999998 5667
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN- 796 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~- 796 (825)
...++|||++.||.|.+.+... .+++.++..++.|++.|+.|||+. +|+|||+||+|+|+...
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD 172 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence 7899999999999999998421 388999999999999999999985 99999999999999543
Q ss_pred ---CcEEEcccCcccccccCCCCCccccccCC
Q 003368 797 ---LTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 797 ---~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+.+|++|||+|+.... .......+||++
T Consensus 173 ~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKP-GERLHTIVGTPE 203 (382)
T ss_pred CCCCcEEEeeCCCceEccC-CceEeeecCCcc
Confidence 5799999999999887 556788889874
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=236.04 Aligned_cols=156 Identities=26% Similarity=0.332 Sum_probs=132.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccc-cccCC-CCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSS-IDFQG-NDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~-~~~~~-~~~~ 720 (825)
.....++|.+|||+.||.|.....|..||+|++-.......+...+||++|+.++ |+|||.+++.+.. ..-.. .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 3566789999999999999997777999999987666677888999999999998 9999999994322 11122 2467
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
+|.||||+||+|-|++..+ ....|++.++++|+.++++|+++||.. +++|||||||.+||||..++..|
T Consensus 118 llLmEyC~gg~Lvd~mn~R----------lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTR----------LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred EeehhhccCCcHHHHHHHH----------HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 8999999999999999422 223599999999999999999999986 78999999999999999999999
Q ss_pred EcccCccccc
Q 003368 801 VGDFGLARLR 810 (825)
Q Consensus 801 i~DFGla~~~ 810 (825)
+||||-|.-.
T Consensus 187 LCDFGSatt~ 196 (738)
T KOG1989|consen 187 LCDFGSATTK 196 (738)
T ss_pred eCcccccccc
Confidence 9999987643
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=231.63 Aligned_cols=147 Identities=27% Similarity=0.319 Sum_probs=129.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|...+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++|||||++++++ .+.+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 4788899999999999999998999999999997542 23345788999999999999999999984 456789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~k 141 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM------------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIK 141 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999998532 3467788889999999999999985 899999999999999999999
Q ss_pred EcccCccccc
Q 003368 801 VGDFGLARLR 810 (825)
Q Consensus 801 i~DFGla~~~ 810 (825)
|+|||+|+..
T Consensus 142 L~DFGla~~~ 151 (382)
T cd05625 142 LTDFGLCTGF 151 (382)
T ss_pred EeECCCCccc
Confidence 9999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=225.43 Aligned_cols=159 Identities=27% Similarity=0.399 Sum_probs=129.1
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHH---hhcCCCCCceeEeecccccccCCCC
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRA---LRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
|...+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+++ ++.++||||+++++++ ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 556789999999999999998899999999997542 1223456666555 4577899999999984 4467
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|..+++. ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~ 139 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-------------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGF 139 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCc
Confidence 89999999999999888742 2588999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+++............+||+
T Consensus 140 ~kL~Dfg~~~~~~~~~~~~~~~~g~~ 165 (324)
T cd05589 140 VKIADFGLCKEGMGFGDRTSTFCGTP 165 (324)
T ss_pred EEeCcccCCccCCCCCCcccccccCc
Confidence 99999999886433333333445554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=225.70 Aligned_cols=151 Identities=27% Similarity=0.328 Sum_probs=130.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+...+++.||||++.... ....+.|.+|+.++..++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 46888999999999999999998899999999997532 22345688999999999999999999874 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~ 141 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF-----------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHI 141 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCE
Confidence 99999999999999998421 23578889999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 142 kl~Dfg~~~~~~~ 154 (331)
T cd05597 142 RLADFGSCLRLLA 154 (331)
T ss_pred EEEECCceeecCC
Confidence 9999999976544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=223.98 Aligned_cols=156 Identities=23% Similarity=0.349 Sum_probs=126.9
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhc-CCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRN-IRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+...+++.||||.++... ....+.+..|.+++.. .+||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999998899999999997542 2233455667777765 4799999999874 4467899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 e~~~gg~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Df 140 (316)
T cd05592 76 EYLNGGDLMFHIQSS------------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADF 140 (316)
T ss_pred cCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccC
Confidence 999999999888432 3578888999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+|+............+||+
T Consensus 141 g~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 141 GMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred cCCeECCCCCCccccccCCc
Confidence 99986544333334445553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=214.89 Aligned_cols=153 Identities=25% Similarity=0.345 Sum_probs=135.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.+|+|.-|+||.++++.++..+|+|++.++.- ......+.|.++|+.++||.+++||+. |+.+.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence 457778899999999999999998899999999987643 334567789999999999999999998 677889
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|||||+||+|+...+. +..+.+++..+..+|.+|+-||+|||.. |||+|||||+||||.++|++
T Consensus 152 ~cl~meyCpGGdL~~Lrqk----------Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQK----------QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHI 218 (459)
T ss_pred eEEEEecCCCccHHHHHhh----------CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcE
Confidence 9999999999999988853 3446789999999999999999999986 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
-++||-|+......
T Consensus 219 MLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVS 232 (459)
T ss_pred EeeeccccccCCCC
Confidence 99999998877443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=228.90 Aligned_cols=151 Identities=29% Similarity=0.401 Sum_probs=132.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||+||+|+...+|+.||||+++... ....+.+.+|+++++.++||||+++++++ .+++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 36888999999999999999998899999999997542 23456788999999999999999999874 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~ 140 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK------------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHI 140 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence 99999999999999998532 3678889999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+++.....
T Consensus 141 kL~Dfg~~~~~~~~ 154 (350)
T cd05573 141 KLADFGLCKKMNKA 154 (350)
T ss_pred EeecCCCCccCccc
Confidence 99999999876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=224.67 Aligned_cols=147 Identities=24% Similarity=0.318 Sum_probs=125.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCC-CceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHR-NLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~~ 719 (825)
+|...+.||+|+||.||+|+...+++.||||++.... ....+.+..|+++++.++|+ +|+++++++ .+.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4778899999999999999998899999999997542 23346788899999999865 577777763 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 140 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQV------------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHI 140 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCE
Confidence 99999999999999888432 3578899999999999999999985 99999999999999999999
Q ss_pred EEcccCccccc
Q 003368 800 HVGDFGLARLR 810 (825)
Q Consensus 800 ki~DFGla~~~ 810 (825)
||+|||+++..
T Consensus 141 kL~Dfg~~~~~ 151 (324)
T cd05587 141 KIADFGMCKEN 151 (324)
T ss_pred EEeecCcceec
Confidence 99999998854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=224.78 Aligned_cols=156 Identities=27% Similarity=0.333 Sum_probs=128.4
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+...+|+.||||++.... ....+.+..|.+++... +||||+++++++ ..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999998899999999997542 22345677899998866 799999999984 4467789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 76 E~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Df 140 (321)
T cd05591 76 EYVNGGDLMFQIQRS------------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADF 140 (321)
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeec
Confidence 999999999888432 3578899999999999999999985 8999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++.............||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 141 GMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred ccceecccCCccccccccCc
Confidence 99986543333333344543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=227.75 Aligned_cols=156 Identities=31% Similarity=0.404 Sum_probs=132.6
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|...+.||.|+||.||-|+...+.+.||||++.-... ...+.+..|+..+.+++|||+|.+.||+.. +...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchHH
Confidence 6677889999999999999999999999999875433 334578999999999999999999998653 55679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
||||||-| +-.|.+. -..+++-+.+...|+.|++.||+|||++ ..||||||+.|||+.+.|.||+
T Consensus 103 LVMEYClG-SAsDlle-----------VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLE-----------VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HHHHHHhc-cHHHHHH-----------HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeee
Confidence 99999964 6666662 1224677788899999999999999997 7899999999999999999999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||.|.++.. ..++||||
T Consensus 168 aDFGSAsi~~P----AnsFvGTP 186 (948)
T KOG0577|consen 168 ADFGSASIMAP----ANSFVGTP 186 (948)
T ss_pred ccccchhhcCc----hhcccCCc
Confidence 99999998654 47788887
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=224.23 Aligned_cols=156 Identities=26% Similarity=0.350 Sum_probs=128.6
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+.+.+++.||||++.... ....+.+..|.+++... +||||+++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999998899999999997542 23345677888888876 699999999884 4567889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 76 Ey~~~g~L~~~i~~~------------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~Df 140 (320)
T cd05590 76 EFVNGGDLMFHIQKS------------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF 140 (320)
T ss_pred cCCCCchHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeC
Confidence 999999999888432 3578889999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++.............||+
T Consensus 141 G~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 141 GMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred CCCeecCcCCCcccccccCc
Confidence 99986533322333444554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=221.90 Aligned_cols=161 Identities=25% Similarity=0.461 Sum_probs=130.4
Q ss_pred ccccccceeccCCeeEEEEEEEcC----------------CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR----------------DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRV 705 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~----------------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 705 (825)
++|...+.||+|+||.||+|.+.. ++..||||.+..... ...++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 457788999999999999998632 345799999876533 335679999999999999999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCccc-------chhcccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE-------NDEIRNLTLLERISIAIDVASAVDYLHHHCQ 778 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~ 778 (825)
+++|. +.+..++||||+++|+|.+++........... ......++|.++.+++.|+++||+|||+.
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-- 157 (304)
T cd05096 85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-- 157 (304)
T ss_pred EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 99864 35668999999999999999864321111000 11234689999999999999999999985
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
+|+||||||+|||+++++.+||+|||+++...
T Consensus 158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~ 189 (304)
T cd05096 158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189 (304)
T ss_pred -CccccCcchhheEEcCCccEEECCCccceecc
Confidence 89999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=230.39 Aligned_cols=146 Identities=26% Similarity=0.319 Sum_probs=128.2
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++.+ .+++..
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 6888999999999999999998899999999986532 22345688999999999999999999874 457789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 77 ~lv~E~~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ik 141 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL------------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK 141 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEE
Confidence 9999999999999998532 3467788888999999999999985 999999999999999999999
Q ss_pred EcccCcccc
Q 003368 801 VGDFGLARL 809 (825)
Q Consensus 801 i~DFGla~~ 809 (825)
|+|||+|+.
T Consensus 142 L~DFG~a~~ 150 (376)
T cd05598 142 LTDFGLCTG 150 (376)
T ss_pred EEeCCCCcc
Confidence 999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=219.59 Aligned_cols=147 Identities=27% Similarity=0.331 Sum_probs=125.1
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||+||+|+...+|+.||||.+..... ...+.+..|++++++++||||+++.+++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 6999999999999988999999999875432 2235678899999999999999998874 3466789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~~g~L~~~~~~~--------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 144 (280)
T cd05608 76 NGGDLRYHIYNV--------DEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144 (280)
T ss_pred CCCCHHHHHHhc--------cccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccc
Confidence 999999887532 11224689999999999999999999985 9999999999999999999999999999
Q ss_pred cccccC
Q 003368 808 RLRQEV 813 (825)
Q Consensus 808 ~~~~~~ 813 (825)
+.....
T Consensus 145 ~~~~~~ 150 (280)
T cd05608 145 VELKDG 150 (280)
T ss_pred eecCCC
Confidence 876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=223.77 Aligned_cols=161 Identities=22% Similarity=0.272 Sum_probs=131.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+|...+.||+|+||.||+|+...+++.||||++..... ...+.+..|.+++... +|++|+++++++ ...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 47788999999999999999988999999999975432 2334567788888877 488888888874 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~ 140 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQV------------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcE
Confidence 89999999999999888432 3578899999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+++............+||+
T Consensus 141 kL~DfG~~~~~~~~~~~~~~~~gt~ 165 (323)
T cd05616 141 KIADFGMCKENMWDGVTTKTFCGTP 165 (323)
T ss_pred EEccCCCceecCCCCCccccCCCCh
Confidence 9999999986543332333445553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-24 Score=243.25 Aligned_cols=169 Identities=26% Similarity=0.328 Sum_probs=147.3
Q ss_pred HHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc---cchhHHHHHHHHHHhhcCCCCCceeEeecccccc
Q 003368 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ---LQGASKSFAAECRALRNIRHRNLVRVITSCSSID 713 (825)
Q Consensus 637 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 713 (825)
++.-..++|...++||+|+||.|..++++.+++.||+|++++. ......-|..|-.+|.....+-||++.-+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA----- 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA----- 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----
Confidence 3444457899999999999999999999999999999999874 23345668899999999999999999876
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
|+++.+.|+|||||+||+|-..+... .++++..+..++..|.-||+-+|+. |+|||||||.|||+
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~------------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKF------------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLL 208 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhc------------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEe
Confidence 89999999999999999999988432 2678888899999999999999986 99999999999999
Q ss_pred cCCCcEEEcccCcccccccCC-CCCccccccCC
Q 003368 794 DNNLTAHVGDFGLARLRQEVP-NNQSSSVGDLE 825 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~~-~~~~~~~gt~~ 825 (825)
|..|++|++|||-+-.+..+. -..+.+||||.
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPD 241 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPD 241 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCC
Confidence 999999999999887776544 46788899983
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=224.18 Aligned_cols=156 Identities=31% Similarity=0.420 Sum_probs=126.4
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHH-HhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECR-ALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+...+|+.||||++.... ....+.+..|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999998899999999997542 122345556655 46779999999999874 4467899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|..++... ..+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 76 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~Df 140 (325)
T cd05604 76 DFVNGGELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDF 140 (325)
T ss_pred cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeec
Confidence 999999999887422 3678999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 G~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 141 GLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCcccCCCCCCCcccccCCh
Confidence 99986433333333445553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=221.28 Aligned_cols=150 Identities=27% Similarity=0.494 Sum_probs=128.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++..... .....+.+|++++++++||||+++++++ .+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 4678999999999999999999988999999999875432 2334678899999999999999999984 446788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++ +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 79 ~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 143 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKH-----------PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELK 143 (303)
T ss_pred EEEEECCC-cCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence 99999995 6888877422 13477888999999999999999985 899999999999999999999
Q ss_pred EcccCcccccc
Q 003368 801 VGDFGLARLRQ 811 (825)
Q Consensus 801 i~DFGla~~~~ 811 (825)
|+|||+|+...
T Consensus 144 l~Dfg~~~~~~ 154 (303)
T cd07869 144 LADFGLARAKS 154 (303)
T ss_pred ECCCCcceecc
Confidence 99999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=224.77 Aligned_cols=151 Identities=25% Similarity=0.303 Sum_probs=131.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+|+.||||+++.... ...+.+.+|+++++.++||||+++++++ .+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 368889999999999999999989999999999976432 2345688999999999999999999874 34677
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~ 141 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY-----------EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHI 141 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCE
Confidence 89999999999999998532 13688889999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 142 kL~Dfg~a~~~~~ 154 (330)
T cd05601 142 KLADFGSAARLTA 154 (330)
T ss_pred EeccCCCCeECCC
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=223.55 Aligned_cols=161 Identities=22% Similarity=0.299 Sum_probs=130.8
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
+|+..++||+|+||+||+|+...+|+.||||++.... ....+.+..|+++++.+. |++|+++.++ +.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence 3677899999999999999998899999999997542 223456788999998886 5667778776 344678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ..+++.++..|+.|++.|++|||+. +|+||||||+|||+++++.+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~i 140 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQV------------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence 89999999999999888432 3588999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+++.............||+
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~gt~ 165 (323)
T cd05615 141 KIADFGMCKEHMVDGVTTRTFCGTP 165 (323)
T ss_pred EEeccccccccCCCCccccCccCCc
Confidence 9999999986533322223334553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=192.52 Aligned_cols=149 Identities=27% Similarity=0.451 Sum_probs=128.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.|+..+.||+|.||+||||+.+.+++.||+|+++... .+......+|+.+++.++|.|||++++.- ..+....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4677889999999999999999999999999998654 33456789999999999999999999873 4466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+|+|||.. +|..|.... .+.++......++.|+++|+.|+|++ .+.|||+||.|.|+..+|+.|+
T Consensus 78 lvfe~cdq-dlkkyfdsl-----------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSL-----------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred EeHHHhhH-HHHHHHHhc-----------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEe
Confidence 99999964 787777432 24577778888999999999999997 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+||...-
T Consensus 143 adfglarafgi 153 (292)
T KOG0662|consen 143 ADFGLARAFGI 153 (292)
T ss_pred cccchhhhcCC
Confidence 99999997644
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=223.01 Aligned_cols=156 Identities=34% Similarity=0.416 Sum_probs=125.3
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHH-HhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECR-ALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|+...+|+.||||++..... ...+.+.+|.. +++.++|||||++++++ .+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 479999999999999988999999999975421 22344555554 57889999999999874 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 140 (321)
T cd05603 76 DYVNGGELFFHLQRE------------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF 140 (321)
T ss_pred cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccC
Confidence 999999998887422 3577888889999999999999985 8999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 141 GLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCCccCCCCCCccccccCCc
Confidence 99986433332233344553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=236.95 Aligned_cols=182 Identities=25% Similarity=0.339 Sum_probs=130.0
Q ss_pred ecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccC
Q 003368 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNL 280 (825)
Q Consensus 201 ~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 280 (825)
++++|+++ .+|. .+++|+.|+|++|+|+++ |.. ..+|+.|++++|++.+.. .
T Consensus 288 ~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~LP-~------------------ 339 (788)
T PRK15387 288 WIFGNQLT-SLPV----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTSLP-T------------------ 339 (788)
T ss_pred ECcCCccc-cccc----cccccceeECCCCccccC-CCC---cccccccccccCcccccc-c------------------
Confidence 44444444 3443 235677777777777753 322 124556666666654321 0
Q ss_pred CCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEE
Q 003368 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFL 360 (825)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 360 (825)
-..+|+.|+|++|+|+ .+|.. ..+|+.|++++|++++ +|.. ..+|+.|
T Consensus 340 ---------------lp~~Lq~LdLS~N~Ls----------~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~L 387 (788)
T PRK15387 340 ---------------LPSGLQELSVSDNQLA----------SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKEL 387 (788)
T ss_pred ---------------cccccceEecCCCccC----------CCCCC---Ccccceehhhcccccc-Cccc---ccccceE
Confidence 0136788888888888 45542 2467788999999994 6653 3579999
Q ss_pred EccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCcc
Q 003368 361 NMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440 (825)
Q Consensus 361 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l 440 (825)
+|++|+|.+ +|.. .++|+.|++++|+|++ +|..+ .+|+.|++++|+++ .+|..++++..+ ..|++++|+|
T Consensus 388 dLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L-~~LdLs~N~L 457 (788)
T PRK15387 388 IVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSE-TTVNLEGNPL 457 (788)
T ss_pred EecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCC-CeEECCCCCC
Confidence 999999994 6654 3689999999999985 66543 46888999999998 899999998888 6899999999
Q ss_pred ccCCCccccccc
Q 003368 441 VGSIPPKIGNLK 452 (825)
Q Consensus 441 ~~~~p~~~~~l~ 452 (825)
++..|..+..+.
T Consensus 458 s~~~~~~L~~l~ 469 (788)
T PRK15387 458 SERTLQALREIT 469 (788)
T ss_pred CchHHHHHHHHh
Confidence 998888775443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=222.41 Aligned_cols=156 Identities=22% Similarity=0.347 Sum_probs=127.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhc-CCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRN-IRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|+...+|+.||||+++... ....+.+..|.+++.. .+||||+++++++ ...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999899999999997642 2234556778888875 4899999999884 4567899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 E~~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Df 140 (316)
T cd05620 76 EFLNGGDLMFHIQDK------------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADF 140 (316)
T ss_pred CCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCcc
Confidence 999999999888432 3578889999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 141 GMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CCCeecccCCCceeccCCCc
Confidence 99985433323334444553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=222.77 Aligned_cols=156 Identities=35% Similarity=0.435 Sum_probs=125.5
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHH-HhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECR-ALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+...+|+.||||++..... ...+.+.+|.. +++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 469999999999999988999999999975421 22334555554 56789999999999874 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 76 e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Df 140 (323)
T cd05575 76 DYVNGGELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF 140 (323)
T ss_pred cCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEecc
Confidence 999999999888432 3578889999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 141 GLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCCcccccCCCccccccCCh
Confidence 99986433322233334553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=241.38 Aligned_cols=155 Identities=30% Similarity=0.495 Sum_probs=132.0
Q ss_pred cccccceeccCCeeEEEEEEEcCC-C----eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRD-G----TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~-g----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.....+.||+|+||.||+|..... | ..||||.+++... +...+|.+|..+|++++|||||+++|.|.. .
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~ 767 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S 767 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence 345678999999999999998432 3 3499999986643 456789999999999999999999999864 5
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++++|||++|+|..||+..+.... ....++..+.+.+|.|||+|+.||++. ++|||||.++|+||++..
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~-----~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPF-----QPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERR 839 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccC-----CCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccC
Confidence 567999999999999999986543222 245789999999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
.|||+|||+||.+-
T Consensus 840 ~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 840 VVKIADFGLARDIY 853 (1025)
T ss_pred cEEEcccchhHhhh
Confidence 99999999999443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=223.91 Aligned_cols=152 Identities=26% Similarity=0.377 Sum_probs=128.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.|+..+.||+|+||.||+|+...+|+.||||++.... ......+.+|++++++++||||+++++++......+....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677899999999999999998899999999987432 22345688999999999999999999987543333334579
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||
T Consensus 81 lv~e~~~-~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 81 VVFELME-SDLHQVIKAN------------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred EEEecCC-CCHHHHHHhc------------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEE
Confidence 9999995 6898887422 3588999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+|+...
T Consensus 145 ~Dfg~~~~~~ 154 (338)
T cd07859 145 CDFGLARVAF 154 (338)
T ss_pred ccCccccccc
Confidence 9999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=222.97 Aligned_cols=156 Identities=24% Similarity=0.312 Sum_probs=129.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|+...+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++ +..+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 479999999999999988999999999986432 2345688999999888 599999999874 4467899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+|||+++++.+||+||
T Consensus 76 e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 140 (327)
T cd05617 76 EYVNGGDLMFHMQRQ------------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDY 140 (327)
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecc
Confidence 999999999887422 3689999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 g~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 141 GMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred ccceeccCCCCceecccCCc
Confidence 99986433322334445554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=221.41 Aligned_cols=142 Identities=25% Similarity=0.393 Sum_probs=122.3
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhc-CCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRN-IRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||+||+|+...+++.||||+++... ....+.+..|.+++.. .+||||+++++++ .+.+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999998889999999997642 2234556778888876 4899999999884 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 76 ey~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 140 (316)
T cd05619 76 EYLNGGDLMFHIQSC------------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADF 140 (316)
T ss_pred eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccC
Confidence 999999999988422 3578899999999999999999985 9999999999999999999999999
Q ss_pred Cccccc
Q 003368 805 GLARLR 810 (825)
Q Consensus 805 Gla~~~ 810 (825)
|+++..
T Consensus 141 g~~~~~ 146 (316)
T cd05619 141 GMCKEN 146 (316)
T ss_pred CcceEC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=222.86 Aligned_cols=151 Identities=26% Similarity=0.310 Sum_probs=130.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||+||+++.+.+++.||+|++.+.. ....+.+..|+.++..++|++|+++++++ ++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 46888999999999999999998899999999986532 22234588899999999999999999874 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+|||++.++.+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~-----------~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~ 141 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF-----------EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI 141 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 99999999999999999531 23578889999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 142 kL~DfG~a~~~~~ 154 (332)
T cd05623 142 RLADFGSCLKLME 154 (332)
T ss_pred EEeecchheeccc
Confidence 9999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=222.20 Aligned_cols=156 Identities=27% Similarity=0.330 Sum_probs=128.9
Q ss_pred ceeccCCeeEEEEEEE---cCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 649 HLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~---~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+.||+|+||.||+++. ..+|+.||||++..... .....+.+|++++++++||||+++++++ ..++..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 5799999999999876 35789999999975432 2234577899999999999999999884 446788999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 77 ~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~D 141 (318)
T cd05582 77 LDFLRGGDLFTRLSKE------------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 141 (318)
T ss_pred EcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEee
Confidence 9999999999988432 3588999999999999999999985 899999999999999999999999
Q ss_pred cCcccccccCCCCCccccccC
Q 003368 804 FGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 804 FGla~~~~~~~~~~~~~~gt~ 824 (825)
||+++.............||+
T Consensus 142 fg~~~~~~~~~~~~~~~~g~~ 162 (318)
T cd05582 142 FGLSKESIDHEKKAYSFCGTV 162 (318)
T ss_pred ccCCcccCCCCCceecccCCh
Confidence 999987654433333344553
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=221.85 Aligned_cols=143 Identities=28% Similarity=0.377 Sum_probs=122.0
Q ss_pred ceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 649 HLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.||+|+||.||+++.. .+++.||||.++... ......+.+|+++++.++||||+++++++ ..++..|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 67999999999999863 468899999997532 12334678899999999999999999884 3466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 77 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 141 (323)
T cd05584 77 LILEYLSGGELFMHLERE------------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKL 141 (323)
T ss_pred EEEeCCCCchHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 999999999999988432 3567788889999999999999985 9999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 142 ~Dfg~~~~~~ 151 (323)
T cd05584 142 TDFGLCKESI 151 (323)
T ss_pred eeCcCCeecc
Confidence 9999998543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-24 Score=221.11 Aligned_cols=162 Identities=28% Similarity=0.395 Sum_probs=141.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.-|...+.||+|+||.||||....+++.||+|++..+.. ...+..++|+.+++.++++||.++||++. .+...+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHH
Confidence 347778999999999999999999999999999987643 34578899999999999999999999854 366789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
++||||.||++.+.|.... .+++....-|.+++..|+.|+|++ +.+|||||++|||+..+|.+|+
T Consensus 88 iiMey~~gGsv~~lL~~~~------------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl 152 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN------------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKL 152 (467)
T ss_pred HHHHHhcCcchhhhhccCC------------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEE
Confidence 9999999999999986442 224455566889999999999996 8999999999999999999999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||+|..++.......+.+|||
T Consensus 153 ~DfgVa~ql~~~~~rr~tfvGTP 175 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKRRKTFVGTP 175 (467)
T ss_pred Eecceeeeeechhhccccccccc
Confidence 99999999988877778999997
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=221.18 Aligned_cols=151 Identities=27% Similarity=0.475 Sum_probs=129.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeE----EEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTI----VAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|+..+.||+|+||.||+|++..+|+. ||||.++... ....++|.+|+.+++.++||||++++|+|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence 4588999999999999999998666654 8999987543 2345678999999999999999999999753
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++|+||+++|+|.+++... ...+++..+.+++.|+++||+|||+. +|+||||||+||++++++
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~ 146 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQ 146 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhc-----------cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCC
Confidence 2467999999999999998532 13578889999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 147 ~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 147 HVKITDFGLAKLLGAD 162 (316)
T ss_pred cEEEccccccccccCC
Confidence 9999999999977543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=220.89 Aligned_cols=152 Identities=23% Similarity=0.344 Sum_probs=132.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|+...+|..||+|.+..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 3678899999999999999999988999999999976533 33467999999999999999999999854 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~k 144 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA------------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIK 144 (331)
T ss_pred EEEeecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEE
Confidence 9999999999999998532 3578889999999999999999974 2699999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++...+
T Consensus 145 l~Dfg~~~~~~~ 156 (331)
T cd06649 145 LCDFGVSGQLID 156 (331)
T ss_pred EccCcccccccc
Confidence 999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=233.21 Aligned_cols=165 Identities=22% Similarity=0.256 Sum_probs=136.4
Q ss_pred cccccceeccCCeeEEEEEEEcCC-CeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRD-GTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.|...+.||+|+||.||+|....+ ++.||+|.+..........+.+|+++++.++|||||+++++|. .++..|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence 378889999999999999998766 7889999876655555567888999999999999999999854 4678999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.++++.. ......+++.++..++.|++.||+|+|+. +|+||||||+|||++.++.+||+
T Consensus 143 v~E~~~gg~L~~~l~~~--------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~ 211 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQR--------LKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLG 211 (478)
T ss_pred EEECCCCCCHHHHHHHH--------HhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEE
Confidence 99999999999988532 11224688889999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccCCC--CCccccccC
Q 003368 803 DFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
|||+|+....... ...+.+||+
T Consensus 212 DFgla~~~~~~~~~~~~~~~~gt~ 235 (478)
T PTZ00267 212 DFGFSKQYSDSVSLDVASSFCGTP 235 (478)
T ss_pred eCcCceecCCccccccccccCCCc
Confidence 9999997654321 123445654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=221.49 Aligned_cols=156 Identities=32% Similarity=0.398 Sum_probs=125.2
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHH-HHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAEC-RALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||+||+|+...+++.||+|++..... ...+.+..|. .+++.++||||+++++++ ...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 469999999999999988999999999975421 2223444444 456789999999999874 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.+...++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 76 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~Df 140 (325)
T cd05602 76 DYINGGELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 140 (325)
T ss_pred eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccC
Confidence 999999999988532 3467778888999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+|+............+||+
T Consensus 141 G~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 141 GLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CCCcccccCCCCcccccCCc
Confidence 99986543333334445654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=238.34 Aligned_cols=159 Identities=25% Similarity=0.332 Sum_probs=133.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.+|+..++||+|+||.||+|+...+|+.||||++..... ...+.|.+|++++++++|||||+++++|. +.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 468889999999999999999988999999999975422 23467999999999999999999999864 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||++||+|.+++....... ..........++..++.++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~-~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhcc-ccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCE
Confidence 899999999999999986421100 00111234578889999999999999999985 89999999999999999999
Q ss_pred EEcccCccccc
Q 003368 800 HVGDFGLARLR 810 (825)
Q Consensus 800 ki~DFGla~~~ 810 (825)
||+|||+|+..
T Consensus 153 KLiDFGLAk~i 163 (932)
T PRK13184 153 VILDWGAAIFK 163 (932)
T ss_pred EEEecCcceec
Confidence 99999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=198.98 Aligned_cols=160 Identities=21% Similarity=0.245 Sum_probs=141.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.+|+|+|..||.++.-.+++.||+|++.....++.+...+|++..++++||||+++++++....-++....|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 56888999999999999999988999999999999887777888999999999999999999999987644445567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
+++|...|+|.+.+.... .+...+++.+.+.|+.||++||++||+. .++.+||||||.|||+.+++.+++.
T Consensus 101 l~Pyy~~Gsl~d~i~~~k--------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLK--------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EeehhccccHHHHHHHHh--------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 999999999999986432 2234689999999999999999999987 4579999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||.+..++
T Consensus 172 D~GS~~~a~ 180 (302)
T KOG2345|consen 172 DLGSATQAP 180 (302)
T ss_pred eccCccccc
Confidence 999988764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=230.40 Aligned_cols=154 Identities=30% Similarity=0.470 Sum_probs=131.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCe----EEEEEEeecc-cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQ-LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+...++||+|+||+||||.|.+.|+ +||||.+... ..+..+++..|+-+|++++|||+++++|.|.. +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------ST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------ch
Confidence 4567899999999999999987775 6899988654 34557899999999999999999999999864 23
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
..||++|||.|+|.+|++.. +.++--...+.++.|||+||.|||.+ ++|||||.++|||+.+-..+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~h-----------r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hv 837 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREH-----------RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHV 837 (1177)
T ss_pred HHHHHHhcccchHHHHHHHh-----------hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeE
Confidence 78999999999999999643 23556667888999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCc
Q 003368 800 HVGDFGLARLRQEVPNNQS 818 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~ 818 (825)
||.|||+|++...++...+
T Consensus 838 kitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 838 KITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred EEEecchhhccCccccccc
Confidence 9999999999876654333
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=220.54 Aligned_cols=162 Identities=25% Similarity=0.374 Sum_probs=138.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
...|.....||+|.|++|..|++..+|..||||.+.+.... ..+.+.+|+++|..+.|||||+++.+ ...+..
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecce
Confidence 45688899999999999999999999999999999865432 33558899999999999999999998 445778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+.+|.+++|+... .......+..+..|+.+|++|+|+. .|||||||++|||||.++++
T Consensus 130 lylV~eya~~ge~~~yl~~~------------gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH------------GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI 194 (596)
T ss_pred eEEEEEeccCchhHHHHHhc------------ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence 99999999999999999644 2344467778899999999999985 89999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||++...... ..-.+.+|++
T Consensus 195 kIaDfgfS~~~~~~-~~lqt~cgsp 218 (596)
T KOG0586|consen 195 KIADFGFSTFFDYG-LMLQTFCGSP 218 (596)
T ss_pred eeeccccceeeccc-ccccccCCCC
Confidence 99999999988743 3456667765
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=216.88 Aligned_cols=168 Identities=23% Similarity=0.322 Sum_probs=141.7
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSS 711 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 711 (825)
+.++++.++.++|+..+.||+|+||.||+|+...+++.||+|++.... ....++.+|+.+++++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556777788899999999999999999999998899999999886532 2346788999999999 69999999998765
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
.....++..++||||+++|+|.++++... .....+++..+..++.|+++|++|||+. +|+|||+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ni 155 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFL--------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNI 155 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhh--------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhE
Confidence 43445567899999999999999875320 1123578888999999999999999985 899999999999
Q ss_pred eecCCCcEEEcccCccccccc
Q 003368 792 LLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~ 812 (825)
++++++.+|++|||+++....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred EECCCCCEEEccCCceeeccc
Confidence 999999999999999987644
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=214.93 Aligned_cols=153 Identities=29% Similarity=0.509 Sum_probs=132.2
Q ss_pred ccccccceeccCCeeEEEEEEE----cCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.+|+..+.||+|+||.||+|.. ..+++.||||.+........+.|.+|++++++++||||++++++|.. .+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence 4677889999999999999985 34688999999876655556789999999999999999999998643 2345
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~ 146 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-----------RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENR 146 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-----------CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCe
Confidence 689999999999999998532 13588999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 147 ~~l~dfg~~~~~~~ 160 (284)
T cd05081 147 VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEECCCcccccccC
Confidence 99999999997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=224.18 Aligned_cols=161 Identities=25% Similarity=0.429 Sum_probs=135.7
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecc----cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ----LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
..++||+|+|-+||||.+..+|.+||--.++.. .....+.|..|+++++.++|||||+++.++.... ....-+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 357899999999999999899999985433321 2334578999999999999999999999976532 345678
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcEEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ki 801 (825)
|+|.|..|+|+.|... .+.++......+|+||++||.|||++ .|||||||||..||+|.. .|.|||
T Consensus 121 iTEL~TSGtLr~Y~kk------------~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKK------------HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred eeecccCCcHHHHHHH------------hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceee
Confidence 9999999999999853 35678888999999999999999998 689999999999999975 689999
Q ss_pred cccCcccccccCCCCCccccccCC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+|.|||+++... +..+.+||||
T Consensus 188 GDLGLAtl~r~s--~aksvIGTPE 209 (632)
T KOG0584|consen 188 GDLGLATLLRKS--HAKSVIGTPE 209 (632)
T ss_pred cchhHHHHhhcc--ccceeccCcc
Confidence 999999998765 4556899997
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=214.87 Aligned_cols=151 Identities=25% Similarity=0.309 Sum_probs=129.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+|+..++||+|+||+||++....+++.||||++..... .....+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 36778999999999999999988999999999975422 2234578899999999999999999885 345689
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 142 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM----------GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred EEEEeccCCCcHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEE
Confidence 9999999999999887532 123588999999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++....
T Consensus 143 l~Dfg~~~~~~~ 154 (285)
T cd05605 143 ISDLGLAVEIPE 154 (285)
T ss_pred EeeCCCceecCC
Confidence 999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=218.96 Aligned_cols=155 Identities=24% Similarity=0.329 Sum_probs=128.0
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||+||+|++..+++.||||+++... ....+.+.+|+++++.+ +||||+++++++ ...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999998899999999997542 22345677899998887 699999999984 3467899999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|..++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 76 e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Df 140 (318)
T cd05570 76 EYVNGGDLMFHIQRS------------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADF 140 (318)
T ss_pred cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEeccc
Confidence 999999999887422 3689999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCcccccc
Q 003368 805 GLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt 823 (825)
|+++............+||
T Consensus 141 g~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 141 GMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCCeecCcCCCcccceecC
Confidence 9998643332223333454
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=219.98 Aligned_cols=149 Identities=25% Similarity=0.322 Sum_probs=126.9
Q ss_pred cccccceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCC-CCCceeEeecccccccC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 715 (825)
+|+..+.||+|+||+||+++.. .+|+.||||++.... ....+.+.+|++++.+++ ||+|++++++ +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence 4778899999999999998863 468999999987532 123456788999999995 9999999887 44
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.++..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~ 140 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQR------------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDS 140 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECC
Confidence 567889999999999999998532 3578889999999999999999985 8999999999999999
Q ss_pred CCcEEEcccCccccccc
Q 003368 796 NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~ 812 (825)
++.+||+|||+++....
T Consensus 141 ~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 141 EGHVVLTDFGLSKEFLS 157 (332)
T ss_pred CCCEEEeeCcCCccccc
Confidence 99999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=219.47 Aligned_cols=152 Identities=23% Similarity=0.359 Sum_probs=132.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|++++++++|||||+++++|. .++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 3678899999999999999999988999999999876533 33467899999999999999999999864 35689
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++.....++.|++.|++|||+. .+|+||||||+||+++.++.+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~k 144 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 144 (333)
T ss_pred EEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEE
Confidence 9999999999999998532 3578888899999999999999973 3699999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++....
T Consensus 145 L~Dfg~~~~~~~ 156 (333)
T cd06650 145 LCDFGVSGQLID 156 (333)
T ss_pred EeeCCcchhhhh
Confidence 999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=212.07 Aligned_cols=150 Identities=25% Similarity=0.400 Sum_probs=132.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||.||+|+...+|+.||+|++........+.+.+|+.++++++||||+++++++. .++..++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence 46888999999999999999998899999999997654445567889999999999999999999854 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.++++.. ..+++.++..++.|++.|++|||+. +|+|||+||+||+++.++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~ 148 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT------------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLA 148 (267)
T ss_pred EEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEC
Confidence 99999999999988522 3578889999999999999999985 99999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 149 dfg~~~~~~~ 158 (267)
T cd06646 149 DFGVAAKITA 158 (267)
T ss_pred cCccceeecc
Confidence 9999986643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=221.91 Aligned_cols=160 Identities=26% Similarity=0.455 Sum_probs=137.0
Q ss_pred HHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 636 ESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 636 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
+++.-...+....+.+|-|-||.||.|.|+.-.-.||||.++.. .-..++|.+|+++|+.++|||+|+|+|.|..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~---- 334 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH---- 334 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhcc----
Confidence 34433334566778999999999999999988899999999765 3346899999999999999999999999975
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+...|+|+|||.+|+|.+||+++ ....++--..+.+|.||+.|++||... .+||||+.++|.|+.+
T Consensus 335 -EpPFYIiTEfM~yGNLLdYLRec----------nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgE 400 (1157)
T KOG4278|consen 335 -EPPFYIITEFMCYGNLLDYLREC----------NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGE 400 (1157)
T ss_pred -CCCeEEEEecccCccHHHHHHHh----------chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccc
Confidence 45679999999999999999754 123455667789999999999999974 8999999999999999
Q ss_pred CCcEEEcccCcccccccCC
Q 003368 796 NLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~ 814 (825)
+..+||+|||++|+|..+.
T Consensus 401 nhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 401 NHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cceEEeeccchhhhhcCCc
Confidence 9999999999999997763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=213.41 Aligned_cols=148 Identities=21% Similarity=0.313 Sum_probs=125.6
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh---HHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA---SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
...||+|++|.||+|++ +|+.||||.++...... .+.|.+|++++++++|||||+++|++... ..+....++||
T Consensus 25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence 46899999999999998 78999999997653322 46788999999999999999999987431 12234679999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..++|..+.+++.+++.|++|||+. .+++||||||+||++++++.+||+||
T Consensus 102 Ey~~~g~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~df 167 (283)
T PHA02988 102 EYCTRGYLREVLDKE------------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICH 167 (283)
T ss_pred EeCCCCcHHHHHhhC------------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEccc
Confidence 999999999999532 3588999999999999999999973 26789999999999999999999999
Q ss_pred Cccccccc
Q 003368 805 GLARLRQE 812 (825)
Q Consensus 805 Gla~~~~~ 812 (825)
|+++....
T Consensus 168 g~~~~~~~ 175 (283)
T PHA02988 168 GLEKILSS 175 (283)
T ss_pred chHhhhcc
Confidence 99987543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=212.46 Aligned_cols=149 Identities=23% Similarity=0.402 Sum_probs=128.6
Q ss_pred ccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||.||+|++. ..+..||+|.++.... ...+.|.+|+.++++++||||+++++++. ..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence 45788899999999999999874 3467899999976533 33467999999999999999999999854 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|.+++.++.|++.|++|||+. +++||||||+||+++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~ 145 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH-----------EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLV 145 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCc
Confidence 789999999999999998532 13588999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccc
Q 003368 799 AHVGDFGLARLR 810 (825)
Q Consensus 799 ~ki~DFGla~~~ 810 (825)
+|++|||.+...
T Consensus 146 ~~l~dfg~~~~~ 157 (266)
T cd05064 146 CKISGFRRLQED 157 (266)
T ss_pred EEECCCcccccc
Confidence 999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=215.02 Aligned_cols=150 Identities=25% Similarity=0.373 Sum_probs=128.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+++.+++.||||++.... ....+.+.+|++++++++||||+++++++ ..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 35888899999999999999998899999999987543 22346788999999999999999999885 446788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 76 YLVFEYVEKNMLELLEEM------------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred EEEEecCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence 999999998877654321 13578889999999999999999985 999999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 141 l~Dfg~~~~~~~ 152 (287)
T cd07848 141 LCDFGFARNLSE 152 (287)
T ss_pred EeeccCcccccc
Confidence 999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=224.17 Aligned_cols=163 Identities=25% Similarity=0.368 Sum_probs=130.9
Q ss_pred cccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.++|+..+.||+|+||.||+|++ ..++..||||+++... ....+.+.+|+++++.+ +|||||+++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 34678889999999999999974 3456789999997543 23446788999999999 8999999999864
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCc-------------------------------------------------
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTD------------------------------------------------- 745 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------- 745 (825)
+.+..++||||+++|+|.++++........
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 356789999999999999998643210000
Q ss_pred --------------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 746 --------------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 746 --------------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
........++|..+.+++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0000123589999999999999999999985 99999999999999999999999999998664
Q ss_pred c
Q 003368 812 E 812 (825)
Q Consensus 812 ~ 812 (825)
.
T Consensus 266 ~ 266 (375)
T cd05104 266 N 266 (375)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=223.88 Aligned_cols=142 Identities=27% Similarity=0.403 Sum_probs=124.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|+..+.||+|+||.||+|+...+++.||||... .+.+.+|++++++++|||||++++++. .....++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEE
Confidence 56999999999999999999999999999999653 235679999999999999999999853 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+. ++|.+++... ..+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+
T Consensus 161 v~e~~~-~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~ 224 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAK------------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLG 224 (391)
T ss_pred EEecCC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEE
Confidence 999995 6888887422 3578999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+|+...
T Consensus 225 DFG~a~~~~ 233 (391)
T PHA03212 225 DFGAACFPV 233 (391)
T ss_pred eCCcccccc
Confidence 999998653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-23 Score=201.87 Aligned_cols=151 Identities=27% Similarity=0.420 Sum_probs=132.4
Q ss_pred HHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccc
Q 003368 635 YESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSID 713 (825)
Q Consensus 635 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 713 (825)
+.++-+-| .+.+|+|+||.|-.++...+|.+||||++.++....+....+|++++..++ |+||++++++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----- 144 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----- 144 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence 45554444 378999999999999998999999999999887777788999999999997 9999999998
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
|+++...|||||-|.||.|..+++. .+.+++.++.++..+||.||.|||.. +|.|||+||+|||.
T Consensus 145 FEdd~~FYLVfEKm~GGplLshI~~------------~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC 209 (463)
T KOG0607|consen 145 FEDDTRFYLVFEKMRGGPLLSHIQK------------RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILC 209 (463)
T ss_pred hcccceEEEEEecccCchHHHHHHH------------hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceee
Confidence 7778889999999999999999853 35789999999999999999999984 99999999999999
Q ss_pred cCCC---cEEEcccCccccc
Q 003368 794 DNNL---TAHVGDFGLARLR 810 (825)
Q Consensus 794 ~~~~---~~ki~DFGla~~~ 810 (825)
.+.. -+|||||.++.-+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred cCCCCcCceeeecccccccc
Confidence 6543 5799999887644
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=224.43 Aligned_cols=163 Identities=26% Similarity=0.419 Sum_probs=130.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.++|+..+.||+|+||.||+|++... ++.||||+++.... ...+.+.+|+++++++ +|||||+++++|.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 34688899999999999999986443 35799999975432 3345788999999999 8999999999864
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCC---------------------------------------------------
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQ--------------------------------------------------- 743 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 743 (825)
+.+..++||||+++|+|.++++......
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 3567899999999999999985421100
Q ss_pred -------CcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 744 -------TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 744 -------~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
..........++|.++.+|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+....
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 000001123589999999999999999999985 999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=213.47 Aligned_cols=155 Identities=28% Similarity=0.450 Sum_probs=125.9
Q ss_pred cccccceeccCCeeEEEEEEEcC-CCeEEEEEEeecccc--hhHHHHHHHHHHhhcC---CCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDR-DGTIVAIKVLNLQLQ--GASKSFAAECRALRNI---RHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~ 717 (825)
+|...+.||+|+||+||+|+... +|+.||||.++.... .....+.+|+++++.+ +||||++++++|........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 57788999999999999999844 578899999875432 2234566777777665 69999999998754333345
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||++ |+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV----------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSG 147 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCC
Confidence 56899999996 6899888532 123578999999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 148 ~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 148 QIKLADFGLARIYSF 162 (290)
T ss_pred CEEEccccceEeccC
Confidence 999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=216.48 Aligned_cols=150 Identities=23% Similarity=0.453 Sum_probs=128.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||+|+||.||+|+...+++.||||.++.... .....+.+|++++++++||||+++++++. .++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence 568889999999999999999988999999999875432 23456789999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++ ++.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 81 lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl 145 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC-----------GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKL 145 (309)
T ss_pred EEEeCCCC-CHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 99999975 888877422 13478889999999999999999985 9999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 146 ~Dfg~~~~~~~ 156 (309)
T cd07872 146 ADFGLARAKSV 156 (309)
T ss_pred CccccceecCC
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=218.99 Aligned_cols=154 Identities=27% Similarity=0.289 Sum_probs=124.1
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcC---CCCCceeEeecccccccCCCCeeeEEE
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNI---RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
||+|+||+||+|+...+|+.||||++..... .....+..|..++.+. +||||+++++++ ...+..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999999988999999999875322 1223455677777665 699999999874 4467889999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 76 e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Df 140 (330)
T cd05586 76 DYMSGGELFWHLQKE------------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDF 140 (330)
T ss_pred cCCCCChHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecC
Confidence 999999999888422 3578899999999999999999985 9999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|+++............+||+
T Consensus 141 g~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 141 GLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred CcCcCCCCCCCCccCccCCc
Confidence 99986433322233344553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=210.49 Aligned_cols=155 Identities=23% Similarity=0.333 Sum_probs=134.0
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++.+++++.....||+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||++++++|. .+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence 4456778888889999999999999998889999999987766556678999999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNL--TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+..++|+||+++++|.+++... ...+ ++..+..++.|+++|++|||+. +|+||||||+||+++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~ 143 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSK-----------WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNT 143 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHh-----------cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcC
Confidence 6789999999999999998532 1123 7778889999999999999985 9999999999999986
Q ss_pred -CCcEEEcccCcccccc
Q 003368 796 -NLTAHVGDFGLARLRQ 811 (825)
Q Consensus 796 -~~~~ki~DFGla~~~~ 811 (825)
++.+||+|||+++...
T Consensus 144 ~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 144 YSGVVKISDFGTSKRLA 160 (268)
T ss_pred CCCeEEEecchhheecc
Confidence 6799999999988654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=236.79 Aligned_cols=153 Identities=29% Similarity=0.413 Sum_probs=132.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++.++||||+++++++ ...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 357888999999999999999998899999999997543 22346788999999999999999999874 3467
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++... ..+++..+..|+.||+.||+|||.. +||||||||+|||++.++.
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~------------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~ 142 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIY------------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGH 142 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCC
Confidence 899999999999999998532 3578888999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccccCC
Q 003368 799 AHVGDFGLARLRQEVP 814 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~ 814 (825)
+||+|||+++......
T Consensus 143 vkL~DFGls~~~~~~~ 158 (669)
T cd05610 143 IKLTDFGLSKVTLNRE 158 (669)
T ss_pred EEEEeCCCCccccCCc
Confidence 9999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=228.09 Aligned_cols=162 Identities=26% Similarity=0.335 Sum_probs=133.2
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccC--
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ-- 715 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-- 715 (825)
...++|...+.||+|+||+||+|+...+|+.||||++.... ......+.+|+..+..++|+|++++.+.+...+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568999999999999999999998899999999987542 23345788999999999999999988765321110
Q ss_pred -CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 716 -GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 716 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.....++||||+++|+|.+++.... .....+++..+..++.|++.||+|+|+. +|+||||||+|||++
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~--------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRA--------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLC 177 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEe
Confidence 1113689999999999999985321 1224688899999999999999999985 999999999999999
Q ss_pred CCCcEEEcccCccccccc
Q 003368 795 NNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~ 812 (825)
.++.+||+|||+++....
T Consensus 178 ~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred CCCCEEEEecccCeeccc
Confidence 999999999999987643
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=212.57 Aligned_cols=150 Identities=27% Similarity=0.369 Sum_probs=132.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|...+.||+|+||.||+|+...+++.||||.+........+.+.+|+.+++.++||||++++++|. .++..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence 46888899999999999999998899999999997655555677899999999999999999999854 3668899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 94 v~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~ 157 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (297)
T ss_pred eecccCCCCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEC
Confidence 9999999999998842 2468889999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||+++.....
T Consensus 158 Dfg~~~~~~~~ 168 (297)
T cd06656 158 DFGFCAQITPE 168 (297)
T ss_pred cCccceEccCC
Confidence 99999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=212.56 Aligned_cols=168 Identities=26% Similarity=0.302 Sum_probs=140.8
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSS 711 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 711 (825)
++.+++.+++++|...+.||+|+||.||+|....+|+.||+|.+.... .....+.+|+.+++++ +|||+++++++|..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677778899999999999999999999998899999999986532 2345678899999998 79999999998764
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
.+....+..++||||+++|+|.++++.. ......++|..+..++.|++.|++|||+. +|+||||||+||
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~--------~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~ni 159 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGL--------LICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNI 159 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHh--------hhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHE
Confidence 3322345689999999999999988532 11224688999999999999999999985 999999999999
Q ss_pred eecCCCcEEEcccCccccccc
Q 003368 792 LLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~ 812 (825)
++++++.+||+|||+++....
T Consensus 160 li~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEcCCCCEEEeecccchhccc
Confidence 999999999999999887543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=210.69 Aligned_cols=159 Identities=26% Similarity=0.406 Sum_probs=133.8
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCC-C
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQG-N 717 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~-~ 717 (825)
.++..|+..+.||+|+||.||+|....+++.||||++.... .....+.+|++++.++ +||||++++++|......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35567888899999999999999998899999999987543 3346788999999998 6999999999875422111 2
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++|+|.+++... ....++|..+..++.|++.|++|||+. +|+|||+||+||++++++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~ 148 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT----------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 148 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCC
Confidence 4689999999999999998532 123578999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 149 ~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 149 EVKLVDFGVSAQLDR 163 (272)
T ss_pred CEEEccCCCceeccc
Confidence 999999999987644
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-23 Score=217.64 Aligned_cols=156 Identities=24% Similarity=0.458 Sum_probs=128.6
Q ss_pred ccccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccc
Q 003368 631 RKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710 (825)
Q Consensus 631 ~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 710 (825)
..+.|++| ...+-+|+|+.|.||+|++ .++.||||+++... ..+|+.|++++||||+++.|.|.
T Consensus 119 WeiPFe~I-------sELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 119 WEIPFEEI-------SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred ccCCHHHh-------hhhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 34556655 3467799999999999998 56899999876432 36899999999999999999996
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
. ...+++|||||+.|-|+..|+.. ..++-...+.+..+||.|+.|||.+ .|||||||+-|
T Consensus 183 q-----sPcyCIiMEfCa~GqL~~VLka~------------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPN 242 (904)
T KOG4721|consen 183 Q-----SPCYCIIMEFCAQGQLYEVLKAG------------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPN 242 (904)
T ss_pred C-----CceeEEeeeccccccHHHHHhcc------------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCc
Confidence 5 45689999999999999999643 3456666778889999999999987 89999999999
Q ss_pred eeecCCCcEEEcccCcccccccCCCCCcccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
|||..+-.+||+|||.++...+-.+ ..+++||
T Consensus 243 iLIs~~d~VKIsDFGTS~e~~~~ST-kMSFaGT 274 (904)
T KOG4721|consen 243 ILISYDDVVKISDFGTSKELSDKST-KMSFAGT 274 (904)
T ss_pred eEeeccceEEeccccchHhhhhhhh-hhhhhhh
Confidence 9999999999999999997655422 3445565
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=212.66 Aligned_cols=151 Identities=24% Similarity=0.334 Sum_probs=131.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||.||+|++..+|..||+|.+..... ...+++.+|++++.+++||||++++++|. .++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence 368889999999999999999988999999999875433 23456889999999999999999999853 467899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ..+++..+..++.|+++||+|||+. .+++||||||+||+++.++.+||
T Consensus 76 lv~ey~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l 141 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA------------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL 141 (308)
T ss_pred EEeeccCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEE
Confidence 999999999999998532 3578889999999999999999973 37999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++.+..
T Consensus 142 ~dfg~~~~~~~ 152 (308)
T cd06615 142 CDFGVSGQLID 152 (308)
T ss_pred ccCCCcccccc
Confidence 99999886643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=219.15 Aligned_cols=153 Identities=25% Similarity=0.359 Sum_probs=128.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999998899999999986532 23346788999999999999999999986532211123689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 81 lv~e~~~-~~l~~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP------------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred EEeeccc-cCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEe
Confidence 9999997 5787777422 3688999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 145 ~Dfg~a~~~~~ 155 (372)
T cd07853 145 CDFGLARVEEP 155 (372)
T ss_pred ccccceeeccc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=224.27 Aligned_cols=155 Identities=26% Similarity=0.381 Sum_probs=124.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc---CCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF---QGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~~ 718 (825)
..+|...+.||+|+||+||+|+...+++.||||++.... ....+|+.++++++|||||++++++....+ ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 456899999999999999999998899999999885432 234579999999999999999887532211 1223
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL- 797 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~- 797 (825)
..++||||+++ ++.+++... ......+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~--------~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHY--------ARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHH--------hhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCC
Confidence 56799999985 677766321 11224688999999999999999999985 899999999999999664
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 209 ~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 209 TLKLCDFGSAKNLLA 223 (440)
T ss_pred ceeeeccccchhccC
Confidence 799999999997654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-22 Score=209.68 Aligned_cols=149 Identities=24% Similarity=0.305 Sum_probs=128.4
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|...+.||+|+||+||+|++..+++.||||.+..... ...+.+.+|++++++++|+|++++.+++ ..++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 5667899999999999999988999999999875432 2234578899999999999999998874 3467889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 77 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl 143 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM----------GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred EEEEeccCccHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEE
Confidence 999999999999888532 123589999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 144 ~Dfg~~~~~~ 153 (285)
T cd05632 144 SDLGLAVKIP 153 (285)
T ss_pred ecCCcceecC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=211.48 Aligned_cols=149 Identities=26% Similarity=0.372 Sum_probs=132.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|...+.||+|+||.||+|+...+++.||+|.+........+.+.+|+++++.++||||+++++++. .+...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence 46788899999999999999988899999999998765555678899999999999999999999854 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 95 v~e~~~~~~L~~~~~~-------------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~ 158 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (296)
T ss_pred eecccCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEC
Confidence 9999999999998842 2468889999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 159 dfg~~~~~~~ 168 (296)
T cd06654 159 DFGFCAQITP 168 (296)
T ss_pred ccccchhccc
Confidence 9999886544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=220.34 Aligned_cols=163 Identities=27% Similarity=0.436 Sum_probs=130.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccc-hhHHHHHHHHHHhhcCC-CCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQ-GASKSFAAECRALRNIR-HRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 714 (825)
.++|...++||+|+||.||+|++... +..||||+++.... ...+.|.+|++++++++ |||||+++++|.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence 45688889999999999999986332 35799999975433 33467999999999996 999999999964
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcc------------------------------------------------
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDE------------------------------------------------ 746 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~------------------------------------------------ 746 (825)
+.+..++||||+++|+|.++++.........
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 3567899999999999999986431100000
Q ss_pred ------------------------------------cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 747 ------------------------------------ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 747 ------------------------------------~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
.......++|.++..++.|+++|++|||+. +|+||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 000123589999999999999999999985 89999999999
Q ss_pred eeecCCCcEEEcccCccccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~ 812 (825)
|++++++.+||+|||+++....
T Consensus 268 ill~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccc
Confidence 9999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=210.75 Aligned_cols=152 Identities=25% Similarity=0.397 Sum_probs=134.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|++..+++.||+|.+........+.|.+|++++++++||||+++++++. .+...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 456888899999999999999998889999999998665555678999999999999999999999853 366789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 79 lv~e~~~~~~L~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l 144 (280)
T cd06611 79 ILIEFCDGGALDSIMLEL-----------ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKL 144 (280)
T ss_pred EEeeccCCCcHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEE
Confidence 999999999999988432 23588999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||++.....
T Consensus 145 ~d~g~~~~~~~ 155 (280)
T cd06611 145 ADFGVSAKNKS 155 (280)
T ss_pred ccCccchhhcc
Confidence 99999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=208.42 Aligned_cols=158 Identities=27% Similarity=0.492 Sum_probs=127.9
Q ss_pred cccceeccCCeeEEEEEEEcCCCe--EEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCCee
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGT--IVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGNDFK 720 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~--~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~ 720 (825)
...+.||+|+||.||+|++..++. .||||.++... ....+.|.+|++++++++||||++++++|.... .......
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999866664 69999887542 334567899999999999999999999875321 1122346
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++..... ......++|.....++.|++.|++|||+. +|+||||||+||++++++.+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRL------GDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcc------cCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEE
Confidence 899999999999998743211 11223589999999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+.+..
T Consensus 153 l~Dfg~~~~~~~ 164 (272)
T cd05075 153 VADFGLSKKIYN 164 (272)
T ss_pred ECCCCcccccCc
Confidence 999999997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-23 Score=202.06 Aligned_cols=157 Identities=27% Similarity=0.370 Sum_probs=130.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCC----CeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD----GTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~----g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
...|+....||+|.||.||+|+...+ .+.+|||+++.+. .+......+|+..++.++|||||.+...+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~---- 98 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS---- 98 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence 34578888999999999999975433 2379999997653 3456788999999999999999999988654
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.+...++++||.+. +|++.++-.+.. ..+.++-.....|..|++.|+.|||+. -|+|||+||+|||+..
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~-------~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRAS-------KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMG 167 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccc-------hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEec
Confidence 25678999999987 888888654322 124678888899999999999999996 7999999999999977
Q ss_pred C----CcEEEcccCcccccccC
Q 003368 796 N----LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ~----~~~ki~DFGla~~~~~~ 813 (825)
+ |.+||+|||+||++...
T Consensus 168 dgperG~VKIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNP 189 (438)
T ss_pred cCCccCeeEeecccHHHHhhcc
Confidence 7 89999999999998764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=208.03 Aligned_cols=146 Identities=39% Similarity=0.642 Sum_probs=123.8
Q ss_pred ccceeccCCeeEEEEEEEc----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 647 STHLIGIGSFGSVYKGTFD----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..+.||+|+||.||+|.+. ..+..||||.++.... ...+.|.+|++.+++++||||++++|+|.. .+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence 4578999999999999996 3467899999965433 346789999999999999999999999863 34589
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.++|... ....++|.++..|+.|+|+||+|||+. +|+|+||+++||++++++.+||
T Consensus 78 lv~e~~~~g~L~~~L~~~----------~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl 144 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSK----------NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKL 144 (259)
T ss_dssp EEEE--TTEBHHHHHHHT----------CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEE
T ss_pred cccccccccccccccccc----------ccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 999999999999999632 124689999999999999999999985 8999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||+++..
T Consensus 145 ~~f~~~~~~ 153 (259)
T PF07714_consen 145 SDFGLSRPI 153 (259)
T ss_dssp ESTTTGEET
T ss_pred ccccccccc
Confidence 999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=209.10 Aligned_cols=149 Identities=26% Similarity=0.403 Sum_probs=131.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|+...+++.||+|.++.........+.+|+.+++.++||||+++++++ ...+..++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence 4677788999999999999999889999999998766544456788999999999999999999985 34678899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~ 148 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT------------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLA 148 (267)
T ss_pred EEeccCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence 99999999999988432 3578899999999999999999986 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 149 dfg~~~~~~ 157 (267)
T cd06645 149 DFGVSAQIT 157 (267)
T ss_pred cceeeeEcc
Confidence 999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=207.42 Aligned_cols=159 Identities=26% Similarity=0.474 Sum_probs=129.5
Q ss_pred ccccceeccCCeeEEEEEEEcCC---CeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCC
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGND 718 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 718 (825)
|...+.||+|+||.||+|++..+ +..||||+++.... ...+++.+|++.+++++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678999999999999998543 37899999875432 334678999999999999999999998754221 2223
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|..++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG------GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc------CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCe
Confidence 478999999999999998543211 1124689999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 152 ~kl~dfg~~~~~~~ 165 (273)
T cd05035 152 VCVADFGLSKKIYS 165 (273)
T ss_pred EEECCccceeeccc
Confidence 99999999987644
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=208.88 Aligned_cols=164 Identities=24% Similarity=0.311 Sum_probs=141.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.+.|..-++||+|+||.||-++.+.+|+.+|.|++.+.+. +...-...|-.++.++..+.||.+-.+ |+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 3568889999999999999999999999999999976542 234456789999999999999998665 67788
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++|+..|.||+|.-+++... ...+++.+++.+|.+|+.||++||.. +||+||+||+|||+|+.|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g----------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHG----------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGH 325 (591)
T ss_pred ceEEEEEeecCCceeEEeeccC----------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCC
Confidence 9999999999999998887541 24688899999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++|+|.|||-.+.+.... ...+||.
T Consensus 326 vRISDLGLAvei~~g~~~-~~rvGT~ 350 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPI-RGRVGTV 350 (591)
T ss_pred eEeeccceEEecCCCCcc-ccccCcc
Confidence 999999999998876544 4447763
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=207.73 Aligned_cols=144 Identities=24% Similarity=0.329 Sum_probs=123.2
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||.||+++.+.+|+.||+|.+..... ...+.+..|++++++++||||+++.+++ ..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 6999999999999988999999999864321 2234566799999999999999998874 4467889999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~g~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~ 142 (277)
T cd05607 76 NGGDLKYHIYNV----------GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA 142 (277)
T ss_pred CCCCHHHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceee
Confidence 999999887532 123578999999999999999999985 9999999999999999999999999999
Q ss_pred ccccc
Q 003368 808 RLRQE 812 (825)
Q Consensus 808 ~~~~~ 812 (825)
+....
T Consensus 143 ~~~~~ 147 (277)
T cd05607 143 VELKD 147 (277)
T ss_pred eecCC
Confidence 87644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=206.07 Aligned_cols=150 Identities=29% Similarity=0.449 Sum_probs=130.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCC---CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||+||+|++..+ ...||||.++.... ...++|.+|+.++++++||||+++++++. +.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 5688899999999999999998543 45899999875543 33567899999999999999999999853 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|.++.+++.|++.|++|||+. +|+||||||+||++++++.
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~ 144 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREN-----------DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLV 144 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCC
Confidence 789999999999999998532 13688999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+|++|||+++...
T Consensus 145 ~~l~dfg~~~~~~ 157 (266)
T cd05033 145 CKVSDFGLSRRLE 157 (266)
T ss_pred EEECccchhhccc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=208.40 Aligned_cols=154 Identities=33% Similarity=0.550 Sum_probs=134.4
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++..+|+..+.||+|+||.||+|+... ++.||+|.+..........+.+|++++++++||||+++++++. +.+.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCC
Confidence 345678889999999999999999955 8999999998765555678999999999999999999999854 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ....++|.++.+++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~ 143 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSP----------EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVC 143 (261)
T ss_pred eEEEEeecccCCHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceE
Confidence 89999999999999999632 123578999999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 144 kl~d~g~~~~~~~ 156 (261)
T cd05148 144 KVADFGLARLIKE 156 (261)
T ss_pred EEccccchhhcCC
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=207.64 Aligned_cols=149 Identities=23% Similarity=0.379 Sum_probs=130.6
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
|+..+.||+|+||.||+|+...++..+|+|.+........+.+.+|+++++.++|||+++++++|. .++..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence 466788999999999999998889999999997655555678899999999999999999999864 356789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|..++... ...++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 82 e~~~~~~l~~~~~~~-----------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~df 147 (282)
T cd06643 82 EFCAGGAVDAVMLEL-----------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADF 147 (282)
T ss_pred EecCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccc
Confidence 999999998887421 23589999999999999999999985 9999999999999999999999999
Q ss_pred Cccccccc
Q 003368 805 GLARLRQE 812 (825)
Q Consensus 805 Gla~~~~~ 812 (825)
|+++....
T Consensus 148 g~~~~~~~ 155 (282)
T cd06643 148 GVSAKNTR 155 (282)
T ss_pred cccccccc
Confidence 99876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=204.13 Aligned_cols=152 Identities=26% Similarity=0.380 Sum_probs=132.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|...+.||+|+||.||+|+...+|+.||+|.+... .....+++.+|++++++++|||++++++++. +.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 467788999999999999999889999999998643 2334567899999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.++++.. ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|+
T Consensus 76 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l 142 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ----------RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKI 142 (256)
T ss_pred EEEEeCCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEE
Confidence 999999999999998532 124688999999999999999999985 9999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 143 ~df~~~~~~~~~ 154 (256)
T cd08529 143 GDLGVAKLLSDN 154 (256)
T ss_pred cccccceeccCc
Confidence 999999976554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=207.64 Aligned_cols=151 Identities=28% Similarity=0.483 Sum_probs=129.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCe----EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
.++|+..+.||+|+||+||+|++..+|+ .||||.++.... ...+++.+|+.+++.++||||++++++|..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 3568888999999999999999877776 489999875433 345678999999999999999999998742
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
...+++|||+++|+|.++++.. ...+++.+++.++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~ 145 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVREN-----------KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSP 145 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC
Confidence 3467999999999999998532 23588999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
+.+||+|||+++....
T Consensus 146 ~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 146 NHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEECCCCceeeccc
Confidence 9999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-22 Score=207.50 Aligned_cols=154 Identities=23% Similarity=0.369 Sum_probs=131.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+++.||||.+.... ....+.+.+|++++++++||||+++++++. +.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence 46888999999999999999998899999999886432 233457889999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++|+||+++|+|.+++... ......+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~ 145 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYF--------KKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEEecCCCcHHHHHHHh--------hhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCE
Confidence 89999999999999887421 01123578888999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
+++|||+++....
T Consensus 146 ~l~d~g~~~~~~~ 158 (267)
T cd08228 146 KLGDLGLGRFFSS 158 (267)
T ss_pred EECccccceeccc
Confidence 9999999887644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=208.05 Aligned_cols=150 Identities=25% Similarity=0.319 Sum_probs=129.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|+..++||+|+||.||+|....+++.||||.+..... ...+.+.+|+.++++++|++++++++++. ..+..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence 6677899999999999999999999999999875422 22345778999999999999999998853 356889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|
T Consensus 77 lv~e~~~g~~L~~~l~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l 143 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM----------GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRI 143 (285)
T ss_pred EEEEecCCCcHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999988432 123588899999999999999999985 9999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 144 ~Dfg~~~~~~~ 154 (285)
T cd05630 144 SDLGLAVHVPE 154 (285)
T ss_pred eeccceeecCC
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=204.84 Aligned_cols=144 Identities=29% Similarity=0.494 Sum_probs=125.5
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
+.||+|+||.||+|++..+|+.||+|.+..... .....|.+|++++++++||||++++++|. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 468999999999999988999999998865432 33567999999999999999999999864 356789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++++|.+++... ...++|.++..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 76 ~~~~L~~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 141 (252)
T cd05084 76 QGGDFLTFLRTE-----------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMS 141 (252)
T ss_pred cCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccC
Confidence 999999998532 13578999999999999999999985 8999999999999999999999999998
Q ss_pred cccc
Q 003368 808 RLRQ 811 (825)
Q Consensus 808 ~~~~ 811 (825)
+...
T Consensus 142 ~~~~ 145 (252)
T cd05084 142 REEE 145 (252)
T ss_pred cccc
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=215.26 Aligned_cols=163 Identities=27% Similarity=0.398 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.++|+..+.||+|+||+||+|++ ..+++.||||+++.... ...+.+.+|++++.++ +||||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 35688899999999999999984 24678999999975432 2345788999999999 68999999998743
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCc-------------------------------------------------
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTD------------------------------------------------- 745 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------- 745 (825)
.+...++||||+++|+|.++++........
T Consensus 83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 245678999999999999998643210000
Q ss_pred ------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 746 ------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 746 ------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
........++|.++.+++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 0000123578999999999999999999985 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=206.61 Aligned_cols=144 Identities=23% Similarity=0.342 Sum_probs=126.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+|+..++||+|+||.||+|++..+++.||||.+.... ....++|.+|++++++++||||++++++|.. .+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence 5777899999999999999998899999999987543 2334678999999999999999999998643 567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+
T Consensus 77 v~e~~~~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~ 137 (279)
T cd06619 77 CTEFMDGGSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLC 137 (279)
T ss_pred EEecCCCCChHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEe
Confidence 99999999996542 357778889999999999999985 99999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 138 dfg~~~~~~ 146 (279)
T cd06619 138 DFGVSTQLV 146 (279)
T ss_pred eCCcceecc
Confidence 999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=206.00 Aligned_cols=152 Identities=29% Similarity=0.493 Sum_probs=129.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCC---eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||.||+|++..++ ..||+|.++.... ...+.|.+|++++++++||||+++++++. .++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 45778899999999999999875443 4799999875432 33567899999999999999999999853 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..|+.|++.|++|||+. +++||||||+||+++.++.
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 144 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKH-----------DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLV 144 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCe
Confidence 789999999999999998532 13578999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+|++|||+++.+...
T Consensus 145 ~~l~dfg~~~~~~~~ 159 (267)
T cd05066 145 CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEeCCCCcccccccc
Confidence 999999999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=207.99 Aligned_cols=149 Identities=24% Similarity=0.378 Sum_probs=131.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|+..+.||+|+||.||+|+...+++.||+|.+........+.+.+|++++++++||||+++++++. .+...++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 55788899999999999999998889999999998765556678999999999999999999999853 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|..++... ...+++..+..++.|++.|++|||+. +|+|||+||+||+++.++.+||+
T Consensus 87 v~e~~~~~~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 87 MIEFCPGGAVDAIMLEL-----------DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred EEecCCCCcHHHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEc
Confidence 99999999998877421 23588999999999999999999985 99999999999999999999999
Q ss_pred ccCccccc
Q 003368 803 DFGLARLR 810 (825)
Q Consensus 803 DFGla~~~ 810 (825)
|||+++..
T Consensus 153 dfg~~~~~ 160 (292)
T cd06644 153 DFGVSAKN 160 (292)
T ss_pred cCccceec
Confidence 99998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=206.97 Aligned_cols=150 Identities=27% Similarity=0.433 Sum_probs=125.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe----EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||+||+|++..+|+ .||+|.+..... ...+++..|+..+++++||||++++++|. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence 457788999999999999999877776 477777754322 23457888999999999999999999863 2
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+++|+|.+++... ...++|..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~ 146 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQH-----------RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDS 146 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCC
Confidence 3467999999999999998532 23589999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+|++|||+++...+
T Consensus 147 ~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 147 IVQIADFGVADLLYP 161 (279)
T ss_pred cEEEcCCccceeccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=209.54 Aligned_cols=149 Identities=25% Similarity=0.477 Sum_probs=128.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||+|+||.||+|+...+++.||+|.++.... .....+.+|++++++++||||+++++++ ..++..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence 568889999999999999999988999999999875432 2345678899999999999999999985 3466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||
T Consensus 81 lv~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 145 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC-----------GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKL 145 (301)
T ss_pred EEEeccc-cCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEE
Confidence 9999997 5898887432 23578889999999999999999985 9999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 146 ~dfg~~~~~~ 155 (301)
T cd07873 146 ADFGLARAKS 155 (301)
T ss_pred CcCcchhccC
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=209.06 Aligned_cols=142 Identities=26% Similarity=0.276 Sum_probs=114.3
Q ss_pred hcccccccceeccCCeeEEEEEEEcC-CCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCcee-Eeecccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDR-DGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVR-VITSCSSID 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~ 713 (825)
..++|...+.||+|+||+||+|.++. +++.||||++.... ....+.|.+|++++++++|+|+|+ ++.+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 34679999999999999999999865 67888999875331 223457999999999999999995 4432
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDL-KPSNIL 792 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdl-k~~NIL 792 (825)
+..|+||||++|++|.... .. ....++.++++||+|+|+. +|+|||| ||+|||
T Consensus 91 ----~~~~LVmE~~~G~~L~~~~-~~------------------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NIL 144 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLAR-PH------------------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWL 144 (365)
T ss_pred ----CCcEEEEEccCCCCHHHhC-cc------------------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEE
Confidence 2469999999999996321 00 0135678999999999985 9999999 999999
Q ss_pred ecCCCcEEEcccCcccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~ 813 (825)
++.++.+||+|||+|+.....
T Consensus 145 v~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 145 MGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EcCCCCEEEEECccceecccC
Confidence 999999999999999976543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=207.58 Aligned_cols=161 Identities=25% Similarity=0.419 Sum_probs=130.0
Q ss_pred ccccccceeccCCeeEEEEEEEc----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||+||+|++. .+++.||+|.+..... ...+.|.+|++++++++||||+++++++. .+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 45778899999999999999852 3567899999975432 33467899999999999999999999843 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCC-----cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQT-----DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
+..++||||+++|+|.+++........ .........+++.+...++.|++.|++|||+. +|+||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 678999999999999999853221000 00111123588999999999999999999985 8999999999999
Q ss_pred ecCCCcEEEcccCcccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~ 811 (825)
+++++.+|++|||+++...
T Consensus 157 i~~~~~~kl~dfg~~~~~~ 175 (283)
T cd05090 157 IGEQLHVKISDLGLSREIY 175 (283)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=219.93 Aligned_cols=145 Identities=26% Similarity=0.373 Sum_probs=125.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..+|...+.||+|+||.||+|++..+++.||||... ...+.+|++++++++|||||++++++.. ++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence 346888999999999999999998899999999643 2345789999999999999999998643 56789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+. |+|.+++... ...++|.++..|+.|+++||+|||+. +||||||||+|||++.++.+||
T Consensus 237 lv~e~~~-~~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL 301 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGAR-----------LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICL 301 (461)
T ss_pred EEEEccC-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEE
Confidence 9999995 7898887421 23689999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 302 ~DFGla~~~~~ 312 (461)
T PHA03211 302 GDFGAACFARG 312 (461)
T ss_pred cccCCceeccc
Confidence 99999987644
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=205.45 Aligned_cols=146 Identities=32% Similarity=0.563 Sum_probs=128.3
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhH--HHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|+||+||+|+...+++.||+|++........ ....+|++++++++||||+++++++. .....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence 4567899999999999999999999999999987654322 23456999999999999999999853 3677899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++++|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|+
T Consensus 76 v~~~~~~~~L~~~l~------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~ 140 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ------------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLI 140 (260)
T ss_dssp EEEEETTEBHHHHHH------------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEES
T ss_pred ccccccccccccccc------------ccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 999999999999984 234689999999999999999999996 99999999999999999999999
Q ss_pred ccCccccc
Q 003368 803 DFGLARLR 810 (825)
Q Consensus 803 DFGla~~~ 810 (825)
|||.+...
T Consensus 141 Dfg~~~~~ 148 (260)
T PF00069_consen 141 DFGSSVKL 148 (260)
T ss_dssp SGTTTEES
T ss_pred cccccccc
Confidence 99999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=204.24 Aligned_cols=148 Identities=28% Similarity=0.448 Sum_probs=127.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||.||+|++ .++..+|+|.+.... ...+.|.+|++++++++||||++++++|. ..+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence 4577789999999999999998 456789999886432 23467899999999999999999999864 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.++++.. ...++|..+..++.|++.|++|||+. +|+||||||+||++++++.+|++
T Consensus 77 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~ 142 (256)
T cd05114 77 VTEFMENGCLLNYLRQR-----------QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVS 142 (256)
T ss_pred EEEcCCCCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEEC
Confidence 99999999999998532 12578999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 143 d~g~~~~~~ 151 (256)
T cd05114 143 DFGMTRYVL 151 (256)
T ss_pred CCCCccccC
Confidence 999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=209.68 Aligned_cols=161 Identities=25% Similarity=0.461 Sum_probs=129.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCC--------------CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD--------------GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVIT 707 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~--------------g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~ 707 (825)
++|...+.||+|+||.||+|+.... ...||||.++.... .....|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4678889999999999999987432 23599999876533 33457999999999999999999999
Q ss_pred cccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 708 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
++. ..+..++||||+++++|.+++.................++|.++..++.|+++|++|||+. +++|||||
T Consensus 85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 864 3567899999999999999985432111001111223578999999999999999999985 89999999
Q ss_pred CCCeeecCCCcEEEcccCcccccc
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|+||++++++.+|++|||+++...
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred hhhEEEcCCCcEEecccccccccc
Confidence 999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=204.13 Aligned_cols=154 Identities=24% Similarity=0.388 Sum_probs=132.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||.||+|....+|+.||+|.++... ....+.+.+|++++++++|+|++++++++. +.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 57888999999999999999998899999999886432 223567899999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ......+++.++..++.++++|++|||+. +|+||||||+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~ 145 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHF--------KKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEecCCCCCHHHHHHHh--------cccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcE
Confidence 89999999999999988532 11224578999999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
|++|||+++....
T Consensus 146 ~l~d~~~~~~~~~ 158 (267)
T cd08224 146 KLGDLGLGRFFSS 158 (267)
T ss_pred EEeccceeeeccC
Confidence 9999999886543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.8e-22 Score=213.71 Aligned_cols=163 Identities=28% Similarity=0.396 Sum_probs=130.3
Q ss_pred ccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
++|+..++||+|+||.||+|+... +++.||+|+++.... ...+.+.+|++++.++ +||||++++++|..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~---- 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK---- 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence 468889999999999999997533 457899999875432 2345688899999999 79999999998743
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCC---c----------------------------------------------c
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQT---D----------------------------------------------E 746 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~----------------------------------------------~ 746 (825)
.+...++||||+++|+|.+++........ . .
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 34568899999999999999854211000 0 0
Q ss_pred cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 747 ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 747 ~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
.......++|..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||+|+.+..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 000123689999999999999999999985 999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=229.13 Aligned_cols=161 Identities=23% Similarity=0.388 Sum_probs=132.9
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..++|...+.||+|+||+||+|++..+++.||+|.+.... ......|..|+.++++++|||||++++++.. ....
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KANQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCCC
Confidence 4567999999999999999999999999999999987542 2335678999999999999999999998543 2345
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeeec
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQ----EPTIHCDLKPSNILLD 794 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~----~~ivHrdlk~~NILl~ 794 (825)
..|+||||+++|+|.+++... ......+++..++.|+.||+.||+|||+... .+||||||||+|||++
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~--------~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKC--------YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHH--------hhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 689999999999999998532 1122468999999999999999999998531 3699999999999996
Q ss_pred CC-----------------CcEEEcccCccccccc
Q 003368 795 NN-----------------LTAHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~-----------------~~~ki~DFGla~~~~~ 812 (825)
.+ ..+||+|||+++....
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccc
Confidence 42 3589999999987643
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=212.40 Aligned_cols=155 Identities=26% Similarity=0.479 Sum_probs=132.7
Q ss_pred ccccceeccCCeeEEEEEEEcCC----CeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRD----GTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
....+.||+|-||.||+|.+... ...||||.-+... ....+.|..|..+|+.++|||||+++|.|.+ ..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QP 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cc
Confidence 44568899999999999997322 2458999887643 3457789999999999999999999999864 56
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|||.++-|.|..||... ...++......+|.|+..||+|||+. ++|||||.++|||+.+...+
T Consensus 465 ~WivmEL~~~GELr~yLq~n-----------k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN-----------KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred eeEEEecccchhHHHHHHhc-----------cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCccee
Confidence 89999999999999999532 34688888999999999999999984 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCcc
Q 003368 800 HVGDFGLARLRQEVPNNQSS 819 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~ 819 (825)
|++|||++|.++++..+..+
T Consensus 531 KLaDFGLSR~~ed~~yYkaS 550 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKAS 550 (974)
T ss_pred eecccchhhhccccchhhcc
Confidence 99999999999887655444
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=204.65 Aligned_cols=151 Identities=28% Similarity=0.503 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|...+.||+|+||.||+|.+..+++.||+|.+... ....+++.+|++++++++||||++++++|.. ++..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence 3477788999999999999999888999999998754 2335678999999999999999999998643 567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....++|..+..++.|+++|++|||+. +++||||||+||++++++.+||+
T Consensus 80 v~e~~~~~~L~~~~~~~----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~ 146 (263)
T cd05052 80 ITEFMTYGNLLDYLREC----------NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA 146 (263)
T ss_pred EEEeCCCCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeC
Confidence 99999999999998532 123588999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 147 df~~~~~~~~ 156 (263)
T cd05052 147 DFGLSRLMTG 156 (263)
T ss_pred CCcccccccc
Confidence 9999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=202.35 Aligned_cols=152 Identities=20% Similarity=0.311 Sum_probs=132.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..++||+|+||.||.++...+++.||+|.+.... ....+.+.+|++++++++|+||+++++++. +.+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence 4778899999999999999998999999999987543 334567889999999999999999999853 467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....+++.++..++.|+++|++|||+. +++||||||+||++++++.+||
T Consensus 76 ~~~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl 142 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ----------KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL 142 (256)
T ss_pred EEEEecCCCcHHHHHHhc----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEE
Confidence 999999999999998532 123578999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 143 ~d~~~~~~~~~~ 154 (256)
T cd08221 143 GDFGISKILGSE 154 (256)
T ss_pred CcCcceEEcccc
Confidence 999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=206.72 Aligned_cols=162 Identities=26% Similarity=0.411 Sum_probs=131.5
Q ss_pred hcccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
+.++|+..+.||+|+||.||+|.+. .++..||||.+..... ....+|.+|+.++++++||||++++++|.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~---- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4567899999999999999999863 2457899999865332 33457899999999999999999999853
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.+...++||||+++|+|.++++....... .......++|..+..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~ 153 (277)
T cd05062 80 -QGQPTLVIMELMTRGDLKSYLRSLRPEME--NNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 153 (277)
T ss_pred -CCCCeEEEEecCCCCCHHHHHHHcCcccc--ccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEc
Confidence 35678999999999999999864321100 011124578999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCccccccc
Q 003368 795 NNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~ 812 (825)
+++.+|++|||+++....
T Consensus 154 ~~~~~~l~dfg~~~~~~~ 171 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYE 171 (277)
T ss_pred CCCCEEECCCCCccccCC
Confidence 999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-22 Score=228.57 Aligned_cols=159 Identities=21% Similarity=0.352 Sum_probs=83.3
Q ss_pred CCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCC
Q 003368 221 NLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNL 300 (825)
Q Consensus 221 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L 300 (825)
+|+.|+|++|+|++ +|..+. ++|+.|++++|++... |..+ .++|+.|++++|.++..+ ..+ .++|
T Consensus 284 sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~L-P~~l--~~sL~~L~Ls~N~Lt~LP-------~~l--~~sL 348 (754)
T PRK15370 284 ELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTAL-PETL--PPGLKTLEAGENALTSLP-------ASL--PPEL 348 (754)
T ss_pred CCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccccC-Cccc--cccceeccccCCccccCC-------hhh--cCcc
Confidence 44455555554443 222221 2444555555554432 2111 134555555555554322 111 1467
Q ss_pred CEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcc----cc
Q 003368 301 SFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS----FG 376 (825)
Q Consensus 301 ~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~ 376 (825)
+.|++++|+++ .+|..+. ++|+.|++++|+++ .+|..+. ..|+.|++++|+|. .+|.. +.
T Consensus 349 ~~L~Ls~N~L~----------~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~ 412 (754)
T PRK15370 349 QVLDVSKNQIT----------VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRG 412 (754)
T ss_pred cEEECCCCCCC----------cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhh
Confidence 77777777766 3443332 46777777777777 3454443 35777777777776 44443 33
Q ss_pred CCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCcc
Q 003368 377 NLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417 (825)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 417 (825)
.++.+..|++.+|.++. ..+.+|+.| ++.+.+.|
T Consensus 413 ~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 413 EGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred cCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 44677778888887762 344445444 44455544
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=207.47 Aligned_cols=150 Identities=25% Similarity=0.377 Sum_probs=133.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|+..+.||.|+||.||+|....+|+.||||.+........+.+.+|+++++.++|||++++++++. .++..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence 45888899999999999999998899999999997665555678899999999999999999999853 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+++|+|.+++.. ..++|.++..++.|+++|++|||+. +++||||||+||+++.++.+||+
T Consensus 94 v~e~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~ 157 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-------------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLT 157 (296)
T ss_pred EEEecCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence 9999999999988742 2578999999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||+++.....
T Consensus 158 dfg~~~~~~~~ 168 (296)
T cd06655 158 DFGFCAQITPE 168 (296)
T ss_pred cCccchhcccc
Confidence 99998865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=207.04 Aligned_cols=142 Identities=23% Similarity=0.362 Sum_probs=118.5
Q ss_pred eeccCCeeEEEEEEEcCCC------------------------eEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeE
Q 003368 650 LIGIGSFGSVYKGTFDRDG------------------------TIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~g------------------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 705 (825)
.||+|+||.||+|.+..+| ..||||.+........++|.+|+++++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999863221 3589999876554455678999999999999999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrd 785 (825)
+++|.. ....++||||+++|+|..++... ...+++.+++.++.|+++||+|||+. +|+|||
T Consensus 82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~d 142 (274)
T cd05076 82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKE-----------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGN 142 (274)
T ss_pred EEEEEe-----CCceEEEEecCCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCC
Confidence 999754 55789999999999999888532 23578899999999999999999975 999999
Q ss_pred CCCCCeeecCCC-------cEEEcccCccccc
Q 003368 786 LKPSNILLDNNL-------TAHVGDFGLARLR 810 (825)
Q Consensus 786 lk~~NILl~~~~-------~~ki~DFGla~~~ 810 (825)
|||+||++++.+ .+|++|||+++..
T Consensus 143 lkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred CCcccEEEeccCcccCccceeeecCCcccccc
Confidence 999999997643 3799999988654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=208.16 Aligned_cols=149 Identities=27% Similarity=0.421 Sum_probs=129.6
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-----hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-----ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|+..+.||+|+||.||+|....+|+.||||.+...... ..+.+..|++++++++|+||+++++++. +++.
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKSN 76 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCCE
Confidence 67788999999999999999888999999999765322 2456778999999999999999999853 3678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+ +|+|.+++... ...++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~-----------~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~ 141 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDK-----------SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVL 141 (298)
T ss_pred EEEEEccc-CCCHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCE
Confidence 89999999 99999998532 12588999999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+++.....
T Consensus 142 ~l~dfg~~~~~~~~ 155 (298)
T cd07841 142 KLADFGLARSFGSP 155 (298)
T ss_pred EEccceeeeeccCC
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=216.08 Aligned_cols=162 Identities=23% Similarity=0.415 Sum_probs=129.9
Q ss_pred ccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCC-CCCceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 715 (825)
++|...+.||+|+||.||+|+++ ..++.||||+++.... ...+.+.+|++++.++. |||||+++++|..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---- 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---- 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc----
Confidence 45677899999999999999963 3457899999975432 23457889999999997 9999999998643
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCC------c--------------------------------------------
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQT------D-------------------------------------------- 745 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~-------------------------------------------- 745 (825)
....++||||+++|+|.++++....... .
T Consensus 113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4578999999999999999975321000 0
Q ss_pred ------------------------------------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 746 ------------------------------------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 746 ------------------------------------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
........++|.+..+|+.|++.||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 0001123578999999999999999999974 8999999999
Q ss_pred CeeecCCCcEEEcccCccccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~ 812 (825)
|||+++++.+|++|||+++....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~ 291 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMR 291 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccc
Confidence 99999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=209.51 Aligned_cols=147 Identities=27% Similarity=0.382 Sum_probs=128.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
|+....||+|+||.||++....+++.||||.+........+.+.+|+..+++++||||+++++++. ..+..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEE
Confidence 444567999999999999998889999999987655555677899999999999999999999853 356789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||+||
T Consensus 99 e~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~df 162 (292)
T cd06658 99 EFLEGGALTDIVTH-------------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDF 162 (292)
T ss_pred eCCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccC
Confidence 99999999998742 2478889999999999999999985 8999999999999999999999999
Q ss_pred Cccccccc
Q 003368 805 GLARLRQE 812 (825)
Q Consensus 805 Gla~~~~~ 812 (825)
|+++....
T Consensus 163 g~~~~~~~ 170 (292)
T cd06658 163 GFCAQVSK 170 (292)
T ss_pred cchhhccc
Confidence 99986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=212.40 Aligned_cols=155 Identities=25% Similarity=0.362 Sum_probs=129.2
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 717 (825)
..++|...+.||+|+||+||+|....+++.||||++..... ...+.+.+|++++++++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45779999999999999999999988999999999875422 234567899999999999999999987642111 122
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-------------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC 155 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence 3568999988 7899887732 2588899999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 156 ~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 156 ELRILDFGLARQADD 170 (343)
T ss_pred CEEEcCCccceecCC
Confidence 999999999987644
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=208.73 Aligned_cols=160 Identities=31% Similarity=0.539 Sum_probs=129.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeE--EEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTI--VAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~--vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||.||+|+++.+|.. +|+|.++... ....+.|.+|++++.++ +||||+++++++. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CC
Confidence 35688889999999999999998777754 5777766432 23456788999999999 8999999999853 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+..++||||+++|+|.++++......... .......+++.++..++.|++.|++|||+. +|+||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 67899999999999999996532111000 011224689999999999999999999985 99999999999999
Q ss_pred cCCCcEEEcccCcccc
Q 003368 794 DNNLTAHVGDFGLARL 809 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~ 809 (825)
++++.+||+|||+++.
T Consensus 158 ~~~~~~kl~dfg~~~~ 173 (303)
T cd05088 158 GENYVAKIADFGLSRG 173 (303)
T ss_pred cCCCcEEeCccccCcc
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-23 Score=218.07 Aligned_cols=161 Identities=22% Similarity=0.344 Sum_probs=139.2
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.....+|.|+||+||+|+.+.++...|-|.+........+.|.-||++++.++||+||+|+++|. .++.+|+..
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwili 108 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWILI 108 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEEE
Confidence 344556899999999999999888888999998777777889999999999999999999999853 256789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
|||.||..+..+- .-.+.++..+...+|.+++.||.|||+. .|||||+|+.|||+.-+|.+|++||
T Consensus 109 EFC~GGAVDaiml-----------EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 109 EFCGGGAVDAIML-----------ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred eecCCchHhHHHH-----------HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence 9999999988773 2345789999999999999999999986 8999999999999999999999999
Q ss_pred CcccccccCCCCCccccccC
Q 003368 805 GLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 805 Gla~~~~~~~~~~~~~~gt~ 824 (825)
|++......-....+++|||
T Consensus 175 GVSAKn~~t~qkRDsFIGTP 194 (1187)
T KOG0579|consen 175 GVSAKNKSTRQKRDSFIGTP 194 (1187)
T ss_pred cccccchhHHhhhccccCCc
Confidence 99776555545567778886
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=203.78 Aligned_cols=151 Identities=28% Similarity=0.530 Sum_probs=130.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++. +.+..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcE
Confidence 35688899999999999999997 567789999886543 23568899999999999999999998853 456789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.++++.. ....+++.++..++.|+++|++|||+. +++||||||+||+++.++.+|+
T Consensus 78 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l 144 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD----------EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI 144 (261)
T ss_pred EEEecCCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEE
Confidence 999999999999998532 124578889999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 145 ~dfg~~~~~~~ 155 (261)
T cd05072 145 ADFGLARVIED 155 (261)
T ss_pred CCCccceecCC
Confidence 99999987654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=204.75 Aligned_cols=146 Identities=29% Similarity=0.398 Sum_probs=120.2
Q ss_pred eeccCCeeEEEEEEEcC--CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 650 LIGIGSFGSVYKGTFDR--DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~--~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.||+|+||+||+|+... ....||+|.+..... .....|.+|++.++.++||||++++++|. .....++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence 58999999999997532 345788998764432 33457889999999999999999999864 35678999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++|+|.+++..... ......++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||+
T Consensus 77 ~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 77 CPLGDLKNYLRSNRG-------MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred CCCCcHHHHHHhccc-------cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccc
Confidence 999999999964311 1112356788899999999999999985 899999999999999999999999999
Q ss_pred cccc
Q 003368 807 ARLR 810 (825)
Q Consensus 807 a~~~ 810 (825)
++..
T Consensus 147 ~~~~ 150 (269)
T cd05042 147 ALEQ 150 (269)
T ss_pred cccc
Confidence 9764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=202.25 Aligned_cols=151 Identities=25% Similarity=0.375 Sum_probs=128.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|...+.||+|+||.||+|+...+|+.||||.+.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence 46888999999999999999998899999999886432 1234578899999999999999999997532 123
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++|+|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 143 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY------------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVG 143 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCC
Confidence 4678999999999999988422 3477888899999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
.+||+|||+++...
T Consensus 144 ~~~l~Dfg~~~~~~ 157 (265)
T cd06652 144 NVKLGDFGASKRLQ 157 (265)
T ss_pred CEEECcCccccccc
Confidence 99999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=206.75 Aligned_cols=151 Identities=26% Similarity=0.466 Sum_probs=128.3
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++++|...+.||+|+||.||+|....+|+.||||.+..... .....+.+|++++++++|+||+++++++. .++.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence 56789999999999999999999988999999999875432 22346789999999999999999999853 4567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+. +++.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~ 142 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQH-----------PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGEL 142 (291)
T ss_pred EEEEEeccc-CCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcE
Confidence 899999996 6787776321 12467888889999999999999985 89999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||+++...
T Consensus 143 ~l~Dfg~~~~~~ 154 (291)
T cd07870 143 KLADFGLARAKS 154 (291)
T ss_pred EEeccccccccC
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=205.35 Aligned_cols=151 Identities=30% Similarity=0.406 Sum_probs=130.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+.+.+|+.||+|++.... ....+.+.+|++++++++|||++++++++ ......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 35788899999999999999998889999999986442 22345688999999999999999999985 346678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++++.+..+.... ..++|.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP------------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred EEEEeccCccHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEE
Confidence 9999999999888776321 3588999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+++.....
T Consensus 141 l~dfg~~~~~~~~ 153 (286)
T cd07847 141 LCDFGFARILTGP 153 (286)
T ss_pred ECccccceecCCC
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=206.06 Aligned_cols=161 Identities=29% Similarity=0.481 Sum_probs=133.2
Q ss_pred ccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|...+.||+|+||+||++.. ..++..||||.+........+.+.+|++++++++||||++++++|. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 4678889999999999999985 2345679999997665555678999999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCc-ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTD-EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
+..++||||+++|+|.+++......... ........++|.++..++.|++.||+|||+. +++||||||+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 6789999999999999998643211110 1112234689999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccc
Q 003368 797 LTAHVGDFGLARLRQ 811 (825)
Q Consensus 797 ~~~ki~DFGla~~~~ 811 (825)
+.+|++|||+++...
T Consensus 157 ~~~kl~dfg~~~~~~ 171 (288)
T cd05093 157 LLVKIGDFGMSRDVY 171 (288)
T ss_pred CcEEeccCCcccccc
Confidence 999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=203.98 Aligned_cols=150 Identities=27% Similarity=0.512 Sum_probs=129.5
Q ss_pred cccccceeccCCeeEEEEEEEcCCCe---EEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGT---IVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+|+..+.||+|+||.||+|++..+|+ .||||.+.... ....++|..|++++++++||||+++++++ .++..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence 46778999999999999999876654 69999987653 33456899999999999999999999984 34667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~ 145 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN-----------DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVC 145 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcE
Confidence 89999999999999998532 13578999999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
|++|||+++....
T Consensus 146 kl~dfg~~~~~~~ 158 (269)
T cd05065 146 KVSDFGLSRFLED 158 (269)
T ss_pred EECCCcccccccc
Confidence 9999999987644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=205.98 Aligned_cols=151 Identities=31% Similarity=0.410 Sum_probs=131.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+++.||||.+.... ....+.+.+|++++++++||||+++++++ ..+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 36788899999999999999998899999999987532 22346788999999999999999999984 34667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~ 140 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS------------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYI 140 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence 89999999999999998532 4678889999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+++.....
T Consensus 141 kl~dfg~~~~~~~~ 154 (290)
T cd05580 141 KITDFGFAKRVKGR 154 (290)
T ss_pred EEeeCCCccccCCC
Confidence 99999999876443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=200.87 Aligned_cols=152 Identities=23% Similarity=0.327 Sum_probs=130.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+|+..+.||+|+||.||+++...+++.||+|.++... ....+.+.+|++++++++||||+++++++ .+++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4677899999999999999998899999999986532 33456788999999999999999999984 44678999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|++.+++... ....+++.....++.|+++|++|||+. +|+|+||||+||++++++.++++
T Consensus 76 v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~ 142 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ----------RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLG 142 (255)
T ss_pred EEeeCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEc
Confidence 99999999999887422 123478888999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||+++.....
T Consensus 143 dfg~~~~~~~~ 153 (255)
T cd08219 143 DFGSARLLTSP 153 (255)
T ss_pred ccCcceeeccc
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=202.23 Aligned_cols=149 Identities=28% Similarity=0.447 Sum_probs=127.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||+||+|++. .+..||||.+.... ...++|.+|++++++++||||++++++|.. .+..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 35777889999999999999984 55679999987543 234679999999999999999999998643 456799
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ...++|.++..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 77 v~e~~~~~~l~~~i~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~ 142 (256)
T cd05113 77 VTEYMSNGCLLNYLREH-----------GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVS 142 (256)
T ss_pred EEEcCCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEEC
Confidence 99999999999998532 12578999999999999999999985 99999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||.++....
T Consensus 143 d~g~~~~~~~ 152 (256)
T cd05113 143 DFGLSRYVLD 152 (256)
T ss_pred CCccceecCC
Confidence 9999986643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=205.34 Aligned_cols=150 Identities=27% Similarity=0.447 Sum_probs=128.2
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|...+.||+|+||.||+|+...+|+.||||.+..... ...+.+.+|++++++++||||+++++++. .++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 46778899999999999999988999999999865432 23467889999999999999999999853 466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++ |+|.+++... .....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l 142 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSL---------PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKL 142 (285)
T ss_pred EEEecCC-CCHHHHHhcC---------CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEE
Confidence 9999997 6898887532 1124588999999999999999999985 9999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 143 ~dfg~~~~~~ 152 (285)
T cd07861 143 ADFGLARAFG 152 (285)
T ss_pred CcccceeecC
Confidence 9999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=205.41 Aligned_cols=155 Identities=23% Similarity=0.363 Sum_probs=132.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|....+|+.||||.+.... ....+++.+|+++++.++||||+++++++. .++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 46778899999999999999998899999999886532 223457889999999999999999999854 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.+++... ......++|.++..++.|++.|++|||+. +++|+||||+||+++.++.+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~ 145 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHF--------KKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 145 (267)
T ss_pred EEEEEEecCCCCHHHHHHHh--------hccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence 89999999999999988521 01124689999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
|++|||+++.....
T Consensus 146 ~l~dfg~~~~~~~~ 159 (267)
T cd08229 146 KLGDLGLGRFFSSK 159 (267)
T ss_pred EECcchhhhccccC
Confidence 99999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=203.17 Aligned_cols=152 Identities=27% Similarity=0.519 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCe---EEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGT---IVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||.||+|+...++. .||||.+.... ....+.+.+|++++++++|||++++.+++. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence 3567888999999999999999865554 79999987553 233567899999999999999999999853 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...++|.++..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDH-----------DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNL 144 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCC
Confidence 6789999999999999998532 13588999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+|++|||+++....
T Consensus 145 ~~kl~dfg~~~~~~~ 159 (268)
T cd05063 145 ECKVSDFGLSRVLED 159 (268)
T ss_pred cEEECCCccceeccc
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=205.45 Aligned_cols=155 Identities=28% Similarity=0.466 Sum_probs=126.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcC---CCCCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNI---RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~ 718 (825)
.|+..+.||+|+||+||+|+.+.+|+.||||.++.... .....+.+|+++++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 36778999999999999999999999999999875432 2234566777777665 699999999987543233345
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++ +|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV----------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 68999999984 888887532 113478999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 147 ~kl~dfg~~~~~~~ 160 (288)
T cd07863 147 VKLADFGLARIYSC 160 (288)
T ss_pred EEECccCccccccC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=206.52 Aligned_cols=162 Identities=27% Similarity=0.427 Sum_probs=130.1
Q ss_pred hcccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
..++|+..+.||+|+||.||+|..+ ..+..||||.+..... .....+.+|++++++++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---- 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence 4567889999999999999999764 2356899998865432 23446889999999999999999999853
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
..+..++||||+++|+|.+++....... .........++..+..++.|++.|++|||+. +|+||||||+||+++
T Consensus 80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~ 153 (288)
T cd05061 80 -KGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVA 153 (288)
T ss_pred -CCCCcEEEEeCCCCCCHHHHHHHhcccc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEc
Confidence 3567899999999999999996421100 0011124567888899999999999999985 999999999999999
Q ss_pred CCCcEEEcccCccccccc
Q 003368 795 NNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~ 812 (825)
+++.+|++|||+|+....
T Consensus 154 ~~~~~~L~Dfg~~~~~~~ 171 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYE 171 (288)
T ss_pred CCCcEEECcCCccccccc
Confidence 999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=201.15 Aligned_cols=143 Identities=27% Similarity=0.461 Sum_probs=122.1
Q ss_pred eeccCCeeEEEEEEEc--CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 650 LIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.||+|+||.||+|++. .++..||||.+..... ...+.|.+|++++++++||||++++++|. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence 3899999999999874 4566799999876533 23467999999999999999999999853 2457999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++|+|.+++... ...+++.++.+++.|++.|++|||+. +++||||||+||+++.++.+|++|||+
T Consensus 76 ~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~ 141 (257)
T cd05115 76 ASGGPLNKFLSGK-----------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGL 141 (257)
T ss_pred CCCCCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCc
Confidence 9999999998532 23588999999999999999999985 899999999999999999999999999
Q ss_pred cccccc
Q 003368 807 ARLRQE 812 (825)
Q Consensus 807 a~~~~~ 812 (825)
++....
T Consensus 142 ~~~~~~ 147 (257)
T cd05115 142 SKALGA 147 (257)
T ss_pred cccccC
Confidence 986544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=205.24 Aligned_cols=152 Identities=27% Similarity=0.514 Sum_probs=129.1
Q ss_pred cccccceeccCCeeEEEEEEE----cCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.|+..+.||+|+||.||+|++ ..+++.||+|.++... ....+.+.+|++++++++|||+++++++|.. .+..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence 367789999999999999985 3567899999987553 2334679999999999999999999998643 2235
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 147 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN-----------KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 147 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCC
Confidence 679999999999999998422 13589999999999999999999985 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 148 ~~l~dfg~~~~~~~ 161 (284)
T cd05079 148 VKIGDFGLTKAIET 161 (284)
T ss_pred EEECCCcccccccc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=201.94 Aligned_cols=149 Identities=26% Similarity=0.438 Sum_probs=129.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-----hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-----GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++||||+++++++ .++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 568889999999999999999988899999999864321 1235688999999999999999999985 345
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~ 141 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAY------------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAG 141 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 6899999999999999988432 3578888999999999999999985 999999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
.+||+|||+++...
T Consensus 142 ~~~l~dfg~~~~~~ 155 (263)
T cd06625 142 NVKLGDFGASKRLQ 155 (263)
T ss_pred CEEEeecccceecc
Confidence 99999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=212.15 Aligned_cols=152 Identities=26% Similarity=0.316 Sum_probs=126.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467889999999999999999998899999999986542 233567889999999999999999999864311 11223
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++ ++.+.++ ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCC
Confidence 57999999975 5655552 2367788889999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+||+|||+|+...
T Consensus 162 ~kl~Dfg~a~~~~ 174 (359)
T cd07876 162 LKILDFGLARTAC 174 (359)
T ss_pred EEEecCCCccccc
Confidence 9999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=202.11 Aligned_cols=148 Identities=30% Similarity=0.443 Sum_probs=127.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+|+..+.||+|+||.||+|+++ ++..+|||.+.... .....|.+|++++++++||||+++++++. ..+..++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV 77 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence 4777889999999999999984 66789999986432 23457889999999999999999999853 35678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++++|.++++.. ...++|..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 78 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d 143 (256)
T cd05059 78 TEYMANGCLLNYLRER-----------KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSD 143 (256)
T ss_pred EecCCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECC
Confidence 9999999999998532 12578999999999999999999985 899999999999999999999999
Q ss_pred cCccccccc
Q 003368 804 FGLARLRQE 812 (825)
Q Consensus 804 FGla~~~~~ 812 (825)
||+++...+
T Consensus 144 fg~~~~~~~ 152 (256)
T cd05059 144 FGLARYVLD 152 (256)
T ss_pred cccceeccc
Confidence 999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=201.30 Aligned_cols=152 Identities=28% Similarity=0.416 Sum_probs=133.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|+...+++.+|+|.+........+.+.+|++++++++||||+++++++ ...+..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEE
Confidence 35688899999999999999999888999999999876555667899999999999999999999974 3466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ...+++.++..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 77 l~~e~~~~~~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l 142 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVT-----------RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKL 142 (262)
T ss_pred EEEeCCCCCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEE
Confidence 999999999999988432 13578889999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 143 ~d~g~~~~~~~ 153 (262)
T cd06613 143 ADFGVSAQLTA 153 (262)
T ss_pred Cccccchhhhh
Confidence 99999886543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=203.39 Aligned_cols=148 Identities=28% Similarity=0.431 Sum_probs=122.5
Q ss_pred ceeccCCeeEEEEEEEc--CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
+.||+|+||.||+|++. .++..+|+|.++.... .....|.+|+.++++++||||++++++|.. ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence 36899999999999864 2456799999876543 234578899999999999999999998643 456899999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.++++.... ......++..+..++.|+++|++|||+. +++||||||+||++++++.+|++|||
T Consensus 76 ~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg 145 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-------AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG 145 (269)
T ss_pred CCCCCcHHHHHHHhhh-------cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcc
Confidence 9999999999964311 1123567888889999999999999985 89999999999999999999999999
Q ss_pred cccccc
Q 003368 806 LARLRQ 811 (825)
Q Consensus 806 la~~~~ 811 (825)
+++...
T Consensus 146 ~~~~~~ 151 (269)
T cd05087 146 LSHNKY 151 (269)
T ss_pred cccccc
Confidence 997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=213.61 Aligned_cols=144 Identities=22% Similarity=0.349 Sum_probs=124.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..+|...+.||+|+||.||+|+...+++.||+|+.... ....|+.++++++|||||++++++. .....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeE
Confidence 45799999999999999999999888999999975432 2356999999999999999999854 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+|+||+. |+|.+++... ...++|..+..|+.|++.||+|||+. +||||||||+|||++.++.+||
T Consensus 134 lv~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl 198 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKR-----------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCI 198 (357)
T ss_pred EEEEccC-CcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999995 6888887422 24689999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 199 ~DfG~a~~~~ 208 (357)
T PHA03209 199 GDLGAAQFPV 208 (357)
T ss_pred ecCccccccc
Confidence 9999998643
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=202.06 Aligned_cols=150 Identities=33% Similarity=0.512 Sum_probs=130.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|.+ .+++.||||.++... ...++|.+|++++++++||||+++++++. ..+..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCee
Confidence 45688889999999999999997 466889999987543 23567899999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....++|.++..++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 78 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l 144 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG----------AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKV 144 (261)
T ss_pred eeeecccCCcHHHHHhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEE
Confidence 999999999999998532 123689999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 145 ~dfg~~~~~~ 154 (261)
T cd05068 145 ADFGLARVIK 154 (261)
T ss_pred CCcceEEEcc
Confidence 9999998765
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=206.48 Aligned_cols=150 Identities=28% Similarity=0.423 Sum_probs=129.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||++++++| .+++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 357788999999999999999988899999998865432 2346788999999999999999999985 346788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++++.+.++.... ..++|.++..++.|+++|++|||+. +|+|||++|+||++++++.+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP------------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred EEEEecCCccHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEE
Confidence 9999999999998776321 2488999999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
++|||+++....
T Consensus 141 l~dfg~~~~~~~ 152 (286)
T cd07846 141 LCDFGFARTLAA 152 (286)
T ss_pred EEeeeeeeeccC
Confidence 999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=206.10 Aligned_cols=160 Identities=30% Similarity=0.554 Sum_probs=129.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe--EEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT--IVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..++||+|+||+||+|+...+|. .+|+|.++... ....+.|.+|+++++++ +||||+++++++. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 568888999999999999999876664 47888887432 23456789999999999 7999999999853 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
..++||||+++|+|.++++........ ........+++..+..|+.|++.|++|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 789999999999999999653221110 0011224689999999999999999999985 999999999999999
Q ss_pred CCCcEEEcccCccccc
Q 003368 795 NNLTAHVGDFGLARLR 810 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~ 810 (825)
+++.+||+|||+++..
T Consensus 154 ~~~~~kl~dfg~~~~~ 169 (297)
T cd05089 154 ENLASKIADFGLSRGE 169 (297)
T ss_pred CCCeEEECCcCCCccc
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=204.67 Aligned_cols=147 Identities=29% Similarity=0.452 Sum_probs=128.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
|+..+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|++++++++||||+++++++. ++...++|
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWII 80 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEEE
Confidence 666788999999999999998889999999987543 334567899999999999999999999853 46678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++|+|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+|++|
T Consensus 81 ~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 81 MEYLGGGSALDLLKP-------------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred EEccCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence 999999999998842 2578889999999999999999985 999999999999999999999999
Q ss_pred cCccccccc
Q 003368 804 FGLARLRQE 812 (825)
Q Consensus 804 FGla~~~~~ 812 (825)
||+++....
T Consensus 145 fg~~~~~~~ 153 (277)
T cd06642 145 FGVAGQLTD 153 (277)
T ss_pred ccccccccC
Confidence 999987644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=205.24 Aligned_cols=164 Identities=25% Similarity=0.411 Sum_probs=133.0
Q ss_pred hcccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
..++|+..+.||+|+||.||+|..... ...||+|.+..... ....++.+|++++.++ +||||++++++|.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 86 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--- 86 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence 345688889999999999999997533 37899999875432 3345688999999999 7999999999864
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
.++..++||||+++|+|.++++......... .......++|..++.++.|++.|++|||+. +|+||||||+
T Consensus 87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~ 161 (293)
T cd05053 87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR 161 (293)
T ss_pred --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence 3567899999999999999996432111000 012345789999999999999999999985 9999999999
Q ss_pred CeeecCCCcEEEcccCccccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~ 812 (825)
||+++.++.+|++|||+++.+..
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred eEEEcCCCeEEeCcccccccccc
Confidence 99999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=205.59 Aligned_cols=160 Identities=25% Similarity=0.451 Sum_probs=131.0
Q ss_pred ccccccceeccCCeeEEEEEEEc----------------CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD----------------RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRV 705 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~----------------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 705 (825)
++|+..+.||+|+||.||++... .++..||||.+..... ...++|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998642 2345799999975533 345689999999999999999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrd 785 (825)
++++. ..+..++||||+++|+|.+++......... .......++|.++..++.|++.|++|||+. +|+|||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~d 155 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAA-EKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRD 155 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCccccc-ccccccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 99853 356789999999999999998754321111 112234689999999999999999999985 899999
Q ss_pred CCCCCeeecCCCcEEEcccCcccccc
Q 003368 786 LKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 786 lk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|||+||++++++.+|++|||+++.+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred CChheEEEcCCCCEEeccCccccccc
Confidence 99999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=207.11 Aligned_cols=147 Identities=24% Similarity=0.342 Sum_probs=127.9
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
+....||+|+||.||+|....+++.||||.+........+.+.+|+.+++.++||||+++++++. .++..++|||
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e 98 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLME 98 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEe
Confidence 34457999999999999998889999999997655555667889999999999999999999853 3677899999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg 162 (297)
T cd06659 99 FLQGGALTDIVSQ-------------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG 162 (297)
T ss_pred cCCCCCHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence 9999999987632 2578899999999999999999985 89999999999999999999999999
Q ss_pred cccccccC
Q 003368 806 LARLRQEV 813 (825)
Q Consensus 806 la~~~~~~ 813 (825)
+++.....
T Consensus 163 ~~~~~~~~ 170 (297)
T cd06659 163 FCAQISKD 170 (297)
T ss_pred hHhhcccc
Confidence 99865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=211.71 Aligned_cols=154 Identities=25% Similarity=0.292 Sum_probs=127.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~ 717 (825)
..++|...+.||+|+||.||+|+...+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... +...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4567999999999999999999998899999999987542 233467889999999999999999999864321 1223
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++ ++.+++. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~--------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~ 156 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 156 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh--------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCC
Confidence 457999999975 6666552 2477888899999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 157 ~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 157 TLKILDFGLARTAGT 171 (355)
T ss_pred CEEEeeCcccccCCC
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=214.40 Aligned_cols=178 Identities=24% Similarity=0.356 Sum_probs=154.3
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSS 711 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 711 (825)
..++.+-..++-|...++||.|.||.||+++.+.+|+.+|||+...... ..++.+.|.++++.. .|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444555567789999999999999999999999999999999877644 346778899998877 49999999999865
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
.+--.++.+|||||||.+|+..|..... ...++.|.....|++++++|+.+||.. .++|||||-.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~----------~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~Ni 154 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNT----------KGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNV 154 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhh----------cccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceE
Confidence 5555678899999999999999998643 146789999999999999999999986 899999999999
Q ss_pred eecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 792 LLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+..++.+|++|||++..+...-.+..+.+|||
T Consensus 155 LLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP 187 (953)
T KOG0587|consen 155 LLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTP 187 (953)
T ss_pred EEeccCcEEEeeeeeeeeeecccccccCcCCCc
Confidence 999999999999999999888777788889987
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=203.94 Aligned_cols=149 Identities=33% Similarity=0.573 Sum_probs=127.2
Q ss_pred ccccceeccCCeeEEEEEEE----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|+..+.||+|+||+||++.. ..+++.||+|.++.... ...+.|.+|++++++++||||++++++|.. .....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence 36788999999999987653 35678999999876532 345678899999999999999999998643 23456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++.. ..++|.++..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-------------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-------------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcE
Confidence 8999999999999999842 2589999999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
|++|||+++.+..
T Consensus 147 ~l~dfg~~~~~~~ 159 (283)
T cd05080 147 KIGDFGLAKAVPE 159 (283)
T ss_pred EEeecccccccCC
Confidence 9999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=205.54 Aligned_cols=163 Identities=24% Similarity=0.433 Sum_probs=131.3
Q ss_pred cccccccceeccCCeeEEEEEEEc-------CCCeEEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-------RDGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-------~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|+.. .++..||+|.+.... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence 456788899999999999999752 234689999987543 23456789999999999 7999999999854
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
.....++||||+++|+|.+++.......... .......++|.++..++.|+++|++|||+. +|+||||||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 165 (304)
T cd05101 92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165 (304)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 3567899999999999999997532111000 001224689999999999999999999985 999999999
Q ss_pred CCeeecCCCcEEEcccCccccccc
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+||++++++.+||+|||+|+....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNN 189 (304)
T ss_pred ceEEEcCCCcEEECCCccceeccc
Confidence 999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=202.38 Aligned_cols=150 Identities=29% Similarity=0.507 Sum_probs=129.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe----EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|+..+.||+|+||+||+|.++.+|+ .||+|....... ....++.+|++++++++||||++++++|..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 457788999999999999999866654 689998875543 345678999999999999999999998742
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++|+|.+++... ...+++..+..++.|+++|++|||+. +|+||||||+||++++++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~ 146 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNH-----------KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQ 146 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCC
Confidence 4679999999999999998532 12488999999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+|++|||+++....
T Consensus 147 ~~kL~dfg~~~~~~~ 161 (279)
T cd05057 147 HVKITDFGLAKLLDV 161 (279)
T ss_pred eEEECCCcccccccC
Confidence 999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-22 Score=225.11 Aligned_cols=156 Identities=27% Similarity=0.387 Sum_probs=124.6
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc----
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF---- 714 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 714 (825)
+...+|++.+++|+||||.||+++.+-+|+.||||+|..... .......+|+.++++++|||||+++.++.+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 456789999999999999999999999999999999986642 223567899999999999999999887651000
Q ss_pred --------------------------------------------------------------------------------
Q 003368 715 -------------------------------------------------------------------------------- 714 (825)
Q Consensus 715 -------------------------------------------------------------------------------- 714 (825)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred -----------------------CC-------CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHH
Q 003368 715 -----------------------QG-------NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764 (825)
Q Consensus 715 -----------------------~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 764 (825)
.+ ....|+-||||+.-.++++++...... .-....++.+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-----------~~d~~wrLFr 704 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-----------QRDEAWRLFR 704 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-----------hhHHHHHHHH
Confidence 00 024577788888877777765431100 2335678899
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 765 ~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
+|+.||+|+|+. +||||||||.||++|++..+||+|||+|+.
T Consensus 705 eIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 705 EILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred HHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchh
Confidence 999999999986 899999999999999999999999999998
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=205.27 Aligned_cols=152 Identities=23% Similarity=0.325 Sum_probs=130.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||.||+|+...+|+.||+|.+..... ...+.+.+|++++++++||||+++++++. ..+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 357788999999999999999988999999999875432 33467899999999999999999999853 367889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|..++... .....+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||
T Consensus 76 lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l 144 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGG---------VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKL 144 (286)
T ss_pred EEEeecCCCCHHHHHHhc---------cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEE
Confidence 999999999999888532 1123689999999999999999999973 48999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||+++..
T Consensus 145 ~dfg~~~~~ 153 (286)
T cd06622 145 CDFGVSGNL 153 (286)
T ss_pred eecCCcccc
Confidence 999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=199.15 Aligned_cols=150 Identities=32% Similarity=0.544 Sum_probs=130.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|.. .|+.||||.+..... ..+++.+|+.++++++|+||+++++++. +.+..+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence 35678889999999999999997 478999999976544 4578999999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....++|..+..++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l 143 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSR----------GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV 143 (256)
T ss_pred EEEEecCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEE
Confidence 999999999999998532 113589999999999999999999985 9999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||.++....
T Consensus 144 ~d~g~~~~~~~ 154 (256)
T cd05039 144 SDFGLAKEASQ 154 (256)
T ss_pred ccccccccccc
Confidence 99999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=198.95 Aligned_cols=148 Identities=31% Similarity=0.463 Sum_probs=129.1
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|+..+.||+|+||+||+|....+++.||+|.+.... ....+.+.+|++++++++||||+++++++. .+..
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EEDN 76 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCCe
Confidence 667789999999999999997789999999986543 224567899999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +|+|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~ 141 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY------------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVV 141 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 89999999999999998532 3578899999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 142 kl~d~~~~~~~~~ 154 (258)
T cd06632 142 KLADFGMAKQVVE 154 (258)
T ss_pred EEccCccceeccc
Confidence 9999999887543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=203.83 Aligned_cols=160 Identities=31% Similarity=0.524 Sum_probs=131.9
Q ss_pred ccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|...+.||+|+||.||+|+... +++.||||.+...... ..+.|.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----- 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence 457778999999999999998742 3578999998765443 45789999999999999999999998643
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcc--cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDE--ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
....++||||+++|+|.+++.......... .......++|.++..++.|++.|++|||+. +++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence 567899999999999999996532111000 012235689999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCccccc
Q 003368 795 NNLTAHVGDFGLARLR 810 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~ 810 (825)
.++.+|++|||+++..
T Consensus 157 ~~~~~kl~d~g~~~~~ 172 (280)
T cd05049 157 YDLVVKIGDFGMSRDV 172 (280)
T ss_pred CCCeEEECCcccceec
Confidence 9999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=199.00 Aligned_cols=151 Identities=25% Similarity=0.398 Sum_probs=128.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|...++||+|+||.||+|....+|+.||+|++.... .+..+.+.+|++++++++||||+++++++.. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence 36888999999999999999998889999999986432 1234568899999999999999999987532 224
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~ 143 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAY------------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAG 143 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCC
Confidence 5678999999999999998532 3478889999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
.+||+|||+++...
T Consensus 144 ~~~l~dfg~~~~~~ 157 (266)
T cd06651 144 NVKLGDFGASKRLQ 157 (266)
T ss_pred CEEEccCCCccccc
Confidence 99999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=198.13 Aligned_cols=152 Identities=27% Similarity=0.417 Sum_probs=130.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+++...+++.||||.+.... ....+.+.+|++++++++|||++++++.+.. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4778899999999999999998889999999987543 2334578899999999999999999886421 234678
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ....+++.++..++.+++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 77 lv~e~~~~~~l~~~l~~~----------~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l 143 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ----------KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKV 143 (257)
T ss_pred EEecccCCCcHHHHHHHh----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEE
Confidence 999999999999998532 123578999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++.+..
T Consensus 144 ~df~~~~~~~~ 154 (257)
T cd08223 144 GDLGIARVLEN 154 (257)
T ss_pred ecccceEEecc
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=202.12 Aligned_cols=161 Identities=27% Similarity=0.489 Sum_probs=130.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCC-----eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDG-----TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g-----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|+..+.||+|+||.||+|.....+ ..||+|.+..... ...++|.+|++++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 46788899999999999999875544 6899999875433 33467899999999999999999999853 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCccc----chhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEE----NDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
....++||||+++|+|.+++........... ......+++.++..++.|++.|++|||+. +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 5668999999999999999964321110000 01124689999999999999999999985 8999999999999
Q ss_pred ecCCCcEEEcccCcccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~ 811 (825)
+++++.+||+|||+++...
T Consensus 157 ~~~~~~~~L~dfg~~~~~~ 175 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIY 175 (283)
T ss_pred EcCCCcEEECCCcceeecc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=198.85 Aligned_cols=149 Identities=29% Similarity=0.475 Sum_probs=127.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|.. .|..||+|.++... ..+.|.+|++++++++|+|++++++++. ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence 4678889999999999999987 57889999986432 3467899999999999999999998753 33556899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....++|..+..++.|++.|++|||+. +|+||||||+||++++++.+|++
T Consensus 78 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~ 144 (256)
T cd05082 78 VTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVS 144 (256)
T ss_pred EEECCCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEec
Confidence 99999999999998532 113478999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 145 dfg~~~~~~~ 154 (256)
T cd05082 145 DFGLTKEASS 154 (256)
T ss_pred CCccceeccc
Confidence 9999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=203.40 Aligned_cols=149 Identities=26% Similarity=0.486 Sum_probs=128.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|+.+.+++.||||.+..... .....+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 3578889999999999999999988899999999875432 2234577899999999999999999985 346788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++ +|.+++... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 79 ~lv~e~~~~-~L~~~~~~~-----------~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k 143 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDC-----------GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELK 143 (291)
T ss_pred EEEEecCCC-CHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEE
Confidence 999999985 999888532 13578889999999999999999985 899999999999999999999
Q ss_pred EcccCccccc
Q 003368 801 VGDFGLARLR 810 (825)
Q Consensus 801 i~DFGla~~~ 810 (825)
++|||+++..
T Consensus 144 l~dfg~~~~~ 153 (291)
T cd07844 144 LADFGLARAK 153 (291)
T ss_pred ECcccccccc
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=210.19 Aligned_cols=154 Identities=24% Similarity=0.285 Sum_probs=128.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~ 717 (825)
..++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... +...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3467899999999999999999998899999999987542 233467889999999999999999998764311 1223
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...|+||||+++ ++.+++. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 163 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 163 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH--------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCC
Confidence 457999999975 6766662 2467888999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 164 ~~kL~DfG~a~~~~~ 178 (364)
T cd07875 164 TLKILDFGLARTAGT 178 (364)
T ss_pred cEEEEeCCCccccCC
Confidence 999999999987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=203.16 Aligned_cols=162 Identities=28% Similarity=0.473 Sum_probs=132.3
Q ss_pred ccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|...+.||+|+||.||+|+.. .++..||+|.+........+.+.+|++++++++||||++++++|. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 34777899999999999999853 245679999987665555678999999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCC----cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQT----DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+..++||||+++|+|.+++........ .........++|..++.++.|++.|++|||+. +|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 678999999999999999964321000 00111224589999999999999999999985 89999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+.++.+||+|||+|+....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~ 175 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYS 175 (291)
T ss_pred ccCCcEEECCCCcccccCC
Confidence 9999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=198.67 Aligned_cols=150 Identities=29% Similarity=0.420 Sum_probs=132.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||.||+|+...+++.||+|.+..... .+++.+|++++++++||||+++++++. .+...++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence 568889999999999999999987899999999875532 678999999999999999999999854 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+++++|.+++... ...++|..+..++.|++.|++|||+. +|+|||++|+||++++++.+||+
T Consensus 76 ~~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~ 141 (256)
T cd06612 76 VMEYCGAGSVSDIMKIT-----------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLA 141 (256)
T ss_pred EEecCCCCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEc
Confidence 99999999999998532 24689999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||++......
T Consensus 142 dfg~~~~~~~~ 152 (256)
T cd06612 142 DFGVSGQLTDT 152 (256)
T ss_pred ccccchhcccC
Confidence 99999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.85 E-value=7e-21 Score=202.92 Aligned_cols=160 Identities=27% Similarity=0.420 Sum_probs=128.7
Q ss_pred cccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+|...+.||+|+||.||+|+... ....||+|.+..... ...+.+.+|++++++++||||++++++|. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 36778899999999999998632 235799998875443 33467899999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCc------------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTD------------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrd 785 (825)
+..++|+||+++|+|.+++......... ........++|.++..++.|++.|++|||+. +|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 6689999999999999998643211000 0011234689999999999999999999985 899999
Q ss_pred CCCCCeeecCCCcEEEcccCcccccc
Q 003368 786 LKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 786 lk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|||+||++++++.+||+|||+++...
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred hhhheEEEcCCCcEEecccccccccc
Confidence 99999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=200.10 Aligned_cols=160 Identities=28% Similarity=0.409 Sum_probs=133.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.+|+|+||.||+|....+|+.||+|.+.... ....+.+..|++++++++||||+++++++.. ..+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4677889999999999999998899999999986532 2334678899999999999999999987542 2345679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC--QEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~--~~~ivHrdlk~~NILl~~~~~~ 799 (825)
+||||+++++|.+++... ......+++..++.++.|++.|++|||..+ ..+|+||||||+||+++.++.+
T Consensus 78 ~~~e~~~~~~L~~~l~~~--------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKC--------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149 (265)
T ss_pred EEehhccCCCHHHHHHHH--------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE
Confidence 999999999999998532 112346899999999999999999999332 3589999999999999999999
Q ss_pred EEcccCcccccccCC
Q 003368 800 HVGDFGLARLRQEVP 814 (825)
Q Consensus 800 ki~DFGla~~~~~~~ 814 (825)
|++|||+++......
T Consensus 150 kl~d~g~~~~~~~~~ 164 (265)
T cd08217 150 KLGDFGLAKILGHDS 164 (265)
T ss_pred EEecccccccccCCc
Confidence 999999999875543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=203.64 Aligned_cols=149 Identities=28% Similarity=0.384 Sum_probs=131.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|...+.||+|+||.||+|....+++.||+|.+........+.+.+|+.++++++||||++++++|. ..+..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence 56788899999999999999987889999999987655555677899999999999999999999853 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+++|+|.+++.. ..+++.++..++.|+++|++|||+. +++|||+||+||+++.++.+||+
T Consensus 94 v~e~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~ 157 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 157 (293)
T ss_pred EEecCCCCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEc
Confidence 9999999999999843 2467889999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||++.....
T Consensus 158 dfg~~~~~~~ 167 (293)
T cd06647 158 DFGFCAQITP 167 (293)
T ss_pred cCcceecccc
Confidence 9999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=204.70 Aligned_cols=147 Identities=24% Similarity=0.350 Sum_probs=129.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||.||+|+...+++.||||.+.... ....+.+.+|+++++.++||||+++++++. .++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 36888899999999999999999999999999987553 223457889999999999999999998853 4667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~ 140 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI------------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHI 140 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCE
Confidence 89999999999999998432 3578889999999999999999985 89999999999999999999
Q ss_pred EEcccCcccc
Q 003368 800 HVGDFGLARL 809 (825)
Q Consensus 800 ki~DFGla~~ 809 (825)
|++|||+++.
T Consensus 141 ~l~dfg~~~~ 150 (305)
T cd05609 141 KLTDFGLSKI 150 (305)
T ss_pred EEeeCCCccc
Confidence 9999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=204.66 Aligned_cols=152 Identities=27% Similarity=0.422 Sum_probs=128.9
Q ss_pred ccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
++|...+.||+|+||.||+|.. ..++..||||.++.... ...+.+.+|+++++++ +||||++++++|.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----- 109 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----- 109 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-----
Confidence 4688899999999999999975 23456899999875532 3346789999999999 7999999999864
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
..+..++||||+++|+|.++++.. ....++|.++..++.|++.|++|||+. +|+||||||+||+++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~----------~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 176 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRK----------RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH 176 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC
Confidence 356789999999999999998532 112389999999999999999999985 8999999999999999
Q ss_pred CCcEEEcccCccccccc
Q 003368 796 NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~ 812 (825)
++.+|++|||+++....
T Consensus 177 ~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 177 GKIVKICDFGLARDIMN 193 (302)
T ss_pred CCeEEECCCcccccccC
Confidence 99999999999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=201.32 Aligned_cols=160 Identities=28% Similarity=0.428 Sum_probs=131.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|...+.||+|+||.||+|..... +..||+|.+..... .....+.+|+.+++.++||||+++++++. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~ 80 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----T 80 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----C
Confidence 5678889999999999999998543 37899999865432 33457889999999999999999999854 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+++|+|.+++........ .......++|..+..++.|++.|++|||+. +|+||||||+||+++++
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~ 155 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAE--NNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED 155 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchh--hccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC
Confidence 5678999999999999999964321100 001223578999999999999999999985 99999999999999999
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
+.+||+|||+++....
T Consensus 156 ~~~kl~dfg~~~~~~~ 171 (277)
T cd05032 156 LTVKIGDFGMTRDIYE 171 (277)
T ss_pred CCEEECCcccchhhcc
Confidence 9999999999986544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=203.54 Aligned_cols=148 Identities=27% Similarity=0.455 Sum_probs=127.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|+||.||+|+...+|+.||+|.++.... .....+.+|++++++++||||+++++++ .+....++
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~l 76 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLTL 76 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceEE
Confidence 6778899999999999999988999999999875422 2235678899999999999999999984 44677899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||++ ++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+
T Consensus 77 v~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~ 141 (284)
T cd07839 77 VFEYCD-QDLKKYFDSC-----------NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLA 141 (284)
T ss_pred EEecCC-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEEC
Confidence 999997 5888877422 13588999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 142 dfg~~~~~~~ 151 (284)
T cd07839 142 DFGLARAFGI 151 (284)
T ss_pred ccchhhccCC
Confidence 9999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-21 Score=201.42 Aligned_cols=149 Identities=29% Similarity=0.399 Sum_probs=131.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+|+..+.||.|+||.||+|+...+++.||+|.+.... ......+.+|++++++++|||++++++++. ++...++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 5777889999999999999998899999999987653 334467889999999999999999999853 3578899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++
T Consensus 77 v~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~ 140 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG-------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLA 140 (274)
T ss_pred EEEeeCCCcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEc
Confidence 99999999999998521 678999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||+++.....
T Consensus 141 d~g~~~~~~~~ 151 (274)
T cd06609 141 DFGVSGQLTST 151 (274)
T ss_pred ccccceeeccc
Confidence 99999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=201.03 Aligned_cols=148 Identities=26% Similarity=0.422 Sum_probs=129.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.|+..+.||+|+||.||+|++..+++.||||.+.... ....+.+.+|++++++++||||+++++++. ++...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence 4677888999999999999998889999999987543 334567899999999999999999999854 3668999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++.. ..+++.+...++.|++.|++|+|+. +++|+||+|+||+++.++.++++
T Consensus 80 v~e~~~~~~L~~~i~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~ 143 (277)
T cd06640 80 IMEYLGGGSALDLLRA-------------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLA 143 (277)
T ss_pred EEecCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEc
Confidence 9999999999998842 2467888899999999999999985 99999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 144 dfg~~~~~~~ 153 (277)
T cd06640 144 DFGVAGQLTD 153 (277)
T ss_pred ccccceeccC
Confidence 9999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=201.50 Aligned_cols=165 Identities=24% Similarity=0.368 Sum_probs=136.9
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSS 711 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 711 (825)
.+..++..+...|+..+.||+|+||.||+|+...+++.||+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 455566667778999999999999999999998899999999986543 2345688999999998 69999999998753
Q ss_pred ccc-CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 712 IDF-QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 712 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
... ...+..++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+|||+||+|
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~n 151 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT----------KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQN 151 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence 211 1245789999999999999988532 113477888899999999999999985 89999999999
Q ss_pred eeecCCCcEEEcccCcccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~ 811 (825)
|++++++.+||+|||+++...
T Consensus 152 ili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEECCCCCEEEeeCcchhhhh
Confidence 999999999999999988654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=200.72 Aligned_cols=147 Identities=28% Similarity=0.456 Sum_probs=128.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
|+..+.||+|+||.||+|....+++.||||.+.... ....+.+.+|++.+++++||||+++++++. ++...++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence 667889999999999999988889999999886443 233467889999999999999999999853 46778999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++|+|.+++.. ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|
T Consensus 81 ~e~~~~~~l~~~i~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~d 144 (277)
T cd06641 81 MEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLAD 144 (277)
T ss_pred EEeCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEee
Confidence 999999999998842 2578999999999999999999985 999999999999999999999999
Q ss_pred cCccccccc
Q 003368 804 FGLARLRQE 812 (825)
Q Consensus 804 FGla~~~~~ 812 (825)
||+++....
T Consensus 145 fg~~~~~~~ 153 (277)
T cd06641 145 FGVAGQLTD 153 (277)
T ss_pred cccceeccc
Confidence 999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.3e-21 Score=201.21 Aligned_cols=151 Identities=29% Similarity=0.503 Sum_probs=130.5
Q ss_pred cccccceeccCCeeEEEEEEEcC----CCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDR----DGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.|...+.||+|+||.||+|++.. +++.||||.+...... ..+.|.+|++++++++||||++++++|.. .++.
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 46677899999999999999743 4789999999765443 46789999999999999999999998643 2355
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~ 147 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH-----------RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDL 147 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC-----------ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCC
Confidence 789999999999999999532 12589999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+|++|||+++...
T Consensus 148 ~~l~dfg~~~~~~ 160 (284)
T cd05038 148 VKISDFGLAKVLP 160 (284)
T ss_pred EEEcccccccccc
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=200.96 Aligned_cols=158 Identities=27% Similarity=0.406 Sum_probs=131.2
Q ss_pred hcccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
++++|...+.||+|+||.||+|.+.. ++..||+|.+..... .....|.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 35678889999999999999999966 678899998875433 334579999999999999999999998543
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.+..++||||+++|+|.+++...+... .....++|.++.+++.|++.|++|||+. +++||||||+||+++
T Consensus 81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~ 150 (277)
T cd05036 81 --RLPRFILLELMAGGDLKSFLRENRPRP-----ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLT 150 (277)
T ss_pred --CCCcEEEEecCCCCCHHHHHHHhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEe
Confidence 456799999999999999986542111 1123689999999999999999999985 899999999999998
Q ss_pred CCC---cEEEcccCcccccc
Q 003368 795 NNL---TAHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~---~~ki~DFGla~~~~ 811 (825)
.++ .+|++|||+++...
T Consensus 151 ~~~~~~~~kl~dfg~~~~~~ 170 (277)
T cd05036 151 CKGPGRVAKIADFGMARDIY 170 (277)
T ss_pred ccCCCcceEeccCccccccC
Confidence 654 69999999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=205.03 Aligned_cols=153 Identities=25% Similarity=0.350 Sum_probs=121.4
Q ss_pred cceeccCCeeEEEEEEEc--CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 648 THLIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
.+.||+|+||+||+|+.. .+++.||||.+.... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence 468999999999999974 366899999986532 23567899999999999999999988643 23456899999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCcEEE
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHV 801 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl----~~~~~~ki 801 (825)
|+. ++|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred ccC-CCHHHHHHhccccc---ccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 986 58888775321111 011223588999999999999999999985 89999999999999 45679999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 154 ~DfG~a~~~~~ 164 (317)
T cd07868 154 ADMGFARLFNS 164 (317)
T ss_pred eecCceeccCC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=198.35 Aligned_cols=143 Identities=25% Similarity=0.441 Sum_probs=122.6
Q ss_pred eeccCCeeEEEEEEE--cCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 650 LIGIGSFGSVYKGTF--DRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~--~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
.||+|+||.||+|.+ ..+++.||||+++.... ...+++.+|+.++++++||||++++++|. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 589999999999975 35678999999865432 33567999999999999999999999853 345689999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
|+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||
T Consensus 76 ~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg 140 (257)
T cd05116 76 LAELGPLNKFLQKN------------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG 140 (257)
T ss_pred cCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCc
Confidence 99999999998432 3578999999999999999999985 89999999999999999999999999
Q ss_pred cccccccC
Q 003368 806 LARLRQEV 813 (825)
Q Consensus 806 la~~~~~~ 813 (825)
+++.....
T Consensus 141 ~~~~~~~~ 148 (257)
T cd05116 141 LSKALGAD 148 (257)
T ss_pred cccccCCC
Confidence 99876543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=199.78 Aligned_cols=149 Identities=22% Similarity=0.386 Sum_probs=129.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+|+..+.||+|+||.||+|+...+++.||+|.+..... ...+.+.+|++++++++||||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 47778999999999999999988999999999875431 1346789999999999999999999985 346
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~ 140 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY------------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTG 140 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 6789999999999999988422 3578899999999999999999985 999999999999998776
Q ss_pred -cEEEcccCccccccc
Q 003368 798 -TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 -~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++.+..
T Consensus 141 ~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 141 QRLRIADFGAAARLAA 156 (268)
T ss_pred CEEEEccccccccccc
Confidence 699999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=202.83 Aligned_cols=162 Identities=23% Similarity=0.394 Sum_probs=130.0
Q ss_pred ccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|...+.||+|+||.||+|+... +++.||||++...... ..+.|.+|+.++++++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 346677889999999999998743 3578999999755433 3467889999999999999999999864 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCC----CcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQ----TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.+..++++||+++++|.+++....... ..........+++..+..++.|++.|++|+|+. +|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 556899999999999999985321100 001111234689999999999999999999985 8999999999999
Q ss_pred ecCCCcEEEcccCccccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~ 812 (825)
+++++.+||+|||+++....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~ 176 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYA 176 (283)
T ss_pred ecCCCceEeccccccccccc
Confidence 99999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=198.95 Aligned_cols=150 Identities=33% Similarity=0.549 Sum_probs=127.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|++.. +..||||++..... ..+.|.+|++++++++||||+++++.+. ++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI 77 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC-CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence 458888999999999999999854 45699999975432 3467899999999999999999998742 345789
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....++|..+..++.|++.||+|+|+. +|+||||||+||++++++.+||+
T Consensus 78 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~ 144 (262)
T cd05071 78 VTEYMSKGSLLDFLKGE----------MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 144 (262)
T ss_pred EEEcCCCCcHHHHHhhc----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEec
Confidence 99999999999999532 123578999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||.++.....
T Consensus 145 dfg~~~~~~~~ 155 (262)
T cd05071 145 DFGLARLIEDN 155 (262)
T ss_pred cCCceeecccc
Confidence 99999876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=199.97 Aligned_cols=143 Identities=26% Similarity=0.441 Sum_probs=121.4
Q ss_pred ceeccCCeeEEEEEEEcCCC----------eEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 649 HLIGIGSFGSVYKGTFDRDG----------TIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
+.||+|+||.||+|.+..++ ..||+|.+...... .+.|.+|++++++++||||++++++|.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 46899999999999997665 35788877654333 6789999999999999999999998642 3
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL- 797 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~- 797 (825)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~ 139 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHRE-----------KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGL 139 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCcc
Confidence 468999999999999998532 12688999999999999999999985 899999999999999887
Q ss_pred ------cEEEcccCccccccc
Q 003368 798 ------TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ------~~ki~DFGla~~~~~ 812 (825)
.+|++|||+|+....
T Consensus 140 ~~~~~~~~kl~Dfg~a~~~~~ 160 (259)
T cd05037 140 NEGYVPFIKLSDPGIPITVLS 160 (259)
T ss_pred ccCCceeEEeCCCCccccccc
Confidence 799999999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=202.12 Aligned_cols=149 Identities=23% Similarity=0.333 Sum_probs=130.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||+||+|+...+|+.||+|++.... ....+.+.+|+++++.++||||+++++++. .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence 46778899999999999999998889999999887543 234568899999999999999999999854 357889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ..+++..+..++.+++.|+.|||+. .+|+||||||+||++++++.++|
T Consensus 80 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l 145 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG------------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKL 145 (284)
T ss_pred EEEecCCCCCHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEE
Confidence 999999999999887422 3578999999999999999999973 37999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||+++..
T Consensus 146 ~d~gl~~~~ 154 (284)
T cd06620 146 CDFGVSGEL 154 (284)
T ss_pred ccCCcccch
Confidence 999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=197.33 Aligned_cols=144 Identities=31% Similarity=0.481 Sum_probs=123.9
Q ss_pred ceeccCCeeEEEEEEEcCCC---eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||.||+|++..++ ..||+|.+..... ...+++.+|++++++++|||||++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence 46999999999999875444 7899999875543 34567999999999999999999999753 34579999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..++|..+..++.|++.|++|||+. +++||||||+||+++.++.+|++||
T Consensus 75 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df 139 (257)
T cd05060 75 ELAPLGPLLKYLKKR------------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDF 139 (257)
T ss_pred EeCCCCcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccc
Confidence 999999999999532 2578999999999999999999985 8999999999999999999999999
Q ss_pred CcccccccC
Q 003368 805 GLARLRQEV 813 (825)
Q Consensus 805 Gla~~~~~~ 813 (825)
|+++.....
T Consensus 140 ~~~~~~~~~ 148 (257)
T cd05060 140 GMSRALGAG 148 (257)
T ss_pred cccceeecC
Confidence 999876443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-21 Score=199.60 Aligned_cols=147 Identities=29% Similarity=0.487 Sum_probs=127.4
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch---------hHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
|...+.||+|+||.||+|....+++.||+|.+...... ..+.+.+|++++++++||||+++++++.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 76 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----- 76 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----
Confidence 55678999999999999999888999999988643221 1256889999999999999999999853
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+.+..++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||++++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~ 141 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY------------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDN 141 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc------------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcC
Confidence 356789999999999999998432 3578889999999999999999985 8999999999999999
Q ss_pred CCcEEEcccCcccccc
Q 003368 796 NLTAHVGDFGLARLRQ 811 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~ 811 (825)
++.+||+|||+++...
T Consensus 142 ~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 142 KGGIKISDFGISKKLE 157 (267)
T ss_pred CCCEEecccCCCcccc
Confidence 9999999999998775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=197.39 Aligned_cols=151 Identities=26% Similarity=0.407 Sum_probs=129.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|...+.||+|+||.||+|+...+|+.||+|.+.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence 46888999999999999999998899999999875421 2234578899999999999999999998532 123
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+++++|.+++... ..+++....+++.|++.|++|||+. +++||||||+||+++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY------------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAG 143 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 4678999999999999988422 3478888999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccc
Q 003368 798 TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 ~~ki~DFGla~~~~ 811 (825)
.+||+|||+++...
T Consensus 144 ~~~l~dfg~~~~~~ 157 (264)
T cd06653 144 NVKLGDFGASKRIQ 157 (264)
T ss_pred CEEECccccccccc
Confidence 99999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=201.71 Aligned_cols=150 Identities=26% Similarity=0.491 Sum_probs=128.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+|+...+|+.||||.+..... ...+.+.+|++++++++||||+++++++ .+++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 47788999999999999999988999999999875432 2335788999999999999999999985 3466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+. ++|.+++... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|+
T Consensus 76 ~v~e~~~-~~l~~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS----------PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred EEeeccc-cCHHHHHHhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence 9999996 6898888532 123588999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 142 ~dfg~~~~~~~ 152 (284)
T cd07860 142 ADFGLARAFGV 152 (284)
T ss_pred eeccchhhccc
Confidence 99999886543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=198.28 Aligned_cols=145 Identities=31% Similarity=0.520 Sum_probs=121.1
Q ss_pred ceeccCCeeEEEEEEEcC---CCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||.||+|++.. .+..||||.+.... ....+.+.+|+.+++.++||||++++++|.. .+...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 468999999999998643 34679999986432 3345678899999999999999999997643 244578999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ....++..+..++.|+++|++|||+. +|+||||||+||++++++.+|++||
T Consensus 77 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~df 142 (262)
T cd05058 77 PYMKHGDLRNFIRSE-----------THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADF 142 (262)
T ss_pred ecCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCc
Confidence 999999999998532 12457778899999999999999985 8999999999999999999999999
Q ss_pred Ccccccc
Q 003368 805 GLARLRQ 811 (825)
Q Consensus 805 Gla~~~~ 811 (825)
|+++...
T Consensus 143 g~~~~~~ 149 (262)
T cd05058 143 GLARDIY 149 (262)
T ss_pred ccccccc
Confidence 9998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.2e-21 Score=200.47 Aligned_cols=161 Identities=25% Similarity=0.372 Sum_probs=135.7
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeeccccccc-CCC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDF-QGN 717 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~~ 717 (825)
.++++|+..+.||+|+||.||+|+...+++.||+|.+..... ..+.|.+|+++++++ +||||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456889999999999999999999988899999999876533 346789999999999 69999999998754221 234
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++++|.+++... ......+++..+..++.|++.|++|||+. +++||||+|+||++++++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGL--------RKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNA 150 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHH--------hhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCC
Confidence 5689999999999999988532 11124688999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+|++|||+++....
T Consensus 151 ~~~l~d~~~~~~~~~ 165 (275)
T cd06608 151 EVKLVDFGVSAQLDS 165 (275)
T ss_pred eEEECCCccceeccc
Confidence 999999999876543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=197.09 Aligned_cols=151 Identities=25% Similarity=0.364 Sum_probs=130.8
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+++...+|+.||||.+.... ....+++.+|++++++++||||+++++++ .+.+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 3778899999999999999998899999999987542 23346789999999999999999999984 4467899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+|+
T Consensus 76 lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l 142 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ----------RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKL 142 (256)
T ss_pred EEEecCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence 999999999999988532 113578889999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 143 ~d~~~~~~~~~ 153 (256)
T cd08218 143 GDFGIARVLNS 153 (256)
T ss_pred eeccceeecCc
Confidence 99999987644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=199.03 Aligned_cols=153 Identities=33% Similarity=0.565 Sum_probs=124.0
Q ss_pred ceeccCCeeEEEEEEEcCCCe--EEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGT--IVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|++..+|. .+|+|.++... ....+.+.+|+++++++ +||||++++++|.. .+..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence 468999999999999977775 46888887433 33456789999999999 79999999998643 55689999
Q ss_pred EccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 725 QYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
||+++|+|.++++........ ........+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999998653211100 0011224588999999999999999999985 999999999999999999999
Q ss_pred EcccCcccc
Q 003368 801 VGDFGLARL 809 (825)
Q Consensus 801 i~DFGla~~ 809 (825)
++|||+++.
T Consensus 153 l~dfgl~~~ 161 (270)
T cd05047 153 IADFGLSRG 161 (270)
T ss_pred ECCCCCccc
Confidence 999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=201.74 Aligned_cols=158 Identities=26% Similarity=0.421 Sum_probs=128.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||.||+|++..+|+.||||.++.... ...+.+.+|++++++++ ||||+++++++......+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368888999999999999999988999999998865432 23467889999999995 699999999865422222234
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCc
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLT 798 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~ 798 (825)
.|+||||+++ ++.+++.... ......+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNG-------RGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhc-------ccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCe
Confidence 7999999985 8988875321 01124689999999999999999999985 9999999999999998 889
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+||+|||+++...
T Consensus 150 ~kl~dfg~~~~~~ 162 (295)
T cd07837 150 LKIADLGLGRAFS 162 (295)
T ss_pred EEEeecccceecC
Confidence 9999999988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=203.91 Aligned_cols=150 Identities=32% Similarity=0.533 Sum_probs=126.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe----EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||.||+|.+..+|+ .||+|.+..... ....++.+|+.++++++||||++++++|..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------ 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence 457788999999999999999877775 478888865432 234478899999999999999999998743
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~ 146 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEH-----------KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPN 146 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCC
Confidence 2357999999999999998532 13578889999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 147 ~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 147 HVKITDFGLARLLEG 161 (303)
T ss_pred ceEEccccccccccC
Confidence 999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=200.35 Aligned_cols=159 Identities=22% Similarity=0.388 Sum_probs=132.1
Q ss_pred cccccccceeccCCeeEEEEEEEcC----CCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR----DGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
.++|...++||+|+||.||+|.+.. ++..||+|++.... ....+.+.+|++++++++||||++++++|.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 4678889999999999999999854 26889999987543 2335678899999999999999999998743 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++++||+++|+|.+++....... ......+++.++..++.|++.|++|||+. +++||||||+||+++++
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~ 153 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGE----ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccc----cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCC
Confidence 466899999999999999986431110 01124689999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccc
Q 003368 797 LTAHVGDFGLARLRQ 811 (825)
Q Consensus 797 ~~~ki~DFGla~~~~ 811 (825)
+.+||+|||+++.+.
T Consensus 154 ~~~kl~d~g~~~~~~ 168 (280)
T cd05043 154 LQVKITDNALSRDLF 168 (280)
T ss_pred CcEEECCCCCccccc
Confidence 999999999998664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=201.21 Aligned_cols=154 Identities=23% Similarity=0.321 Sum_probs=126.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHH-hhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRA-LRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+...+|+.||||+++.... .....+..|++. ++..+||||+++++++. .+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence 468888999999999999999988999999999876532 233456666665 56678999999999864 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++ |+|.+++.... .....+++..+..++.|++.|++|||+. .+++||||||+||+++.++.+|
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~k 144 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY--------DKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVK 144 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc--------cCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEE
Confidence 99999997 68888774321 1124689999999999999999999974 3799999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++.+..
T Consensus 145 l~dfg~~~~~~~ 156 (283)
T cd06617 145 LCDFGISGYLVD 156 (283)
T ss_pred Eeeccccccccc
Confidence 999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=207.17 Aligned_cols=157 Identities=24% Similarity=0.368 Sum_probs=134.9
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccC
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMP 728 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~ 728 (825)
-++|+|.||+||.|++..+...+|||-+.....+..+-...||+.-++++|.|||+++|+|.+ +++.-+.||-+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCC
Confidence 479999999999999999999999999988777777788899999999999999999999643 567889999999
Q ss_pred CCChhhhccCCCCCCCcccchhcccC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCcEEEcccC
Q 003368 729 NGSLENWLHPDAIPQTDEENDEIRNL--TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFG 805 (825)
Q Consensus 729 ~gsL~~~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~-~~~~~ki~DFG 805 (825)
||+|.+.|+..= +++ .+.+.-.+..||++||.|||+. .|||||||-.|||+. -.|.+||+|||
T Consensus 656 GGSLSsLLrskW-----------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFG 721 (1226)
T KOG4279|consen 656 GGSLSSLLRSKW-----------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFG 721 (1226)
T ss_pred CCcHHHHHHhcc-----------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccc
Confidence 999999996531 122 5566777899999999999996 899999999999996 57899999999
Q ss_pred cccccccCCCCCccccccC
Q 003368 806 LARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 806 la~~~~~~~~~~~~~~gt~ 824 (825)
.+|.+..-.+-..+..||+
T Consensus 722 TsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 722 TSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred cchhhccCCccccccccch
Confidence 9998765555566777775
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=203.39 Aligned_cols=163 Identities=25% Similarity=0.422 Sum_probs=130.5
Q ss_pred cccccccceeccCCeeEEEEEEEc-------CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-------RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|+.. ..+..||+|.+..... .....+.+|+++++++ +||||++++++|.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 356778899999999999999752 2346799999875432 3345788999999999 5999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
..+..++||||+++|+|.+++......... ........++|.++.+++.|++.|++|||+. +|+||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 356789999999999999999653211000 0011224689999999999999999999985 999999999
Q ss_pred CCeeecCCCcEEEcccCccccccc
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+||++++++.+|++|||+++....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~ 186 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHD 186 (314)
T ss_pred eeEEEcCCCcEEEccccccccccc
Confidence 999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-21 Score=203.67 Aligned_cols=161 Identities=25% Similarity=0.422 Sum_probs=130.0
Q ss_pred ccccccceeccCCeeEEEEEEEcC-------CCeEEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
++|...+.||+|+||.||+|+... ++..||+|.+.... ....+++.+|+++++++ +||||++++++|.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence 568889999999999999998632 23579999997543 23345788999999999 7999999999864
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
..+..++||||+++|+|.+++......... ........++|.++.+++.|++.||+|||+. +++||||||+
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 169 (307)
T cd05098 95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 169 (307)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHH
Confidence 356789999999999999999653211000 0001224689999999999999999999985 9999999999
Q ss_pred CeeecCCCcEEEcccCcccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~ 811 (825)
||+++.++.+|++|||+|+...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIH 191 (307)
T ss_pred heEEcCCCcEEECCCccccccc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=198.17 Aligned_cols=149 Identities=34% Similarity=0.573 Sum_probs=128.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||.||+|.. .++..||+|.+..... ..+.|.+|++++++++|||++++++++. +...++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEe-cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence 4677889999999999999987 4677899999875433 3467999999999999999999998742 345789
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.++++.. ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++
T Consensus 78 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~ 144 (260)
T cd05070 78 VTEYMSKGSLLDFLKDG----------EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIA 144 (260)
T ss_pred EEEecCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeC
Confidence 99999999999998532 123578999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 145 dfg~~~~~~~ 154 (260)
T cd05070 145 DFGLARLIED 154 (260)
T ss_pred CceeeeeccC
Confidence 9999987644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.61 Aligned_cols=154 Identities=32% Similarity=0.534 Sum_probs=129.6
Q ss_pred ceeccCCeeEEEEEEEcCC---CeEEEEEEeecccchh-HHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||.||+|+.... +..||||.++...... .+.+.+|++.++.++|+|++++++++. .....++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999999755 8899999998664433 678999999999999999999999854 366789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++....... .......++|.++..++.|+++|++|||+. +|+||||||+||++++++.+|++||
T Consensus 76 e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~df 149 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDF 149 (262)
T ss_pred EeccCCcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccc
Confidence 9999999999985421000 001125689999999999999999999985 9999999999999999999999999
Q ss_pred CcccccccC
Q 003368 805 GLARLRQEV 813 (825)
Q Consensus 805 Gla~~~~~~ 813 (825)
|.++.....
T Consensus 150 g~~~~~~~~ 158 (262)
T cd00192 150 GLSRDVYDD 158 (262)
T ss_pred ccccccccc
Confidence 999987653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=195.50 Aligned_cols=143 Identities=31% Similarity=0.556 Sum_probs=123.3
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
++||+|+||.||+|.. .++..||+|.+...... ....|.+|++++++++||||++++++|.. .+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 4689999999999997 57889999998765432 34578999999999999999999998643 45689999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ...++|..+..++.|++.|+.|+|.. +++||||||+||+++.++.+|++|||++
T Consensus 75 ~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 140 (250)
T cd05085 75 PGGDFLSFLRKK-----------KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS 140 (250)
T ss_pred CCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccc
Confidence 999999988432 13478999999999999999999985 8999999999999999999999999999
Q ss_pred cccc
Q 003368 808 RLRQ 811 (825)
Q Consensus 808 ~~~~ 811 (825)
+...
T Consensus 141 ~~~~ 144 (250)
T cd05085 141 RQED 144 (250)
T ss_pred eecc
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=200.74 Aligned_cols=150 Identities=27% Similarity=0.488 Sum_probs=128.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+|+..+.||+|++|.||+|+...+|+.||||.++.... ...+.+.+|++++++++||||+++++++. +.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 47788999999999999999988999999999876533 23456788999999999999999999854 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++ +|.+++.... ....+++.++..++.|++.|++|||+. +|+||||||+||++++++.+|++
T Consensus 76 v~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~ 142 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHG---------VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLA 142 (284)
T ss_pred EEecCCc-cHHHHHHhcC---------CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEe
Confidence 9999985 8888875321 123589999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 143 d~g~~~~~~ 151 (284)
T cd07836 143 DFGLARAFG 151 (284)
T ss_pred ecchhhhhc
Confidence 999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=200.94 Aligned_cols=160 Identities=22% Similarity=0.326 Sum_probs=136.9
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|-|++|-.|++--+|+.||||++.+..-. ....+.+|++.|+-++|||||++|+. .+.....||
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKlyL 94 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKLYL 94 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceEEE
Confidence 77788999999999999999999999999999876432 34568899999999999999999997 556778999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCcEEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL-DNNLTAHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl-~~~~~~ki 801 (825)
|.|.=.+|+|++|+... ...+.+.-+.++..||..|+.|+|.. .+||||+||+||.+ ..-|-+|+
T Consensus 95 iLELGD~GDl~DyImKH-----------e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKH-----------EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEecCCchHHHHHHhh-----------hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEe
Confidence 99999999999999533 23578888999999999999999986 89999999999987 56789999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.|||++-..+... .-.+.+|++
T Consensus 161 TDFGFSNkf~PG~-kL~TsCGSL 182 (864)
T KOG4717|consen 161 TDFGFSNKFQPGK-KLTTSCGSL 182 (864)
T ss_pred eeccccccCCCcc-hhhcccchh
Confidence 9999998876653 346667765
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=200.29 Aligned_cols=157 Identities=21% Similarity=0.374 Sum_probs=130.0
Q ss_pred ccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|+..+.||+|+||.||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++||||++++++|. +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence 568888999999999999999743 3467999988765443 4567999999999999999999999853 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+++|+|.+++...... ........++|..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~---~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~ 153 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSK---DEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQ 153 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccc---cccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCC
Confidence 56789999999999999998643110 0001123689999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCccccc
Q 003368 797 LTAHVGDFGLARLR 810 (825)
Q Consensus 797 ~~~ki~DFGla~~~ 810 (825)
+.+|++|||+++..
T Consensus 154 ~~~~l~~~~~~~~~ 167 (275)
T cd05046 154 REVKVSLLSLSKDV 167 (275)
T ss_pred CcEEEccccccccc
Confidence 99999999998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.98 Aligned_cols=151 Identities=26% Similarity=0.430 Sum_probs=133.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|++|.||+|+...+++.||||++..... ...+.+.+|++.+++++|||++++++++. .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence 357888999999999999999988899999999876543 34578999999999999999999999854 357889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeeecCCCcEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHH-HCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~-~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
+||||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.+|
T Consensus 76 lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~ 140 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV------------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVK 140 (264)
T ss_pred EEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEE
Confidence 999999999999998432 467889999999999999999998 5 899999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
++|||+++.....
T Consensus 141 l~df~~~~~~~~~ 153 (264)
T cd06623 141 IADFGISKVLENT 153 (264)
T ss_pred EccCccceecccC
Confidence 9999999877544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=201.76 Aligned_cols=161 Identities=25% Similarity=0.416 Sum_probs=131.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC----------------eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCcee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG----------------TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVR 704 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g----------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 704 (825)
..+|+..+.||+|+||.||+|+....+ ..||+|.+..... ...+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 356888999999999999999875433 5689999876543 34567899999999999999999
Q ss_pred EeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 003368 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHC 784 (825)
Q Consensus 705 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHr 784 (825)
++++|. .++..++||||+++++|.+++.......... ......+++..+..++.|++.|++|||+. +|+||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~ 154 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHR 154 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 999864 3467899999999999999986432111000 11224689999999999999999999985 89999
Q ss_pred CCCCCCeeecCCCcEEEcccCcccccc
Q 003368 785 DLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 785 dlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
||||+||+++.++.+|++|||+++...
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred ccchhceeecCCCceEEccccceeecc
Confidence 999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=197.00 Aligned_cols=150 Identities=29% Similarity=0.442 Sum_probs=131.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.|+..+.||+|+||.||+|....+++.||||.+...... ..+.+.+|++++++++|+||+++++.+. ..+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 367788999999999999999888999999999765442 5678999999999999999999999843 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+|+||+++++|.+++... ..+++..+..++.++++|++|||+. +|+||||+|+||++++++.+||
T Consensus 76 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 76 IFMEYCSGGTLEELLEHG------------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred EEEecCCCCcHHHHHhhc------------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 999999999999998532 3478888999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 141 ~d~g~~~~~~~~ 152 (264)
T cd06626 141 GDFGCAVKLKNN 152 (264)
T ss_pred cccccccccCCC
Confidence 999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=199.43 Aligned_cols=149 Identities=27% Similarity=0.428 Sum_probs=129.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCC---CCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIR---HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~~ 719 (825)
.|+..+.||+|+||.||+|++..+|+.||||.+.... ....+++.+|++++++++ |||+++++++|. ++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 3677889999999999999998899999999987543 234567889999999997 999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.+++.. ..++|.....++.|++.|++|||+. +|+||||+|+||++++++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~ 140 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNV 140 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCE
Confidence 8999999999999998742 2578999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
+++|||+++.....
T Consensus 141 ~l~dfg~~~~~~~~ 154 (277)
T cd06917 141 KLCDFGVAALLNQN 154 (277)
T ss_pred EEccCCceeecCCC
Confidence 99999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=199.36 Aligned_cols=148 Identities=25% Similarity=0.360 Sum_probs=129.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
.|...+.||+|++|.||+|....+++.||+|.+........+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3555689999999999999998889999999987655455567889999999999999999999853 36678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
+||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 95 ~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d 158 (285)
T cd06648 95 MEFLEGGALTDIVTH-------------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSD 158 (285)
T ss_pred EeccCCCCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcc
Confidence 999999999998842 2578889999999999999999985 899999999999999999999999
Q ss_pred cCccccccc
Q 003368 804 FGLARLRQE 812 (825)
Q Consensus 804 FGla~~~~~ 812 (825)
||+++....
T Consensus 159 ~g~~~~~~~ 167 (285)
T cd06648 159 FGFCAQVSK 167 (285)
T ss_pred cccchhhcc
Confidence 999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=198.06 Aligned_cols=144 Identities=23% Similarity=0.364 Sum_probs=120.1
Q ss_pred ceeccCCeeEEEEEEEcCC------------CeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 649 HLIGIGSFGSVYKGTFDRD------------GTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~------------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
+.||+|+||.||+|++..+ ...||+|.+..........|.+|+.+++.++||||++++++|..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~----- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR----- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence 4689999999999986322 23589998876555556688999999999999999999998643
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+++|+|..+++.. ...+++.++..++.|+++|++|||+. +|+||||||+|||++.+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~ 141 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK-----------SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecC
Confidence 45679999999999999887532 13588999999999999999999985 99999999999999876
Q ss_pred Cc-------EEEcccCcccccc
Q 003368 797 LT-------AHVGDFGLARLRQ 811 (825)
Q Consensus 797 ~~-------~ki~DFGla~~~~ 811 (825)
+. +|++|||+++...
T Consensus 142 ~~~~~~~~~~~l~d~g~~~~~~ 163 (262)
T cd05077 142 GIDGECGPFIKLSDPGIPITVL 163 (262)
T ss_pred CccCCCCceeEeCCCCCCcccc
Confidence 54 8999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=204.82 Aligned_cols=145 Identities=20% Similarity=0.275 Sum_probs=124.2
Q ss_pred ccceeccC--CeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 647 STHLIGIG--SFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 647 ~~~~ig~G--~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
..++||+| +||+||+++.+.+|+.||||++.... ....+.+.+|+++++.++|||||+++++|. .++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 35789999 78999999999999999999997543 233456788999999999999999999864 3667899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++
T Consensus 77 v~e~~~~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~ 143 (327)
T cd08227 77 VTSFMAYGSAKDLICTH----------FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS 143 (327)
T ss_pred EEeccCCCcHHHHHHhh----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEc
Confidence 99999999999998432 113588999999999999999999985 89999999999999999999999
Q ss_pred ccCcccc
Q 003368 803 DFGLARL 809 (825)
Q Consensus 803 DFGla~~ 809 (825)
|||.+..
T Consensus 144 ~~~~~~~ 150 (327)
T cd08227 144 GLRSNLS 150 (327)
T ss_pred ccchhhc
Confidence 9986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=201.33 Aligned_cols=162 Identities=26% Similarity=0.426 Sum_probs=132.2
Q ss_pred cccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|+..+.||+|+||.||+|+.. .++..||||.+..... ...++|.+|++++++++||||++++++|.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467888999999999999999874 2578999999876533 33467999999999999999999999864
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcc----------cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDE----------ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrd 785 (825)
.++..++||||+++|+|.+++.......... .......+++.+++.++.|++.||+|||+. +++|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 3556899999999999999996432111000 011224588999999999999999999985 899999
Q ss_pred CCCCCeeecCCCcEEEcccCcccccc
Q 003368 786 LKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 786 lk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|||+||++++++.+|++|||+++...
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred ccHhheEecCCCceEECccccceecc
Confidence 99999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=197.00 Aligned_cols=149 Identities=32% Similarity=0.542 Sum_probs=126.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|.+. .+..||+|.+.... ...+.|.+|++++++++|||++++++++. .+..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence 45777889999999999999984 44569999886543 23467899999999999999999998742 345789
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.++++.. ....++|..+..++.|++.|++|||+. +|+||||||+||++++++.+||+
T Consensus 78 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~ 144 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG----------DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIA 144 (260)
T ss_pred EEEcCCCCCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEEC
Confidence 99999999999999532 123578999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 145 dfg~~~~~~~ 154 (260)
T cd05069 145 DFGLARLIED 154 (260)
T ss_pred CCccceEccC
Confidence 9999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-21 Score=223.04 Aligned_cols=289 Identities=21% Similarity=0.389 Sum_probs=178.7
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+.+.|+++.+++. .+|..+. +.|+.|+|++|+|+ .+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 35678888888876 4565553 47888899999888 5666554 47888888888888 4565543 46888888
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL------------- 306 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGI------------- 306 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhH-------------
Confidence 888888 5676654 47888888888888 4566553 478888888888874 443221 123
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
+.|++++|+++ .+|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|++.. +|..
T Consensus 307 ------~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~-------- 364 (754)
T PRK15370 307 ------THLNVQSNSLT-ALPETLP---PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPET-------- 364 (754)
T ss_pred ------HHHHhcCCccc-cCCcccc---ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChh--------
Confidence 33466677776 4555433 567777777777764 343332 456666666665542 2211
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc-
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE- 350 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~- 350 (825)
+ .++|+.|++++|+++ .+|..+. ..|+.|++++|+++ .+|..
T Consensus 365 ----------------------l--p~~L~~LdLs~N~Lt----------~LP~~l~--~sL~~LdLs~N~L~-~LP~sl 407 (754)
T PRK15370 365 ----------------------L--PPTITTLDVSRNALT----------NLPENLP--AALQIMQASRNNLV-RLPESL 407 (754)
T ss_pred ----------------------h--cCCcCEEECCCCcCC----------CCCHhHH--HHHHHHhhccCCcc-cCchhH
Confidence 1 135667777777766 3444433 25677777777776 44443
Q ss_pred ---ccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCcccc-ccCCCCCCCCccceeecCCCCCcc
Q 003368 351 ---MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSG-VIPSSLGNLKQLALLHLFQNDLSG 417 (825)
Q Consensus 351 ---~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g 417 (825)
++.++++..|++.+|.++. ..+.+|+.| ++.+.+.| .++...+...+++....-.+...+
T Consensus 408 ~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~~ 471 (754)
T PRK15370 408 PHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQG 471 (754)
T ss_pred HHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHhc
Confidence 3445777888888888762 234455555 34454443 233344444555443333333333
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=202.32 Aligned_cols=153 Identities=28% Similarity=0.389 Sum_probs=129.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+...+++.||||.++.... .....+.+|++++++++||||+++++++.. .+....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG---SNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe---cCCCcE
Confidence 568888999999999999999988899999999975432 223457789999999999999999998643 123678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++ ++|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 82 ~lv~e~~~-~~L~~~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~ 146 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM-----------KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILK 146 (293)
T ss_pred EEEehhcC-cCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEE
Confidence 99999997 4898887532 12589999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+++.....
T Consensus 147 l~d~g~~~~~~~~ 159 (293)
T cd07843 147 ICDFGLAREYGSP 159 (293)
T ss_pred EeecCceeeccCC
Confidence 9999999876553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=198.70 Aligned_cols=150 Identities=25% Similarity=0.448 Sum_probs=127.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCC---CeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+.||+|+||.||+|.+... ...||||...... ....+.+.+|++++++++||||++++++|. .+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence 3477789999999999999987433 3579999887654 344568999999999999999999999863 24
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|..+..++.+++.|++|||+. +++||||||+||+++.++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~ 145 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-----------KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDC 145 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCC
Confidence 568999999999999998532 13579999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+|++|||+++....
T Consensus 146 ~~l~d~g~~~~~~~ 159 (270)
T cd05056 146 VKLGDFGLSRYLED 159 (270)
T ss_pred eEEccCceeeeccc
Confidence 99999999987644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=196.92 Aligned_cols=148 Identities=32% Similarity=0.539 Sum_probs=128.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||.||+|.. .+++.||||.+..... ..+.|.+|++++++++||||+++++++ ..+..++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~~ 77 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIYI 77 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcEE
Confidence 5688889999999999999997 5788999999875433 346789999999999999999999863 2346899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.++++
T Consensus 78 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~ 144 (260)
T cd05067 78 ITEYMENGSLVDFLKTP----------EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIA 144 (260)
T ss_pred EEEcCCCCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEc
Confidence 99999999999998532 124688999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 145 dfg~~~~~~ 153 (260)
T cd05067 145 DFGLARLIE 153 (260)
T ss_pred cCcceeecC
Confidence 999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=198.30 Aligned_cols=144 Identities=28% Similarity=0.439 Sum_probs=117.8
Q ss_pred eeccCCeeEEEEEEEcCC--CeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 650 LIGIGSFGSVYKGTFDRD--GTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~--g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.||+|+||.||+|+...+ ...+++|.+.... ....+.|.+|+++++.++||||++++++|.. ....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence 589999999999986332 2356677765443 2345689999999999999999999998643 5678999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++|+|.++++... ......++.....++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 77 CELGDLKSYLSQEQ--------WHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred CCCCcHHHHHHhhh--------cccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccc
Confidence 99999999996431 1123456777889999999999999985 899999999999999999999999999
Q ss_pred ccc
Q 003368 807 ARL 809 (825)
Q Consensus 807 a~~ 809 (825)
++.
T Consensus 146 ~~~ 148 (268)
T cd05086 146 GPS 148 (268)
T ss_pred ccc
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-21 Score=210.36 Aligned_cols=145 Identities=26% Similarity=0.319 Sum_probs=123.5
Q ss_pred ccccccceeccCCeeEEEEEEEc--CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..|...+.||+|+||.||+|... .+++.||||.+... +.+.+|++++++++|||||++++++ ......
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 161 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKSTV 161 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEE
Confidence 45888999999999999999763 34678999987643 3356899999999999999999874 346678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+. ++|.+++.. ...++|.+++.|+.|++.||+|||+. +||||||||+|||++.++.+|
T Consensus 162 ~lv~e~~~-~~l~~~l~~------------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR------------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred EEEehhcC-CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEE
Confidence 99999996 688888732 24689999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+|+.....
T Consensus 226 l~DfG~a~~~~~~ 238 (392)
T PHA03207 226 LGDFGAACKLDAH 238 (392)
T ss_pred EccCccccccCcc
Confidence 9999999876543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=209.73 Aligned_cols=153 Identities=29% Similarity=0.424 Sum_probs=130.2
Q ss_pred ccccceeccCCeeEEEEEEEcCC-C--eEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRD-G--TIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~-g--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
....++||+|+||+|++|.|... | ..||||+++..... ....|.+|+.+|-+++|||+|+|||... +...
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp~ 185 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQPA 185 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cchh
Confidence 34568899999999999999543 3 46899999876554 5678999999999999999999999853 2457
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
+||+|.++.|+|.+.|+.. ....+-......+|.|||.||+||... ++||||+.++|+|+-..-.+|
T Consensus 186 mMV~ELaplGSLldrLrka----------~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKA----------KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred hHHhhhcccchHHHHHhhc----------cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceee
Confidence 8999999999999999742 223567778899999999999999984 999999999999999999999
Q ss_pred EcccCcccccccCCCC
Q 003368 801 VGDFGLARLRQEVPNN 816 (825)
Q Consensus 801 i~DFGla~~~~~~~~~ 816 (825)
|+||||.|-+...+.+
T Consensus 253 I~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDM 268 (1039)
T ss_pred eecccceeccCCCCcc
Confidence 9999999988776544
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=198.34 Aligned_cols=147 Identities=24% Similarity=0.456 Sum_probs=127.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc----------hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ----------GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
|...+.||+|+||.||+|....+|+.||||.++.... ...+.+.+|++++++++|||+++++++|.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 78 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---- 78 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec----
Confidence 5677899999999999999888899999998864211 11346788999999999999999999854
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
+.+..++||||+++|+|.+++... ..+++..+..++.|++.|+.|||+. +++||||||+||+++
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~ 142 (272)
T cd06629 79 -TEEYLSIFLEYVPGGSIGSCLRTY------------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVD 142 (272)
T ss_pred -cCCceEEEEecCCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEc
Confidence 356789999999999999998532 3578889999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 003368 795 NNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~ 811 (825)
+++.+|++|||+++...
T Consensus 143 ~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 143 ADGICKISDFGISKKSD 159 (272)
T ss_pred CCCeEEEeecccccccc
Confidence 99999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=205.33 Aligned_cols=154 Identities=26% Similarity=0.403 Sum_probs=131.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|...+.||+|+||.||+|+...+|+.||||.+.... ......+.+|++++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999998899999999986432 2334568899999999999999999998765444445568
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++|+||+++ ++.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 84 ~lv~e~~~~-~l~~~~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-------------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred EEEehhccc-CHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence 999999974 78777632 2588899999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++....
T Consensus 147 l~dfg~~~~~~~ 158 (336)
T cd07849 147 ICDFGLARIADP 158 (336)
T ss_pred ECcccceeeccc
Confidence 999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=197.88 Aligned_cols=149 Identities=29% Similarity=0.388 Sum_probs=130.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+|+..+.||+|+||.||+|+...+++.||+|.+..... ...+.+.+|++++++++||||+++++++ .+++..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 47788999999999999999988899999999975432 3456889999999999999999999874 456789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++|+||+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++.+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~ 140 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK------------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVH 140 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEE
Confidence 9999999999999998422 3678889999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
++|||++.....
T Consensus 141 l~d~~~~~~~~~ 152 (258)
T cd05578 141 ITDFNIATKVTP 152 (258)
T ss_pred EeecccccccCC
Confidence 999999887544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=199.17 Aligned_cols=161 Identities=28% Similarity=0.450 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.+|...+.||+|+||.||+|... .++..||+|.+........+.|.+|++++++++||||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence 35677889999999999999742 356789999988665556678999999999999999999999853 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCc---ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTD---EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
+..++||||+++|+|.++++........ ........++|.++..++.|++.|++|||+. +|+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 6689999999999999998643210000 0011124589999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 003368 795 NNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~ 811 (825)
+++.+||+|||+++.+.
T Consensus 157 ~~~~~kL~dfg~~~~~~ 173 (280)
T cd05092 157 QGLVVKIGDFGMSRDIY 173 (280)
T ss_pred CCCCEEECCCCceeEcC
Confidence 99999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=200.76 Aligned_cols=145 Identities=26% Similarity=0.377 Sum_probs=127.1
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
....||+|+||.||+|....+|+.||||.+........+.+.+|+.++++++|||++++++++. .++..++||||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEec
Confidence 3467999999999999998899999999986554455667899999999999999999999853 46789999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++++|.+++.. ..+++.....++.|++.|++|||+. +++||||||+||++++++.++|+|||+
T Consensus 99 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~ 162 (292)
T cd06657 99 LEGGALTDIVTH-------------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGF 162 (292)
T ss_pred CCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccc
Confidence 999999988732 2478889999999999999999985 899999999999999999999999999
Q ss_pred cccccc
Q 003368 807 ARLRQE 812 (825)
Q Consensus 807 a~~~~~ 812 (825)
+.....
T Consensus 163 ~~~~~~ 168 (292)
T cd06657 163 CAQVSK 168 (292)
T ss_pred ceeccc
Confidence 876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=197.43 Aligned_cols=159 Identities=28% Similarity=0.481 Sum_probs=126.9
Q ss_pred ccccceeccCCeeEEEEEEEcC---CCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC-C
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN-D 718 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~-~ 718 (825)
|...++||+|+||.||+|.+.. +++.||||++.... ....+++.+|++++++++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567889999999999998643 57899999987543 2345678899999999999999999998653211111 1
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++++||+++|+|.+++..... ......+++.....++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~ 151 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRI------GEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMT 151 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcc------cCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCC
Confidence 34789999999999988753211 11123578899999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+|++|||+++....
T Consensus 152 ~kl~dfg~~~~~~~ 165 (273)
T cd05074 152 VCVADFGLSKKIYS 165 (273)
T ss_pred EEECcccccccccC
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=203.60 Aligned_cols=162 Identities=25% Similarity=0.415 Sum_probs=129.7
Q ss_pred ccccccceeccCCeeEEEEEEEcC-------CCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
.+|...+.||+|+||.||+|+... .+..||+|.+..... ...+++.+|+++++++ +||||++++++|..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 357788999999999999998632 224799998875432 3356789999999999 79999999998643
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
++..++||||+++|+|.+++......... ........++|.+++.++.|++.|++|||+. +|+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 55789999999999999998643210000 0011234689999999999999999999985 9999999999
Q ss_pred CeeecCCCcEEEcccCccccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~ 812 (825)
||++++++.+||+|||+++....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHN 186 (334)
T ss_pred eEEEcCCCcEEECCcccceeccc
Confidence 99999999999999999986644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=202.30 Aligned_cols=153 Identities=25% Similarity=0.354 Sum_probs=121.4
Q ss_pred cceeccCCeeEEEEEEEcC--CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 648 THLIGIGSFGSVYKGTFDR--DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~--~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
...||+|+||.||+|+... ++..||+|.+.... ....+.+|++++++++||||+++++++.. ..+...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence 4689999999999999743 56789999886542 23567899999999999999999998643 23556899999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCcEEE
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHV 801 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl----~~~~~~ki 801 (825)
|+++ +|.+++....... .......+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK---ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred eeCC-cHHHHHHhhhccc---cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9875 7877774321110 011223588999999999999999999985 89999999999999 56679999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 154 ~DfG~a~~~~~ 164 (317)
T cd07867 154 ADMGFARLFNS 164 (317)
T ss_pred eeccceeccCC
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=195.83 Aligned_cols=150 Identities=33% Similarity=0.578 Sum_probs=129.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|.. .+++.||||.+.... ...+++.+|++++++++||||+++++++. .....+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEE-cCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 45688899999999999999998 466889999987543 23467899999999999999999999843 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ....++|.++..++.|++.|++|||+. +|+||||||+||++++++.+|+
T Consensus 78 ~v~e~~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l 144 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG----------EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKI 144 (261)
T ss_pred EEEeccCCCCHHHHHhcc----------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999998532 123589999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 145 ~d~g~~~~~~ 154 (261)
T cd05034 145 ADFGLARLIE 154 (261)
T ss_pred Cccccceecc
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=199.05 Aligned_cols=150 Identities=29% Similarity=0.410 Sum_probs=131.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 3677889999999999999998899999999997654 23356789999999999999999999985 3467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+ +++|.+++... ...+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.+|+
T Consensus 76 ~v~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE-----------ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred EEeccc-CCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEE
Confidence 999999 99999988532 14588999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 141 ~dfg~~~~~~~~ 152 (286)
T cd07832 141 ADFGLARLFSEE 152 (286)
T ss_pred eeeeecccccCC
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=199.32 Aligned_cols=155 Identities=23% Similarity=0.296 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||.|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++||||++++++|.. ......+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence 367888999999999999999988899999999875433 345678999999999999999999998743 2244689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ......+++.....++.|+++||+|||+. +++||||+|+||++++++.+||
T Consensus 78 lv~e~~~~~~L~~~l~~~--------~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l 146 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKV--------KKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKL 146 (287)
T ss_pred EEEEecCCCCHHHHHHHH--------HhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEE
Confidence 999999999999887421 11224578889999999999999999985 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 147 ~dfg~~~~~~ 156 (287)
T cd06621 147 CDFGVSGELV 156 (287)
T ss_pred eecccccccc
Confidence 9999987643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=195.86 Aligned_cols=145 Identities=30% Similarity=0.468 Sum_probs=125.2
Q ss_pred ceeccCCeeEEEEEEEcC-CC--eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDR-DG--TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~-~g--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+.|.+|++++++++||||+++++++. + ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999854 33 3699999987655 55678999999999999999999999853 2 6789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++.... ...++|.....++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 75 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~df 141 (257)
T cd05040 75 ELAPLGSLLDRLRKDA----------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDF 141 (257)
T ss_pred EecCCCcHHHHHHhcc----------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccc
Confidence 9999999999985321 13689999999999999999999985 9999999999999999999999999
Q ss_pred Cccccccc
Q 003368 805 GLARLRQE 812 (825)
Q Consensus 805 Gla~~~~~ 812 (825)
|+++....
T Consensus 142 g~~~~~~~ 149 (257)
T cd05040 142 GLMRALPQ 149 (257)
T ss_pred cccccccc
Confidence 99987754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.06 Aligned_cols=146 Identities=29% Similarity=0.546 Sum_probs=125.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|+. +++.||+|.++... ..+.+.+|++++++++|||++++++++.. +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence 4578889999999999999985 77899999986542 34678999999999999999999998532 34689
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 76 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~ 142 (254)
T cd05083 76 VMELMSKGNLVNFLRTR----------GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVS 142 (254)
T ss_pred EEECCCCCCHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEEC
Confidence 99999999999998532 123578999999999999999999985 99999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 143 Dfg~~~~~~ 151 (254)
T cd05083 143 DFGLARVGS 151 (254)
T ss_pred CCccceecc
Confidence 999998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=198.14 Aligned_cols=143 Identities=24% Similarity=0.337 Sum_probs=123.6
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||+||+|....+|+.||+|.+.... ....+.+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999998899999999987532 22344677899999999999999999874 3466789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ....+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+|++|||++
T Consensus 76 ~~~~L~~~l~~~----------~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~ 142 (277)
T cd05577 76 NGGDLKYHIYNV----------GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA 142 (277)
T ss_pred CCCcHHHHHHHc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcch
Confidence 999999998532 113588999999999999999999985 9999999999999999999999999999
Q ss_pred cccc
Q 003368 808 RLRQ 811 (825)
Q Consensus 808 ~~~~ 811 (825)
+...
T Consensus 143 ~~~~ 146 (277)
T cd05577 143 VELK 146 (277)
T ss_pred hhhc
Confidence 8764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-21 Score=200.36 Aligned_cols=144 Identities=24% Similarity=0.373 Sum_probs=121.3
Q ss_pred ceeccCCeeEEEEEEEcCCCe-------EEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 649 HLIGIGSFGSVYKGTFDRDGT-------IVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~-------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.||+|+||.||+|..+..+. .||+|.+........+++.+|+.+++.++|||||++++++. .++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence 468999999999999855443 48889887655555678899999999999999999999864 345689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT--- 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~--- 798 (825)
+||||+++|+|.++++.. ...++|..+..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~ 141 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN-----------KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKT 141 (258)
T ss_pred EEEecCCCCcHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEeccccccc
Confidence 999999999999998643 12578999999999999999999985 9999999999999987765
Q ss_pred -----EEEcccCcccccc
Q 003368 799 -----AHVGDFGLARLRQ 811 (825)
Q Consensus 799 -----~ki~DFGla~~~~ 811 (825)
+|++|||++....
T Consensus 142 ~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 142 GNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCceEEecccccccccC
Confidence 6999999987554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=201.18 Aligned_cols=152 Identities=28% Similarity=0.373 Sum_probs=131.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch---hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||.||+|....+++.||||.+...... ..+.+.+|++++++++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 3678889999999999999999888999999999765322 345788999999999999999999885 34667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.+++... ....+++..+..++.|+++||+|||.. +++||||||+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~----------~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 142 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ----------PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHI 142 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC----------CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCE
Confidence 89999999999999998532 123588899999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
+|+|||+++....
T Consensus 143 ~l~dfg~~~~~~~ 155 (316)
T cd05574 143 MLSDFDLSKQSDV 155 (316)
T ss_pred EEeecchhhcccc
Confidence 9999999886543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=213.53 Aligned_cols=152 Identities=20% Similarity=0.321 Sum_probs=121.6
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCC------CceeEeecccc
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHR------NLVRVITSCSS 711 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~ 711 (825)
+...+++|...++||+|+||+||+|++..+++.||||+++... ...+++..|++++.+++|+ +++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999998899999999996432 2234556677777776554 57888887532
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
+....++|||++ +++|.+++... ..+++..+..|+.|++.||+|||+. .+||||||||+||
T Consensus 203 ----~~~~~~iv~~~~-g~~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NI 263 (467)
T PTZ00284 203 ----ETGHMCIVMPKY-GPCLLDWIMKH------------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENI 263 (467)
T ss_pred ----CCceEEEEEecc-CCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHE
Confidence 245689999988 77898888422 3688999999999999999999973 3899999999999
Q ss_pred eecCCC----------------cEEEcccCcccc
Q 003368 792 LLDNNL----------------TAHVGDFGLARL 809 (825)
Q Consensus 792 Ll~~~~----------------~~ki~DFGla~~ 809 (825)
|++.++ .+||+|||.+..
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~ 297 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCcccc
Confidence 998765 499999998864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=203.85 Aligned_cols=156 Identities=25% Similarity=0.363 Sum_probs=130.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.+.|...+.||+|+||+||+|+...+|+.||||.+.... ......+.+|++++++++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999998899999999987532 223456778999999999999999999865422222245
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS------------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCE
Confidence 799999996 6888887422 3588899999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+++.....
T Consensus 148 kL~Dfg~~~~~~~~ 161 (337)
T cd07858 148 KICDFGLARTTSEK 161 (337)
T ss_pred EECcCccccccCCC
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=208.66 Aligned_cols=169 Identities=20% Similarity=0.253 Sum_probs=125.8
Q ss_pred hcccccccceeccCCeeEEEEEEEc----------------CCCeEEEEEEeecccchhHHH--------------HHHH
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFD----------------RDGTIVAIKVLNLQLQGASKS--------------FAAE 690 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~E 690 (825)
..++|+..++||+|+||+||+|.+. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 345689999987544332233 3457
Q ss_pred HHHhhcCCCCCc-----eeEeeccccccc---CCCCeeeEEEEccCCCChhhhccCCCCCCCc------------ccchh
Q 003368 691 CRALRNIRHRNL-----VRVITSCSSIDF---QGNDFKALVYQYMPNGSLENWLHPDAIPQTD------------EENDE 750 (825)
Q Consensus 691 ~~~l~~l~H~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------~~~~~ 750 (825)
+.++.+++|.++ ++++++|..... ...+..+|||||+++|+|.++++........ .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877655 677777754211 1234579999999999999999753211100 00011
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 751 ~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
...++|..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~ 361 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT 361 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCcccccc
Confidence 23468889999999999999999985 899999999999999999999999999986543
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=195.56 Aligned_cols=146 Identities=25% Similarity=0.460 Sum_probs=126.2
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+|...+.||+|+||+||+|.. .+|+.||||.+..... ...+.+.+|++++++++|+||++++++|. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 366788999999999999987 6889999999864321 12346889999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ..+++..+..++.|++.|++|||+. +|+|+||||+||++++++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 139 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF------------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNG 139 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCC
Confidence 7889999999999999998432 3578889999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccc
Q 003368 798 TAHVGDFGLARLR 810 (825)
Q Consensus 798 ~~ki~DFGla~~~ 810 (825)
.+||+|||+++..
T Consensus 140 ~~~l~dfg~~~~~ 152 (265)
T cd06631 140 IIKLIDFGCARRL 152 (265)
T ss_pred eEEeccchhhHhh
Confidence 9999999998865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=196.76 Aligned_cols=142 Identities=25% Similarity=0.287 Sum_probs=116.7
Q ss_pred eeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhh---cCCCCCceeEeecccccccCCCCeeeEE
Q 003368 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALR---NIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+||+|+||.||+|....+|+.||||.+..... ...+.+.+|..+++ ..+||||+.+++++. .++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 48999999999999988899999999865422 12233445544333 347999999988743 35678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++|+|.+++... ..++|..+..|+.|++.|++|||+. +|+||||||+||++++++.+|++|
T Consensus 76 ~e~~~~~~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~d 140 (279)
T cd05633 76 LDLMNGGDLHYHLSQH------------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD 140 (279)
T ss_pred EecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEcc
Confidence 9999999999888422 3589999999999999999999985 899999999999999999999999
Q ss_pred cCcccccc
Q 003368 804 FGLARLRQ 811 (825)
Q Consensus 804 FGla~~~~ 811 (825)
||+++...
T Consensus 141 fg~~~~~~ 148 (279)
T cd05633 141 LGLACDFS 148 (279)
T ss_pred CCcceecc
Confidence 99987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=192.04 Aligned_cols=151 Identities=32% Similarity=0.463 Sum_probs=132.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|++|.||+|+...+++.||||.+..... ...+.+.+|++++++++|||++++++++. .+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 36778999999999999999988899999999976543 34567999999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ..++|..+..++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 76 IILEYAENGSLRQIIKKF------------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred EEEecCCCCcHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEE
Confidence 999999999999988422 4689999999999999999999985 9999999999999999999999
Q ss_pred cccCcccccccCC
Q 003368 802 GDFGLARLRQEVP 814 (825)
Q Consensus 802 ~DFGla~~~~~~~ 814 (825)
+|||+++......
T Consensus 141 ~d~~~~~~~~~~~ 153 (254)
T cd06627 141 ADFGVATKLNDVS 153 (254)
T ss_pred eccccceecCCCc
Confidence 9999999765543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=198.83 Aligned_cols=158 Identities=30% Similarity=0.455 Sum_probs=131.4
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc----
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID---- 713 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 713 (825)
.+.++|+..+.||+|+||.||+|....+|+.||||.++... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34577899999999999999999998899999999997543 223456788999999999999999999865321
Q ss_pred -cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 714 -FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 714 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
..+....++|+||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nil 148 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-----------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNIL 148 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 1123478999999986 677666421 23589999999999999999999985 9999999999999
Q ss_pred ecCCCcEEEcccCccccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~ 812 (825)
+++++.+||+|||+++....
T Consensus 149 i~~~~~~kl~dfg~~~~~~~ 168 (302)
T cd07864 149 LNNKGQIKLADFGLARLYNS 168 (302)
T ss_pred ECCCCcEEeCcccccccccC
Confidence 99999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=199.44 Aligned_cols=153 Identities=29% Similarity=0.406 Sum_probs=129.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|+...+|+.||+|.++.... .....+.+|++++++++|+||+++++++.. ...+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence 4678999999999999999999988999999999875432 223356789999999999999999998542 12346
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+.+ +|.+++... ...++|.++..++.|+++|++|||+. +++||||||+||++++++.+
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~-----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 147 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNM-----------PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCL 147 (309)
T ss_pred EEEEEecCCC-CHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 7999999974 888887432 14689999999999999999999986 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 148 kL~dfg~~~~~~~ 160 (309)
T cd07845 148 KIADFGLARTYGL 160 (309)
T ss_pred EECccceeeecCC
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=204.08 Aligned_cols=150 Identities=31% Similarity=0.480 Sum_probs=128.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-C-----CCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-H-----RNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~~ 717 (825)
.|...++||+|+||+|.||....+++.||||+++.... -.++...|+.+|..++ | -|+|+++++ |...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence 57889999999999999999999999999999986633 3355678999999987 4 689999998 5567
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN- 796 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~- 796 (825)
++.|||+|.++. +|+++++.. ....++......|+.||+.||.+||+. +|||+||||+||||.+.
T Consensus 261 ~HlciVfELL~~-NLYellK~n----------~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNN----------KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK 326 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence 899999999865 999999654 234688999999999999999999986 99999999999999653
Q ss_pred -CcEEEcccCcccccccC
Q 003368 797 -LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 -~~~ki~DFGla~~~~~~ 813 (825)
..+||+|||.|....+.
T Consensus 327 r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR 344 (586)
T ss_pred cCceeEEecccccccCCc
Confidence 48999999999876443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=197.42 Aligned_cols=149 Identities=26% Similarity=0.343 Sum_probs=126.5
Q ss_pred cccccceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
+|+..+.||+|+||.||+|+.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 3677889999999999999874 478999999987532 12346788999999999 599999998873 4
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.+...++||||+++|+|.+++... ..+++.+...++.|+++||+|||+. +++||||||+||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~ 140 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQR------------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDS 140 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECC
Confidence 466789999999999999998532 3577888899999999999999985 8999999999999999
Q ss_pred CCcEEEcccCccccccc
Q 003368 796 NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~ 812 (825)
++.+||+|||+++....
T Consensus 141 ~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 141 NGHVVLTDFGLSKEFHE 157 (290)
T ss_pred CCCEEEeeCccceeccc
Confidence 99999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=193.18 Aligned_cols=150 Identities=31% Similarity=0.556 Sum_probs=129.3
Q ss_pred cccceeccCCeeEEEEEEEcCCC----eEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
...+.||+|+||.||+|+...++ ..||+|.+...... ..+.+..|++.+..++|+||+++++++. ..+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 45688999999999999997665 89999999765443 4678999999999999999999999854 34678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++++|.+++... ....+++.++..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 77 ~~i~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~ 143 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKN----------RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143 (258)
T ss_pred EEEEeccCCCCHHHHHHhh----------hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEE
Confidence 9999999999999998532 111289999999999999999999985 999999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
++|||+++.....
T Consensus 144 l~dfg~~~~~~~~ 156 (258)
T smart00219 144 ISDFGLSRDLYDD 156 (258)
T ss_pred EcccCCceecccc
Confidence 9999999876544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=194.14 Aligned_cols=152 Identities=25% Similarity=0.380 Sum_probs=129.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|...+.||+|+||.||+|....+|..||+|.+.... ....+.+.+|++++++++|+||++++++|. ..+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence 4677899999999999999998899999999987542 123457889999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~k 800 (825)
+|+||+++++|.+++... ....++|..+..++.|+++|++|||+. +++|||+||+||++++++ .+|
T Consensus 76 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~ 142 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ----------RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAK 142 (257)
T ss_pred EEEecCCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEE
Confidence 999999999999998532 122578999999999999999999985 899999999999999875 569
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
++|||.+......
T Consensus 143 l~d~~~~~~~~~~ 155 (257)
T cd08225 143 LGDFGIARQLNDS 155 (257)
T ss_pred ecccccchhccCC
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=198.38 Aligned_cols=151 Identities=29% Similarity=0.408 Sum_probs=129.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+|.+..+++.||||.++... ....+.+.+|++++++++|+||+++++++. .++..+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEEE
Confidence 5788899999999999999998889999999987542 233467899999999999999999999864 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++++.+..+... ...+++.++..++.||+.|++|||+. +++|||++|+||++++++.+||
T Consensus 77 iv~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 77 LVFEYVERTLLELLEAS------------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred EEEecCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 99999998777655421 13478899999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccCC
Q 003368 802 GDFGLARLRQEVP 814 (825)
Q Consensus 802 ~DFGla~~~~~~~ 814 (825)
+|||+++......
T Consensus 142 ~d~g~~~~~~~~~ 154 (288)
T cd07833 142 CDFGFARALRARP 154 (288)
T ss_pred EeeecccccCCCc
Confidence 9999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=193.17 Aligned_cols=150 Identities=27% Similarity=0.510 Sum_probs=127.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|.. ..+..||+|.+... ....+.|.+|++++++++|+||+++.+++. . ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeE
Confidence 35688899999999999999987 46677999988654 223467899999999999999999998753 2 4579
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ....++|.+++.++.|++.|++|||+. +++||||||+||+++.++.+|+
T Consensus 77 ~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l 143 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD----------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI 143 (260)
T ss_pred EEEEeCCCCcHHHHHHhC----------CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence 999999999999998532 123578899999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||.++....
T Consensus 144 ~d~~~~~~~~~ 154 (260)
T cd05073 144 ADFGLARVIED 154 (260)
T ss_pred CCCcceeeccC
Confidence 99999986543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-20 Score=194.99 Aligned_cols=142 Identities=30% Similarity=0.433 Sum_probs=124.3
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||.||+|+...+|+.||+|.+..... ...+.+.+|++++++++||||+++++.+ .++...++||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999988899999999875433 3456788999999999999999998874 4467789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.+|++|||++
T Consensus 76 ~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~ 140 (265)
T cd05579 76 PGGDLASLLENV------------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLS 140 (265)
T ss_pred CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccc
Confidence 999999998532 3688999999999999999999985 8999999999999999999999999998
Q ss_pred ccccc
Q 003368 808 RLRQE 812 (825)
Q Consensus 808 ~~~~~ 812 (825)
+....
T Consensus 141 ~~~~~ 145 (265)
T cd05579 141 KVGLV 145 (265)
T ss_pred hhccc
Confidence 86543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=196.19 Aligned_cols=153 Identities=28% Similarity=0.416 Sum_probs=134.1
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
..++.|+..+.+|+|+||.||+|.+..+++.||+|.+..... ..+.+.+|++++++++|+|++++++++.. ++.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence 456678888999999999999999987899999999976544 45678999999999999999999998643 577
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++|+||+++++|.+++... ...+++.++..++.|++.|++|||.. +|+|+|+||+||+++.++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----------~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~ 155 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQN-----------FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSV 155 (286)
T ss_pred EEEEEeccCCCcHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCE
Confidence 89999999999999998532 13689999999999999999999985 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||++.....
T Consensus 156 ~l~d~~~~~~~~~ 168 (286)
T cd06614 156 KLADFGFAAQLTK 168 (286)
T ss_pred EECccchhhhhcc
Confidence 9999998876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=192.08 Aligned_cols=143 Identities=31% Similarity=0.544 Sum_probs=124.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
++||+|+||.||+|.... ++.||+|.+...... ..+.|.+|++++++++||||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence 468999999999999865 999999998765443 4568999999999999999999999853 356789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++++|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~l~~~l~~~-----------~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 140 (251)
T cd05041 75 PGGSLLTFLRKK-----------KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS 140 (251)
T ss_pred CCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccc
Confidence 999999998532 12578889999999999999999985 8999999999999999999999999999
Q ss_pred cccc
Q 003368 808 RLRQ 811 (825)
Q Consensus 808 ~~~~ 811 (825)
+...
T Consensus 141 ~~~~ 144 (251)
T cd05041 141 REEE 144 (251)
T ss_pred cccc
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=196.34 Aligned_cols=151 Identities=26% Similarity=0.414 Sum_probs=125.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|++|.||+|+...+|+.||||.+..... ...+.+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 468888999999999999999988999999999865422 23457889999999999999999999853 46689
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTA 799 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ 799 (825)
++||||++ +++.+++... ....+++.....++.|++.||+|||+. +|+||||||+||++++ ++.+
T Consensus 77 ~lv~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS----------PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred EEEEeccc-ccHHHHHHhC----------CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEE
Confidence 99999996 5888777422 112357778889999999999999985 8999999999999985 5679
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 143 kl~dfg~~~~~~~ 155 (294)
T PLN00009 143 KLADFGLARAFGI 155 (294)
T ss_pred EEcccccccccCC
Confidence 9999999986543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=194.53 Aligned_cols=142 Identities=24% Similarity=0.284 Sum_probs=117.0
Q ss_pred eeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHH---HhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECR---ALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+||+|+||.||+|+...+|+.||||.+..... .....+..|.. .++...||+|+++.+++ .+.+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 48999999999999988899999999875422 11223444433 44456799999998874 446788999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
|||+++|+|.+++... ..++|..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|
T Consensus 76 ~e~~~g~~L~~~l~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~d 140 (278)
T cd05606 76 LDLMNGGDLHYHLSQH------------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD 140 (278)
T ss_pred EecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEcc
Confidence 9999999999888422 3689999999999999999999985 899999999999999999999999
Q ss_pred cCcccccc
Q 003368 804 FGLARLRQ 811 (825)
Q Consensus 804 FGla~~~~ 811 (825)
||+++...
T Consensus 141 fg~~~~~~ 148 (278)
T cd05606 141 LGLACDFS 148 (278)
T ss_pred CcCccccC
Confidence 99988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.3e-20 Score=192.86 Aligned_cols=154 Identities=27% Similarity=0.394 Sum_probs=132.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||+||+|....++..||+|++.... ....+.+.+|++.++.++|+|++++++.+ ..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence 46888999999999999999998889999999986543 23456789999999999999999999875 3466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++.... ....+++.....++.|++.|++|||+. +|+||||||+||++++++.+|+
T Consensus 76 iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l 143 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSY---------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKI 143 (267)
T ss_pred EEEeccCCCcHHHHHHHhc---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEE
Confidence 9999999999999985321 113578999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||++..+...
T Consensus 144 ~df~~~~~~~~~ 155 (267)
T cd06610 144 ADFGVSASLADG 155 (267)
T ss_pred cccchHHHhccC
Confidence 999998876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=201.74 Aligned_cols=154 Identities=27% Similarity=0.396 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|....+|+.||+|++..... ...+.+.+|++++++++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 3678889999999999999999988999999999875432 33456788999999999999999998754321 23456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~ 146 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD------------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCEL 146 (334)
T ss_pred EEEEEehhh-hhHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 899999995 6898888532 3488999999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 147 kl~dfg~~~~~~~ 159 (334)
T cd07855 147 RIGDFGMARGLSS 159 (334)
T ss_pred Eecccccceeecc
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=196.00 Aligned_cols=171 Identities=25% Similarity=0.314 Sum_probs=139.4
Q ss_pred cHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcC-CCCCceeEeecc
Q 003368 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNI-RHRNLVRVITSC 709 (825)
Q Consensus 634 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 709 (825)
+-.+..+++ +|.-..+||+|+||+|..|..+.+.+.+|||++++... .+.+--..|-++++-- +-|.+|++..+
T Consensus 341 ~~~d~i~~t-DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc- 418 (683)
T KOG0696|consen 341 SKRDRIKAT-DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC- 418 (683)
T ss_pred Ccccceeec-ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-
Confidence 333444444 58889999999999999999999999999999987642 1222234566777655 57888888876
Q ss_pred cccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 710 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
|+.-+.+|.||||+.||+|.-+++ ..+.+.++.++.+|.+||-||-|||+. +||+||+|..
T Consensus 419 ----FQTmDRLyFVMEyvnGGDLMyhiQ------------Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLD 479 (683)
T KOG0696|consen 419 ----FQTMDRLYFVMEYVNGGDLMYHIQ------------QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLD 479 (683)
T ss_pred ----hhhhhheeeEEEEecCchhhhHHH------------HhcccCCchhhhhhHHHHHHhhhhhcC---Ceeeeecccc
Confidence 778889999999999999987773 345677888999999999999999985 9999999999
Q ss_pred CeeecCCCcEEEcccCcccccccCCCCCccccccCC
Q 003368 790 NILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
||++|.+|++||+|||++|.-.-+..-..+.+|||.
T Consensus 480 NvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPd 515 (683)
T KOG0696|consen 480 NVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPD 515 (683)
T ss_pred ceEeccCCceEeeecccccccccCCcceeeecCCCc
Confidence 999999999999999999976555555677899983
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-20 Score=195.59 Aligned_cols=148 Identities=28% Similarity=0.497 Sum_probs=127.5
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|++|.||+|....+|+.||||++.... ....+.+.+|++++++++|||++++++++. +++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 556789999999999999998899999999987543 223457889999999999999999999854 3578899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||++ ++|.+++... ....++|..+..++.|+++||+|||+. +++||||+|+||+++.++.+|++
T Consensus 76 v~e~~~-~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 141 (283)
T cd07835 76 VFEFLD-LDLKKYMDSS----------PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLA 141 (283)
T ss_pred EEeccC-cCHHHHHhhC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEe
Confidence 999995 6899988532 113589999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 142 df~~~~~~~ 150 (283)
T cd07835 142 DFGLARAFG 150 (283)
T ss_pred ecccccccC
Confidence 999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-21 Score=195.39 Aligned_cols=156 Identities=29% Similarity=0.435 Sum_probs=131.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-------hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
.|-..+++|+|+|+.||||.+....+.||||+-...... -.+...+|.++-+.+.||-||++|+++.. +
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl----D 539 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL----D 539 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee----c
Confidence 466678999999999999998888899999986543221 12456789999999999999999999642 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN- 795 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~- 795 (825)
.+..|-|.|||+|.+|+-||... +.+++.++..|+.||+.||.||.+- .+||||-|+||.|||+..
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh------------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G 606 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH------------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG 606 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh------------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence 45679999999999999999533 4688889999999999999999986 679999999999999953
Q ss_pred --CCcEEEcccCcccccccCCCC
Q 003368 796 --NLTAHVGDFGLARLRQEVPNN 816 (825)
Q Consensus 796 --~~~~ki~DFGla~~~~~~~~~ 816 (825)
.|.+||.|||++|+|+++...
T Consensus 607 tacGeIKITDFGLSKIMdddSy~ 629 (775)
T KOG1151|consen 607 TACGEIKITDFGLSKIMDDDSYN 629 (775)
T ss_pred cccceeEeeecchhhhccCCccC
Confidence 578999999999999876543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=197.42 Aligned_cols=149 Identities=32% Similarity=0.408 Sum_probs=127.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
..|+..+.||+|+||.||+|+...+|+.||+|.+.... ....+++.+|++++++++||||+++.++|.. .+.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 45788899999999999999998889999999986432 2334578899999999999999999998643 567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||++ |++.+++... ...+++.++..++.|++.|++|||+. +|+||||+|+||+++.++.+
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~ 154 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVH-----------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTV 154 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCE
Confidence 899999997 5776666321 23588999999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||+++...
T Consensus 155 kL~dfg~~~~~~ 166 (307)
T cd06607 155 KLADFGSASLVS 166 (307)
T ss_pred EEeecCcceecC
Confidence 999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=201.21 Aligned_cols=157 Identities=27% Similarity=0.330 Sum_probs=132.8
Q ss_pred ccHHHHHhhc---ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEe
Q 003368 633 VSYESLLKAT---DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVI 706 (825)
Q Consensus 633 ~~~~~~~~~~---~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~ 706 (825)
..|-.+++|. .-|-..+.||-|+||+|..+.-..+...||+|.+++... .+.....+|-.+|+.-..+-||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 3455555554 348888999999999999998878888999999987642 3344577899999999999999998
Q ss_pred ecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003368 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDL 786 (825)
Q Consensus 707 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdl 786 (825)
-. |++.+.+|.||||++||++...|... +-+.+.-+..++.+++.|+++.|.. ++|||||
T Consensus 696 yS-----FQDkdnLYFVMdYIPGGDmMSLLIrm------------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDi 755 (1034)
T KOG0608|consen 696 YS-----FQDKDNLYFVMDYIPGGDMMSLLIRM------------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDI 755 (1034)
T ss_pred EE-----eccCCceEEEEeccCCccHHHHHHHh------------ccCHHHHHHHHHHHHHHHHHHHHhc---cceeccc
Confidence 76 89999999999999999999988532 3466667778888999999999985 9999999
Q ss_pred CCCCeeecCCCcEEEcccCcccc
Q 003368 787 KPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 787 k~~NILl~~~~~~ki~DFGla~~ 809 (825)
||.|||||.+|++|+.||||+.=
T Consensus 756 KPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 756 KPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred CccceEEccCCceeeeecccccc
Confidence 99999999999999999999753
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=191.36 Aligned_cols=154 Identities=25% Similarity=0.440 Sum_probs=133.1
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||++....+++.||+|++..... ...+++.+|++++++++|||++++.+.+. ..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 46778899999999999999988899999999976533 45567899999999999999999998743 357889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+|+||+++++|.+++.... .....+++.++..++.++++|++|||+. +++|+||+|+||++++++.+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l 144 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK--------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKL 144 (258)
T ss_pred EEEEecCCCcHHHHHHHhh--------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEE
Confidence 9999999999999985421 1125689999999999999999999986 9999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||++......
T Consensus 145 ~d~~~~~~~~~~ 156 (258)
T cd08215 145 GDFGISKVLSST 156 (258)
T ss_pred CCccceeecccC
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=191.65 Aligned_cols=148 Identities=26% Similarity=0.487 Sum_probs=127.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+|+..+.||+|+||.||+|.+. .+..+|||.+..... ...+|.+|++++++++|||++++++++. .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence 45777899999999999999984 577899998865422 3467899999999999999999999853 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ...++|..+..++.+++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 77 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~ 142 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ-----------RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVS 142 (256)
T ss_pred EEEcCCCCcHHHHHHhC-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEEC
Confidence 99999999999998532 13578899999999999999999985 89999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||+++...
T Consensus 143 d~g~~~~~~ 151 (256)
T cd05112 143 DFGMTRFVL 151 (256)
T ss_pred CCcceeecc
Confidence 999988653
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-20 Score=192.35 Aligned_cols=143 Identities=24% Similarity=0.345 Sum_probs=125.1
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||.||+|+...+++.||||.+..... ...+.+.+|++++++++||||+++++++ .++...++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 6899999999999988899999999875432 3346789999999999999999999984 3456789999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++|+|.+++... ..+++..+..++.|+++|++|||+. +++|+||||+||+++.++.+|++|||++
T Consensus 76 ~~~~L~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~ 140 (262)
T cd05572 76 LGGELWTILRDR------------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFA 140 (262)
T ss_pred CCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcc
Confidence 999999998532 2478889999999999999999985 9999999999999999999999999999
Q ss_pred cccccC
Q 003368 808 RLRQEV 813 (825)
Q Consensus 808 ~~~~~~ 813 (825)
+.....
T Consensus 141 ~~~~~~ 146 (262)
T cd05572 141 KKLKSG 146 (262)
T ss_pred cccCcc
Confidence 977543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=193.45 Aligned_cols=155 Identities=25% Similarity=0.432 Sum_probs=127.5
Q ss_pred cccccceeccCCeeEEEEEEEcC-CCeEEEEEEeeccc----------chhHHHHHHHHHHhhc-CCCCCceeEeecccc
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDR-DGTIVAIKVLNLQL----------QGASKSFAAECRALRN-IRHRNLVRVITSCSS 711 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~-~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 711 (825)
+|+..+.||+|+||.||+|.+.. +++.||||.+.... ....+++.+|++++.+ ++||||++++++|.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 47778899999999999999976 67899999886432 1223457789988875 79999999999853
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
+++..++||||+++++|.+++... ......+++..+..++.|++.|++|||+. .+++||||||+||
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~ni 145 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSL--------KEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNI 145 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHH--------HhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHE
Confidence 467889999999999999887421 11224688899999999999999999963 3799999999999
Q ss_pred eecCCCcEEEcccCcccccccC
Q 003368 792 LLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~~ 813 (825)
+++.++.+|++|||+++.....
T Consensus 146 l~~~~~~~~l~dfg~~~~~~~~ 167 (269)
T cd08528 146 MLGEDDKVTITDFGLAKQKQPE 167 (269)
T ss_pred EECCCCcEEEecccceeecccc
Confidence 9999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-21 Score=208.52 Aligned_cols=164 Identities=27% Similarity=0.429 Sum_probs=146.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|.....+|+|+||.||||+.+.+++.+|||.++........-.++|+-+++.++|||||.++|.+.. .+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcCc
Confidence 45678889999999999999999999999999999998877677778899999999999999999998543 5678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|++|||+.+|+|++..+.. ..+++.+...+++...+|++|||+. +-+|||||-.|||+.+.|.+|
T Consensus 88 wicMEycgggslQdiy~~T------------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvk 152 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT------------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVK 152 (829)
T ss_pred EEEEEecCCCcccceeeec------------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCcee
Confidence 9999999999999988754 4788889999999999999999985 778999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++|||.+..+...-....++.||+
T Consensus 153 laDfgvsaqitati~KrksfiGtp 176 (829)
T KOG0576|consen 153 LADFGVSAQITATIAKRKSFIGTP 176 (829)
T ss_pred ecccCchhhhhhhhhhhhcccCCc
Confidence 999999988877666667778886
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=197.72 Aligned_cols=155 Identities=28% Similarity=0.414 Sum_probs=127.7
Q ss_pred cccccceeccCCeeEEEEEEEcC--CCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDR--DGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~--~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.|+..+.||+|+||.||+|+... +++.||||.+.... ....+.+.+|++++++++||||++++++|.. ..+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence 36778899999999999999977 78999999997633 3345678899999999999999999998653 2236
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN--- 795 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~--- 795 (825)
..++||||+++ ++.+++..... .....+++.....|+.|++.|++|||+. +|+||||||+||+++.
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~ 146 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ-------AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGP 146 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc-------CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCC
Confidence 78999999975 67766642210 1113678889999999999999999985 8999999999999999
Q ss_pred -CCcEEEcccCccccccc
Q 003368 796 -NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 -~~~~ki~DFGla~~~~~ 812 (825)
++.+||+|||+++....
T Consensus 147 ~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 147 ERGVVKIGDLGLARLFNA 164 (316)
T ss_pred ccceEEECCCccccccCC
Confidence 99999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=199.05 Aligned_cols=162 Identities=24% Similarity=0.369 Sum_probs=133.5
Q ss_pred cHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccc
Q 003368 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSS 711 (825)
Q Consensus 634 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 711 (825)
...++...+++|...+.||+|+||.||+|....+|+.||||++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34456667899999999999999999999988899999999987532 2234568889999999999999999987643
Q ss_pred cc-cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 712 ID-FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 712 ~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
.. +......++|++++ +++|.+++.. ..++|..+..++.|+++|++|||+. +|+||||||+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~N 150 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSN 150 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHH
Confidence 11 12234467888876 7899887742 2578999999999999999999985 89999999999
Q ss_pred eeecCCCcEEEcccCccccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~ 812 (825)
|++++++.+||+|||+++....
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred EEEcCCCCEEEecccccccccc
Confidence 9999999999999999986543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=198.70 Aligned_cols=161 Identities=20% Similarity=0.308 Sum_probs=135.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh--------HHHHHHHHHHhhcCC---CCCceeEeeccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--------SKSFAAECRALRNIR---HRNLVRVITSCS 710 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l~---H~niv~l~~~~~ 710 (825)
..+|...+.+|+|+||+|+.|.+++...+|+||.+.+++--. .-..-.||++|+.++ |+||++++.+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-- 637 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-- 637 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe--
Confidence 356888999999999999999999999999999997654211 112346999999998 9999999998
Q ss_pred ccccCCCCeeeEEEEcc-CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 711 SIDFQGNDFKALVYQYM-PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
|++++++||+||-. ++-+|.+++.. ...+++.++..|..||+-|+++||+. +|||||||-+
T Consensus 638 ---FEddd~yyl~te~hg~gIDLFd~IE~------------kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikde 699 (772)
T KOG1152|consen 638 ---FEDDDYYYLETEVHGEGIDLFDFIEF------------KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDE 699 (772)
T ss_pred ---eecCCeeEEEecCCCCCcchhhhhhc------------cCccchHHHHHHHHHHHhcccccccc---Cceecccccc
Confidence 78899999999975 56688888832 35789999999999999999999986 9999999999
Q ss_pred CeeecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 790 NILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||.+|.+|-+|+.|||.|......+ -...+||.
T Consensus 700 nvivd~~g~~klidfgsaa~~ksgp--fd~f~gtv 732 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKSGP--FDVFVGTV 732 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcCCC--cceeeeec
Confidence 9999999999999999998765543 34556664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=184.24 Aligned_cols=140 Identities=16% Similarity=0.145 Sum_probs=106.5
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--h-------H-----------------HHHHHHHHHhhcCCCCC
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--A-------S-----------------KSFAAECRALRNIRHRN 701 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~n 701 (825)
...||+|+||.||+|... +|+.||||+++..... . . ....+|++.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999985 8999999999754221 0 0 12235999999998877
Q ss_pred ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHH-HhcCCCC
Q 003368 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYL-HHHCQEP 780 (825)
Q Consensus 702 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yL-H~~~~~~ 780 (825)
+.....+. ....++||||++++++..... ....+++.+...++.|++.+|+|+ |+. +
T Consensus 81 v~~p~~~~-------~~~~~iVmE~i~g~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~l~H~~---g 138 (190)
T cd05147 81 IPCPEPIL-------LKSHVLVMEFIGDDGWAAPRL------------KDAPLSESKARELYLQVIQIMRILYQDC---R 138 (190)
T ss_pred CCCCcEEE-------ecCCEEEEEEeCCCCCcchhh------------hcCCCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence 64322211 112389999999987654321 113578889999999999999999 453 8
Q ss_pred eeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 781 TIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 781 ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|+||||||+||++++ +.++++|||+|....
T Consensus 139 iiHrDlkP~NIli~~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 139 LVHADLSEYNLLYHD-GKLYIIDVSQSVEHD 168 (190)
T ss_pred cccCCCCHHHEEEEC-CcEEEEEccccccCC
Confidence 999999999999984 789999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=190.41 Aligned_cols=151 Identities=23% Similarity=0.434 Sum_probs=129.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+|....+++.||||.+.... ....+.+.+|++++++++|||++++++.+ ..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 3777899999999999999998899999999987542 23456789999999999999999999874 3467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CcEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-LTAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-~~~k 800 (825)
+||||+++++|.+++... ....+++..+..++.++++|++|||+. +|+||||||+||+++++ +.+|
T Consensus 76 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~ 142 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR----------CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVK 142 (256)
T ss_pred EEEecCCCCCHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 999999999999998532 123578999999999999999999985 99999999999999855 4689
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
++|||+++....
T Consensus 143 l~d~~~~~~~~~ 154 (256)
T cd08220 143 IGDFGISKILSS 154 (256)
T ss_pred EccCCCceecCC
Confidence 999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.2e-22 Score=189.71 Aligned_cols=153 Identities=25% Similarity=0.427 Sum_probs=125.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeeccccccc---CCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF---QGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~~ 718 (825)
.|.....||+|.||.||+|+.+.+|+.||+|++-.+ ..+-.....+|+.++..++|+|++.+++.|....- .+..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 355667899999999999999999999999876432 23334567899999999999999999999975221 2233
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||++|+. +|.-.|.. ...+++..+..+++.++..||.|+|.. .|+|||+||+|||++.++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn-----------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgi 162 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN-----------RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGI 162 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC-----------ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCce
Confidence 47999999986 66666632 224688889999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+||+|||+||...
T Consensus 163 lklADFGlar~fs 175 (376)
T KOG0669|consen 163 LKLADFGLARAFS 175 (376)
T ss_pred EEeecccccccee
Confidence 9999999997653
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.4e-20 Score=200.55 Aligned_cols=151 Identities=28% Similarity=0.435 Sum_probs=127.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|....+|+.||||++.... ......+.+|+++++++ +||||++++++|.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 456888899999999999999998889999999885432 22345677899999999 99999999998643 2234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~ 145 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRA-------------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCR 145 (337)
T ss_pred eEEEEecccc-cCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCc
Confidence 6799999997 599888742 1578889999999999999999985 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 146 ~kl~d~g~~~~~~~ 159 (337)
T cd07852 146 VKLADFGLARSLSE 159 (337)
T ss_pred EEEeeccchhcccc
Confidence 99999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-20 Score=194.12 Aligned_cols=150 Identities=29% Similarity=0.449 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+.||+|+||.||+|+...+|+.||+|++.... ....+.+.+|++++++++ ||||+++++++ .+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 36788899999999999999998899999999987532 233467889999999999 99999999874 4466
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++++|.+++... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~ 140 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY------------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMH 140 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCC
Confidence 789999999999999998432 3689999999999999999999985 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
++++|||+++....
T Consensus 141 ~~l~df~~~~~~~~ 154 (280)
T cd05581 141 IKITDFGTAKVLDP 154 (280)
T ss_pred EEecCCccccccCC
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=198.80 Aligned_cols=155 Identities=25% Similarity=0.365 Sum_probs=128.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~ 717 (825)
..++|+..+.||+|+||.||+|....+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999998899999999986432 223456889999999999999999999864311 1111
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-------------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 2468999999 7789887732 2578999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+|++|||+++....
T Consensus 156 ~~kl~dfg~~~~~~~ 170 (343)
T cd07880 156 ELKILDFGLARQTDS 170 (343)
T ss_pred CEEEeeccccccccc
Confidence 999999999987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=199.25 Aligned_cols=153 Identities=25% Similarity=0.307 Sum_probs=127.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.++|+..+.||+|+||.||+|+...+|+.||||.+.... ....+.+.+|++++++++||||+++++++.... +.+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467889999999999999999998899999999986432 233456788999999999999999999864311 12234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+. |+|.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence 5799999996 588777631 277888899999999999999985 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 157 ~kL~Dfg~~~~~~~ 170 (353)
T cd07850 157 LKILDFGLARTAGT 170 (353)
T ss_pred EEEccCccceeCCC
Confidence 99999999987644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=194.13 Aligned_cols=150 Identities=26% Similarity=0.350 Sum_probs=130.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+|+..+.||+|+||.||+|..+.+++.||+|.+..... ...+++.+|++++++++||||++++++|.. +...++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence 57778899999999999999988999999999876533 345678999999999999999999998543 577899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+||+++++|.+++... ...+++.....++.|++.|++|+|+. .+++||||||+||++++++.+||+
T Consensus 77 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 77 CMEYMDGGSLDKILKEV-----------QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEecCCCcHHHHHHHc-----------cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999998532 14678888999999999999999982 389999999999999999999999
Q ss_pred ccCcccccc
Q 003368 803 DFGLARLRQ 811 (825)
Q Consensus 803 DFGla~~~~ 811 (825)
|||.++...
T Consensus 144 d~g~~~~~~ 152 (265)
T cd06605 144 DFGVSGQLV 152 (265)
T ss_pred ecccchhhH
Confidence 999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=174.84 Aligned_cols=160 Identities=21% Similarity=0.278 Sum_probs=129.4
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
+..+.++....+.||+|+||+|-+-++..+|...|||+++.... +..+...+|+.+..+. ..|.+|.++|+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~----- 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF----- 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----
Confidence 44445556667889999999999999999999999999986643 3345678888876655 5999999999842
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.+...++.||.|.. +|..+... .-.....+++...=+||..|..||.|||+. ..+||||+||+|||++.
T Consensus 116 regdvwIcME~M~t-Sldkfy~~--------v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRK--------VLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINY 184 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHH--------HHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEcc
Confidence 35568999999964 77766532 123345678888889999999999999996 68999999999999999
Q ss_pred CCcEEEcccCcccccccC
Q 003368 796 NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~ 813 (825)
+|.+||||||.+..+.+.
T Consensus 185 ~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 185 DGQVKICDFGISGYLVDS 202 (282)
T ss_pred CCcEEEcccccceeehhh
Confidence 999999999998877653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=194.06 Aligned_cols=150 Identities=32% Similarity=0.468 Sum_probs=123.6
Q ss_pred ceeccCCeeEEEEEEEcCCC------eEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 649 HLIGIGSFGSVYKGTFDRDG------TIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.||+|+||.||+|+..... +.||||.+.... ......|.+|++++++++||||++++++|. ..+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36899999999999975433 689999886543 234567899999999999999999999864 355689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL---- 797 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~---- 797 (825)
+||||+++|+|.+++...... ......++|.+++.++.|++.|++|||+. +++|+||||+||+++.+.
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~ 147 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVE-----RFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDAD 147 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhc-----ccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCC
Confidence 999999999999999643111 01223578999999999999999999975 899999999999999877
Q ss_pred -cEEEcccCcccccc
Q 003368 798 -TAHVGDFGLARLRQ 811 (825)
Q Consensus 798 -~~ki~DFGla~~~~ 811 (825)
.+|++|||+++...
T Consensus 148 ~~~~l~dfg~~~~~~ 162 (269)
T cd05044 148 RVVKIGDFGLARDIY 162 (269)
T ss_pred cceEECCcccccccc
Confidence 89999999998653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=187.37 Aligned_cols=151 Identities=30% Similarity=0.463 Sum_probs=133.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+|+..+.||+|++|.||+|....+++.||+|++........+.+.+|++.+++++||+++++++++. .....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4677889999999999999998889999999998765555678999999999999999999999853 35678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
+||+++++|.+++... ...+++.++..++.|++.|++|||.. +++||||+|+||++++++.+||+|
T Consensus 76 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d 141 (253)
T cd05122 76 MEFCSGGSLKDLLKST-----------NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLID 141 (253)
T ss_pred EecCCCCcHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEee
Confidence 9999999999998532 14689999999999999999999985 899999999999999999999999
Q ss_pred cCcccccccC
Q 003368 804 FGLARLRQEV 813 (825)
Q Consensus 804 FGla~~~~~~ 813 (825)
||.+......
T Consensus 142 ~~~~~~~~~~ 151 (253)
T cd05122 142 FGLSAQLSDT 151 (253)
T ss_pred cccccccccc
Confidence 9999877554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=185.15 Aligned_cols=152 Identities=28% Similarity=0.373 Sum_probs=126.6
Q ss_pred cccccc-cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSS-THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~-~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|++|.. .++||-|-.|+|..+.++.+|+.+|+|++... ....+|++.--+. .|||||++++.+.. .+++...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh-hccCcee
Confidence 455543 46899999999999999999999999988532 3446788765544 59999999998754 4677788
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---C
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---N 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~ 796 (825)
..+|||.|+||.|...+..+ ....+++.++..|+.||+.|+.|||+. .|.||||||+|+|... +
T Consensus 134 LLiVmE~meGGeLfsriq~~----------g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR----------GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred eEeeeecccchHHHHHHHHc----------ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence 89999999999999888532 335799999999999999999999986 8999999999999954 4
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
...|++|||+||.-++
T Consensus 201 a~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE 216 (400)
T ss_pred cceEecccccccccCC
Confidence 5789999999998653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=194.37 Aligned_cols=148 Identities=30% Similarity=0.406 Sum_probs=126.2
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|+..+.||+|+||.||+|+...+|+.||||.+.... ....+.+.+|++++++++|||+++++++|.. ++..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence 667789999999999999998899999999987432 2234578899999999999999999998643 56789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++ |++.+++... ...++|.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||
T Consensus 102 lv~e~~~-g~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl 166 (317)
T cd06635 102 LVMEYCL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL 166 (317)
T ss_pred EEEeCCC-CCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEE
Confidence 9999997 5777776421 23588999999999999999999985 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 167 ~dfg~~~~~~~ 177 (317)
T cd06635 167 ADFGSASIASP 177 (317)
T ss_pred ecCCCccccCC
Confidence 99999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=180.00 Aligned_cols=141 Identities=18% Similarity=0.129 Sum_probs=110.3
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--------------------------hHHHHHHHHHHhhcCCCCC
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--------------------------ASKSFAAECRALRNIRHRN 701 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~n 701 (825)
...||+|+||+||+|+.. +|+.||||+++..... ....+.+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999985 8999999998764211 0122467999999999998
Q ss_pred ceeEeecccccccCCCCeeeEEEEccCCCChhhh-ccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHh-cCCC
Q 003368 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENW-LHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHH-HCQE 779 (825)
Q Consensus 702 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~-~~~~ 779 (825)
+.....+.. ...++||||++++++... +. ...++..++..++.|++.++.|+|+ .
T Consensus 81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~-------------~~~~~~~~~~~i~~~l~~~l~~lH~~~--- 137 (190)
T cd05145 81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLK-------------DVPLEEEEAEELYEQVVEQMRRLYQEA--- 137 (190)
T ss_pred CCCceEEEe-------cCCEEEEEEecCCCchhhhhh-------------hccCCHHHHHHHHHHHHHHHHHHHHhC---
Confidence 754433311 124899999998865332 21 1245677889999999999999998 5
Q ss_pred CeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 780 PTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 780 ~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+|+||||||+||+++ ++.++++|||+|+.....
T Consensus 138 givHrDlkP~NIll~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 138 GLVHGDLSEYNILYH-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CEecCCCChhhEEEE-CCCEEEEEcccceecCCC
Confidence 999999999999999 789999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=194.71 Aligned_cols=156 Identities=26% Similarity=0.409 Sum_probs=128.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc---CC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF---QG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 716 (825)
.++|+..+.||+|+||.||+|+...+|+.||||.+..... .....+.+|++++++++||||++++++|..... ..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4568889999999999999999988999999999865432 223456789999999999999999998754221 11
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+.+ ++.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~ 155 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK-----------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKD 155 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCC
Confidence 2356999999964 788777421 13588999999999999999999986 89999999999999999
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
+.+||+|||+++....
T Consensus 156 ~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 156 GILKLADFGLARAFSL 171 (310)
T ss_pred CcEEECcCCCcccccC
Confidence 9999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=189.78 Aligned_cols=154 Identities=27% Similarity=0.396 Sum_probs=132.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|+..+.||+|+||.||+++...+|+.+|||.+.... .....++.+|++++++++||||+++++++. +....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4677889999999999999998899999999987543 233557889999999999999999998853 357789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++++|.+++... ......+++..+..++.|+++|++|||+. +++||||+|+||++++++.+|+
T Consensus 76 ~v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl 144 (256)
T cd08530 76 IVMEYAPFGDLSKAISKR--------KKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKI 144 (256)
T ss_pred EEehhcCCCCHHHHHHHH--------HhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEE
Confidence 999999999999998532 11234689999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 145 ~d~g~~~~~~~~ 156 (256)
T cd08530 145 GDLGISKVLKKN 156 (256)
T ss_pred eeccchhhhccC
Confidence 999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-21 Score=187.17 Aligned_cols=153 Identities=24% Similarity=0.276 Sum_probs=121.2
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+....||.|+||+|+|..++++|+..|||+++.... ...+++..|.++..+- +.||||+++|++.. + +-.|+
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----E-GdcWi 140 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----E-GDCWI 140 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----C-Cceee
Confidence 4456789999999999999999999999999987654 4456788888876554 58999999999743 3 44699
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
.||.|.- +++.+...- ..-....+++.-.-+|++...+||.||-+. ..|||||+||+|||+|..|.+|+|
T Consensus 141 CMELMd~-SlDklYk~v-------y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 141 CMELMDI-SLDKLYKRV-------YSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred eHHHHhh-hHHHHHHHH-------HHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeee
Confidence 9999954 665543210 011223567777778888889999999886 589999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||++..+.+
T Consensus 211 DFGIcGqLv~ 220 (361)
T KOG1006|consen 211 DFGICGQLVD 220 (361)
T ss_pred cccchHhHHH
Confidence 9999876654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=187.59 Aligned_cols=152 Identities=27% Similarity=0.419 Sum_probs=132.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|...+.||+|++|.||+|....+++.||||.+..... ...+.+.+|++++++++||||+++++.+... .....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence 36778999999999999999988899999999876542 3467889999999999999999999986431 126789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+|+||+++++|.+++... ..++|.++..++.|+++|++|||+. +++|+|++|+||+++.++.+||
T Consensus 78 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l 142 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF------------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKL 142 (260)
T ss_pred EEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence 999999999999998432 2789999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||.++.....
T Consensus 143 ~d~~~~~~~~~~ 154 (260)
T cd06606 143 ADFGCAKRLGDI 154 (260)
T ss_pred cccccEEecccc
Confidence 999999877654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-20 Score=183.51 Aligned_cols=165 Identities=22% Similarity=0.308 Sum_probs=142.5
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 716 (825)
..++|+..++||+|+|++|..++++.+.+.+|+|+++++. .++....+.|-.++.+- +||.+|.+..+ |+.
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence 3568999999999999999999999999999999998753 23344566777777665 69999999887 788
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
+...+.|.||++||+|.-++.. .+.+++..+..+..+|.-||.|||+. +||+||+|..|||+|..
T Consensus 323 esrlffvieyv~ggdlmfhmqr------------qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldae 387 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR------------QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAE 387 (593)
T ss_pred cceEEEEEEEecCcceeeehhh------------hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccC
Confidence 8999999999999999877743 35788888899999999999999985 99999999999999999
Q ss_pred CcEEEcccCcccccccCCCCCccccccCC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|++|+.|+|++|.--.+..-.++.+|||+
T Consensus 388 ghikltdygmcke~l~~gd~tstfcgtpn 416 (593)
T KOG0695|consen 388 GHIKLTDYGMCKEGLGPGDTTSTFCGTPN 416 (593)
T ss_pred CceeecccchhhcCCCCCcccccccCCCc
Confidence 99999999999977666666789999985
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-20 Score=210.52 Aligned_cols=167 Identities=20% Similarity=0.244 Sum_probs=121.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC-eEEEEEEe--------------ec---ccchhHHHHHHHHHHhhcCCCCCce
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG-TIVAIKVL--------------NL---QLQGASKSFAAECRALRNIRHRNLV 703 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g-~~vAvK~~--------------~~---~~~~~~~~~~~E~~~l~~l~H~niv 703 (825)
.++|...+.||+|+||+||+|..+... ..+++|.+ .+ ......+.+.+|++++++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999999864332 22222211 00 0112345688999999999999999
Q ss_pred eEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 003368 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIH 783 (825)
Q Consensus 704 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivH 783 (825)
++++++. ..+..|+|+|++. +++.+++....... .....+.+...|+.|++.||+|||+. +|||
T Consensus 227 ~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~-------~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiH 290 (501)
T PHA03210 227 KIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDW-------KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290 (501)
T ss_pred cEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhccccc-------cccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 9999853 4567899999985 57888775432111 11234556778999999999999985 8999
Q ss_pred cCCCCCCeeecCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 784 CDLKPSNILLDNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 784 rdlk~~NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
|||||+|||++.++.+||+|||+|+....... .....+||+
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~ 332 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCc
Confidence 99999999999999999999999987754322 223345553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-21 Score=200.83 Aligned_cols=163 Identities=23% Similarity=0.296 Sum_probs=140.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc---cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ---LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..+++....+|-|+||.|=..+.......+|+|++++. ...+.+....|-.+|..++.|.||++|.. |.+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccch
Confidence 34566677899999999999887555455899888754 23445678889999999999999999987 67788
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
+.|+.||-|-||.++..|+.+ +.++..++..|+..|.+|++|||+. +||+||+||+|.++|.+|-
T Consensus 494 yvYmLmEaClGGElWTiLrdR------------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy 558 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR------------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGY 558 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc------------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCc
Confidence 999999999999999999533 4678888889999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccCC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+|+.|||+||.+... ....+.+||||
T Consensus 559 ~KLVDFGFAKki~~g-~KTwTFcGTpE 584 (732)
T KOG0614|consen 559 LKLVDFGFAKKIGSG-RKTWTFCGTPE 584 (732)
T ss_pred eEEeehhhHHHhccC-CceeeecCCcc
Confidence 999999999998775 56799999997
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=191.90 Aligned_cols=151 Identities=29% Similarity=0.478 Sum_probs=128.8
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++|||++++++++... +.+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 456788999999999999998889999999998653 33446788999999999999999999986431 1367899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++ +|.+++... ...+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+
T Consensus 78 v~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~ 142 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP-----------EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLA 142 (287)
T ss_pred Eeccccc-cHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEc
Confidence 9999975 888887432 13688999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||+++.....
T Consensus 143 d~g~~~~~~~~ 153 (287)
T cd07840 143 DFGLARPYTKR 153 (287)
T ss_pred cccceeeccCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-21 Score=217.87 Aligned_cols=162 Identities=29% Similarity=0.392 Sum_probs=133.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
-+++....||.|.||.||.|....+|+..|||-+..+.. ...+...+|+.++..++|||+|+.+|.-.. .+..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----REKV 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HHHH
Confidence 345667889999999999999999999999998876543 234567899999999999999999998433 5678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++.||||++|+|.+.+... +..++.....+..|++.|++|||++ +||||||||+||++|.+|.+|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g------------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG------------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc------------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEE
Confidence 9999999999999988432 3455555667889999999999997 999999999999999999999
Q ss_pred EcccCcccccccCC-C---CCccccccC
Q 003368 801 VGDFGLARLRQEVP-N---NQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~-~---~~~~~~gt~ 824 (825)
.+|||.|+.+.... + .-...+||+
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTP 1402 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCc
Confidence 99999999875542 1 124557776
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-19 Score=187.54 Aligned_cols=151 Identities=21% Similarity=0.277 Sum_probs=120.9
Q ss_pred HHHhhccccccccee--ccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhc-CCCCCceeEeecccccc
Q 003368 637 SLLKATDGFSSTHLI--GIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRN-IRHRNLVRVITSCSSID 713 (825)
Q Consensus 637 ~~~~~~~~f~~~~~i--g~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~ 713 (825)
+.....++|+..+.+ |+|+||.||+++.+.+++.+|+|.+........ |+..... .+||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~--- 79 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT--- 79 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe---
Confidence 333344556666665 999999999999989999999999875422111 2222221 27999999999854
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
..+..++||||+++|+|.+++... ..++|.++..++.|+++|++|||+. +++||||||+||++
T Consensus 80 --~~~~~~iv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~ 142 (267)
T PHA03390 80 --TLKGHVLIMDYIKDGDLFDLLKKE------------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLY 142 (267)
T ss_pred --cCCeeEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEE
Confidence 356899999999999999998532 2689999999999999999999985 89999999999999
Q ss_pred cCCC-cEEEcccCccccccc
Q 003368 794 DNNL-TAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~-~~ki~DFGla~~~~~ 812 (825)
+.++ .+||+|||+++....
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eCCCCeEEEecCccceecCC
Confidence 9988 999999999886543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=187.64 Aligned_cols=143 Identities=27% Similarity=0.348 Sum_probs=118.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHh-hcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRAL-RNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||.||+|....+|+.||||.++.... .....+..|..++ ...+|||++++++++. .++..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 568999999999999988899999999865432 1223345555544 4558999999999853 356789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||+|+||++++++.+|++||
T Consensus 77 e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 141 (260)
T cd05611 77 EYLNGGDCASLIKTL------------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDF 141 (260)
T ss_pred eccCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeec
Confidence 999999999998432 3578889999999999999999985 8999999999999999999999999
Q ss_pred Ccccccc
Q 003368 805 GLARLRQ 811 (825)
Q Consensus 805 Gla~~~~ 811 (825)
|+++...
T Consensus 142 g~~~~~~ 148 (260)
T cd05611 142 GLSRNGL 148 (260)
T ss_pred ccceecc
Confidence 9988643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=191.58 Aligned_cols=149 Identities=27% Similarity=0.346 Sum_probs=125.6
Q ss_pred cccccceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
+|+..+.||+|+||.||+|+.. .+++.||||.++... ....+.+.+|++++.++ +||||++++++ +.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence 3667889999999999999863 467899999987532 12345688999999999 59999999887 34
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.+...++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~ 140 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR------------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDS 140 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc------------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECC
Confidence 466789999999999999988532 3578889999999999999999984 8999999999999999
Q ss_pred CCcEEEcccCccccccc
Q 003368 796 NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~ 812 (825)
++.+|++|||+++....
T Consensus 141 ~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 141 EGHVVLTDFGLSKEFLA 157 (288)
T ss_pred CCCEEEEECcccccccc
Confidence 99999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=195.30 Aligned_cols=151 Identities=26% Similarity=0.380 Sum_probs=125.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ......
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888999999999999999998899999999986532 222456889999999999999999999864321 112234
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++|+||+.. ++.++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 95 ~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~ 156 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG--------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL 156 (342)
T ss_pred EEEEeccccc-CHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 6899999964 6665541 2478889999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
|++|||+++...
T Consensus 157 kL~dfg~~~~~~ 168 (342)
T cd07879 157 KILDFGLARHAD 168 (342)
T ss_pred EEeeCCCCcCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=196.38 Aligned_cols=154 Identities=28% Similarity=0.363 Sum_probs=130.3
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++......+....|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3677899999999999999998889999999987643 33456789999999999999999999986542211223679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++ ++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|+
T Consensus 81 lv~e~~~-~~l~~~l~~~------------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 81 IVTELME-TDLHKVIKSP------------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred EEecchh-hhHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 9999998 4888887432 2688999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 145 ~dfg~~~~~~~~ 156 (330)
T cd07834 145 CDFGLARGVDPD 156 (330)
T ss_pred cccCceEeeccc
Confidence 999999977554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=195.11 Aligned_cols=154 Identities=27% Similarity=0.398 Sum_probs=129.8
Q ss_pred HHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 637 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
++...+++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++.+++..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 80 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS--- 80 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence 34456788999999999999999999998899999999886432 2335678899999999999999999998632
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.....++|+||+ +++|.+++.. ..+++.....++.|+++|++|||+. +|+||||||+||+++
T Consensus 81 -~~~~~~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~ 142 (328)
T cd07856 81 -PLEDIYFVTELL-GTDLHRLLTS-------------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILIN 142 (328)
T ss_pred -CCCcEEEEeehh-ccCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeEC
Confidence 244678999998 5688887742 2467777888999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 003368 795 NNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~ 811 (825)
+++.+|++|||+++...
T Consensus 143 ~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 143 ENCDLKICDFGLARIQD 159 (328)
T ss_pred CCCCEEeCccccccccC
Confidence 99999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=195.77 Aligned_cols=144 Identities=26% Similarity=0.395 Sum_probs=122.9
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh--------------HHHHHHHHHHhhcCCCCCceeEeeccccc
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--------------SKSFAAECRALRNIRHRNLVRVITSCSSI 712 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 712 (825)
..+.||+|+||+||+|+...+|+.||||.+....... ...+.+|++++++++||||+++++++.
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 90 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV-- 90 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe--
Confidence 3577999999999999998899999999986532211 125778999999999999999999853
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.++..++||||++ |+|.+++... ..+++.....++.|++.|++|||+. +|+||||||+||+
T Consensus 91 ---~~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nil 151 (335)
T PTZ00024 91 ---EGDFINLVMDIMA-SDLKKVVDRK------------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIF 151 (335)
T ss_pred ---cCCcEEEEEeccc-cCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeE
Confidence 3568899999997 6898888422 3578889999999999999999985 8999999999999
Q ss_pred ecCCCcEEEcccCcccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~ 811 (825)
++.++.+|++|||+++...
T Consensus 152 l~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 152 INSKGICKIADFGLARRYG 170 (335)
T ss_pred ECCCCCEEECCccceeecc
Confidence 9999999999999998765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=194.04 Aligned_cols=151 Identities=24% Similarity=0.312 Sum_probs=125.2
Q ss_pred cccccceeccCCeeEEEEEEEcCC--CeEEEEEEeecccc--hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRD--GTIVAIKVLNLQLQ--GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~--g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 718 (825)
+|...+.||+|+||.||+|+...+ +..||||++..... ...+.+.+|++++++++ ||||+++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence 367788999999999999999777 88999999875322 23457889999999995 99999999875431 12234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++++||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~ 143 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG------------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCE 143 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCC
Confidence 5788899886 6898888432 3588999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+||+|||+|+...
T Consensus 144 ~kl~Dfg~a~~~~ 156 (332)
T cd07857 144 LKICDFGLARGFS 156 (332)
T ss_pred EEeCcCCCceecc
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=189.32 Aligned_cols=149 Identities=26% Similarity=0.352 Sum_probs=123.6
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|...+.||+|+||.||+|+...+++.||||+++.... .......+|+.++.++. |||++++++++.. ...+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~---~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD---RKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec---CCCCcEEE
Confidence 4567889999999999999988999999999875432 22334567899999886 9999999998643 11257899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||++ |++.+++... ...++|.++..++.|++.||+|||+. +|+||||||+||+++. +.+||+
T Consensus 78 v~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~ 141 (282)
T cd07831 78 VFELMD-MNLYELIKGR-----------KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLA 141 (282)
T ss_pred EEecCC-ccHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEE
Confidence 999997 5888887432 13689999999999999999999985 8999999999999999 999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 142 dfg~~~~~~~ 151 (282)
T cd07831 142 DFGSCRGIYS 151 (282)
T ss_pred eccccccccc
Confidence 9999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=188.01 Aligned_cols=152 Identities=25% Similarity=0.338 Sum_probs=124.2
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|...+.||+|+||.||+++....+..+++|.++... .....++.+|+.++++++||||+++++++. +.+.
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 76 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERDA 76 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCCc
Confidence 667789999999999999987777767777665321 223346778999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.+++... ......++|.++..++.|++.|++|||+. +++|+|+||+||+++. +.+
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEEL--------KHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHH--------hhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCE
Confidence 89999999999999888532 11234689999999999999999999985 9999999999999976 569
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
|++|||+++.....
T Consensus 145 ~l~d~g~~~~~~~~ 158 (260)
T cd08222 145 KIGDFGVSRLLMGS 158 (260)
T ss_pred eecccCceeecCCC
Confidence 99999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=195.37 Aligned_cols=152 Identities=26% Similarity=0.395 Sum_probs=127.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccc---------
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSID--------- 713 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------- 713 (825)
.+|...+.||+|+||.||+|....+|+.||+|.+........+.+.+|++++++++||||+++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 56888999999999999999998899999999997765556678899999999999999999988754211
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+.+....++||||++ ++|.+++.. ..+++.....++.|++.|++|||+. +|+||||||+||++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili 147 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-------------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFI 147 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 111235789999997 588877732 2578889999999999999999985 89999999999999
Q ss_pred cC-CCcEEEcccCcccccc
Q 003368 794 DN-NLTAHVGDFGLARLRQ 811 (825)
Q Consensus 794 ~~-~~~~ki~DFGla~~~~ 811 (825)
+. ++.+|++|||+++...
T Consensus 148 ~~~~~~~kl~dfg~~~~~~ 166 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVD 166 (342)
T ss_pred cCCCceEEECCcccceecC
Confidence 74 5678999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=191.23 Aligned_cols=155 Identities=24% Similarity=0.276 Sum_probs=124.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|...+.||+|+||.||+++...+|+.||||.+..... .....+.+|+.++.++. ||||+++++++. .+...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 356667889999999999999988999999999875432 34567889999999997 999999999853 35567
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+.. ++.++.... .......+++..+..++.+++.|++|||+. .+|+||||||+||+++.++.+|
T Consensus 79 ~~~~e~~~~-~l~~l~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~k 148 (288)
T cd06616 79 WICMELMDI-SLDKFYKYV-------YEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIK 148 (288)
T ss_pred EEEEecccC-CHHHHHHHH-------HHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEE
Confidence 899999864 554432110 001124688999999999999999999974 4899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 149 l~dfg~~~~~~~ 160 (288)
T cd06616 149 LCDFGISGQLVD 160 (288)
T ss_pred EeecchhHHhcc
Confidence 999999986543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=184.26 Aligned_cols=142 Identities=31% Similarity=0.402 Sum_probs=124.6
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEcc
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYM 727 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~ 727 (825)
||+|+||.||++....+++.||+|.+..... .....+..|++++++++||||+++++.+ ..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999988899999999876432 2345789999999999999999999874 4567889999999
Q ss_pred CCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcc
Q 003368 728 PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807 (825)
Q Consensus 728 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla 807 (825)
++++|.+++... ..+++.++..++.|+++|+.|+|+. +++|+||||+||+++.++.++++|||++
T Consensus 76 ~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~ 140 (250)
T cd05123 76 PGGELFSHLSKE------------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLA 140 (250)
T ss_pred CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcc
Confidence 999999998432 2578999999999999999999985 8999999999999999999999999999
Q ss_pred ccccc
Q 003368 808 RLRQE 812 (825)
Q Consensus 808 ~~~~~ 812 (825)
+....
T Consensus 141 ~~~~~ 145 (250)
T cd05123 141 KELSS 145 (250)
T ss_pred eeccc
Confidence 87644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=193.90 Aligned_cols=142 Identities=21% Similarity=0.295 Sum_probs=120.7
Q ss_pred ceeccC--CeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIG--SFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G--~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+| +||+||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. .++..++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 356666 99999999998899999999987543 223467889999999999999999999853 466789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|++.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++||
T Consensus 79 e~~~~~~l~~~l~~~----------~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~ 145 (328)
T cd08226 79 PFMAYGSANSLLKTY----------FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGL 145 (328)
T ss_pred ecccCCCHHHHHHhh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEech
Confidence 999999999988532 112478889999999999999999985 8999999999999999999999999
Q ss_pred Cccc
Q 003368 805 GLAR 808 (825)
Q Consensus 805 Gla~ 808 (825)
|.+.
T Consensus 146 ~~~~ 149 (328)
T cd08226 146 SHLY 149 (328)
T ss_pred HHHh
Confidence 7543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=188.55 Aligned_cols=148 Identities=29% Similarity=0.467 Sum_probs=128.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|+||.||+|+...+++.||+|.+.... ....+.+.+|++++++++|+|++++++++. +.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 455678999999999999998889999999998653 233467889999999999999999999854 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||++ ++|.+++... ...+++..+..++.|+++|++|||+. +|+||||+|+||++++++.+||+
T Consensus 76 v~e~~~-~~l~~~i~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR-----------PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred EecCcC-cCHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEe
Confidence 999998 5899998532 13688999999999999999999986 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 141 d~g~~~~~~~ 150 (282)
T cd07829 141 DFGLARAFGI 150 (282)
T ss_pred cCCcccccCC
Confidence 9999987644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=187.83 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=128.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|+..+.||+|++|.||+|+...+|+.||+|.+..... ...+.+.+|++++++++||||+++++++. .++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 4556789999999999999988999999999875433 24567889999999999999999999854 3577899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++ ++.+++... ...+++.++..++.|++.|++|||+. +|+|+||||+||++++++.+||+
T Consensus 76 v~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~ 140 (283)
T cd05118 76 VFEFMDT-DLYKLIKDR-----------QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLA 140 (283)
T ss_pred EEeccCC-CHHHHHHhh-----------cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEe
Confidence 9999975 888887431 14689999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||.+......
T Consensus 141 df~~~~~~~~~ 151 (283)
T cd05118 141 DFGLARSFGSP 151 (283)
T ss_pred eeeeeEecCCC
Confidence 99999877554
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=188.88 Aligned_cols=152 Identities=22% Similarity=0.310 Sum_probs=125.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|++..+|+.||||.++... .....++.+|++++.+.+ ||||++++++|. +...
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence 356788899999999999999998789999999997543 233456777888777776 999999999864 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||++ +++.+++.. ....+++..+..++.|+++|++|||+. .+|+||||+|+||++++++.+
T Consensus 89 ~~~v~e~~~-~~l~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~ 154 (296)
T cd06618 89 VFICMELMS-TCLDKLLKR-----------IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNV 154 (296)
T ss_pred EEEEeeccC-cCHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCE
Confidence 899999985 467666532 123689999999999999999999973 389999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 155 kL~dfg~~~~~~~ 167 (296)
T cd06618 155 KLCDFGISGRLVD 167 (296)
T ss_pred EECccccchhccC
Confidence 9999999986643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.2e-19 Score=187.00 Aligned_cols=154 Identities=29% Similarity=0.456 Sum_probs=125.3
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcC---CCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNI---RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|+..+.||+|+||.||+|+++.+++.||||.+..... .....+.+|++++.++ +|||++++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999987899999999975432 2234567788777665 5999999999976533222334
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+.+ +|.+++... ....++|.++..++.|+++||+|||+. +++|+|+||+||+++.++.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~----------~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC----------PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eEEEehhccc-CHHHHHHHc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCE
Confidence 8999999974 898887532 112589999999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 147 ~l~dfg~~~~~~~ 159 (287)
T cd07838 147 KIADFGLARIYSF 159 (287)
T ss_pred EEeccCcceeccC
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=188.01 Aligned_cols=149 Identities=28% Similarity=0.448 Sum_probs=126.9
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|...+.||+|+||.||+|+...+++.||||++...... ......+|++.+++++ |||++++++++. .++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 45678899999999999999888999999998755332 2234567999999999 999999999853 3667899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+ +|++.+++... ....++|.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+
T Consensus 76 v~e~~-~~~l~~~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~ 141 (283)
T cd07830 76 VFEYM-EGNLYQLMKDR----------KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIA 141 (283)
T ss_pred EEecC-CCCHHHHHHhc----------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEe
Confidence 99999 88999888532 123679999999999999999999985 89999999999999999999999
Q ss_pred ccCccccccc
Q 003368 803 DFGLARLRQE 812 (825)
Q Consensus 803 DFGla~~~~~ 812 (825)
|||+++....
T Consensus 142 d~~~~~~~~~ 151 (283)
T cd07830 142 DFGLAREIRS 151 (283)
T ss_pred ecccceeccC
Confidence 9999987654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=188.16 Aligned_cols=146 Identities=29% Similarity=0.413 Sum_probs=124.4
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|...+.||+|+||+||+|+...+|+.||||++..... ...+.+.+|++++++++|||++++++++. +.+..|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence 5566789999999999999988999999999875322 23356889999999999999999999854 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+. |++.+++... ...++|.++..++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 98 lv~e~~~-~~l~~~l~~~-----------~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL 162 (313)
T cd06633 98 LVMEYCL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL 162 (313)
T ss_pred EEEecCC-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEE
Confidence 9999996 5777776421 23588999999999999999999985 8999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||++...
T Consensus 163 ~dfg~~~~~ 171 (313)
T cd06633 163 ADFGSASKS 171 (313)
T ss_pred eecCCCccc
Confidence 999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=189.44 Aligned_cols=149 Identities=31% Similarity=0.415 Sum_probs=126.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|+..+.||+|+||.||+|+...+++.||||.+.... ....+++.+|+++++.++|+|++++++++.. ....
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence 3667788999999999999998889999999986432 2334568899999999999999999998643 5678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+. |++.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 91 ~lv~e~~~-~~l~~~~~~~-----------~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVH-----------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred EEEEEccC-CCHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEE
Confidence 99999996 6887776421 13578889999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
++|||++.....
T Consensus 156 l~dfg~~~~~~~ 167 (308)
T cd06634 156 LGDFGSASIMAP 167 (308)
T ss_pred ECCcccceeecC
Confidence 999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-19 Score=193.36 Aligned_cols=155 Identities=26% Similarity=0.373 Sum_probs=128.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~ 717 (825)
..++|...+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++|||++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999998889999999986532 2234567889999999999999999887532111 112
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+ +++|.+++.. ..+++.++..++.|+++|++|||+. +|+||||||+||++++++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~ 155 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-------------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDC 155 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 2479999998 6799888742 3588999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 156 ~~kL~dfg~~~~~~~ 170 (343)
T cd07851 156 ELKILDFGLARHTDD 170 (343)
T ss_pred CEEEccccccccccc
Confidence 999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-19 Score=189.48 Aligned_cols=156 Identities=27% Similarity=0.412 Sum_probs=128.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc---CC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF---QG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 716 (825)
.++|...+.||+|+||.||+|+...+++.||||++..... .....+.+|++++++++||||+++++++....- ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5689999999999999999999988999999999865432 223467889999999999999999987543110 12
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+.+ ++...+... ...+++.++..++.|+++||+|||+. +|+||||||+||+++++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-----------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~ 151 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-----------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQ 151 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 3457999999975 676666421 23689999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
+.+|++|||+++....
T Consensus 152 ~~~~l~dfg~~~~~~~ 167 (311)
T cd07866 152 GILKIADFGLARPYDG 167 (311)
T ss_pred CCEEECcCccchhccC
Confidence 9999999999986643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=185.52 Aligned_cols=153 Identities=22% Similarity=0.310 Sum_probs=112.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCC---CeEEEEEEeecccchh-----------HHHHHHHHHHhhcCCCCCceeEeec
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQGA-----------SKSFAAECRALRNIRHRNLVRVITS 708 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~~ 708 (825)
..|...++||+|+||+||+|++..+ +..+|+|......... ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4688899999999999999998766 6677777654322111 1122344455677899999999987
Q ss_pred ccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 709 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
+... .....+.++++|++.. ++.+.+.. ....++..+..|+.|+++|++|||+. +|+||||||
T Consensus 92 ~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp 154 (294)
T PHA02882 92 GSFK-RCRMYYRFILLEKLVE-NTKEIFKR------------IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKP 154 (294)
T ss_pred eeEe-cCCceEEEEEEehhcc-CHHHHHHh------------hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 5421 1112245778887643 55544421 12356778889999999999999985 899999999
Q ss_pred CCeeecCCCcEEEcccCccccccc
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+|||++.++.+||+|||+|+....
T Consensus 155 ~Nill~~~~~~~l~DFGla~~~~~ 178 (294)
T PHA02882 155 ENIMVDGNNRGYIIDYGIASHFII 178 (294)
T ss_pred HHEEEcCCCcEEEEEcCCceeecc
Confidence 999999999999999999987643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.78 E-value=9e-19 Score=188.96 Aligned_cols=143 Identities=25% Similarity=0.242 Sum_probs=116.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
+.+|.|++ ||.++...+|+.||||++... .....+.+.+|++++++++||||+++++++ ...+..+++|||
T Consensus 8 ~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~ 80 (314)
T cd08216 8 KCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPL 80 (314)
T ss_pred HhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEec
Confidence 33444455 455554458999999999764 233456799999999999999999999974 346678999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++|++.+++... ....+++.....++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.
T Consensus 81 ~~~~~l~~~l~~~----------~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~ 147 (314)
T cd08216 81 MAYGSCEDLLKTH----------FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRY 147 (314)
T ss_pred cCCCCHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCcc
Confidence 9999999998532 113477888899999999999999986 899999999999999999999999998
Q ss_pred ccccc
Q 003368 807 ARLRQ 811 (825)
Q Consensus 807 a~~~~ 811 (825)
+....
T Consensus 148 ~~~~~ 152 (314)
T cd08216 148 SVSMI 152 (314)
T ss_pred ceeec
Confidence 87553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-20 Score=179.91 Aligned_cols=154 Identities=25% Similarity=0.353 Sum_probs=122.2
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+..+.||.|+||+||...+.++|+.||.|++...- -...+.+.+|++++.-++|.|++..++.--....+.-.+.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 456788999999999999999999999999986432 234577899999999999999998877521111111124678
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|+|.|. .+|++.+... ..++-....-+..||++||.|||+. +|.||||||.|.|+.++...|||
T Consensus 135 ~TELmQ-SDLHKIIVSP------------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP------------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred HHHHHH-hhhhheeccC------------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEec
Confidence 889885 4888777432 3456666677889999999999986 99999999999999999999999
Q ss_pred ccCcccccccCC
Q 003368 803 DFGLARLRQEVP 814 (825)
Q Consensus 803 DFGla~~~~~~~ 814 (825)
|||+||.-+.++
T Consensus 199 DFGLARvee~d~ 210 (449)
T KOG0664|consen 199 DFGLARTWDQRD 210 (449)
T ss_pred ccccccccchhh
Confidence 999999765443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=171.66 Aligned_cols=148 Identities=22% Similarity=0.401 Sum_probs=123.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|...+.+|+|.||.+-.|+++++.+.+|+|.++... ...++|.+|...--.+ .|.||+.-|+.. |+..+.+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence 45788899999999999999999999999999987543 3457899998765556 499999887763 77788999
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCC-CcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL-DNN-LTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl-~~~-~~~ 799 (825)
.++||+|.|+|.+-+... .+.+....+++.|+++|++|+|+. .+||||||.+|||+ +.| ..+
T Consensus 99 F~qE~aP~gdL~snv~~~-------------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rv 162 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-------------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRV 162 (378)
T ss_pred EeeccCccchhhhhcCcc-------------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEE
Confidence 999999999998776432 355667788999999999999985 89999999999999 444 489
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
|+||||+.+...
T Consensus 163 KlcDFG~t~k~g 174 (378)
T KOG1345|consen 163 KLCDFGLTRKVG 174 (378)
T ss_pred EeeecccccccC
Confidence 999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=171.75 Aligned_cols=143 Identities=17% Similarity=0.288 Sum_probs=107.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-----CCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-----RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+...++||+|+||.||+ +..++.. +||++........+.+.+|+++++.+ .||||++++|++.. -.+...
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et--~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET--DCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe--CCCCeE
Confidence 45578999999999996 5455554 79988765445567899999999999 57999999998532 111234
Q ss_pred -eeEEEEc--cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeeecC
Q 003368 720 -KALVYQY--MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV-DYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 720 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l-~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
..+|+|| +++|+|.+++... .+++. ..++.+++.++ +|||++ +||||||||+|||++.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-------------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~ 140 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-------------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQR 140 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-------------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEec
Confidence 3478999 6689999999422 23333 35577888888 999986 9999999999999974
Q ss_pred ----CCcEEEcc-cCccccc
Q 003368 796 ----NLTAHVGD-FGLARLR 810 (825)
Q Consensus 796 ----~~~~ki~D-FGla~~~ 810 (825)
+..++|+| ||.+..+
T Consensus 141 ~~~~~~~~~LiDg~G~~~~i 160 (210)
T PRK10345 141 ISESEVIPVVCDNIGESTFI 160 (210)
T ss_pred cCCCCCcEEEEECCCCccee
Confidence 34799999 5655553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-19 Score=200.83 Aligned_cols=165 Identities=20% Similarity=0.227 Sum_probs=110.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCC----CeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccc-cccC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRD----GTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSS-IDFQ 715 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~----g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~ 715 (825)
..++|...+.||+|+||.||+|++..+ +..||||++..... .+.+..| .+....+.+++.+...+.. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 89999998764321 1112221 1222223333322222111 0013
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCccc--------chhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEE--------NDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
.+...++||||+++|+|.+++.....+..... ........+..+..|+.|+++||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45678999999999999999864321110000 00001122334567999999999999985 89999999
Q ss_pred CCCeeecC-CCcEEEcccCccccccc
Q 003368 788 PSNILLDN-NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 788 ~~NILl~~-~~~~ki~DFGla~~~~~ 812 (825)
|+|||+++ ++.+||+|||+|+.+..
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~ 308 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRV 308 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccc
Confidence 99999986 57999999999986643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=178.03 Aligned_cols=134 Identities=22% Similarity=0.156 Sum_probs=114.0
Q ss_pred CCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChh
Q 003368 654 GSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLE 733 (825)
Q Consensus 654 G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 733 (825)
|.||.||+++...+|+.||+|.+.... .+.+|...+....||||+++++++ .+.+..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999987542 234455555666799999999984 3467889999999999999
Q ss_pred hhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 734 NWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+++... ..+++..+..++.|+++|++|+|+. +|+||||||+||+++.++.+|++|||.++....
T Consensus 74 ~~l~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 74 SHISKF------------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred HHHHHh------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 988422 3588999999999999999999985 899999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-19 Score=171.73 Aligned_cols=153 Identities=22% Similarity=0.282 Sum_probs=122.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
.+....+|.|+.|+|++++.+.+|..+|||...... .+..+.+...+.++.+.+ .|.||+-+||+. .+...++
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~I 168 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFI 168 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHH
Confidence 344567999999999999999999999999997653 334456778888888776 899999999953 3556788
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
.||.|.. ..+..+.. -..++++...=++.+.+.+||.||.+. .+|||||+||+|||+|+.|++|+|
T Consensus 169 cMelMs~-C~ekLlkr-----------ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKR-----------IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred HHHHHHH-HHHHHHHH-----------hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEee
Confidence 8998854 44544432 123566766778888999999999875 489999999999999999999999
Q ss_pred ccCcccccccCCCC
Q 003368 803 DFGLARLRQEVPNN 816 (825)
Q Consensus 803 DFGla~~~~~~~~~ 816 (825)
|||++..+.+...+
T Consensus 235 DFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 235 DFGISGRLVDSKAH 248 (391)
T ss_pred cccccceeeccccc
Confidence 99999988776544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=200.41 Aligned_cols=167 Identities=25% Similarity=0.420 Sum_probs=133.4
Q ss_pred hcccccccceeccCCeeEEEEEEEc---C----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCC-CCCceeEeecccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFD---R----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIR-HRNLVRVITSCSS 711 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~---~----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 711 (825)
..++....+.+|+|+||+|++|... . ....||||.++.... ...+.+..|+++|..+. |||||.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3444555669999999999999852 1 146799999986544 34678999999999985 9999999999864
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCC-CCCccc-chhc--ccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAI-PQTDEE-NDEI--RNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~-~~~~--~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
.+..++|+||++.|+|.+||+..+. ...... .... ..++..+.+.+|.|||+|++||++. ++||||+.
T Consensus 374 -----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 374 -----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred -----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 5678999999999999999987650 000000 0001 2489999999999999999999985 89999999
Q ss_pred CCCeeecCCCcEEEcccCcccccccCCC
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQEVPN 815 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~~~~~ 815 (825)
++|||+.++..+||+|||+||.....+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~ 473 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDY 473 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCc
Confidence 9999999999999999999997655443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-19 Score=167.92 Aligned_cols=151 Identities=22% Similarity=0.402 Sum_probs=127.5
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
..++|+..+.+|+|.|+.||.|....+.+.++||+++... .+.+.+|+.++..++ ||||+++++....+ ....
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccC
Confidence 3577889999999999999999987888999999997543 466889999999998 99999999985432 2334
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-Cc
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-LT 798 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-~~ 798 (825)
..||+||+.+-+..... ..++..+...+..++++||.|+|+. ||+|||+||.||++|.. -.
T Consensus 110 paLiFE~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred chhHhhhhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhce
Confidence 57999999997776544 3567778889999999999999996 99999999999999964 58
Q ss_pred EEEcccCcccccccCCC
Q 003368 799 AHVGDFGLARLRQEVPN 815 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~ 815 (825)
.++.|+|+|.++....+
T Consensus 172 LrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKE 188 (338)
T ss_pred eeeeecchHhhcCCCce
Confidence 99999999999876643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3e-20 Score=167.76 Aligned_cols=149 Identities=32% Similarity=0.527 Sum_probs=84.9
Q ss_pred CCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEc
Q 003368 80 FRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISL 159 (825)
Q Consensus 80 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 159 (825)
.+.+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..+..+++|+.|+++.|++. +.|..|+.++.|++|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 34444444444444 33444444455555555555554 45666666666666666666666 56666666666666666
Q ss_pred ccCcCcc-cCCcccccccccceecCcCc----CCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCC
Q 003368 160 AYNSLGG-NIPSSLGQLKELKSLGLGGT----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS 233 (825)
Q Consensus 160 s~N~l~~-~~p~~~~~l~~L~~L~L~~~----~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~ 233 (825)
.+|+++. ..|..|..++.|+.|+|+.+ +|+.+++++.|+.|.+.+|.+. ++|..++ .++.|++|++.+|+++
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig-~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIG-DLTRLRELHIQGNRLT 186 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHH-HHHHHHHHhcccceee
Confidence 6666654 55666666666666655432 3444444444444455555555 4555555 5555666666666655
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=170.02 Aligned_cols=145 Identities=19% Similarity=0.149 Sum_probs=111.6
Q ss_pred cccccceeccCCeeEEEEEE-EcCCCeEEEEEEeecccch------------------------hHHHHHHHHHHhhcCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGT-FDRDGTIVAIKVLNLQLQG------------------------ASKSFAAECRALRNIR 698 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~-~~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 698 (825)
.|+..+.||+|+||.||+|. ...+|+.||||+++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46677899999999999998 5578999999998753210 1123568999999998
Q ss_pred CCC--ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc
Q 003368 699 HRN--LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH 776 (825)
Q Consensus 699 H~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~ 776 (825)
+.. +.+.+++ ...++||||++++++..+.... ......+...++.|++.+++|||+.
T Consensus 109 ~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~ 167 (237)
T smart00090 109 EAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD------------VEPEEEEEFELYDDILEEMRKLYKE 167 (237)
T ss_pred hcCCCCCeeeEe---------cCceEEEEEecCCccccccccc------------CCcchHHHHHHHHHHHHHHHHHHhc
Confidence 643 3344432 1248999999998887654211 1234456678999999999999986
Q ss_pred CCCC-eeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 777 CQEP-TIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 777 ~~~~-ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+ |+|||+||+||+++ ++.++++|||.|+.....
T Consensus 168 ---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 168 ---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred ---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 7 99999999999999 789999999999976554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=168.83 Aligned_cols=149 Identities=31% Similarity=0.477 Sum_probs=130.5
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
|...+.||+|++|.||+|....+++.+|||.+...... ..+.+.+|++.+++++|+|++++++++.. ....++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 45678899999999999999777899999999876544 56789999999999999999999998543 4678999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhccc-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRN-LTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
+||+++++|.+++... .. +++..+..++.+++++++|||.. +++|+|++|+||+++.++.++++
T Consensus 76 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~ 140 (225)
T smart00221 76 MEYCEGGDLFDYLRKK------------GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLA 140 (225)
T ss_pred EeccCCCCHHHHHHhc------------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 9999999999998532 12 78889999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccC
Q 003368 803 DFGLARLRQEV 813 (825)
Q Consensus 803 DFGla~~~~~~ 813 (825)
|||.++.....
T Consensus 141 d~g~~~~~~~~ 151 (225)
T smart00221 141 DFGLARFIHRD 151 (225)
T ss_pred eCceeeEecCc
Confidence 99999987554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.1e-20 Score=164.95 Aligned_cols=167 Identities=28% Similarity=0.532 Sum_probs=124.8
Q ss_pred ccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccc
Q 003368 327 IGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406 (825)
Q Consensus 327 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 406 (825)
+.++..++.|.||+|+++ .+|+.+..+.+|+.|++++|++. .+|.++..+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445666777778888887 66777888888888888888887 78888888888888888888887 7788888888888
Q ss_pred eeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCC
Q 003368 407 LLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAEN 486 (825)
Q Consensus 407 ~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N 486 (825)
+|||.+|++.. ..+|..|..++.|+-|+|+.|.+. .+|..++++++||.|.+.+|
T Consensus 106 vldltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 106 VLDLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hhhcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence 88888888762 134555555666666666666665 66667777777777777777
Q ss_pred cCCCCCCccccCCCCCCEEECCCCccccccCcccccc
Q 003368 487 FFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL 523 (825)
Q Consensus 487 ~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l 523 (825)
.+- ++|..++.++.|+.|.+.+|+++ .+|..++.+
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 766 67777777888888888888877 555555544
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.9e-18 Score=178.60 Aligned_cols=161 Identities=22% Similarity=0.270 Sum_probs=132.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
..|+..+.||+||.++||++.. .+.+.||+|++... ..+....|..|++.|.+++ |.+||++++|- .++++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 3478889999999999999997 56678888877543 2345678999999999997 99999999994 34789
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.||||||= .-+|..+|.... .....| .+..|..|++.|+.++|.+ +|||-||||+|.|+-+ |.+
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~----------~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~L 498 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK----------SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRL 498 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc----------CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeE
Confidence 99999976 459999996431 112335 6788999999999999997 9999999999999987 689
Q ss_pred EEcccCcccccccCCCC--CccccccCC
Q 003368 800 HVGDFGLARLRQEVPNN--QSSSVGDLE 825 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~--~~~~~gt~~ 825 (825)
||+|||+|+-++.+.+. .-+.+||++
T Consensus 499 KLIDFGIA~aI~~DTTsI~kdsQvGT~N 526 (677)
T KOG0596|consen 499 KLIDFGIANAIQPDTTSIVKDSQVGTVN 526 (677)
T ss_pred EeeeechhcccCccccceeeccccCccc
Confidence 99999999999888765 456689863
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-19 Score=195.72 Aligned_cols=131 Identities=26% Similarity=0.259 Sum_probs=80.7
Q ss_pred EEECCCCCCc-cccCcCCCCCCCCCEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCC------CCCcCCCCCC
Q 003368 36 VLDLKSKGLI-GSLSPQIGNLSFLREIHLSNNTIQG----KIPGEIGRLFRLEALYLSHNSLVG------EIPGNLSYCS 104 (825)
Q Consensus 36 ~l~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 104 (825)
.|+|+.+.+. ......+..++.|++|+++++.++. .++..+...++|++|+++++.+.+ .++..|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 3445555666677777777777743 245556666677777777777652 2233455666
Q ss_pred CCCEEEcCCCCCCCCCChhhhcccc---cceeecccccccc----ccCccCCCC-CCCCEEEcccCcCcc
Q 003368 105 RLIGLYLGRNKLEGSIPSEFVSLYN---LKELAIQENNLTG----GIPHFLGNI-TSLEAISLAYNSLGG 166 (825)
Q Consensus 105 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~ 166 (825)
+|+.|++++|.+.+..+..|..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 151 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG 151 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCc
Confidence 7777777777776555555555555 7777777776652 222334445 666667776666663
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-19 Score=194.86 Aligned_cols=87 Identities=22% Similarity=0.358 Sum_probs=40.7
Q ss_pred CCCcCEEEcccCccccc----CCccccCCCCCCEEEccccccccccCcccc-----CCCCCcEEEcccCccc----cccC
Q 003368 330 LVSLYLIEMDHNQFEGK----IPEEMSRLQNLQFLNMRHNQLSGEIPSSFG-----NLSSLVKLILGNNNLS----GVIP 396 (825)
Q Consensus 330 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~----~~~p 396 (825)
+++|+.|++++|.+++. ++..+..+++|++|++++|.+.+.....+. ..+.|+.|++++|.++ ..+.
T Consensus 192 ~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~ 271 (319)
T cd00116 192 NCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLA 271 (319)
T ss_pred CCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHH
Confidence 34455555555544322 222334455555555555555432211111 1245666666666554 1122
Q ss_pred CCCCCCCccceeecCCCCCc
Q 003368 397 SSLGNLKQLALLHLFQNDLS 416 (825)
Q Consensus 397 ~~~~~l~~L~~L~L~~N~l~ 416 (825)
..+..+++|+++++++|.++
T Consensus 272 ~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 272 EVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHhcCCCccEEECCCCCCc
Confidence 23344456666666666665
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=160.18 Aligned_cols=138 Identities=22% Similarity=0.198 Sum_probs=107.8
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch----------------------hHHHHHHHHHHhhcCCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG----------------------ASKSFAAECRALRNIRHRN 701 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n 701 (825)
-|...+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|...+.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 366778999999999999998 58999999987643210 1123678899999998874
Q ss_pred --ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003368 702 --LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQE 779 (825)
Q Consensus 702 --iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~ 779 (825)
+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------------~~~~~~~~~i~~~l~~lh~~--- 144 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------------EDPEEVLDEILEEIVKAYKH--- 144 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhcccc------------------ccHHHHHHHHHHHHHHHHHC---
Confidence 4444432 245899999999998755310 13356889999999999985
Q ss_pred CeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 780 PTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 780 ~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+|+||||||+||++++++.++|+|||.|+-...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=159.57 Aligned_cols=144 Identities=32% Similarity=0.528 Sum_probs=124.8
Q ss_pred eccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCC
Q 003368 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPN 729 (825)
Q Consensus 651 ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~ 729 (825)
||+|++|.||+++...+|+.++||++...... ..+.+.+|++.+++++|++++++++++.. ....++|+||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 68999999999999777999999999765432 34678999999999999999999998543 4678999999999
Q ss_pred CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcEEEcccCccc
Q 003368 730 GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVGDFGLAR 808 (825)
Q Consensus 730 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ki~DFGla~ 808 (825)
++|.+++... ...+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+.
T Consensus 76 ~~l~~~~~~~-----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~ 141 (215)
T cd00180 76 GSLKDLLKEN-----------EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSK 141 (215)
T ss_pred CcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceE
Confidence 9999998432 13578999999999999999999985 9999999999999999 8999999999998
Q ss_pred ccccC
Q 003368 809 LRQEV 813 (825)
Q Consensus 809 ~~~~~ 813 (825)
.....
T Consensus 142 ~~~~~ 146 (215)
T cd00180 142 LLTSD 146 (215)
T ss_pred EccCC
Confidence 76543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=165.44 Aligned_cols=139 Identities=35% Similarity=0.489 Sum_probs=122.2
Q ss_pred CeeEEEEEEEcCCCeEEEEEEeecccchh-HHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChh
Q 003368 655 SFGSVYKGTFDRDGTIVAIKVLNLQLQGA-SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLE 733 (825)
Q Consensus 655 ~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 733 (825)
+||.||+|+...+|+.||+|++....... .+.+.+|++.+++++|+|++++++++.. ....++|+||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999998889999999997665443 6789999999999999999999998643 46789999999999999
Q ss_pred hhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 734 NWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 734 ~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+++... ..+++..+..++.+++++++|||.. +|+|+||+|+||++++++.++++|||.+......
T Consensus 76 ~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 76 DLLKKR------------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred HHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 988432 1278899999999999999999985 9999999999999999999999999999977553
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=184.56 Aligned_cols=140 Identities=24% Similarity=0.287 Sum_probs=109.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cc------hhHHHHHHHHHHhhcCCCCCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQ------GASKSFAAECRALRNIRHRNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 713 (825)
...|...+.||+|+||.||+|.+. +..+++|+.... .. ...+.+.+|++++++++|++++....++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 344567899999999999999983 334444433211 11 123568899999999999999887766432
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
....++||||+++++|.+++. .+..++.+++++++|||+. +|+|||+||+||++
T Consensus 408 ---~~~~~lv~E~~~g~~L~~~l~--------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl 461 (535)
T PRK09605 408 ---PEEKTIVMEYIGGKDLKDVLE--------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV 461 (535)
T ss_pred ---CCCCEEEEEecCCCcHHHHHH--------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE
Confidence 345689999999999988772 3567899999999999985 99999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+++.++|+|||+|+....
T Consensus 462 -~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 462 -RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred -ECCcEEEEeCcccccCCc
Confidence 577999999999998644
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-17 Score=181.36 Aligned_cols=148 Identities=29% Similarity=0.468 Sum_probs=115.2
Q ss_pred ccccceeccCCeeE-EEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeE
Q 003368 645 FSSTHLIGIGSFGS-VYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 645 f~~~~~ig~G~~g~-Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
|...+++|.|+-|+ ||+|.. .|++||||++-.+. ..-..+||..++.-+ |||||++++. -+++.+.|+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence 55668899999884 799998 78899999986432 234578999999885 9999999875 355778999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---C--C
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---N--L 797 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~--~ 797 (825)
+.|.|. .+|.+++..... ..+ ...-...+.+..|++.|+++||+. +|||||+||.||||+. + .
T Consensus 581 alELC~-~sL~dlie~~~~-----d~~---~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ 648 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGL-----DVE---MQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTL 648 (903)
T ss_pred EehHhh-hhHHHHHhcccc-----chh---hcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcce
Confidence 999995 599999964310 000 011024456788999999999995 9999999999999965 3 5
Q ss_pred cEEEcccCcccccccCC
Q 003368 798 TAHVGDFGLARLRQEVP 814 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~ 814 (825)
.|+|+|||++|.+..+.
T Consensus 649 ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 649 RAKISDFGLSKKLAGGK 665 (903)
T ss_pred eEEecccccccccCCCc
Confidence 89999999999987654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=158.68 Aligned_cols=145 Identities=11% Similarity=0.129 Sum_probs=113.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHH---------HHHHHHHHhhcCCCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK---------SFAAECRALRNIRHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~~~~~~~ 712 (825)
...|...+++|+|+||.||.+.. ++..+|||.++.......+ .|.+|+..+++++||+|..+..+....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 35689999999999999999765 5668999999755432222 268999999999999999988774321
Q ss_pred c---cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 713 D---FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 713 ~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
. +......++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~ 164 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKG 164 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChH
Confidence 1 111345799999999999987631 111 2456899999999986 9999999999
Q ss_pred CeeecCCCcEEEcccCccccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~ 812 (825)
||++++++ ++++|||..+...+
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccc
Confidence 99999988 99999999887643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=161.01 Aligned_cols=136 Identities=23% Similarity=0.319 Sum_probs=110.4
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--------hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+.||+|++|.||+|.+ .|..|+||+....... ....+.+|++++..++|++++....++. +.+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence 5799999999999997 6778999986543211 1245788999999999999876665532 23457
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++|++|.+++... .+ .+..++.+++.+++++|.. +++|||++|+||+++ ++.++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~---------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~ 134 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN---------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIY 134 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc---------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEE
Confidence 8999999999999887421 12 7788999999999999985 899999999999999 78999
Q ss_pred EcccCcccccc
Q 003368 801 VGDFGLARLRQ 811 (825)
Q Consensus 801 i~DFGla~~~~ 811 (825)
++|||.++...
T Consensus 135 liDf~~a~~~~ 145 (211)
T PRK14879 135 LIDFGLAEFSK 145 (211)
T ss_pred EEECCcccCCC
Confidence 99999998754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=152.55 Aligned_cols=133 Identities=19% Similarity=0.127 Sum_probs=104.5
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch----hHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCee
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG----ASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.....+++|+||+||.+.. .+..++.+.+...... ..+-|.+|++++++++ |+++++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence 4567899999999997764 6677887776544321 1225789999999996 5889999875 235
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeecCCCcE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDL-KPSNILLDNNLTA 799 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdl-k~~NILl~~~~~~ 799 (825)
++||||++|.+|.+.... ....+..|++++++|+|+. +|+|||| ||+|||+++++.+
T Consensus 74 ~lvmeyI~G~~L~~~~~~-------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i 131 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR-------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSP 131 (218)
T ss_pred EEEEeeecCccHHhhhhh-------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCE
Confidence 899999999998654310 0124678999999999986 9999999 7999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
+|+|||+|+...
T Consensus 132 ~LIDFG~A~~~~ 143 (218)
T PRK12274 132 AVIDFQLAVRGN 143 (218)
T ss_pred EEEECCCceecC
Confidence 999999998543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-17 Score=176.89 Aligned_cols=147 Identities=24% Similarity=0.311 Sum_probs=121.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++.|.....+|.|+|+.|-++.+..+++..|||++..... +-.+|+.++... +||||+++.+.| .++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 4556666779999999999999999999999999986632 234677666665 599999999984 457789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCcE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL-DNNLTA 799 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl-~~~~~~ 799 (825)
|+|||++.+|-+.+.+... +... ..+..|+.+++.|+.|||++ +|||||+||+|||+ ++.+++
T Consensus 392 ~~v~e~l~g~ell~ri~~~------------~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSK------------PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred eeeehhccccHHHHHHHhc------------chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcE
Confidence 9999999999888776432 1222 67788999999999999985 99999999999999 588999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||.|+..+..
T Consensus 456 rltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 456 RLTYFGFWSELERS 469 (612)
T ss_pred EEEEechhhhCchh
Confidence 99999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=148.95 Aligned_cols=150 Identities=26% Similarity=0.384 Sum_probs=120.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC-CCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH-RNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..|...+.||+|+||.+|.|....+|+.||||.-...... .+...|..+...++| ..|..+..+ ..+.++..
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~ynv 87 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYNV 87 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhh-----ccccccce
Confidence 4688999999999999999999999999999987654332 346678888888875 344444444 34567789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---Cc
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN---LT 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~---~~ 798 (825)
+|||.+ |.+|++.+.- ..+.++..+.+..|-|++.-++|+|.. .+|||||||+|.|..-+ ..
T Consensus 88 lVMdLL-GPsLEdLfnf-----------C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNF-----------CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred eeeecc-CccHHHHHHH-----------HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence 999988 7899988742 235788999999999999999999986 89999999999999643 46
Q ss_pred EEEcccCcccccccCC
Q 003368 799 AHVGDFGLARLRQEVP 814 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~ 814 (825)
+.++|||+||.+.+..
T Consensus 153 l~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIR 168 (341)
T ss_pred EEEEeccchhhhcccc
Confidence 8899999999886543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.8e-16 Score=155.67 Aligned_cols=133 Identities=24% Similarity=0.314 Sum_probs=104.3
Q ss_pred eeccCCeeEEEEEEEcCCCeEEEEEEeeccc-c-------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-Q-------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.||+|+||.||+|.+ +|..|+||...... . ...+.+.+|++++.+++|+++.....++. ..+..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 489999999999996 67889999864321 1 11256788999999999887554433322 234568
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++|++|.+++... . ..++.+++++++++|.. +++|||++|.||+++ ++.+++
T Consensus 74 lv~e~~~g~~l~~~~~~~------------~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~l 130 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG------------N-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYL 130 (199)
T ss_pred EEEEEECCccHHHHHhhc------------H-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEE
Confidence 999999999998877321 0 07899999999999985 999999999999999 789999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
.|||+++....
T Consensus 131 iDfg~a~~~~~ 141 (199)
T TIGR03724 131 IDFGLGKYSDE 141 (199)
T ss_pred EECCCCcCCCc
Confidence 99999988644
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=155.26 Aligned_cols=152 Identities=24% Similarity=0.339 Sum_probs=123.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
-+|..++.||+|+||+++.|+.--++++||||.-..... ..++..|....+.+. -+.|...+-+ -+++-+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence 358889999999999999999888999999998765432 235667777777664 6778777655 23456678
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-----
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN----- 796 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~----- 796 (825)
||+|.+ |.+|+|.+.- ..+.++..+.+.||.|++.-++|+|+. ..|+|||||+|.||...
T Consensus 101 LVidLL-GPSLEDLFD~-----------CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~ 165 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDL-----------CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDA 165 (449)
T ss_pred hhhhhh-CcCHHHHHHH-----------hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCC
Confidence 999988 7899988742 346799999999999999999999986 89999999999999643
Q ss_pred CcEEEcccCcccccccCCCC
Q 003368 797 LTAHVGDFGLARLRQEVPNN 816 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~ 816 (825)
..+.|.|||+||.+.+..+.
T Consensus 166 n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 166 NVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred ceEEEEeccchhhhcCcccc
Confidence 36899999999999877553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.1e-16 Score=158.91 Aligned_cols=153 Identities=24% Similarity=0.327 Sum_probs=125.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC--CC----ceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH--RN----LVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~n----iv~l~~~~~~~~~~ 715 (825)
+..|.....+|+|.||+|-++..+.++..||||+++.. ..-.++..-|+++++++.+ |+ +|++.++ |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 56788899999999999999999999999999998754 3345667789999999942 22 5667666 55
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
-.++.++|+|.| |-+++++|... ...+++......|+.|++++++|||+. +++|-|+||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N----------~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN----------NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS 227 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC----------CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence 577889999988 66999999643 345788899999999999999999996 9999999999999832
Q ss_pred --------------------CCcEEEcccCcccccccCC
Q 003368 796 --------------------NLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 796 --------------------~~~~ki~DFGla~~~~~~~ 814 (825)
...+||.|||-|+...+..
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc
Confidence 2358999999999865543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.9e-16 Score=161.30 Aligned_cols=144 Identities=28% Similarity=0.404 Sum_probs=123.7
Q ss_pred cccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 717 (825)
.+.|...+.||+|+|++||+|.+.. ..+.||+|.+..... .....+|++++..+. +.||+++.++ +..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~-----~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC-----FRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----hccC
Confidence 3457889999999999999999876 678999999865432 345789999999986 9999999987 5567
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-C
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-N 796 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~ 796 (825)
+...+|+||++..+..+++. .++..+...+.+.+..||+|+|.. +||||||||+|+|.+. .
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t 169 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRT 169 (418)
T ss_pred CeeEEEecccCccCHHHHHh---------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccccc
Confidence 88999999999988888773 467788899999999999999985 9999999999999985 4
Q ss_pred CcEEEcccCccccc
Q 003368 797 LTAHVGDFGLARLR 810 (825)
Q Consensus 797 ~~~ki~DFGla~~~ 810 (825)
+.-.+.|||+|...
T Consensus 170 ~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 170 QRGVLVDFGLAQRY 183 (418)
T ss_pred CCceEEechhHHHH
Confidence 67899999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=156.56 Aligned_cols=139 Identities=24% Similarity=0.417 Sum_probs=116.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-----C---CCceeEeeccccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-----H---RNLVRVITSCSSIDF 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~~~ 714 (825)
..|...+.+|=|-|++||.|++..+.+.||+|+.+.+ +.-.+....||+++++++ | ..||+|++++....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 4577889999999999999999999999999998754 444677889999999985 2 46999999876532
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
..+.+.+||+||+ |-+|..++... ..+.++.....+||.||+.||.|||+.| +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s----------~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS----------NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh----------CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 3456799999999 67888888532 3457889999999999999999999986 899999999999996
Q ss_pred CC
Q 003368 795 NN 796 (825)
Q Consensus 795 ~~ 796 (825)
.+
T Consensus 223 ~~ 224 (590)
T KOG1290|consen 223 ST 224 (590)
T ss_pred cc
Confidence 54
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.5e-16 Score=154.29 Aligned_cols=151 Identities=26% Similarity=0.291 Sum_probs=120.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccC-CCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ-GNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~~~~~ 720 (825)
.|.....+|.|+- .|..|.+.-.+++||+|++.... ....+...+|...+..++|+||++++.++....+. .....
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4566778888887 67777777788999999886442 23346678999999999999999999987542221 12346
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+|||||. ++|...++ ..++..+...|..|++.|+.|||+. +|+|||+||+||++..+..+|
T Consensus 97 y~v~e~m~-~nl~~vi~--------------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL--------------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred HHHHHhhh-hHHHHHHH--------------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhee
Confidence 89999995 47877664 2356667888999999999999986 999999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|.|||+|+....+
T Consensus 159 i~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 159 ILDFGLARTEDTD 171 (369)
T ss_pred eccchhhcccCcc
Confidence 9999999976544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.4e-15 Score=146.45 Aligned_cols=139 Identities=21% Similarity=0.196 Sum_probs=97.6
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh--HHH----------------------HHHHHHHhhcCCCCC--
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKS----------------------FAAECRALRNIRHRN-- 701 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n-- 701 (825)
.+.||+|+||+||+|+.. +|+.||||+++...... ... ...|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999984 89999999987542211 111 134555555554432
Q ss_pred ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003368 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPT 781 (825)
Q Consensus 702 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~i 781 (825)
+.+.+++ ...++||||+++|.+....-.. . ... .++..++.+++.++.++|.. .+|
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~----------~--~~~-~~~~~~~~~~~~~l~~lh~~--~~i 136 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKD----------V--RLL-EDPEELYDQILELMRKLYRE--AGL 136 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhh----------h--hhc-ccHHHHHHHHHHHHHHHhhc--cCc
Confidence 3333332 2358999999996643211000 0 001 45678999999999999982 389
Q ss_pred eecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 782 IHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 782 vHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+|||+||+||+++ ++.++++|||.|+....
T Consensus 137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 137 VHGDLSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcCCCChhhEEEE-CCcEEEEECcccccccC
Confidence 9999999999999 89999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=138.60 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=113.0
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC--CCceeEeecccccccCCCCeeeEEE
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH--RNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
..+.||+|.++.||++.. .+..++||....... ...+.+|++.+..++| +.+++++++. ...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence 356799999999999998 337899999865433 4678899999999987 4888888763 3345789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||++++.+..+ ++..+..++.+++++++++|....++++|+|++|+||++++.+.+++.||
T Consensus 73 e~~~g~~~~~~-------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df 133 (155)
T cd05120 73 EWIEGETLDEV-------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW 133 (155)
T ss_pred EecCCeecccC-------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence 99998776432 44567788999999999999865567999999999999999899999999
Q ss_pred Cccccccc
Q 003368 805 GLARLRQE 812 (825)
Q Consensus 805 Gla~~~~~ 812 (825)
|.++....
T Consensus 134 ~~~~~~~~ 141 (155)
T cd05120 134 EYAGYGPP 141 (155)
T ss_pred ccccCCCh
Confidence 99987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.4e-15 Score=151.01 Aligned_cols=163 Identities=21% Similarity=0.292 Sum_probs=131.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCC-----eEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDG-----TIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g-----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
..+++....++-+|.||+||+|.|++.. +.|-||.++....+ +...+..|...+..+.|||+.++.+.|.+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 3455777788999999999999886443 45667777654332 34568899999999999999999999864
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
+.+..+.+|.|+.-|+|..||..++... ......++-.+.+.+|.|++.|++|||.+ +|||.||.++|.++|
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~----~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDD----PSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCC----CccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 4556789999999999999997554222 12345678888999999999999999986 999999999999999
Q ss_pred CCCcEEEcccCcccccccCC
Q 003368 795 NNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~~ 814 (825)
+...+|++|-.++|-+-..+
T Consensus 431 d~LqVkltDsaLSRDLFP~D 450 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGD 450 (563)
T ss_pred hheeEEeccchhccccCccc
Confidence 99999999999999764433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=156.86 Aligned_cols=147 Identities=25% Similarity=0.369 Sum_probs=118.5
Q ss_pred cccccceeccCCeeEEEEEEEcCCC-eEEEEEEeecccchhHHHHHHHHHHhhcCCC----CCceeEeecccccccCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDG-TIVAIKVLNLQLQGASKSFAAECRALRNIRH----RNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~~~~~~~~~~ 718 (825)
.|...+.||+|+||.||.+....++ +.+|+|............+..|+.++..+.. +++.+++.... ..+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7889999999999999999986554 6789998766533322367788888888873 57788877631 3466
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-- 796 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-- 796 (825)
+.++||+.+ |.+|.+..... ..+.++-.+..+||.|++.+|+++|+. +++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~----------~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~ 160 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRN----------PPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSR 160 (322)
T ss_pred eeEEEEecc-CccHHHHHHhC----------CCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCC
Confidence 789999977 78999876322 135788899999999999999999985 99999999999999754
Q ss_pred ---CcEEEcccCccc
Q 003368 797 ---LTAHVGDFGLAR 808 (825)
Q Consensus 797 ---~~~ki~DFGla~ 808 (825)
..+.+.|||+|+
T Consensus 161 ~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 161 SEVRTLYLLDFGLAR 175 (322)
T ss_pred cccceEEEEecCCCc
Confidence 469999999999
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.4e-14 Score=143.29 Aligned_cols=141 Identities=18% Similarity=0.150 Sum_probs=105.2
Q ss_pred cceec-cCCeeEEEEEEEcCCCeEEEEEEeeccc-------------chhHHHHHHHHHHhhcCCCCCc--eeEeecccc
Q 003368 648 THLIG-IGSFGSVYKGTFDRDGTIVAIKVLNLQL-------------QGASKSFAAECRALRNIRHRNL--VRVITSCSS 711 (825)
Q Consensus 648 ~~~ig-~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~ 711 (825)
..+|| .|+.|+||+++. .+..+|||++.... ......+.+|++++.+++|+++ ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 46788 899999999987 47789999885321 0123457889999999998885 666665322
Q ss_pred cccCCCCeeeEEEEccCC-CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 712 IDFQGNDFKALVYQYMPN-GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
.. ......++||||+++ .+|.+++... .++. ..+.+++.++++||+. +|+|||+||+|
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------------~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~N 172 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQEA-------------PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHN 172 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhcC-------------CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchh
Confidence 10 001123599999997 6898887421 2222 2356899999999985 99999999999
Q ss_pred eeecCCCcEEEcccCcccccc
Q 003368 791 ILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~ 811 (825)
||++.++.++++|||.++...
T Consensus 173 ILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 173 ILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred EEEcCCCCEEEEECCCcccCC
Confidence 999998899999999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.8e-14 Score=164.93 Aligned_cols=130 Identities=32% Similarity=0.502 Sum_probs=105.6
Q ss_pred cCCCCCCCCc----eeeceeecCC--C--CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCC
Q 003368 11 NSWNDSHHFC----DWEGITCSPR--H--RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRL 82 (825)
Q Consensus 11 ~~w~~~~~~C----~~~g~~c~~~--~--~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 82 (825)
.+|. ++.|| .|.|++|... . ..|+.|+|++|++.+.+|+.|+.+++|+.|+|++|+++|.+|..|+.+++|
T Consensus 390 ~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L 468 (623)
T PLN03150 390 FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468 (623)
T ss_pred CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence 3796 33442 7999999632 2 258889999999999999999999999999999999988889888889999
Q ss_pred CEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcc-cccceeeccccccc
Q 003368 83 EALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSL-YNLKELAIQENNLT 141 (825)
Q Consensus 83 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~ 141 (825)
+.|||++|++++.+|..++++++|+.|+|++|+++|.+|..+..+ .++..+++.+|...
T Consensus 469 ~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999988888888888888888888888888888887664 45667777777543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-15 Score=161.16 Aligned_cols=195 Identities=29% Similarity=0.478 Sum_probs=157.8
Q ss_pred CCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcccc
Q 003368 297 CSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376 (825)
Q Consensus 297 l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 376 (825)
+.--.+.||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..+.++..|++|||+.|+++ .+|..++
T Consensus 74 ltdt~~aDlsrNR~~----------elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC 141 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS----------ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLC 141 (722)
T ss_pred ccchhhhhccccccc----------cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhh
Confidence 445567788999988 78888888888888999999998 78888999999999999999998 7888888
Q ss_pred CCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccE
Q 003368 377 NLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRM 456 (825)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~ 456 (825)
.|+ |+.|.+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+..+ ..|++..|++. .+|++++.|+ |..
T Consensus 142 ~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~Lp-Li~ 215 (722)
T KOG0532|consen 142 DLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSLP-LIR 215 (722)
T ss_pred cCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCCc-eee
Confidence 876 899999999997 67888888889999999999998 788888888777 56788888887 5677777554 778
Q ss_pred EeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCC---CCCEEECCCCc
Q 003368 457 FVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLK---DLREIDLSQNN 511 (825)
Q Consensus 457 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~---~L~~Ldls~N~ 511 (825)
||+|+|+++ .||-.|..|+.|++|-|.+|.+. ..|..++..- =.++|+..-++
T Consensus 216 lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 216 LDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 888888888 88888888888888888888887 5666654332 24556655553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.8e-13 Score=144.82 Aligned_cols=149 Identities=35% Similarity=0.509 Sum_probs=124.0
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch---hHHHHHHHHHHhhcCCCC-CceeEeecccccccCCCCee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIRHR-NLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~~~ 720 (825)
|...+.+|.|+||.||++... ..+|+|.+...... ..+.|.+|+.+++.+.|+ +++++.... ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 556788999999999999985 78999999765433 367899999999999988 799999884 334447
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TA 799 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~ 799 (825)
++|+||+.++++.+++...... ..++......++.|++.+++|+|.. +++|||+||+||+++... .+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~ 141 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVV 141 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeE
Confidence 9999999999999776432100 2577888999999999999999986 799999999999999988 79
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
|++|||.++.....
T Consensus 142 ~l~dfg~~~~~~~~ 155 (384)
T COG0515 142 KLIDFGLAKLLPDP 155 (384)
T ss_pred EEeccCcceecCCC
Confidence 99999999866544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.7e-13 Score=156.65 Aligned_cols=89 Identities=38% Similarity=0.620 Sum_probs=48.9
Q ss_pred ccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCc
Q 003368 432 SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNN 511 (825)
Q Consensus 432 ~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~ 511 (825)
.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|||++|+
T Consensus 422 ~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~ 501 (623)
T PLN03150 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501 (623)
T ss_pred EEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence 44555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cccccCccc
Q 003368 512 LSGKIPISL 520 (825)
Q Consensus 512 l~~~~p~~~ 520 (825)
++|.+|..+
T Consensus 502 l~g~iP~~l 510 (623)
T PLN03150 502 LSGRVPAAL 510 (623)
T ss_pred ccccCChHH
Confidence 555555444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-13 Score=143.48 Aligned_cols=152 Identities=23% Similarity=0.310 Sum_probs=121.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC------CCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR------HRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~~~ 716 (825)
..|......|+|-|+.|.+|.....|..||||+|.... -..+.=++|+++|.++. --|+++++.. |..
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F~h 505 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----FKH 505 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----hhh
Confidence 34777778899999999999998889999999997542 22344568999999985 3467777776 445
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
..++|||+|-+. -+|.+.|... .....+.......+|.|+.-||..|-.. +|+|.||||.|||+.+.
T Consensus 506 knHLClVFE~Ls-lNLRevLKKy---------G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 506 KNHLCLVFEPLS-LNLREVLKKY---------GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred cceeEEEehhhh-chHHHHHHHh---------CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 788999999874 4888888533 1223467778888999999999999986 99999999999999875
Q ss_pred -CcEEEcccCcccccccC
Q 003368 797 -LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 -~~~ki~DFGla~~~~~~ 813 (825)
...||||||-|....+.
T Consensus 573 k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASEN 590 (752)
T ss_pred cceeeeccCccccccccc
Confidence 46799999999887654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.2e-15 Score=157.55 Aligned_cols=194 Identities=28% Similarity=0.467 Sum_probs=168.9
Q ss_pred CCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCcccee
Q 003368 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALL 408 (825)
Q Consensus 329 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 408 (825)
.+..-...||+.|++. .+|..++.+..|+.+.|.+|.+. .+|..++++..|++|||+.|+++ .+|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4555667899999998 89999999999999999999998 89999999999999999999998 7788888886 9999
Q ss_pred ecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcC
Q 003368 409 HLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFF 488 (825)
Q Consensus 409 ~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l 488 (825)
-+++|+++ .+|++++....+ ..||.+.|.+. .+|..++++.+|+.|.+..|++. .+|++++ .-.|..||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCce
Confidence 99999998 899999955555 57899999997 78999999999999999999998 7888888 44699999999999
Q ss_pred CCCCCccccCCCCCCEEECCCCccccccCcccccc----cCceeeCCCC
Q 003368 489 RGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL----PLEYLNLSFN 533 (825)
Q Consensus 489 ~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l----~L~~l~ls~N 533 (825)
+ .||..|..|+.|++|-|.+|.|. ..|..+... -.+||+..-.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 9 89999999999999999999998 456544222 2567776655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.7e-13 Score=147.64 Aligned_cols=143 Identities=20% Similarity=0.245 Sum_probs=100.1
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh----------------------------------------HHHH
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA----------------------------------------SKSF 687 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~----------------------------------------~~~~ 687 (825)
.+.||+|++|+||+|++ .+|+.||||+.+...... .-.|
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 47899999999999999 589999999986532110 0024
Q ss_pred HHHHHHhhcCC----CCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHH
Q 003368 688 AAECRALRNIR----HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763 (825)
Q Consensus 688 ~~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~ 763 (825)
.+|++.+.+++ |.+-|.+-..+.. .....+|||||++|+++.++.... .... ++.+++
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~-----------~~~~---~~~~ia 262 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALD-----------EAGL---DRKALA 262 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHH-----------hcCC---CHHHHH
Confidence 55666666553 3333333333221 123468999999999998775321 0011 244567
Q ss_pred HHHHH-HHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 764 IDVAS-AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 764 ~~va~-~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
..+++ .+..+|.. +++|+|+||.||++++++.+++.|||+++.+.+
T Consensus 263 ~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 263 ENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 76666 46778875 999999999999999999999999999987754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-12 Score=153.11 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=110.3
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC---CCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR---HRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~ 717 (825)
.-+.|...+.||+|+||+||+|... +|+.||+|+-+.... .+|---.+++.+++ -+-|..+..+ +...
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~-~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a-----~~~~ 766 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS-NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSA-----HVFQ 766 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC-CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHH-----HccC
Confidence 3456888899999999999999995 599999998654432 22322334444555 1222222222 1224
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-- 795 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-- 795 (825)
+.-+||+||.+.|+|.+++.. .+.++|.-.+.++.|+++-+++||.. +|||+||||.|.+|..
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~------------~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT------------NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREI 831 (974)
T ss_pred CcceeeeeccccccHHHhhcc------------CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeeccc
Confidence 456899999999999999852 24689999999999999999999986 9999999999999932
Q ss_pred -----CCcEEEcccCccccccc
Q 003368 796 -----NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 -----~~~~ki~DFGla~~~~~ 812 (825)
...++|+|||-|--|.-
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred CCCCcccceEEEecccceeeeE
Confidence 34689999998876643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.7e-12 Score=144.51 Aligned_cols=192 Identities=32% Similarity=0.517 Sum_probs=124.1
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCC-CCCEEEcCCCCCCCCCChhhhcccccceeecccc
Q 003368 60 EIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS-RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 60 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 138 (825)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5788888775 23444555677888888888887 5566666664 8888888888888 56677788888888888888
Q ss_pred ccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCc----CCccccCCCCCceeecCCccccccCCch
Q 003368 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT----IPPSIYNLSLLANFSVPENRLHGSLPPS 214 (825)
Q Consensus 139 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~----~p~~i~~l~~l~~l~l~~N~l~~~lp~~ 214 (825)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|.++++ .+..+.++..+..+.+.+|++. .++..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccch
Confidence 888 55555557788888888888887 56665555566777755543 2333444444444455555554 22333
Q ss_pred hhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCcc
Q 003368 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260 (825)
Q Consensus 215 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 260 (825)
+. .+++++.|++++|+++.+.+ +..+.+++.|++++|.+...+
T Consensus 251 ~~-~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~ 293 (394)
T COG4886 251 IG-NLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNAL 293 (394)
T ss_pred hc-cccccceecccccccccccc--ccccCccCEEeccCccccccc
Confidence 33 45556666666666554333 555555566666555554444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-12 Score=143.69 Aligned_cols=186 Identities=35% Similarity=0.540 Sum_probs=127.0
Q ss_pred cccCCCCcCEEEcccCcccccCCccccCCC-CCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCc
Q 003368 326 EIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ-NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQ 404 (825)
Q Consensus 326 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 404 (825)
.+..++.+..|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++
T Consensus 111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~ 187 (394)
T COG4886 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187 (394)
T ss_pred hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence 3444466677777777776 4555555553 7777777777776 55566677777777777777776 44544556677
Q ss_pred cceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEcc
Q 003368 405 LALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMA 484 (825)
Q Consensus 405 L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~ 484 (825)
|+.|++++|+++ .+|..+.....+ ..+.+++|+.. .++..+.++..+..+.+++|++. .+|..++.+..++.|+++
T Consensus 188 L~~L~ls~N~i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s 263 (394)
T COG4886 188 LNNLDLSGNKIS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS 263 (394)
T ss_pred hhheeccCCccc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccc
Confidence 777777777776 666654333333 46666676532 45666777778888888888876 447777888888888888
Q ss_pred CCcCCCCCCccccCCCCCCEEECCCCccccccCccc
Q 003368 485 ENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520 (825)
Q Consensus 485 ~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~ 520 (825)
+|+++ .++. ++.+.+|+.||+++|.++..+|...
T Consensus 264 ~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 264 NNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccc-cccc-ccccCccCEEeccCccccccchhhh
Confidence 88887 4444 7788888888888888886666544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.3e-12 Score=140.64 Aligned_cols=150 Identities=17% Similarity=0.189 Sum_probs=93.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch----------------------------------hHH---
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG----------------------------------ASK--- 685 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~----------------------------------~~~--- 685 (825)
..|+. +.||+|++|+||+|+++.+|+.||||+.+..... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7899999999999999766999999999754210 001
Q ss_pred ---HHHHHHHHhhcCC----CCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHH
Q 003368 686 ---SFAAECRALRNIR----HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758 (825)
Q Consensus 686 ---~~~~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~ 758 (825)
+|.+|++.+.+++ +...|.+-..+. +-....+|||||++|+.+.++-.-.. .......+....
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~----d~st~~VLvmE~i~G~~l~d~~~l~~------~g~d~~~la~~~ 268 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYW----DYCSETVMVMERMYGIPVSDVAALRA------AGTDMKLLAERG 268 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeec----ccCCCceEEEeeecCccHHhHHHHHh------cCCCHHHHHHHH
Confidence 2445665555553 333333222211 11235689999999999976421000 000001122222
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----cEEEcccCcccccccC
Q 003368 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL----TAHVGDFGLARLRQEV 813 (825)
Q Consensus 759 ~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~----~~ki~DFGla~~~~~~ 813 (825)
...++.|+. . .+++|+|+||.||+++.++ .+++.|||++..+.+.
T Consensus 269 v~~~~~Qif-------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 269 VEVFFTQVF-------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHHHH-------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 222233332 2 3899999999999999888 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.4e-11 Score=117.14 Aligned_cols=133 Identities=14% Similarity=0.102 Sum_probs=97.5
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCce-eEeecccccccCCCCeeeEEEEc
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLV-RVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.+.++.|.++.||+++. .|+.|++|....... ....+.+|+++++.+.+..++ +++.+. ....++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEe
Confidence 46789999999999997 478899998764422 223467899999988765554 444431 2235799999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC--QEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~--~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
++|.++.+.- .....++.+++++++.||... ...++|+|++|.||+++ ++.+++.||
T Consensus 73 i~G~~l~~~~--------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf 131 (170)
T cd05151 73 IEGSELLTED--------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW 131 (170)
T ss_pred cCCCcccccc--------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence 9998875320 011235678999999999863 22369999999999999 568999999
Q ss_pred Ccccccc
Q 003368 805 GLARLRQ 811 (825)
Q Consensus 805 Gla~~~~ 811 (825)
|.|....
T Consensus 132 ~~a~~~~ 138 (170)
T cd05151 132 EYAGMND 138 (170)
T ss_pred ccccCCC
Confidence 9988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=117.77 Aligned_cols=127 Identities=29% Similarity=0.310 Sum_probs=51.1
Q ss_pred CCCCCCCCEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhh-hcccc
Q 003368 52 IGNLSFLREIHLSNNTIQGKIPGEIG-RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF-VSLYN 129 (825)
Q Consensus 52 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 129 (825)
+.+...+++|+|++|+|+. +. .++ .+.+|+.||||+|.|+... .+..++.|++|++++|+|+.+ ++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence 4455678999999999984 43 465 5889999999999999543 588899999999999999954 4444 57899
Q ss_pred cceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccC---CcccccccccceecC
Q 003368 130 LKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNI---PSSLGQLKELKSLGL 183 (825)
Q Consensus 130 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~L 183 (825)
|++|+|++|+|...-. ..+..+++|++|+|.+|.++... .-.+..+++|+.||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 9999999999975322 45678899999999999997432 123567788888753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=125.24 Aligned_cols=95 Identities=29% Similarity=0.347 Sum_probs=72.7
Q ss_pred CCCCceeEeecccccc----------------------cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCC
Q 003368 698 RHRNLVRVITSCSSID----------------------FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755 (825)
Q Consensus 698 ~H~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~ 755 (825)
+|||||++.++++..- +-.....|+||.-++. +|++|+... ..+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------------~~s 339 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------------HRS 339 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------------CCc
Confidence 6999999988764200 1123457889887754 899888533 345
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--cCCC--cEEEcccCcccc
Q 003368 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL--DNNL--TAHVGDFGLARL 809 (825)
Q Consensus 756 ~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl--~~~~--~~ki~DFGla~~ 809 (825)
...+..|..|+++|+.|||.+ +|.|||+|+.|||+ |+|+ ...|+|||.+--
T Consensus 340 ~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred hHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 567778899999999999987 99999999999999 5555 468999997654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=2e-11 Score=116.59 Aligned_cols=122 Identities=25% Similarity=0.340 Sum_probs=54.1
Q ss_pred CcEEEEECCCCCCccccCcCCC-CCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCC-CCCCCCCEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIG-NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNL-SYCSRLIGL 109 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 109 (825)
.+++.|+|++|.|... +.++ .+.+|+.|||++|+|+. ++ .+..+++|++|++++|+|+.. +..+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEE
Confidence 3578899999999753 3565 68999999999999994 44 488899999999999999954 3334 468999999
Q ss_pred EcCCCCCCCCCC-hhhhcccccceeeccccccccccCc----cCCCCCCCCEEEc
Q 003368 110 YLGRNKLEGSIP-SEFVSLYNLKELAIQENNLTGGIPH----FLGNITSLEAISL 159 (825)
Q Consensus 110 ~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L 159 (825)
+|++|+|..... ..+..+++|++|+|.+|.++.. +. .+..+|+|+.||-
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 999999986433 5678899999999999999843 32 3667999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-11 Score=119.89 Aligned_cols=137 Identities=27% Similarity=0.466 Sum_probs=110.7
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
...|.+...|+.|+|+|. |..+++|++... .....+.|..|.-.++-+.||||+.++|+|-+ .....++..
T Consensus 195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppnlv~isq 267 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPNLVIISQ 267 (448)
T ss_pred hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCCceEeee
Confidence 345778889999999994 456777877543 23446789999999999999999999999965 345789999
Q ss_pred ccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 726 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||+.|+|+..||+. ....++-.+++++|.++|+|++|||+. .+-|---.+.+..|++|++.++||+
T Consensus 268 ~mp~gslynvlhe~----------t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ----------TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred eccchHHHHHHhcC----------ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 99999999999864 223467779999999999999999997 3334445689999999999998885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-11 Score=132.92 Aligned_cols=145 Identities=24% Similarity=0.267 Sum_probs=115.7
Q ss_pred eeccCCeeEEEEEE---EcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeEE
Q 003368 650 LIGIGSFGSVYKGT---FDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~---~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
++|+|+||.|+.++ -...|..+|+|...+... ........|..++..++ ||.+|++..+ ++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence 36899999987643 234677899998876532 11225567888999998 9999999876 6777889999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
.+|..+|.+...+... ..++......+...+|-|++++|.. +|+|||+|++||++|.+|++|+.|
T Consensus 76 ld~~rgg~lft~l~~~------------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~td 140 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKE------------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTD 140 (612)
T ss_pred hhhcccchhhhccccC------------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCC
Confidence 9999999998777532 2455556666777888999999986 999999999999999999999999
Q ss_pred cCcccccccCC
Q 003368 804 FGLARLRQEVP 814 (825)
Q Consensus 804 FGla~~~~~~~ 814 (825)
||++|...+..
T Consensus 141 fglske~v~~~ 151 (612)
T KOG0603|consen 141 FGLSKEAVKEK 151 (612)
T ss_pred chhhhHhHhhh
Confidence 99999876653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.5e-11 Score=134.59 Aligned_cols=147 Identities=22% Similarity=0.264 Sum_probs=111.3
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecc--cchhH----HHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGAS----KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~--~~~~~----~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
...+++|.|++|.|+.+......+..+.|..+.. ..... ..+..|+.+-..++|||++..+..+.. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-----~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-----IDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-----ccc
Confidence 3468899999998888887666666666654311 11111 225568888888999999877665432 223
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
..-+|||+++ +|...+... ..++-.++..+..|+..|+.|+|+. +|.|||+|++|+++...+.+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~------------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~l 459 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSN------------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGIL 459 (601)
T ss_pred chhhhhcccH-HHHHHHhcc------------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCce
Confidence 3344999999 999888532 2466778889999999999999996 99999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||.+....-+
T Consensus 460 ki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 460 KIIDFGAASVFRYP 473 (601)
T ss_pred EEeecCcceeeccC
Confidence 99999998765433
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-09 Score=109.95 Aligned_cols=147 Identities=20% Similarity=0.204 Sum_probs=107.9
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCC--CceeEeecccccccCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHR--NLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
.+.++.|.++.||++.. .+|+.+++|+...... .....+.+|+++++.+++. .+.+++.++.... ..+..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEE
Confidence 36789999999999998 4568899999765432 1345688999999999763 4566776643211 012458999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC--------------------------- 777 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~--------------------------- 777 (825)
||++|+++.+.+.. ..++..++..++.++++++++||+..
T Consensus 80 e~i~G~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (223)
T cd05154 80 ERVDGRVLRDRLLR-------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQY 146 (223)
T ss_pred EEeCCEecCCCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHH
Confidence 99999888765420 23566677778888888888888421
Q ss_pred --------------------------CCCeeecCCCCCCeeecC--CCcEEEcccCccccc
Q 003368 778 --------------------------QEPTIHCDLKPSNILLDN--NLTAHVGDFGLARLR 810 (825)
Q Consensus 778 --------------------------~~~ivHrdlk~~NILl~~--~~~~ki~DFGla~~~ 810 (825)
...++|+|+.+.||+++. ++.+.|.||+.+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 147 DASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 235799999999999998 667899999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-11 Score=127.24 Aligned_cols=182 Identities=26% Similarity=0.247 Sum_probs=111.9
Q ss_pred CCCCCCCEEEcCCCcccccCC--ccccCCCCCCEEECCCCcCCCCC--CcCCCCCCCCCEEEcCCCCCCCCCCh-hhhcc
Q 003368 53 GNLSFLREIHLSNNTIQGKIP--GEIGRLFRLEALYLSHNSLVGEI--PGNLSYCSRLIGLYLGRNKLEGSIPS-EFVSL 127 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l 127 (825)
.++.+|+...|.+..+. .++ .....+++++.||||+|-|.... -.....+++|+.|+|+.|++.-.... .-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46778888888888776 333 35667888888888888777432 23356788888888888887632221 12356
Q ss_pred cccceeeccccccccc-cCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCcc
Q 003368 128 YNLKELAIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENR 206 (825)
Q Consensus 128 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~ 206 (825)
+.|+.|.|++|.|+.. +......+|+|+.|+|+.|..-.....+...+..|+.| +|++|+
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L-------------------dLs~N~ 257 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL-------------------DLSNNN 257 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc-------------------cccCCc
Confidence 7788888888887621 22334567888888888885333333444445555555 445555
Q ss_pred ccccCC--chhhhcCCCCcEEEcccccCCCCC-Ccc-----ccCCCCccEEEeecccc
Q 003368 207 LHGSLP--PSLGLTLSNLQLFQISNNFFSGSF-PLA-----FSNASNLQSLEILGNNF 256 (825)
Q Consensus 207 l~~~lp--~~~~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~~L~~L~L~~N~l 256 (825)
+. .++ ...+ .++.|+.|+++.+.+..+- |+. -..+++|++|+++.|++
T Consensus 258 li-~~~~~~~~~-~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 258 LI-DFDQGYKVG-TLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred cc-ccccccccc-cccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 44 222 1122 5666777777766665442 222 24556666666666665
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.6e-10 Score=140.24 Aligned_cols=100 Identities=16% Similarity=0.284 Sum_probs=74.2
Q ss_pred cCCC-CCceeEeeccccccc--CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHH
Q 003368 696 NIRH-RNLVRVITSCSSIDF--QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDY 772 (825)
Q Consensus 696 ~l~H-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~y 772 (825)
..+| +||++++++|..... ...+..+.++||+ +++|++++... ...+++.+++.|+.||++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~ 95 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----------DRSVDAFECFHVFRQIVEIVNA 95 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----------cccccHHHHHHHHHHHHHHHHH
Confidence 3455 577788887522111 1223467788887 56999999521 2358999999999999999999
Q ss_pred HHhcCCCCeeecCCCCCCeeecC-------------------CCcEEEcccCccccc
Q 003368 773 LHHHCQEPTIHCDLKPSNILLDN-------------------NLTAHVGDFGLARLR 810 (825)
Q Consensus 773 LH~~~~~~ivHrdlk~~NILl~~-------------------~~~~ki~DFGla~~~ 810 (825)
||+. +||||||||+|||++. ++.+|++|||+++..
T Consensus 96 lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 96 AHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred HHhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 9985 9999999999999954 456677777777653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-09 Score=104.47 Aligned_cols=137 Identities=20% Similarity=0.144 Sum_probs=96.2
Q ss_pred ceeccCCeeEEEEEEEcC------CCeEEEEEEeecccc----------------------hhHHH----HHHHHHHhhc
Q 003368 649 HLIGIGSFGSVYKGTFDR------DGTIVAIKVLNLQLQ----------------------GASKS----FAAECRALRN 696 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~------~g~~vAvK~~~~~~~----------------------~~~~~----~~~E~~~l~~ 696 (825)
..||.|.=+.||.|.... .+..+|||+.+.... ...+. ..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998632 357999998863210 01122 3379999998
Q ss_pred CCC--CCceeEeecccccccCCCCeeeEEEEccCCCChhhh-ccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHH
Q 003368 697 IRH--RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENW-LHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYL 773 (825)
Q Consensus 697 l~H--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yL 773 (825)
++. -++.+.+++ ...++||||+.++.+... +. ...++..+...+..+++.++.++
T Consensus 83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lk-------------d~~~~~~~~~~i~~~i~~~l~~l 140 (197)
T cd05146 83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLK-------------DAKLNDEEMKNAYYQVLSMMKQL 140 (197)
T ss_pred HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhh-------------ccccCHHHHHHHHHHHHHHHHHH
Confidence 864 455566653 235899999977544211 11 01233345567788999999999
Q ss_pred -HhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 774 -HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 774 -H~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|.. +|||+|+++.||++++ +.+.|+|||-|-...
T Consensus 141 ~H~~---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 141 YKEC---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHhC---CeecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 654 9999999999999974 689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.1e-11 Score=119.24 Aligned_cols=104 Identities=28% Similarity=0.263 Sum_probs=69.6
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeec
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 135 (825)
+.|++||||+|.|+ .+..+..-+++++.|++|+|.|... +.+..+++|+.||||+|.++ .+.++=..+.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 45677777777777 5666666677777777777777633 23667777777777777776 34455556667777777
Q ss_pred cccccccccCccCCCCCCCCEEEcccCcCc
Q 003368 136 QENNLTGGIPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 136 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
++|.|... ..+..|-+|..||+++|+|.
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchh
Confidence 77776532 24556667777777777775
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-11 Score=118.07 Aligned_cols=150 Identities=25% Similarity=0.322 Sum_probs=119.0
Q ss_pred CCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcC
Q 003368 13 WNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92 (825)
Q Consensus 13 w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 92 (825)
|.+..+.-...-+...+..+-++.+|||.|.+. .+.+++.-++.++.|++|+|.|. .+. .+..|.+|+.||||+|.+
T Consensus 265 ~~~E~~t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~L 341 (490)
T KOG1259|consen 265 SGSEPSTSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLL 341 (490)
T ss_pred cCCCCCccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchh
Confidence 543333333333334444578899999999884 78899999999999999999998 333 388899999999999999
Q ss_pred CCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccccccccc-CccCCCCCCCCEEEcccCcCcccC
Q 003368 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGI-PHFLGNITSLEAISLAYNSLGGNI 168 (825)
Q Consensus 93 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~ 168 (825)
+ .+-+.=..+.+.+.|.|+.|.|.. -..++.+-+|..||+++|+|.... -..+++||-|+++.|-+|.+.+..
T Consensus 342 s-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 342 A-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred H-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 8 555555678899999999999984 246788899999999999997432 256899999999999999998543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.5e-11 Score=131.61 Aligned_cols=193 Identities=31% Similarity=0.334 Sum_probs=125.9
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccce
Q 003368 53 GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKE 132 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 132 (825)
..+..++.+++..|.|. .+-..++.+++|+.|++..|+|..+ ...+..+.+|++|+|++|+|+.+. .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhh
Confidence 35677788889999988 4556688889999999999999844 334788999999999999998654 3566777999
Q ss_pred eeccccccccccCccCCCCCCCCEEEcccCcCcccCC-cccccccccceecCcCcCCccccCCCCCc---eeecCCcccc
Q 003368 133 LAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP-SSLGQLKELKSLGLGGTIPPSIYNLSLLA---NFSVPENRLH 208 (825)
Q Consensus 133 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~~~p~~i~~l~~l~---~l~l~~N~l~ 208 (825)
|++++|.|+.. ..+..+++|+.+++++|+++...+ . ...+.+++.++++++....+..+..+. .+++..|.++
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHHHHHHHhhcccccce
Confidence 99999999843 456668999999999999985544 2 466777777777665444443333222 2245555554
Q ss_pred ccCCchhhhcCC--CCcEEEcccccCCCCCCccccCCCCccEEEeecccc
Q 003368 209 GSLPPSLGLTLS--NLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF 256 (825)
Q Consensus 209 ~~lp~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 256 (825)
..-+.. .+. +|+.+++++|.+... +..+..+..+..|++.+|++
T Consensus 222 ~~~~l~---~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 222 KLEGLN---ELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred eccCcc---cchhHHHHHHhcccCccccc-cccccccccccccchhhccc
Confidence 211100 111 145555555555421 13334444455555554444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-10 Score=121.18 Aligned_cols=212 Identities=20% Similarity=0.208 Sum_probs=115.0
Q ss_pred CCCCCCEEEcCCCCCCCCCC--hhhhcccccceeeccccccccccC--ccCCCCCCCCEEEcccCcCcccCCcccccccc
Q 003368 102 YCSRLIGLYLGRNKLEGSIP--SEFVSLYNLKELAIQENNLTGGIP--HFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177 (825)
Q Consensus 102 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 177 (825)
++.+|++.-|.+..+. ..+ .....+++++.||||.|-++...| .....|++|+.|+|+.|++.-.....
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~------ 191 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN------ 191 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc------
Confidence 5556666666666665 233 355667777777777777664322 33456777777777777775222111
Q ss_pred cceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 178 L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
.+. .++.++.|.|+.|.++..--..+....++|+.|+|+.|....+.......+..|+.|||++|++.
T Consensus 192 -~~~-----------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li 259 (505)
T KOG3207|consen 192 -TTL-----------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI 259 (505)
T ss_pred -chh-----------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence 000 22334444555555543211223335667777777777533333334455566666676666654
Q ss_pred CccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCcc-----ccCCCC
Q 003368 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSE-----IGKLVS 332 (825)
Q Consensus 258 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~-----l~~l~~ 332 (825)
.... ....+.++.|+.|+++.+.+... .+|+. ...+++
T Consensus 260 ~~~~-----------------------------~~~~~~l~~L~~Lnls~tgi~si--------~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 260 DFDQ-----------------------------GYKVGTLPGLNQLNLSSTGIASI--------AEPDVESLDKTHTFPK 302 (505)
T ss_pred cccc-----------------------------ccccccccchhhhhccccCcchh--------cCCCccchhhhccccc
Confidence 3221 11233445555555555554421 12221 345667
Q ss_pred cCEEEcccCcccccC-CccccCCCCCCEEEcccccccc
Q 003368 333 LYLIEMDHNQFEGKI-PEEMSRLQNLQFLNMRHNQLSG 369 (825)
Q Consensus 333 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 369 (825)
|++|+++.|++.... -..+..+++|+.|....|.|.-
T Consensus 303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 777888888775211 1234456778888888888863
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.9e-10 Score=128.43 Aligned_cols=211 Identities=27% Similarity=0.298 Sum_probs=153.9
Q ss_pred EEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 34 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
+..+++..|.+.. +-..+..+++|+.|++.+|+|+ .+...+..+++|++|+||+|+|+.+. .+..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence 3444555666543 3445788999999999999999 45555788999999999999998664 366777799999999
Q ss_pred CCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcccc
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIY 192 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~ 192 (825)
|.|+.+ ..|..+++|+.+++++|+++...+ . ...+.+++.+++..|.+.. ...+..+..+..+++..+....+.
T Consensus 150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 150 NLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred Ccchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceecc
Confidence 999843 456669999999999999996554 2 5788999999999999963 334455555555566655444444
Q ss_pred CCCC-----CceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 193 NLSL-----LANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 193 ~l~~-----l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
.+.. |+.+++++|.+. .++..+. .+.++..|++++|++.... .+...+.+..+.+..|.+.
T Consensus 225 ~l~~~~~~~L~~l~l~~n~i~-~~~~~~~-~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 225 GLNELVMLHLRELYLSGNRIS-RSPEGLE-NLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLA 290 (414)
T ss_pred CcccchhHHHHHHhcccCccc-ccccccc-ccccccccchhhccccccc--cccccchHHHhccCcchhc
Confidence 4333 788999999997 3333333 6889999999999987542 2345556666666666654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.4e-10 Score=87.38 Aligned_cols=60 Identities=35% Similarity=0.380 Sum_probs=34.8
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 57 FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
+|++|++++|+|+.+.++.|.++++|++|++++|+|+...|+.|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666655555555666666666666666555555555555555555555543
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.1e-09 Score=97.69 Aligned_cols=133 Identities=26% Similarity=0.325 Sum_probs=96.7
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEe-ecccch-------hHHHHHHHHHHhhcCCCCCce--eEeecccccccCCCC
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVL-NLQLQG-------ASKSFAAECRALRNIRHRNLV--RVITSCSSIDFQGND 718 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~-~~~~~~-------~~~~~~~E~~~l~~l~H~niv--~l~~~~~~~~~~~~~ 718 (825)
..+++|+=+.+|.+.+ -|..+++|.= ++.... ..+.-.+|+.++++++-.-|. .++.+ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence 3578999999999987 3445666643 222211 123467899999988744333 33332 345
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
...+||||++|-.|.+.+... +..++..|-.-+.-||.. +|||+|+.++||.+..+.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~- 129 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR- 129 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-
Confidence 668999999999988887321 345778888888899986 999999999999998765
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+.+.|||+++...+.
T Consensus 130 i~~IDfGLg~~s~~~ 144 (204)
T COG3642 130 IYFIDFGLGEFSDEV 144 (204)
T ss_pred EEEEECCcccccccH
Confidence 999999999976554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.4e-09 Score=107.68 Aligned_cols=157 Identities=24% Similarity=0.311 Sum_probs=97.5
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCC-----------CCce-----e
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRH-----------RNLV-----R 704 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-----------~niv-----~ 704 (825)
.+...+.||.|+++.||.+++.++|+.+|||+...... ...+++.+|.-....+.+ .-++ +
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567899999999999999999999999998864432 234566666655544322 1111 1
Q ss_pred EeecccccccCCC---C-----eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc
Q 003368 705 VITSCSSIDFQGN---D-----FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH 776 (825)
Q Consensus 705 l~~~~~~~~~~~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~ 776 (825)
+.+-= ..++.. . ..+++|+-+ .++|.+.+..-. ........+....|+.+..|+++.+++||+.
T Consensus 93 i~~~~--~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~-----~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 93 IPGKP--PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALF-----SRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp ETTS---SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHH-----HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EcCCC--cceecCCCCccceeehhhhccchh-hhcHHHHHHHHh-----hcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 11100 000001 1 125677766 468877753100 0001122345566788889999999999996
Q ss_pred CCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 777 CQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 777 ~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
++||+||||+|++++++|.++++||+......
T Consensus 165 ---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 165 ---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp ---TEEEST-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred ---ceEecccceeeEEEcCCCCEEEcChHHHeecC
Confidence 99999999999999999999999998766543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1e-09 Score=86.21 Aligned_cols=60 Identities=37% Similarity=0.485 Sum_probs=35.3
Q ss_pred CCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcC
Q 003368 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 105 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
+|++|++++|+|+.+.+++|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555555555566666666666666666655555666666666666666553
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-10 Score=116.26 Aligned_cols=191 Identities=18% Similarity=0.246 Sum_probs=107.5
Q ss_pred cCCCCcEEEcccccCCCCCCcc----ccCCCCccEEEeecccccCcc-------------ccCcCCCCCCcEEEcccccC
Q 003368 218 TLSNLQLFQISNNFFSGSFPLA----FSNASNLQSLEILGNNFFGKL-------------SVNFGDMKSLAYLNVAINNL 280 (825)
Q Consensus 218 ~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~-------------~~~~~~l~~L~~L~ls~N~l 280 (825)
..++|++||||+|.|.-.-+.. ++.++.|+.|.|.+|-+...- ....+.-+.|+.+...+|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 3456777777777765443333 345677777777777553211 11234456677777777766
Q ss_pred CCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc----CCccccCCCC
Q 003368 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK----IPEEMSRLQN 356 (825)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~ 356 (825)
...... .+-..|..++.|+.+.++.|.+.. ... ..+-..+..+++|++|||..|.|+.. +...++.+++
T Consensus 170 en~ga~--~~A~~~~~~~~leevr~~qN~I~~---eG~--~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~ 242 (382)
T KOG1909|consen 170 ENGGAT--ALAEAFQSHPTLEEVRLSQNGIRP---EGV--TALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPH 242 (382)
T ss_pred ccccHH--HHHHHHHhccccceEEEecccccC---chh--HHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccch
Confidence 543322 223345556677777777776641 110 01223456677777777777777632 2344556677
Q ss_pred CCEEEccccccccccCccc-----cCCCCCcEEEcccCcccc----ccCCCCCCCCccceeecCCCCC
Q 003368 357 LQFLNMRHNQLSGEIPSSF-----GNLSSLVKLILGNNNLSG----VIPSSLGNLKQLALLHLFQNDL 415 (825)
Q Consensus 357 L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l 415 (825)
|+.|++++|.+...-...| ...++|++|.|.+|.++- .+-......+.|..|+|+.|++
T Consensus 243 L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 243 LRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred heeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 7777777777753222221 135667777777776652 1222334466666677777766
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-11 Score=120.19 Aligned_cols=142 Identities=18% Similarity=0.263 Sum_probs=89.8
Q ss_pred CCCCcEEEcccccCCCCCC----ccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCcccccccc
Q 003368 219 LSNLQLFQISNNFFSGSFP----LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSL 294 (825)
Q Consensus 219 l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~ 294 (825)
-++|+++...+|++..... ..|...+.|+.+.++.|.+...- . ......+
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG------------------------~--~al~eal 209 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEG------------------------V--TALAEAL 209 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCch------------------------h--HHHHHHH
Confidence 4556777777776653322 23455566666666666542111 0 1123456
Q ss_pred ccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc-----cCCCCCCEEEcccccccc
Q 003368 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-----SRLQNLQFLNMRHNQLSG 369 (825)
Q Consensus 295 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~ 369 (825)
..|++|+.|||..|-|+... +-.+...++.|++|+.|+++++.+...-..+| ...++|++|.|.+|.++.
T Consensus 210 ~~~~~LevLdl~DNtft~eg-----s~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~ 284 (382)
T KOG1909|consen 210 EHCPHLEVLDLRDNTFTLEG-----SVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITR 284 (382)
T ss_pred HhCCcceeeecccchhhhHH-----HHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHH
Confidence 67888888888888776310 00233456778888888888888875433322 246899999999999863
Q ss_pred ----ccCccccCCCCCcEEEcccCcc
Q 003368 370 ----EIPSSFGNLSSLVKLILGNNNL 391 (825)
Q Consensus 370 ----~~p~~~~~l~~L~~L~Ls~N~l 391 (825)
.+...+...+.|..|+|++|++
T Consensus 285 da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 285 DAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHHHHHhcchhhHHhcCCcccc
Confidence 2334455688999999999998
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.4e-08 Score=92.08 Aligned_cols=147 Identities=22% Similarity=0.269 Sum_probs=100.7
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEe-ecccc-------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVL-NLQLQ-------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~-~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
...++-+|+=+.|+++.+ .|+...||.- .+... -..+...+|++.+.+++--.|.-..-+ +.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 578899999999999998 6777777743 22221 123456789999998864433321111 11233
Q ss_pred eeeEEEEccCC-CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 719 FKALVYQYMPN-GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 719 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
.-.++|||++| -++.+++.....+.. .-......+..|-+.+.-||.. .|||+|+..+||++.+++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~----------~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~ 150 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDES----------EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDG 150 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcc----------cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCC
Confidence 45799999977 477888754322111 1112256788889999999986 999999999999996554
Q ss_pred ---cEEEcccCcccccccC
Q 003368 798 ---TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ---~~ki~DFGla~~~~~~ 813 (825)
.+.+.|||++.....+
T Consensus 151 ~~~~~~lIdfgls~~s~~~ 169 (229)
T KOG3087|consen 151 NQITPILIDFGLSSVSRLP 169 (229)
T ss_pred CcCceEEEeecchhcccCc
Confidence 5689999998876543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3e-09 Score=126.65 Aligned_cols=125 Identities=28% Similarity=0.347 Sum_probs=60.9
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCc--CCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccccee
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS--LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 133 (825)
...+...+-+|++. .++.+..+ ++|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+||+|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 44445555555554 33333322 245555555553 332333334455555555555544444555555555555555
Q ss_pred eccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecC
Q 003368 134 AIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183 (825)
Q Consensus 134 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 183 (825)
+|++..+. .+|..+++|..|.+|++..+.-...+|.....|++|++|.+
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l 649 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRL 649 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEe
Confidence 55555555 45555555555555555555443344444444555555543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.4e-08 Score=94.76 Aligned_cols=126 Identities=21% Similarity=0.249 Sum_probs=81.1
Q ss_pred EEEEEEcCCCeEEEEEEeecccc--------------------------hhHHHHHHHHHHhhcCCCC--CceeEeeccc
Q 003368 659 VYKGTFDRDGTIVAIKVLNLQLQ--------------------------GASKSFAAECRALRNIRHR--NLVRVITSCS 710 (825)
Q Consensus 659 Vy~~~~~~~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 710 (825)
||.|.. .+|..||||+.+.... .......+|.+.|.++... ++.+.+.+
T Consensus 2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 899998 7889999998864210 0123467899999999865 45666654
Q ss_pred ccccCCCCeeeEEEEccC--CCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 711 SIDFQGNDFKALVYQYMP--NGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
...++||||++ |..+..... . .++......++.+++..+..+++. .+|||+|+.+
T Consensus 79 -------~~~~ivME~I~~~G~~~~~l~~-~-------------~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~ 135 (188)
T PF01163_consen 79 -------NRNVIVMEYIGEDGVPLPRLKD-V-------------DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSE 135 (188)
T ss_dssp -------ETTEEEEE--EETTEEGGCHHH-C-------------GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-ST
T ss_pred -------eCCEEEEEecCCCccchhhHHh-c-------------cccchhHHHHHHHHHHHHHHHHHh--cCceecCCCh
Confidence 13479999998 544432221 0 111223456777888867775432 4999999999
Q ss_pred CCeeecCCCcEEEcccCcccccc
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~ 811 (825)
.||+++++ .+.|.|||-|....
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETT
T ss_pred hhEEeecc-eEEEEecCcceecC
Confidence 99999988 99999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-08 Score=120.15 Aligned_cols=128 Identities=22% Similarity=0.232 Sum_probs=103.0
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCc--ccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNT--IQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+....+-+|.+. .++.+. ..+.|+.|=+..|. +.....+.|..++.|+.||||+|.=-+.+|..++.|.+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4455555555553 333333 22379999999996 6645555688899999999999876679999999999999999
Q ss_pred cCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCc
Q 003368 111 LGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS 163 (825)
Q Consensus 111 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 163 (825)
|++..|+ .+|..+.+|.+|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 9999999 789999999999999999988766778888889999999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-07 Score=94.83 Aligned_cols=148 Identities=15% Similarity=0.020 Sum_probs=99.9
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-----------hhHHHHHHHHHHhhcCCCCCce--eEeeccccccc
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-----------GASKSFAAECRALRNIRHRNLV--RVITSCSSIDF 714 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv--~l~~~~~~~~~ 714 (825)
.+++-+.....|++..+ .|+.|.||+.....- .....+.+|...+.++....|. +++++......
T Consensus 27 ~e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~ 104 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN 104 (268)
T ss_pred CcEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence 45566555566778876 678899997643221 1112478899888887533332 33444211000
Q ss_pred CCCCeeeEEEEccCCC-ChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 715 QGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.....-++|+|++++- +|.+++.... ....+...+..++.++++.++-||.. +|+|+|++++|||+
T Consensus 105 ~~~~~s~LVte~l~~~~sL~~~~~~~~----------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl 171 (268)
T PRK15123 105 PATRTSFIITEDLAPTISLEDYCADWA----------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLL 171 (268)
T ss_pred CccceeEEEEeeCCCCccHHHHHHhhc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEE
Confidence 0123468999999986 7888873210 01234456778999999999999986 99999999999999
Q ss_pred cC-------CCcEEEcccCccccc
Q 003368 794 DN-------NLTAHVGDFGLARLR 810 (825)
Q Consensus 794 ~~-------~~~~ki~DFGla~~~ 810 (825)
+. +..+.++||+.++..
T Consensus 172 ~~~~~~~~~~~~~~LIDl~r~~~~ 195 (268)
T PRK15123 172 HLPFPGREEDLKLSVIDLHRAQIR 195 (268)
T ss_pred eccccCCCCCceEEEEECCccccc
Confidence 75 468999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.1e-09 Score=120.51 Aligned_cols=141 Identities=23% Similarity=0.255 Sum_probs=108.8
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHH---HHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAA---ECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++...+.+|++.|=+|.||++ +.|. |+||++-++. .-..+.|.+ |++ ..-++|||.+++.-. ...+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-----~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-----LVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-----HHhhHH
Confidence 466678999999999999998 4666 8999886654 233444444 444 556789999987654 223445
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|||=+|+.. +|+|.+..+ ..+...+..=||.|++.|+.-+|.. +|+|+|||.+|||+....=+
T Consensus 96 AylvRqyvkh-nLyDRlSTR------------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~ 159 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTR------------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWL 159 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccc------------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechh
Confidence 6788888865 888888432 3456667778999999999999985 99999999999999998889
Q ss_pred EEcccCccc
Q 003368 800 HVGDFGLAR 808 (825)
Q Consensus 800 ki~DFGla~ 808 (825)
-++||.--|
T Consensus 160 ~LtDFAsFK 168 (1431)
T KOG1240|consen 160 YLTDFASFK 168 (1431)
T ss_pred hhhcccccC
Confidence 999997655
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.5e-08 Score=106.80 Aligned_cols=100 Identities=30% Similarity=0.444 Sum_probs=87.2
Q ss_pred hhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHH
Q 003368 694 LRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYL 773 (825)
Q Consensus 694 l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yL 773 (825)
|+.+.|.|+.+++|.|.. +...+.|.+|++.|+|.|.+.. ....++|.-...+.++++.||+|+
T Consensus 1 l~~l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~-----------~~~~~d~~F~~s~~rdi~~Gl~yl 64 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSN-----------EDIKLDYFFILSFIRDISKGLAYL 64 (484)
T ss_pred CcccchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhc-----------cccCccHHHHHHHHHHHHHHHHHH
Confidence 457899999999999864 3678999999999999999953 234688999999999999999999
Q ss_pred HhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 774 HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 774 H~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|+- +-..|+.++++|.++|..+.+|++|||+..+.+
T Consensus 65 h~s--~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 65 HNS--PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred hcC--cceeeeeeccccceeeeeEEEEechhhhccccc
Confidence 984 333899999999999999999999999999885
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-07 Score=98.15 Aligned_cols=155 Identities=18% Similarity=0.185 Sum_probs=118.1
Q ss_pred eeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCC-CChhh
Q 003368 656 FGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPN-GSLEN 734 (825)
Q Consensus 656 ~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~ 734 (825)
-.+.||+....+|..|+.|+++.........-..-++..+++.|+|+|++...+....|. +...++||+|.|+ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~-D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG-DLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccC-cceEEEEEecCCCCchHHH
Confidence 356899999999999999999654433322233457788999999999999987643343 4568999999987 78888
Q ss_pred hccCCCCCCCcc---cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 735 WLHPDAIPQTDE---ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 735 ~l~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
+........... ........++...+.++.|++.||.++|+. +..-+-+.+.+|+++.+.+++|+..|...+.+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 765432221000 012234577888899999999999999986 78789999999999999999999999988887
Q ss_pred cCC
Q 003368 812 EVP 814 (825)
Q Consensus 812 ~~~ 814 (825)
+++
T Consensus 445 ~d~ 447 (655)
T KOG3741|consen 445 EDP 447 (655)
T ss_pred CCC
Confidence 765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9e-07 Score=88.36 Aligned_cols=133 Identities=23% Similarity=0.194 Sum_probs=91.5
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc----------------------hhHHHHHHHHHHhhcCCCC--Cc
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ----------------------GASKSFAAECRALRNIRHR--NL 702 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--ni 702 (825)
..+.||-|.=+.||.|.. +.|.++|||.=+.... -.....++|.++|.++.-. .+
T Consensus 95 iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 457899999999999998 6899999997543211 0123567899999998754 66
Q ss_pred eeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 003368 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTI 782 (825)
Q Consensus 703 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~iv 782 (825)
.+.+++ +..++||||++|-.|...= ++-...-.|+..|+.-+.-.-. .+||
T Consensus 174 P~P~~~---------nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~~---~GiV 224 (304)
T COG0478 174 PKPIAW---------NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAYR---RGIV 224 (304)
T ss_pred CCcccc---------ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHHH---cCcc
Confidence 666654 4578999999986664221 0111112233333332222223 3899
Q ss_pred ecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 783 HCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 783 Hrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
|+|+.+=||+++++|.+.+.||-=+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999965544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.8e-08 Score=112.48 Aligned_cols=152 Identities=26% Similarity=0.368 Sum_probs=114.6
Q ss_pred ccccccceeccCCeeEEEEEEEc-CCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-RDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 718 (825)
..|...+.||+|+|+.|-.+... .....+|+|.+.... ....+....|..+=..+. |+|++.+++.. ...+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence 34666777999999999887763 234567778776543 122233445666666666 99999999974 4467
Q ss_pred eeeEEEEccCCCChhhhc-cCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 719 FKALVYQYMPNGSLENWL-HPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
..+++.||..+|++.+.. +... ...+......+..|+..++.|+|.. .++.|||+||+|.+++..+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~-----------~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDS-----------TGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESG 161 (601)
T ss_pred ccccccCcccccccccccccCCc-----------cCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCC
Confidence 789999999999998877 3221 1234445677889999999999932 4899999999999999999
Q ss_pred -cEEEcccCccccccc
Q 003368 798 -TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 -~~ki~DFGla~~~~~ 812 (825)
..|++|||+|.....
T Consensus 162 ~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 162 SALKIADFGLATAYRN 177 (601)
T ss_pred CcccCCCchhhccccc
Confidence 999999999987765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.9e-07 Score=99.17 Aligned_cols=127 Identities=18% Similarity=0.264 Sum_probs=99.1
Q ss_pred EEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCC
Q 003368 661 KGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDA 740 (825)
Q Consensus 661 ~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 740 (825)
.|..+.++.+|.|...+...........+.++.++.+|||||++++.. ++.+...|+|+|-+. -|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH--
Confidence 466667889999998876654444556788899999999999999987 455678899999875 34444421
Q ss_pred CCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 741 IPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 741 ~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
+.-....-.+.||+.||.|||+.| .++|++|.-..|++++.|+-||++|-++....
T Consensus 101 -------------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 101 -------------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred -------------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 222344456789999999999864 89999999999999999999999998775443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.2e-09 Score=113.65 Aligned_cols=123 Identities=30% Similarity=0.277 Sum_probs=72.6
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
|...+.+.|.+. ....++.-++.|+.||||+|+++... .+..|+.|+.|||++|.+....--...++. |+.|.|++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 444555666665 45555666666777777777766432 566666777777777776633222333443 77777777
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccC-CcccccccccceecCcCc
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNI-PSSLGQLKELKSLGLGGT 186 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~~ 186 (825)
|.++.. ..+.+|.+|+.||+++|-|++.- -..++.|..|+.|+|.||
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGN 289 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGN 289 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCC
Confidence 776633 24556677777777777666421 223455666666666554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.2e-08 Score=87.26 Aligned_cols=133 Identities=24% Similarity=0.387 Sum_probs=93.6
Q ss_pred CCCEEEcccccccccCCCCcccccCCc---cccCCCCcCEEEcccCcccccCCcccc-CCCCCCEEEccccccccccCcc
Q 003368 299 NLSFLNLVANQFKGALPHSIVSGSIPS---EIGKLVSLYLIEMDHNQFEGKIPEEMS-RLQNLQFLNMRHNQLSGEIPSS 374 (825)
Q Consensus 299 ~L~~L~L~~N~l~~~~~~~~~~~~ip~---~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~ 374 (825)
.+..++|+++++- .+++ .+.....|...+|++|.|. .+|+.|. ..+.++.|+|++|+|+ .+|..
T Consensus 28 E~h~ldLssc~lm----------~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE 95 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM----------YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEE 95 (177)
T ss_pred Hhhhcccccchhh----------HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHH
Confidence 3566777777664 3444 3455566777888999888 4454444 5568889999999998 78888
Q ss_pred ccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCc
Q 003368 375 FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPP 446 (825)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~ 446 (825)
+..++.|+.|+++.|.+. ..|..+..+.+|..|+..+|.+. .||..++.-. +.-..++.++.+.+.-|.
T Consensus 96 ~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~-~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 96 LAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSS-LPALIKLGNEPLGDETKK 164 (177)
T ss_pred HhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccc-cHHHHHhcCCcccccCcc
Confidence 999999999999999987 56777777888888888888887 6776644322 223345555555554443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.7e-07 Score=105.51 Aligned_cols=112 Identities=29% Similarity=0.431 Sum_probs=76.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...++|..|+||.||..+++.+.+.+|+| ++++.. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence 467999999999999999999998888999994 443311 1110 22222233322
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
|+=...+..- +.++ .+.+.+++|+|+ .+|+|||+||.|.++..-|++|+
T Consensus 136 --------gDc~tllk~~------------g~lP--------vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKl 184 (1205)
T KOG0606|consen 136 --------GDCATLLKNI------------GPLP--------VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKL 184 (1205)
T ss_pred --------chhhhhcccC------------CCCc--------chhhHHhHhhcc---CCeecCCCCCCcceeeecccccc
Confidence 2211112110 1111 122679999998 59999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
.|||+.+..
T Consensus 185 TDfgLsk~G 193 (1205)
T KOG0606|consen 185 TDFGLSKKG 193 (1205)
T ss_pred cchhhhhhh
Confidence 999998865
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.29 E-value=4e-06 Score=83.97 Aligned_cols=111 Identities=23% Similarity=0.275 Sum_probs=80.8
Q ss_pred HHHHHHHHHhhcCCCCC--ceeEeecccccccCCCCeeeEEEEccCCC-ChhhhccCCCCCCCcccchhcccCCHHHHHH
Q 003368 685 KSFAAECRALRNIRHRN--LVRVITSCSSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERIS 761 (825)
Q Consensus 685 ~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~ 761 (825)
..+.+|...+.+++... ..+.+++..... ......++|+|++++- +|.+++... ...+...+..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~------------~~~~~~~~~~ 122 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQW------------EQLDPSQRRE 122 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhh------------cccchhhHHH
Confidence 35678888877775333 334555432211 1113458999999984 788887431 1144456778
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---cEEEcccCcccccc
Q 003368 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL---TAHVGDFGLARLRQ 811 (825)
Q Consensus 762 i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~---~~ki~DFGla~~~~ 811 (825)
++.++++.++-||+. +|+|+|+++.|||++.+. .+.+.||+-++...
T Consensus 123 ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 123 LLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999986 999999999999998876 89999999888754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.9e-06 Score=80.03 Aligned_cols=143 Identities=16% Similarity=0.166 Sum_probs=100.7
Q ss_pred ccCCeeEEEEEEEcCCCeEEEEEEeeccc------chhHHHHHHHHHHhhcCCCCC--ceeEeecccccccCCCCeeeEE
Q 003368 652 GIGSFGSVYKGTFDRDGTIVAIKVLNLQL------QGASKSFAAECRALRNIRHRN--LVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 652 g~G~~g~Vy~~~~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~~~~lv 723 (825)
|+|+-+.|++-.+ .|+.+=+|+-.... +.....|.+|...+.++...+ +.+.. ++........-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5677778998876 45568888765221 234578999999999886332 44444 3221111122335799
Q ss_pred EEccCC-CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--EE
Q 003368 724 YQYMPN-GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT--AH 800 (825)
Q Consensus 724 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~--~k 800 (825)
+|-+++ -+|.+++.... ..+.+...+..+..+|++.++-||+. ++.|+|+.+.||+++.++. ++
T Consensus 104 Te~L~g~~~L~~~l~~~~----------~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA----------VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred EEeCCCCccHHHHHhcCC----------cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEE
Confidence 998764 58888874321 12345667789999999999999986 9999999999999986666 99
Q ss_pred EcccCccccc
Q 003368 801 VGDFGLARLR 810 (825)
Q Consensus 801 i~DFGla~~~ 810 (825)
+.||--++..
T Consensus 171 lIDlEk~r~~ 180 (216)
T PRK09902 171 FLDLEKSRRR 180 (216)
T ss_pred EEEhhccchh
Confidence 9999876654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-08 Score=111.69 Aligned_cols=127 Identities=24% Similarity=0.214 Sum_probs=102.5
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
.+...+.++|.+. ....++.-++.|+.|||++|+++... .+..+++|++|||++|.++....-....|. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4555677788875 66778888999999999999998543 889999999999999999955444455565 9999999
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCc
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 165 (825)
+|.++.. ..+.+|.+|+.||++.|-|.+--. ..+..|..|+.|.|.+|.+-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999853 467899999999999999875321 23567788999999999985
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.5e-06 Score=94.50 Aligned_cols=142 Identities=18% Similarity=0.214 Sum_probs=92.0
Q ss_pred ceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------------------------------hHH----------HHH
Q 003368 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------------------------------ASK----------SFA 688 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------------------------------~~~----------~~~ 688 (825)
+.|+.++-|+||+|++ .+|+.||||+.+..... ..+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 7899999999999999 57999999998653211 001 244
Q ss_pred HHHHHhhcCC-----CCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHH
Q 003368 689 AECRALRNIR-----HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763 (825)
Q Consensus 689 ~E~~~l~~l~-----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~ 763 (825)
+|...+.+++ .|.+. +=..|+ +-.....|+|||++|-.+.+...-. ....+ +..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~-VP~V~w----e~t~~~VLtmE~i~Gi~i~d~~~l~-----------~~g~d---~k~ia 270 (517)
T COG0661 210 REAANAERFRENFKDDPDVY-VPKVYW----EYTTRRVLTMEWIDGIKISDIAALK-----------SAGID---RKELA 270 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeE-eceeeh----hccCCcEEEEEeeCCEecccHHHHH-----------hcCCC---HHHHH
Confidence 5666666553 23332 222222 2234578999999998887763211 01222 33444
Q ss_pred HHHHHHHHH-HHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 764 IDVASAVDY-LHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 764 ~~va~~l~y-LH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
..++++.-. +-. -+++|.|..|.||+++.++.+..-|||+...+.+.
T Consensus 271 ~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 271 ELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 444433211 111 28999999999999999999999999998876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.3e-07 Score=97.71 Aligned_cols=149 Identities=23% Similarity=0.232 Sum_probs=112.7
Q ss_pred hhcccccccceeccCCeeEEEEEEEc-CCCeEEEEEEeecccchhHH--HHHHHHHHhhcCC-CCCceeEeecccccccC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFD-RDGTIVAIKVLNLQLQGASK--SFAAECRALRNIR-HRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~g~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 715 (825)
..+.+|.....||.|.|+.||+...+ .++..||+|.+......... .-..|+-+...+. |.++++....+ .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----S 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----c
Confidence 44567999999999999999998876 67889999988654432221 2234555555554 88888766653 3
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.-+..|+=-||+++++...... -...++...++++..|++.++.++|+ +.++|+|+||+||++..
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~------------~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSV------------TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISN 401 (524)
T ss_pred ccccccCchhhhcCcchhhhhH------------HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeecc
Confidence 3445678889999998875541 11245666788889999999999997 58999999999999988
Q ss_pred C-CcEEEcccCccc
Q 003368 796 N-LTAHVGDFGLAR 808 (825)
Q Consensus 796 ~-~~~ki~DFGla~ 808 (825)
+ +..+++|||.+.
T Consensus 402 ~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWT 415 (524)
T ss_pred chhhhhcccccccc
Confidence 6 788999999886
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.4e-07 Score=89.76 Aligned_cols=64 Identities=17% Similarity=0.118 Sum_probs=35.1
Q ss_pred cCCCCcEEEcccccCCCCCC-ccccCCCCccEEEeecccccCccc-cCcCCCCCCcEEEcccccCC
Q 003368 218 TLSNLQLFQISNNFFSGSFP-LAFSNASNLQSLEILGNNFFGKLS-VNFGDMKSLAYLNVAINNLG 281 (825)
Q Consensus 218 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~ 281 (825)
.++++..+-+..|.+..... ..+..++.+..|+|+.|++-.-.. +.+..+++|.-|.+++|.+.
T Consensus 197 ~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 197 IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 34566666666666553322 335556666666666666533221 23555566666666665554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.9e-06 Score=82.72 Aligned_cols=62 Identities=24% Similarity=0.213 Sum_probs=52.7
Q ss_pred CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 730 GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 730 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
|+|.+++... ...++|.++..|+.|+++||+|||+. + ||+||+++.++.+|+ ||+++.
T Consensus 1 GsL~~~l~~~-----------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVR-----------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHh-----------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEe
Confidence 6888888421 24689999999999999999999985 2 999999999999999 999998
Q ss_pred cccC
Q 003368 810 RQEV 813 (825)
Q Consensus 810 ~~~~ 813 (825)
....
T Consensus 59 ~~~~ 62 (176)
T smart00750 59 KTPE 62 (176)
T ss_pred eccc
Confidence 6543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.3e-06 Score=88.33 Aligned_cols=102 Identities=24% Similarity=0.383 Sum_probs=82.9
Q ss_pred HHhhcCCCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHH
Q 003368 692 RALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVD 771 (825)
Q Consensus 692 ~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~ 771 (825)
..+-.+-|-|||++..|+....+.+......+.|||+.|++..+|++.+ .....+......+++-||..||.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~--------~~~~a~~~~~wkkw~tqIlsal~ 190 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK--------KNQKALFQKAWKKWCTQILSALS 190 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH--------HhhhhhhHHHHHHHHHHHHhhhh
Confidence 3455567999999999987765556667789999999999999997431 22334555566789999999999
Q ss_pred HHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 772 YLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 772 yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|||+. .|+|+|+++...-|++..++-+||.
T Consensus 191 yLhs~-~PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 191 YLHSC-DPPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred hhhcc-CCccccCCcchhheeecCCceEEec
Confidence 99985 7899999999999999999988886
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.5e-06 Score=95.81 Aligned_cols=150 Identities=26% Similarity=0.289 Sum_probs=112.1
Q ss_pred ccccceecc--CCeeEEEEEEE--cCCCeEEEEEEee--cccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCC
Q 003368 645 FSSTHLIGI--GSFGSVYKGTF--DRDGTIVAIKVLN--LQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 645 f~~~~~ig~--G~~g~Vy~~~~--~~~g~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~ 717 (825)
|....-+|. |.+|.||.+.. +.++..+|+|.=+ .........=.+|+..-.+++ |+|.|+.+.. +.+.
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~~ 190 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEGS 190 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cccC
Confidence 445667888 99999999998 8899999999843 222233333456777777776 9999996555 5667
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeee
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS----AVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~----~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+..++-.|++. .++.++-+... ..++......+..+..+ |++++|.. .|+|-|+||.||..
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~-----------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPC-----------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFT 255 (524)
T ss_pred Ccceeeecccc-chhHHhhhccc-----------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheec
Confidence 78888888875 68877765321 12333444455566666 99999985 89999999999999
Q ss_pred cCC-CcEEEcccCcccccccCC
Q 003368 794 DNN-LTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 794 ~~~-~~~ki~DFGla~~~~~~~ 814 (825)
.++ ...+.+|||+.+.+.+..
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~ 277 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGN 277 (524)
T ss_pred ccccceeecCCcceeEEccCCc
Confidence 998 899999999988876654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.6e-07 Score=97.13 Aligned_cols=81 Identities=30% Similarity=0.491 Sum_probs=69.0
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
+.|+.|+++..++|.+|+... .....-+|.....++.|++.|++| ++.+|||+||.||....+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr---------~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR---------RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC---------CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchh
Confidence 578999999999999999643 122356788889999999999999 37899999999999998889
Q ss_pred EEEcccCcccccccCC
Q 003368 799 AHVGDFGLARLRQEVP 814 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~ 814 (825)
+||.|||+..-....+
T Consensus 395 ~kIgDFgl~ts~~~~~ 410 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDE 410 (516)
T ss_pred hhhhhhhheeecccCC
Confidence 9999999988776554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.4e-05 Score=89.39 Aligned_cols=141 Identities=19% Similarity=0.220 Sum_probs=89.5
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh-------------------------------------HHHHHHH
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-------------------------------------SKSFAAE 690 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~-------------------------------------~~~~~~E 690 (825)
.+.||.-+.|+||+|+++ +|+.||||+-+...... +-.|.+|
T Consensus 166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 368999999999999994 69999999866432110 0125556
Q ss_pred HHHhhcC----CCCC------ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHH
Q 003368 691 CRALRNI----RHRN------LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760 (825)
Q Consensus 691 ~~~l~~l----~H~n------iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~ 760 (825)
++...++ +|-+ |.+++..+ ...+.|+||||+|..+.|.-.-. ...++-.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-------st~RVLtME~~~G~~i~Dl~~i~-----------~~gi~~~--- 303 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL-------STKRVLTMEYVDGIKINDLDAID-----------KRGISPH--- 303 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc-------CcceEEEEEecCCccCCCHHHHH-----------HcCCCHH---
Confidence 6555443 3544 44444332 23578999999998776653211 1122222
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC----CCcEEEcccCccccccc
Q 003368 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN----NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 761 ~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~----~~~~ki~DFGla~~~~~ 812 (825)
.|+..+.++...+ --..|++|.|-.|.||++.. ++.+.+-|||+.+.+..
T Consensus 304 ~i~~~l~~~~~~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 304 DILNKLVEAYLEQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHHHHH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3333333322221 11138999999999999983 67899999999886543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.1e-05 Score=78.53 Aligned_cols=151 Identities=13% Similarity=0.166 Sum_probs=81.8
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc--eeEeecccccccCCCCeeeEEE
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL--VRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~~~~lv~ 724 (825)
....||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++. ..+...+||
T Consensus 5 ~~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~ 73 (226)
T TIGR02172 5 DWTQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIY 73 (226)
T ss_pred HheeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeee
Confidence 4578999999999984 24457788876533 23446789988888764333 34454431 234467899
Q ss_pred EccCCCC-hhhhc---------------------cCCCCCCCcccchhcccC-CHHHHHH-HHHHHH-HHHHHHHhc-CC
Q 003368 725 QYMPNGS-LENWL---------------------HPDAIPQTDEENDEIRNL-TLLERIS-IAIDVA-SAVDYLHHH-CQ 778 (825)
Q Consensus 725 e~~~~gs-L~~~l---------------------~~~~~~~~~~~~~~~~~l-~~~~~~~-i~~~va-~~l~yLH~~-~~ 778 (825)
|+++|.+ +.+.+ |....+..... .....+ .+..+.. ....+. ...++|... ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~-~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQ-SYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHH-HHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 9999863 22111 11100000000 000000 0000000 000001 112222221 13
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
+.++|+|+.|.||++++++ +.|.||+.|..-
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 4578999999999999888 999999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.7e-05 Score=77.75 Aligned_cols=105 Identities=18% Similarity=0.246 Sum_probs=81.9
Q ss_pred HHHHHHhhcCCC-CCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHH
Q 003368 688 AAECRALRNIRH-RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766 (825)
Q Consensus 688 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~v 766 (825)
..|.-+++.+++ +++.+++|+|- .++|.||.+.+++..... .-.....-+|.+|.+||.++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~---------~l~~~~~~~w~~R~~iA~~l 68 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYR---------PLSQFLQSPWEQRAKIALQL 68 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCcccccccc---------ccccccccCHHHHHHHHHHH
Confidence 357788888876 69999999984 368999999876643210 00111246899999999999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 767 a~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
++.++++++...-.+.-.|++++|+-+++++++|+.|..-+-..
T Consensus 69 L~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 69 LELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999864445778999999999999999999999765544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 825 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-41 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-17 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-41 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 9e-25 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-24 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-22 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-09 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 8e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 7e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 7e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-07 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-06 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-06 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-06 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 5e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-06 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 9e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 5e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 6e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 6e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 2e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 6e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 6e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 452 bits (1166), Expect = e-148
Identities = 163/574 (28%), Positives = 248/574 (43%), Gaps = 46/574 (8%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
LD+ S + P +G+ S L+ + +S N + G I L+ L +S N VG
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV-SLYNLKELAIQENNLTGGIPHFLGNITS 153
IP L L L NK G IP + L L + N+ G +P F G+ +
Sbjct: 262 PIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 154 LEAISLAYNSLGGNIP-SSLGQLKELKSLGLG-----GTIPPSIYNLSL-LANFSVPENR 206
LE+++L+ N+ G +P +L +++ LK L L G +P S+ NLS L + N
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 207 LHGSLPPSLG-LTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFG 265
G + P+L + LQ + NN F+G P SN S L SL + N G + + G
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 266 DMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIV------ 319
+ L L + +N L GE L L L L N G +P +
Sbjct: 440 SLSKLRDLKLWLNML-EGE-----IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLN 493
Query: 320 ---------SGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGE 370
+G IP IG+L +L ++++ +N F G IP E+ ++L +L++ N +G
Sbjct: 494 WISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553
Query: 371 IPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQND--LSGAIPEEIFNISH 428
IP++ S + N ++G + N H N G E++ +S
Sbjct: 554 IPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609
Query: 429 MSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFF 488
+ N G P N + +S N LSG IP EIGS YL + + N
Sbjct: 610 RN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 489 RGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFAN 547
GSIP + L+ L +DLS N L G+IP ++ L L ++LS N+L G +P G F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728
Query: 548 ASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHK 581
N LCG LP+C +N+ +
Sbjct: 729 FPPAKFLNNPG-LCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 416 bits (1071), Expect = e-134
Identities = 166/620 (26%), Positives = 289/620 (46%), Gaps = 53/620 (8%)
Query: 8 GVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGL---IGSLSPQIGNLSFLREIHLS 64
+L W+ + + C ++G+TC +VT +DL SK L ++S + +L+ L + LS
Sbjct: 28 NLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85
Query: 65 NNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP--GNLSYCSRLIGLYLGRNKLEGSIP- 121
N+ I G + L +L LS NSL G + +L CS L L + N L+
Sbjct: 86 NSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144
Query: 122 SEFVSLYNLKELAIQENNLTGGIP---HFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178
S + L +L+ L + N+++G L+ ++++ N + G++ + + L
Sbjct: 145 SGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNL 202
Query: 179 KSLGLG-----GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS 233
+ L + I P + + S L + + N+L G ++ T + L+L IS+N F
Sbjct: 203 EFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSNQFV 260
Query: 234 GSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIH 292
G P +LQ L + N F G++ G +L L+++ N+ G +
Sbjct: 261 GPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHF-YG-----AVPP 312
Query: 293 SLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMS 352
+CS L L L +N F G LP + K+ L ++++ N+F G++PE ++
Sbjct: 313 FFGSCSLLESLALSSNNFSGELP--------MDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 353 RL-QNLQFLNMRHNQLSGEIPSSFGN--LSSLVKLILGNNNLSGVIPSSLGNLKQLALLH 409
L +L L++ N SG I + ++L +L L NN +G IP +L N +L LH
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 410 LFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP 469
L N LSG IP + ++S + D L N L G IP ++ +K L ++ N+L+GEIP
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRD-LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
Query: 470 SEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYL 528
S + +C L I ++ N G IP + L++L + LS N+ SG IP L L +L
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543
Query: 529 NLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPK----NNSRNHKVYR 584
+L+ N G +P +F + I+ +N + G + + + N ++
Sbjct: 544 DLNTNLFNGTIPA-AMFKQSGKIA----ANFIAGKRYV-YIKNDGMKKECHGAGNLLEFQ 597
Query: 585 GVLKVIISTCSVFSGLLLGS 604
G+ ++ S + + S
Sbjct: 598 GIRSEQLNRLSTRNPCNITS 617
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-121
Identities = 147/546 (26%), Positives = 220/546 (40%), Gaps = 63/546 (11%)
Query: 35 TVLDLKSKGLIGSLSPQI---GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
VLDL + + G+ L+ + +S N I G + + R LE L +S N+
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
IP L CS L L + NKL G + LK L I N G IP +
Sbjct: 212 FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PL 268
Query: 152 TSLEAISLAYNSLGGNIPSSL-GQLKELKSLGLG-----GTIPPSIYNLSLLANFSVPEN 205
SL+ +SLA N G IP L G L L L G +PP + SLL + ++ N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 206 RLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNAS-NLQSLEILGNNFFGKLSVNF 264
G LP L + L++ +S N FSG P + +N S +L +L++ NNF G + N
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324
+ L L L N F +G IP
Sbjct: 389 CQNPK----------------------------NTLQELYLQNNGF---------TGKIP 411
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKL 384
+ L + + N G IP + L L+ L + N L GEIP + +L L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 385 ILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSI 444
IL N+L+G IPS L N L + L N L+G IP+ I + +++ L + N G+I
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA-ILKLSNNSFSGNI 530
Query: 445 PPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLRE 504
P ++G+ + L +++N +G IP+ + +A NF G + + +E
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKE 586
Query: 505 IDLSQN--NLSGKIPISLERLP-LEYLNLSFNDLEGQVPTK-GIFANASAISVSGNSNRL 560
+ N G L RL N++ G + + +S N L
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS--YNML 644
Query: 561 CGGIPE 566
G IP+
Sbjct: 645 SGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-63
Identities = 100/365 (27%), Positives = 153/365 (41%), Gaps = 47/365 (12%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
+ L L L G++ +G+LS LR++ L N ++G+IP E+ + LE L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
L GEIP LS C+ L + L N+L G IP L NL L + N+ +G IP LG+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 152 TSLEAISLAYNSLGGNIPSSLGQL-KELKSLGLGGTIPPSIYNLSLLANFSVPEN--RLH 208
SL + L N G IP+++ + ++ + + G I N + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 209 GSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268
G L LS I++ + G F N ++ L++ N G + G M
Sbjct: 598 GIRSEQLN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
L LN+ N++ SGSIP E+G
Sbjct: 657 YLFILNLGHNDI---------------------------------------SGSIPDEVG 677
Query: 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS--FGNLSSLVKLIL 386
L L ++++ N+ +G+IP+ MS L L +++ +N LSG IP F L
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK--FL 735
Query: 387 GNNNL 391
N L
Sbjct: 736 NNPGL 740
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-90
Identities = 103/581 (17%), Positives = 188/581 (32%), Gaps = 74/581 (12%)
Query: 12 SWNDSHHFCDW---EGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI 68
+WN + W G++ + + RVT L L+ G G + IG L+ L + L ++
Sbjct: 59 NWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 69 QG----KIPGEIGRLFRLEALYLSHNSLVGEIPGNLSY--CSRLIGLYLGRNKLEGSIPS 122
+ P I E S LI + + + SI
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 123 EFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLG 182
++ NN+T + + +T L + + + + +
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ 236
Query: 183 LGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSN 242
T NL L + V LP L L +QL ++ N
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACN------------ 283
Query: 243 ASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSF 302
S E L +++ + + + + NNL + + SL L
Sbjct: 284 --RGISGEQLKDDWQALAD--APVGEKIQIIYIGYNNLKTFPVET-----SLQKMKKLGM 334
Query: 303 LNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNM 362
L + NQ +G G + L + + +NQ + ++ L+
Sbjct: 335 LECLYNQLEG----------KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSF 384
Query: 363 RHNQLSGEIPSSF--GNLSSLVKLILGNNNLSGV-------IPSSLGNLKQLALLHLFQN 413
HN+L IP+ F ++S + + N + V + + ++ ++L N
Sbjct: 385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443
Query: 414 DLSGAIPEEIFNISHMSDSLNFARNHLVG-------SIPPKIGNLKVLRMFVVSSNNLSG 466
+S E S +S S+N N L N +L + N L+
Sbjct: 444 QISKFPKELFSTGSPLS-SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 467 EIPSEI--GSCFYLQEIYMAENFFRGSIPSSLVSLKDLREI------DLSQNNLSGKIPI 518
+ + + YL I ++ N F P+ ++ L+ D N + P
Sbjct: 503 -LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 519 SLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSN 558
+ P L L + ND+ V + I N S + + N N
Sbjct: 561 GITLCPSLTQLQIGSNDIRK-VN-EKITPNISVLDIKDNPN 599
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 9e-77
Identities = 80/496 (16%), Positives = 159/496 (32%), Gaps = 46/496 (9%)
Query: 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
+ + S S+ +I +N I + + RL +L Y+ ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
V E C + + ++ +L +L ++ + +P FL +
Sbjct: 219 VAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRL-HGSL 211
++ I++A N + + L + + N L +
Sbjct: 274 EMQLINVACN-----------RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSL 270
SL + L + + N G P AF + L SL L N ++ N G + +
Sbjct: 323 ETSLQ-KMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN-LAYNQITEIPANFCGFTEQV 379
Query: 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKL 330
L+ A N L + I + S +S ++ N+ + + K
Sbjct: 380 ENLSFAHNKLKY-----IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF--DPLDPTPFKG 432
Query: 331 VSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSG-------EIPSSFGNLSSLVK 383
+++ I + +NQ E S L +N+ N L+ + +F N L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 384 LILGNNNLSGVIPS-SLGNLKQLALLHLFQNDLSGAIPEEIFNIS-----HMSDSLNFAR 437
+ L N L+ + L L + L N S P + N S + + +
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 438 NHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLV 497
N + P I L + SN++ + +I + + + +N S +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP--NISVLDIKDNPNISIDLSYVC 608
Query: 498 SLKDLREIDLSQNNLS 513
+ L +
Sbjct: 609 PYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-49
Identities = 65/402 (16%), Positives = 139/402 (34%), Gaps = 49/402 (12%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI--------QGKIPGEIGRLFRLEALY 86
T +++ + + L + L ++ I+++ N + + +++ +Y
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 87 LSHNSL-VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP 145
+ +N+L + +L +L L N+LEG +P F S L L + N +T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA 370
Query: 146 HFLGNITSLEAISLAYNSLGGNIPSSL--GQLKELKSLGLG------------GTIPPSI 191
+F G +E +S A+N L IP+ + + ++ + P+
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG-------SFPLAFSNAS 244
+ +++ ++ N++ P L T S L + N + F N
Sbjct: 430 FKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 245 NLQSLEILGNNFFGKL--SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSF 302
L S+ L N KL + L ++++ N+ F N S L
Sbjct: 489 LLTSI-DLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-------FPTQPLNSSTLKG 540
Query: 303 LNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNM 362
+ + + P I SL +++ N + E++ N+ L++
Sbjct: 541 FGIRNQRD---AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDI 594
Query: 363 RHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQ 404
+ N S +L + + ++K+
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 3e-89
Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 16/283 (5%)
Query: 292 HSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM-DHNQFEGKIPEE 350
+ ++ L+L IPS + L L + + N G IP
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPK-------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+++L L +L + H +SG IP + +LV L N LSG +P S+ +L L +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 411 FQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPS 470
N +SGAIP+ + S + S+ +RN L G IPP NL L +S N L G+
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
Query: 471 EIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLN 529
GS Q+I++A+N + + K+L +DL N + G +P L +L L LN
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 530 LSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKC 572
+SFN+L G++P G + + N LCG LP C
Sbjct: 275 VSFNNLCGEIPQGGNLQRFDVSAYANN-KCLCGSP----LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-66
Identities = 81/309 (26%), Positives = 124/309 (40%), Gaps = 37/309 (11%)
Query: 8 GVLNSWNDSHHFCD--WEGITCSPRHR--RVTVLDLKSKGLIGS--LSPQIGNLSFLREI 61
L+SW + C+ W G+ C + RV LDL L + + NL +L +
Sbjct: 22 TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81
Query: 62 HLSN-NTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSI 120
++ N + G IP I +L +L LY++H ++ G IP LS L+ L N L G++
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 121 PSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL-EAISLAYNSLGGNIPSSLGQLKELK 179
P SL NL + N ++G IP G+ + L +++++ N L G IP + L L
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA 200
Query: 180 SLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLA 239
+ L N L G G + N Q ++ N +
Sbjct: 201 FVDLSR-------------------NMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLG-K 239
Query: 240 FSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN 299
+ NL L++ N +G L +K L LNV+ NNL GE I N
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL-CGE------IPQGGNLQR 292
Query: 300 LSFLNLVAN 308
N
Sbjct: 293 FDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-55
Identities = 67/232 (28%), Positives = 114/232 (49%), Gaps = 9/232 (3%)
Query: 340 HNQFEGKIPEEMSRLQNLQFLNMRHNQLSGE--IPSSFGNLSSLVKLILGN-NNLSGVIP 396
+ + G + + ++ + L++ L IPSS NL L L +G NNL G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 397 SSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRM 456
++ L QL L++ ++SGAIP+ + I + +L+F+ N L G++PP I +L L
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV-TLDFSYNALSGTLPPSISSLPNLVG 153
Query: 457 FVVSSNNLSGEIPSEIGSCFYL-QEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGK 515
N +SG IP GS L + ++ N G IP + +L L +DLS+N L G
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGD 212
Query: 516 IPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPE 566
+ + ++L+ N L + G+ N + + + +NR+ G +P+
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQ 262
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 6/212 (2%)
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGV--IPSSLGNLKQLALLHLF-QNDLSGAIP 420
+ G + + + L L NL IPSSL NL L L++ N+L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 421 EEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQE 480
I ++ + L ++ G+IP + +K L S N LSG +P I S L
Sbjct: 95 PAIAKLTQLH-YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 481 IYMAENFFRGSIPSSLVSLKDLRE-IDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQV 539
I N G+IP S S L + +S+N L+GKIP + L L +++LS N LEG
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213
Query: 540 PTKGIFANASAISVSGNSNRLCGGIPELQLPK 571
++ + + N L + ++ L K
Sbjct: 214 SV-LFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 10/157 (6%)
Query: 418 AIPEEIFNISHMSD---SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE--IPSEI 472
I +++ N + +S + + +G + + +S NL IPS +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 473 GSCFYLQEIYMA-ENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNL 530
+ YL +Y+ N G IP ++ L L + ++ N+SG IP L ++ L L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 531 SFNDLEGQVPTK-GIFANASAISVSGNSNRLCGGIPE 566
S+N L G +P N I+ NR+ G IP+
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFD--GNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 30/111 (27%), Positives = 45/111 (40%), Gaps = 2/111 (1%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
+DL L G S G+ ++IHL+ N++ + ++G L L L +N + G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYG 258
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP 145
+P L+ L L + N L G IP L A N G P
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSP 308
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-83
Identities = 109/538 (20%), Positives = 187/538 (34%), Gaps = 44/538 (8%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
LDL L S + L+ + LS IQ G L L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNIT 152
G S S L L L L LKEL + N + +P + N+T
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLG--------GTIPPSIYNLSLLANFSVPE 204
+LE + L+ N + + L L ++ L L I P + L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL---------GNN 255
N ++ + L+ L++ ++ F L + S L+ L L +
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 256 FFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG--- 312
+ + F + +++ ++ + + + L LV +F
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFGQFPT 321
Query: 313 -------ALPHSIVSGSIPSEIGKLVSLYLIEMDHNQ--FEGKIPEEMSRLQNLQFLNMR 363
L + G L SL +++ N F+G + +L++L++
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS-LGNLKQLALLHLFQNDLSGAIPEE 422
N + + S+F L L L ++NL + S +L+ L L + A
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 423 IFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEI 481
+S + L A N + P I L+ L +S L P+ S LQ +
Sbjct: 441 FNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 482 YMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP--LEYLNLSFNDLEG 537
M+ N F L L+ +D S N++ L+ P L +LNL+ ND
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-75
Identities = 92/527 (17%), Positives = 185/527 (35%), Gaps = 31/527 (5%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+ + LS N ++ L+ L LS + G S L L L N ++
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL-GGNIPSSLGQLK 176
F L +L++L E NL +G++ +L+ +++A+N + +P L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 177 ELKSLGLG-----GTIPPSIYNLSLLANFSVP----ENRLHGSLPPSLGLTLSNLQLFQI 227
L+ L L + L + ++ N ++ P + L +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--RLHKLTL 207
Query: 228 SNNFFSGSFP-LAFSNASNLQSLEILGNNFFGK---LSVNFGDMKSLAYLNVAINNLGSG 283
NNF S + + L+ ++ F + + ++ L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 284 ESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI--------VSGSIPSEIGKLVSLYL 335
+ I +N+S +LV+ + S + + L L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 336 IEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS--GEIPSSFGNLSSLVKLILGNNNLSG 393
+ +G L +L+FL++ N LS G S +SL L L N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 394 VIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKV 453
+ S+ L+QL L ++L +F L+ + H + L
Sbjct: 388 -MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 454 LRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNL 512
L + ++ N+ +I L + +++ P++ SL L+ +++S NN
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
Query: 513 SGKIPISLERLP-LEYLNLSFNDLEGQVPT--KGIFANASAISVSGN 556
+ L L+ L+ S N + + ++ + ++++ N
Sbjct: 507 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-63
Identities = 105/537 (19%), Positives = 185/537 (34%), Gaps = 55/537 (10%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
+ L L + LS L+++ + IG L L+ L ++HN +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 95 -EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLK----ELAIQENNLTGGIPHFLG 149
++P S + L L L NK++ ++ L+ + L + N + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198
Query: 150 NITSLEAISLAYNSLGGNIPS-SLGQLKELKSLGL--------GGTIPPSIYNLSLLANF 200
I L ++L N N+ + L L+ L G L L N
Sbjct: 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 201 SVPENRLH-----GSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNN 255
++ E RL L L+N+ F + + FS Q LE++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCK 315
Query: 256 FFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ--FKGA 313
F ++ +K L + + N S + +L FL+L N FKG
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGN-----------AFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 314 LPHSIVS--------------GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQ 358
S ++ S L L ++ H+ + + L+NL
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 359 FLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVI-PSSLGNLKQLALLHLFQNDLSG 417
+L++ H F LSSL L + N+ P L+ L L L Q L
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 418 AIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY 477
P ++S + LN + N+ L L++ S N++ E+
Sbjct: 485 LSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 478 -LQEIYMAENFFRGSIPSS--LVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLS 531
L + + +N F + L +KD R++ + + P + +P+ LN++
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 25/122 (20%), Positives = 47/122 (38%), Gaps = 3/122 (2%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
R +T LDL L +LS L+ +++S+N L L+ L S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 92 LVGEIPGNLSYC-SRLIGLYLGRNKLEGSIPSE-FVS-LYNLKELAIQENNLTGGIPHFL 148
++ L + S L L L +N + + F+ + + ++L ++ + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 149 GN 150
Sbjct: 590 QG 591
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-79
Identities = 114/532 (21%), Positives = 197/532 (37%), Gaps = 32/532 (6%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
+TVL+L L + S L + + NTI P +L L+ L L HN
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
L ++C+ L L+L N ++ + FV NL L + N L+ +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 152 TSLEAISLAYNSLGGNIPSSLG--QLKELKSLGLG-----GTIPPSIYNLSLLANFSVPE 204
+L+ + L+ N + L LK L L P + + L +
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 205 NRLHGSLPPSL--GLTLSNLQLFQISNNFFSGSFPLAFSN--ASNLQSLEILGNNFFGKL 260
+L SL L L ++++ +SN+ S + F +NL L++ NN
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS 320
+ +F + L Y + NN+ S HSL N+ +LNL + K ++ + +
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFS------HSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 321 GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGE--IPSSFGNL 378
L L + M+ N G + L NL++L++ ++ S +F +L
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 379 --SSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFA 436
S L L L N +S + + L L +L L N++ + + + + +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 437 RNHLVGSIPPKIGNLKVLRMFVVSSNNLSG--EIPSEIGSCFYLQEIYMAENFFRGSIPS 494
N + + L+ ++ L PS L + ++ N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 495 SLVSLKDLREIDLSQNNLS--------GKIPISLERLP-LEYLNLSFNDLEG 537
L L+ L +DL NNL+ G L+ L L LNL N +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 4e-72
Identities = 106/511 (20%), Positives = 186/511 (36%), Gaps = 57/511 (11%)
Query: 51 QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSY---CSRLI 107
I S L+++ LS+N I+ PG + RL L+L++ L + L + +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 108 GLYLGRNKLEGSIPSEFVSL--YNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG 165
L L ++L + + F+ L NL L + NNL + LE L YN++
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 166 GNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLF 225
SL L ++ L L + + S+ L + L L+
Sbjct: 286 HLFSHSLHGLFNVRYLNLK-------RSFTKQ---SISLASLPK-IDDFSFQWLKCLEHL 334
Query: 226 QISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD-----MKSLAYLNVAINNL 280
+ +N G F+ NL+ L L N+F ++ L LN+ N +
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYL-SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDH 340
ESD + + +L L+L N+ L E L +++ I + +
Sbjct: 394 SKIESD------AFSWLGHLEVLDLGLNEIGQELT--------GQEWRGLENIFEIYLSY 439
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSG--EIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
N++ + + +LQ L +R L PS F L +L L L NNN++ +
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 399 LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFV 458
L L++L +L L N+L+ ++ G + L L +
Sbjct: 500 LEGLEKLEILDLQHNNLA-----------------RLWKHANPGGPIYFLKGLSHLHILN 542
Query: 459 VSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPI 518
+ SN F L+ I + N S + L+ ++L +N ++
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 519 SLERLP--LEYLNLSFNDLEGQVPTKGIFAN 547
L L++ FN + + F N
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-68
Identities = 96/523 (18%), Positives = 183/523 (34%), Gaps = 55/523 (10%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
V D L + + + + ++L++N ++ R +L +L + N++
Sbjct: 7 EVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
P L L L N+L F NL EL + N++ + +L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214
+ L++N L + QL+ L+ L L N++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSN-------------------NKIQALKSEE 164
Query: 215 LG-LTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD---MKSL 270
L S+L+ ++S+N P F L L + L+ S+
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224
Query: 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKL 330
L+++ + L + + +F+ +NL+ L+L N + L
Sbjct: 225 RNLSLSNSQLST--TSNTTFLGL--KWTNLTMLDLSYNNL---------NVVGNDSFAWL 271
Query: 331 VSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHN---------QLSGEIPSSFGNLSSL 381
L +++N + + L N+++LN++ + L SF L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS-GAIPEEIFNISHMSD--SLNFARN 438
L + +N++ G+ + L L L L + S + E F S LN +N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391
Query: 439 HLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP-SEIGSCFYLQEIYMAENFFRGSIPSSLV 497
+ L L + + N + E+ E + EIY++ N + +S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 498 SLKDLREIDLSQNNLSG--KIPISLERLP-LEYLNLSFNDLEG 537
+ L+ + L + L P + L L L+LS N++
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 3e-53
Identities = 81/473 (17%), Positives = 163/473 (34%), Gaps = 50/473 (10%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIG---NLSFLREIHLSNNTIQGKIPGEIG--RLFRLEALY 86
R+ L L + L SL+ ++ + +R + LSN+ + + L L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 87 LSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKE---------LAIQE 137
LS+N+L + ++ +L +L N ++ L+N++ +I
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG------TIPPSI 191
+L + LE +++ N + G + L LK L L T+
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 192 Y---NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFP-LAFSNASNLQ 247
+ S L ++ +N++ + L +L++ + N + N+
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFS-WLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 248 SLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVA 307
+ + N + +F + SL L + L + +S F NL+ L+L
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF----QPLRNLTILDLSN 489
Query: 308 NQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQ--------FEGKIPEEMSRLQNLQF 359
N + + L L ++++ HN G + L +L
Sbjct: 490 NNI---------ANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
LN+ N F +L L + LG NNL+ + S N L L+L +N ++
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEI 472
+ L+ N + ++ ++ ++ E+ S
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINETHTNIPELSSHY 649
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-67
Identities = 97/523 (18%), Positives = 175/523 (33%), Gaps = 31/523 (5%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
L+ L + L L + L+ I RL+ L L+ N L+
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITS 153
LS L L+ + + + L+ L + N+++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLG------GTIPPSIYNLSLLANFSVPENRL 207
L+ + N++ + L++ +L L I P ++ ++ + + +
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 208 HGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSN--ASNLQSLEILGNNFFGKLSVNF 264
+ L T+ +L L + P F +++S+ + + FF S F
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324
L L++ +L L S L L L AN+F
Sbjct: 275 HCFSGLQELDLTATHLSE-------LPSGLVGLSTLKKLVLSANKF---------ENLCQ 318
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQL--SGEIPSSFGNLSSL 381
SL + + N ++ L+NL+ L++ H+ + S NLS L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L N + + QL LL L L + F H+ LN + + L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGS---CFYLQEIYMAENFFRGSIPSSLVS 498
S L L+ + N+ + S L+ + ++ + S
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
Query: 499 LKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPT 541
LK + +DLS N L+ +L L YLNL+ N + +P+
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-62
Identities = 102/549 (18%), Positives = 183/549 (33%), Gaps = 39/549 (7%)
Query: 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE 95
+ ++ GL + + + + S N + RL L L L+ +
Sbjct: 16 TYNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 96 IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLE 155
RL L L N L + LK L + ++ L N +LE
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 156 AISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPP-SIYNLSLLANFSVPENRLH-G 209
++ L N + ++LK L + + +L N S+ N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFP-LAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268
+ P + L F L S +L + F +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 269 --SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSE 326
S+ +N+ + + S+ + S L L+L A +PS
Sbjct: 253 EMSVESINLQKHYFFNISSN------TFHCFSGLQELDLTATHLS----------ELPSG 296
Query: 327 IGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS-SFGNLSSLVKLI 385
+ L +L + + N+FE S +L L+++ N E+ + NL +L +L
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 386 LGNNNL--SGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGS 443
L ++++ S L NL L L+L N+ E + L+ A L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRLKVK 415
Query: 444 IPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSI---PSSLVSL 499
NL +L++ +S + L LQ + + N F +SL +L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSN 558
L + LS +LS + L + +++LS N L ++ I ++ SN
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSHLKGIYLNLASN 533
Query: 559 RLCGGIPEL 567
+ +P L
Sbjct: 534 HISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-58
Identities = 92/511 (18%), Positives = 167/511 (32%), Gaps = 40/511 (7%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
T LDL + + L + L+ N + + L+ L+ +
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
L L LYLG N + + LK L Q N + + ++
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 155 EAISL--AYNSLGGNIPSSLGQLKELKSLGLGG-----TIPPSIYNLSL--LANFSVPEN 205
+SL N + G I +SL GG I + N ++ L + +
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 206 RLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNF 264
P GL +++ + ++F F S LQ L+ L +L
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD-LTATHLSELPSGL 297
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG--- 321
+ +L L ++ N + S +N +L+ L++ N + L +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQ------ISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 322 ---------------SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQ 366
++ L L + + +N+ E L+ L++ +
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 367 LSG-EIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
L + S F NL L L L ++ L L L L+L N ++ +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
Query: 426 ISHMS--DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYM 483
+ + + L + L +LK++ +S N L+ + + + +
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNL 530
Query: 484 AENFFRGSIPSSLVSLKDLREIDLSQNNLSG 514
A N +PS L L R I+L QN L
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-43
Identities = 87/426 (20%), Positives = 149/426 (34%), Gaps = 36/426 (8%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLR--EIHLSNNTIQGKIPGEIGRLFRLEALYLSH 89
++ VLD ++ + + +L ++L+ N I G I ++L
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGG 211
Query: 90 NSLVGEIPGNLSYCS--RLIGLYLGRNKLEGSIPSEFVSLY--NLKELAIQENNLTGGIP 145
+ I L + L E P+ F L +++ + +Q++
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 146 HFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPP-SIYNLSLLANF 200
+ + L+ + L L +PS L L LK L L + S N L +
Sbjct: 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNF--FSGSFPLAFSNASNLQSLEILGNNFFG 258
S+ N L L NL+ +S++ S L N S+LQSL L N
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL-NLSYNEPL 389
Query: 259 KLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317
L F + L L++A L ++ N L LNL +
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQ-----SPFQNLHLLKVLNLSHSLL------- 437
Query: 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKI---PEEMSRLQNLQFLNMRHNQLSGEIPSS 374
S L +L + + N F + L L+ L + LS +
Sbjct: 438 --DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 375 FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLN 434
F +L + + L +N L+ +L +LK + L+L N +S I + I ++N
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI-ILPSLLPILSQQRTIN 553
Query: 435 FARNHL 440
+N L
Sbjct: 554 LRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 32/223 (14%), Positives = 72/223 (32%), Gaps = 3/223 (1%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ + L N L ++F L +L L L + + + + +L L L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
+ + L F + + + N K L + SN++S +
Sbjct: 94 IFMAETALSGPKALK-HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 476 FYLQEIYMAENFFRGSIPSSLVSLKDLR--EIDLSQNNLSGKIPISLERLPLEYLNLSFN 533
L+ + N + SL+ ++L+ N+++G P + + + LN
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 534 DLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNN 576
+ + ++ + + I + +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-63
Identities = 97/534 (18%), Positives = 182/534 (34%), Gaps = 42/534 (7%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+DL L S N S L+ + LS I+ L L L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNIT 152
PG+ S + L L KL L LK+L + N + +P + N+T
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLG--------GTIPPSIYNLSLLANFSVPE 204
+L + L+YN + + L L+E + L I + L ++
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL--------GNNF 256
N ++ + L+ L + ++ F L S ++ L + N
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 257 FGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPH 316
F V F + +++ +++A ++ ++ + L+++ Q K
Sbjct: 274 FSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 317 SIVS----------GSIPSEIGKLVSLYLIEMDHNQFEGKIPE--EMSRLQNLQFLNMRH 364
+ GSI + L SL +++ N +L+ L++
Sbjct: 326 DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 365 NQLSGEIPSSFGNLSSLVKLILGNNNLSGVIP-SSLGNLKQLALLHLFQNDLSGAIPEEI 423
N + ++F L L L ++ L V S+ +L++L L + +
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 424 FNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIY 482
++ ++ +L A N + + N L +S L + LQ +
Sbjct: 445 LGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503
Query: 483 MAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
M+ N S L L +D S N + I L + NL+ N +
Sbjct: 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-56
Identities = 88/527 (16%), Positives = 176/527 (33%), Gaps = 68/527 (12%)
Query: 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115
S + I LS N ++ L+ L LS + L L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQ 174
++ P F L +L+ L E L +G + +L+ +++A+N + +P+
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 175 LKELKSLGLGG--------------------------------TIPPSIYNLSLLANFSV 202
L L + L I + L ++
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL 211
Query: 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL--------GN 254
N ++ + L+ L + ++ F L S ++ L +
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 255 NFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGAL 314
N F V F + +++ +++A ++ ++ + L+++ Q K
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSI--------KYLEDVPKHFKWQSLSIIRCQLK--- 320
Query: 315 PHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS 374
P+ L L + + N+ G I + L +L +L++ N LS S
Sbjct: 321 -------QFPT--LDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCS 369
Query: 375 FGNL--SSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDS 432
+ +L +SL L L N ++ ++ L++L L + L F
Sbjct: 370 YSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428
Query: 433 LNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGS 491
L+ + + L L ++ N+ S + + L + +++
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 492 IPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEG 537
+L L+ +++S NNL +L L L+ SFN +E
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 75/392 (19%), Positives = 123/392 (31%), Gaps = 31/392 (7%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGR-LFRLEALYLSHNSLVG- 94
LD+ S I + Q L E+ L N I + L L L
Sbjct: 186 LDM-SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244
Query: 95 --------EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPH 146
I L + L +F L N+ +++ ++
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LE 301
Query: 147 FLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENR 206
+ +++S+ L L LK L G+I L L+ + N
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNA 361
Query: 207 LHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-F 264
L S S L ++L+ +S N F LQ L+ + + F
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324
++ L YL+++ N ++ F ++L+ L + N FK
Sbjct: 421 LSLEKLLYLDISYTNT------KIDFDGIFLGLTSLNTLKMAGNSFKDNTL--------S 466
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKL 384
+ +L +++ Q E L LQ LNM HN L S + L SL L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526
Query: 385 ILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416
N + K LA +L N ++
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-63
Identities = 73/555 (13%), Positives = 158/555 (28%), Gaps = 90/555 (16%)
Query: 6 PEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSN 65
+WN + W + N + + L+
Sbjct: 295 NTIHSLNWNFNKELDMWGDQPGV----------------------DLDNNGRVTGLSLAG 332
Query: 66 NTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV 125
+G++P IG+L L+ L +S ++++ F+
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 126 S-LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGN------IPSSLGQLKEL 178
L + ++ + + I ISL +G I ++ +L +L
Sbjct: 393 DYDQRLNLSDLLQDAINRNPE--MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 179 KSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL 238
+ + + ++ +N + L
Sbjct: 451 QIIYFAN-------------------SPFTY-DNIAVDWEDANS-----DYAKQYENEEL 485
Query: 239 AFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIH---SLA 295
++SN +L +E+ +L D+ L LN+A N S + +
Sbjct: 486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 296 NCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355
+ + N + P + + K+V L L++ HN+ + E
Sbjct: 546 TGPKIQIFYMGYNNLEE-FP-------ASASLQKMVKLGLLDCVHNKV--RHLEAFGTNV 595
Query: 356 NLQFLNMRHNQLSGEIPSS-FGNLSSLVKLILGNNNLSGVIPS-SLGNLKQLALLHLFQN 413
L L + +NQ+ EIP + L +N L + + ++ + + N
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 414 DLSGAIPEEIFNISHMSD-----SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLS--- 465
+ I ++ + N + + ++S+N ++
Sbjct: 655 KIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 466 ----GEIPSEIGSCFYLQEIYMAENFFRGSIPSSLV--SLKDLREIDLSQNNLSGKIPIS 519
+ + L I + N S+ +L L +D+S N S P
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 520 LERLP-LEYLNLSFN 533
L+ +
Sbjct: 772 PLNSSQLKAFGIRHQ 786
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-53
Identities = 61/443 (13%), Positives = 133/443 (30%), Gaps = 54/443 (12%)
Query: 25 ITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEA 84
T + + NL L ++ L N ++P + L L++
Sbjct: 460 FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-G 143
L ++ N + + + + + ++ + NNL
Sbjct: 520 LNIACNRGISAAQLKADW---------------TRLADDEDTGPKIQIFYMGYNNLEEFP 564
Query: 144 IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPPSI-YNLSLLA 198
L + L + +N + + G +L L L IP +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVE 622
Query: 199 NFSVPENRLHGSLPPSLGLT-LSNLQLFQISNNFFSG-----SFPLAFSNASNLQSLEIL 252
N+L +P + + S N S + N ++ +
Sbjct: 623 GLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 253 GNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFI-HSLANCSNLSFLNLVANQFK 311
N + F ++ + ++ N + S + + + N L+ ++L N+
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
Query: 312 GALPHSIVSGSIPSEI--GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRH----- 364
S+ + L L +++ +N F P + L+ +RH
Sbjct: 742 ----------SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE 790
Query: 365 -NQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL-SGAIPEE 422
N++ + P+ SL++L +G+N++ V L L + N S +
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIAD---NPNISIDVTSV 847
Query: 423 IFNISHMSDSLNFARNHLVGSIP 445
I L + + +
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRGCD 870
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-45
Identities = 59/432 (13%), Positives = 132/432 (30%), Gaps = 63/432 (14%)
Query: 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLL 197
+ L N + +SLA G +P ++GQL ELK L G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGT------------ 356
Query: 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257
+ S L+ + + + L ++L +
Sbjct: 357 -------HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409
Query: 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317
+K + +++ +G+ + ++ + L + + F
Sbjct: 410 RNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY----- 462
Query: 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN 377
+ + D+ + S L++L + + + ++P +
Sbjct: 463 -----DNIAVDWEDAN----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 378 LSSLVKLILGNNNLSGV---------IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISH 428
L L L + N + ++ + ++ N+L P +
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASAS-LQK 571
Query: 429 MSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCF-YLQEIYMAE 485
M L+ N + G L + N + EIP + + ++ + +
Sbjct: 572 MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH 628
Query: 486 NFFRGSIPS--SLVSLKDLREIDLSQNNLSG---KIPISLERLP---LEYLNLSFNDLEG 537
N + IP+ + S+ + +D S N + I S++ + LS+N+++
Sbjct: 629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687
Query: 538 QVPTKGIFANAS 549
+FA S
Sbjct: 688 FPT--ELFATGS 697
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 26/229 (11%), Positives = 73/229 (31%), Gaps = 34/229 (14%)
Query: 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397
+ + + + ++ + L++ G +P + G L+ L L G ++ +
Sbjct: 306 KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRL 365
Query: 398 SLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL----------------- 440
+ ++ + + + + + ++ +
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISL 425
Query: 441 -----------VGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFR 489
+ I I L L++ +++ + + + ++
Sbjct: 426 KDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQY 480
Query: 490 GSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEG 537
+ S +LKDL +++L ++P L LP L+ LN++ N
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 30/232 (12%), Positives = 59/232 (25%), Gaps = 37/232 (15%)
Query: 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
+ ++ N F N + + N + L L G +P +
Sbjct: 284 KNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342
Query: 399 LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP------------- 445
+G L +L +L + + + D ++ +
Sbjct: 343 IGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401
Query: 446 ----------PKIGNLKVLRM------FVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFR 489
P++ +K + + N I I LQ IY A + F
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFT 461
Query: 490 GSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVP 540
+ + + +S L L + L Q+P
Sbjct: 462 YDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-55
Identities = 70/181 (38%), Positives = 94/181 (51%), Gaps = 15/181 (8%)
Query: 630 LRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ-LQGASKSFA 688
L++ S L A+D FS+ +++G G FG VYKG DGT+VA+K L + QG F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQ 75
Query: 689 AECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN 748
E + HRNL+R+ C + + LVY YM NGS+ + L E
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR--------ERP 122
Query: 749 DEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ L +R IA+ A + YLH HC IH D+K +NILLD A VGDFGLA+
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 809 L 809
L
Sbjct: 183 L 183
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 613 RRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVA 672
+ S ++ +V L +AT+ F LIG G FG VYKG DG VA
Sbjct: 9 TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVA 67
Query: 673 IKVLNLQ-LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGS 731
+K + QG + F E L RH +LV +I C + L+Y+YM NG+
Sbjct: 68 LKRRTPESSQGI-EEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGN 121
Query: 732 LENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791
L+ L+ +P +++ +R+ I I A + YLH IH D+K NI
Sbjct: 122 LKRHLYGSDLPTM--------SMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINI 170
Query: 792 LLDNNLTAHVGDFGLARL 809
LLD N + DFG+++
Sbjct: 171 LLDENFVPKITDFGISKK 188
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-47
Identities = 102/524 (19%), Positives = 182/524 (34%), Gaps = 45/524 (8%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
LDL L S + L+ + LS IQ G L L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT-GGIPHFLGNIT 152
G S S L L L L LKEL + N + +P + N+T
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLG--------GTIPPSIYNLSLLANFSVPE 204
+LE + L+ N + + L L ++ L L I P + L ++
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL---------GNN 255
N ++ + L+ L++ ++ F L + S L+ L L +
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDY 269
Query: 256 FFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALP 315
+ + F + +++ ++ + + + L LV +F
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTI--------ERVKDFSYNFGWQHLELVNCKFG---- 317
Query: 316 HSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS--GEIPS 373
P+ KL SL + N+ E L +L+FL++ N LS G
Sbjct: 318 ------QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 374 SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSL 433
S +SL L L N + + S+ L+QL L ++L +F L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 434 NFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSI 492
+ + H + L L + ++ N+ +I L + +++
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 493 PSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
P++ SL L+ ++++ N L +RL L+ + L N
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 90/408 (22%), Positives = 146/408 (35%), Gaps = 54/408 (13%)
Query: 47 SLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEA----LYLSHNSLVGEIPGNLSY 102
L NL+ L + LS+N IQ ++ L ++ L LS N + I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFK 198
Query: 103 CSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQ------ENNLTGGIPHFLGNITSLE 155
RL L L N ++ L L+ + E NL L + +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 156 AISLAYNSL---GGNIPSSLGQLKELKSLGLGG----TIPPSIYNLSL--LANFSVPENR 206
L +I L + S L + YN L + +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 207 LHGSLPPSL---------------GLTLSNLQLFQISNNF--FSGSFPLAFSNASNLQSL 249
SL + L +L+ +S N F G + ++L+ L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 250 EILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
+ L N +S NF ++ L +L+ +NL E S SL NL +L++
Sbjct: 379 D-LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ--MSEFSVFLSL---RNLIYLDISHTH 432
Query: 310 FKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLS 368
+ + I +G L SL +++M N F+ ++ + L+NL FL++ QL
Sbjct: 433 TRV-AFNGIFNG--------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 369 GEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416
P++F +LSSL L + +N L V L L + L N
Sbjct: 484 QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 62/357 (17%), Positives = 108/357 (30%), Gaps = 37/357 (10%)
Query: 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIP-GEIGRLFRLEALYL------SHNSLVGEIP 97
+ + P L ++ L NN + I L LE L + +L
Sbjct: 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 98 GNLSYCSRLIGLYLGRNKLEGS---IPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
L L L+ I F L N+ ++ + + F N
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN-FGW 306
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHG-SLPP 213
+ + L G L LK L G S +L L + N L
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCS 366
Query: 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAY 272
++L+ +S N + F L+ L+ +N + F +++L Y
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG----------- 321
L+++ + ++F S+L L + N F+ I +
Sbjct: 426 LDISHTHT------RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 322 ----SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS 373
+ L SL ++ M NQ + RL +LQ + + N P
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 20/89 (22%), Positives = 32/89 (35%), Gaps = 1/89 (1%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
VL + + P I L L + LS ++ P L L+ L ++ N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPS 122
G + L ++L N + S P
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 35/193 (18%)
Query: 630 LRKVSYESLLKATDGFSS------THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA 683
S+ L T+ F + +G G FG VYKG + T VA+K L +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDIT 69
Query: 684 S----KSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPD 739
+ + F E + + +H NLV ++ S D LVY YMPNGSL + L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLS-- 122
Query: 740 AIPQTDEENDEIRNLTLLE---RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796
+ L R IA A+ +++LH + IH D+K +NILLD
Sbjct: 123 ----------CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEA 169
Query: 797 LTAHVGDFGLARL 809
TA + DFGLAR
Sbjct: 170 FTAKISDFGLARA 182
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-42
Identities = 104/509 (20%), Positives = 182/509 (35%), Gaps = 75/509 (14%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
L + ++S +L + + I K + L L + S+N L
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITS 153
P L ++L+ + + N++ P +L NL L + N +T P L N+T+
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTN 135
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTI--PPSIYNLSLLANFSVPENRLHGSL 211
L + L+ N++ S+L L L+ L G + + NL+ L + N++
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-- 191
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271
L L+NL+ +NN S PL +NL L L N + + +L
Sbjct: 192 ISVLA-KLTNLESLIATNNQISDITPL--GILTNLDELS-LNGNQLKDIG-TLASLTNLT 246
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLV 331
L++A N + S + L+ + L+ L L ANQ S + L
Sbjct: 247 DLDLANNQI--------SNLAPLSGLTKLTELKLGANQISN-----------ISPLAGLT 287
Query: 332 SLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNL 391
+L +E++ NQ E +S L+NL +L + N +S P +L+ L +L NN +
Sbjct: 288 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 392 SGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNL 451
S SSL NL + L N +S P + NL
Sbjct: 344 SD--VSSLANLTNINWLSAGHNQISDLTP---------------------------LANL 374
Query: 452 KVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNN 511
+ ++ + + + + P+++ E D++ N
Sbjct: 375 TRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNL 432
Query: 512 LSGKIPISLERLPLEYLNLSFNDLEGQVP 540
S +S + G V
Sbjct: 433 PSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-41
Identities = 87/503 (17%), Positives = 163/503 (32%), Gaps = 94/503 (18%)
Query: 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
+ + I + L+ + L + + L ++ L +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
+ + Y + L + N+L P +L L ++ + N + P L N+T
Sbjct: 59 --KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLP 212
+L ++L N + L L L L L N +
Sbjct: 113 NLTGLTLFNNQI--TDIDPLKNLTNLNRLELSS-------------------NTISD--I 149
Query: 213 PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272
+L L++LQ N + +N + L+ L+ + +N +S + +L
Sbjct: 150 SALS-GLTSLQQLSFGNQV---TDLKPLANLTTLERLD-ISSNKVSDIS-VLAKLTNLES 203
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVS 332
L N + I L +NL L+L NQ K + L +
Sbjct: 204 LIATNNQISD--------ITPLGILTNLDELSLNGNQLKD-----------IGTLASLTN 244
Query: 333 LYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
L +++ +NQ P +S L L L + NQ+S P L++L L L N L
Sbjct: 245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300
Query: 393 GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLK 452
+ P + NLK L L L+ N++S P + +L
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDISP---------------------------VSSLT 331
Query: 453 VLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNL 512
L+ +N +S S + + + + N P L +L + ++ L+
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 513 SGKIPISLERLPLEYLNLSFNDL 535
+ + + +
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-20
Identities = 52/250 (20%), Positives = 98/250 (39%), Gaps = 34/250 (13%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
I + + L + L + ++ D K +
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVS-----------QTDLDQVTTLQADRLGI--KSIDG 63
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+ L NL +N +NQL+ P NL+ LV +++ NN ++ + P L NL L L L
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 411 FQNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
F N ++ I + ++++ L + N + S + L L+ N ++
Sbjct: 120 FNNQITD-----IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLK 171
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEY 527
P + + L+ + ++ N S S L L +L + + N +S P+ L L+
Sbjct: 172 P--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDE 225
Query: 528 LNLSFNDLEG 537
L+L+ N L+
Sbjct: 226 LSLNGNQLKD 235
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-42
Identities = 98/504 (19%), Positives = 161/504 (31%), Gaps = 94/504 (18%)
Query: 48 LSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLS------ 101
++P+ + +FL+E ++ + ++P E + Y + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 102 -------YCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
+ L L L S+P +L+ L N+LT +P ++ SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSL 211
+ +L P L+ LG+ P + N S L V N L L
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KL 168
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271
P +L+ NN P N L ++ N L SL
Sbjct: 169 PDLPP----SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNN----SLKKLPDLPLSLE 218
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLV 331
+ N L + L N L+ + N K ++P L
Sbjct: 219 SIVAGNNIL--------EELPELQNLPFLTTIYADNNLLK----------TLPDLPPSLE 260
Query: 332 SLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNL 391
+L + N +PE L L + LS P +L L +N +
Sbjct: 261 ALNV---RDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEI 309
Query: 392 SGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNL 451
+ +L++ L++ N L +P + L + NHL +P NL
Sbjct: 310 R-SLCDLPPSLEE---LNVSNNKLI-ELPALPPRLER----LIASFNHLA-EVPELPQNL 359
Query: 452 KVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNN 511
K L V N L E P S L+ N +P +LK L + N
Sbjct: 360 KQLH---VEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQNLKQL---HVETNP 407
Query: 512 LSGKIPISLERLPLEYLNLSFNDL 535
L + P E +E L ++ +
Sbjct: 408 LR-EFPDIPES--VEDLRMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-38
Identities = 89/482 (18%), Positives = 159/482 (32%), Gaps = 92/482 (19%)
Query: 72 IPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLK 131
I L+ ++L E+P Y ++ E + P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 132 ELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TI 187
+++ + L L ++P L+ L +
Sbjct: 62 VSRLRDCLD-----------RQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLTEL 106
Query: 188 PPSIYNLSLLANFSVPENRLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNL 246
P +L L + L LPP L L +SN QL ++ N+S L
Sbjct: 107 PELPQSLKSLLVDNNNLKALS-DLPPLLEYLGVSNNQLEKLPE----------LQNSSFL 155
Query: 247 QSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLV 306
+ +++ N L SL ++ N L + L N L+ +
Sbjct: 156 KIIDVDNN----SLKKLPDLPPSLEFIAAGNNQL--------EELPELQNLPFLTAIYAD 203
Query: 307 ANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQ 366
N K +P L S+ +N E E+ L L + +N
Sbjct: 204 NNSLK----------KLPDLPLSLESIVA---GNNILE--ELPELQNLPFLTTIYADNNL 248
Query: 367 LSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPE-EIFN 425
L +P +L +L + +N L+ +P +L L + + LS P N
Sbjct: 249 LK-TLPDLPPSLEALN---VRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLN 303
Query: 426 ISHMS-----------DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGS 474
S + LN + N L+ +P L+ L S N+L+ E+P +
Sbjct: 304 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQN 358
Query: 475 CFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFND 534
L+++++ N R P S++DLR N+ ++P + L+ L++ N
Sbjct: 359 ---LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQN--LKQLHVETNP 407
Query: 535 LE 536
L
Sbjct: 408 LR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 68/355 (19%), Positives = 123/355 (34%), Gaps = 60/355 (16%)
Query: 50 PQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGL 109
P++ N SFL+ I + NN+++ K+P L E + +N L E+P L L +
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQLE-ELP-ELQNLPFLTAI 200
Query: 110 YLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169
Y N L+ +P +L+ + N L L N+ L I N L +P
Sbjct: 201 YADNNSLK-KLPDL---PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLP 253
Query: 170 SSLGQLKELKSLGLGGT-IPPSIYNLSLLANFSVPENRLHGSLPPSLG-LTLSNLQLFQI 227
L+ L T +P +L+ L + L LPP+L L S+ ++ +
Sbjct: 254 DLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSL 312
Query: 228 SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
+ +L+ L + NN +L L L + N+L
Sbjct: 313 CDLP------------PSLEEL-NVSNNKLIELPALPP---RLERLIASFNHL------- 349
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVS----------GSIPSEIGKLVSLYLIE 337
NL L++ N + P S +P L L++
Sbjct: 350 AEVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHV-- 403
Query: 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
+ N + P+ +++L M ++ + L + +++
Sbjct: 404 -ETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 52/248 (20%), Positives = 87/248 (35%), Gaps = 38/248 (15%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRL-------------QNLQFLNMRHNQLS 368
+P E + S +++E P + L + + LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 369 GEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISH 428
+P +L S L+ N+L+ +P +LK L + + LS P
Sbjct: 85 -SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLE----- 134
Query: 429 MSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFF 488
L + N L +P + N L++ V +N+L ++P S L+ I N
Sbjct: 135 ---YLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQL 185
Query: 489 RGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTKGIFANA 548
+P L +L L I N+L K+P LE + N LE ++P
Sbjct: 186 E-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS--LESIVAGNNILE-ELPELQNLPFL 239
Query: 549 SAISVSGN 556
+ I N
Sbjct: 240 TTIYADNN 247
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 19/176 (10%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
IG GSFG+V++ + G+ VA+K+L Q A F E ++ +RH N+V +
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + Q + ++V +Y+ GSL LH ++ L R+S+A DV
Sbjct: 101 GAVT----QPPNL-SIVTEYLSRGSLYRLLH---------KSGAREQLDERRRLSMAYDV 146
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A ++YLH+ P +H +LK N+L+D T V DFGL+RL+ + S+ G
Sbjct: 147 AKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 24/183 (13%)
Query: 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRA 693
E+L + + G FG V+K VA+K+ +Q S E +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 694 LRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN 753
L ++H N+++ I + D L+ + GSL ++L
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA-------------NV 117
Query: 754 LTLLERISIAIDVASAVDYLHHHCQEPT-------IHCDLKPSNILLDNNLTAHVGDFGL 806
++ E IA +A + YLH H D+K N+LL NNLTA + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177
Query: 807 ARL 809
A
Sbjct: 178 ALK 180
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-41
Identities = 75/376 (19%), Positives = 144/376 (38%), Gaps = 45/376 (11%)
Query: 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS 104
I + P +L+ L ++ + L + L ++ + I G + Y +
Sbjct: 12 INQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASIQG-IEYLT 66
Query: 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164
L L L N++ P +L L L I N +T L N+T+L + L +++
Sbjct: 67 NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNI 122
Query: 165 GGNIPSSLGQLKELKSLGLGG----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLS 220
S L L ++ SL LG + + N++ L +V E+++ + L+
Sbjct: 123 SD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDV--TPIA-NLT 177
Query: 221 NLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNL 280
+L ++ N PL ++ ++L N ++ +M L L + N +
Sbjct: 178 DLYSLSLNYNQIEDISPL--ASLTSLHYFT-AYVNQITDIT-PVANMTRLNSLKIGNNKI 233
Query: 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDH 340
+ LAN S L++L + NQ + + L L ++ +
Sbjct: 234 TD--------LSPLANLSQLTWLEIGTNQISD-----------INAVKDLTKLKMLNVGS 274
Query: 341 NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLG 400
NQ ++ L L L + +NQL E G L++L L L N+++ + P L
Sbjct: 275 NQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330
Query: 401 NLKQLALLHLFQNDLS 416
+L ++ +
Sbjct: 331 SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 76/410 (18%), Positives = 156/410 (38%), Gaps = 68/410 (16%)
Query: 130 LKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPP 189
LA + P ++ L S+ + +L+ + L + G
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 190 SIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSL 249
SI + L +NL+ ++ N + PL SN L +L
Sbjct: 58 SIQGIEYL----------------------TNLEYLNLNGNQITDISPL--SNLVKLTNL 93
Query: 250 EILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
+G N +S ++ +L L + +N+ S I LAN + + LNL AN
Sbjct: 94 Y-IGTNKITDIS-ALQNLTNLRELYLNEDNI--------SDISPLANLTKMYSLNLGANH 143
Query: 310 FKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSG 369
S S + + L + + ++ + ++ L +L L++ +NQ+
Sbjct: 144 NL----------SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED 191
Query: 370 EIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHM 429
P +L+SL N ++ + P + N+ +L L + N ++ + ++++
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-----LSPLANL 242
Query: 430 SD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENF 487
S L N + S + +L L+M V SN +S S + + L +++ N
Sbjct: 243 SQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQ 298
Query: 488 FRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
+ L +L + LSQN+++ P++ L ++ + + ++
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 68/366 (18%), Positives = 130/366 (35%), Gaps = 48/366 (13%)
Query: 178 LKSLGLGGTIPPSIYNLSLLAN---FSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG 234
+L I+ + LA + + + + L ++ ++ +
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVA- 57
Query: 235 SFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSL 294
S +NL+ L L N +S ++ L L + N + + I +L
Sbjct: 58 SIQ-GIEYLTNLEYLN-LNGNQITDIS-PLSNLVKLTNLYIGTNKI--------TDISAL 106
Query: 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRL 354
N +NL L L + S + L +Y + + N +S +
Sbjct: 107 QNLTNLRELYLNEDNISD-----------ISPLANLTKMYSLNLGANHNL-SDLSPLSNM 154
Query: 355 QNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQND 414
L +L + +++ P NL+ L L L N + + P L +L L + N
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210
Query: 415 LSGAIPEEIFNISHMS--DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEI 472
++ P +++M+ +SL N + P + NL L + +N +S + +
Sbjct: 211 ITDITP-----VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAV 261
Query: 473 GSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLS 531
L+ + + N S S L +L L + L+ N L + + L L L LS
Sbjct: 262 KDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 532 FNDLEG 537
N +
Sbjct: 320 QNHITD 325
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 18/166 (10%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA--SKSFAAECRALRNIRHRNLVRVI 706
+ G ++KG + G + +KVL ++ S+ F EC LR H N++ V+
Sbjct: 16 TKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+C S L+ +MP GSL N LH + + + A+D+
Sbjct: 74 GACQS---PPAPHPTLITHWMPYGSLYNVLH----------EGTNFVVDQSQAVKFALDM 120
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
A + +LH + L ++++D ++TA + + Q
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-40
Identities = 110/579 (18%), Positives = 207/579 (35%), Gaps = 89/579 (15%)
Query: 26 TCSPRHRRVTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEA 84
+CS R + + L Q+ L+ + LS N I+ L +L+
Sbjct: 1 SCSFDGR---IAFYRFCNL-----TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQL 52
Query: 85 LYLSHNSLVGEIPGN-LSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG 143
L L I L L LG +K+ P F L++L EL + L+
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 144 I--PHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANF 200
+ + N+ +L + L+ N + + S G+L LKS+
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS--------------- 157
Query: 201 SVPENRLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASN------LQSLEILG 253
N++ L L L F ++ N + + N L+ L++ G
Sbjct: 158 ----NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213
Query: 254 NNFFGKLSVNFGD------------MKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLS 301
N + ++ NF + + +N+ + + LA S++
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN---TFAGLAR-SSVR 269
Query: 302 FLNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFL 360
L+L S+ S + L L ++ + +N+ E L NLQ L
Sbjct: 270 HLDLSHGFVF----------SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVL 319
Query: 361 NMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN------- 413
N+ +N L S+F L + + L N+++ + + L++L L L N
Sbjct: 320 NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF 379
Query: 414 -------DLSGAIPEEIFNISHMSDSLNFARNHLVG-SIPPKIGNLKVLRMFVVSSNNLS 465
LSG + I+ ++ ++ + N L I + + L++ +++ N S
Sbjct: 380 IPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
Query: 466 G-EIPSEIGSCFYLQEIYMAENFFRGSIPSSLVS-----LKDLREIDLSQNNLSGKIPIS 519
L+++++ EN + + + L L L+ + L+ N L+ P
Sbjct: 440 SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGV 499
Query: 520 LERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNS 557
L L L+L+ N L + + AN + +S N
Sbjct: 500 FSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-36
Identities = 115/626 (18%), Positives = 211/626 (33%), Gaps = 78/626 (12%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+L+L S+ ++ + NL LR + L ++ I P LF L L L L
Sbjct: 51 QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110
Query: 94 GEI--PGNLSYCSRLIGLYLGRNKLEG-SIPSEFVSLYNLKELAIQENNLTGGIPHFLGN 150
+ G L L L +N++ + F L +LK + N + H L
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 151 IT--SLEAISLAYNSLGGNIPSSLGQLKE------LKSLGLGGTIPPSIYNLSLLANFSV 202
+ +L SLA NSL + G+ L+ L + G + S
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230
Query: 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSV 262
+ +G + N F+G S+++ L++ F S
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR------SSVRHLDLSHGFVFSLNSR 284
Query: 263 NFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGS 322
F +K L LN+A N + + + NL LNL N
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADE------AFYGLDNLQVLNLSYNLLG----------E 328
Query: 323 IPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+ S L + I++ N + L+ LQ L++R N L+ + + S+
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSI 383
Query: 382 VKLILGNNNLSGV---------------------IPSSLGNLKQLALLHLFQNDLSGAIP 420
+ L N L + I L + L +L L QN S
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 421 EEIFNISHMSDSLNFARNHLVGSIPPKI-----GNLKVLRMFVVSSNNLSGEIPSEIGSC 475
++ + + + L N L + ++ L L++ ++ N L+ +P + S
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSH 502
Query: 476 FY-LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFND 534
L+ + + N + L +L +D+S+N L P L L+++ N
Sbjct: 503 LTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS--VLDITHNK 558
Query: 535 LEGQVPTKGI--FANASAISVSGNSNRLCGGIPE----LQLPKCPKNNSRNHKVYRGVLK 588
+ + N + ++++G + P+ + L +V + +
Sbjct: 559 FICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKF 618
Query: 589 VIISTCSVFSGLLLGSFFIFYWLRRR 614
+ C+V L L + R
Sbjct: 619 SLFIVCTVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 67/411 (16%), Positives = 122/411 (29%), Gaps = 43/411 (10%)
Query: 2 ITQYPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREI 61
+ + E + S V + S + S + + +
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 62 HLSNNTIQGKIPGEIGRLFR--LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGS 119
+ I+ L R + L LSH + L L L NK+
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI 305
Query: 120 IPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELK 179
F L NL+ L + N L + + I L N + + L++L+
Sbjct: 306 ADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ 365
Query: 180 SLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLA 239
+L L +I+ + + + + LS +L + +
Sbjct: 366 TLDLRDNALTTIHFIPSIPD-----------------IFLSGNKLVTLPKINLT------ 402
Query: 240 FSNASNLQSLEILGNNFFG-KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCS 298
+ + N + + L L + N S D + +
Sbjct: 403 ------ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGD-----QTPSENP 451
Query: 299 NLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQ 358
+L L L N + A + + L LYL +HN P S L L+
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVF-EGLSHLQVLYL---NHNYLNSLPPGVFSHLTALR 507
Query: 359 FLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLH 409
L++ N+L+ + ++L L + N L P +L L + H
Sbjct: 508 GLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITH 556
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-40
Identities = 82/457 (17%), Positives = 149/457 (32%), Gaps = 31/457 (6%)
Query: 35 TVLDLKSKGLIGSLSPQ-IGNLSFLREIHLSNNTIQG-KIPGEIGRLFRLEALYLSHNSL 92
LDL S + SLS G LS L+ ++L N Q + L L+ L + +
Sbjct: 77 EHLDL-SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 93 VGEIP-GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
EI + + + L L + L S+ ++ L + + + F +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211
+S+ + L +L S L + + + + S + L S
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271
TL L + + L ++ L I F LS + ++ +
Sbjct: 256 VEFDDCTL--NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLV 331
+ V + + + +L FL+L N + + G
Sbjct: 314 RITVENSKVFLVPCS------FSQHLKSLEFLDLSENLMVEEYLKN------SACKGAWP 361
Query: 332 SLYLIEMDHNQFE--GKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
SL + + N K E + L+NL L++ N +P S + L L +
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 390 NLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIG 449
+ V L+ L + + N+L + + + L +RN L P
Sbjct: 421 GIRVVKTCIPQTLEVLDVSN---NNLD-SFSLFLPRLQE----LYISRNKL--KTLPDAS 470
Query: 450 NLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAEN 486
VL + +S N L LQ+I++ N
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-39
Identities = 91/522 (17%), Positives = 182/522 (34%), Gaps = 41/522 (7%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
V D +S+ S+ + + ++ + LS N I G++ L+ L L + +
Sbjct: 8 GVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT 64
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITS 153
L L L N L S F L +LK L + N G+ N+T+
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 154 LEAISLAYNSLGGNIP-SSLGQLKELKSLGLGG----TIPP-SIYNLSLLANFSVPENRL 207
L+ + + I L L L + S+ ++ + + ++ +
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 208 HGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF-------FGKL 260
L LS+++ ++ + + ++ L F +L
Sbjct: 185 A-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS 320
+ L+ + L S ++ + + + +P +
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH----IPQFYLF 299
Query: 321 GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI---PSSFGN 377
+ + L + I +++++ L++L+FL++ N + E + G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 378 LSSLVKLILGNNNLS--GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNF 435
SL L+L N+L L LK L L + +N +P+ M LN
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR-FLNL 417
Query: 436 ARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPS 494
+ + + I L+VL + S+NNL + LQE+Y++ N + ++P
Sbjct: 418 SSTGIR-VVKTCIPQTLEVLDV---SNNNLD-SFSLFLPR---LQELYISRNKLK-TLPD 468
Query: 495 SLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
+ L + +S+N L +RL L+ + L N
Sbjct: 469 A-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 42/227 (18%), Positives = 81/227 (35%), Gaps = 4/227 (1%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
SIPS + ++ +++ N+ ++ NLQ L ++ ++++ +F +L SL
Sbjct: 19 SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L +N+LS + S G L L L+L N +F +L
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 442 GSIPPK-IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLK 500
I L L + + +L + S + + + + + L
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 501 DLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTKGIFAN 547
+R ++L NL+ + S + + G V T F
Sbjct: 197 SVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 48/184 (26%), Positives = 71/184 (38%), Gaps = 26/184 (14%)
Query: 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECR- 692
+ D LIG G +G+VYKG+ D VA+KV + ++F E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA---NRQNFINEKNI 58
Query: 693 -ALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI 751
+ + H N+ R I + G LV +Y PNGSL +L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------------- 105
Query: 752 RNLTLLERISIAIDVASAVDYLH------HHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
+ +A V + YLH H + H DL N+L+ N+ T + DFG
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 806 LARL 809
L+
Sbjct: 166 LSMR 169
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 24/175 (13%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
++G G+FG V K + VAIK + + + K+F E R L + H N+V++ +
Sbjct: 14 EVVGRGAFGVVCKAKWR--AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C N LV +Y GSL N LH + + T +S + +
Sbjct: 70 CL------NPV-CLVMEYAEGGSLYNVLH---------GAEPLPYYTAAHAMSWCLQCSQ 113
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARLRQEVPNNQSSSVG 822
V YLH + IH DLKP N+LL + DFG A ++ + +++ G
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNKG 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 60/389 (15%), Positives = 116/389 (29%), Gaps = 68/389 (17%)
Query: 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPP-SIYNLSLLANF 200
G H + + E + ++ L Q + + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 201 SVPENRLHGSLPPSLG-LTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259
+ L + L T ++ + FP S+LQ + + +
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMT-IDAAGLME 118
Query: 260 LSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVA-NQFKGALPHSI 318
L L L +A N L + S+A+ + L L++ A +
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-------RALPASIASLNRLRELSIRACPELT------- 164
Query: 319 VSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNL 378
+P + E L NLQ L + + +P+S NL
Sbjct: 165 ---ELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANL 205
Query: 379 SSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARN 438
+L L + N+ LS + ++ +L +L L L
Sbjct: 206 QNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC------------------------T 240
Query: 439 HLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVS 498
L + PP G L+ ++ + +P +I L+++ + +PS +
Sbjct: 241 ALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 499 LKDLREIDLSQN---NLSGKIPISLERLP 524
L I + + L P++ P
Sbjct: 300 LPANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-36
Identities = 53/342 (15%), Positives = 107/342 (31%), Gaps = 46/342 (13%)
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
+G + + S LY + ++ L + + N N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGST---ALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSN 56
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKE--LKSLGLGG----TIPPSIYNLSLLANFSVPENR 206
+ + + +L L + +L L P + LS L + ++
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAG 115
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
L LP ++ + L+ ++ N + P + ++ + L+ L I +L
Sbjct: 116 LM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 267 MKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSE 326
+ NL L L + S+P+
Sbjct: 173 TDASG---------------------EHQGLVNLQSLRLEWTGIR----------SLPAS 201
Query: 327 IGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLIL 386
I L +L +++ ++ + + L L+ L++R P FG + L +LIL
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 387 GNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISH 428
+ + +P + L QL L L +P I +
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 60/377 (15%), Positives = 115/377 (30%), Gaps = 77/377 (20%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
L + + + + H + + + + + +L
Sbjct: 15 ENLYFQGSTALRPYHDVLSQW----QRHYNADRNRWHSAWRQANSNNPQIETRTGRALK- 69
Query: 95 EIPGNLSYCSR--LIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
L ++ + L L L P + L +L+ + I L +P +
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG-----TIPPSIYNLSLLANFSVPENRL 207
LE ++LA N L +P+S+ L L+ L + +P + +
Sbjct: 128 GLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ------ 180
Query: 208 HGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267
L NLQ ++ S P + +N NL+SL+ + N+ L +
Sbjct: 181 ----------GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK-IRNSPLSALGPAIHHL 228
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
L L+ L C+ L + P
Sbjct: 229 PKLEELD-------------------LRGCTALR--------------------NYPPIF 249
Query: 328 GKLVSL-YLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLIL 386
G L LI D + +P ++ RL L+ L++R +PS L + +++
Sbjct: 250 GGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 387 GNN---NLSGVIPSSLG 400
+ L P +
Sbjct: 309 PPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 53/342 (15%), Positives = 102/342 (29%), Gaps = 48/342 (14%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
E LY ++ + LS R R + N + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 142 GGIPHFLGNITS--LEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPPSIYNLS 195
L + T A+ L L P +L L+ + + +P ++ +
Sbjct: 70 A-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFA 127
Query: 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNN 255
L ++ N L +LP S+ +L+ L+ I P ++
Sbjct: 128 GLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLASTDASGEH------ 179
Query: 256 FFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALP 315
+ +L L + + S S+AN NL L + +
Sbjct: 180 ---------QGLVNLQSLRLEWTGI-------RSLPASIANLQNLKSLKIRNSPLS---- 219
Query: 316 HSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRH-NQLSGEIPSS 374
++ I L L +++ P L+ L ++ + L +P
Sbjct: 220 ------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLD 272
Query: 375 FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416
L+ L KL L +PS + L ++ + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 38/249 (15%), Positives = 73/249 (29%), Gaps = 39/249 (15%)
Query: 292 HSLANCSNLSFLNLV-ANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
H + S L + + + + Y + + +
Sbjct: 6 HHHHHSSGRENLYFQGSTALR----------PYHDVLSQWQRHYNADRNRWHSAWRQAN- 54
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSS--LVKLILGNNNLSGVIPSSLGNLKQLALL 408
N Q L + + V L L + L P L L +
Sbjct: 55 ---SNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 409 HLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
+ L +P+ + + + +L ARN L ++P I +L LR + + E+
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLE-TLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEY 527
P + S L +L+ + L + +P S+ L L+
Sbjct: 167 PEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210
Query: 528 LNLSFNDLE 536
L + + L
Sbjct: 211 LKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 24/120 (20%), Positives = 42/120 (35%), Gaps = 1/120 (0%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
L +++ L +L P I +L L E+ L T P G L+ L L S +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
+P ++ ++L L L +PS L + + + H +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 45/186 (24%), Positives = 73/186 (39%), Gaps = 34/186 (18%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ----GASKSFAAECRALRNIRHRNLVR 704
+IGIG FG VY+ + G VA+K ++ E + ++H N++
Sbjct: 13 EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ C + + LV ++ G L L + + ++ A+
Sbjct: 71 LRGVCL----KEPNL-CLVMEFARGGPLNRVLSG-------------KRIPPDILVNWAV 112
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDN--------NLTAHVGDFGLARLRQEVPNN 816
+A ++YLH P IH DLK SNIL+ N + DFGLAR
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TT 170
Query: 817 QSSSVG 822
+ S+ G
Sbjct: 171 KMSAAG 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 34/186 (18%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ-------LQGASKSFAAECRALRNIRHRN 701
IG G FG V+KG +D ++VAIK L L + + F E + N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V++ + +V +++P G L + L D+ + ++
Sbjct: 85 IVKLYGLMHNP-------PRMVMEFVPCGDLYHRLL-----------DKAHPIKWSVKLR 126
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-----NLTAHVGDFGLARLRQEVPNN 816
+ +D+A ++Y+ + P +H DL+ NI L + + A V DFGL++ + ++
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHS 182
Query: 817 QSSSVG 822
S +G
Sbjct: 183 VSGLLG 188
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 53/171 (30%), Positives = 76/171 (44%), Gaps = 25/171 (14%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVI 706
IG GSFG+VYKG + D VA+K+LN+ ++F E LR RH N++ +
Sbjct: 30 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
++ A+V Q+ SL + LH + + I IA
Sbjct: 87 GYSTAPQL------AIVTQWCEGSSLYHHLH-----------ASETKFEMKKLIDIARQT 129
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ 817
A +DYLH IH DLK +NI L + T +GDFGLA + +
Sbjct: 130 ARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 19/174 (10%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
++G G FG K T G ++ +K L + ++F E + +R + H N+++ I
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ + +Y+ G+L + +R+S A D+AS
Sbjct: 76 LY----KDKRL-NFITEYIKGGTLRGIIK-----------SMDSQYPWSQRVSFAKDIAS 119
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ YLH IH DL N L+ N V DFGLARL +
Sbjct: 120 GMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 44/185 (23%), Positives = 74/185 (40%), Gaps = 30/185 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAEC--RALRNIRHRNLVRVI 706
+G G +G V++G++ G VA+K+ + + KS+ E +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFI 68
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S + L+ Y GSL ++L L + + I + +
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL-------------TTLDTVSCLRIVLSI 114
Query: 767 ASAVDYLH-----HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN----NQ 817
AS + +LH + H DLK NIL+ N + D GLA + + N
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 818 SSSVG 822
+ VG
Sbjct: 175 NPRVG 179
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 44/174 (25%), Positives = 63/174 (36%), Gaps = 22/174 (12%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G +G V+ G + G VA+KV + AS E +RH N++ I +
Sbjct: 43 KQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
L+ Y NGSL ++L L + +A S
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS-------------TTLDAKSMLKLAYSSVS 145
Query: 769 AVDYLH-----HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ 817
+ +LH + H DLK NIL+ N T + D GLA N
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 62/462 (13%), Positives = 129/462 (27%), Gaps = 54/462 (11%)
Query: 79 LFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138
R + ++ +SL + + L L N L ++ L+ L + N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLA 198
L ++++L + L N + L +++L
Sbjct: 69 VLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAAN------------- 108
Query: 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258
N + + S G N+ L +NN + L S +Q L+ L N
Sbjct: 109 ------NNIS-RVSCSRGQGKKNIYL---ANNKITMLRDLDEGCRSRVQYLD-LKLNEID 157
Query: 259 KLSVN--FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPH 316
++ +L +LN+ N + + + L L+L +N+
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFI--------YDVKGQVVFAKLKTLDLSSNKLA----- 204
Query: 317 SIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS-GEIPSSF 375
+ E + I + +N+ I + + QNL+ ++R N G + F
Sbjct: 205 -----FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 376 GNLSSLVKLIL-GNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLN 434
+ + L+G DL + + + +L
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 435 FARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPS 494
+ + + N R I + + + +
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 495 SLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLE 536
+ +L + E+ PL+ L E
Sbjct: 379 GRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 51/413 (12%), Positives = 131/413 (31%), Gaps = 36/413 (8%)
Query: 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178
+I + K + +++L + + +++ + L+ N L + L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 179 KSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235
+ L L + +LS L + N + L +++ +NN S
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR- 113
Query: 236 FPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLA 295
++ S +++ + N ++ G + YL++ +N + + E+ A
Sbjct: 114 --VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL-----AA 166
Query: 296 NCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355
+ L LNL N + ++ L +++ N+ + E
Sbjct: 167 SSDTLEHLNLQYNFIY----------DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ ++++R+N+L I + +L L N K + + + +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTV 272
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
+ + + ++ P L L+ + + G +
Sbjct: 273 KK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECE 331
Query: 476 FY----LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP 524
+EI + +R I + + ++ + L ++
Sbjct: 332 RENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 63/459 (13%), Positives = 138/459 (30%), Gaps = 50/459 (10%)
Query: 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
R + + L +L+ + ++E+ LS N + ++ +LE L LS N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 93 VGEIP-----------------GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135
+ L + L+ N + + K + +
Sbjct: 71 YETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYL 127
Query: 136 QENNLTGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGG----TIPPS 190
N +T G + ++ + L N + N L+ L L +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ 187
Query: 191 IYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLE 250
+ + L + N+L + P + + + + NN A + NL+ +
Sbjct: 188 V-VFAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFD 243
Query: 251 ILGNNF-FGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
+ GN F G L F + + + +G+++E C+ + + A
Sbjct: 244 LRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE--------ECTVPTLGHYGAYC 295
Query: 310 FKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSG 369
+ LP I K L+ ++ E ++ E + ++ Q
Sbjct: 296 CE-DLPAPFADRLIAL---KRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRT 350
Query: 370 EIPSSFGNLSSLVKLILGNNNLSGVIP---SSLGNLKQLALLHLFQNDLSGAIPEEIFNI 426
I + + L L + + L + Q +L A
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE----EQ 406
Query: 427 SHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLS 465
S + + + + + +R + + + +
Sbjct: 407 SPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 53/360 (14%), Positives = 107/360 (29%), Gaps = 80/360 (22%)
Query: 213 PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272
+ + ++ +++++ + +A N++ L++ GN + + L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVS 332
LN++ N L L + S L L+L N E+ S
Sbjct: 63 LNLSSNVLYE--------TLDLESLSTLRTLDLNNNYV--------------QELLVGPS 100
Query: 333 LYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
+ + +N ++ Q + + + +N+++ G S + L L N +
Sbjct: 101 IETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 393 GV-IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNL 451
V + L L+L N + + ++ L
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-----------------------FAKL 193
Query: 452 KVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNN 511
K L +SSN L+ + S + I L N
Sbjct: 194 KTLD---LSSNKLA-------------------------FMGPEFQSAAGVTWISLRNNK 225
Query: 512 LSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLP 570
L I +L LE+ +L N N +V+ + + G E +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-21
Identities = 33/234 (14%), Positives = 73/234 (31%), Gaps = 26/234 (11%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+I + ++ + + + N++ L++ N LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 382 VKLILGNNNLSGVIP-----------------SSLGNLKQLALLHLFQNDLSGAIPEEIF 424
L L +N L + L + LH N++S +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 425 NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSG-EIPSEIGSCFYLQEIYM 483
++ A N + G ++ + N + S L+ + +
Sbjct: 120 Q---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 484 AENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
NF + + L+ +DLS N L+ + + + +++L N L
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 25/174 (14%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
LIG G FG VY G + + VAI++++++ K+F E A R RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+C S A++ +L + + D L + + IA ++
Sbjct: 96 GACMS-----PPHLAIITSLCKGRTLYSVVR-----------DAKIVLDVNKTRQIAQEI 139
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+ YLH + +H DLK N+ DN + DFGL + + +
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECR--ALRNIRHRNLVRVI 706
IG G FG V++G + G VA+K+ + + + +S+ E +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + + LV Y +GSL ++L+ +T+ I +A+
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALST 148
Query: 767 ASAVDYLH-----HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
AS + +LH + H DLK NIL+ N T + D GLA +
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 106/499 (21%), Positives = 185/499 (37%), Gaps = 42/499 (8%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
++D GLI + + +++S N I +I L +L L +SHN +
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITS 153
+ L L L NKL I NLK L + N I GN++
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV-------PENR 206
L+ + L+ L + + L K L + G + L +F+ P N+
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
+ T++NL+L I S + LQ+ L N + +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 267 M---------KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317
++ Y +++ L G+ D F +S + LS +V++ F P S
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQ-GQLDFRDFDYSGTSLKALSIHQVVSDVFG--FPQS 293
Query: 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN 377
+ ++ + + S++ L+ +N L+ + + G+
Sbjct: 294 YIYE-------IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
Query: 378 LSSLVKLILGNNNLSGV--IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNF 435
L+ L LIL N L + I +K L L + QN +S + + + SLN
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 436 ARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIP- 493
+ N L +I + +KVL + SN + IP ++ LQE+ +A N + S+P
Sbjct: 407 SSNILTDTIFRCLPPRIKVLDL---HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
Query: 494 SSLVSLKDLREIDLSQNNL 512
L L++I L N
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 89/470 (18%), Positives = 166/470 (35%), Gaps = 32/470 (6%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
L +S N + ++ S+L L + N+++ S F L+ L + N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 142 GGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGT-----IPPSIYNLS 195
I +L+ + L++N+ I G + +LK LGL T I +L+
Sbjct: 83 -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 196 LLANFSVPENRLHGSLPPSL--GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILG 253
+ V P +L + +N F ++ +NL+ I
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199
Query: 254 NNFFGKLSVNFGDMKSLAYLNVAIN---NLGSGESDEMSFIHSLANCSNLSFLNLVANQF 310
K S + L N N + I L + + + ++ +
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259
Query: 311 KGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGE 370
+G L S S L +L + ++ + F N+ N +
Sbjct: 260 QGQLDFRDFDYSGTS----LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 371 IPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS 430
+S + L NN L+ + + G+L +L L L N L + + + M
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 431 --DSLNFARNHLVGSIPPKI----GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMA 484
L+ ++N + +L L M SSN L+ I + ++ + +
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM---SSNILTDTIFRCLPP--RIKVLDLH 429
Query: 485 ENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFN 533
N + SIP +V L+ L+E++++ N L +RL L+ + L N
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 39/209 (18%), Positives = 82/209 (39%), Gaps = 12/209 (5%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
+ +++ + S S S + + + + + ++ L S+N
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE---FVSLYNLKELAIQENNLTGGIPH-F 147
L + N + + L L L N+L+ + + +L++L I +N+++
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
Query: 148 LGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPPSIYNLSLLANFSVP 203
SL +++++ N L I L +K L L +IP + L L +V
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVA 452
Query: 204 ENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
N+L S+P + L++LQ + N +
Sbjct: 453 SNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 40/251 (15%), Positives = 80/251 (31%), Gaps = 36/251 (14%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+P ++ + ++ + N ++ L L+ L + HN++ S F L
Sbjct: 14 HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLAL----------------------LHLFQNDLSGAI 419
L L +N L + NLK L L L L L +
Sbjct: 72 EYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNN--LSGEIPSEIGSCFY 477
I +++ L + P + + + +V N + + +
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 478 LQEIYMAENFFRG------SIPSSLVSLKDLREIDLSQNNLSGKIPISLERL----PLEY 527
L+ + SI + L + L + L+ + I + +L + Y
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 528 LNLSFNDLEGQ 538
++S L+GQ
Sbjct: 252 FSISNVKLQGQ 262
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 36/164 (21%), Positives = 69/164 (42%), Gaps = 6/164 (3%)
Query: 25 ITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQ--GKIPGEIGRLFRL 82
+ C + LD + L ++ G+L+ L + L N ++ KI ++ L
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376
Query: 83 EALYLSHNSL-VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
+ L +S NS+ E G+ S+ L+ L + N L +I +K L + N +
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
Query: 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG 185
IP + + +L+ +++A N L +L L+ + L
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 33/203 (16%), Positives = 60/203 (29%), Gaps = 51/203 (25%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
LN+ N +S S +LS L LI+ +N + + S ++L L L N L
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
++ NLK L + S N +P
Sbjct: 82 V---------------KISCH----------PTVNLKHLDL---SFNAFD-ALP------ 106
Query: 476 FYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDL 535
I ++ L+ + LS +L + + L + + L +
Sbjct: 107 ----------------ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 536 EGQVPTKGIFANASAISVSGNSN 558
G+ + + S+
Sbjct: 151 YGEKEDPEGLQDFNTESLHIVFP 173
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 69/428 (16%), Positives = 148/428 (34%), Gaps = 58/428 (13%)
Query: 96 IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLE 155
I NL Y +++ + E ++L N K + + + + L + +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 156 AISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSL 215
++L + + ++ L +G N + LPP +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGF-------------------NAIR-YLPPHV 112
Query: 216 GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLN 274
+ L + + N S F N L +L + NN ++ + F SL L
Sbjct: 113 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS-MSNNNLERIEDDTFQATTSLQNLQ 171
Query: 275 VAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLY 334
++ N L L+ +L N+ N S + +++
Sbjct: 172 LSSNRLTHV---------DLSLIPSLFHANVSYNLL--------------STLAIPIAVE 208
Query: 335 LIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV 394
++ HN + + L L ++HN L+ + N LV++ L N L +
Sbjct: 209 ELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKI 263
Query: 395 IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVL 454
+ +++L L++ N L A+ I + L+ + NHL+ + L
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRL 320
Query: 455 RMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSG 514
+ N++ + + + L+ + ++ N + + +L +++ + +
Sbjct: 321 ENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHC 375
Query: 515 KIPISLER 522
KI LE
Sbjct: 376 KIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-31
Identities = 67/370 (18%), Positives = 125/370 (33%), Gaps = 43/370 (11%)
Query: 54 NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113
++H+ T E L + + ++++ L ++ L L
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78
Query: 114 NKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSL 172
++E I + F + +++L + N + PH N+ L + L N L
Sbjct: 79 LQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 137
Query: 173 GQLKELKSLGLGG----TIPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI 227
+L +L + I + L N + NRL + SL + +L +
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANV 193
Query: 228 SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
S N S + ++ L+ N+ V L L + NNL
Sbjct: 194 SYNLLS-----TLAIPIAVEELDASHNSI---NVVRGPVNVELTILKLQHNNLTD----- 240
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGK 346
L N L ++L N+ + I K+ L + + +N+
Sbjct: 241 ---TAWLLNYPGLVEVDLSYNELE----------KIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406
+ + L+ L++ HN L + + L L L +N++ + S+ LK L
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 345
Query: 407 LLHLFQNDLS 416
L H ND
Sbjct: 346 LSH---NDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 45/248 (18%), Positives = 89/248 (35%), Gaps = 16/248 (6%)
Query: 312 GALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI 371
P I S + Y + +D + E L N + + +++ +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61
Query: 372 PSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSD 431
+ + + L L + + + + + L++ N + +P +F +
Sbjct: 62 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 120
Query: 432 SLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFR 489
L RN L S+P I N L +S+NNL I + + LQ + ++ N
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
Query: 490 GSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANA 548
+ SL + L ++S N LS +L +E L+ S N + V +
Sbjct: 179 -HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVEL 228
Query: 549 SAISVSGN 556
+ + + N
Sbjct: 229 TILKLQHN 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 5/115 (4%)
Query: 50 PQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGL 109
+ N L E+ LS N ++ + ++ RLE LY+S+N LV + L L
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 110 YLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164
L N L + L+ L + N++ + L +L+ ++L++N
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 25/201 (12%), Positives = 58/201 (28%), Gaps = 11/201 (5%)
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG----AI 419
+N + + + + + ++ + + L + +
Sbjct: 1 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCF-Y 477
P + + + LN + I ++ + N + +P +
Sbjct: 61 PAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118
Query: 478 LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
L + + N + L + +S NNL + + L+ L LS N L
Sbjct: 119 LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 537 GQVPTKGIFANASAISVSGNS 557
V + + +VS N
Sbjct: 179 -HVDL-SLIPSLFHANVSYNL 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 73/344 (21%), Positives = 123/344 (35%), Gaps = 64/344 (18%)
Query: 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILG 253
+ A +V E+ L +LP L +++ I +N + S P L++LE +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLE-VS 89
Query: 254 NNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGA 313
N L V + L+ + + +L + S L L + NQ
Sbjct: 90 GNQLTSLPVLPPGLLELSIFSNPLTHLPA-------------LPSGLCKLWIFGNQLT-- 134
Query: 314 LPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS 373
S+P L L + NQ +P S L L +NQL+ +P
Sbjct: 135 --------SLPVLPPGLQELSV---SDNQLA-SLPALPSELCKL---WAYNNQLT-SLPM 178
Query: 374 SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSL 433
L +L + +N L+ +P+ L +L + N L+ ++P + L
Sbjct: 179 LPSGL---QELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLK----EL 226
Query: 434 NFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIP 493
+ N L S+P LK L VS N L+ +P L + + N +P
Sbjct: 227 IVSGNRL-TSLPVLPSELKELM---VSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLP 277
Query: 494 SSLVSLKDLREIDLSQNNLS---GKIPISLERLPLEYLNLSFND 534
SL+ L ++L N LS + + P + D
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 69/353 (19%), Positives = 116/353 (32%), Gaps = 59/353 (16%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+++ + + +P + + L + N+L +P L L + N+L
Sbjct: 42 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT 94
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177
S+P L L + +L + L + + N L ++P L+E
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVLPPGLQE 145
Query: 178 LKSLGLG-GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236
L ++P L L N+L SLP LQ +S+N + S
Sbjct: 146 LSVSDNQLASLPALPSELCKL---WAYNNQLT-SLPMLPS----GLQELSVSDNQLA-SL 196
Query: 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSL-A 295
P S L L N +L+ L L V+ N L S L
Sbjct: 197 PTLPSE---LYKLWAYNN----RLTSLPALPSGLKELIVSGNRLTS-----------LPV 238
Query: 296 NCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355
S L L + N+ S+P L+SL + NQ ++PE + L
Sbjct: 239 LPSELKELMVSGNRLT----------SLPMLPSGLLSLSV---YRNQLT-RLPESLIHLS 284
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALL 408
+ +N+ N LS + ++S S+ + L L
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 48/243 (19%), Positives = 87/243 (35%), Gaps = 46/243 (18%)
Query: 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK-LVSLYLIEMDHNQFEGKIPEEMSR 353
+ + LN+ + ++P + + +L + N +P
Sbjct: 37 CLNNGNAVLNVGESGLT----------TLPDCLPAHITTLVI---PDNNLT-SLPAL--- 79
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+ L + NQL+ +P L L +L P+ L +L +F N
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKL---WIFGN 131
Query: 414 DLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIG 473
L+ ++P + L+ + N L S+P L L +N L+ +P
Sbjct: 132 QLT-SLPVLPPGLQ----ELSVSDNQL-ASLPALPSELCKLW---AYNNQLT-SLPMLPS 181
Query: 474 SCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFN 533
LQE+ +++N S+P+ L L N L+ +P L + L +S N
Sbjct: 182 G---LQELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGL--KELIVSGN 231
Query: 534 DLE 536
L
Sbjct: 232 RLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 60/266 (22%), Positives = 93/266 (34%), Gaps = 35/266 (13%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
L++ S + SL L L + G L L++ N L
Sbjct: 84 RTLEV-SGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQL-T 134
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
+P L L + N+L S+P+ L +L N LT +P + L
Sbjct: 135 SLPVLP---PGLQELSVSDNQLA-SLPAL---PSELCKLWAYNNQLT-SLPMLPSGLQEL 186
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGGT-IPPSIYNLSLLANFSVPENRLHGSLPP 213
S++ N L ++P+ +L +L + T +P L L V NRL SLP
Sbjct: 187 ---SVSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKEL---IVSGNRL-TSLPV 238
Query: 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273
L+ +S N + S P S L SL + N +L + + S +
Sbjct: 239 LPS----ELKELMVSGNRLT-SLP---MLPSGLLSLS-VYRNQLTRLPESLIHLSSETTV 289
Query: 274 NVAINNLGSGESDEMSFIHSLANCSN 299
N+ N L + I S S
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 39/214 (18%), Positives = 69/214 (32%), Gaps = 17/214 (7%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
L + S + SL L L NN + +P L + L +S N L
Sbjct: 184 QELSV-SDNQLASLPTLPSELYKLW---AYNNRLT-SLPALPSGL---KELIVSGNRL-T 234
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
+P S L L + N+L S+P L L++ N LT +P L +++S
Sbjct: 235 SLPVLPS---ELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTR-LPESLIHLSSE 286
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214
++L N L +L ++ + ++ +P
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAR 346
Query: 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQS 248
G + + +F L S ++
Sbjct: 347 EGEPAPADRWHMFGQEDNADAFSLFLDRLSETEN 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 86/542 (15%), Positives = 180/542 (33%), Gaps = 49/542 (9%)
Query: 54 NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113
++H+ T E L + + ++++ L ++ L L
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84
Query: 114 NKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSL 172
++E I + F + +++L + N + PH N+ L + L N L
Sbjct: 85 LQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143
Query: 173 GQLKELKSLGLGG----TIPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI 227
+L +L + I + L N + NRL + SL + +L +
Sbjct: 144 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANV 199
Query: 228 SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
S N S + ++ L+ N+ V L L + NNL
Sbjct: 200 SYNLLS-----TLAIPIAVEELDASHNSI---NVVRGPVNVELTILKLQHNNLTD----- 246
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGK 346
L N L ++L N+ + I K+ L + + +N+
Sbjct: 247 ---TAWLLNYPGLVEVDLSYNELE----------KIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406
+ + L+ L++ HN L + + L L L +N++ + S+ LK L
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLT 351
Query: 407 LLHL-FQNDLSGAIPEEIFNISHMSDSLNFA-----RNHLVGSIPPKIGNLKVLRMFVVS 460
L H + + A+ + + + + L K ++L+ ++
Sbjct: 352 LSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY--IA 409
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIP-IS 519
++ ++ G C I ++ V L+ +++ N L ++ ++
Sbjct: 410 LTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLT 469
Query: 520 LERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRN 579
E++ E L + + S N N++ + E Q K + +R
Sbjct: 470 NEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARR 529
Query: 580 HK 581
+
Sbjct: 530 TE 531
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 67/376 (17%), Positives = 132/376 (35%), Gaps = 40/376 (10%)
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
I NL Y +++ + E ++L N K + + + + L + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 155 EAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPPSI-YNLSLLANFSVPENRLHG 209
E ++L + + ++ L +G +PP + N+ LL + N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKS 269
SLP + L +SNN F ++LQ+L++ N V+ + S
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THVDLSLIPS 193
Query: 270 LAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK 329
L + NV+ N L +LA + L+ N + +
Sbjct: 194 LFHANVSYNLL-----------STLAIPIAVEELDASHNSIN----------VVRGPV-- 230
Query: 330 LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
V L ++++ HN + L +++ +N+L + F + L +L + NN
Sbjct: 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288
Query: 390 NLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIG 449
L + + L +L L N L + + +L N +V ++
Sbjct: 289 RLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV-TLKL--S 342
Query: 450 NLKVLRMFVVSSNNLS 465
L+ +S N+
Sbjct: 343 THHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 45/248 (18%), Positives = 89/248 (35%), Gaps = 16/248 (6%)
Query: 312 GALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI 371
P I S + Y + +D + E L N + + +++ +
Sbjct: 8 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 67
Query: 372 PSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSD 431
+ + + L L + + + + + L++ N + +P +F +
Sbjct: 68 AALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLT 126
Query: 432 SLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFR 489
L RN L S+P I N L +S+NNL I + + LQ + ++ N
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
Query: 490 GSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANA 548
+ SL + L ++S N LS +L +E L+ S N + V +
Sbjct: 185 -HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVEL 234
Query: 549 SAISVSGN 556
+ + + N
Sbjct: 235 TILKLQHN 242
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 54/369 (14%), Positives = 112/369 (30%), Gaps = 25/369 (6%)
Query: 50 PQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGL 109
+ N L E+ LS N ++ + ++ RLE LY+S+N LV + L L
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 110 YLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169
L N L + L+ L + N++ + L +L+ ++L++N N
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN-- 360
Query: 170 SSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISN 229
S + + + + L E S P L L + L +
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKE-----SDKPYLDRLLQYIALTSVVE 415
Query: 230 NFFSGSFPLAFSNASNLQ--SLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
+ ++ N + L N + L + L + + +
Sbjct: 416 KVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQ 475
Query: 288 MSFIHSL--ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEG 345
+ L +NL L + S ++ L ++ Q
Sbjct: 476 EQLLQGLHAEIDTNLRRYRLPKDGLAR------SSDNLNKVFTHLKERQAFKLRETQA-- 527
Query: 346 KIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG-NLSSLVKLILGNNNLSGVIPSSLGNLKQ 404
+ E ++ + + L + L ++ + + L + + N
Sbjct: 528 RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNRNPDT 587
Query: 405 LALLHLFQN 413
+ H +
Sbjct: 588 RRVSHHHHH 596
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 26/205 (12%), Positives = 61/205 (29%), Gaps = 13/205 (6%)
Query: 361 NMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL-----LHLFQNDL 415
R+N + + + + + ++ + + L + + +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGS 474
+P + + + LN + I ++ + N + +P +
Sbjct: 64 R-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 120
Query: 475 CF-YLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSF 532
L + + N + L + +S NNL + + L+ L LS
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180
Query: 533 NDLEGQVPTKGIFANASAISVSGNS 557
N L V + + +VS N
Sbjct: 181 NRLT-HVDL-SLIPSLFHANVSYNL 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 53/361 (14%), Positives = 108/361 (29%), Gaps = 54/361 (14%)
Query: 72 IPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLK 131
I R + ++ +SL + + L L N L ++ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 132 ELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191
L + N L ++++L + L N + L +++L
Sbjct: 62 LLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAAN------ 108
Query: 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEI 251
N + + S G N+ L +NN + L S +Q L+
Sbjct: 109 -------------NNIS-RVSCSRGQGKKNIYL---ANNKITMLRDLDEGCRSRVQYLD- 150
Query: 252 LGNNFFGKLSVN--FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
L N ++ +L +LN+ N + + + L L+L +N+
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFI--------YDVKGQVVFAKLKTLDLSSNK 202
Query: 310 FKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS- 368
+ E + I + +N+ I + + QNL+ ++R N
Sbjct: 203 LA----------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 369 GEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQ-NDLSGAIPEEIFNIS 427
G + F + + + L + DL + + +
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
Query: 428 H 428
H
Sbjct: 312 H 312
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 48/325 (14%), Positives = 102/325 (31%), Gaps = 55/325 (16%)
Query: 213 PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272
+ + ++ +++++ + +A N++ L++ GN + + L
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVS 332
LN++ N L L + S L L+L N E+ S
Sbjct: 63 LNLSSNVLYE--------TLDLESLSTLRTLDLNNNYV--------------QELLVGPS 100
Query: 333 LYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
+ + +N ++ Q + + + +N+++ G S + L L N +
Sbjct: 101 IETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 393 GV-IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNL 451
V + L L+L N + + ++ L
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-----------------------FAKL 193
Query: 452 KVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNN 511
K L +SSN L+ + E S + I + N I +L ++L DL N
Sbjct: 194 KTLD---LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNG 248
Query: 512 LSGKIPISLERLPLEYLNLSFNDLE 536
++ ++
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 49/304 (16%), Positives = 105/304 (34%), Gaps = 37/304 (12%)
Query: 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178
+I + K + +++L + + +++ + L+ N L + L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 179 KSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235
+ L L + +LS L + N + L +++ +NN S
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR- 113
Query: 236 FPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSL 294
++ S +++ L NN L G + YL++ +N + D ++F
Sbjct: 114 --VSCSRGQGKKNIY-LANNKITMLRDLDEGCRSRVQYLDLKLNEI-----DTVNFAELA 165
Query: 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG--KLVSLYLIEMDHNQFEGKIPEEMS 352
A+ L LNL N + ++ KL +L L N+ + E
Sbjct: 166 ASSDTLEHLNLQYNFIY----------DVKGQVVFAKLKTLDL---SSNKLA-FMGPEFQ 211
Query: 353 RLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQ 412
+ ++++R+N+L I + +L L N K + + +
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAK 269
Query: 413 NDLS 416
+
Sbjct: 270 QTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 34/234 (14%), Positives = 73/234 (31%), Gaps = 26/234 (11%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+I + ++ + + + N++ L++ N LS + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 382 VKLILGNNNLSGVIP-----------------SSLGNLKQLALLHLFQNDLSGAIPEEIF 424
L L +N L + L + LH N++S +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 425 NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSG-EIPSEIGSCFYLQEIYM 483
++ A N + G ++ + N + S L+ + +
Sbjct: 120 Q---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 484 AENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
NF + V L+ +DLS N L+ + + + +++L N L
Sbjct: 177 QYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 50/323 (15%), Positives = 108/323 (33%), Gaps = 26/323 (8%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
R + + L +L+ + ++E+ LS N + ++ +LE L LS N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
L E +L S L L L N + E + +++ L NN++ +
Sbjct: 70 LY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSRG 119
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG------TIPPSIYNLSLLANFSVPEN 205
+ I LA N + G ++ L L + L + ++ N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 206 RLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFG 265
++ + + L+ +S+N + F +A+ + + L NN +
Sbjct: 180 FIY-DVKGQVVFA--KLKTLDLSSNKLA-FMGPEFQSAAGVTWI-SLRNNKLVLIEKALR 234
Query: 266 DMKSLAYLNVAINNLGSGESDE----MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321
++L + ++ N G + + ++A + L +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK-QTVKKLTGQNEEECTVPTLGHYGA 293
Query: 322 SIPSEIGKLVSLYLIEMDHNQFE 344
++ + LI + H+
Sbjct: 294 YCCEDLPAPFADRLIALGHHHHH 316
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 88/418 (21%), Positives = 146/418 (34%), Gaps = 50/418 (11%)
Query: 26 TCSPRHRRVTVLDLKSKGL--IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLE 83
CS ++GL + L + + LS N+I RL L+
Sbjct: 7 ECSVIGYNA---ICINRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQ 57
Query: 84 ALYLSHNSLVGEIPGNL-SYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLT 141
L + + I N S LI L L N+ + + F L NL+ L + + NL
Sbjct: 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLD 116
Query: 142 GG-IPH-FLGNITSLEAISLAYNSLGGNIPSSL-GQLKELKSLGLGGTIPPSIYNLSLLA 198
G + F +TSLE + L N++ P+S ++ L L +
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN------KVK--- 167
Query: 199 NFSVPENRLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257
S+ E L L LS++ L ++ + +++ +L++ GN F
Sbjct: 168 --SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
Query: 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSF--IHSLANC-------SNLSFLNLVAN 308
++ F D + + I + N S + +L +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285
Query: 309 QFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQL 367
+ + S+ S L L L N+ KI + L +L LN+ N L
Sbjct: 286 KI------FALLKSVFSHFTDLEQLTL---AQNEIN-KIDDNAFWGLTHLLKLNLSQNFL 335
Query: 368 SGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
F NL L L L N++ + S L L L L N L ++P+ IF+
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 76/405 (18%), Positives = 136/405 (33%), Gaps = 56/405 (13%)
Query: 34 VTVLDLKSKGLIGSLSPQ-IGNLSFLREIHLSNNTIQGKIP-GEIGRLFRLEALYLSHNS 91
V +DL S I L+ L L+ + + T I L L L L +N
Sbjct: 32 VNYVDL-SLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGS-IPSE-FVSLYNLKELAIQENNLTGGIPH-FL 148
+ G + + L L L + L+G+ + F L +L+ L +++NN+ P F
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 149 GNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLAN--FSVPENR 206
N+ + L +N ++K + L L L + + E
Sbjct: 151 LNMRRFHVLDLTFN-----------KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
L G +++ +S N F S F +A ++ L + + +FG
Sbjct: 200 L-GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258
Query: 267 MK---------------SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFK 311
+ +++ + + + ++ ++L L L N+
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK------SVFSHFTDLEQLTLAQNEIN 312
Query: 312 GALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSG 369
I L L + + N G I M L L+ L++ +N +
Sbjct: 313 ----------KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR- 360
Query: 370 EIPS-SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
+ SF L +L +L L N L V L L + L N
Sbjct: 361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 72/392 (18%), Positives = 135/392 (34%), Gaps = 55/392 (14%)
Query: 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL-AFSNAS 244
+P + + L N + L + L +LQ ++ F S
Sbjct: 27 ELPAHVNYVDL------SLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79
Query: 245 NLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
+L L+ L N F +L F + +L L + NL F ++L L
Sbjct: 80 SLIILK-LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFF----KPLTSLEML 134
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFE----------GKIPEEMSR 353
L N K P S + +++++ N+ + + R
Sbjct: 135 VLRDNNIKKIQPASFFLN--------MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS---SLGNLKQLALLHL 410
L ++ +M L E + +S+ L L N + ++ L L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 411 FQNDLSGA---------IPEEIFNISHMSD--SLNFARNHLVGSIPPKI-GNLKVLRMFV 458
+ G+ F S + + +++ + ++ + + L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLT 305
Query: 459 VSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPS-SLVSLKDLREIDLSQNNLSGKI 516
++ N ++ +I +L ++ +++NF GSI S +L L +DLS N++
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALG 363
Query: 517 PISLERLP-LEYLNLSFNDLEGQVPTKGIFAN 547
S LP L+ L L N L+ VP GIF
Sbjct: 364 DQSFLGLPNLKELALDTNQLKS-VP-DGIFDR 393
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 81/370 (21%), Positives = 139/370 (37%), Gaps = 47/370 (12%)
Query: 26 TCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEAL 85
CS + R V K + ++ I + R + L N I+ E LE L
Sbjct: 8 ECSAQDRAV---LCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 86 YLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGI 144
L+ N + PG + L L L N+L+ IP F L NL +L I EN + +
Sbjct: 62 ELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILL 120
Query: 145 PHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPE 204
+ ++ +L+++ + N L + L L+ L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK------------------- 161
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNF 264
L S+P L L + ++ + + +F L+ LEI + ++ N
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324
+L L++ NL + ++ + L FLNL N +I
Sbjct: 221 LYGLNLTSLSITHCNLTAVPYL------AVRHLVYLRFLNLSYNPIS----------TIE 264
Query: 325 SEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLV 382
+ +L+ L I++ Q + L L+ LN+ NQL+ S F ++ +L
Sbjct: 265 GSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 383 KLILGNNNLS 392
LIL +N L+
Sbjct: 324 TLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 27/299 (9%)
Query: 244 SNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSF 302
+ + L+ LG N L+ + F L L + N + + E + N NL
Sbjct: 32 TETRLLD-LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AFNNLFNLRT 84
Query: 303 LNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFL 360
L L +N+ K IP + L +L +++ N+ + + M L NL+ L
Sbjct: 85 LGLRSNRLK----------LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSL 133
Query: 361 NMRHNQLSGEIPS-SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
+ N L I +F L+SL +L L NL+ + +L +L L +L L +++ AI
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AI 191
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSE-IGSCFYL 478
+ F + L + + ++ P L ++ NL+ +P + YL
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250
Query: 479 QEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
+ + ++ N S L L L+EI L L+ P + L L LN+S N L
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 84/431 (19%), Positives = 143/431 (33%), Gaps = 115/431 (26%)
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGI 144
+ V +P + + L LG+N+++ EF S +L+EL + EN
Sbjct: 16 VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI----- 67
Query: 145 PHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPE 204
++++E P + L L++LGL
Sbjct: 68 ------VSAVE-------------PGAFNNLFNLRTLGLRS------------------- 89
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN- 263
NRL +P + LSNL IS N F + NL+SLE +G+N +S
Sbjct: 90 NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE-VGDNDLVYISHRA 147
Query: 264 FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI 323
F + SL L + NL S ++ +L++ L L L
Sbjct: 148 FSGLNSLEQLTLEKCNLTSIPTE------ALSHLHGLIVLRLRHLN-------------- 187
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383
+ + F+ L L+ L + H + + +L
Sbjct: 188 -----------INAIRDYSFKR--------LYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228
Query: 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGS 443
L + + NL+ V ++ +L L L+L N +S I + + + L
Sbjct: 229 LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AV 286
Query: 444 IPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDL 502
+ P L LR+ VS N L+ + S S+ +L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLE-----------------------ESVFHSVGNL 322
Query: 503 REIDLSQNNLS 513
+ L N L+
Sbjct: 323 ETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 14/221 (6%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
++P I L+++ N+ + +E + +L+ L + N +S P +F NL +L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L +N L + L L L + +N + + + +F + SL N LV
Sbjct: 83 RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 442 GSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFY----LQEIYMAENFFRGSIPSSL 496
I + L L + NL+ IP+E L + + S
Sbjct: 142 -YISHRAFSGLNSLEQLTLEKCNLT-SIPTE---ALSHLHGLIVLRLRHLNINAIRDYSF 196
Query: 497 VSLKDLREIDLSQNNLSGKI-PISLERLPLEYLNLSFNDLE 536
L L+ +++S + P L L L L+++ +L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-28
Identities = 88/465 (18%), Positives = 159/465 (34%), Gaps = 45/465 (9%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNL 140
+AL LS NS+ ++S+ S L L L N++ S+ F+ +L+ L + N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 141 TGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGTI-----PPSIYNL 194
I + SL + L++N + G L +L LGL + +L
Sbjct: 113 QN-IS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 195 SLLANFSVPE-NRLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQ--SLE 250
L + G SL + L L N+ FS ++ + +LQ +++
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 251 ILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQF 310
+ N ++ + LNV + ++ + + +LN+
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHI-ETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 311 KGALPHSIVSGS-------------------IPSEIG-KLVSLYLIEMDHNQFEGKIPEE 350
+ + S + + + + +
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV--IPSSLGNLKQLALL 408
+ FLN N + + L L LIL N L + N+ L L
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408
Query: 409 HLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGE 467
+ N L+ + + LN + N L GS+ + +KVL + +N +
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDL---HNNRIM-S 464
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIP-SSLVSLKDLREIDLSQNN 511
IP ++ LQE+ +A N + S+P L L+ I L N
Sbjct: 465 IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 33/252 (13%), Positives = 77/252 (30%), Gaps = 36/252 (14%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
+P ++ + +L L N ++S L L+ L + HN++ F
Sbjct: 45 HVPKDLPPRTKALSL---SQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD 101
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLAL----------------------LHLFQNDLSGA 418
L L + +N L + + +L+ L L L L
Sbjct: 102 LEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 419 IPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIG----S 474
+ ++ L+ H+ G + + +V N + +
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 475 CFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSG------KIPISLERLPLEYL 528
L I + + + + + ++++ ++ K+ P+EYL
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 529 NLSFNDLEGQVP 540
N+ + ++
Sbjct: 282 NIYNLTITERID 293
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 45/233 (19%), Positives = 77/233 (33%), Gaps = 22/233 (9%)
Query: 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96
L + + + L L H+ N + LS +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT--GGIPHFLGNITSL 154
S L +N S+ +L L+ L +Q N L + N++SL
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405
Query: 155 EAISLAYNSLGGNIPSSLGQLKE-LKSLGLGGT---------IPPSIYNLSLLANFSVPE 204
E + ++ NSL + E + L L +PP + L L
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDL------HN 459
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL-AFSNASNLQSLEILGNNF 256
NR+ S+P + L LQ +++N S P F ++LQ + + N +
Sbjct: 460 NRIM-SIPKDV-THLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 53/333 (15%), Positives = 108/333 (32%), Gaps = 36/333 (10%)
Query: 220 SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAIN 278
+ +S N S S S L+ L L +N L + F + L YL+V+ N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVL-RLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338
L + M+ +L L+L N F LP + E G L L + +
Sbjct: 111 RLQNISCCPMA---------SLRHLDLSFNDFD-VLP-------VCKEFGNLTKLTFLGL 153
Query: 339 DHNQFEGKIPEEMSRLQ-NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397
+F ++ L + L++ + G S ++ V ++ + N +
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 398 SLGNLKQLALLHLFQNDLSGA----IPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKV 453
++ + L L L L+ + + ++ LN H+ + + +
Sbjct: 214 NMS-VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 454 LRM-----FVVSSNNLSGEIPSEIGSCF-----YLQEIYMAENFFRGSIPSSLVSLKDLR 503
+ + ++ I E + L ++ F S + ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 504 EIDLSQNNL-SGKIPISLERLPLEYLNLSFNDL 535
LS ++ + +LN + N
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 50/285 (17%), Positives = 90/285 (31%), Gaps = 21/285 (7%)
Query: 10 LNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQ 69
LN N +T P VT+ +++ Q + +++ N TI
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 70 GKIPGEIGR-----LFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF 124
+I E L L ++ + + S + + L +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 125 VSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG 184
S + L +N T + + L+ + L N L N K + SL
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETL 408
Query: 185 G----TIPPSIYN-----LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235
++ Y+ + ++ N L GS+ L + L L NN S
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDL---HNNRIM-S 464
Query: 236 FPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINN 279
P ++ LQ L + +N + F + SL Y+ + N
Sbjct: 465 IPKDVTHLQALQELN-VASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 36/202 (17%), Positives = 69/202 (34%), Gaps = 26/202 (12%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL- 92
+ + L + S ++ + N + L RL+ L L N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 93 -VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSL-YNLKELAIQENNLTGGIPHFLGN 150
++ S L L + N L + ++ L + N LTG + L
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449
Query: 151 ITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGS 210
++ + L N + +IP + L+ L+ L + N+L S
Sbjct: 450 -PKVKVLDLHNNRI-MSIPKDVTHLQALQELNVAS-------------------NQLK-S 487
Query: 211 LPPSLGLTLSNLQLFQISNNFF 232
+P + L++LQ + +N +
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 31/209 (14%), Positives = 56/209 (26%), Gaps = 57/209 (27%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ L++ N +S LS L L L +N + + + L L + N L
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
+I + LR +S N+
Sbjct: 113 Q--------------------------NISC--CPMASLRHLDLSFNDFD---------- 134
Query: 476 FYLQEIYMAENFFRGSIPSSLV--SLKDLREIDLSQNNLSGKIPISLERLPLEY--LNLS 531
+P +L L + LS + + L L L+L
Sbjct: 135 ---------------VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLV 179
Query: 532 FNDLEGQVPTKGIFANASAISVSGNSNRL 560
++G N + + + + N L
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSL 208
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVITS 708
+G G +G VY+G + + VA+K L + + F E ++ I+H NLV+++
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
C+ + F ++ ++M G+L ++L + ++ + + +A ++S
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYLR----------ECNRQEVSAVVLLYMATQISS 329
Query: 769 AVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
A++YL + IH +L N L+ N V DFGL+RL
Sbjct: 330 AMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 649 HLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLV 703
++G G FGSV +G D VA+K + L Q + F +E +++ H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
R++ C + QG ++ +M G L +L +++ L +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL------LYSRLETGPKHIPLQTLLKFM 153
Query: 764 IDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+D+A ++YL + + +H DL N +L +++T V DFGL++
Sbjct: 154 VDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 651 IGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FGSV + D G +VA+K L + + F E L++++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C S G L+ +Y+P GSL ++L Q +E + ++ + +
Sbjct: 78 GVCYS---AGRRNLKLIMEYLPYGSLRDYL------QKHKE-----RIDHIKLLQYTSQI 123
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
++YL IH DL NIL++N +GDFGL ++
Sbjct: 124 CKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 43/170 (25%), Positives = 65/170 (38%), Gaps = 34/170 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRNLVR-- 704
IG G+FG V+ G D T+VA+K + F E R L+ H N+VR
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 705 -VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
V T I +V + + G +L E L + + +
Sbjct: 179 GVCTQKQPI--------YIVMELVQGGDFLTFLR-----------TEGARLRVKTLLQMV 219
Query: 764 IDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
D A+ ++YL C IH DL N L+ + DFG++R +
Sbjct: 220 GDAAAGMEYLESKCC----IHRDLAARNCLVTEKNVLKISDFGMSREEAD 265
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 25/162 (15%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIRHRNLVRVIT 707
IG G FG V G + G VA+K + A+ ++F AE + +RH NLV+++
Sbjct: 27 QTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
+ +V +YM GSL ++L + L + ++DV
Sbjct: 82 VIV----EEKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVC 127
Query: 768 SAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A++YL ++ +H DL N+L+ + A V DFGL +
Sbjct: 128 EAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 25/162 (15%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIRHRNLVRVIT 707
IG G FG V G + G VA+K + A+ ++F AE + +RH NLV+++
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
+ +V +YM GSL ++L + L + ++DV
Sbjct: 254 VIV----EEKGGLYIVTEYMAKGSLVDYLR----------SRGRSVLGGDCLLKFSLDVC 299
Query: 768 SAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A++YL ++ +H DL N+L+ + A V DFGL +
Sbjct: 300 EAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 23/164 (14%)
Query: 651 IGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FGSV + D G +VA+K L + + F E L++++H N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C S G L+ +Y+P GSL ++L Q +E + ++ + +
Sbjct: 109 GVCYS---AGRRNLKLIMEYLPYGSLRDYL------QKHKE-----RIDHIKLLQYTSQI 154
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
++YL IH DL NIL++N +GDFGL ++
Sbjct: 155 CKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 651 IGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G FG V + D G VA+K L + G + E LRN+ H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C+ G + L+ +++P+GSL+ +L ++ + L +++ A+
Sbjct: 89 KGICTE---DGGNGIKLIMEFLPSGSLKEYL------PKNKNK-----INLKQQLKYAVQ 134
Query: 766 VASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ +DYL +H DL N+L+++ +GDFGL +
Sbjct: 135 ICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 75/423 (17%), Positives = 148/423 (34%), Gaps = 34/423 (8%)
Query: 52 IGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111
L+ L + N++I + G I +L L L + N++ + LS + L L
Sbjct: 38 EEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSS 171
NKL ++ L L L N LT + + L ++ A N+L S
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEIDVSH 146
Query: 172 LGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF 231
QL EL + + L N++ L S L N
Sbjct: 147 NTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELDVS---QNKLLNRLNCDTNN 202
Query: 232 FSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFI 291
+ L + L L+ N ++ + L Y + ++N L + +S +
Sbjct: 203 ITK---LDLNQNIQLTFLDCSSNKL---TEIDVTPLTQLTYFDCSVNPLTELDVSTLSKL 256
Query: 292 HSLANCSN-LSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
+L L ++L N ++ LYL++ ++
Sbjct: 257 TTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD-- 313
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+S+ L +L + + +L+ E+ + + L L N ++ SS+G + L
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFE 368
Query: 411 FQNDLSGAIPEEIFNISHMSDSLN---FARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
+ +P+E + ++ +++ + +I P G + ++ NLS +
Sbjct: 369 AEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTD 427
Query: 468 IPS 470
P+
Sbjct: 428 NPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 58/411 (14%), Positives = 123/411 (29%), Gaps = 60/411 (14%)
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG--- 185
N + + +L ++ +S+ + + +L L L
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNI 76
Query: 186 -TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNAS 244
T+ S + L + N+L +L + L+ L N + L S
Sbjct: 77 TTLDLS--QNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKLT---KLDVSQNP 127
Query: 245 NLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLN 304
L L N ++ L L+ +N + + + L+ L+
Sbjct: 128 LLTYLNCARNTL---TEIDVSHNTQLTELDCHLNKKIT--------KLDVTPQTQLTTLD 176
Query: 305 LVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRH 364
N+ ++ + L + D N K+ +++ L FL+
Sbjct: 177 CSFNKITE------------LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSS 221
Query: 365 NQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF 424
N+L+ EI L+ L N L+ + S+L L LH Q DL
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTT---LHCIQTDLL------EI 269
Query: 425 NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMA 484
+++H + + F + + L + + ++ E+ + L +Y+
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLN 326
Query: 485 ENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDL 535
+ S L+ + ++ + L +
Sbjct: 327 NTELT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 44/294 (14%), Positives = 100/294 (34%), Gaps = 45/294 (15%)
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
N S +++ + +L L+ +++ + + + L+ L
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--------MTGIEKLTGLTKL 69
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMR 363
+N ++ + + +L + D N+ + ++ L L +LN
Sbjct: 70 ICTSNNIT----------TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCD 114
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEI 423
N+L+ L L N L+ + + + QL L N + +
Sbjct: 115 TNKLT---KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--V 166
Query: 424 FNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYM 483
+ ++ +L+ + N + + + K+L +NN++ ++ + L +
Sbjct: 167 TPQTQLT-TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDC 219
Query: 484 AENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
+ N I + L L D S N L+ + + L L L+ DL
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 58/336 (17%), Positives = 108/336 (32%), Gaps = 62/336 (18%)
Query: 220 SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINN 279
N + + ++ + L SL+ N+ ++ + L L NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLD-CHNSSITDMT-GIEKLTGLTKLICTSNN 75
Query: 280 LGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMD 339
+ + L+ +NL++L +N+ ++ + L L + D
Sbjct: 76 ITT---------LDLSQNTNLTYLACDSNKLT----------NLD--VTPLTKLTYLNCD 114
Query: 340 HNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSL 399
N+ K+ S+ L +LN N L+ EI + + L +L N + +
Sbjct: 115 TNKLT-KLDV--SQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--V 166
Query: 400 GNLKQLALLHLFQNDLSGAIPEEIFNISHMS--DSLNFARNHLVGSIPPKIGNLKVLRMF 457
QL L N ++ ++S + LN N++ + + L
Sbjct: 167 TPQTQLTTLDCSFNKITE------LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFL 217
Query: 458 VVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLR-------EIDLSQN 510
SSN L+ EI + L + N S+L L L EIDL+ N
Sbjct: 218 DCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHN 274
Query: 511 ---------NLSGKIPISLERLP-LEYLNLSFNDLE 536
+ + L L+ +
Sbjct: 275 TQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 25/167 (14%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
H +G G +G VY+G + + VA+K L + + F E ++ I+H NLV+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C+ + F ++ ++M G+L ++L + ++ + + +A +
Sbjct: 76 GVCT----REPPF-YIITEFMTYGNLLDYLR----------ECNRQEVSAVVLLYMATQI 120
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+SA++YL + IH DL N L+ N V DFGL+RL
Sbjct: 121 SSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 651 IGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FGSV + D G +VA+K L + F E + L+ + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
G LV +Y+P+G L ++L Q L + + +
Sbjct: 91 GVSYG---PGRQSLRLVMEYLPSGCLRDFL------QRHRA-----RLDASRLLLYSSQI 136
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
++YL C +H DL NIL+++ + DFGLA+L
Sbjct: 137 CKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKL 176
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 39/165 (23%), Positives = 70/165 (42%), Gaps = 17/165 (10%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G FGSV + D VA+K+L ++ + F E ++ H ++ ++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 706 ITSCSSIDFQGNDFKAL-VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ +G + + +M +G L +L + NL L + +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL------LASRIGENPFNLPLQTLVRFMV 144
Query: 765 DVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
D+A ++YL + IH DL N +L ++T V DFGL+R
Sbjct: 145 DIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G+FG+VYKG + +G VAIK L + E + ++ + ++ R+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C + Q L+ Q MP G L +++ E+ + N+ ++ +
Sbjct: 83 LGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKD--NIGSQYLLNWCVQ 125
Query: 766 VASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A ++YL +H DL N+L+ + DFGLA+L
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
+G G FG V+ G + T VA+K L QG+ +F AE ++ ++H+ LVR+
Sbjct: 19 ERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + ++ +YM NGSL ++L LT+ + + +A +
Sbjct: 75 AVVT------QEPIYIITEYMENGSLVDFLK----------TPSGIKLTINKLLDMAAQI 118
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
A + ++ + IH DL+ +NIL+ + L+ + DFGLARL ++
Sbjct: 119 AEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIED 161
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVITS 708
+G G FG V+ T+ T VA+K + G+ ++F AE ++ ++H LV++
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ + ++ ++M GSL ++L +DE L + I + +A
Sbjct: 252 VT------KEPIYIITEFMAKGSLLDFLK----------SDEGSKQPLPKLIDFSAQIAE 295
Query: 769 AVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ ++ + IH DL+ +NIL+ +L + DFGLAR+
Sbjct: 296 GMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNLV 703
IG G FG VY G + ++ AIK L+ + ++F E +R + H N++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+I ++ YM +G L ++ RN T+ + IS
Sbjct: 86 ALIGIML----PPEGLPHVLLPYMCHGDLLQFIR-----------SPQRNPTVKDLISFG 130
Query: 764 IDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ VA ++YL +H DL N +LD + T V DFGLAR
Sbjct: 131 LQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARD 173
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 46/166 (27%), Positives = 67/166 (40%), Gaps = 28/166 (16%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR 704
+G GSFG V +G + VA+K L L A F E A+ ++ HRNL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ + + +V + P GSL + L ++ + L A+
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLR---------KHQ--GHFLLGTLSRYAV 128
Query: 765 DVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
VA + YL IH DL N+LL +GDFGL R
Sbjct: 129 QVAEGMGYLESKRF----IHRDLAARNLLLATRDLVKIGDFGLMRA 170
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 30/168 (17%)
Query: 649 HLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+IG G FG VY GT D A+K LN + F E +++ H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ ++ C +G+ +V YM +G L N++ +E N T+ + I
Sbjct: 88 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR-----------NETHNPTVKDLIG 132
Query: 762 IAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ VA + YL +H DL N +LD T V DFGLAR
Sbjct: 133 FGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA-ECRALRNIRHRNLVRVITS 708
+G G FG V++ D AIK + L + ++ E +AL + H +VR +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 709 C----SSIDFQGNDFKALVY---QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ Q + K +Y Q +L++W++ + E +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLH-------- 122
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
I + +A AV++LH +H DLKPSNI + VGDFGL
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 27/165 (16%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G FG+V+KG + +G V IKV+ + S A+ ++ H ++VR+
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C Q LV QY+P GSL + + ++ L ++ +
Sbjct: 81 LGLCPGSSLQ------LVTQYLPLGSLLDHVR---------QHRG--ALGPQLLLNWGVQ 123
Query: 766 VASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A + YL H +H +L N+LL + V DFG+A L
Sbjct: 124 IAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
+G G FG V G + + VA+K++ +G+ F E + + + H LV+
Sbjct: 14 KELGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
CS + +V +Y+ NG L N+L + L + + + DV
Sbjct: 70 GVCS----KEYPI-YIVTEYISNGCLLNYLR-----------SHGKGLEPSQLLEMCYDV 113
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ +L H IH DL N L+D +L V DFG+ R +
Sbjct: 114 CEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 26/167 (15%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRVI 706
+G G FG VY+G + + VA+K +K F +E ++N+ H ++V++I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
++ + P G L ++L N +L +L + ++ +
Sbjct: 80 GIIEEEPTW------IIMELYPYGELGHYLE---------RNK--NSLKVLTLVLYSLQI 122
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
A+ YL +C +H D+ NIL+ + +GDFGL+R ++
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED 165
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 26/165 (15%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G FG V +D +VA+K L +S + E LR + H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C LV +Y+P GSL ++L ++ L + + A
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-------------HSIGLAQLLLFAQQ 142
Query: 766 VASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + YLH H IH DL N+LLDN+ +GDFGLA+
Sbjct: 143 ICEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS--FAAECRALRNIRHRNLVRVI 706
+G G FG V+ GT+ T VAIK L G F E + ++ +RH LV++
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S +V +YM GSL ++L + + L L + + +A +
Sbjct: 246 AVVSEEPIY------IVTEYMSKGSLLDFLK----------GETGKYLRLPQLVDMAAQI 289
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
AS + Y+ + +H DL+ +NIL+ NL V DFGLARL ++
Sbjct: 290 ASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 649 HLIGIGSFGSVYKGTFDRDG--TIVAIKVLNLQLQGASKS----FAAECRALRNI-RHRN 701
+IG G+FG V K +DG AIK + + ASK FA E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL----HPDAIPQTDEENDEIRNLTLL 757
++ ++ +C + L +Y P+G+L ++L + P N L+
Sbjct: 88 IINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 758 ERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + A DVA +DYL IH DL NIL+ N A + DFGL+R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 27/164 (16%)
Query: 651 IGIGSFGSVYKGTFDRDG--TIVAIKVL--NLQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FG+V KG + VA+K+L AE ++ + + +VR+I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C + + LV + G L +L +N +++ ++E + V
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYLQ---------QNRHVKDKNIIE---LVHQV 126
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + YL + +H DL N+LL A + DFGL++
Sbjct: 127 SMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 41/167 (24%), Positives = 63/167 (37%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
IG G FG V+ G + + VAIK + +GA + F E + + H LV++
Sbjct: 14 QEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C LV ++M +G L ++L + + +DV
Sbjct: 70 GVCLE-----QAPICLVTEFMEHGCLSDYLR---------TQRG--LFAAETLLGMCLDV 113
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ YL IH DL N L+ N V DFG+ R +
Sbjct: 114 CEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 30/168 (17%)
Query: 649 HLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+IG G FG VY GT D A+K LN + F E +++ H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ ++ C +G+ +V YM +G L N++ +E N T+ + I
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFIR-----------NETHNPTVKDLIG 196
Query: 762 IAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ VA + +L +H DL N +LD T V DFGLAR
Sbjct: 197 FGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 57/300 (19%)
Query: 241 SNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANC--S 298
S S ++ ++F + A N + L C +
Sbjct: 14 SQNSFYNTISGTYADYFSAWD----KWEKQALPGENRNEA----------VSLLKECLIN 59
Query: 299 NLSFLNLVANQFKGALPHSIVSGSIPSEIGK-LVSLYLIEMDHNQFEGKIPEEMSRLQNL 357
S L L S+P + + L + N +PE +L
Sbjct: 60 QFSELQLNRLNLS----------SLPDNLPPQITVLEI---TQNALI-SLPEL---PASL 102
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
++L+ N+LS +P +L L + NN L+ ++P L+ + + N L+
Sbjct: 103 EYLDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALLEYI---NADNNQLT- 153
Query: 418 AIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY 477
+PE ++ L+ N L +P +L+ L VS+N L +P+ +
Sbjct: 154 MLPELPTSLE----VLSVRNNQL-TFLPELPESLEALD---VSTNLLE-SLPAVPVRNHH 204
Query: 478 LQE----IYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFN 533
+E EN IP +++SL I L N LS +I SL + +
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 8e-21
Identities = 54/332 (16%), Positives = 102/332 (30%), Gaps = 55/332 (16%)
Query: 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSV-NFGDMKSLAY 272
SL + ++FS + + G N +S+ + +
Sbjct: 12 SLSQNSFYNTISGTYADYFS--------AWDKWEKQALPGENRNEAVSLLKECLINQFSE 63
Query: 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVS 332
L + NL S +L ++ L + N S+P L
Sbjct: 64 LQLNRLNL-------SSLPDNL--PPQITVLEITQNALI----------SLPELPASLEY 104
Query: 333 LYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392
L N+ +PE +L+ L++ +NQL+ +P L + NN L+
Sbjct: 105 LDA---CDNRLS-TLPEL---PASLKHLDVDNNQLT-MLPELPALLE---YINADNNQLT 153
Query: 393 GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLK 452
++P +L+ L++ + N L+ +PE ++ L+ + N L S+P
Sbjct: 154 -MLPELPTSLEVLSVRN---NQLT-FLPELPESLEA----LDVSTNLLE-SLPAVPVRNH 203
Query: 453 VLR----MFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLS 508
F N ++ IP I S I + +N S +S + +
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHG 261
Query: 509 QNNLSGKIPISLERLPLEYLNLSFNDLEGQVP 540
L +
Sbjct: 262 PRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 4e-18
Identities = 62/438 (14%), Positives = 110/438 (25%), Gaps = 117/438 (26%)
Query: 47 SLSPQIGNLSFLREIHLSNN--TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS 104
S+ I N L + N + + + N V + L +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164
+ L L R L S+P + L I +N L +P ++ L+ N L
Sbjct: 60 QFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALIS-LPELPASLEYLD---ACDNRL 112
Query: 165 GGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQL 224
+P LK L ++ N+L LP L+
Sbjct: 113 S-TLPELPASLKHL--------------DVD--------NNQLT-MLPELPA----LLEY 144
Query: 225 FQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGE 284
NN + P ++L+ L + N
Sbjct: 145 INADNNQLT-MLP---ELPTSLEVLSVRNNQ----------------------------- 171
Query: 285 SDEMSFIHSLANC-SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSL----YLIEMD 339
+ L +L L++ N + S+P+ +
Sbjct: 172 ------LTFLPELPESLEALDVSTNLLE----------SLPAVPVRNHHSEETEIFFRCR 215
Query: 340 HNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSL 399
N+ IPE + L + + N LS I S ++ S
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ- 273
Query: 400 GNLKQLALLHLFQNDLSGAIPEEI-----------------FNISHMSDSLNFARNHL-- 440
N L ++ + +SD+++
Sbjct: 274 -NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFR 332
Query: 441 --VGSIPPKIGNLKVLRM 456
V + K+ LR
Sbjct: 333 EQVAAWLEKLSASAELRQ 350
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 24/165 (14%), Positives = 44/165 (26%), Gaps = 12/165 (7%)
Query: 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLE----ALYLSHNSLVGEIPGNL 100
+ L +L + +S N ++ +P R E N + IP N+
Sbjct: 172 LTFLPELPESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226
Query: 101 SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160
+ L N L S E +S + + A ++
Sbjct: 227 LSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT 285
Query: 161 YNSLGGNIPSSLGQL-KELKSLGLGGTIPPSIYNLSLLANFSVPE 204
N S + Q+ + T + LS +
Sbjct: 286 -AWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTS 329
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 27/165 (16%)
Query: 651 IGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRV 705
+G G+FG+VYKG + +G VAIK L + E + ++ + ++ R+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C + Q L+ Q MP G L +++ E+ + N+ ++ +
Sbjct: 83 LGICLTSTVQ------LITQLMPFGCLLDYVR---------EHKD--NIGSQYLLNWCVQ 125
Query: 766 VASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+A ++YL +H DL N+L+ + DFGLA+L
Sbjct: 126 IAKGMNYLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 37/170 (21%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNLV 703
IG G G V G + VAIK L G + + F +E + H N++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 704 R---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
R V+T +V +YM NGSL+ +L T+++ +
Sbjct: 114 RLEGVVTRGRLA--------MIVTEYMENGSLDTFLRTHD-----------GQFTIMQLV 154
Query: 761 SIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ V + + YL +H DL N+L+D+NL V DFGL+R+
Sbjct: 155 GMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
+G G FG V G + R VAIK++ +G+ F E + + N+ H LV++
Sbjct: 30 KELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C+ ++ +YM NG L N+L E + + + DV
Sbjct: 86 GVCTK-----QRPIFIITEYMANGCLLNYLR---------EMR--HRFQTQQLLEMCKDV 129
Query: 767 ASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
A++YL +H DL N L+++ V DFGL+R +
Sbjct: 130 CEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 38/184 (20%)
Query: 651 IGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNL 702
IG G FG VYKG + VAIK L G + F E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 703 VR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
+R VI+ + ++ +YM NG+L+ +L E D ++L+
Sbjct: 109 IRLEGVISKYKPM--------MIITEYMENGALDKFLR---------EKD--GEFSVLQL 149
Query: 760 ISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
+ + +A+ + YL + + +H DL NIL+++NL V DFGL+R+ ++ P
Sbjct: 150 VGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 819 SSVG 822
++ G
Sbjct: 206 TTSG 209
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG V+ ++D +VA+K L + A + F E L ++H+++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWL---HPDAIPQTDEENDEIRNLTLLERISI 762
C+ +G +V++YM +G L +L PDA E+ L L + +++
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 763 AIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A VA+ + YL H +H DL N L+ L +GDFG++R
Sbjct: 164 ASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI-RHR 700
+G G+FG V + VA+K+L +GA+ S +E + L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL----HPDAIPQTDEENDEIRNLTL 756
N+V ++ +C+ + ++ ++ G+L +L + + E+ LTL
Sbjct: 92 NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 757 LERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
I + VA +++L C IH DL NILL + DFGLAR
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 39/170 (22%), Positives = 68/170 (40%), Gaps = 32/170 (18%)
Query: 651 IGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNLV 703
IG G FG V++G + VAIK S + F E +R H ++V
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
++I + ++ + G L ++L +L L I A
Sbjct: 80 KLIGVITENPVW------IIMELCTLGELRSFLQ---------VRK--YSLDLASLILYA 122
Query: 764 IDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+++A+ YL +H D+ N+L+ +N +GDFGL+R ++
Sbjct: 123 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 23/184 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR----- 704
++G G+FG V K D AIK + + + +E L ++ H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 705 VITSCSSIDFQGNDFKALVY---QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+ K+ ++ +Y NG+L + +H + +++ DE
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWR-------- 120
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ + A+ Y+H IH DLKP NI +D + +GDFGLA+ +
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 822 GDLE 825
+L
Sbjct: 178 QNLP 181
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 24/168 (14%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G GSFG VY+G D T VAIK +N + AS F E ++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+VR++ S QG ++ + M G L+++L ++ N + +L + I
Sbjct: 90 VVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLR--SLRPAMANNPVLAPPSLSKMIQ 142
Query: 762 IAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A ++A + YL+ + +H DL N ++ + T +GDFG+ R
Sbjct: 143 MAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 5e-23
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 27/167 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS--FAAECRALRNIRHRNLVRVI 706
+G G FG V+ GT+ T VAIK L G F E + ++ +RH LV++
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
S +V +YM GSL ++L + + L L + + +A +
Sbjct: 329 AVVSEEPIY------IVTEYMSKGSLLDFLK----------GETGKYLRLPQLVDMAAQI 372
Query: 767 ASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
AS + Y+ + +H DL+ +NIL+ NL V DFGLARL ++
Sbjct: 373 ASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIED 415
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 25/163 (15%)
Query: 651 IGIGSFGSVYKGTF-DRDGTI-VAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRVIT 707
+G G+FGSV +G + R I VAIKVL + A E + + + + +VR+I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
C + LV + G L +L + + + V+
Sbjct: 78 VCQAEALM------LVMEMAGGGPLHKFLV---------GKR--EEIPVSNVAELLHQVS 120
Query: 768 SAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ YL + +H DL N+LL N A + DFGL++
Sbjct: 121 MGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 651 IGIGSFGSVYKGT-----FDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI-RHR 700
+G G+FG V + T VA+K+L A + +E + L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL------HPDAIPQTDEENDEIRNL 754
N+V ++ +C+ G ++ +Y G L N+L + D+ L
Sbjct: 88 NIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 755 TLLERISIAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L + +S + VA + +L +C IH DL NILL + + DFGLAR
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 40/172 (23%), Positives = 69/172 (40%), Gaps = 26/172 (15%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G FG VYKG VAIK L A F E ++H N
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH----PDAIPQTDEENDEIRNLTLL 757
+V ++ + + ++++ Y +G L +L + TD++ L
Sbjct: 74 VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 758 ERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + + +A+ ++YL HH +H DL N+L+ + L + D GL R
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 43/170 (25%), Positives = 65/170 (38%), Gaps = 28/170 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS- 708
LIG G FG V+K DG IK + + A + E +AL + H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCW 73
Query: 709 -------CSSIDFQGNDFKALVY---QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
+S ++ ++ G+LE W+ + D+
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV--LALE----- 126
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + VDY+H I+ DLKPSNI L + +GDFGL
Sbjct: 127 ---LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 33/169 (19%), Positives = 57/169 (33%), Gaps = 12/169 (7%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
+G G F V DG A+K + Q + E R H N++R++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
++ L+ + G+L N + D+I + + +
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNFLTEDQILW--------LLLGICRG 146
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
++ +H H DLKP+NILL + + D G
Sbjct: 147 LEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 34/180 (18%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G G FG V K T T VA+K+L + AS S +E L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL------------HPDAIPQTDEEND 749
++++ +CS Q L+ +Y GSL +L + + ++
Sbjct: 88 VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 750 EIRNLTLLERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ R LT+ + IS A ++ + YL +H DL NIL+ + DFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 37/183 (20%)
Query: 651 IGIGSFGSVYKGTF---DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNIRHRNLV 703
+G G FG V G + VAIK L G + + F E + H N++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 704 R---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
R V+T + +V +YM NGSL+++L ++D T+++ +
Sbjct: 110 RLEGVVTKSKPV--------MIVTEYMENGSLDSFLR---------KHD--AQFTVIQLV 150
Query: 761 SIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
+ +AS + YL +H DL NIL+++NL V DFGL R+ ++ P +
Sbjct: 151 GMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 820 SVG 822
+ G
Sbjct: 207 TRG 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 25/171 (14%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI-RHR 700
+G G+FG V + T + VA+K+L A +E + + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQHE 110
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLTLLE 758
N+V ++ +C+ G ++ +Y G L N+L + + +
Sbjct: 111 NIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 759 RISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + VA + +L +C IH D+ N+LL N A +GDFGLAR
Sbjct: 166 LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G+FG V+ +D +VA+K L A K F E L N++H ++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLH----PDAIPQTDEENDEIRNLTLLERIS 761
C G+ +V++YM +G L +L I + L L + +
Sbjct: 83 YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 762 IAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
IA +AS + YL H +H DL N L+ NL +GDFG++R
Sbjct: 138 IASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 29/175 (16%)
Query: 651 IGIGSFGSVYKGT-------FDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI-R 698
+G G+FG V ++ VA+K+L A++ +E ++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL----HPDAIPQTDEENDEIRNL 754
H+N++ ++ +C+ Q ++ +Y G+L +L P D +
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 755 TLLERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
T + +S +A ++YL C IH DL N+L+ N + DFGLAR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-22
Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 67/313 (21%)
Query: 81 RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNL 140
+ + +L E+P +S + L L N+++ + F L +L+ L + N++
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 141 TGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANF 200
+ +L + L N L + L +LK L L
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN--------------- 145
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260
N + S+P AF+ +L+ L++ +
Sbjct: 146 ----NPIE-SIPSY------------------------AFNRIPSLRRLDLGELKRLSYI 176
Query: 261 SVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIV 319
S F + +L YLN+A+ NL I +L L L+L N +I
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNL--------REIPNLTPLIKLDELDLSGNHL-----SAIR 223
Query: 320 SGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNL 378
GS L+ L + M +Q + I LQ+L +N+ HN L+ F L
Sbjct: 224 PGSFQG----LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278
Query: 379 SSLVKLILGNNNL 391
L ++ L +N
Sbjct: 279 HHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 9/218 (4%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
+P I L L NQ + L++L+ L + N + +F L++
Sbjct: 57 EVPDGISTNTRLLNL---HENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
L L L +N L+ + + L +L L L N + +IP FN L+
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 441 VGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
+ I L LR ++ NL EIP+ + L E+ ++ N P S L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
L+++ + Q+ + + + L L +NL+ N+L
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 62/305 (20%), Positives = 97/305 (31%), Gaps = 72/305 (23%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMK 268
+P + L L N +F + +L+ L+ L N + + F +
Sbjct: 57 EVPDGISTNTRLLNL---HENQIQIIKVNSFKHLRHLEILQ-LSRNHIRTIEIGAFNGLA 112
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
+L L + N L + + + S L L L N + + I
Sbjct: 113 NLNTLELFDNRLTTIPNG------AFVYLSKLKELWLRNNPI------ESIPSYAFNRIP 160
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
L L L E+ + I E L NL++LN+ L EIP+ L L +L L
Sbjct: 161 SLRRLDLGEL--KRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
N+LS + P S L L L + Q+ + I F+
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD---------------------- 252
Query: 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL 507
NL+ L ++ NNL+ +P L L I L
Sbjct: 253 --NLQSLVEINLAHNNLT-LLP-----------------------HDLFTPLHHLERIHL 286
Query: 508 SQNNL 512
N
Sbjct: 287 HHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 9/229 (3%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
R ++L N IQ L LE L LS N + G + + L L L N+L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 118 GSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA-YNSLGGNIPSSLGQL 175
+IP+ FV L LKEL ++ N + + I SL + L L + L
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 176 KELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
L+ L L P++ L L + N L ++ P L +LQ + +
Sbjct: 185 SNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQI 243
Query: 233 SGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNL 280
AF N +L + L +N L + F + L +++ N
Sbjct: 244 QVIERNAFDNLQSLVEIN-LAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 36/135 (26%), Positives = 62/135 (45%), Gaps = 5/135 (3%)
Query: 32 RRVTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHN 90
+ LDL + +S LS LR ++L+ ++ +IP + L +L+ L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 91 SLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLG 149
L PG+ L L++ +++++ I F +L +L E+ + NNLT
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 150 NITSLEAISLAYNSL 164
+ LE I L +N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 19/176 (10%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVIT 707
IG GSF +VYKG VA L + S + F E L+ ++H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S S LV + M +G+L+ +L + + + S +
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLK------------RFKVMKIKVLRSWCRQIL 139
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TAHVGDFGLARLRQEVPNNQSSSVG 822
+ +LH P IH DLK NI + + +GD GLA L++ + + +G
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIG 192
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 74/431 (17%), Positives = 127/431 (29%), Gaps = 136/431 (31%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
L + S L ++P +L L L NK+ +F +L NL L + N
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-- 87
Query: 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFS 201
I+ + P + L +L+ L L
Sbjct: 88 ---------ISKIS-------------PGAFAPLVKLERLYLSK---------------- 109
Query: 202 VPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS 261
N+L LP + LQ ++ N + F+ + + +E LG N
Sbjct: 110 ---NQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTN------ 155
Query: 262 VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321
L S + +F LS++ +
Sbjct: 156 -----------------PLKSSGIENGAF----QGMKKLSYIRIADTNIT---------- 184
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLS 379
+IP + L L+L D N+ K+ L NL L + N +S S N
Sbjct: 185 TIPQGLPPSLTELHL---DGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439
L +L L NN L +P L + K + +++L N++S AI F +
Sbjct: 241 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA----- 293
Query: 440 LVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
+ + + +N +Q + + FR +
Sbjct: 294 ----------SYSGVSL----FSN-------------PVQYWEIQPSTFRC--------V 318
Query: 500 KDLREIDLSQN 510
+ L
Sbjct: 319 YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 20/290 (6%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+ L NN I G+ L L L L +N + PG + +L LYL +N+L+
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNI--PSSLGQL 175
+P + L+EL + EN +T + + + L N L + + +
Sbjct: 114 -ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170
Query: 176 KELKSLGLGG----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF 231
K+L + + TIP + L + N++ + + L+NL +S N
Sbjct: 171 KKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227
Query: 232 FSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFI 291
S + +N +L+ L L NN K+ D K + + + NN+ + S++
Sbjct: 228 ISAVDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286
Query: 292 HSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHN 341
++ S ++L +N + + + S + ++ L +
Sbjct: 287 GYNTKKASYSGVSLFSNP----VQYWEIQPSTFRCVYVRAAVQL---GNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 59/291 (20%), Positives = 119/291 (40%), Gaps = 36/291 (12%)
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
A L++ N + + N NL L L+ N+ S +S + +
Sbjct: 52 PDTALLDLQNNKITEIKDG------DFKNLKNLHTLILINNKI------SKISPGAFAPL 99
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
KL LYL NQ + ++PE+M + LQ L + N+++ S F L+ ++ + LG
Sbjct: 100 VKLERLYL---SKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153
Query: 388 NNNL--SGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF-NISHMSDSLNFARNHLVGSI 444
N L SG+ + +K+L+ + + +++ IP+ + +++ L+ N + +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTE----LHLDGNKI-TKV 207
Query: 445 PPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLR 503
L L +S N++S + + +L+E+++ N +P L K ++
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 266
Query: 504 EIDLSQNNLSG------KIPISLERLP-LEYLNLSFNDLEGQVPTKGIFAN 547
+ L NN+S P + ++L N ++ F
Sbjct: 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 47/241 (19%), Positives = 90/241 (37%), Gaps = 35/241 (14%)
Query: 322 SIPSEIGK-LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
+P ++ L L +N+ + L+NL L + +N++S P +F L
Sbjct: 45 KVPKDLPPDTALLDL---QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLAL---------------------LHLFQNDL-SGA 418
L +L L N L + L++L + + L N L S
Sbjct: 102 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161
Query: 419 IPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEI-GSCF 476
I F + A ++ +IP + +L L + N ++ ++ +
Sbjct: 162 IENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL---DGNKIT-KVDAASLKGLN 216
Query: 477 YLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
L ++ ++ N SL + LRE+ L+ N L K+P L ++ + L N++
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
Query: 536 E 536
Sbjct: 276 S 276
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 34/180 (18%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
IG G+FG V++ T+VA+K+L + AS F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL------------HPDAIPQTDEEND 749
+V+++ C+ G L+++YM G L +L H D + +
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 750 EIRNLTLLERISIAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L+ E++ IA VA+ + YL +H DL N L+ N+ + DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-22
Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 29/177 (16%)
Query: 649 HLIGIGSFGSVYKGT-------FDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI 697
+G G+FG V T VA+K+L A++ +E ++ I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMI 131
Query: 698 -RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL----HPDAIPQTDEENDEIR 752
+H+N++ ++ +C+ Q ++ +Y G+L +L P + ++
Sbjct: 132 GKHKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 753 NLTLLERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L+ + +S A VA ++YL C IH DL N+L+ + + DFGLAR
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-22
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 25/163 (15%)
Query: 651 IGIGSFGSVYKGTF-DRDGTI-VAIKVLNLQLQGASKS-FAAECRALRNIRHRNLVRVIT 707
+G G+FGSV +G + R I VAIKVL + A E + + + + +VR+I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
C + LV + G L +L E + + + V+
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLV---------GKRE--EIPVSNVAELLHQVS 446
Query: 768 SAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ YL + +H +L N+LL N A + DFGL++
Sbjct: 447 MGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKA 485
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-22
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 651 IGIGSFGSVYKGT-------FDRDGTIVAIKVLNLQLQGASKS----FAAECRALRNI-R 698
+G G FG V ++ VA+K+L A++ +E ++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL----HPDAIPQTDEENDEIRNL 754
H+N++ ++ +C+ Q ++ +Y G+L +L P D +
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 755 TLLERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
T + +S +A ++YL C IH DL N+L+ N + DFGLAR
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 37/177 (20%), Positives = 66/177 (37%), Gaps = 19/177 (10%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK---SFAAECRALRNIRHRNLVRV 705
IG G F VY+ DG VA+K + + +K E L+ + H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
S F ++ +V + G L + + + +
Sbjct: 98 YAS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK--------YFVQ 144
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ SA++++H +H D+KP+N+ + +GD GL R S VG
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 13/175 (7%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVIT 707
++ G F VY+ G A+K L + +++ E ++ + H N+V+ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 708 SCSSI--DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ S + + L+ + G L +L D + I
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC-DTVLK--------IFYQ 144
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
AV ++H + P IH DLK N+LL N T + DFG A P+ S+
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 20/171 (11%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGASKSFAAECRALRNIRHRN 701
+ + ++G G+ +V++G + G + AIKV N + E L+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V++ + + K L+ ++ P GSL L EE L E +
Sbjct: 69 IVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVL---------EEPSNAYGLPESEFLI 116
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHVGDFGLAR 808
+ DV +++L + +H ++KP NI+ D + DFG AR
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 42/180 (23%), Positives = 76/180 (42%), Gaps = 34/180 (18%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNI-RHR 700
+G G+FG V T VA+K+L + A ++ +E + + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL-----------HPDAIPQTDEEND 749
N+V ++ +C+ L+++Y G L N+L + EE +
Sbjct: 110 NIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 750 EIRNLTLLERISIAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++ LT + + A VA +++L C +H DL N+L+ + + DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 22/176 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
++G G++G VY G + +AIK + + S+ E ++++H+N+V+ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISIAIDVA 767
F N F + + +P GSL L P D E I T +LE
Sbjct: 88 ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILE--------- 133
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ YLH + +H D+K N+L++ + + DFG ++ + + G
Sbjct: 134 -GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG 185
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 43/177 (24%), Positives = 71/177 (40%), Gaps = 15/177 (8%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVIT 707
IG GS+G K DG I+ K L+ + + +E LR ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY- 71
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
I + N +V +Y G L + + + + + + + +
Sbjct: 72 --DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR--------VMTQLT 121
Query: 768 SAVDYLHHHCQEPT--IHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A+ H +H DLKP+N+ LD +GDFGLAR+ + + VG
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 63/313 (20%), Positives = 104/313 (33%), Gaps = 67/313 (21%)
Query: 81 RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNL 140
+ + + L E+P + S L L N ++ F L++L+ L + N++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 141 TGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANF 200
+ SL + L N L + L +L+ L L
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN--------------- 156
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260
N + S+P AF+ +L L++ +
Sbjct: 157 ----NPIE-SIPSY------------------------AFNRVPSLMRLDLGELKKLEYI 187
Query: 261 SVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIV 319
S F + +L YLN+ + N+ + +L L L + N F I
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNI--------KDMPNLTPLVGLEELEMSGNHF-----PEIR 234
Query: 320 SGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNL 378
GS L SL + + ++Q I L +L LN+ HN LS F L
Sbjct: 235 PGSFHG----LSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289
Query: 379 SSLVKLILGNNNL 391
LV+L L +N
Sbjct: 290 RYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 28/254 (11%)
Query: 187 IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNL 246
IP + L+L EN + + L +L++ Q+ N AF+ ++L
Sbjct: 73 IPSNTRYLNL------MENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 247 QSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNL 305
+LE L +N+ + F + L L + N + S S + +L L+L
Sbjct: 126 NTLE-LFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSY------AFNRVPSLMRLDL 178
Query: 306 V-ANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRH 364
+ + + G + L L L + +P ++ L L+ L M
Sbjct: 179 GELKKLE-YISEGAFEG-----LFNLKYLNL---GMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 365 NQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF 424
N P SF LSSL KL + N+ +S + ++ L L L+L N+LS ++P ++F
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 425 NISHMSDSLNFARN 438
L+ N
Sbjct: 287 TPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 9/218 (4%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
+P I L L N + + L +L+ L + N + +F L+S
Sbjct: 68 EVPQGIPSNTRYLNL---MENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS 124
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
L L L +N L+ + + L +L L L N + +IP FN L+
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 441 VGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
+ I L L+ + N+ ++P+ + L+E+ M+ N F P S L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
L+++ + + +S + + L L LNL+ N+L
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 59/305 (19%), Positives = 96/305 (31%), Gaps = 72/305 (23%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMK 268
+P + L L N F + +L+ L+ LG N ++ V F +
Sbjct: 68 EVPQGIPSNTRYLNL---MENNIQMIQADTFRHLHHLEVLQ-LGRNSIRQIEVGAFNGLA 123
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
SL L + N L S + S L L L N + + +
Sbjct: 124 SLNTLELFDNWLTVIPSG------AFEYLSKLRELWLRNNPI------ESIPSYAFNRVP 171
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
L+ L L + + E I E L NL++LN+ + ++P+ L L +L +
Sbjct: 172 SLMRLDL--GELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMS 226
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
N+ + P S L L L + + +S I F+
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFD---------------------- 263
Query: 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL 507
L L ++ NNLS +P L+ L E+ L
Sbjct: 264 --GLASLVELNLAHNNLS-SLP-----------------------HDLFTPLRYLVELHL 297
Query: 508 SQNNL 512
N
Sbjct: 298 HHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 9/229 (3%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
R ++L N IQ L LE L L NS+ G + + L L L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT 136
Query: 118 GSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA-YNSLGGNIPSSLGQL 175
IPS F L L+EL ++ N + + + SL + L L + L
Sbjct: 137 -VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195
Query: 176 KELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
LK L LG P++ L L + N + P LS+L+ + N+
Sbjct: 196 FNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
Query: 233 SGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNL 280
S AF ++L L L +N L + F ++ L L++ N
Sbjct: 255 SLIERNAFDGLASLVELN-LAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 5/132 (3%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
LDL + +S L L+ ++L I+ +P + L LE L +S N
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNIT 152
PG+ S L L++ +++ I F L +L EL + NNL+ +
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 153 SLEAISLAYNSL 164
L + L +N
Sbjct: 291 YLVELHLHHNPW 302
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 20/175 (11%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVIT 707
IG GSFG DG IK +N+ + + E L N++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
S F+ N +V Y G L ++ E+ +I + + +
Sbjct: 91 S-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED--QILD--------WFVQIC 135
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A+ ++H +H D+K NI L + T +GDFG+AR+ + +G
Sbjct: 136 LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG 187
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 36/175 (20%)
Query: 651 IGIGSFGSVYKGTFDRDG-------TIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLV 703
+G G+F ++KG G T V +KVL+ + S+SF + + H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
C D LV +++ GSL+ +L + +L ++ +A
Sbjct: 76 LNYGVCVC-----GDENILVQEFVKFGSLDTYLK-----------KNKNCINILWKLEVA 119
Query: 764 IDVASAVDYL-HHHCQEPTIHCDLKPSNILLD--------NNLTAHVGDFGLARL 809
+A+A+ +L + IH ++ NILL N + D G++
Sbjct: 120 KQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 30/171 (17%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G G+FG VY+G D VA+K L + S+ F E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+VR I Q ++ + M G L+++L +T + +L +L+ +
Sbjct: 95 IVRCIGVSL----QSLPR-FILMELMAGGDLKSFLR-----ETRPRPSQPSSLAMLDLLH 144
Query: 762 IAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
+A D+A YL +H IH D+ N LL A +GDFG+AR
Sbjct: 145 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 8e-21
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 32/170 (18%)
Query: 651 IGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQGASKS----FAAECRALRNIRHRNLV 703
IG G FG V++G + VAIK S S F E +R H ++V
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
++I + ++ + G L ++L +L L I A
Sbjct: 455 KLIGVITENPVW------IIMELCTLGELRSFLQ---------VRKF--SLDLASLILYA 497
Query: 764 IDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+++A+ YL +H D+ N+L+ +N +GDFGL+R ++
Sbjct: 498 YQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 38/162 (23%), Positives = 63/162 (38%), Gaps = 22/162 (13%)
Query: 650 LIGIGSFGSVYKGTFDR--DGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVI 706
I G G +Y DR +G V +K L A AE + L + H ++V++
Sbjct: 87 CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
D G+ +V +Y+ SL+ + L + E I+ +++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--------------QKLPVAEAIAYLLEI 191
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A+ YLH ++ DLKP NI+L + D G
Sbjct: 192 LPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 69/345 (20%), Positives = 114/345 (33%), Gaps = 97/345 (28%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
L + S L +P +S L L N + +F L +L L + N
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK-- 89
Query: 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFS 201
I+ + + L++L+ L +
Sbjct: 90 ---------ISKIH-------------EKAFSPLRKLQKLYISK---------------- 111
Query: 202 VPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS 261
N L +PP+L S+L +I +N FS N+ +E +G N
Sbjct: 112 ---NHLV-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIE-MGGNPLENSG 163
Query: 262 VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321
G L L++L + +
Sbjct: 164 FEPGAFDGL----------------------------KLNYLRISEAKLT---------- 185
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLS 379
IP ++ L L+L DHN+ + I E R L L + HNQ+ S L
Sbjct: 186 GIPKDLPETLNELHL---DHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF 424
+L +L L NN LS +P+ L +LK L +++L N+++ + F
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 50/291 (17%), Positives = 95/291 (32%), Gaps = 21/291 (7%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+ L NN I + L L AL L +N + S +L LY+ +N L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG-GNIPSSLGQLK 176
IP +L EL I +N + + ++ I + N L
Sbjct: 116 -EIPPN--LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172
Query: 177 ELKSLGLGG----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
+L L + IP + L + N++ ++ L S L + +N
Sbjct: 173 KLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 233 SGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIH 292
+ S L+ L L NN ++ D+K L + + NN+ ++ +
Sbjct: 230 RMIENGSLSFLPTLRELH-LDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVG 288
Query: 293 SLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQ 342
+ + ++L N + + + I+ + +
Sbjct: 289 FGVKRAYYNGISLFNNP--------VPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 63/336 (18%), Positives = 109/336 (32%), Gaps = 63/336 (18%)
Query: 34 VTVLDLKSKGLIGSLSP-QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
T+LDL I L L L + L NN I L +L+ LY+S N L
Sbjct: 56 TTLLDL-QNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLT-GGIPHFLGN 150
V EIP NL S L+ L + N++ +P F L N+ + + N L G +
Sbjct: 115 V-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 151 ITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGS 210
L + ++ L IP L + L L L N++ +
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDH-------------------NKIQ-A 207
Query: 211 LPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270
+ L S L + +N + S L+ L L NN ++ D+K L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH-LDNNKLSRVPAGLPDLKLL 266
Query: 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKL 330
+ + NN+ ++ + + + ++L N + +
Sbjct: 267 QVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP--------VPYWEVQPAT--- 315
Query: 331 VSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQ 366
F + + + + +
Sbjct: 316 ------------FRC--------VTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 63/347 (18%), Positives = 111/347 (31%), Gaps = 84/347 (24%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMK 268
++P + + L L NN S F +L +L +L NN K+ F ++
Sbjct: 47 AVPKEISPDTTLLDL---QNNDISELRKDDFKGLQHLYAL-VLVNNKISKIHEKAFSPLR 102
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
L L ++ N+L + S+L L + N+ + +P + SG
Sbjct: 103 KLQKLYISKNHLVEIPPN--LP-------SSLVELRIHDNRIR-KVPKGVFSG------- 145
Query: 329 KLVSLYLIEMDHNQF-EGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
L ++ IEM N L +L + +L+ IP +L +L L
Sbjct: 146 -LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLD 201
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
+N + + L +L L L N + I +
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLS---------------------- 238
Query: 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL 507
L LR + +N LS +P+ L LK L+ + L
Sbjct: 239 --FLPTLRELHLDNNKLS-------------------------RVPAGLPDLKLLQVVYL 271
Query: 508 SQNNLS-------GKIPISLERLPLEYLNLSFNDLEGQVPTKGIFAN 547
NN++ + ++R ++L N + F
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 35/206 (16%), Positives = 60/206 (29%), Gaps = 56/206 (27%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+L+ + L +P L L NN++S + L+ L L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSC 475
S I E+ F+ + L+ L + S N+L
Sbjct: 91 S-KIHEKAFS---------------------PLRKLQKLYI---SKNHLV---------- 115
Query: 476 FYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFND 534
IP +L L E+ + N + L + + + N
Sbjct: 116 ---------------EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158
Query: 535 LEGQVPTKGIFANASAISVSGNSNRL 560
LE G F + + +L
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKL 184
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 1e-20
Identities = 36/248 (14%), Positives = 66/248 (26%), Gaps = 35/248 (14%)
Query: 597 FSGLLLGSFFIFYWLRRRGGSGKEPSEPILRRAL------------RKVSYESLLKATDG 644
F G G I R + + ++ A + ES L
Sbjct: 19 FRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 78
Query: 645 -FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECRALRNIRH- 699
++G + + T G + V + S K E LR +R
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 700 ---------------RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQT 744
+LV+ I + ++ V
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 745 DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804
+ ++L R+ + + V + LHH+ +H L+P +I+LD + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 805 GLARLRQE 812
Sbjct: 256 EHLVRDGA 263
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 30/216 (13%)
Query: 613 RRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVA 672
RR E SE + ES + F +G GS+G V+K DG + A
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQ--QSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 673 IKVLNLQLQGAS--KSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVYQYMPN 729
+K +G AE + + +H VR+ + ++ L +
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELC-G 140
Query: 730 GSLENWL--HPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787
SL+ ++P+ ++ D A+ +LH +H D+K
Sbjct: 141 PSLQQHCEAWGASLPE-----AQVWG--------YLRDTLLALAHLHSQ---GLVHLDVK 184
Query: 788 PSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGD 823
P+NI L +GDFGL GD
Sbjct: 185 PANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGD 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 20/171 (11%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGASKSFAAECRALRNIRHRN 701
+ + ++G G+ +V++G + G + AIKV N + E L+ + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V++ + + K L+ ++ P GSL L EE L E +
Sbjct: 69 IVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVL---------EEPSNAYGLPESEFLI 116
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHVGDFGLAR 808
+ DV +++L + +H ++KP NI+ D + DFG AR
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 47/169 (27%), Positives = 72/169 (42%), Gaps = 19/169 (11%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS-FAAECRALRNIRHRN 701
D + +IG G+ V VAIK +NL+ S E +A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V TS F D LV + + GS+ + I + E ++ L E
Sbjct: 75 IVSYYTS-----FVVKDELWLVMKLLSGGSVLD------IIKHIVAKGEHKSGVLDEST- 122
Query: 762 IAI---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
IA +V ++YLH + Q IH D+K NILL + + + DFG++
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 20/182 (10%), Positives = 39/182 (21%), Gaps = 31/182 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVI 706
+ +G V+ A+KV + + A + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 707 TSC------------------SSIDFQGNDFKALVYQYMP--NGSLENWLHPDAIPQTDE 746
Q + A MP + LE D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE-----LLFSTLDF 183
Query: 747 ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806
+ +L + + L +H P N+ + + +GD
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 807 AR 808
Sbjct: 241 LW 242
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 30/171 (17%)
Query: 651 IGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQGASKS----FAAECRALRNIRHRN 701
+G G+FG VY+G D VA+K L + S+ F E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+VR I Q ++ + M G L+++L +T + +L +L+ +
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGDLKSFLR-----ETRPRPSQPSSLAMLDLLH 185
Query: 762 IAIDVASAVDYL-HHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
+A D+A YL +H IH D+ N LL A +GDFG+AR
Sbjct: 186 VARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 35/168 (20%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR- 704
+G G F ++ + + A K++ L + + E R++ H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN---LTLLER 759
+ +V + SL + + LT E
Sbjct: 81 HGFFEDNDFV--------FVVLELCRRRSL---------------LELHKRRKALTEPEA 117
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ YLH + IH DLK N+ L+ +L +GDFGLA
Sbjct: 118 RYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 63/311 (20%), Positives = 116/311 (37%), Gaps = 40/311 (12%)
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN- 263
+ S+P L + +L L SNN + NLQ+L L +N + +
Sbjct: 40 SGSLNSIPSGLTEAVKSLDL---SNNRITYISNSDLQRCVNLQALV-LTSNGINTIEEDS 95
Query: 264 FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI 323
F + SL +L+++ N L + S S+L+FLNL+ N +K S+ S
Sbjct: 96 FSSLGSLEHLDLSYNYLSNLSSS------WFKPLSSLTFLNLLGNPYKTLGETSLFSH-- 147
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLV 382
L L ++ + + KI + + L L+ L + + L P S ++ ++
Sbjct: 148 ------LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201
Query: 383 KLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVG 442
LIL ++ + + L L DL E+ ++SL
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE--TNSL--------- 250
Query: 443 SIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLV-SLKD 501
R ++ +L ++ + L E+ + N + S+P + L
Sbjct: 251 ------IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS 302
Query: 502 LREIDLSQNNL 512
L++I L N
Sbjct: 303 LQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 52/311 (16%), Positives = 105/311 (33%), Gaps = 52/311 (16%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNL 140
+++L LS+N + +L C L L L N + +I + F SL +L+ L + N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 141 TGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANF 200
+ + ++SL ++L N +LG+ L + L +
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPY-----KTLGETSLFSHL-------TKLQILRVGNMD 160
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260
+ + L+ L+ +I + P + + N+ L + L
Sbjct: 161 TF------TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214
Query: 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS 320
+ S+ L + +L + E+ S +L+
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSEL---------STGETNSLI-------------- 251
Query: 321 GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
K + +++ ++ + ++++ L L NQL F L+S
Sbjct: 252 --------KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302
Query: 381 LVKLILGNNNL 391
L K+ L N
Sbjct: 303 LQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 58/278 (20%), Positives = 103/278 (37%), Gaps = 37/278 (13%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
+ L+L N+ + +S + L +L L N I E+ S L +
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQR-----CVNLQALVL---TSNGIN-TIEEDSFSSLGS 101
Query: 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSL-GNLKQLALLHLFQNDL 415
L+ L++ +N LS S F LSSL L L N + +SL +L +L +L + D
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPP----KIGNLKVLRMFVVSSNNLSGEIPSE 471
I + F + L + L S P I N+ L + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLIL---HMKQHI-LLLEI 216
Query: 472 IGSCFY-LQEIYMAENFFRG----SIPS----SLVSLKDLREIDLSQNNLSGKIPISLER 522
++ + + + + + SL+ R + ++ +L ++ L +
Sbjct: 217 FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQ 275
Query: 523 LP-LEYLNLSFNDLEGQVPTKGIFANASA---ISVSGN 556
+ L L S N L+ VP GIF ++ I + N
Sbjct: 276 ISGLLELEFSRNQLKS-VP-DGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 48/219 (21%), Positives = 76/219 (34%), Gaps = 30/219 (13%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
SIPS + + SL L +N+ ++ R NLQ L + N ++ SF +L S
Sbjct: 45 SIPSGLTEAVKSLDL---SNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
L L L N LS + S L L L+L N +F+ L
Sbjct: 102 LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 441 VGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
I K L L + +++L P SL S+
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQ-SYE-----------------------PKSLKSI 197
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEG 537
+++ + L + I ++ +E L L DL+
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 25/159 (15%), Positives = 59/159 (37%), Gaps = 13/159 (8%)
Query: 32 RRVTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHN 90
++ +L + + + + L+FL E+ + + +Q P + + + L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 91 SLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE--------FVSLYNLKELAIQENNLTG 142
+ + + S + L L L+ SE + + + + I + +L
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267
Query: 143 GIPHFLGNITSLEAISLAYN---SLGGNIPSSLGQLKEL 178
+ L I+ L + + N S+ I L L+++
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 19/97 (19%), Positives = 40/97 (41%), Gaps = 11/97 (11%)
Query: 54 NLSFLREIHLSNNTIQGKIPGEI--------GRLFRLEALYLSHNSLVGEIPGNLSYCSR 105
S + + L + + E+ + F + ++ SL ++ L+ S
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 106 LIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLT 141
L+ L RN+L+ S+P F L +L+++ + N
Sbjct: 279 LLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 46/201 (22%), Positives = 75/201 (37%), Gaps = 42/201 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNI-RHRN 701
F IG G FGSV+K DG I AIK L G+ A E A + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+VR ++ + +D + +Y GSL + + + + + E+++L L
Sbjct: 73 VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL----- 122
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-------------------LTAHVG 802
V + Y+H +H D+KPSNI + + +G
Sbjct: 123 ---QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 803 DFGLARLRQEVPNNQSSSVGD 823
D G ++ GD
Sbjct: 177 DLGHVTRI----SSPQVEEGD 193
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 35/168 (20%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR- 704
+G G F ++ + + A K++ L + + E R++ H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN---LTLLER 759
+ +V + SL + + LT E
Sbjct: 107 HGFFEDNDFV--------FVVLELCRRRSL---------------LELHKRRKALTEPEA 143
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ YLH + IH DLK N+ L+ +L +GDFGLA
Sbjct: 144 RYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 69/335 (20%), Positives = 111/335 (33%), Gaps = 88/335 (26%)
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT-GG 143
+ + L +P + S L L NKL+ F L L +L++ N L+ G
Sbjct: 12 IRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 144 IPHF-LGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV 202
TSL+ + L++N + + S+ L++L+ L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH----------------- 110
Query: 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSV 262
+ L S+ L+L NL IS+ +F F+ S+L+ L++ GN+F
Sbjct: 111 --SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF------ 162
Query: 263 NFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGS 322
N NL+FL+L Q +
Sbjct: 163 --------------QENFLPD---------IFTELRNLTFLDLSQCQLE----------Q 189
Query: 323 IPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLV 382
+ F L +LQ LNM HN + L+SL
Sbjct: 190 LSPTA---------------FNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226
Query: 383 KLILGNNNLSGVIPSSLGNL-KQLALLHLFQNDLS 416
L N++ L + LA L+L QND +
Sbjct: 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 46/220 (20%), Positives = 85/220 (38%), Gaps = 9/220 (4%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS--GEIPSSFGNLS 379
S+P+ I S +E++ N+ + +L L L++ N LS G S +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439
SL L L N + + S+ L+QL L ++L +F L+ + H
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 440 LVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPSSLV 497
I L L + ++ N+ +I L + +++ P++
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 498 SLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLE 536
SL L+ +++S NN + L L+ L+ S N +
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 30/257 (11%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL--VGEIPGNLSYCSRLIGLYLGRNK 115
+ L +N +Q G +L +L L LS N L G + + L L L N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPH-FLGNITSLEAISLAYNSLGGNIPSSLGQ 174
+ ++ S F+ L L+ L Q +NL ++ +L + +++
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 175 LKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG 234
L L+ L + G N + P + L NL +S
Sbjct: 149 LSSLEVLKMAG-------------------NSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189
Query: 235 SFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHS 293
P AF++ S+LQ L + +N F L + + SL L+ ++N++ + + E+
Sbjct: 190 LSPTAFNSLSSLQVL-NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF-- 246
Query: 294 LANCSNLSFLNLVANQF 310
S+L+FLNL N F
Sbjct: 247 ---PSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 51/273 (18%), Positives = 93/273 (34%), Gaps = 47/273 (17%)
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI- 327
S L + N L S + L+ L+L +N + S+
Sbjct: 29 SATRLELESNKLQSLPHG------VFDKLTQLTKLSLSSNG--------LSFKGCCSQSD 74
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS--FGNLSSLVKLI 385
SL +++ N + L+ L+ L+ +H+ L ++ F +L +L+ L
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLD 132
Query: 386 LGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP 445
+ + + L L +L + N +IF
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT-------------------- 172
Query: 446 PKIGNLKVLRMFVVSSNNLSGEIPSEIGSC-FYLQEIYMAENFFRGSIPSSLVSLKDLRE 504
++ NL L + S L ++ + LQ + M+ N F L L+
Sbjct: 173 -ELRNLTFLDL---SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 505 IDLSQNNLSGKIPISLERLP--LEYLNLSFNDL 535
+D S N++ L+ P L +LNL+ ND
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 29/136 (21%), Positives = 48/136 (35%), Gaps = 6/136 (4%)
Query: 54 NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI-PGNLSYCSRLIGLYLG 112
+L L + +S+ + G L LE L ++ NS P + L L L
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 113 RNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSS 171
+ +LE + F SL +L+ L + NN + SL+ + + N +
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQ 241
Query: 172 L--GQLKELKSLGLGG 185
L L L
Sbjct: 242 ELQHFPSSLAFLNLTQ 257
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 29/179 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNL--VRV 705
IG G V++ + I AIK +NL+ S+ E L ++ + +R+
Sbjct: 63 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
D++ D + N L +WL + +++ ER S +
Sbjct: 122 Y------DYEITDQYIYMVMECGNIDLNSWLK------------KKKSIDPWERKSYWKN 163
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ--SSSVG 822
+ AV +H H +H DLKP+N L+ + + DFG+A Q + S VG
Sbjct: 164 MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 27/177 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIRHRNLVRVI 706
+G G +VY VAIK + + + K F E + H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM- 76
Query: 707 TSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
ID + LV +Y+ +L ++ L++ I+
Sbjct: 77 -----ID-VDEEDDCYYLVMEYIEGPTLSEYIE------------SHGPLSVDTAINFTN 118
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ + + H +H D+KP NIL+D+N T + DFG+A+ E Q++ V
Sbjct: 119 QILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV 172
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 29/179 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNL--VRV 705
IG G V++ + I AIK +NL+ S+ E L ++ + +R+
Sbjct: 16 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
D++ D + N L +WL + +++ ER S +
Sbjct: 75 Y------DYEITDQYIYMVMECGNIDLNSWLK------------KKKSIDPWERKSYWKN 116
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ--SSSVG 822
+ AV +H H +H DLKP+N L+ + + DFG+A Q + S VG
Sbjct: 117 MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-19
Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 35/200 (17%)
Query: 616 GSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV 675
G G+ PS P + + +G G FG V + G VAIK
Sbjct: 1 GGGRSPSLP--------------TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ 46
Query: 676 LNLQLQGASK-SFAAECRALRNIRHRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGS 731
+L ++ + E + ++ + H N+V V + ND L +Y G
Sbjct: 47 CRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL--APNDLPLLAMEYCEGGD 104
Query: 732 LENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791
L +L+ + + L ++ D++SA+ YLH + IH DLKP NI
Sbjct: 105 LRKYLN---------QFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENI 152
Query: 792 LLD---NNLTAHVGDFGLAR 808
+L L + D G A+
Sbjct: 153 VLQPGPQRLIHKIIDLGYAK 172
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 29/179 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVIT 707
IG G V++ + I AIK +NL+ S+ E L ++ + ++I
Sbjct: 35 QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII- 91
Query: 708 SCSSIDFQGNDFKALVYQYM--PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
D++ D +Y M N L +WL + +++ ER S +
Sbjct: 92 --RLYDYEITDQY--IYMVMECGNIDLNSWLK------------KKKSIDPWERKSYWKN 135
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ--SSSVG 822
+ AV +H H +H DLKP+N L+ + + DFG+A Q + S VG
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 27/178 (15%), Positives = 56/178 (31%), Gaps = 22/178 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS------KSFAAECRALRNIRH---- 699
++G + + T G + V + S K R LR I++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD---------EENDE 750
+ +R I + V + + + Q++ +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++L R+ + + V + LHH+ +H L+P +I+LD + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 28/165 (16%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR- 704
+L+G GSF VY+ G VAIK+++ + G + E + ++H +++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
+ + LV + NG + +L + ++ + E
Sbjct: 77 YNYFEDSNYV--------YLVLEMCHNGEMNRYLK-----------NRVKPFSENEARHF 117
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ + + YLH H +H DL SN+LL N+ + DFGLA
Sbjct: 118 MHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
++ IG G+ G+VY G VAI+ +NLQ Q + E +R ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ S + D +V +Y+ GSL D + + E IA
Sbjct: 82 YLDS-----YLVGDELWVVMEYLAGGSL---------------TDVVTETCMDEG-QIAA 120
Query: 765 ---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ A+++LH IH D+K NILL + + + DFG
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 40/193 (20%), Positives = 73/193 (37%), Gaps = 7/193 (3%)
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406
+P + Q + + N++S +SF +L L L +N L+ + ++ L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 407 LLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLS 465
L L N ++ F+ +L+ R L + P + L L+ + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 466 GEIPSEI-GSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP 524
+P + L +++ N + L L + L QN ++ P + L
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 525 -LEYLNLSFNDLE 536
L L L N+L
Sbjct: 202 RLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 15/219 (6%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
++P I ++L N+ +NL L + N L+ ++F L+
Sbjct: 25 AVPVGIPAASQRIFL---HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 381 LVKLILGNNNLSGVIPSS-LGNLKQLALLHLFQNDLSGAIPEEIFNISHMS--DSLNFAR 437
L +L L +N + + L +L LHL + L + +F ++ L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF--RGLAALQYLYLQD 138
Query: 438 NHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPSS 495
N L ++P +L L + N +S +P L + + +N P +
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 496 LVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFN 533
L L + L NNLS +L L L+YL L+ N
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 45/206 (21%), Positives = 68/206 (33%), Gaps = 9/206 (4%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+ I L N I L L+L N L + + L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 118 GSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPS-SLGQL 175
S+ F L L L + L P + +L+ + L N+L +P + L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDL 152
Query: 176 KELKSLGLGG----TIPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNN 230
L L L G ++P L L + +NR+ + P L L + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFAN 211
Query: 231 FFSGSFPLAFSNASNLQSLEILGNNF 256
S A + LQ L + N +
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 49/233 (21%), Positives = 85/233 (36%), Gaps = 18/233 (7%)
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGI 144
L +P + + ++L N++ + F + NL L + N L
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 145 PHFLGNITSLEAISLAYNSLGGNIPSS-LGQLKELKSLGLGG----TIPPSI-YNLSLLA 198
+ LE + L+ N+ ++ + L L +L L + P + L+ L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258
+ +N L +LP L NL + N S AF +L L L N
Sbjct: 133 YLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL-LHQNRVA 190
Query: 259 KLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQF 310
+ + F D+ L L + NNL + ++ +LA L +L L N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTE------ALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 43/208 (20%), Positives = 74/208 (35%), Gaps = 13/208 (6%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNL 140
+ ++L N + + C L L+L N L I + F L L++L + +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 141 TGGIP-HFLGNITSLEAISLAYNSLGGNIPS-SLGQLKELKSLGLGG----TIPPSI-YN 193
+ + L + L L + L L+ L L +P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILG 253
L L + + NR+ S+P L +L + N + P AF + L +L L
Sbjct: 152 LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY-LF 209
Query: 254 NNFFGKLSVN-FGDMKSLAYLNVAINNL 280
N L +++L YL + N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 6/136 (4%)
Query: 32 RRVTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEI-GRLFRLEALYLSH 89
R+ L L + + L P + L+ L+ ++L +N +Q +P + L L L+L
Sbjct: 105 GRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162
Query: 90 NSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFL 148
N + L L L +N++ + F L L L + NNL+ L
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 149 GNITSLEAISLAYNSL 164
+ +L+ + L N
Sbjct: 222 APLRALQYLRLNDNPW 237
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 40/165 (24%), Positives = 69/165 (41%), Gaps = 25/165 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
S IG GS G V G VA+K+++L+ Q + E +R+ +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER-IS-I 762
+ S + + ++ +++ G+L D + + L E I+ +
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGAL---------------TDIVSQVRLNEEQIATV 146
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
V A+ YLH + IH D+K +ILL + + DFG
Sbjct: 147 CEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 22/186 (11%)
Query: 627 RRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS 686
R+L ++ +L F L+G G++G VYKG + G + AIKV+++ +
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEE 66
Query: 687 FAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKA-LVYQYMPNGSLENWLHPDAIPQT 744
E L+ HRN+ + + G D + LV ++ GS+ + +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 745 DEENDEIRNLTLLERISIAI---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801
EE IA ++ + +LH H IH D+K N+LL N +
Sbjct: 127 KEE-------------WIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170
Query: 802 GDFGLA 807
DFG++
Sbjct: 171 VDFGVS 176
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 29/178 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVI 706
L+G G G VY+ IVA+K+++ L E R ++ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 707 TSCSSIDF---QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
DF G + + + + L L L ++I
Sbjct: 101 ------DFGEIDGQLY--VDMRLINGVDLAAMLRRQG------------PLAPPRAVAIV 140
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ SA+D H H D+KP NIL+ + A++ DFG+A + Q +
Sbjct: 141 RQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 41/216 (18%), Positives = 68/216 (31%), Gaps = 47/216 (21%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRALRNIRHRNLVRVIT 707
+G G FG V++ D AIK + L + + + E +AL + H +VR
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI---------------- 751
+ + + + P + + +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 752 ------------RNLTLLERIS---------------IAIDVASAVDYLHHHCQEPTIHC 784
R L + ++ I I +A AV++LH +H
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188
Query: 785 DLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
DLKPSNI + VGDFGL + Q+
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 32/166 (19%), Positives = 69/166 (41%), Gaps = 25/166 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
+ +G G+FG VYK G + A KV+ + + + + E L H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
++ + + + ++ ++ P G+++ + T+ + I +
Sbjct: 81 LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--------------IQV 121
Query: 765 ---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ A+++LH + IH DLK N+L+ + DFG++
Sbjct: 122 VCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 32/182 (17%), Positives = 67/182 (36%), Gaps = 36/182 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN-----------------LQLQGASKSFAAECRA 693
+ G F + +D A+K + ++ F E +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 694 LRNIRHRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDE 750
+ +I++ + +IT+ + + ++Y+YM N S+ + + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEV------Y--IIYEYMENDSILKFD----EYFFVLDKNY 144
Query: 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
+ + I V ++ Y+H+ H D+KPSNIL+D N + DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 811 QE 812
+
Sbjct: 203 VD 204
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLV 703
F+ IG GSFG V+KG +R +VAIK+++L + + + E L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 704 RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ S + + ++ +Y+ GS + L P + DE IA
Sbjct: 84 KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGPL---DET-------------QIA 122
Query: 764 I---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++ +DYLH + IH D+K +N+LL + + DFG+A
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 41/211 (19%), Positives = 74/211 (35%), Gaps = 27/211 (12%)
Query: 611 LRRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTI 670
L+R G ++ +L L+ V YE + + +G GSFG V++ + G
Sbjct: 27 LQRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 671 VAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNG 730
A+K + L+ E A + +V + + + + + + + G
Sbjct: 86 CAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGG 135
Query: 731 SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790
SL + D ++YLH +H D+K N
Sbjct: 136 SLGQLIKQMGC----LPEDRALYYLG--------QALEGLEYLH---TRRILHGDVKADN 180
Query: 791 ILLDNN-LTAHVGDFGLARLRQEVPNNQSSS 820
+LL ++ A + DFG A Q +S
Sbjct: 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 21/255 (8%)
Query: 334 YLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS---FGNLSSLVKLILGNNN 390
YL++ + + ++ + +L+ L +R ++ I +S L +L L N
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 391 LSGVIPSSLGNLKQLALLHLFQNDLS----GAIPEEIFNISHMS-DSLNFARNHLVGSIP 445
++G P L L L ++S A E+ L+ A+ H +
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 446 PKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY----LQEIYMAENFFR---GSIPSSLVS 498
++ L +S N GE C LQ + + G + +
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226
Query: 499 LKDLREIDLSQNNLSGKIPISLERLP--LEYLNLSFNDLEGQVPTKGIFANASAISVSGN 556
L+ +DLS N+L P L LNLSF L+ QVP KG+ A S + +S
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP-KGLPAKLSVLDLS-- 282
Query: 557 SNRLCGGIPELQLPK 571
NRL +LP+
Sbjct: 283 YNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 48/313 (15%), Positives = 87/313 (27%), Gaps = 54/313 (17%)
Query: 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN---FGDMKSLA 271
G S L + + + +L+ L + ++ + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLV 331
L + + +G + + + + L+ N+ + +E+ + +
Sbjct: 99 ELTLENLEV-TGTAPPPLLEATGPDLNILNLRNVSWATR----------DAWLAELQQWL 147
Query: 332 SLYL--IEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS----FGNLSSLVKLI 385
L + + E++ L L++ N GE +L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 386 LGNNN---LSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVG 442
L N SGV + QL L L N L A + +SLN + L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266
Query: 443 SIPPKIG-NLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKD 501
+P + L VL +S N L PS L
Sbjct: 267 QVPKGLPAKLSVLD---LSYNRLD-------------------------RNPSPD-ELPQ 297
Query: 502 LREIDLSQNNLSG 514
+ + L N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 39/262 (14%), Positives = 74/262 (28%), Gaps = 37/262 (14%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLF--RLEALYLSH 89
+R+TV + I + ++ +S L+E+ L N + G P + L L L +
Sbjct: 71 KRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 90 NSLVGEIPGNLS----YCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP 145
S L L + + + L L + +N G
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 146 H----FLGNITSLEAISLAYN---SLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLA 198
+L+ ++L + G + +L+ L +LS
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL-----------DLS--- 236
Query: 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258
N L + S L +S + L L L N
Sbjct: 237 -----HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVL-DLSYNRLD 287
Query: 259 KLSVNFGDMKSLAYLNVAINNL 280
+ ++ + L++ N
Sbjct: 288 RNPS-PDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 36/218 (16%), Positives = 67/218 (30%), Gaps = 37/218 (16%)
Query: 30 RHRRVTVLDLK--SKGLIGSLSPQIGNLSF--LREIHLSNNTIQGKIPGEIGRLFRLEAL 85
+ +L+L+ S + ++ L+ + ++ ++ L L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 86 YLSHNSLVGEIPGNLSYC----SRLIGLYLGRNKLE---GSIPSEFVSLYNLKELAIQEN 138
LS N +GE + C L L L +E G + + L+ L + N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 139 NLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLL 197
+L + L +++L++ L +L L +LS
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL--------------DLS-- 282
Query: 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235
NRL P L + + N F S
Sbjct: 283 ------YNRLD-RNPSPDELP--QVGNLSLKGNPFLDS 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRV 705
+G G FG+VY + I+A+KVL L+ G E ++RH N++R+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL-ERIS--I 762
F L+ +Y P G++ E++ L+ E+ +
Sbjct: 75 YGY-----FHDATRVYLILEYAPLGTV---------------YRELQKLSKFDEQRTATY 114
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++A+A+ Y H IH D+KP N+LL + + DFG +
Sbjct: 115 ITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 29/161 (18%), Positives = 57/161 (35%), Gaps = 26/161 (16%)
Query: 652 GIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVITSC 709
G +V + G V ++ +NL+ E + H N+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT- 94
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI---DV 766
F ++ +V +M GS ++ + + +E +IA V
Sbjct: 95 ----FIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL-------------AIAYILQGV 137
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
A+DY+HH +H +K S+IL+ + ++
Sbjct: 138 LKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 31/168 (18%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG---ASKSFAAECRALRNIRHRNLVRVI 706
++G G V+ RD VA+KVL L F E + + H +V V
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 707 TSCSSIDFQGNDFKA------LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
D G +V +Y+ +L + +H +T I
Sbjct: 79 ------D-TGEAETPAGPLPYIVMEYVDGVTLRDIVH------------TEGPMTPKRAI 119
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ D A+++ H + IH D+KP+NI++ V DFG+AR
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 32/192 (16%), Positives = 60/192 (31%), Gaps = 31/192 (16%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQGASKSFAAECRALRN 696
+ HL+G G+F VY+ T ++ +KV L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
++ ++ + LV + G+L +AI + + +
Sbjct: 124 SMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLL-----NAINLYKNTPE--KVMPQ 171
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG-----------DFG 805
IS A+ + ++ +H IH D+KP N +L N D G
Sbjct: 172 GLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 806 LARLRQEVPNNQ 817
+ + P
Sbjct: 229 QSIDMKLFPKGT 240
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 31/165 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVR---V 705
IG G++G VYK G +VA+K + L + G + E L+ + H N+V+ V
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISIA 763
I + + + LV++++ L+ ++ DA T I++ LL+
Sbjct: 71 IHTENKL--------YLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQ----- 114
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H H +H DLKP N+L++ + DFGLAR
Sbjct: 115 -----GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 40/167 (23%), Positives = 67/167 (40%), Gaps = 27/167 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVI 706
+G G FG+VY ++ I+A+KVL L+ +G E ++RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS--IAI 764
F L+ ++ P G L L ++ E+ S
Sbjct: 81 NY-----FHDRKRIYLMLEFAPRGELYKEL--------------QKHGRFDEQRSATFME 121
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811
++A A+ Y H IH D+KP N+L+ + DFG +
Sbjct: 122 ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 49/181 (27%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN----LQLQGASKSFAAECRALRNIRHRNLVR- 704
L+G GS+G V + A+K+L ++ + E + LR +RH+N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS- 761
V+ + +V +Y G E +L+ +
Sbjct: 72 VDVLYNEEKQKM------YMVMEYCVCGMQE----------------------MLDSVPE 103
Query: 762 --IAIDVA--------SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811
+ A ++YLH +H D+KP N+LL T + G+A
Sbjct: 104 KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 812 E 812
Sbjct: 161 P 161
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 33/165 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVR---V 705
+G G++G VYK D G IVA+K + L + G + E L+ + H N+V V
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISIA 763
I S + LV+++M L+ L + D + I+ LL
Sbjct: 88 IHSERCL--------TLVFEFMEK-DLKKVLDENKTGLQDSQ---IKIYLYQLLR----- 130
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V + H H +H DLKP N+L++++ + DFGLAR
Sbjct: 131 -----GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 30/166 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVR---VI 706
+G G++ +VYKG G VA+K + L + G + E ++ ++H N+VR VI
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLT--LLERISI 762
+ + + LV+++M N L+ ++ E + ++ LL+
Sbjct: 73 HTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ---- 119
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H + +H DLKP N+L++ +GDFGLAR
Sbjct: 120 ------GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 28/163 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK--VLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG GS+G V+K G IVAIK + + K E R L+ ++H NLV ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68
Query: 709 CSSID-FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISIAID 765
+ F+ LV++Y + ++ + L D + E ++++T L+
Sbjct: 69 ----EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPE-HLVKSITWQTLQ------- 113
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
AV++ H H IH D+KP NIL+ + + DFG AR
Sbjct: 114 ---AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 41/172 (23%), Positives = 74/172 (43%), Gaps = 31/172 (18%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRN 701
+ + +G G++ +VYKG +VA+K + L+ + GA + E L++++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 702 LVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--L 756
+V +I + S+ LV++Y+ L+ +L ++ L
Sbjct: 62 IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQL 109
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L + Y H +H DLKP N+L++ + DFGLAR
Sbjct: 110 LR----------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 8e-16
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 32/165 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVR---V 705
IG G++G+V+K IVA+K + L G S E L+ ++H+N+VR V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERISIA 763
+ S + LV+++ L+ + E +++ LL+
Sbjct: 70 LHSDKKL--------TLVFEFCDQ-DLKKYFDSCNGDLDPEI---VKSFLFQLLK----- 112
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H +H DLKP N+L++ N + +FGLAR
Sbjct: 113 -----GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 37/167 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVR---V 705
IG G++G VYK + G A+K + L+ + G + E L+ ++H N+V+ V
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLT--LLERIS 761
I + + LV++++ L+ L + ++ LL
Sbjct: 69 IHTKKRL--------VLVFEHLDQ-DLKKLLDVCEGGLES-----VTAKSFLLQLLN--- 111
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ Y H +H DLKP N+L++ + DFGLAR
Sbjct: 112 -------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 23/164 (14%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
F +G GS+GSVYK G IVAIK + ++ + E ++ ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS-IA 763
S + N +V +Y GS+ D I ++ E + I+ I
Sbjct: 89 YYGS-----YFKNTDLWIVMEYCGAGSVS-----DIIRLRNKTLTE-------DEIATIL 131
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
++YLH IH D+K NILL+ A + DFG+A
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 30/170 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI---------RHR 700
IG+G++G+VYK G VA+K + + G +R + H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP--ISTVREVALLRRLEAFEHP 74
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLE 758
N+VR++ C++ LV++++ L +L D P + I++L L
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLR 131
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+D+LH +C +H DLKP NIL+ + T + DFGLAR
Sbjct: 132 ----------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 35/168 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKS---FAA--ECRALRNIRHRNLVR- 704
+G G F +VYK IVAIK + L + +K A E + L+ + H N++
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 705 --VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLERI 760
S+I +LV+ +M LE + +++ T I+ L+
Sbjct: 78 LDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQ-- 123
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
++YLH H +H DLKP+N+LLD N + DFGLA+
Sbjct: 124 --------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 34/172 (19%)
Query: 645 FSSTHLIGIGSFGS-VYKGTFDRDGTIVAIKVLNLQ-LQGASKSFAAECRALRNI-RHRN 701
F ++G G+ G+ VY+G FD VA+K + + A + E + LR H N
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFADR----EVQLLRESDEHPN 79
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++R + + F+ + + +L+ + + Q D + LE I+
Sbjct: 80 VIRYFCT-----EKDRQFQYIAIELCA-ATLQ-----EYVEQKDFAHLG------LEPIT 122
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-----NLTAHVGDFGLAR 808
+ S + +LH +H DLKP NIL+ + A + DFGL +
Sbjct: 123 LLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 40/168 (23%), Positives = 72/168 (42%), Gaps = 30/168 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA--ECRALRNIRHRNLVR---V 705
IG G+FG V+K + G VA+K + ++ + A E + L+ ++H N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 706 ITSCSSIDFQGNDFKALVYQYMPN---GSLENWLHPDAIPQTDEENDEIRNLT--LLERI 760
+ +S + LV+ + + G L N EI+ + LL
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQMLLN-- 135
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ Y+H + +H D+K +N+L+ + + DFGLAR
Sbjct: 136 --------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 34/168 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVR---V 705
+G G++G VYK VAIK + L+ + G + E L+ ++HRN++ V
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
I + L+++Y N L+ ++ D+ ++++ S
Sbjct: 102 IHHNHRL--------HLIFEYAEN-DLKKYM------------DKNPDVSMRVIKSFLYQ 140
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG-----DFGLAR 808
+ + V++ H +H DLKP N+LL + + DFGLAR
Sbjct: 141 LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 37/188 (19%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLF 411
N++ ++ + L+S+ ++I N+++ V + L + L L
Sbjct: 18 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 73
Query: 412 QNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP 469
N L+ +I ++++ + L N + + + +LK L+ + N +S +I
Sbjct: 74 GNKLT-----DIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 125
Query: 470 SEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYL 528
+ L+ +Y+ N + + + L L L + L N +S I L L L+ L
Sbjct: 126 G-LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 180
Query: 529 NLSFNDLE 536
LS N +
Sbjct: 181 YLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 50/325 (15%), Positives = 113/325 (34%), Gaps = 40/325 (12%)
Query: 236 FPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLA 295
FP + L ++ S+ + +++ S + +
Sbjct: 15 FPD--DAFAETIKDN-LKKKSVTDAV-TQNELNSIDQIIANNSDIKS--------VQGIQ 62
Query: 296 NCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355
N++ L L N+ I + L +L + +D N+ + + + L+
Sbjct: 63 YLPNVTKLFLNGNKLT----------DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLK 109
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
L+ L++ HN +S +I + +L L L LGNN ++ + + L L +L L L N +
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 165
Query: 416 SGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIG 473
S +I ++ ++ +L ++NH+ + + LK L + + S + +
Sbjct: 166 S-----DIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 218
Query: 474 SCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFN 533
+ + + P + D + ++ + +S + +
Sbjct: 219 NLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276
Query: 534 DLEGQVPTKGIFANASAISVSGNSN 558
G+V + V G
Sbjct: 277 RFHGRVTQPLKEVYTVSYDVDGTVI 301
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 58/313 (18%), Positives = 112/313 (35%), Gaps = 22/313 (7%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+L K + Q L+ + +I +N+ I+ + G I L + L+L+ N L
Sbjct: 23 TIKDNL-KKKSVTDAVTQ-NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 78
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITS 153
+I L+ L L+L NK++ + S L LK L+++ N ++ I L ++
Sbjct: 79 -DIK-PLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT----IPPSIYNLSLLANFSVPENRLHG 209
LE++ L N + + L +L +L +L L I P + L+ L N + +N +
Sbjct: 133 LESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS- 188
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKS 269
L GL NL + ++ + SN +++ + ++ D
Sbjct: 189 DLRALAGLK--NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGD 244
Query: 270 LAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK 329
NV + F + + + Q + K
Sbjct: 245 YEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTK 304
Query: 330 LVSLYLIEMDHNQ 342
+ + I
Sbjct: 305 VEAGTRITAPKPP 317
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 5e-13
Identities = 45/295 (15%), Positives = 94/295 (31%), Gaps = 55/295 (18%)
Query: 126 SLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG 185
+ + +++ ++T + + S++ I + + ++ + L + L L G
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN 245
I L+ L N L L ++ +S+ +
Sbjct: 75 NKLTDIKPLTNLKNLGW--------------LFLDENKIKDLSS----------LKDLKK 110
Query: 246 LQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNL 305
L+SL L +N ++ + L L + N + + I L+ + L L+L
Sbjct: 111 LKSLS-LEHNGISDIN-GLVHLPQLESLYLGNNKI--------TDITVLSRLTKLDTLSL 160
Query: 306 VANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHN 365
NQ I + L L + + N ++ L+NL L +
Sbjct: 161 EDNQIS----------DI-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQ 207
Query: 366 QLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS----LGNLKQLALLHLFQNDLS 416
+ + + NL + + +L S L F N++S
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 39/196 (19%)
Query: 645 FSSTHLIGIGSFGSV-YKGTFDRDGTIVAIKVLNLQ-LQGASKSFAAECRALR-NIRHRN 701
S ++G GS G+V ++G+F G VA+K + + A E + L + H N
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCDIALM----EIKLLTESDDHPN 70
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++R S + F + + N +L+ D + + ++ ++ IS
Sbjct: 71 VIRYYCS-----ETTDRFLYIALELC-NLNLQ-----DLVESKNVSDENLKLQKEYNPIS 119
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-------------NLTAHVGDFGLAR 808
+ +AS V +LH IH DLKP NIL+ NL + DFGL +
Sbjct: 120 LLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 809 LRQEVPNNQSSSVGDL 824
+ + QSS +L
Sbjct: 177 K---LDSGQSSFRTNL 189
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 32/165 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIK--VLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G GS+G V K G IVAIK + + + K E + L+ +RH NLV ++
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL-- 90
Query: 709 CSSID-FQGNDFKALVYQYMPNGSLENWL--HPDAIPQTDEENDEIRNLT--LLERISIA 763
+ + LV++++ + ++ + L P+ + ++ ++
Sbjct: 91 ----EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDY-----QVVQKYLFQIIN----- 135
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ + H H IH D+KP NIL+ + + DFG AR
Sbjct: 136 -----GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 44/171 (25%), Positives = 80/171 (46%), Gaps = 33/171 (19%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR-- 704
+G+G+FG V G G VA+K+LN ++ E + L+ RH ++++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 705 -VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
VI++ + +V +Y+ G L +++ ++ + E +
Sbjct: 78 QVISTPTDF--------FMVMEYVSGGELFDYI--------------CKHGRVEEMEARR 115
Query: 764 I--DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ + SAVDY H H +H DLKP N+LLD ++ A + DFGL+ + +
Sbjct: 116 LFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 18/202 (8%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ + L++ N L SF + L L L + + + +L L+ L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGS 474
++ F+ L +L S+ G+LK L+ V+ N +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP--E 143
Query: 475 CFY----LQEIYMAENFFRGSIP----SSLVSLKDLR-EIDLSQNNLSGKIPISLERLPL 525
F L+ + ++ N + SI L + L +DLS N ++ P + + + L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 526 EYLNLSFNDLEGQVPTKGIFAN 547
+ L L N L+ VP GIF
Sbjct: 203 KELALDTNQLK-SVP-DGIFDR 222
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 15/191 (7%)
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPS-SFGNLSSLVKLIL 386
L ++++ + + I + L +L L + N + + +F LSSL KL+
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107
Query: 387 GNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS--DSLNFARNHLVGSI 444
NL+ + +G+LK L L++ N + E F S+++ + L+ + N + SI
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF--SNLTNLEHLDLSSNKIQ-SI 164
Query: 445 PPKI----GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPS-SLVSL 499
+ +L + + S N I L+E+ + N + S+P L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRL 223
Query: 500 KDLREIDLSQN 510
L++I L N
Sbjct: 224 TSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 54/207 (26%), Positives = 81/207 (39%), Gaps = 14/207 (6%)
Query: 35 TVLDLKSKGLIGSLSP-QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
LDL S + L + L+ + LS IQ G L L L L+ N +
Sbjct: 31 KNLDL-SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTG-GIPHFLGNI 151
G S S L L L S+ + L LKEL + N + +P + N+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 152 TSLEAISLAYN---SLGGNIPSSLGQLKELK-SLGLGG----TIPPSIYNLSLLANFSVP 203
T+LE + L+ N S+ L Q+ L SL L I P + L ++
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALD 208
Query: 204 ENRLHGSLPPSLGLTLSNLQLFQISNN 230
N+L S+P + L++LQ + N
Sbjct: 209 TNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 58/283 (20%), Positives = 90/283 (31%), Gaps = 83/283 (29%)
Query: 109 LYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNI 168
L L N L F S L+ L + + I
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-------------------------TI 67
Query: 169 PSSL-GQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI 227
L L +L L G N + SL LS+LQ
Sbjct: 68 EDGAYQSLSHLSTLILTG-------------------NPIQ-SLALGAFSGLSSLQKLVA 107
Query: 228 SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287
NL SLE + G +K+L LNVA N + S + E
Sbjct: 108 VET--------------NLASLE----------NFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYL-IEMDHNQFEGK 346
+N +NL L+L +N+ + ++ + + + ++ L L +++ N
Sbjct: 144 Y-----FSNLTNLEHLDLSSNKIQ-SIYCTDLRV-----LHQMPLLNLSLDLSLNPMN-F 191
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
I + L+ L + NQL F L+SL K+ L N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 46/169 (27%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECRALRNIRHRN 701
FS IG GSFG+VY R+ +VAIK ++ + ++ + E R L+ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ + LV +Y + D + E+ L E
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCLGSAS------DLL--------EVHKKPLQEV-E 155
Query: 762 IAI---DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
IA + YLH IH D+K NILL +GDFG A
Sbjct: 156 IAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 51/312 (16%), Positives = 112/312 (35%), Gaps = 55/312 (17%)
Query: 99 NLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAIS 158
+ I + G++ + L + L+ +T I + + +L +
Sbjct: 14 PDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLE 69
Query: 159 LAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLT 218
L N + ++ + L L ++ L L G + N+S +A
Sbjct: 70 LKDNQIT-DL-APLKNLTKITELELSGN---PLKNVSAIAG------------------- 105
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
L +++ +++ + PL + SNLQ L L N +S + +L YL++
Sbjct: 106 LQSIKTLDLTSTQITDVTPL--AGLSNLQVLY-LDLNQITNIS-PLAGLTNLQYLSIGNA 161
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338
+ + LAN S L+ L N+ I S + L +L + +
Sbjct: 162 QVSD--------LTPLANLSKLTTLKADDNKIS----------DI-SPLASLPNLIEVHL 202
Query: 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
+NQ ++ NL + + + ++ + NL ++ + + + P++
Sbjct: 203 KNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPAT 258
Query: 399 LGNLKQLALLHL 410
+ + A +L
Sbjct: 259 ISDNGTYASPNL 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 45/240 (18%), Positives = 91/240 (37%), Gaps = 30/240 (12%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
+ A+ ++ L+ +I + L +L +E+ NQ
Sbjct: 34 TVTQADLDGITTLSAFGTGVT----------TI-EGVQYLNNLIGLELKDNQITD--LAP 80
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+ L + L + N L S+ L S+ L L + ++ V P L L L +L+L
Sbjct: 81 LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136
Query: 411 FQNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
N ++ I ++ +++ L+ + + P + NL L N +S +I
Sbjct: 137 DLNQIT-----NISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DI 188
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYL 528
S + S L E+++ N S S L + +L + L+ ++ + L + +
Sbjct: 189 -SPLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 55/326 (16%), Positives = 122/326 (37%), Gaps = 61/326 (18%)
Query: 126 SLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG 185
+L N ++A ++N+T + ++ + +S + I + L L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN 245
I +L+ L N L+ + ++S N + + +
Sbjct: 73 N---QITDLAPLKN-------------------LTKITELELSGNPLKNVSAI--AGLQS 108
Query: 246 LQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNL 305
+++L+ L + ++ + +L L + +N + + I LA +NL +L++
Sbjct: 109 IKTLD-LTSTQITDVT-PLAGLSNLQVLYLDLNQI--------TNISPLAGLTNLQYLSI 158
Query: 306 VANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHN 365
Q + + + L L ++ D N+ I ++ L NL +++++N
Sbjct: 159 GNAQVS----------DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNN 205
Query: 366 QLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
Q+S S N S+L + L N ++ NL ++
Sbjct: 206 QISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG--------APIA 255
Query: 426 ISHMSDSLNFARNHLVGSIPPKIGNL 451
+ +SD+ +A +L ++ I N+
Sbjct: 256 PATISDNGTYASPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 46/248 (18%), Positives = 90/248 (36%), Gaps = 33/248 (13%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
I +N + + L + + I E
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD-----------TVTQADLDGITTLSAFGTGVT-TI-EG 58
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+ L NL L ++ NQ++ + NL+ + +L L N L V S++ L+ + L L
Sbjct: 59 VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL 114
Query: 411 FQNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
++ ++ ++ +S+ L N + +I P + L L+ + + +S
Sbjct: 115 TSTQIT-----DVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL- 166
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEY 527
+ + + L + +N I S L SL +L E+ L N +S P L L
Sbjct: 167 -TPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 528 LNLSFNDL 535
+ L+ +
Sbjct: 222 VTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 54/252 (21%), Positives = 92/252 (36%), Gaps = 23/252 (9%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+ K + +L + + + I G + L L L L N +
Sbjct: 21 AIKIAA-GKSNVTDTVT-QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITS 153
++ L +++ L L N L S L ++K L + +T P L +++
Sbjct: 77 -DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSN 130
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGS 210
L+ + L N + NI S L L L+ L +G + + NLS L +N++
Sbjct: 131 LQVLYLDLNQI-TNI-SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS-D 187
Query: 211 LPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270
+ P L NL + NN S PL +N SNL + + + +L
Sbjct: 188 ISPLASLP--NLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTIT---NQPVFYNNNL 240
Query: 271 AYLNVAINNLGS 282
NV G+
Sbjct: 241 VVPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 49/282 (17%), Positives = 106/282 (37%), Gaps = 24/282 (8%)
Query: 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
+T L G + ++ + L+ L + L +N I + + L ++ L LS N L
Sbjct: 42 GITTLSAFGTG-VTTIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL 97
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
+ ++ + L L ++ + + L NL+ L + N +T P L +T
Sbjct: 98 --KNVSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQITNISP--LAGLT 151
Query: 153 SLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT----IPPSIYNLSLLANFSVPENRLH 208
+L+ +S+ + ++ + L L +L +L I P + +L L + N++
Sbjct: 152 NLQYLSIGNAQV-SDL-TPLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQIS 208
Query: 209 GSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS-VNFGDM 267
+ P + NL + ++N + +NL ++ ++ D
Sbjct: 209 -DVSPLANTS--NLFIVTLTNQTITNQPVFYN---NNLVVPNVVKGPSGAPIAPATISDN 262
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
+ A N+ N + +F S+ + + Q
Sbjct: 263 GTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTVTQ 304
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 22/166 (13%), Positives = 44/166 (26%), Gaps = 33/166 (19%)
Query: 650 LIGIGSFGSVYKGT---FDRDGTIVAIKVLNLQLQGASKS---FAAECRALRNIRHRNLV 703
G ++ DR VA+ ++ Q + L I +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQ---VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 704 RVITSCSSIDF-QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
RV+ D +V +++ GSL+ + + + I
Sbjct: 95 RVL------DVVHTRAGGLVVAEWIRGGSLQEVAD--------------TSPSPVGAIRA 134
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+A+A D H PS + + + +
Sbjct: 135 MQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 35/164 (21%), Positives = 60/164 (36%), Gaps = 27/164 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVR---V 705
+G G++G V VA+K++++ + ++ E + + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ L +Y G L + + PD + L
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------- 115
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ V YLH H D+KP N+LLD + DFGLA +
Sbjct: 116 --AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 36/172 (20%)
Query: 651 IGIGSFGSVYKGTFDRD-GTIVAIKVLNLQLQ--GASKSFAAECRALRNI---------R 698
IG G++G V+K ++ G VA+K + +Q G S +R +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS------TIREVAVLRHLETFE 72
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--L 756
H N+VR+ C+ LV++++ L +L D +P+ + I+++ L
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 129
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L +D+LH H +H DLKP NIL+ ++ + DFGLAR
Sbjct: 130 LR----------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 26/173 (15%), Positives = 54/173 (31%), Gaps = 20/173 (11%)
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
S ++ ++ M SL Y+ +A N+ + + N+ L
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD--------LTGIEYAHNIKDL 71
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMR 363
+ + I L +L + + +S L +L L++
Sbjct: 72 TINNIHATNY-----------NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416
H+ I + L + + L N I L L +L L++ + +
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 29/150 (19%), Positives = 56/150 (37%), Gaps = 8/150 (5%)
Query: 52 IGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111
++ L I L+N + + G I ++ L +++ +S S L L +
Sbjct: 40 EAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRI 95
Query: 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSS 171
+ L +L L I + I + + + +I L+YN +I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 172 LGQLKELKSLGLGGTIPPSIYNLSLLANFS 201
L L ELKSL + +++ + +F
Sbjct: 155 LKTLPELKSLNIQFD---GVHDYRGIEDFP 181
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 26/183 (14%), Positives = 64/183 (34%), Gaps = 16/183 (8%)
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
+ + + + + ++SL + L N N++ + + + + L +
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 414 DLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSE 471
+ IS +S+ L + P + L L + +S + I ++
Sbjct: 77 HAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 472 IGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNL 530
I + + I ++ N I L +L +L+ +++ + + +E P L L
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 531 SFN 533
Sbjct: 189 FSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 31/160 (19%), Positives = 65/160 (40%), Gaps = 14/160 (8%)
Query: 377 NLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS--DSLN 434
+ + +LG ++ + + + + +L + L ++ DL+G I + L
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--------IEYAHNIKDLT 72
Query: 435 FARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPS 494
H + P I L L + +++ + + L + ++ + SI +
Sbjct: 73 INNIHA-TNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 495 SLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFN 533
+ +L + IDLS N I L+ LP L+ LN+ F+
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 24/181 (13%), Positives = 56/181 (30%), Gaps = 31/181 (17%)
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIP 188
K + + SL I+LA ++ ++ + + +K L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI-- 76
Query: 189 PSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQS 248
N + ++ LSNL+ +I + S ++L
Sbjct: 77 -HATNYNPISG-------------------LSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116
Query: 249 LEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVAN 308
L+I + + + + ++++ N ++ I L L LN+ +
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA-------ITDIMPLKTLPELKSLNIQFD 169
Query: 309 Q 309
Sbjct: 170 G 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 32/243 (13%), Positives = 73/243 (30%), Gaps = 66/243 (27%)
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211
++ +A + Q+ L + L ++ +L+ +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANI---NVTDLTGIEY------------ 64
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271
N++ I+N + P+ S SNL+ L I+G + N + SL
Sbjct: 65 -------AHNIKDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLV 331
L+++ + S + + ++ ++L N I ++
Sbjct: 116 LLDISHSAHDD------SILTKINTLPKVNSIDLSYNG----------------AITDIM 153
Query: 332 SLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNL 391
L L L+ LN++ + + + L +L + +
Sbjct: 154 PL------------------KTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTI 193
Query: 392 SGV 394
G
Sbjct: 194 GGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 19/108 (17%), Positives = 40/108 (37%), Gaps = 3/108 (2%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
L + K + P + L+ L + +S++ I +I L ++ ++ LS+N +
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG 142
+I L L L + + + L +L + G
Sbjct: 151 DIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 34/174 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---------LQLQGASKSFAAECRALRNI-RHR 700
+G G V + A+K+++ ++Q ++ E LR + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
N++++ + ++ N F LV+ M G L D + +TL E+
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGELF-----DYL---------TEKVTLSEKE 125
Query: 761 --SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
I + + LH +H DLKP NILLD+++ + DFG +
Sbjct: 126 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 33/171 (19%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR-- 704
+G+G+FG V G + G VA+K+LN ++ E + L+ RH ++++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 705 -VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
VI++ S I +V +Y+ G L +++ +N L E+ S
Sbjct: 83 QVISTPSDI--------FMVMEYVSGGELFDYI--------------CKNGRLDEKESRR 120
Query: 764 I--DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ + S VDY H H +H DLKP N+LLD ++ A + DFGL+ + +
Sbjct: 121 LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 34/167 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR--- 704
IG G+F V G VAIK+++ L K F E R ++ + H N+V+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
VI + ++ L+ +Y G + ++L + + + E+ + +
Sbjct: 82 VIETEKTL--------YLIMEYASGGEVFDYL--------------VAHGRMKEKEARSK 119
Query: 765 --DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ SAV Y H +H DLK N+LLD ++ + DFG +
Sbjct: 120 FRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE 163
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 75.7 bits (185), Expect = 5e-14
Identities = 111/707 (15%), Positives = 195/707 (27%), Gaps = 231/707 (32%)
Query: 17 HHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGN-------LSFLREIHLSNNTIQ 69
HH D+E + K ++ + + I LS I
Sbjct: 4 HHHMDFE----------TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI-LSKEEID 52
Query: 70 G--KIPGEIGRLFRLEALYLSHNS-----LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPS 122
+ RL LS V E+ ++Y + K E PS
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL-RINY-----KFLMSPIKTEQRQPS 106
Query: 123 EFVSLYNLKELAIQENNLTGGIPHFL-GNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181
+Y Q + L F N++ L+ + +L +L+ K++
Sbjct: 107 MMTRMYIE-----QRDRLYNDNQVFAKYNVSRLQPYL--------KLRQALLELRPAKNV 153
Query: 182 ---GLGGTIPPSIYNLSLLANFSVPENRLHGSLPP-----SLG------LTLSNLQ--LF 225
G+ G+ + +A ++ + +L L LQ L+
Sbjct: 154 LIDGVLGS------GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 226 QISNNFFSGSFPLA----------------FSNASNLQSLEILGNNFFGKLSVNFGDMKS 269
QI N+ S S + + L +L N V + K+
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN-------VQ--NAKA 258
Query: 270 LAYLNVA------------INNLGSGESDEMSFIH---SLANCSNLSFLNLVANQFKGAL 314
N++ + L + + +S H +L S L + L
Sbjct: 259 WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 315 PHSIVSGSIP---SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI 371
P +++ + P S I + + + ++ N + +N ++L+ I
Sbjct: 319 PREVLTTN-PRRLSIIAESIR----------------DGLATWDNWKHVN--CDKLTTII 359
Query: 372 PSSFGNLSS------LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
SS L +L + + IP+ LL L D+ + + N
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAH--IPT--------ILLSLIWFDVIKSDVMVVVN 409
Query: 426 ISHMSDSLNFARNHLVGSIP-------PKIGNLKVLRMFVVSSNNL------SGEIPSEI 472
H + SIP K+ N L +V N+ IP +
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYL 469
Query: 473 GSCFY------LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLE 526
FY L+ I E +
Sbjct: 470 DQYFYSHIGHHLKNIEHPERM---------------------------------TLFRMV 496
Query: 527 YLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRGV 586
+L+ F LE ++ NAS N L QL K Y+
Sbjct: 497 FLDFRF--LEQKIRHDSTAWNAS----GSILNTL------QQL-----------KFYK-- 531
Query: 587 LKVIISTCSVFSGLL--LGSFFIFYWLRRRGGSG-KEPSEPILRRAL 630
I + L+ + F L + + +LR AL
Sbjct: 532 -PYICDNDPKYERLVNAILDF-----LPKIEENLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 36/254 (14%), Positives = 80/254 (31%), Gaps = 54/254 (21%)
Query: 601 LLGSFFIFYWLRRRG--------GSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIG 652
+ G+ +F+ L + + L ++ + + T +
Sbjct: 61 VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM-TRMYIEQRDRL 119
Query: 653 IGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-----------GASKS-FAAE-CRALRNIRH 699
K R + ++ L+L+ G+ K+ A + C + + ++
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK-VQC 178
Query: 700 RNLVRV----ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQ-TDEENDEIRNL 754
+ ++ + +C+S + + L+YQ PN + H I E+R L
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT-SRSDHSSNIKLRIHSIQAELRRL 237
Query: 755 TLLERISIAI----DVASA--VDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFG 805
+ + +V +A + + C+ ILL +T DF
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCK------------ILLTTRFKQVT----DFL 281
Query: 806 LARLRQEVPNNQSS 819
A + + S
Sbjct: 282 SAATTTHISLDHHS 295
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 2e-07
Identities = 58/472 (12%), Positives = 121/472 (25%), Gaps = 170/472 (36%)
Query: 348 PEEMSRLQN-LQFLNMRHNQ------LSGEIPSSFGNLSSLVKLILGNNNLSGVIPS--- 397
+ +L+ L +R + + G G + + + + + +
Sbjct: 134 LQPYLKLRQALL--ELRPAKNVLIDGVLG-----SGK-TWVALDVCLSYKVQCKMDFKIF 185
Query: 398 --SLGN-------LKQL-ALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
+L N L+ L LL+ + + + + NI S+ L+ S P +
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 448 --------IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
+ N K F NLS C L++
Sbjct: 245 NCLLVLLNVQNAKAWNAF-----NLS---------C------------------KILLTT 272
Query: 500 KDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEGQVPTKGIFANASAISVSGNSNR 559
+ + D LS + L++ +++ E K +
Sbjct: 273 RFKQVTDF----LSAATT---THISLDHHSMTLTPDE----VKSLLLKYLDCRPQDLPRE 321
Query: 560 LCGGIP--------ELQLPKCPKNNSRNHKVYRGVLKVIISTCSVFSGL-------LLGS 604
+ P ++ +N ++ + L II + + L +
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESS--LNVLEPAEYRKMFDR 377
Query: 605 FFIF-------------YWLRRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLI 651
+F W K ++ + + SL++ ST
Sbjct: 378 LSVFPPSAHIPTILLSLIW----FDVIKSDVMVVVNKLHKY----SLVEK-QPKESTI-- 426
Query: 652 GIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR--VITSC 709
S+ ++ L + + HR++V I
Sbjct: 427 ------SIP----------------SIYL-----ELKVKLENEYAL-HRSIVDHYNIPKT 458
Query: 710 SSIDFQGNDFKAL-----VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
F +D Y ++ + H I E R + L
Sbjct: 459 ----FDSDDLIPPYLDQYFYSHIGH-------HLKNIEHP-ERMTLFRMVFL 498
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 35/164 (21%), Positives = 60/164 (36%), Gaps = 27/164 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNLVR---V 705
+G G++G V VA+K++++ + ++ E + + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ L +Y G L + + PD + L
Sbjct: 74 RREGNIQ--------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM---------- 115
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ V YLH H D+KP N+LLD + DFGLA +
Sbjct: 116 --AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 30/235 (12%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
I S + NL +L S+ I +++ + + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTD-----------AVTQNELNSIDQIIANNSDIK-SV-QG 63
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+ L N+ L + N+L+ +I NL +L L L N + + SSL +LK+L L L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSL 119
Query: 411 FQNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
N +S +I + H+ SL N + I + L L + N +S +I
Sbjct: 120 EHNGIS-----DINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI 171
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL 523
+ LQ +Y+++N S +L LK+L ++L K L
Sbjct: 172 -VPLAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLELFSQECLNKPINHQSNL 223
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 37/188 (19%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLF 411
N++ ++ + L+S+ ++I N+++ V + L + L L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76
Query: 412 QNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP 469
N L+ +I ++++ + L N + + + +LK L+ + N +S +I
Sbjct: 77 GNKLT-----DIKPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 128
Query: 470 SEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYL 528
+ L+ +Y+ N + + + L L L + L N +S I L L L+ L
Sbjct: 129 G-LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 183
Query: 529 NLSFNDLE 536
LS N +
Sbjct: 184 YLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 18/230 (7%)
Query: 54 NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113
+ + +L ++ + L ++ + +++ + + G + Y + L+L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLG 173
NKL I +L NL L + EN + L ++ L+++SL +N + + + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SDINGLV 131
Query: 174 QLKELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNN 230
L +L+SL LG T + L+ L S+ +N++ + P GLT LQ +S N
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIVPLAGLT--KLQNLYLSKN 188
Query: 231 FFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNL 280
S L + NL LE+ K + ++ + +L
Sbjct: 189 HISDLRAL--AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 42/288 (14%), Positives = 95/288 (32%), Gaps = 53/288 (18%)
Query: 126 SLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG 185
+ + +++ ++T + + S++ I + + ++ + L + L L G
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN 245
I L+ L N L L ++ +S+ +
Sbjct: 78 NKLTDIKPLANLKNLGW--------------LFLDENKVKDLSS----------LKDLKK 113
Query: 246 LQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNL 305
L+SL L +N ++ + L L + N + + I L+ + L L+L
Sbjct: 114 LKSLS-LEHNGISDIN-GLVHLPQLESLYLGNNKI--------TDITVLSRLTKLDTLSL 163
Query: 306 VANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHN 365
NQ I + L L + + N + ++ L+NL L +
Sbjct: 164 EDNQIS----------DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQ 210
Query: 366 QLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
+ + + NL + + +L V P + + ++ +
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 28/120 (23%), Positives = 49/120 (40%), Gaps = 7/120 (5%)
Query: 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS 104
I ++ + +L L ++L NN I I + RL +L+ L L N + +I L+ +
Sbjct: 124 ISDING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLT 178
Query: 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164
+L LYL +N + + L NL L + + N+ + SL
Sbjct: 179 KLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 24/168 (14%)
Query: 651 IGIGSFGSVYKGTF--DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR---V 705
+G G++G VYK +D A+K + G S S E LR ++H N++ V
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKV 86
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
S + L++ Y + L + + + + N + L S+
Sbjct: 87 FLSHADRKV------WLLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH----VGDFGLARL 809
+ + YLH + +H DLKP+NIL+ + D G ARL
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 37/216 (17%)
Query: 612 RRRGGSGKEPSEPILRRALRKVSYESLLKATDGFSST----HLIGIGSFGSVYKGTFDRD 667
++ + + +E + +++ A F +IG G V +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 668 GTIVAIKVLNL--------QLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718
G A+K++ + QL+ ++ E LR + H +++ +I S ++ +
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSS 173
Query: 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDVASAVDYLHHH 776
F LV+ M G L D + + L E+ SI + AV +LH +
Sbjct: 174 FMFLVFDLMRKGELF-----DYL---------TEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 777 CQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+H DLKP NILLD+N+ + DFG + +
Sbjct: 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 27/168 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
++G G+F V+ G + A+K + S E L+ I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIAIDVA 767
++ LV Q + G L D I + E+ + V
Sbjct: 75 ----YESTTHYYLVMQLVSGGELF-----DRI---------LERGVYTEKDASLVIQQVL 116
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
SAV YLH + +H DLKP N+L + N + DFGL+++ Q
Sbjct: 117 SAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 40/188 (21%), Positives = 69/188 (36%), Gaps = 49/188 (26%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAA----------------- 689
IG GS+G V + D T A+KVL+ L Q
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 690 ------ECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQ 743
E L+ + H N+V+++ +D D +V++ + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVM---------- 126
Query: 744 TDEENDEIRNLTLLERISIAI--DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801
+ L E + D+ ++YLH+ IH D+KPSN+L+ + +
Sbjct: 127 -----EVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKI 178
Query: 802 GDFGLARL 809
DFG++
Sbjct: 179 ADFGVSNE 186
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 43/191 (22%), Positives = 70/191 (36%), Gaps = 32/191 (16%)
Query: 630 LRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIK-VLNLQLQGASKSFA 688
+ E K D F + G G+FG+V G G VAIK V+ F
Sbjct: 10 AAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFR 63
Query: 689 ----AECRALRNIRHRNLVR---VITSCSSIDFQGND-FKALVYQYMPNGSLENWLHPDA 740
+ L + H N+V+ + D D + +V +Y+P+ +L
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR--RDIYLNVVMEYVPD-TLHRCCRNYY 120
Query: 741 IPQTDEENDEIRNLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNL 797
Q I+ L+ ++ LH H D+KP N+L++ +
Sbjct: 121 RRQVAPPPILIKVFLFQLIR----------SIGCLHLPSVN-VCHRDIKPHNVLVNEADG 169
Query: 798 TAHVGDFGLAR 808
T + DFG A+
Sbjct: 170 TLKLCDFGSAK 180
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 43/233 (18%), Positives = 77/233 (33%), Gaps = 30/233 (12%)
Query: 187 IPPSIYNLSLLANF--SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL-AFSNA 243
+P + L + + + G +L+ +IS N FSN
Sbjct: 28 LPRNAIELRFVLTKLRVIQKGAFSG---------FGDLEKIEISQNDVLEVIEADVFSNL 78
Query: 244 SNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSF 302
L + I N ++ F ++ +L YL ++ + IHSL
Sbjct: 79 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV--HKIHSL----QKVL 132
Query: 303 LNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSR-LQNLQFLN 361
L++ N + S + V L+L + N + +I Q +
Sbjct: 133 LDIQDNINIHTIER----NSFVGLSFESVILWL---NKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 362 MRHNQLSGEIPS-SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
+N L E+P+ F S V L + + + L NLK+L +
Sbjct: 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 40/220 (18%), Positives = 80/220 (36%), Gaps = 18/220 (8%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSS-FGNLS 379
IPS++ + + + I + S +L+ + + N + I + F NL
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 380 SLVKL-ILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARN 438
L ++ I NNL + P + NL L L + + +P+ S L+ N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 439 HLVGSIPPKI-----GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIP 493
+ +I +L + + N + EI + + L E+ +++N +P
Sbjct: 139 INIHTIERNSFVGLSFESVILWL---NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 494 S-SLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLS 531
+ +D+S+ + LE L L +
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 49/335 (14%), Positives = 84/335 (25%), Gaps = 89/335 (26%)
Query: 83 EALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG 142
+ + EIP +L I L KL F +L+++ I +N++
Sbjct: 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 143 GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV 202
I L +L + +
Sbjct: 69 VIE-----------------------ADVFSNLPKLHEIRIEKA---------------- 89
Query: 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSV 262
N L + P L NLQ ISN + ++ L+I N +
Sbjct: 90 --NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 263 NFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGS 322
N + L L L N +
Sbjct: 147 N------------SFVGL----------------SFESVILWLNKNGIQ----------E 168
Query: 323 IPSEIGKLVSL-YLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
I + L L D+N E ++P ++ L++ ++ NL
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 227
Query: 381 LVKLILGNNNLSGVIP-SSLGNLKQLALLHLFQND 414
L NL + L L + +L +
Sbjct: 228 LR--ARSTYNLKKLPTLEKLVALMEASLTYPSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 36/232 (15%), Positives = 71/232 (30%), Gaps = 38/232 (16%)
Query: 201 SVPENRLHGSLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259
+P + LP + L +L I AFS +L+ +EI N+
Sbjct: 23 EIPSD-----LPRNAIELRFVLTKLRVIQKG--------AFSGFGDLEKIEISQNDVLEV 69
Query: 260 LSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHS--LANCSNLSFLNLVANQFKGALPH 316
+ + F ++ L + + N + +I+ N NL +L + K
Sbjct: 70 IEADVFSNLPKLHEIRIEKAN-------NLLYINPEAFQNLPNLQYLLISNTGIK----- 117
Query: 317 SIVSGSIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSR--LQNLQFLNMRHNQLSGEIPS 373
+P + L+++ N I L + N + S
Sbjct: 118 -----HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNS 172
Query: 374 SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
+F + NNNL + +L + + + ++P
Sbjct: 173 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 43/251 (17%), Positives = 73/251 (29%), Gaps = 23/251 (9%)
Query: 20 CDWEGITCSPRH--RRVTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEI 76
C +T P R L + + L +I +S N + I ++
Sbjct: 16 CQESKVTEIPSDLPRNAIELRF-VLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 77 -GRLFRLEALYLSHNSLVGEIPGN-LSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKEL 133
L +L + + + + I L L + ++ +P + L
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 134 AIQENNLTGGIPH--FLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG-----T 186
IQ+N I F+G + L N + I +S +L L L
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEE 192
Query: 187 IPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN 245
+P + + S + R+H SLP L L+ N P
Sbjct: 193 LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVA 247
Query: 246 LQSLEILGNNF 256
L L
Sbjct: 248 LMEAS-LTYPS 257
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 33/168 (19%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAA-----ECRALRNIRHRNL 702
+G G+FG V+ V +K + + + E L + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 703 VR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
++ + + LV + +G L+ + D P+ DE
Sbjct: 92 IKVLDIFENQGFF--------QLVMEKHGSG-LDLFAFIDRHPRLDE--PLASY------ 134
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
I + SAV YL IH D+K NI++ + T + DFG A
Sbjct: 135 --IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 43/209 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-----KSFAAECRALRNIRHRNLVRV 705
IG GS+G V ++ I AIK++N + E R ++ + H N+ R+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSL--------------------------ENWLHPD 739
++ + LV + G L + +
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 740 AIPQTDEENDEIRNLTLLERISIAI--DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797
AI + E + E++ I + SA+ YLH+ H D+KP N L N
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 798 TAHV--GDFGLARLRQEVPNNQSSSVGDL 824
+ + DFGL++ ++ N + +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
+G G+FG V+ G IK +N + Q + AE L+++ H N++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
F+ +V + G L + I + L+ + + +A
Sbjct: 89 ----FEDYHNMYIVMETCEGGELL-----ERI---VSAQARGKALSEGYVAELMKQMMNA 136
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
+ Y H +H DLKP NIL + + + DFGLA
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 34/171 (19%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVR-- 704
+G GSFG V T + VA+K ++ L+ E L+ +RH ++++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 705 -VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
VIT+ + I +V +Y G L +++ + + E
Sbjct: 76 DVITTPTDI--------VMVIEYA-GGELFDYI--------------VEKKRMTEDEGRR 112
Query: 764 I--DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ A++Y H H +H DLKP N+LLD+NL + DFGL+ + +
Sbjct: 113 FFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 36/177 (20%), Positives = 68/177 (38%), Gaps = 36/177 (20%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLN--------LQLQGASKSFAAECRALRNIRHR 700
+G G+ G V + VAI++++ + + + E L+ + H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
++++ + D+ +V + M G L + + + N L E
Sbjct: 201 CIIKIKNFFDAEDYY------IVLELMEGGELFDKV--------------VGNKRLKEAT 240
Query: 761 S--IAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
+ AV YLH + IH DLKP N+LL + + + DFG +++ E
Sbjct: 241 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 26/211 (12%)
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNF 264
R +LPP L + L L S N + L L L KL V
Sbjct: 19 KRNLTALPPDLPKDTTILHL---SENLLYTFSLATLMPYTRLTQLN-LDRAELTKLQV-D 73
Query: 265 GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324
G + L L+++ N L S L+ L++ N+ +LP + G
Sbjct: 74 GTLPVLGTLDLSHNQLQSLPL-------LGQTLPALTVLDVSFNRLT-SLPLGALRG--- 122
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSS-FGNLSSLV 382
+G+L LYL N+ + +P + + L+ L++ +N L+ E+P+ L +L
Sbjct: 123 --LGELQELYL---KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175
Query: 383 KLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+L N+L IP L L N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 46/204 (22%), Positives = 74/204 (36%), Gaps = 19/204 (9%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
++ + L +L P + +HLS N + + RL L L L
Sbjct: 13 LEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-T 68
Query: 95 EIP--GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT 152
++ G L L L L N+L+ S+P +L L L + N LT L +
Sbjct: 69 KLQVDGTL---PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 153 SLEAISLAYNSLGGNIPSSL-GQLKELKSLGLGG----TIPPSIY-NLSLLANFSVPENR 206
L+ + L N L +P L +L+ L L +P + L L + EN
Sbjct: 125 ELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 207 LHGSLPPSLGLTLSNLQLFQISNN 230
L+ ++P L + N
Sbjct: 184 LY-TIPKGF-FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 42/190 (22%), Positives = 76/190 (40%), Gaps = 16/190 (8%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNL 357
+ + L+L N + + +L L L D + K+ + L L
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPY-----TRLTQLNL---DRAELT-KLQVD-GTLPVL 79
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
L++ HNQL +P L +L L + N L+ + +L L +L L+L N+L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 418 AIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGSCF 476
+P + + + L+ A N+L +P + L+ L ++ N+L IP
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSH 195
Query: 477 YLQEIYMAEN 486
L ++ N
Sbjct: 196 LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 45/231 (19%), Positives = 78/231 (33%), Gaps = 61/231 (26%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
++P ++ ++ + N + L LN+ +L+ ++ G L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVL 79
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L +N L +P L L +L + N L+ ++P L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL------RGL-------- 123
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSL-VSLK 500
G L+ L + N L ++P L
Sbjct: 124 -------GELQELYL---KGNELK-------------------------TLPPGLLTPTP 148
Query: 501 DLREIDLSQNNLSGKIPISL-ERLP-LEYLNLSFNDLEGQVPTKGIFANAS 549
L ++ L+ NNL+ ++P L L L+ L L N L +P KG F +
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 41/203 (20%), Positives = 71/203 (34%), Gaps = 15/203 (7%)
Query: 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT 141
+ +L +P +L L+L N L + + L +L + LT
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG----TIPPSIY-NLSL 196
+ G + L + L++N L ++P L L L + ++P L
Sbjct: 69 -KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 197 LANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL-AFSNASNLQSLEILGNN 255
L + N L +LPP L L+ ++NN + P + NL +L L N
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL-LQEN 182
Query: 256 FFGKLSVNFGDMKSLAYLNVAIN 278
+ F L + + N
Sbjct: 183 SLYTIPKGFFGSHLLPFAFLHGN 205
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 36/175 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN--------LQLQGASKSFAAECRALRNIRHRNL 702
+G G+ G V + VAIK+++ + + + E L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
+++ F D+ +V + M G L D + + N L E
Sbjct: 78 IKIKNF-----FDAEDY-YIVLELMEGGELF-----DKV---------VGNKRLKEATCK 117
Query: 763 AI--DVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
+ AV YLH + IH DLKP N+LL + + + DFG +++ E
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 41/185 (22%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI------R 698
++ T +IG GSFG VY+ G +VAIK K + R +
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLD 105
Query: 699 HRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
H N+VR SS + + + LV Y+P ++ + + ++
Sbjct: 106 HCNIVRLRYFFY--SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 756 --LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLAR-LR 810
L ++ Y+H H D+KP N+LLD + TA + DFG A+ L
Sbjct: 163 YQLF----------RSLAYIHSFG---ICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQLV 208
Query: 811 QEVPN 815
+ PN
Sbjct: 209 RGEPN 213
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 39/173 (22%), Positives = 59/173 (34%), Gaps = 45/173 (26%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR---VI 706
IG G+FG +VA+K + ++ E R++RH N+VR VI
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + + A++ +Y G L + E D
Sbjct: 86 LTPTHL--------AIIMEYASGGELYERI--------------CNAGRFSE------DE 117
Query: 767 A--------SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH--VGDFGLARL 809
A S V Y H H DLK N LLD + + DFG ++
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 21/166 (12%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
S T ++G G FG V+K G +A K++ + + E + + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ + F+ + LV +Y+ G L D I DE NLT L+ I
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELF-----DRI------IDESYNLTELDTILFMK 194
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLAR 808
+ + ++H +H DLKP NIL N + DFGLAR
Sbjct: 195 QICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 34/133 (25%), Positives = 55/133 (41%), Gaps = 6/133 (4%)
Query: 10 LNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQ 69
+D E + V VL L K L ++ + L + + LS+N ++
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR 476
Query: 70 GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEG-SIPSEFVSLY 128
+P + L LE L S N+L + G ++ RL L L N+L+ + VS
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCP 533
Query: 129 NLKELAIQENNLT 141
L L +Q N+L
Sbjct: 534 RLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 62/330 (18%), Positives = 111/330 (33%), Gaps = 16/330 (4%)
Query: 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNITSLE 155
P + S L LGR + + VS LT G L +
Sbjct: 223 PNDQSAWFYHRWL-LGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEA 281
Query: 156 AISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSL 215
+S+ + + G S L +L + L +P + + + S E L P
Sbjct: 282 PLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW 341
Query: 216 GLTLSNL-QLFQISNNFF-SGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273
+ QLF+ + S + LQ LE + + + L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401
Query: 274 NVAINN------LGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
+ + + + + S N A+ L H ++ + +
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-L 459
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
+L+ + +++ HN+ +P ++ L+ L+ L N L + NL L +L+L
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLC 516
Query: 388 NNNLSGV-IPSSLGNLKQLALLHLFQNDLS 416
NN L L + +L LL+L N L
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 28/190 (14%), Positives = 67/190 (35%), Gaps = 11/190 (5%)
Query: 348 PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407
+ + + L + + + + S + L +L N I + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 408 LHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
S + +++ + R+ + +R+ ++ +L+
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYL----DDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-- 454
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LE 526
+ + + + ++ N R ++P +L +L+ L + S N L + + LP L+
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQ 511
Query: 527 YLNLSFNDLE 536
L L N L+
Sbjct: 512 ELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 39/274 (14%), Positives = 86/274 (31%), Gaps = 58/274 (21%)
Query: 245 NLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSF--IHSLANCSNLSF 302
+ Q +L + + + L +++ +S+ S + L +
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCL 385
Query: 303 LNLVA-NQFKGALPHSIVSGSIPSEIGKLVSLYLIEMD--HNQFEGKIPEEMSRLQNLQF 359
L ++ + L + + S + + + +D ++F + +++
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
L++ H L+ + L + L L +N L +P +L L+ L +L N L
Sbjct: 446 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--- 499
Query: 420 PEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQ 479
++ + NL L+ ++ +N L
Sbjct: 500 -----------------------NVDG-VANLPRLQELLLCNNRLQQ-----------SA 524
Query: 480 EIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLS 513
I LVS L ++L N+L
Sbjct: 525 AI------------QPLVSCPRLVLLNLQGNSLC 546
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 21/159 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECR-ALRNIRHRNLVRVITS 708
IG G++GSV K G I+A+K + + K + +R+ +V+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDV 766
F+ D + + M + S + + + + + E I I +
Sbjct: 90 L----FREGDCW-ICMELM-STSFDKFYK---------YVYSVLDDVIPEEILGKITLAT 134
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
A+++L + + IH D+KPSNILLD + + DFG
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG 171
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 42/173 (24%), Positives = 57/173 (32%), Gaps = 47/173 (27%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG GS+G V A K + F E ++++ H N++R+ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI---------- 760
F+ N LV + G E L ER+
Sbjct: 75 ---FEDNTDIYLVMELCTGG-------------------E-----LFERVVHKRVFRESD 107
Query: 761 --SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
I DV SAV Y H H DLKP N L + + DFGLA
Sbjct: 108 AARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 37/190 (19%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-------SKSFAA----E 690
++ I GS+G+V G D +G VAIK + + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 691 CRALRNIRHRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE 747
R L + H N++ + + LV + M L +H I +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRT-DLAQVIHDQRIVISP-- 133
Query: 748 NDEIRNLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805
I+ +L + LH + +H DL P NILL +N + DF
Sbjct: 134 -QHIQYFMYHIL----------LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 806 LARLRQEVPN 815
LAR N
Sbjct: 180 LAREDTADAN 189
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 36/174 (20%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D F +G G+ G V+K + G ++A K+++L+++ A ++ + +R +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-----QIIREL----- 82
Query: 703 VRVITSCSS---IDFQGNDFKA----LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
+V+ C+S + F G + + ++M GSL+ L +
Sbjct: 83 -QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--------------KAGR 127
Query: 756 LLERI--SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ E+I ++I V + YL + +H D+KPSNIL+++ + DFG++
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 52/283 (18%), Positives = 89/283 (31%), Gaps = 78/283 (27%)
Query: 323 IPSEIGKLVSLYLIEMDHNQFEGKIPEEM--SRLQNLQFLNMRHNQLSGEIPS-SFGNLS 379
+PS L ++ HN ++ E +RL NL L + HN L+ I S +F +
Sbjct: 37 LPSYTALL------DLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439
+L L L +N+L + +L+ L +L L+ N + + F
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE-------------- 133
Query: 440 LVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSL 499
+ L+ L + S N +S P E+ + L
Sbjct: 134 -------DMAQLQKLYL---SQNQIS-RFPVEL---------------IKD-----GNKL 162
Query: 500 KDLREIDLSQNNLSGKIPI----SLERLPLEYLNLSFN-------------DLEGQVPTK 542
L +DLS N L K+P+ L L L N + + +
Sbjct: 163 PKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSS 221
Query: 543 GIFANASAISVSGNSNRLCGGIPELQLPKCPKNNSRNHKVYRG 585
+ + I L C + + + G
Sbjct: 222 VMDFQEDLYCMHSKKLH---NIFSLDFFNCSEYKESAWEAHLG 261
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 37/173 (21%), Positives = 63/173 (36%), Gaps = 12/173 (6%)
Query: 20 CDWEGITCSPRH--RRVTVLDLKSKGLIGSLSPQI--GNLSFLREIHLSNNTIQGKIPGE 75
C + + P+ +LDL S + L + L+ L + LS+N + I E
Sbjct: 25 CSKQQLPNVPQSLPSYTALLDL-SHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82
Query: 76 I-GRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKEL 133
+ L L LS N L S L L L N + + F + L++L
Sbjct: 83 AFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141
Query: 134 AIQENNLT---GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183
+ +N ++ + + L + L+ N L + L +L GL
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 40/182 (21%), Positives = 63/182 (34%), Gaps = 31/182 (17%)
Query: 82 LEALYLSHNSLVGEIPGN--LSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQEN 138
L LSHN+L + + + L L L N L I SE FV + NL+ L + N
Sbjct: 41 TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPS-SLGQLKELKSLGLGGTIPPSIYNLSLL 197
+L ++ +LE + L N + + + + +L+ L L
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ------------ 145
Query: 198 ANFSVPENRLHGSLPPSL---GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEI-LG 253
N++ P L G L L L +S+N + L
Sbjct: 146 -------NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
Query: 254 NN 255
NN
Sbjct: 198 NN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 10/112 (8%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEI-GRLFRLEALYLSHNSL 92
LDL S + +L + +L L + L NN I + + +L+ LYLS N +
Sbjct: 91 RYLDL-SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 93 VGEIP----GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQ-ENN 139
P + + +L+ L L NKL+ ++ L + + NN
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMK 268
++P ++ L L +N S AF + L+ L L +N L F ++K
Sbjct: 30 AIPSNIPADTKKLDL---QSNKLSSLPSKAFHRLTKLRLLY-LNDNKLQTLPAGIFKELK 85
Query: 269 SLAYLNVAINNLGS---GESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPS 325
+L L V N L + G D++ NL+ L L NQ K S+P
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLV---------NLAELRLDRNQLK----------SLPP 126
Query: 326 EI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383
+ L L + + +N+ + +P+ + +L +L+ L + +NQL +F L+ L
Sbjct: 127 RVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT 185
Query: 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L L NN L V + +L++L +L L +N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+++ L +N + RL +L LYL+ N L G L L++ NKL+
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 118 GSIPSE-FVSLYNLKELAIQENNLT---GGIPHFLGNITSLEAISLAYNSLGGNIPSSL- 172
++P F L NL EL + N L + L +T L SL YN L ++P +
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---SLGYNEL-QSLPKGVF 153
Query: 173 GQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
+L LK L L N+L +P L+ L+ ++ NN
Sbjct: 154 DKLTSLKELRLYN-------------------NQLK-RVPEGAFDKLTELKTLKLDNNQL 193
Query: 233 SGSFPLAFSNASNLQSLEILGN 254
AF + L+ L++ N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
LDL+S + SL + L+ LR ++L++N +Q G L LE L+++ N L
Sbjct: 40 KKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 94 GEIPGNL-SYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPH--FLG 149
+P + L L L RN+L+ S+P F SL L L++ N L +P F
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF-D 154
Query: 150 NITSLEAISLAYN---SLGGNIPSSLGQLKEL 178
+TSL+ + L N + L +LK L
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTL 186
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 14/179 (7%)
Query: 109 LYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT---GGIPHFLGNITSLEAISLAYNSLG 165
L L NKL F L L+ L + +N L GI L N+ +L + N L
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL---WVTDNKL- 97
Query: 166 GNIPSSL-GQLKELKSLGLGG----TIPPSIY-NLSLLANFSVPENRLHGSLPPSLGLTL 219
+P + QL L L L ++PP ++ +L+ L S+ N L SLP + L
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 220 SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
++L+ ++ NN AF + L++L++ N F ++ L L + N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 17/196 (8%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS-FGNLS 379
+IPS I L L N+ + RL L+ L + N+L +P+ F L
Sbjct: 30 AIPSNIPADTKKLDL---QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439
+L L + +N L + L LA L L +N L ++P +F+ L+ N
Sbjct: 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144
Query: 440 LVGSIPP----KIGNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPS 494
L S+P K+ +LK LR+ +N L +P L+ + + N +
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRL---YNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 495 SLVSLKDLREIDLSQN 510
+ SL+ L+ + L +N
Sbjct: 200 AFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 33/135 (24%), Positives = 53/135 (39%), Gaps = 14/135 (10%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEI-GRLFRLEALYLSHNSL 92
L + L +L + L L E+ L N ++ +P + L +L L L +N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 93 VGEIPGN----LSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHF 147
+P L+ L L L N+L+ +P F L LK L + N L
Sbjct: 146 Q-SLPKGVFDKLT---SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 148 LGNITSLEAISLAYN 162
++ L+ + L N
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 33/162 (20%), Positives = 60/162 (37%), Gaps = 25/162 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G+FG V++ G + K +N + E + + H L+ + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI--DVAS 768
F+ L+ +++ G L D I + + E I
Sbjct: 117 ---FEDKYEMVLILEFLSGGELF-----DRIAA--------EDYKMSEAEVINYMRQACE 160
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLAR 808
+ ++H H +H D+KP NI+ + + V DFGLA
Sbjct: 161 GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 29/169 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVITS 708
+G G+F V + G A K++N + A + E R R ++H N+VR+ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDV 766
Q F LV+ + G L + I + E +
Sbjct: 74 -----IQEESFHYLVFDLVTGGELF-----EDI---------VAREFYSEADASHCIQQI 114
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
++ Y H + +H +LKP N+LL + DFGLA +
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/191 (16%), Positives = 65/191 (34%), Gaps = 14/191 (7%)
Query: 356 NLQFLNMRHNQLSGEIPS-SFGNLSSLVKLIL-GNNNLSGVIPSSLGNLKQLALLHLFQN 413
+ Q L + L IPS +F NL ++ ++ + + L + S NL ++ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 414 DLSGAIPEEIFNISHMSDSLNFARNHLVGSIPP--KIGNLKVLRMFVVSSNNLSGEIPSE 471
I + + L L P K+ + + + ++ N IP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 472 I--GSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIP----ISLERLPL 525
G C + + N F S+ + L + L++N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG-P 207
Query: 526 EYLNLSFNDLE 536
L++S +
Sbjct: 208 SLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 38/231 (16%), Positives = 83/231 (35%), Gaps = 24/231 (10%)
Query: 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQIS-NNFFSGSFPLAFSNAS 244
++PPS L L E L ++P L N+ +S + +F N S
Sbjct: 28 SLPPSTQTLKL------IETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 245 NLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
+ +EI + + ++ L +L + L +++ ++S L
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM--FPDLTKVYST---DIFFIL 135
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMR 363
+ N + ++P + + ++L L +N F + L + +
Sbjct: 136 EITDNPYMTSIP----VNAFQGLCNETLTLKL---YNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 364 HNQLSGEIPS-SFGNL-SSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQ 412
N+ I +FG + S L + +++ + L +LK+L + +
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 28/204 (13%), Positives = 66/204 (32%), Gaps = 14/204 (6%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNL-SYCSRLIGLYLGRNKL 116
+ + L ++ L + +Y+S + + ++ + S++ + + +
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 117 EGSIPSE-FVSLYNLKELAIQENNLTGGIPH--FLGNITSLEAISLAYNSLGGNIPSSL- 172
I + L LK L I L P + + + + N +IP +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 173 -GQLKELKSLGLGG----TIPPSIYNLSLLANFSVPENRLHGSLPPSL--GLTLSNLQLF 225
G E +L L ++ +N + L + +N+ + G+ S L
Sbjct: 152 QGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY-SGPSLL 210
Query: 226 QISNNFFSGSFPLAFSNASNLQSL 249
+S + + L +
Sbjct: 211 DVSQTSVTALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 45/254 (17%), Positives = 84/254 (33%), Gaps = 57/254 (22%)
Query: 210 SLPPSL-GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDM 267
SLPPS L L L I ++ AFSN N+ + + + +L + F ++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSH--------AFSNLPNISRIYVSIDVTLQQLESHSFYNL 79
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHS--LANCSNLSFLNLVANQFKGALPHSIVSGSIPS 325
+ ++ + +++I L L FL + K P
Sbjct: 80 SKVTHIEIRNTR-------NLTYIDPDALKELPLLKFLGIFNTGLK----------MFPD 122
Query: 326 EIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS-SFGNLSS-LVK 383
+ L + N IP +F L + +
Sbjct: 123 LTK----------------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF-NISHMSDSLNFARNHLVG 442
L L NN + + N +L ++L +N I ++ F + L+ ++ +
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT- 218
Query: 443 SIPPKI-GNLKVLR 455
++P K +LK L
Sbjct: 219 ALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 27/184 (14%), Positives = 59/184 (32%), Gaps = 12/184 (6%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ + + IPS S L L +L + + NL ++ +++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSE--I 472
+ F + + I P L +L+ + + L P +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
Query: 473 GSCFYLQEIYMAENFFRGSIPS-SLVSL-KDLREIDLSQNNLSGKIPIS-LERLPLEYLN 529
S + + +N + SIP + L + + L N + + L+ +
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 530 LSFN 533
L+ N
Sbjct: 186 LNKN 189
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 42/191 (21%), Positives = 65/191 (34%), Gaps = 48/191 (25%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITS 708
++G G+ V A+K++ Q E L + HRN++ +I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI-------- 760
F+ D LV++ M GS+ L I
Sbjct: 80 -----FEEEDRFYLVFEKMRGGSI------------------------LSHIHKRRHFNE 110
Query: 761 ----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQEV 813
+ DVASA+D+LH+ H DLKP NIL + + DF L +
Sbjct: 111 LEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 814 PNNQSSSVGDL 824
+ S +L
Sbjct: 168 GDCSPISTPEL 178
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 47/202 (23%), Positives = 79/202 (39%), Gaps = 54/202 (26%)
Query: 639 LKATDGFSSTHLIGIGSFGSVY----KGTFDRDGTIVAIKVLNLQL---QGASKSFAAEC 691
+KA D + +IG G+FG V K T + A+K+L+ + S F E
Sbjct: 66 MKAED-YEVVKVIGRGAFGEVQLVRHKST----RKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 692 RALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI 751
+ +V++ + FQ + + +V +YMP G L
Sbjct: 121 DIMAFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL------------------- 156
Query: 752 RNLTLLERISIAIDVA--------SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV-- 801
+ L+ + A A+D +H IH D+KP N+LLD + H+
Sbjct: 157 --VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKL 209
Query: 802 GDFGLA-RLRQEVPNNQSSSVG 822
DFG ++ +E ++VG
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAVG 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 32/168 (19%), Positives = 64/168 (38%), Gaps = 28/168 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKV-----LNLQLQGASKSFAAECRALRNIRHRNLVRV 705
IG G F V + G A+K+ +++ E ++H ++V +
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI- 764
+ + + + +V+++M L I + D + E ++
Sbjct: 92 LET-----YSSDGMLYMVFEFMDGADLC-----FEI---VKRADAGFVYS--EAVASHYM 136
Query: 765 -DVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLAR 808
+ A+ Y H + IH D+KP +LL +N+ +G FG+A
Sbjct: 137 RQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 39/105 (37%), Positives = 59/105 (56%), Gaps = 6/105 (5%)
Query: 322 SIPSEIGKLV-SLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
+P I + V LYL D NQF +P+E+S ++L +++ +N++S SF N++
Sbjct: 24 VLPKGIPRDVTELYL---DGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
L+ LIL N L + P + LK L LL L ND+S +PE FN
Sbjct: 80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN 123
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 22/94 (23%), Positives = 44/94 (46%), Gaps = 13/94 (13%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
+L+ ++L N+ L + S + L + + +N+ IP L++
Sbjct: 54 KHLTLIDLSNNRIS-TLSNQSFS--------NMTQLLTLILSYNRLRC-IPPRTFDGLKS 103
Query: 357 LQFLNMRHNQLSGEIP-SSFGNLSSLVKLILGNN 389
L+ L++ N +S +P +F +LS+L L +G N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 31/106 (29%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
VT L L + ++ N L I LSNN I + +L L LS+N L
Sbjct: 33 VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQEN 138
P L L L N + +P F L L LAI N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 29/169 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGAS-KSFAAECRALRNIRHRNLVRVITS 708
+G G+F V + G A K++N +L + E R R ++H N+VR+ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIAIDV 766
Q F LV+ + G L + I + E +
Sbjct: 97 -----IQEESFHYLVFDLVTGGELF-----EDI---------VAREFYSEADASHCIQQI 137
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
++ Y H + +H +LKP N+LL + DFGLA +
Sbjct: 138 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 37/178 (20%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNI 697
+ S +G G++GSV R G VAIK L+ Q S+ FA E L+++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHM 80
Query: 698 RHRNLVR---VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
+H N++ V T SS+ +F LV +M + L I ++I+
Sbjct: 81 QHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQ--KIMGLKFSEEKIQ 129
Query: 753 NLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L +L + Y+H +H DLKP N+ ++ + + DFGLAR
Sbjct: 130 YLVYQML----------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 22/161 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECR-ALRNIRHRNLVRVITS 708
+G G++G V K G I+A+K + + K + ++R + V +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDV 766
F+ D + + M + SL+ + + + T+ E I IA+ +
Sbjct: 75 L----FREGDVW-ICMELM-DTSLDKFY----------KQVIDKGQTIPEDILGKIAVSI 118
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
A+++LH IH D+KPSN+L++ + DFG++
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS 157
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 49/193 (25%), Positives = 74/193 (38%), Gaps = 55/193 (28%)
Query: 650 LIGIGSFGSVY----KGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNL 702
+IG G+F V K T G + A+K++N + +G F E L N R +
Sbjct: 68 VIGRGAFSEVAVVKMKQT----GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
++ + FQ ++ LV +Y G L LTLL +
Sbjct: 124 TQLHFA-----FQDENYLYLVMEYYVGGDL---------------------LTLLSKFGE 157
Query: 763 AID----------VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA-RL 809
I + A+D +H +H D+KP NILLD H+ DFG +L
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKL 212
Query: 810 RQEVPNNQSSSVG 822
R + +VG
Sbjct: 213 RADGTVRSLVAVG 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 45/218 (20%), Positives = 72/218 (33%), Gaps = 49/218 (22%)
Query: 616 GSGKEPSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKV 675
G+ EP + + K + F ++G GSF +V AIK+
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 676 LNLQLQGASKSFA---AECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSL 732
L + E + + H V++ + FQ ++ Y NG L
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGEL 117
Query: 733 ENWLHPDAIPQTDEENDEIRNLTLLERISI---------AIDVASAVDYLHHHCQEPTIH 783
L + +I ++ SA++YLH IH
Sbjct: 118 ---------------------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIH 153
Query: 784 CDLKPSNILLDNN----LTAHVGDFGLARLRQEVPNNQ 817
DLKP NILL+ + +T DFG A++
Sbjct: 154 RDLKPENILLNEDMHIQIT----DFGTAKVLSPESKQA 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 37/184 (20%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNI 697
+ + IG G+ G V VAIK L+ Q +++ A E ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCV 118
Query: 698 RHRNLVR---VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
H+N++ V T +++ +F+ LV + M + L + Q + +++ +
Sbjct: 119 NHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLC--QVIQMELDHERMS 167
Query: 753 NLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
L +L + +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 168 YLLYQML----------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 811 QEVP 814
Sbjct: 215 GTSF 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 43/195 (22%), Positives = 72/195 (36%), Gaps = 36/195 (18%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNI 697
D + HLIG GS+G V + + +VAIK + + E L +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE--DLIDCKRILREIAILNRL 109
Query: 698 RHRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE--ENDEIR 752
H ++V+ ++ F ++ +V + ++ + +T I+
Sbjct: 110 NHDHVVKVLDIVIPKDVEKF--DEL-YVVLEIA-----DSDFK--KLFRTPVYLTELHIK 159
Query: 753 NLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
L LL V Y+H +H DLKP+N L++ + + V DFGLAR
Sbjct: 160 TLLYNLL----------VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 811 QEVPNNQSSSVGDLE 825
N S
Sbjct: 207 DYPENGNSQLPISPR 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 35/160 (21%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G+FG V++ T G A K + + ++ E + + +RH LV + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
F+ ++ ++Y++M G L ++ DE ++ E + V +
Sbjct: 223 ---FEDDNEMVMIYEFMSGGEL-----------FEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLAR 808
++H + +H DLKP NI+ + + DFGL
Sbjct: 269 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 38/176 (21%), Positives = 67/176 (38%), Gaps = 50/176 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRNLVRVIT 707
+G GSFG V G A+KV++ ++ + +S E + L+ + H N++++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI------- 760
F+ + LV + G L + I
Sbjct: 94 F-----FEDKGYFYLVGEVYTGG------------------------ELFDEIISRKRFS 124
Query: 761 -----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
I V S + Y+H + +H DLKP N+LL++ + + DFGL+
Sbjct: 125 EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 29/165 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN--LQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G GSFG V K A+KV+N + + E L+ + H N++++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDV 766
+ + +V + G L D I I+ E I V
Sbjct: 90 -----LEDSSSFYIVGELYTGGELF-----DEI---------IKRKRFSEHDAARIIKQV 130
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLAR 808
S + Y+H H +H DLKP NILL + + + DFGL+
Sbjct: 131 FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 37/175 (21%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHR 700
+ + IG G+ G V VAIK L+ Q +++ A E ++ + H+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHK 84
Query: 701 NLVR---VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
N++ V T S++ +F+ +V + M + L + Q + +++ + L
Sbjct: 85 NIIGLLNVFTPQKSLE----EFQDVYIVMELM-----DANLC--QVIQMELDHERMSYLL 133
Query: 756 --LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+L + +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 134 YQML----------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 51/188 (27%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGASKSFAAECRALRNIRHR 700
+ F L+G G++G V T G IVAIK + + E + L++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 701 NLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT-- 755
N++ + S +F N+ ++ + M + LH I +D I+
Sbjct: 70 NIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLH-RVISTQMLSDDHIQYFIYQ 120
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
L AV LH IH DLKPSN+L+++N V DFGLAR+ E
Sbjct: 121 TL----------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 816 NQSSSVGD 823
+ S G
Sbjct: 168 DNSEPTGQ 175
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 34/193 (17%), Positives = 66/193 (34%), Gaps = 40/193 (20%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIK-VLNLQLQGASKSFAA-ECRALRNIRHRNL 702
+S +G GSFG V + G A+K VL + E ++ + H N+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNI 62
Query: 703 VR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL--- 756
++ + + + + + N H I + N+ +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY--LNVIMEYV 120
Query: 757 ---LERISIAIDVAS-----------------AVDYLHHHCQEPTIHCDLKPSNILLD-N 795
L ++ + + AV ++H H D+KP N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177
Query: 796 NLTAHVGDFGLAR 808
+ T + DFG A+
Sbjct: 178 DNTLKLCDFGSAK 190
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 36/178 (20%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNI 697
+ + + +G G++GSV + G VA+K L+ Q S A E R L+++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHM 85
Query: 698 RHRNLVR---VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
+H N++ V T S++ +F LV M L+ + + +D ++
Sbjct: 86 KHENVIGLLDVFTPARSLE----EFNDVYLVTHLM-----GADLN-NIVKCQKLTDDHVQ 135
Query: 753 NLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L +L + Y+H IH DLKPSN+ ++ + + DFGLAR
Sbjct: 136 FLIYQIL----------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 36/175 (20%), Positives = 56/175 (32%), Gaps = 49/175 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITS 708
+G G+F V + G A ++N + + E R R ++H N+VR+ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI-------- 760
L++ + G E L E I
Sbjct: 79 -----ISEEGHHYLIFDLVTGG-------------------E-----LFEDIVAREYYSE 109
Query: 761 ----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLAR 808
+ AV + H +H +LKP N+LL + DFGLA
Sbjct: 110 ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 47/236 (19%), Positives = 77/236 (32%), Gaps = 66/236 (27%)
Query: 649 HLIGIGSFGSVYKGT-----FDRDGTIVAIKVLNLQLQGAS----KSFAAECRALRNI-R 698
+G G+FG V + VA+K+L +GA+ ++ +E + L +I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGH 84
Query: 699 HRNLVRVITSCSSIDFQ----------GN-------------DFKALVYQYMPNGSLENW 735
H N+V ++ +C+ GN +K ++
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 736 LHPDAIPQTD---------------------------EENDEIRNLTLLERISIAIDVAS 768
+ D + D E+ LTL I + VA
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824
+++L IH DL NILL + DFGLAR + P+ L
Sbjct: 205 GMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 38/175 (21%), Positives = 59/175 (33%), Gaps = 49/175 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASK--SFAAECRALRNIRHRNLVRVITS 708
+G G++G V AIK++ S E L+ + H N++++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI-------- 760
F+ LV + G L + I
Sbjct: 105 -----FEDKRNYYLVMECYKGG------------------------ELFDEIIHRMKFNE 135
Query: 761 ----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
I V S V YLH H +H DLKP N+LL++ + + DFGL+
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 43/182 (23%), Positives = 66/182 (36%), Gaps = 54/182 (29%)
Query: 645 FSSTHLIGIGSFGSVY----KGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNI 697
F +IG G+FG V K + A+K+LN + + + F E L N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNA----DKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+ + + + FQ ++ LV Y G L LTLL
Sbjct: 132 DSKWITTLHYA-----FQDDNNLYLVMDYYVGGDL---------------------LTLL 165
Query: 758 ERISIAID----------VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFG 805
+ + + A+D +H +H D+KP NIL+D N H+ DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFG 220
Query: 806 LA 807
Sbjct: 221 SC 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 26/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V++ K + ++ E L RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-- 69
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIAIDVAS 768
F+ + ++++++ + + I L ER +S V
Sbjct: 70 ---FESMEELVMIFEFISGLDIF-----ERINT--------SAFELNEREIVSYVHQVCE 113
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLAR 808
A+ +LH H H D++P NI+ ++ + +FG AR
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 40/178 (22%), Positives = 64/178 (35%), Gaps = 40/178 (22%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAA---ECRALRNIRHR--N 701
L+G G FGSVY G D VAIK + + G + E L+ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 702 LVR---VITSCSSIDFQGNDFKALVYQY-MPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
++R S L+ + P L +++ L
Sbjct: 110 VIRLLDWFERPDSF--------VLILERPEPVQDLFDFI--------------TERGALQ 147
Query: 758 ERISIAI--DVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARLRQE 812
E ++ + V AV + H+ +H D+K NIL+D N + DFG L ++
Sbjct: 148 EELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 40/174 (22%), Positives = 67/174 (38%), Gaps = 39/174 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHRNLVRVI 706
+G G G V+ + VAIK + L E + +R + H N+V+V
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 707 -------TSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT-- 755
+ + + + +V +YM E L + + Q + R
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLA-NVLEQGPLLEEHARLFMYQ 128
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLAR 808
LL + Y+H +H DLKP+N+ ++ +L +GDFGLAR
Sbjct: 129 LL----------RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 36/178 (20%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNI 697
D + HLIG GS+G VY VAIK +N + E L +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--DLIDCKRILREITILNRL 82
Query: 698 RHRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE--ENDEIR 752
+ ++R +I + F ++ +V + ++ L + +T + I+
Sbjct: 83 KSDYIIRLYDLIIPDDLLKF--DEL-YIVLEIA-----DSDLK--KLFKTPIFLTEEHIK 132
Query: 753 NLT--LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ LL +++H + IH DLKP+N LL+ + + V DFGLAR
Sbjct: 133 TILYNLL----------LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 40/195 (20%)
Query: 622 SEPILRRALRKVSYE--SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ 679
S P + V+++ +L+A IG GSFG V + + A+K +N Q
Sbjct: 1 SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 680 LQGASKSFA---AECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL 736
E + ++ + H LV + S FQ + +V + G L L
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHL 106
Query: 737 HPDAIPQTDEENDEIRNLTLLE---RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793
+N+ E ++ I ++ A+DYL + IH D+KP NILL
Sbjct: 107 Q--------------QNVHFKEETVKLFIC-ELVMALDYLQNQ---RIIHRDMKPDNILL 148
Query: 794 DNNLTAHVGDFGLAR 808
D + H+ DF +A
Sbjct: 149 DEHGHVHITDFNIAA 163
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 28/179 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIK-VLNLQLQGASKSFAAECRALRNIRHRNLV 703
+++ IG G++G V + + VAIK + + Q + E + L RH N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 704 R---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLE 758
+I + + D +V M E L+ + ND I +L
Sbjct: 89 GINDIIRAPTIEQM--KDV-YIVQDLM-----ETDLY-KLLKTQHLSNDHICYFLYQIL- 138
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQ 817
+ Y+H +H DLKPSN+LL+ + DFGLAR+ ++
Sbjct: 139 ---------RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 36/201 (17%), Positives = 58/201 (28%), Gaps = 33/201 (16%)
Query: 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVL--------NLQLQGASKSFA 688
S T+ IG G FG V++ D T VAIK++ N Q +
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 689 AE---CRALRNIRHRNLVRVITSCSSIDF---QGNDFKALVYQYM----PNGSLENWLHP 738
E + L + R QG+ L+ + GS +
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 739 DAIPQ-----------TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787
Q D E + +L SI + +++ + H DL
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 788 PSNILLDNNLTAHVGDFGLAR 808
N+LL + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 38/175 (21%), Positives = 62/175 (35%), Gaps = 49/175 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQ--LQGASKSFAAECRALRNIRHRNLVRVITS 708
+G GSFG V K A+KV+N + + E L+ + H N++++
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI-------- 760
+ + +V + G L + I
Sbjct: 90 -----LEDSSSFYIVGELYTGG------------------------ELFDEIIKRKRFSE 120
Query: 761 ----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
I V S + Y+H H +H DLKP NILL++ + + DFGL+
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 31/171 (18%), Positives = 63/171 (36%), Gaps = 48/171 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-------HRNLV 703
+G G + V++ + V +K+L + + R I+ N++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKP--------VKKK-KIKREIKILENLRGGPNII 94
Query: 704 R---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT--LLE 758
++ S ALV++++ N + + +IR +L+
Sbjct: 95 TLADIVKDPVS----RTP--ALVFEHVNNTDFKQLYQTL-------TDYDIRFYMYEILK 141
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLAR 808
A+DY H +H D+KP N+++D + + D+GLA
Sbjct: 142 ----------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 37/171 (21%), Positives = 57/171 (33%), Gaps = 26/171 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
L+G G FG+V+ G D VAIKV+ + + V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 710 SSI----DFQGNDFKA-LVYQY-MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ D+ LV + +P L +++ L E S
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--------------TEKGPLGEGPSRC 143
Query: 764 I--DVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARLRQ 811
V +A+ + H +H D+K NIL+D A + DFG L
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 38/170 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHRNLVR-- 704
+G G++G+V R G VAIK L Q S+ FA E R L+++RH N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 705 -VITSCSSIDFQGNDFKA--LVYQYMPNGSLENWLHPDAIPQTDE-ENDEIRNLT--LLE 758
V T ++D DF LV +M L + + ++ D I+ L +L
Sbjct: 91 DVFTPDETLD----DFTDFYLVMPFM-----GTDLG--KLMKHEKLGEDRIQFLVYQML- 138
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ Y+H IH DLKP N+ ++ + + DFGLAR
Sbjct: 139 ---------KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 51/178 (28%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSC 709
+G GSF K + A+K+++ +++ ++ E AL+ H N+V++
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--------- 760
F LV + + G L ERI
Sbjct: 75 ----FHDQLHTFLVMELLNGGEL------------------------FERIKKKKHFSET 106
Query: 761 ---SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
I + SAV ++H +H DLKP N+L ++NL + DFG ARL+
Sbjct: 107 EASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 40/168 (23%), Positives = 62/168 (36%), Gaps = 30/168 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA------ECRALRNIRHRNLVR 704
+G G F V K G A K + + AS+ + E LR + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ ++ L+ + + G L D + +E+ L+ E S
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELF-----DFL--AQKES-----LSEEEATSFIK 122
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHVGDFGLAR 808
+ V+YLH H DLKP NI+L + DFGLA
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 40/168 (23%), Positives = 62/168 (36%), Gaps = 30/168 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA------ECRALRNIRHRNLVR 704
+G G F V K G A K + + AS+ E LR + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ ++ L+ + + G L D + +E +L+ E S
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELF-----DFL--AQKE-----SLSEEEATSFIK 122
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH----VGDFGLAR 808
+ V+YLH H DLKP NI+L + + DFGLA
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 26/125 (20%), Positives = 50/125 (40%), Gaps = 13/125 (10%)
Query: 303 LNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLN 361
L L N+F + + I ++ +L + +N+ I E + +
Sbjct: 37 LRLNNNEF-----TVLEATGIFKKLPQLRKINF---SNNKIT-DIEEGAFEGASGVNEIL 87
Query: 362 MRHNQLSGEIPSS-FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIP 420
+ N+L + F L SL L+L +N ++ V S L + LL L+ N ++ +
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
Query: 421 EEIFN 425
F+
Sbjct: 146 PGAFD 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 28/133 (21%), Positives = 51/133 (38%), Gaps = 7/133 (5%)
Query: 34 VTVLDLKSKGLIGSLSPQIG--NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
L L + L L LR+I+ SNN I G + + L+ N
Sbjct: 34 TAELRLNNNE-FTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPH-FLG 149
L L L L N++ + ++ F+ L +++ L++ +N +T +
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150
Query: 150 NITSLEAISLAYN 162
+ SL ++L N
Sbjct: 151 TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 11/117 (9%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
L +N N+ + G + I + N+ E + +M L++
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEG--------ASGVNEILLTSNRLEN-VQHKMFKGLES 106
Query: 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+ L +R N+++ SF LSS+ L L +N ++ V P + L L+ L+L N
Sbjct: 107 LKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 9/144 (6%)
Query: 119 SIPSEFVSLYNLKELAIQENNLTGGIPH-FLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177
IP EL + N T + L I+ + N + +
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 178 LKSLGLGG----TIPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF 232
+ + L + + L L + NR+ + + LS+++L + +N
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 233 SGSFPLAFSNASNLQSLEILGNNF 256
+ P AF +L +L +L N F
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 25/161 (15%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-KSFAAECRAL-RNIRHRNLVRVITS 708
+G G+ G V+K F + G ++A+K + K + + ++ +V+ +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--SIAIDV 766
D + + M + + + + ERI + + +
Sbjct: 93 F----ITNTDVF-IAMELM-GTCA------EKL-------KKRMQGPIPERILGKMTVAI 133
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
A+ YL + IH D+KPSNILLD + DFG++
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 37/186 (19%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR------ 698
+ +G G++G V+K R G +VA+K + Q + + A R R I
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--NSTDAQ--RTFREIMILTELS 66
Query: 699 -HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE-ENDEIRNLT- 755
H N+V ++ + + D LV+ YM E LH A+ + + E + +
Sbjct: 67 GHENIVNLLNVLRADND--RDV-YLVFDYM-----ETDLH--AVIRANILEPVHKQYVVY 116
Query: 756 -LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVP 814
L+ + YLH +H D+KPSNILL+ V DFGL+R +
Sbjct: 117 QLI----------KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163
Query: 815 NNQSSS 820
++
Sbjct: 164 RVTNNI 169
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 33/125 (26%), Positives = 56/125 (44%), Gaps = 14/125 (11%)
Query: 303 LNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLN 361
+ L N K +P S KL + L +NQ ++ + L++L L
Sbjct: 37 IRLEQNTIK-VIPPGAFSP-----YKKLRRIDL---SNNQIS-ELAPDAFQGLRSLNSLV 86
Query: 362 MRHNQLSGEIPSS-FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIP 420
+ N+++ E+P S F L SL L+L N ++ + + +L L LL L+ N L I
Sbjct: 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIA 144
Query: 421 EEIFN 425
+ F+
Sbjct: 145 KGTFS 149
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 33/131 (25%), Positives = 51/131 (38%), Gaps = 4/131 (3%)
Query: 34 VTVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSL 92
+T + L+ I + P LR I LSNN I P L L +L L N +
Sbjct: 34 ITEIRLEQNT-IKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 93 VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPHFLGNI 151
L L L NK+ + + F L+NL L++ +N L +
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 152 TSLEAISLAYN 162
+++ + LA N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 28/117 (23%), Positives = 51/117 (43%), Gaps = 11/117 (9%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
L ++L NQ L G L SL + + N+ ++P+ + L +
Sbjct: 56 KKLRRIDLSNNQIS-ELAPDAFQG--------LRSLNSLVLYGNKIT-ELPKSLFEGLFS 105
Query: 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
LQ L + N+++ +F +L +L L L +N L + + L+ + +HL QN
Sbjct: 106 LQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 4/129 (3%)
Query: 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEG 118
EI L NTI+ PG +L + LS+N + P L L L NK+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 119 SIPSE-FVSLYNLKELAIQENNLTGGIPHFL-GNITSLEAISLAYNSLGGNIPSSLGQLK 176
+P F L++L+ L + N + + ++ +L +SL N L + L+
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 177 ELKSLGLGG 185
++++ L
Sbjct: 153 AIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 25/132 (18%), Positives = 52/132 (39%), Gaps = 3/132 (2%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
+ + + N + P +F L ++ L NN +S + P + L+ L L L+ N +
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 416 SGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI-GNLKVLRMFVVSSNNLSGEIPSEIGS 474
+ +P+ +F L N + + +L L + + N L
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 475 CFYLQEIYMAEN 486
+Q +++A+N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 32/143 (22%), Positives = 55/143 (38%), Gaps = 8/143 (5%)
Query: 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178
IP+ + E+ +++N + P L I L+ N + P + L+ L
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 179 KSLGLGG----TIPPSI-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS 233
SL L G +P S+ L L + N+++ L L NL L + +N
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 234 GSFPLAFSNASNLQSLEILGNNF 256
FS +Q++ + N F
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 27/161 (16%), Positives = 57/161 (35%), Gaps = 36/161 (22%)
Query: 379 SSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARN 438
++ ++ L N + + P + K+L + L N +S + + F
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF-------------Q 77
Query: 439 HLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY----LQEIYMAENFFRGSIPS 494
L +L L + N ++ E+P + F LQ + + N +
Sbjct: 78 GLR--------SLNSLVL---YGNKIT-ELPKSL---FEGLFSLQLLLLNANKIN-CLRV 121
Query: 495 -SLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFN 533
+ L +L + L N L + L ++ ++L+ N
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 35/175 (20%), Positives = 63/175 (36%), Gaps = 53/175 (30%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRAL-RNIRHRNLVRVITSC 709
IG+GS+ + A+K+++ + ++ E L R +H N++ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDV- 84
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--------- 760
+ + +V + M G L L++I
Sbjct: 85 ----YDDGKYVYVVTELMKGGEL------------------------LDKILRQKFFSER 116
Query: 761 ---SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNLTAHVGDFGLAR 808
++ + V+YLH +H DLKPSNIL N + + DFG A+
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 39/176 (22%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI------R 698
+++ +IG GSFG V++ + VAIK K + R + +
Sbjct: 42 YTNCKVIGNGSFGVVFQAK-LVESDEVAIK----------KVLQDKRFKNRELQIMRIVK 90
Query: 699 HRNLVR---VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
H N+V S + D + F LV +Y+P ++ A + I+
Sbjct: 91 HPNVVDLKAFFYS--NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 756 --LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLAR 808
LL ++ Y+H H D+KP N+LLD + + DFG A+
Sbjct: 148 YQLLR----------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 33/177 (18%), Positives = 59/177 (33%), Gaps = 51/177 (28%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRAL-RNIRHRNLVRVITS 708
++G+G G V + R G A+K+L S E + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI-------- 760
++ ++ + M G L RI
Sbjct: 91 YENMHHGKRCL-LIIMECMEGGEL------------------------FSRIQERGDQAF 125
Query: 761 ------SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLAR 808
I D+ +A+ +LH H H D+KP N+L + + + DFG A+
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 30/168 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA------ECRALRNIRHRNLVR 704
+G G F V K G A K + + +S+ + E L+ I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ ++ L+ + + G L D + + + +LT E
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELF-----DFLAEKE-------SLTEEEATEFLK 121
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH----VGDFGLAR 808
+ + V YLH H DLKP NI+L + + DFGLA
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 36/174 (20%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLN-------------LQLQGASKSFAAECRALRNI 697
+G G++G V + AIKV+ ++ + E L+++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
H N++++ F+ + LV ++ G L + I
Sbjct: 104 DHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELF-----EQI-------INRHKFDEC 146
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NLTAHVGDFGLAR 808
+ +I + S + YLH H +H D+KP NILL+N L + DFGL+
Sbjct: 147 DAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 57/198 (28%), Positives = 82/198 (41%), Gaps = 37/198 (18%)
Query: 617 SGKEPSEPILRRALRKVSYES--LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIK 674
SG E E L + +V+ LK L+G G+FG V G A+K
Sbjct: 129 SGAEEMEVSLAKPKHRVTMNEFEYLK---------LLGKGTFGKVILVKEKATGRYYAMK 179
Query: 675 VLNLQLQGASKSFA---AECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGS 731
+L ++ A A E R L+N RH L + S FQ +D V +Y G
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVMEYANGGE 234
Query: 732 LENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791
L L + E R R A ++ SA+DYLH ++ ++ DLK N+
Sbjct: 235 LFFHL------SRERVFSEDR-----ARFYGA-EIVSALDYLHS--EKNVVYRDLKLENL 280
Query: 792 LLDNNLTAHV--GDFGLA 807
+LD + H+ DFGL
Sbjct: 281 MLDKD--GHIKITDFGLC 296
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 46/165 (27%), Positives = 68/165 (41%), Gaps = 20/165 (12%)
Query: 252 LGNNFFGKLSVN-FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQF 310
L + LS F + L +LN+ N L + + F + L L L NQ
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG--VFDDL----TELGTLGLANNQL 95
Query: 311 KGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSG 369
+LP + + +L LYL NQ + +P + RL L+ L + NQL
Sbjct: 96 A-SLPLGV-----FDHLTQLDKLYL---GGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ- 144
Query: 370 EIPSS-FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
IP+ F L++L L L N L V + L +L + LF N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 48/182 (26%), Positives = 67/182 (36%), Gaps = 22/182 (12%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMK 268
S+P + L L + + F + L L L N LS F D+
Sbjct: 28 SVPSGIPADTEKLDL---QSTGLATLSDATFRGLTKLTWLN-LDYNQLQTLSAGVFDDLT 83
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
L L +A N L S F L L L L NQ K +LP +
Sbjct: 84 ELGTLGLANNQLASLPLG--VF-DHLTQ---LDKLYLGGNQLK-SLPSGVFD-------- 128
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
+L L + ++ NQ + IP +L NLQ L++ NQL +F L L + L
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 388 NN 389
N
Sbjct: 188 GN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 44/159 (27%), Positives = 61/159 (38%), Gaps = 26/159 (16%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
S+PS I L L L L +LN+ +NQL F +L+
Sbjct: 28 SVPSGIPADTEKLDL---QSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDS------LN 434
L L L NN L+ + +L QL L+L N L ++P +F D L
Sbjct: 85 LGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF------DRLTKLKELR 137
Query: 435 FARNHLVGSIPP----KIGNLKVLRMFVVSSNNLSGEIP 469
N L SIP K+ NL+ L + S N +P
Sbjct: 138 LNTNQL-QSIPAGAFDKLTNLQTLSL----STNQLQSVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
LDL+S GL L+ L ++L N +Q G L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPH--FLGNI 151
G + ++L LYLG N+L+ S+PS F L LKEL + N L IP F +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAF-DKL 154
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183
T+L+ +SL+ N L + +L +L+++ L
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 41/181 (22%), Positives = 67/181 (37%), Gaps = 28/181 (15%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRHRN 701
F ++G G FG V G + A K L ++ + E + L + R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V + + ++ D LV M G L+ ++ E
Sbjct: 246 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---------RAVFY 291
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLARLRQEVPNNQSS 819
A ++ ++ LH ++ DLKP NILLD++ H+ D GLA VP Q+
Sbjct: 292 AA-EICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRISDLGLAV---HVPEGQTI 342
Query: 820 S 820
Sbjct: 343 K 343
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 24/164 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHR-NLVRVIT 707
+G G F V + G A K L + +G E L + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
++ L+ +Y G + E ++ + I + +
Sbjct: 97 V-----YENTSEIILILEYAAGGEIF-----SLCLPELAEM-----VSENDVIRLIKQIL 141
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH---VGDFGLAR 808
V YLH + +H DLKP NILL + + DFG++R
Sbjct: 142 EGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 30/168 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA------ECRALRNIRHRNLVR 704
+G G F V K G A K + + +S+ + E LR IRH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ F+ L+ + + G L D + + + +LT E
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELF-----DFLAEKE-------SLTEDEATQFLK 115
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH----VGDFGLAR 808
+ V YLH H DLKP NI+L + + + DFG+A
Sbjct: 116 QILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 46/172 (26%), Positives = 67/172 (38%), Gaps = 31/172 (18%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRH 699
D F +G GSFG V G A+K+L+ Q K E R L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
LV++ S F+ N +V +Y+ G + + H I + E R
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEP---------HAR 144
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN----LTAHVGDFGLA 807
A + +YLH I+ DLKP N+L+D +T DFG A
Sbjct: 145 FYAA-QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVT----DFGFA 188
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 23/170 (13%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRH 699
D F ++G G FG V+ G + A K LN L+ + + E + L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
R +V + F+ LV M G + H + + + E R
Sbjct: 245 RFIVS-LAYA----FETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPR-----AI 292
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
A + S +++LH I+ DLKP N+LLD++ +V D GLA
Sbjct: 293 FYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDD--GNVRISDLGLA 336
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 31/175 (17%), Positives = 63/175 (36%), Gaps = 33/175 (18%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNL------QLQGASKSF---AAECRALRNIRHR 700
IG G FG +Y A V+ + L K + A + + I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 701 NLVRV----ITSCSSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLT 755
L + +F+G ++ +V + + G L+ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS------------GQNGTFK 149
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD--NNLTAHVGDFGLAR 808
+ + I + ++Y+H + +H D+K +N+LL N ++ D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 3/96 (3%)
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPS-SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQL 405
+ +NL L + + Q + L L L + + L V P + +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 406 ALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
+ L+L N L ++ + + L + N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 20/102 (19%), Positives = 38/102 (37%), Gaps = 3/102 (2%)
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS-SLGNLKQLALLHLFQNDLSGAIPEE 422
+ + +L +L + N + L L +L L + ++ L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 423 IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNL 464
F+ + LN + N L S+ K L+ V+S N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 23/104 (22%), Positives = 36/104 (34%), Gaps = 9/104 (8%)
Query: 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKI 347
+ +H L NL+ L + Q L + G L L + + +
Sbjct: 21 LDSLHHLPGAENLTELYIENQQHLQHLELRDLRG--------LGELRNLTIVKSGLRFVA 72
Query: 348 PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNL 391
P+ L LN+ N L + L SL +L+L N L
Sbjct: 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 23/102 (22%), Positives = 39/102 (38%), Gaps = 6/102 (5%)
Query: 20 CDWEGITCSPRH----RRVTVLDLKSKGLIGSLSPQ-IGNLSFLREIHLSNNTIQGKIPG 74
C +G S H +T L ++++ + L + + L LR + + + ++ P
Sbjct: 15 CTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74
Query: 75 EIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116
RL L LS N+L + L L L N L
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 16/94 (17%), Positives = 34/94 (36%), Gaps = 1/94 (1%)
Query: 443 SIPPKIGNLKVLRMFVVSSNNLSGEIPSE-IGSCFYLQEIYMAENFFRGSIPSSLVSLKD 501
+ + L + + + + L+ + + ++ R P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 502 LREIDLSQNNLSGKIPISLERLPLEYLNLSFNDL 535
L ++LS N L +++ L L+ L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 46/179 (25%), Positives = 67/179 (37%), Gaps = 49/179 (27%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRN 701
F +G GSFG V+ +G A+KVL ++ K E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++R+ + FQ ++ Y+ G L +LL +
Sbjct: 68 IIRMWGT-----FQDAQQIFMIMDYIEGGEL---------------------FSLLRKSQ 101
Query: 762 I---------AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN----LTAHVGDFGLA 807
A +V A++YLH I+ DLKP NILLD N +T DFG A
Sbjct: 102 RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT----DFGFA 153
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 29/168 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
+G G+ VY+ A+KVL + K E L + H N++++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI- 116
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER--ISIAIDVA 767
F+ +LV + + G L D I + ER +
Sbjct: 117 ----FETPTEISLVLELVTGGELF-----DRI---------VEKGYYSERDAADAVKQIL 158
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
AV YLH + +H DLKP N+L + + DFGL+++ +
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 34/175 (19%), Positives = 54/175 (30%), Gaps = 51/175 (29%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSC 709
+G+G G V + R A+K+L E + ++VR++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI--------- 760
+ + G +V + + G E L RI
Sbjct: 81 EN-LYAGRKCLLIVMECLDGG-------------------E-----LFSRIQDRGDQAFT 115
Query: 761 -----SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLA 807
I + A+ YLH H D+KP N+L N + DFG A
Sbjct: 116 EREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 19/234 (8%)
Query: 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+L K + L LS ++ + N+ IQ + G + L+ L+LSHN +
Sbjct: 21 AVKQNL-GKQSVTDLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITS 153
++ L ++L L + RN+L+ ++ + L L + N L L ++ +
Sbjct: 77 -DLS-PLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--TDSLIHLKN 129
Query: 154 LEAISLAYNSLGGNIPSSLGQLKELKSLGLGG---TIPPSIYNLSLLANFSVPENRLHGS 210
LE +S+ N L +I LG L +L+ L L G T + L + + +
Sbjct: 130 LEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187
Query: 211 LPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNF 264
+ + S P SN + +L V++
Sbjct: 188 PVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPVYTDEVSY 238
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 38/231 (16%), Positives = 75/231 (32%), Gaps = 29/231 (12%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
+ +N NL + +L + D++ + +
Sbjct: 12 VFPDPGLANAVKQNLGKQSV-----------TDLVSQKELSGVQNFNGDNSNIQ-SL-AG 58
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
M NL+ L++ HNQ+S ++ S +L+ L +L + N L + L + L L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFL 113
Query: 411 FQNDLSGAIPEEIFNISHMSD--SLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
N+L + ++ H+ + L+ N L SI +G L L + + N ++
Sbjct: 114 DNNELR-----DTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT 165
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPIS 519
+ + I + L + IS
Sbjct: 166 -GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYIS 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 38/263 (14%), Positives = 84/263 (31%), Gaps = 52/263 (19%)
Query: 148 LGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRL 207
+ + +L S+ S +L +++ + S+ + N
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLKE----- 67
Query: 208 HGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267
L LS+ Q+ +S + + L+ L + N ++N
Sbjct: 68 ---------LHLSHNQISDLSP----------LKDLTKLEELSVNRNRL---KNLNGIPS 105
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
L+ L + N L SL + NL L++ N+ K SI +
Sbjct: 106 ACLSRLFLDNNEL--------RDTDSLIHLKNLEILSIRNNKLK----------SI-VML 146
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
G L L ++++ N+ ++RL+ + ++++ + E L +
Sbjct: 147 GFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDP 204
Query: 388 NNNLSGVIPSSLGNLKQLALLHL 410
+ + P + N +
Sbjct: 205 DGRW--ISPYYISNGGSYVDGCV 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 30/223 (13%), Positives = 78/223 (34%), Gaps = 42/223 (18%)
Query: 87 LSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPH 146
+ + + ++ + + LG+ + + L ++ +N+
Sbjct: 3 IQRPTPINQV-FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSLAG- 58
Query: 147 FLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENR 206
+ T+L+ + L++N + ++ S L L +L+ L + + NL+ + + +
Sbjct: 59 -MQFFTNLKELHLSHNQI-SDL-SPLKDLTKLEELSVNRN---RLKNLNGIPSACLSR-- 110
Query: 207 LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGD 266
L L N +L + + NL+ L + NN + G
Sbjct: 111 ----------LFLDNNELRDTDS----------LIHLKNLEILS-IRNNKLKSIV-MLGF 148
Query: 267 MKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQ 309
+ L L++ N + + L +++++L +
Sbjct: 149 LSKLEVLDLHGNEI--------TNTGGLTRLKKVNWIDLTGQK 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 77/465 (16%), Positives = 139/465 (29%), Gaps = 87/465 (18%)
Query: 129 NLKELAIQENNLT-GGIPHFLGNITSLEAISLAYNSLG----GNIPSSLGQLKELKSLGL 183
+++ L IQ L+ L + + + L L +I S+L L L L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 184 GGTIPPSIYNLSLLANFSVPENRLHGS----LPPSLGLTLSNLQLFQISNNFFS----GS 235
N L + L +Q + N + G
Sbjct: 64 RS-------------------NELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 104
Query: 236 FPLAFSNASNLQSLEILGNNFFG-----KLSVNFGDMKS-LAYLNVAINNLGSGESDEMS 289
LQ L L +N G L D + L L + +L +
Sbjct: 105 LSSTLRTLPTLQELH-LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS--AASCEP 161
Query: 290 FIHSLANCSNLSFLNLVANQF--KGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK- 346
L + L + N G ++ + +L +L L +
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGV---RVLCQGLKDSPCQLEALKL---ESCGVTSDN 215
Query: 347 ---IPEEMSRLQNLQFLNMRHNQLSGE-----IPSSFGNLSSLVKLILGNNNLSGV---- 394
+ ++ +L+ L + N+L P S L L + ++
Sbjct: 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275
Query: 395 IPSSLGNLKQLALLHLFQNDLSG----AIPEEIFNISHMSDSLNFARNHL----VGSIPP 446
+ L + L L L N+L + E + +SL
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335
Query: 447 KIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY-----LQEIYMAENFFR----GSIPSSLV 497
+ + L +S+N L E+ L+ +++A+ S+ ++L+
Sbjct: 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 498 SLKDLREIDLSQNNL--SGKIPISLERLP-----LEYLNLSFNDL 535
+ LRE+DLS N L +G + + E + LE L L
Sbjct: 396 ANHSLRELDLSNNCLGDAGILQLV-ESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 70/428 (16%), Positives = 135/428 (31%), Gaps = 87/428 (20%)
Query: 32 RRVTVLDLKSKGL----IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFR-----L 82
++ V+ L GL +S + L E++L +N + + + + +
Sbjct: 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 83 EALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT- 141
+ L L + L G ++ L L+EL + +N L
Sbjct: 88 QKLSLQNCCLTGA-------GCGVLSSTLRTLP-------------TLQELHLSDNLLGD 127
Query: 142 GGIPHF----LGNITSLEAISLAYNSLG----GNIPSSLGQLKELKSLGLGGTIPPSIYN 193
G+ L LE + L Y SL + S L + K L + I
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN---DINE 184
Query: 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS----GSFPLAFSNASNLQSL 249
+ L L + L+ ++ + + ++ ++L+ L
Sbjct: 185 AGVRV------------LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL 232
Query: 250 EILGNNFFG-----KLSVNFGDM-KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
LG+N G +L L L + + L +L L
Sbjct: 233 A-LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI--TAKGCGDLCRVLRAKESLKEL 289
Query: 304 NLVANQF--KGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK----IPEEMSRLQNL 357
+L N+ +GA ++ ++ +L SL++ F +++ + L
Sbjct: 290 SLAGNELGDEGA---RLLCETLLEPGCQLESLWV---KSCSFTAACCSHFSSVLAQNRFL 343
Query: 358 QFLNMRHNQLSGEIPSSFG-----NLSSLVKLILGNNNLSGV----IPSSLGNLKQLALL 408
L + +N+L S L L L + ++S + ++L L L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 409 HLFQNDLS 416
L N L
Sbjct: 404 DLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 50/360 (13%), Positives = 109/360 (30%), Gaps = 64/360 (17%)
Query: 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNA----SNLQSLEILGNNFFGKLSVN-FGDM- 267
L L Q+ ++ + + + S+A L L L +N G + V+
Sbjct: 22 ELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN-LRSNELGDVGVHCVLQGL 80
Query: 268 ----KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI 323
+ L++ L + +L L L+L N A + G +
Sbjct: 81 QTPSCKIQKLSLQNCCLT--GAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138
Query: 324 PSEIGKLVSLYLIEMDHNQFEGK----IPEEMSRLQNLQFLNMRHNQLSGEIPSSFG--- 376
+ +L L L ++ + + + + L + +N ++
Sbjct: 139 DPQC-RLEKLQL---EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL 194
Query: 377 --NLSSLVKLILGNNNLS----GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS 430
+ L L L + ++ + + + L L L N L ++ +
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------GMAELC 248
Query: 431 DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE----IPSEIGSCFYLQEIYMAEN 486
L + LR + ++ + + + + L+E+ +A N
Sbjct: 249 PGL--------------LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294
Query: 487 FFRGSIPSSLV-SLKD----LREIDLSQNNLSGK----IPISLERLP-LEYLNLSFNDLE 536
L +L + L + + + + L + L L +S N LE
Sbjct: 295 ELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 37/209 (17%), Positives = 73/209 (34%), Gaps = 28/209 (13%)
Query: 355 QNLQFLNMRHNQLSGE-IPSSFGNLSSLVKLILGNNNLS----GVIPSSLGNLKQLALLH 409
++Q L+++ +LS L + L + L+ I S+L LA L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 410 LFQNDLSG----AIPEEIFNISHMSDSLNFARNHL----VGSIPPKIGNLKVLRMFVVSS 461
L N+L + + + S L+ L G + + L L+ +S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 462 NNLSGEIPSEIGS-----CFYLQEIYMAENFFR----GSIPSSLVSLKDLREIDLSQNNL 512
N L + L+++ + + S L + D +E+ +S N++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 513 SGK----IPISLE--RLPLEYLNLSFNDL 535
+ + L+ LE L L +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 61/330 (18%), Positives = 106/330 (32%), Gaps = 53/330 (16%)
Query: 31 HRRVTVLDLKSKGL----IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFR----- 81
++ L L++ L G LS + L L+E+HLS+N + +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 82 LEALYLSHNSL----VGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF-----VSLYNLKE 132
LE L L + SL + L L + N + + S L+
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 133 LAIQENNLTG-GIPHF---LGNITSLEAISLAYNSLGGN-----IPSSLGQLKELKSLGL 183
L ++ +T + + SL ++L N LG P L L++L +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263
Query: 184 GG---------TIPPSIYNLSLLANFSVPENRLHGS----LPPSLGLTLSNLQLFQISNN 230
+ + L S+ N L L +L L+ + +
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 231 FFSGSFPLAFSNA----SNLQSLEILGNNFFGKLSVN-FGDM-----KSLAYLNVAINNL 280
F+ + FS+ L L+ + NN V L L +A ++
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQ-ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 281 GSGESDEMSFIHSLANCSNLSFLNLVANQF 310
+S S +L +L L+L N
Sbjct: 383 --SDSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 39/168 (23%), Positives = 65/168 (38%), Gaps = 30/168 (17%)
Query: 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH-RNLVRVI 706
IG G+FG + G VAIK+ ++ + E R + + + +V
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVY 71
Query: 707 TSCSSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ A+V + + G SLE D + R +L + IAI
Sbjct: 72 YFG-----PCGKYNAMVLELL--GPSLE-----------DLFDLCDRTFSLKTVLMIAIQ 113
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILL-----DNNLTAHVGDFGLAR 808
+ S ++Y+H I+ D+KP N L+ H+ DF LA+
Sbjct: 114 LISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 37/219 (16%), Positives = 64/219 (29%), Gaps = 55/219 (25%)
Query: 616 GSGKEPSEPILRRALRKVSYESLLKATDGFS----STHLIGIGSFGSVYKGTFDRDGTIV 671
+ P P + V +K ++ ++G+G G V + R
Sbjct: 31 PPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKF 90
Query: 672 AIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNG 730
A+K+L E + ++VR++ + + G +V + + G
Sbjct: 91 ALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGG 144
Query: 731 SLENWLHPDAIPQTDEENDEIRNLTLLERI--------------SIAIDVASAVDYLHHH 776
L RI I + A+ YLH
Sbjct: 145 EL------------------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 777 CQEPTIHCDLKPSNILL---DNNLTAHVGDFGLARLRQE 812
H D+KP N+L N + DFG A+
Sbjct: 181 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 42/197 (21%)
Query: 622 SEPILRRALRKVSYES--LLKATDGFSSTHLIGIGSFGSVY---KGTFDRDGTIVAIKVL 676
SE + R K+ E LL+ ++G G +G V+ K T G I A+KVL
Sbjct: 3 SETSVNRGPEKIRPECFELLR---------VLGKGGYGKVFQVRKVTGANTGKIFAMKVL 53
Query: 677 N----LQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSL 732
++ + AE L ++H +V +I + FQ L+ +Y+ G L
Sbjct: 54 KKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL 108
Query: 733 ENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792
L + + E +A +++ A+ +LH I+ DLKP NI+
Sbjct: 109 FMQL------EREGIFMEDT-----ACFYLA-EISMALGHLHQK---GIIYRDLKPENIM 153
Query: 793 LDNNLTAHV--GDFGLA 807
L++ HV DFGL
Sbjct: 154 LNHQ--GHVKLTDFGLC 168
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 4/115 (3%)
Query: 49 SPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIG 108
+ Q N RE+ L I I L + +A+ S N + ++ RL
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 109 LYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYN 162
L + N++ +L +L EL + N+L G L ++ SL + + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 13/124 (10%)
Query: 291 IHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350
N L+L + I + L I+ N+ K+ +
Sbjct: 12 AAQYTNAVRDRELDLRGYK----------IPVIENLGATLDQFDAIDFSDNEIR-KL-DG 59
Query: 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV-IPSSLGNLKQLALLH 409
L+ L+ L + +N++ L L +LIL NN+L + L +LK L L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119
Query: 410 LFQN 413
+ +N
Sbjct: 120 ILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 19/116 (16%), Positives = 41/116 (35%), Gaps = 7/116 (6%)
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKL 384
++ V +++ + I + L ++ N++ ++ F L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 385 ILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSD--SLNFARN 438
++ NN + + L L L L N L ++ ++ + L RN
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 43/185 (23%), Positives = 68/185 (36%), Gaps = 35/185 (18%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN----LQLQGASKSFAAECRAL---RNI 697
FS +IG G FG VY G + A+K L+ QG + + E L
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTG 249
Query: 698 RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLL 757
+V + + F D + + M G L L E
Sbjct: 250 DCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEAD----- 293
Query: 758 ERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLARLRQEVPN 815
R A ++ ++++H+ ++ DLKP+NILLD + HV D GLA +
Sbjct: 294 MRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLAC---DFSK 344
Query: 816 NQSSS 820
+ +
Sbjct: 345 KKPHA 349
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 54 NLSFLREIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112
S ++E+ L N+ GK+ G LE L + L I NL ++L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYN 162
N++ G + NL L + N + L + +L+++ L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 3/99 (3%)
Query: 316 HSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSF 375
G + + L + + I + +L L+ L + N++SG +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 376 GNLSSLVKLILGNNNLSGV-IPSSLGNLKQLALLHLFQN 413
+L L L N + + L L+ L L LF
Sbjct: 85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 8/112 (7%)
Query: 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGN 388
+ L L + EGK+ + L+FL+ + L+ I ++ L+ L KL L +
Sbjct: 18 DVKELVLD--NSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 389 NNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSD--SLNFARN 438
N +SG + L L+L N + I + + + SL+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 36/117 (30%), Positives = 51/117 (43%), Gaps = 12/117 (10%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
NL L L +NQ ALP G + + +L L L NQ +P + RL +
Sbjct: 64 INLKELYLGSNQLG-ALP----VG-VFDSLTQLTVLDL---GTNQLT-VLPSAVFDRLVH 113
Query: 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+ L M N+L+ E+P L+ L L L N L + + L L +LF N
Sbjct: 114 LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 23/142 (16%)
Query: 252 LGNNFFGKLSVN-FGDMKSLAYLNVAINNLGS---GESDEMSFIHSLANCSNLSFLNLVA 307
L +N KL F + +L L + N LG+ G D ++ L+ L+L
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLT---------QLTVLDLGT 97
Query: 308 NQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQL 367
NQ LP ++ +LV L + M N+ ++P + RL +L L + NQL
Sbjct: 98 NQLT-VLPSAV--------FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 368 SGEIPSSFGNLSSLVKLILGNN 389
+F LSSL L N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 36/131 (27%), Positives = 54/131 (41%), Gaps = 7/131 (5%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
+L L + L P + +L L+E++L +N + G L +L L L N L
Sbjct: 43 QILYLHDNQI-TKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPH--FLGNI 151
L L++ NKL +P L +L LA+ +N L IPH F +
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAF-DRL 158
Query: 152 TSLEAISLAYN 162
+SL L N
Sbjct: 159 SSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 14/113 (12%)
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
Q L + NQ++ P F +L +L +L LG+N L + +L QL +L L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 418 AIPEEIFNISHMSDSL------NFARNHLVGSIPPKIGNLKVLRMFVVSSNNL 464
+P +F D L N L +P I L L + N L
Sbjct: 102 VLPSAVF------DRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 38/142 (26%), Positives = 60/142 (42%), Gaps = 6/142 (4%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
S+P+ I + ++ + NQ P L NL+ L + NQL F +L+ L
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L LG N L+ + + L L L + N L+ +P I ++H++ L +N L
Sbjct: 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTH-LALDQNQL- 147
Query: 442 GSIPPKI-GNLKVLRMFVVSSN 462
SIP L L + N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 41/150 (27%), Positives = 58/150 (38%), Gaps = 29/150 (19%)
Query: 109 LYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT---GGIPHFLGNITSLEAISLAYNSLG 165
LYL N++ P F SL NLKEL + N L G+ L +T L LG
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL--------DLG 96
Query: 166 GNIPSSLGQLKELKSLGLGGTIPPSIYN-LSLLANFSVPENRLHGSLPPSLGLTLSNLQL 224
N QL L P ++++ L L + N+L LP + L++L
Sbjct: 97 TN------QLTVL---------PSAVFDRLVHLKELFMCCNKLT-ELPRGIE-RLTHLTH 139
Query: 225 FQISNNFFSGSFPLAFSNASNLQSLEILGN 254
+ N AF S+L + GN
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRALRNIRHRNLVRVI 706
L+G G+FG V G A+K+L ++ A A E R L+N RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ FQ +D V +Y G L L + E R R A ++
Sbjct: 72 YA-----FQTHDRLCFVMEYANGGELFFHL------SRERVFTEER-----ARFYGA-EI 114
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
SA++YLH ++ D+K N++LD + H+ DFGL
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLC 152
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 6/106 (5%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSSFGNLS 379
IP +I L L + N+ + + RL +L L ++ NQL+G P++F S
Sbjct: 22 EIPRDIPLHTTELLL---NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
+ +L LG N + + L QL L+L+ N +S + F
Sbjct: 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFE 123
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 26/87 (29%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPS-SFGNLSSLVKLIL 386
+L L +E+ NQ I ++Q L + N++ EI + F L L L L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 387 GNNNLSGVIPSSLGNLKQLALLHLFQN 413
+N +S V+P S +L L L+L N
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 13/93 (13%)
Query: 299 NLSFLNLVANQFKGALPHSIVSGSIPSEI-GKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
+L L L NQ I + +++ N+ + +I +M L
Sbjct: 55 HLVKLELKRNQLT----------GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQ 103
Query: 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
L+ LN+ NQ+S +P SF +L+SL L L +N
Sbjct: 104 LKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 30/177 (16%), Positives = 69/177 (38%), Gaps = 36/177 (20%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVL--NLQLQGASKSFAAECRALRNIR--------H 699
+G G F +V+ + T VA+K++ + A++ E + L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 700 RNLVRVITSCSSIDFQGNDFK--ALVYQYMPNGSLENWLHPDAIPQTDEENDEIR-NLTL 756
++ + +G + +V++ + +L + + + L
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK---------KYEHRGIPLIY 132
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH------VGDFGLA 807
+++I + + +DY+H C IH D+KP N+L++ + + D G A
Sbjct: 133 VKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/179 (12%), Positives = 60/179 (33%), Gaps = 40/179 (22%)
Query: 651 IGIGSFGSVYKGTFDRDGTI--------VAIKV--LNLQLQGASKSFAAECRA------- 693
+ G +Y+ T ++K+ + +L F +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 694 -LRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEI 751
L + + + + ++ LV + G SL++ L + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQSAL---------DVSPK- 153
Query: 752 RNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL--DNNLTAHVGDFGLAR 808
L+ + +A + A+++LH + +H ++ NI + ++ + +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 34/178 (19%)
Query: 649 HLIGIGSFGSVYKGTFD-----RDGTIVAIKVL---NLQLQGASKSF--AAECRALRNIR 698
IG G FG +Y + +KV N L K + AA+ ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 699 HRNLVRV-----ITSCSSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIR 752
++ D G ++ ++ G L+ +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY-----------EANAK 147
Query: 753 NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD--NNLTAHVGDFGLAR 808
+ + +++ + ++Y+H H +H D+K SN+LL+ N ++ D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 45/179 (25%), Positives = 70/179 (39%), Gaps = 43/179 (24%)
Query: 643 DGFSSTHLIGIGSFGSVY---KGTFDRDGTIVAIKVLNLQLQGASKSF---------AAE 690
F ++G GSFG V+ K + + A+KVL K+ E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76
Query: 691 CRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDE 750
L + H +V++ + FQ L+ ++ G L L + E
Sbjct: 77 RDILVEVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL------SKEVMFTE 125
Query: 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
+ +A ++A A+D+LH I+ DLKP NILLD H+ DFGL+
Sbjct: 126 ED-----VKFYLA-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLS 173
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH-RNLVRVITSC 709
IG GSFG +Y GT G VAIK+ ++ + E + + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 710 SSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
D+ +V + + G SLE+ N R +L + +A + S
Sbjct: 75 -----AEGDYNVMVMELL--GPSLEDLF-----------NFCSRKFSLKTVLLLADQMIS 116
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILL---DNNLTAHVGDFGLAR 808
++Y+H IH D+KP N L+ ++ DFGLA+
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 54 NLSFLREIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112
+ +RE+ L N GKI G LE L L + L+ + NL +L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYN 162
N++ G + L NL L + N L L + L+++ L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 21/99 (21%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 316 HSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSF 375
G I + V+L + + + + + +L L+ L + N++ G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 376 GNLSSLVKLILGNNNLSGV-IPSSLGNLKQLALLHLFQN 413
L +L L L N L + L L+ L L LF
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 2/72 (2%)
Query: 345 GKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQ 404
GKI + NL+FL++ + L + S+ L L KL L N + G + L
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 405 LALLHLFQNDLS 416
L L+L N L
Sbjct: 97 LTHLNLSGNKLK 108
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 8/120 (6%)
Query: 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCS 104
I + + L + + LS N I+ KI + + L L L N + +I +
Sbjct: 37 IEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVAD 93
Query: 105 RLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLT--GGIPHFLGNITSLEAISLAYN 162
L L++ N++ S+ S L NL+ L + N +T G I L + LE + LA N
Sbjct: 94 TLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 29/122 (23%), Positives = 53/122 (43%), Gaps = 8/122 (6%)
Query: 60 EIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGS 119
E+H I+ K+ + L + L LS N++ +I +LS L L LGRN ++
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-K 84
Query: 120 IPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELK 179
I + L+EL I N + + + + +L + ++ N + + +L L
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALD 140
Query: 180 SL 181
L
Sbjct: 141 KL 142
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 8/112 (7%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
+ L L S I +S + + LR + L N I+ KI LE L++S+N
Sbjct: 48 KACKHLAL-STNNIEKISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ 104
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLE--GSIPSEFVSLYNLKELAIQENNLT 141
+ + L LY+ NK+ G I + +L L++L + N L
Sbjct: 105 I--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 22/101 (21%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGI 144
L+ + ++ LS L L N +E I S + NL+ L++ N + I
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KI 85
Query: 145 PHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG 185
+ +LE + ++YN + ++ S + +L L+ L +
Sbjct: 86 ENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSN 124
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 33/155 (21%)
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
V+L + + ++L LK L L N++ E+I ++S M
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGME---------- 70
Query: 441 VGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLK 500
NL++L + N + +I + L+E++++ N S+ S + L
Sbjct: 71 ---------NLRIL---SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLV 115
Query: 501 DLREIDLSQNNLSGKIPIS-LERLP-LEYLNLSFN 533
+LR + +S N ++ I L L LE L L+ N
Sbjct: 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 30/165 (18%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH-RNLVRVITSC 709
IG GSFG +++GT + VAIK + + E R + + + V
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 710 SSIDFQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
Q LV + G SLE+ L + R ++ A + +
Sbjct: 76 -----QEGLHNVLVIDLL--GPSLEDLL-----------DLCGRKFSVKTVAMAAKQMLA 117
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILL-----DNNLTAHVGDFGLAR 808
V +H ++ D+KP N L+ N +V DFG+ +
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 47/222 (21%)
Query: 613 RRGGSGKEPSEPILRRALRKVSYES--LLKATDGFSSTHLIGIGSFGSVY---KGTFDRD 667
+ E L KV E+ LLK ++G G++G V+ K +
Sbjct: 31 QLLTVKHELRTANLTGHAEKVGIENFELLK---------VLGTGAYGKVFLVRKISGHDT 81
Query: 668 GTIVAIKVLN----LQLQGASKSFAAECRALRNIRHRN-LVRVITSCSSIDFQGNDFKAL 722
G + A+KVL +Q ++ E + L +IR LV + + FQ L
Sbjct: 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQTETKLHL 136
Query: 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTI 782
+ Y+ G L L E E +I + ++ A+++LH I
Sbjct: 137 ILDYINGGELFTHL------SQRERFTEHE-----VQIYVG-EIVLALEHLHKL---GII 181
Query: 783 HCDLKPSNILLDNN----LTAHVGDFGLARLRQEVPNNQSSS 820
+ D+K NILLD+N LT DFGL++ ++
Sbjct: 182 YRDIKLENILLDSNGHVVLT----DFGLSKEFVADETERAYD 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 44/173 (25%), Positives = 67/173 (38%), Gaps = 42/173 (24%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAA----ECRALRNIRHR---NL 702
+IG GSFG V K + VA+K++ K F E R L ++R + N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-----NEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 703 VRVITSCSSIDFQGN---DFKAL---VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+ VI + F+ + F+ L +Y+ + + +L
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF-------------------QGFSL 199
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH--VGDFGLA 807
A + +D LH + IHCDLKP NILL + V DFG +
Sbjct: 200 PLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
T LDL++ L + L+ L +++L N +Q G +L L L LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPH--FLGNI 151
G ++L L L N+L+ S+P F L LK+L + +N L +P F +
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVF-DRL 147
Query: 152 TSLEAISLAYN 162
TSL+ I L N
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 13/118 (11%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQN 356
++L+ L L N+ + +LP+ + + KL SL + + NQ + +P + +L
Sbjct: 52 TSLTQLYLGGNKLQ-SLPNGVFN--------KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQ 101
Query: 357 LQFLNMRHNQLSGEIPS-SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+ L + NQL +P F L+ L L L N L V L L + L N
Sbjct: 102 LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
S+P+ I ++++ N + L +L L + N+L F L+SL
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIF 424
L L N L + L QL L L N L ++P+ +F
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVF 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 43/132 (32%), Positives = 60/132 (45%), Gaps = 8/132 (6%)
Query: 35 TVLDLKSKGLIGSLSPQI-GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93
T L L L SL + L+ L+E+ L N +Q G +L L L L+HN L
Sbjct: 88 TYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ 146
Query: 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTGGIPH--FLGN 150
G + L L L N+L+ S+P F L LK+L + +N L +P F
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVF-DR 203
Query: 151 ITSLEAISLAYN 162
+TSL+ I L N
Sbjct: 204 LTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 35/229 (15%)
Query: 167 NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQ 226
+ + + LK + T + L+ + + + S+ L N++
Sbjct: 16 DAFAETIKA-NLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQGIQYLP--NVRYLA 69
Query: 227 ISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-FGDMKSLAYLNVAINNLGS--- 282
+ N A +NL L L N L F + +L L + N L S
Sbjct: 70 LGGNKLH-DIS-ALKELTNLTYLI-LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPD 126
Query: 283 GESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQ 342
G D+++ NL++LNL NQ + +LP + KL +L +++ +NQ
Sbjct: 127 GVFDKLT---------NLTYLNLAHNQLQ-SLPKGVFD--------KLTNLTELDLSYNQ 168
Query: 343 FEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPS-SFGNLSSLVKLILGNN 389
+ +PE + +L L+ L + NQL +P F L+SL + L +N
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 25/175 (14%)
Query: 296 NCSNLSFLNLVANQFKGALPHSIVSG----SIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351
N S + V ++ I + S+ I L ++ + + N+ I +
Sbjct: 25 NLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLH-DISA-L 81
Query: 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLF 411
L NL +L + NQL F L++L +L+L N L + L L L+L
Sbjct: 82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141
Query: 412 QNDLSGAIPEEIFNISHMSDS------LNFARNHLVGSIPP----KIGNLKVLRM 456
N L ++P+ +F D L+ + N L S+P K+ LK LR+
Sbjct: 142 HNQLQ-SLPKGVF------DKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRL 188
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 52/164 (31%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRAL-RNIRHRNLVRV 705
+IG GSFG V + A+KVL + K +E L +N++H LV +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
S FQ D V Y+ G L L Q + E R R A +
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGELFYHL------QRERCFLEPR-----ARFYAA-E 147
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
+ASA+ YLH ++ DLKP NILLD+ H+ DFGL
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLC 186
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 28/171 (16%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRAL-RNIR 698
F+ ++G GSFG V + A+K+L + E R L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
L + + SC FQ D V +Y+ G L H + + E
Sbjct: 401 PPFLTQ-LHSC----FQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEP---------HA 444
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
A ++A + +L I+ DLK N++LD+ H+ DFG+
Sbjct: 445 VFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMC 489
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 58/343 (16%), Positives = 113/343 (32%), Gaps = 68/343 (19%)
Query: 128 YNLKELAIQENNLTG----GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183
++++ +++ + +T + L S++ I L+ N++G + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG---------TEAARWLSE 54
Query: 184 GGTIPPSIYNLSLLANFSVPENRLHGSLPPSLG------LTLSNLQLFQISNNFFS--GS 235
+ F+ R+ +P +L L L ++S+N F
Sbjct: 55 NIASKKDLEIAEFSDIFT---GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 236 FPLA--FSNASNLQSLEILGNNFFG--------------KLSVNFGDMKSLAYLNVAINN 279
PL S + L+ L L NN G ++ + L + N
Sbjct: 112 EPLIDFLSKHTPLEHL-YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 280 LGSGESDEMSFIHSLANCSNLSFLNLVANQF--KGALPHSIVSGSIPSEIGKLVSLYLIE 337
L +G E + + + L + +V N +G + + L +++
Sbjct: 171 LENGSMKEWA--KTFQSHRLLHTVKMVQNGIRPEGI------EHLLLEGLAYCQELKVLD 222
Query: 338 MDHNQF--EG--KIPEEMSRLQNLQFLNMRHNQLSGE----IPSSFGNLS--SLVKLILG 387
+ N F G + + NL+ L + LS + +F L L L L
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 282
Query: 388 NNNLSGVIPSSLG-----NLKQLALLHLFQNDLS--GAIPEEI 423
N + +L + L L L N S + +EI
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEI 325
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 49/248 (19%), Positives = 74/248 (29%), Gaps = 55/248 (22%)
Query: 47 SLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFR----LEALYLSHNSL---------- 92
L + L + LS+N + LE LYL +N L
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 93 ---VGEIPGNLSYCSRLIGLYLGRNKLEG----SIPSEFVSLYNLKELAIQENNLTG-GI 144
+ L + GRN+LE F S L + + +N + GI
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 145 PHFLGNI----TSLEAISLAYNSLGGN----IPSSLGQLKELKSLGLGGTIPPSIYN--- 193
H L L+ + L N+ + +L L+ LGL +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC---LLSARGA 261
Query: 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS--GSFPLAFS---NASNLQS 248
+++ FS EN L L+L N L +L
Sbjct: 262 AAVVDAFSKLENI-----------GLQTLRL---QYNEIELDAVRTLKTVIDEKMPDLLF 307
Query: 249 LEILGNNF 256
LE+ GN F
Sbjct: 308 LELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 58/418 (13%), Positives = 113/418 (27%), Gaps = 103/418 (24%)
Query: 34 VTVLDLKSKGL----IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFR----LEAL 85
+ LK + S+ + ++EI LS NTI + + LE
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 86 YLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG--- 142
S G + + RL+ L + L + + +N
Sbjct: 66 EFSDIFT-GRVKDEIPEALRLLLQALLKCP-------------KLHTVRLSDNAFGPTAQ 111
Query: 143 -GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFS 201
+ FL T LE + L N LG + + +
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-------------------------- 145
Query: 202 VPENRLHGSLPPSLGLTLSNLQLFQISNNFFS--GSFPLA--FSNASNLQSLEILGNNFF 257
L L+ N A F + L +++++ N
Sbjct: 146 -----LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
Query: 258 GK-----LSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312
+ L + L L++ N S ++ +L + NL L L
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA--IALKSWPNLRELGLNDCL--- 255
Query: 313 ALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIP 372
+ + V ++++ LQ L +++N++ +
Sbjct: 256 ----------LSARGAAAVVDAFSKLEN--------------IGLQTLRLQYNEIELDAV 291
Query: 373 SSFG-----NLSSLVKLILGNNNLS--GVIPSSLGN-LKQLALLHLFQNDLSGAIPEE 422
+ + L+ L L N S + + L + D + +E
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDE 349
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
S+P+ I L L + N+ + +L L L++ NQ+ F L+
Sbjct: 21 SVPTGIPSSATRLEL---ESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK 77
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFN 425
L L L N L + L QL L L N L ++P+ IF+
Sbjct: 78 LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFD 121
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 329 KLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIPSS-FGNLSSLVKLIL 386
KL L + + NQ + +P+ + +L L L + N+L +P+ F L+ L +L L
Sbjct: 50 KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107
Query: 387 GNNNLSGVIPSSLGNLKQLALLHLFQN 413
N L V L L + L N
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 11/92 (11%)
Query: 299 NLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNL 357
L+ L+L NQ + +LP + KL L ++ + N+ + +P + +L L
Sbjct: 53 QLTKLSLSQNQIQ-SLPDGVFD--------KLTKLTILYLHENKLQ-SLPNGVFDKLTQL 102
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
+ L + NQL F L+SL K+ L N
Sbjct: 103 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG GSFG +Y GT + VAIK+ N++ + E + R ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGI-----PN 67
Query: 711 SIDF-QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
F D+ LV + SLE+ N R L+L + +A + +
Sbjct: 68 VRWFGVEGDYNVLVMDLLGP-SLEDLF-----------NFCSRKLSLKTVLMLADQMINR 115
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAH---VGDFGLAR 808
V+++H +H D+KP N L+ A+ + DFGLA+
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 45/183 (24%), Positives = 69/183 (37%), Gaps = 29/183 (15%)
Query: 631 RKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA-- 688
+ S + LK D F ++G GSFG V+ F + AIK L +
Sbjct: 6 ERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 689 -AECRAL-RNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE 746
E R L H L + + FQ + V +Y+ G L + Q+
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHI------QSCH 113
Query: 747 ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDF 804
+ D R A ++ + +LH ++ DLK NILLD + H+ DF
Sbjct: 114 KFDLSR-----ATFYAA-EIILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADF 162
Query: 805 GLA 807
G+
Sbjct: 163 GMC 165
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-----HRNLV 703
+G G F +V+ + VA+KV+ + +++ E R L+++R N
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 704 RVITSCSSIDFQGNDFK--ALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERI 760
V+ G + +V++ + G L W+ + L L
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI----------IKSNYQGLPLPCVK 149
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793
I V +DYLH C+ IH D+KP NILL
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 49/193 (25%), Positives = 71/193 (36%), Gaps = 29/193 (15%)
Query: 621 PSEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL 680
P E V+ + L + F ++G GSFG V G + A+KVL +
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDN-FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60
Query: 681 QGASKSFA---AECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWL 736
E R L H L ++ FQ D V +++ G L +
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLFCC-----FQTPDRLFFVMEFVNGGDLMFHI 115
Query: 737 HPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796
Q DE R R A ++ SA+ +LH I+ DLK N+LLD+
Sbjct: 116 ------QKSRRFDEAR-----ARFYAA-EIISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 797 LTAHV--GDFGLA 807
H DFG+
Sbjct: 161 --GHCKLADFGMC 171
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 34/172 (19%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRAL-RNIRHR 700
F+ ++G GSFG V + A+K+L + E R L +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE-- 758
L ++ + FQ D V +Y+ G L + + E
Sbjct: 82 FLTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQ--------------QVGRFKEPH 122
Query: 759 -RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
A ++A + +L I+ DLK N++LD+ H+ DFG+
Sbjct: 123 AVFYAA-EIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMC 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 39/181 (21%)
Query: 650 LIGIGSFGSVYKGTFD--RDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHR---NL 702
+G G+FG V + D R + VA+K++ + + A++ E L+ I+ + N
Sbjct: 26 NLGEGTFGKVVEC-LDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENK 81
Query: 703 VRVITSCSSIDFQGN---DFKAL---VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+ +F G+ F+ L ++++ N P +P +R
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKE----NNFQPYPLPH-------VR---- 126
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN 816
+A + A+ +LH + H DLKP NIL N+ + + + + V N
Sbjct: 127 ----HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 817 Q 817
Sbjct: 180 S 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 26/166 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHR---NLVR 704
LIG GSFG V K + VAIK++ ++ E R L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKYY 117
Query: 705 VITSCSSIDFQGNDFKALVYQYM-PNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
++ F+ + LV++ + N L+ D + T+ R ++L A
Sbjct: 118 IVHLKRHFMFRNHLC--LVFEMLSYN------LY-DLLRNTNF-----RGVSLNLTRKFA 163
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH--VGDFGLA 807
+ +A+ +L + IHCDLKP NILL N + + DFG +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 39/181 (21%)
Query: 650 LIGIGSFGSVYKGTFD--RDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHR---NL 702
+G G+FG V + D G VA+K++ + A++S E + L ++ +
Sbjct: 21 TLGEGAFGKVVEC-IDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNST 76
Query: 703 VRVITSCSSIDFQGN---DFKAL---VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
R + + G+ F+ L Y ++ N P + IR
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE----NGFLPFRLDH-------IR---- 121
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN 816
+A + +V++LH + H DLKP NIL + + + R + + N
Sbjct: 122 ----KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 817 Q 817
Sbjct: 175 D 175
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 38/164 (23%), Positives = 64/164 (39%), Gaps = 28/164 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRAL-RNIRHRNLVRV 705
+IG GS+ V + I A++V+ +L + E + H LV +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ FQ V +Y+ G L + Q + E R A +
Sbjct: 119 HSC-----FQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEH-----ARFYSA-E 161
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
++ A++YLH I+ DLK N+LLD+ H+ D+G+
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMC 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 39/164 (23%), Positives = 64/164 (39%), Gaps = 28/164 (17%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFA---AECRAL-RNIRHRNLVRV 705
+IG GS+ V + I A+KV+ +L + E + H LV +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ FQ V +Y+ G L + Q + E R A +
Sbjct: 76 HSC-----FQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEH-----ARFYSA-E 118
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLA 807
++ A++YLH I+ DLK N+LLD+ H+ D+G+
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMC 157
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS-FGNLS 379
S+P+ I LYL NQ P RL L L++ +NQL+ +P+ F L+
Sbjct: 23 SVPTGIPTTTQVLYL---YDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT 78
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L +L L +N L + + NLK L + L N
Sbjct: 79 QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 34/160 (21%), Positives = 60/160 (37%), Gaps = 41/160 (25%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVL--NLQLQGASKSFAAECRALRNIRHR-----NL 702
+G G+FG V + A+KV+ + ++K E L+ I++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98
Query: 703 VRVITSCSSIDFQGN---DFKAL---VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
V+ + + F+ L +Y+ + N + I I+
Sbjct: 99 VKYH---GKFMYYDHMCLIFEPLGPSLYEIITR----NNYNGFHIED-------IK---- 140
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796
I++ A++YL H DLKP NILLD+
Sbjct: 141 ----LYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 322 SIPSEI-GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS-FGNLS 379
S+P+ I L+L ++NQ P L NLQ L N+L+ IP+ F L+
Sbjct: 26 SVPAGIPTDKQRLWL---NNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLT 81
Query: 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L +L L +N+L + + NLK L ++L+ N
Sbjct: 82 QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.95 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.93 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.92 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.92 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.92 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.92 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.92 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.92 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.92 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.92 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.92 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.92 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.92 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.92 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.92 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.91 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.91 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.91 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.91 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.91 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.91 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.91 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.91 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.91 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.91 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.91 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.91 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.91 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.91 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.91 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.91 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.91 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.91 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.91 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.91 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.91 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.91 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.91 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.91 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.91 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.91 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.91 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.91 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.9 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.9 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.9 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.9 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.9 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.9 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.9 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.9 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.9 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.9 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.9 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.9 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.9 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.9 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.9 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.9 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.9 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.9 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.9 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.9 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.9 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.9 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.9 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.9 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.9 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.9 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.9 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.9 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.9 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.9 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.9 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.9 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.9 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.9 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.9 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.9 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.9 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.9 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.9 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.9 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.9 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.9 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.89 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.89 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.89 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.89 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.89 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.89 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.89 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.89 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.89 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.89 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.89 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.89 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.89 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.89 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.89 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.89 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.89 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.89 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.89 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.89 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.89 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.89 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.89 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.89 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.88 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.88 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.88 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.88 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.88 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.88 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.88 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.88 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.88 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.88 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.88 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.88 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.87 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.87 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.87 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.87 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.87 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.86 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.86 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.85 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.85 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.85 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.84 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.84 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.2 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.9 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.86 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.76 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.65 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.0 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.86 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.6 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.28 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.79 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-75 Score=701.39 Aligned_cols=551 Identities=33% Similarity=0.511 Sum_probs=405.5
Q ss_pred CCcccccCCCCCCCCceeeceeecCCCCcEEEEECCCCCCccc---cC-----------------------cCCCCCCCC
Q 003368 5 YPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGS---LS-----------------------PQIGNLSFL 58 (825)
Q Consensus 5 ~~~~~~~~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~---~~-----------------------~~~~~l~~L 58 (825)
||. ++++|..+++||.|.||+|+ .++|+.|||+++++.|. +| +.|+.+++|
T Consensus 26 ~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L 102 (768)
T 3rgz_A 26 DKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASL 102 (768)
T ss_dssp CTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTC
T ss_pred Ccc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCCC
Confidence 887 89999888899999999998 58999999999999886 43 578889999
Q ss_pred CEEEcCCCcccccCCc--cccCCCCCCEEECCCCcCCCCCCcCC-CCCCCCCEEEcCCCCCCCCCChh---hhc------
Q 003368 59 REIHLSNNTIQGKIPG--EIGRLFRLEALYLSHNSLVGEIPGNL-SYCSRLIGLYLGRNKLEGSIPSE---FVS------ 126 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~---~~~------ 126 (825)
++|||++|.++|.+|. .|+++++|++|||++|.+++..|..+ ..+++|++|||++|++++..|.. +.+
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~ 182 (768)
T 3rgz_A 103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182 (768)
T ss_dssp CEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCE
T ss_pred CEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCE
Confidence 9999999999998888 99999999999999999998888776 78888888888888888777665 444
Q ss_pred ----------------ccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCc----
Q 003368 127 ----------------LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT---- 186 (825)
Q Consensus 127 ----------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~---- 186 (825)
+++|++|+|++|++++.+|. |+++++|++|+|++|++++.+|..|+++++|++|+++++
T Consensus 183 L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~ 261 (768)
T 3rgz_A 183 LAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261 (768)
T ss_dssp EECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEE
T ss_pred EECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccC
Confidence 44555555555555555554 666677777777777776666777777777777766642
Q ss_pred -CCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccC-c
Q 003368 187 -IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN-F 264 (825)
Q Consensus 187 -~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~ 264 (825)
+|.. .++.|+.|++++|+++|.+|..++..+++|++|+|++|.+++.+|..|.++++|++|+|++|++.+.+|.. +
T Consensus 262 ~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l 339 (768)
T 3rgz_A 262 PIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339 (768)
T ss_dssp SCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHH
T ss_pred ccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHH
Confidence 2222 56666666777777766777766644577777777777777777777777777777777777777666654 7
Q ss_pred CCCCCCcEEEcccccCCCCCCCc---------------------------------------------cccccccccCCC
Q 003368 265 GDMKSLAYLNVAINNLGSGESDE---------------------------------------------MSFIHSLANCSN 299 (825)
Q Consensus 265 ~~l~~L~~L~ls~N~l~~~~~~~---------------------------------------------~~~~~~~~~l~~ 299 (825)
..+++|++|+++.|.+....... ...|..+.++++
T Consensus 340 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~ 419 (768)
T 3rgz_A 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419 (768)
T ss_dssp TTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTT
T ss_pred hcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCC
Confidence 77777777777777664211100 012233444444
Q ss_pred CCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCC
Q 003368 300 LSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLS 379 (825)
Q Consensus 300 L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 379 (825)
|+.|++++|++++ .+|..+..+++|+.|++++|++++.+|..+..+++|++|+|++|++.+.+|.++.+++
T Consensus 420 L~~L~Ls~N~l~~---------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 490 (768)
T 3rgz_A 420 LVSLHLSFNYLSG---------TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490 (768)
T ss_dssp CCEEECCSSEEES---------CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred CCEEECcCCcccC---------cccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC
Confidence 5555555554444 4445555555555555555555555555555555555555555555555555555555
Q ss_pred CCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCC--------------
Q 003368 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP-------------- 445 (825)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p-------------- 445 (825)
+|++|+|++|++++.+|.+++.+++|++|++++|+++|.+|..+..+..+ +.|++++|+++|.+|
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~ 569 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANF 569 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCST
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhc
Confidence 55555555555555555555555566666666666655555555555554 455555555555555
Q ss_pred --------------------------------------------------------ccccccccccEEeecCceecccCC
Q 003368 446 --------------------------------------------------------PKIGNLKVLRMFVVSSNNLSGEIP 469 (825)
Q Consensus 446 --------------------------------------------------------~~~~~l~~L~~L~ls~N~l~g~~p 469 (825)
..++.++.|+.||+++|+++|.+|
T Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip 649 (768)
T 3rgz_A 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649 (768)
T ss_dssp TCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCC
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCC
Confidence 445556789999999999999999
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCCCccCcc
Q 003368 470 SEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTKGIFANA 548 (825)
Q Consensus 470 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~~~~~~~ 548 (825)
.+++.++.|+.|+|++|+++|.+|..++++++|+.||||+|+++|.+|..+..+ .|++||+|+|+++|.||..++|.++
T Consensus 650 ~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~ 729 (768)
T 3rgz_A 650 KEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729 (768)
T ss_dssp GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGS
T ss_pred HHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccC
Confidence 999999999999999999999999999999999999999999999999999999 6999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCcCCCCCCCCC
Q 003368 549 SAISVSGNSNRLCGGIPELQLPKCPKNN 576 (825)
Q Consensus 549 ~~~~~~~n~~~lc~~~~~~~~~~~~~~~ 576 (825)
...+|.||+ .+||.+. ++|....
T Consensus 730 ~~~~~~gN~-~Lcg~~l----~~C~~~~ 752 (768)
T 3rgz_A 730 PPAKFLNNP-GLCGYPL----PRCDPSN 752 (768)
T ss_dssp CGGGGCSCT-EEESTTS----CCCCSCC
T ss_pred CHHHhcCCc-hhcCCCC----cCCCCCc
Confidence 999999999 9999752 3786544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-63 Score=598.60 Aligned_cols=488 Identities=33% Similarity=0.495 Sum_probs=367.7
Q ss_pred CcEEEEECCCCCCccccCcC---CCCCCCCCEEEcCCCccc----------------------ccCCccccCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQ---IGNLSFLREIHLSNNTIQ----------------------GKIPGEIGRLFRLEALY 86 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~---~~~l~~L~~L~Ls~N~l~----------------------~~~p~~~~~l~~L~~L~ 86 (825)
.+++.|||++|++.+..|.. +.++++|++|+|++|+++ +.+|. |+++++|++|+
T Consensus 151 ~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~ 229 (768)
T 3rgz_A 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229 (768)
T ss_dssp TTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEE
T ss_pred CCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEE
Confidence 45666666666666655544 445555555555555544 44443 44444455555
Q ss_pred CCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCC-CCCCEEEcccCcCc
Q 003368 87 LSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI-TSLEAISLAYNSLG 165 (825)
Q Consensus 87 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 165 (825)
|++|++++.+|..|..+++|++|+|++|++++.+|.. .+++|++|+|++|++++.+|..+..+ ++|++|+|++|+++
T Consensus 230 Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~ 307 (768)
T 3rgz_A 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY 307 (768)
T ss_dssp CCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred CcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence 5555444444444444555555555555544444432 44455555555555555555555543 66666666666666
Q ss_pred ccCCcccccccccceecCcC-----cCCcc-ccCCCCCceeecCCccccccCCchhhhcCC-CCcEEEcccccCCCCCCc
Q 003368 166 GNIPSSLGQLKELKSLGLGG-----TIPPS-IYNLSLLANFSVPENRLHGSLPPSLGLTLS-NLQLFQISNNFFSGSFPL 238 (825)
Q Consensus 166 ~~~p~~~~~l~~L~~L~L~~-----~~p~~-i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~-~L~~L~Ls~N~l~~~~p~ 238 (825)
+.+|..|+++++|++|++++ .+|.. +..++.|+.|++++|+++|.+|..+. .++ +|+.|+|++|.+++.+|.
T Consensus 308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~~L~~L~Ls~N~l~~~~~~ 386 (768)
T 3rgz_A 308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT-NLSASLLTLDLSSNNFSGPILP 386 (768)
T ss_dssp ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHH-HHTTTCSEEECCSSEEEEECCT
T ss_pred CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHH-hhhcCCcEEEccCCCcCCCcCh
Confidence 66666666666666666653 34443 56666666666666666666666665 343 666666666666666666
Q ss_pred cccC--CCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCC
Q 003368 239 AFSN--ASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPH 316 (825)
Q Consensus 239 ~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 316 (825)
.+.. +++|++|+|++|++.+.+|..+..+++|++|++++|.+... .|..+..+++|+.|++++|.+++
T Consensus 387 ~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~------~p~~l~~l~~L~~L~L~~n~l~~---- 456 (768)
T 3rgz_A 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT------IPSSLGSLSKLRDLKLWLNMLEG---- 456 (768)
T ss_dssp TTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESC------CCGGGGGCTTCCEEECCSSCCCS----
T ss_pred hhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCc------ccHHHhcCCCCCEEECCCCcccC----
Confidence 6555 67788888888888878888888888888888888887643 36678899999999999999987
Q ss_pred CcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccC
Q 003368 317 SIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIP 396 (825)
Q Consensus 317 ~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 396 (825)
.+|..+..+++|+.|++++|++++.+|..+.++++|++|+|++|++.+.+|.+++.+++|++|+|++|+++|.+|
T Consensus 457 -----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 531 (768)
T 3rgz_A 457 -----EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531 (768)
T ss_dssp -----CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred -----cCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence 788889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCccceeecCCCCCccccchhhhccc-------------------------------------------------
Q 003368 397 SSLGNLKQLALLHLFQNDLSGAIPEEIFNIS------------------------------------------------- 427 (825)
Q Consensus 397 ~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~------------------------------------------------- 427 (825)
..++.+++|+.|++++|+++|.+|..++...
T Consensus 532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (768)
T 3rgz_A 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 9999999999999999999999998776421
Q ss_pred --------------------ccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCc
Q 003368 428 --------------------HMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENF 487 (825)
Q Consensus 428 --------------------~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~ 487 (825)
..++.||+++|+++|.+|..+++++.|+.|+|++|+++|.+|.+++.+++|+.|+|++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 112579999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCEEECCCCccccccCcccccccCceeeCCCCc-ceec
Q 003368 488 FRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFND-LEGQ 538 (825)
Q Consensus 488 l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~L~~l~ls~N~-l~g~ 538 (825)
++|.+|..+..+++|++||+|+|+++|.||..-.-..+....+.+|+ ++|.
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999999999999975332245566677774 7764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-57 Score=531.98 Aligned_cols=491 Identities=19% Similarity=0.193 Sum_probs=405.2
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
..++.|||++|.+.+..|.+|+++++|++|+|++|++++..|.+|+++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 68999999999999988999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccc--eecCcCc---
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELK--SLGLGGT--- 186 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--~L~L~~~--- 186 (825)
++|+|++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|+.+++|+ .|+++++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999987788999999999999999999986555566699999999999999988899999999999 7888764
Q ss_pred -CCccccCCCCCceeecCCccccc-------------------------cCCchhhhcCC--CCcEEEcccccCCCCCCc
Q 003368 187 -IPPSIYNLSLLANFSVPENRLHG-------------------------SLPPSLGLTLS--NLQLFQISNNFFSGSFPL 238 (825)
Q Consensus 187 -~p~~i~~l~~l~~l~l~~N~l~~-------------------------~lp~~~~~~l~--~L~~L~Ls~N~l~~~~p~ 238 (825)
+++.......|+.+++++|.... .++...+..+. +|+.|++++|.+++..+.
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 34444555678888888775110 12222222222 678888888888888888
Q ss_pred cccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCc
Q 003368 239 AFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSI 318 (825)
Q Consensus 239 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 318 (825)
.|.++++|++|+|++|++. .+|..+..+++|++|++++|.+.... +..+..+++|++|++++|.+.+
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~n~~~~------ 339 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC------QISASNFPSLTHLSIKGNTKRL------ 339 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG------GGCGGGCTTCSEEECCSCSSCC------
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc------hhhhhccCcCCEEECCCCCccc------
Confidence 8888888888888888887 56677888888888888888876432 4467778888888888888876
Q ss_pred ccccCCc-cccCCCCcCEEEcccCcccccC--CccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCcccccc
Q 003368 319 VSGSIPS-EIGKLVSLYLIEMDHNQFEGKI--PEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVI 395 (825)
Q Consensus 319 ~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 395 (825)
.+|. .+..+++|+.|++++|.+++.. |..+..+++|++|++++|++.+..|..|..+++|++|++++|++++..
T Consensus 340 ---~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 416 (606)
T 3t6q_A 340 ---ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416 (606)
T ss_dssp ---BCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCT
T ss_pred ---ccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcc
Confidence 4443 3677888888888888888765 777888888888888888888888888888888888888888888776
Q ss_pred CCC-CCCCCccceeecCCCCCccccchhhhcccccccccccCCCcccc---CCCccccccccccEEeecCceecccCCcc
Q 003368 396 PSS-LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVG---SIPPKIGNLKVLRMFVVSSNNLSGEIPSE 471 (825)
Q Consensus 396 p~~-~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~---~~p~~~~~l~~L~~L~ls~N~l~g~~p~~ 471 (825)
|.. +..+++|+.|++++|.+++..|..+..+..+ +.|++++|++++ ..+..++.+++|+.|++++|++++..|..
T Consensus 417 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 495 (606)
T 3t6q_A 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495 (606)
T ss_dssp TCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTT
T ss_pred cchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC-CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhh
Confidence 544 7888888888888888887777777777776 688888888876 23356888888888888888888888888
Q ss_pred ccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCC
Q 003368 472 IGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVP 540 (825)
Q Consensus 472 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p 540 (825)
++.+++|+.|++++|++++..|..+..++.| .||+++|++++.+|..+..+ .|+++++++|++.+..+
T Consensus 496 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp TTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred hccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 8888888888888888888888888888888 88888888888777777777 58888888888876554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=535.19 Aligned_cols=539 Identities=21% Similarity=0.238 Sum_probs=443.8
Q ss_pred CceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC
Q 003368 19 FCDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96 (825)
Q Consensus 19 ~C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 96 (825)
.|++.+++..|. ..+++.|||++|++.+..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+|++..
T Consensus 10 ~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~ 89 (680)
T 1ziw_A 10 DCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS 89 (680)
T ss_dssp ECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCC
T ss_pred ECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccC
Confidence 466666666654 368999999999999888889999999999999999999999999999999999999999999877
Q ss_pred CcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccc--c
Q 003368 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLG--Q 174 (825)
Q Consensus 97 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~ 174 (825)
+..|.++++|++|+|++|+++++.|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|. .
T Consensus 90 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 169 (680)
T 1ziw_A 90 DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169 (680)
T ss_dssp TTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGT
T ss_pred hhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccc
Confidence 77899999999999999999988889999999999999999999999999999999999999999999988887765 4
Q ss_pred ccccceecCcCc-----CCccccCC---------------------------CCCceeecCCccccccCCchhhhcCC--
Q 003368 175 LKELKSLGLGGT-----IPPSIYNL---------------------------SLLANFSVPENRLHGSLPPSLGLTLS-- 220 (825)
Q Consensus 175 l~~L~~L~L~~~-----~p~~i~~l---------------------------~~l~~l~l~~N~l~~~lp~~~~~~l~-- 220 (825)
+++|+.|+++++ .|..+..+ +.|+.|++++|.+++..|..+. .++
T Consensus 170 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~-~l~~~ 248 (680)
T 1ziw_A 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL-GLKWT 248 (680)
T ss_dssp TCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG-GGGGS
T ss_pred cccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh-ccCcC
Confidence 589999999864 23333332 5677888888888877666654 554
Q ss_pred CCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCcccccc----cccc
Q 003368 221 NLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIH----SLAN 296 (825)
Q Consensus 221 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~----~~~~ 296 (825)
+|+.|+|++|.+++..|..|..+++|++|+|++|++.+..+..|..+++|++|+++.|....... ...+|. .+..
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~-~~~lp~i~~~~~~~ 327 (680)
T 1ziw_A 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS-LASLPKIDDFSFQW 327 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------CCEECTTTTTT
T ss_pred CCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc-cccccccChhhccc
Confidence 49999999999998888889999999999999999998888888888888888888764331100 001111 4567
Q ss_pred CCCCCEEEcccccccccCCCCccc----------------ccCCc-cccC--CCCcCEEEcccCcccccCCccccCCCCC
Q 003368 297 CSNLSFLNLVANQFKGALPHSIVS----------------GSIPS-EIGK--LVSLYLIEMDHNQFEGKIPEEMSRLQNL 357 (825)
Q Consensus 297 l~~L~~L~L~~N~l~~~~~~~~~~----------------~~ip~-~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L 357 (825)
+++|++|++++|.+++..+..+.. ..++. .+.. .++|+.|++++|++++..|..|..+++|
T Consensus 328 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 407 (680)
T 1ziw_A 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL 407 (680)
T ss_dssp CTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC
Confidence 778888888888777643322100 00111 1111 2478888888899998889999999999
Q ss_pred CEEEccccccccccC-ccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCc--cccchhhhcccccccccc
Q 003368 358 QFLNMRHNQLSGEIP-SSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS--GAIPEEIFNISHMSDSLN 434 (825)
Q Consensus 358 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--g~ip~~~~~~~~l~~~l~ 434 (825)
++|+|++|++.+.+| ..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+..+..+ +.|+
T Consensus 408 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L-~~L~ 486 (680)
T 1ziw_A 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL-TILD 486 (680)
T ss_dssp CEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC-CEEE
T ss_pred CEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC-CEEE
Confidence 999999999988776 68899999999999999999998999999999999999999987 6788888888887 7899
Q ss_pred cCCCccccCCCccccccccccEEeecCceecccCC--------ccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEE
Q 003368 435 FARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP--------SEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREID 506 (825)
Q Consensus 435 l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ld 506 (825)
+++|++++..|..++.+++|+.|++++|++++..+ ..++.+++|+.|++++|+++...+..|..+++|+.||
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 99999998888889999999999999999986422 3478899999999999999954445689999999999
Q ss_pred CCCCccccccCcccccc-cCceeeCCCCcceecCCCC-C-ccCccccccccCCCCCCC
Q 003368 507 LSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTK-G-IFANASAISVSGNSNRLC 561 (825)
Q Consensus 507 ls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~-~-~~~~~~~~~~~~n~~~lc 561 (825)
|++|++++..+..+..+ .|+.|++++|++++.+|.. + .+.++....+.+|+ -.|
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~-~~c 623 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP-FDC 623 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCC-CCB
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCC-ccc
Confidence 99999997777777777 6999999999999876642 2 45677788899998 444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=522.93 Aligned_cols=497 Identities=20% Similarity=0.184 Sum_probs=370.5
Q ss_pred CCceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC
Q 003368 18 HFCDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE 95 (825)
Q Consensus 18 ~~C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 95 (825)
-.|.+.+++..|. ..+++.|||++|++.+..+..|.++++|++|+|++|++++..|.+|+++++|++|+|++|+|++.
T Consensus 16 ~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~ 95 (606)
T 3vq2_A 16 YQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95 (606)
T ss_dssp EECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCC
T ss_pred eEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccccc
Confidence 3455566666554 36899999999999998888999999999999999999998899999999999999999999999
Q ss_pred CCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccccccc-ccCccCCCCCCCCEEEcccCcCcccCCccccc
Q 003368 96 IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQ 174 (825)
Q Consensus 96 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 174 (825)
.|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..|+.
T Consensus 96 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 175 (606)
T 3vq2_A 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175 (606)
T ss_dssp CTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHH
T ss_pred ChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhh
Confidence 99999999999999999999998888899999999999999999986 56999999999999999999999999999999
Q ss_pred ccccc----eecCcCc----CCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEc-------------------
Q 003368 175 LKELK----SLGLGGT----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQI------------------- 227 (825)
Q Consensus 175 l~~L~----~L~L~~~----~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~L------------------- 227 (825)
+.+|+ +|+++++ +++.......|+.|++++|.+++...+.....+++|+.+++
T Consensus 176 l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~ 255 (606)
T 3vq2_A 176 LRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255 (606)
T ss_dssp HHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGG
T ss_pred hhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHh
Confidence 88876 6888764 45555555689999999999875444444447888887776
Q ss_pred --------------ccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccc
Q 003368 228 --------------SNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHS 293 (825)
Q Consensus 228 --------------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~ 293 (825)
..|.+++.+|. |..+++|+.|++++|.+... + .+..+++|+.|++++|.+... | .
T Consensus 256 ~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l~~l-------p-~ 324 (606)
T 3vq2_A 256 EGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQLKQF-------P-T 324 (606)
T ss_dssp TTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCCSSC-------C-C
T ss_pred hhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccCccc-------c-c
Confidence 44555555554 66667777777777766443 3 566666777777777766332 2 2
Q ss_pred cccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc--CCccccCCCCCCEEEcccccccccc
Q 003368 294 LANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK--IPEEMSRLQNLQFLNMRHNQLSGEI 371 (825)
Q Consensus 294 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~ 371 (825)
+ .+++|+.|++++|+..+ .+ .+..+++|+.|++++|++++. +|..+..+++|++|++++|.+.+ +
T Consensus 325 ~-~l~~L~~L~l~~n~~~~---------~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~ 391 (606)
T 3vq2_A 325 L-DLPFLKSLTLTMNKGSI---------SF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391 (606)
T ss_dssp C-CCSSCCEEEEESCSSCE---------EC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-E
T ss_pred C-CCCccceeeccCCcCcc---------ch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-c
Confidence 3 56667777777764433 22 345666777777777777655 36666777777777777777663 5
Q ss_pred CccccCCCCCcEEEcccCccccccC-CCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCcccc-CCCcccc
Q 003368 372 PSSFGNLSSLVKLILGNNNLSGVIP-SSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVG-SIPPKIG 449 (825)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~-~~p~~~~ 449 (825)
|..|..+++|++|++++|++.+..| ..+..+++|+.|++++|++++.+|..+..+..+ +.|++++|++++ .+|..++
T Consensus 392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~ 470 (606)
T 3vq2_A 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFA 470 (606)
T ss_dssp CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCT
T ss_pred hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC-CEEECCCCcCCCcchHHhhc
Confidence 5666777777777777777776665 566677777777777777776666666666665 567777777766 3566677
Q ss_pred ccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-c-Cce
Q 003368 450 NLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-P-LEY 527 (825)
Q Consensus 450 ~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~-L~~ 527 (825)
.+++|+.|++++|++++..|..++.+++|+.|++++|++++.+|..+..+++|+.||+++|+++ .+|..+..+ . |++
T Consensus 471 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~ 549 (606)
T 3vq2_A 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAF 549 (606)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCE
T ss_pred cCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcE
Confidence 7777777777777777666777777777777777777777666777777777777777777776 455555555 2 677
Q ss_pred eeCCCCcceecCC
Q 003368 528 LNLSFNDLEGQVP 540 (825)
Q Consensus 528 l~ls~N~l~g~~p 540 (825)
+++++|++.+..+
T Consensus 550 l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 550 FNLTNNSVACICE 562 (606)
T ss_dssp EECCSCCCCCSST
T ss_pred EEccCCCcccCCc
Confidence 7777777665444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=513.31 Aligned_cols=498 Identities=20% Similarity=0.200 Sum_probs=433.9
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
+|.++.++. .+|..+.. .+++|||++|+|++..|.+|+++++|++|+|++|+|++..|..|.++++|++|+|++|++
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455555554 56666543 789999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcC-----Cccc
Q 003368 117 EGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTI-----PPSI 191 (825)
Q Consensus 117 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~-----p~~i 191 (825)
++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|+++++- |..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 99999999999999999999999998888999999999999999999998655566669999999998752 4557
Q ss_pred cCCCCCc--eeecCCccccccCCchhhhcCCCCcEEEcccccC--------------------------CCCCCccccCC
Q 003368 192 YNLSLLA--NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF--------------------------SGSFPLAFSNA 243 (825)
Q Consensus 192 ~~l~~l~--~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l--------------------------~~~~p~~~~~l 243 (825)
..++.|+ .+++++|.+++..|..+ ...+|+.|++++|.- ..+.+..|..+
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~--~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAF--DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTT--TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHh--hhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 7888888 89999999997655543 457888999888741 11222334444
Q ss_pred C--CccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccc
Q 003368 244 S--NLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSG 321 (825)
Q Consensus 244 ~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 321 (825)
. +|+.|++++|.+.+..+..|..+++|++|++++|.+... |..+..+++|++|++++|.+++
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~l-------p~~l~~l~~L~~L~l~~n~l~~--------- 315 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-------PSGLVGLSTLKKLVLSANKFEN--------- 315 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCC-------CSSCCSCTTCCEEECTTCCCSB---------
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCC-------ChhhcccccCCEEECccCCcCc---------
Confidence 3 799999999999999999999999999999999998753 5567889999999999999985
Q ss_pred cCCccccCCCCcCEEEcccCcccccCCc-cccCCCCCCEEEcccccccccc--CccccCCCCCcEEEcccCccccccCCC
Q 003368 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPE-EMSRLQNLQFLNMRHNQLSGEI--PSSFGNLSSLVKLILGNNNLSGVIPSS 398 (825)
Q Consensus 322 ~ip~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 398 (825)
..|..+..+++|+.|++++|.+.+.+|. .+..+++|++|++++|++.+.. |..+..+++|++|++++|++.+..|..
T Consensus 316 ~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 395 (606)
T 3t6q_A 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395 (606)
T ss_dssp GGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT
T ss_pred CchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH
Confidence 4466788999999999999999977765 5899999999999999999776 888999999999999999999999999
Q ss_pred CCCCCccceeecCCCCCccccchh-hhcccccccccccCCCccccCCCccccccccccEEeecCceeccc---CCccccC
Q 003368 399 LGNLKQLALLHLFQNDLSGAIPEE-IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGE---IPSEIGS 474 (825)
Q Consensus 399 ~~~l~~L~~L~L~~N~l~g~ip~~-~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~---~p~~~~~ 474 (825)
|..+++|+.|++++|++++..|.. +..+..+ +.|++++|.+.+..|..++.+++|+.|++++|++++. .+..++.
T Consensus 396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~ 474 (606)
T 3t6q_A 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474 (606)
T ss_dssp TTTCTTCSEEECTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGG
T ss_pred hcCCccCCeEECCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhcc
Confidence 999999999999999999887765 5566666 7999999999999999999999999999999999873 3467999
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCC-CccCcccccc
Q 003368 475 CFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTK-GIFANASAIS 552 (825)
Q Consensus 475 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~ 552 (825)
+++|+.|++++|++++..|..+..+++|+.||+++|++++.+|..+..+ .| +|++++|++++.+|.. ..+.++....
T Consensus 475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~ 553 (606)
T 3t6q_A 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTIN 553 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEE
T ss_pred CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEe
Confidence 9999999999999999999999999999999999999999999999988 58 9999999999877753 3455667788
Q ss_pred ccCCC
Q 003368 553 VSGNS 557 (825)
Q Consensus 553 ~~~n~ 557 (825)
+.+|+
T Consensus 554 l~~N~ 558 (606)
T 3t6q_A 554 LRQNP 558 (606)
T ss_dssp CTTCC
T ss_pred CCCCC
Confidence 88887
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=531.79 Aligned_cols=459 Identities=21% Similarity=0.269 Sum_probs=313.3
Q ss_pred CcccccCCCCCCCCcee---eceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcc------cc------
Q 003368 6 PEGVLNSWNDSHHFCDW---EGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI------QG------ 70 (825)
Q Consensus 6 ~~~~~~~w~~~~~~C~~---~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l------~~------ 70 (825)
+.....+|..++++|.| .||+|+.. ++|+.|+|+++++.|.+|++|++|++|++|||++|.+ .+
T Consensus 53 ~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~ 131 (636)
T 4eco_A 53 GTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISA 131 (636)
T ss_dssp -----CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCT
T ss_pred CCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCcccccccccc
Confidence 33445689988999999 99999866 7999999999999999999999999999999999987 22
Q ss_pred cCCccccCCCCCCEEECCCCcCCCCCCcCCCCC-------------------CCCCEEEcC--CCCCCCCCChhhhcccc
Q 003368 71 KIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYC-------------------SRLIGLYLG--RNKLEGSIPSEFVSLYN 129 (825)
Q Consensus 71 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-------------------~~L~~L~Ls--~N~l~~~~p~~~~~l~~ 129 (825)
.+|... +.+|+ +++++|.+.+.+|..+..+ ..++.+++. .|++++ +|.+|+++++
T Consensus 132 ~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~ 207 (636)
T 4eco_A 132 NMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTK 207 (636)
T ss_dssp TCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTT
T ss_pred CchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccC
Confidence 344433 45566 7888888887777666521 122333332 578887 7888888888
Q ss_pred cceeeccccccccc-----------------cCccCC--CCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcc
Q 003368 130 LKELAIQENNLTGG-----------------IPHFLG--NITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPS 190 (825)
Q Consensus 130 L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~ 190 (825)
|++|+|++|++++. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|
T Consensus 208 L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L--------- 278 (636)
T 4eco_A 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI--------- 278 (636)
T ss_dssp CCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEE---------
T ss_pred CCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEE---------
Confidence 88888888888875 788888 88888888888888888888877777777777
Q ss_pred ccCCCCCceeecCCcc-ccc-cCCchhhhcC------CCCcEEEcccccCCCCCCc--cccCCCCccEEEeecccccCcc
Q 003368 191 IYNLSLLANFSVPENR-LHG-SLPPSLGLTL------SNLQLFQISNNFFSGSFPL--AFSNASNLQSLEILGNNFFGKL 260 (825)
Q Consensus 191 i~~l~~l~~l~l~~N~-l~~-~lp~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~ 260 (825)
++++|+ ++| .+|..++ .+ ++|++|+|++|+++ .+|. .|.++++|+.|+|++|++.|.+
T Consensus 279 ----------~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~i 346 (636)
T 4eco_A 279 ----------NVACNRGISGEQLKDDWQ-ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKL 346 (636)
T ss_dssp ----------ECTTCTTSCHHHHHHHHH-HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEEC
T ss_pred ----------ECcCCCCCccccchHHHH-hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccch
Confidence 777887 887 7888776 44 88999999999888 6777 8888889999999988888777
Q ss_pred ccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCC-CCEEEcccccccccCCCCcccccCCccccCCC--CcCEEE
Q 003368 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN-LSFLNLVANQFKGALPHSIVSGSIPSEIGKLV--SLYLIE 337 (825)
Q Consensus 261 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~--~L~~L~ 337 (825)
| .++.+++|++|++++|.+.. +|..+..+++ |+.|++++|+++ .+|..+..+. +|+.|+
T Consensus 347 p-~~~~l~~L~~L~L~~N~l~~-------lp~~l~~l~~~L~~L~Ls~N~l~----------~lp~~~~~~~l~~L~~L~ 408 (636)
T 4eco_A 347 P-AFGSEIKLASLNLAYNQITE-------IPANFCGFTEQVENLSFAHNKLK----------YIPNIFDAKSVSVMSAID 408 (636)
T ss_dssp C-CCEEEEEESEEECCSSEEEE-------CCTTSEEECTTCCEEECCSSCCS----------SCCSCCCTTCSSCEEEEE
T ss_pred h-hhCCCCCCCEEECCCCcccc-------ccHhhhhhcccCcEEEccCCcCc----------ccchhhhhcccCccCEEE
Confidence 7 67777777777777666652 2444566666 666777666665 3454444433 666666
Q ss_pred cccCcccccCCcccc-------CCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCC-C-------
Q 003368 338 MDHNQFEGKIPEEMS-------RLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGN-L------- 402 (825)
Q Consensus 338 L~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l------- 402 (825)
+++|++++.+|..+. .+++|++|+|++|++.+..+..+..+++|++|+|++|+++ .+|..+.. .
T Consensus 409 Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l 487 (636)
T 4eco_A 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNT 487 (636)
T ss_dssp CCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTG
T ss_pred CcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhcccccccccc
Confidence 666666666666666 5566666666666666332233445666666666666666 33433222 2
Q ss_pred CccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEE
Q 003368 403 KQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIY 482 (825)
Q Consensus 403 ~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ 482 (825)
++|+.|+|++|+++ .+|..++. ..+++|+.|++++|++++ +|..++.+++|+.|+
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~-----------------------~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~ 542 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRA-----------------------TTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGST-----------------------TTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEE
T ss_pred CCccEEECcCCcCC-ccChhhhh-----------------------ccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEE
Confidence 25666666666665 45544430 144445555555555554 455555555555555
Q ss_pred c------cCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccccCceeeCCCCcce
Q 003368 483 M------AENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLE 536 (825)
Q Consensus 483 l------~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~L~~l~ls~N~l~ 536 (825)
| ++|++.+.+|..+..+++|+.|||++|++ +.+|..+. -.|++|++++|++.
T Consensus 543 Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~-~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT-PNISVLDIKDNPNI 600 (636)
T ss_dssp CCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-TTCCEEECCSCTTC
T ss_pred CCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh-CcCCEEECcCCCCc
Confidence 5 45566666666666666666666666666 45565543 24666666666655
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=526.34 Aligned_cols=490 Identities=18% Similarity=0.166 Sum_probs=350.1
Q ss_pred ceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccC-CccccCCCCCCEEECCCCcCCCCCCc
Q 003368 20 CDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKI-PGEIGRLFRLEALYLSHNSLVGEIPG 98 (825)
Q Consensus 20 C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 98 (825)
|.|..|.+ ...+++.|||++|.+.+..|.+|.++++|++|||++|.+.+.+ |.+|+++++|++|+|++|.|++..|+
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 34555555 3478999999999999999999999999999999999665555 88999999999999999999999999
Q ss_pred CCCCCCCCCEEEcCCCCCCCCCChh--hhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccCCcccccc
Q 003368 99 NLSYCSRLIGLYLGRNKLEGSIPSE--FVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSSLGQL 175 (825)
Q Consensus 99 ~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 175 (825)
.|.++++|++|+|++|++++..|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++..|..|..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999877665 9999999999999999998765 579999999999999999999999999988
Q ss_pred --cccceecCcCc-----CCccccCCCC------CceeecCCccccccCCchhhhc------------------------
Q 003368 176 --KELKSLGLGGT-----IPPSIYNLSL------LANFSVPENRLHGSLPPSLGLT------------------------ 218 (825)
Q Consensus 176 --~~L~~L~L~~~-----~p~~i~~l~~------l~~l~l~~N~l~~~lp~~~~~~------------------------ 218 (825)
++|+.|+++++ .|..+..+.. |+.|++++|.+++.+|..+...
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999998753 4555555554 9999999999988777665422
Q ss_pred -------------CCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCC
Q 003368 219 -------------LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGES 285 (825)
Q Consensus 219 -------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~ 285 (825)
.++|+.|+|++|.+.+..|..|..+++|+.|+|++|++.+..+..|..+++|++|+++.|.+....
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~- 330 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY- 330 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC-
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC-
Confidence 145666666666666666666666666666666666666666666666666666666666665432
Q ss_pred CccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEcccc
Q 003368 286 DEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHN 365 (825)
Q Consensus 286 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 365 (825)
+..+..+++|+.|++++|.+++ ..+..+..+++|+.|+|++|.+++. + .+++|+.|++++|
T Consensus 331 -----~~~~~~l~~L~~L~L~~N~i~~---------~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~N 391 (844)
T 3j0a_A 331 -----SSNFYGLPKVAYIDLQKNHIAI---------IQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSGN 391 (844)
T ss_dssp -----SCSCSSCTTCCEEECCSCCCCC---------CCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEESC
T ss_pred -----HHHhcCCCCCCEEECCCCCCCc---------cChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCCC
Confidence 3345566666666666666653 2223455666666666666666532 2 2566666666666
Q ss_pred ccccccCccccCCCCCcEEEcccCccccccC-CCCCCCCccceeecCCCCCccccchhhh-cccccccccccCCCccc--
Q 003368 366 QLSGEIPSSFGNLSSLVKLILGNNNLSGVIP-SSLGNLKQLALLHLFQNDLSGAIPEEIF-NISHMSDSLNFARNHLV-- 441 (825)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~ip~~~~-~~~~l~~~l~l~~N~l~-- 441 (825)
++. .+|.. ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+.... ....+ +.|++++|.++
T Consensus 392 ~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L-~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 392 KLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL-EQLFLGENMLQLA 466 (844)
T ss_dssp CCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC-CBCEEESCCCSSS
T ss_pred Ccc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc-ccccCCCCccccc
Confidence 666 34443 3456666666666664321 1234666777777777777644333222 22333 56677777765
Q ss_pred ---cCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCc
Q 003368 442 ---GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPI 518 (825)
Q Consensus 442 ---~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~ 518 (825)
+..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+. ++|+.|||++|++++.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 33445566677777777777777766666677777777777777777755555444 6677777777777776666
Q ss_pred ccccccCceeeCCCCcceecCC
Q 003368 519 SLERLPLEYLNLSFNDLEGQVP 540 (825)
Q Consensus 519 ~~~~l~L~~l~ls~N~l~g~~p 540 (825)
.+. .|+.+++++|++....+
T Consensus 545 ~~~--~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 545 VFV--SLSVLDITHNKFICECE 564 (844)
T ss_dssp CCS--SCCEEEEEEECCCCSSS
T ss_pred HhC--CcCEEEecCCCcccccc
Confidence 553 35667777776665444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=502.54 Aligned_cols=502 Identities=20% Similarity=0.217 Sum_probs=393.5
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|||++|.+.+..|..|+++++|++|+|++|++++..+.+|+++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 57888888888888888888888888888888888888666667888888888888888888777788888888888888
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCC--CCCCCCEEEcccCcCcccCCccccccccc-----------
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLG--NITSLEAISLAYNSLGGNIPSSLGQLKEL----------- 178 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L----------- 178 (825)
++|++++..|..|.++++|++|++++|++++..+..|. .+++|+.|++++|++++..|..|..+.+|
T Consensus 129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~ 208 (680)
T 1ziw_A 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208 (680)
T ss_dssp CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence 88888888888888888888888888888877766554 45788888888888888878777766544
Q ss_pred ----------------ceecCcCc-----CCccccCCCC--CceeecCCccccccCCchhhhcCCCCcEEEcccccCCCC
Q 003368 179 ----------------KSLGLGGT-----IPPSIYNLSL--LANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235 (825)
Q Consensus 179 ----------------~~L~L~~~-----~p~~i~~l~~--l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~ 235 (825)
+.|+++++ .|..+..++. |+.|++++|++++..|..+. .+++|++|+|++|.+++.
T Consensus 209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~ 287 (680)
T 1ziw_A 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFA-WLPQLEYFFLEYNNIQHL 287 (680)
T ss_dssp HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSCCBSEE
T ss_pred hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCccccc-CcccccEeeCCCCccCcc
Confidence 44444432 3455555554 88888888888765555554 778888888888888877
Q ss_pred CCccccCCCCccEEEeecccccCc-----cc----cCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcc
Q 003368 236 FPLAFSNASNLQSLEILGNNFFGK-----LS----VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLV 306 (825)
Q Consensus 236 ~p~~~~~l~~L~~L~L~~N~l~~~-----~~----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~ 306 (825)
.|.+|..+++|+.|++++|...+. +| ..|..+++|++|+++.|.+.... +..+.++++|++|+++
T Consensus 288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~Ls 361 (680)
T 1ziw_A 288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK------SNMFTGLINLKYLSLS 361 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCC------TTTTTTCTTCCEEECT
T ss_pred ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCC------hhHhccccCCcEEECC
Confidence 777777777777777776544321 12 25666677777777777666543 2234455555555555
Q ss_pred cccccccC-C------------------CCcccccCCccccCCCCcCEEEcccCcccccCC-ccccCCCCCCEEEccccc
Q 003368 307 ANQFKGAL-P------------------HSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIP-EEMSRLQNLQFLNMRHNQ 366 (825)
Q Consensus 307 ~N~l~~~~-~------------------~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~ 366 (825)
+|.+++.. + ...+.+..|..+..+++|+.|++++|++++.+| ..|.++++|++|++++|+
T Consensus 362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~ 441 (680)
T 1ziw_A 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441 (680)
T ss_dssp TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence 55432110 0 001122456778899999999999999998776 689999999999999999
Q ss_pred cccccCccccCCCCCcEEEcccCccc--cccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCC
Q 003368 367 LSGEIPSSFGNLSSLVKLILGNNNLS--GVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSI 444 (825)
Q Consensus 367 l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~ 444 (825)
+.+..+..|..+++|++|++++|.+. +.+|..|+.+++|+.|++++|++++..|..+..+..+ +.|++++|++++..
T Consensus 442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~ 520 (680)
T 1ziw_A 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLW 520 (680)
T ss_dssp EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGG
T ss_pred cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccc
Confidence 99999999999999999999999987 6789999999999999999999996555556677776 79999999998642
Q ss_pred --------CccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCcccccc
Q 003368 445 --------PPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKI 516 (825)
Q Consensus 445 --------p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~ 516 (825)
+..++++++|+.|++++|+++...+..|+.+++|+.|+|++|++++..+..|..+++|+.|++++|++++..
T Consensus 521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~ 600 (680)
T 1ziw_A 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600 (680)
T ss_dssp STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence 234789999999999999999444456999999999999999999777777899999999999999999888
Q ss_pred Ccccc-cc-cCceeeCCCCcceecCCC
Q 003368 517 PISLE-RL-PLEYLNLSFNDLEGQVPT 541 (825)
Q Consensus 517 p~~~~-~l-~L~~l~ls~N~l~g~~p~ 541 (825)
|..+. .+ .|+.+++++|++....+.
T Consensus 601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 601 KKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred hhHhcccccccCEEEccCCCcccCCcc
Confidence 87776 45 699999999999877653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=504.31 Aligned_cols=492 Identities=18% Similarity=0.179 Sum_probs=429.7
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.+|.+++++. .+|..+. ++|++|+|++|++++..+.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4677778875 5666554 889999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc-cCCcccccccccceecCcCc-----CCc
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGT-----IPP 189 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~~-----~p~ 189 (825)
+++..|.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+++++ .|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 999889999999999999999999998888999999999999999999986 57999999999999999875 245
Q ss_pred cccCCCCCc----eeecCCccccccCCchhhhcCCCCcEEEcccccCC-CCCCccccCCCCccEEEe-------------
Q 003368 190 SIYNLSLLA----NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS-GSFPLAFSNASNLQSLEI------------- 251 (825)
Q Consensus 190 ~i~~l~~l~----~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L------------- 251 (825)
.+..+..++ .+++++|.++ .+|+..+ ...+|+.|++++|.++ +..|..+.++++|+.+++
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~-~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~ 249 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPID-FIQDQAF-QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred hhhhhhccccccceeeccCCCcc-eeCcccc-cCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence 566666554 7999999998 5666666 4458999999999987 345666777777777666
Q ss_pred --------------------ecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEccccccc
Q 003368 252 --------------------LGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFK 311 (825)
Q Consensus 252 --------------------~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 311 (825)
..|.+.+.++. +..+++|+.|++++|.+...+ .+..+++|+.|++++|.+.
T Consensus 250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l~ 320 (606)
T 3vq2_A 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQLK 320 (606)
T ss_dssp CCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCCS
T ss_pred cChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccCc
Confidence 55666677766 889999999999999986542 5678899999999999994
Q ss_pred ccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccc--cCccccCCCCCcEEEcccC
Q 003368 312 GALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGE--IPSSFGNLSSLVKLILGNN 389 (825)
Q Consensus 312 ~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N 389 (825)
.+| .+ .+++|+.|++++|+..+.+ .+..+++|++|++++|++++. +|..+..+++|++|++++|
T Consensus 321 ----------~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n 386 (606)
T 3vq2_A 321 ----------QFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386 (606)
T ss_dssp ----------SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSC
T ss_pred ----------ccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCC
Confidence 677 45 8999999999999766555 678999999999999999876 4888999999999999999
Q ss_pred ccccccCCCCCCCCccceeecCCCCCccccc-hhhhcccccccccccCCCccccCCCccccccccccEEeecCceecc-c
Q 003368 390 NLSGVIPSSLGNLKQLALLHLFQNDLSGAIP-EEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSG-E 467 (825)
Q Consensus 390 ~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip-~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~ 467 (825)
.+++ +|..+..+++|+.|++++|++++..| ..+..+..+ +.|++++|++.+..|..++.+++|+.|++++|++++ .
T Consensus 387 ~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 464 (606)
T 3vq2_A 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464 (606)
T ss_dssp SEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred cccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 9985 66899999999999999999998877 566677776 799999999999999999999999999999999998 4
Q ss_pred CCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCCCccC
Q 003368 468 IPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTKGIFA 546 (825)
Q Consensus 468 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~~~~~ 546 (825)
+|..++.+++|+.|++++|++++..|..+..+++|+.|++++|++++.+|..+..+ .|++|++++|+++..++....++
T Consensus 465 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~ 544 (606)
T 3vq2_A 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544 (606)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSC
T ss_pred hHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhc
Confidence 89999999999999999999999999999999999999999999999999999988 69999999999995444333343
Q ss_pred -ccccccccCCC
Q 003368 547 -NASAISVSGNS 557 (825)
Q Consensus 547 -~~~~~~~~~n~ 557 (825)
+.....+.+|+
T Consensus 545 ~~L~~l~l~~N~ 556 (606)
T 3vq2_A 545 KSLAFFNLTNNS 556 (606)
T ss_dssp TTCCEEECCSCC
T ss_pred ccCcEEEccCCC
Confidence 46778888887
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=513.49 Aligned_cols=470 Identities=20% Similarity=0.266 Sum_probs=272.1
Q ss_pred CCCCCC-----CC--cee------------eceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEc-CCCccccc
Q 003368 12 SWNDSH-----HF--CDW------------EGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHL-SNNTIQGK 71 (825)
Q Consensus 12 ~w~~~~-----~~--C~~------------~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~L-s~N~l~~~ 71 (825)
+|+.+. ++ |.| .||+|+. .++|+.|+|+++++.|.+|++|++|++|++||| ++|.++|.
T Consensus 285 ~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~ 363 (876)
T 4ecn_A 285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363 (876)
T ss_dssp GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHT
T ss_pred CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCchHHhccccceEeeeccccccccc
Confidence 786543 55 999 9999987 689999999999999999999999999999999 99999877
Q ss_pred CCccccCCCCCCEEECC--------------------CCcCC-----------CCCCcCCCCCCCCCEEEcCC--CCCCC
Q 003368 72 IPGEIGRLFRLEALYLS--------------------HNSLV-----------GEIPGNLSYCSRLIGLYLGR--NKLEG 118 (825)
Q Consensus 72 ~p~~~~~l~~L~~L~Ls--------------------~N~l~-----------~~~p~~~~~l~~L~~L~Ls~--N~l~~ 118 (825)
.|-.-... .++++ ...+. ...+........++.+.++. |++++
T Consensus 364 ~~~~~~~~----~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~ 439 (876)
T 4ecn_A 364 RLFGDEEL----TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF 439 (876)
T ss_dssp TCBTTBCC----CSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE
T ss_pred cccccccc----ccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc
Confidence 44321111 00000 00000 00000011112222222322 44444
Q ss_pred CCChhhhcccccceeecccccccc-----------------ccCccCC--CCCCCCEEEcccCcCcccCCcccccccccc
Q 003368 119 SIPSEFVSLYNLKELAIQENNLTG-----------------GIPHFLG--NITSLEAISLAYNSLGGNIPSSLGQLKELK 179 (825)
Q Consensus 119 ~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 179 (825)
+|..|+++++|++|+|++|+|++ .+|..++ ++++|++|+|++|++.+.+|..|+++++|+
T Consensus 440 -IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~ 518 (876)
T 4ecn_A 440 -ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518 (876)
T ss_dssp -ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCC
T ss_pred -hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCC
Confidence 44444444444444444444444 2555544 555555555555555555555555555555
Q ss_pred eecCcCcCCccccCCCCCceeecCCcc-ccc-cCCchhhhcC-------CCCcEEEcccccCCCCCCc--cccCCCCccE
Q 003368 180 SLGLGGTIPPSIYNLSLLANFSVPENR-LHG-SLPPSLGLTL-------SNLQLFQISNNFFSGSFPL--AFSNASNLQS 248 (825)
Q Consensus 180 ~L~L~~~~p~~i~~l~~l~~l~l~~N~-l~~-~lp~~~~~~l-------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~ 248 (825)
.| ++++|+ ++| .+|..++ .+ ++|+.|+|++|.++ .+|. .|.++++|+.
T Consensus 519 ~L-------------------~Ls~N~~lsg~~iP~~i~-~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 519 SL-------------------NIACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp EE-------------------ECTTCTTSCHHHHHHHHH-HHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred EE-------------------ECcCCCCcccccchHHHH-hhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 55 344444 444 4444333 22 25555555555555 4444 5555555555
Q ss_pred EEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCC-CCEEEcccccccccCCCCcccccCCccc
Q 003368 249 LEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN-LSFLNLVANQFKGALPHSIVSGSIPSEI 327 (825)
Q Consensus 249 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~ip~~l 327 (825)
|+|++|++. .+| .|+.+++|+.|++++|.+.. +|..+.++++ |+.|+|++|.++ .+|..+
T Consensus 578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~-------lp~~l~~l~~~L~~L~Ls~N~L~----------~lp~~~ 638 (876)
T 4ecn_A 578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-------IPEDFCAFTDQVEGLGFSHNKLK----------YIPNIF 638 (876)
T ss_dssp EECTTSCCC-BCC-CCCTTSEESEEECCSSCCSC-------CCTTSCEECTTCCEEECCSSCCC----------SCCSCC
T ss_pred EECCCCCcc-cch-hhcCCCcceEEECcCCcccc-------chHHHhhccccCCEEECcCCCCC----------cCchhh
Confidence 555555554 444 55555555555555555542 1334455555 666666666655 344444
Q ss_pred cCCCC--cCEEEcccCcccccCCcc---cc--CCCCCCEEEccccccccccCccc-cCCCCCcEEEcccCccccccCCCC
Q 003368 328 GKLVS--LYLIEMDHNQFEGKIPEE---MS--RLQNLQFLNMRHNQLSGEIPSSF-GNLSSLVKLILGNNNLSGVIPSSL 399 (825)
Q Consensus 328 ~~l~~--L~~L~L~~N~l~~~~p~~---~~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~ 399 (825)
..+.. |+.|+|++|++.+.+|.. +. .+++|++|+|++|++. .+|..+ ..+++|+.|+|++|+++ .+|..+
T Consensus 639 ~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 716 (876)
T 4ecn_A 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENS 716 (876)
T ss_dssp CTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTS
T ss_pred hccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHH
Confidence 44432 666666666666554432 12 2336666666666666 344433 35666666666666666 334333
Q ss_pred CC--------CCccceeecCCCCCccccchhhh--cccccccccccCCCccccCCCccccccccccEEeecC------ce
Q 003368 400 GN--------LKQLALLHLFQNDLSGAIPEEIF--NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSS------NN 463 (825)
Q Consensus 400 ~~--------l~~L~~L~L~~N~l~g~ip~~~~--~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~------N~ 463 (825)
.. +++|+.|+|++|+++ .+|..++ .+..+ +.|++++|++++ +|..++.+++|+.|+|++ |+
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L-~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~ 793 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL-SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR 793 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTC-CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCB
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCc-CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccc
Confidence 22 236777777777776 6666665 55555 566666666665 666777777777777765 77
Q ss_pred ecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcc
Q 003368 464 LSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDL 535 (825)
Q Consensus 464 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l 535 (825)
+.+.+|..++.+++|+.|+|++|++ +.+|..+. ++|+.|||++|++...-+..+... .+..+.+++|++
T Consensus 794 l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 794 ILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863 (876)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred ccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence 7777777777777788888888877 57777665 577888888887775555444333 345555555544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=505.13 Aligned_cols=492 Identities=23% Similarity=0.274 Sum_probs=404.2
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC-CcCCCCCCCCCEEEcCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI-PGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N 114 (825)
..|.+++++.. +|. ..++|++|||++|+|++..|.+|.++++|++|||++|.+.+.+ |..|.++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 45666777764 444 4689999999999999999999999999999999999665555 899999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCcc--CCCCCCCCEEEcccCcCcccCC-cccccccccceecCcCc-----
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHF--LGNITSLEAISLAYNSLGGNIP-SSLGQLKELKSLGLGGT----- 186 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~~----- 186 (825)
+|++..|.+|.++++|++|+|++|.+++..|.. |+++++|++|+|++|++++..+ ..|+++++|++|+|+++
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877665 9999999999999999998765 67999999999999875
Q ss_pred CCccccCC--CCCceeecCCccccccCCchhhhcCC------CCcEEEcccccCCCCCCccccCC---------------
Q 003368 187 IPPSIYNL--SLLANFSVPENRLHGSLPPSLGLTLS------NLQLFQISNNFFSGSFPLAFSNA--------------- 243 (825)
Q Consensus 187 ~p~~i~~l--~~l~~l~l~~N~l~~~lp~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l--------------- 243 (825)
.+..+..+ +.|+.|+++.|.+.+..|..+. .++ +|+.|+|++|.+++..|..+...
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred CHHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 34566666 8899999999999988877654 344 49999999999887776655432
Q ss_pred -----------------------CCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCC
Q 003368 244 -----------------------SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNL 300 (825)
Q Consensus 244 -----------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L 300 (825)
++|+.|+|++|.+.+..+..|..+++|+.|+++.|.+.... +..|.++++|
T Consensus 243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~------~~~~~~l~~L 316 (844)
T 3j0a_A 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA------DEAFYGLDNL 316 (844)
T ss_dssp CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC------TTTTTTCSSC
T ss_pred ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC------hHHhcCCCCC
Confidence 57888888888888887888888888888888888876543 3456778888
Q ss_pred CEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCC
Q 003368 301 SFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380 (825)
Q Consensus 301 ~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 380 (825)
++|+|++|++++ ..|..+..+++|+.|++++|++.+..+..|..+++|++|+|++|.+++ ++ .+++
T Consensus 317 ~~L~Ls~N~l~~---------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~ 382 (844)
T 3j0a_A 317 QVLNLSYNLLGE---------LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPS 382 (844)
T ss_dssp CEEEEESCCCSC---------CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCS
T ss_pred CEEECCCCCCCc---------cCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCC
Confidence 888888888874 445677788888888888888887777778888888888888888873 22 2677
Q ss_pred CcEEEcccCccccccCCCCCCCCccceeecCCCCCcccc-chhhhcccccccccccCCCccccCCCc-cccccccccEEe
Q 003368 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI-PEEIFNISHMSDSLNFARNHLVGSIPP-KIGNLKVLRMFV 458 (825)
Q Consensus 381 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i-p~~~~~~~~l~~~l~l~~N~l~~~~p~-~~~~l~~L~~L~ 458 (825)
|+.|++++|+++ .+|.. ..+++.|++++|++++.- +..+..+..+ +.|++++|++++..+. .+..+++|+.|+
T Consensus 383 L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~ 457 (844)
T 3j0a_A 383 IPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLF 457 (844)
T ss_dssp CSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCE
T ss_pred cchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCcc-ceeeCCCCcccccccccccccCCcccccc
Confidence 888888888887 44543 457888899999988531 2233456666 7899999999876544 456789999999
Q ss_pred ecCceec-----ccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccccCceeeCCCC
Q 003368 459 VSSNNLS-----GEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFN 533 (825)
Q Consensus 459 ls~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~L~~l~ls~N 533 (825)
+++|.++ +..|..|..+++|+.|+|++|++++..|..+..+++|+.|||++|+|++..|..+. ..|+.|++++|
T Consensus 458 Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N 536 (844)
T 3j0a_A 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRN 536 (844)
T ss_dssp EESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEE
T ss_pred CCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCC
Confidence 9999997 55567789999999999999999999999999999999999999999987776665 46999999999
Q ss_pred cceecCCCCCccCccccccccCCCCCCC
Q 003368 534 DLEGQVPTKGIFANASAISVSGNSNRLC 561 (825)
Q Consensus 534 ~l~g~~p~~~~~~~~~~~~~~~n~~~lc 561 (825)
++++.+|. .|..+....+.+|+ ..|
T Consensus 537 ~l~~~~~~--~~~~L~~l~l~~Np-~~C 561 (844)
T 3j0a_A 537 QLLAPNPD--VFVSLSVLDITHNK-FIC 561 (844)
T ss_dssp CCCCCCSC--CCSSCCEEEEEEEC-CCC
T ss_pred cCCCCChh--HhCCcCEEEecCCC-ccc
Confidence 99998885 36677888899998 444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=478.98 Aligned_cols=501 Identities=20% Similarity=0.192 Sum_probs=386.0
Q ss_pred CCceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC
Q 003368 18 HFCDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE 95 (825)
Q Consensus 18 ~~C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 95 (825)
-.|.+.+++-.|. ..+++.|||++|++.+..+.+|..+++|++|+|++|++++..|.+|+++++|++|+|++|++++.
T Consensus 12 ~~c~~~~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~ 91 (570)
T 2z63_A 12 YQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91 (570)
T ss_dssp EECCSSCCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred EEeCCCCccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCcc
Confidence 3566667766664 36799999999999988888999999999999999999988889999999999999999999988
Q ss_pred CCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccccccc-ccCccCCCCCCCCEEEcccCcCcccCCccccc
Q 003368 96 IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQ 174 (825)
Q Consensus 96 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 174 (825)
.|..|.++++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..|+.
T Consensus 92 ~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 171 (570)
T 2z63_A 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171 (570)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHH
T ss_pred CHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccc
Confidence 88999999999999999999997776689999999999999999987 36899999999999999999999888888999
Q ss_pred cccc----ceecCcCc----CCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCC------CCCCccc
Q 003368 175 LKEL----KSLGLGGT----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS------GSFPLAF 240 (825)
Q Consensus 175 l~~L----~~L~L~~~----~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~------~~~p~~~ 240 (825)
+++| +.|+++++ +++.......|+.+++++|......-+.....+++++.+.+.-+.+. ......|
T Consensus 172 l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~ 251 (570)
T 2z63_A 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251 (570)
T ss_dssp HHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTT
T ss_pred hhccchhhhhcccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhh
Confidence 8888 67776653 22222223356777776664332111122224555555444332221 1122233
Q ss_pred cCCCC--ccEEEeecc-cccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCC
Q 003368 241 SNASN--LQSLEILGN-NFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317 (825)
Q Consensus 241 ~~l~~--L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 317 (825)
..+++ ++.+++++| .+.+..+..+..+++|+.|+++.|.+... |..+..+ +|+.|++++|.++
T Consensus 252 ~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l-------~~~~~~~-~L~~L~l~~n~~~------ 317 (570)
T 2z63_A 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-------KDFSYNF-GWQHLELVNCKFG------ 317 (570)
T ss_dssp GGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSC-------CBCCSCC-CCSEEEEESCBCS------
T ss_pred ccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhh-------hhhhccC-CccEEeeccCccc------
Confidence 33332 456666666 66777777777888888888888777643 4445566 7888888888776
Q ss_pred cccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEcccccccccc--CccccCCCCCcEEEcccCcccccc
Q 003368 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEI--PSSFGNLSSLVKLILGNNNLSGVI 395 (825)
Q Consensus 318 ~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~ 395 (825)
.+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++.+.. |..+..+++|++|++++|++.+..
T Consensus 318 ----~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 389 (570)
T 2z63_A 318 ----QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389 (570)
T ss_dssp ----SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE
T ss_pred ----ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc
Confidence 4554 4667788888888887766654 67788888888888887543 667777888888888888887655
Q ss_pred CCCCCCCCccceeecCCCCCccccch-hhhcccccccccccCCCccccCCCccccccccccEEeecCceec-ccCCcccc
Q 003368 396 PSSLGNLKQLALLHLFQNDLSGAIPE-EIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLS-GEIPSEIG 473 (825)
Q Consensus 396 p~~~~~l~~L~~L~L~~N~l~g~ip~-~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~ 473 (825)
+. +..+++|+.|++++|.+++..|. .+..+..+ +.|++++|.+.+..|..++.+++|+.|++++|+++ +.+|..++
T Consensus 390 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~ 467 (570)
T 2z63_A 390 SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467 (570)
T ss_dssp EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred cc-ccccCCCCEEEccCCccccccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence 54 77888888888888888766553 44455555 67888888888888888888999999999999987 67888899
Q ss_pred CCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCC
Q 003368 474 SCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTK 542 (825)
Q Consensus 474 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~ 542 (825)
.+++|++|++++|++++..|..+..+++|++|++++|++++.+|..+..+ .|+.+++++|++++..|..
T Consensus 468 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999999999998888889999999999999999998877777777 5899999999999888764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=478.11 Aligned_cols=492 Identities=19% Similarity=0.216 Sum_probs=343.1
Q ss_pred CceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCc
Q 003368 19 FCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPG 98 (825)
Q Consensus 19 ~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 98 (825)
.|.|.|+ |+. +++++. .+|+.+. ++|++|+|++|++++..|.+|+++++|++|+|++|+|++..|+
T Consensus 3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 5888887 754 334443 3444443 5677777777777766666677777777777777777766666
Q ss_pred CCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccc-cCccCCCCCCCCEEEcccCcCcccC-Cccccccc
Q 003368 99 NLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNI-PSSLGQLK 176 (825)
Q Consensus 99 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~ 176 (825)
.|..+++|++|+|++|++++..|..|+++++|++|+|++|++++. .|..|+++++|++|++++|++.+.+ +..|.+++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 677777777777777777766666677777777777777777652 4556667777777777777633333 35666777
Q ss_pred ccceecCcC-----cCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCC--C-ccccCCCCccE
Q 003368 177 ELKSLGLGG-----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF--P-LAFSNASNLQS 248 (825)
Q Consensus 177 ~L~~L~L~~-----~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~ 248 (825)
+|++|++++ ..|..+..++.|+.|+++.|.+. .+|..+...+++|++|++++|++++.. | .....+++|+.
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~ 227 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence 777776653 24556666677777778777775 566666556888888888888888652 2 22345778888
Q ss_pred EEeecccccCccc----cCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC
Q 003368 249 LEILGNNFFGKLS----VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324 (825)
Q Consensus 249 L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip 324 (825)
|++++|.+.+..+ ..+..+++|+.++++.|.+.............+..+++|+.|++.++.+.... ....++
T Consensus 228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~----~~~~l~ 303 (549)
T 2z81_A 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY----LFYDLS 303 (549)
T ss_dssp EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG----GSCCCC
T ss_pred eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh----hcccch
Confidence 8888888765433 33456778888888887765543221111234556778888888887665311 111233
Q ss_pred ccccCCCCcCEEEcccCcccccCCccc-cCCCCCCEEEccccccccccC---ccccCCCCCcEEEcccCccccccC--CC
Q 003368 325 SEIGKLVSLYLIEMDHNQFEGKIPEEM-SRLQNLQFLNMRHNQLSGEIP---SSFGNLSSLVKLILGNNNLSGVIP--SS 398 (825)
Q Consensus 325 ~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~ 398 (825)
..+....+|+.|++++|++. .+|..+ ..+++|++|+|++|++.+.+| ..++.+++|++|+|++|++++..+ ..
T Consensus 304 ~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 382 (549)
T 2z81_A 304 TVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382 (549)
T ss_dssp HHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHH
T ss_pred hhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhh
Confidence 33344567888888888887 566655 578888888888888887664 346778888888888888876532 45
Q ss_pred CCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCC
Q 003368 399 LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYL 478 (825)
Q Consensus 399 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 478 (825)
++.+++|++|++++|+++ .+|..+..+..+ +.|++++|+++ .+|..+. ++|+.|++++|++++.+ +.+++|
T Consensus 383 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L 453 (549)
T 2z81_A 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRL 453 (549)
T ss_dssp GGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTC
T ss_pred hhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChh
Confidence 778888888888888888 678777766666 67888888876 3444432 57889999999988643 577889
Q ss_pred CEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCC
Q 003368 479 QEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPT 541 (825)
Q Consensus 479 ~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~ 541 (825)
++|++++|+++ .+|. ...+++|++|||++|++++.+|..+..+ .|+.|++++|++.+..|.
T Consensus 454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99999999998 6776 4678899999999999998888878777 589999999998877763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=479.03 Aligned_cols=450 Identities=21% Similarity=0.300 Sum_probs=317.8
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCC------C------CCCcCCCCCCCCCEEEcCCCCCCCCCChh
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV------G------EIPGNLSYCSRLIGLYLGRNKLEGSIPSE 123 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 123 (825)
..++.|+|++|.++|.+|.+|++|++|++|||++|.+. + .+|... +..|+ ++++.|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 47899999999999999999999999999999999873 2 222222 34566 788888888877776
Q ss_pred hhcc-cccceeecc--------------------ccccccccCccCCCCCCCCEEEcccCcCccc-CCccccccccccee
Q 003368 124 FVSL-YNLKELAIQ--------------------ENNLTGGIPHFLGNITSLEAISLAYNSLGGN-IPSSLGQLKELKSL 181 (825)
Q Consensus 124 ~~~l-~~L~~L~L~--------------------~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 181 (825)
+..+ ..+..+++. .|+++| +|..|+++++|++|+|++|++++. ++..+..- .. -
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~-~~--~ 233 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-NS--E 233 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT-TS--H
T ss_pred HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc-cc--c
Confidence 6532 222222222 688888 888899999999999999998873 11110000 00 0
Q ss_pred cCcCcCCcccc--CCCCCceeecCCccccccCCchhhhcCCCCcEEEccccc-CCC-CCCccccCCCCccEEEeeccccc
Q 003368 182 GLGGTIPPSIY--NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF-FSG-SFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 182 ~L~~~~p~~i~--~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
.+.+.+|+.++ +++.|+.|++++|++.|.+|..+. .+++|++|+|++|+ +++ .+|..+.++.
T Consensus 234 ~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~------------- 299 (636)
T 4eco_A 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQALA------------- 299 (636)
T ss_dssp HHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHH-------------
T ss_pred hhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh-cCCCCCEEECcCCCCCccccchHHHHhhh-------------
Confidence 00011222222 233333335555555555554444 45555555555554 554 4444444430
Q ss_pred CccccCcCCCCCCcEEEcccccCCCCCCCcccccc--ccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCE
Q 003368 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIH--SLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYL 335 (825)
Q Consensus 258 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~ 335 (825)
.+..+++|++|++++|++.. +|. .+.++++|+.|++++|+++| .+| .+..+++|+.
T Consensus 300 -----~~~~l~~L~~L~L~~n~l~~-------ip~~~~l~~l~~L~~L~L~~N~l~g---------~ip-~~~~l~~L~~ 357 (636)
T 4eco_A 300 -----DAPVGEKIQIIYIGYNNLKT-------FPVETSLQKMKKLGMLECLYNQLEG---------KLP-AFGSEIKLAS 357 (636)
T ss_dssp -----HSGGGGTCCEEECCSSCCSS-------CCCHHHHTTCTTCCEEECCSCCCEE---------ECC-CCEEEEEESE
T ss_pred -----ccccCCCCCEEECCCCcCCc-------cCchhhhccCCCCCEEeCcCCcCcc---------chh-hhCCCCCCCE
Confidence 00001444444444444432 134 56677777777777777776 666 6777788888
Q ss_pred EEcccCcccccCCccccCCCC-CCEEEccccccccccCccccCCC--CCcEEEcccCccccccCCCCC-------CCCcc
Q 003368 336 IEMDHNQFEGKIPEEMSRLQN-LQFLNMRHNQLSGEIPSSFGNLS--SLVKLILGNNNLSGVIPSSLG-------NLKQL 405 (825)
Q Consensus 336 L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L 405 (825)
|++++|+++ .+|..+..+++ |++|++++|++. .+|..+..++ +|++|++++|++++.+|..+. .+++|
T Consensus 358 L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L 435 (636)
T 4eco_A 358 LNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435 (636)
T ss_dssp EECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred EECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence 888888887 67777888887 888888888887 6777776654 788888888888888777777 77788
Q ss_pred ceeecCCCCCccccchhhhc-ccccccccccCCCccccCCCccccc--------cccccEEeecCceecccCCcccc--C
Q 003368 406 ALLHLFQNDLSGAIPEEIFN-ISHMSDSLNFARNHLVGSIPPKIGN--------LKVLRMFVVSSNNLSGEIPSEIG--S 474 (825)
Q Consensus 406 ~~L~L~~N~l~g~ip~~~~~-~~~l~~~l~l~~N~l~~~~p~~~~~--------l~~L~~L~ls~N~l~g~~p~~~~--~ 474 (825)
+.|+|++|+++ .+|..++. +..+ +.|++++|+++ .+|..+.. +++|+.|++++|+++ .+|..+. .
T Consensus 436 ~~L~Ls~N~l~-~lp~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~ 511 (636)
T 4eco_A 436 SSINLSNNQIS-KFPKELFSTGSPL-SSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATT 511 (636)
T ss_dssp EEEECCSSCCC-SCCTHHHHTTCCC-SEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTT
T ss_pred CEEECcCCccC-cCCHHHHccCCCC-CEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhcc
Confidence 88888888887 67777665 4444 67888888887 56654433 339999999999999 8999997 9
Q ss_pred CCCCCEEEccCCcCCCCCCccccCCCCCCEEEC------CCCccccccCcccccc-cCceeeCCCCcceecCCCCCccCc
Q 003368 475 CFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL------SQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTKGIFAN 547 (825)
Q Consensus 475 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldl------s~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~~~~~~ 547 (825)
+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+ .|++|++++|++ +.+|.. .+.+
T Consensus 512 l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~ 588 (636)
T 4eco_A 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPN 588 (636)
T ss_dssp CTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTT
T ss_pred CCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCc
Confidence 9999999999999997 9999999999999999 5688999999999888 699999999999 778865 3467
Q ss_pred cccccccCCC
Q 003368 548 ASAISVSGNS 557 (825)
Q Consensus 548 ~~~~~~~~n~ 557 (825)
+....+.+|+
T Consensus 589 L~~L~Ls~N~ 598 (636)
T 4eco_A 589 ISVLDIKDNP 598 (636)
T ss_dssp CCEEECCSCT
T ss_pred CCEEECcCCC
Confidence 8888889987
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=453.70 Aligned_cols=473 Identities=20% Similarity=0.211 Sum_probs=378.3
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
++.++.++. .+|..+. +++++|+|++|++++..+.+|.++++|++|||++|+|++..|..|.++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 455555554 4565543 5799999999999998899999999999999999999999999999999999999999999
Q ss_pred CCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc-cCCcccccccccceecCcCcCCccccCCC
Q 003368 117 EGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGTIPPSIYNLS 195 (825)
Q Consensus 117 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~~~p~~i~~l~ 195 (825)
++..|.+|.++++|++|++++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|+++
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~----------- 157 (570)
T 2z63_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS----------- 157 (570)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECT-----------
T ss_pred CccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCc-----------
Confidence 99888999999999999999999997777789999999999999999987 468889989888888554
Q ss_pred CCceeecCCccccccCCchhhhcCCCC----cEEEcccccCCCCCCccccCCCCccEEEeeccccc--------------
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNL----QLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF-------------- 257 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------------- 257 (825)
+|++++..|..+. .+++| +.|++++|.+++..|..|..+ +|+.|++++|...
T Consensus 158 --------~n~l~~~~~~~~~-~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l 227 (570)
T 2z63_A 158 --------SNKIQSIYCTDLR-VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGL 227 (570)
T ss_dssp --------TSCCCEECGGGGH-HHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTC
T ss_pred --------CCccceecHHHcc-chhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCcccc
Confidence 4444433222222 44444 455555555555555554443 4555555554221
Q ss_pred -----------------CccccCcCCCCC--CcEEEcccc-cCCCCCCCccccccccccCCCCCEEEcccccccccCCCC
Q 003368 258 -----------------GKLSVNFGDMKS--LAYLNVAIN-NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317 (825)
Q Consensus 258 -----------------~~~~~~~~~l~~--L~~L~ls~N-~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 317 (825)
......+..+.+ ++.++++.+ .+.. ..+..+..+++|+.|++++|.++
T Consensus 228 ~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~------~~~~~~~~l~~L~~L~l~~~~l~------ 295 (570)
T 2z63_A 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD------DIIDLFNCLTNVSSFSLVSVTIE------ 295 (570)
T ss_dssp EEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEES------CSTTTTGGGTTCSEEEEESCEEC------
T ss_pred ceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhh------hchhhhcCcCcccEEEecCccch------
Confidence 111112222222 233333333 2211 12456778899999999999998
Q ss_pred cccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCcccccc--
Q 003368 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVI-- 395 (825)
Q Consensus 318 ~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-- 395 (825)
.+|..+..+ +|+.|++++|.+. .+|. ..+++|++|++++|.+.+..+. ..+++|++|++++|++++..
T Consensus 296 ----~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~ 365 (570)
T 2z63_A 296 ----RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCC 365 (570)
T ss_dssp ----SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEE
T ss_pred ----hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccc
Confidence 678888888 9999999999998 6665 5789999999999999877665 78899999999999998664
Q ss_pred CCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCC-ccccccccccEEeecCceecccCCccccC
Q 003368 396 PSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP-PKIGNLKVLRMFVVSSNNLSGEIPSEIGS 474 (825)
Q Consensus 396 p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 474 (825)
|..+..+++|++|++++|.+++ +|..+..+..+ +.|++++|.+.+..| ..+..+++|+.|++++|.+++.+|..+..
T Consensus 366 ~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 443 (570)
T 2z63_A 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443 (570)
T ss_dssp EHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred cccccccCccCEEECCCCcccc-ccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc
Confidence 6778899999999999999985 55557777777 789999999998777 57899999999999999999999999999
Q ss_pred CCCCCEEEccCCcCC-CCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcceecCCCC-CccCccccc
Q 003368 475 CFYLQEIYMAENFFR-GSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLEGQVPTK-GIFANASAI 551 (825)
Q Consensus 475 l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~g~~p~~-~~~~~~~~~ 551 (825)
+++|++|++++|.++ +.+|..+..+++|++||+++|++++..|..+..+ .|++|++++|++++.+|.. ..+.++...
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 999999999999998 6799999999999999999999999889999888 6999999999999877653 456677778
Q ss_pred cccCCC
Q 003368 552 SVSGNS 557 (825)
Q Consensus 552 ~~~~n~ 557 (825)
.+.+|+
T Consensus 524 ~l~~N~ 529 (570)
T 2z63_A 524 WLHTNP 529 (570)
T ss_dssp ECCSSC
T ss_pred EecCCc
Confidence 888887
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=453.10 Aligned_cols=455 Identities=20% Similarity=0.237 Sum_probs=376.7
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
+.+|+++|++. .+|..+. ++|++|+|++|++++..|.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999998 5777776 89999999999999888889999999999999999999888999999999999999999
Q ss_pred CCCCCCChhhhcccccceeecccccccc-ccCccCCCCCCCCEEEcccCcCcccCCccccccccc--ceecCcCcCCccc
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTG-GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL--KSLGLGGTIPPSI 191 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~~~p~~i 191 (825)
+|+. +|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..|..+++| +.|
T Consensus 80 ~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L---------- 143 (520)
T 2z7x_B 80 KLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKV---------- 143 (520)
T ss_dssp CCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEE----------
T ss_pred ceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEE----------
Confidence 9994 5655 89999999999999987 468899999999999999999985 456666666 555
Q ss_pred cCCCCCceeecCCccc--cccCCchhhhcCC-CCcEEEcccccCCCCCC-ccccCCCCccEEEeeccc-------ccCcc
Q 003368 192 YNLSLLANFSVPENRL--HGSLPPSLGLTLS-NLQLFQISNNFFSGSFP-LAFSNASNLQSLEILGNN-------FFGKL 260 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l--~~~lp~~~~~~l~-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-------l~~~~ 260 (825)
++++|.+ .+..|..+. .+. +...+++++|.+.+.++ ..+.++++|+.|++++|. +.+.+
T Consensus 144 ---------~l~~n~l~~~~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~ 213 (520)
T 2z7x_B 144 ---------LLVLGETYGEKEDPEGLQ-DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213 (520)
T ss_dssp ---------EEEECTTTTSSCCTTTTT-TCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHH
T ss_pred ---------Eeeccccccccccccccc-ccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecch
Confidence 6777777 666666544 332 23467888888877665 467888999999999887 66666
Q ss_pred ccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccc-----cCCCCcCE
Q 003368 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI-----GKLVSLYL 335 (825)
Q Consensus 261 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l-----~~l~~L~~ 335 (825)
+ .+..+++|+.|+++.|.+...... .++.. ..+++|++|++++|+++| .+|..+ ..++.|+.
T Consensus 214 ~-~l~~l~~L~~L~l~~~~l~~~~~~--~~~~~-~~~~~L~~L~l~~n~l~~---------~~p~~~~~~~~~~l~~L~~ 280 (520)
T 2z7x_B 214 A-KLQTNPKLSNLTLNNIETTWNSFI--RILQL-VWHTTVWYFSISNVKLQG---------QLDFRDFDYSGTSLKALSI 280 (520)
T ss_dssp H-GGGGCTTCCEEEEEEEEEEHHHHH--HHHHH-HHTSSCSEEEEEEEEEES---------CCCCCCCCCCSCCCCEEEE
T ss_pred h-hhccccchhhccccccccCHHHHH--HHHHH-hhhCcccEEEeecccccC---------ccccchhhcccccCceeEe
Confidence 6 788889999999988876531100 01111 124689999999999998 566666 88999999
Q ss_pred EEcccCcccccCC-ccccCC---CCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecC
Q 003368 336 IEMDHNQFEGKIP-EEMSRL---QNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLF 411 (825)
Q Consensus 336 L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 411 (825)
+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..++.+++|+.|+++
T Consensus 281 l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 356 (520)
T 2z7x_B 281 HQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356 (520)
T ss_dssp EEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECC
T ss_pred ccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEcc
Confidence 99999999 455 556555 78999999999987432 12678999999999999999999999999999999999
Q ss_pred CCCCcc--ccchhhhcccccccccccCCCccccCCCcc-ccccccccEEeecCceecccCCccccCCCCCCEEEccCCcC
Q 003368 412 QNDLSG--AIPEEIFNISHMSDSLNFARNHLVGSIPPK-IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFF 488 (825)
Q Consensus 412 ~N~l~g--~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~-~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l 488 (825)
+|++++ .+|..+..+..+ +.|++++|++++.+|.. +..+++|+.|++++|++++.+|..+. ++|+.|++++|++
T Consensus 357 ~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 357 MNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433 (520)
T ss_dssp SSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCC
T ss_pred CCccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcc
Confidence 999996 677778888887 78999999999877764 88899999999999999999988776 7899999999999
Q ss_pred CCCCCccccCCCCCCEEECCCCccccccCcc-cccc-cCceeeCCCCcceecCC
Q 003368 489 RGSIPSSLVSLKDLREIDLSQNNLSGKIPIS-LERL-PLEYLNLSFNDLEGQVP 540 (825)
Q Consensus 489 ~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~-~~~l-~L~~l~ls~N~l~g~~p 540 (825)
+ .+|..+..+++|++||+++|++++ +|.. +..+ .|++|++++|++++..+
T Consensus 434 ~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 434 K-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp C-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred c-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 9 899988999999999999999995 6654 7777 69999999999987655
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=452.67 Aligned_cols=496 Identities=21% Similarity=0.192 Sum_probs=335.5
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
..++.|||++|+|.+..+.+|.++++|++|||++|+|+++.|++|.++++|++|+|++|+|++..++.|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 57999999999999888889999999999999999999888889999999999999999999888889999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccc-cCccCCCCCCCCEEEcccCcCcccCCcccccccccce----ecCcCc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKS----LGLGGT 186 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~----L~L~~~ 186 (825)
++|+|+++.+..|+++++|++|+|++|++++. .|..++.+++|++|+|++|+|++..|..|..+.+++. ++++.+
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 99999988888899999999999999999864 5788899999999999999999988998988877664 444432
Q ss_pred ----CCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccC------CCCCCccccCCCCccEEEeecccc
Q 003368 187 ----IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFF------SGSFPLAFSNASNLQSLEILGNNF 256 (825)
Q Consensus 187 ----~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l------~~~~p~~~~~l~~L~~L~L~~N~l 256 (825)
+++.......+..+++.+|.....++...+..+..++...+..+.. .......+..+..+..+++..+..
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence 3444445555667778877766555555555677777766654432 222233444444555555444432
Q ss_pred cC---ccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcc----------cccC
Q 003368 257 FG---KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIV----------SGSI 323 (825)
Q Consensus 257 ~~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------~~~i 323 (825)
.. .....+..+.+++.+++..+.+... ..+.....|+.|++.+|.+.+..+.... .+..
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--------~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERV--------KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEEC--------GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred cccccchhhhhhhhcccccccccccccccc--------cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 21 1222334444555555554443321 1223334455555555554421110000 0011
Q ss_pred CccccCCCCcCEEEcccCcccc--cCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccC-CCCC
Q 003368 324 PSEIGKLVSLYLIEMDHNQFEG--KIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIP-SSLG 400 (825)
Q Consensus 324 p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~ 400 (825)
+.....+++|+.+++++|.+.. ..+..+..+.+|++|+++.|.+. ..+..+..+++|+.++++.|+.....+ ..|.
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~ 442 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 442 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTT
T ss_pred Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccc
Confidence 1223456667777777776643 34555566667777777777666 345556667777777777666554433 3466
Q ss_pred CCCccceeecCCCCCccccchhhhcccccccccccCCCccc-cCCCccccccccccEEeecCceecccCCccccCCCCCC
Q 003368 401 NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV-GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQ 479 (825)
Q Consensus 401 ~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~ 479 (825)
.+++++.++++.|.+.+..|..+.....+ +.|++++|++. +.+|..+..+++|+.|+|++|++++..|..|+.+++|+
T Consensus 443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~ 521 (635)
T 4g8a_A 443 SLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 521 (635)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cccccccccccccccccccccccccchhh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence 67777777777777776555555444444 56777776643 34566677777777777777777777777777777777
Q ss_pred EEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc--cCceeeCCCCccee
Q 003368 480 EIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL--PLEYLNLSFNDLEG 537 (825)
Q Consensus 480 ~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l--~L~~l~ls~N~l~g 537 (825)
+|+|++|+|++..|..|..+++|++|||++|+|++.+|..+..+ .|++|++++|++..
T Consensus 522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 77777777776666667777777777777777777667666655 37777777776653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=446.29 Aligned_cols=478 Identities=19% Similarity=0.207 Sum_probs=388.4
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 138 (825)
-..|.++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|
T Consensus 8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 84 (549)
T 2z81_A 8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84 (549)
T ss_dssp SEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred ceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence 44688999999 6777664 78999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCccCCCCCCCCEEEcccCcCcc-cCCcccccccccceecCcCc-----CC-ccccCCCCCceeecCCccccccC
Q 003368 139 NLTGGIPHFLGNITSLEAISLAYNSLGG-NIPSSLGQLKELKSLGLGGT-----IP-PSIYNLSLLANFSVPENRLHGSL 211 (825)
Q Consensus 139 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~~-----~p-~~i~~l~~l~~l~l~~N~l~~~l 211 (825)
++++..|..|+++++|++|+|++|++++ ..|..|+++++|++|+++++ +| ..+..++.|+.|++++|.+++.+
T Consensus 85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 9998888889999999999999999987 46788999999999998754 33 46788999999999999999888
Q ss_pred CchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCcc---ccCcCCCCCCcEEEcccccCCCCCCCcc
Q 003368 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL---SVNFGDMKSLAYLNVAINNLGSGESDEM 288 (825)
Q Consensus 212 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 288 (825)
|..+. .+++|+.|+++.|.+....+..+..+++|++|++++|++.+.. ......+++|+.|+++.|.+..... .
T Consensus 165 ~~~l~-~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~--~ 241 (549)
T 2z81_A 165 SQSLK-SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF--N 241 (549)
T ss_dssp TTTTT-TCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH--H
T ss_pred hhhhh-ccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH--H
Confidence 88776 7889999999999887443334567899999999999987752 2234567889999998887753211 1
Q ss_pred ccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc-----CCccccCCCCCCEEEcc
Q 003368 289 SFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK-----IPEEMSRLQNLQFLNMR 363 (825)
Q Consensus 289 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls 363 (825)
.++..+..+++|+.+++++|.+.+...... .....+..+.+|+.+++.++.+... ++..+..+++|+.|+++
T Consensus 242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~---~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~ 318 (549)
T 2z81_A 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNP---SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318 (549)
T ss_dssp HHHGGGGGCTTCCEEEEESCEEECCSCCCC---CTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEE
T ss_pred HHHHHhhhhccccccccccccccccccccc---cchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEec
Confidence 223445677899999999999886321110 1123456778888999998876532 22334456789999999
Q ss_pred ccccccccCccc-cCCCCCcEEEcccCccccccC---CCCCCCCccceeecCCCCCccccc--hhhhcccccccccccCC
Q 003368 364 HNQLSGEIPSSF-GNLSSLVKLILGNNNLSGVIP---SSLGNLKQLALLHLFQNDLSGAIP--EEIFNISHMSDSLNFAR 437 (825)
Q Consensus 364 ~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~g~ip--~~~~~~~~l~~~l~l~~ 437 (825)
+|++. .+|..+ ..+++|++|+|++|++++.+| ..++.+++|+.|++++|++++..+ ..+..+..+ +.|++++
T Consensus 319 ~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L-~~L~Ls~ 396 (549)
T 2z81_A 319 NSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL-TSLDISR 396 (549)
T ss_dssp SSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTC-CEEECTT
T ss_pred cCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCC-CEEECCC
Confidence 99998 677766 579999999999999998764 458899999999999999985332 346666666 7899999
Q ss_pred CccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccC
Q 003368 438 NHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIP 517 (825)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p 517 (825)
|+++ .+|..++.+++|++|++++|+++ .+|..+. ++|+.|++++|++++.+ ..+++|++|||++|+++ .+|
T Consensus 397 N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip 467 (549)
T 2z81_A 397 NTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLP 467 (549)
T ss_dssp CCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCC
T ss_pred CCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCC
Confidence 9998 78999999999999999999998 5565543 58999999999999753 57899999999999999 677
Q ss_pred cccccc-cCceeeCCCCcceecCCC-CCccCccccccccCCC
Q 003368 518 ISLERL-PLEYLNLSFNDLEGQVPT-KGIFANASAISVSGNS 557 (825)
Q Consensus 518 ~~~~~l-~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~ 557 (825)
.. ..+ .|++|++++|++++.+|. ...+.++....+.+|+
T Consensus 468 ~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 508 (549)
T 2z81_A 468 DA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508 (549)
T ss_dssp CG-GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSC
T ss_pred Cc-ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCC
Confidence 64 345 699999999999998775 3556677778888887
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=462.17 Aligned_cols=437 Identities=19% Similarity=0.229 Sum_probs=360.8
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEEC-CCCcCCCCCCcCCCCCC-CCCE-----E---------E-cCCCCCCC
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYL-SHNSLVGEIPGNLSYCS-RLIG-----L---------Y-LGRNKLEG 118 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l~-~L~~-----L---------~-Ls~N~l~~ 118 (825)
..++.|+|++|.++|.+|++|++|++|++||| ++|.++|..|-.-.... .+.. + + .....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 99999877443211110 0000 0 0 00011111
Q ss_pred CCCh-----------hhhcccccceeeccc--cccccccCccCCCCCCCCEEEcccCcCcc-----------------cC
Q 003368 119 SIPS-----------EFVSLYNLKELAIQE--NNLTGGIPHFLGNITSLEAISLAYNSLGG-----------------NI 168 (825)
Q Consensus 119 ~~p~-----------~~~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~ 168 (825)
..+. .......++.+.+.. |++++ +|..|+++++|++|+|++|+|++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1111 112333456666655 99998 89999999999999999999998 37
Q ss_pred Ccccc--cccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEccccc-CCC-CCCccccCCC
Q 003368 169 PSSLG--QLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF-FSG-SFPLAFSNAS 244 (825)
Q Consensus 169 p~~~~--~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~ 244 (825)
|..++ ++++|++| +|++|++.+.+|..+. .+++|+.|+|++|+ +++ .+|..+.+++
T Consensus 482 P~~l~f~~L~~L~~L-------------------~Ls~N~l~~~iP~~l~-~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~ 541 (876)
T 4ecn_A 482 NEELSWSNLKDLTDV-------------------ELYNCPNMTQLPDFLY-DLPELQSLNIACNRGISAAQLKADWTRLA 541 (876)
T ss_dssp TSCCCGGGCTTCCEE-------------------EEESCTTCCSCCGGGG-GCSSCCEEECTTCTTSCHHHHHHHHHHHH
T ss_pred ChhhhhccCCCCCEE-------------------ECcCCCCCccChHHHh-CCCCCCEEECcCCCCcccccchHHHHhhh
Confidence 77766 77777766 8889999999998887 99999999999998 998 7887666555
Q ss_pred -------CccEEEeecccccCcccc--CcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCC
Q 003368 245 -------NLQSLEILGNNFFGKLSV--NFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALP 315 (825)
Q Consensus 245 -------~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 315 (825)
+|+.|+|++|++. .+|. .++.+++|+.|++++|.+... | .+..+++|+.|+|++|+++
T Consensus 542 ~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~l-------p-~~~~L~~L~~L~Ls~N~l~---- 608 (876)
T 4ecn_A 542 DDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHL-------E-AFGTNVKLTDLKLDYNQIE---- 608 (876)
T ss_dssp HCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBC-------C-CCCTTSEESEEECCSSCCS----
T ss_pred hcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccc-------h-hhcCCCcceEEECcCCccc----
Confidence 9999999999999 7787 899999999999999998732 4 6788999999999999998
Q ss_pred CCcccccCCccccCCCC-cCEEEcccCcccccCCccccCCCC--CCEEEccccccccccCccc---c--CCCCCcEEEcc
Q 003368 316 HSIVSGSIPSEIGKLVS-LYLIEMDHNQFEGKIPEEMSRLQN--LQFLNMRHNQLSGEIPSSF---G--NLSSLVKLILG 387 (825)
Q Consensus 316 ~~~~~~~ip~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~Ls 387 (825)
.+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|+|++|++.+.+|... . .+++|+.|+|+
T Consensus 609 ------~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 609 ------EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp ------CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred ------cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 68888999999 999999999999 78888887754 9999999999998776433 2 34589999999
Q ss_pred cCccccccCCC-CCCCCccceeecCCCCCccccchhhhccc--------ccccccccCCCccccCCCcccc--ccccccE
Q 003368 388 NNNLSGVIPSS-LGNLKQLALLHLFQNDLSGAIPEEIFNIS--------HMSDSLNFARNHLVGSIPPKIG--NLKVLRM 456 (825)
Q Consensus 388 ~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~g~ip~~~~~~~--------~l~~~l~l~~N~l~~~~p~~~~--~l~~L~~ 456 (825)
+|+++. +|.. +..+++|+.|+|++|+++ .+|..++... .+ +.|++++|+++ .+|..+. .+++|+.
T Consensus 682 ~N~L~~-lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L-~~L~Ls~N~L~-~lp~~l~~~~l~~L~~ 757 (876)
T 4ecn_A 682 YNEIQK-FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL-TTIDLRFNKLT-SLSDDFRATTLPYLSN 757 (876)
T ss_dssp SSCCCS-CCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGC-CEEECCSSCCC-CCCGGGSTTTCTTCCE
T ss_pred CCcCCc-cCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCc-cEEECCCCCCc-cchHHhhhccCCCcCE
Confidence 999994 5554 458999999999999999 8999887654 44 78999999999 8999987 9999999
Q ss_pred EeecCceecccCCccccCCCCCCEEEccC------CcCCCCCCccccCCCCCCEEECCCCccccccCcccccccCceeeC
Q 003368 457 FVVSSNNLSGEIPSEIGSCFYLQEIYMAE------NFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNL 530 (825)
Q Consensus 457 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~------N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~L~~l~l 530 (825)
|+|++|++++ +|..++.+++|+.|+|++ |++.+.+|..+..+++|+.|+|++|++ +.+|..+.. .|+.||+
T Consensus 758 L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~-~L~~LdL 834 (876)
T 4ecn_A 758 MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTP-QLYILDI 834 (876)
T ss_dssp EECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCS-SSCEEEC
T ss_pred EEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcC-CCCEEEC
Confidence 9999999997 899999999999999976 889999999999999999999999999 788887653 7999999
Q ss_pred CCCcceecCC
Q 003368 531 SFNDLEGQVP 540 (825)
Q Consensus 531 s~N~l~g~~p 540 (825)
++|++....+
T Consensus 835 s~N~l~~i~~ 844 (876)
T 4ecn_A 835 ADNPNISIDV 844 (876)
T ss_dssp CSCTTCEEEC
T ss_pred CCCCCCccCh
Confidence 9999875443
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=444.07 Aligned_cols=431 Identities=21% Similarity=0.203 Sum_probs=332.6
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|||++|++.+..|..|..+++|++|+|++|+|++..|.+|+++++|++|||++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 68999999999999888889999999999999999999988999999999999999999999 45555 8999999999
Q ss_pred CCCCCCC-CCChhhhcccccceeeccccccccccCccCCCCCCC--CEEEcccCcC--cccCCcccccccc-cceecCcC
Q 003368 112 GRNKLEG-SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL--EAISLAYNSL--GGNIPSSLGQLKE-LKSLGLGG 185 (825)
Q Consensus 112 s~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~~-L~~L~L~~ 185 (825)
++|+|++ .+|..|+++++|++|+|++|++++ ..|..+++| +.|+|++|++ ++..|..|..+.. ...+++++
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9999997 478999999999999999999986 467788888 9999999999 8889998888773 22334433
Q ss_pred c-----C-CccccCCCCCceeecCCcc-------ccccCCchhhhcCCCCcEEEcccccCCCCCCccc---cCCCCccEE
Q 003368 186 T-----I-PPSIYNLSLLANFSVPENR-------LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAF---SNASNLQSL 249 (825)
Q Consensus 186 ~-----~-p~~i~~l~~l~~l~l~~N~-------l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L 249 (825)
+ + +..+..++.|+.+++++|. +.+.+| .+. .+++|+.|++++|.+++..+..+ ...++|+.|
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~-~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQ-TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGG-GCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred Ccchhhhhhhhhhcccceeeccccccccccccceeecchh-hhc-cccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 2 1 2345667888888888886 666655 343 67888888888887765332211 124578888
Q ss_pred EeecccccCccccCc-----CCCCCCcEEEcccccCCCCCCCccccccccccC---CCCCEEEcccccccccCCCCcccc
Q 003368 250 EILGNNFFGKLSVNF-----GDMKSLAYLNVAINNLGSGESDEMSFIHSLANC---SNLSFLNLVANQFKGALPHSIVSG 321 (825)
Q Consensus 250 ~L~~N~l~~~~~~~~-----~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~~ 321 (825)
++++|++.+.+|..+ +.+++|+.++++.|.+ ..+. ..+..+ .+|+.|++++|.+.+
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~------~~~~~~~~~~~L~~L~l~~n~l~~--------- 316 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQ------SYIYEIFSNMNIKNFTVSGTRMVH--------- 316 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCT------HHHHHHHHTCCCSEEEEESSCCCC---------
T ss_pred EeecccccCccccchhhcccccCceeEeccccccce-ecch------hhhhcccccCceeEEEcCCCcccc---------
Confidence 888888887777777 7788888888887776 2211 122222 567888888877653
Q ss_pred cCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEcccccccc--ccCccccCCCCCcEEEcccCccccccCC-C
Q 003368 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSG--EIPSSFGNLSSLVKLILGNNNLSGVIPS-S 398 (825)
Q Consensus 322 ~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~ 398 (825)
++ ....+++|+.|++++|++++.+|..++.+++|++|+|++|++.+ .+|..+..+++|++|++++|++++.+|. .
T Consensus 317 -~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~ 394 (520)
T 2z7x_B 317 -ML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394 (520)
T ss_dssp -CC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCS
T ss_pred -cc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccch
Confidence 11 11466777777788777777777777777777788887777775 4556677777777777777777764443 4
Q ss_pred CCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCC
Q 003368 399 LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYL 478 (825)
Q Consensus 399 ~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L 478 (825)
+..+++|+.|++++|++++.+|. .+. ++|+.|++++|+++ .+|..+..+++|
T Consensus 395 ~~~l~~L~~L~Ls~N~l~~~~~~-------------------------~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L 446 (520)
T 2z7x_B 395 CSWTKSLLSLNMSSNILTDTIFR-------------------------CLP--PRIKVLDLHSNKIK-SIPKQVVKLEAL 446 (520)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGG-------------------------SCC--TTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred hccCccCCEEECcCCCCCcchhh-------------------------hhc--ccCCEEECCCCccc-ccchhhhcCCCC
Confidence 67777777777777777654443 222 56888999999998 888888899999
Q ss_pred CEEEccCCcCCCCCCcc-ccCCCCCCEEECCCCccccccC
Q 003368 479 QEIYMAENFFRGSIPSS-LVSLKDLREIDLSQNNLSGKIP 517 (825)
Q Consensus 479 ~~L~l~~N~l~g~~p~~-~~~l~~L~~Ldls~N~l~~~~p 517 (825)
++|++++|+++ .+|.. +..+++|+.|++++|++++..+
T Consensus 447 ~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 447 QELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 99999999998 56665 8899999999999999987654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=429.32 Aligned_cols=457 Identities=19% Similarity=0.210 Sum_probs=361.7
Q ss_pred EEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 34 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
.+.+|++++++.+ +|..+. ++|++|+|++|+|++..|.+|.++++|++|+|++|+|++..|+.|.++++|++|||++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3789999999985 777664 8999999999999988889999999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhcccccceeeccccccccc-cCccCCCCCCCCEEEcccCcCcccCCccccccccc--ceecCcCcCCcc
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL--KSLGLGGTIPPS 190 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~~~p~~ 190 (825)
|+|+. +|.. .+++|++|+|++|++++. +|..|+++++|++|+|++|++++ ..|..+++| +.|
T Consensus 110 N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L--------- 174 (562)
T 3a79_B 110 NRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCI--------- 174 (562)
T ss_dssp SCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEE---------
T ss_pred CcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEE---------
Confidence 99994 5655 899999999999999974 46899999999999999999985 345555554 555
Q ss_pred ccCCCCCceeecCCccc--cccCCchhhhcCC-CCcEEEcccccCCCCCCc-cccCCCCccEEEeeccc-----ccCccc
Q 003368 191 IYNLSLLANFSVPENRL--HGSLPPSLGLTLS-NLQLFQISNNFFSGSFPL-AFSNASNLQSLEILGNN-----FFGKLS 261 (825)
Q Consensus 191 i~~l~~l~~l~l~~N~l--~~~lp~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~~ 261 (825)
++++|.+ ++..|..+. .+. ..-.+++++|.+.+.++. .+.++++|+.|++++|+ +.+. .
T Consensus 175 ----------~L~~n~l~~~~~~~~~l~-~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~ 242 (562)
T 3a79_B 175 ----------LLDLVSYHIKGGETESLQ-IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-L 242 (562)
T ss_dssp ----------EEEESSCCCCSSSCCEEE-ECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-H
T ss_pred ----------EeecccccccccCccccc-ccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-H
Confidence 6667777 656665544 322 112557788887776653 46778888888888875 2222 2
Q ss_pred cCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccc-----cCCCCcCEE
Q 003368 262 VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI-----GKLVSLYLI 336 (825)
Q Consensus 262 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l-----~~l~~L~~L 336 (825)
..+..++.|+.+++..+.+..... ...+.. ...++|++|++++|.++| .+|..+ .+++.|+.+
T Consensus 243 ~~l~~l~~L~~L~L~~~~l~~~~~--~~~~~~-~~~~~L~~L~l~~n~l~~---------~ip~~~~~~~~~~L~~L~~~ 310 (562)
T 3a79_B 243 SELTRGPTLLNVTLQHIETTWKCS--VKLFQF-FWPRPVEYLNIYNLTITE---------RIDREEFTYSETALKSLMIE 310 (562)
T ss_dssp HHHHSCSSCEEEEEEEEEECHHHH--HHHHHH-HTTSSEEEEEEEEEEECS---------CCCCCCCCCCSCSCCEEEEE
T ss_pred HHHhccCcceEEEecCCcCcHHHH--HHHHHh-hhcccccEEEEeccEeec---------cccchhhhcccccchheehh
Confidence 346677888888887776642110 011111 234589999999999998 455544 778888888
Q ss_pred EcccCcccccCC-ccccCC---CCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCC
Q 003368 337 EMDHNQFEGKIP-EEMSRL---QNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQ 412 (825)
Q Consensus 337 ~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 412 (825)
+++.|.+ .+| ..+..+ .+|++|++++|.+.... ....+++|++|++++|++++.+|..++++++|+.|++++
T Consensus 311 ~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 386 (562)
T 3a79_B 311 HVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386 (562)
T ss_dssp EEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCS
T ss_pred hccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCC
Confidence 8888888 455 333332 67999999999986322 126789999999999999998999999999999999999
Q ss_pred CCCcc--ccchhhhcccccccccccCCCccccCCCc-cccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCC
Q 003368 413 NDLSG--AIPEEIFNISHMSDSLNFARNHLVGSIPP-KIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFR 489 (825)
Q Consensus 413 N~l~g--~ip~~~~~~~~l~~~l~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 489 (825)
|++++ .+|..+..+..+ +.|++++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|++++|+++
T Consensus 387 N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~ 463 (562)
T 3a79_B 387 NGLKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463 (562)
T ss_dssp SCCCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC
T ss_pred CCcCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc
Confidence 99986 445667777777 7899999999986665 488899999999999999988887765 68999999999999
Q ss_pred CCCCccccCCCCCCEEECCCCccccccCcc-cccc-cCceeeCCCCcceecCCC
Q 003368 490 GSIPSSLVSLKDLREIDLSQNNLSGKIPIS-LERL-PLEYLNLSFNDLEGQVPT 541 (825)
Q Consensus 490 g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~-~~~l-~L~~l~ls~N~l~g~~p~ 541 (825)
.+|..+..+++|++||+++|++++ +|.. +..+ .|+++++++|++.+..|.
T Consensus 464 -~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 464 -SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp -CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred -ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 788888899999999999999994 5554 7777 699999999999886653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=422.11 Aligned_cols=536 Identities=19% Similarity=0.182 Sum_probs=371.3
Q ss_pred CCcccccCCCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCE
Q 003368 5 YPEGVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEA 84 (825)
Q Consensus 5 ~~~~~~~~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 84 (825)
|+...+++|..+ -+..|..+.|...... .|-++.+++ .+|..+- +++++|||++|+|+++.|.+|.++++|++
T Consensus 8 ~~~~~~~~~~~~-~p~~~~~c~~~~~~~~---~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~ 80 (635)
T 4g8a_A 8 DDDDKLAAANSS-IPESWEPCVEVVPNIT---YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQV 80 (635)
T ss_dssp ------------------CCSEEEETTTE---EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCcchhhcccCC-CCCCCCCccccCCCCE---EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCE
Confidence 455667778643 3444666666543322 345555664 5666552 47999999999999888899999999999
Q ss_pred EECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcC
Q 003368 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 85 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
|||++|+|+++.|++|.++++|++|+|++|+|++..+.+|.++++|++|+|++|+|++..+..|+++++|++|+|++|++
T Consensus 81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCcc
Confidence 99999999999999999999999999999999988889999999999999999999988888999999999999999999
Q ss_pred cc-cCCcccccccccceecCcCcC-----CccccCCCCC----ceeecCCccccccCCchhhhcCCCCcEEEcccccCCC
Q 003368 165 GG-NIPSSLGQLKELKSLGLGGTI-----PPSIYNLSLL----ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG 234 (825)
Q Consensus 165 ~~-~~p~~~~~l~~L~~L~L~~~~-----p~~i~~l~~l----~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~ 234 (825)
++ .+|..++.+++|++|+++++- |..+..+..+ ..++++.|.++ .+++..+ ....++.+++++|....
T Consensus 161 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~-~~~~~~~l~l~~n~~~~ 238 (635)
T 4g8a_A 161 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF-KEIRLHKLTLRNNFDSL 238 (635)
T ss_dssp CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTT-TTCEEEEEEEESCCSSH
T ss_pred ccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCcccc-cchhhhhhhhhcccccc
Confidence 86 457888888888888665432 2222222221 23444555554 2333332 22334445555544332
Q ss_pred CC-CccccCCCCccEEEeeccccc------CccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEccc
Q 003368 235 SF-PLAFSNASNLQSLEILGNNFF------GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVA 307 (825)
Q Consensus 235 ~~-p~~~~~l~~L~~L~L~~N~l~------~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~ 307 (825)
.. +..+..+..++...+..+... ......+..+..+...++..+..... ....+..+..+.+++.+++.+
T Consensus 239 ~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 239 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY---LDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp HHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSC---EEECTTTTGGGTTCSEEEEES
T ss_pred cccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccc---ccchhhhhhhhcccccccccc
Confidence 11 223444444444444333221 11122233333444444433322211 111123455677899999999
Q ss_pred ccccccCCCCccc------------ccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccc--cccCc
Q 003368 308 NQFKGALPHSIVS------------GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS--GEIPS 373 (825)
Q Consensus 308 N~l~~~~~~~~~~------------~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~ 373 (825)
|.+.+..+..... +.++ ...+..|+.++++.|.+... .....+++|++|++++|.+. +..+.
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--~~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~ 391 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFP--TLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQ 391 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCC--CCBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCH
T ss_pred cccccccccccchhhhhhhcccccccCcC--cccchhhhhcccccccCCCC--cccccccccccchhhcccccccccccc
Confidence 9887422111000 0000 11234455555555554422 22346788999999999885 34566
Q ss_pred cccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCcccccccc
Q 003368 374 SFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKV 453 (825)
Q Consensus 374 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~ 453 (825)
.+..+.+|++|+++.|.+.+ .+..+..+++|+.++++.|......+...+........++++.|.+.+..|..+..++.
T Consensus 392 ~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~ 470 (635)
T 4g8a_A 392 SDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 470 (635)
T ss_dssp HHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred chhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchh
Confidence 77788899999999998874 46678899999999999998887766655443333478999999999999999999999
Q ss_pred ccEEeecCceec-ccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCC
Q 003368 454 LRMFVVSSNNLS-GEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLS 531 (825)
Q Consensus 454 L~~L~ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls 531 (825)
|+.|++++|++. +.+|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..+..+ .|++|+++
T Consensus 471 L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 550 (635)
T 4g8a_A 471 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 550 (635)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECT
T ss_pred hhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECC
Confidence 999999999854 4678899999999999999999999999999999999999999999999888889888 69999999
Q ss_pred CCcceecCCCC-Ccc-CccccccccCCC
Q 003368 532 FNDLEGQVPTK-GIF-ANASAISVSGNS 557 (825)
Q Consensus 532 ~N~l~g~~p~~-~~~-~~~~~~~~~~n~ 557 (825)
+|+|++.+|.. ..+ .++....+.+|+
T Consensus 551 ~N~l~~~~~~~l~~l~~~L~~L~L~~Np 578 (635)
T 4g8a_A 551 LNHIMTSKKQELQHFPSSLAFLNLTQND 578 (635)
T ss_dssp TSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred CCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence 99999988854 223 456778888988
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=419.60 Aligned_cols=433 Identities=22% Similarity=0.187 Sum_probs=304.2
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|||++|.+.+..|.+|..+++|++|+|++|+|++..|++|+++++|++|||++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 68999999999999988899999999999999999999999999999999999999999999 55655 8999999999
Q ss_pred CCCCCCCC-CChhhhcccccceeeccccccccccCccCCCCCCC--CEEEcccCcC--cccCCcccccccccce--ecCc
Q 003368 112 GRNKLEGS-IPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL--EAISLAYNSL--GGNIPSSLGQLKELKS--LGLG 184 (825)
Q Consensus 112 s~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~~L~~--L~L~ 184 (825)
++|++++. .|..|+++++|++|+|++|++++. .|..+++| +.|+|++|++ ++..|..|..+.. +. ++++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~-~~l~l~l~ 204 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNT-TVLHLVFH 204 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCE-EEEEEEEC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCc-ceEEEEec
Confidence 99999974 468999999999999999999863 56666666 9999999999 8899998888752 22 3333
Q ss_pred Cc-----CC-ccccCCCCCceeecCCcc-----ccccCCchhhhcCCCCcEEEcccccCCCCCCc---cccCCCCccEEE
Q 003368 185 GT-----IP-PSIYNLSLLANFSVPENR-----LHGSLPPSLGLTLSNLQLFQISNNFFSGSFPL---AFSNASNLQSLE 250 (825)
Q Consensus 185 ~~-----~p-~~i~~l~~l~~l~l~~N~-----l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~ 250 (825)
++ ++ ..+..++.|+.+++++|+ +.+.+ ..+. .+++|+.|+|+++.+++.... .....++|++|+
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~-~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~ 282 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELT-RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHH-SCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHh-ccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEE
Confidence 21 11 133456666777777664 22221 1222 566677777666665432110 011234677777
Q ss_pred eecccccCccccCc-----CCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCc
Q 003368 251 ILGNNFFGKLSVNF-----GDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPS 325 (825)
Q Consensus 251 L~~N~l~~~~~~~~-----~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~ 325 (825)
+++|++.+.+|..+ ..++.|+.+++..|.+ ..+. .....+....+|+.|++++|.+.. ++
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~---~~~~~~~~~~~L~~L~l~~n~~~~----------~~- 347 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSK---EALYSVFAEMNIKMLSISDTPFIH----------MV- 347 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCH---HHHHHHHHTCCCSEEEEESSCCCC----------CC-
T ss_pred EeccEeeccccchhhhcccccchheehhhccccee-ecCh---hhhhhhhccCcceEEEccCCCccc----------cc-
Confidence 77777776666655 5555555555555544 1110 000111112456666666666542 11
Q ss_pred cccCCCCcCEEEcccCcccccCCccccCCCCCCEEEcccccccc--ccCccccCCCCCcEEEcccCccccccC-CCCCCC
Q 003368 326 EIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSG--EIPSSFGNLSSLVKLILGNNNLSGVIP-SSLGNL 402 (825)
Q Consensus 326 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l 402 (825)
....+++|+.|++++|++++.+|..++++++|++|+|++|++++ .+|..|..+++|++|++++|++++.+| ..+..+
T Consensus 348 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 427 (562)
T 3a79_B 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427 (562)
T ss_dssp CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence 11455666666666666666666666666666666666666664 234556666666666666666665333 335666
Q ss_pred CccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEE
Q 003368 403 KQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIY 482 (825)
Q Consensus 403 ~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~ 482 (825)
++|+.|++++|++++. +|..+. ++|+.|++++|+++ .+|..+..+++|+.|+
T Consensus 428 ~~L~~L~l~~n~l~~~-------------------------~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 428 ESILVLNLSSNMLTGS-------------------------VFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp TTCCEEECCSSCCCGG-------------------------GGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred ccCCEEECCCCCCCcc-------------------------hhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 6666666666666543 333332 57889999999998 7888888999999999
Q ss_pred ccCCcCCCCCCcc-ccCCCCCCEEECCCCccccccC
Q 003368 483 MAENFFRGSIPSS-LVSLKDLREIDLSQNNLSGKIP 517 (825)
Q Consensus 483 l~~N~l~g~~p~~-~~~l~~L~~Ldls~N~l~~~~p 517 (825)
+++|+++ .+|.. +..+++|+.|++++|++++..|
T Consensus 480 L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9999999 56665 8999999999999999997665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=395.63 Aligned_cols=367 Identities=20% Similarity=0.222 Sum_probs=243.3
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC-CcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI-PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
++|++|+|++|+|++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67888888888888777888888888888888888886443 56788888888888888888877788888888888888
Q ss_pred ccccccccccCcc--CCCCCCCCEEEcccCcCcccCCcc-cccccccceecCcCcCCccccCCCCCceeecCCccccccC
Q 003368 135 IQENNLTGGIPHF--LGNITSLEAISLAYNSLGGNIPSS-LGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211 (825)
Q Consensus 135 L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~l 211 (825)
|++|++++..|.. |+++++|++|+|++|++++..|.. |.++++|++| ++++|++++..
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L-------------------~L~~n~l~~~~ 170 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL-------------------DLTFNKVKSIC 170 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEE-------------------ECTTCCBSCCC
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEE-------------------eCCCCcccccC
Confidence 8888887654443 778888888888888887666654 5555555555 55555555444
Q ss_pred CchhhhcC--CCCcEEEcccccCCCCCCccc--------cCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCC
Q 003368 212 PPSLGLTL--SNLQLFQISNNFFSGSFPLAF--------SNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLG 281 (825)
Q Consensus 212 p~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 281 (825)
|..+. .+ .+|+.|++++|.+.+..+..+ ..+++|+.|+|++|++.+..+..+..+
T Consensus 171 ~~~l~-~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~-------------- 235 (455)
T 3v47_A 171 EEDLL-NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-------------- 235 (455)
T ss_dssp TTTSG-GGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH--------------
T ss_pred hhhhh-ccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcc--------------
Confidence 44333 22 456666666666665443322 234555555555555544433222111
Q ss_pred CCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccC--CCCCCE
Q 003368 282 SGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSR--LQNLQF 359 (825)
Q Consensus 282 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~ 359 (825)
...++|+.|++++|.+.+.. +..+.+.+..+..+.. .++|++
T Consensus 236 -------------~~~~~L~~L~l~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~L~~ 279 (455)
T 3v47_A 236 -------------IAGTKIQSLILSNSYNMGSS-----------------------FGHTNFKDPDNFTFKGLEASGVKT 279 (455)
T ss_dssp -------------TTTCCEEEEECTTCTTTSCC-----------------------TTCCSSCCCCTTTTGGGTTSCCCE
T ss_pred -------------ccccceeeEeeccccccccc-----------------------cchhhhccCcccccccccccCceE
Confidence 11244555555555444210 0111222222222222 356777
Q ss_pred EEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCc
Q 003368 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNH 439 (825)
Q Consensus 360 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~ 439 (825)
|++++|++.+..|..|..+++|++|+|++|++++..|..|+.+++|+.|+|++|++++.
T Consensus 280 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--------------------- 338 (455)
T 3v47_A 280 CDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI--------------------- 338 (455)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE---------------------
T ss_pred EEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc---------------------
Confidence 77777777777777777777777777777777777777777777777777777766532
Q ss_pred cccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccC
Q 003368 440 LVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIP 517 (825)
Q Consensus 440 l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p 517 (825)
.|..++.+++|+.|++++|++++..|..++.+++|++|++++|++++..+..+..+++|+.|++++|++++.+|
T Consensus 339 ----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 339 ----DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp ----CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ----ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 23345566777788888888877777788888888888888888886666667788888888888888887776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=389.38 Aligned_cols=406 Identities=23% Similarity=0.255 Sum_probs=224.1
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCC-------------CEEECCCCcCCCCCCc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRL-------------EALYLSHNSLVGEIPG 98 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 98 (825)
.+++.|++++|++ +.+|++|+++++|++|++++|+++|.+|.+++.+.+| ++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 5788899999988 8899999999999999999999998899999888765 8888888888853 33
Q ss_pred CCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCccccccccc
Q 003368 99 NLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178 (825)
Q Consensus 99 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 178 (825)
. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3678888888888886 5543 3778888888888885 3322 1688888888888875 55 47777777
Q ss_pred ceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccC
Q 003368 179 KSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258 (825)
Q Consensus 179 ~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 258 (825)
++| ++++|++++ +|.. ..+|++|++++|++++ +| .|.++++|+.|++++|++.+
T Consensus 156 ~~L-------------------~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~ 209 (454)
T 1jl5_A 156 KII-------------------DVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK 209 (454)
T ss_dssp CEE-------------------ECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS
T ss_pred CEE-------------------ECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc
Confidence 666 667777774 5543 3588888888888886 45 58888888888888888776
Q ss_pred ccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEc
Q 003368 259 KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338 (825)
Q Consensus 259 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L 338 (825)
. |.. .++|++|++++|.+... | .+..+++|++|++++|++++ +|.. +++|+.|++
T Consensus 210 l-~~~---~~~L~~L~l~~n~l~~l-------p-~~~~l~~L~~L~l~~N~l~~----------l~~~---~~~L~~L~l 264 (454)
T 1jl5_A 210 L-PDL---PLSLESIVAGNNILEEL-------P-ELQNLPFLTTIYADNNLLKT----------LPDL---PPSLEALNV 264 (454)
T ss_dssp C-CCC---CTTCCEEECCSSCCSSC-------C-CCTTCTTCCEEECCSSCCSS----------CCSC---CTTCCEEEC
T ss_pred C-CCC---cCcccEEECcCCcCCcc-------c-ccCCCCCCCEEECCCCcCCc----------cccc---ccccCEEEC
Confidence 3 222 24777777777776532 2 25567777777777777763 3322 256777777
Q ss_pred ccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccc
Q 003368 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGA 418 (825)
Q Consensus 339 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ 418 (825)
++|++++ +|.. .++|++|++++|++++ +|.. .++|++|++++|++++. +.. .++|+.|++++|++++
T Consensus 265 ~~N~l~~-l~~~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~i-~~~---~~~L~~L~Ls~N~l~~- 331 (454)
T 1jl5_A 265 RDNYLTD-LPEL---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRSL-CDL---PPSLEELNVSNNKLIE- 331 (454)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSEE-CCC---CTTCCEEECCSSCCSC-
T ss_pred CCCcccc-cCcc---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCcc-cCC---cCcCCEEECCCCcccc-
Confidence 7777775 4432 3667777777777765 2221 15677777777777652 221 1466777777777764
Q ss_pred cchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecc--cCCccccCCCCCCEEEccCCcCCCCCCccc
Q 003368 419 IPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSG--EIPSEIGSCFYLQEIYMAENFFRGSIPSSL 496 (825)
Q Consensus 419 ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~ 496 (825)
+|..+ ..+ +.|++++|+++ .+|. .+++|+.|++++|++++ .+|.+++. ++.|.+.|.+|..
T Consensus 332 lp~~~---~~L-~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~- 394 (454)
T 1jl5_A 332 LPALP---PRL-ERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL- 394 (454)
T ss_dssp CCCCC---TTC-CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------
T ss_pred ccccC---CcC-CEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc-
Confidence 55432 222 45666666665 3444 34556666666666665 45544432 2235555555542
Q ss_pred cCCCCCCEEECCCCcccc--ccCcccccccCceeeCCCCcceecCC
Q 003368 497 VSLKDLREIDLSQNNLSG--KIPISLERLPLEYLNLSFNDLEGQVP 540 (825)
Q Consensus 497 ~~l~~L~~Ldls~N~l~~--~~p~~~~~l~L~~l~ls~N~l~g~~p 540 (825)
+++|+.||+++|++++ .+|.++ +.|.+.+|.+.+.+|
T Consensus 395 --~~~L~~L~ls~N~l~~~~~iP~sl-----~~L~~~~~~~~~~~~ 433 (454)
T 1jl5_A 395 --PQNLKQLHVETNPLREFPDIPESV-----EDLRMNSERVVDPYE 433 (454)
T ss_dssp ----------------------------------------------
T ss_pred --cCcCCEEECCCCcCCccccchhhH-----hheeCcCcccCCccc
Confidence 3567777777777765 455443 334555555555444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=389.63 Aligned_cols=366 Identities=20% Similarity=0.213 Sum_probs=245.6
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccC-CccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKI-PGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+++.|||++|++.+..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67999999999999999999999999999999999998554 67899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCChh--hhcccccceeeccccccccccCcc-CCCCCCCCEEEcccCcCcccCCcccccc--cccceecCcC
Q 003368 111 LGRNKLEGSIPSE--FVSLYNLKELAIQENNLTGGIPHF-LGNITSLEAISLAYNSLGGNIPSSLGQL--KELKSLGLGG 185 (825)
Q Consensus 111 Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~ 185 (825)
|++|++++..|.. |..+++|++|+|++|++++..|.. |.++++|++|+|++|++++..|..+..+ .+|+.|+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~--- 186 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--- 186 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEE---
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccc---
Confidence 9999999866555 999999999999999999888876 8999999999999999999999888877 5666664
Q ss_pred cCCccccCCCCCceeecCCccccccCCchh-------hhcCCCCcEEEcccccCCCCCCccccCC---CCccEEEeeccc
Q 003368 186 TIPPSIYNLSLLANFSVPENRLHGSLPPSL-------GLTLSNLQLFQISNNFFSGSFPLAFSNA---SNLQSLEILGNN 255 (825)
Q Consensus 186 ~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~-------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~ 255 (825)
+++|.+.+.-+..+ ...+++|+.|++++|.+++..|..|... ++|+.|++++|.
T Consensus 187 ----------------l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~ 250 (455)
T 3v47_A 187 ----------------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250 (455)
T ss_dssp ----------------CTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCT
T ss_pred ----------------cccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccc
Confidence 44555542211110 0134567777777777766666555443 667777777765
Q ss_pred ccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCE
Q 003368 256 FFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYL 335 (825)
Q Consensus 256 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~ 335 (825)
+.+... ..+.+.......+ .-...++|+.|++++|.+++ .+|..+..+++|+.
T Consensus 251 ~~~~~~--------------~~~~~~~~~~~~~----~~~~~~~L~~L~l~~n~l~~---------~~~~~~~~l~~L~~ 303 (455)
T 3v47_A 251 NMGSSF--------------GHTNFKDPDNFTF----KGLEASGVKTCDLSKSKIFA---------LLKSVFSHFTDLEQ 303 (455)
T ss_dssp TTSCCT--------------TCCSSCCCCTTTT----GGGTTSCCCEEECCSSCCCE---------ECTTTTTTCTTCCE
T ss_pred cccccc--------------chhhhccCccccc----ccccccCceEEEecCccccc---------cchhhcccCCCCCE
Confidence 543211 0111111000000 00112455555555555553 33444555555555
Q ss_pred EEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCC
Q 003368 336 IEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415 (825)
Q Consensus 336 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 415 (825)
|++++|++++..|..|.++++|++|+|++|++.+..|..|..+++|++|+|++|++++..|..|..+++|++|++++|++
T Consensus 304 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcc
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccchh-hhcccccccccccCCCccccCCC
Q 003368 416 SGAIPEE-IFNISHMSDSLNFARNHLVGSIP 445 (825)
Q Consensus 416 ~g~ip~~-~~~~~~l~~~l~l~~N~l~~~~p 445 (825)
++ +|.. +..+..+ +.|++++|++++..|
T Consensus 384 ~~-~~~~~~~~l~~L-~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 384 KS-VPDGIFDRLTSL-QKIWLHTNPWDCSCP 412 (455)
T ss_dssp SC-CCTTTTTTCTTC-CEEECCSSCBCCCTT
T ss_pred cc-CCHhHhccCCcc-cEEEccCCCcccCCC
Confidence 53 3332 2333333 455555555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=387.97 Aligned_cols=389 Identities=24% Similarity=0.288 Sum_probs=274.2
Q ss_pred CCcEEEEECCCCCCccccCcCCCCCCCC-------------CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC
Q 003368 31 HRRVTVLDLKSKGLIGSLSPQIGNLSFL-------------REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP 97 (825)
Q Consensus 31 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L-------------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 97 (825)
..+++.|++++|++.+.+|+.++.+++| ++|++++|++++ +|.. .++|++|++++|++++ +|
T Consensus 33 L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp 107 (454)
T 1jl5_A 33 VKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LP 107 (454)
T ss_dssp -CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CC
T ss_pred ccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cc
Confidence 3678889999999999999999999875 999999999996 4542 4789999999999997 66
Q ss_pred cCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccc
Q 003368 98 GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 177 (825)
.. +++|++|++++|++++ +|.. .++|++|++++|++++ +| .|+++++|++|++++|++++ +|..+ .+
T Consensus 108 ~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~ 174 (454)
T 1jl5_A 108 EL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PS 174 (454)
T ss_dssp CC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TT
T ss_pred cc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---cc
Confidence 53 4899999999999996 3332 2689999999999996 67 59999999999999999985 55433 24
Q ss_pred cceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 178 L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
|+ .|++++|++++ +| .+. .+++|+.|++++|++++ +|.. .++|++|++++|++.
T Consensus 175 L~-------------------~L~L~~n~l~~-l~-~~~-~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 175 LE-------------------FIAAGNNQLEE-LP-ELQ-NLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE 228 (454)
T ss_dssp CC-------------------EEECCSSCCSS-CC-CCT-TCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS
T ss_pred cc-------------------EEECcCCcCCc-Cc-ccc-CCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC
Confidence 44 44888899985 77 344 89999999999999997 4433 258999999999998
Q ss_pred CccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEE
Q 003368 258 GKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIE 337 (825)
Q Consensus 258 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~ 337 (825)
.+| .++.+++|++|++++|++...+. .+++|+.|++++|++++ +|.. .++|+.|+
T Consensus 229 -~lp-~~~~l~~L~~L~l~~N~l~~l~~----------~~~~L~~L~l~~N~l~~----------l~~~---~~~L~~L~ 283 (454)
T 1jl5_A 229 -ELP-ELQNLPFLTTIYADNNLLKTLPD----------LPPSLEALNVRDNYLTD----------LPEL---PQSLTFLD 283 (454)
T ss_dssp -SCC-CCTTCTTCCEEECCSSCCSSCCS----------CCTTCCEEECCSSCCSC----------CCCC---CTTCCEEE
T ss_pred -ccc-ccCCCCCCCEEECCCCcCCcccc----------cccccCEEECCCCcccc----------cCcc---cCcCCEEE
Confidence 455 48999999999999999976431 23789999999999984 4443 37899999
Q ss_pred cccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCcc
Q 003368 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417 (825)
Q Consensus 338 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 417 (825)
+++|++++. |.. .++|++|++++|++.+ ++.. .++|++|++++|++++ +|.. +++|+.|++++|+++
T Consensus 284 ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~- 350 (454)
T 1jl5_A 284 VSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA- 350 (454)
T ss_dssp CCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-
T ss_pred CcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-
Confidence 999999973 221 2689999999999985 3321 2589999999999997 5654 588999999999999
Q ss_pred ccchhhhcccccccccccCCCcccc--CCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCC--CCC
Q 003368 418 AIPEEIFNISHMSDSLNFARNHLVG--SIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRG--SIP 493 (825)
Q Consensus 418 ~ip~~~~~~~~l~~~l~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p 493 (825)
.+|. .+..+ +.|++++|++++ .+|..+++ ++.|++.|.+|.. +++|+.|++++|++++ .+|
T Consensus 351 ~lp~---~l~~L-~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 EVPE---LPQNL-KQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp CCCC---CCTTC-CEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred cccc---hhhhc-cEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 6887 23444 789999999999 78887764 3468888888874 5789999999999997 677
Q ss_pred ccccCCCCCCEEECCCCccccccCccccc
Q 003368 494 SSLVSLKDLREIDLSQNNLSGKIPISLER 522 (825)
Q Consensus 494 ~~~~~l~~L~~Ldls~N~l~~~~p~~~~~ 522 (825)
.+ ++.|++++|.+.+.+|.....
T Consensus 416 ~s------l~~L~~~~~~~~~~~~~~~~~ 438 (454)
T 1jl5_A 416 ES------VEDLRMNSERVVDPYEFAHET 438 (454)
T ss_dssp -----------------------------
T ss_pred hh------HhheeCcCcccCCccccCHHH
Confidence 54 566788999998887765543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.39 Aligned_cols=362 Identities=19% Similarity=0.174 Sum_probs=260.0
Q ss_pred ccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhh
Q 003368 45 IGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF 124 (825)
Q Consensus 45 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 124 (825)
.+..+..++.+++|++|++++|.|++. | .|+.+++|++|+|++|+|++. | |+.+++|++|+|++|+|++. | |
T Consensus 31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~ 102 (457)
T 3bz5_A 31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--V 102 (457)
T ss_dssp CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--c
Confidence 344455677888889999999988864 5 688888899999999988865 3 88888888888888888864 3 7
Q ss_pred hcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCC
Q 003368 125 VSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPE 204 (825)
Q Consensus 125 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~ 204 (825)
+.+++|++|++++|++++. | ++.+++|++|++++|++++. + ++.+++|++| ++++
T Consensus 103 ~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L-------------------~l~~ 157 (457)
T 3bz5_A 103 TPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTEL-------------------DCHL 157 (457)
T ss_dssp TTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEE-------------------ECTT
T ss_pred CCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEE-------------------ECCC
Confidence 8888888888888888864 3 78888888888888888753 2 4555555554 4555
Q ss_pred ccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCC
Q 003368 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGE 284 (825)
Q Consensus 205 N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 284 (825)
|...+.++ +. .+++|+.|++++|++++. | +..+++|+.|++++|++.+.
T Consensus 158 n~~~~~~~--~~-~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~------------------------- 206 (457)
T 3bz5_A 158 NKKITKLD--VT-PQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL------------------------- 206 (457)
T ss_dssp CSCCCCCC--CT-TCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC-------------------------
T ss_pred CCcccccc--cc-cCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee-------------------------
Confidence 54444442 22 556666666666666652 2 55556666666665555432
Q ss_pred CCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccc
Q 003368 285 SDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRH 364 (825)
Q Consensus 285 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 364 (825)
.+..+++|+.|++++|++++ +| +..+++|+.|++++|++++.. ++.+++|+.|++++
T Consensus 207 --------~l~~l~~L~~L~Ls~N~l~~----------ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~ 263 (457)
T 3bz5_A 207 --------DLNQNIQLTFLDCSSNKLTE----------ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQ 263 (457)
T ss_dssp --------CCTTCTTCSEEECCSSCCSC----------CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTT
T ss_pred --------ccccCCCCCEEECcCCcccc----------cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccC
Confidence 13455667777777777763 44 566777777777777777643 34567777777776
Q ss_pred cccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCC
Q 003368 365 NQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSI 444 (825)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~ 444 (825)
| +|+.|++++|.+.+.+| ++.+++|+.|++++|.+.|.+|.... .+ +.+++++
T Consensus 264 n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~---~L-~~L~l~~------- 316 (457)
T 3bz5_A 264 T--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAA---GI-TELDLSQ------- 316 (457)
T ss_dssp C--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTC---CC-SCCCCTT-------
T ss_pred C--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCC---cc-eEechhh-------
Confidence 5 35567788888777776 56788888888888888887775332 22 3444443
Q ss_pred CccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-
Q 003368 445 PPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL- 523 (825)
Q Consensus 445 p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l- 523 (825)
+++|+.|++++|+++| +| ++.+++|+.|++++|++++ ++.|..|++++|+++|. + .+
T Consensus 317 ------~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~----~~~ 374 (457)
T 3bz5_A 317 ------NPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G----QTI 374 (457)
T ss_dssp ------CTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E----EEE
T ss_pred ------cccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c----eee
Confidence 3678999999999998 43 8999999999999999985 35677788999999986 2 23
Q ss_pred cCceeeCCCCcceecCCCC
Q 003368 524 PLEYLNLSFNDLEGQVPTK 542 (825)
Q Consensus 524 ~L~~l~ls~N~l~g~~p~~ 542 (825)
.+..+++++|+++|.+|..
T Consensus 375 ~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 375 TMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp ECCCBCCBTTBEEEECCTT
T ss_pred ecCccccccCcEEEEcChh
Confidence 5788999999999999863
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.87 Aligned_cols=348 Identities=17% Similarity=0.188 Sum_probs=259.9
Q ss_pred CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 31 HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 31 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
..+++.||+++|++.+. | .++.+++|++|+|++|+|++. | |+.+++|++|+|++|+|++. | |..+++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 36899999999999875 4 799999999999999999974 4 89999999999999999975 3 99999999999
Q ss_pred cCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcc
Q 003368 111 LGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPS 190 (825)
Q Consensus 111 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~ 190 (825)
|++|++++. | ++.+++|++|++++|++++. .++.+++|++|++++|+..+.+ .++.+++|++|
T Consensus 113 L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L--------- 175 (457)
T 3bz5_A 113 CDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL--------- 175 (457)
T ss_dssp CCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE---------
T ss_pred CCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEE---------
Confidence 999999974 4 89999999999999999975 3889999999999999765555 46677777777
Q ss_pred ccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCC
Q 003368 191 IYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270 (825)
Q Consensus 191 i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 270 (825)
++++|++++ +| + ..+++|+.|++++|.+++. .+..+++|+.|+|++|++.+ +| +..+++|
T Consensus 176 ----------~ls~n~l~~-l~--l-~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L 235 (457)
T 3bz5_A 176 ----------DCSFNKITE-LD--V-SQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQL 235 (457)
T ss_dssp ----------ECCSSCCCC-CC--C-TTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred ----------ECCCCccce-ec--c-ccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCC
Confidence 666666664 44 2 2667777777777777764 36777777777777777776 33 6677777
Q ss_pred cEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc
Q 003368 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350 (825)
Q Consensus 271 ~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~ 350 (825)
++|++++|++.... +..+++|+.|+++.|+++ .+++++|.+.+.+|
T Consensus 236 ~~L~l~~N~l~~~~---------~~~l~~L~~L~l~~n~L~-----------------------~L~l~~n~~~~~~~-- 281 (457)
T 3bz5_A 236 TYFDCSVNPLTELD---------VSTLSKLTTLHCIQTDLL-----------------------EIDLTHNTQLIYFQ-- 281 (457)
T ss_dssp SEEECCSSCCSCCC---------CTTCTTCCEEECTTCCCS-----------------------CCCCTTCTTCCEEE--
T ss_pred CEEEeeCCcCCCcC---------HHHCCCCCEEeccCCCCC-----------------------EEECCCCccCCccc--
Confidence 77777777776532 234556666666555443 23344444444443
Q ss_pred ccCCCCCCEEEccccccccccCcc--------ccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchh
Q 003368 351 MSRLQNLQFLNMRHNQLSGEIPSS--------FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEE 422 (825)
Q Consensus 351 ~~~l~~L~~L~Ls~N~l~~~~p~~--------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~ 422 (825)
++.+++|++|++++|.+.+.+|.. +..+++|++|++++|++++. + ++.+++|+.|++++|+++| +|
T Consensus 282 ~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l~-- 355 (457)
T 3bz5_A 282 AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-FS-- 355 (457)
T ss_dssp CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-CT--
T ss_pred ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-cc--
Confidence 234444444444444444333321 23346889999999999984 3 8889999999999999986 32
Q ss_pred hhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccC
Q 003368 423 IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGS 474 (825)
Q Consensus 423 ~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~ 474 (825)
.+ ..|++++|.+.|. +.+..|+.+++++|+++|.+|..+..
T Consensus 356 -----~L-~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 356 -----SV-GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp -----TG-GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred -----cc-ccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence 22 4677888888876 46677888899999999999876644
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=359.55 Aligned_cols=344 Identities=27% Similarity=0.414 Sum_probs=190.1
Q ss_pred CCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 55 LSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
+++|+.|++++|.++. +|. +..+++|++|||++|.+++..| |..+++|++|++++|++++..+ |.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 4556666666666653 342 5566666666666666664443 6666666666666666664433 66666666666
Q ss_pred ccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCch
Q 003368 135 IQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214 (825)
Q Consensus 135 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~ 214 (825)
+++|++++..+ +.++++|++|++++|++++ ++ .++.+++|+.|++++ .+.+ +++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~--------------------~~~~-~~~- 172 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFGN--------------------QVTD-LKP- 172 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEEE--------------------SCCC-CGG-
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecCC--------------------cccC-chh-
Confidence 66666664432 6666666666666666653 22 355555555553321 1111 111
Q ss_pred hhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCcccccccc
Q 003368 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSL 294 (825)
Q Consensus 215 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~ 294 (825)
+ ..+++|+.|++++|.+++. ..+..+++|++|++++|.+.+..+ ++.+++|+.|++++|.+... ..+
T Consensus 173 ~-~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--------~~l 239 (466)
T 1o6v_A 173 L-ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--------GTL 239 (466)
T ss_dssp G-TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--------GGG
T ss_pred h-ccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--------hhh
Confidence 1 2455555555555555533 235555555566655555554443 44455555555555555432 234
Q ss_pred ccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcc
Q 003368 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS 374 (825)
Q Consensus 295 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 374 (825)
..+++|+.|++++|.+++ +++ +..+++|+.|++++|.+++..+ +..+++|++|+|++|++.+..|
T Consensus 240 ~~l~~L~~L~l~~n~l~~----------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-- 304 (466)
T 1o6v_A 240 ASLTNLTDLDLANNQISN----------LAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-- 304 (466)
T ss_dssp GGCTTCSEEECCSSCCCC----------CGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--
T ss_pred hcCCCCCEEECCCCcccc----------chh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--
Confidence 556666666666666653 222 5566666666666666665433 6666666666666666665433
Q ss_pred ccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccc
Q 003368 375 FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVL 454 (825)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L 454 (825)
+..+++|++|++++|++++..| +..+++|+.|++++|++++. +.+..+..+ +.|++++|++++..| +..+++|
T Consensus 305 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L-~~L~l~~n~l~~~~~--~~~l~~L 377 (466)
T 1o6v_A 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNI-NWLSAGHNQISDLTP--LANLTRI 377 (466)
T ss_dssp GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTC-CEEECCSSCCCBCGG--GTTCTTC
T ss_pred hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCC-CEEeCCCCccCccch--hhcCCCC
Confidence 5666666666666666666554 55666666666666666532 122233322 333444444433333 4444455
Q ss_pred cEEeecCceec
Q 003368 455 RMFVVSSNNLS 465 (825)
Q Consensus 455 ~~L~ls~N~l~ 465 (825)
+.|++++|.++
T Consensus 378 ~~L~l~~n~~~ 388 (466)
T 1o6v_A 378 TQLGLNDQAWT 388 (466)
T ss_dssp CEEECCCEEEE
T ss_pred CEEeccCCccc
Confidence 55555555555
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=350.98 Aligned_cols=278 Identities=29% Similarity=0.537 Sum_probs=216.7
Q ss_pred CCcccccCCCCCCCCce--eeceeecCCC--CcEEEEECCCCCCcc--ccCcCCCCCCCCCEEEcCC-CcccccCCcccc
Q 003368 5 YPEGVLNSWNDSHHFCD--WEGITCSPRH--RRVTVLDLKSKGLIG--SLSPQIGNLSFLREIHLSN-NTIQGKIPGEIG 77 (825)
Q Consensus 5 ~~~~~~~~w~~~~~~C~--~~g~~c~~~~--~~l~~l~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~ 77 (825)
||. .+.+|..+++||. |.||+|.... ++|+.|||++|++.+ .+|+.|..+++|++|+|++ |.+.+.+|.+|+
T Consensus 20 ~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~ 98 (313)
T 1ogq_A 20 NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98 (313)
T ss_dssp CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGG
T ss_pred Ccc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHh
Confidence 665 7999988889998 9999998765 789999999999998 8899999999999999994 888888898899
Q ss_pred CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCC-CCCE
Q 003368 78 RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT-SLEA 156 (825)
Q Consensus 78 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~ 156 (825)
++++|++|+|++|+|++.+|..|..+++|++|+|++|+|++.+|..|..+++|++|+|++|++++.+|..|..++ +|++
T Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~ 178 (313)
T 1ogq_A 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE
Confidence 999999999988888888888888888888888888888888888888888888888888888877777777777 7788
Q ss_pred EEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCC
Q 003368 157 ISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236 (825)
Q Consensus 157 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~ 236 (825)
|+|++|++++.+|..|..++ |+.|+|++|.+++..
T Consensus 179 L~L~~N~l~~~~~~~~~~l~---------------------------------------------L~~L~Ls~N~l~~~~ 213 (313)
T 1ogq_A 179 MTISRNRLTGKIPPTFANLN---------------------------------------------LAFVDLSRNMLEGDA 213 (313)
T ss_dssp EECCSSEEEEECCGGGGGCC---------------------------------------------CSEEECCSSEEEECC
T ss_pred EECcCCeeeccCChHHhCCc---------------------------------------------ccEEECcCCcccCcC
Confidence 87777777766665544432 555555566665556
Q ss_pred CccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCC
Q 003368 237 PLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPH 316 (825)
Q Consensus 237 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 316 (825)
|..|..+++|+.|+|++|++.+.++. +..+++|++|+|++|++++
T Consensus 214 ~~~~~~l~~L~~L~L~~N~l~~~~~~-------------------------------~~~l~~L~~L~Ls~N~l~~---- 258 (313)
T 1ogq_A 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------------VGLSKNLNGLDLRNNRIYG---- 258 (313)
T ss_dssp GGGCCTTSCCSEEECCSSEECCBGGG-------------------------------CCCCTTCCEEECCSSCCEE----
T ss_pred CHHHhcCCCCCEEECCCCceeeecCc-------------------------------ccccCCCCEEECcCCcccC----
Confidence 66666777777777777766544322 3345566777777777765
Q ss_pred CcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccc-ccc
Q 003368 317 SIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQ-LSG 369 (825)
Q Consensus 317 ~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 369 (825)
.+|..+..+++|+.|++++|+++|.+|.. ..+++|+.|++++|. +.|
T Consensus 259 -----~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 259 -----TLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp -----CCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred -----cCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence 56677777888888888888888888775 778888888888887 554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=355.71 Aligned_cols=321 Identities=22% Similarity=0.238 Sum_probs=264.0
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.++.+++++. .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3555666664 4566553 689999999999998889999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCC
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLS 195 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~ 195 (825)
++++.+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-------------- 157 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQL-------------- 157 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEE--------------
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEE--------------
Confidence 998777789999999999999999998889999999999999999999998888888887777777
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
++++|+++ .+|...+..+++|+.|+|++|.+++..+..|..+++|+.|++++|++.+.++....
T Consensus 158 -----~l~~n~l~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~---------- 221 (477)
T 2id5_A 158 -----TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL---------- 221 (477)
T ss_dssp -----EEESCCCS-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT----------
T ss_pred -----ECCCCcCc-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc----------
Confidence 66677777 45655555788888888888888887777888888888888888876655543322
Q ss_pred ccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCcccccCCccccCC
Q 003368 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSRL 354 (825)
Q Consensus 276 s~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 354 (825)
...+|+.|++++|+++ .+| ..+..+++|+.|+|++|.+++..+..|.++
T Consensus 222 --------------------~~~~L~~L~l~~n~l~----------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (477)
T 2id5_A 222 --------------------YGLNLTSLSITHCNLT----------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271 (477)
T ss_dssp --------------------TTCCCSEEEEESSCCC----------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTC
T ss_pred --------------------cCccccEEECcCCccc----------ccCHHHhcCccccCeeECCCCcCCccChhhcccc
Confidence 2336777777777776 344 356778888888888888887777788888
Q ss_pred CCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCcccc
Q 003368 355 QNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419 (825)
Q Consensus 355 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i 419 (825)
++|++|+|++|++.+..|..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+....
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 88888888888888888888888888999999999888777777888888999999998887543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.72 Aligned_cols=346 Identities=25% Similarity=0.387 Sum_probs=208.3
Q ss_pred CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEE
Q 003368 78 RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAI 157 (825)
Q Consensus 78 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 157 (825)
.+.+|+.|++++|.++. +|. +..+++|++|+|++|++++..| |.++++|++|++++|++++..+ |+++++|++|
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L 117 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence 45678999999998874 453 7888899999999999886544 8888889999999998886655 8888888888
Q ss_pred EcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCC
Q 003368 158 SLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFP 237 (825)
Q Consensus 158 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p 237 (825)
+|++|++++..+ |..+++|++| ++++|.+++ +|. +. .+++|+.|+++ |.+.+..
T Consensus 118 ~L~~n~l~~~~~--~~~l~~L~~L-------------------~l~~n~l~~-~~~-~~-~l~~L~~L~l~-~~~~~~~- 171 (466)
T 1o6v_A 118 TLFNNQITDIDP--LKNLTNLNRL-------------------ELSSNTISD-ISA-LS-GLTSLQQLSFG-NQVTDLK- 171 (466)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEE-------------------EEEEEEECC-CGG-GT-TCTTCSEEEEE-ESCCCCG-
T ss_pred ECCCCCCCCChH--HcCCCCCCEE-------------------ECCCCccCC-Chh-hc-cCCcccEeecC-CcccCch-
Confidence 888888875432 4444444444 444444442 221 22 45555555554 3333221
Q ss_pred ccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCC
Q 003368 238 LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317 (825)
Q Consensus 238 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 317 (825)
.+.++++|+.|++++|.+.+. ..+..+++|++|++++|.+++
T Consensus 172 -~~~~l~~L~~L~l~~n~l~~~--------------------------------~~l~~l~~L~~L~l~~n~l~~----- 213 (466)
T 1o6v_A 172 -PLANLTTLERLDISSNKVSDI--------------------------------SVLAKLTNLESLIATNNQISD----- 213 (466)
T ss_dssp -GGTTCTTCCEEECCSSCCCCC--------------------------------GGGGGCTTCSEEECCSSCCCC-----
T ss_pred -hhccCCCCCEEECcCCcCCCC--------------------------------hhhccCCCCCEEEecCCcccc-----
Confidence 244555555555555544332 124455566666666666553
Q ss_pred cccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCC
Q 003368 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397 (825)
Q Consensus 318 ~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 397 (825)
+++ ++.+++|+.|++++|++++. +.+..+++|++|++++|++.+..| +..+++|++|++++|++++..|
T Consensus 214 -----~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~- 282 (466)
T 1o6v_A 214 -----ITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 282 (466)
T ss_dssp -----CGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-
T ss_pred -----ccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-
Confidence 111 44556666666666666542 245566666666666666664433 5566666666666666665433
Q ss_pred CCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCCccccCCCC
Q 003368 398 SLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY 477 (825)
Q Consensus 398 ~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~ 477 (825)
+..+++|+.|++++|++++..| +..+..+ +.|++++|++++..| ++.+++|+.|++++|++++. +.++.+++
T Consensus 283 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~ 354 (466)
T 1o6v_A 283 -LAGLTALTNLELNENQLEDISP--ISNLKNL-TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTN 354 (466)
T ss_dssp -GTTCTTCSEEECCSSCCSCCGG--GGGCTTC-SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred -ccCCCccCeEEcCCCcccCchh--hcCCCCC-CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCC
Confidence 5566666666666666653222 2233333 344444444443333 45556666666666666643 35666666
Q ss_pred CCEEEccCCcCCCCCCccccCCCCCCEEECCCCcccc
Q 003368 478 LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSG 514 (825)
Q Consensus 478 L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~ 514 (825)
|+.|++++|++++..| +..+++|+.|++++|++++
T Consensus 355 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred CCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 6666666666665554 5666666666666666664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.48 Aligned_cols=351 Identities=18% Similarity=0.179 Sum_probs=277.5
Q ss_pred ccCCCCCCCCce-eeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECC
Q 003368 10 LNSWNDSHHFCD-WEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLS 88 (825)
Q Consensus 10 ~~~w~~~~~~C~-~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 88 (825)
+++|..+.+||. |.+..|.....++ ............-..+++++.|++++|.++...+..|..+++|++|+|+
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 678988888885 6666665433222 1111111222223457899999999999997666678999999999999
Q ss_pred CCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccC
Q 003368 89 HNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNI 168 (825)
Q Consensus 89 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 168 (825)
+|.|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|.++++|++|+|++|++++..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 99999888889999999999999999999988899999999999999999999766667899999999999999999888
Q ss_pred CcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccE
Q 003368 169 PSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQS 248 (825)
Q Consensus 169 p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 248 (825)
|..|..+++|++| ++++|++++ ++. ..+++|+.|++++|.+++ +...++|+.
T Consensus 158 ~~~~~~l~~L~~L-------------------~l~~n~l~~-~~~---~~l~~L~~L~l~~n~l~~-----~~~~~~L~~ 209 (390)
T 3o6n_A 158 DDTFQATTSLQNL-------------------QLSSNRLTH-VDL---SLIPSLFHANVSYNLLST-----LAIPIAVEE 209 (390)
T ss_dssp TTTTSSCTTCCEE-------------------ECCSSCCSB-CCG---GGCTTCSEEECCSSCCSE-----EECCSSCSE
T ss_pred hhhccCCCCCCEE-------------------ECCCCcCCc-ccc---ccccccceeecccccccc-----cCCCCcceE
Confidence 8888888888888 666777763 332 267889999999998874 345568999
Q ss_pred EEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCcccc
Q 003368 249 LEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328 (825)
Q Consensus 249 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~ 328 (825)
|++++|.+...... ..++|+.|++++|.+... ..+..+++|+.|++++|.+++ ..|..+.
T Consensus 210 L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~Ls~n~l~~---------~~~~~~~ 269 (390)
T 3o6n_A 210 LDASHNSINVVRGP---VNVELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEK---------IMYHPFV 269 (390)
T ss_dssp EECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCE---------EESGGGT
T ss_pred EECCCCeeeecccc---ccccccEEECCCCCCccc--------HHHcCCCCccEEECCCCcCCC---------cChhHcc
Confidence 99999988765332 347889999999988752 357788999999999999986 4567788
Q ss_pred CCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCcccee
Q 003368 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALL 408 (825)
Q Consensus 329 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 408 (825)
.+++|+.|++++|++++ +|..+..+++|++|+|++|++. .+|..+..+++|++|+|++|+++.. | +..+++|+.|
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L 344 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNL 344 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEE
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEE
Confidence 89999999999999985 5666788999999999999998 5677788899999999999999854 3 7788899999
Q ss_pred ecCCCCCccc
Q 003368 409 HLFQNDLSGA 418 (825)
Q Consensus 409 ~L~~N~l~g~ 418 (825)
++++|.+++.
T Consensus 345 ~l~~N~~~~~ 354 (390)
T 3o6n_A 345 TLSHNDWDCN 354 (390)
T ss_dssp ECCSSCEEHH
T ss_pred EcCCCCccch
Confidence 9999999854
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=359.14 Aligned_cols=359 Identities=18% Similarity=0.181 Sum_probs=277.5
Q ss_pred cCCcccccCCCCCCCCce-eeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCC
Q 003368 4 QYPEGVLNSWNDSHHFCD-WEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRL 82 (825)
Q Consensus 4 ~~~~~~~~~w~~~~~~C~-~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 82 (825)
.++.-.+++|..+.+||. |.+..|......+ +........ ...-..+.+++.|++++|.++...+..|..+++|
T Consensus 3 g~~~~~l~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L 77 (597)
T 3oja_B 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHI---DMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77 (597)
T ss_dssp --------CCCSEECCCCC--CCSEEECSCEE---CSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred CcccccccCCCCCCcCcccCcCceeEecCcee---ccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence 344556899988888885 4444454332111 111112111 1122357889999999999998777788999999
Q ss_pred CEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccC
Q 003368 83 EALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYN 162 (825)
Q Consensus 83 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 162 (825)
++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|
T Consensus 78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N 157 (597)
T 3oja_B 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN 157 (597)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence 99999999999999999999999999999999999988899999999999999999999777777899999999999999
Q ss_pred cCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccC
Q 003368 163 SLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSN 242 (825)
Q Consensus 163 ~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 242 (825)
.+++..|..|+.+++|++| ++++|.+++ ++. ..+++|+.|++++|.+++ +..
T Consensus 158 ~l~~~~~~~~~~l~~L~~L-------------------~L~~N~l~~-~~~---~~l~~L~~L~l~~n~l~~-----l~~ 209 (597)
T 3oja_B 158 NLERIEDDTFQATTSLQNL-------------------QLSSNRLTH-VDL---SLIPSLFHANVSYNLLST-----LAI 209 (597)
T ss_dssp CCCBCCTTTTTTCTTCCEE-------------------ECTTSCCSB-CCG---GGCTTCSEEECCSSCCSE-----EEC
T ss_pred cCCCCChhhhhcCCcCcEE-------------------ECcCCCCCC-cCh---hhhhhhhhhhcccCcccc-----ccC
Confidence 9998888888888888888 666777764 332 267889999999998874 345
Q ss_pred CCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCccccc
Q 003368 243 ASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGS 322 (825)
Q Consensus 243 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 322 (825)
.++|+.|++++|.+....+.. .++|+.|++++|.+.. +..+..+++|+.|+|++|.+++ .
T Consensus 210 ~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--------~~~l~~l~~L~~L~Ls~N~l~~---------~ 269 (597)
T 3oja_B 210 PIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--------TAWLLNYPGLVEVDLSYNELEK---------I 269 (597)
T ss_dssp CTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--------CGGGGGCTTCSEEECCSSCCCE---------E
T ss_pred CchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--------ChhhccCCCCCEEECCCCccCC---------C
Confidence 568899999999886554332 2578888888888865 3457788889999999998886 5
Q ss_pred CCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCC
Q 003368 323 IPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNL 402 (825)
Q Consensus 323 ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 402 (825)
.|..+..+++|+.|+|++|.+++ +|..+..+++|++|+|++|.+. .+|..+..+++|++|+|++|.+++. | +..+
T Consensus 270 ~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~ 344 (597)
T 3oja_B 270 MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTH 344 (597)
T ss_dssp ESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTT
T ss_pred CHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhc
Confidence 56778888889999999998886 5666777889999999999888 6777788888999999999988754 2 6677
Q ss_pred CccceeecCCCCCccccc
Q 003368 403 KQLALLHLFQNDLSGAIP 420 (825)
Q Consensus 403 ~~L~~L~L~~N~l~g~ip 420 (825)
++|+.|++++|.+++..+
T Consensus 345 ~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 345 HTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp CCCSEEECCSSCEEHHHH
T ss_pred CCCCEEEeeCCCCCChhH
Confidence 888888998888876533
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=349.29 Aligned_cols=304 Identities=25% Similarity=0.262 Sum_probs=262.7
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|||++|++.+..+..|..+++|++|+|++|+|++..|.+|+++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 58999999999999999999999999999999999999999999999999999999999999888888999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|++++..|..|..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L---------- 181 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVL---------- 181 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEE----------
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEE----------
Confidence 9999999999999999999999999999999999999999999999999999998777778888888877
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
++++|.+++..+ ..+..+++|+.|++++|.+.+.+|..+....+|+.|+|++|++....+.
T Consensus 182 ---------~l~~n~i~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~--------- 242 (477)
T 2id5_A 182 ---------RLRHLNINAIRD-YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL--------- 242 (477)
T ss_dssp ---------EEESCCCCEECT-TCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH---------
T ss_pred ---------eCCCCcCcEeCh-hhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH---------
Confidence 677777775433 3344889999999999988888877766777899999999988654433
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
.+..+++|+.|+|++|.+++ ..+..+..+++|+.|+|++|++++..|..|
T Consensus 243 ---------------------~~~~l~~L~~L~Ls~n~l~~---------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 292 (477)
T 2id5_A 243 ---------------------AVRHLVYLRFLNLSYNPIST---------IEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292 (477)
T ss_dssp ---------------------HHTTCTTCCEEECCSSCCCE---------ECTTSCTTCTTCCEEECCSSCCSEECTTTB
T ss_pred ---------------------HhcCccccCeeECCCCcCCc---------cChhhccccccCCEEECCCCccceECHHHh
Confidence 34555666666777776664 233456778888888888898888888899
Q ss_pred cCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccc
Q 003368 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV 394 (825)
Q Consensus 352 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 394 (825)
.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.+.
T Consensus 293 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp TTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred cCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 9999999999999999977777888899999999999998753
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=326.11 Aligned_cols=310 Identities=15% Similarity=0.183 Sum_probs=236.5
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|+++++.+....+..+..+++|++|+|++|++++..+.+|+.+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 57889999999987665556889999999999999999888889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|+++...+..|.++++|++|+|++|++++..|..|.++++|++|++++|++++. .+..+++|+.|+++++....+
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 99999976666789999999999999999998899999999999999999999864 356778888887776666666
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
.....++.|++++|.++. +|.. ..++|+.|++++|.+++. ..+..+++|+.|+|++|.+.+..+..
T Consensus 202 ~~~~~L~~L~l~~n~l~~-~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~-------- 267 (390)
T 3o6n_A 202 AIPIAVEELDASHNSINV-VRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP-------- 267 (390)
T ss_dssp ECCSSCSEEECCSSCCCE-EECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG--------
T ss_pred CCCCcceEEECCCCeeee-cccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH--------
Confidence 656666666666666653 3332 235666666666666543 35566666666666666665554444
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++ .+|..+
T Consensus 268 ----------------------~~~l~~L~~L~L~~n~l~----------~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~ 314 (390)
T 3o6n_A 268 ----------------------FVKMQRLERLYISNNRLV----------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314 (390)
T ss_dssp ----------------------GTTCSSCCEEECCSSCCC----------EEECSSSCCTTCCEEECCSSCCC-CCGGGH
T ss_pred ----------------------ccccccCCEEECCCCcCc----------ccCcccCCCCCCCEEECCCCcce-ecCccc
Confidence 445555666666666665 34444556667777777777776 456666
Q ss_pred cCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccc
Q 003368 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV 394 (825)
Q Consensus 352 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 394 (825)
..+++|++|+|++|++... | +..+++|++|++++|.+.+.
T Consensus 315 ~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 315 PQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp HHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence 7777777777777777643 3 56677788888888877653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=339.59 Aligned_cols=310 Identities=15% Similarity=0.180 Sum_probs=245.3
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.++++++.+....+..+..+++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 46788999999987766667899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++.. ++.+++|+.|+++++....+
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc
Confidence 999999877777899999999999999999999999999999999999999998652 56678888887777766666
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
.....|+.|++++|.++. +|... .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+.+..|.
T Consensus 208 ~~~~~L~~L~ls~n~l~~-~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~--------- 272 (597)
T 3oja_B 208 AIPIAVEELDASHNSINV-VRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYH--------- 272 (597)
T ss_dssp ECCTTCSEEECCSSCCCE-EECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESG---------
T ss_pred cCCchhheeeccCCcccc-ccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHH---------
Confidence 666667777777777652 33222 2566777777776665 34566666666666666666655544
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
.+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.++ .+|..+
T Consensus 273 ---------------------~~~~l~~L~~L~Ls~N~l~----------~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~ 320 (597)
T 3oja_B 273 ---------------------PFVKMQRLERLYISNNRLV----------ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 320 (597)
T ss_dssp ---------------------GGTTCSSCCEEECTTSCCC----------EEECSSSCCTTCCEEECCSSCCC-CCGGGH
T ss_pred ---------------------HhcCccCCCEEECCCCCCC----------CCCcccccCCCCcEEECCCCCCC-ccCccc
Confidence 4455556666666666665 34555566777888888888887 566777
Q ss_pred cCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccc
Q 003368 352 SRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV 394 (825)
Q Consensus 352 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 394 (825)
..+++|++|+|++|.+.+. | +..+++|++|++++|.+.+.
T Consensus 321 ~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 321 PQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp HHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred ccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 7788888888888888744 3 56678888888888888754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=308.73 Aligned_cols=306 Identities=25% Similarity=0.399 Sum_probs=187.3
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccce
Q 003368 53 GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKE 132 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 132 (825)
..+++|++|++++|.++. +| .|..+++|++|++++|++++..+ |..+++|++|+|++|+++. + .+|..+++|++
T Consensus 41 ~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~ 114 (347)
T 4fmz_A 41 EELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNLRE 114 (347)
T ss_dssp HHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSE
T ss_pred hhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCE
Confidence 355666666666666653 33 25666666666666666664333 6666666666666666664 2 24666666666
Q ss_pred eeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCC
Q 003368 133 LAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLP 212 (825)
Q Consensus 133 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp 212 (825)
|++++|++++..+ +..+++|+.|++++|.....++ .+..+++|++| ++++|.+.+ ++
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L-------------------~l~~~~~~~-~~ 171 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYL-------------------TVTESKVKD-VT 171 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEE-------------------ECCSSCCCC-CG
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEE-------------------EecCCCcCC-ch
Confidence 6666666664332 5666666666666664443322 24444444444 444444442 22
Q ss_pred chhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCcccccc
Q 003368 213 PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIH 292 (825)
Q Consensus 213 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~ 292 (825)
. +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+....
T Consensus 172 ~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~-------- 237 (347)
T 4fmz_A 172 P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS-------- 237 (347)
T ss_dssp G--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG--------
T ss_pred h--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc--------
Confidence 2 2255666666666666654332 5566666666666666655443 555666666666666554421
Q ss_pred ccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccC
Q 003368 293 SLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIP 372 (825)
Q Consensus 293 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 372 (825)
.+..+++|+.|++++|.+++ + +.+..+++|+.|++++|++++. +.+..+++|++|++++|++.+..|
T Consensus 238 ~~~~l~~L~~L~l~~n~l~~----------~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 238 PLANLSQLTWLEIGTNQISD----------I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM 304 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCC----------C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGH
T ss_pred chhcCCCCCEEECCCCccCC----------C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcCh
Confidence 15566777777777777763 2 2466677777777777777753 357777888888888888877777
Q ss_pred ccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCc
Q 003368 373 SSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416 (825)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 416 (825)
..|..+++|++|++++|++++..| +..+++|+.|++++|.++
T Consensus 305 ~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 777778888888888888876655 777778888888877764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.25 Aligned_cols=304 Identities=22% Similarity=0.345 Sum_probs=257.9
Q ss_pred CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 31 HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 31 ~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
..+++.|+++++++... + .+..+++|++|++++|++++. |. |..+++|++|+|++|.++.. ..|..+++|++|+
T Consensus 43 l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 43 LESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELY 116 (347)
T ss_dssp HTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred cccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEE
Confidence 46899999999998653 3 488999999999999999954 44 99999999999999999864 3699999999999
Q ss_pred cCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcc
Q 003368 111 LGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPS 190 (825)
Q Consensus 111 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~ 190 (825)
|++|++++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|
T Consensus 117 l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L--------- 182 (347)
T 4fmz_A 117 LNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL--------- 182 (347)
T ss_dssp CTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE---------
T ss_pred CcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEE---------
Confidence 999999964 43 8999999999999997664544 48999999999999999985544 6677777776
Q ss_pred ccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCC
Q 003368 191 IYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSL 270 (825)
Q Consensus 191 i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 270 (825)
++++|.+++ ++. ...+++|+.|++++|.+++..+ +..+++|++|++++|++.+..+ +..+++|
T Consensus 183 ----------~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L 245 (347)
T 4fmz_A 183 ----------SLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQL 245 (347)
T ss_dssp ----------ECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred ----------EccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCC
Confidence 667777763 444 3378999999999999987655 8889999999999999987665 8899999
Q ss_pred cEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc
Q 003368 271 AYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350 (825)
Q Consensus 271 ~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~ 350 (825)
++|++++|.+... ..+..+++|++|++++|++++ + +.+..+++|+.|++++|++++..|..
T Consensus 246 ~~L~l~~n~l~~~--------~~~~~l~~L~~L~l~~n~l~~----------~-~~~~~l~~L~~L~L~~n~l~~~~~~~ 306 (347)
T 4fmz_A 246 TWLEIGTNQISDI--------NAVKDLTKLKMLNVGSNQISD----------I-SVLNNLSQLNSLFLNNNQLGNEDMEV 306 (347)
T ss_dssp CEEECCSSCCCCC--------GGGTTCTTCCEEECCSSCCCC----------C-GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred CEEECCCCccCCC--------hhHhcCCCcCEEEccCCccCC----------C-hhhcCCCCCCEEECcCCcCCCcChhH
Confidence 9999999988763 357788999999999999984 4 35788999999999999999999999
Q ss_pred ccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccc
Q 003368 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS 392 (825)
Q Consensus 351 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 392 (825)
++.+++|++|++++|++++..| +..+++|++|++++|.|+
T Consensus 307 l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999999999999997666 888999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=304.14 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=223.0
Q ss_pred CCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEccc-CcccccCCccccCCCCCCEEEccccccccccCcccc
Q 003368 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDH-NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376 (825)
Q Consensus 298 ~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 376 (825)
.+++.|+|++|.++|.. .+|..+.++++|++|++++ |.+.+.+|..|+++++|++|+|++|++.+.+|..|.
T Consensus 50 ~~l~~L~L~~~~l~~~~-------~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 122 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPY-------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122 (313)
T ss_dssp CCEEEEEEECCCCSSCE-------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG
T ss_pred ceEEEEECCCCCccCCc-------ccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHh
Confidence 46788888888887410 3667788888899999984 888888888888999999999999999888888888
Q ss_pred CCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccE
Q 003368 377 NLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRM 456 (825)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~ 456 (825)
.+++|++|+|++|++++.+|..++.+++|++|++++|+++|.+|..++.+...++.|++++|++++.+|..++.++ |+.
T Consensus 123 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~ 201 (313)
T 1ogq_A 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAF 201 (313)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSE
T ss_pred CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccE
Confidence 8999999999999998888888888999999999999998888888888874447889999999988999998887 999
Q ss_pred EeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcc
Q 003368 457 FVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDL 535 (825)
Q Consensus 457 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l 535 (825)
|++++|++++.+|..++.+++|+.|++++|.+++.+|. +..+++|++||+++|++++.+|..+..+ .|++|++++|++
T Consensus 202 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 280 (313)
T 1ogq_A 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280 (313)
T ss_dssp EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred EECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcc
Confidence 99999999999999999999999999999999877665 7888999999999999999999988888 699999999999
Q ss_pred eecCCCCCccCccccccccCCCCCCCCCC
Q 003368 536 EGQVPTKGIFANASAISVSGNSNRLCGGI 564 (825)
Q Consensus 536 ~g~~p~~~~~~~~~~~~~~~n~~~lc~~~ 564 (825)
+|.+|..+.+.++....+.+|+ .+||.+
T Consensus 281 ~~~ip~~~~l~~L~~l~l~~N~-~lc~~p 308 (313)
T 1ogq_A 281 CGEIPQGGNLQRFDVSAYANNK-CLCGSP 308 (313)
T ss_dssp EEECCCSTTGGGSCGGGTCSSS-EEESTT
T ss_pred cccCCCCccccccChHHhcCCC-CccCCC
Confidence 9999988888888889999998 889864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.17 Aligned_cols=286 Identities=20% Similarity=0.253 Sum_probs=188.1
Q ss_pred EEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 34 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
++.++++++++. .+|..+. ++|++|+|++|++++..|.+|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 456777777775 5666553 6888899999988877788888888899999999988888888888888899999998
Q ss_pred CCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc--cCCcccccccccceecCcCcCCccc
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG--NIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++. ..|..|..+ +|+.|
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L---------- 177 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL---------- 177 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC----------
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE----------
Confidence 8888 4554443 788888888888887777778888888888888888863 556666555 55555
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
++++|+++ .+|..++ ++|++|+|++|.+++..+..|.++++|+.|+|++|++.+..+..+
T Consensus 178 ---------~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~------- 237 (332)
T 2ft3_A 178 ---------RISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL------- 237 (332)
T ss_dssp ---------BCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG-------
T ss_pred ---------ECcCCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh-------
Confidence 66667776 3665543 577777777777777666677777777777777776655443333
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 238 -----------------------~~l~~L~~L~L~~N~l~----------~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~ 284 (332)
T 2ft3_A 238 -----------------------SFLPTLRELHLDNNKLS----------RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284 (332)
T ss_dssp -----------------------GGCTTCCEEECCSSCCC----------BCCTTGGGCTTCCEEECCSSCCCBCCTTSS
T ss_pred -----------------------hCCCCCCEEECCCCcCe----------ecChhhhcCccCCEEECCCCCCCccChhHc
Confidence 33444444455555444 344444455555555555555554444433
Q ss_pred cC------CCCCCEEEccccccc--cccCccccCCCCCcEEEcccC
Q 003368 352 SR------LQNLQFLNMRHNQLS--GEIPSSFGNLSSLVKLILGNN 389 (825)
Q Consensus 352 ~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N 389 (825)
.. ..+|+.|++++|.+. +..|..|..+++|+.+++++|
T Consensus 285 ~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred cccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 32 234455555555544 334444444555555555444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=298.62 Aligned_cols=287 Identities=20% Similarity=0.285 Sum_probs=183.0
Q ss_pred EEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 34 VTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 34 l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
++.++++++++. .+|..+. +.|++|+|++|+|++..+..|+++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 445666667665 4555543 6788889998888877777888888899999988888888888888888888888888
Q ss_pred CCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc--cCCcccccccccceecCcCcCCccc
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG--NIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|+++. ..+..|.++++|++|
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L---------- 176 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI---------- 176 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEE----------
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEE----------
Confidence 8888 4555443 688888888888887777778888888888888888853 555556666655555
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
++++|.++ .+|..+. ++|++|++++|++++..|..|..+++|+.|+|++|++.+..+..
T Consensus 177 ---------~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-------- 235 (330)
T 1xku_A 177 ---------RIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS-------- 235 (330)
T ss_dssp ---------ECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT--------
T ss_pred ---------ECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhh--------
Confidence 55556665 3554432 56777777777776666666666666666666666665544333
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
+..+++|+.|++++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 236 ----------------------~~~l~~L~~L~L~~N~l~----------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 236 ----------------------LANTPHLRELHLNNNKLV----------KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp ----------------------GGGSTTCCEEECCSSCCS----------SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred ----------------------ccCCCCCCEEECCCCcCc----------cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 333444445555555444 344444455555555555555554444433
Q ss_pred cC------CCCCCEEEcccccccc--ccCccccCCCCCcEEEcccC
Q 003368 352 SR------LQNLQFLNMRHNQLSG--EIPSSFGNLSSLVKLILGNN 389 (825)
Q Consensus 352 ~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N 389 (825)
.. ...|+.|++++|.+.. ..|..|..+.+++.++|++|
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 32 2344455555554431 23344444444444444444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.62 Aligned_cols=161 Identities=25% Similarity=0.348 Sum_probs=145.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++ .+++..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 4588899999999999999999999999999999876555567789999999999999999999984 45778999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|||||++|+|.+++.. ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+
T Consensus 149 vmEy~~gg~L~~~l~~-------------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~ 212 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 212 (346)
T ss_dssp EECCCTTEEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEeCCCCCcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEe
Confidence 9999999999998842 3589999999999999999999986 99999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||+|+..........+.+||+
T Consensus 213 DFGla~~~~~~~~~~~~~~GTp 234 (346)
T 4fih_A 213 DFGFCAQVSKEVPRRKSLVGTP 234 (346)
T ss_dssp CCTTCEECCSSSCCBCCCCSCG
T ss_pred cCcCceecCCCCCcccccccCc
Confidence 9999998877666677889997
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.33 Aligned_cols=174 Identities=25% Similarity=0.399 Sum_probs=133.0
Q ss_pred ccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|...+.||+|+||+||+|+++ .+++.||||+++.......++|.+|++++++++|||||+++|+|.. +
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 45777889999999999999974 3588999999987666667889999999999999999999999753 5
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCc---ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTD---EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
+..++|||||++|+|.++++........ .......+++|.++++|+.|||+||+|||+. +||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 6789999999999999999754221110 0111235799999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccccCCCC--CccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
+++.+||+|||+||........ ....+||+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp TTTEEEECCCC----------------CCCCG
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccc
Confidence 9999999999999987554322 23446664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.67 Aligned_cols=164 Identities=26% Similarity=0.390 Sum_probs=144.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..++||+|+||+||+|+.+.+|+.||||++.+.. ....+.+.+|++++++++|||||+++++ |++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCC
Confidence 367999999999999999999999999999999997542 2345679999999999999999999998 56678
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||++||+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||+++++.
T Consensus 106 ~~yivmEy~~gG~L~~~i~~------------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~ 170 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMH 170 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred EEEEEEecCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCC
Confidence 89999999999999999942 24689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCC--CCCccccccCC
Q 003368 799 AHVGDFGLARLRQEVP--NNQSSSVGDLE 825 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~--~~~~~~~gt~~ 825 (825)
+||+|||+|+.+.... ....+.+||+.
T Consensus 171 vKl~DFGla~~~~~~~~~~~~~~~~GTp~ 199 (311)
T 4aw0_A 171 IQITDFGTAKVLSPESKQARANSFVGTAQ 199 (311)
T ss_dssp EEECCCTTCEECCTTTTCCCBCCCCSCGG
T ss_pred EEEEEcCCceecCCCCCcccccCcccCcc
Confidence 9999999999875443 24567789973
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=299.21 Aligned_cols=164 Identities=28% Similarity=0.461 Sum_probs=134.3
Q ss_pred ccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|...+.||+|+||+||+|++. .+|+.||||+++.......++|.+|++++++++|||||+++|+|.. +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence 46778899999999999999974 3578999999987666667889999999999999999999999753 5
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCC-CcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQ-TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
+..++|||||++|+|.++|+...... ..........++|.++++|+.|||+||+|||+. +||||||||+|||++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 67899999999999999996431000 000011234799999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccccCC
Q 003368 797 LTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~ 814 (825)
+.+||+|||+|+......
T Consensus 165 ~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp GCEEECCCSCHHHHTGGG
T ss_pred CcEEECCcccceecCCCC
Confidence 999999999999775543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.97 Aligned_cols=289 Identities=21% Similarity=0.280 Sum_probs=190.5
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeec
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 135 (825)
.+++.+++++|.++ .+|..+. ++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|+|
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 36889999999998 6777664 68999999999999888888999999999999999999888888999999999999
Q ss_pred cccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccc--cCCc
Q 003368 136 QENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHG--SLPP 213 (825)
Q Consensus 136 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~--~lp~ 213 (825)
++|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.| ++++|.++. ..|.
T Consensus 110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L-------------------~l~~n~l~~~~~~~~ 167 (332)
T 2ft3_A 110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCI-------------------EMGGNPLENSGFEPG 167 (332)
T ss_dssp CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEE-------------------ECCSCCCBGGGSCTT
T ss_pred CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEE-------------------ECCCCccccCCCCcc
Confidence 999988 4555444 788899999888886655566666666665 445555531 2222
Q ss_pred hhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccc
Q 003368 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHS 293 (825)
Q Consensus 214 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~ 293 (825)
.+. .+ +|+.|++++|++++ +|..+. ++|++|+|++|++.+.. +..
T Consensus 168 ~~~-~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~------------------------------~~~ 212 (332)
T 2ft3_A 168 AFD-GL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIE------------------------------LED 212 (332)
T ss_dssp SSC-SC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCC------------------------------TTS
T ss_pred ccc-CC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccC------------------------------HHH
Confidence 222 33 55555555555554 222221 34444444444443322 223
Q ss_pred cccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCc
Q 003368 294 LANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPS 373 (825)
Q Consensus 294 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 373 (825)
+..+++|+.|++++|++++ ..|..+..+++|+.|++++|+++ .+|..+..+++|++|++++|++++..+.
T Consensus 213 l~~l~~L~~L~L~~N~l~~---------~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 213 LLRYSKLYRLGLGHNQIRM---------IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp STTCTTCSCCBCCSSCCCC---------CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred hcCCCCCCEEECCCCcCCc---------CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChh
Confidence 4455566666666666653 22335666777777777777776 5666677777777777777777765555
Q ss_pred cccCC------CCCcEEEcccCccc--cccCCCCCCCCccceeecCCCC
Q 003368 374 SFGNL------SSLVKLILGNNNLS--GVIPSSLGNLKQLALLHLFQND 414 (825)
Q Consensus 374 ~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~ 414 (825)
.|... .+|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 283 ~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred HccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 55442 45667777777665 4555666667777777766654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-32 Score=292.07 Aligned_cols=120 Identities=22% Similarity=0.319 Sum_probs=92.2
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeec
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 135 (825)
.+++.++++++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|.+|..+++|++|+|
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 46788888888888 5666654 57888888888888777778888888888888888888877888888888888888
Q ss_pred cccccccccCccCCCCCCCCEEEcccCcCcccCCccccccccccee
Q 003368 136 QENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181 (825)
Q Consensus 136 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 181 (825)
++|+++ .+|..+. ++|+.|++++|++++..+..|.++++|+.|
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 150 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVV 150 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEE
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEE
Confidence 888888 4454443 678888888888876555555555555555
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.00 Aligned_cols=166 Identities=23% Similarity=0.340 Sum_probs=137.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.|.+|++++++++|||||++++++ ++++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 467999999999999999999999999999999997653 23456799999999999999999999984 45778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|||||+||+|.+++... ....+++.++..|+.||+.||+|||+. +||||||||+|||+++++.+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~----------~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 164 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ----------KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTV 164 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCE
T ss_pred EEEEEeCCCCCcHHHHHHHc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCE
Confidence 99999999999999999532 223578889999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccCC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
||+|||+|+..........+.+||+.
T Consensus 165 Kl~DFGla~~~~~~~~~~~~~~GT~~ 190 (350)
T 4b9d_A 165 QLGDFGIARVLNSTVELARACIGTPY 190 (350)
T ss_dssp EECSTTEESCCCHHHHHHHHHHSCCT
T ss_pred EEcccccceeecCCcccccccCCCcc
Confidence 99999999987654333456678873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.09 Aligned_cols=162 Identities=25% Similarity=0.340 Sum_probs=146.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++ .+++..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence 5689999999999999999999999999999999876655667799999999999999999999985 44678999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
|||||+||+|.+++.. ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+
T Consensus 226 VmEy~~gG~L~~~i~~-------------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~ 289 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS 289 (423)
T ss_dssp EEECCTTEEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEEC
T ss_pred EEeCCCCCcHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEe
Confidence 9999999999998842 3588999999999999999999986 99999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccCC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|||+|+.+........+.+||+.
T Consensus 290 DFGla~~~~~~~~~~~~~~GTp~ 312 (423)
T 4fie_A 290 DFGFCAQVSKEVPRRKSLVGTPY 312 (423)
T ss_dssp CCTTCEECCSSCCCBCCCEECTT
T ss_pred cCccceECCCCCccccccccCcC
Confidence 99999988776666778899973
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.80 Aligned_cols=254 Identities=18% Similarity=0.290 Sum_probs=212.3
Q ss_pred ccCCcccccCC----CCCCCCceeeceeec--------CCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccc
Q 003368 3 TQYPEGVLNSW----NDSHHFCDWEGITCS--------PRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQG 70 (825)
Q Consensus 3 ~~~~~~~~~~w----~~~~~~C~~~g~~c~--------~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 70 (825)
+.||.+++.+| ....++|.|.|++|. ....+|+.|||++|++. .+|+.++.+++|++|+|++|+++
T Consensus 40 ~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~- 117 (328)
T 4fcg_A 40 NADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117 (328)
T ss_dssp HHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-
T ss_pred cCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-
Confidence 45788889999 456799999999995 23468999999999987 78888889999999999999999
Q ss_pred cCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhc---------ccccceeeccccccc
Q 003368 71 KIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVS---------LYNLKELAIQENNLT 141 (825)
Q Consensus 71 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~ 141 (825)
.+|..|+.+++|++|+|++|+|+ .+|..|..+++|++|+|++|++.+.+|..+.. +++|++|+|++|+++
T Consensus 118 ~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 196 (328)
T 4fcg_A 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196 (328)
T ss_dssp CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC
T ss_pred chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC
Confidence 88999999999999999999998 77888999999999999998888888887664 888999999999888
Q ss_pred cccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCC
Q 003368 142 GGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSN 221 (825)
Q Consensus 142 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~ 221 (825)
.+|..|+++++|++|+|++|++++ +|..|+.+++|++| ++++|++.+.+|..+. .+++
T Consensus 197 -~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L-------------------~Ls~n~~~~~~p~~~~-~l~~ 254 (328)
T 4fcg_A 197 -SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL-------------------DLRGCTALRNYPPIFG-GRAP 254 (328)
T ss_dssp -CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE-------------------ECTTCTTCCBCCCCTT-CCCC
T ss_pred -cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE-------------------ECcCCcchhhhHHHhc-CCCC
Confidence 778888888899999999998884 55567777776666 7777788878887766 7888
Q ss_pred CcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCC
Q 003368 222 LQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLG 281 (825)
Q Consensus 222 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 281 (825)
|++|+|++|.+.+.+|..|.++++|+.|+|++|++.+.+|..++.+++|+.+++..+.+.
T Consensus 255 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 255 LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888888888888888888888888877777777777777666554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=295.12 Aligned_cols=173 Identities=23% Similarity=0.365 Sum_probs=137.2
Q ss_pred cccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+++..+.||+|+||+||+|++. .+++.||||+++.... ...++|.+|++++++++|||||+++|+|.. +
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 101 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D 101 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence 4556789999999999999974 3578999999975543 345789999999999999999999999753 5
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCC----CcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQ----TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+..++|||||++|+|.++|+...... ..........++|.++++|+.|||+||+|||+. +||||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 67899999999999999996532111 001112235799999999999999999999985 89999999999999
Q ss_pred cCCCcEEEcccCcccccccCCC--CCccccccC
Q 003368 794 DNNLTAHVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
++++.+||+|||+||....... ...+.+||+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCC
Confidence 9999999999999998755432 233456664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=292.52 Aligned_cols=161 Identities=33% Similarity=0.520 Sum_probs=131.5
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..+++...+.||+|+||+||+|+++. .||||+++... ....++|.+|++++++++|||||+++|+|. ++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KD 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CC
Confidence 34567788999999999999999742 59999987543 334578999999999999999999999874 24
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++|||||++|+|.++|+.. ...++|.++++|+.|||+||+|||+. +||||||||+|||+++++.
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~ 170 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQ-----------ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLT 170 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTS-----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEE
T ss_pred eEEEEEEcCCCCCHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCc
Confidence 579999999999999999632 23689999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccccCCC--CCccccccC
Q 003368 799 AHVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
+||+|||+|+....... ...+.+||+
T Consensus 171 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGSQQVEQPTGSV 198 (307)
T ss_dssp EEECCCSSCBC------------CCCCT
T ss_pred EEEeeccCceecccCCcceeecccccCC
Confidence 99999999998764332 234567886
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=286.74 Aligned_cols=164 Identities=29% Similarity=0.439 Sum_probs=137.4
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+..+.||+|+||+||+|+++.+++.||||++.... ....+.|.+|++++++++|||||+++++|... ..++...|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence 45678999999999999999999999999997543 23456799999999999999999999986431 1234568999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcEEEc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVG 802 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ki~ 802 (825)
||||++|+|.+++.. ...+++.++..|+.||++||+|||+. .++||||||||+|||++. ++.+||+
T Consensus 108 mEy~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EeCCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEE
Confidence 999999999999942 24689999999999999999999986 235999999999999984 7999999
Q ss_pred ccCcccccccCCCCCccccccCC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
|||+|+.... ....+.+||+.
T Consensus 175 DFGla~~~~~--~~~~~~~GTp~ 195 (290)
T 3fpq_A 175 DLGLATLKRA--SFAKAVIGTPE 195 (290)
T ss_dssp CTTGGGGCCT--TSBEESCSSCC
T ss_pred eCcCCEeCCC--CccCCcccCcc
Confidence 9999997543 34567789973
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=290.04 Aligned_cols=164 Identities=29% Similarity=0.376 Sum_probs=130.7
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+|...+.||+|+||+||+|++ +|+.||||+++.... ....+++|+..+.+++|||||+++|+|.... ......|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 467789999999999999998 689999999975422 2233455677778899999999999986421 112357999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCCc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-----QEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-----~~~ivHrdlk~~NILl~~~~~ 798 (825)
||||++|+|.++++. ..++|.++.+|+.|+|+||+|||+.+ .++||||||||+|||+|+++.
T Consensus 80 ~Ey~~~gsL~~~l~~-------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred ecCCCCCcHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 999999999999953 25899999999999999999999752 468999999999999999999
Q ss_pred EEEcccCcccccccCCCC----CccccccC
Q 003368 799 AHVGDFGLARLRQEVPNN----QSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~----~~~~~gt~ 824 (825)
+||+|||+|+........ ..+.+||+
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCG
T ss_pred EEEEeCCCCccccCCCCceeeecccccccc
Confidence 999999999987654322 23346775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=285.87 Aligned_cols=159 Identities=26% Similarity=0.416 Sum_probs=127.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccc-------c
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSID-------F 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------~ 714 (825)
++|+..+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++...+ .
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468999999999999999999999999999999976543 34567999999999999999999999865321 1
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
....+.|+|||||++|+|.+++.... .....++..+..|+.||++||+|||+. +||||||||+|||++
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~---------~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC---------TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFT 152 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC---------SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC---------CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEEC
Confidence 12335799999999999999996431 123456777889999999999999986 999999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+|+.....
T Consensus 153 ~~~~vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQD 171 (299)
T ss_dssp TTCCEEECCCCCC------
T ss_pred CCCcEEEccCccceecCCC
Confidence 9999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=281.50 Aligned_cols=161 Identities=27% Similarity=0.466 Sum_probs=126.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+.+.+|+.||||++++.. ....+.+.+|++++++++|||||+++++ +++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence 57999999999999999999999999999999997543 2335679999999999999999999998 455778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +||||||||+|||+++++.+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~------------~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~v 151 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQ------------RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNV 151 (275)
T ss_dssp EEEEEECC-CEEHHHHHHH------------SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCE
T ss_pred EEEEEeCC-CCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCE
Confidence 99999999 6899999842 24689999999999999999999986 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccCC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
||+|||+|+...+. ....+.+||+.
T Consensus 152 kl~DFGla~~~~~~-~~~~~~~GT~~ 176 (275)
T 3hyh_A 152 KIADFGLSNIMTDG-NFLKTSCGSPN 176 (275)
T ss_dssp EECCSSCC----------------CT
T ss_pred EEeecCCCeecCCC-CccCCeeECcc
Confidence 99999999987554 23456788873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-33 Score=291.00 Aligned_cols=162 Identities=26% Similarity=0.289 Sum_probs=132.8
Q ss_pred ccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||+||+|+.. .+++.||||+++.... .....+.+|++++++++|||||++++++ +++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 56999999999999999999873 4678999999975432 2234688999999999999999999984 457
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..|+|||||+||+|.+++.. ...+++.++..|+.|++.||+|||+. +||||||||+|||+++++
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~------------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK------------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEG 163 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTS
T ss_pred CEEEEEEEcCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCC
Confidence 789999999999999999842 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+...+......+.+||+
T Consensus 164 ~vKl~DFGla~~~~~~~~~~~~~~GT~ 190 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEKKAYSFCGTV 190 (304)
T ss_dssp CEEEESSEEEEC-----CCCCSCCCCG
T ss_pred CEEecccccceeccCCCccccccccCc
Confidence 999999999998766655667788987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=288.96 Aligned_cols=158 Identities=21% Similarity=0.259 Sum_probs=133.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.+.|...+.||+|+||+||+|+++.+|+.||||+++.+.. +.+|++++++++|||||++++++ ++++..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 4568888999999999999999999999999999976532 24799999999999999999985 4467899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~k 800 (825)
+|||||+||+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+|
T Consensus 127 ivmEy~~gg~L~~~l~~------------~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vK 191 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ------------MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA 191 (336)
T ss_dssp EEECCCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEE
T ss_pred EEEeccCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEE
Confidence 99999999999999942 24699999999999999999999985 999999999999999987 699
Q ss_pred EcccCcccccccCCCC-----CccccccC
Q 003368 801 VGDFGLARLRQEVPNN-----QSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~-----~~~~~gt~ 824 (825)
|+|||+|+........ ..+.+||+
T Consensus 192 l~DFGla~~~~~~~~~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTE 220 (336)
T ss_dssp ECCCTTCEEC------------CCCCCCG
T ss_pred EeeCCCCeEccCCCcccceecCCccccCc
Confidence 9999999987654321 22347886
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=293.06 Aligned_cols=293 Identities=20% Similarity=0.226 Sum_probs=198.9
Q ss_pred CCCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCc
Q 003368 12 SWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91 (825)
Q Consensus 12 ~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 91 (825)
.|......|.|.++ |+ ++++++. .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 45556678888876 64 4566665 5666554 589999999999998777799999999999999999
Q ss_pred CCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccC-cCcccCC
Q 003368 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYN-SLGGNIP 169 (825)
Q Consensus 92 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p 169 (825)
|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 167 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence 999889999999999999999999997766779999999999999999996554 58999999999999999 4665556
Q ss_pred cccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEE
Q 003368 170 SSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSL 249 (825)
Q Consensus 170 ~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 249 (825)
..|.++++|++| ++++|.+++..|..+. .+++|++|++++|.++...+..+..+++|+.|
T Consensus 168 ~~~~~l~~L~~L-------------------~l~~n~l~~~~~~~l~-~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 227 (353)
T 2z80_A 168 KDFAGLTFLEEL-------------------EIDASDLQSYEPKSLK-SIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227 (353)
T ss_dssp TTTTTCCEEEEE-------------------EEEETTCCEECTTTTT-TCSEEEEEEEECSCSTTHHHHHHHHTTTEEEE
T ss_pred HHccCCCCCCEE-------------------ECCCCCcCccCHHHHh-ccccCCeecCCCCccccchhhhhhhcccccEE
Confidence 666666666655 5555566554444444 55666666666666543333334445556666
Q ss_pred EeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccC
Q 003368 250 EILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK 329 (825)
Q Consensus 250 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~ 329 (825)
+|++|++.+..+..+. .....+.++.++|+++.+++
T Consensus 228 ~L~~n~l~~~~~~~l~---------------------------~~~~~~~l~~l~L~~~~l~~----------------- 263 (353)
T 2z80_A 228 ELRDTDLDTFHFSELS---------------------------TGETNSLIKKFTFRNVKITD----------------- 263 (353)
T ss_dssp EEESCBCTTCCCC---------------------------------CCCCCCEEEEESCBCCH-----------------
T ss_pred ECCCCccccccccccc---------------------------cccccchhhccccccccccC-----------------
Confidence 6665555443211110 01123344455554444432
Q ss_pred CCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcc-ccCCCCCcEEEcccCcccccc
Q 003368 330 LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS-FGNLSSLVKLILGNNNLSGVI 395 (825)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~ 395 (825)
|.+. .+|..+..+++|++|+|++|+++ .+|.. |..+++|++|+|++|.+.+..
T Consensus 264 -----------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 264 -----------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp -----------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred -----------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 1221 35666777777777777777777 34444 567777777777777776543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-35 Score=332.86 Aligned_cols=359 Identities=18% Similarity=0.133 Sum_probs=223.8
Q ss_pred CcEEEEECCCCCCccccCcC-CCCCCCCCEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCCCCcCC-CCCC-
Q 003368 32 RRVTVLDLKSKGLIGSLSPQ-IGNLSFLREIHLSNNTIQG----KIPGEIGRLFRLEALYLSHNSLVGEIPGNL-SYCS- 104 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 104 (825)
.+++.|||+++++....... +..+++|++|+|++|+++. .++..+..+++|++|+|++|+++...+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46889999999987655444 7788999999999999884 356778888999999999999886544333 2344
Q ss_pred ---CCCEEEcCCCCCCC----CCChhhhcccccceeeccccccccccCccC-----CCCCCCCEEEcccCcCcccC----
Q 003368 105 ---RLIGLYLGRNKLEG----SIPSEFVSLYNLKELAIQENNLTGGIPHFL-----GNITSLEAISLAYNSLGGNI---- 168 (825)
Q Consensus 105 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~---- 168 (825)
+|++|+|++|+|+. .++..|..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 69999999999984 558888899999999999999875544332 33568999999999988643
Q ss_pred CcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhh----hcCCCCcEEEcccccCCCC----CCccc
Q 003368 169 PSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLG----LTLSNLQLFQISNNFFSGS----FPLAF 240 (825)
Q Consensus 169 p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~ 240 (825)
+..+..+++|++| ++++|.+++..+..+. ...++|++|+|++|.+++. ++..+
T Consensus 163 ~~~l~~~~~L~~L-------------------~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 223 (461)
T 1z7x_W 163 ASVLRAKPDFKEL-------------------TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223 (461)
T ss_dssp HHHHHHCTTCCEE-------------------ECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred HHHHhhCCCCCEE-------------------ECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence 4444455555555 6777777644333332 2356888888888888764 35667
Q ss_pred cCCCCccEEEeecccccCcc-----ccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCC
Q 003368 241 SNASNLQSLEILGNNFFGKL-----SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALP 315 (825)
Q Consensus 241 ~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 315 (825)
..+++|+.|+|++|.+.... +..+..+++|++|++++|.++... ...++..+..+++|++|++++|.+++..+
T Consensus 224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~--~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG--CGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH--HHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHH--HHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 77888888888888775432 222334566666666666554210 01123344455666666666665543110
Q ss_pred CCcccccCCcccc-CCCCcCEEEcccCccccc----CCccccCCCCCCEEEccccccccccCccccC-----CCCCcEEE
Q 003368 316 HSIVSGSIPSEIG-KLVSLYLIEMDHNQFEGK----IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN-----LSSLVKLI 385 (825)
Q Consensus 316 ~~~~~~~ip~~l~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~ 385 (825)
. .+...+. ..++|+.|++++|.+++. ++..+..+++|++|+|++|++.+..+..+.. .++|++|+
T Consensus 302 ~-----~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 302 R-----LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp H-----HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred H-----HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 0 0111111 123555566666655543 3444445555555555555555433332221 34555555
Q ss_pred cccCcccc----ccCCCCCCCCccceeecCCCCCc
Q 003368 386 LGNNNLSG----VIPSSLGNLKQLALLHLFQNDLS 416 (825)
Q Consensus 386 Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 416 (825)
|++|++++ .+|..+..+++|++|++++|+++
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 55555553 44444455555555555555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-34 Score=328.78 Aligned_cols=385 Identities=17% Similarity=0.157 Sum_probs=237.3
Q ss_pred CCCCEEEcCCCCCCCCCChh-hhcccccceeecccccccc----ccCccCCCCCCCCEEEcccCcCcccCCccccc-ccc
Q 003368 104 SRLIGLYLGRNKLEGSIPSE-FVSLYNLKELAIQENNLTG----GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQ-LKE 177 (825)
Q Consensus 104 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~ 177 (825)
++|++|||++|+++...... |..+++|++|+|++|++++ .++..+..+++|++|+|++|+++...+..+.. +..
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46778888888887544333 6777888888888888774 34556677778888888888776433322221 210
Q ss_pred cceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCC----CCCccccCCCCccEEEeec
Q 003368 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG----SFPLAFSNASNLQSLEILG 253 (825)
Q Consensus 178 L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~ 253 (825)
..++|++|+|++|.++. .++..|..+++|++|+|++
T Consensus 83 ----------------------------------------~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~ 122 (461)
T 1z7x_W 83 ----------------------------------------PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122 (461)
T ss_dssp ----------------------------------------TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCS
T ss_pred ----------------------------------------CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCC
Confidence 00134455555554442 2244455555555555555
Q ss_pred ccccCccccC-----cCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCcccc
Q 003368 254 NNFFGKLSVN-----FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328 (825)
Q Consensus 254 N~l~~~~~~~-----~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~ 328 (825)
|.+....+.. +...++|++|++++|.+.... ...++..+..+++|+.|++++|.+++..+. .+...+.
T Consensus 123 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~--~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-----~l~~~l~ 195 (461)
T 1z7x_W 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS--CEPLASVLRAKPDFKELTVSNNDINEAGVR-----VLCQGLK 195 (461)
T ss_dssp SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG--HHHHHHHHHHCTTCCEEECCSSBCHHHHHH-----HHHHHHH
T ss_pred CcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH--HHHHHHHHhhCCCCCEEECcCCCcchHHHH-----HHHHHHh
Confidence 5543322211 122345566666655554211 112234456667777777777776631110 0111111
Q ss_pred -CCCCcCEEEcccCccccc----CCccccCCCCCCEEEcccccccccc-----CccccCCCCCcEEEcccCccccc----
Q 003368 329 -KLVSLYLIEMDHNQFEGK----IPEEMSRLQNLQFLNMRHNQLSGEI-----PSSFGNLSSLVKLILGNNNLSGV---- 394 (825)
Q Consensus 329 -~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~---- 394 (825)
..++|+.|++++|.+++. ++..+..+++|++|+|++|++.+.. +..+..+++|++|++++|++++.
T Consensus 196 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 275 (461)
T 1z7x_W 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD 275 (461)
T ss_dssp HSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH
T ss_pred cCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHH
Confidence 245777888888877753 4666777788888888888776432 33334577888888888887753
Q ss_pred cCCCCCCCCccceeecCCCCCccccchhhhcc-----cccccccccCCCccccC----CCccccccccccEEeecCceec
Q 003368 395 IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNI-----SHMSDSLNFARNHLVGS----IPPKIGNLKVLRMFVVSSNNLS 465 (825)
Q Consensus 395 ~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~-----~~l~~~l~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 465 (825)
++..+..+++|+.|++++|.+++..+..+... ..+ +.|++++|.+++. +|..+..+++|+.|++++|.++
T Consensus 276 l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp HHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred HHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 45566667788888888888765444433322 233 6777888877654 4566677788999999999888
Q ss_pred ccCCccccC-----CCCCCEEEccCCcCCC----CCCccccCCCCCCEEECCCCccccccCcc----ccc-c-cCceeeC
Q 003368 466 GEIPSEIGS-----CFYLQEIYMAENFFRG----SIPSSLVSLKDLREIDLSQNNLSGKIPIS----LER-L-PLEYLNL 530 (825)
Q Consensus 466 g~~p~~~~~-----l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~Ldls~N~l~~~~p~~----~~~-l-~L~~l~l 530 (825)
+..+..+.. .++|+.|++++|.+++ .+|..+..+++|++||+++|++++.-... +.. . .|+.|++
T Consensus 355 ~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~ 434 (461)
T 1z7x_W 355 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 434 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred cccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheee
Confidence 765555543 6689999999999886 67888888899999999999888642111 111 1 3666666
Q ss_pred CCCcce
Q 003368 531 SFNDLE 536 (825)
Q Consensus 531 s~N~l~ 536 (825)
.++.+.
T Consensus 435 ~~~~~~ 440 (461)
T 1z7x_W 435 YDIYWS 440 (461)
T ss_dssp TTCCCC
T ss_pred cccccC
Confidence 666554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.52 Aligned_cols=184 Identities=24% Similarity=0.310 Sum_probs=144.4
Q ss_pred cHHHHHhhcccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCC-CCceeEe
Q 003368 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRH-RNLVRVI 706 (825)
Q Consensus 634 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~ 706 (825)
..+++....++|+..+.||+|+||+||+|++... ++.||||++..... ...++|.+|++++++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 3445555668899999999999999999998543 36899999976543 345689999999999975 8999999
Q ss_pred ecccccccCCCCeeeEEEEccCCCChhhhccCCCCCC----CcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 003368 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQ----TDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTI 782 (825)
Q Consensus 707 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~iv 782 (825)
|+|.. .++..++|||||++|+|.++|+...... ..........++|.+++.|+.|||+||+|||+. +||
T Consensus 135 g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~ii 207 (353)
T 4ase_A 135 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI 207 (353)
T ss_dssp EEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred EEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Cee
Confidence 99853 3456899999999999999996432100 000011234689999999999999999999985 899
Q ss_pred ecCCCCCCeeecCCCcEEEcccCcccccccCCCC--CccccccC
Q 003368 783 HCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 783 Hrdlk~~NILl~~~~~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
||||||+|||+++++.+||+|||+||........ ..+.+||+
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 9999999999999999999999999987655432 23445664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=297.70 Aligned_cols=297 Identities=24% Similarity=0.284 Sum_probs=187.9
Q ss_pred cCCcccccCCCCCCCCceeeceeec------CCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCcccc
Q 003368 4 QYPEGVLNSWNDSHHFCDWEGITCS------PRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIG 77 (825)
Q Consensus 4 ~~~~~~~~~w~~~~~~C~~~g~~c~------~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 77 (825)
.|+..+..+|....++|.|+|..|. +....++.|++++|++. .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 6 ~~~~~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~--- 78 (622)
T 3g06_A 6 AEYDAVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--- 78 (622)
T ss_dssp ----CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---
T ss_pred HHHHHHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---
Confidence 3556677889877899999774332 22245888888888887 6676665 78888888888888 4555
Q ss_pred CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEE
Q 003368 78 RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAI 157 (825)
Q Consensus 78 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 157 (825)
.+++|++|+|++|+|++ +|. .+++|++|+|++|+|++. |. .+++|+.|++++|+|++ +|.. +++|++|
T Consensus 79 ~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L 146 (622)
T 3g06_A 79 LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQEL 146 (622)
T ss_dssp CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEE
Confidence 46788888888888874 444 567788888888888753 33 56677777777777774 4432 3677777
Q ss_pred EcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCC
Q 003368 158 SLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFP 237 (825)
Q Consensus 158 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p 237 (825)
+|++|++++ +|. .+++|+.|++++|.+++ +|
T Consensus 147 ~Ls~N~l~~-l~~-----------------------------------------------~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 147 SVSDNQLAS-LPA-----------------------------------------------LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp ECCSSCCSC-CCC-----------------------------------------------CCTTCCEEECCSSCCSC-CC
T ss_pred ECcCCcCCC-cCC-----------------------------------------------ccCCCCEEECCCCCCCC-Cc
Confidence 777777763 221 12334444555555443 22
Q ss_pred ccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCC
Q 003368 238 LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317 (825)
Q Consensus 238 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 317 (825)
..+++|+.|+|++|++.+..+ .+++|+.|++++|.++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~l~~----------------------------------~~~~L~~L~L~~N~l~------ 214 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLASLPT----------------------------------LPSELYKLWAYNNRLT------ 214 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSCCCC----------------------------------CCTTCCEEECCSSCCS------
T ss_pred ---ccCCCCcEEECCCCCCCCCCC----------------------------------ccchhhEEECcCCccc------
Confidence 223445555555554433110 0134455555555554
Q ss_pred cccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCC
Q 003368 318 IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397 (825)
Q Consensus 318 ~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 397 (825)
.+|.. +++|+.|++++|++++ +| ..+++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.
T Consensus 215 ----~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~ 278 (622)
T 3g06_A 215 ----SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE 278 (622)
T ss_dssp ----SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred ----ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence 23321 2456666666666664 44 34567777777777777 4555 4577788888888887 5677
Q ss_pred CCCCCCccceeecCCCCCccccchhhhccc
Q 003368 398 SLGNLKQLALLHLFQNDLSGAIPEEIFNIS 427 (825)
Q Consensus 398 ~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~ 427 (825)
.+.++++|+.|+|++|.+++.+|..+..+.
T Consensus 279 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 279 SLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp GGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred HHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 778888888888888888877777665443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=281.30 Aligned_cols=279 Identities=19% Similarity=0.194 Sum_probs=190.6
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeec
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 135 (825)
+.....++++|.++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|
T Consensus 31 ~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 34456788899998 5676655 48899999999998777778888889999999999888887888888888888888
Q ss_pred cccccccccCccCCCCCCCCEEEcccCcCcccCC-cccccccccceecCcCcCCccccCCCCCceeecCCccccccCCch
Q 003368 136 QENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP-SSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214 (825)
Q Consensus 136 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~ 214 (825)
++|++++..+..|+++++|++|+|++|++++..+ ..|..+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~------------------------------------- 150 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK------------------------------------- 150 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTT-------------------------------------
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCC-------------------------------------
Confidence 8888886666668888888888888888874332 24444444
Q ss_pred hhhcCCCCcEEEcccc-cCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccc
Q 003368 215 LGLTLSNLQLFQISNN-FFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHS 293 (825)
Q Consensus 215 ~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~ 293 (825)
|++|++++| .+++..+..|.++++|+.|++++|++.+..+..+..+++|++|++++|.+.... ...
T Consensus 151 -------L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~------~~~ 217 (353)
T 2z80_A 151 -------LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL------EIF 217 (353)
T ss_dssp -------CCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHH------HHH
T ss_pred -------CcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccch------hhh
Confidence 444444444 244344445555555555555555555554444544444444444444442211 112
Q ss_pred cccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc---ccCCCCCCEEEcccccccc-
Q 003368 294 LANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE---MSRLQNLQFLNMRHNQLSG- 369 (825)
Q Consensus 294 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~Ls~N~l~~- 369 (825)
+..+++|+.|++++|.+++ ..+.. ......++.++|++|.+.+
T Consensus 218 ~~~~~~L~~L~L~~n~l~~---------------------------------~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 218 VDVTSSVECLELRDTDLDT---------------------------------FHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp HHHTTTEEEEEEESCBCTT---------------------------------CCCC------CCCCCCEEEEESCBCCHH
T ss_pred hhhcccccEEECCCCcccc---------------------------------ccccccccccccchhhccccccccccCc
Confidence 2345666666666666653 11111 1234556677777777664
Q ss_pred ---ccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccc
Q 003368 370 ---EIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIP 420 (825)
Q Consensus 370 ---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 420 (825)
.+|.++..+++|++|+|++|+++...+..|+.+++|+.|++++|.+++..|
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 478889999999999999999995444446999999999999999998766
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=274.97 Aligned_cols=204 Identities=26% Similarity=0.320 Sum_probs=131.9
Q ss_pred CceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC--C
Q 003368 19 FCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE--I 96 (825)
Q Consensus 19 ~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~ 96 (825)
.|.|.++.|.. +++. .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+|+.. .
T Consensus 6 ~C~~~~l~c~~------------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 6 SCSGTEIRCNS------------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EEETTEEECCS------------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eeCCCEEEcCC------------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 36677766653 3443 4454443 5788888888888855555678888888888888888733 3
Q ss_pred CcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccCCcccccc
Q 003368 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSSLGQL 175 (825)
Q Consensus 97 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 175 (825)
|..+..+++|++|+|++|+++ .+|..|..+++|++|++++|++++..+ ..|..+++|++|++++|++++..|..|..+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred ccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 566667788888888888887 456667778888888888888876554 567778888888888888776666666555
Q ss_pred cccceecCcCcCCccccCCCCCceeecCCccccc-cCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecc
Q 003368 176 KELKSLGLGGTIPPSIYNLSLLANFSVPENRLHG-SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGN 254 (825)
Q Consensus 176 ~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~-~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 254 (825)
++|++| ++++|.+++ .+|..+. .+++|++|+|++|.+++..|..|..+++|+.|+|++|
T Consensus 150 ~~L~~L-------------------~l~~n~l~~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 209 (306)
T 2z66_A 150 SSLEVL-------------------KMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209 (306)
T ss_dssp TTCCEE-------------------ECTTCEEGGGEECSCCT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cCCCEE-------------------ECCCCccccccchhHHh-hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCC
Confidence 555555 445555554 2333332 4555555555555555444444555555555555444
Q ss_pred cccC
Q 003368 255 NFFG 258 (825)
Q Consensus 255 ~l~~ 258 (825)
++.+
T Consensus 210 ~l~~ 213 (306)
T 2z66_A 210 NFFS 213 (306)
T ss_dssp CCSB
T ss_pred ccCc
Confidence 4433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=280.27 Aligned_cols=166 Identities=26% Similarity=0.380 Sum_probs=139.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccc-ccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSI-DFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++... .+.+.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999975432 3356788999999999999999999986532 2445567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+|||||+ |+|.+++... ..+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~------------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS------------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCE
T ss_pred EEEEEeCCC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCE
Confidence 899999996 6899998532 4689999999999999999999986 99999999999999999999
Q ss_pred EEcccCcccccccCC----CCCccccccC
Q 003368 800 HVGDFGLARLRQEVP----NNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~----~~~~~~~gt~ 824 (825)
||+|||+|+...... ....+.+||+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~ 226 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATR 226 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCC
T ss_pred EEeecceeeecccCccccccccccceeCh
Confidence 999999999764432 2345678887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-32 Score=317.85 Aligned_cols=433 Identities=16% Similarity=0.163 Sum_probs=227.1
Q ss_pred CceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcc---cccCCcccc------------CCCCCC
Q 003368 19 FCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI---QGKIPGEIG------------RLFRLE 83 (825)
Q Consensus 19 ~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l---~~~~p~~~~------------~l~~L~ 83 (825)
|+.|.++.+... .+ +.+. +.....++..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~~-~~---l~~~-~~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSETR-EH---VTMA-LCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHHC-CE---EEES-CGGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhccc-cE---EEEe-eccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 347999865322 12 2222 222333444556778889999977532 134444444 566777
Q ss_pred EEECCCCcCCCCCCcCCCCC--CCCCEEEcCCCC-CCC-CCChhhhcccccceeeccccccccc----cCccCCCCCCCC
Q 003368 84 ALYLSHNSLVGEIPGNLSYC--SRLIGLYLGRNK-LEG-SIPSEFVSLYNLKELAIQENNLTGG----IPHFLGNITSLE 155 (825)
Q Consensus 84 ~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~ 155 (825)
+|+|++|.+++..+..+... .+|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+.++++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 77777776665555545442 237777777665 110 1122233566777777777766544 233345566777
Q ss_pred EEEcccCcCcc----cCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEccccc
Q 003368 156 AISLAYNSLGG----NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF 231 (825)
Q Consensus 156 ~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~ 231 (825)
.|+|++|.+++ .++..+.++++|+.| ++++|.+.+ +|..+. .+++|+.|+++...
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L-------------------~L~~~~~~~-l~~~~~-~~~~L~~L~l~~~~ 254 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSV-------------------KVGDFEILE-LVGFFK-AAANLEEFCGGSLN 254 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEE-------------------ECSSCBGGG-GHHHHH-HCTTCCEEEECBCC
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEE-------------------eccCccHHH-HHHHHh-hhhHHHhhcccccc
Confidence 77777777652 222223333444443 555666653 444433 66777777776532
Q ss_pred CC---CCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccc
Q 003368 232 FS---GSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVAN 308 (825)
Q Consensus 232 l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N 308 (825)
.. +..+..+..+++|+.|+++++. ...++..+..+++|++|++++|.+... .+...+..+++|+.|+++ +
T Consensus 255 ~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~-----~~~~~~~~~~~L~~L~L~-~ 327 (592)
T 3ogk_B 255 EDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETE-----DHCTLIQKCPNLEVLETR-N 327 (592)
T ss_dssp CCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHH-----HHHHHHTTCTTCCEEEEE-G
T ss_pred cccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHH-----HHHHHHHhCcCCCEEecc-C
Confidence 22 1223445566666666666542 233444555556666666666553211 111223455566666665 2
Q ss_pred cccccCCCCcccccCCccccCCCCcCEEEcc-----------cCccccc-CCccccCCCCCCEEEccccccccccCcccc
Q 003368 309 QFKGALPHSIVSGSIPSEIGKLVSLYLIEMD-----------HNQFEGK-IPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376 (825)
Q Consensus 309 ~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 376 (825)
.+.. +.++.....+++|+.|+++ .|.+++. ++.....+++|++|+++.|.+++..+..+.
T Consensus 328 ~~~~--------~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~ 399 (592)
T 3ogk_B 328 VIGD--------RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399 (592)
T ss_dssp GGHH--------HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred ccCH--------HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence 2221 0222223445556666665 2444432 112233455566666655555554444444
Q ss_pred C-CCCCcEEEcc----cCccccc-----cCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCc
Q 003368 377 N-LSSLVKLILG----NNNLSGV-----IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPP 446 (825)
Q Consensus 377 ~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~ 446 (825)
. +++|+.|+++ .|.+++. ++..+.++++|+.|++++|. +.+++..+.
T Consensus 400 ~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~-----------------------~~l~~~~~~ 456 (592)
T 3ogk_B 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ-----------------------GGLTDLGLS 456 (592)
T ss_dssp HHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCG-----------------------GGCCHHHHH
T ss_pred hhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCC-----------------------CCccHHHHH
Confidence 3 5555666554 4444432 12223345555555554322 112222222
Q ss_pred ccc-ccccccEEeecCceecc-cCCccccCCCCCCEEEccCCcCCCC-CCccccCCCCCCEEECCCCccccc
Q 003368 447 KIG-NLKVLRMFVVSSNNLSG-EIPSEIGSCFYLQEIYMAENFFRGS-IPSSLVSLKDLREIDLSQNNLSGK 515 (825)
Q Consensus 447 ~~~-~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~Ldls~N~l~~~ 515 (825)
.++ .+++|+.|++++|++++ .++..+..+++|+.|++++|.+++. ++..+..+++|++|++++|++++.
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 222 25667777777777765 3444556677777777777777543 334445677888888888887754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=276.45 Aligned_cols=247 Identities=24% Similarity=0.248 Sum_probs=160.6
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
.+.++.+++.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456777777777 4565554 5677777777777777777777777777777777777777777777777777777777
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhh
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGL 217 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~ 217 (825)
|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L------------------------------------ 176 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL------------------------------------ 176 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEE------------------------------------
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEE------------------------------------
Confidence 77776666677777777777777777775444445444444444
Q ss_pred cCCCCcEEEcccc-cCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCcccccccccc
Q 003368 218 TLSNLQLFQISNN-FFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLAN 296 (825)
Q Consensus 218 ~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~ 296 (825)
+|++| .+..+.+..|.++++|++|+|++|++.+
T Consensus 177 --------~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-------------------------------------- 210 (452)
T 3zyi_A 177 --------DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-------------------------------------- 210 (452)
T ss_dssp --------ECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS--------------------------------------
T ss_pred --------eCCCCCCccccChhhccCCCCCCEEECCCCcccc--------------------------------------
Confidence 33331 2221122233333444444443333321
Q ss_pred CCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcccc
Q 003368 297 CSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376 (825)
Q Consensus 297 l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 376 (825)
+| .+..+++|+.|+|++|++++..|..|.++++|++|+|++|++.+..|..|.
T Consensus 211 --------------------------~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 263 (452)
T 3zyi_A 211 --------------------------MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD 263 (452)
T ss_dssp --------------------------CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred --------------------------cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhc
Confidence 11 133444555566666666666666777777777777777777777777777
Q ss_pred CCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCc
Q 003368 377 NLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLS 416 (825)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 416 (825)
.+++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 264 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 7777777777777777666667777777777777777775
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=287.10 Aligned_cols=162 Identities=23% Similarity=0.302 Sum_probs=138.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHH---HHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSF---AAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|+..++||+|+||+||+|+.+.+|+.||||++.+.. ......+ ..++++++.++|||||+++++ |+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EE
Confidence 468999999999999999999999999999999997542 1122223 345677888899999999998 56
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+.+..|+|||||+||+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||+|.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~------------~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~ 327 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ------------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE 327 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECT
T ss_pred ECCEEEEEEecCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeC
Confidence 78899999999999999999942 24689999999999999999999985 9999999999999999
Q ss_pred CCcEEEcccCcccccccCCCCCccccccCC
Q 003368 796 NLTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+|++||+|||+|+..... ...+.+||++
T Consensus 328 ~G~vKL~DFGlA~~~~~~--~~~t~~GTp~ 355 (689)
T 3v5w_A 328 HGHVRISDLGLACDFSKK--KPHASVGTHG 355 (689)
T ss_dssp TSCEEECCCTTCEECSSC--CCCSCCSCGG
T ss_pred CCCEEecccceeeecCCC--CCCCccCCcC
Confidence 999999999999987543 3466789973
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=274.42 Aligned_cols=89 Identities=28% Similarity=0.353 Sum_probs=63.3
Q ss_pred cCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccce
Q 003368 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407 (825)
Q Consensus 328 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 407 (825)
..+++|+.|+|++|++++..|..|.++++|++|+|++|++.+..|..|..+++|++|+|++|++++..+..|..+++|+.
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 283 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCE
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCE
Confidence 33445555556666666566667777777777777777777777777777777777777777777766667777777777
Q ss_pred eecCCCCCc
Q 003368 408 LHLFQNDLS 416 (825)
Q Consensus 408 L~L~~N~l~ 416 (825)
|+|++|.+.
T Consensus 284 L~L~~Np~~ 292 (440)
T 3zyj_A 284 IHLHHNPWN 292 (440)
T ss_dssp EECCSSCEE
T ss_pred EEcCCCCcc
Confidence 777777775
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=281.52 Aligned_cols=224 Identities=18% Similarity=0.161 Sum_probs=173.3
Q ss_pred ccCCCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcc-cccCCcccc-------CCCC
Q 003368 10 LNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTI-QGKIPGEIG-------RLFR 81 (825)
Q Consensus 10 ~~~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~ 81 (825)
..+|.....|+.+..+......++++.+++++|.+ .+|..+... |+.|+|++|++ ...+|..+. ++++
T Consensus 21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~ 96 (312)
T 1wwl_A 21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG 96 (312)
T ss_dssp SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence 45676555666666665555556788899999998 777766554 89999999999 456777766 7899
Q ss_pred CCEEECCCCcCCCCCCcCC--CCCCCCCEEEcCCCCCCCCCChhhhcc-----cccceeeccccccccccCccCCCCCCC
Q 003368 82 LEALYLSHNSLVGEIPGNL--SYCSRLIGLYLGRNKLEGSIPSEFVSL-----YNLKELAIQENNLTGGIPHFLGNITSL 154 (825)
Q Consensus 82 L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L 154 (825)
|++|+|++|+|++.+|..+ ..+++|++|+|++|++++. |..|..+ ++|++|+|++|++++..|..|+.+++|
T Consensus 97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L 175 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence 9999999999998888876 8999999999999999977 8888888 899999999999998888999999999
Q ss_pred CEEEcccCcCcccC--Cccc--ccccccceecCcCcCCccccCCCCCceeecCCccccc--cCCchhhhcCCCCcEEEcc
Q 003368 155 EAISLAYNSLGGNI--PSSL--GQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHG--SLPPSLGLTLSNLQLFQIS 228 (825)
Q Consensus 155 ~~L~Ls~N~l~~~~--p~~~--~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~--~lp~~~~~~l~~L~~L~Ls 228 (825)
++|+|++|++++.+ |..+ ..+++|++| ++++|++++ .++..++..+++|++|+|+
T Consensus 176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L-------------------~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls 236 (312)
T 1wwl_A 176 STLDLSDNPELGERGLISALCPLKFPTLQVL-------------------ALRNAGMETPSGVCSALAAARVQLQGLDLS 236 (312)
T ss_dssp CEEECCSCTTCHHHHHHHHSCTTSCTTCCEE-------------------ECTTSCCCCHHHHHHHHHHTTCCCSEEECT
T ss_pred CEEECCCCCcCcchHHHHHHHhccCCCCCEE-------------------ECCCCcCcchHHHHHHHHhcCCCCCEEECC
Confidence 99999999987642 3333 555555555 667777762 3444555567788888888
Q ss_pred cccCCCCCC-ccccCCCCccEEEeeccccc
Q 003368 229 NNFFSGSFP-LAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 229 ~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 257 (825)
+|++++..| ..+..+++|++|+|++|++.
T Consensus 237 ~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp TSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 888887665 45566777777777777776
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=278.49 Aligned_cols=247 Identities=25% Similarity=0.228 Sum_probs=201.9
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
..++.+++++. .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34566666665 4665554 68999999999999888999999999999999999999888899999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEccc-CcCcccCCcccccccccceecCcCcCCccccC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAY-NSLGGNIPSSLGQLKELKSLGLGGTIPPSIYN 193 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~ 193 (825)
+|++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++ |.++...+..|.++++|++|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L------------ 201 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL------------ 201 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE------------
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE------------
Confidence 99988788899999999999999999987788899999999999998 45554445567777777777
Q ss_pred CCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEE
Q 003368 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273 (825)
Q Consensus 194 l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 273 (825)
++++|+++ .+|. +. .+++|+.|+|++|.+++..|..|.++++|+.|+|++|++.+..+..|..+++|+.|
T Consensus 202 -------~L~~n~l~-~~~~-~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 271 (452)
T 3zyi_A 202 -------NLGMCNIK-DMPN-LT-PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271 (452)
T ss_dssp -------ECTTSCCS-SCCC-CT-TCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred -------ECCCCccc-cccc-cc-ccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence 66667666 3443 22 67888888888888888888888888888888888888888888888888888888
Q ss_pred EcccccCCCCCCCccccccccccCCCCCEEEcccccccc
Q 003368 274 NVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312 (825)
Q Consensus 274 ~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 312 (825)
++++|++.... +..+..+++|+.|+|++|.+..
T Consensus 272 ~L~~N~l~~~~------~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 272 NLAHNNLSSLP------HDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp ECCSSCCSCCC------TTSSTTCTTCCEEECCSSCEEC
T ss_pred ECCCCcCCccC------hHHhccccCCCEEEccCCCcCC
Confidence 88888887654 2345678888999999998874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=264.24 Aligned_cols=231 Identities=22% Similarity=0.250 Sum_probs=172.1
Q ss_pred ceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCC
Q 003368 24 GITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYC 103 (825)
Q Consensus 24 g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 103 (825)
+++|... ..+.+|.+.+++. .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..|..+
T Consensus 5 ~C~C~~~--~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 79 (285)
T 1ozn_A 5 ACVCYNE--PKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (285)
T ss_dssp TCEEECS--SSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CceECCC--CCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCc
Confidence 3445433 2366788888876 445544 4689999999999998888889999999999999999998889999999
Q ss_pred CCCCEEEcCCCC-CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceec
Q 003368 104 SRLIGLYLGRNK-LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLG 182 (825)
Q Consensus 104 ~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 182 (825)
++|++|+|++|+ ++...|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L- 158 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL- 158 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE-
Confidence 999999999997 887778899999999999999999998888889999999999999999987666666666666666
Q ss_pred CcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCcccc
Q 003368 183 LGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSV 262 (825)
Q Consensus 183 L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 262 (825)
++++|+++ .+|...+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++.+..+.
T Consensus 159 ------------------~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 219 (285)
T 1ozn_A 159 ------------------FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (285)
T ss_dssp ------------------ECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred ------------------ECCCCccc-ccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHH
Confidence 55666666 34443333667777777777777766666676777777777777666654443
Q ss_pred CcCCCCCCcEEEccccc
Q 003368 263 NFGDMKSLAYLNVAINN 279 (825)
Q Consensus 263 ~~~~l~~L~~L~ls~N~ 279 (825)
.+..+++|+.|++++|.
T Consensus 220 ~~~~l~~L~~L~l~~N~ 236 (285)
T 1ozn_A 220 ALAPLRALQYLRLNDNP 236 (285)
T ss_dssp HHTTCTTCCEEECCSSC
T ss_pred HcccCcccCEEeccCCC
Confidence 34444444444444433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=264.04 Aligned_cols=277 Identities=21% Similarity=0.249 Sum_probs=172.2
Q ss_pred ceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEccc
Q 003368 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAI 277 (825)
Q Consensus 198 ~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~ 277 (825)
+.++.+++.++ .+|..+. ++|++|+|++|.++.+.+..|.++++|++|+|++|++....
T Consensus 10 ~~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~----------------- 68 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG----------------- 68 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE-----------------
T ss_pred CEEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc-----------------
Confidence 34566666666 5665432 56777777777776555555666677777777666654221
Q ss_pred ccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCC-ccccCCCC
Q 003368 278 NNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIP-EEMSRLQN 356 (825)
Q Consensus 278 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~ 356 (825)
..+..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++++..+ ..+..+++
T Consensus 69 -----------~~~~~~~~~~~L~~L~Ls~n~i~----------~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~ 127 (306)
T 2z66_A 69 -----------CCSQSDFGTTSLKYLDLSFNGVI----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127 (306)
T ss_dssp -----------EEEHHHHSCSCCCEEECCSCSEE----------EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTT
T ss_pred -----------CcccccccccccCEEECCCCccc----------cChhhcCCCCCCCEEECCCCcccccccchhhhhccC
Confidence 00223344566666666666665 455556666777777777777665444 45667777
Q ss_pred CCEEEccccccccccCccccCCCCCcEEEcccCcccc-ccCCCCCCCCccceeecCCCCCccccchhhhccccccccccc
Q 003368 357 LQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSG-VIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNF 435 (825)
Q Consensus 357 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l 435 (825)
|++|++++|.+.+..|..|..+++|++|++++|.+++ .+|..+..+++|+.|++++|++++.
T Consensus 128 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~----------------- 190 (306)
T 2z66_A 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL----------------- 190 (306)
T ss_dssp CCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE-----------------
T ss_pred CCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCc-----------------
Confidence 7777777777776666667777777777777777765 4666677777777766666666532
Q ss_pred CCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCC-CCCEEECCCCcccc
Q 003368 436 ARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLK-DLREIDLSQNNLSG 514 (825)
Q Consensus 436 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~-~L~~Ldls~N~l~~ 514 (825)
.|..++.+++|+.|++++|++++..+..+..+++|+.|++++|++++..|..+..++ +|++|++++|++++
T Consensus 191 --------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 191 --------SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp --------CTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred --------CHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 233445556666677777776665555666677777777777777777777777763 77777777777775
Q ss_pred ccCc--ccccc-cCceeeCCCCcceecCCC
Q 003368 515 KIPI--SLERL-PLEYLNLSFNDLEGQVPT 541 (825)
Q Consensus 515 ~~p~--~~~~l-~L~~l~ls~N~l~g~~p~ 541 (825)
..+. ....+ ..+.+.+..+.+....|.
T Consensus 263 ~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 263 TCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp SGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred ccChHHHHHHHHhhhhhhccccccccCCch
Confidence 4321 11111 234445555555555553
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=275.34 Aligned_cols=270 Identities=19% Similarity=0.191 Sum_probs=177.1
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++..+++.+.+...+...+..+++|++|+|++|+|++..|..|+.+++|++|+|++|++++..| |..+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 457777888888876666667777888888888888887777888888888888888888886655 888888888888
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|+|++.. ..++|++|++++|++++..+.. +++|+.|++++|++++..|..|+.+++|++|
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L---------- 149 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYL---------- 149 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEE----------
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEE----------
Confidence 888887533 3478888888888888665544 5678888888888887666666666666555
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
++++|.+++..|..+...+++|++|+|++|.+++..+ ...
T Consensus 150 ---------~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~----------------------------- 189 (317)
T 3o53_A 150 ---------DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVV----------------------------- 189 (317)
T ss_dssp ---------ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCC-----------------------------
T ss_pred ---------ECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccc-----------------------------
Confidence 5556666544444443345555555555555543211 111
Q ss_pred EEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEM 351 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~ 351 (825)
+++|++|+|++|+++ .+|+.+..+++|+.|++++|+++ .+|..+
T Consensus 190 -------------------------l~~L~~L~Ls~N~l~----------~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~ 233 (317)
T 3o53_A 190 -------------------------FAKLKTLDLSSNKLA----------FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233 (317)
T ss_dssp -------------------------CTTCCEEECCSSCCC----------EECGGGGGGTTCSEEECTTSCCC-EECTTC
T ss_pred -------------------------cccCCEEECCCCcCC----------cchhhhcccCcccEEECcCCccc-chhhHh
Confidence 334444444445444 33444555555666666666665 345556
Q ss_pred cCCCCCCEEEccccccc-cccCccccCCCCCcEEEcc-cCccccccCC
Q 003368 352 SRLQNLQFLNMRHNQLS-GEIPSSFGNLSSLVKLILG-NNNLSGVIPS 397 (825)
Q Consensus 352 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~ 397 (825)
..+++|++|+|++|.+. +.+|.++..+++|+.|+++ .+.++|..|.
T Consensus 234 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp CCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred hcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 66666666666666665 5556666666666666666 3445554443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-28 Score=272.64 Aligned_cols=247 Identities=25% Similarity=0.226 Sum_probs=210.8
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
..++.+++++. .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45677777775 5666654 68999999999999888899999999999999999999888899999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccC-cCcccCCcccccccccceecCcCcCCccccC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYN-SLGGNIPSSLGQLKELKSLGLGGTIPPSIYN 193 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~ 193 (825)
+|+.+.+..|..+++|++|+|++|++++..+..|.++++|+.|+|++| .++...+..|.++++|++|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L------------ 190 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL------------ 190 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE------------
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee------------
Confidence 999887788999999999999999999888889999999999999984 5554455567777777777
Q ss_pred CCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEE
Q 003368 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYL 273 (825)
Q Consensus 194 l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 273 (825)
++++|+++ .+|. + ..+++|+.|+|++|++++..|..|.++++|+.|+|++|++.+..+..|..+++|+.|
T Consensus 191 -------~L~~n~l~-~~~~-~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 260 (440)
T 3zyj_A 191 -------NLAMCNLR-EIPN-L-TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260 (440)
T ss_dssp -------ECTTSCCS-SCCC-C-TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred -------cCCCCcCc-cccc-c-CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence 66677776 5554 3 378899999999999998888899999999999999999998888889999999999
Q ss_pred EcccccCCCCCCCccccccccccCCCCCEEEcccccccc
Q 003368 274 NVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312 (825)
Q Consensus 274 ~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~ 312 (825)
++++|+++... +..+..+++|+.|+|++|.+..
T Consensus 261 ~L~~N~l~~~~------~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 261 NLAHNNLTLLP------HDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp ECTTSCCCCCC------TTTTSSCTTCCEEECCSSCEEC
T ss_pred ECCCCCCCccC------hhHhccccCCCEEEcCCCCccC
Confidence 99999988655 3356778899999999999884
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=263.36 Aligned_cols=225 Identities=19% Similarity=0.272 Sum_probs=172.0
Q ss_pred CCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcccc
Q 003368 297 CSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFG 376 (825)
Q Consensus 297 l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 376 (825)
.++++.|+|++|.++ .+|..+.++++|++|+|++|.++ .+|..++.+++|++|+|++|++. .+|..++
T Consensus 80 ~~~l~~L~L~~n~l~----------~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~ 147 (328)
T 4fcg_A 80 QPGRVALELRSVPLP----------QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIA 147 (328)
T ss_dssp STTCCEEEEESSCCS----------SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGG
T ss_pred ccceeEEEccCCCch----------hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHh
Confidence 356777777777776 56666777777777777777777 67777777777777777777777 6677777
Q ss_pred CCCCCcEEEcccCccccccCCCCCC---------CCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCcc
Q 003368 377 NLSSLVKLILGNNNLSGVIPSSLGN---------LKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447 (825)
Q Consensus 377 ~l~~L~~L~Ls~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~ 447 (825)
.+++|++|+|++|++.+.+|..++. +++|++|++++|+++ .+|..+..+..+ +.|++++|++++ +|+.
T Consensus 148 ~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~~-l~~~ 224 (328)
T 4fcg_A 148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPA 224 (328)
T ss_dssp GCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCCC-CCGG
T ss_pred cCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCCc-Cchh
Confidence 7777777777777777777766654 777777777777777 677777776666 577777777774 6667
Q ss_pred ccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCc
Q 003368 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLE 526 (825)
Q Consensus 448 ~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~ 526 (825)
++.+++|+.|++++|++.+.+|..++.+++|+.|++++|.+.+.+|..+..+++|+.||+++|++.+.+|..+..+ .++
T Consensus 225 l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~ 304 (328)
T 4fcg_A 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304 (328)
T ss_dssp GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTC
T ss_pred hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCce
Confidence 7888888888888888888888888888888888888888888888888888888888888888888888888777 578
Q ss_pred eeeCCCCcce
Q 003368 527 YLNLSFNDLE 536 (825)
Q Consensus 527 ~l~ls~N~l~ 536 (825)
.+++..|.+.
T Consensus 305 ~l~l~~~~~~ 314 (328)
T 4fcg_A 305 IILVPPHLQA 314 (328)
T ss_dssp EEECCGGGSC
T ss_pred EEeCCHHHHH
Confidence 8877765443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=275.56 Aligned_cols=266 Identities=17% Similarity=0.160 Sum_probs=174.4
Q ss_pred EECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcC
Q 003368 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 85 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
++++.+.+....+..+..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..| |..+++|++|+|++|++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 3444444443333344444455555555555554444555555555555555555554333 55555555555555555
Q ss_pred cccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCC
Q 003368 165 GGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNAS 244 (825)
Q Consensus 165 ~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (825)
++.. ..++|++| ++++|++++..+. .+++|+.|++++|++++..+..|..++
T Consensus 93 ~~l~-----~~~~L~~L-------------------~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~ 144 (317)
T 3o53_A 93 QELL-----VGPSIETL-------------------HAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRS 144 (317)
T ss_dssp EEEE-----ECTTCCEE-------------------ECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGS
T ss_pred cccc-----CCCCcCEE-------------------ECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccC
Confidence 4211 11222222 4444444422111 346677777777777776677777777
Q ss_pred CccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC
Q 003368 245 NLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP 324 (825)
Q Consensus 245 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip 324 (825)
+|++|+|++|++.+..+..+ ...+++|++|+|++|.+++ +|
T Consensus 145 ~L~~L~Ls~N~l~~~~~~~~-----------------------------~~~l~~L~~L~L~~N~l~~----------~~ 185 (317)
T 3o53_A 145 RVQYLDLKLNEIDTVNFAEL-----------------------------AASSDTLEHLNLQYNFIYD----------VK 185 (317)
T ss_dssp SEEEEECTTSCCCEEEGGGG-----------------------------GGGTTTCCEEECTTSCCCE----------EE
T ss_pred CCCEEECCCCCCCcccHHHH-----------------------------hhccCcCCEEECCCCcCcc----------cc
Confidence 77777777777665432211 2356778888888888874 33
Q ss_pred ccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccc-cccCCCCCCCC
Q 003368 325 SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS-GVIPSSLGNLK 403 (825)
Q Consensus 325 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~ 403 (825)
....+++|+.|++++|++++. |..+..+++|++|+|++|++. .+|..+..+++|++|++++|.+. +.+|..+..++
T Consensus 186 -~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~ 262 (317)
T 3o53_A 186 -GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (317)
T ss_dssp -CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred -cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence 233588999999999999965 555999999999999999999 57888999999999999999998 78888899999
Q ss_pred ccceeecC-CCCCccccchh
Q 003368 404 QLALLHLF-QNDLSGAIPEE 422 (825)
Q Consensus 404 ~L~~L~L~-~N~l~g~ip~~ 422 (825)
+|+.++++ .+.++|..|..
T Consensus 263 ~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 263 RVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHHHHHHHHHHHHSSSSCC
T ss_pred cceEEECCCchhccCCchhc
Confidence 99999998 45666665544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-31 Score=309.65 Aligned_cols=422 Identities=13% Similarity=0.084 Sum_probs=300.0
Q ss_pred CcEEEEECCCCCC---ccccCcCCC------------CCCCCCEEEcCCCcccccCCccccCC--CCCCEEECCCCc-CC
Q 003368 32 RRVTVLDLKSKGL---IGSLSPQIG------------NLSFLREIHLSNNTIQGKIPGEIGRL--FRLEALYLSHNS-LV 93 (825)
Q Consensus 32 ~~l~~l~L~~n~l---~~~~~~~~~------------~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~ 93 (825)
++++.|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+..+ .+|++|+|++|. ++
T Consensus 73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~ 152 (592)
T 3ogk_B 73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT 152 (592)
T ss_dssp TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence 5699999977532 134554444 78999999999999987777777664 459999999987 22
Q ss_pred C-CCCcCCCCCCCCCEEEcCCCCCCCC----CChhhhcccccceeeccccccc----cccCccCCCCCCCCEEEcccCcC
Q 003368 94 G-EIPGNLSYCSRLIGLYLGRNKLEGS----IPSEFVSLYNLKELAIQENNLT----GGIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 94 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
. .++.....+++|++|+|++|.+++. ++..+..+++|++|++++|.++ +.++..+.++++|+.|+|++|.+
T Consensus 153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~ 232 (592)
T 3ogk_B 153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI 232 (592)
T ss_dssp HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBG
T ss_pred HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccH
Confidence 1 1223335789999999999999866 4456678999999999999997 34556677899999999999999
Q ss_pred cccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCC
Q 003368 165 GGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNAS 244 (825)
Q Consensus 165 ~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (825)
.+ +|..+..+++|++|++++... .+ -.+..+..+. .+++|+.|+++++.. +.+|..+..++
T Consensus 233 ~~-l~~~~~~~~~L~~L~l~~~~~-~~---------------~~~~~~~~l~-~~~~L~~L~l~~~~~-~~l~~~~~~~~ 293 (592)
T 3ogk_B 233 LE-LVGFFKAAANLEEFCGGSLNE-DI---------------GMPEKYMNLV-FPRKLCRLGLSYMGP-NEMPILFPFAA 293 (592)
T ss_dssp GG-GHHHHHHCTTCCEEEECBCCC-CT---------------TCTTSSSCCC-CCTTCCEEEETTCCT-TTGGGGGGGGG
T ss_pred HH-HHHHHhhhhHHHhhccccccc-cc---------------chHHHHHHhh-ccccccccCccccch-hHHHHHHhhcC
Confidence 85 678899999999996653100 00 0012222333 678999999998643 45677888999
Q ss_pred CccEEEeecccccCccc-cCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEccc-----------ccccc
Q 003368 245 NLQSLEILGNNFFGKLS-VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVA-----------NQFKG 312 (825)
Q Consensus 245 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~-----------N~l~~ 312 (825)
+|++|+|++|.+.+... ..+..+++|+.|+++ +.+.. ..++.....+++|+.|++++ |.+++
T Consensus 294 ~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~-----~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~ 367 (592)
T 3ogk_B 294 QIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD-----RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQ 367 (592)
T ss_dssp GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH-----HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCH
T ss_pred CCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH-----HHHHHHHHhCCCCCEEEeecCccccccccccCccCH
Confidence 99999999999755433 346889999999998 44432 12233446789999999993 55553
Q ss_pred cCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccC-CCCCCEEEcc----ccccccc-----cCccccCCCCCc
Q 003368 313 ALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSR-LQNLQFLNMR----HNQLSGE-----IPSSFGNLSSLV 382 (825)
Q Consensus 313 ~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~ 382 (825)
. .++.....+++|+.|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+.++++|+
T Consensus 368 ~--------~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~ 439 (592)
T 3ogk_B 368 R--------GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR 439 (592)
T ss_dssp H--------HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCC
T ss_pred H--------HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCC
Confidence 1 12233456889999999999999887777765 9999999997 7788763 444577799999
Q ss_pred EEEcccC--ccccccCCCCC-CCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEee
Q 003368 383 KLILGNN--NLSGVIPSSLG-NLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVV 459 (825)
Q Consensus 383 ~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l 459 (825)
+|+++.+ .+++..+..+. .+++|+.|++++|.+++.- ++..+..+++|+.|++
T Consensus 440 ~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~------------------------~~~~~~~~~~L~~L~l 495 (592)
T 3ogk_B 440 RFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG------------------------LMEFSRGCPNLQKLEM 495 (592)
T ss_dssp EEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHH------------------------HHHHHTCCTTCCEEEE
T ss_pred EEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHH------------------------HHHHHhcCcccCeeec
Confidence 9999853 36654444443 3788999999999887421 1112234566777888
Q ss_pred cCceeccc-CCccccCCCCCCEEEccCCcCCCCCCccc-cCCCCCCEEECCCC
Q 003368 460 SSNNLSGE-IPSEIGSCFYLQEIYMAENFFRGSIPSSL-VSLKDLREIDLSQN 510 (825)
Q Consensus 460 s~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~Ldls~N 510 (825)
++|.+++. ++..+..+++|+.|++++|++++.-...+ ..++.+....+..+
T Consensus 496 ~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 496 RGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp ESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred cCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 88877654 33444567778888888888775432222 34566655555444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-30 Score=280.10 Aligned_cols=254 Identities=18% Similarity=0.202 Sum_probs=142.3
Q ss_pred CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCC-CCCCcCCC-------CCCCCCEEEcCCCCCCCCCChh
Q 003368 52 IGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV-GEIPGNLS-------YCSRLIGLYLGRNKLEGSIPSE 123 (825)
Q Consensus 52 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~ 123 (825)
++..++|++|++++|.+ .+|..+... |+.|+|++|+++ ..+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566777788888887 567666544 777777777773 34454444 5666777777777776666665
Q ss_pred h--hcccccceeeccccccccccCccCCCC-----CCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCC
Q 003368 124 F--VSLYNLKELAIQENNLTGGIPHFLGNI-----TSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSL 196 (825)
Q Consensus 124 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~ 196 (825)
+ ..+++|++|+|++|++++. |..|+.+ ++|++|+|++|++++..|..|+.+++|++|
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--------------- 178 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL--------------- 178 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEE---------------
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEE---------------
Confidence 4 6666777777777777655 6666655 667777777776666555555555555555
Q ss_pred CceeecCCccccccC--CchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEE
Q 003368 197 LANFSVPENRLHGSL--PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLN 274 (825)
Q Consensus 197 l~~l~l~~N~l~~~l--p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 274 (825)
++++|++.+.+ |..+ .+.++++|++|+|++|++.+....
T Consensus 179 ----~Ls~N~l~~~~~~~~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~------------ 219 (312)
T 1wwl_A 179 ----DLSDNPELGERGLISAL-----------------------CPLKFPTLQVLALRNAGMETPSGV------------ 219 (312)
T ss_dssp ----ECCSCTTCHHHHHHHHS-----------------------CTTSCTTCCEEECTTSCCCCHHHH------------
T ss_pred ----ECCCCCcCcchHHHHHH-----------------------HhccCCCCCEEECCCCcCcchHHH------------
Confidence 44555554431 1111 124444455555555444321100
Q ss_pred cccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCcccccCCccccC
Q 003368 275 VAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSR 353 (825)
Q Consensus 275 ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 353 (825)
....+..+++|++|++++|++++ ..| ..+..+++|+.|+|++|+++ .+|..+.
T Consensus 220 ---------------~~~~~~~l~~L~~L~Ls~N~l~~---------~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 220 ---------------CSALAAARVQLQGLDLSHNSLRD---------AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp ---------------HHHHHHTTCCCSEEECTTSCCCS---------SCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred ---------------HHHHHhcCCCCCEEECCCCcCCc---------ccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence 00112233444444444444443 111 12333455555666666655 4454444
Q ss_pred CCCCCEEEccccccccccCccccCCCCCcEEEcccCcccc
Q 003368 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSG 393 (825)
Q Consensus 354 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 393 (825)
++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5666666666666644 44 6666666666666666654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=249.61 Aligned_cols=218 Identities=26% Similarity=0.345 Sum_probs=173.6
Q ss_pred CCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC
Q 003368 17 HHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI 96 (825)
Q Consensus 17 ~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 96 (825)
.++|.|.|+.|.+. .+++.+|++++++. .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 58999999999764 35678999999987 4666654 68999999999999877789999999999999999999888
Q ss_pred CcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCccccccc
Q 003368 97 PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLK 176 (825)
Q Consensus 97 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 176 (825)
+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 88889999999999999999988888899999999999999999988888899999999999999999866666566666
Q ss_pred ccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccc
Q 003368 177 ELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF 256 (825)
Q Consensus 177 ~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 256 (825)
+|++| ++++|+++ .+|+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 158 ~L~~L-------------------~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 158 SLKEL-------------------RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp TCCEE-------------------ECCSSCCS-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred cccee-------------------EecCCcCc-EeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 66665 55566665 34443333566667777777766665555666666666666666665
Q ss_pred cC
Q 003368 257 FG 258 (825)
Q Consensus 257 ~~ 258 (825)
..
T Consensus 218 ~c 219 (270)
T 2o6q_A 218 DC 219 (270)
T ss_dssp CC
T ss_pred eC
Confidence 43
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=265.66 Aligned_cols=147 Identities=27% Similarity=0.376 Sum_probs=128.3
Q ss_pred hcccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 716 (825)
..+.|+..+.||+|+||+||+|+.+ .+++.||||++.... ....+.+|+++++.+ +|||||+++++ |++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~~ 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC-----FRK 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE-----EEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE-----EEE
Confidence 4567999999999999999999874 457899999986543 345688999999998 69999999997 455
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..|+||||+++|+|.+++. .+++.++..|+.|++.||+|||+. +||||||||+|||++.+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~---------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN---------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRR 153 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT---------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred CCEEEEEEeCCCcccHHHHHc---------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCC
Confidence 788999999999999999882 478889999999999999999986 99999999999999877
Q ss_pred -CcEEEcccCccccccc
Q 003368 797 -LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 -~~~ki~DFGla~~~~~ 812 (825)
+.+||+|||+|+...+
T Consensus 154 ~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 154 LKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TTEEEECCCTTCEECTT
T ss_pred CCeEEECcCCCCcccCC
Confidence 7999999999986643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=282.16 Aligned_cols=163 Identities=21% Similarity=0.356 Sum_probs=142.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||++........+.+.+|+++|+.++|||||+++++ |++++..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 3679999999999999999999999999999999987665566789999999999999999999998 45678899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--CcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN--LTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~--~~~ 799 (825)
+|||||+||+|.+++... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 231 iv~E~~~gg~L~~~i~~~-----------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~v 296 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADE-----------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296 (573)
T ss_dssp EEEECCCCCBHHHHHTCT-----------TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred EEEeecCCCcHHHHHHHh-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCE
Confidence 999999999999998532 23688999999999999999999986 99999999999999854 899
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+.+... ....+.+||+
T Consensus 297 Kl~DFG~a~~~~~~-~~~~~~~GT~ 320 (573)
T 3uto_A 297 KLIDFGLTAHLDPK-QSVKVTTGTA 320 (573)
T ss_dssp EECCCSSCEECCTT-SEEEEECSSG
T ss_pred EEeeccceeEccCC-CceeeeEECc
Confidence 99999999987554 3345667886
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=252.63 Aligned_cols=223 Identities=22% Similarity=0.199 Sum_probs=202.1
Q ss_pred CCceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCc-CCC
Q 003368 18 HFCDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS-LVG 94 (825)
Q Consensus 18 ~~C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~ 94 (825)
-.|++.+++..|. ..+++.|+|++|++.+..+..|..+++|++|+|++|++++..|.+|.++++|++|+|++|. ++.
T Consensus 16 ~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~ 95 (285)
T 1ozn_A 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95 (285)
T ss_dssp EECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCC
T ss_pred EEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccc
Confidence 3477777777765 3689999999999998888899999999999999999999889999999999999999997 888
Q ss_pred CCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCccccc
Q 003368 95 EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQ 174 (825)
Q Consensus 95 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 174 (825)
..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|..
T Consensus 96 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 175 (285)
T 1ozn_A 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175 (285)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcC
Confidence 88999999999999999999999988999999999999999999999888888999999999999999999777777888
Q ss_pred ccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecc
Q 003368 175 LKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGN 254 (825)
Q Consensus 175 l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 254 (825)
+++|+.| ++++|.+++..|..+. .+++|+.|+|++|.+++..+..|..+++|+.|+|++|
T Consensus 176 l~~L~~L-------------------~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 176 LHSLDRL-------------------LLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (285)
T ss_dssp CTTCCEE-------------------ECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred ccccCEE-------------------ECCCCcccccCHhHcc-CcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCC
Confidence 8888777 7788888877677665 8999999999999999887788999999999999999
Q ss_pred cccCcc
Q 003368 255 NFFGKL 260 (825)
Q Consensus 255 ~l~~~~ 260 (825)
++....
T Consensus 236 ~~~c~~ 241 (285)
T 1ozn_A 236 PWVCDC 241 (285)
T ss_dssp CEECSG
T ss_pred CccCCC
Confidence 997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=265.74 Aligned_cols=172 Identities=24% Similarity=0.275 Sum_probs=145.6
Q ss_pred cHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeeccc
Q 003368 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCS 710 (825)
Q Consensus 634 ~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 710 (825)
.+.++...+++|+..++||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++..++|||||+++++|
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~- 143 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF- 143 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 455666678899999999999999999999998999999999975321 2233488999999999999999999985
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
++++..|+|||||++|+|.+++... ...+++..+..++.|++.||+|||+. +||||||||+|
T Consensus 144 ----~~~~~~~lV~Ey~~gg~L~~~l~~~-----------~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~N 205 (437)
T 4aw2_A 144 ----QDDNNLYLVMDYYVGGDLLTLLSKF-----------EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDN 205 (437)
T ss_dssp ----ECSSEEEEEECCCTTCBHHHHHHTT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred ----eeCCEEEEEEecCCCCcHHHHHHHc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHH
Confidence 4467899999999999999999531 23689999999999999999999985 89999999999
Q ss_pred eeecCCCcEEEcccCcccccccCCCC-CccccccC
Q 003368 791 ILLDNNLTAHVGDFGLARLRQEVPNN-QSSSVGDL 824 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~~~~~-~~~~~gt~ 824 (825)
||++.++.+||+|||+|+........ .+..+||+
T Consensus 206 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~ 240 (437)
T 4aw2_A 206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240 (437)
T ss_dssp EEECTTSCEEECCCTTCEECCTTSCEECCSCCSCG
T ss_pred eeEcCCCCEEEcchhhhhhcccCCCcccccccCCc
Confidence 99999999999999999877554332 34457775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=274.47 Aligned_cols=254 Identities=19% Similarity=0.185 Sum_probs=167.5
Q ss_pred ECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCC
Q 003368 38 DLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 38 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+++...+...+.......++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..| |..+++|++|+|++|+|+
T Consensus 16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~ 93 (487)
T 3oja_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ 93 (487)
T ss_dssp SCCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE
T ss_pred cCchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC
Confidence 344444443333344445578888888888888777888888888888888888887665 888888888888888887
Q ss_pred CCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCC
Q 003368 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLL 197 (825)
Q Consensus 118 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l 197 (825)
+..+ .++|++|++++|.+++..+.. +++|+.|+|++|++++..|..|+.+++|+.|
T Consensus 94 ~l~~-----~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L---------------- 149 (487)
T 3oja_A 94 ELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYL---------------- 149 (487)
T ss_dssp EEEE-----CTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEE----------------
T ss_pred CCCC-----CCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEE----------------
Confidence 5432 377888888888888665543 4678888888888887767666666666555
Q ss_pred ceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEccc
Q 003368 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAI 277 (825)
Q Consensus 198 ~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~ 277 (825)
++++|.+++..|..++..+++|+.|+|++|.|++..+ +.
T Consensus 150 ---~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~------------------------------------ 188 (487)
T 3oja_A 150 ---DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QV------------------------------------ 188 (487)
T ss_dssp ---ECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CC------------------------------------
T ss_pred ---ECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cc------------------------------------
Confidence 5556666655555544345556666666555553311 11
Q ss_pred ccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCC
Q 003368 278 NNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNL 357 (825)
Q Consensus 278 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 357 (825)
.+++|+.|+|++|.++ .+|+.+..+++|+.|+|++|.+++ +|..+..+++|
T Consensus 189 ------------------~l~~L~~L~Ls~N~l~----------~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L 239 (487)
T 3oja_A 189 ------------------VFAKLKTLDLSSNKLA----------FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239 (487)
T ss_dssp ------------------CCTTCCEEECCSSCCC----------EECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTC
T ss_pred ------------------cCCCCCEEECCCCCCC----------CCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCC
Confidence 2344555555555555 244445566666666666666664 55556667777
Q ss_pred CEEEccccccc-cccCccccCCCCCcEEEcc
Q 003368 358 QFLNMRHNQLS-GEIPSSFGNLSSLVKLILG 387 (825)
Q Consensus 358 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 387 (825)
+.|++++|.+. +.+|.++..++.|+.++++
T Consensus 240 ~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 77777777776 5666667777777777665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-26 Score=262.34 Aligned_cols=267 Identities=26% Similarity=0.320 Sum_probs=203.9
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
.++.+++++|.++ .+|..++ ++|+.|+|++|.|+. +|. .+++|++|+|++|++.+.. . .+++|++|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~---~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp-~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLP-V---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC---TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCC-C---CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC---CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCC-C---CCCCCCEEEC
Confidence 3556688888887 7887664 788999999998885 444 5788999999999887543 3 6788888899
Q ss_pred ccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCC
Q 003368 276 AINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQ 355 (825)
Q Consensus 276 s~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 355 (825)
++|.+...+. .+++|+.|++++|+++ .+|.. +++|++|++++|++++ +|. .++
T Consensus 109 s~N~l~~l~~----------~l~~L~~L~L~~N~l~----------~lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~ 161 (622)
T 3g06_A 109 FSNPLTHLPA----------LPSGLCKLWIFGNQLT----------SLPVL---PPGLQELSVSDNQLAS-LPA---LPS 161 (622)
T ss_dssp CSCCCCCCCC----------CCTTCCEEECCSSCCS----------CCCCC---CTTCCEEECCSSCCSC-CCC---CCT
T ss_pred cCCcCCCCCC----------CCCCcCEEECCCCCCC----------cCCCC---CCCCCEEECcCCcCCC-cCC---ccC
Confidence 8888876432 4578889999999887 45543 3788889999998885 443 356
Q ss_pred CCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhccccccccccc
Q 003368 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNF 435 (825)
Q Consensus 356 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l 435 (825)
+|+.|++++|+|++ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|.++ .+|..+ ..+ +.|++
T Consensus 162 ~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~~---~~L-~~L~L 228 (622)
T 3g06_A 162 ELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SGL-KELIV 228 (622)
T ss_dssp TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCCC---TTC-CEEEC
T ss_pred CCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCCC---CCC-CEEEc
Confidence 78888999999884 55 446888899999999885 4443 467888889999888 566532 233 67888
Q ss_pred CCCccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccc
Q 003368 436 ARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGK 515 (825)
Q Consensus 436 ~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~ 515 (825)
++|++++ +| ..+++|+.|++++|+|+ .+|. .+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++.
T Consensus 229 s~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~ 299 (622)
T 3g06_A 229 SGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299 (622)
T ss_dssp CSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHH
T ss_pred cCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCc
Confidence 8888875 55 45577888888888888 5666 5677888889888888 7788888888888999999988888
Q ss_pred cCcccccc
Q 003368 516 IPISLERL 523 (825)
Q Consensus 516 ~p~~~~~l 523 (825)
+|..+..+
T Consensus 300 ~~~~l~~L 307 (622)
T 3g06_A 300 TLQALREI 307 (622)
T ss_dssp HHHHHHHH
T ss_pred CHHHHHhc
Confidence 88766554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=249.35 Aligned_cols=173 Identities=25% Similarity=0.308 Sum_probs=147.5
Q ss_pred ccccHHHHHhhccc----------ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCC
Q 003368 631 RKVSYESLLKATDG----------FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHR 700 (825)
Q Consensus 631 ~~~~~~~~~~~~~~----------f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ 700 (825)
..++++++..+++. |+..+.||+|+||.||+|+...+|+.||||++........+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777777776653 66678999999999999999889999999999876666677899999999999999
Q ss_pred CceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 003368 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEP 780 (825)
Q Consensus 701 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ 780 (825)
||++++++|.. .+..++||||+++|+|.+++.. ..++|.++..++.|+++||+|||+. +
T Consensus 103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~---~ 161 (321)
T 2c30_A 103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ-------------VRLNEEQIATVCEAVLQALAYLHAQ---G 161 (321)
T ss_dssp TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 99999998643 5678999999999999999842 2589999999999999999999985 9
Q ss_pred eeecCCCCCCeeecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 781 TIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 781 ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+||||||+||+++.++.+||+|||+++............+||+
T Consensus 162 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 205 (321)
T 2c30_A 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205 (321)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCG
T ss_pred eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCc
Confidence 99999999999999999999999999998765544444555654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-28 Score=273.82 Aligned_cols=234 Identities=20% Similarity=0.177 Sum_probs=164.8
Q ss_pred CCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcc
Q 003368 81 RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160 (825)
Q Consensus 81 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 160 (825)
+|++|+|++|.|++..|..|..+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+ .++|+.|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 56666666666665555555555555555555555554433 5555555555555555553322 1455555555
Q ss_pred cCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccc
Q 003368 161 YNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAF 240 (825)
Q Consensus 161 ~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 240 (825)
+|.+++.. +. .+++|+.|+|++|.+++..|..|
T Consensus 108 ~N~l~~~~-------------------------------------------~~----~l~~L~~L~L~~N~l~~~~~~~~ 140 (487)
T 3oja_A 108 NNNISRVS-------------------------------------------CS----RGQGKKNIYLANNKITMLRDLDE 140 (487)
T ss_dssp SSCCCCEE-------------------------------------------EC----CCSSCEEEECCSSCCCSGGGBCG
T ss_pred CCcCCCCC-------------------------------------------cc----ccCCCCEEECCCCCCCCCCchhh
Confidence 55554321 11 34567777777777777777777
Q ss_pred cCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccc-cCCCCCEEEcccccccccCCCCcc
Q 003368 241 SNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLA-NCSNLSFLNLVANQFKGALPHSIV 319 (825)
Q Consensus 241 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~ 319 (825)
..+++|+.|+|++|.+.+..|. .+. .+++|+.|+|++|.+++
T Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~------------------------------~l~~~l~~L~~L~Ls~N~l~~------- 183 (487)
T 3oja_A 141 GCRSRVQYLDLKLNEIDTVNFA------------------------------ELAASSDTLEHLNLQYNFIYD------- 183 (487)
T ss_dssp GGGSSEEEEECTTSCCCEEEGG------------------------------GGGGGTTTCCEEECTTSCCCE-------
T ss_pred cCCCCCCEEECCCCCCCCcChH------------------------------HHhhhCCcccEEecCCCcccc-------
Confidence 7788888888888877665532 332 56778888888888874
Q ss_pred cccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccc-cccCCC
Q 003368 320 SGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLS-GVIPSS 398 (825)
Q Consensus 320 ~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~ 398 (825)
+| ....+++|+.|+|++|.+++.+| .+..+++|++|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..
T Consensus 184 ---~~-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~ 257 (487)
T 3oja_A 184 ---VK-GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (487)
T ss_dssp ---EE-CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred ---cc-ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence 22 23458999999999999997555 59999999999999999995 7888999999999999999998 777888
Q ss_pred CCCCCccceeecC
Q 003368 399 LGNLKQLALLHLF 411 (825)
Q Consensus 399 ~~~l~~L~~L~L~ 411 (825)
+..++.|+.++++
T Consensus 258 ~~~l~~L~~l~~~ 270 (487)
T 3oja_A 258 FSKNQRVQTVAKQ 270 (487)
T ss_dssp HTTCHHHHHHHHH
T ss_pred HHhCCCCcEEecc
Confidence 8999999998886
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=250.92 Aligned_cols=163 Identities=26% Similarity=0.346 Sum_probs=140.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|+++++.++||||+++++++ +..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 467999999999999999999998899999999997642 23456788999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 143 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR------------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH 143 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred EEEEEEeCCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCC
Confidence 89999999999999998842 24688999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..........+.+||+
T Consensus 144 vkL~DFG~a~~~~~~~~~~~~~~gt~ 169 (337)
T 1o6l_A 144 IKITDFGLCKEGISDGATMKTFCGTP 169 (337)
T ss_dssp EEECCCTTCBCSCCTTCCBCCCEECG
T ss_pred EEEeeccchhhcccCCCcccccccCh
Confidence 99999999997554444445566765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=241.01 Aligned_cols=204 Identities=21% Similarity=0.221 Sum_probs=106.8
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecc
Q 003368 57 FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQ 136 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 136 (825)
+|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555555444455555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccccccCccCCCCCCCCEEEcccCcCccc-CCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchh
Q 003368 137 ENNLTGGIPHFLGNITSLEAISLAYNSLGGN-IPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSL 215 (825)
Q Consensus 137 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~ 215 (825)
+|++++..+..|+.+++|++|+|++|++++. +|..|..+++|++| ++++|++++..+..+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L-------------------~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL-------------------DLSSNKIQSIYCTDL 169 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE-------------------ECCSSCCCEECGGGG
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE-------------------ECCCCCCCcCCHHHh
Confidence 5555554444555555555555555555542 35555555555544 334444442222222
Q ss_pred hhcCCCCc----EEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCC
Q 003368 216 GLTLSNLQ----LFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLG 281 (825)
Q Consensus 216 ~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 281 (825)
. .+++|+ .|++++|.+++..+..|.. .+|+.|+|++|++.+..+..|..+++|+.|++++|.+.
T Consensus 170 ~-~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 237 (276)
T 2z62_A 170 R-VLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237 (276)
T ss_dssp H-HHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred h-hhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence 1 333333 5555555555444443332 25555555555555555555555556666666655554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=245.58 Aligned_cols=162 Identities=26% Similarity=0.365 Sum_probs=142.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||+||+|+...+|+.||||++........+.+.+|+.++++++|||||++++++. .++..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence 356999999999999999999998999999999998766666778999999999999999999999854 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 94 lv~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl 157 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157 (297)
T ss_dssp EEEECCTTCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred EEEECCCCCCHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEE
Confidence 99999999999999842 2578899999999999999999986 9999999999999999999999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||+|+............+||+
T Consensus 158 ~Dfg~~~~~~~~~~~~~~~~gt~ 180 (297)
T 3fxz_A 158 TDFGFCAQITPEQSKRSTMVGTP 180 (297)
T ss_dssp CCCTTCEECCSTTCCBCCCCSCG
T ss_pred eeCCCceecCCcccccCCccCCc
Confidence 99999998766554455556664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=252.35 Aligned_cols=163 Identities=25% Similarity=0.337 Sum_probs=135.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..++||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|+++++.+ +|||||++++++ ++.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence 467999999999999999999999999999999997642 23456788999999988 699999999984 456
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..|+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g 161 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQK------------SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG 161 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CEEEEEEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCC
Confidence 789999999999999999842 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+..........+.+||+
T Consensus 162 ~ikL~DFG~a~~~~~~~~~~~~~~gt~ 188 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGVTTATFCGTP 188 (353)
T ss_dssp CEEECCCTTCBCSCC---------CCG
T ss_pred CEEEccccceeecccCCccccccCCCc
Confidence 999999999997655444556667775
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9e-27 Score=257.86 Aligned_cols=173 Identities=24% Similarity=0.308 Sum_probs=145.9
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSC 709 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 709 (825)
+.+.+.....++|+..++||+|+||+||+|+.+.+|+.||||++++.. ....+.+.+|++++.+++|||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345556667789999999999999999999998899999999997532 12234588999999999999999999984
Q ss_pred cccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 710 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
++.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +||||||||+
T Consensus 131 -----~~~~~~~lVmE~~~gg~L~~~l~~-----------~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~ 191 (412)
T 2vd5_A 131 -----QDENYLYLVMEYYVGGDLLTLLSK-----------FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPD 191 (412)
T ss_dssp -----ECSSEEEEEECCCCSCBHHHHHHH-----------HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred -----eeCCEEEEEEcCCCCCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHH
Confidence 457789999999999999999842 123689999999999999999999985 9999999999
Q ss_pred CeeecCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 790 NILLDNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
|||++.++++||+|||+|+....... .....+||+
T Consensus 192 NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~ 227 (412)
T 2vd5_A 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227 (412)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCG
T ss_pred HeeecCCCCEEEeechhheeccCCCccccceecccc
Confidence 99999999999999999998765433 233457775
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=254.15 Aligned_cols=164 Identities=23% Similarity=0.307 Sum_probs=140.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcC-CCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 716 (825)
..++|+..++||+|+||+||+|+.+.+++.||||++++... ...+.+.+|..++.++ +|||||++++++ ++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 34679999999999999999999999999999999986532 2234578899999887 899999999984 45
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +||||||||+|||++.+
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~ 189 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQR------------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE 189 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCC
Confidence 7789999999999999998842 24689999999999999999999986 99999999999999999
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+..........+.+||+
T Consensus 190 g~ikL~DFGla~~~~~~~~~~~~~~gt~ 217 (396)
T 4dc2_A 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTP 217 (396)
T ss_dssp SCEEECCCTTCBCCCCTTCCBCCCCBCG
T ss_pred CCEEEeecceeeecccCCCccccccCCc
Confidence 9999999999997554444556677876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=249.36 Aligned_cols=165 Identities=23% Similarity=0.363 Sum_probs=140.8
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 715 (825)
...++|...++||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|.+++..+ +||||+++++++ +
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~ 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence 34578999999999999999999999999999999997642 23456688899999887 899999999984 4
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+.+..|+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS------------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDK 153 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECC
Confidence 56789999999999999999842 24689999999999999999999986 9999999999999999
Q ss_pred CCcEEEcccCcccccccCCCCCccccccC
Q 003368 796 NLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.+||+|||+|+..........+.+||+
T Consensus 154 ~g~vkL~DFG~a~~~~~~~~~~~~~~gt~ 182 (345)
T 1xjd_A 154 DGHIKIADFGMCKENMLGDAKTNTFCGTP 182 (345)
T ss_dssp TSCEEECCCTTCBCCCCTTCCBCCCCSCG
T ss_pred CCCEEEeEChhhhhcccCCCcccCCCCCc
Confidence 99999999999997654444455667775
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-27 Score=258.38 Aligned_cols=169 Identities=24% Similarity=0.315 Sum_probs=143.4
Q ss_pred HHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccc
Q 003368 635 YESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSS 711 (825)
Q Consensus 635 ~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 711 (825)
..++....++|...++||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|+++++.++|||||+++++|
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-- 138 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-- 138 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence 3455566789999999999999999999999999999999997532 12234588999999999999999999984
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
++++..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +||||||||+||
T Consensus 139 ---~~~~~~~lV~E~~~gg~L~~~l~~-------------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NI 199 (410)
T 3v8s_A 139 ---QDDRYLYMVMEYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM 199 (410)
T ss_dssp ---ECSSEEEEEECCCTTEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred ---EECCEEEEEEeCCCCCcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence 457789999999999999998842 2578889999999999999999986 999999999999
Q ss_pred eecCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 792 LLDNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
|++.++.+||+|||+|+....... ...+.+||+
T Consensus 200 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~ 233 (410)
T 3v8s_A 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233 (410)
T ss_dssp EECTTSCEEECCCTTCEECCTTSEEECCSCCSCG
T ss_pred eECCCCCEEEeccceeEeeccCCcccccCCcCCc
Confidence 999999999999999997755432 234566775
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=244.57 Aligned_cols=153 Identities=27% Similarity=0.437 Sum_probs=136.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||+||+|++..+|+.||||++........+.|.+|++++++++||||++++++|. +++..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence 456888999999999999999999899999999987665666788999999999999999999999964 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ...++|.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 84 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 149 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-----------DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVV 149 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-----------CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEE
T ss_pred EEEEecCCCcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEE
Confidence 999999999999998531 24689999999999999999999986 8999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+|+.....
T Consensus 150 ~Dfg~~~~~~~~ 161 (310)
T 3s95_A 150 ADFGLARLMVDE 161 (310)
T ss_dssp CCCTTCEECC--
T ss_pred eecccceecccc
Confidence 999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=247.75 Aligned_cols=163 Identities=23% Similarity=0.314 Sum_probs=140.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||.||+|+.+.+|+.||||++.... ....+.+.+|++++.++ +|||||++++++ +..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 357899999999999999999999999999999998653 23345688999999988 899999999984 456
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g 147 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR------------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEG 147 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CEEEEEEeCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCC
Confidence 789999999999999999842 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+..........+.+||+
T Consensus 148 ~~kL~DFG~a~~~~~~~~~~~~~~gt~ 174 (345)
T 3a8x_A 148 HIKLTDYGMCKEGLRPGDTTSTFCGTP 174 (345)
T ss_dssp CEEECCGGGCBCSCCTTCCBCCCCSCG
T ss_pred CEEEEeccccccccCCCCcccccCCCc
Confidence 999999999997544444455667775
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=245.26 Aligned_cols=163 Identities=23% Similarity=0.345 Sum_probs=139.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+++++.++||||+++++++ ...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 3567999999999999999999998999999999997643 23456788999999999999999999985 3467
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~------------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~ 152 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA------------HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMN 152 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred EEEEEEECCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCC
Confidence 78999999999999999842 24688999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+...... .....+||+
T Consensus 153 ~kl~DFG~a~~~~~~~-~~~~~~gt~ 177 (328)
T 3fe3_A 153 IKIADFGFSNEFTVGG-KLDAFCGAP 177 (328)
T ss_dssp EEECSTTCCGGGSSSC-GGGTTSSSG
T ss_pred EEEeeccCceecCCCC-ccccccCCc
Confidence 9999999998765432 234445654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=247.50 Aligned_cols=172 Identities=39% Similarity=0.626 Sum_probs=147.2
Q ss_pred hcccccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEee
Q 003368 629 ALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVIT 707 (825)
Q Consensus 629 ~~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~ 707 (825)
....+++.++..+.++|...+.||+|+||.||+|+. .+|+.||||++...... ....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 356789999999999999999999999999999986 57899999999765322 2346899999999999999999999
Q ss_pred cccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 708 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
+|. .....++||||+++|+|.+++.... .....++|..+..|+.|++.||+|||+.+.++|+|||||
T Consensus 95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlk 161 (326)
T 3uim_A 95 FCM-----TPTERLLVYPYMANGSVASCLRERP--------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161 (326)
T ss_dssp EEC-----CSSCCEEEEECCTTCBHHHHHHCCS--------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCS
T ss_pred EEe-----cCCceEEEEEeccCCCHHHHHHhcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCc
Confidence 864 3566799999999999999996431 223468999999999999999999999766699999999
Q ss_pred CCCeeecCCCcEEEcccCcccccccCC
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~~~~ 814 (825)
|+||+++.++.+||+|||+|+......
T Consensus 162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 188 (326)
T 3uim_A 162 AANILLDEEFEAVVGDFGLAKLMDYKD 188 (326)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred hhhEEECCCCCEEeccCccccccCccc
Confidence 999999999999999999999875443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=247.79 Aligned_cols=163 Identities=21% Similarity=0.271 Sum_probs=140.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|...++||+|+||+||+|+.+.+|+.||||+++... ....+.+.+|.++++.+ +||||+++++++ ++.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence 467999999999999999999998889999999997642 23456788999999988 799999999984 456
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..|+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQ------------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred CEEEEEEeCCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCC
Confidence 789999999999999999842 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+..........+.+||+
T Consensus 159 ~vkL~DFG~a~~~~~~~~~~~~~~gt~ 185 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGVTTKTFCGTP 185 (353)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCG
T ss_pred cEEEEeCCcccccccCCcccccccCCc
Confidence 999999999997554444455667775
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=244.14 Aligned_cols=163 Identities=36% Similarity=0.581 Sum_probs=141.8
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccc
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSI 712 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 712 (825)
+.+.++..++++|+..+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||++++++|.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 105 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-- 105 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 44455667889999999999999999999997 578999999988766666778999999999999999999999853
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
..+..++||||+++|+|.+++.... .....++|.++..++.|+++||+|||+. +|+||||||+||+
T Consensus 106 ---~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil 171 (321)
T 2qkw_B 106 ---ERNEMILIYKYMENGNLKRHLYGSD--------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINIL 171 (321)
T ss_dssp ---CTTCCEEEEECCTTCBTGGGSSSSC--------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEE
T ss_pred ---CCCeEEEEEEcCCCCcHHHHHhccC--------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEE
Confidence 3567899999999999999996431 1123689999999999999999999985 9999999999999
Q ss_pred ecCCCcEEEcccCccccccc
Q 003368 793 LDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~ 812 (825)
++.++.+||+|||+++....
T Consensus 172 ~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 172 LDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECTTCCEEECCCTTCEECSS
T ss_pred ECCCCCEEEeeccccccccc
Confidence 99999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=242.22 Aligned_cols=160 Identities=28% Similarity=0.367 Sum_probs=138.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||+||+|+...+|+.||||+++... ....+.+.+|+.+++.++|||||++++++ ++..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 467899999999999999999998899999999997642 23456788999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 144 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK------------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGH 144 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH------------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSC
T ss_pred EEEEEEeCCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCC
Confidence 89999999999999999842 24688999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..... ..+.+||+
T Consensus 145 ~kL~Dfg~a~~~~~~---~~~~~gt~ 167 (318)
T 1fot_A 145 IKITDFGFAKYVPDV---TYTLCGTP 167 (318)
T ss_dssp EEECCCSSCEECSSC---BCCCCSCT
T ss_pred EEEeecCcceecCCc---cccccCCc
Confidence 999999999976442 34456665
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=242.08 Aligned_cols=160 Identities=26% Similarity=0.398 Sum_probs=134.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc------
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF------ 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 714 (825)
.++|+..+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||+++++|.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 3568899999999999999999988999999999975433 345789999999999999999999998753210
Q ss_pred ----------------------------------------------CCCCeeeEEEEccCCCChhhhccCCCCCCCcccc
Q 003368 715 ----------------------------------------------QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN 748 (825)
Q Consensus 715 ----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 748 (825)
......++||||+++|+|.+++...
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------- 155 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR--------- 155 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC---------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc---------
Confidence 1122479999999999999999643
Q ss_pred hhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 749 DEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 749 ~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
......++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 1223467888999999999999999986 9999999999999999999999999999987654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-25 Score=232.90 Aligned_cols=224 Identities=22% Similarity=0.184 Sum_probs=193.8
Q ss_pred ceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC
Q 003368 20 CDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP 97 (825)
Q Consensus 20 C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 97 (825)
|...+++..|. ..+++.|+|++|++.+..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+
T Consensus 14 c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (276)
T 2z62_A 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93 (276)
T ss_dssp CTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred ecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccCh
Confidence 44444444443 2579999999999998888899999999999999999998888899999999999999999999988
Q ss_pred cCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccc-cCccCCCCCCCCEEEcccCcCcccCCccccccc
Q 003368 98 GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLK 176 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 176 (825)
..|..+++|++|++++|++++..+..|..+++|++|++++|++++. +|..|.++++|++|+|++|++++..+..|..+.
T Consensus 94 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 173 (276)
T 2z62_A 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173 (276)
T ss_dssp TTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH
T ss_pred hhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhh
Confidence 9999999999999999999988777899999999999999999874 589999999999999999999988888888888
Q ss_pred ccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccc
Q 003368 177 ELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF 256 (825)
Q Consensus 177 ~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 256 (825)
+|+.+.+ .+++++|.+++ +|...+ ...+|+.|+|++|++++..+..|.++++|+.|+|++|++
T Consensus 174 ~L~~l~l---------------~L~ls~n~l~~-~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 236 (276)
T 2z62_A 174 QMPLLNL---------------SLDLSLNPMNF-IQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236 (276)
T ss_dssp TCTTCCE---------------EEECCSSCCCE-ECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCB
T ss_pred hccccce---------------eeecCCCcccc-cCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCcc
Confidence 7775421 45888999984 555555 456899999999999988888899999999999999999
Q ss_pred cCcc
Q 003368 257 FGKL 260 (825)
Q Consensus 257 ~~~~ 260 (825)
.+..
T Consensus 237 ~c~c 240 (276)
T 2z62_A 237 DCSC 240 (276)
T ss_dssp CCCT
T ss_pred cccC
Confidence 8654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=247.59 Aligned_cols=164 Identities=32% Similarity=0.390 Sum_probs=132.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHH-hhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRA-LRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..++||+|+||+||+|+.+.+++.||||+++.... ...+.+.+|..+ ++.++|||||++++++ ++.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~ 111 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA 111 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence 4679999999999999999999999999999999976532 233456777776 5778999999999984 456
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..|+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g 176 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQR------------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQG 176 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred CEEEEEEeCCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCC
Confidence 789999999999999999842 24688889999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccCC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
.+||+|||+|+..........+.+||++
T Consensus 177 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~ 204 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHNSTTSTFCGTPE 204 (373)
T ss_dssp CEEECCCCBCGGGBCCCCCCCSBSCCCC
T ss_pred CEEEeeCccccccccCCCccccccCCcc
Confidence 9999999999976554445566678763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=238.82 Aligned_cols=164 Identities=24% Similarity=0.369 Sum_probs=134.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------------------------hhHHHHHHHHHHhh
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------------------------GASKSFAAECRALR 695 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 695 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4679999999999999999999988999999999975421 11346889999999
Q ss_pred cCCCCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHh
Q 003368 696 NIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHH 775 (825)
Q Consensus 696 ~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~ 775 (825)
+++||||+++++++.. ...+..++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL-------------KPLSEDQARFYFQDLIKGIEYLHY 155 (298)
T ss_dssp TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS-------------SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998643 225678999999999999876532 368999999999999999999998
Q ss_pred cCCCCeeecCCCCCCeeecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 776 HCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 776 ~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
. +|+||||||+||+++.++.+||+|||+|+.............||+
T Consensus 156 ~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 201 (298)
T 2zv2_A 156 Q---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201 (298)
T ss_dssp T---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCG
T ss_pred C---CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCc
Confidence 6 899999999999999999999999999998765433333444543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=247.76 Aligned_cols=162 Identities=26% Similarity=0.363 Sum_probs=139.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++|||||++++++ .+.+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 357899999999999999999999999999999997542 23456789999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 153 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN------------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGH 153 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEEEEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCC
Confidence 899999999999999998532 4689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..... ....+.+||+
T Consensus 154 vkL~DFG~a~~~~~~-~~~~~~~gt~ 178 (384)
T 4fr4_A 154 VHITDFNIAAMLPRE-TQITTMAGTK 178 (384)
T ss_dssp EEECCCTTCEECCTT-CCBCCCCSCG
T ss_pred EEEeccceeeeccCC-CceeccCCCc
Confidence 999999999987543 2334556664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.6e-26 Score=240.99 Aligned_cols=168 Identities=32% Similarity=0.488 Sum_probs=129.1
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
...++|+..+.||+|+||+||+|++ +|+.||||++..... ...++|.+|++++++++||||+++++++. ..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----QP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----ST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 3456788999999999999999987 688999999876532 33467999999999999999999999853 45
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... .....+++.++..++.|+++||+|||+. .++|+||||||+||+++.++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKS---------GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHST---------THHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC
T ss_pred CceEEEEecCCCCcHHHHHhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC
Confidence 6689999999999999999643 1223589999999999999999999986 12399999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+.............||+
T Consensus 177 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 203 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFLSSKSAAGTP 203 (309)
T ss_dssp CEEECCCC-----------------CC
T ss_pred cEEECCCCCCccccccccccccCCCCc
Confidence 999999999987655433334445554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=243.40 Aligned_cols=162 Identities=24% Similarity=0.330 Sum_probs=138.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------hHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.+.|...+.||+|+||.||+|+...+|+.||||++...... ..+.+.+|++++++++|||||++++++ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence 45688999999999999999999999999999999765321 346799999999999999999999985 4
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+....++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~ 150 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLD 150 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTC------------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeC
Confidence 467899999999999999998532 3689999999999999999999986 9999999999999987
Q ss_pred CC----cEEEcccCcccccccCCCCCccccccC
Q 003368 796 NL----TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~~----~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++ .+||+|||+|+...... .....+||+
T Consensus 151 ~~~~~~~vkl~DFG~a~~~~~~~-~~~~~~gt~ 182 (361)
T 2yab_A 151 KNIPIPHIKLIDFGLAHEIEDGV-EFKNIFGTP 182 (361)
T ss_dssp TTSSSCCEEECCCSSCEECCTTC-CCCCCCSCG
T ss_pred CCCCccCEEEEecCCceEcCCCC-ccccCCCCc
Confidence 76 79999999999876542 234455664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=243.24 Aligned_cols=160 Identities=27% Similarity=0.347 Sum_probs=138.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++ .+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence 367899999999999999999998899999999997542 23456788999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 179 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR------------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEEEEEcCCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCC
Confidence 89999999999999999842 24689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..... ..+.+||+
T Consensus 180 ~kL~DFg~a~~~~~~---~~~~~gt~ 202 (350)
T 1rdq_E 180 IQVTDFGFAKRVKGR---TWTLCGTP 202 (350)
T ss_dssp EEECCCTTCEECSSC---BCCCEECG
T ss_pred EEEcccccceeccCC---cccccCCc
Confidence 999999999976442 33445664
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=254.26 Aligned_cols=167 Identities=23% Similarity=0.316 Sum_probs=143.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...++||+|+||+||+|+.+.+|+.||||++..... ...+.+.+|++++++++|||||++++++ +...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence 4678999999999999999999988999999999975432 3346788999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~--------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVD--------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSS--------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred EEEEEEEeccCCCHHHHHHHhh--------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCC
Confidence 8999999999999999986431 1224689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..........+.+||+
T Consensus 328 vkL~DFGla~~~~~~~~~~~~~~GT~ 353 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTKTKGYAGTP 353 (543)
T ss_dssp EEECCCTTCEECCTTCCCBCCCCSCT
T ss_pred EEEeecceeeeccCCCcccccccCCc
Confidence 99999999998766554445567876
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-24 Score=225.88 Aligned_cols=205 Identities=24% Similarity=0.269 Sum_probs=174.8
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeec
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAI 135 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 135 (825)
...+.+++++|+++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 35789999999999 5777665 68999999999999888889999999999999999999877778899999999999
Q ss_pred cccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchh
Q 003368 136 QENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSL 215 (825)
Q Consensus 136 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~ 215 (825)
++|++++..+..|.++++|++|+|++|++++..+..|..+++|++| ++++|+++ .+|...
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-------------------~Ls~n~l~-~~~~~~ 152 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL-------------------SLGYNELQ-SLPKGV 152 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE-------------------ECCSSCCC-CCCTTT
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE-------------------ECCCCcCC-ccCHhH
Confidence 9999998888889999999999999999998877778777777777 67778777 456655
Q ss_pred hhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCC
Q 003368 216 GLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSG 283 (825)
Q Consensus 216 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 283 (825)
+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++.+..+..|..+++|+.|++++|.+...
T Consensus 153 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 55788999999999999888777888889999999999988877776777777777777777776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=244.52 Aligned_cols=166 Identities=20% Similarity=0.299 Sum_probs=138.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-----hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-----GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+.|...+.||+|+||+||+|+.+.+|+.||||++..... ...+.+.+|++++++++|||||++++++. .+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence 458889999999999999999999999999999864321 13577999999999999999999999853 36
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ......+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~ 167 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKR--------ADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKE 167 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSS
T ss_pred CEEEEEEeCCCCCCHHHHHHHh--------cccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCC
Confidence 7889999999999999887421 11223589999999999999999999986 999999999999998665
Q ss_pred c---EEEcccCcccccccCCCCCccccccC
Q 003368 798 T---AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~---~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
. +||+|||+|+...+........+||+
T Consensus 168 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~ 197 (351)
T 3c0i_A 168 NSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197 (351)
T ss_dssp TTCCEEECCCTTCEECCTTSCBCCCCCSCG
T ss_pred CCCcEEEecCcceeEecCCCeeecCCcCCc
Confidence 4 99999999998766544344556664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=235.85 Aligned_cols=162 Identities=24% Similarity=0.385 Sum_probs=133.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|...+.||+|+||.||+|+...+++.||||.+.... ....+.|.+|++++++++||||+++++++ ..++.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDDC 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSSE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCCe
Confidence 56889999999999999999998899999999986543 23346789999999999999999999985 34677
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 86 ~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIES------------HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp EEEEEECCCSCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEeCCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 8999999999999999842 24689999999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccCCC-CCccccccC
Q 003368 800 HVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
||+|||+|+....... ......||+
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~gt~ 176 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLTQTNHVLGTV 176 (294)
T ss_dssp EECCCSSSTTC-------------CC
T ss_pred EEEeCCCccccccccccccCccccCc
Confidence 9999999997754432 223334554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-26 Score=253.97 Aligned_cols=164 Identities=26% Similarity=0.337 Sum_probs=129.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+++++.++||||++++++|. ..+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence 467999999999999999999999999999999997542 233456789999999999999999999864 366
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. .+||||||||+|||++.++.
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSR------------ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSC
T ss_pred EEEEEEeeCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCC
Confidence 78999999999999998842 24689999999999999999999972 38999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..........+.+||+
T Consensus 288 ~kl~DFG~a~~~~~~~~~~~~~~gt~ 313 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDGATMKTFCGTP 313 (446)
T ss_dssp EEECCCCCCCTTCC-----CCSSSCG
T ss_pred EEEccCCCceeccCCCcccccccCCc
Confidence 99999999997655444455566765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=240.16 Aligned_cols=163 Identities=24% Similarity=0.329 Sum_probs=127.0
Q ss_pred cccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
.++|+..+.||+|+||.||+|+.. .+|+.||||+++... ......+.+|++++++++|||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 467899999999999999999984 588999999997642 12345678999999999999999999985
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
...+..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~ 155 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLER------------EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLN 155 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEEC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEEC
Confidence 346678999999999999999842 24688899999999999999999986 999999999999999
Q ss_pred CCCcEEEcccCcccccccCCCCCccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.++.+||+|||+|+............+||+
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 185 (327)
T 3a62_A 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185 (327)
T ss_dssp TTSCEEECCCSCC----------CTTSSCC
T ss_pred CCCcEEEEeCCcccccccCCccccccCCCc
Confidence 999999999999987654433344455664
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=238.96 Aligned_cols=151 Identities=23% Similarity=0.383 Sum_probs=131.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||+||+|+...+++.||||++..... ...+.+.+|+++++.++|||||++++++. .++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 3678999999999999999999988999999999975432 23467889999999999999999999853 46778
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k 145 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK 145 (323)
T ss_dssp EEEEECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEcCCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEE
Confidence 9999999999999998532 3589999999999999999999985 999999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 146 l~Dfg~a~~~~~ 157 (323)
T 3tki_A 146 ISDFGLATVFRY 157 (323)
T ss_dssp ECCCTTCEECEE
T ss_pred EEEeeccceecc
Confidence 999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=237.96 Aligned_cols=168 Identities=27% Similarity=0.463 Sum_probs=125.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|+...+|+.||||+++.... ...+.+.+|++++++++|||||++++++ ..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 4578899999999999999999988999999999975532 2346788999999999999999999985 446788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++ |+|.+++..... ......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~------~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 148 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTV------GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLK 148 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHS------SSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEecC-CCHHHHHHhccc------cccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEE
Confidence 99999998 699998853210 01123588999999999999999999985 999999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+............+||+
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~t~ 172 (317)
T 2pmi_A 149 LGDFGLARAFGIPVNTFSSEVVTL 172 (317)
T ss_dssp ECCCSSCEETTSCCCCCCCCCSCC
T ss_pred ECcCccceecCCCcccCCCCcccc
Confidence 999999998754433334445553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=246.70 Aligned_cols=163 Identities=21% Similarity=0.275 Sum_probs=138.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|+...+|+.||+|++..... ...+.+.+|++++++++|||||++++++ .+++.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 4578999999999999999999999999999999976542 3346789999999999999999999985 44678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD---NN 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~---~~ 796 (825)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++ .+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~------------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAR------------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTT
T ss_pred EEEEEEeCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCC
Confidence 89999999999999988432 4689999999999999999999986 999999999999998 46
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+............+||+
T Consensus 150 ~~vkL~DFG~a~~~~~~~~~~~~~~gt~ 177 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQAWFGFAGTP 177 (444)
T ss_dssp CCEEECCCSSCBCCCTTCCBCCCSCSCG
T ss_pred CcEEEccCceeEEecCCCceeecccCCc
Confidence 7899999999998766544444556664
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-25 Score=233.66 Aligned_cols=166 Identities=37% Similarity=0.572 Sum_probs=144.0
Q ss_pred hcccccHHHHHhhccccccc------ceeccCCeeEEEEEEEcCCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCC
Q 003368 629 ALRKVSYESLLKATDGFSST------HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL----QGASKSFAAECRALRNIR 698 (825)
Q Consensus 629 ~~~~~~~~~~~~~~~~f~~~------~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~ 698 (825)
....+++.++.+++++|+.. +.||+|+||.||+|+. +++.||||++.... ....+.+.+|++++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 35678999999999999887 8999999999999996 67899999986532 234567999999999999
Q ss_pred CCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003368 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQ 778 (825)
Q Consensus 699 H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~ 778 (825)
||||+++++++. ..+..++||||+++|+|.+++... .....++|..+..++.|+++||+|||+.
T Consensus 89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~i~~~i~~~l~~lH~~-- 152 (307)
T 2nru_A 89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCL---------DGTPPLSWHMRCKIAQGAANGINFLHEN-- 152 (307)
T ss_dssp CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTG---------GGCCCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhc---------cCCCCCCHHHHHHHHHHHHHHHHHHhcC--
Confidence 999999999853 356789999999999999998532 2234689999999999999999999985
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+|+||||||+||++++++.+||+|||+++.....
T Consensus 153 -~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 153 -HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp -TEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred -CeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 9999999999999999999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=234.39 Aligned_cols=161 Identities=25% Similarity=0.389 Sum_probs=135.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||+||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 468889999999999999999999999999999975432 33467889999999999999999999854 46788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++ ++.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 77 ~lv~e~~~~-~l~~~~~~-----------~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS-----------CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEEECCSE-EHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEecCCC-CHHHHHHh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 999999986 56555531 124689999999999999999999996 999999999999999999999
Q ss_pred EcccCcccccccCCCCCcccccc
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt 823 (825)
|+|||+|+............+||
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~t 164 (292)
T 3o0g_A 142 LANFGLARAFGIPVRCYSAEVVT 164 (292)
T ss_dssp ECCCTTCEECCSCCSCCCSCCSC
T ss_pred EeecccceecCCccccccCCccc
Confidence 99999999876544334444554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=236.59 Aligned_cols=161 Identities=24% Similarity=0.317 Sum_probs=137.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
+.|...+.||+|+||.||+|+...+|+.||||++...... ..+.+.+|++++++++|||||++++++. .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 4588899999999999999999889999999999764321 3567999999999999999999999853 4
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~ 150 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 150 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS------------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCS
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecC
Confidence 67789999999999999998532 3588999999999999999999985 99999999999999988
Q ss_pred C----cEEEcccCcccccccCCCCCccccccC
Q 003368 797 L----TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~----~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+ .+||+|||+|+...... .....+||+
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~ 181 (326)
T 2y0a_A 151 NVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTP 181 (326)
T ss_dssp SSSSCCEEECCCTTCEECCTTS-CCCCCCSCT
T ss_pred CCCCCCEEEEECCCCeECCCCC-ccccccCCc
Confidence 7 89999999999875432 223345554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=237.33 Aligned_cols=162 Identities=20% Similarity=0.266 Sum_probs=137.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|+...+|+.||+|.+.... ...+.+.+|+++++.++||||+++++++. +.+..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence 467889999999999999999999999999999987543 34567889999999999999999999853 467889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN--NLTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~--~~~~ 799 (825)
+||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+|||++. ++.+
T Consensus 78 lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~ 143 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-----------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI 143 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred EEEEeCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCE
Confidence 999999999999998532 23588999999999999999999986 9999999999999987 7899
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... .....+||+
T Consensus 144 kl~Dfg~a~~~~~~~-~~~~~~gt~ 167 (321)
T 1tki_A 144 KIIEFGQARQLKPGD-NFRLLFTAP 167 (321)
T ss_dssp EECCCTTCEECCTTC-EEEEEESCG
T ss_pred EEEECCCCeECCCCC-ccccccCCh
Confidence 999999999875432 223344554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=238.07 Aligned_cols=152 Identities=28% Similarity=0.491 Sum_probs=131.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCC---eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+.||+|+||.||+|++..+| ..||||+++.... ...+.|.+|++++++++||||++++++|. +++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 123 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RGR 123 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GGG
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence 46888899999999999999997544 4599999976533 34567999999999999999999999863 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..|+.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTH-----------DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTT-----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred ccEEEeeCCCCCcHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCC
Confidence 789999999999999998532 23689999999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 190 ~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 190 CKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCCSSCEECC--
T ss_pred EEECCCCcccccccC
Confidence 999999999987554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=253.27 Aligned_cols=164 Identities=24% Similarity=0.325 Sum_probs=140.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...++||+|+||.||+|+.+.+|+.||||++.... ....+.+.+|++++++++|||||++++++ ++.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence 467999999999999999999998899999999997542 23356788999999999999999999984 4567
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++... ....+++.++..|+.||+.||+|||+. +||||||||+|||++.++.
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~----------~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~ 324 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHM----------GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGH 324 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSS----------SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred EEEEEEEcCCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCC
Confidence 899999999999999998532 123489999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+...... ...+.+||+
T Consensus 325 vKL~DFGla~~~~~~~-~~~~~~GT~ 349 (576)
T 2acx_A 325 IRISDLGLAVHVPEGQ-TIKGRVGTV 349 (576)
T ss_dssp EEECCCTTCEECCTTC-CEECCCSCG
T ss_pred eEEEecccceecccCc-cccccCCCc
Confidence 9999999999876543 234456765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=244.22 Aligned_cols=152 Identities=29% Similarity=0.517 Sum_probs=125.5
Q ss_pred ccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+.||+|+||.||+|++. .++..||||+++.... ...+.|.+|++++++++|||||+++++|. ..+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~ 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSK 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCC
Confidence 56889999999999999999985 4677899999976533 34568999999999999999999999964 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...++|.++..|+.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 185 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-----------DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV 185 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred ceEEEEeCCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCC
Confidence 789999999999999999532 23689999999999999999999985 8999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 186 ~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 186 CKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCC---------
T ss_pred EEECcCccccccccC
Confidence 999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=236.62 Aligned_cols=154 Identities=28% Similarity=0.504 Sum_probs=131.8
Q ss_pred ccccccceeccCCeeEEEEEE----EcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGT----FDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~----~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||.||+|+ ...+|+.||||++........+.|.+|++++++++||||++++++|.. .+..
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~ 86 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 86 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH---HHHT
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCC
Confidence 568889999999999999998 456889999999987666666789999999999999999999998743 1234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 152 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH-----------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred ceEEEEEeCCCCCHHHHHHhc-----------ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCe
Confidence 579999999999999998532 23589999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 153 ~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCCCSCC-----
T ss_pred EEEccCcccccccCC
Confidence 999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=241.62 Aligned_cols=160 Identities=26% Similarity=0.376 Sum_probs=131.3
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+...++||+|+||.||+|+...+|+.||||+++.......+.+.+|++++++++|||||+++++|. ..+..++||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~ 165 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM 165 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence 344678999999999999998899999999998765556678999999999999999999999854 356789999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--cCCCcEEEc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL--DNNLTAHVG 802 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl--~~~~~~ki~ 802 (825)
||+++|+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 166 E~~~~~~L~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~ 231 (373)
T 2x4f_A 166 EYVDGGELFDRIID-----------ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKII 231 (373)
T ss_dssp ECCTTCEEHHHHHH-----------TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEEC
T ss_pred eCCCCCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEE
Confidence 99999999998842 224689999999999999999999986 89999999999999 667899999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||+|+...... .....+||+
T Consensus 232 DFG~a~~~~~~~-~~~~~~gt~ 252 (373)
T 2x4f_A 232 DFGLARRYKPRE-KLKVNFGTP 252 (373)
T ss_dssp CCSSCEECCTTC-BCCCCCSSC
T ss_pred eCCCceecCCcc-ccccccCCC
Confidence 999999875542 223345654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=250.68 Aligned_cols=155 Identities=27% Similarity=0.387 Sum_probs=126.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|++++++++|||||+++++|....++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999998899999999996543 234567899999999999999999999986544455567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+ +|+|.+++... ..+++..+..|+.||++||+|||+. +||||||||+|||++.++.+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~ 195 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP------------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSV 195 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCE
T ss_pred EEEEEecc-ccchhhhcccC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCE
Confidence 89999998 57899888532 3689999999999999999999986 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 196 kl~DFGla~~~~~ 208 (458)
T 3rp9_A 196 KVCDFGLARTVDY 208 (458)
T ss_dssp EECCCTTCBCTTS
T ss_pred eecccccchhccC
Confidence 9999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=238.24 Aligned_cols=161 Identities=27% Similarity=0.422 Sum_probs=137.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+++++.++||||+++++++. ..+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 357889999999999999999999999999999997542 122457899999999999999999999854 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+ +|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 146 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVE------------KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLN 146 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCC
T ss_pred EEEEEEECC-CCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCC
Confidence 789999999 7899988842 24689999999999999999999996 8999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+...... ...+.+||+
T Consensus 147 ~kl~DFG~s~~~~~~~-~~~~~~gt~ 171 (336)
T 3h4j_B 147 VKIADFGLSNIMTDGN-FLKTSCGSP 171 (336)
T ss_dssp EEECCSSCTBTTTTSB-TTCCCTTST
T ss_pred EEEEEeccceeccCCc-ccccccCCc
Confidence 9999999999875542 234445654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=7.8e-25 Score=240.80 Aligned_cols=163 Identities=18% Similarity=0.303 Sum_probs=138.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.+.|+..+.||+|+||.||+|+...+|+.||+|++..........+.+|++++++++|||||++++++ .+....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 35789999999999999999999889999999999876555567899999999999999999999985 3467889
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN--NLTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~--~~~~ 799 (825)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+
T Consensus 125 lv~E~~~gg~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~v 190 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-----------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-----------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCE
T ss_pred EEEEcCCCCcHHHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCce
Confidence 999999999999998532 23589999999999999999999986 9999999999999974 4789
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... ......||+
T Consensus 191 kL~DFG~a~~~~~~~-~~~~~~gt~ 214 (387)
T 1kob_A 191 KIIDFGLATKLNPDE-IVKVTTATA 214 (387)
T ss_dssp EECCCTTCEECCTTS-CEEEECSSG
T ss_pred EEEecccceecCCCc-ceeeeccCC
Confidence 999999999875432 223335553
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=240.07 Aligned_cols=164 Identities=23% Similarity=0.435 Sum_probs=134.0
Q ss_pred cccccccceeccCCeeEEEEEEEc-------CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-------RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++++ +|||||+++++|.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 467889999999999999999874 3567899999976543 3456799999999999 8999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
..+..|+||||+++|+|.+++.......... .......++|.++..++.|+++||+|||+. +|+||||||
T Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 3567899999999999999996532110000 001124589999999999999999999986 999999999
Q ss_pred CCeeecCCCcEEEcccCcccccccC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+|||++.++.+||+|||+|+.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~ 256 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNI 256 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCC
T ss_pred hhEEECCCCCEEEccccCCcccCcc
Confidence 9999999999999999999976544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.8e-25 Score=258.24 Aligned_cols=165 Identities=21% Similarity=0.288 Sum_probs=142.2
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 716 (825)
..++|+..++||+|+||+||+|+.+.+++.||||+++... ....+.+..|.+++..+ +||+|++++++ +++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence 3567999999999999999999999999999999997542 23456788999999987 69999999988 556
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..|+||||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||++.+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~ 478 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ------------VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE 478 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSS
T ss_pred CCEEEEEEeCcCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCC
Confidence 7789999999999999999842 24689999999999999999999986 99999999999999999
Q ss_pred CcEEEcccCcccccccCCCCCccccccCC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDLE 825 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~~ 825 (825)
+.+||+|||+|+..........+.+||++
T Consensus 479 g~ikL~DFGla~~~~~~~~~~~~~~GT~~ 507 (674)
T 3pfq_A 479 GHIKIADFGMCKENIWDGVTTKTFCGTPD 507 (674)
T ss_dssp SCEEECCCTTCEECCCTTCCBCCCCSCSS
T ss_pred CcEEEeecceeeccccCCcccccccCCCc
Confidence 99999999999976554445566778863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=239.07 Aligned_cols=162 Identities=23% Similarity=0.371 Sum_probs=137.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|+.+.+|+.||||++..... ...+.+.+|++++++++|||||++++++ .+++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 3568899999999999999999988999999999976532 3346789999999999999999999985 34678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN--- 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~--- 796 (825)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTT
T ss_pred EEEEEecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCC
Confidence 89999999999999998532 3588999999999999999999986 99999999999999865
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+...+.. .....+||+
T Consensus 168 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~ 194 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDSE-AWHGFAGTP 194 (362)
T ss_dssp CCEEECCCTTCBCCTTCC-SCCCSCSCT
T ss_pred CCEEEeecCcceEecCCc-ccccCCCCc
Confidence 459999999999876432 233445664
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-25 Score=234.80 Aligned_cols=165 Identities=24% Similarity=0.378 Sum_probs=137.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|...+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.. ......+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence 46888999999999999999998899999999997543 2345778899999999999999999998643 2234679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCC
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNL 797 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl----~~~~ 797 (825)
+||||+++|+|.+++... .....+++.++..|+.|+++||+|||+. +|+||||||+||++ +.++
T Consensus 86 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEP---------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp EEEECCTTCBHHHHHHSG---------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCE
T ss_pred EEEeCCCCCCHHHHHHHh---------ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCc
Confidence 999999999999999532 1223489999999999999999999986 99999999999999 7888
Q ss_pred cEEEcccCcccccccCCCCCcccccc
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
.+||+|||+|+....... ..+.+||
T Consensus 154 ~~kL~Dfg~a~~~~~~~~-~~~~~gt 178 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQ-FVSLYGT 178 (319)
T ss_dssp EEEECCCTTCEECCTTCC-BCCCCSC
T ss_pred eEEEccCCCceecCCCCc-eeecccC
Confidence 999999999998765432 2333454
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=236.62 Aligned_cols=155 Identities=28% Similarity=0.355 Sum_probs=130.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||+||+|++ .++.||||++.... .....+.+|+.++++++|||||+++++|.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 46789999999999999999998 47999999997543 23455677999999999999999999975421 1133479
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeecCCCCCCeeec
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-------QEPTIHCDLKPSNILLD 794 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-------~~~ivHrdlk~~NILl~ 794 (825)
+||||+++|+|.+++.. ..++|.++..|+.|+++||+|||+.+ .++|+||||||+|||++
T Consensus 99 lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EEEECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred EEEecCCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence 99999999999999842 25899999999999999999999741 23899999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+|+.....
T Consensus 166 ~~~~~kL~DFg~a~~~~~~ 184 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAG 184 (322)
T ss_dssp TTCCEEECCCTTCEEECTT
T ss_pred CCCeEEEccCCcccccccc
Confidence 9999999999999877554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-25 Score=246.77 Aligned_cols=162 Identities=28% Similarity=0.465 Sum_probs=139.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+++++.++||||+++++++. ..+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence 3568899999999999999999988999999999975432 23467899999999999999999999853 456
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~ 154 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMN 154 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS------------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCC
Confidence 789999999999999998532 3589999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+...... ...+.+||+
T Consensus 155 vkL~DFG~a~~~~~~~-~~~~~~gt~ 179 (476)
T 2y94_A 155 AKIADFGLSNMMSDGE-FLRTSCGSP 179 (476)
T ss_dssp EEECCCSSCEECCTTC-CBCCCCSCS
T ss_pred eEEEeccchhhccccc-cccccCCCc
Confidence 9999999999875532 334456665
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=243.27 Aligned_cols=153 Identities=27% Similarity=0.469 Sum_probs=134.0
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
..++|...+.||+|+||.||+|++..+++.||||.++.... ...++|.+|++++++++|||||+++++|. .++.
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence 45678889999999999999999988999999999875532 23457889999999999999999999964 3566
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++.. ....+++.++..++.|+|+||+|||+. +|+||||||+|||+++++.+
T Consensus 187 ~~lv~e~~~~g~L~~~l~~-----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~ 252 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT-----------EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVL 252 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH-----------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred cEEEEEcCCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcE
Confidence 8999999999999999842 234689999999999999999999986 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+...+
T Consensus 253 kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 253 KISDFGMSREEAD 265 (377)
T ss_dssp EECCGGGCEECTT
T ss_pred EECcCCCceecCC
Confidence 9999999987543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-28 Score=283.52 Aligned_cols=380 Identities=15% Similarity=0.130 Sum_probs=191.5
Q ss_pred CCCCCCEEEcCCCCCCCCCChhhh-cccccceeecccc-ccccc-cCccCCCCCCCCEEEcccCcCcccCCccccccccc
Q 003368 102 YCSRLIGLYLGRNKLEGSIPSEFV-SLYNLKELAIQEN-NLTGG-IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKEL 178 (825)
Q Consensus 102 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 178 (825)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+..+.
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~-- 180 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFP-- 180 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSC--
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHh--
Confidence 455666666666666655555554 5667777777666 44322 333444666777777777766654433332211
Q ss_pred ceecCcCcCCccccCCCCCceeecCCcc--ccccCCchhhhcCCCCcEEEcccc-cCCCCCCccccCCCCccEEEeecc-
Q 003368 179 KSLGLGGTIPPSIYNLSLLANFSVPENR--LHGSLPPSLGLTLSNLQLFQISNN-FFSGSFPLAFSNASNLQSLEILGN- 254 (825)
Q Consensus 179 ~~L~L~~~~p~~i~~l~~l~~l~l~~N~--l~~~lp~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N- 254 (825)
..++.|+.|++++|. ++......+...+++|++|+|++| .+.+ +|..+.++++|+.|++..+
T Consensus 181 -------------~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~ 246 (594)
T 2p1m_B 181 -------------DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYT 246 (594)
T ss_dssp -------------TTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCC
T ss_pred -------------hcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccccc
Confidence 112223333444443 111111222335789999999988 4443 6677788889999985543
Q ss_pred ------cccCccccCcCCCCCCcEEE-cccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccc
Q 003368 255 ------NFFGKLSVNFGDMKSLAYLN-VAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327 (825)
Q Consensus 255 ------~l~~~~~~~~~~l~~L~~L~-ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l 327 (825)
.+.+ ++..+.++++|+.+. +.... ...++..+..+++|+.|++++|.+++. .++..+
T Consensus 247 ~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~-------~~~l~~~~~~~~~L~~L~L~~~~l~~~--------~l~~~~ 310 (594)
T 2p1m_B 247 AEVRPDVYSG-LSVALSGCKELRCLSGFWDAV-------PAYLPAVYSVCSRLTTLNLSYATVQSY--------DLVKLL 310 (594)
T ss_dssp CCCCHHHHHH-HHHHHHTCTTCCEEECCBTCC-------GGGGGGGHHHHTTCCEEECTTCCCCHH--------HHHHHH
T ss_pred CccchhhHHH-HHHHHhcCCCcccccCCcccc-------hhhHHHHHHhhCCCCEEEccCCCCCHH--------HHHHHH
Confidence 3333 223556667777662 22110 112233334566777777777765431 122224
Q ss_pred cCCCCcCEEEcccCcccc-cCCccccCCCCCCEEEcc---------ccccccccCcccc-CCCCCcEEEcccCccccccC
Q 003368 328 GKLVSLYLIEMDHNQFEG-KIPEEMSRLQNLQFLNMR---------HNQLSGEIPSSFG-NLSSLVKLILGNNNLSGVIP 396 (825)
Q Consensus 328 ~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p 396 (825)
..+++|+.|++++| +.. .++.....+++|++|+++ .+.+++.....+. .+++|++|+++.|.+++..+
T Consensus 311 ~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~ 389 (594)
T 2p1m_B 311 CQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL 389 (594)
T ss_dssp TTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH
T ss_pred hcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH
Confidence 45666777777766 332 222223346667777663 2344432222222 35666666666666665443
Q ss_pred CCCC-CCCccceeecC--C----CCCccccchhhhcccccccccccCCCccccCCCccccccccccEEeecCceecccCC
Q 003368 397 SSLG-NLKQLALLHLF--Q----NDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIP 469 (825)
Q Consensus 397 ~~~~-~l~~L~~L~L~--~----N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p 469 (825)
..+. .+++|+.|+++ + |.+++ .|.. ..++..+..+++|+.|++++ .+++..+
T Consensus 390 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~-------------------~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 390 ITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLD-------------------IGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp HHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTH-------------------HHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred HHHHhhCCCcceeEeecccCCCcccccC-Cchh-------------------hHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 3333 35666666666 2 33331 1100 00111133445555555544 4444433
Q ss_pred ccccC-CCCCCEEEccCCcCCCCCCccc-cCCCCCCEEECCCCccccccCc-ccccc-cCceeeCCCCcc
Q 003368 470 SEIGS-CFYLQEIYMAENFFRGSIPSSL-VSLKDLREIDLSQNNLSGKIPI-SLERL-PLEYLNLSFNDL 535 (825)
Q Consensus 470 ~~~~~-l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~Ldls~N~l~~~~p~-~~~~l-~L~~l~ls~N~l 535 (825)
..++. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++..+. ....+ .|++|++++|++
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44433 5555556665555543333333 3455566666666655433222 12223 355666665554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.7e-25 Score=233.90 Aligned_cols=162 Identities=27% Similarity=0.423 Sum_probs=132.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++ ..++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence 46799999999999999999998 5799999999975432 2346789999999999999999999985 34667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++ +|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDEN-----------KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTC-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred EEEEEcCCCC-CHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence 8999999985 888877432 23588999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+............+||+
T Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~~t~ 183 (311)
T 3niz_A 159 KLADFGLARAFGIPVRSYTHEVVTL 183 (311)
T ss_dssp EECCCTTCEETTSCCC---CCCCCC
T ss_pred EEccCcCceecCCCcccccCCcccC
Confidence 9999999998765433334445553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-24 Score=222.56 Aligned_cols=158 Identities=22% Similarity=0.220 Sum_probs=130.3
Q ss_pred CCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC
Q 003368 18 HFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP 97 (825)
Q Consensus 18 ~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 97 (825)
+||.|.|++|.. ..+.+|++++++. .+|..+. +.|+.|+|++|++++..+..|.++++|++|+|++|+|++..|
T Consensus 3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 688999999963 4457899998886 5666554 689999999999998888889999999999999999998888
Q ss_pred cCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccc
Q 003368 98 GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 177 (825)
..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 88999999999999999999888888889999999999999999777777888999999999999888655545544444
Q ss_pred ccee
Q 003368 178 LKSL 181 (825)
Q Consensus 178 L~~L 181 (825)
|++|
T Consensus 157 L~~L 160 (251)
T 3m19_A 157 LQTL 160 (251)
T ss_dssp CCEE
T ss_pred CCEE
Confidence 4433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.8e-25 Score=232.36 Aligned_cols=154 Identities=27% Similarity=0.442 Sum_probs=127.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhc--CCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRN--IRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||+||+|++ +|+.||||++... ..+.+.+|.+++.. ++||||+++++++... ......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence 46789999999999999999998 6899999998653 33455666666665 8999999999987542 233456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeec
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-----QEPTIHCDLKPSNILLD 794 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-----~~~ivHrdlk~~NILl~ 794 (825)
.++||||+++|+|.+++.. ..+++..+..|+.|+++||+|||+.. ..+|+||||||+|||++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~ 147 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred eEEehhhccCCCHHHHHhh-------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc
Confidence 8999999999999999943 25899999999999999999999211 25999999999999999
Q ss_pred CCCcEEEcccCcccccccCC
Q 003368 795 NNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~~ 814 (825)
.++.+||+|||+|+......
T Consensus 148 ~~~~~kl~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 148 KNGQCCIADLGLAVMHSQST 167 (301)
T ss_dssp TTSCEEECCCTTCEEEETTT
T ss_pred CCCCEEEeeCCCeeeccccc
Confidence 99999999999998765543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=244.42 Aligned_cols=156 Identities=28% Similarity=0.342 Sum_probs=133.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++|||||++++++....+.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999999999999999997542 234567899999999999999999999976533333367
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+. |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~ 168 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP------------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSV 168 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred EEEEEecCC-cCHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCE
Confidence 899999986 5999988532 3589999999999999999999996 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 169 kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 169 KVCDFGLARTINSE 182 (432)
T ss_dssp EECCCTTCEEC---
T ss_pred EEccCCCccccccc
Confidence 99999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=240.17 Aligned_cols=174 Identities=24% Similarity=0.326 Sum_probs=140.2
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEE-----EcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeE
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGT-----FDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRV 705 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~-----~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 705 (825)
+...++....++|...+.||+|+||.||+|+ ...+++.||||+++.... ...+.+.+|+++++++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4455566677889999999999999999998 445678999999976543 3356799999999999 79999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCc----------------------------------------
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD---------------------------------------- 745 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------- 745 (825)
+++|.. .+...++||||+++|+|.++++........
T Consensus 92 ~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 998743 344589999999999999999754211000
Q ss_pred --------------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 746 --------------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 746 --------------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
........+++..+..|+.|+++||+|||+. +|+||||||+||+++.++.+||+|||+|+...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 0000022389999999999999999999986 89999999999999999999999999999765
Q ss_pred cC
Q 003368 812 EV 813 (825)
Q Consensus 812 ~~ 813 (825)
..
T Consensus 245 ~~ 246 (359)
T 3vhe_A 245 KD 246 (359)
T ss_dssp SC
T ss_pred cc
Confidence 43
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-25 Score=224.79 Aligned_cols=203 Identities=15% Similarity=0.114 Sum_probs=163.3
Q ss_pred cccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCc-CCCCCCcCCCCCCCCCEEEcCC-CCCCCCCChh
Q 003368 46 GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS-LVGEIPGNLSYCSRLIGLYLGR-NKLEGSIPSE 123 (825)
Q Consensus 46 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~ 123 (825)
+.+|. +. ++|++|+|++|+|+++.+.+|.++++|++|+|++|+ ++.+.+..|..+++|++|+|++ |+|+++.+.+
T Consensus 24 ~~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~ 100 (239)
T 2xwt_C 24 QRIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA 100 (239)
T ss_dssp SSCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTS
T ss_pred cccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHH
Confidence 35565 43 389999999999998888899999999999999997 9888888999999999999998 9999888889
Q ss_pred hhcccccceeeccccccccccCccCCCCCCCC---EEEcccC-cCcccCCcccccccccc-eecCcCcCCccccCCCCCc
Q 003368 124 FVSLYNLKELAIQENNLTGGIPHFLGNITSLE---AISLAYN-SLGGNIPSSLGQLKELK-SLGLGGTIPPSIYNLSLLA 198 (825)
Q Consensus 124 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~~~p~~i~~l~~l~ 198 (825)
|.++++|++|++++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L----------------- 161 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL----------------- 161 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE-----------------
T ss_pred hCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEE-----------------
Confidence 9999999999999999996 665 88888888 9999999 99877777788877777 77
Q ss_pred eeecCCccccccCCchhhhcCCCCcEEEccccc-CCCCCCccccCC-CCccEEEeecccccCccccCcCCCCCCcEEEcc
Q 003368 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNF-FSGSFPLAFSNA-SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVA 276 (825)
Q Consensus 199 ~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 276 (825)
++++|+++ .+|...+.. ++|+.|+|++|+ ++++.+..|..+ ++|+.|+|++|++.+..+. .+++|+.|+++
T Consensus 162 --~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~ 234 (239)
T 2xwt_C 162 --KLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIAR 234 (239)
T ss_dssp --ECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECT
T ss_pred --EcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeecc
Confidence 66777777 677766633 788888888884 887777778888 8888888888887654433 34455555544
Q ss_pred c
Q 003368 277 I 277 (825)
Q Consensus 277 ~ 277 (825)
+
T Consensus 235 ~ 235 (239)
T 2xwt_C 235 N 235 (239)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=227.11 Aligned_cols=161 Identities=25% Similarity=0.296 Sum_probs=139.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|...+.||+|+||.||+|+...+++.||+|++........+.+.+|++++++++||||++++++|. +....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEEE
Confidence 56888999999999999999998899999999998766666788999999999999999999999853 4677899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCcE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTA 799 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~~~ 799 (825)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 84 v~e~~~~~~L~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 84 VMELCTGGELFERVVH------------KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp EEECCCSCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred EEeccCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence 9999999999998842 24689999999999999999999986 89999999999999 788999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... ......||+
T Consensus 149 ~l~Dfg~~~~~~~~~-~~~~~~~t~ 172 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK-MMRTKVGTP 172 (277)
T ss_dssp EECCCTTCEECCTTS-CBCCCCSCT
T ss_pred EEEecccceeccCcc-chhccCCCC
Confidence 999999998765432 223344543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-25 Score=242.46 Aligned_cols=153 Identities=21% Similarity=0.271 Sum_probs=124.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCC---------CCCcee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIR---------HRNLVR 704 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---------H~niv~ 704 (825)
.++|...+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|++++++++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35688899999999999999998 789999999976531 22477889999998886 777777
Q ss_pred Eeeccccc-------------------------ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHH
Q 003368 705 VITSCSSI-------------------------DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759 (825)
Q Consensus 705 l~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~ 759 (825)
+.+.+... ++.+....++||||+++|++.+.+.. ..+++.++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------------~~~~~~~~ 163 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------------KLSSLATA 163 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------------TCCCHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------------cCCCHHHH
Confidence 76653210 01135678999999999987776632 25789999
Q ss_pred HHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeeecCCC--------------------cEEEcccCccccccc
Q 003368 760 ISIAIDVASAVDYLH-HHCQEPTIHCDLKPSNILLDNNL--------------------TAHVGDFGLARLRQE 812 (825)
Q Consensus 760 ~~i~~~va~~l~yLH-~~~~~~ivHrdlk~~NILl~~~~--------------------~~ki~DFGla~~~~~ 812 (825)
..|+.|++.||+||| +. +||||||||+|||++.++ .+||+|||+|+...+
T Consensus 164 ~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 999999999999999 75 899999999999999887 899999999998654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=225.04 Aligned_cols=197 Identities=25% Similarity=0.232 Sum_probs=105.5
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
+++.++++++++. .+|..+. +.++.|+|++|+|++..|..|..+++|++|+|++|+|++..+. ..+++|++|+|+
T Consensus 11 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls 85 (290)
T 1p9a_G 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLS 85 (290)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECC
T ss_pred CccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECC
Confidence 4556666666654 3444432 4566666666666655556666666666666666666644332 555666666666
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcccc
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIY 192 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~ 192 (825)
+|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|
T Consensus 86 ~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L----------- 153 (290)
T 1p9a_G 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL----------- 153 (290)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE-----------
T ss_pred CCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE-----------
Confidence 66665 445555666666666666666665555556666666666666666654444444444444444
Q ss_pred CCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccc
Q 003368 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF 256 (825)
Q Consensus 193 ~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 256 (825)
++++|+++ .+|...+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 154 --------~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 154 --------SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp --------ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred --------ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 44444444 344433334444444444444444 2333333344444444444443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=236.09 Aligned_cols=151 Identities=24% Similarity=0.279 Sum_probs=126.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|++..+|+.||||++..... .....+..|+..+.++ +|||||+++++|. +++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 568999999999999999999988999999999865432 2334556666666655 8999999999964 3678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+ +|+|.+++.. ....++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEA-----------WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEEECC-CCBHHHHHHH-----------HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCE
T ss_pred EEEEEecc-CCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence 89999999 7799988742 234689999999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 197 kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 197 KLGDFGLLVELGTA 210 (311)
T ss_dssp EECCCTTCEECC--
T ss_pred EEccceeeeecccC
Confidence 99999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=228.27 Aligned_cols=163 Identities=23% Similarity=0.316 Sum_probs=138.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence 356888999999999999999998899999999987543 234567899999999999999999999853 366
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++++|.+++. ....+++.++..++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 89 ~~~lv~e~~~~~~L~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 153 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 153 (294)
T ss_dssp EEEEEEECCTTCBHHHHHH------------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred EEEEEEecCCCCCHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCC
Confidence 7899999999999999873 224689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+++.............||+
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGERKKVLCGTP 179 (294)
T ss_dssp EEECCCTTCEECCSTTCCBCCCCSCC
T ss_pred EEEEeccCceecccCccccccccCCC
Confidence 99999999998764433334444553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=237.91 Aligned_cols=161 Identities=24% Similarity=0.293 Sum_probs=129.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||+||+|+...+|+.||||++..... ..+.+.+|+.++++++|||||++++++. .....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 4679999999999999999999988999999999975432 3467889999999999999999999854 466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--E
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT--A 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~--~ 799 (825)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +
T Consensus 93 lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~ 157 (361)
T 3uc3_A 93 IIMEYASGGELYERICN------------AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRL 157 (361)
T ss_dssp EEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCE
T ss_pred EEEEeCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceE
Confidence 99999999999998842 24689999999999999999999985 8999999999999987765 9
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... .....+||+
T Consensus 158 kl~Dfg~a~~~~~~~-~~~~~~gt~ 181 (361)
T 3uc3_A 158 KICDFGYSKSSVLHS-QPKSTVGTP 181 (361)
T ss_dssp EECCCCCC----------------C
T ss_pred EEeecCccccccccC-CCCCCcCCC
Confidence 999999998543322 223345554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-25 Score=234.19 Aligned_cols=156 Identities=25% Similarity=0.386 Sum_probs=129.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 3568899999999999999999989999999999976532 23457899999999999999999999865321 1122
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~ 154 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT------------EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA 154 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSC
T ss_pred ccEEEEecCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCC
Confidence 45999999999999999842 24689999999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 155 ~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 155 VKVMDFGIARAIADS 169 (311)
T ss_dssp EEECCCSCC------
T ss_pred EEEeeccCccccccc
Confidence 999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=241.01 Aligned_cols=166 Identities=19% Similarity=0.240 Sum_probs=133.2
Q ss_pred hcccccccceeccCCeeEEEEEE-----EcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC---CCCceeEeeccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGT-----FDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR---HRNLVRVITSCSSI 712 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~-----~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 712 (825)
..++|...+.||+|+||+||+|+ ...+++.||||++... ..+++.+|++++.+++ |+||+++++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~-- 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL-- 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE--
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee--
Confidence 45678999999999999999994 5568899999998754 3456778888888777 999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
..+..++||||+++|+|.+++.... ......++|.++..|+.|+++||+|||+. +||||||||+|||
T Consensus 138 ---~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIl 204 (365)
T 3e7e_A 138 ---FQNGSVLVGELYSYGTLLNAINLYK-------NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFI 204 (365)
T ss_dssp ---CSSCEEEEECCCCSCBHHHHHHHHH-------TSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEE
T ss_pred ---cCCCcEEEEeccCCCcHHHHHHHhh-------cccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 3567899999999999999995310 01234699999999999999999999985 8999999999999
Q ss_pred ecC-----------CCcEEEcccCcccccccCCC--CCccccccC
Q 003368 793 LDN-----------NLTAHVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 793 l~~-----------~~~~ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
++. ++.+||+|||+|+.+..... .....+||+
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 249 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence 998 89999999999987653322 234445664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=228.17 Aligned_cols=164 Identities=24% Similarity=0.430 Sum_probs=134.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
..++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. +.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 34679999999999999999999988999999999975422 23467899999999999999999999853 46
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~ 149 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNR-----------VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNM 149 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTC-----------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTC
T ss_pred CeEEEEEecCCCCcHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence 7789999999999999998532 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccCCCCCcccccc
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
.+||+|||+++.............||
T Consensus 150 ~~kl~dfg~~~~~~~~~~~~~~~~~~ 175 (278)
T 3cok_A 150 NIKIADFGLATQLKMPHEKHYTLCGT 175 (278)
T ss_dssp CEEECCCTTCEECC------------
T ss_pred CEEEEeecceeeccCCCCcceeccCC
Confidence 99999999999765433323333444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=232.78 Aligned_cols=163 Identities=23% Similarity=0.316 Sum_probs=139.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+++.||+|++.... ....+.+.+|++++++++||||+++++++. +.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 356888999999999999999998899999999997543 234567899999999999999999999853 466
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++++|.+++. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 115 ~~~lv~e~~~~~~L~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 179 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE 179 (335)
T ss_dssp EEEEEECCCTTCBHHHHHH------------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred eEEEEEecCCCCCHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCC
Confidence 7899999999999999873 224689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+++.............||+
T Consensus 180 ~kl~Dfg~~~~~~~~~~~~~~~~gt~ 205 (335)
T 2owb_A 180 VKIGDFGLATKVEYDGERKKVLCGTP 205 (335)
T ss_dssp EEECCCTTCEECCSTTCCBCCCCSCC
T ss_pred EEEeeccCceecccCcccccccCCCc
Confidence 99999999998764443334445553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=233.08 Aligned_cols=154 Identities=24% Similarity=0.337 Sum_probs=125.0
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeEEEEc
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.+.||+|+||.||+|++..+|+.||||++... ....+.+|++++..++ |||||++++++ .++...++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence 47899999999999999989999999999753 3466789999999997 99999999985 346788999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---cEEEcc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL---TAHVGD 803 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~---~~ki~D 803 (825)
+++|+|.+++.. ...+++.++..|+.|+++||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~D 152 (325)
T 3kn6_A 88 LNGGELFERIKK------------KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIID 152 (325)
T ss_dssp CCSCBHHHHHHH------------CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECC
T ss_pred cCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEec
Confidence 999999999853 24689999999999999999999985 999999999999997765 899999
Q ss_pred cCcccccccCCCCCccccccC
Q 003368 804 FGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 804 FGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|+............+||+
T Consensus 153 fg~a~~~~~~~~~~~~~~~t~ 173 (325)
T 3kn6_A 153 FGFARLKPPDNQPLKTPCFTL 173 (325)
T ss_dssp CTTCEECCC------------
T ss_pred cccceecCCCCCcccccCCCc
Confidence 999997765444444445543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=230.29 Aligned_cols=160 Identities=24% Similarity=0.402 Sum_probs=130.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 4688899999999999999998 6899999999975432 23467889999999999999999999853 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++ +|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 76 ~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k 140 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVC-----------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK 140 (288)
T ss_dssp EEEEECCSE-EHHHHHHTS-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred EEEEEecCC-CHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence 999999985 898888532 23588999999999999999999985 999999999999999999999
Q ss_pred EcccCcccccccCCCCCcccccc
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt 823 (825)
|+|||+|+.............||
T Consensus 141 l~Dfg~~~~~~~~~~~~~~~~~t 163 (288)
T 1ob3_A 141 IADFGLARAFGIPVRKYTHEIVT 163 (288)
T ss_dssp ECCTTHHHHHCC---------CC
T ss_pred EeECccccccCcccccccccccc
Confidence 99999998765433233333444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=223.83 Aligned_cols=206 Identities=22% Similarity=0.263 Sum_probs=124.8
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|+++++.+.. .+.+..+++|++|+|++|++++. ..++.+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 456666666666542 12356666666666666666642 35666666666666666666666666666666666666
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|++++..+..|..+++|++|+|++|++++..+..|+.+++|+.|+|++|++++..+..|+.+++|+.|
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L---------- 186 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL---------- 186 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE----------
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE----------
Confidence 6666666555566666666666666666665555556666666666666666665555555555555555
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCC
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 268 (825)
++++|++++ +|+..+..+++|+.|+|++|.+.+ .+++|+.|++..|++.|.+|..++.+.
T Consensus 187 ---------~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 187 ---------RLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp ---------ECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred ---------ECCCCcCCc-cCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccC
Confidence 555666664 333333356666666666666653 244566666666666666665555443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=231.84 Aligned_cols=161 Identities=29% Similarity=0.394 Sum_probs=132.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 568889999999999999999988999999999865433 23467889999999999999999999864 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 78 ~lv~e~~~~~~l~~~~~~~------------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~k 142 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQ------------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIK 142 (311)
T ss_dssp EEEEECCSEEHHHHHHHTS------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEeCCCchHHHHHhhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEE
Confidence 9999999999999887422 3588999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCCCCcccccc
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt 823 (825)
|+|||+|+............+||
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~~ 165 (311)
T 4agu_A 143 LCDFGFARLLTGPSDYYDDEVAT 165 (311)
T ss_dssp ECCCTTCEECC------------
T ss_pred EeeCCCchhccCcccccCCCcCC
Confidence 99999999876543333333444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=224.30 Aligned_cols=200 Identities=25% Similarity=0.286 Sum_probs=121.4
Q ss_pred CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccc
Q 003368 52 IGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLK 131 (825)
Q Consensus 52 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 131 (825)
+..+++|++|++++|.++. + ..+..+++|++|+|++|++++. ..+..+++|++|+|++|++++..+..|..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 4466777777777777762 2 2466677777777777777653 3566777777777777777766666677777777
Q ss_pred eeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccC
Q 003368 132 ELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211 (825)
Q Consensus 132 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~l 211 (825)
+|+|++|++++..+..|+++++|++|+|++|++++..+..|..++
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~----------------------------------- 157 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT----------------------------------- 157 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----------------------------------
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCc-----------------------------------
Confidence 777777777766666677777777777777777655444444444
Q ss_pred CchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccc
Q 003368 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFI 291 (825)
Q Consensus 212 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~ 291 (825)
+|+.|+|++|++++..+..|..+++|+.|+|++|++.+..+..+..+++|++|++++|.+.
T Consensus 158 ---------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~---------- 218 (272)
T 3rfs_A 158 ---------NLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD---------- 218 (272)
T ss_dssp ---------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC----------
T ss_pred ---------cCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc----------
Confidence 4444444444444444444455555555555555555444444444444444444444332
Q ss_pred cccccCCCCCEEEcccccccc
Q 003368 292 HSLANCSNLSFLNLVANQFKG 312 (825)
Q Consensus 292 ~~~~~l~~L~~L~L~~N~l~~ 312 (825)
+.+++|+.|+++.|.++|
T Consensus 219 ---~~~~~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 219 ---CTCPGIRYLSEWINKHSG 236 (272)
T ss_dssp ---CCTTTTHHHHHHHHHTGG
T ss_pred ---ccCcHHHHHHHHHHhCCC
Confidence 224456666677777766
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=233.19 Aligned_cols=159 Identities=22% Similarity=0.352 Sum_probs=133.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|...+.||+|+||+||+|+.+.+|+.||||++...... +.+|++++.++ +|||||++++++ .+++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY-----DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence 45688999999999999999999999999999999765432 35688888887 799999999984 456789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-C---
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-N--- 796 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~--- 796 (825)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+|||+.+ +
T Consensus 92 ~lv~E~~~gg~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~ 156 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ------------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNP 156 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC------------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSG
T ss_pred EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCc
Confidence 9999999999999998532 3589999999999999999999986 9999999999999843 3
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+..........+.+||+
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 184 (342)
T 2qr7_A 157 ESIRICDFGFAKQLRAENGLLMTPCYTA 184 (342)
T ss_dssp GGEEECCCTTCEECBCTTCCBCCSSCCS
T ss_pred CeEEEEECCCcccCcCCCCceeccCCCc
Confidence 3599999999998766544445566665
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=238.89 Aligned_cols=166 Identities=24% Similarity=0.370 Sum_probs=137.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|...++||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++|||||++++++.. ......+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCeeE
Confidence 46888999999999999999998899999999997543 2345678899999999999999999998643 2234679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCC
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNL 797 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl----~~~~ 797 (825)
+||||+++|+|.+++... .....+++.++..++.|++.||+|||+. +|+||||||+|||+ +.++
T Consensus 86 lv~e~~~~g~L~~~l~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEP---------SNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp EEECCCTTEEHHHHTTSG---------GGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCE
T ss_pred EEEecCCCCCHHHHHHhh---------hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCce
Confidence 999999999999999532 1223489999999999999999999986 89999999999999 7788
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+...... .....+||+
T Consensus 154 ~~kL~DFG~a~~~~~~~-~~~~~~gt~ 179 (396)
T 4eut_A 154 VYKLTDFGAARELEDDE-QFVSLYGTE 179 (396)
T ss_dssp EEEECCGGGCEECCCGG-GSSCSSSCC
T ss_pred eEEEecCCCceEccCCC-ccccccCCc
Confidence 89999999999875542 223344554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=235.77 Aligned_cols=150 Identities=23% Similarity=0.354 Sum_probs=120.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..+.|...+.||+|+||.||+|+...+++.||||++.... ..+.+.+|++++++++||||++++++|. ..+..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence 3467889999999999999999998899999999997543 3467889999999999999999999864 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~~ 797 (825)
++||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++. ++
T Consensus 124 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK------------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC------------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTC
T ss_pred EEEEEeCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCC
Confidence 9999999999999998532 3588999999999999999999986 8999999999999975 88
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 189 ~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 189 PLKIADFGLSKIVEH 203 (349)
T ss_dssp CEEECCCC-------
T ss_pred CEEEccCccccccCc
Confidence 999999999997654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=222.51 Aligned_cols=206 Identities=21% Similarity=0.261 Sum_probs=183.1
Q ss_pred CCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccc
Q 003368 51 QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNL 130 (825)
Q Consensus 51 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 130 (825)
.+.++++++++++++|+++ .+|..+. ++++.|+|++|+|++..|..|..+++|++|+|++|+|++..+. ..+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 3678899999999999999 5676664 6899999999999999999999999999999999999975443 789999
Q ss_pred ceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCcccccc
Q 003368 131 KELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGS 210 (825)
Q Consensus 131 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~ 210 (825)
++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|++| ++++|+++ .
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L-------------------~L~~N~l~-~ 138 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL-------------------YLKGNELK-T 138 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE-------------------ECTTSCCC-C
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE-------------------ECCCCCCC-c
Confidence 99999999999 678899999999999999999998888888888888888 77888888 5
Q ss_pred CCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCC
Q 003368 211 LPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSG 283 (825)
Q Consensus 211 lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~ 283 (825)
+|...+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++. .+|..+..+.+|+.+++++|.+...
T Consensus 139 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 66666668999999999999999888888999999999999999998 5666777788999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=234.53 Aligned_cols=149 Identities=26% Similarity=0.360 Sum_probs=130.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||+|+||.||+|+...+|+.||||++..... .+.+.+|+++++++ +||||+++++++. .++..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~~ 81 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYNA 81 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCccE
Confidence 578999999999999999999988999999999875432 34688999999999 8999999999854 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT--- 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~--- 798 (825)
+||||+ +|+|.+++... ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 82 lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~ 146 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC-----------DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQ 146 (330)
T ss_dssp EEEECC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCT
T ss_pred EEEEeC-CCCHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCC
Confidence 999999 99999998521 24689999999999999999999986 9999999999999998887
Q ss_pred --EEEcccCcccccccC
Q 003368 799 --AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 --~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 147 ~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 147 QVIHIIDFALAKEYIDP 163 (330)
T ss_dssp TSEEECCCTTCEESBCT
T ss_pred ceEEEEEcccceeeecC
Confidence 999999999987554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=224.44 Aligned_cols=150 Identities=26% Similarity=0.442 Sum_probs=131.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|++. +++.||||++..... ..+++.+|++++++++||||+++++++. ++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 356888999999999999999984 688899999976533 3467999999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||
T Consensus 82 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl 147 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQ-----------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV 147 (269)
T ss_dssp EEEECCTTCBHHHHHHTT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEE
T ss_pred EEEEeCCCCcHHHHHHhc-----------CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEe
Confidence 999999999999998532 23588999999999999999999986 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 148 ~Dfg~~~~~~~ 158 (269)
T 4hcu_A 148 SDFGMTRFVLD 158 (269)
T ss_dssp CCTTGGGGBCC
T ss_pred ccccccccccc
Confidence 99999987643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=227.46 Aligned_cols=151 Identities=25% Similarity=0.405 Sum_probs=132.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC-------eEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG-------TIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
.++|...+.||+|+||.||+|+...++ ..||+|++........+.+.+|++++++++||||++++++|.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 356888999999999999999987766 579999998766666788999999999999999999999864
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.++..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 147 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKN-----------KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLI 147 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHT-----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEe
Confidence 356679999999999999999532 23489999999999999999999986 899999999999999
Q ss_pred CCCc--------EEEcccCcccccc
Q 003368 795 NNLT--------AHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~~--------~ki~DFGla~~~~ 811 (825)
.++. +||+|||+++...
T Consensus 148 ~~~~~~~~~~~~~kl~Dfg~~~~~~ 172 (289)
T 4fvq_A 148 REEDRKTGNPPFIKLSDPGISITVL 172 (289)
T ss_dssp ECCBGGGTBCCEEEECCCCSCTTTS
T ss_pred cCCcccccccceeeeccCccccccc
Confidence 8887 9999999997653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=246.84 Aligned_cols=153 Identities=27% Similarity=0.490 Sum_probs=134.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|...+.||+|+||.||+|++..++..||||.++... ...++|.+|++++++++|||||+++++|.. ....
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~ 291 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF 291 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcE
Confidence 3456888999999999999999998889999999997653 345789999999999999999999999643 5678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ....+++..+..|+.||++||+|||+. +|+||||||+|||++.++.+|
T Consensus 292 ~lv~E~~~~g~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k 358 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVK 358 (495)
T ss_dssp EEEEECCTTCBHHHHHHHS----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred EEEEEccCCCCHHHHHHhc----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEE
Confidence 9999999999999999532 123588999999999999999999985 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 359 l~DFG~a~~~~~ 370 (495)
T 1opk_A 359 VADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCEECCTT
T ss_pred EeecccceeccC
Confidence 999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.9e-25 Score=239.04 Aligned_cols=158 Identities=27% Similarity=0.417 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|...+.||+|+||+||+|++ ..+++.||||+++... ......+.+|+.++++++|||||++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 35688899999999999999994 3467899999997543 334567899999999999999999999853
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.....++||||+++|+|.+++...... ......+++.++..|+.|+++||+|||+. +|+||||||+|||++.
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPR-----PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC 216 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCC-----SSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccc-----cCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEec
Confidence 356679999999999999999643110 11224689999999999999999999986 9999999999999995
Q ss_pred CC---cEEEcccCccccccc
Q 003368 796 NL---TAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~---~~ki~DFGla~~~~~ 812 (825)
++ .+||+|||+|+....
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~ 236 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYR 236 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHH
T ss_pred CCCCceEEECCCcccccccc
Confidence 54 599999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=240.33 Aligned_cols=161 Identities=22% Similarity=0.317 Sum_probs=128.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCCCCCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIRHRNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 713 (825)
.++|...+.||+|+||+||+|+...+++.||||++..... .....+.+|++++++++|||||++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 4678999999999999999999999999999999975421 11235889999999999999999999852
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.+..++||||+++|+|.+++... ..+++.++..|+.|+++||+|||+. +|+||||||+|||+
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll 272 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSS------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred ---cCceEEEEEcCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence 34579999999999999988532 3689999999999999999999986 89999999999999
Q ss_pred cCC---CcEEEcccCcccccccCCCCCccccccC
Q 003368 794 DNN---LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 794 ~~~---~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+ +.+||+|||+|+...... ...+.+||+
T Consensus 273 ~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~ 305 (419)
T 3i6u_A 273 SSQEEDCLIKITDFGHSKILGETS-LMRTLCGTP 305 (419)
T ss_dssp SSSSSSCCEEECCSSTTTSCC------------C
T ss_pred ecCCCcceEEEeecccceecCCCc-cccccCCCC
Confidence 654 459999999999875432 223445553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-27 Score=278.99 Aligned_cols=429 Identities=17% Similarity=0.168 Sum_probs=262.3
Q ss_pred CceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCccc---ccCCcc------------ccCCCCCC
Q 003368 19 FCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQ---GKIPGE------------IGRLFRLE 83 (825)
Q Consensus 19 ~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~p~~------------~~~l~~L~ 83 (825)
|+.|.++... ....++++..... .....+..+++|++|+|++|... +..|.. +..+++|+
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 4468888322 2234555432211 12234567788999999987532 122222 34678999
Q ss_pred EEECCCCcCCCCCCcCCC-CCCCCCEEEcCCC-CCCCC-CChhhhcccccceeeccccccccccCccC----CCCCCCCE
Q 003368 84 ALYLSHNSLVGEIPGNLS-YCSRLIGLYLGRN-KLEGS-IPSEFVSLYNLKELAIQENNLTGGIPHFL----GNITSLEA 156 (825)
Q Consensus 84 ~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~ 156 (825)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|+.
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 999999999877776665 6899999999999 55532 44555689999999999999886554444 36679999
Q ss_pred EEcccCc--Ccc-cCCcccccccccceecCcCcCCccccCCCCCceeecCCc-cccccCCchhhhcCCCCcEEEcccc--
Q 003368 157 ISLAYNS--LGG-NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPEN-RLHGSLPPSLGLTLSNLQLFQISNN-- 230 (825)
Q Consensus 157 L~Ls~N~--l~~-~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N-~l~~~lp~~~~~~l~~L~~L~Ls~N-- 230 (825)
|+|++|. ++. .++..+..+++|++| ++++| .+. .+|..+. .+++|+.|+++.+
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L-------------------~L~~~~~~~-~l~~~~~-~~~~L~~L~l~~~~~ 247 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSL-------------------KLNRAVPLE-KLATLLQ-RAPQLEELGTGGYTA 247 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEE-------------------ECCTTSCHH-HHHHHHH-HCTTCSEEECSBCCC
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEE-------------------ecCCCCcHH-HHHHHHh-cCCcceEcccccccC
Confidence 9999987 221 111112334666666 45554 222 2444433 6677777774433
Q ss_pred -----cCCCCCCccccCCCCccEE-EeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEE
Q 003368 231 -----FFSGSFPLAFSNASNLQSL-EILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLN 304 (825)
Q Consensus 231 -----~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~ 304 (825)
.+.+ ++..+.++++|+.| .+.+.. ...++..+..+++|+.|++++|.+.. ..+...+..+++|+.|+
T Consensus 248 ~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~-----~~l~~~~~~~~~L~~L~ 320 (594)
T 2p1m_B 248 EVRPDVYSG-LSVALSGCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQS-----YDLVKLLCQCPKLQRLW 320 (594)
T ss_dssp CCCHHHHHH-HHHHHHTCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCH-----HHHHHHHTTCTTCCEEE
T ss_pred ccchhhHHH-HHHHHhcCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCH-----HHHHHHHhcCCCcCEEe
Confidence 3333 22356677777777 333222 12333334456777788877776532 11223345778888888
Q ss_pred cccccccccCCCCcccccCCccccCCCCcCEEEc---------ccCcccccCCcccc-CCCCCCEEEccccccccccCcc
Q 003368 305 LVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM---------DHNQFEGKIPEEMS-RLQNLQFLNMRHNQLSGEIPSS 374 (825)
Q Consensus 305 L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~ 374 (825)
+++| ++. ..++.....+++|+.|++ +.+.+++.....+. ++++|++|+++.|.+++..+..
T Consensus 321 l~~~-~~~--------~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~ 391 (594)
T 2p1m_B 321 VLDY-IED--------AGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391 (594)
T ss_dssp EEGG-GHH--------HHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHH
T ss_pred CcCc-cCH--------HHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHH
Confidence 8877 432 022223345778888888 33555543333333 4889999999889988766555
Q ss_pred cc-CCCCCcEEEcc--c----Cccccc-----cCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCcccc
Q 003368 375 FG-NLSSLVKLILG--N----NNLSGV-----IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVG 442 (825)
Q Consensus 375 ~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~ 442 (825)
+. .+++|+.|+++ + |.+++. ++..+..+++|+.|++++ .+++..+..+..
T Consensus 392 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~----------------- 453 (594)
T 2p1m_B 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGT----------------- 453 (594)
T ss_dssp HHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHH-----------------
T ss_pred HHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHH-----------------
Confidence 54 57899999998 4 555521 111245677888888866 555433332222
Q ss_pred CCCccccccccccEEeecCceecccCCccc-cCCCCCCEEEccCCcCCCCCCc-cccCCCCCCEEECCCCcccc
Q 003368 443 SIPPKIGNLKVLRMFVVSSNNLSGEIPSEI-GSCFYLQEIYMAENFFRGSIPS-SLVSLKDLREIDLSQNNLSG 514 (825)
Q Consensus 443 ~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~Ldls~N~l~~ 514 (825)
.+++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++..+. .+..+++|+.|++++|+++.
T Consensus 454 -------~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 454 -------YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp -------HCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred -------hchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 14556777777777665444444 4567777777777777543332 33457788888888887754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=230.32 Aligned_cols=154 Identities=25% Similarity=0.431 Sum_probs=135.7
Q ss_pred ccccccceeccCCeeEEEEEEE----cCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||.||+|++ ..+++.||||++........+.+.+|++++++++||||+++++++.. .+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence 5688899999999999999994 56889999999987766666789999999999999999999998643 3456
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ....+++.++..|+.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~ 165 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAH 165 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHH-----------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred eEEEEEeecCCCCHHHHHHh-----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCC
Confidence 78999999999999999842 224689999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+++.....
T Consensus 166 ~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 166 VKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCGGGCEECCTT
T ss_pred EEEcccccceecccC
Confidence 999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-24 Score=242.08 Aligned_cols=164 Identities=24% Similarity=0.254 Sum_probs=129.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.++|+..+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|+++++.++|||||++++++.... +.+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999999999999999997542 334567889999999999999999999875321 12335
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||++++ +.+.+. ..+++.++..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~--------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred eEEEEEeCCCCC-HHHHHh--------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCC
Confidence 679999999864 655552 2478889999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..... ......+||+
T Consensus 203 ~kl~DFG~a~~~~~~-~~~~~~~gt~ 227 (464)
T 3ttj_A 203 LKILDFGLARTAGTS-FMMTPYVVTR 227 (464)
T ss_dssp EEECCCCCC-----C-CCC----CCC
T ss_pred EEEEEEEeeeecCCC-cccCCCcccc
Confidence 999999999987543 2334456664
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=234.81 Aligned_cols=162 Identities=23% Similarity=0.320 Sum_probs=137.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCCCCCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIRHRNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 713 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 4578999999999999999999999999999999976531 1234577899999999999999999985
Q ss_pred cCCCCeeeEEEEccCCC-ChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 714 FQGNDFKALVYQYMPNG-SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
...+..++||||+.+| +|.+++... ..+++..+..|+.|++.||+|||+. +|+||||||+||+
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 162 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDRH------------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIV 162 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHTC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEE
Confidence 3467889999999877 999988532 3689999999999999999999986 9999999999999
Q ss_pred ecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.++.+||+|||+|+...... .....+||+
T Consensus 163 l~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~ 193 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLERGK-LFYTFCGTI 193 (335)
T ss_dssp ECTTSCEEECCCTTCEECCTTC-CBCEECSCG
T ss_pred EcCCCcEEEeecccceECCCCC-ceeccCCCc
Confidence 9999999999999999876543 223445553
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=222.46 Aligned_cols=151 Identities=27% Similarity=0.454 Sum_probs=132.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|++ .++..||||++..... ..+++.+|++++++++||||++++++|. .+...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence 46788999999999999999998 5778899999976533 3467999999999999999999999853 456789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 80 lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l 145 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS-----------HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV 145 (268)
T ss_dssp EEEECCTTCBHHHHHHH-----------HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEE
T ss_pred EEEEccCCCcHHHHHHH-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEE
Confidence 99999999999999842 234689999999999999999999985 9999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+|+.....
T Consensus 146 ~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 146 SDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCEEECCTT
T ss_pred ccCccceecchh
Confidence 999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=241.60 Aligned_cols=153 Identities=26% Similarity=0.489 Sum_probs=133.3
Q ss_pred HhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 639 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
....++|...+.||+|+||.||+|++ .++..||||+++... ...++|.+|++++++++|||||+++++|. .+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred eechHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence 34456788899999999999999999 467899999997653 34678999999999999999999999863 34
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ....+++.++..++.|+|+||+|||+. +|+||||||+|||++.++.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSD----------EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLV 322 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSH----------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCC
T ss_pred ccEEEEeecCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCc
Confidence 579999999999999999531 224688999999999999999999986 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 323 ~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 323 CKIADFGLARVIED 336 (454)
T ss_dssp EEECSTTGGGGBCC
T ss_pred EEEeeCCCceEcCC
Confidence 99999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=226.96 Aligned_cols=155 Identities=24% Similarity=0.320 Sum_probs=131.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. +....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence 458889999999999999999988999999999976543 34578999999999999999999999853 466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCc
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLT 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~~ 798 (825)
+||||+++|+|.+++... ......+++..+..|+.|+++||+|||+. +|+||||||+||++ +.++.
T Consensus 97 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~ 165 (285)
T 3is5_A 97 IVMETCEGGELLERIVSA--------QARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSP 165 (285)
T ss_dssp EEECCCSCCBHHHHHHHH--------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCC
T ss_pred EEEEeCCCCcHHHHHHhh--------hhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCC
Confidence 999999999999988421 12235689999999999999999999985 89999999999999 45678
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 166 ~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 166 IKIIDFGLAELFKSD 180 (285)
T ss_dssp EEECCCCCCCC----
T ss_pred EEEEeeecceecCCc
Confidence 999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=225.09 Aligned_cols=152 Identities=26% Similarity=0.412 Sum_probs=132.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+.++|+..+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++||||++++++|. +.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cC
Confidence 4577999999999999999999999999999999986542 223567899999999999999999999853 45
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++|+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~ 146 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK------------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAG 146 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTS
T ss_pred CEEEEEEecCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCC
Confidence 678999999999999998842 24689999999999999999999985 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||++.....
T Consensus 147 ~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 147 ELKIADFGWSVHAPS 161 (279)
T ss_dssp CEEECSCCEESCC--
T ss_pred CEEEEeccccccCCc
Confidence 999999999876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=226.91 Aligned_cols=164 Identities=22% Similarity=0.328 Sum_probs=133.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|....+||+|+||.||+|+...+++.||||.+........+.+.+|+++++.++||||+++++++. ..+..++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEE
Confidence 34556679999999999999998899999999998766556678999999999999999999999864 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCcEEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-~~~~ki 801 (825)
||||+++|+|.+++... .....+++..+..++.|+++||+|||+. +|+||||||+||+++. ++.+||
T Consensus 97 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl 164 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSK---------WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKI 164 (295)
T ss_dssp EEECCSEEEHHHHHHHT---------TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEE
T ss_pred EEEeCCCCCHHHHHHhh---------ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEE
Confidence 99999999999998532 1123467888999999999999999986 9999999999999987 899999
Q ss_pred cccCcccccccCCCCCcccccc
Q 003368 802 GDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt 823 (825)
+|||+++.............||
T Consensus 165 ~Dfg~~~~~~~~~~~~~~~~~~ 186 (295)
T 2clq_A 165 SDFGTSKRLAGINPCTETFTGT 186 (295)
T ss_dssp CCTTTCEESCC-----CCCCCC
T ss_pred eecccccccCCCCCcccccCCC
Confidence 9999998765433223333444
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=234.00 Aligned_cols=166 Identities=25% Similarity=0.407 Sum_probs=135.4
Q ss_pred HhhcccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccc
Q 003368 639 LKATDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSI 712 (825)
Q Consensus 639 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 712 (825)
....++|...+.||+|+||.||+|++. .+++.||||+++.... ...+.|.+|++++++++||||++++++|.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--
Confidence 334678999999999999999999986 3458999999976543 34567999999999999999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCC------------cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQT------------DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEP 780 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ 780 (825)
..+..++||||+++|+|.+++........ .........+++.++..|+.|+++||+|||+. +
T Consensus 121 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 121 ---VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ---cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 35678999999999999999964311000 00001125799999999999999999999986 9
Q ss_pred eeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 781 TIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 781 ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
|+||||||+||+++.++.+||+|||+++....
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCccccc
Confidence 99999999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=236.60 Aligned_cols=153 Identities=19% Similarity=0.256 Sum_probs=134.0
Q ss_pred hcccccccceeccC--CeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIG--SFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G--~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
..++|+..+.||+| +||.||+|+...+|+.||||++.... ....+.+.+|++++++++|||||++++++. .
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~ 97 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A 97 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence 34679999999999 99999999998899999999997653 233567889999999999999999999854 4
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
++..++||||+++|+|.+++... ....+++..+..|+.|+++||+|||+. +|+||||||+|||++.+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~ 164 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTH----------FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD 164 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHT----------CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCEEEEEEEccCCCCHHHHHhhh----------cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 67889999999999999998532 123589999999999999999999986 89999999999999999
Q ss_pred CcEEEcccCcccccc
Q 003368 797 LTAHVGDFGLARLRQ 811 (825)
Q Consensus 797 ~~~ki~DFGla~~~~ 811 (825)
+.+||+|||.+....
T Consensus 165 ~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 165 GKVYLSGLRSNLSMI 179 (389)
T ss_dssp CCEEECCGGGCEECE
T ss_pred CCEEEcccccceeec
Confidence 999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=230.88 Aligned_cols=153 Identities=31% Similarity=0.488 Sum_probs=126.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHH--HhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECR--ALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~--~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|+. +++.||||++.... .+.+..|.+ .+..++||||+++++++......+...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46789999999999999999987 78999999997543 233444444 455689999999998765544555667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeee
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC------QEPTIHCDLKPSNILL 793 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~------~~~ivHrdlk~~NILl 793 (825)
.++||||+++|+|.+++... ..+|..+..|+.|+++||+|||+.+ .++|+||||||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred EEEEEecCCCCcHHHHHhhc-------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 89999999999999998432 3588999999999999999999852 2389999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+.++.+||+|||+|+.+..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~ 172 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTG 172 (336)
T ss_dssp CTTSCEEECCCTTCEECSS
T ss_pred cCCCcEEEeeccceeeccc
Confidence 9999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=229.02 Aligned_cols=151 Identities=25% Similarity=0.353 Sum_probs=133.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------hHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
+.|...+.||+|+||.||+|+...+|+.||||++...... ..+.+.+|++++++++||||+++++++. +
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----N 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence 5688899999999999999999889999999999764321 3567999999999999999999999853 4
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK 151 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC------------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence 66789999999999999998532 3578999999999999999999986 99999999999999988
Q ss_pred C----cEEEcccCcccccccC
Q 003368 797 L----TAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ~----~~ki~DFGla~~~~~~ 813 (825)
+ .+||+|||+++.....
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~ 172 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDG 172 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTT
T ss_pred CCCcCCEEEccCccceecCcc
Confidence 7 7999999999987554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=226.79 Aligned_cols=154 Identities=27% Similarity=0.476 Sum_probs=130.2
Q ss_pred ccccccceeccCCeeEEEEEE----EcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGT----FDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~----~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
..|+..+.||+|+||.||+|+ ...+|+.||||++..... ...+.+.+|++++++++||||+++++++.. .+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence 347888999999999999999 456889999999975432 345789999999999999999999998753 223
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~ 163 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK-----------NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 163 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH-----------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ceEEEEEEeCCCCcHHHHHHh-----------ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCC
Confidence 567999999999999999842 224589999999999999999999985 999999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 164 ~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 164 QVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEECCCTTCEECCTT
T ss_pred CEEECcccccccccCC
Confidence 9999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=232.64 Aligned_cols=151 Identities=27% Similarity=0.477 Sum_probs=125.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeE----EEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTI----VAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||.||+|++..+|+. ||+|.+.... ....++|.+|++++++++|||||+++++|..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------ 88 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence 5688999999999999999998777765 4777775432 2345789999999999999999999999753
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+++|+|.+++... ...+++..+..|+.|+++||+|||+. +|+||||||+|||++.++
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~ 154 (327)
T 3poz_A 89 STVQLITQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp SSEEEEEECCTTCBHHHHHHHS-----------TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred CCeEEEEEecCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCC
Confidence 3478999999999999998532 24689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 155 ~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 155 HVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCTTHHHHHTTT
T ss_pred CEEEccCcceeEccCC
Confidence 9999999999987554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-24 Score=240.10 Aligned_cols=150 Identities=29% Similarity=0.464 Sum_probs=130.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|...+.||+|+||.||+|++ .|+.||||+++... ..+.|.+|++++++++|||||+++++|.. .....
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCce
Confidence 456788899999999999999998 47899999997643 45789999999999999999999998743 33468
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ....+++..+..++.|+|+||+|||+. +|+||||||+|||+++++.+|
T Consensus 263 ~iv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp EEEEECCTTCBHHHHHHHH----------CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEecCCCcHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEE
Confidence 9999999999999999532 122478999999999999999999986 899999999999999999999
Q ss_pred EcccCcccccc
Q 003368 801 VGDFGLARLRQ 811 (825)
Q Consensus 801 i~DFGla~~~~ 811 (825)
|+|||+|+...
T Consensus 330 l~DfG~a~~~~ 340 (450)
T 1k9a_A 330 VSDFGLTKEAS 340 (450)
T ss_dssp ECCCTTCEECC
T ss_pred EeeCCCccccc
Confidence 99999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=234.09 Aligned_cols=164 Identities=26% Similarity=0.410 Sum_probs=131.2
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-----hHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-----ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
..++|...+.||+|+||.||+|+...+|+.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG----- 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence 346799999999999999999999889999999999754221 1346889999999999999999999853
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
..+..++||||+++ +|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDN-----------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 147 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTC-----------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eCCceEEEEEcCCC-CHHHHHHhc-----------CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcC
Confidence 45678999999986 888888532 23577888999999999999999986 8999999999999999
Q ss_pred CCcEEEcccCcccccccCCCCCccccccC
Q 003368 796 NLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.+||+|||+|+............+||+
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~ 176 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNRAYTHQVVTR 176 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCCCCCCSCCCC
T ss_pred CCCEEEEecccceeccCCcccCCcccccc
Confidence 99999999999998765444444455554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-24 Score=227.14 Aligned_cols=169 Identities=28% Similarity=0.428 Sum_probs=133.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-----hhHHHHHHHHHHhhcCC---CCCceeEeeccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-----GASKSFAAECRALRNIR---HRNLVRVITSCSSI 712 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 712 (825)
..++|+..+.||+|+||+||+|++..+|+.||||++..... .....+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35689999999999999999999988999999999975321 12346778888777765 99999999997643
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
........++||||+. |+|.+++... ....+++.++..|+.|+++||+|||+. +|+||||||+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil 152 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA----------PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENIL 152 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC----------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 2222235799999997 5999998543 113489999999999999999999996 8999999999999
Q ss_pred ecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.++.+||+|||+|+...... .....+||+
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~ 183 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM-ALTPVVVTL 183 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC-CSGGGGCCC
T ss_pred EcCCCCEEEeeCccccccCCCc-ccCCccccc
Confidence 9999999999999999765432 234445554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-24 Score=223.67 Aligned_cols=151 Identities=27% Similarity=0.460 Sum_probs=129.7
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|...+.||+|+||.||+|++ .++..||||++..... ..+++.+|++++++++||||++++++|. .....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence 456788999999999999999998 5788999999976533 3467999999999999999999999853 45678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 95 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM-----------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG-----------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEE
T ss_pred EEEEeccCCCcHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEE
Confidence 9999999999999998531 24689999999999999999999985 999999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+++....
T Consensus 161 l~Dfg~~~~~~~ 172 (283)
T 3gen_A 161 VSDFGLSRYVLD 172 (283)
T ss_dssp ECSTTGGGGBCC
T ss_pred Eccccccccccc
Confidence 999999987643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=225.72 Aligned_cols=160 Identities=27% Similarity=0.436 Sum_probs=137.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence 45888999999999999999998899999999997653 3345789999999999999999999998643 56789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 97 lv~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp EEEECCTTEEHHHHHTT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEeCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEE
Confidence 99999999999999842 2588999999999999999999986 9999999999999999999999
Q ss_pred cccCcccccccCCCCCcccccc
Q 003368 802 GDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt 823 (825)
+|||+++.............||
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~ 182 (303)
T 3a7i_A 161 ADFGVAGQLTDTQIKRNTFVGT 182 (303)
T ss_dssp CCCTTCEECBTTBCCBCCCCSC
T ss_pred eecccceecCccccccCccCCC
Confidence 9999998876543333334444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=231.43 Aligned_cols=150 Identities=31% Similarity=0.415 Sum_probs=130.6
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+.|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++|||||+++++|.. ++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence 458888999999999999999988999999999975432 234678999999999999999999998643 567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||++ |++.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 129 ~~lv~e~~~-g~l~~~l~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 193 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEV-----------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193 (348)
T ss_dssp EEEEEECCS-EEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEE
T ss_pred EEEEEecCC-CCHHHHHHH-----------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCE
Confidence 899999997 688887731 224689999999999999999999996 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 194 kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 194 KLGDFGSASIMAP 206 (348)
T ss_dssp EECCCTTCBSSSS
T ss_pred EEeeccCceecCC
Confidence 9999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.5e-24 Score=226.70 Aligned_cols=150 Identities=33% Similarity=0.483 Sum_probs=124.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||+||+|++ .++.||||++... ...+.|.+|++++++++||||++++++|. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence 5688899999999999999998 4789999998643 34578999999999999999999999863 23689
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-EEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT-AHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~-~ki 801 (825)
||||+++|+|.+++... .....+++..+..++.|+++||+|||+....+|+||||||+||+++.++. +||
T Consensus 77 v~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA---------EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp EEECCTTCBHHHHHHCS---------SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred EEEcCCCCCHHHHHhcc---------CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 99999999999999643 12235788999999999999999999854458999999999999998886 799
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+|+....
T Consensus 148 ~Dfg~~~~~~~ 158 (307)
T 2eva_A 148 CDFGTACDIQT 158 (307)
T ss_dssp CCCCC------
T ss_pred ccccccccccc
Confidence 99999986543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=232.01 Aligned_cols=163 Identities=25% Similarity=0.437 Sum_probs=127.1
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
...++|...+.||+|+||+||+|+...+|+.||||+++.... ...+.+.+|++++++++|||||++++++. .+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 345789999999999999999999989999999999975532 22456789999999999999999999854 46
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---- 793 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---- 793 (825)
+..++||||++ |+|.+++... ..+++.++..|+.|++.||+|||+. +|+||||||+|||+
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~~------------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~ 169 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDKN------------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSD 169 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC--
T ss_pred CEEEEEEecCC-CCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCC
Confidence 78899999998 5999988432 3588999999999999999999986 99999999999999
Q ss_pred -cCCCcEEEcccCcccccccCCCCCcccccc
Q 003368 794 -DNNLTAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 794 -~~~~~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
+.++.+||+|||+|+............+||
T Consensus 170 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t 200 (329)
T 3gbz_A 170 ASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200 (329)
T ss_dssp ---CCEEEECCTTHHHHHC-----------C
T ss_pred CCccceEEECcCCCccccCCcccccCCCcCC
Confidence 455569999999998765443333333444
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=232.52 Aligned_cols=165 Identities=24% Similarity=0.296 Sum_probs=133.0
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-----chhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
...++|...+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++|||||+++++|.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~---- 98 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE---- 98 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc----
Confidence 34567899999999999999999999999999999987542 234578999999999999999999999853
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCc----------------------------ccchhcccCCHHHHHHHHHHH
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTD----------------------------EENDEIRNLTLLERISIAIDV 766 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------~~~~~~~~l~~~~~~~i~~~v 766 (825)
+.+..++||||+++|+|.+++......... ........+++..+..|+.|+
T Consensus 99 -~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 99 -DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp -CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred -cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 467889999999999999998521000000 000012234677788999999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCCeeecCCC--cEEEcccCccccccc
Q 003368 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNL--TAHVGDFGLARLRQE 812 (825)
Q Consensus 767 a~~l~yLH~~~~~~ivHrdlk~~NILl~~~~--~~ki~DFGla~~~~~ 812 (825)
++||+|||+. +|+||||||+||+++.++ .+||+|||+|+....
T Consensus 178 ~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 178 FSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 9999999986 899999999999998766 899999999997654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=224.26 Aligned_cols=152 Identities=28% Similarity=0.476 Sum_probs=128.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh-------HHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-------SKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
.++|...+.||+|+||.||+|++..+++.||||++....... .+.+.+|++++++++||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 94 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--- 94 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence 357888999999999999999998899999999986543211 1678999999999999999999998532
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
. .++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. .++|+||||||+||+++
T Consensus 95 --~--~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 95 --P--PRMVMEFVPCGDLYHRLLDK-----------AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp --T--TEEEEECCTTCBHHHHHHCT-----------TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEES
T ss_pred --C--CeEEEEecCCCCHHHHHhcc-----------cCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEe
Confidence 2 37999999999999888532 24689999999999999999999986 12399999999999998
Q ss_pred CCCc-----EEEcccCccccccc
Q 003368 795 NNLT-----AHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~~~-----~ki~DFGla~~~~~ 812 (825)
.++. +||+|||+|+....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~ 181 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH 181 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS
T ss_pred ccCCCCceeEEeCCCCccccccc
Confidence 8776 99999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=227.66 Aligned_cols=161 Identities=26% Similarity=0.414 Sum_probs=132.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 467889999999999999999998899999999997543 2345679999999999999999999998643 23457
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC--QEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~--~~~ivHrdlk~~NILl~~~~ 797 (825)
.++||||+++|+|.+++... ......+++..+..++.|+++||+|||+.. ..+|+||||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKG--------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS
T ss_pred EEEEEeCCCCCCHHHHHHhh--------cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC
Confidence 89999999999999998521 112235899999999999999999999862 11299999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+++.....
T Consensus 154 ~~kl~dfg~~~~~~~~ 169 (279)
T 2w5a_A 154 NVKLGDFGLARILNHD 169 (279)
T ss_dssp CEEECCCCHHHHC---
T ss_pred CEEEecCchheeeccc
Confidence 9999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=233.10 Aligned_cols=161 Identities=23% Similarity=0.406 Sum_probs=127.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||+|+||.||+|+...+|+.||||++...... ....+.+|++++++++||||+++++++. .++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 5688899999999999999999889999999999754322 1224568999999999999999999853 456789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||++ |+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl 141 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-----------GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKL 141 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEE
T ss_pred EEecccc-cCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEE
Confidence 9999997 5898888422 23588999999999999999999986 9999999999999999999999
Q ss_pred cccCcccccccCCCCCcccccc
Q 003368 802 GDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt 823 (825)
+|||+|+............+||
T Consensus 142 ~Dfg~a~~~~~~~~~~~~~~~t 163 (324)
T 3mtl_A 142 ADFGLARAKSIPTKTYDNEVVT 163 (324)
T ss_dssp CSSSEEECC------------C
T ss_pred ccCcccccccCCccccccccCc
Confidence 9999998765443333333444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=230.80 Aligned_cols=164 Identities=27% Similarity=0.422 Sum_probs=138.0
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcC-CCCCceeEeeccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNI-RHRNLVRVITSCS 710 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 710 (825)
...++|...+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 334678999999999999999999988999999999875431 1245688999999999 7999999999853
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
.....++||||+++|+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|
T Consensus 171 -----~~~~~~lv~e~~~g~~L~~~l~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~N 230 (365)
T 2y7j_A 171 -----SSSFMFLVFDLMRKGELFDYLT------------EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPEN 230 (365)
T ss_dssp -----BSSEEEEEECCCTTCBHHHHHH------------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred -----eCCEEEEEEEeCCCCcHHHHHH------------hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 3678899999999999999984 224689999999999999999999986 99999999999
Q ss_pred eeecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 791 ILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+++.++.+||+|||+++...... .....+||+
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~~-~~~~~~gt~ 263 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTP 263 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTTC-CBCCCCSCG
T ss_pred EEECCCCCEEEEecCcccccCCCc-ccccCCCCC
Confidence 999999999999999998775532 223345553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=231.17 Aligned_cols=151 Identities=27% Similarity=0.446 Sum_probs=128.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeE----EEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTI----VAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|...+.||+|+||+||+|++..+|+. ||+|.+.... ....+.+.+|+.++++++||||++++++|. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 4688899999999999999999877765 7777765432 223356788999999999999999999863 3
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~ 152 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQH-----------RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPS 152 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSS-----------GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSS
T ss_pred CccEEEEEeCCCCCHHHHHHHc-----------cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCC
Confidence 4578999999999999998532 24688889999999999999999986 899999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 153 ~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 153 QVQVADFGVADLLPPD 168 (325)
T ss_dssp CEEECSCSGGGGSCCC
T ss_pred eEEECCCCcccccCcc
Confidence 9999999999987554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.8e-24 Score=226.41 Aligned_cols=165 Identities=26% Similarity=0.409 Sum_probs=134.0
Q ss_pred hcccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
..++|...+.||+|+||.||+|+. +.+++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 346788899999999999999987 34568999999976432 34567899999999999999999999853
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCC------------cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQT------------DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTI 782 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~iv 782 (825)
..+..++||||+++|+|.+++........ .........+++.++..++.|+++||+|||+. +|+
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 97 -QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred -cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 35678999999999999999964321000 00001124589999999999999999999986 899
Q ss_pred ecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 783 HCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 783 Hrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
||||||+||++++++.+||+|||+++.....
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 203 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEE 203 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred ccccchheEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=235.81 Aligned_cols=150 Identities=26% Similarity=0.426 Sum_probs=122.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++ |||||++++++.. .+..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCC
Confidence 467999999999999999999999999999999986542 234567889999999998 9999999998643 2334
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+|||||+ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-------------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred EEEEEecccC-cCHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCC
Confidence 6899999998 589888742 3588899999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccc
Q 003368 799 AHVGDFGLARLRQ 811 (825)
Q Consensus 799 ~ki~DFGla~~~~ 811 (825)
+||+|||+|+...
T Consensus 148 ~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 148 VKVADFGLSRSFV 160 (388)
T ss_dssp EEECCCTTCEESS
T ss_pred EEecCCccccccc
Confidence 9999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.90 Aligned_cols=150 Identities=23% Similarity=0.382 Sum_probs=133.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++. .++..+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence 56889999999999999999998899999999997543 234578899999999999999999999854 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 82 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence 999999999999998532 3588999999999999999999985 9999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 147 ~dfg~~~~~~~ 157 (276)
T 2yex_A 147 SDFGLATVFRY 157 (276)
T ss_dssp CCCTTCEECEE
T ss_pred eeCCCccccCC
Confidence 99999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=232.85 Aligned_cols=163 Identities=23% Similarity=0.360 Sum_probs=137.8
Q ss_pred cccccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-----CCCcee
Q 003368 630 LRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-----HRNLVR 704 (825)
Q Consensus 630 ~~~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 704 (825)
...+++.+.....++|...+.||+|+||+||+|++..+++.||||+++.. ....+.+..|++++++++ |||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455555555678899999999999999999999889999999999743 334567788999999986 999999
Q ss_pred EeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 003368 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHC 784 (825)
Q Consensus 705 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHr 784 (825)
+++++. ..+..++||||+ +|+|.+++... ....+++.++..++.|++.||+|||+. +|+||
T Consensus 101 ~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHr 161 (360)
T 3llt_A 101 YHGKFM-----YYDHMCLIFEPL-GPSLYEIITRN----------NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHT 161 (360)
T ss_dssp EEEEEE-----ETTEEEEEECCC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred ccceee-----ECCeeEEEEcCC-CCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeC
Confidence 999864 356789999999 99999998532 123588999999999999999999985 99999
Q ss_pred CCCCCCeeecC-------------------------CCcEEEcccCccccccc
Q 003368 785 DLKPSNILLDN-------------------------NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 785 dlk~~NILl~~-------------------------~~~~ki~DFGla~~~~~ 812 (825)
||||+|||++. ++.+||+|||+|+....
T Consensus 162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 99999999975 78999999999997544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=221.72 Aligned_cols=155 Identities=29% Similarity=0.435 Sum_probs=131.9
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.|...+.||+|+||.||+|+...++..||+|.+.... ....+.+.+|++++++++||||+++++++... ..+....+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence 3677789999999999999999999999999997543 33456789999999999999999999986532 23456789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCcEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~-~~~~~k 800 (825)
+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.. ++|+||||||+||+++ +++.+|
T Consensus 106 lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEecCCCCHHHHHHH------------ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEE
Confidence 99999999999999842 246889999999999999999999861 2399999999999998 789999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 173 l~Dfg~~~~~~~ 184 (290)
T 1t4h_A 173 IGDLGLATLKRA 184 (290)
T ss_dssp ECCTTGGGGCCT
T ss_pred EeeCCCcccccc
Confidence 999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=227.06 Aligned_cols=149 Identities=28% Similarity=0.359 Sum_probs=128.6
Q ss_pred ccccc-cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCee
Q 003368 643 DGFSS-THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~-~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+.|.. .+.||+|+||.||+|+...+|+.||||++........+.+.+|++++.++ +||||+++++++. +++..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence 34665 47899999999999999889999999999876555667899999999985 7999999999854 36788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT-- 798 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~-- 798 (825)
++||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 151 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHK------------RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVS 151 (316)
T ss_dssp EEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSC
T ss_pred EEEEEcCCCCcHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcC
Confidence 999999999999999842 24689999999999999999999996 9999999999999998765
Q ss_pred -EEEcccCcccccc
Q 003368 799 -AHVGDFGLARLRQ 811 (825)
Q Consensus 799 -~ki~DFGla~~~~ 811 (825)
+||+|||+++...
T Consensus 152 ~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 152 PVKICDFDLGSGIK 165 (316)
T ss_dssp SEEECCTTCCC---
T ss_pred ceEEEEccCccccc
Confidence 9999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-24 Score=235.41 Aligned_cols=162 Identities=22% Similarity=0.319 Sum_probs=125.9
Q ss_pred cccccc-ceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhh-cCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSST-HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALR-NIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~-~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|... ++||+|+||+||+|++..+|+.||||+++.. ..+.+|++++. ..+||||+++++++... +.+....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence 456555 7899999999999999999999999998632 45678888874 45899999999986431 2335678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~~ 797 (825)
|+||||+++|+|.+++... ....+++.++..|+.|+++||+|||+. +|+||||||+|||++. ++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTC
T ss_pred EEEEEeCCCCcHHHHHHHh----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCc
Confidence 9999999999999999642 123589999999999999999999985 9999999999999997 78
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+...... ...+.+||+
T Consensus 202 ~~kl~DFG~a~~~~~~~-~~~~~~gt~ 227 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHN-SLTTPCYTP 227 (400)
T ss_dssp CEEECCCTTCEECC------------C
T ss_pred cEEEEecccccccCCCC-ccccCCCCC
Confidence 99999999999765432 223445554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-24 Score=233.13 Aligned_cols=157 Identities=23% Similarity=0.311 Sum_probs=135.5
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
...++|...+.||+|+||.||+|+...+++.||||++..... ...+.+.+|++++++++||||+++++++.........
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 345679999999999999999999988999999999975432 3346789999999999999999999987654444445
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+. |+|.+++.. ..+++.++..|+.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred eEEEEEcccC-cCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCC
Confidence 7899999997 589888742 3589999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 167 ~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 167 LKICDFGLARVADPD 181 (364)
T ss_dssp EEECCCTTCEECCGG
T ss_pred EEEEeCcceEecCCC
Confidence 999999999977543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-24 Score=224.98 Aligned_cols=156 Identities=26% Similarity=0.408 Sum_probs=133.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccc--------
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSID-------- 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 713 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++... ....+.+.+|++++++++||||++++++|....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688999999999999999999889999999999653 334577899999999999999999999864311
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.......++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~ 149 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE-----------NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFI 149 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS-----------CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc-----------ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEE
Confidence 12345689999999999999999522 23578889999999999999999986 89999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+.++.+||+|||+++....
T Consensus 150 ~~~~~~kl~dfg~~~~~~~ 168 (303)
T 1zy4_A 150 DESRNVKIGDFGLAKNVHR 168 (303)
T ss_dssp CTTSCEEECCCCCCSCTTC
T ss_pred cCCCCEEEeeCcchhhccc
Confidence 9999999999999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=229.76 Aligned_cols=150 Identities=22% Similarity=0.379 Sum_probs=130.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.+.|+..+.||+|+||.||+|++..+|+.||+|++........+.+.+|++++++++||||+++++++. ..+..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeEE
Confidence 456888999999999999999998889999999998765556788999999999999999999999864 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 93 lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 158 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLE-----------LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRL 158 (302)
T ss_dssp EEEECCTTEEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred EEEEeCCCCcHHHHHHh-----------hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999999999998742 224689999999999999999999986 8999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||+++..
T Consensus 159 ~Dfg~~~~~ 167 (302)
T 2j7t_A 159 ADFGVSAKN 167 (302)
T ss_dssp CCCHHHHHH
T ss_pred EECCCCccc
Confidence 999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=240.06 Aligned_cols=162 Identities=22% Similarity=0.364 Sum_probs=135.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-------------hhHHHHHHHHHHhhcCCCCCceeEeec
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-------------GASKSFAAECRALRNIRHRNLVRVITS 708 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 708 (825)
.+.|...+.||+|+||+||+|+...+++.||||++..... ...+.+.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4678999999999999999999998999999999975431 234678999999999999999999998
Q ss_pred ccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 709 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
| .+....++||||+++|+|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||
T Consensus 115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp 174 (504)
T 3q5i_A 115 F-----EDKKYFYLVTEFYEGGELFEQIIN------------RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKP 174 (504)
T ss_dssp E-----ECSSEEEEEEECCTTCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred E-----EcCCEEEEEEecCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcH
Confidence 5 346788999999999999998842 24689999999999999999999986 999999999
Q ss_pred CCeeecCCC---cEEEcccCcccccccCCCCCccccccC
Q 003368 789 SNILLDNNL---TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 789 ~NILl~~~~---~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||++.++ .+||+|||+|+...... .....+||+
T Consensus 175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~ 212 (504)
T 3q5i_A 175 ENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTA 212 (504)
T ss_dssp GGEEESSTTCCSSEEECCCTTCEECCTTS-CBCCCCSCT
T ss_pred HHEEEecCCCCccEEEEECCCCEEcCCCC-ccccccCCc
Confidence 999998775 69999999999875542 234445664
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=232.03 Aligned_cols=165 Identities=24% Similarity=0.451 Sum_probs=121.0
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCe---EEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGT---IVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~---~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
...++|...+.||+|+||.||+|++..++. .||||+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345679999999999999999999866664 89999997652 3446789999999999999999999998654211
Q ss_pred CCC-CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 715 QGN-DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 715 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.+. ...++||||+++|+|.+++..... ......+++.++..|+.|+++||+|||+. +|+||||||+||++
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRI------GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhc------cccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 110 123899999999999999853210 11123589999999999999999999986 89999999999999
Q ss_pred cCCCcEEEcccCcccccccC
Q 003368 794 DNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~ 813 (825)
++++.+||+|||+|+.....
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSG 190 (323)
T ss_dssp CTTSCEEECCCCC-------
T ss_pred cCCCCEEEeecccccccccc
Confidence 99999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=240.71 Aligned_cols=161 Identities=22% Similarity=0.344 Sum_probs=132.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
+.|...+.||+|+||+||+|+...+++.||||++.... ....+.+.+|+++++.++|||||+++++|. .....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence 45888999999999999999998899999999997653 233567899999999999999999999853 46778
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~~ 797 (825)
++||||+++|+|.+++.. ...+++.++..|+.|+++||+|||+. +|+||||||+|||++. ++
T Consensus 112 ~lv~e~~~~g~L~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIH------------RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp EEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred EEEEecCCCCcHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCC
Confidence 999999999999988842 24689999999999999999999986 9999999999999976 45
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+...... .....+||+
T Consensus 177 ~~kl~DfG~a~~~~~~~-~~~~~~gt~ 202 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQK-KMKERLGTA 202 (494)
T ss_dssp CEEECCCTTCEECBTTB-CBCCCCSCT
T ss_pred cEEEEECCCCeECCCCc-cccccCCCc
Confidence 59999999999876532 234445664
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-24 Score=232.68 Aligned_cols=154 Identities=25% Similarity=0.365 Sum_probs=125.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.+.|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999998999999999996542 233567899999999999999999999865321 11123
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 166 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCE 166 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred eEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCC
Confidence 469999999 8899988842 3588999999999999999999986 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 167 ~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 167 LKILDFGLARQADS 180 (367)
T ss_dssp EEECCCTTCEECCS
T ss_pred EEEEeeeccccccc
Confidence 99999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-24 Score=228.04 Aligned_cols=157 Identities=22% Similarity=0.245 Sum_probs=134.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|+...+|+.||||++........+.+.+|++++++++||||+++++++... .......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence 45789999999999999999999889999999999776556677899999999999999999999987531 12244689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 107 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERL--------KDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEECCTTCBHHHHHHHH--------HTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEeCCCCcHHHHHHHH--------HhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEE
Confidence 999999999999998531 11235689999999999999999999986 9999999999999999999999
Q ss_pred cccCccccc
Q 003368 802 GDFGLARLR 810 (825)
Q Consensus 802 ~DFGla~~~ 810 (825)
+|||+++..
T Consensus 176 ~dfg~~~~~ 184 (317)
T 2buj_A 176 MDLGSMNQA 184 (317)
T ss_dssp CCCSSCEES
T ss_pred EecCcchhc
Confidence 999998765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.7e-24 Score=226.10 Aligned_cols=166 Identities=23% Similarity=0.355 Sum_probs=126.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 457899999999999999999998899999999997532 2345678999999999999999999998643 56
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ......+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~ 174 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHF--------KKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGV 174 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred cEEEEEecCCCCCHHHHHHHh--------cccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCC
Confidence 789999999999999998421 11234689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCcccccc
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
+||+|||+++.............||
T Consensus 175 ~kl~Dfg~~~~~~~~~~~~~~~~~~ 199 (310)
T 2wqm_A 175 VKLGDLGLGRFFSSKTTAAHSLVGT 199 (310)
T ss_dssp EEECCC------------------C
T ss_pred EEEEeccceeeecCCCccccccCCC
Confidence 9999999998765543333333444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.6e-24 Score=222.96 Aligned_cols=156 Identities=26% Similarity=0.397 Sum_probs=133.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+++.||||++.... .....++.+|+..+.++ +||||+++++++. .++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCC
Confidence 456889999999999999999998899999999997643 33456788999999999 8999999999864 366
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN--- 795 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~--- 795 (825)
..++||||+++|+|.+++... ......+++.++..|+.|+++||+|||+. +|+||||||+||+++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISEN--------YRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--------HHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----
T ss_pred eEEEEEEecCCCcHHHHHHhh--------cccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCC
Confidence 889999999999999998521 11224689999999999999999999986 9999999999999984
Q ss_pred ----------------CCcEEEcccCcccccccC
Q 003368 796 ----------------NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ----------------~~~~ki~DFGla~~~~~~ 813 (825)
...+||+|||+++.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCS
T ss_pred CcccccccccccccCCceEEEEcccccccccCCc
Confidence 447999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-24 Score=229.57 Aligned_cols=162 Identities=26% Similarity=0.382 Sum_probs=131.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||++++++|. +.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence 4578899999999999999999988999999999865433 23456889999999999999999999864 3667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++++|.++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~ 163 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFP------------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVV 163 (331)
T ss_dssp EEEEEECCSEEHHHHHHHST------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEecCCcchHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcE
Confidence 89999999999998876322 3589999999999999999999986 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCcccccc
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
||+|||+++.............||
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~t 187 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGEVYDDEVAT 187 (331)
T ss_dssp EECCCTTC------------CCCC
T ss_pred EEEeCCCceeecCCccccCCCcCC
Confidence 999999998765543333333444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-25 Score=245.44 Aligned_cols=258 Identities=16% Similarity=0.173 Sum_probs=164.3
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCC----ccccCCC-CCCEEECCCCcCCCCCCcCCCCC-----CC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIP----GEIGRLF-RLEALYLSHNSLVGEIPGNLSYC-----SR 105 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 105 (825)
.++++.|++.+.+|..+...++|++|||++|.|++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788888888888887777789999999999887666 7788888 89999999998888777777665 88
Q ss_pred CCEEEcCCCCCCCCCChhhhcc-----cccceeeccccccccccCccC----CCC-CCCCEEEcccCcCcccCCcc----
Q 003368 106 LIGLYLGRNKLEGSIPSEFVSL-----YNLKELAIQENNLTGGIPHFL----GNI-TSLEAISLAYNSLGGNIPSS---- 171 (825)
Q Consensus 106 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~----~~l-~~L~~L~Ls~N~l~~~~p~~---- 171 (825)
|++|+|++|+|++..+..+... ++|++|+|++|++++..+..+ ..+ ++|++|+|++|+++...+..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 8999999998887777655544 788888888888886665543 332 58888888888887533322
Q ss_pred ccccc-ccceecCcCcCCccccCCCCCceeecCCccccccCCchhh---hcC-CCCcEEEcccccCCCC----CCccccC
Q 003368 172 LGQLK-ELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLG---LTL-SNLQLFQISNNFFSGS----FPLAFSN 242 (825)
Q Consensus 172 ~~~l~-~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~---~~l-~~L~~L~Ls~N~l~~~----~p~~~~~ 242 (825)
+..++ +|++| ++++|++++..+..+. ... ++|++|+|++|.+++. ++..+..
T Consensus 162 l~~~~~~L~~L-------------------~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 162 LAAIPANVNSL-------------------NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp HHTSCTTCCEE-------------------ECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred HhcCCccccEe-------------------eecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 22332 44444 6666666644433322 123 4677777777766643 2233333
Q ss_pred -CCCccEEEeecccccCccc----cCcCCCCCCcEEEcccccCCCCCCC-ccccccccccCCCCCEEEcccccccc
Q 003368 243 -ASNLQSLEILGNNFFGKLS----VNFGDMKSLAYLNVAINNLGSGESD-EMSFIHSLANCSNLSFLNLVANQFKG 312 (825)
Q Consensus 243 -l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~~~~l~~L~~L~L~~N~l~~ 312 (825)
.++|++|+|++|++.+... ..+..+++|+.|++++|.+...... ...++..+..+++|+.||+++|.+.+
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 3466666666666654432 2334455555555555554332211 11122334445555555555555543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=234.34 Aligned_cols=163 Identities=24% Similarity=0.297 Sum_probs=135.3
Q ss_pred cccccccceeccCCeeEEEEEEEc---CCCeEEEEEEeeccc----chhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD---RDGTIVAIKVLNLQL----QGASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~---~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
.++|...+.||+|+||.||+|+.. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 467999999999999999999984 488999999987532 22345677899999999 6999999999853
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.++..++||||+++|+|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+|||+
T Consensus 130 --~~~~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 192 (355)
T 1vzo_A 130 --TETKLHLILDYINGGELFTHLSQ------------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILL 192 (355)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred --eCceEEEEeecCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence 35678999999999999999842 24689999999999999999999985 89999999999999
Q ss_pred cCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 794 DNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
+.++.+||+|||+|+....... .....+||+
T Consensus 193 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~ 224 (355)
T 1vzo_A 193 DSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224 (355)
T ss_dssp CTTSCEEESCSSEEEECCGGGGGGGCGGGSCC
T ss_pred CCCCcEEEeeCCCCeecccCCCCcccCcccCc
Confidence 9999999999999987643322 223345654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=226.56 Aligned_cols=155 Identities=27% Similarity=0.479 Sum_probs=136.3
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
...++|...+.||+|+||.||+|++..+++.||||++.... ...+.+.+|++++++++||||++++++|. .+..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence 35577899999999999999999998889999999997543 34578999999999999999999999853 4567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 150 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC----------CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEEcCCCCcHHHHHHhc----------ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCE
Confidence 89999999999999998532 124589999999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 151 ~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 151 KVADFGLSRLMTGD 164 (288)
T ss_dssp EECCCCGGGTSCSS
T ss_pred EEccCccceeccCC
Confidence 99999999987544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=231.09 Aligned_cols=164 Identities=24% Similarity=0.421 Sum_probs=134.3
Q ss_pred cccccccceeccCCeeEEEEEEEcC-------CCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|++.. .+..||||++..... ...+.+.+|+++++++ +|||||+++++|.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence 4578889999999999999999743 346899999976543 3346799999999999 8999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
.++..++||||+++|+|.+++......... ........+++.++..|+.|+++||+|||+. +|+||||||
T Consensus 146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 356789999999999999999643211000 0011234699999999999999999999985 999999999
Q ss_pred CCeeecCCCcEEEcccCcccccccC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+|||+++++.+||+|||+|+.....
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCC
T ss_pred ceEEEcCCCcEEEcccCcccccccc
Confidence 9999999999999999999977543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=222.07 Aligned_cols=153 Identities=24% Similarity=0.372 Sum_probs=134.0
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---------chhHHHHHHHHHHhhcCC-CCCceeEeeccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---------QGASKSFAAECRALRNIR-HRNLVRVITSCS 710 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 710 (825)
-.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++ ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 3467999999999999999999998899999999997543 122457889999999996 99999999985
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSN 790 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~N 790 (825)
......++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~N 154 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE------------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPEN 154 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcce
Confidence 346788999999999999999842 24689999999999999999999986 89999999999
Q ss_pred eeecCCCcEEEcccCcccccccC
Q 003368 791 ILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 791 ILl~~~~~~ki~DFGla~~~~~~ 813 (825)
|+++.++.+||+|||+++.....
T Consensus 155 il~~~~~~~kl~dfg~~~~~~~~ 177 (298)
T 1phk_A 155 ILLDDDMNIKLTDFGFSCQLDPG 177 (298)
T ss_dssp EEECTTCCEEECCCTTCEECCTT
T ss_pred EEEcCCCcEEEecccchhhcCCC
Confidence 99999999999999999876543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=220.93 Aligned_cols=151 Identities=26% Similarity=0.349 Sum_probs=131.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 458889999999999999999988999999999875432 13578999999999999999999999854 3
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
....++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 144 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE------------KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDK 144 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCS
T ss_pred CCeEEEEEeecCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecC
Confidence 5678999999999999999842 24689999999999999999999985 99999999999999887
Q ss_pred C----cEEEcccCcccccccC
Q 003368 797 L----TAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ~----~~ki~DFGla~~~~~~ 813 (825)
+ .+||+|||+++.....
T Consensus 145 ~~~~~~~kl~dfg~~~~~~~~ 165 (283)
T 3bhy_A 145 NVPNPRIKLIDFGIAHKIEAG 165 (283)
T ss_dssp SSSSCCEEECCCTTCEECC--
T ss_pred CCCCCceEEEecccceeccCC
Confidence 7 8999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=229.75 Aligned_cols=178 Identities=24% Similarity=0.377 Sum_probs=137.7
Q ss_pred cccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeeccc
Q 003368 632 KVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCS 710 (825)
Q Consensus 632 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 710 (825)
.+++.++....+.|...+.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444555566788999999999999999999998899999999997543 3356789999999999 7999999999875
Q ss_pred ccccC-CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 711 SIDFQ-GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 711 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
..... ..+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~ 158 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT----------KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 158 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGG
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHH
Confidence 42111 145789999999999999998532 224688999999999999999999986 8999999999
Q ss_pred CeeecCCCcEEEcccCcccccccCCCCCcccccc
Q 003368 790 NILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~gt 823 (825)
||+++.++.+||+|||+++.............||
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 192 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192 (326)
T ss_dssp GEEECTTCCEEECCCTTTC-------------CC
T ss_pred HEEEcCCCCEEEeeCcCceecCcCccccccccCC
Confidence 9999999999999999998765443233333444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=228.26 Aligned_cols=165 Identities=24% Similarity=0.456 Sum_probs=126.9
Q ss_pred hhcccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
...++|...+.||+|+||.||+|++.. +++.||||+++... ....+.+.+|++++++++||||++++++|.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345678899999999999999998754 45689999997543 2334679999999999999999999999765322
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.+....++||||+++|+|.+++..... ......+++.++..|+.|+++||+|||+. +|+||||||+||+++
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~ 181 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRL------ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR 181 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTB------TTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEEC
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhh------hcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEc
Confidence 222356999999999999999853211 11234689999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+++.....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~ 200 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSG 200 (313)
T ss_dssp TTSCEEECSCSCC------
T ss_pred CCCcEEEeecCcceecccc
Confidence 9999999999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=221.32 Aligned_cols=151 Identities=25% Similarity=0.409 Sum_probs=132.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++. +.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence 357899999999999999999998899999999996542 223467899999999999999999999853 466
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++.. ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 152 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK------------HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGE 152 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCC
T ss_pred EEEEEEEeCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCC
Confidence 78999999999999999842 24688999999999999999999985 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 153 ~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 153 LKIADFGWSVHAPS 166 (284)
T ss_dssp EEECCCTTCEECSS
T ss_pred EEEecccccccCcc
Confidence 99999999986644
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=220.48 Aligned_cols=152 Identities=24% Similarity=0.388 Sum_probs=132.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|....+|+.||||++..... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 4678999999999999999999988999999999976532 33467889999999999999999999853 4667
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT- 798 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~- 798 (825)
.++||||+++|+|.+++.. ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.
T Consensus 80 ~~~v~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 144 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA------------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 144 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTT
T ss_pred EEEEEecCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCC
Confidence 8999999999999988742 24689999999999999999999986 8999999999999986655
Q ss_pred --EEEcccCcccccccC
Q 003368 799 --AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 --~ki~DFGla~~~~~~ 813 (825)
+||+|||+++.....
T Consensus 145 ~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 145 AAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCEEECCCTTCEECCSS
T ss_pred CcEEEeeceeeEEcccC
Confidence 999999999876544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=232.13 Aligned_cols=152 Identities=22% Similarity=0.356 Sum_probs=133.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence 3568999999999999999999988999999999986533 34567999999999999999999999864 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+|
T Consensus 107 ~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~k 172 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172 (360)
T ss_dssp EEEECCCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEECCCCCCHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEE
Confidence 999999999999999842 24688999999999999999999973 2799999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 173 l~Dfg~~~~~~~ 184 (360)
T 3eqc_A 173 LCDFGVSGQLID 184 (360)
T ss_dssp ECCCCCCHHHHH
T ss_pred EEECCCCccccc
Confidence 999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=233.50 Aligned_cols=158 Identities=21% Similarity=0.296 Sum_probs=127.5
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc-----
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF----- 714 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 714 (825)
...++|...+.||+|+||+||+|+...+|+.||||++..... ...+|+++++.++|||||++++++....-
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 345789999999999999999999999999999999865432 23479999999999999999998743211
Q ss_pred ----------------------------CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHH
Q 003368 715 ----------------------------QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766 (825)
Q Consensus 715 ----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~v 766 (825)
.+..+.++||||++ |+|.+.+... ......+++..+..++.|+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~l~~~~~~~i~~qi 150 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF--------IRSGRSIPMNLISIYIYQL 150 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHH--------HHTTCCCCHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH--------HhcCCCCCHHHHHHHHHHH
Confidence 23445889999998 5887777421 1223568999999999999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCCeeec-CCCcEEEcccCcccccccC
Q 003368 767 ASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 767 a~~l~yLH~~~~~~ivHrdlk~~NILl~-~~~~~ki~DFGla~~~~~~ 813 (825)
++||+|||+. +|+||||||+||+++ .++.+||+|||+|+.....
T Consensus 151 ~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 195 (383)
T 3eb0_A 151 FRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195 (383)
T ss_dssp HHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred HHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence 9999999985 999999999999998 6889999999999976543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=215.37 Aligned_cols=198 Identities=16% Similarity=0.116 Sum_probs=171.6
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCc-ccccCCccccCCCCCCEEECCC-CcCCCCCCcCCCCCCCCCEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNT-IQGKIPGEIGRLFRLEALYLSH-NSLVGEIPGNLSYCSRLIGL 109 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 109 (825)
..++.|++++|++.+..+..|..+++|++|++++|+ ++++.+.+|.++++|++|+|++ |+|++..+..|..+++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 579999999999998888899999999999999997 9988888999999999999999 99998888999999999999
Q ss_pred EcCCCCCCCCCChhhhcccccc---eeecccc-ccccccCccCCCCCCCC-EEEcccCcCcccCCcccccccccceecCc
Q 003368 110 YLGRNKLEGSIPSEFVSLYNLK---ELAIQEN-NLTGGIPHFLGNITSLE-AISLAYNSLGGNIPSSLGQLKELKSLGLG 184 (825)
Q Consensus 110 ~Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 184 (825)
++++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++...+..|.. ++|+.|
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L--- 184 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV--- 184 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE---
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE---
Confidence 999999996 665 88999998 9999999 99988888899999999 9999999998444444444 677776
Q ss_pred CcCCccccCCCCCceeecCCcc-ccccCCchhhhcC-CCCcEEEcccccCCCCCCccccCCCCccEEEeeccc
Q 003368 185 GTIPPSIYNLSLLANFSVPENR-LHGSLPPSLGLTL-SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNN 255 (825)
Q Consensus 185 ~~~p~~i~~l~~l~~l~l~~N~-l~~~lp~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 255 (825)
++++|+ ++ .+|+..+..+ ++|+.|++++|++++..+. .+++|+.|+++++.
T Consensus 185 ----------------~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 185 ----------------YLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW 237 (239)
T ss_dssp ----------------ECTTCTTCC-EECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred ----------------EcCCCCCcc-cCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence 778884 77 5666666578 9999999999999965544 67788999988763
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=245.33 Aligned_cols=263 Identities=16% Similarity=0.164 Sum_probs=176.5
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC----cCCCCCC-CCCEEEcCCCCCCCCCChhhhcc-----cc
Q 003368 60 EIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP----GNLSYCS-RLIGLYLGRNKLEGSIPSEFVSL-----YN 129 (825)
Q Consensus 60 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 129 (825)
+++|+.|.+++.+|..+....+|++|||++|.|++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999888888889999999999998777 7788898 89999999999998888888886 99
Q ss_pred cceeeccccccccccCccCC----CC-CCCCEEEcccCcCcccCCcccccc-----cccceecCcCcCCccccCCCCCce
Q 003368 130 LKELAIQENNLTGGIPHFLG----NI-TSLEAISLAYNSLGGNIPSSLGQL-----KELKSLGLGGTIPPSIYNLSLLAN 199 (825)
Q Consensus 130 L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~~~p~~i~~l~~l~~ 199 (825)
|++|+|++|++++..+..+. .+ ++|++|+|++|++++..+..+... ++|++|
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L------------------ 143 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL------------------ 143 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEE------------------
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEE------------------
Confidence 99999999999977766444 44 899999999999987666554431 344444
Q ss_pred eecCCccccccCC----chhhhcCC-CCcEEEcccccCCCCCCccc----cCC-CCccEEEeecccccCccccCcCCCCC
Q 003368 200 FSVPENRLHGSLP----PSLGLTLS-NLQLFQISNNFFSGSFPLAF----SNA-SNLQSLEILGNNFFGKLSVNFGDMKS 269 (825)
Q Consensus 200 l~l~~N~l~~~lp----~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~----~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~ 269 (825)
++++|.+++..+ ..+. .++ +|++|+|++|++++..+..+ ..+ ++|++|+|++|.+......
T Consensus 144 -~Ls~N~l~~~~~~~l~~~l~-~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~------- 214 (362)
T 3goz_A 144 -NLRGNDLGIKSSDELIQILA-AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA------- 214 (362)
T ss_dssp -ECTTSCGGGSCHHHHHHHHH-TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH-------
T ss_pred -EccCCcCCHHHHHHHHHHHh-cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH-------
Confidence 777777774332 2222 343 78888888888877665443 334 4788888888877652111
Q ss_pred CcEEEcccccCCCCCCCcccccccccc-CCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc--
Q 003368 270 LAYLNVAINNLGSGESDEMSFIHSLAN-CSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK-- 346 (825)
Q Consensus 270 L~~L~ls~N~l~~~~~~~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~-- 346 (825)
.++..+.. .++|+.|+|++|.+++..+. .+...+..+++|+.|+|++|.+.+.
T Consensus 215 -------------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-----~l~~~~~~l~~L~~L~L~~n~l~~i~~ 270 (362)
T 3goz_A 215 -------------------ELAYIFSSIPNHVVSLNLCLNCLHGPSLE-----NLKLLKDSLKHLQTVYLDYDIVKNMSK 270 (362)
T ss_dssp -------------------HHHHHHHHSCTTCCEEECCSSCCCCCCHH-----HHHHTTTTTTTCSEEEEEHHHHTTCCH
T ss_pred -------------------HHHHHHhcCCCCceEEECcCCCCCcHHHH-----HHHHHHhcCCCccEEEeccCCccccCH
Confidence 11222222 23555555555555431100 1112234455566666666653322
Q ss_pred -----CCccccCCCCCCEEEccccccccccCc
Q 003368 347 -----IPEEMSRLQNLQFLNMRHNQLSGEIPS 373 (825)
Q Consensus 347 -----~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 373 (825)
++..+..+++|++||+++|++.+..+.
T Consensus 271 ~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~ 302 (362)
T 3goz_A 271 EQCKALGAAFPNIQKIILVDKNGKEIHPSHSI 302 (362)
T ss_dssp HHHHHHHTTSTTCCEEEEECTTSCBCCGGGCH
T ss_pred HHHHHHHHHhccCCceEEEecCCCcCCCcchH
Confidence 223455667777777777777655443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.17 Aligned_cols=152 Identities=28% Similarity=0.458 Sum_probs=121.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc----hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ----GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||.||+|++ .|+.||||++..... ...+.+.+|+++++.++||||++++++|. .+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 35788899999999999999998 489999999875432 23467899999999999999999999864 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-- 795 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-- 795 (825)
+..++||||+++|+|.+++.. ..+++..+..++.|+++|++|||+....+|+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~ 145 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG-------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS-------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred CceEEEEEcCCCCCHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence 678999999999999999842 25889999999999999999999973334999999999999986
Q ss_pred ------CCcEEEcccCcccccccC
Q 003368 796 ------NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ------~~~~ki~DFGla~~~~~~ 813 (825)
++.+||+|||+++.....
T Consensus 146 ~~~~~~~~~~kl~Dfg~~~~~~~~ 169 (271)
T 3dtc_A 146 ENGDLSNKILKITDFGLAREWHRT 169 (271)
T ss_dssp SSSCCSSCCEEECCCCC-------
T ss_pred ccccccCcceEEccCCcccccccc
Confidence 678999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=239.99 Aligned_cols=152 Identities=32% Similarity=0.543 Sum_probs=129.5
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
...++|...+.||+|+||.||+|++. .+..||||+++... ...++|.+|++++++++|||||+++++|. .+.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCc
Confidence 34567888999999999999999994 56789999997653 23578999999999999999999999863 245
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++.. .....+++.++..++.|+++||+|||+. +|+||||||+|||+++++.+
T Consensus 253 ~~iv~e~~~~gsL~~~l~~----------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~ 319 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKG----------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVC 319 (452)
T ss_dssp CEEEECCCTTCBHHHHHSH----------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred eEEEehhhcCCCHHHHHHh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCE
Confidence 7999999999999999952 1224589999999999999999999985 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 320 kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 320 KVADFGLARLIED 332 (452)
T ss_dssp EECCCCTTC----
T ss_pred EECCCccceecCC
Confidence 9999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=226.34 Aligned_cols=154 Identities=28% Similarity=0.521 Sum_probs=133.3
Q ss_pred ccccccceeccCCeeEEEEEEE----cCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..+.||+|+||.||+|++ ..+|+.||||++........+.+.+|++++++++||||++++++|.. .+..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCCC
Confidence 4588899999999999999994 46899999999987666667789999999999999999999998643 2234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 183 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH-----------KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 183 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS-----------TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred ceEEEEECCCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCc
Confidence 679999999999999998532 23589999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 184 ~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQD 198 (326)
T ss_dssp EEECCCTTCEECCSS
T ss_pred EEEecCcchhhcccc
Confidence 999999999987554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7e-24 Score=232.24 Aligned_cols=156 Identities=17% Similarity=0.287 Sum_probs=127.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCC-----CeEEEEEEeecccchh-----------HHHHHHHHHHhhcCCCCCceeE
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD-----GTIVAIKVLNLQLQGA-----------SKSFAAECRALRNIRHRNLVRV 705 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-----g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 705 (825)
.++|...+.||+|+||.||+|++..+ ++.||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998654 5789999987653211 1234567777888999999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrd 785 (825)
+++|... ..+....++||||+ +|+|.+++.. ....++|.++..|+.|++.||+|||+. +|+|||
T Consensus 114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~-----------~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrD 177 (364)
T 3op5_A 114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEA-----------NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGD 177 (364)
T ss_dssp EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHH-----------TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHh-----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEec
Confidence 9997642 12235689999999 9999999842 224689999999999999999999986 999999
Q ss_pred CCCCCeeec--CCCcEEEcccCcccccccC
Q 003368 786 LKPSNILLD--NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 786 lk~~NILl~--~~~~~ki~DFGla~~~~~~ 813 (825)
|||+|||++ .++.+||+|||+|+.+...
T Consensus 178 lkp~Nill~~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp CCGGGEEEESSCTTCEEECCCTTCEESSGG
T ss_pred CCHHHEEEecCCCCeEEEEECCcceecccC
Confidence 999999999 8899999999999877543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-24 Score=223.05 Aligned_cols=154 Identities=28% Similarity=0.482 Sum_probs=131.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc--------
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF-------- 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------- 714 (825)
.+|+..+.||+|+||.||+|++..+|+.||||++.... +.+.+|++++++++||||+++++++....+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46889999999999999999998899999999997543 356789999999999999999998643211
Q ss_pred ---CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 715 ---QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 715 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
......++||||+++|+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni 153 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR----------RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG----------GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence 1234579999999999999998421 224689999999999999999999986 999999999999
Q ss_pred eecCCCcEEEcccCcccccccC
Q 003368 792 LLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 792 Ll~~~~~~ki~DFGla~~~~~~ 813 (825)
++++++.+||+|||+++.....
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKND 175 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCC
T ss_pred EEcCCCCEEECcchhheecccc
Confidence 9999999999999999887554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=224.50 Aligned_cols=150 Identities=27% Similarity=0.404 Sum_probs=129.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||.||+|+...+|+.||||++........+.+.+|++++++++||||+++++++. +.+..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEEE
Confidence 46888999999999999999998899999999998665445567899999999999999999999853 4667899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCcE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLTA 799 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~~~ 799 (825)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.+
T Consensus 84 v~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 84 VMQLVSGGELFDRILE------------RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp EECCCCSCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCE
T ss_pred EEEcCCCccHHHHHHH------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCE
Confidence 9999999999998842 24688999999999999999999986 99999999999999 788999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 149 kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 149 MITDFGLSKMEQN 161 (304)
T ss_dssp EBCSCSTTCCCCC
T ss_pred EEccCCcceecCC
Confidence 9999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=219.83 Aligned_cols=151 Identities=29% Similarity=0.492 Sum_probs=133.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++||||+++++++. ..+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 357889999999999999999998899999999997542 223567899999999999999999999853 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~ 149 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK------------HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMN 149 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSC
T ss_pred eEEEEEeccCCCcHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCC
Confidence 78999999999999999842 24688999999999999999999986 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 150 ~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 150 AKIADFGLSNMMSD 163 (276)
T ss_dssp EEECCCCGGGCCCC
T ss_pred EEEeecccccccCC
Confidence 99999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=227.65 Aligned_cols=166 Identities=24% Similarity=0.439 Sum_probs=132.3
Q ss_pred hcccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
..++|...+.||+|+||.||+|++ ..+++.||||++.... ....+.+.+|+++++++ +||||++++++|.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--- 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence 457789999999999999999997 2466789999997543 23456799999999999 8999999999864
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCc-----------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTD-----------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTI 782 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~iv 782 (825)
..+..++||||+++|+|.+++......... ........++|.++..++.|+++||+|||+. +|+
T Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 356789999999999999999754211100 0011124589999999999999999999985 999
Q ss_pred ecCCCCCCeeecCCCcEEEcccCcccccccCC
Q 003368 783 HCDLKPSNILLDNNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 783 Hrdlk~~NILl~~~~~~ki~DFGla~~~~~~~ 814 (825)
||||||+||+++.++.+||+|||+|+......
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCc
Confidence 99999999999999999999999999775543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=240.05 Aligned_cols=161 Identities=24% Similarity=0.378 Sum_probs=135.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|...+.||+|+||+||+|+...+|+.||||++.... ....+.+.+|++++++++|||||++++++. .....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCEE
Confidence 46888999999999999999998899999999996542 234578899999999999999999999853 46788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD---NNL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~---~~~ 797 (825)
++||||+++|+|.+++.. ...+++.++..|+.|++.||+|||+. +|+||||||+|||++ .++
T Consensus 97 ~lv~e~~~~~~L~~~~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIK------------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp EEEECCCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred EEEEEcCCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 999999999999988842 24689999999999999999999986 899999999999995 456
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+...... .....+||+
T Consensus 162 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~ 187 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT-KMKDRIGTA 187 (486)
T ss_dssp CEEECSCSCTTTBCCC-----CCTTGG
T ss_pred CEEEEECCcCeECCCCC-ccCCCcCCC
Confidence 89999999999765432 233445554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=7.4e-24 Score=232.22 Aligned_cols=151 Identities=30% Similarity=0.493 Sum_probs=122.3
Q ss_pred cccccceeccCCeeEEEEEEEcCC---CeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.|...+.||+|+||.||+|++..+ +..||||.++... ....+.|.+|++++++++|||||+++++|.. .++.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCC
Confidence 366778999999999999997433 2468999987543 3445789999999999999999999998743 3456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+|||++.++.+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNE-----------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCT-----------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEECCCCCCHHHHHhhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCE
Confidence 79999999999999999532 23578899999999999999999986 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 232 kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 232 KVADFGLARDMYD 244 (373)
T ss_dssp EECCC--------
T ss_pred EEeeccccccccc
Confidence 9999999987644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.9e-24 Score=222.27 Aligned_cols=152 Identities=25% Similarity=0.408 Sum_probs=122.8
Q ss_pred cccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||.||+|++.. .+..||||.+..... ...+.+.+|+.++++++||||+++++++. +
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence 4578889999999999999999854 356799999875432 34567999999999999999999999852 3
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 153 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-----------KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 153 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-----------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred CccEEEEecCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCC
Confidence 4578999999999999998522 23589999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 154 ~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 154 CVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEEECC----------
T ss_pred CEEECccccccccCcc
Confidence 9999999999987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=241.02 Aligned_cols=161 Identities=24% Similarity=0.410 Sum_probs=137.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+.|...++||+|+||.||+|+...+|+.||||++.... ....+.+.+|++++++++|||||++++++ .....
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence 46888999999999999999998899999999997543 23467899999999999999999999985 34678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNN 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~ 796 (825)
.++||||+++|+|.+++... ..+++.++..|+.|++.||+|||+. +|+||||||+|||+ +.+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR------------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC------------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTT
T ss_pred EEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCC
Confidence 89999999999999988532 3688999999999999999999996 89999999999999 467
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+...... .....+||+
T Consensus 166 ~~~kl~Dfg~a~~~~~~~-~~~~~~gt~ 192 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASK-KMKDKIGTA 192 (484)
T ss_dssp CCEEECCTTHHHHBCCCC-SHHHHTTGG
T ss_pred CcEEEEeeeeeEEccccc-ccccCCCCc
Confidence 899999999998775542 233445554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=223.99 Aligned_cols=152 Identities=22% Similarity=0.283 Sum_probs=129.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+++.||||++..... ...+.+.+|++++++++||||+++++++. .++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence 4679999999999999999999988999999999975532 22467899999999999999999999864 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~ 172 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRR------------QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDF 172 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred eEEEEEEecCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCC
Confidence 78999999999999999842 24689999999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+++.....
T Consensus 173 ~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 173 AYLVDFGIASATTDE 187 (309)
T ss_dssp EEECSCCC-------
T ss_pred EEEecCccCcccccc
Confidence 999999999876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=224.36 Aligned_cols=162 Identities=27% Similarity=0.397 Sum_probs=132.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..+.|+..+.||+|+||.||+|+...+|+.||||++.... ..+.+.+|++++++++||||+++++++.. .+..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 3467899999999999999999998889999999997643 34678999999999999999999998643 5678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++.. ....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 100 ~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 165 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL-----------RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAK 165 (314)
T ss_dssp EEEEECCTTEEHHHHHHH-----------HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred EEEeecCCCCCHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEE
Confidence 999999999999999841 224689999999999999999999986 899999999999999999999
Q ss_pred EcccCcccccccCCCCCcccccc
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGD 823 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt 823 (825)
|+|||+++.............||
T Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~ 188 (314)
T 3com_A 166 LADFGVAGQLTDTMAKRNTVIGT 188 (314)
T ss_dssp ECCCTTCEECBTTBSCBCCCCSC
T ss_pred EeecccchhhhhhccccCccCCC
Confidence 99999998775543333333444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=226.01 Aligned_cols=164 Identities=23% Similarity=0.437 Sum_probs=132.3
Q ss_pred cccccccceeccCCeeEEEEEEEc-------CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-------RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-------~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|++. .+++.||||++..... ...+.+.+|+++++++ +||||++++++|.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 467889999999999999999974 3577899999976533 3456789999999999 8999999999864
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
..+..++||||+++|+|.+++.......... .......+++.++..++.|+++||+|||+. +|+||||||
T Consensus 112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 3567899999999999999997542111000 001123589999999999999999999986 999999999
Q ss_pred CCeeecCCCcEEEcccCcccccccC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+||+++.++.+||+|||+|+.....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~ 210 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNI 210 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTT
T ss_pred ceEEEcCCCCEEEcccccccccccc
Confidence 9999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=229.69 Aligned_cols=164 Identities=24% Similarity=0.284 Sum_probs=133.8
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-----------hHHHHHHHHHHhhcCCCCC
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-----------ASKSFAAECRALRNIRHRN 701 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~n 701 (825)
....++....++|...+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEEC-TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEEC-CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 34556777789999999999999999999998 46999999998653221 2367999999999999999
Q ss_pred ceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003368 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPT 781 (825)
Q Consensus 702 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~i 781 (825)
|+++++++...........++||||++ |+|.+++... ...+++..+..++.|+++||+|||+. +|
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i 155 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-----------RIVISPQHIQYFMYHILLGLHVLHEA---GV 155 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHC---cC
Confidence 999999875433234457899999998 6888887532 23689999999999999999999996 89
Q ss_pred eecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 782 IHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 782 vHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+||||||+||+++.++.+||+|||+|+....
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTA 186 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------
T ss_pred EecCCChHHEEEcCCCCEEEEecCccccccc
Confidence 9999999999999999999999999986544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=219.90 Aligned_cols=152 Identities=29% Similarity=0.524 Sum_probs=132.0
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|...+.||+|+||.||+|+. .++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence 446788999999999999999998 577899999987543 34578999999999999999999999853 3457
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++... ....+++.++..++.|+++||+|||+. +|+||||||+||++++++.+|
T Consensus 83 ~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k 149 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTP----------SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149 (279)
T ss_dssp EEEEECCTTCBHHHHTTSH----------HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCCHHHHHhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEE
Confidence 9999999999999998521 223689999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+++.....
T Consensus 150 l~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 150 IADFGLARLIEDN 162 (279)
T ss_dssp ECCCTTCEECSSS
T ss_pred ECCCcccccccCc
Confidence 9999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=226.87 Aligned_cols=171 Identities=25% Similarity=0.383 Sum_probs=137.8
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEe
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVI 706 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~ 706 (825)
+..+++....++|...+.||+|+||.||+|++. .+++.||||++..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334445556678999999999999999999875 3578899999975533 3345789999999999999999999
Q ss_pred ecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 003368 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDL 786 (825)
Q Consensus 707 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdl 786 (825)
+++. ..+..++||||+++|+|.+++...... .........+++.++..++.|+++||+|||+. +|+||||
T Consensus 95 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~di 164 (322)
T 1p4o_A 95 GVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPA--MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDL 164 (322)
T ss_dssp EEEC-----SSSSCEEEEECCTTCBHHHHHHHHHHH--HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCC
T ss_pred EEEc-----cCCccEEEEEeCCCCcHHHHHHHhchh--hccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCC
Confidence 9853 356789999999999999998532000 00000113578999999999999999999986 8999999
Q ss_pred CCCCeeecCCCcEEEcccCcccccccC
Q 003368 787 KPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 787 k~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
||+||+++.++.+||+|||+++.....
T Consensus 165 kp~NIli~~~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 165 AARNCMVAEDFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp SGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred ccceEEEcCCCeEEECcCccccccccc
Confidence 999999999999999999999876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=230.38 Aligned_cols=154 Identities=25% Similarity=0.381 Sum_probs=117.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccc-ccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSI-DFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .+....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467999999999999999999998999999999996542 23456788999999999999999999986432 112235
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 170 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 170 (367)
T ss_dssp CCEEEEECC-CEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred eEEEEeccc-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCC
Confidence 579999999 7899888742 3588999999999999999999985 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 171 ~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 171 LKILDFGLARHTAD 184 (367)
T ss_dssp EEECC---------
T ss_pred EEEeeccccccccc
Confidence 99999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=227.31 Aligned_cols=154 Identities=28% Similarity=0.386 Sum_probs=134.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|...+.||+|+||.||+|++..+|+.||||++..... .....+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4679999999999999999999988999999999975432 335678899999999999999999998765445555778
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+. |+|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 90 ~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-------------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred EEEEeccC-ccHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEE
Confidence 99999997 689888742 3588999999999999999999986 999999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 153 l~Dfg~a~~~~~ 164 (353)
T 2b9h_A 153 VCDFGLARIIDE 164 (353)
T ss_dssp ECCCTTCEECC-
T ss_pred EEeccccccccc
Confidence 999999998754
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=222.55 Aligned_cols=152 Identities=26% Similarity=0.484 Sum_probs=129.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++. .++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 77 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEe-----cCCce
Confidence 578899999999999999999988999999999875432 23467889999999999999999999854 35678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||++ |+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 78 ~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k 143 (299)
T 2r3i_A 78 YLVFEFLH-QDLKKFMDAS----------ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 143 (299)
T ss_dssp EEEEECCS-EEHHHHHHHT----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEEccc-CCHHHHHHhh----------hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEE
Confidence 99999998 6999988532 123578899999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+++.....
T Consensus 144 l~dfg~~~~~~~~ 156 (299)
T 2r3i_A 144 LADFGLARAFGVP 156 (299)
T ss_dssp ECSTTHHHHHCCC
T ss_pred ECcchhhhhccCC
Confidence 9999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=222.38 Aligned_cols=153 Identities=25% Similarity=0.391 Sum_probs=126.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccc---------c
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSI---------D 713 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------~ 713 (825)
++|...+.||+|+||.||+|+...+|+.||||++........+.+.+|++++++++||||+++++++... .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 5688899999999999999999888999999999876666677899999999999999999999886321 1
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
+......++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-------------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFI 153 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-------------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence 234567899999998 699998842 2578889999999999999999986 99999999999999
Q ss_pred c-CCCcEEEcccCccccccc
Q 003368 794 D-NNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~-~~~~~ki~DFGla~~~~~ 812 (825)
+ +++.+||+|||+++....
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~ 173 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDP 173 (320)
T ss_dssp ETTTTEEEECCCTTCBCC--
T ss_pred cCCCCeEEEccCccccccCC
Confidence 7 567999999999997653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.8e-24 Score=242.94 Aligned_cols=154 Identities=32% Similarity=0.529 Sum_probs=132.6
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+....++|...+.||+|+||.||+|++. .+..||||+++... ...++|.+|++++++++|||||+++++|. .
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~ 333 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------E 333 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred eecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe------e
Confidence 3344567888999999999999999994 56789999997653 23578999999999999999999999863 2
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++.. .....+++.+++.|+.||++||+|||+. +||||||||+|||+++++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~ 400 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKG----------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENL 400 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSH----------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred ccceEeeehhcCCcHHHHHhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCC
Confidence 457999999999999999952 1224589999999999999999999985 899999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 401 ~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 401 VCKVADFGLARLIED 415 (535)
T ss_dssp CEEECCTTSTTTCCC
T ss_pred cEEEcccccceecCC
Confidence 999999999997643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=223.29 Aligned_cols=148 Identities=22% Similarity=0.373 Sum_probs=129.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||.||+|+...+++.||||++... ..+.+.+|++++++++ ||||+++++++.. ......
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence 35789999999999999999999899999999998743 3467899999999997 9999999998643 224568
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TA 799 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~ 799 (825)
++||||+++++|.+++. .+++.++..++.|+++||+|||+. +|+||||||+|||++.++ .+
T Consensus 109 ~lv~e~~~~~~l~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp EEEEECCCCCCHHHHGG---------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EEEEeccCchhHHHHHH---------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEE
Confidence 99999999999998872 478889999999999999999986 899999999999999776 89
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 171 kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 171 RLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEeCCCceEcCCC
Confidence 99999999976544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=225.98 Aligned_cols=152 Identities=29% Similarity=0.511 Sum_probs=125.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCC----eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
+.|...+.||+|+||.||+|++..++ ..||||+++.... ...+.+.+|++++++++||||+++++++. ..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence 45677899999999999999985443 4699999976533 33557999999999999999999999853 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~ 184 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-----------DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNL 184 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCC
Confidence 6789999999999999998521 24689999999999999999999986 899999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+++.....
T Consensus 185 ~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDD 200 (333)
T ss_dssp CEEECCCCC-------
T ss_pred cEEECCCCcchhhccc
Confidence 9999999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-24 Score=235.48 Aligned_cols=162 Identities=17% Similarity=0.205 Sum_probs=126.2
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecc---cchhHHHHHHHH---HHhhcCCCCCceeEeecccccc-
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ---LQGASKSFAAEC---RALRNIRHRNLVRVITSCSSID- 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~~~~~~~~- 713 (825)
..++|...+.||+|+||+||+|++..+|+.||||++... .....+.|.+|+ +.+++++|||||++++.+....
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346788899999999999999999888999999999743 234457899999 5666668999999986543100
Q ss_pred -cCCC------------C-----eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHh
Q 003368 714 -FQGN------------D-----FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHH 775 (825)
Q Consensus 714 -~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~ 775 (825)
+... + ..++||||+ +|+|.+++..... .......++|..+..|+.|+++||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-----HSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH-----TTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc-----cccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 1111 1 268999999 6899999953200 00112346678899999999999999999
Q ss_pred cCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 776 HCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 776 ~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 225 ~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 225 Y---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp T---TEECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred C---CeecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 6 89999999999999999999999999999643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-23 Score=221.83 Aligned_cols=152 Identities=30% Similarity=0.497 Sum_probs=128.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCC---CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..|...+.||+|+||.||+|++..+ +..||||.+..... ...+.+.+|++++++++||||++++++|. ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence 4578889999999999999997433 34689999875433 34567999999999999999999999864 3455
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE-----------THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCC
T ss_pred ceEEEEeCCCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCC
Confidence 779999999999999999532 23578999999999999999999986 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 167 ~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 167 VKVADFGLARDMYD 180 (298)
T ss_dssp EEECSCGGGCCCSC
T ss_pred EEECcccccccccc
Confidence 99999999987644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=220.89 Aligned_cols=150 Identities=31% Similarity=0.484 Sum_probs=127.4
Q ss_pred ccccceeccCCeeEEEEEEEcCCCe---EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGT---IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~---~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
|...++||+|+||.||+|++..+++ .||||.+..... ...+.|.+|++++++++||||+++++++.. .+...
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 98 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGLP 98 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSCC
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCCc
Confidence 5567899999999999999754443 799999875433 345789999999999999999999998642 23445
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+.+|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 99 ~~v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSP-----------QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp EEEECCCTTCBHHHHHHCT-----------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEecccCCCHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 8999999999999999532 24678999999999999999999986 899999999999999999999
Q ss_pred EcccCccccccc
Q 003368 801 VGDFGLARLRQE 812 (825)
Q Consensus 801 i~DFGla~~~~~ 812 (825)
|+|||+|+....
T Consensus 165 l~Dfg~~~~~~~ 176 (298)
T 3pls_A 165 VADFGLARDILD 176 (298)
T ss_dssp ECCTTSSCTTTT
T ss_pred eCcCCCcccccC
Confidence 999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=226.89 Aligned_cols=155 Identities=25% Similarity=0.426 Sum_probs=130.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc---CC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF---QG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~ 716 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... .....+.+|++++++++||||++++++|..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4578999999999999999999989999999999865432 234678899999999999999999998754211 11
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+++ ++.+.+... ...+++.++..|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV-----------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CceEEEEEeccCC-CHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC
Confidence 4568999999985 777776422 23589999999999999999999986 99999999999999999
Q ss_pred CcEEEcccCcccccc
Q 003368 797 LTAHVGDFGLARLRQ 811 (825)
Q Consensus 797 ~~~ki~DFGla~~~~ 811 (825)
+.+||+|||+|+...
T Consensus 161 ~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 161 GVLKLADFGLARAFS 175 (351)
T ss_dssp SCEEECCCTTCEECC
T ss_pred CCEEEccchhccccc
Confidence 999999999998765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=224.95 Aligned_cols=203 Identities=15% Similarity=0.132 Sum_probs=151.4
Q ss_pred CCCCEEEcCCCcccccC-C--ccccCCCCCCEEECCCCcCCCCCCcCC--CCCCCCCEEEcCCCCCCCCCC----hhhhc
Q 003368 56 SFLREIHLSNNTIQGKI-P--GEIGRLFRLEALYLSHNSLVGEIPGNL--SYCSRLIGLYLGRNKLEGSIP----SEFVS 126 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~-p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 126 (825)
..++.|.+.++.++... . ..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 35788999888876321 1 112235679999999999999999998 899999999999999997665 45567
Q ss_pred ccccceeeccccccccccCccCCCCCCCCEEEcccCcCccc--C--CcccccccccceecCcCcCCccccCCCCCceeec
Q 003368 127 LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGN--I--PSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV 202 (825)
Q Consensus 127 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l 202 (825)
+++|++|+|++|++++..|..|+.+++|++|+|++|++.+. + +..+..+++|++| ++
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L-------------------~L 204 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNL-------------------AL 204 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSC-------------------BC
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEE-------------------EC
Confidence 99999999999999988889999999999999999998752 2 1223556666665 77
Q ss_pred CCccccccCCc---hhhhcCCCCcEEEcccccCCCCCCccccCC---CCccEEEeecccccCccccCcCCCCCCcEEEcc
Q 003368 203 PENRLHGSLPP---SLGLTLSNLQLFQISNNFFSGSFPLAFSNA---SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVA 276 (825)
Q Consensus 203 ~~N~l~~~lp~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 276 (825)
++|+++ .+|. .++..+++|++|+|++|++++..|..+..+ ++|++|+|++|++.. +|..+. ++|+.|+++
T Consensus 205 s~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls 280 (310)
T 4glp_A 205 RNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLS 280 (310)
T ss_dssp CSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECC
T ss_pred CCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECC
Confidence 778776 2332 244478899999999999998878777766 588888888888773 333332 455555555
Q ss_pred cccCC
Q 003368 277 INNLG 281 (825)
Q Consensus 277 ~N~l~ 281 (825)
+|+++
T Consensus 281 ~N~l~ 285 (310)
T 4glp_A 281 SNRLN 285 (310)
T ss_dssp SCCCC
T ss_pred CCcCC
Confidence 55544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=217.02 Aligned_cols=149 Identities=26% Similarity=0.427 Sum_probs=131.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|++ .+++.||||++..... ..+.+.+|++++++++||||+++++++. .++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred hhheeeeeEecCCCceeEEEEEe-cCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 35688899999999999999998 4788999999976543 3467999999999999999999999853 356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 80 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl 145 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ-----------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV 145 (267)
T ss_dssp EEECCCTTCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEE
T ss_pred EEEeCCCCCcHHHHHhhC-----------cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEE
Confidence 999999999999998532 23588999999999999999999986 8999999999999999999999
Q ss_pred cccCcccccc
Q 003368 802 GDFGLARLRQ 811 (825)
Q Consensus 802 ~DFGla~~~~ 811 (825)
+|||+++...
T Consensus 146 ~dfg~~~~~~ 155 (267)
T 3t9t_A 146 SDFGMTRFVL 155 (267)
T ss_dssp CCTTGGGGBC
T ss_pred cccccccccc
Confidence 9999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=225.35 Aligned_cols=161 Identities=24% Similarity=0.284 Sum_probs=135.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccc---cCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSID---FQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~---~~~~ 717 (825)
..+|...++||+|+||.||+|++..+|+.||||++........+.+.+|++++.+++ ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 356889999999999999999998899999999997665566678999999999996 999999999874211 1334
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+. |+|.+++... .....+++.++..|+.|++.||+|||+. .++|+||||||+|||++.++
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKM---------ESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHH---------HTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS
T ss_pred ceEEEEEEecC-CCHHHHHHHh---------hccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC
Confidence 56799999996 7999988421 1234689999999999999999999986 12399999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+++.....
T Consensus 176 ~~kl~Dfg~~~~~~~~ 191 (337)
T 3ll6_A 176 TIKLCDFGSATTISHY 191 (337)
T ss_dssp CEEBCCCTTCBCCSSC
T ss_pred CEEEecCccceecccc
Confidence 9999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=223.02 Aligned_cols=166 Identities=26% Similarity=0.376 Sum_probs=135.0
Q ss_pred hcccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSID 713 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 713 (825)
..++|...+.||+|+||.||+|++ ..+++.||||++..... ...+.+.+|+++++++ +||||++++++|.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 346788899999999999999985 35678999999976543 3456799999999999 8999999999864
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCc------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTD------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
.++..++||||+++|+|.+++......... ........+++.++..++.|+++||+|||+. +|+|||||
T Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 356789999999999999999643211000 0011223589999999999999999999986 99999999
Q ss_pred CCCeeecCCCcEEEcccCcccccccCC
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~~~~ 814 (825)
|+||+++.++.+||+|||+++......
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCT
T ss_pred cceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=243.12 Aligned_cols=144 Identities=26% Similarity=0.437 Sum_probs=125.1
Q ss_pred eeccCCeeEEEEEEEc--CCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEEEc
Q 003368 650 LIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.||+|+||.||+|+++ .++..||||+++... ....++|.+|++++++++|||||+++++|.. +..++||||
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~ 416 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM 416 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence 7999999999999875 356789999997653 3356789999999999999999999998642 458999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCc
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGL 806 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGl 806 (825)
+++|+|.+++... ...+++.++..|+.||++||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 417 ~~~g~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGl 482 (613)
T 2ozo_A 417 AGGGPLHKFLVGK-----------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL 482 (613)
T ss_dssp CTTCBHHHHHTTC-----------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCST
T ss_pred CCCCcHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccC
Confidence 9999999999532 23589999999999999999999985 899999999999999999999999999
Q ss_pred ccccccC
Q 003368 807 ARLRQEV 813 (825)
Q Consensus 807 a~~~~~~ 813 (825)
|+.....
T Consensus 483 a~~~~~~ 489 (613)
T 2ozo_A 483 SKALGAD 489 (613)
T ss_dssp TTTCC--
T ss_pred cccccCC
Confidence 9987543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=209.58 Aligned_cols=179 Identities=25% Similarity=0.294 Sum_probs=136.2
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecc
Q 003368 57 FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQ 136 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 136 (825)
..++++++++.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4678999999998 5776665 589999999999998888899999999999999999998888889999999999999
Q ss_pred ccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhh
Q 003368 137 ENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLG 216 (825)
Q Consensus 137 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~ 216 (825)
+|++++..+..|..+++|++|+|++|+|++..+..|..+++|++| ++++|+++ .+|+..+
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-------------------~Ls~N~l~-~~~~~~~ 151 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL-------------------RLNTNQLQ-SIPAGAF 151 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-------------------ECCSSCCC-CCCTTTT
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE-------------------ECcCCcCC-ccCHHHc
Confidence 999998888888999999999999999986666556666555555 55556665 3333333
Q ss_pred hcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccC
Q 003368 217 LTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258 (825)
Q Consensus 217 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 258 (825)
..+++|++|+|++|++++..+..|..+++|+.|+|++|++.+
T Consensus 152 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 356666666666666665555556666666666666665544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=219.50 Aligned_cols=149 Identities=23% Similarity=0.292 Sum_probs=129.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|...+.||+|+||.||+|+...+|+.||||++.... ..+.+.+|+++++++ +|+|++++++++. .....+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~ 82 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV 82 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeE
Confidence 56899999999999999999998899999999986543 234678999999999 7999999999853 466789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT--- 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~--- 798 (825)
+||||+ +|+|.+++... ...+++.++..|+.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 83 lv~e~~-~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC-----------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp EEEECC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEec-CCCHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCC
Confidence 999999 99999998532 23589999999999999999999985 9999999999999988776
Q ss_pred --EEEcccCcccccccC
Q 003368 799 --AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 --~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 148 ~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp TCEEECCCTTCEESBCT
T ss_pred CeEEEEECccccccccc
Confidence 999999999987654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-24 Score=244.96 Aligned_cols=152 Identities=16% Similarity=0.095 Sum_probs=117.5
Q ss_pred eeccCCeeEEEEEEEcCCCeEEEEEEeeccc----------chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL----------QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 650 ~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
..+.|+.|.+++++....|+.||||++.... ....++|.+|+++|+++ .|+||++++++ ++++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence 3567777777777766788999999997542 12345799999999999 69999999998 56678
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..||||||++||+|.+++... ..++. .+|+.||+.||+|+|+. +||||||||+|||+++++.
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~------------~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~ 377 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAG------------EEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQH 377 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTT------------CCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSC
T ss_pred EEEEEEecCCCCcHHHHHHhC------------CCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCC
Confidence 899999999999999999543 23443 35899999999999996 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..........+.+||+
T Consensus 378 vKL~DFGlAr~~~~~~~~~~t~vGTp 403 (569)
T 4azs_A 378 ARLIDFGSIVTTPQDCSWPTNLVQSF 403 (569)
T ss_dssp EEECCCTTEESCC---CCSHHHHHHH
T ss_pred EEEeecccCeeCCCCCccccCceech
Confidence 99999999998876655566677775
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=223.97 Aligned_cols=153 Identities=27% Similarity=0.359 Sum_probs=124.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC--CCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI--RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||.||+|++ +|+.||||++.... ...+.+|.+++... +||||+++++++... ......
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 109 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG-TGSWTQ 109 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES-CGGGCE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC-CCCCCc
Confidence 46799999999999999999998 48999999986432 33455566665554 899999999987542 111257
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeec
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-----QEPTIHCDLKPSNILLD 794 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-----~~~ivHrdlk~~NILl~ 794 (825)
.++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ .++|+||||||+|||++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred eEEEEeccCCCcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 8999999999999999842 25889999999999999999999741 23899999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+|+.....
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~ 195 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISD 195 (337)
T ss_dssp TTSCEEECCCTTCEECC--
T ss_pred CCCCEEEEeCCCceeeccc
Confidence 9999999999999876544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-24 Score=226.18 Aligned_cols=224 Identities=17% Similarity=0.155 Sum_probs=179.0
Q ss_pred cEEEEECCCCCCccccCc---CCCCCCCCCEEEcCCCcccccCCccc--cCCCCCCEEECCCCcCCCCCC----cCCCCC
Q 003368 33 RVTVLDLKSKGLIGSLSP---QIGNLSFLREIHLSNNTIQGKIPGEI--GRLFRLEALYLSHNSLVGEIP----GNLSYC 103 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l 103 (825)
+++.++++...+....-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 578888888777532111 12245679999999999999999998 899999999999999997665 455689
Q ss_pred CCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccc---c-CccCCCCCCCCEEEcccCcCcccCCc----ccccc
Q 003368 104 SRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGG---I-PHFLGNITSLEAISLAYNSLGGNIPS----SLGQL 175 (825)
Q Consensus 104 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~-p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 175 (825)
++|++|+|++|+|++..|..|..+++|++|+|++|++.+. . +..++.+++|++|+|++|+++. +|. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999988889999999999999999998752 2 2345789999999999999973 332 24566
Q ss_pred cccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcC---CCCcEEEcccccCCCCCCccccCCCCccEEEee
Q 003368 176 KELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTL---SNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL 252 (825)
Q Consensus 176 ~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 252 (825)
++|++| ++++|++++.+|+.++ .+ ++|++|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 224 ~~L~~L-------------------~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls 280 (310)
T 4glp_A 224 VQPHSL-------------------DLSHNSLRATVNPSAP-RCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLS 280 (310)
T ss_dssp CCCSSE-------------------ECTTSCCCCCCCSCCS-SCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECC
T ss_pred CCCCEE-------------------ECCCCCCCccchhhHH-hccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECC
Confidence 777766 7788888877677665 44 68999999999998 4566654 789999999
Q ss_pred cccccCccccCcCCCCCCcEEEcccccCCC
Q 003368 253 GNNFFGKLSVNFGDMKSLAYLNVAINNLGS 282 (825)
Q Consensus 253 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 282 (825)
+|++.+. |. +..+++|+.|++++|+++.
T Consensus 281 ~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 281 SNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 9999875 22 6788999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=223.36 Aligned_cols=174 Identities=24% Similarity=0.327 Sum_probs=138.7
Q ss_pred ccHHHHHhhcccccccceeccCCeeEEEEEEE-----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeE
Q 003368 633 VSYESLLKATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRV 705 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~-----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l 705 (825)
+...++....++|...+.||+|+||.||+|++ ..+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555667899999999999999999985 34678999999976543 3346789999999999 69999999
Q ss_pred eecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003368 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPT 781 (825)
Q Consensus 706 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~i 781 (825)
+++|.. .+...++||||+++|+|.+++......... ........+++.++..++.|+++||+|||+. +|
T Consensus 97 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i 169 (316)
T 2xir_A 97 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169 (316)
T ss_dssp EEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 998643 244589999999999999999654211000 0000122388999999999999999999986 99
Q ss_pred eecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 782 IHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 782 vHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+||||||+||+++.++.+||+|||+|+.....
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 201 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccC
Confidence 99999999999999999999999999976544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=216.96 Aligned_cols=154 Identities=24% Similarity=0.398 Sum_probs=130.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|++ +|+.||||++.... ....+.|.+|++++++++||||++++++|.. .....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PPAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT---TTSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc---CCCCC
Confidence 35688899999999999999998 48999999997653 2345679999999999999999999998743 22356
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ....+++.++..|+.|+++||+|||+. .++|+||||||+||+++.++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEG----------TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSC----------SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCE
T ss_pred eEeeecccCCCcHHHHHhhc----------ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcce
Confidence 79999999999999999642 113589999999999999999999985 2239999999999999999999
Q ss_pred EEcccCcccccc
Q 003368 800 HVGDFGLARLRQ 811 (825)
Q Consensus 800 ki~DFGla~~~~ 811 (825)
||+|||++....
T Consensus 153 ~l~~~~~~~~~~ 164 (271)
T 3kmu_A 153 RISMADVKFSFQ 164 (271)
T ss_dssp EEEGGGSCCTTS
T ss_pred eEEeccceeeec
Confidence 999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=244.52 Aligned_cols=144 Identities=26% Similarity=0.438 Sum_probs=125.2
Q ss_pred ceeccCCeeEEEEEEE--cCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTF--DRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~--~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||.||+|.+ ..+++.||||+++.... ...++|.+|++++++++|||||+++++|. .+..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence 5799999999999965 45678999999976432 33578999999999999999999999863 23478999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 449 E~~~~g~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DF 513 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 513 (635)
T ss_dssp ECCTTEEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCT
T ss_pred EccCCCCHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEc
Confidence 99999999999942 24689999999999999999999986 8999999999999999999999999
Q ss_pred CcccccccC
Q 003368 805 GLARLRQEV 813 (825)
Q Consensus 805 Gla~~~~~~ 813 (825)
|+|+.....
T Consensus 514 Gla~~~~~~ 522 (635)
T 4fl3_A 514 GLSKALRAD 522 (635)
T ss_dssp THHHHTTC-
T ss_pred CCccccccC
Confidence 999987554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.8e-25 Score=238.77 Aligned_cols=212 Identities=18% Similarity=0.254 Sum_probs=159.2
Q ss_pred CCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCC--CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC
Q 003368 18 HFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNL--SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE 95 (825)
Q Consensus 18 ~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 95 (825)
-|..|.++.|++. .++.+|++++++. +..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 4446999988653 5778999888876 4556666 8899999999999876665 55788999999999988866
Q ss_pred -CCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccc-ccccc-cCccCCCCCCCCEEEcccC-cCccc-CCc
Q 003368 96 -IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN-NLTGG-IPHFLGNITSLEAISLAYN-SLGGN-IPS 170 (825)
Q Consensus 96 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~ 170 (825)
+|..+..+++|++|+|++|++++..+..|..+++|++|+|++| .+++. ++..+.++++|++|+|++| .+++. ++.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 7778888899999999999888878888888889999999988 67753 5666788888999999888 88753 455
Q ss_pred cccccc-ccceecCcCcCCccccCCCCCceeecCCc--ccc-ccCCchhhhcCCCCcEEEccccc-CCCCCCccccCCCC
Q 003368 171 SLGQLK-ELKSLGLGGTIPPSIYNLSLLANFSVPEN--RLH-GSLPPSLGLTLSNLQLFQISNNF-FSGSFPLAFSNASN 245 (825)
Q Consensus 171 ~~~~l~-~L~~L~L~~~~p~~i~~l~~l~~l~l~~N--~l~-~~lp~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 245 (825)
.+..++ +|++| ++++| .++ +.+|..+. .+++|+.|++++|. +++..+..+.++++
T Consensus 189 ~~~~l~~~L~~L-------------------~l~~~~~~~~~~~l~~~~~-~~~~L~~L~l~~~~~l~~~~~~~l~~l~~ 248 (336)
T 2ast_B 189 AVAHVSETITQL-------------------NLSGYRKNLQKSDLSTLVR-RCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248 (336)
T ss_dssp HHHHSCTTCCEE-------------------ECCSCGGGSCHHHHHHHHH-HCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred HHHhcccCCCEE-------------------EeCCCcccCCHHHHHHHHh-hCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence 566666 66666 55555 333 33444433 67777777777777 66556666777777
Q ss_pred ccEEEeeccc
Q 003368 246 LQSLEILGNN 255 (825)
Q Consensus 246 L~~L~L~~N~ 255 (825)
|+.|+|++|.
T Consensus 249 L~~L~l~~~~ 258 (336)
T 2ast_B 249 LQHLSLSRCY 258 (336)
T ss_dssp CCEEECTTCT
T ss_pred CCEeeCCCCC
Confidence 7777777774
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=226.20 Aligned_cols=153 Identities=18% Similarity=0.268 Sum_probs=124.6
Q ss_pred ccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeecccch-----------hHHHHHHHHHHhhcCCCCCceeEeec
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQLQG-----------ASKSFAAECRALRNIRHRNLVRVITS 708 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~ 708 (825)
++|...+.||+|+||.||+|+... ++..||||+....... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 568899999999999999999976 7889999998764321 12347788999999999999999998
Q ss_pred ccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 709 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
+... +.+....++||||+ +|+|.+++... ..+++.++..|+.|+++||+|||+. +|+||||||
T Consensus 117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 179 (345)
T 2v62_A 117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQN------------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKA 179 (345)
T ss_dssp EEEE-SSSCEEEEEEEECE-EEEHHHHCBGG------------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred cccc-cCCCcEEEEEEecc-CCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCH
Confidence 7542 34467889999999 99999998522 3789999999999999999999986 999999999
Q ss_pred CCeeecCCC--cEEEcccCccccccc
Q 003368 789 SNILLDNNL--TAHVGDFGLARLRQE 812 (825)
Q Consensus 789 ~NILl~~~~--~~ki~DFGla~~~~~ 812 (825)
+||+++.++ .+||+|||+|+.+..
T Consensus 180 ~NIll~~~~~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 180 ANLLLGYKNPDQVYLADYGLSYRYCP 205 (345)
T ss_dssp GGEEEESSSTTSEEECCCTTCEESSG
T ss_pred HHEEEccCCCCcEEEEeCCCceeccc
Confidence 999999887 999999999987754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-23 Score=222.90 Aligned_cols=149 Identities=23% Similarity=0.341 Sum_probs=126.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
++|...+.||+|+||.||+|+...+|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 85 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---- 85 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc----
Confidence 568899999999999999999988999999999865421 12345889999999999999999999853
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.+ ..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++
T Consensus 86 -~~-~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 86 -AE-DYYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS 148 (322)
T ss_dssp -SS-SEEEEEECCTTEETHHHHSTT------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred -CC-ceEEEEecCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence 22 379999999999999988532 3688999999999999999999986 999999999999998
Q ss_pred CCCc---EEEcccCccccccc
Q 003368 795 NNLT---AHVGDFGLARLRQE 812 (825)
Q Consensus 795 ~~~~---~ki~DFGla~~~~~ 812 (825)
.++. +||+|||+++....
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCC
T ss_pred cCCCCCeEEEccCccceeccc
Confidence 7654 99999999987644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=225.68 Aligned_cols=157 Identities=20% Similarity=0.300 Sum_probs=131.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchh-----------------HHHHHHHHHHhhcCCCCCcee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGA-----------------SKSFAAECRALRNIRHRNLVR 704 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~ 704 (825)
.++|...+.||+|+||.||+|+. +|+.||||++....... .+.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46799999999999999999998 89999999997543211 178999999999999999999
Q ss_pred EeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHh-cCCCCeee
Q 003368 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHH-HCQEPTIH 783 (825)
Q Consensus 705 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~-~~~~~ivH 783 (825)
+++++. ..+..++||||+++|+|.+++.....- .......+++..+..++.|++.||+|||+ . +|+|
T Consensus 108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l----~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVL----DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESS----CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhh----hhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 999854 356889999999999999994211000 00113578999999999999999999998 5 9999
Q ss_pred cCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 784 CDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 784 rdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
|||||+||+++.++.+||+|||+++....
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBT
T ss_pred cCCChHhEEEcCCCcEEEecccccccccc
Confidence 99999999999999999999999987644
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=224.31 Aligned_cols=151 Identities=27% Similarity=0.477 Sum_probs=124.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEE----EEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIV----AIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~v----AvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..+.||+|+||.||+|++..+++.| |+|.+.... ....+.+.+|++++++++||||++++++|..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------ 88 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 88 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES------
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec------
Confidence 56899999999999999999998787655 666664332 3456789999999999999999999998643
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++|+||+++|+|.+++... ...+++..+..|+.|+++||+|||+. +|+||||||+||+++.++
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~ 154 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred CCceEEEEecCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCC
Confidence 2378999999999999998532 24688999999999999999999986 899999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 155 ~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 155 HVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCTTC-------
T ss_pred CEEEccCcceeEccCc
Confidence 9999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=224.72 Aligned_cols=160 Identities=26% Similarity=0.374 Sum_probs=129.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCC--CCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRH--RNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~ 717 (825)
.+.|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++| |||+++++++. .+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 35688999999999999999998 5789999999975432 334678999999999987 99999999854 36
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||| +.+|+|.+++.. ...+++.++..|+.|+++||+|||+. +|+||||||+|||++ ++
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~ 144 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKK------------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG 144 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH------------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TT
T ss_pred CEEEEEEe-CCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CC
Confidence 68899999 568899999853 24688999999999999999999986 899999999999997 57
Q ss_pred cEEEcccCcccccccCCCC--CccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
.+||+|||+|+........ ....+||+
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173 (343)
T ss_dssp EEEECCCSSSCCC------------CCCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCc
Confidence 8999999999987554322 23445664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=5.6e-23 Score=225.60 Aligned_cols=153 Identities=24% Similarity=0.287 Sum_probs=126.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++.... ....+.+.+|+++++.++||||+++++++.... +.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467899999999999999999998899999999997543 234567889999999999999999999865321 12234
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++ +|.+++. ..+++.++..++.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ceEEEEEcCCC-CHHHHHh--------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCC
Confidence 68999999975 7877763 2478889999999999999999986 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 166 ~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 166 LKILDFGLARTAGT 179 (371)
T ss_dssp EEECCCCC------
T ss_pred EEEEEeeccccccc
Confidence 99999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=231.54 Aligned_cols=165 Identities=25% Similarity=0.347 Sum_probs=128.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~ 721 (825)
..|...++||+|+||+||+|++..+|+.||||++..... .+.+|++++++++|||||+++++|..... .+..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 358889999999999999999988999999999865422 23479999999999999999998754211 2233467
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CcEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN-LTAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~-~~~k 800 (825)
+||||+++ ++.+.+... ......+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+|
T Consensus 130 lv~e~~~~-~l~~~~~~~--------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHY--------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp EEEECCCE-EHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEE
T ss_pred eehhcccc-cHHHHHHHH--------hhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEE
Confidence 99999986 566555310 11235689999999999999999999985 99999999999999965 5789
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+....... ....+||+
T Consensus 198 l~DFG~a~~~~~~~~-~~~~~~t~ 220 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEP-NVSYICSR 220 (420)
T ss_dssp ECCCTTCEECCTTCC-CCSCCSCT
T ss_pred eccchhhhhcccCCC-ceeeeeCC
Confidence 999999997654332 23345553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=222.21 Aligned_cols=153 Identities=22% Similarity=0.301 Sum_probs=129.8
Q ss_pred cccccc-ceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCC
Q 003368 643 DGFSST-HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~-~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~ 718 (825)
+.|... +.||+|+||.||+|+...+|+.||||++..... ...+++.+|++++.+++ ||||+++++++ ...+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~~ 102 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENTS 102 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeCC
Confidence 445555 889999999999999988999999999976432 33578999999999995 69999999985 3467
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN--- 795 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~--- 795 (825)
..++||||+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPE----------LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSC----------C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred eEEEEEEecCCCcHHHHHHHh----------cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence 789999999999999998532 124689999999999999999999986 8999999999999988
Q ss_pred CCcEEEcccCcccccccC
Q 003368 796 NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~ 813 (825)
++.+||+|||+|+.....
T Consensus 170 ~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp BCCEEECCGGGCEEC---
T ss_pred CCcEEEeeCccccccCCc
Confidence 789999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=217.45 Aligned_cols=144 Identities=13% Similarity=0.051 Sum_probs=125.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
+.|...+.||+|+||.||+|++..+|+.||||++..... ...+.|.+|++.+++++||||+++++++. .++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence 468899999999999999999988899999999976533 23467999999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++... ....++.+|+.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCE
T ss_pred EEEEEEecCCCCHHHHHhcC--------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCE
Confidence 89999999999999998421 24456788999999999999986 99999999999999999999
Q ss_pred EEcccCccc
Q 003368 800 HVGDFGLAR 808 (825)
Q Consensus 800 ki~DFGla~ 808 (825)
||+++|...
T Consensus 169 kl~~~~~~~ 177 (286)
T 3uqc_A 169 VLAYPATMP 177 (286)
T ss_dssp EECSCCCCT
T ss_pred EEEeccccC
Confidence 999887643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-23 Score=218.89 Aligned_cols=154 Identities=21% Similarity=0.353 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL----QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|...+.||+|+||.||+|....+++.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 357999999999999999999998899999999997542 2345679999999999999999999998642 334
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
...++||||+++| +.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~----------~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~ 146 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSV----------PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGG 146 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHS----------TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred CeEEEEehhccCC-HHHHHHhC----------cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCC
Confidence 5789999999987 76766421 124689999999999999999999986 999999999999999999
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+++....
T Consensus 147 ~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 147 TLKISALGVAEALHP 161 (305)
T ss_dssp CEEECCCTTCEECCT
T ss_pred cEEeeccccccccCc
Confidence 999999999987653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=218.08 Aligned_cols=153 Identities=24% Similarity=0.470 Sum_probs=129.1
Q ss_pred hcccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
..++|...+.||+|+||.||+|++.. ++..||||.+.... ....+.|.+|++++++++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------ 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------
Confidence 35678899999999999999998643 34569999997653 234578999999999999999999999853
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+++|+|.+++.. ....+++..+..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLER-----------NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASP 149 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH-----------HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEET
T ss_pred CCCCEEEEecCCCCCHHHHHHh-----------ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCC
Confidence 2346899999999999999842 224589999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccccC
Q 003368 797 LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~ 813 (825)
+.+||+|||+++.....
T Consensus 150 ~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp TEEEECCCCGGGCC---
T ss_pred CcEEeCccCCCcccccc
Confidence 99999999999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=219.18 Aligned_cols=151 Identities=25% Similarity=0.423 Sum_probs=128.4
Q ss_pred cccccccc-eeccCCeeEEEEEEE--cCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 642 TDGFSSTH-LIGIGSFGSVYKGTF--DRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 642 ~~~f~~~~-~ig~G~~g~Vy~~~~--~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
.++|...+ .||+|+||.||+|.+ ..+++.||||+++.... ...+++.+|++++++++||||++++++|.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------ 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence 45677777 999999999999954 55678999999975532 23568999999999999999999999862
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCC
Confidence 35679999999999999998532 3588999999999999999999986 99999999999999999
Q ss_pred CcEEEcccCcccccccC
Q 003368 797 LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~ 813 (825)
+.+||+|||+++.....
T Consensus 154 ~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 154 HYAKISDFGLSKALRAD 170 (291)
T ss_dssp TEEEECCCTTCEECCTT
T ss_pred CcEEEccCCcceeeccC
Confidence 99999999999877544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=5e-23 Score=224.00 Aligned_cols=208 Identities=17% Similarity=0.097 Sum_probs=156.5
Q ss_pred CCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC-CcCCCCCCCCCE-EEcCCCCCCC
Q 003368 41 SKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI-PGNLSYCSRLIG-LYLGRNKLEG 118 (825)
Q Consensus 41 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~-L~Ls~N~l~~ 118 (825)
+++++ .+|..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +++|.++++|++ ++++.|+|+.
T Consensus 18 ~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~ 94 (350)
T 4ay9_X 18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 94 (350)
T ss_dssp STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCE
T ss_pred CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccc
Confidence 45554 566665 367999999999999776778999999999999999986654 467889988765 6677899998
Q ss_pred CCChhhhcccccceeeccccccccccCccCCCCCCCCEEEccc-CcCcccCCccccccc-ccceecCcCcCCccccCCCC
Q 003368 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAY-NSLGGNIPSSLGQLK-ELKSLGLGGTIPPSIYNLSL 196 (825)
Q Consensus 119 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~~~p~~i~~l~~ 196 (825)
+.|++|..+++|++|++++|++++..+..+....++..|++.+ |+++...+..|..+. .++.|
T Consensus 95 l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L--------------- 159 (350)
T 4ay9_X 95 INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL--------------- 159 (350)
T ss_dssp ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE---------------
T ss_pred cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhh---------------
Confidence 8889999999999999999999977777787888888898865 567655556666654 34444
Q ss_pred CceeecCCccccccCCchhhhcCCCCcEEEccc-ccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcE
Q 003368 197 LANFSVPENRLHGSLPPSLGLTLSNLQLFQISN-NFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272 (825)
Q Consensus 197 l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 272 (825)
++++|+++ .+|...+ ...+|+.|++++ |.++.+.+.+|..+++|++|+|++|++....+..|.++++|+.
T Consensus 160 ----~L~~N~i~-~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~ 230 (350)
T 4ay9_X 160 ----WLNKNGIQ-EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230 (350)
T ss_dssp ----ECCSSCCC-EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEEC
T ss_pred ----cccccccc-CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhh
Confidence 77777777 5666666 566788888864 6666655567888888888888888887666555554444443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=219.37 Aligned_cols=157 Identities=20% Similarity=0.256 Sum_probs=121.4
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch--hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG--ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..++|+..+.||+|+||.||+|+...+|+.||||++...... ..+.+.++...++.++||||+++++++. .++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence 346799999999999999999999899999999999765322 2234455566688899999999999864 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||++ |+|.+++... ......+++..+..|+.|++.||+|||+. .+|+||||||+||+++.++.
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~--------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~ 148 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQV--------IDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQ 148 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCC
T ss_pred CEEEEEehhc-cchHHHHHHH--------HhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCC
Confidence 7899999997 5888877421 12235789999999999999999999984 38999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 149 ~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 149 VKMCDFGISGYLVDD 163 (290)
T ss_dssp EEBCCC---------
T ss_pred EEEeecCCccccccc
Confidence 999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=222.98 Aligned_cols=160 Identities=26% Similarity=0.334 Sum_probs=117.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
..++|...+.||+|+||.||+|+...+++.||||++.... ....+++.+|++++++++||||+++++++. ..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence 3567999999999999999999988889999999987543 234567889999999999999999999864 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++...... .......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAK----GEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHT----TTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred cEEEehhccCCchHHHHHHHhhc----cccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCE
Confidence 89999999999999998521000 001124589999999999999999999986 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+++....
T Consensus 161 kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 161 QIADFGVSAFLAT 173 (303)
T ss_dssp EECCCHHHHHCC-
T ss_pred EEEeccchheecc
Confidence 9999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=217.14 Aligned_cols=150 Identities=29% Similarity=0.465 Sum_probs=124.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|+. +|+.||||+++... ..+.+.+|++++++++||||+++++++.. ..+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence 46788999999999999999997 58999999987543 45679999999999999999999998642 344679
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.+++.. .....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||
T Consensus 92 lv~e~~~~~~L~~~l~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l 158 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRS----------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 158 (278)
T ss_dssp EEECCCTTEEHHHHHHH----------HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCCHHHHHHh----------cccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEE
Confidence 99999999999999842 1223488999999999999999999986 8999999999999999999999
Q ss_pred cccCccccccc
Q 003368 802 GDFGLARLRQE 812 (825)
Q Consensus 802 ~DFGla~~~~~ 812 (825)
+|||+++....
T Consensus 159 ~Dfg~~~~~~~ 169 (278)
T 1byg_A 159 SDFGLTKEASS 169 (278)
T ss_dssp CCCCC------
T ss_pred eeccccccccc
Confidence 99999986544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=218.16 Aligned_cols=148 Identities=35% Similarity=0.535 Sum_probs=121.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.+.|...+.||+|+||.||+|++.. .||||+++.... ...+.|.+|++++++++||||+++++++. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence 4568889999999999999998732 599999975532 34567999999999999999999999742 345
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHAS-----------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC--------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred cEEEEEecCCCcHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCE
Confidence 79999999999999998532 24689999999999999999999986 89999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
||+|||+|+....
T Consensus 160 kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 160 KIGDFGLATEKSR 172 (289)
T ss_dssp EECCCC-------
T ss_pred EEccceecccccc
Confidence 9999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=223.00 Aligned_cols=167 Identities=23% Similarity=0.353 Sum_probs=134.5
Q ss_pred HhhcccccccceeccCCeeEEEEEEEcCCCe-----EEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeecccc
Q 003368 639 LKATDGFSSTHLIGIGSFGSVYKGTFDRDGT-----IVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSS 711 (825)
Q Consensus 639 ~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~-----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 711 (825)
....++|...+.||+|+||.||+|+...+++ .||||.+..... ...+.+.+|+++++++ +||||++++++|.
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 3445779999999999999999999866554 799999976543 3456799999999999 8999999999864
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCC--CCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIP--QTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
..+..++||||+++|+|.+++...... ...........+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 121 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 121 ----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp ----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred ----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 356789999999999999998532000 0000000123579999999999999999999986 9999999999
Q ss_pred CeeecCCCcEEEcccCcccccccC
Q 003368 790 NILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 790 NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
||+++.++.+||+|||+|+.....
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~ 217 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMND 217 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGC
T ss_pred eEEECCCCeEEECccccccccccc
Confidence 999999999999999999976544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.8e-23 Score=222.37 Aligned_cols=153 Identities=29% Similarity=0.430 Sum_probs=128.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhc--CCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRN--IRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|++ +|+.||||++... ..+.+.+|++++.. ++||||+++++++.... .....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~ 114 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 114 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccce
Confidence 45688999999999999999998 5899999998643 34567888888887 78999999999865311 11126
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeec
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-----QEPTIHCDLKPSNILLD 794 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-----~~~ivHrdlk~~NILl~ 794 (825)
.++||||+++|+|.+++.. ..+++.++..++.|+++||+|||... ..+|+||||||+||+++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred eEEEEeecCCCcHHHHHhc-------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 8999999999999999842 25899999999999999999999310 24899999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+|+.....
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~ 200 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSA 200 (342)
T ss_dssp TTSCEEECCCTTCEEEETT
T ss_pred CCCCEEEEECCCceecccc
Confidence 9999999999999877654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=219.89 Aligned_cols=150 Identities=31% Similarity=0.527 Sum_probs=129.5
Q ss_pred ccccceeccCCeeEEEEEEE----cCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 645 FSSTHLIGIGSFGSVYKGTF----DRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~----~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
|...+.||+|+||.||+|.+ ..+|+.||||++..... ...+.+.+|++++++++||||+++++++.. .+...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence 47889999999999988865 34789999999986543 345679999999999999999999998753 23467
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEecccCCcHHHHHhhC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCE
Confidence 89999999999999998532 488999999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+|+.....
T Consensus 174 kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 174 KIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCGGGCEECCTT
T ss_pred EECCcccccccccc
Confidence 99999999987554
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-23 Score=222.40 Aligned_cols=161 Identities=31% Similarity=0.553 Sum_probs=130.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEE--EEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIV--AIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~v--AvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+.||+|+||.||+|+...+|..+ |||.+.... ....+.+.+|+++++++ +||||+++++++. ..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence 56888999999999999999998888765 999987533 23445789999999999 8999999999864 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcc----cchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDE----ENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
..++||||+++|+|.+++.......... .......+++.++..++.|+++||+|||+. +|+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 7899999999999999996431000000 001124689999999999999999999985 999999999999999
Q ss_pred CCCcEEEcccCcccccc
Q 003368 795 NNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~ 811 (825)
.++.+||+|||+++...
T Consensus 177 ~~~~~kL~Dfg~~~~~~ 193 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQE 193 (327)
T ss_dssp GGGCEEECCTTCEESSC
T ss_pred CCCeEEEcccCcCcccc
Confidence 99999999999998543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.4e-23 Score=226.39 Aligned_cols=159 Identities=26% Similarity=0.387 Sum_probs=129.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCC--CCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR--HRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~ 718 (825)
..|...+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++ |||||++++++. .++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 45899999999999999999984 59999999997543 234568999999999997 599999999864 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||| +.+|+|.+++... ..+++.++..|+.|+++||+|||+. +|+||||||+|||++ ++.
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~ 192 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGM 192 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC------------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSC
T ss_pred EEEEEEe-cCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCe
Confidence 7899999 5688999998532 3678899999999999999999985 899999999999996 579
Q ss_pred EEEcccCcccccccCCCC--CccccccC
Q 003368 799 AHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
+||+|||+|+........ ....+||+
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 193 LKLIDFGIANQMQPDTTSVVKDSQVGAV 220 (390)
T ss_dssp EEECCCSSSCCC---------CCSCCCG
T ss_pred EEEEecCccccccCCCccccCCCCCcCC
Confidence 999999999987554321 23445664
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=203.50 Aligned_cols=185 Identities=23% Similarity=0.254 Sum_probs=145.0
Q ss_pred CCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCC
Q 003368 18 HFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIP 97 (825)
Q Consensus 18 ~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 97 (825)
-.|.|.++.|.. +++. .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+
T Consensus 5 C~C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 5 CSCSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp CEEETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 357898888864 2332 344443 4589999999999998777788999999999999999998888
Q ss_pred cCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccc
Q 003368 98 GNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 177 (825)
..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 88899999999999999999877778899999999999999999887888899999999999999998766666777777
Q ss_pred cceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCC
Q 003368 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNAS 244 (825)
Q Consensus 178 L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 244 (825)
|++| ++++|.+.+ .+++|+.|+++.|+++|.+|..+++++
T Consensus 150 L~~L-------------------~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 150 LQYI-------------------WLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp CCEE-------------------ECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred ccEE-------------------EecCCCeec--------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 6666 555555543 344566666666666666666555544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=214.91 Aligned_cols=151 Identities=26% Similarity=0.429 Sum_probs=128.8
Q ss_pred ccccccc-eeccCCeeEEEEEEEc--CCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTH-LIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~-~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+ .||+|+||.||+|++. .+++.||||+++... ....+.+.+|++++++++||||+++++++. .+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence 4455555 8999999999999863 468899999997653 334578999999999999999999999862 34
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~ 148 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK-----------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 148 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-----------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred CcEEEEEeCCCCCHHHHHHhC-----------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCC
Confidence 589999999999999998532 23589999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+++.....
T Consensus 149 ~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 149 AKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCCTTCEECTTC
T ss_pred EEECcccceeeeccC
Confidence 999999999977543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=239.57 Aligned_cols=263 Identities=19% Similarity=0.240 Sum_probs=141.0
Q ss_pred cCCccccCCCCCCEEECCCCcCCCCC----CcCCCCCCCCCEEEcCCC---CCCCCCChhh-------hcccccceeecc
Q 003368 71 KIPGEIGRLFRLEALYLSHNSLVGEI----PGNLSYCSRLIGLYLGRN---KLEGSIPSEF-------VSLYNLKELAIQ 136 (825)
Q Consensus 71 ~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~L~ 136 (825)
.++..+..+++|++|+|++|.|+... +..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 45555666666666666666666542 233556666666666664 3334445444 566777777777
Q ss_pred cccccc----ccCccCCCCCCCCEEEcccCcCcccCCcccccc-cccceecCcCcCCccccCCCCCceeecCCccccccC
Q 003368 137 ENNLTG----GIPHFLGNITSLEAISLAYNSLGGNIPSSLGQL-KELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211 (825)
Q Consensus 137 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~l 211 (825)
+|.+++ .+|..+..+++|++|+|++|.++...+..+... ..+ ..|++.+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l------------------------~~~~~~~-- 156 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL------------------------AVNKKAK-- 156 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH------------------------HHHHHHH--
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH------------------------hhhhhcc--
Confidence 777765 356666777777777777777764433333221 100 0011110
Q ss_pred CchhhhcCCCCcEEEcccccCC-CCCC---ccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCc
Q 003368 212 PPSLGLTLSNLQLFQISNNFFS-GSFP---LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDE 287 (825)
Q Consensus 212 p~~~~~~l~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~ 287 (825)
..++|++|+|++|.++ +.+| ..|..+++|+.|+|++|++...--.
T Consensus 157 ------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~------------------------- 205 (386)
T 2ca6_A 157 ------NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE------------------------- 205 (386)
T ss_dssp ------TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHH-------------------------
T ss_pred ------cCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHH-------------------------
Confidence 1144555555555544 2222 2344555566666666655311000
Q ss_pred cccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc----CCcccc--CCCCCCEEE
Q 003368 288 MSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK----IPEEMS--RLQNLQFLN 361 (825)
Q Consensus 288 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~----~p~~~~--~l~~L~~L~ 361 (825)
...+..+..+++|+.|+|++|.++... .+.+|..+..+++|+.|+|++|.+++. +|..+. .+++|++|+
T Consensus 206 ~l~~~~l~~~~~L~~L~Ls~n~l~~~g-----~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 206 HLLLEGLAYCQELKVLDLQDNTFTHLG-----SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHTTGGGCTTCCEEECCSSCCHHHH-----HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HHHHHHhhcCCCccEEECcCCCCCcHH-----HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 000113344455555555555553100 003455556666666666666666654 455553 367777777
Q ss_pred cccccccc----ccCccc-cCCCCCcEEEcccCcccccc
Q 003368 362 MRHNQLSG----EIPSSF-GNLSSLVKLILGNNNLSGVI 395 (825)
Q Consensus 362 Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 395 (825)
|++|.+.+ .+|..+ .++++|++|+|++|++++..
T Consensus 281 L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 77777775 366655 55677777777777777544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=223.40 Aligned_cols=153 Identities=24% Similarity=0.355 Sum_probs=125.9
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 718 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... ...+.+.+|++++++++||||+++++++..... ....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578889999999999999999989999999999976432 235678899999999999999999998653211 0111
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+. |+|.+++. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred eEEEEEcccc-ccHHHHhh--------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCC
Confidence 2499999997 68887763 2488999999999999999999986 9999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+|+....
T Consensus 183 ~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 183 LKILDFGLARHADA 196 (371)
T ss_dssp EEECSTTCC-----
T ss_pred EEEEecCccccccc
Confidence 99999999987644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=221.77 Aligned_cols=158 Identities=27% Similarity=0.417 Sum_probs=127.3
Q ss_pred cccccccceeccCCeeEEEEEE-----EcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGT-----FDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~-----~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|...+.||+|+||.||+|+ ...+++.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 3578899999999999999999 44577899999997543 334567999999999999999999999854
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.....++||||+++|+|.+++...... ......+++.++..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPR-----PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC 175 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCC-----SSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhccc-----ccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEec
Confidence 356679999999999999999643211 11124589999999999999999999986 8999999999999984
Q ss_pred ---CCcEEEcccCccccccc
Q 003368 796 ---NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 ---~~~~ki~DFGla~~~~~ 812 (825)
+..+||+|||+++....
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~ 195 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYR 195 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC
T ss_pred CCCcceEEECcccccccccc
Confidence 44699999999986544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.8e-23 Score=241.88 Aligned_cols=153 Identities=24% Similarity=0.325 Sum_probs=127.7
Q ss_pred ccccccceeccCCeeEEEEEEEcC-CCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR-DGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|...+.||+|+||+||+|++.. +|+.||||++.... ....+.|.+|++++++++|||||+++++|......+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 578999999999999999999965 78999999986543 2345678999999999999999999999765322222236
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||||+++|+|.+++. ..++|.++..|+.||++||+|||+. +||||||||+|||++.+ .+|
T Consensus 160 ~lv~E~~~g~~L~~~~~--------------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG--------------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp EEEEECCCCEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEE
T ss_pred EEEEEeCCCCcHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEE
Confidence 99999999999987763 1589999999999999999999986 89999999999999986 899
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+++.....
T Consensus 222 l~DFG~a~~~~~~ 234 (681)
T 2pzi_A 222 LIDLGAVSRINSF 234 (681)
T ss_dssp ECCCTTCEETTCC
T ss_pred EEecccchhcccC
Confidence 9999999976543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=215.43 Aligned_cols=152 Identities=26% Similarity=0.421 Sum_probs=127.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|...+.||+|+||.||+|+...+|+.||||++..... .+.+.+|++++++++|++++..+++|. ...+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence 34679999999999999999999988999999998765432 235789999999999999888887763 345678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~ 797 (825)
++||||+ +|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-----------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTT
T ss_pred EEEEEcc-CCCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCC
Confidence 9999999 99999998521 23589999999999999999999986 89999999999999 7889
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 146 ~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CEEECCCTTCEECBCT
T ss_pred eEEEecCccceeccCc
Confidence 9999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=214.66 Aligned_cols=152 Identities=26% Similarity=0.419 Sum_probs=131.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... .+++.+|++++++++|++++..+.+|. ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence 4679999999999999999999988999999999875432 346889999999999999887777653 2456789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCc
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLT 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~~ 798 (825)
+||||+ +|+|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+||++ +.++.
T Consensus 82 lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~ 146 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC-----------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTC
T ss_pred EEEEec-CCCHHHHHHhh-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCe
Confidence 999999 99999998521 23689999999999999999999986 99999999999999 58889
Q ss_pred EEEcccCcccccccCC
Q 003368 799 AHVGDFGLARLRQEVP 814 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~ 814 (825)
+||+|||+|+......
T Consensus 147 ~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCTTCEECBCTT
T ss_pred EEEeeCCCcccccccc
Confidence 9999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=226.67 Aligned_cols=151 Identities=25% Similarity=0.394 Sum_probs=127.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC------CCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI------RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 715 (825)
..+|+..+.||+|+||+||+|+...+++.||||+++.. ....+++.+|+++++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----- 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----- 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence 34688999999999999999999889999999999754 23345677888888776 5779999999854
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.....++||||+. |+|.+++... ....++|..+..|+.|+++||+|||+. +||||||||+|||++.
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~ 235 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKN----------KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQ 235 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESS
T ss_pred cCCeEEEEEeccC-CCHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcc
Confidence 3567899999996 6999988532 123589999999999999999999986 8999999999999999
Q ss_pred CCc--EEEcccCccccccc
Q 003368 796 NLT--AHVGDFGLARLRQE 812 (825)
Q Consensus 796 ~~~--~ki~DFGla~~~~~ 812 (825)
++. +||+|||+|+....
T Consensus 236 ~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 236 QGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp TTSCCEEECCCTTCEETTC
T ss_pred CCCcceEEeecccceecCC
Confidence 887 99999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=216.00 Aligned_cols=151 Identities=24% Similarity=0.368 Sum_probs=127.4
Q ss_pred cccccc-ceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHh-hcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSST-HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRAL-RNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~-~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|... ++||+|+||.||+|+...+|+.||||+++.. ..+.+|++++ +..+||||+++++++... +.+....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence 456665 7899999999999999899999999998642 4567888888 566899999999986431 2235568
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~~ 797 (825)
++||||+++|+|.+++... ....+++.++..++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC----------TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTC
T ss_pred EEEEeecCCCcHHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCC
Confidence 9999999999999998532 123589999999999999999999985 8999999999999998 78
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 158 ~~kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 158 ILKLTDFGFAKETTG 172 (299)
T ss_dssp CEEECCCTTCEECTT
T ss_pred cEEEecccccccccc
Confidence 999999999987654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=224.78 Aligned_cols=155 Identities=11% Similarity=0.039 Sum_probs=112.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHH---HHhhcCCCCCceeEeeccc----c
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAEC---RALRNIRHRNLVRVITSCS----S 711 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~H~niv~l~~~~~----~ 711 (825)
...|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+ +.++. +||||++++..+. .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 4458889999999999999999988999999999987542 2345677785 55555 7999888553321 0
Q ss_pred cccCC---------------CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHH------HHHHHHHHHHH
Q 003368 712 IDFQG---------------NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER------ISIAIDVASAV 770 (825)
Q Consensus 712 ~~~~~---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~va~~l 770 (825)
....+ ....++||||++ |+|.+++... ...+.+..+ ..++.|+++||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------~~~~~~~~~~~~~vk~~i~~qi~~aL 207 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-----------DFVYVFRGDEGILALHILTAQLIRLA 207 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-----------HHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-----------ccccchhhhhhhhhHHHHHHHHHHHH
Confidence 00000 034799999999 8999999531 123455556 78889999999
Q ss_pred HHHHhcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 771 ~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+|||+. +||||||||+|||++.++.+||+|||+|+....
T Consensus 208 ~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 208 ANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp HHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred HHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 999986 899999999999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=220.22 Aligned_cols=153 Identities=24% Similarity=0.354 Sum_probs=127.2
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~ 718 (825)
.++|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3568889999999999999999988999999999975432 235678999999999999999999998643110 0112
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||++ |+|.+++. ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~ 164 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCE 164 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCC
T ss_pred eEEEEecccc-CCHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCc
Confidence 3599999997 68887763 2488999999999999999999986 8999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 165 ~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 165 LKILDFGLARHADA 178 (353)
T ss_dssp EEECSTTCTTC---
T ss_pred EEEeecccccCCCC
Confidence 99999999987543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-23 Score=228.38 Aligned_cols=121 Identities=17% Similarity=0.208 Sum_probs=90.5
Q ss_pred CCCEEEcCCCcccccCCccccCC--CCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCC-CChhhhccccccee
Q 003368 57 FLREIHLSNNTIQGKIPGEIGRL--FRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGS-IPSEFVSLYNLKEL 133 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 133 (825)
.++.||+++|.+. |..+..+ .+++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4788889888876 5666666 7888889988888877665 45688888888888888765 77778888888888
Q ss_pred eccccccccccCccCCCCCCCCEEEcccC-cCcc-cCCccccccccccee
Q 003368 134 AIQENNLTGGIPHFLGNITSLEAISLAYN-SLGG-NIPSSLGQLKELKSL 181 (825)
Q Consensus 134 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~-~~p~~~~~l~~L~~L 181 (825)
+|++|++++..+..|+.+++|++|+|++| .+++ .++..+..+++|++|
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L 173 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 173 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEE
Confidence 88888888777777888888888888888 5654 234444444444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-23 Score=236.32 Aligned_cols=210 Identities=22% Similarity=0.291 Sum_probs=170.7
Q ss_pred ccccCCCCCCCCc-----eeece-eecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCC
Q 003368 8 GVLNSWNDSHHFC-----DWEGI-TCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFR 81 (825)
Q Consensus 8 ~~~~~w~~~~~~C-----~~~g~-~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 81 (825)
..+.+|....++| .|.++ .|.. .+++.|+|++|++.+ +|..+. ++|++|+|++|+|+ .+| ..+++
T Consensus 31 ~~l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~ 101 (571)
T 3cvr_A 31 SAWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPAS 101 (571)
T ss_dssp HHHHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTT
T ss_pred HHHHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCC
Confidence 3467797777888 79999 7864 479999999999987 777664 88999999999999 677 45799
Q ss_pred CCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEccc
Q 003368 82 LEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAY 161 (825)
Q Consensus 82 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 161 (825)
|++|+|++|+|++ +|. |.. +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++
T Consensus 102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 9999999999997 666 665 99999999999997 565 68999999999999996 565 578999999999
Q ss_pred CcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCC-------cEEEcccccCCC
Q 003368 162 NSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNL-------QLFQISNNFFSG 234 (825)
Q Consensus 162 N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L-------~~L~Ls~N~l~~ 234 (825)
|+|++ +|. |. ++|+.| +|++|+|+ .+|. +. . +| +.|+|++|+|+.
T Consensus 170 N~L~~-lp~-l~--~~L~~L-------------------~Ls~N~L~-~lp~-~~-~--~L~~~~~~L~~L~Ls~N~l~~ 221 (571)
T 3cvr_A 170 NQLTF-LPE-LP--ESLEAL-------------------DVSTNLLE-SLPA-VP-V--RNHHSEETEIFFRCRENRITH 221 (571)
T ss_dssp SCCSC-CCC-CC--TTCCEE-------------------ECCSSCCS-SCCC-CC-----------CCEEEECCSSCCCC
T ss_pred CCCCC-cch-hh--CCCCEE-------------------ECcCCCCC-chhh-HH-H--hhhcccccceEEecCCCccee
Confidence 99986 665 55 666666 77788887 6776 43 2 56 999999999984
Q ss_pred CCCccccCCCCccEEEeecccccCccccCcCCC
Q 003368 235 SFPLAFSNASNLQSLEILGNNFFGKLSVNFGDM 267 (825)
Q Consensus 235 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 267 (825)
+|..+.++++|+.|+|++|++.+.+|..+..+
T Consensus 222 -lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 222 -IPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp -CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred -cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 67777779999999999999988776655443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=224.57 Aligned_cols=154 Identities=25% Similarity=0.325 Sum_probs=122.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~ 721 (825)
..|...++||+|+||+||+|++..++ .||||++..... ...+|+++++.++|||||++++++..... .+..+.+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45888999999999999999996554 589998864322 22379999999999999999998754221 2334578
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCcEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~-~~~~~k 800 (825)
+||||++++.+....+. ......+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+|
T Consensus 115 lv~e~~~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHY---------AKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp EEEECCSEEHHHHHHHH---------HHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred EEeeccCccHHHHHHHH---------HhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEE
Confidence 99999987544333210 11234689999999999999999999986 999999999999999 799999
Q ss_pred EcccCcccccccC
Q 003368 801 VGDFGLARLRQEV 813 (825)
Q Consensus 801 i~DFGla~~~~~~ 813 (825)
|+|||+|+.....
T Consensus 183 L~DFG~a~~~~~~ 195 (394)
T 4e7w_A 183 LIDFGSAKILIAG 195 (394)
T ss_dssp ECCCTTCEECCTT
T ss_pred EeeCCCcccccCC
Confidence 9999999987544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=221.24 Aligned_cols=167 Identities=22% Similarity=0.284 Sum_probs=121.1
Q ss_pred HHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeeccccccc-
Q 003368 636 ESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDF- 714 (825)
Q Consensus 636 ~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 714 (825)
.+.....++|...+.||+|+||.||+|++..+|+.||||++..... ..+.+.+|++.++.++|||||++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 3445567889999999999999999999988999999999865432 23456788888999999999999999754221
Q ss_pred -CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 715 -QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 715 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
....+.++||||+++ ++.+.+... ......+++..+..++.|++.|++|||.+ ..+|+||||||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNY--------YRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLV 164 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHH--------HTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHH--------hhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEE
Confidence 122347899999986 444443210 11234678889999999999999999932 2499999999999999
Q ss_pred cC-CCcEEEcccCcccccccC
Q 003368 794 DN-NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 794 ~~-~~~~ki~DFGla~~~~~~ 813 (825)
+. ++.+||+|||+|+.....
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~ 185 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPS 185 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTT
T ss_pred eCCCCcEEEeeCCCceecCCC
Confidence 96 899999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-22 Score=211.45 Aligned_cols=152 Identities=25% Similarity=0.378 Sum_probs=132.1
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|+...+++.||||++..... ...+.+.+|++++++++||||+++++++. ....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 3568899999999999999999988999999999975432 34578999999999999999999999853 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN--- 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~--- 796 (825)
.++||||+++++|.+++.. ...+++.++..++.|+++||+|||+. +|+||||||+||+++.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK------------RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred EEEEEEccCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCc
Confidence 8999999999999988742 24689999999999999999999986 99999999999999754
Q ss_pred CcEEEcccCcccccccC
Q 003368 797 LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~ 813 (825)
+.+||+|||+++.....
T Consensus 161 ~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCEEECSTTGGGTBCCC
T ss_pred ccEEEeccCcceeecCC
Confidence 47999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=218.17 Aligned_cols=159 Identities=28% Similarity=0.446 Sum_probs=130.7
Q ss_pred hhcccccccceeccCCeeEEEEEEEc-CCCeEEEEEEeecccc--hhHHHHHHHHHHhhcC---CCCCceeEeecccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFD-RDGTIVAIKVLNLQLQ--GASKSFAAECRALRNI---RHRNLVRVITSCSSID 713 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~-~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~ 713 (825)
++.++|...+.||+|+||.||+|+.. .+|+.||||++..... .....+.+|+++++.+ +||||++++++|....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45578999999999999999999984 6789999999975432 1233566788777766 8999999999875322
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.......++||||++ |+|.+++... ....+++.++..++.|+++||+|||+. +|+||||||+||++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili 153 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV----------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILV 153 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS----------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEE
Confidence 234567899999998 6999998532 123488999999999999999999986 99999999999999
Q ss_pred cCCCcEEEcccCccccccc
Q 003368 794 DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~ 812 (825)
+.++.+||+|||+++....
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~ 172 (326)
T 1blx_A 154 TSSGQIKLADFGLARIYSF 172 (326)
T ss_dssp CTTCCEEECSCCSCCCCCG
T ss_pred cCCCCEEEecCcccccccC
Confidence 9999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=224.67 Aligned_cols=152 Identities=14% Similarity=0.185 Sum_probs=124.8
Q ss_pred ccccccceeccCCeeEEEEEEEcC--------CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccc---
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDR--------DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSS--- 711 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--- 711 (825)
++|...+.||+|+||.||+|+... .++.||||++... +.+.+|++++++++|||||++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 579999999999999999999976 3889999998754 457899999999999999984332110
Q ss_pred --------cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 003368 712 --------IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIH 783 (825)
Q Consensus 712 --------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivH 783 (825)
....++...++||||+ +|+|.+++... ....+++.++..|+.|+++||+|||+. +|+|
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH 182 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS----------PKHVLSERSVLQVACRLLDALEFLHEN---EYVH 182 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC----------CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence 0012356789999999 99999999522 135799999999999999999999986 9999
Q ss_pred cCCCCCCeeecCCC--cEEEcccCcccccccC
Q 003368 784 CDLKPSNILLDNNL--TAHVGDFGLARLRQEV 813 (825)
Q Consensus 784 rdlk~~NILl~~~~--~~ki~DFGla~~~~~~ 813 (825)
|||||+||+++.++ .+||+|||+|+.....
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 214 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGG
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCC
Confidence 99999999999998 9999999999877543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-24 Score=238.21 Aligned_cols=257 Identities=16% Similarity=0.193 Sum_probs=171.1
Q ss_pred CChhhhcccccceeecccccccccc----CccCCCCCCCCEEEcccC---cCcccCCcccccccccceecCcCcCCcccc
Q 003368 120 IPSEFVSLYNLKELAIQENNLTGGI----PHFLGNITSLEAISLAYN---SLGGNIPSSLGQLKELKSLGLGGTIPPSIY 192 (825)
Q Consensus 120 ~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~ 192 (825)
++..+..+++|++|+|++|++++.. +..|..+++|++|+|++| ++++.+|..+..+. ..+.
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~------------~~l~ 91 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL------------QALL 91 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHH------------HHHT
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHH------------HHHh
Confidence 4455555555666666666555432 223555666666666654 33334444332110 1222
Q ss_pred CCCCCceeecCCccccc----cCCchhhhcCCCCcEEEcccccCCCCCCccc----cCC---------CCccEEEeeccc
Q 003368 193 NLSLLANFSVPENRLHG----SLPPSLGLTLSNLQLFQISNNFFSGSFPLAF----SNA---------SNLQSLEILGNN 255 (825)
Q Consensus 193 ~l~~l~~l~l~~N~l~~----~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~ 255 (825)
.++.|+.|+|++|.+++ .+|..+. .+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+
T Consensus 92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLS-KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHH-HCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hCCcccEEECCCCcCCHHHHHHHHHHHH-hCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 23333333555566554 2444444 67777777777777754333333 333 899999999999
Q ss_pred ccC-ccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcC
Q 003368 256 FFG-KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLY 334 (825)
Q Consensus 256 l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~ 334 (825)
+.. .++ .+...+..+++|+.|+|++|.++... +...+|..+..+++|+
T Consensus 171 l~~~~~~---------------------------~l~~~l~~~~~L~~L~L~~n~l~~~g----~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 171 LENGSMK---------------------------EWAKTFQSHRLLHTVKMVQNGIRPEG----IEHLLLEGLAYCQELK 219 (386)
T ss_dssp CTGGGHH---------------------------HHHHHHHHCTTCCEEECCSSCCCHHH----HHHHHHTTGGGCTTCC
T ss_pred CCcHHHH---------------------------HHHHHHHhCCCcCEEECcCCCCCHhH----HHHHHHHHhhcCCCcc
Confidence 862 221 11235667788999999999886200 0001333778899999
Q ss_pred EEEcccCccc----ccCCccccCCCCCCEEEccccccccc----cCccc--cCCCCCcEEEcccCcccc----ccCCCC-
Q 003368 335 LIEMDHNQFE----GKIPEEMSRLQNLQFLNMRHNQLSGE----IPSSF--GNLSSLVKLILGNNNLSG----VIPSSL- 399 (825)
Q Consensus 335 ~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~- 399 (825)
.|+|++|.++ +.+|..+..+++|++|+|++|++.+. +|..+ +.+++|++|+|++|.+++ .+|..+
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~ 299 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHH
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHH
Confidence 9999999996 67888999999999999999999866 56766 448999999999999998 477776
Q ss_pred CCCCccceeecCCCCCccccc
Q 003368 400 GNLKQLALLHLFQNDLSGAIP 420 (825)
Q Consensus 400 ~~l~~L~~L~L~~N~l~g~ip 420 (825)
.++++|+.|++++|.+++..|
T Consensus 300 ~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 300 EKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHCTTCCEEECTTSBSCTTSH
T ss_pred hcCCCceEEEccCCcCCcchh
Confidence 668999999999999997664
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-23 Score=219.02 Aligned_cols=153 Identities=25% Similarity=0.298 Sum_probs=125.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------hHHHHHHHHHHhhcC----CCCCceeEeeccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------ASKSFAAECRALRNI----RHRNLVRVITSCS 710 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~~~~~ 710 (825)
-.++|...+.||+|+||.||+|+...+|+.||||++...... ....+.+|++++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 346799999999999999999999889999999999754321 223456799999888 8999999999853
Q ss_pred ccccCCCCeeeEEEEc-cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 003368 711 SIDFQGNDFKALVYQY-MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPS 789 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~ 789 (825)
..+..++|||| +++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+
T Consensus 109 -----~~~~~~~v~e~~~~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 168 (312)
T 2iwi_A 109 -----TQEGFMLVLERPLPAQDLFDYITE------------KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE 168 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred -----cCCeEEEEEEecCCCCCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence 35678999999 799999999842 24689999999999999999999986 8999999999
Q ss_pred Ceeec-CCCcEEEcccCcccccccC
Q 003368 790 NILLD-NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 790 NILl~-~~~~~ki~DFGla~~~~~~ 813 (825)
||+++ .++.+||+|||+++.....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDE 193 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSS
T ss_pred hEEEeCCCCeEEEEEcchhhhcccC
Confidence 99999 8899999999999987543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=226.52 Aligned_cols=152 Identities=26% Similarity=0.399 Sum_probs=127.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||.||+|++..+|+.||||++..... .+++.+|+++++.++|++.+..+.++. ...+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 3679999999999999999999988999999998875432 245789999999999755554444332 2356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCc
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL---DNNLT 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl---~~~~~ 798 (825)
+||||+ +|+|.+++... ...++|.++..|+.||+.||+|||+. +||||||||+|||+ +.++.
T Consensus 80 lvme~~-g~sL~~ll~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-----------SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTC
T ss_pred EEEECC-CCCHHHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCe
Confidence 999999 99999998521 24689999999999999999999986 99999999999999 68899
Q ss_pred EEEcccCcccccccCC
Q 003368 799 AHVGDFGLARLRQEVP 814 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~ 814 (825)
+||+|||+|+......
T Consensus 145 vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCTTCEECBCTT
T ss_pred EEEEeCCcceeccCCc
Confidence 9999999999876543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.6e-22 Score=210.93 Aligned_cols=172 Identities=23% Similarity=0.334 Sum_probs=105.8
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccce
Q 003368 53 GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKE 132 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 132 (825)
..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ |..+++|++|+|++|++++. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 356677777777777763 44 56777777777777777775444 77777777777777777753 35777777777
Q ss_pred eeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCC
Q 003368 133 LAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLP 212 (825)
Q Consensus 133 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp 212 (825)
|+|++|++++. + .+..+++|+.|+|++|++++..+ +..+++|+.| ++++|++++ ++
T Consensus 112 L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L-------------------~l~~n~l~~-~~ 167 (308)
T 1h6u_A 112 LDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL-------------------SIGNAQVSD-LT 167 (308)
T ss_dssp EECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE-------------------ECCSSCCCC-CG
T ss_pred EECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEE-------------------EccCCcCCC-Ch
Confidence 77777777753 2 26777777777777777764332 4444444444 444454442 22
Q ss_pred chhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccC
Q 003368 213 PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFG 258 (825)
Q Consensus 213 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 258 (825)
. + ..+++|+.|+|++|++++..+ +..+++|+.|+|++|++.+
T Consensus 168 ~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~ 209 (308)
T 1h6u_A 168 P-L-ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209 (308)
T ss_dssp G-G-TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCB
T ss_pred h-h-cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCc
Confidence 2 2 245555555555555554332 4555555555555555543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=235.02 Aligned_cols=152 Identities=25% Similarity=0.407 Sum_probs=130.2
Q ss_pred cccccccceeccCCeeEEEEEEEcC---CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR---DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|...+.||+|+||.||+|++.. .+..||||.+..... ...+.|.+|+.++++++|||||+++++|. +
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------c
Confidence 4568888999999999999999854 356899999875433 33568999999999999999999999863 3
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~ 528 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-----------KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 528 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-----------TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred CceEEEEEcCCCCcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCC
Confidence 4579999999999999998522 23589999999999999999999986 999999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 529 ~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 529 CVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEEECCCCCCCSCCC-
T ss_pred CEEEEecCCCeecCCC
Confidence 9999999999987554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=212.89 Aligned_cols=152 Identities=31% Similarity=0.450 Sum_probs=122.1
Q ss_pred cccccccceeccCCeeEEEEEEEcC-CC--eEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDR-DG--TIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~-~g--~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|+..+.||+|+||.||+|++.. ++ ..||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 92 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 92 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence 3568899999999999999998643 33 369999987542 2345789999999999999999999998642
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
...++||||+++|+|.+++.. ....+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 93 --~~~~~v~e~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~ 156 (291)
T 1u46_A 93 --PPMKMVTELAPLGSLLDRLRK-----------HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLAT 156 (291)
T ss_dssp --SSCEEEEECCTTCBHHHHHHH-----------HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEE
T ss_pred --CCceeeEecccCCCHHHHHHh-----------ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcC
Confidence 237899999999999999842 224689999999999999999999986 9999999999999999
Q ss_pred CCcEEEcccCcccccccC
Q 003368 796 NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~ 813 (825)
++.+||+|||+++.....
T Consensus 157 ~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 157 RDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp TTEEEECCCTTCEECCC-
T ss_pred CCCEEEcccccccccccc
Confidence 999999999999887544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=222.84 Aligned_cols=156 Identities=26% Similarity=0.354 Sum_probs=116.5
Q ss_pred ccc-cceeccCCeeEEEEEEEc--CCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 645 FSS-THLIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~-~~~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
|.. .++||+|+||.||+|+++ .+++.||||++.... ..+.+.+|++++++++|||||++++++.. ......+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence 544 568999999999999975 468899999997542 23578899999999999999999998643 3356789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCC
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL----DNNL 797 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl----~~~~ 797 (825)
+||||++ |+|.+++...... ........+++..+..|+.|++.||+|||+. +|+||||||+|||+ +.++
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRAS---KANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHH---C-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred EEEeCCC-CCHHHHHHHhccc---cccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 9999997 5888877421000 0001123589999999999999999999986 89999999999999 7788
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 170 ~~kl~Dfg~a~~~~~ 184 (405)
T 3rgf_A 170 RVKIADMGFARLFNS 184 (405)
T ss_dssp CEEECCTTCCC----
T ss_pred cEEEEECCCceecCC
Confidence 999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=216.32 Aligned_cols=152 Identities=25% Similarity=0.302 Sum_probs=130.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch------hHHHHHHHHHHhhcCC--CCCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG------ASKSFAAECRALRNIR--HRNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~ 713 (825)
.++|...+.||+|+||.||+|+...+|+.||||++...... ..+.+.+|++++++++ ||||+++++++.
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--- 118 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 118 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence 46689999999999999999999899999999999754321 2245678999999996 599999999853
Q ss_pred cCCCCeeeEEEEccCC-CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 714 FQGNDFKALVYQYMPN-GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.++..++||||+.+ ++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+
T Consensus 119 --~~~~~~lv~e~~~~~~~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 181 (320)
T 3a99_A 119 --RPDSFVLILERPEPVQDLFDFITE------------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL 181 (320)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred --cCCcEEEEEEcCCCCccHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEE
Confidence 46678999999986 899999842 24689999999999999999999985 9999999999999
Q ss_pred ec-CCCcEEEcccCcccccccC
Q 003368 793 LD-NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 793 l~-~~~~~ki~DFGla~~~~~~ 813 (825)
++ +++.+||+|||+++.....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~ 203 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDT 203 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSS
T ss_pred EeCCCCCEEEeeCccccccccc
Confidence 99 7899999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=221.54 Aligned_cols=140 Identities=25% Similarity=0.399 Sum_probs=115.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC--------CCCceeEeeccccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR--------HRNLVRVITSCSSIDF 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~~~~~ 714 (825)
++|...+.||+|+||+||+|+...+|+.||||++... ....+.+.+|++++++++ ||||+++++++... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~-~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-G 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE-E
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec-C
Confidence 5689999999999999999999899999999999754 334567889999999986 78899999986421 1
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
......++||||+ +|++.+++... ....+++..+..|+.|+++||+|||+.+ +|+||||||+|||++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~ 181 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS----------NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLS 181 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEEC
T ss_pred CCCceEEEEEecc-CccHHHHHHhc----------ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEe
Confidence 1345789999999 66777666321 1245899999999999999999999842 899999999999999
Q ss_pred CCC
Q 003368 795 NNL 797 (825)
Q Consensus 795 ~~~ 797 (825)
.++
T Consensus 182 ~~~ 184 (397)
T 1wak_A 182 VNE 184 (397)
T ss_dssp CCH
T ss_pred ccc
Confidence 775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=208.46 Aligned_cols=192 Identities=24% Similarity=0.362 Sum_probs=164.6
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|+++++++.. +| .+..+++|++|+|++|++++..+ |..+++|++|+|++|+|++. ..|..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEEC
Confidence 579999999999875 44 68999999999999999996544 99999999999999999964 36999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|++++. + .+..+++|++|++++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|
T Consensus 115 ~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L---------- 178 (308)
T 1h6u_A 115 TSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL---------- 178 (308)
T ss_dssp TTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE----------
T ss_pred CCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEE----------
Confidence 99999964 4 39999999999999999997654 8999999999999999986443 7777777776
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 259 (825)
++++|++++ ++. + ..+++|+.|+|++|++++..| +..+++|+.|+|++|++.+.
T Consensus 179 ---------~l~~n~l~~-~~~-l-~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 179 ---------KADDNKISD-ISP-L-ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp ---------ECCSSCCCC-CGG-G-GGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred ---------ECCCCccCc-Chh-h-cCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 777888874 443 3 489999999999999997653 88999999999999998763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=233.10 Aligned_cols=159 Identities=26% Similarity=0.398 Sum_probs=132.2
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~ 720 (825)
++|...+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|++++++++|||||++++++.... +...+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999998899999999987643 334567999999999999999999999864311 2235678
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT-- 798 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~-- 798 (825)
++||||+++|+|.+++... .....+++..+..|+.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 94 ~LVmEy~~ggsL~~~L~~~---------~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQF---------ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCEEECCSSCBHHHHHHSS---------SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSC
T ss_pred EEEEEeCCCCCHHHHHHhc---------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCce
Confidence 9999999999999999643 1123578889999999999999999985 8999999999999997664
Q ss_pred -EEEcccCcccccccC
Q 003368 799 -AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 -~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 162 ~vKL~DFG~a~~~~~~ 177 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQG 177 (676)
T ss_dssp EEEECSCCCCCBTTSC
T ss_pred eEEEcccccccccccc
Confidence 999999999987554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-22 Score=214.94 Aligned_cols=150 Identities=23% Similarity=0.365 Sum_probs=127.5
Q ss_pred ccccccceeccCCeeEEEEEEE-cCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC------ceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTF-DRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN------LVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 715 (825)
++|+..+.||+|+||.||+|.. ..+|+.||||+++.. ....+.+.+|+++++.++|++ ++++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~----- 87 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE----- 87 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-----
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-----
Confidence 5789999999999999999998 568899999998754 234567889999999887765 899999853
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
..+..++||||+ +|+|.+++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKEN----------GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ 153 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhc----------CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEec
Confidence 466889999999 89999998532 123588999999999999999999986 9999999999999987
Q ss_pred -------------------CCcEEEcccCccccccc
Q 003368 796 -------------------NLTAHVGDFGLARLRQE 812 (825)
Q Consensus 796 -------------------~~~~ki~DFGla~~~~~ 812 (825)
++.+||+|||+|+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTS
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCcc
Confidence 66899999999987544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.1e-22 Score=213.65 Aligned_cols=153 Identities=23% Similarity=0.379 Sum_probs=121.5
Q ss_pred ccccccc-ceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSST-HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~-~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|... ++||+|+||.||+|+...+|+.||||++.... +........++.++||||+++++++... ..+....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENM-HHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhc-cCCCceE
Confidence 4567774 57999999999999998899999999986532 1112223345667999999999986531 1224457
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---NL 797 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~~ 797 (825)
++||||+++|+|.+++... ....+++.++..++.|+++||+|||+. +|+||||||+||+++. ++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~----------~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER----------GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-----------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred EEEEeccCCCCHHHHHHhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCc
Confidence 9999999999999999632 123689999999999999999999986 9999999999999976 45
Q ss_pred cEEEcccCccccccc
Q 003368 798 TAHVGDFGLARLRQE 812 (825)
Q Consensus 798 ~~ki~DFGla~~~~~ 812 (825)
.+||+|||+|+....
T Consensus 169 ~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQ 183 (336)
T ss_dssp CEEECCCTTCEEC--
T ss_pred eEEEeccccceeccc
Confidence 699999999987654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.7e-22 Score=212.66 Aligned_cols=157 Identities=21% Similarity=0.255 Sum_probs=126.0
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHH-HhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECR-ALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||.||+|+...+|+.||||++..... ...+++.+|+. +++.++||||+++++++. ..+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence 3678889999999999999999988999999999976533 23445666666 778889999999999864 3567
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++ +|.+++... .......+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYV-------YSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHH-------HHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEE
T ss_pred eEEEEeecCC-ChHHHHHHH-------HhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCE
Confidence 8999999985 787776321 001134688999999999999999999984 389999999999999999999
Q ss_pred EEcccCcccccccC
Q 003368 800 HVGDFGLARLRQEV 813 (825)
Q Consensus 800 ki~DFGla~~~~~~ 813 (825)
||+|||+++.....
T Consensus 166 kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 166 KLCDFGISGQLVDS 179 (327)
T ss_dssp EECCCSSSCC----
T ss_pred EEccCCCceecccc
Confidence 99999999876543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=213.56 Aligned_cols=233 Identities=16% Similarity=0.121 Sum_probs=179.3
Q ss_pred ceeeceeecC-------C--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCC-ccccCCCCCCE-EECC
Q 003368 20 CDWEGITCSP-------R--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIP-GEIGRLFRLEA-LYLS 88 (825)
Q Consensus 20 C~~~g~~c~~-------~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~Ls 88 (825)
|.|+.|.|.. . ..+++.|+|++|+|....+.+|.++++|++|+|++|++.+.+| .+|.++++|++ ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 5666677753 2 2579999999999987667789999999999999999976555 57899998775 6778
Q ss_pred CCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc-cccccccCccCCCCC-CCCEEEcccCcCcc
Q 003368 89 HNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE-NNLTGGIPHFLGNIT-SLEAISLAYNSLGG 166 (825)
Q Consensus 89 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 166 (825)
+|+|+.+.|+.|..+++|++|++++|+|+...+..+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999999999999999999999999999988888888888999999966 678877777888875 69999999999985
Q ss_pred cCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCc
Q 003368 167 NIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNL 246 (825)
Q Consensus 167 ~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 246 (825)
..+..| ...+|+.| ++++|+..+.+|...+..+++|++|+|++|+|+.+.+..|.+++
T Consensus 169 i~~~~f-~~~~L~~l-------------------~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~-- 226 (350)
T 4ay9_X 169 IHNSAF-NGTQLDEL-------------------NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK-- 226 (350)
T ss_dssp ECTTSS-TTEEEEEE-------------------ECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCC--
T ss_pred CChhhc-cccchhHH-------------------hhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccch--
Confidence 444444 45567666 66554444488888777899999999999999977666665555
Q ss_pred cEEEeecccccCccccCcCCCCCCcEEEcc
Q 003368 247 QSLEILGNNFFGKLSVNFGDMKSLAYLNVA 276 (825)
Q Consensus 247 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 276 (825)
.|.+.+++-...+| .+..+++|+.++++
T Consensus 227 -~L~~l~~~~l~~lP-~l~~l~~L~~l~l~ 254 (350)
T 4ay9_X 227 -KLRARSTYNLKKLP-TLEKLVALMEASLT 254 (350)
T ss_dssp -EEECTTCTTCCCCC-CTTTCCSCCEEECS
T ss_pred -HhhhccCCCcCcCC-CchhCcChhhCcCC
Confidence 44444443333343 24445555555544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-22 Score=217.32 Aligned_cols=155 Identities=28% Similarity=0.367 Sum_probs=128.3
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CC-----CceeEeecccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HR-----NLVRVITSCSSID 713 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~ 713 (825)
...++|...+.||+|+||+||+|+...+|+.||||+++.. ....+++.+|+++++.++ |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--- 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--- 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE---
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec---
Confidence 3467899999999999999999999889999999999754 233466788898888875 44 4899988854
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
..+..++||||++ |+|.+++... ....+++..+..++.|++.||+|||++ ..+||||||||+|||+
T Consensus 127 --~~~~~~lv~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 127 --FRNHLCLVFEMLS-YNLYDLLRNT----------NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL 192 (382)
T ss_dssp --ETTEEEEEEECCC-CBHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred --cCCceEEEEecCC-CCHHHHHhhc----------CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence 3568899999996 5999998532 123589999999999999999999963 3589999999999999
Q ss_pred c--CCCcEEEcccCccccccc
Q 003368 794 D--NNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 ~--~~~~~ki~DFGla~~~~~ 812 (825)
+ .++.+||+|||+|+....
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTC
T ss_pred ecCCCCcEEEEeccCceeccc
Confidence 4 578899999999987644
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=204.23 Aligned_cols=143 Identities=17% Similarity=0.141 Sum_probs=113.4
Q ss_pred HHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------------------hhHHHHHHHHHHhhcCC
Q 003368 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------------------GASKSFAAECRALRNIR 698 (825)
Q Consensus 637 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 698 (825)
.+......|...+.||+|+||.||+|++ .+|+.||||.++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444445566779999999999999999 8899999999964321 13457899999999999
Q ss_pred CCCceeEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003368 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQ 778 (825)
Q Consensus 699 H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~ 778 (825)
| +++.+++. .+..++||||+++|+|.+ +.. .+...++.|+++|++|||+.
T Consensus 163 ~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~------------------~~~~~i~~qi~~~l~~lH~~-- 212 (282)
T 1zar_A 163 G---LAVPKVYA------WEGNAVLMELIDAKELYR-VRV------------------ENPDEVLDMILEEVAKFYHR-- 212 (282)
T ss_dssp T---SSSCCEEE------EETTEEEEECCCCEEGGG-CCC------------------SCHHHHHHHHHHHHHHHHHT--
T ss_pred C---CCcCeEEe------ccceEEEEEecCCCcHHH-cch------------------hhHHHHHHHHHHHHHHHHHC--
Confidence 4 55554321 234699999999999988 421 12346999999999999985
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+|+||||||+|||++ ++.+||+|||+|+....
T Consensus 213 -giiHrDlkp~NILl~-~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 213 -GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp -TEECSCCSTTSEEEE-TTEEEECCCTTCEETTS
T ss_pred -CCEeCCCCHHHEEEE-CCcEEEEECCCCeECCC
Confidence 999999999999999 99999999999997643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.7e-22 Score=212.27 Aligned_cols=159 Identities=25% Similarity=0.355 Sum_probs=129.6
Q ss_pred cccHHHHHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCC--CCCceeEee
Q 003368 632 KVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIR--HRNLVRVIT 707 (825)
Q Consensus 632 ~~~~~~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~ 707 (825)
.+.+..+....++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++ ||||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344444444567799999999999999999998 568999999997543 234567899999999997 599999999
Q ss_pred cccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 708 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
++. .++..++||| +.+|+|.+++.. ...+++.++..++.|+++||+|||+. +|+|||||
T Consensus 96 ~~~-----~~~~~~lv~e-~~~~~L~~~l~~------------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlk 154 (313)
T 3cek_A 96 YEI-----TDQYIYMVME-CGNIDLNSWLKK------------KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLK 154 (313)
T ss_dssp EEE-----CSSEEEEEEC-CCSEEHHHHHHH------------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred Eee-----cCCEEEEEEe-cCCCcHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCC
Confidence 864 3567899999 668899999843 24688999999999999999999986 99999999
Q ss_pred CCCeeecCCCcEEEcccCcccccccC
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
|+||++++ +.+||+|||+++.....
T Consensus 155 p~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 155 PANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp GGGEEEET-TEEEECCCSSSCC----
T ss_pred cccEEEEC-CeEEEeeccccccccCc
Confidence 99999975 89999999999977543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=208.19 Aligned_cols=153 Identities=20% Similarity=0.276 Sum_probs=115.3
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-h-HHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-A-SKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
..++|...+.||+|+||.||+|++..+|+.||||++...... . .+.+..+..+++.++||||+++++++. .++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence 346788899999999999999999889999999999765332 2 234445556788889999999999864 356
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++||||+ ++.+..+.. .....+++..+..++.|+++||+|||+. .+|+||||||+||+++.++.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~-----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~ 163 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKK-----------RMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQ 163 (318)
T ss_dssp EEEEEECCC-SEEHHHHHH-----------HHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSC
T ss_pred cEEEEEecc-CCcHHHHHH-----------HhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCC
Confidence 789999999 444444432 1234689999999999999999999972 18999999999999999999
Q ss_pred EEEcccCccccccc
Q 003368 799 AHVGDFGLARLRQE 812 (825)
Q Consensus 799 ~ki~DFGla~~~~~ 812 (825)
+||+|||+++....
T Consensus 164 ~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 164 IKLCDFGISGRLVD 177 (318)
T ss_dssp EEECCCTTC-----
T ss_pred EEEEECCCchhccC
Confidence 99999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.9e-21 Score=212.04 Aligned_cols=150 Identities=23% Similarity=0.368 Sum_probs=125.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCC-eEEEEEEeecccchhHHHHHHHHHHhhcCCCCC------ceeEeecccccccC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDG-TIVAIKVLNLQLQGASKSFAAECRALRNIRHRN------LVRVITSCSSIDFQ 715 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 715 (825)
++|...+.||+|+||+||+|+...++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++ .
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----~ 92 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----N 92 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----E
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----e
Confidence 57889999999999999999997666 79999999754 234567889999999998776 88888774 3
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL-- 793 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl-- 793 (825)
.....++||||+ +|++.+++... ....+++.++..|+.|+++||+|||+. +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~----------~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN----------NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN 158 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT----------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec
Confidence 356889999999 67777777422 123589999999999999999999985 99999999999999
Q ss_pred -----------------cCCCcEEEcccCccccccc
Q 003368 794 -----------------DNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 794 -----------------~~~~~~ki~DFGla~~~~~ 812 (825)
+.++.+||+|||+|+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccc
Confidence 6678999999999987544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.7e-21 Score=192.65 Aligned_cols=156 Identities=26% Similarity=0.312 Sum_probs=130.2
Q ss_pred ccCCCCCCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCC
Q 003368 10 LNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSH 89 (825)
Q Consensus 10 ~~~w~~~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 89 (825)
..-|..++..|+|.++.|... ++ +.+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 9 ~~~~~~~~~~Cs~~~v~c~~~------------~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 73 (229)
T 3e6j_A 9 HSAACPSQCSCSGTTVDCRSK------------RH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73 (229)
T ss_dssp --CCCCTTCEEETTEEECTTS------------CC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred hhccCCCCCEEeCCEeEccCC------------Cc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCC
Confidence 445666789999999999642 23 35555543 7899999999999988888999999999999999
Q ss_pred CcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCC
Q 003368 90 NSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169 (825)
Q Consensus 90 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 169 (825)
|+|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+
T Consensus 74 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 74 NQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence 9998777788899999999999999999887788899999999999999998 678888899999999999999987777
Q ss_pred ccccccccccee
Q 003368 170 SSLGQLKELKSL 181 (825)
Q Consensus 170 ~~~~~l~~L~~L 181 (825)
..|..+++|+.|
T Consensus 153 ~~~~~l~~L~~L 164 (229)
T 3e6j_A 153 GAFDRLSSLTHA 164 (229)
T ss_dssp TTTTTCTTCCEE
T ss_pred HHHhCCCCCCEE
Confidence 778888877777
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-21 Score=190.54 Aligned_cols=181 Identities=24% Similarity=0.274 Sum_probs=154.0
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 138 (825)
+.++.+++.++ .+|..+ .++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57889999998 566555 468999999999999888888999999999999999999887788999999999999999
Q ss_pred ccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhc
Q 003368 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLT 218 (825)
Q Consensus 139 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~ 218 (825)
++++..+..|.++++|++|+|++|++++..+..|..+++|++| ++++|+++ .+|+..+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-------------------~l~~N~l~-~~~~~~~~~ 146 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL-------------------RLYQNQLK-SVPDGVFDR 146 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-------------------ECCSSCCS-CCCTTTTTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE-------------------ECCCCccc-eeCHHHhcc
Confidence 9998888889999999999999999997777777777777777 77788887 455555557
Q ss_pred CCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCC
Q 003368 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKS 269 (825)
Q Consensus 219 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 269 (825)
+++|+.|+|++|.+.+ .+++|+.|+++.|++.|.+|..++.++.
T Consensus 147 l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 147 LTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp CTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred CCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 8999999999998764 4668899999999999988877766543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=219.01 Aligned_cols=151 Identities=26% Similarity=0.351 Sum_probs=116.7
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCeeeEE
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
|...++||+|+||+||.+.. .+|+.||||++... ..+.+.+|+++++++ +|||||++++++ .+++..++|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv 87 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA 87 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence 45568899999999987654 68999999998653 235678999999886 899999999884 346788999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-------
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN------- 796 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~------- 796 (825)
|||+. |+|.+++....... ......++..+..|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~-----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSD-----ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp ECCCS-EEHHHHHHTC-----------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred EecCC-CCHHHHHhccCCCc-----hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence 99995 69999996542111 0011123445678999999999999986 99999999999999754
Q ss_pred ------CcEEEcccCcccccccC
Q 003368 797 ------LTAHVGDFGLARLRQEV 813 (825)
Q Consensus 797 ------~~~ki~DFGla~~~~~~ 813 (825)
+.+||+|||+|+.....
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~ 181 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSG 181 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC-
T ss_pred ccCCCceEEEEcccccceecCCC
Confidence 48999999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=214.13 Aligned_cols=156 Identities=20% Similarity=0.342 Sum_probs=128.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-----------CCCceeEeecccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-----------HRNLVRVITSCSS 711 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 711 (825)
++|...+.||+|+||+||+|+...+|+.||||++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5688999999999999999999889999999999753 234567889999999886 8999999998653
Q ss_pred cccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 003368 712 IDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNI 791 (825)
Q Consensus 712 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NI 791 (825)
.. ......++||||+ +|+|.+++... ....+++..+..|+.|++.||+|||+. .+|+||||||+||
T Consensus 98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NI 163 (373)
T 1q8y_A 98 KG-PNGVHVVMVFEVL-GENLLALIKKY----------EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENV 163 (373)
T ss_dssp EE-TTEEEEEEEECCC-CEEHHHHHHHT----------TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGE
T ss_pred cC-CCCceEEEEEecC-CCCHHHHHHHh----------hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHe
Confidence 21 1223689999999 89999998532 123588999999999999999999983 2899999999999
Q ss_pred eec------CCCcEEEcccCcccccccC
Q 003368 792 LLD------NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 792 Ll~------~~~~~ki~DFGla~~~~~~ 813 (825)
|++ ..+.+||+|||+|+.....
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC
T ss_pred EEeccCCCcCcceEEEcccccccccCCC
Confidence 994 4458999999999877543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-21 Score=218.15 Aligned_cols=148 Identities=24% Similarity=0.343 Sum_probs=116.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..+|...++||+|+||+||.... .+|+.||||++..... +.+.+|+++++++ +|||||++++++ .+....
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence 45688899999999998654333 5889999999865432 2356899999999 799999999885 346778
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN----- 795 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~----- 795 (825)
|+||||+. |+|.+++.... ....+.++..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD-----------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS-----------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTT
T ss_pred EEEEECCC-CCHHHHHHhcC-----------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCC
Confidence 99999996 69999986432 1233345678999999999999986 8999999999999943
Q ss_pred CCcEEEcccCcccccccC
Q 003368 796 NLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~ 813 (825)
...+||+|||+|+.....
T Consensus 159 ~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp BCCEEECCTTEEECC---
T ss_pred ceeEEEecccceeeccCC
Confidence 346889999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.4e-22 Score=213.00 Aligned_cols=151 Identities=28% Similarity=0.433 Sum_probs=124.6
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.....++|...+.||+|+||.||+|++.. .||||++..... ...+.|.+|++++++++||||+++++++..
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 100 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS---- 100 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC----
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec----
Confidence 33345778999999999999999999843 499999875432 233567899999999999999999998643
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.+..++||||+++|+|.+++... ...+++.++..++.|+++||+|||+. +|+||||||+||+++
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~- 164 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDA-----------KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD- 164 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSS-----------CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC-
T ss_pred -CCceEEEeecccCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-
Confidence 55689999999999999999532 13588899999999999999999986 999999999999998
Q ss_pred CCcEEEcccCcccccc
Q 003368 796 NLTAHVGDFGLARLRQ 811 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~ 811 (825)
++.+||+|||+|+...
T Consensus 165 ~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 165 NGKVVITDFGLFSISG 180 (319)
T ss_dssp --CCEECCCSCCC---
T ss_pred CCCEEEeecCCccccc
Confidence 6799999999988654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=223.27 Aligned_cols=136 Identities=23% Similarity=0.264 Sum_probs=105.1
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
...++||+|+||+||+|+. .++.+|+|+...... ...+.|.+|++++++++||||+++..++.. .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L 411 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence 4467899999999999964 678899998643221 113458999999999999999955555432 3
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++.. +..|+.|+++||+|||+. +|+||||||+|||++.
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~--------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~-- 466 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED--------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK-- 466 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT--------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--
T ss_pred CccEEEEECCCCCCHHHHHHH--------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--
Confidence 456999999999999999842 457899999999999985 8999999999999999
Q ss_pred cEEEcccCcccccccC
Q 003368 798 TAHVGDFGLARLRQEV 813 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~ 813 (825)
.+||+|||+|+.....
T Consensus 467 ~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 467 DLYIIDFGLGKISNLD 482 (540)
T ss_dssp SEEECCCTTCEECCCH
T ss_pred eEEEEECccCEECCCc
Confidence 9999999999987553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=215.98 Aligned_cols=188 Identities=26% Similarity=0.365 Sum_probs=145.3
Q ss_pred CCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccC
Q 003368 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN 377 (825)
Q Consensus 298 ~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 377 (825)
.+|+.|+|++|.+++ +|..+. ++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +..
T Consensus 59 ~~L~~L~Ls~n~L~~----------lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~ 120 (571)
T 3cvr_A 59 NQFSELQLNRLNLSS----------LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA 120 (571)
T ss_dssp TTCSEEECCSSCCSC----------CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT
T ss_pred CCccEEEeCCCCCCc----------cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc
Confidence 378888888888773 444332 57888888888887 566 456788888888888886 666 554
Q ss_pred CCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEE
Q 003368 378 LSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMF 457 (825)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L 457 (825)
+|++|+|++|+|++ +|. .+++|+.|+|++|++++ +|. .+..+ +.|++++|++++ +|. +. ++|+.|
T Consensus 121 --~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L-~~L~Ls~N~L~~-lp~-l~--~~L~~L 185 (571)
T 3cvr_A 121 --SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSL-EVLSVRNNQLTF-LPE-LP--ESLEAL 185 (571)
T ss_dssp --TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTC-CEEECCSSCCSC-CCC-CC--TTCCEE
T ss_pred --CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCc-CEEECCCCCCCC-cch-hh--CCCCEE
Confidence 78888888888886 555 57788888888888875 676 23344 678888888876 776 65 889999
Q ss_pred eecCceecccCCccccCCCCC-------CEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc
Q 003368 458 VVSSNNLSGEIPSEIGSCFYL-------QEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL 523 (825)
Q Consensus 458 ~ls~N~l~g~~p~~~~~l~~L-------~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l 523 (825)
++++|+|+ .+|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 186 ~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 186 DVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp ECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred ECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 99999998 7777 665 67 99999999999 689989899999999999999999999887664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-20 Score=186.15 Aligned_cols=143 Identities=23% Similarity=0.288 Sum_probs=130.6
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCC-ccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIP-GEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
.+|+++|++.. +|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 68888888864 676654 457899999999998755 56899999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCccccccccccee
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 181 (825)
+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 158 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence 9999888999999999999999999999999999999999999999999999889999988888888
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.8e-20 Score=185.06 Aligned_cols=145 Identities=24% Similarity=0.328 Sum_probs=127.7
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.++++++++. .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4566667765 4566554 689999999999998888899999999999999999999999999999999999999999
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecC
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 183 (825)
|+.+.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 159 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHL 159 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEe
Confidence 99877778899999999999999999988999999999999999999999888888888888888733
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.4e-20 Score=203.59 Aligned_cols=179 Identities=20% Similarity=0.144 Sum_probs=137.1
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCcccc-CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIG-RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
.++++++++.. +|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 57888888764 566553 4588899999999988888887 8899999999999998888888888899999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNL 194 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l 194 (825)
+|+++.+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~------------------- 159 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG------------------- 159 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC---------------------
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCc-------------------
Confidence 9888777788888888888888888888878888888888888888888874333222110
Q ss_pred CCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCC--ccEEEeecccccC
Q 003368 195 SLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN--LQSLEILGNNFFG 258 (825)
Q Consensus 195 ~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~ 258 (825)
..+++|+.|+|++|+|++..+..|..++. |+.|+|++|.+..
T Consensus 160 ----------------------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 160 ----------------------NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp ------------------------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ----------------------ccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 14566777777777777655566666766 3677777777654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.5e-20 Score=184.77 Aligned_cols=148 Identities=22% Similarity=0.225 Sum_probs=137.6
Q ss_pred CceeeceeecCC---------CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCC
Q 003368 19 FCDWEGITCSPR---------HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSH 89 (825)
Q Consensus 19 ~C~~~g~~c~~~---------~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 89 (825)
.|.|..+.|... ..+++.|+|++|++.+..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 467888888643 14799999999999988888999999999999999999999999999999999999999
Q ss_pred CcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc
Q 003368 90 NSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG 166 (825)
Q Consensus 90 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 166 (825)
|+|+...+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99998888889999999999999999999999999999999999999999998888899999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=207.76 Aligned_cols=164 Identities=16% Similarity=0.184 Sum_probs=119.4
Q ss_pred hhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCC-CCceeEeec-------
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRH-RNLVRVITS------- 708 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l~~~------- 708 (825)
..+..|...++||+|+||+||+|++..+|+.||||++..... ...+.|.+|+.+++.++| +|......+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345568888999999999999999989999999999874332 225679999999999987 332211111
Q ss_pred --ccc---c---c-cCC-----CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHH
Q 003368 709 --CSS---I---D-FQG-----NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLH 774 (825)
Q Consensus 709 --~~~---~---~-~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH 774 (825)
+.. . . +.. ....+++|+++ +|+|.+++.... ........++|..+..|+.|+++||+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~-----~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-----SHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHH-----HHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh-----cccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 000 0 0 000 12346666654 689998883110 00012346889999999999999999999
Q ss_pred hcCCCCeeecCCCCCCeeecCCCcEEEcccCccccccc
Q 003368 775 HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812 (825)
Q Consensus 775 ~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~ 812 (825)
+. +||||||||+|||++.++.+||+|||+|+....
T Consensus 229 ~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~ 263 (413)
T 3dzo_A 229 HY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263 (413)
T ss_dssp HT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred hC---CcccCCcccceEEEecCCeEEEEeccceeecCC
Confidence 85 999999999999999999999999999987544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.1e-20 Score=199.06 Aligned_cols=158 Identities=21% Similarity=0.166 Sum_probs=138.8
Q ss_pred ceeeceeecCC---------CCcEEEEECCCCCCccccCcCCC-CCCCCCEEEcCCCcccccCCccccCCCCCCEEECCC
Q 003368 20 CDWEGITCSPR---------HRRVTVLDLKSKGLIGSLSPQIG-NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSH 89 (825)
Q Consensus 20 C~~~g~~c~~~---------~~~l~~l~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 89 (825)
|.+..+.|... ...++.|||++|++.+..+..+. .+++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 56666777532 24688999999999988888888 999999999999999988889999999999999999
Q ss_pred CcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccC---CCCCCCCEEEcccCcCcc
Q 003368 90 NSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFL---GNITSLEAISLAYNSLGG 166 (825)
Q Consensus 90 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~ 166 (825)
|+|+...+..|..+++|++|+|++|+|+++.|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99999888999999999999999999999999999999999999999999997666666 679999999999999996
Q ss_pred cCCcccccccc
Q 003368 167 NIPSSLGQLKE 177 (825)
Q Consensus 167 ~~p~~~~~l~~ 177 (825)
..+..|..++.
T Consensus 178 l~~~~~~~l~~ 188 (361)
T 2xot_A 178 LPLTDLQKLPA 188 (361)
T ss_dssp CCHHHHHHSCH
T ss_pred cCHHHhhhccH
Confidence 66566666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=183.56 Aligned_cols=151 Identities=21% Similarity=0.264 Sum_probs=137.7
Q ss_pred CceeeceeecCC---------CCcEEEEECCCCCCccccCc-CCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECC
Q 003368 19 FCDWEGITCSPR---------HRRVTVLDLKSKGLIGSLSP-QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLS 88 (825)
Q Consensus 19 ~C~~~g~~c~~~---------~~~l~~l~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 88 (825)
.|.|..+.|... ...++.|+|++|++.+..+. .|..+++|++|+|++|+|+++.+.+|.++++|++|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 467888877643 14688999999999988664 58999999999999999999888899999999999999
Q ss_pred CCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccC
Q 003368 89 HNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNI 168 (825)
Q Consensus 89 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 168 (825)
+|+|++..|..|..+++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.++...
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999999999999999999999999999999999999999999999999999998999999999999999999998654
Q ss_pred C
Q 003368 169 P 169 (825)
Q Consensus 169 p 169 (825)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.2e-19 Score=179.27 Aligned_cols=154 Identities=23% Similarity=0.302 Sum_probs=112.6
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
-+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+.+.+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 356888888887 5666554 7888888888888888888888888888888888888876667778888888888888
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhh
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGL 217 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~ 217 (825)
|+|++..+..|..+++|++|+|++|+|+ .+|..+.
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~-------------------------------------------- 132 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE-------------------------------------------- 132 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGG--------------------------------------------
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccc--------------------------------------------
Confidence 8888777777788888888888888876 4444333
Q ss_pred cCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCc
Q 003368 218 TLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259 (825)
Q Consensus 218 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 259 (825)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+.
T Consensus 133 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp GCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred cCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 445556666666666655555566666666666666666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=210.64 Aligned_cols=189 Identities=26% Similarity=0.391 Sum_probs=120.9
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.+++..+.+...++ +..|++|+.|++++|.|+. +| .|..+++|+.|+|++|+|++..| |..+++|+.|+|++|+
T Consensus 25 ~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 25 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 34455555544333 4466777777777777763 33 47777777777777777776554 7777777777777777
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCC
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLS 195 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~ 195 (825)
|++ +| .|..+++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++. ..|..+++|+.|
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L-------------- 158 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL-------------- 158 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE--------------
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE--------------
Confidence 774 23 577777777777777777743 3466777777777777777643 344444444444
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCcc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 260 (825)
+|++|.+++..| + ..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++.+..
T Consensus 159 -----~Ls~N~l~~~~~--l-~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p 213 (605)
T 1m9s_A 159 -----SLEDNQISDIVP--L-AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP 213 (605)
T ss_dssp -----ECCSSCCCCCGG--G-TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred -----ECcCCcCCCchh--h-ccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence 556666664333 2 2666777777777777653 34666777777777777665543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=190.68 Aligned_cols=187 Identities=27% Similarity=0.390 Sum_probs=131.2
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
+.+..+.+.+..+ +..+++|++|++++|.++.. | .+..+++|++|+|++|+|++..+ +..+++|++|+|++|++
T Consensus 29 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence 3455555544322 34677888888888888743 4 47778888888888888886555 88888888888888888
Q ss_pred CCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCC
Q 003368 117 EGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSL 196 (825)
Q Consensus 117 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~ 196 (825)
++ + ..+..+++|++|+|++|++++. +.+..+++|+.|+|++|++++. ..+..+++|+.|
T Consensus 103 ~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L--------------- 161 (291)
T 1h6t_A 103 KD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL--------------- 161 (291)
T ss_dssp CC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE---------------
T ss_pred CC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE---------------
Confidence 75 2 3478888888888888888754 4577888888888888888753 345555555555
Q ss_pred CceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCc
Q 003368 197 LANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259 (825)
Q Consensus 197 l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 259 (825)
++++|++++. ++ + ..+++|+.|+|++|.+++. | .+..+++|+.|++++|++...
T Consensus 162 ----~L~~N~l~~~-~~-l-~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 162 ----SLEDNQISDI-VP-L-AGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp ----ECCSSCCCCC-GG-G-TTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred ----EccCCccccc-hh-h-cCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 6666666643 33 3 3677777777777777753 3 377777777777777776553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=187.97 Aligned_cols=170 Identities=22% Similarity=0.329 Sum_probs=146.4
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|++++|++... +.+..+++|++|+|++|++++..+ +..+++|++|+|++|++++. | .+..+++|++|+|
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEEEC
Confidence 5789999999998755 358999999999999999996554 99999999999999999863 3 4999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|+|++. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L---------- 183 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL---------- 183 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE----------
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEE----------
Confidence 99999964 5799999999999999999976 679999999999999999987654 7777777777
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCC
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~ 235 (825)
++++|.+++ +|. + ..+++|+.|++++|.++..
T Consensus 184 ---------~L~~N~i~~-l~~-l-~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 184 ---------YLSKNHISD-LRA-L-AGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp ---------ECCSSCCCB-CGG-G-TTCTTCSEEEEEEEEEECC
T ss_pred ---------ECCCCcCCC-Chh-h-ccCCCCCEEECcCCcccCC
Confidence 777788874 553 3 3899999999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=186.88 Aligned_cols=138 Identities=20% Similarity=0.190 Sum_probs=106.3
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeE--EEEEEeecccch------------------------hHHHHHHHHHHhhcCC
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTI--VAIKVLNLQLQG------------------------ASKSFAAECRALRNIR 698 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 698 (825)
|...+.||+|+||.||+|.+..+|+. ||||+++..... ....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998678999 999987543111 1236889999999999
Q ss_pred CCCc--eeEeecccccccCCCCeeeEEEEccCC-C----ChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHH
Q 003368 699 HRNL--VRVITSCSSIDFQGNDFKALVYQYMPN-G----SLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVD 771 (825)
Q Consensus 699 H~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~ 771 (825)
|+++ ...+++ ...++||||+.+ | +|.++.. ..++.++..++.|++.|++
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~---------------~~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGR---------------ELKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGG---------------GGGGSCHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhh---------------ccChHHHHHHHHHHHHHHH
Confidence 8864 333332 245899999942 4 5554431 1223456789999999999
Q ss_pred HHH-hcCCCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 772 YLH-HHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 772 yLH-~~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
||| +. +||||||||+|||+++ .++|+|||+|+...
T Consensus 185 ~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 185 RLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp HHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999 64 9999999999999998 99999999998764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-20 Score=220.20 Aligned_cols=210 Identities=22% Similarity=0.186 Sum_probs=111.4
Q ss_pred CCCC-CCCCceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCC-----EEEcCCCcccccCCccccCCCCCCEE
Q 003368 12 SWND-SHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLR-----EIHLSNNTIQGKIPGEIGRLFRLEAL 85 (825)
Q Consensus 12 ~w~~-~~~~C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~-----~L~Ls~N~l~~~~p~~~~~l~~L~~L 85 (825)
.|.. .+..+.|.+.++.. .+++.|+|..|++... +..+.....|+ .++++.|.+. ..|..|..+.+|+.|
T Consensus 154 ~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L 229 (727)
T 4b8c_D 154 QPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHAL 229 (727)
T ss_dssp ------------------------------------------------------------------------CCCCCCEE
T ss_pred CCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEE
Confidence 4532 34567788877754 5799999998888763 44332222222 2333444444 567888889999999
Q ss_pred ECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCc
Q 003368 86 YLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 86 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
+|++|.|. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+
T Consensus 230 ~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 306 (727)
T 4b8c_D 230 DLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT 306 (727)
T ss_dssp ECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC
T ss_pred ECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC
Confidence 99999988 66666778889999999999998 77888889999999999999998 67888889999999999999886
Q ss_pred ccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCC
Q 003368 166 GNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASN 245 (825)
Q Consensus 166 ~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 245 (825)
.+|..|+.+++|+.| +|++|.+++.+|..+......+..|+|++|.+++.+|..
T Consensus 307 -~lp~~~~~l~~L~~L-------------------~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------ 360 (727)
T 4b8c_D 307 -TLPWEFGNLCNLQFL-------------------GVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------ 360 (727)
T ss_dssp -CCCSSTTSCTTCCCE-------------------ECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------
T ss_pred -ccChhhhcCCCccEE-------------------eCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------
Confidence 667767777777776 778888888777766522222334778888888877753
Q ss_pred ccEEEeecc
Q 003368 246 LQSLEILGN 254 (825)
Q Consensus 246 L~~L~L~~N 254 (825)
|+.|+++.|
T Consensus 361 l~~l~l~~n 369 (727)
T 4b8c_D 361 RRFIEINTD 369 (727)
T ss_dssp ---------
T ss_pred cceeEeecc
Confidence 455666666
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=204.70 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=86.9
Q ss_pred cCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccC
Q 003368 218 TLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANC 297 (825)
Q Consensus 218 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l 297 (825)
.+++|+.|+|++|.+++. | .+..+++|+.|+|++|++.+. ..+..+
T Consensus 85 ~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~l--------------------------------~~l~~l 130 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKDL-S-SLKDLKKLKSLSLEHNGISDI--------------------------------NGLVHL 130 (605)
T ss_dssp GCTTCCEEECCSSCCCCC-T-TSTTCTTCCEEECTTSCCCCC--------------------------------GGGGGC
T ss_pred cCCCCCEEECcCCCCCCC-h-hhccCCCCCEEEecCCCCCCC--------------------------------ccccCC
Confidence 566666667777766642 2 455566666666666555432 234556
Q ss_pred CCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccC
Q 003368 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN 377 (825)
Q Consensus 298 ~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 377 (825)
++|+.|+|++|.+++ + ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++. +.+..
T Consensus 131 ~~L~~L~Ls~N~l~~----------l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~ 195 (605)
T 1m9s_A 131 PQLESLYLGNNKITD----------I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAG 195 (605)
T ss_dssp TTCSEEECCSSCCCC----------C-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTT
T ss_pred CccCEEECCCCccCC----------c-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHcc
Confidence 677777777777663 2 356677777777777777776555 77777777777777777753 34777
Q ss_pred CCCCcEEEcccCccccccCCCCCC
Q 003368 378 LSSLVKLILGNNNLSGVIPSSLGN 401 (825)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~ 401 (825)
+++|+.|+|++|++.+.....+..
T Consensus 196 l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 196 LKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp CTTCSEEECCSEEEECCCCCCCSS
T ss_pred CCCCCEEEccCCcCcCCccccccc
Confidence 777778888877777544333333
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-21 Score=222.67 Aligned_cols=184 Identities=20% Similarity=0.159 Sum_probs=95.7
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccce
Q 003368 53 GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKE 132 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 132 (825)
..+++|+.|+|++|+++ .+|..++.+++|+.|++++|......|.. +..+.+.+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence 45566666666666665 55666666666666666555411000000 0011244556666777777777
Q ss_pred ee-ccccc-------------cccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCc
Q 003368 133 LA-IQENN-------------LTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLA 198 (825)
Q Consensus 133 L~-L~~N~-------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~ 198 (825)
|+ ++.|. ++...+ ..|+.|+|++|+|++ +|. |+.+++|+.|
T Consensus 414 L~~l~~n~~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L----------------- 468 (567)
T 1dce_A 414 VDPMRAAYLDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHL----------------- 468 (567)
T ss_dssp HCGGGHHHHHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEE-----------------
T ss_pred CcchhhcccchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEe-----------------
Confidence 66 45543 332211 136666666666664 343 5555555554
Q ss_pred eeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCcc-ccCcCCCCCCcEEEccc
Q 003368 199 NFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL-SVNFGDMKSLAYLNVAI 277 (825)
Q Consensus 199 ~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~ 277 (825)
+|++|+++ .+|..+. .+++|+.|+|++|.|++ +| .|.++++|+.|+|++|++.+.. |..++.+++|+.|++++
T Consensus 469 --~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~ 542 (567)
T 1dce_A 469 --DLSHNRLR-ALPPALA-ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542 (567)
T ss_dssp --ECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTT
T ss_pred --ecCccccc-ccchhhh-cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecC
Confidence 55555555 5555544 55666666666666654 34 5555555666666555555543 44444333333333333
Q ss_pred cc
Q 003368 278 NN 279 (825)
Q Consensus 278 N~ 279 (825)
|.
T Consensus 543 N~ 544 (567)
T 1dce_A 543 NS 544 (567)
T ss_dssp SG
T ss_pred Cc
Confidence 33
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-18 Score=167.83 Aligned_cols=132 Identities=28% Similarity=0.382 Sum_probs=120.3
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCc-cccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPG-EIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGR 113 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 113 (825)
+.+|++++++ +.+|..+.. +|++|+|++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4678888888 567776654 899999999999977765 599999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCC
Q 003368 114 NKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169 (825)
Q Consensus 114 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 169 (825)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999999999999999999999999999999999999999999999999987554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=8e-21 Score=218.60 Aligned_cols=190 Identities=22% Similarity=0.262 Sum_probs=106.6
Q ss_pred ccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCc-------------ccccCCccccCCCCCCEEE
Q 003368 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQ-------------FEGKIPEEMSRLQNLQFLN 361 (825)
Q Consensus 295 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~ 361 (825)
..++.|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~----------~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~ 415 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST----------VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415 (567)
T ss_dssp STTTTSSSCCCCHHHHH----------HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHC
T ss_pred ccCccceeccCChhhHH----------hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCc
Confidence 34566667777777766 566667777777777766554 4445555566666666665
Q ss_pred -ccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCcc
Q 003368 362 -MRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440 (825)
Q Consensus 362 -Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l 440 (825)
++.|.+. +|..+.+++|.+++..+. .|+.|+|++|++++ +|. +..+..+ +.|++++|++
T Consensus 416 ~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L-~~L~Ls~N~l 475 (567)
T 1dce_A 416 PMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLV-THLDLSHNRL 475 (567)
T ss_dssp GGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTC-CEEECCSSCC
T ss_pred chhhcccc-----------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccC-cEeecCcccc
Confidence 4544432 222333344444432221 24455555555542 443 4443333 3444455544
Q ss_pred ccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCC-CccccCCCCCCEEECCCCccccccC
Q 003368 441 VGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSI-PSSLVSLKDLREIDLSQNNLSGKIP 517 (825)
Q Consensus 441 ~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~Ldls~N~l~~~~p 517 (825)
+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|++++.+ |..++.+++|+.|+|++|++++.+|
T Consensus 476 ~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 476 R-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp C-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred c-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 4 455556666666666666666664 45 5666666666666666666554 6666666666666666666665544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-19 Score=209.37 Aligned_cols=197 Identities=19% Similarity=0.195 Sum_probs=125.3
Q ss_pred CCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCC
Q 003368 220 SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN 299 (825)
Q Consensus 220 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~ 299 (825)
+.++.|+|.+|.+... +. ..|+.++|+.|.+.+. +++.|.+. ..+..+..++.
T Consensus 173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~~~--------------~~~~n~~~-------~~~~~~~~l~~ 225 (727)
T 4b8c_D 173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSIDED--------------DDIENRMV-------MPKDSKYDDQL 225 (727)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred CccceEEeeCCCCCcc-hh-----hHhhcCccCcccccCc--------------ccccccee-------cChhhhccCCC
Confidence 4567777777777642 22 2344555555554322 22233332 12456778899
Q ss_pred CCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCC
Q 003368 300 LSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLS 379 (825)
Q Consensus 300 L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 379 (825)
|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|+.++
T Consensus 226 L~~L~Ls~n~l~----------~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 226 WHALDLSNLQIF----------NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp CCEEECTTSCCS----------CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred CcEEECCCCCCC----------CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 999999999998 68888889999999999999999 88999999999999999999999 7899999999
Q ss_pred CCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEEee
Q 003368 380 SLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVV 459 (825)
Q Consensus 380 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L~l 459 (825)
+|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|+|.+|..+.........+++++|.++|.+|..+ ..|++
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l 366 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEI 366 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------------
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------ceeEe
Confidence 9999999999997 6788899999999999999999999998887654433457889999998888754 45556
Q ss_pred cCc
Q 003368 460 SSN 462 (825)
Q Consensus 460 s~N 462 (825)
+.|
T Consensus 367 ~~n 369 (727)
T 4b8c_D 367 NTD 369 (727)
T ss_dssp ---
T ss_pred ecc
Confidence 665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-18 Score=169.01 Aligned_cols=154 Identities=16% Similarity=0.222 Sum_probs=85.7
Q ss_pred cCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCE
Q 003368 77 GRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA 156 (825)
Q Consensus 77 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 156 (825)
+.+++|+.|++++|.|+ .+| .+..+++|++|++++|.++. +..+..+++|++|++++|++++..|..|+.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 33445555555555555 333 35555555555555554442 235555666666666666666555556666666666
Q ss_pred EEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCC
Q 003368 157 ISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSF 236 (825)
Q Consensus 157 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~ 236 (825)
|+|++|++++..|..|+.+++|++| ++++|.+.+.+| .+. .+++|+.|++++|.+++..
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L-------------------~L~~n~~i~~~~-~l~-~l~~L~~L~l~~n~i~~~~ 175 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSI-------------------DLSYNGAITDIM-PLK-TLPELKSLNIQFDGVHDYR 175 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEE-------------------ECCSCTBCCCCG-GGG-GCSSCCEEECTTBCCCCCT
T ss_pred EEecCCccCcHhHHHHhhCCCCCEE-------------------EccCCCCccccH-hhc-CCCCCCEEECCCCCCcChH
Confidence 6666666665555555555555544 444444222343 222 5677777777777776532
Q ss_pred CccccCCCCccEEEeeccccc
Q 003368 237 PLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 237 p~~~~~l~~L~~L~L~~N~l~ 257 (825)
.+..+++|+.|++++|++.
T Consensus 176 --~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 176 --GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp --TGGGCSSCCEEEECBC---
T ss_pred --HhccCCCCCEEEeeCcccC
Confidence 5667777777777777653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-18 Score=180.57 Aligned_cols=170 Identities=20% Similarity=0.326 Sum_probs=92.5
Q ss_pred CCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 55 LSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
+.+++.++++.|.++... .+..+++|++|++++|.|+. +| .+..+++|++|+|++|+|++..+ |..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344445555555555322 34555555555555555552 23 45555555555555555554332 55555555555
Q ss_pred ccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCch
Q 003368 135 IQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214 (825)
Q Consensus 135 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~ 214 (825)
|++|++++. |... . ++|+.|+|++|++++. + .|..+++|+.| ++++|++++ +| .
T Consensus 92 L~~N~l~~l-~~~~-~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L-------------------~Ls~N~i~~-~~-~ 145 (263)
T 1xeu_A 92 VNRNRLKNL-NGIP-S-ACLSRLFLDNNELRDT-D-SLIHLKNLEIL-------------------SIRNNKLKS-IV-M 145 (263)
T ss_dssp CCSSCCSCC-TTCC-C-SSCCEEECCSSCCSBS-G-GGTTCTTCCEE-------------------ECTTSCCCB-CG-G
T ss_pred CCCCccCCc-Cccc-c-CcccEEEccCCccCCC-h-hhcCcccccEE-------------------ECCCCcCCC-Ch-H
Confidence 555555532 2211 1 5566666666665532 1 23344443333 444555542 22 2
Q ss_pred hhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCc
Q 003368 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGK 259 (825)
Q Consensus 215 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 259 (825)
+. .+++|+.|+|++|++++. ..+..+++|+.|++++|++.+.
T Consensus 146 l~-~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 146 LG-FLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp GG-GCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred Hc-cCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 22 567777777777777765 5577777778888877777654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=5.1e-18 Score=167.40 Aligned_cols=120 Identities=24% Similarity=0.354 Sum_probs=108.6
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCc-CCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPG-NLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
+.+++++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|.+|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999997 67876654 899999999999977775 589999999999999999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccCCccccccccccee
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 181 (825)
|+|++..|..|.++++|++|+|++|+|++.+|..|..+++|++|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 131 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence 99999989999999999999999999998888888888777777
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=167.27 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=117.3
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|++++|++. .+| .+..+++|++|++++|.++ .+..|..+++|++|++++|++++..|..|..+++|++|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 46888999988887 555 6888899999999999776 3457888999999999999998878888999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccc-cccccCccCCCCCCCCEEEcccCcCcccCCccccccccccee
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENN-LTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSL 181 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 181 (825)
++|++++..|..|..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|+.|
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L 186 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQL 186 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEE
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEE
Confidence 9999988788888999999999999998 55 455 68888999999999999875 33 66677777776
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.7e-18 Score=175.89 Aligned_cols=169 Identities=22% Similarity=0.283 Sum_probs=138.8
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.++++.+.+.+.. .+..+++|++|++++|+|+ .+| .+..+++|++|+|++|+|++..+ |..+++|++|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 34566778888887544 6788999999999999998 456 78999999999999999997665 999999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|++++. |. +.. ++|++|+|++|++++. +.+..+++|+.|+|++|++++. | .+..+++|+.|
T Consensus 93 ~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L---------- 155 (263)
T 1xeu_A 93 NRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVL---------- 155 (263)
T ss_dssp CSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEE----------
T ss_pred CCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEE----------
Confidence 99999964 43 233 8999999999999964 3689999999999999999864 3 57777777766
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCC
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGS 235 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~ 235 (825)
++++|++++. ..+ ..+++|+.|++++|.+++.
T Consensus 156 ---------~L~~N~i~~~--~~l-~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 156 ---------DLHGNEITNT--GGL-TRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ---------ECTTSCCCBC--TTS-TTCCCCCEEEEEEEEEECC
T ss_pred ---------ECCCCcCcch--HHh-ccCCCCCEEeCCCCcccCC
Confidence 7778888754 333 3789999999999999865
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-18 Score=185.07 Aligned_cols=258 Identities=16% Similarity=0.144 Sum_probs=151.9
Q ss_pred CCCCCEEEcCCCccc--ccCCccccCCCCCCEEECCCCcCCCCCCcCCCC--------CCCCCEEEcCCCCCCCCCChhh
Q 003368 55 LSFLREIHLSNNTIQ--GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSY--------CSRLIGLYLGRNKLEGSIPSEF 124 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~ 124 (825)
+++|+.|||++|+|. ...+..+. .+..+++..|. +.+.+|.+ |++|+.|+|.+ .++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCcccccc---ccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 455555555555555 22222221 13333333332 23445555 66666666666 6665555666
Q ss_pred hcccccceeeccccccccccCccCCCCCCCCEEEcccCc----CcccCCcccccccccc-eecCc--CcCCcccc----C
Q 003368 125 VSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS----LGGNIPSSLGQLKELK-SLGLG--GTIPPSIY----N 193 (825)
Q Consensus 125 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~----l~~~~p~~~~~l~~L~-~L~L~--~~~p~~i~----~ 193 (825)
.++++|+.|++++|.++.+.+.+|.+..++..+.+..+. .....+.+|.++..|+ .+.+. +.++..+. .
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 666666666666666665556666665555555544421 2223334455555554 22221 11111111 1
Q ss_pred CCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc-E
Q 003368 194 LSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA-Y 272 (825)
Q Consensus 194 l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~ 272 (825)
...+..+.+.++-.. .-...+...+++|+.|+|++|.++.+.+.+|.++++|+.|+|.+| +..+.+.+|.++.+|+ .
T Consensus 201 ~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~ 278 (329)
T 3sb4_A 201 PRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGT 278 (329)
T ss_dssp GGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEE
T ss_pred ccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEE
Confidence 222233333222111 111112224788999999999998888888999999999999888 7777888899999998 9
Q ss_pred EEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCc-cccCCCCcCEEEc
Q 003368 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPS-EIGKLVSLYLIEM 338 (825)
Q Consensus 273 L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~-~l~~l~~L~~L~L 338 (825)
+++.. ++..++ ..+|.+|++|+.+++++|+++ .|+. .|.++++|+.++.
T Consensus 279 l~l~~-~l~~I~------~~aF~~c~~L~~l~l~~n~i~----------~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 279 LELPA-SVTAIE------FGAFMGCDNLRYVLATGDKIT----------TLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECT-TCCEEC------TTTTTTCTTEEEEEECSSCCC----------EECTTTTCTTCCCCEEEC
T ss_pred EEEcc-cceEEc------hhhhhCCccCCEEEeCCCccC----------ccchhhhcCCcchhhhcc
Confidence 99877 565544 357888999999999999888 4443 6778888887753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=155.29 Aligned_cols=128 Identities=22% Similarity=0.198 Sum_probs=109.2
Q ss_pred CCCCCEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccccee
Q 003368 55 LSFLREIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 133 (825)
.++|++|++++|.++ +.+|..|..+++|++|+|++|+|++. ..|..+++|++|+|++|+|++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 467889999999988 77888888899999999999999866 778889999999999999998788888889999999
Q ss_pred eccccccccc-cCccCCCCCCCCEEEcccCcCcccCC---cccccccccceecCc
Q 003368 134 AIQENNLTGG-IPHFLGNITSLEAISLAYNSLGGNIP---SSLGQLKELKSLGLG 184 (825)
Q Consensus 134 ~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~ 184 (825)
++++|++++. .+..++.+++|++|++++|++++..+ ..|..+++|+.|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 9999999864 34788899999999999999987665 578888888888664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.9e-17 Score=156.69 Aligned_cols=129 Identities=32% Similarity=0.358 Sum_probs=112.9
Q ss_pred ECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCC
Q 003368 38 DLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 38 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+++++++. .+|..+ .++|++|++++|++++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 13 ~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~ 89 (177)
T 2o6r_A 13 RCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89 (177)
T ss_dssp ECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred EecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCcc
Confidence 33445554 345444 378999999999999888888999999999999999999888888999999999999999999
Q ss_pred CCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCC
Q 003368 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169 (825)
Q Consensus 118 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 169 (825)
+..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 8888889999999999999999998777788999999999999999987554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-16 Score=157.47 Aligned_cols=127 Identities=24% Similarity=0.309 Sum_probs=116.1
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.++++++++. .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 5788888886 5666553 68999999999999 788999999999999999999999999999999999999999999
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG 166 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 166 (825)
|+++.|.+|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 999988999999999999999999998777889999999999999999974
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.2e-17 Score=157.12 Aligned_cols=127 Identities=26% Similarity=0.257 Sum_probs=87.1
Q ss_pred CCCCCEEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccccee
Q 003368 55 LSFLREIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 133 (825)
.++|++|+|++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356777777777776 56666677777777777777777655 667777777777777777776667767677777777
Q ss_pred ecccccccccc-CccCCCCCCCCEEEcccCcCcccCC---cccccccccceecC
Q 003368 134 AIQENNLTGGI-PHFLGNITSLEAISLAYNSLGGNIP---SSLGQLKELKSLGL 183 (825)
Q Consensus 134 ~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L 183 (825)
+|++|++++.. +..|..+++|++|++++|++++..+ ..|..+++|++|++
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 154 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG 154 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETT
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecC
Confidence 77777777542 2567777777777777777765444 35666666666644
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-17 Score=159.05 Aligned_cols=136 Identities=20% Similarity=0.144 Sum_probs=123.7
Q ss_pred CcEEEEECCCCCCc-cccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLI-GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+++.|++++|++. +.+|..+..+++|++|+|++|+|++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 68999999999998 78899999999999999999999966 8899999999999999999988899898999999999
Q ss_pred cCCCCCCCCCC-hhhhcccccceeeccccccccccC---ccCCCCCCCCEEEcccCcCcccCCc
Q 003368 111 LGRNKLEGSIP-SEFVSLYNLKELAIQENNLTGGIP---HFLGNITSLEAISLAYNSLGGNIPS 170 (825)
Q Consensus 111 Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~ 170 (825)
|++|+|++..+ ..|..+++|++|++++|.+++..+ ..|..+++|++|++++|.+. .+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999996532 789999999999999999996655 58999999999999999997 4444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.8e-17 Score=154.00 Aligned_cols=128 Identities=21% Similarity=0.189 Sum_probs=117.8
Q ss_pred CcEEEEECCCCCCc-cccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLI-GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+++.|++++|++. +.+|+.+..+++|++|++++|++++. ..|+.+++|++|+|++|+|++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 67999999999998 78999999999999999999999976 7899999999999999999988899888999999999
Q ss_pred cCCCCCCCC-CChhhhcccccceeeccccccccccC---ccCCCCCCCCEEEccc
Q 003368 111 LGRNKLEGS-IPSEFVSLYNLKELAIQENNLTGGIP---HFLGNITSLEAISLAY 161 (825)
Q Consensus 111 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~ 161 (825)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|++||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999974 34889999999999999999997766 5799999999999874
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.6e-16 Score=154.11 Aligned_cols=121 Identities=23% Similarity=0.308 Sum_probs=110.5
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 138 (825)
+.+++++|+++ .+|..+. .+|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 68999999999 6777654 68999999999998 77899999999999999999999988899999999999999999
Q ss_pred ccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecC
Q 003368 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGL 183 (825)
Q Consensus 139 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 183 (825)
+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI 133 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence 999999999999999999999999999777777888888888833
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.6e-16 Score=150.10 Aligned_cols=133 Identities=23% Similarity=0.248 Sum_probs=116.7
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
.+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 478999999999 5665543 6899999999999988888899999999999999999988888899999999999999
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCC
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLP 212 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp 212 (825)
|+|++..+..|..+++|++|+|++|++++..+..|..+++|++| ++++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L-------------------~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKI-------------------WLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE-------------------ECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEE-------------------EecCCCeeccCc
Confidence 99998888889999999999999999997777667888888877 667777776544
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.65 E-value=3.2e-16 Score=168.65 Aligned_cols=256 Identities=13% Similarity=0.100 Sum_probs=195.0
Q ss_pred CCcEEEEECCCCCCc--cccCcCCCCCCCCCEEEcCCCcccccCCccccC--------CCCCCEEECCCCcCCCCCCcCC
Q 003368 31 HRRVTVLDLKSKGLI--GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGR--------LFRLEALYLSHNSLVGEIPGNL 100 (825)
Q Consensus 31 ~~~l~~l~L~~n~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~ 100 (825)
..+++.|||++|++. ...+..+ +.++.+.+..|.| .+.+|.+ +++|+.|+|++ .++.+.+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 357999999999987 3333333 2256666777743 4567777 99999999999 8988888999
Q ss_pred CCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccccc----ccccCccCCCCCCCC-EEEcccCcCcccCCccc---
Q 003368 101 SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNL----TGGIPHFLGNITSLE-AISLAYNSLGGNIPSSL--- 172 (825)
Q Consensus 101 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~--- 172 (825)
.+|++|+.|++++|.+..+.+.+|.++.++..+.+..+.. ....+..|.++.+|+ .+++.... .++..+
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~ 197 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKA 197 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHT
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC---cHHHHHhhc
Confidence 9999999999999999988889999998888888877432 334455677777777 55554322 222221
Q ss_pred -ccccccceecCcCcCCcc----c-cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCc
Q 003368 173 -GQLKELKSLGLGGTIPPS----I-YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNL 246 (825)
Q Consensus 173 -~~l~~L~~L~L~~~~p~~----i-~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 246 (825)
....+++.+.+.+.+... + ..++.|+.+++++|+++ .||+..|..+++|+.|+|.+| ++.+.+.+|.++++|
T Consensus 198 ~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L 275 (329)
T 3sb4_A 198 GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRL 275 (329)
T ss_dssp TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhc
Confidence 134556666666544321 1 13788888999999988 788888889999999999998 887888899999999
Q ss_pred c-EEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEc
Q 003368 247 Q-SLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNL 305 (825)
Q Consensus 247 ~-~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L 305 (825)
+ .+++.+ ++..+.+.+|.++++|+.++++.|++..+. ..+|.+|++|+.++.
T Consensus 276 ~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~------~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 276 AGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG------DELFGNGVPSKLIYK 328 (329)
T ss_dssp CEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC------TTTTCTTCCCCEEEC
T ss_pred cEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc------hhhhcCCcchhhhcc
Confidence 9 999988 788888899999999999999999888765 346888999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-14 Score=159.02 Aligned_cols=265 Identities=12% Similarity=0.126 Sum_probs=183.3
Q ss_pred CCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 55 LSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 55 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
...++.+.+.+ .++.+.+.+|.+. +|+.++|..| ++.+...+|.++ +|+.+++.. .++.+.+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 46677777764 4665667788874 7888888776 776777888885 688888885 77767778888888888888
Q ss_pred ccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCch
Q 003368 135 IQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPS 214 (825)
Q Consensus 135 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~ 214 (825)
|++|+++.+....|. .++|+.+.|.. .++.+...+|.++++|+.+++..+ ++ .|+..
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~--------------------l~-~I~~~ 243 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN--------------------VS-TIGQE 243 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT--------------------CC-EECTT
T ss_pred cCCCcceEechhhEe-ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC--------------------cc-Ccccc
Confidence 888888876667777 47888888874 477677777888888888754321 22 34444
Q ss_pred hhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc-----CccccCcCCCCCCcEEEcccccCCCCCCCccc
Q 003368 215 LGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF-----GKLSVNFGDMKSLAYLNVAINNLGSGESDEMS 289 (825)
Q Consensus 215 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 289 (825)
.+.. .+|+.+.| .|.++.+.+.+|.++++|+.+++.+|.+. .+.+
T Consensus 244 aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~---------------------------- 293 (401)
T 4fdw_A 244 AFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHP---------------------------- 293 (401)
T ss_dssp TTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECT----------------------------
T ss_pred cccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECH----------------------------
Confidence 4434 67888888 45566666778888888888888777654 2222
Q ss_pred cccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccc
Q 003368 290 FIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLS 368 (825)
Q Consensus 290 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 368 (825)
.+|.+|++|+.+++.+ .++ .|+ ..|..+++|+.+.+..| ++..-+.+|.++ +|+.+++++|.+.
T Consensus 294 --~aF~~c~~L~~l~l~~-~i~----------~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 294 --YCLEGCPKLARFEIPE-SIR----------ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp --TTTTTCTTCCEECCCT-TCC----------EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred --HHhhCCccCCeEEeCC-ceE----------EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 3455566666666653 243 222 24556667777777444 555556677777 8888888888777
Q ss_pred cccCccccCCC-CCcEEEcccCccc
Q 003368 369 GEIPSSFGNLS-SLVKLILGNNNLS 392 (825)
Q Consensus 369 ~~~p~~~~~l~-~L~~L~Ls~N~l~ 392 (825)
...+..|.+++ +++.|.+..+.+.
T Consensus 359 ~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 359 QVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp BCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred ccccccccCCCCCccEEEeCHHHHH
Confidence 66666777774 6778887777654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=3.5e-16 Score=167.87 Aligned_cols=135 Identities=17% Similarity=0.162 Sum_probs=96.5
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--------------hhHHH--------HHHHHHHhhcCCCCC
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--------------GASKS--------FAAECRALRNIRHRN 701 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~H~n 701 (825)
-|...+.||+|+||.||+|.. .+|+.||||+++.... ..... ..+|...+.++.++.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 378889999999999999998 6899999998753211 01111 234555555554433
Q ss_pred ce--eEeecccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003368 702 LV--RVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQE 779 (825)
Q Consensus 702 iv--~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~ 779 (825)
+. +.+++ ...+|||||++|+.|.++... .....++.|++.++.|||..
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------------~~~~~l~~qll~~l~~lH~~--- 224 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------------PDPASLYADLIALILRLAKH--- 224 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------------SCHHHHHHHHHHHHHHHHHT---
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhccc------------------HHHHHHHHHHHHHHHHHHHC---
Confidence 32 11111 124799999999888765421 12346789999999999985
Q ss_pred CeeecCCCCCCeeecCCC----------cEEEcccCcccc
Q 003368 780 PTIHCDLKPSNILLDNNL----------TAHVGDFGLARL 809 (825)
Q Consensus 780 ~ivHrdlk~~NILl~~~~----------~~ki~DFGla~~ 809 (825)
+||||||||.|||+++++ .+.|+||+=|--
T Consensus 225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 899999999999998776 389999996654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.5e-14 Score=157.27 Aligned_cols=203 Identities=13% Similarity=0.122 Sum_probs=158.9
Q ss_pred CCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCCh
Q 003368 43 GLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPS 122 (825)
Q Consensus 43 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 122 (825)
++...-+.+|.+. +|+.+++..| ++.+...+|.+. +|+.+++.. .++.+.+.+|.+|.+|+.++|++|+++.+...
T Consensus 123 ~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~ 198 (401)
T 4fdw_A 123 SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAS 198 (401)
T ss_dssp TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTT
T ss_pred ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechh
Confidence 4444445577774 7999999877 877888899884 799999996 78878889999999999999999999988788
Q ss_pred hhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeec
Q 003368 123 EFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV 202 (825)
Q Consensus 123 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l 202 (825)
+|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+.
T Consensus 199 aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp------------------ 256 (401)
T 4fdw_A 199 TFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP------------------ 256 (401)
T ss_dssp TTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE------------------
T ss_pred hEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC------------------
Confidence 888 589999999854 88788899999999999999875 66677777877 678877442
Q ss_pred CCccccccCCchhhhcCCCCcEEEcccccCC-----CCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFS-----GSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 203 ~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
+.++ .++...+..+++|+.+++.+|.+. .+.+.+|.++++|+.++|. +.+..+....|.++++|+.+.+
T Consensus 257 --~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 257 --NGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp --TTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred --CCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 2233 466666668888999998888765 4566789999999999887 4465555555555555555555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=146.09 Aligned_cols=128 Identities=21% Similarity=0.252 Sum_probs=95.0
Q ss_pred CCCCCCCCCEEEcCCCcccccCCccccCCC-CCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccc
Q 003368 51 QIGNLSFLREIHLSNNTIQGKIPGEIGRLF-RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYN 129 (825)
Q Consensus 51 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 129 (825)
.+.++.+|++|+|++|+++. +|. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|+|++..+..|..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 35567788888888888884 454 44444 888888888888865 57888888888888888888766666788888
Q ss_pred cceeeccccccccccCc--cCCCCCCCCEEEcccCcCcccCCcc----cccccccceecCc
Q 003368 130 LKELAIQENNLTGGIPH--FLGNITSLEAISLAYNSLGGNIPSS----LGQLKELKSLGLG 184 (825)
Q Consensus 130 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~ 184 (825)
|++|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|+++
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~ 148 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQ 148 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTE
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCC
Confidence 888888888886 4454 6778888888888888887 44543 6777777777443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=139.83 Aligned_cols=104 Identities=25% Similarity=0.305 Sum_probs=56.6
Q ss_pred EEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccc
Q 003368 60 EIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENN 139 (825)
Q Consensus 60 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 139 (825)
.|++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 3444444444 2333332 445555555555555555555555555555555555555555555556666666666666
Q ss_pred cccccCccCCCCCCCCEEEcccCcCcc
Q 003368 140 LTGGIPHFLGNITSLEAISLAYNSLGG 166 (825)
Q Consensus 140 l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 166 (825)
|++..+..|..+++|++|+|++|.++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 665555556666666666666666653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.8e-15 Score=145.50 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=113.1
Q ss_pred CcEEEEECCCCCCccccCcCCCCCC-CCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLS-FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 110 (825)
.+++.|++++|++.. +|. +..+. +|++|+|++|+|++. ..|+.+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 579999999999985 444 55555 999999999999975 6899999999999999999977667779999999999
Q ss_pred cCCCCCCCCCCh--hhhcccccceeeccccccccccCcc----CCCCCCCCEEEcccCcCcc
Q 003368 111 LGRNKLEGSIPS--EFVSLYNLKELAIQENNLTGGIPHF----LGNITSLEAISLAYNSLGG 166 (825)
Q Consensus 111 Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~ 166 (825)
|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|++||++.|.+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999997 4565 8999999999999999998 45654 8999999999999999863
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-17 Score=165.04 Aligned_cols=146 Identities=24% Similarity=0.329 Sum_probs=123.5
Q ss_pred CcEEEEECCCCCCccccCc------CCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCC
Q 003368 32 RRVTVLDLKSKGLIGSLSP------QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSR 105 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 105 (825)
.+++.++++.+.+.+.+|+ .+..+++|++|+|++|++++ +| .|..+++|++|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4667777777788777776 88999999999999999996 67 8999999999999999998 67777888899
Q ss_pred CCEEEcCCCCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccCCcc----------ccc
Q 003368 106 LIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSS----------LGQ 174 (825)
Q Consensus 106 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~ 174 (825)
|++|+|++|+|++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999996 45 68999999999999999986443 57889999999999999998776653 677
Q ss_pred ccccceec
Q 003368 175 LKELKSLG 182 (825)
Q Consensus 175 l~~L~~L~ 182 (825)
+++|+.|+
T Consensus 173 l~~L~~Ld 180 (198)
T 1ds9_A 173 LPNLKKLD 180 (198)
T ss_dssp CSSCSEEC
T ss_pred CCCcEEEC
Confidence 77777774
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-14 Score=138.18 Aligned_cols=107 Identities=25% Similarity=0.278 Sum_probs=97.4
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
+.+|+++|++.. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 468888888865 676663 89999999999999998999999999999999999999998999999999999999999
Q ss_pred CCCCCCChhhhcccccceeecccccccccc
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGI 144 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 144 (825)
+|+++.+..|..+++|++|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999888888999999999999999998543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=2.8e-14 Score=137.93 Aligned_cols=86 Identities=27% Similarity=0.321 Sum_probs=44.4
Q ss_pred CCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEc
Q 003368 80 FRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISL 159 (825)
Q Consensus 80 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 159 (825)
++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444444444445555554444444455555555555555555444444555666666666
Q ss_pred ccCcCc
Q 003368 160 AYNSLG 165 (825)
Q Consensus 160 s~N~l~ 165 (825)
++|.+.
T Consensus 113 ~~N~~~ 118 (174)
T 2r9u_A 113 YNNPWD 118 (174)
T ss_dssp CSSCBC
T ss_pred CCCCcc
Confidence 666655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.3e-14 Score=137.35 Aligned_cols=106 Identities=25% Similarity=0.319 Sum_probs=97.3
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
+.+|+++|++ +.+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 5789999998 46777765 89999999999999999999999999999999999999888888999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccc
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGG 143 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 143 (825)
+|+++.+..|..+++|++|+|++|.+...
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 99987777899999999999999999843
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-16 Score=158.48 Aligned_cols=125 Identities=23% Similarity=0.257 Sum_probs=93.2
Q ss_pred CCCCCCCCEEEcCCCcccccCCc------cccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhh
Q 003368 52 IGNLSFLREIHLSNNTIQGKIPG------EIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV 125 (825)
Q Consensus 52 ~~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 125 (825)
+.....++.++++.|.+++.+|. .|..+++|++|+|++|+|++ +| .|..+++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34556777888888888877776 88888888888888888886 55 7788888888888888888 5677777
Q ss_pred cccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCC-ccccccccccee
Q 003368 126 SLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP-SSLGQLKELKSL 181 (825)
Q Consensus 126 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 181 (825)
.+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 77888888888888885 34 57778888888888888874322 344445544444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=9.8e-13 Score=145.07 Aligned_cols=308 Identities=17% Similarity=0.084 Sum_probs=174.2
Q ss_pred ccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhc
Q 003368 47 SLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVS 126 (825)
Q Consensus 47 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 126 (825)
.-..+|.++++|+.+.+.. .++.+-..+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ +..+...+|.+
T Consensus 62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~ 138 (394)
T 4fs7_A 62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG 138 (394)
T ss_dssp ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence 3345788889999999974 477677788999999999999765 66677788999999988877655 55466677877
Q ss_pred ccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcC----CccccCCCCCceeec
Q 003368 127 LYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTI----PPSIYNLSLLANFSV 202 (825)
Q Consensus 127 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~----p~~i~~l~~l~~l~l 202 (825)
+..++....... ......+|.++++|+.+.+..+. ......+|.++.+|+.+.+..++ ...+.++..|+.+.+
T Consensus 139 ~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~~~~I~~~~F~~~~~L~~i~~ 215 (394)
T 4fs7_A 139 CDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRNLKIIRDYCFAECILLENMEF 215 (394)
T ss_dssp CCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCTTCCBCCC
T ss_pred ccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCCceEeCchhhccccccceeec
Confidence 765544443333 33445678888889999887654 44666778888888888765432 123345555555555
Q ss_pred CCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCC
Q 003368 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGS 282 (825)
Q Consensus 203 ~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 282 (825)
..+... +....+ ...+|+.+.+..+ ++.+...+|..+.+|+.+.+..+. .......|.....++......+.+.
T Consensus 216 ~~~~~~--i~~~~~-~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~-~~i~~~~F~~~~~l~~~~~~~~~i~- 289 (394)
T 4fs7_A 216 PNSLYY--LGDFAL-SKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK-LRIGGSLFYNCSGLKKVIYGSVIVP- 289 (394)
T ss_dssp CTTCCE--ECTTTT-TTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT-CEECSCTTTTCTTCCEEEECSSEEC-
T ss_pred CCCceE--eehhhc-ccCCCceEEECCC-ceecccccccccccceeEEcCCCc-ceeeccccccccccceeccCceeec-
Confidence 544332 222222 4456666666533 333444566666666666665543 2233444555555555444333221
Q ss_pred CCCCccccccccccCCCCCEEEcccccccccCCCCcccccCC-ccccCCCCcCEEEcccCcccccCCccccCCCCCCEEE
Q 003368 283 GESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLN 361 (825)
Q Consensus 283 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 361 (825)
...|..+.+|+.+.+..+ ++ .|+ ..|.++.+|+.+++.++ ++..-..+|.++.+|+.++
T Consensus 290 --------~~~F~~~~~L~~i~l~~~-i~----------~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~ 349 (394)
T 4fs7_A 290 --------EKTFYGCSSLTEVKLLDS-VK----------FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNIN 349 (394)
T ss_dssp --------TTTTTTCTTCCEEEECTT-CC----------EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEEC
T ss_pred --------cccccccccccccccccc-cc----------eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEE
Confidence 113344455555544332 22 111 12334444444444322 3333334444444444444
Q ss_pred ccccccccccCccccCCCCCcEEEcc
Q 003368 362 MRHNQLSGEIPSSFGNLSSLVKLILG 387 (825)
Q Consensus 362 Ls~N~l~~~~p~~~~~l~~L~~L~Ls 387 (825)
+..| +...-..+|.++++|+.+++.
T Consensus 350 lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 350 FPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred ECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 4433 332333344444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.49 E-value=9.8e-13 Score=145.07 Aligned_cols=161 Identities=12% Similarity=0.057 Sum_probs=96.8
Q ss_pred cccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCc
Q 003368 67 TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPH 146 (825)
Q Consensus 67 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 146 (825)
.++.+-..+|.++.+|+.+.|..+ ++.+...+|.+|++|+.++|..+ ++.+...+|.++.+|+.+.+..+ ++.....
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence 355566677888888888888743 77677778888888888888755 66566677888888888777654 4445566
Q ss_pred cCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEE
Q 003368 147 FLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQ 226 (825)
Q Consensus 147 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~ 226 (825)
+|.+...++...... .......+|.++++|+.+.+ .++. . .++...+....+|+.++
T Consensus 135 aF~~~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l-------------------~~~~-~-~I~~~~F~~c~~L~~i~ 191 (394)
T 4fs7_A 135 AFKGCDFKEITIPEG--VTVIGDEAFATCESLEYVSL-------------------PDSM-E-TLHNGLFSGCGKLKSIK 191 (394)
T ss_dssp TTTTCCCSEEECCTT--CCEECTTTTTTCTTCCEEEC-------------------CTTC-C-EECTTTTTTCTTCCBCC
T ss_pred eeecccccccccCcc--ccccchhhhcccCCCcEEec-------------------CCcc-c-eeccccccCCCCceEEE
Confidence 676665444333222 22233455666666666633 2211 1 23444444556666666
Q ss_pred cccccCCCCCCccccCCCCccEEEeecc
Q 003368 227 ISNNFFSGSFPLAFSNASNLQSLEILGN 254 (825)
Q Consensus 227 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 254 (825)
+..| ++.+...+|.++..|+.+.+..+
T Consensus 192 l~~~-~~~I~~~~F~~~~~L~~i~~~~~ 218 (394)
T 4fs7_A 192 LPRN-LKIIRDYCFAECILLENMEFPNS 218 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCBCCCCTT
T ss_pred cCCC-ceEeCchhhccccccceeecCCC
Confidence 6554 44344455666666665555443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=8.3e-13 Score=143.03 Aligned_cols=76 Identities=22% Similarity=0.197 Sum_probs=41.7
Q ss_pred cCcCCCCCCCCCEEEcCC-CcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhh
Q 003368 48 LSPQIGNLSFLREIHLSN-NTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF 124 (825)
Q Consensus 48 ~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 124 (825)
+|. |..+++|++|+|++ |+|+++.|.+|+++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|
T Consensus 24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 100 (347)
T 2ifg_A 24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV 100 (347)
T ss_dssp TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTT
T ss_pred cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHc
Confidence 455 66666666666664 66665555556666666666655555555555555555555555555555544333333
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=141.39 Aligned_cols=104 Identities=17% Similarity=0.163 Sum_probs=94.0
Q ss_pred EEEcCCC-cccccCCccccCCCCCCEEECCC-CcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 60 EIHLSNN-TIQGKIPGEIGRLFRLEALYLSH-NSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 60 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
.++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|.++++|+.|+|++|+|+++.|.+|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3466666 788 4787 99999999999996 999999889999999999999999999999999999999999999999
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcc
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGG 166 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 166 (825)
|+|++..+..|..++ |+.|+|++|.+..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999988777888777 9999999999974
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=4e-10 Score=124.11 Aligned_cols=162 Identities=12% Similarity=0.101 Sum_probs=94.4
Q ss_pred ccccCCccccCCC-CCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC---CCCCCChhhhcccccceeeccccccccc
Q 003368 68 IQGKIPGEIGRLF-RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK---LEGSIPSEFVSLYNLKELAIQENNLTGG 143 (825)
Q Consensus 68 l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 143 (825)
++.+-..+|.+.. .|+.+.+..+ ++.+...+|.+|++|+.+.++.|. ++.+-..+|.++.+|+.+.+..+ ++.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I 128 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEI 128 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-ccee
Confidence 3434455666653 4777777643 555666777777777777776654 55555667777777777776654 4545
Q ss_pred cCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCc
Q 003368 144 IPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQ 223 (825)
Q Consensus 144 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~ 223 (825)
....|.++.+|+.+.+..+ ++......|..+.+|+.+.+..+ ++ .+....+ .-.+|+
T Consensus 129 ~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~--------------------~~-~I~~~aF-~~~~l~ 185 (394)
T 4gt6_A 129 DSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS--------------------VT-AIEERAF-TGTALT 185 (394)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT--------------------CC-EECTTTT-TTCCCS
T ss_pred hhhhhhhhcccccccccce-eeeecccceecccccccccccce--------------------ee-Eeccccc-ccccee
Confidence 5667777777777777643 33355566667777766643221 11 2223333 234566
Q ss_pred EEEcccccCCCCCCccccCCCCccEEEeeccc
Q 003368 224 LFQISNNFFSGSFPLAFSNASNLQSLEILGNN 255 (825)
Q Consensus 224 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 255 (825)
.+.+..+. +.+...+|.++.+++......+.
T Consensus 186 ~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~ 216 (394)
T 4gt6_A 186 QIHIPAKV-TRIGTNAFSECFALSTITSDSES 216 (394)
T ss_dssp EEEECTTC-CEECTTTTTTCTTCCEEEECCSS
T ss_pred EEEECCcc-cccccchhhhccccceecccccc
Confidence 66655432 22344566666666666654443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=8.8e-14 Score=151.45 Aligned_cols=110 Identities=22% Similarity=0.185 Sum_probs=48.5
Q ss_pred CCCCEEEcCCCcccccCCccccCC-----CCCCEEECCCCcCCCCCCcCC-CCCCCCCEEEcCCCCCCCCCChhhh----
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRL-----FRLEALYLSHNSLVGEIPGNL-SYCSRLIGLYLGRNKLEGSIPSEFV---- 125 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---- 125 (825)
+.|++|+|++|.|+......|... .+|++|||++|.|+......+ ..+++|+.|+|++|+|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345555555555553322222221 455555555555543222222 1234455555555555432222221
Q ss_pred -cccccceeeccccccccc----cCccCCCCCCCCEEEcccCcCc
Q 003368 126 -SLYNLKELAIQENNLTGG----IPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 126 -~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
..++|++|+|++|.|+.. ++..+..+++|++|+|++|+|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 234455555555555421 2222344455555555555554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=3e-11 Score=125.16 Aligned_cols=146 Identities=14% Similarity=0.062 Sum_probs=110.3
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCe
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~ 719 (825)
..++|......+.|+.+.||++.. .|..+++|+...........+.+|+++++.+. |..+.++++++. ..+.
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~ 84 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence 345677777888889999999985 46789999987533233346889999999885 667778888753 2457
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC---------------------- 777 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~---------------------- 777 (825)
.|+||||++|.++.+.+.. ..+...++.+++++++.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~~-----------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYED-----------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEEECCSSEEHHHHCCT-----------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred eEEEEEecCCeehhhccCC-----------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence 8999999999999776411 0123467889999999999810
Q ss_pred ----------------------------------CCCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 778 ----------------------------------QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 778 ----------------------------------~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
.+.++|+|+++.||+++++..+.|.||+.|...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 134899999999999987666789999987653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-09 Score=120.26 Aligned_cols=131 Identities=12% Similarity=0.144 Sum_probs=101.6
Q ss_pred CcCCCCCC-CCCEEEcCCCcccccCCccccCCCCCCEEECCCCc---CCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhh
Q 003368 49 SPQIGNLS-FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS---LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEF 124 (825)
Q Consensus 49 ~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 124 (825)
..+|.+.. .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++.+...+|.+|.+|+.+.+..+ ++.+...+|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 34677774 5999999754 776778899999999999998874 77677888999999999888765 665777889
Q ss_pred hcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCc
Q 003368 125 VSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG 184 (825)
Q Consensus 125 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 184 (825)
.++.+|+.+.+..+ ++.+....|.+..+|+.+.+..+ ++..-..+|.. .+|+.+.+.
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip 190 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP 190 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence 99999999999754 45466788999999999999765 55455566654 567777543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.2e-13 Score=146.05 Aligned_cols=160 Identities=18% Similarity=0.195 Sum_probs=119.2
Q ss_pred CcEEEEECCCCCCccccCcCCCC-----CCCCCEEEcCCCcccccCCccc-cCCCCCCEEECCCCcCCCCCCcCC-----
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGN-----LSFLREIHLSNNTIQGKIPGEI-GRLFRLEALYLSHNSLVGEIPGNL----- 100 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 100 (825)
..++.|+|++|.+.......+.. .++|++|+|++|.|+......+ ..+.+|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 46899999999997654443332 3799999999999975433333 346789999999999986544444
Q ss_pred CCCCCCCEEEcCCCCCCC----CCChhhhcccccceeeccccccccc----cCccCCCCCCCCEEEcccCcCcccC----
Q 003368 101 SYCSRLIGLYLGRNKLEG----SIPSEFVSLYNLKELAIQENNLTGG----IPHFLGNITSLEAISLAYNSLGGNI---- 168 (825)
Q Consensus 101 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~---- 168 (825)
...++|++|+|++|.|+. .++.++..+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 357899999999999975 2445567889999999999999853 2566778889999999999998532
Q ss_pred CcccccccccceecCcCcCCccccCCCCCceeecCCcccccc
Q 003368 169 PSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGS 210 (825)
Q Consensus 169 p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~ 210 (825)
+..+...++|++| +|++|.++..
T Consensus 232 ~~~L~~~~~L~~L-------------------~Ls~N~i~~~ 254 (372)
T 3un9_A 232 ARAAREHPSLELL-------------------HLYFNELSSE 254 (372)
T ss_dssp HHHHHHCSSCCEE-------------------ECTTSSCCHH
T ss_pred HHHHHhCCCCCEE-------------------eccCCCCCHH
Confidence 2333344555555 7788887643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.4e-10 Score=119.82 Aligned_cols=141 Identities=16% Similarity=0.090 Sum_probs=98.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc--eeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL--VRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~~ 719 (825)
..++....+.+.|..+.||++.. .+|+.++||+.... ....+.+|+++++.+++..+ .++++++. .++.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~ 89 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGR 89 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSC
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCC
Confidence 33444433334566799999976 56788999987643 22457789999998875554 45777632 2455
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC----------------------
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC---------------------- 777 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~---------------------- 777 (825)
.++||||++|.++. ... . ....++.++++.++.||...
T Consensus 90 ~~~v~e~i~G~~l~--~~~---------------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH---------------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME 149 (264)
T ss_dssp EEEEEECCSSEETT--TSC---------------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred CEEEEEecCCcccC--cCc---------------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 79999999998884 210 0 11256777778888888642
Q ss_pred ---------------------------------CCCeeecCCCCCCeeecCCCcEEEcccCcccccc
Q 003368 778 ---------------------------------QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 778 ---------------------------------~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
.+.++|+|++|.||+++++..++|.|||.|....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 1129999999999999887667899999987643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=3.3e-09 Score=115.16 Aligned_cols=146 Identities=13% Similarity=0.174 Sum_probs=105.2
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEee--cccc-hhHHHHHHHHHHhhcCC--CCCceeEeecccccccCCCCeee
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLN--LQLQ-GASKSFAAECRALRNIR--HRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..+.++.|.++.||+... .+..+++|+.. .... .....+.+|+++++.++ +..+.+++++|.... ..+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence 457789999999999986 34678888876 3321 22346788999999887 455778888764321 113468
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC------------------------ 777 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~------------------------ 777 (825)
+||||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 118 ~vme~v~G~~l~~~~--------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp EEEECCCCBCCCCTT--------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc--------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 999999998775321 123677788899999999999999731
Q ss_pred -------------------------------CCCeeecCCCCCCeeecCCCc--EEEcccCccccc
Q 003368 778 -------------------------------QEPTIHCDLKPSNILLDNNLT--AHVGDFGLARLR 810 (825)
Q Consensus 778 -------------------------------~~~ivHrdlk~~NILl~~~~~--~ki~DFGla~~~ 810 (825)
.+.+||+|+++.||+++.++. +.|.||+.|..-
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246899999999999997753 689999988753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.90 E-value=6.1e-08 Score=105.92 Aligned_cols=95 Identities=16% Similarity=0.144 Sum_probs=57.6
Q ss_pred ccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccc
Q 003368 327 IGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406 (825)
Q Consensus 327 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 406 (825)
+.++.+|+.+.+..+ +.......|.++.+|+.+.+.++.+...-...|.++.+|+.+.|..+ ++.+-..+|.++++|+
T Consensus 259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 336 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS 336 (379)
T ss_dssp TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence 444555555555432 33344456677777777777777776555667777777777777644 5544456777777777
Q ss_pred eeecCCCCCccccchhhhc
Q 003368 407 LLHLFQNDLSGAIPEEIFN 425 (825)
Q Consensus 407 ~L~L~~N~l~g~ip~~~~~ 425 (825)
.+.+..+ ++ .|....|.
T Consensus 337 ~i~ip~~-v~-~I~~~aF~ 353 (379)
T 4h09_A 337 TISYPKS-IT-LIESGAFE 353 (379)
T ss_dssp CCCCCTT-CC-EECTTTTT
T ss_pred EEEECCc-cC-EEchhHhh
Confidence 7776544 43 44444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-07 Score=101.98 Aligned_cols=147 Identities=20% Similarity=0.216 Sum_probs=86.9
Q ss_pred ccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCC
Q 003368 238 LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHS 317 (825)
Q Consensus 238 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 317 (825)
.+|..+.+|+.+.+..+ +..+....|.+...|+.+.+..+ +..+. ..+|.++.+|+.+.+..+ ++
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~------~~aF~~~~~l~~i~l~~~-i~------ 275 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIG------SFLLQNCTALKTLNFYAK-VK------ 275 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEEC------TTTTTTCTTCCEEEECCC-CS------
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeC------ccccceeehhcccccccc-ce------
Confidence 34444445555544332 33333344445555555544332 22211 224556666776666443 32
Q ss_pred cccccCC-ccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccC
Q 003368 318 IVSGSIP-SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIP 396 (825)
Q Consensus 318 ~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 396 (825)
.++ ..|..+.+|+.+.+.++.++..-..+|.++.+|+.++|..+ +...-..+|.++++|+.+.+..+ ++.+-.
T Consensus 276 ----~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~ 349 (379)
T 4h09_A 276 ----TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIES 349 (379)
T ss_dssp ----EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred ----eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEch
Confidence 222 24566778888888777777666678888888888888755 65455667888888888888655 554555
Q ss_pred CCCCCCCcc
Q 003368 397 SSLGNLKQL 405 (825)
Q Consensus 397 ~~~~~l~~L 405 (825)
.+|.++..+
T Consensus 350 ~aF~~c~~~ 358 (379)
T 4h09_A 350 GAFEGSSIT 358 (379)
T ss_dssp TTTTTSSCC
T ss_pred hHhhCCCCC
Confidence 677776533
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.86 E-value=6.6e-11 Score=120.98 Aligned_cols=163 Identities=20% Similarity=0.165 Sum_probs=91.8
Q ss_pred CCCceeeceeecCCCCcEEEEECCC---CCCccccCc-CCCCCCCCCEEEcCCCcccccCCc-cccCCCCCCE--EECCC
Q 003368 17 HHFCDWEGITCSPRHRRVTVLDLKS---KGLIGSLSP-QIGNLSFLREIHLSNNTIQGKIPG-EIGRLFRLEA--LYLSH 89 (825)
Q Consensus 17 ~~~C~~~g~~c~~~~~~l~~l~L~~---n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~--L~Ls~ 89 (825)
...|+|.|+.|++...+|+.+-..+ ..+.+.+++ .+..++. .|...+|.-++.++- .|...+.|.. ++++.
T Consensus 75 ~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~ 152 (267)
T 3rw6_A 75 SALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVL 152 (267)
T ss_dssp HHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCT
T ss_pred HHHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccC
Confidence 3568999999998776776654433 112222221 1111111 111112211111111 1333344444 56666
Q ss_pred CcCC---CCCCcCCCCCCCCCEEEcCCCCCCC--CCChhhhcccccceeeccccccccccCccCCCCC--CCCEEEcccC
Q 003368 90 NSLV---GEIPGNLSYCSRLIGLYLGRNKLEG--SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNIT--SLEAISLAYN 162 (825)
Q Consensus 90 N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N 162 (825)
|+.. ...+....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|
T Consensus 153 N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~N 230 (267)
T 3rw6_A 153 NRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGN 230 (267)
T ss_dssp TSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTS
T ss_pred CHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCC
Confidence 6433 1122222456777888888888876 3456677788888888888888755 2344444 7888888888
Q ss_pred cCcccCC-------cccccccccceecC
Q 003368 163 SLGGNIP-------SSLGQLKELKSLGL 183 (825)
Q Consensus 163 ~l~~~~p-------~~~~~l~~L~~L~L 183 (825)
.+++.+| ..+..+++|+.||=
T Consensus 231 pl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 231 SLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp TTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred cCccccCcchhHHHHHHHHCcccCeECC
Confidence 8877655 23667888888753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.9e-09 Score=116.10 Aligned_cols=131 Identities=11% Similarity=0.154 Sum_probs=73.1
Q ss_pred CcEEEEECCCCCCcc-c-------cCcCCCCCCCCCEEEcCCCccc---------ccCCccccCCCCCCEEECCCCc-CC
Q 003368 32 RRVTVLDLKSKGLIG-S-------LSPQIGNLSFLREIHLSNNTIQ---------GKIPGEIGRLFRLEALYLSHNS-LV 93 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~-~-------~~~~~~~l~~L~~L~Ls~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~-l~ 93 (825)
.+|+.|.+...+..+ . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|. +.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 467778777655442 1 2344566788999988765432 1233445667778888887763 22
Q ss_pred CCCCcCCCCCCCCCEEEcCCCCCCCCCChhhh--cccccceeeccc--cccccc-----cCccC--CCCCCCCEEEcccC
Q 003368 94 GEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV--SLYNLKELAIQE--NNLTGG-----IPHFL--GNITSLEAISLAYN 162 (825)
Q Consensus 94 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N 162 (825)
++. +. +++|+.|+|..+.+....-..+. .+++|+.|+|+. |...+. +...+ ..+++|++|+|++|
T Consensus 187 --l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 187 --IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp --CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred --ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 222 33 66777777777776543333343 567777777643 221111 01112 23566666666666
Q ss_pred cCcc
Q 003368 163 SLGG 166 (825)
Q Consensus 163 ~l~~ 166 (825)
.++.
T Consensus 263 ~i~~ 266 (362)
T 2ra8_A 263 EEQN 266 (362)
T ss_dssp TTHH
T ss_pred CCch
Confidence 6653
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.65 E-value=4.8e-09 Score=113.05 Aligned_cols=102 Identities=20% Similarity=0.211 Sum_probs=47.4
Q ss_pred CCCCEEEcCCCcccc-c-------CCccccCCCCCCEEECCCCcCCC---------CCCcCCCCCCCCCEEEcCCCCCCC
Q 003368 56 SFLREIHLSNNTIQG-K-------IPGEIGRLFRLEALYLSHNSLVG---------EIPGNLSYCSRLIGLYLGRNKLEG 118 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~-~-------~p~~~~~l~~L~~L~Ls~N~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~ 118 (825)
..++.|.+......+ . +..++..+++|+.|.+..+.... .++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 456778777665442 1 12335566788888776543210 12222334455555555554211
Q ss_pred CCChhhhcccccceeeccccccccccCccCC--CCCCCCEEEcc
Q 003368 119 SIPSEFVSLYNLKELAIQENNLTGGIPHFLG--NITSLEAISLA 160 (825)
Q Consensus 119 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls 160 (825)
.++. + .+++|+.|+|..+.++...-..+. .+++|+.|+|+
T Consensus 186 ~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 186 SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 1111 2 244555555555544322222222 34555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=2.9e-09 Score=103.54 Aligned_cols=119 Identities=21% Similarity=0.201 Sum_probs=82.8
Q ss_pred ccCcCCCCCCCCCEEEcCCC-cccc----cCCccccCCCCCCEEECCCCcCCCC----CCcCCCCCCCCCEEEcCCCCCC
Q 003368 47 SLSPQIGNLSFLREIHLSNN-TIQG----KIPGEIGRLFRLEALYLSHNSLVGE----IPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 47 ~~~~~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
.+...+...+.|++|+|++| .|.. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34445667788888888888 7763 2345566677888888888888743 2334555677888888888887
Q ss_pred CC----CChhhhcccccceeec--cccccccc----cCccCCCCCCCCEEEcccCcCc
Q 003368 118 GS----IPSEFVSLYNLKELAI--QENNLTGG----IPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 118 ~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
.. +..++...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 42 3455666778888888 77888643 2334555678888888888875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.53 E-value=9.2e-09 Score=105.05 Aligned_cols=105 Identities=20% Similarity=0.177 Sum_probs=80.2
Q ss_pred CCCCCCCCE--EEcCCCccc---ccCCccccCCCCCCEEECCCCcCCC--CCCcCCCCCCCCCEEEcCCCCCCCCCChhh
Q 003368 52 IGNLSFLRE--IHLSNNTIQ---GKIPGEIGRLFRLEALYLSHNSLVG--EIPGNLSYCSRLIGLYLGRNKLEGSIPSEF 124 (825)
Q Consensus 52 ~~~l~~L~~--L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 124 (825)
+...+.|+. ++++.|+.. +.++-...++++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 445555665 778888543 2233333568899999999999998 4567778999999999999999975 445
Q ss_pred hccc--ccceeeccccccccccCc-------cCCCCCCCCEEE
Q 003368 125 VSLY--NLKELAIQENNLTGGIPH-------FLGNITSLEAIS 158 (825)
Q Consensus 125 ~~l~--~L~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~ 158 (825)
..+. +|++|+|++|.+++..|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 5555 899999999999976663 477889999987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.44 E-value=3.6e-07 Score=96.48 Aligned_cols=140 Identities=21% Similarity=0.211 Sum_probs=97.1
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCC--ceeEeecccccccCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRN--LVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
.+.++.|.+..||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+.+..+.. -......|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceEEE
Confidence 4678999999999864 35888885432 33467889999998874 333 3344443211 01112348999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc----------------------------
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH---------------------------- 776 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~---------------------------- 776 (825)
||++|.++.+.. ...++..++..++.++++.++.||..
T Consensus 96 ~~i~G~~l~~~~--------------~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (304)
T 3sg8_A 96 TKIKGVPLTPLL--------------LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL 161 (304)
T ss_dssp ECCCCEECCHHH--------------HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred cccCCeECCccc--------------cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence 999998775422 12456667778888888888888851
Q ss_pred ---------------------------CCCCeeecCCCCCCeeecC--CCcEEEcccCccccc
Q 003368 777 ---------------------------CQEPTIHCDLKPSNILLDN--NLTAHVGDFGLARLR 810 (825)
Q Consensus 777 ---------------------------~~~~ivHrdlk~~NILl~~--~~~~ki~DFGla~~~ 810 (825)
..+.++|+|+++.||++++ ...+.|.||+.+...
T Consensus 162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1135799999999999998 456899999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=8.2e-08 Score=93.23 Aligned_cols=112 Identities=11% Similarity=0.144 Sum_probs=90.6
Q ss_pred CCCcEEEEECCCC-CCccc----cCcCCCCCCCCCEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCC----C
Q 003368 30 RHRRVTVLDLKSK-GLIGS----LSPQIGNLSFLREIHLSNNTIQGK----IPGEIGRLFRLEALYLSHNSLVGE----I 96 (825)
Q Consensus 30 ~~~~l~~l~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 96 (825)
....++.|+|++| .+... +...+...++|++|+|++|+|... +...+...+.|++|+|++|.|... +
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3468999999999 88643 556677789999999999999742 345566678999999999999854 4
Q ss_pred CcCCCCCCCCCEEEc--CCCCCCCC----CChhhhcccccceeeccccccc
Q 003368 97 PGNLSYCSRLIGLYL--GRNKLEGS----IPSEFVSLYNLKELAIQENNLT 141 (825)
Q Consensus 97 p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 141 (825)
...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 567788899999999 88999853 3445666789999999999986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.3e-06 Score=88.16 Aligned_cols=139 Identities=16% Similarity=0.111 Sum_probs=90.7
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCC---CceeEeecccccccCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHR---NLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
.+.++.|....||+. |..++||+-.. ......+.+|+++++.+++. -+.+.+.++. ...+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence 467888999999987 45688887432 23346788999999999753 2445555542 1234568999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhc----------------------------
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHH---------------------------- 776 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~---------------------------- 776 (825)
||++|..+.+... ..++..++..++.++++.++.||..
T Consensus 93 e~i~G~~l~~~~~--------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~ 158 (306)
T 3tdw_A 93 RKVQGQILGEDGM--------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVED 158 (306)
T ss_dssp ECCCSEECHHHHH--------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHH
T ss_pred eccCCeECchhhh--------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHH
Confidence 9999988765211 1122333334444444444444421
Q ss_pred -----------------------------CCCCeeecCCCCCCeeecC---CCc-EEEcccCcccccc
Q 003368 777 -----------------------------CQEPTIHCDLKPSNILLDN---NLT-AHVGDFGLARLRQ 811 (825)
Q Consensus 777 -----------------------------~~~~ivHrdlk~~NILl~~---~~~-~ki~DFGla~~~~ 811 (825)
..+.++|+|+++.||+++. ++. +.|.||+.+..-.
T Consensus 159 ~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 159 QVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred hcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2345799999999999987 455 5899999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.6e-06 Score=85.55 Aligned_cols=138 Identities=15% Similarity=0.077 Sum_probs=93.0
Q ss_pred ceeccCCee-EEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeeeEEEEc
Q 003368 649 HLIGIGSFG-SVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 649 ~~ig~G~~g-~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
+.+..|..| .||+.....++..+.+|+-... ....+.+|.+.++.+. +--+.+++++|. +++..++|||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~ 101 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTA 101 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEEC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEe
Confidence 445556665 6999887667788999986533 3456788999888775 323556676653 24567999999
Q ss_pred cCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 003368 727 MPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC----------------------------- 777 (825)
Q Consensus 727 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~----------------------------- 777 (825)
++|.++.+..... ...+..++.++++.++-||...
T Consensus 102 l~G~~~~~~~~~~----------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (272)
T 4gkh_A 102 IPGKTAFQVLEEY----------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDAS 165 (272)
T ss_dssp CCSEEHHHHHHHC----------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGG
T ss_pred eCCccccccccCC----------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhh
Confidence 9998776543110 1122334555555555555310
Q ss_pred --------------------------CCCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 778 --------------------------QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 778 --------------------------~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
.+.++|+|+.+.||+++.++.+-|.||+.|...
T Consensus 166 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 166 DFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp GCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred hccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113789999999999998877789999988754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=2.4e-05 Score=84.34 Aligned_cols=85 Identities=9% Similarity=-0.036 Sum_probs=55.2
Q ss_pred ccee-ccCCeeEEEEEEEc--C----CCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCC---CCceeEeeccccccc
Q 003368 648 THLI-GIGSFGSVYKGTFD--R----DGTIVAIKVLNLQL---QGASKSFAAECRALRNIRH---RNLVRVITSCSSIDF 714 (825)
Q Consensus 648 ~~~i-g~G~~g~Vy~~~~~--~----~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~ 714 (825)
.+.| +.|....+|+.... . +|+.+++|+..... ......+.+|+++++.++. ..+.++++++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88999999998762 0 26788999865432 1012456788888887753 245677776532111
Q ss_pred CCCCeeeEEEEccCCCChhh
Q 003368 715 QGNDFKALVYQYMPNGSLEN 734 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~ 734 (825)
....++||||++|..+.+
T Consensus 105 --~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp --TSSCEEEEECCCCBCCCB
T ss_pred --cCCceEEEEecCCCChhh
Confidence 134589999999977754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=3.5e-05 Score=84.39 Aligned_cols=76 Identities=17% Similarity=0.087 Sum_probs=48.8
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-------hhHHHHHHHHHHhhcCCC--CC-ceeEeecccccccCCC
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-------GASKSFAAECRALRNIRH--RN-LVRVITSCSSIDFQGN 717 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~~ 717 (825)
.+.+|.|.++.||++....+++.|+||....... ...+.+..|.++++.+.. |. +.+++.+. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~ 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence 5679999999999997655678899998653211 122456778888887742 33 33555431 2
Q ss_pred CeeeEEEEccCCC
Q 003368 718 DFKALVYQYMPNG 730 (825)
Q Consensus 718 ~~~~lv~e~~~~g 730 (825)
+..++||||+++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 3358999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00016 Score=77.28 Aligned_cols=156 Identities=16% Similarity=0.104 Sum_probs=80.9
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC--CCceeEeecccccc-cCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH--RNLVRVITSCSSID-FQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~-~~~~~~~~lv~ 724 (825)
.+.++.|..+.||+... .+| .+++|+.... ...+..|++++..++. -.+.+++....... ....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~-~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-DSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEE-TTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEe-CCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 34566678899999987 344 5899988752 1233345555544431 12333333110000 01245678999
Q ss_pred EccCCCChh--------------hhccCCCCCC--CcccchhcccCCHHHH-----------------------------
Q 003368 725 QYMPNGSLE--------------NWLHPDAIPQ--TDEENDEIRNLTLLER----------------------------- 759 (825)
Q Consensus 725 e~~~~gsL~--------------~~l~~~~~~~--~~~~~~~~~~l~~~~~----------------------------- 759 (825)
||++|..+. ..+|...... ..........-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986553 1122110000 0000000011123211
Q ss_pred --HHHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 760 --ISIAIDVASAVDYLHH----------HCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 760 --~~i~~~va~~l~yLH~----------~~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
..+...+.+++++|+. ...+.+||+|+++.||+++.++.+.|.||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111224456677763 1246899999999999998888999999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=76.62 Aligned_cols=78 Identities=17% Similarity=0.141 Sum_probs=56.5
Q ss_pred ccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC---CCceeEeecccccccCCCCeee
Q 003368 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH---RNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 645 f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~~~~~~ 721 (825)
....+.+|.|..+.||+.+. .+|+.|.||+-..........|.+|++.|+.+.- --+.+.+++. ..+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 44567899999999999998 6899999998765443334568899998888742 2244555431 237
Q ss_pred EEEEccCCCCh
Q 003368 722 LVYQYMPNGSL 732 (825)
Q Consensus 722 lv~e~~~~gsL 732 (825)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 99999987654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=1.6e-05 Score=75.12 Aligned_cols=84 Identities=12% Similarity=0.105 Sum_probs=53.9
Q ss_pred CCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC-CCCCCChhhhcc----cccceeeccccc-cccccCccCCCCCC
Q 003368 80 FRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK-LEGSIPSEFVSL----YNLKELAIQENN-LTGGIPHFLGNITS 153 (825)
Q Consensus 80 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 153 (825)
.+|+.||||++.|+..--..+..+++|+.|+|++|. |+..--..+..+ ++|++|+|++|. +|..-=..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 356777777776665544556677777777777774 553222334443 368888888874 66443345667788
Q ss_pred CCEEEcccCc
Q 003368 154 LEAISLAYNS 163 (825)
Q Consensus 154 L~~L~Ls~N~ 163 (825)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00051 Score=71.98 Aligned_cols=149 Identities=13% Similarity=0.070 Sum_probs=91.0
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC---CCCceeEeecccccccCCCCeeeE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR---HRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
...+.|+.|....+|+... ++..++||+.... ....|.+|.+.++.+. ...+.++++++.. .+..++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~l 108 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFL 108 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEE
Confidence 3456789999999999885 4678889987643 3466889998888874 2556777776432 356899
Q ss_pred EEEccCCCChhh-----------hccCCCC-CCC---ccc-ch-----hcccCCHHHHH---HHHH--H-----------
Q 003368 723 VYQYMPNGSLEN-----------WLHPDAI-PQT---DEE-ND-----EIRNLTLLERI---SIAI--D----------- 765 (825)
Q Consensus 723 v~e~~~~gsL~~-----------~l~~~~~-~~~---~~~-~~-----~~~~l~~~~~~---~i~~--~----------- 765 (825)
||||+++..+.. .||.... +.. ... .. ..-.-+|.+.. ++.. +
T Consensus 109 vme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~ 188 (312)
T 3jr1_A 109 LLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGN 188 (312)
T ss_dssp EEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSC
T ss_pred EEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence 999999976521 1232211 100 000 00 00112565321 1111 1
Q ss_pred ---HH-HHHHHHHh-cCCCCeeecCCCCCCeeecCCCcEEEcccC
Q 003368 766 ---VA-SAVDYLHH-HCQEPTIHCDLKPSNILLDNNLTAHVGDFG 805 (825)
Q Consensus 766 ---va-~~l~yLH~-~~~~~ivHrdlk~~NILl~~~~~~ki~DFG 805 (825)
+. +..+.|.. ...+.+||+|+.+.||+++.++ +.|.||+
T Consensus 189 ~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 189 IDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 11223421 2246799999999999999887 8899984
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.44 E-value=2e-05 Score=74.52 Aligned_cols=84 Identities=13% Similarity=0.054 Sum_probs=56.5
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCCc-CCCCCCcCCCCC----CCCCEEEcCCCC-CCCCCChhhhcccc
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS-LVGEIPGNLSYC----SRLIGLYLGRNK-LEGSIPSEFVSLYN 129 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 129 (825)
-+|++|||+++.|+..--..+.++++|++|+|++|. |+..-=..++.+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357788888777765444556777888888888874 664333334443 368888888874 76433345677888
Q ss_pred cceeeccccc
Q 003368 130 LKELAIQENN 139 (825)
Q Consensus 130 L~~L~L~~N~ 139 (825)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00098 Score=73.36 Aligned_cols=32 Identities=19% Similarity=0.287 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 778 QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 778 ~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
.+.++|+|+++.||+++.++ ++|.||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45799999999999998876 999999887754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.17 E-value=5.5e-05 Score=72.84 Aligned_cols=113 Identities=12% Similarity=0.134 Sum_probs=67.6
Q ss_pred CCCCCCCCEEEcCCC-cccc----cCCccccCCCCCCEEECCCCcCCCCCC----cCCCCCCCCCEEEcCCCCCCCC---
Q 003368 52 IGNLSFLREIHLSNN-TIQG----KIPGEIGRLFRLEALYLSHNSLVGEIP----GNLSYCSRLIGLYLGRNKLEGS--- 119 (825)
Q Consensus 52 ~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~--- 119 (825)
+.+-+.|++|+|++| +|.. .+-.++..-+.|+.|+|++|+|...-. ..+..-+.|+.|+|++|+|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 345567888888875 6652 234455666778888888888774332 2334556778888888877632
Q ss_pred -CChhhhcccccceeecccc---cccc----ccCccCCCCCCCCEEEcccCcC
Q 003368 120 -IPSEFVSLYNLKELAIQEN---NLTG----GIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 120 -~p~~~~~l~~L~~L~L~~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
+-+++..-+.|++|+|++| .+.. .+-+.+..-+.|+.|+++.|.+
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 1223444456777777654 2221 1223344456777777776655
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00079 Score=71.10 Aligned_cols=171 Identities=11% Similarity=0.075 Sum_probs=87.4
Q ss_pred ccHHHHHhhcccccc-----cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC--ceeE
Q 003368 633 VSYESLLKATDGFSS-----THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN--LVRV 705 (825)
Q Consensus 633 ~~~~~~~~~~~~f~~-----~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l 705 (825)
++.+++....+.|.. .+.|+.|....+|+... .+| .+++|+..... ..+.+..|++++..++... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344444444443433 35577788899999987 344 68899886521 1234556777776664222 2333
Q ss_pred eecccccc-cCCCCeeeEEEEccCCCChhh--------------hccCC--CCCCCcccchhcccCCHHHHHH-------
Q 003368 706 ITSCSSID-FQGNDFKALVYQYMPNGSLEN--------------WLHPD--AIPQTDEENDEIRNLTLLERIS------- 761 (825)
Q Consensus 706 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~~~~~~~~~~~~~~l~~~~~~~------- 761 (825)
+....... ....+..++||+|++|..+.. .+|.. ....... .......|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~--~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRP--NALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCB--CTTSHHHHHHHHHHHGGGGG
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCccc--CccChHHHHHHHHHHHHHHH
Confidence 32210000 011245689999999865421 01211 0000000 0000112332111
Q ss_pred -----HHHHHHHHHHHHHhc----CCCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 762 -----IAIDVASAVDYLHHH----CQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 762 -----i~~~va~~l~yLH~~----~~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
+...+.+.+++++.. ....+||+|+.+.||+++++..+.|.||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666532 134689999999999999876668999987764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.002 Score=68.15 Aligned_cols=81 Identities=9% Similarity=0.058 Sum_probs=49.1
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC--ceeEeecccccc-cCCCCeeeEEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN--LVRVITSCSSID-FQGNDFKALVY 724 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~-~~~~~~~~lv~ 724 (825)
...++ |....||+... .+|+.+++|+..... .....+..|.+++..++... +.+++.. .... ...++..++||
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVF 106 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEE
Confidence 34566 77889998876 467789999986432 12345667887777765222 3344432 1000 11134568899
Q ss_pred EccCCCCh
Q 003368 725 QYMPNGSL 732 (825)
Q Consensus 725 e~~~~gsL 732 (825)
||++|..+
T Consensus 107 ~~i~G~~~ 114 (328)
T 1zyl_A 107 PSVGGRQF 114 (328)
T ss_dssp ECCCCEEC
T ss_pred EecCCCCC
Confidence 99988544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0018 Score=58.08 Aligned_cols=55 Identities=22% Similarity=0.255 Sum_probs=25.3
Q ss_pred EEEcCCCccc-ccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCC
Q 003368 60 EIHLSNNTIQ-GKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKL 116 (825)
Q Consensus 60 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 116 (825)
.++.+++.++ ..+|..+. .+|++|+|++|+|+.+.++.|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 23333221 2345555555555544444444444444444444444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0031 Score=65.78 Aligned_cols=73 Identities=12% Similarity=0.084 Sum_probs=43.6
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc-eeEeecccccccCCCCeeeEEE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL-VRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~~lv~ 724 (825)
...+.++.|....+|+. ..+++|+....... .-...+|+++++.+....+ .++++++ .+.-++|+
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~ 86 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVT 86 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEE
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEE
Confidence 33678999999999998 34888887543211 1112457777766643223 3555542 22347899
Q ss_pred Ecc-CCCCh
Q 003368 725 QYM-PNGSL 732 (825)
Q Consensus 725 e~~-~~gsL 732 (825)
||+ ++.++
T Consensus 87 e~i~~g~~l 95 (301)
T 3dxq_A 87 RYIAGAQTM 95 (301)
T ss_dssp ECCTTCEEC
T ss_pred eecCCCccC
Confidence 999 55444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0018 Score=58.20 Aligned_cols=56 Identities=25% Similarity=0.304 Sum_probs=31.3
Q ss_pred EEECCCCCCc-cccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCC
Q 003368 36 VLDLKSKGLI-GSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLV 93 (825)
Q Consensus 36 ~l~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 93 (825)
.+|.++++++ ..+|..+. .+|++|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555554 24443321 24666666666666555555666666666666666553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.00035 Score=67.22 Aligned_cols=111 Identities=14% Similarity=0.137 Sum_probs=83.2
Q ss_pred CCcEEEEECCCC-CCcc----ccCcCCCCCCCCCEEEcCCCccccc----CCccccCCCCCCEEECCCCcCCCC----CC
Q 003368 31 HRRVTVLDLKSK-GLIG----SLSPQIGNLSFLREIHLSNNTIQGK----IPGEIGRLFRLEALYLSHNSLVGE----IP 97 (825)
Q Consensus 31 ~~~l~~l~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 97 (825)
...++.|+|+++ ++.. .+-+.+..-+.|+.|+|++|+|... +...+..-+.|++|+|++|+|... +.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 467999999986 6643 3556677778999999999999742 344555678899999999999854 33
Q ss_pred cCCCCCCCCCEEEcCCCC---CCC----CCChhhhcccccceeeccccccc
Q 003368 98 GNLSYCSRLIGLYLGRNK---LEG----SIPSEFVSLYNLKELAIQENNLT 141 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~---l~~----~~p~~~~~l~~L~~L~L~~N~l~ 141 (825)
..+..-+.|++|+|++|. +.. .+-.++..-+.|+.|+++.|.+.
T Consensus 120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 456677889999999764 332 23345667788999999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0041 Score=68.42 Aligned_cols=74 Identities=15% Similarity=0.198 Sum_probs=49.5
Q ss_pred cceeccCCeeEEEEEEEcC-------CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc-eeEeecccccccCCCCe
Q 003368 648 THLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL-VRVITSCSSIDFQGNDF 719 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~ 719 (825)
.+.|+.|-...||+..... +++.|++|+.... .....+.+|..+++.+...++ .++++.+ . +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~--~- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----S--G- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T--T-
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----C--C-
Confidence 4678888889999998742 2578999987432 112456689888888753334 4666642 1 1
Q ss_pred eeEEEEccCCCCh
Q 003368 720 KALVYQYMPNGSL 732 (825)
Q Consensus 720 ~~lv~e~~~~gsL 732 (825)
.+||||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=65.20 Aligned_cols=75 Identities=11% Similarity=0.059 Sum_probs=47.1
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc-eeEeecccccccCCCCeeeEEEEc
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL-VRVITSCSSIDFQGNDFKALVYQY 726 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~~lv~e~ 726 (825)
.+.|+.|-...+|+.....++..|++|+........ -.-.+|.++++.+...++ .++++++ . + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~--~--G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----T--N--GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----T--T--EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----C--C--eEEEEe
Confidence 467888889999999984335788899875332111 011478888888865445 4666653 1 1 259999
Q ss_pred cCCCCh
Q 003368 727 MPNGSL 732 (825)
Q Consensus 727 ~~~gsL 732 (825)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0075 Score=64.84 Aligned_cols=145 Identities=14% Similarity=0.160 Sum_probs=80.7
Q ss_pred cceeccCCeeEEEEEEEcC-------CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC-ceeEeecccccccCCCCe
Q 003368 648 THLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN-LVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~~~~ 719 (825)
.+.+..|-...+|+..... +++.|++|+.... ........+|.++++.+.-.. ..++++++ . +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~--~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----P--E- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----T--T-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----C--C-
Confidence 4567778888999998732 3578999986332 223455668998888775322 34666653 1 1
Q ss_pred eeEEEEccCCCChhhh-----------------ccCCCCCCCcccchhcccCC--HHHHHHHHHHH--------------
Q 003368 720 KALVYQYMPNGSLENW-----------------LHPDAIPQTDEENDEIRNLT--LLERISIAIDV-------------- 766 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~-----------------l~~~~~~~~~~~~~~~~~l~--~~~~~~i~~~v-------------- 766 (825)
.+||||++|..+..- ||....+. .+... |.+..++..++
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~-------~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPF-------TKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSS-------CCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCC-------CCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 289999998655421 11111110 01111 23333333222
Q ss_pred -----HHHHHHHH----hc-CCCCeeecCCCCCCeeecCC----CcEEEcccCcccc
Q 003368 767 -----ASAVDYLH----HH-CQEPTIHCDLKPSNILLDNN----LTAHVGDFGLARL 809 (825)
Q Consensus 767 -----a~~l~yLH----~~-~~~~ivHrdlk~~NILl~~~----~~~ki~DFGla~~ 809 (825)
...+++|. .. ....++|+|+.+.||+++.+ +.+.+.||..|..
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 12233332 21 23358899999999999876 7899999988765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.017 Score=61.12 Aligned_cols=33 Identities=27% Similarity=0.269 Sum_probs=28.1
Q ss_pred CCCeeecCCCCCCeeecCC----CcEEEcccCccccc
Q 003368 778 QEPTIHCDLKPSNILLDNN----LTAHVGDFGLARLR 810 (825)
Q Consensus 778 ~~~ivHrdlk~~NILl~~~----~~~ki~DFGla~~~ 810 (825)
.+.++|+|+.+.||+++.+ ..+.|.||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3578999999999999874 68999999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.13 E-value=0.012 Score=63.19 Aligned_cols=75 Identities=9% Similarity=0.159 Sum_probs=43.4
Q ss_pred cceeccCCeeEEEEEEEcC--------CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc-eeEeecccccccCCCC
Q 003368 648 THLIGIGSFGSVYKGTFDR--------DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL-VRVITSCSSIDFQGND 718 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~ 718 (825)
.+.++.|....+|+..... .++.+++|+....... ......|.++++.+....+ .++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~-------~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF-------N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE-------T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec-------C-
Confidence 4567788888999998732 1267888887543211 1123567777777753333 3566531 1
Q ss_pred eeeEEEEccCCCCh
Q 003368 719 FKALVYQYMPNGSL 732 (825)
Q Consensus 719 ~~~lv~e~~~~gsL 732 (825)
-++||||++|..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.73 E-value=0.053 Score=57.40 Aligned_cols=32 Identities=22% Similarity=0.287 Sum_probs=27.9
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
..++|+|+.+.||++++++.+.|.||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46899999999999998888999999876654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.60 E-value=0.12 Score=56.24 Aligned_cols=75 Identities=9% Similarity=0.130 Sum_probs=46.4
Q ss_pred cceeccCCeeEEEEEEEcCC-------CeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC-ceeEeecccccccCCCCe
Q 003368 648 THLIGIGSFGSVYKGTFDRD-------GTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN-LVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~-------g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~~~~ 719 (825)
.+.+..|-...+|+...... ++.|++|+....... .-.-.+|.++++.+.-.. ..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~-------~-- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF-------P-- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE-------T--
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc-------C--
Confidence 45677788889999987421 578999986543211 111246777777765323 34555432 1
Q ss_pred eeEEEEccCCCCh
Q 003368 720 KALVYQYMPNGSL 732 (825)
Q Consensus 720 ~~lv~e~~~~gsL 732 (825)
-++||||++|..+
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2689999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.28 E-value=0.49 Score=51.15 Aligned_cols=30 Identities=27% Similarity=0.322 Sum_probs=24.9
Q ss_pred eeecCCCCCCeee------cCCCcEEEcccCccccc
Q 003368 781 TIHCDLKPSNILL------DNNLTAHVGDFGLARLR 810 (825)
Q Consensus 781 ivHrdlk~~NILl------~~~~~~ki~DFGla~~~ 810 (825)
++|+|+.+.||++ +++..+++.||-.|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 44567999999887653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.79 E-value=0.1 Score=57.69 Aligned_cols=60 Identities=7% Similarity=-0.016 Sum_probs=16.7
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEE------EEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccc
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAI------KVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCS 710 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAv------K~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 710 (825)
.+.+| ||.||+|.+.....+||| |..+... .+..+.|.+|..++...+|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 44565 999999999655568999 6655322 223356889999999999999999887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 825 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-29 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-24 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-24 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-19 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 54/174 (31%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFAAECRALRNIRHRNLVRVI 706
IG GSFG+VYKG + D VA+K+LN+ ++F E LR RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ A+V Q+ SL + LH +++ I IA
Sbjct: 71 ------GYSTAPQLAIVTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQT 113
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
A +DYLH IH DLK +NI L +LT +GDFGLA ++ +
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 2e-35
Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 32/200 (16%)
Query: 634 SYESLLKATDGFSST---------HLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQL- 680
++E +A F+ +IG G FG V G G VAIK L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 681 QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDA 740
+ + F +E + H N++ + + + ++ ++M NGSL+++L +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122
Query: 741 IPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800
T + + + +A+ + YL +H DL NIL+++NL
Sbjct: 123 GQFTVIQ-----------LVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCK 168
Query: 801 VGDFGLARLRQEVPNNQSSS 820
V DFGL+R ++ ++ + +
Sbjct: 169 VSDFGLSRFLEDDTSDPTYT 188
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-35
Identities = 35/173 (20%), Positives = 69/173 (39%), Gaps = 20/173 (11%)
Query: 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRH 699
D F +G G+ G V+K + G ++A K+++L++ E + L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
+V + S + ++ ++M GSL+ L + +
Sbjct: 64 PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK------------KAGRIPEQIL 106
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
++I V + YL +H D+KPSNIL+++ + DFG++ +
Sbjct: 107 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 40/191 (20%), Positives = 78/191 (40%), Gaps = 22/191 (11%)
Query: 635 YESL---LKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAEC 691
YE + L D + +G G+FG VYK + A KV++ + + + + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 692 RALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEI 751
L + H N+V+++ + + ++ ++ G+++ + +
Sbjct: 61 DILASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVML-----------ELE 104
Query: 752 RNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQ 811
R LT + + A++YLH + IH DLK NIL + + DFG++
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161
Query: 812 EVPNNQSSSVG 822
+ S +G
Sbjct: 162 RTIQRRDSFIG 172
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 15/171 (8%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHR 700
+ + + IG GS+G K DG I+ K L+ + + +E LR ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
N+VR + N +V +Y G L + + + E + L +
Sbjct: 64 NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVIT--------KGTKERQYLDEEFVL 112
Query: 761 SIAIDVASAVDYLHHH--CQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + A+ H +H DLKP+N+ LD +GDFGLAR+
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 9e-34
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 21/173 (12%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G G FG V+ G T VA+K L +F AE ++ ++H+ LVR+
Sbjct: 19 ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ + ++ +YM NGSL ++L LT+ + + +A +A
Sbjct: 77 VT------QEPIYIITEYMENGSLVDFLK----------TPSGIKLTINKLLDMAAQIAE 120
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ ++ IH DL+ +NIL+ + L+ + DFGLARL ++
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 3e-33
Identities = 44/174 (25%), Positives = 65/174 (37%), Gaps = 23/174 (13%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL---QLQGASKSFAAECRALRNIR 698
FS IG GSFG+VY R+ +VAIK ++ Q + E R L+ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
H N ++ LV +Y + + + L +E
Sbjct: 74 HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHK------------KPLQEVE 116
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
++ + YLH H IH D+K NILL +GDFG A +
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 17/164 (10%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITS 708
IG GSF +VYKG VA L + + + F E L+ ++H N+VR S
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
S +G LV + M +G+L+ +L + + + S +
Sbjct: 77 WES-TVKGKKCIVLVTELMTSGTLKTYLK------------RFKVMKIKVLRSWCRQILK 123
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILL-DNNLTAHVGDFGLARLRQ 811
+ +LH P IH DLK NI + + +GD GLA L++
Sbjct: 124 GLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 38/175 (21%), Positives = 69/175 (39%), Gaps = 23/175 (13%)
Query: 651 IGIGSFGSVYKGTF--DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVIT 707
+G G+FGSV +G + + VAIKVL + ++ E + + + + +VR+I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVA 767
C + LV + G L +L + + + + V+
Sbjct: 77 VCQAEAL------MLVMEMAGGGPLHKFLV-----------GKREEIPVSNVAELLHQVS 119
Query: 768 SAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ YL +H DL N+LL N A + DFGL++ + ++
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G FG V++G + G VA+K+ + + + S AE +RH N++ I + +
Sbjct: 11 IGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
+ LV Y +GSL ++L+ +T+ I +A+ AS +
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGL 113
Query: 771 DYLHHHC-----QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
+LH + H DLK NIL+ N T + D GLA + +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-32
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 21/173 (12%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G G FG V+ GT T VAIK L ++F E + ++ +RH LV++
Sbjct: 23 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
S + +V +YM GSL ++L + + + +A +AS
Sbjct: 81 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----------QLVDMAAQIAS 124
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ Y+ +H DL+ +NIL+ NL V DFGLARL ++
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 3e-32
Identities = 43/174 (24%), Positives = 71/174 (40%), Gaps = 21/174 (12%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
IG G FG V G G VA+K + +++F AE + +RH NLV+++
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ +V +YM GSL ++L + + ++DV
Sbjct: 69 I----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----------CLLKFSLDVCE 114
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A++YL + +H DL N+L+ + A V DFGL + + V
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 165
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 26/182 (14%)
Query: 649 HLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRN 701
++G G+FG V T VA+K+L + ++ +E + + + H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH-----------PDAIPQTDEENDE 750
+V ++ +C+ + L+++Y G L N+L + EE ++
Sbjct: 103 IVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 751 IRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810
+ LT + + A VA +++L +H DL N+L+ + + DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 811 QE 812
Sbjct: 215 MS 216
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-31
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 26/205 (12%)
Query: 634 SYESLLKATDGFSSTHLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNLQL-QGASKSF 687
SL + IG G+FG V++ T+VA+K+L + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 688 AAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH---------- 737
E + + N+V+++ C+ L+++YM G L +L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 738 --PDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795
D + + L+ E++ IA VA+ + YL +H DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGE 175
Query: 796 NLTAHVGDFGLARLRQEVPNNQSSS 820
N+ + DFGL+R ++
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADG 200
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 5e-31
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 19/179 (10%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
+ H +G G +G VY+G + + VA+K L + F E ++ I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V+++ C+ ++ ++M G+L ++L + + +
Sbjct: 76 VQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNRQEVSAV----------VLLYM 120
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
A ++SA++YL IH DL N L+ N V DFGL+RL +
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-31
Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 23/169 (13%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRALRNIRH 699
+ F +G G FG+VY + I+A+KVL L+ G E ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
N++R+ L+ +Y P G++ L ++
Sbjct: 66 PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQ------------KLSKFDEQRT 108
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
+ ++A+A+ Y H IH D+KP N+LL + + DFG +
Sbjct: 109 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 154
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 9e-31
Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTI--VAIKVLNLQL-QGASKSFAAECRALRNI-R 698
+ +IG G+FG V K +DG AIK + + + FA E L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEE----NDEIRNL 754
H N++ ++ +C + + L +Y P+G+L ++L + +TD N L
Sbjct: 70 HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 755 TLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ + + A DVA + + Q+ IH DL NIL+ N A + DFGL+R ++
Sbjct: 125 SSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 21/172 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
+G G FG V G R VAIK++ F E + + N+ H LV++ C+
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
++ +YM NG L N+L + + + DV A+
Sbjct: 70 K-----QRPIFIITEYMANGCLLNYLRE-----------MRHRFQTQQLLEMCKDVCEAM 113
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+YL +H DL N L+++ V DFGL+R + S
Sbjct: 114 EYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 34/168 (20%), Positives = 65/168 (38%), Gaps = 21/168 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRN 701
+ + +G G++G V VA+K++++ + ++ E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
+V+ + + + L +Y G L + + PD + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD------------IGMPEPDAQR 107
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + V YLH H D+KP N+LLD + DFGLA +
Sbjct: 108 FFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATV 152
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 121 bits (304), Expect = 2e-30
Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 21/172 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D + +G G+FG V++ T G A K + + ++ E + + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
V + + F+ ++ ++Y++M G L + DE ++ E +
Sbjct: 86 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVA-----------DEHNKMSEDEAVEY 129
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLARLRQE 812
V + ++H + +H DLKP NI+ + + DFGL
Sbjct: 130 MRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 21/185 (11%)
Query: 649 HLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNL-QLQGASKSFAAECRALRNI-RHRN 701
+G G+FG V + T VA+K+L ++ +E + L + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH------PDAIPQTDEENDEIRNLT 755
+V ++ +C+ ++ +Y G L N+L + D+ L
Sbjct: 89 IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
L + +S + VA + +L IH DL NILL + + DFGLAR + N
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 816 NQSSS 820
Sbjct: 201 YVVKG 205
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 4e-30
Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 21/171 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCS 710
IG G FG V+ G + VAIK + + F E + + H LV++ C
Sbjct: 13 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAV 770
LV+++M +G L ++L E + + +DV
Sbjct: 71 E-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAET-----------LLGMCLDVCEG- 113
Query: 771 DYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSV 821
+ + + IH DL N L+ N V DFG+ R + S+
Sbjct: 114 --MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-30
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 23/201 (11%)
Query: 622 SEPILRRALRKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ 681
S+ + LR + S+ ++ IG G+ G+VY G VAI+ +NLQ Q
Sbjct: 1 SDEEILEKLRSIV--SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 682 GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAI 741
+ E +R ++ N+V + S D +V +Y+ GSL + + +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCM 113
Query: 742 PQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801
+ + ++ + A+++LH + IH D+K NILL + + +
Sbjct: 114 DEG-------------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 802 GDFGLARLRQEVPNNQSSSVG 822
DFG + +S+ VG
Sbjct: 158 TDFGFCAQITPEQSKRSTMVG 178
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-30
Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 23/184 (12%)
Query: 640 KATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRN 696
K + F ++G GSF +V AIK+L + + E +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+ H V++ + FQ ++ Y NG L ++ +I +
Sbjct: 65 LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIR------------KIGSFDE 107
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN 816
++ SA++YLH IH DLKP NILL+ ++ + DFG A++
Sbjct: 108 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 817 QSSS 820
++
Sbjct: 165 ARAN 168
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 39/176 (22%), Positives = 69/176 (39%), Gaps = 25/176 (14%)
Query: 651 IGIGSFGSVYKGTF--DRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVI 706
+G G+FG+V KG + + VA+K+L + AE ++ + + +VR+I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
C + LV + G L +L + R++ I + V
Sbjct: 75 GICE------AESWMLVMEMAELGPLNKYLQQN------------RHVKDKNIIELVHQV 116
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+ + YL +H DL N+LL A + DFGL++ + N +
Sbjct: 117 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-29
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 24/177 (13%)
Query: 650 LIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRV 705
IG G FG V++G + + VAIK + F E +R H ++V++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
I + + ++ + G L ++L +L L I A
Sbjct: 74 IGVIT------ENPVWIIMELCTLGELRSFLQ-----------VRKYSLDLASLILYAYQ 116
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
+++A+ YL +H D+ N+L+ +N +GDFGL+R ++ ++S
Sbjct: 117 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 44/190 (23%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS-----KSFAAECR 692
+LK T+ F ++G G+FG+VYKG + +G V I V +L+ A+ K E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 693 ALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
+ ++ + ++ R++ C + Q L+ Q MP G L +++ +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 112
Query: 753 NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
++ + +A ++YL +H DL N+L+ + DFGLA+L
Sbjct: 113 ------LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163
Query: 813 VPNNQSSSVG 822
+ G
Sbjct: 164 EEKEYHAEGG 173
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 46/176 (26%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 651 IGIGSFGSVYKGTFDRD---GTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVR 704
+G GSFG V +G +D VA+K L + A F E A+ ++ HRNL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ + + +V + P GSL + L + L A+
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLR-----------KHQGHFLLGTLSRYAV 118
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
VA + YL IH DL N+LL +GDFGL R + ++
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 115 bits (288), Expect = 2e-28
Identities = 33/172 (19%), Positives = 64/172 (37%), Gaps = 21/172 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL 702
D + +G G+FG V++ G + K +N + E + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
+ + + F+ L+ +++ G L + + E ++ E I+
Sbjct: 89 INLHDA-----FEDKYEMVLILEFLSGGELFDRIA-----------AEDYKMSEAEVINY 132
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLARLRQE 812
+ ++H H +H D+KP NI+ + + V DFGLA
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-28
Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQL-QGASKSFAAECRALRNIRH 699
+ +IG G FG VYKG VAIK L + F E + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
N++R+ S ++ +YM NG+L+ +L ++ ++L+
Sbjct: 69 HNIIRLEGVISK-----YKPMMIITEYMENGALDKFLR-----------EKDGEFSVLQL 112
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
+ + +A+ + YL + +H DL NIL+++NL V DFGL+R+ ++ P +
Sbjct: 113 VGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 820 SVG 822
+ G
Sbjct: 170 TSG 172
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-28
Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 22/175 (12%)
Query: 650 LIGIGSFGSVYKGTF---DRDGTIVAIKVLN-LQLQGASKSFAAECRALRNIRHRNLVRV 705
+IG G FG VY GT D A+K LN + G F E +++ H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 706 ITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
+ C + +V YM +G L N++ E N T+ + I +
Sbjct: 94 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQ 138
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
VA + + +H DL N +LD T V DFGLAR + + +
Sbjct: 139 VAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 40/182 (21%), Positives = 67/182 (36%), Gaps = 16/182 (8%)
Query: 649 HLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNL 702
+G G+FG V + VA+K+L ++ +E + L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLH----PDAIPQTDEENDEIRNLTLLE 758
V + + ++ ++ G+L +L + E+ LTL
Sbjct: 79 VVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
I + VA +++L IH DL NILL + DFGLAR + P+
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 819 SS 820
Sbjct: 193 KG 194
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-27
Identities = 42/180 (23%), Positives = 74/180 (41%), Gaps = 16/180 (8%)
Query: 649 HLIGIGSFGSVYKGTF-----DRDGTIVAIKVLNL-QLQGASKSFAAECRALRNIRHRNL 702
+G GSFG VY+G D T VAIK +N F E ++ ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 703 VRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISI 762
VR++ ++ + M G L+++L + N + +L + I +
Sbjct: 86 VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRS--LRPAMANNPVLAPPSLSKMIQM 138
Query: 763 AIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
A ++A + YL+ + +H DL N ++ + T +GDFG+ R E + G
Sbjct: 139 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 109 bits (272), Expect = 5e-27
Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 30/176 (17%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL---------QLQGASKSFAAECRA 693
+ + ++G G V + A+K++++ ++Q ++ E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 694 LRNIR-HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIR 752
LR + H N++++ ++ N F LV+ M G L ++L E
Sbjct: 63 LRKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLT------------EKV 105
Query: 753 NLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
L+ E I + + LH +H DLKP NILLD+++ + DFG +
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSC 158
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 108 bits (270), Expect = 1e-26
Identities = 39/182 (21%), Positives = 72/182 (39%), Gaps = 19/182 (10%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIR 698
+D + ++G G V+ R VA+KVL L F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
H +V V + + + +V +Y+ +L + +H +T
Sbjct: 66 HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVH------------TEGPMTPKR 112
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
I + D A+++ H + IH D+KP+NI++ V DFG+AR + N+ +
Sbjct: 113 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169
Query: 819 SS 820
+
Sbjct: 170 QT 171
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-26
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 645 FSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVR 704
++ T +IG GSFG VY+ G +VAIK + + E + +R + H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 705 VITSC-SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIA 763
+ SS + + + LV Y+P H + + L ++
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH---------YSRAKQTLPVIYVKLYM 128
Query: 764 IDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARL 809
+ ++ Y+H H D+KP N+LLD + + DFG A+
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 2e-26
Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 26/172 (15%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNL------QLQGASKSFAAECRALRN 696
+ FS +IG G FG VY G + A+K L+ Q + + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
+V + + F D + + M G L L + +
Sbjct: 64 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---------- 108
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
A ++ ++++H+ ++ DLKP+NILLD + + D GLA
Sbjct: 109 --MRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC 155
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-26
Identities = 35/174 (20%), Positives = 67/174 (38%), Gaps = 18/174 (10%)
Query: 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN-LQLQGASKSFAAECRALR 695
+ +++ IG G++G V + + VAIK ++ + Q + E + L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 696 NIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
RH N++ + + + + ++ L L ++L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMK-DVYLVTHLMGADLYKLLKT-------------QHLS 107
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + Y+H +H DLKPSN+LL+ + DFGLAR+
Sbjct: 108 NDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARV 158
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-26
Identities = 32/162 (19%), Positives = 62/162 (38%), Gaps = 22/162 (13%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
+G G FG V++ K + ++ E L RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES- 69
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
F+ + ++++++ + ++ A L E +S V A
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSAFE-----------LNEREIVSYVHQVCEA 114
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV--GDFGLARL 809
+ +LH H H D++P NI+ ++ + +FG AR
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 8e-26
Identities = 37/169 (21%), Positives = 61/169 (36%), Gaps = 18/169 (10%)
Query: 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQ-LQGASKSFAAECRALRNIRHR 700
D + ++G G+F V R +VAIK + + L+G S E L I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
N+V + ++ L+ Q + G L + + E T +
Sbjct: 68 NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIV------------EKGFYTERDAS 110
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ V AV YLH LD + + DFGL+++
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 38/184 (20%), Positives = 75/184 (40%), Gaps = 21/184 (11%)
Query: 649 HLIGIGSFGSVYKGT-------FDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNI-RH 699
+G G+FG V T VA+K+L + +E ++ I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRN----LT 755
+N++ ++ +C+ + ++ +Y G+L +L P + + N L+
Sbjct: 79 KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
+ +S A VA + + + IH DL N+L+ + + DFGLAR +
Sbjct: 134 SKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 816 NQSS 819
+ +
Sbjct: 191 YKKT 194
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 7e-25
Identities = 38/164 (23%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITS 708
IG G+FG V+K + G VA+K + ++ +G + E + L+ ++H N+V +I
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 709 CSSIDFQGNDFKA---LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAID 765
C + N K LV+ + + + + TL E +
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------------VLVKFTLSEIKRVMQM 125
Query: 766 VASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + L++ + +H D+K +N+L+ + + DFGLAR
Sbjct: 126 LLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 38/184 (20%), Positives = 64/184 (34%), Gaps = 24/184 (13%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLN---LQLQGASKSFAAECRAL-RNIR 698
+ F ++G GSFG V+ F + AIK L + + + E R L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 699 HRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLE 758
H L + + Q + V +Y+ G L + L
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ------------SCHKFDLSR 104
Query: 759 RISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
A ++ + +LH ++ DLK NILLD + + DFG+ + +
Sbjct: 105 ATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161
Query: 819 SSVG 822
+ G
Sbjct: 162 TFCG 165
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 3e-24
Identities = 40/179 (22%), Positives = 64/179 (35%), Gaps = 26/179 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVI 706
+G GSFG V+ +G A+KVL ++ + E L + H ++R+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 707 TSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ Q ++ Y+ G L + L
Sbjct: 71 GTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---------------AKFYA 110
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVGDLE 825
A L + + I+ DLKP NILLD N + DFG A+ VP+ + G +
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYTLCGTPD 166
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-24
Identities = 34/163 (20%), Positives = 61/163 (37%), Gaps = 23/163 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRAL-RNIRHRNLVRVITS 708
++G+G G V + R A+K+L E R + ++VR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
++ + G +V + + G L + + + + T E I +
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQ----------DRGDQAFTEREASEIMKSIGE 122
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLD---NNLTAHVGDFGLAR 808
A+ YLH H D+KP N+L N + DFG A+
Sbjct: 123 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-24
Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 25/178 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-----QGASKSFAAECRALRNIRHRNLVR 704
+G G F +VYK IVAIK + L G +++ E + L+ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
++ + +LV+ +M LT + +
Sbjct: 65 LLDAF-----GHKSNISLVFDFMETDLEVIIKDNS------------LVLTPSHIKAYML 107
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSSVG 822
++YLH H +H DLKP+N+LLD N + DFGLA+ + V
Sbjct: 108 MTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 8e-23
Identities = 42/186 (22%), Positives = 67/186 (36%), Gaps = 23/186 (12%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS---KSFAAECRALRNIRH 699
+ F L+G G+FG V G A+K+L ++ A E R L+N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 700 RNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLER 759
L + + Q +D V +Y G L L + R T
Sbjct: 65 PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE------------RVFTEERA 107
Query: 760 ISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSS 819
++ SA L + ++ D+K N++LD + + DFGL + +
Sbjct: 108 RFYGAEIVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 820 SVGDLE 825
G E
Sbjct: 165 FCGTPE 170
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.0 bits (243), Expect = 1e-22
Identities = 51/203 (25%), Positives = 75/203 (36%), Gaps = 28/203 (13%)
Query: 614 RGGSGKEPSEPILRRA----LRKVSYESLLKAT-DGFSSTHLIGIGSFGSVYKGTFDRDG 668
+ GS +E + L +A L+K S A D F +G GSFG V G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 669 TIVAIKVLNLQLQGASK---SFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQ 725
A+K+L+ Q K E R L+ + LV++ S V +
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VME 121
Query: 726 YMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCD 785
Y+ G + + L I + A + +YLH I+ D
Sbjct: 122 YVAGGEMFSHLR------------RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166
Query: 786 LKPSNILLDNNLTAHVGDFGLAR 808
LKP N+L+D V DFG A+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 4e-22
Identities = 40/185 (21%), Positives = 71/185 (38%), Gaps = 21/185 (11%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHR 700
+ F IG G++G VYK G +VA+K + L +G + E L+ + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 701 NLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERI 760
N+V+++ + LV++++ + + + L
Sbjct: 62 NIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA-----------SALTGIPLPLIK 105
Query: 761 SIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQSSS 820
S + + + H H +H DLKP N+L++ + DFGLAR +
Sbjct: 106 SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162
Query: 821 VGDLE 825
V L
Sbjct: 163 VVTLW 167
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 95.3 bits (236), Expect = 5e-22
Identities = 38/171 (22%), Positives = 68/171 (39%), Gaps = 24/171 (14%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
IG GSFG +Y GT G VAIK+ ++ + E + + ++ + I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
D+ +V + + + + R +L + +A + S
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCS------------RKFSLKTVLLLADQMISR 115
Query: 770 VDYLHHHCQEPTIHCDLKPSNIL---LDNNLTAHVGDFGLARLRQEVPNNQ 817
++Y+H IH D+KP N L ++ DFGLA+ ++ +Q
Sbjct: 116 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.0 bits (235), Expect = 5e-22
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITS 708
IG G++G VYK + G A+K + L+ +G + E L+ ++H N+V++
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
+ LV++++ + + L + S + + +
Sbjct: 69 IHT-----KKRLVLVFEHLDQDLKKLLDVCE------------GGLESVTAKSFLLQLLN 111
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ Y H +H DLKP N+L++ + DFGLAR
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 5e-22
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 20/174 (11%)
Query: 651 IGIGSFGSVYKGTFDRD-GTIVAIKVLNLQL--QGASKSF---AAECRALRNIRHRNLVR 704
IG G++G V+K ++ G VA+K + +Q +G S A R L H N+VR
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 705 VITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAI 764
+ C+ LV++++ + +
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-----------VPEPGVPTETIKDMMF 123
Query: 765 DVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPNNQS 818
+ +D+LH H +H DLKP NIL+ ++ + DFGLAR+ S
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 174
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 5e-22
Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 20/166 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVIT 707
+G G++G+V R G VAIK L Q +K E R L+++RH N++ ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 708 SCSSIDFQGNDFK-ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + + LV +M + H L + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--------------EKLGEDRIQFLVYQM 130
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ Y+H IH DLKP N+ ++ + + DFGLAR
Sbjct: 131 LKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADS 173
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 7e-22
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 651 IGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITS 708
IG G++G+V+K IVA+K + L +G S E L+ ++H+N+VR+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
S + LV+++ + + + + S +
Sbjct: 70 LHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPEI------------VKSFLFQLLK 112
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809
+ + H +H DLKP N+L++ N + +FGLAR
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 33/172 (19%), Positives = 67/172 (38%), Gaps = 26/172 (15%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRN 701
D + +G G + V++ + V +K+L + K E + L N+R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++ + + ALV++++ N + + LT +
Sbjct: 92 IITLADIVKDPV---SRTPALVFEHVNNTDFKQL---------------YQTLTDYDIRF 133
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-NLTAHVGDFGLARLRQE 812
++ A+DY H +H D+KP N+++D+ + + D+GLA
Sbjct: 134 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 4e-21
Identities = 38/166 (22%), Positives = 62/166 (37%), Gaps = 21/166 (12%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVIT 707
IG G+ G V VAIK L+ Q +K E ++ + H+N++ ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 708 SCSSID-FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDV 766
+ + LV + M + D E + +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHE----------RMSYLLYQM 128
Query: 767 ASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQE 812
+ +LH IH DLKPSNI++ ++ T + DFGLAR
Sbjct: 129 LCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 6e-21
Identities = 37/179 (20%), Positives = 74/179 (41%), Gaps = 18/179 (10%)
Query: 631 RKVSYESLLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS--KSFA 688
R+ +++ + + + + +G G++GSV + G VA+K L+ Q K
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 689 AECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEEN 748
E R L++++H N++ ++ + + ++ L N +
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---------- 115
Query: 749 DEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLA 807
+ LT + + + Y+H IH DLKPSN+ ++ + + DFGLA
Sbjct: 116 ---QKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 30/173 (17%), Positives = 57/173 (32%), Gaps = 26/173 (15%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
IG GSFG +++GT + VAIK + + E R + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
Q LV + + R ++ A + +
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLCG------------RKFSVKTVAMAAKQMLAR 113
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG-----DFGLARLRQEVPNNQ 817
V +H ++ D+KP N L+ + + DFG+ + ++ Q
Sbjct: 114 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.8 bits (222), Expect = 3e-20
Identities = 36/176 (20%), Positives = 64/176 (36%), Gaps = 30/176 (17%)
Query: 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGAS------KSFAAECRALRN 696
D + + +G G F V K G A K + + +S + E L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 697 IRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTL 756
I+H N++ + ++ L+ + + G L ++L E +LT
Sbjct: 70 IQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA------------EKESLTE 112
Query: 757 LERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN----LTAHVGDFGLAR 808
E + + +++ H DLKP NI+L + + DFGLA
Sbjct: 113 EEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.6 bits (226), Expect = 3e-20
Identities = 80/386 (20%), Positives = 140/386 (36%), Gaps = 24/386 (6%)
Query: 150 NITSLEAISLAYNSLGGNIP-SSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLH 208
+ L ++ + + L Q+ L++ LG + L+ L + N+L
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLT 79
Query: 209 GSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268
P L+ L ++NN + PLA +L L +
Sbjct: 80 DITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIG 328
N + + + ++L L + + + + VS S +
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--DISVLA 194
Query: 329 KLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGN 388
KL +L + +NQ P + NL L++ NQL + +L++L L L N
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 389 NNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKI 448
N +S + P L L +L L L N +S P ++ ++ N N I
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISPI 303
Query: 449 GNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLS 508
NLK L + NN+S P + S LQ ++ A N SSL +L ++ +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 509 QNNLSGKIPISLERLP-LEYLNLSFN 533
N +S P++ L + L L+
Sbjct: 360 HNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.5 bits (218), Expect = 3e-19
Identities = 83/393 (21%), Positives = 149/393 (37%), Gaps = 42/393 (10%)
Query: 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNS 91
L + ++S +L + + I+ I G + L L + S+N
Sbjct: 22 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 77
Query: 92 LVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNI 151
L P L ++L+ + + N++ P ++ + N L N+
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTG----LTLFNNQITDIDPLKNL 131
Query: 152 TSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSL 211
T+L + L+ N++ S + S G T + NL+ L + N++
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 212 PPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271
+ L+NL+ +NN S P +NL L + GN + + +L
Sbjct: 192 VLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLT 244
Query: 272 YLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI-------- 323
L++A N + S + L+ + L+ L L ANQ P + ++
Sbjct: 245 DLDLANNQI--------SNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296
Query: 324 ---PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
S I L +L + + N P +S L LQ L +N++S SS NL++
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
+ L G+N +S + P L NL ++ L L
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 8e-18
Identities = 73/407 (17%), Positives = 144/407 (35%), Gaps = 45/407 (11%)
Query: 104 SRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNS 163
+ + LG+ + ++ L + L + + + +L I+ + N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 77
Query: 164 LGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQ 223
L P L L +L + + I L+ L N + + L+NL
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 224 LFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSG 283
++S+N S L+ + S ++ +L L+++ N
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLS-----FGNQVTDLKPLANLTTLERLDISSNK---- 186
Query: 284 ESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQF 343
+S I LA +NL L NQ P I++ +L + ++ NQ
Sbjct: 187 ----VSDISVLAKLTNLESLIATNNQISDITPLGILT-----------NLDELSLNGNQL 231
Query: 344 EGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLK 403
+ ++ L NL L++ +NQ+S P L+ L +L LG N +S + P L
Sbjct: 232 KD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LA 282
Query: 404 QLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNN 463
L L + + + + L N++ P + +L L+ ++N
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340
Query: 464 LSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQN 510
+S S + + + + N P L +L + ++ L+
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 81.2 bits (199), Expect = 7e-17
Identities = 59/323 (18%), Positives = 111/323 (34%), Gaps = 20/323 (6%)
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
L+NL SNN + P N + L + + N + + L
Sbjct: 65 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 122
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338
+ + + + +S ++ ++ + + L +L +++
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182
Query: 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
N+ +++L NL+ L +NQ+S P ++L +L L N L +
Sbjct: 183 SSNKV--SDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGT 236
Query: 399 LGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFV 458
L +L L L L N +S P + L N + P + L L
Sbjct: 237 LASLTNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 291
Query: 459 VSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPI 518
++ N E S I + L + + N P + SL L+ + + N +S
Sbjct: 292 LNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345
Query: 519 SLERLP-LEYLNLSFNDLEGQVP 540
SL L + +L+ N + P
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 7e-13
Identities = 71/367 (19%), Positives = 125/367 (34%), Gaps = 44/367 (11%)
Query: 79 LFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138
L L ++ + + ++ L R ++ SI L NL ++ N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 139 NLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLA 198
LT P L N+T L I + N + P + +L
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 199 NFSVPEN----------------RLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSN 242
N + +L + L+NL + + + ++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 243 ASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSF 302
I NN ++ G + +L L++ N L I +LA+ +NL+
Sbjct: 195 KLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQL--------KDIGTLASLTNLTD 245
Query: 303 LNLVANQFKGALPHS---------IVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSR 353
L+L NQ P S + + I + L ++ N+ + + +S
Sbjct: 246 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L+NL +L + N +S P +L+ L +L NN +S SSL NL + L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 414 DLSGAIP 420
+S P
Sbjct: 362 QISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 1e-12
Identities = 40/193 (20%), Positives = 63/193 (32%), Gaps = 30/193 (15%)
Query: 13 WNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKI 72
+ IT + L L L + +L+ L ++ L+NN I
Sbjct: 200 ESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257
Query: 73 PGEIGRLFRLEALYLSHNSLVGEIP--------------------GNLSYCSRLIGLYLG 112
P + L +L L L N + P +S L L L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315
Query: 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSL 172
N + P SL L+ L N ++ L N+T++ +S +N + P L
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 173 GQLKELKSLGLGG 185
L + LGL
Sbjct: 370 ANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 58.9 bits (141), Expect = 1e-09
Identities = 34/165 (20%), Positives = 57/165 (34%), Gaps = 28/165 (16%)
Query: 18 HFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIP---- 73
+ + I +T LDL + + + L+ L E+ L N I P
Sbjct: 227 NGNQLKDIGTLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPLAGL 284
Query: 74 ----------------GEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
I L L L L N++ P +S ++L L+ NK+
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYN 162
S +L N+ L+ N ++ P L N+T + + L
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 4e-08
Identities = 20/107 (18%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 8 GVLNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNT 67
G+ N + E I+ + +T L L + + +L+ L+ + +NN
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNK 340
Query: 68 IQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114
+ + L + L HN + P L+ +R+ L L
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 2e-07
Identities = 47/256 (18%), Positives = 97/256 (37%), Gaps = 48/256 (18%)
Query: 325 SEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKL 384
+++ ++ +L + +G + L NL +N +NQL+ P NL+ LV +
Sbjct: 41 TDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 93
Query: 385 ILGNNNLSGVIP------------------------------------SSLGNLKQLALL 408
++ NN ++ + P +++ ++ L+ L
Sbjct: 94 LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGL 153
Query: 409 HLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
Q G ++ +++++ + S + L L + ++N +S
Sbjct: 154 TSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT 213
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYL 528
P I L E+ + N + +L SL +L ++DL+ N +S P+S L L
Sbjct: 214 PLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTEL 268
Query: 529 NLSFNDLEGQVPTKGI 544
L N + P G+
Sbjct: 269 KLGANQISNISPLAGL 284
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 89.4 bits (220), Expect = 6e-20
Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 11/286 (3%)
Query: 8 GVLNSWNDSHHFCD--WEGITCSP--RHRRVTVLDLKSKGLIG--SLSPQIGNLSFLREI 61
L+SW + C+ W G+ C + RV LDL L + + NL +L +
Sbjct: 22 TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81
Query: 62 HLSNNT-IQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSI 120
++ + G IP I +L +L LY++H ++ G IP LS L+ L N L G++
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 121 PSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEA-ISLAYNSLGGNIPSSLGQLKELK 179
P SL NL + N ++G IP G+ + L ++++ N L G IP + L
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF 201
Query: 180 SLGLGGTIPPSIYNLSLLANF--SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFP 237
+ L + + + NL + NN G+ P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 238 LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSG 283
+ L SL + NN G++ G+++ A N G
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.9 bits (185), Expect = 2e-15
Identities = 58/280 (20%), Positives = 92/280 (32%), Gaps = 26/280 (9%)
Query: 149 GNITSLEAISLAYNSLGGN--IPSSLGQLKELKSLGLGG------TIPPSIYNLSLLANF 200
+ + L+ +L IPSSL L L L +GG IPP+I L+ L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260
+ P + L S N SG+ P + S+ NL + GN G +
Sbjct: 107 YITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS 320
++G L N +G+ +LA + +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN--- 222
Query: 321 GSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
++ +NL L++R+N++ G +P L
Sbjct: 223 -------------TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIP 420
L L + NNL G IP GNL++ + N P
Sbjct: 270 LHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 63/260 (24%), Positives = 101/260 (38%), Gaps = 30/260 (11%)
Query: 299 NLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHN-QFEGKIPEEMSRLQNL 357
++ L+L P IPS + L L + + G IP +++L L
Sbjct: 51 RVNNLDLSGLNLPKPYP-------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
+L + H +SG IP + +LV L N LSG +P S+ +L L + N +SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 418 AIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY 477
AIP+ + S + S+ +RN L G IPP NL + + + +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 478 ----------------------LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGK 515
L + + N G++P L LK L +++S NNL G+
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 516 IPISLERLPLEYLNLSFNDL 535
IP + + N
Sbjct: 284 IPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 86 YLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP 145
L +N + G +P L+ L L + N L G IP + +L A N G P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 110 YLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSL--GGN 167
L N++ G++P L L L + NNL G IP GN+ + + A N G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
Query: 168 IPS 170
+P+
Sbjct: 309 LPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 25/109 (22%), Positives = 39/109 (35%), Gaps = 1/109 (0%)
Query: 13 WNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKI 72
+ D + + T +K + ++G L + L NN I G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 73 PGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
P + +L L +L +S N+L GEIP R NK P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 37/141 (26%), Positives = 49/141 (34%), Gaps = 2/141 (1%)
Query: 373 SSFGNLSSLVKLILGNNNLSGV--IPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMS 430
+ + L L NL IPSSL NL L L++ +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 431 DSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRG 490
L ++ G+IP + +K L S N LSG +P I S L I N G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 491 SIPSSLVSLKDLREIDLSQNN 511
+IP S S L N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 2/134 (1%)
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGA--IPEEIFNISHMSDSLNFARNHLVGSIP 445
N GV+ + ++ L L +L IP + N+ +++ N+LVG IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 446 PKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREI 505
P I L L ++ N+SG IP + L + + N G++P S+ SL +L I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 506 DLSQNNLSGKIPIS 519
N +SG IP S
Sbjct: 155 TFDGNRISGAIPDS 168
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.4 bits (216), Expect = 1e-19
Identities = 38/172 (22%), Positives = 56/172 (32%), Gaps = 28/172 (16%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL------QGASKSFAAECRALRNIR--HRN 701
L+G G FGSVY G D VAIK + E L+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 702 LVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERIS 761
++R++ D L+ + E L S
Sbjct: 71 VIRLLDWFER-----PDSFVLILERPEPVQDLFDFI-----------TERGALQEELARS 114
Query: 762 IAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARLRQE 812
V AV + H+ +H D+K NIL+D N + DFG L ++
Sbjct: 115 FFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 1e-19
Identities = 41/183 (22%), Positives = 69/183 (37%), Gaps = 26/183 (14%)
Query: 643 DGFSSTHLIGIGSFGSVYKG---TFDRDGTIVAIKVLN----LQLQGASKSFAAECRALR 695
+ F ++G G++G V+ + G + A+KVL +Q ++ E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 696 NIRHRNLVRVITSCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLT 755
+IR + + FQ L+ Y+ G L L E
Sbjct: 84 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEHE--------- 130
Query: 756 LLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEVPN 815
+ I V V L H + I+ D+K NILLD+N + DFGL++
Sbjct: 131 ------VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 816 NQS 818
++
Sbjct: 185 ERA 187
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 6e-18
Identities = 27/162 (16%), Positives = 69/162 (42%), Gaps = 5/162 (3%)
Query: 649 HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITS 708
+G G F +V+ + T VA+K++ + +++ E + L+ + + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 709 CSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVAS 768
++ + D + + + + + ++ + R + L+ I+ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH-RGIPLIYVKQISKQLLL 136
Query: 769 AVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVGDFGLARL 809
+DY+H C IH D+KP N+L++ + ++ +A L
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 23/159 (14%), Positives = 46/159 (28%), Gaps = 15/159 (9%)
Query: 650 LIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSC 709
L+G G +V+ +K + S E R ++ L
Sbjct: 7 LMGEGKESAVFNCY-SEKFGECVVKFHKVGH--TSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 710 SSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASA 769
+F+AL +A+ + E+ + + + +
Sbjct: 64 --------EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115
Query: 770 VDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDFGLAR 808
V +H +H DL N+L+ + DF +
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.7 bits (195), Expect = 9e-17
Identities = 55/306 (17%), Positives = 106/306 (34%), Gaps = 32/306 (10%)
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKS 269
+P L + L L NN + F N NL +L ++ N F +
Sbjct: 24 KVPKDLPPDTALLDL---QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 270 LAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK 329
L L ++ N L + L N + V S+ + + +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHEN---------------EITKVRKSVFNGLNQ 125
Query: 330 LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
++ + L + G ++ L ++ + ++ IP G SL +L L N
Sbjct: 126 MIVVELGTN-PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 181
Query: 390 NLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIG 449
++ V +SL L LA L L N +S + N H+ + N+ + +P +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL--HLNNNKLVKVPGGLA 239
Query: 450 NLKVLRMFVVSSNNLSG------EIPSEIGSCFYLQEIYMAENF--FRGSIPSSLVSLKD 501
+ K +++ + +NN+S P + + N + PS+ +
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299
Query: 502 LREIDL 507
+ L
Sbjct: 300 RAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.3 bits (194), Expect = 1e-16
Identities = 46/237 (19%), Positives = 92/237 (38%), Gaps = 8/237 (3%)
Query: 322 SIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+P ++ L+++ +N+ + L+NL L + +N++S P +F L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 382 VKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
+L L N L + L++L + + ++ + + + L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV--ELGTNPLKSS 139
Query: 442 GSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKD 501
G +K L ++ N++ IP + L E+++ N +SL L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAASLKGLNN 196
Query: 502 LREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDLEGQVPTKGIFANASAISVSGNS 557
L ++ LS N++S SL P L L+L+ N L + + N+
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 3e-16
Identities = 51/258 (19%), Positives = 98/258 (37%), Gaps = 9/258 (3%)
Query: 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117
+ L NN I G+ L L L L +N + PG + +L LYL +N+L+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKE 177
+L L+ + + + + L + +E + S G + +K+
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-GIENGAFQGMKK 151
Query: 178 LKSLGLGG----TIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFS 233
L + + TIP + L + N++ SL L+NL +S N S
Sbjct: 152 LSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLK-GLNNLAKLGLSFNSIS 208
Query: 234 GSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHS 293
+ +N +L+ L + N D K + + + NN+ + S++
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 294 LANCSNLSFLNLVANQFK 311
++ S ++L +N +
Sbjct: 268 NTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.5 bits (171), Expect = 1e-13
Identities = 42/240 (17%), Positives = 84/240 (35%), Gaps = 14/240 (5%)
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNL 357
+ + L+L N+ + + L +L+ + + +N+ P + L L
Sbjct: 31 PDTALLDLQNNKI---------TEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
+ L + NQL L L N ++ V S L Q+ ++ L N L
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVH---ENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 418 AIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFY 477
+ E S + + +IP G L + N ++ + +
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 478 LQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEG 537
L ++ ++ N SL + LRE+ L+ N L + ++ + L N++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 66.6 bits (161), Expect = 2e-12
Identities = 47/276 (17%), Positives = 99/276 (35%), Gaps = 28/276 (10%)
Query: 268 KSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEI 327
A L++ N + + N NL L L+ N+ P
Sbjct: 31 PDTALLDLQNNKITEIKDG------DFKNLKNLHTLILINNKISK---------ISPGAF 75
Query: 328 GKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILG 387
LV L + + NQ + + LQ L+ ++ + + N +V+L
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTN 134
Query: 388 NNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPK 447
SG+ + +K+L+ + + +++ IP+ + L+ N +
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLT---ELHLDGNKITKVDAAS 190
Query: 448 IGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDL 507
+ L L +S N++S + + +L+E+++ N +P L K ++ + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 508 SQNNLSG------KIPISLERLP-LEYLNLSFNDLE 536
NN+S P + ++L N ++
Sbjct: 250 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 53/294 (18%), Positives = 99/294 (33%), Gaps = 42/294 (14%)
Query: 244 SNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
+ Q + + GN + +F ++L L + N L ++ + + L
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMR 363
L P+ L L+ + +D + P L LQ+L ++
Sbjct: 92 QL--------------RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEI 423
N L +F +L +L L L N +S V + L L L L QN ++ P
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
Query: 424 FNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYM 483
++ + + +NNLS + LQ + +
Sbjct: 198 RDLGRL-------------------------MTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 484 AENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLEYLNLSFNDLEG 537
+N + + + L++ S + + +P L L L+ NDL+G
Sbjct: 233 NDNPWVCDCRARPL-WAWLQKFRGSSSEVPCSLPQRLAGRDL--KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 4e-13
Identities = 49/230 (21%), Positives = 80/230 (34%), Gaps = 9/230 (3%)
Query: 10 LNSWNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSP-QIGNLSFLREIHLSNNTI 68
L + + LDL + S+ P L L +HL +
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 69 QGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLY 128
Q PG L L+ LYL N+L L L+L N++ F L+
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGT-- 186
+L L + +N + PH ++ L + L N+L +L L+ L+ L L
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
Query: 187 --IPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSG 234
+ + L F + + SLP L+ L +++ N G
Sbjct: 238 VCDCRARPLWAWLQKFRGSSSEVPCSLPQR----LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (152), Expect = 2e-11
Identities = 40/225 (17%), Positives = 74/225 (32%), Gaps = 2/225 (0%)
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLA 406
+P + Q + + N++S +SF +L L L +N L+ + ++ L L
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 407 LLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSG 466
L L N ++ F+ +L+ R L P L L+ + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 467 EIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLPLE 526
L +++ N + L L + L QN ++ P + L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 527 YLNLSFNDLEGQVPTKGIFANASAISVSGNSNRLCGGIPELQLPK 571
F + +PT+ + + + N N L
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA 248
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.5 bits (150), Expect = 4e-11
Identities = 52/292 (17%), Positives = 84/292 (28%), Gaps = 20/292 (6%)
Query: 27 CSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALY 86
C + +GL ++ I + I L N I L L+
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 87 LSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSI-PSEFVSLYNLKELAIQENNLTGGIP 145
L N L + + L L L N S+ P+ F L L L + L P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 146 HFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG-----GTIPPSIYNLSLLANF 200
+ +L+ + L N+L + L L L L + L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKL 260
+ +NR+ P + L L + N S A + LQ L + N +
Sbjct: 183 LLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 261 SVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312
L + + + + + L AN +G
Sbjct: 242 R-ARPLWAWLQKFRGSSSEVPCSLPQRL---------AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 6e-11
Identities = 58/334 (17%), Positives = 99/334 (29%), Gaps = 67/334 (20%)
Query: 85 LYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGI 144
L +P + + ++L N++ + F + NL L + N L
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 145 PHFLGNITSLEAISLAYNSLGGNI-PSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVP 203
+ LE + L+ N+ ++ P++ L L +L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD------------------- 113
Query: 204 ENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVN 263
L P L L+ LQ + +N F + NL L + GN
Sbjct: 114 -RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 264 FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI 323
F + SL L + N V+
Sbjct: 173 FRGLHSLDRLLLHQNR---------------------------------------VAHVH 193
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVK 383
P L L + + N E ++ L+ LQ+L + N + + + L K
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQK 252
Query: 384 LILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSG 417
++ + +P L L L NDL G
Sbjct: 253 FRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 39/211 (18%), Positives = 72/211 (34%), Gaps = 9/211 (4%)
Query: 326 EIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLI 385
E+ K+ S + D +P ++ + + L++ N L ++ + L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 386 LGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIP 445
L L+ + L L L L N L + + + N L
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL--DVSFNRLTSLPL 117
Query: 446 PKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREI 505
+ L L+ + N L P + L+++ +A N L L++L +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 506 DLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
L +N+L IP L + L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 34/207 (16%), Positives = 64/207 (30%), Gaps = 5/207 (2%)
Query: 51 QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLY 110
++ ++ E++ + +P ++ + L+LS N L L +RL L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 111 LGRNK-LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP 169
L R + + + L L Q +L + + + G +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 170 SSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISN 229
+ T+PP + + N LP L L NL +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 230 NFFSGSFPLAFSNASNLQSLEILGNNF 256
N + P F + L + GN +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 39/205 (19%), Positives = 57/205 (27%), Gaps = 50/205 (24%)
Query: 26 TCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEAL 85
S + V + + L +L P + +HLS N + + RL L
Sbjct: 5 EVSKVASHLEV-NCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 86 YLSHNS---------------------------------------------LVGEIPGNL 100
L L G L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 101 SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160
L LYL N+L+ P L++L++ NNLT L + +L+ + L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 161 YNSLGGNIPSSLGQLKELKSLGLGG 185
NS IP L L G
Sbjct: 181 ENS-LYTIPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 35/211 (16%), Positives = 61/211 (28%), Gaps = 11/211 (5%)
Query: 101 SYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160
S + + + + L ++P + + L + EN L L T L ++L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 161 YNS-LGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTL 219
+ +L L L P + SLP L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 220 SNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINN 279
LQ + N P + L+ L + NN + +++L L + N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 280 LGSGESDEMSFIHSLANCSNLSFLNLVANQF 310
L + L F L N +
Sbjct: 184 L-------YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPS 397
N +I +L+ LN+ +N+L E+P+ L +LI N+L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPE 321
Query: 398 SLGNLKQLALLHLFQNDLSGAIPEEIFNISHM 429
NLKQ LH+ N L P+ ++ +
Sbjct: 322 LPQNLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 9e-07
Identities = 19/95 (20%), Positives = 33/95 (34%), Gaps = 18/95 (18%)
Query: 287 EMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK 346
+L LN+ N+ +P+ +L L N +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI----------ELPALPPRLERLIA---SFNHLA-E 318
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSL 381
+PE QNL+ L++ +N L E P ++ L
Sbjct: 319 VPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 24/93 (25%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 62 HLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIP 121
N +I LE L +S+N L+ E+P RL L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP 320
Query: 122 SEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
NLK+L ++ N L P ++ L
Sbjct: 321 E---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 409 HLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEI 468
+ N S I + LN + N L+ +P L+ L S N+L+ E+
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLE-ELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EV 319
Query: 469 PSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLR 503
P + L+++++ N R P S++DLR
Sbjct: 320 PELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 18/108 (16%), Positives = 33/108 (30%), Gaps = 24/108 (22%)
Query: 254 NNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGA 313
N ++ SL LNV+ N L A L L N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELP----------ALPPRLERLIASFNHLA-- 317
Query: 314 LPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLN 361
+P L L++ ++N + P+ +++L+ +
Sbjct: 318 --------EVPELPQNLKQLHV---EYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 5/60 (8%)
Query: 356 NLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDL 415
L + + LS +P +L SL + N+L+ +P +LK L + + L
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 47/251 (18%), Positives = 81/251 (32%), Gaps = 14/251 (5%)
Query: 205 NRLHGSLPPSLGLTLSNLQLFQISNNFFSG-SFPLAFSNASNLQSLEILGNNFFGKLSVN 263
R P + + +Q +SN+ + S S LQ+L + G +
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 264 FGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSI 323
+L LN++ + S + + CS L LNL + +
Sbjct: 91 LAKNSNLVRLNLSGCSGFSEFALQTLLSS----CSRLDELNLSWCFDFTEKHVQVA---V 143
Query: 324 PSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQL-SGEIPSSFGNLSSLV 382
+ L L N + + + R NL L++ + + + F L+ L
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203
Query: 383 KLILGN-NNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLV 441
L L ++ LG + L L +F G + + H L +H
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH----LQINCSHFT 259
Query: 442 GSIPPKIGNLK 452
P IGN K
Sbjct: 260 TIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 35/233 (15%), Positives = 76/233 (32%), Gaps = 12/233 (5%)
Query: 314 LPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK-IPEEMSRLQNLQFLNMRHNQLSGEIP 372
P S + + E + +++ ++ E + +S+ LQ L++ +LS I
Sbjct: 30 CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 88
Query: 373 SSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL--------FQNDLSGAIPEEIF 424
++ S+LV+L L + L L + + A+
Sbjct: 89 NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 148
Query: 425 NISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMA 484
I+ ++ S ++ + + S L + E YLQ + ++
Sbjct: 149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 208
Query: 485 E-NFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLSFNDL 535
L + L+ + + G + + E LP L+ F +
Sbjct: 209 RCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTI 261
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 6e-05
Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG 94
LDL K L ++ ++ + + + + + E FR++ + LS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60
Query: 95 E-IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133
+ G LS CS+L L L +L I + NL L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 28/284 (9%), Positives = 78/284 (27%), Gaps = 44/284 (15%)
Query: 145 PHFLGNITSLEAISL--AYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSV 202
P G + S I+ + + + + ++ + L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSN----------------- 55
Query: 203 PENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLS- 261
+ + S + S LQ + S + SNL L + G + F + +
Sbjct: 56 --SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL 113
Query: 262 ---------VNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312
++ ++ + E +L+ + ++ +
Sbjct: 114 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173
Query: 313 ALPHSIVSGSIPSEIGKLVSLYLIEMDH---------NQFEGKIPEEMSRLQNLQFLNMR 363
+ S + ++++ + E+ + L+ L +
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233
Query: 364 HNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLAL 407
G + +L L + ++ + + ++GN K +
Sbjct: 234 GIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 32/218 (14%), Positives = 65/218 (29%), Gaps = 10/218 (4%)
Query: 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEIL 252
L+ + ++ + ++ + L + + + +NL LE+
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTIEGV--QYLNNLIGLEL- 70
Query: 253 GNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKG 312
+N L+ K + I +L S
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 313 ALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIP 372
+ I + L + + ++ L L L N++S P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 373 SSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410
+L +L+++ L NN +S V P L N L ++ L
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 5e-06
Identities = 32/239 (13%), Positives = 72/239 (30%), Gaps = 29/239 (12%)
Query: 150 NITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHG 209
+ + I+ +++ + + L + +L GT + + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGT---GVTTIEGVQY---------- 61
Query: 210 SLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKS 269
L+NL ++ +N + PL L ++
Sbjct: 62 ---------LNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTL 112
Query: 270 LAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGK 329
+ + ++ + L L S + +
Sbjct: 113 DLTSTQITDVTPLAGLSNLQVLYL-DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLAN 171
Query: 330 LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGN 388
L L ++ D N+ P ++ L NL +++++NQ+S P N S+L + L N
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 32/216 (14%), Positives = 63/216 (29%), Gaps = 22/216 (10%)
Query: 330 LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN 389
L + I + + + + L + L+ ++ L++L+ L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 390 NLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFAR------------ 437
++ + P L AI + S
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 438 -NHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSL 496
+ I + + +S N + + + L + +N P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 497 VSLKDLREIDLSQNNLSGKIPISLERLP-LEYLNLS 531
SL +L E+ L N +S P L L + L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 8e-05
Identities = 26/201 (12%), Positives = 61/201 (30%), Gaps = 20/201 (9%)
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L N + + ++ + + +L + L ++ + + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 414 DLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVSS------------ 461
++ P + + ++ + L ++
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 462 -NNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
+I + Y++ + S + L +L L + N +S P++
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192
Query: 521 ERLP-LEYLNLSFNDLEGQVP 540
LP L ++L N + P
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 29/202 (14%), Positives = 62/202 (30%), Gaps = 7/202 (3%)
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
L+N + + + ++ + +L G + + +L L + N
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELKDN 73
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338
+ + + S N+ A ++ ++ + +++ L L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS-NLQ 132
Query: 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
+I + + NLS L L +N +S + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 399 LGNLKQLALLHLFQNDLSGAIP 420
L +L L +HL N +S P
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP 212
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 6e-07
Identities = 15/104 (14%), Positives = 34/104 (32%), Gaps = 5/104 (4%)
Query: 331 VSLYLIEMDHNQF-EGKIPEEMSRLQNLQFLNMRHNQLSGE----IPSSFGNLSSLVKLI 385
+ + +++ + + + E + LQ Q + + L+ I S+ +L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 386 LGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHM 429
L +N L V + Q + + L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 18/102 (17%), Positives = 31/102 (30%), Gaps = 12/102 (11%)
Query: 334 YLIEMDHNQFEGKIPEEMSRLQN---LQFLNMRHNQLSGE----IPSSFGNLSSLVKLIL 386
I + + G Q L+ L + +S + ++ SL +L L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 387 GNNNLSGVIPSSLG-----NLKQLALLHLFQNDLSGAIPEEI 423
NN L L L L L+ S + + +
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 11/82 (13%), Positives = 27/82 (32%), Gaps = 9/82 (10%)
Query: 332 SLYLIEMDHNQFEGK----IPEEMSRLQNLQFLNMRHNQLSGEIPSSFG-----NLSSLV 382
L ++ + + + +L+ L++ +N L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 383 KLILGNNNLSGVIPSSLGNLKQ 404
+L+L + S + L L++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 14/95 (14%), Positives = 28/95 (29%), Gaps = 5/95 (5%)
Query: 58 LREIHLSNNTIQGKIPGEI-GRLFRLEALYLSHNSL----VGEIPGNLSYCSRLIGLYLG 112
++ + + + E+ L + + + L L +I L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHF 147
N+L + IQ+ +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 15/93 (16%), Positives = 32/93 (34%), Gaps = 14/93 (15%)
Query: 450 NLKVLRMFVVSSNNLSGEIPSEIGSCF-YLQEIYMAENFFRG----SIPSSLVSLKDLRE 504
+++ L + LS +E+ Q + + + I S+L L E
Sbjct: 3 DIQSLDI---QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 505 IDLSQNNLSGKIPISLER------LPLEYLNLS 531
++L N L + + ++ L+L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 10/77 (12%)
Query: 474 SCFYLQEIYMAENFFRG----SIPSSLVSLKDLREIDLSQNNLSGKIPISLERL------ 523
L+ +++A+ S+ ++L++ LRE+DLS N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 524 PLEYLNLSFNDLEGQVP 540
LE L L ++
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 8e-04
Identities = 15/80 (18%), Positives = 30/80 (37%), Gaps = 5/80 (6%)
Query: 109 LYLGRNKLEGSIPSEFVS-LYNLKELAIQENNLTG----GIPHFLGNITSLEAISLAYNS 163
L + +L + +E + L + + + + LT I L +L ++L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 164 LGGNIPSSLGQLKELKSLGL 183
LG + Q + S +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 16/91 (17%), Positives = 39/91 (42%), Gaps = 12/91 (13%)
Query: 450 NLKVLRMFVVSSNNLSGE----IPSEIGSCFYLQEIYMAENFFRGSIPSSLV-SLKD--- 501
L+VL + + ++S + + + + L+E+ ++ N + LV S++
Sbjct: 370 VLRVLWL---ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 502 -LREIDLSQNNLSGKIPISLERLPLEYLNLS 531
L ++ L S ++ L+ L + +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 5/62 (8%)
Query: 129 NLKELAIQENNLT-GGIPHFLGNITSLEAISLAYNSLGG----NIPSSLGQLKELKSLGL 183
+++ L IQ L+ L + + + L L +I S+L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 184 GG 185
Sbjct: 63 RS 64
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 20/128 (15%), Positives = 33/128 (25%), Gaps = 9/128 (7%)
Query: 13 WNDSHHFCDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKI 72
HF +++ L+ G+ S LR + L++ +
Sbjct: 326 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385
Query: 73 PGEIGRLFR----LEALYLSHNSLVGEIPGNLS-----YCSRLIGLYLGRNKLEGSIPSE 123
+ L L LS+N L L L L L +
Sbjct: 386 CSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
Query: 124 FVSLYNLK 131
+L K
Sbjct: 446 LQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 16/102 (15%), Positives = 30/102 (29%), Gaps = 23/102 (22%)
Query: 82 LEALYLSHNSLVGE----IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137
L L+L+ + + L L L L N L + + V ++++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-------SVRQ 423
Query: 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELK 179
LE + L + L L++ K
Sbjct: 424 PG------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 245 NLQSLEILGNNF-FGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFL 303
++QSL+I + + ++ + + L E+ +L L+ L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT--EARCKDISSALRVNPALAEL 60
Query: 304 NLVANQFKGALPHSIVSGSIPSEIGKLVSLYL 335
NL +N+ H ++ G + + K+ L L
Sbjct: 61 NLRSNELGDVGVHCVLQG-LQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 6/67 (8%)
Query: 478 LQEIYMAENFFRGSIPSSLVS-LKDLREIDLSQNNLSGK----IPISLERLP-LEYLNLS 531
+Q + + + + L+ L+ + + L L+ I +L P L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 532 FNDLEGQ 538
N+L
Sbjct: 64 SNELGDV 70
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 33/193 (17%), Positives = 66/193 (34%), Gaps = 22/193 (11%)
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
N++ ++ + + L+S+ ++I N+++ V + L + L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 414 DLSGAIPEE--------------IFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVV 459
L+ P + ++S + D L + I L L
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 460 SSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPIS 519
+ + S + E+ I L L L+ + LS+N++S + +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-A 195
Query: 520 LERLP-LEYLNLS 531
L L L+ L L
Sbjct: 196 LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 6e-05
Identities = 26/193 (13%), Positives = 59/193 (30%), Gaps = 7/193 (3%)
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
+ + + + + +++ + ++ K + ++ L + N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN 78
Query: 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEM 338
L + +L + + L + + S+I LV L +E
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138
Query: 339 DHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSS 398
+ + + +I L+ L L L N++S + +
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RA 195
Query: 399 LGNLKQLALLHLF 411
L LK L +L LF
Sbjct: 196 LAGLKNLDVLELF 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 6e-06
Identities = 28/120 (23%), Positives = 46/120 (38%), Gaps = 7/120 (5%)
Query: 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE 95
VL L K L ++ + L + + LS+N ++ P + L LE L S N+L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 96 IPGNLSYCSRLIGLYLGRNKLEG-SIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154
+ L L N+L+ + VS L L +Q N+L + +
Sbjct: 59 DGVANLPRLQE--LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 9e-06
Identities = 21/126 (16%), Positives = 48/126 (38%), Gaps = 19/126 (15%)
Query: 287 EMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK 346
+++ + L ++ L+L N+ + +P + L L +++ N +
Sbjct: 9 DLTVLCHLEQLLLVTHLDLSHNRLRA----------LPPALAALRCLEVLQASDNAL--E 56
Query: 347 IPEEMSRLQNLQFLNMRHNQL-SGEIPSSFGNLSSLVKLILGNNNLSGV------IPSSL 399
+ ++ L LQ L + +N+L + LV L L N+L + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 400 GNLKQL 405
++ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 5e-04
Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 7/107 (6%)
Query: 433 LNFARNHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSI 492
L+ A L ++ + L ++ +S N L P+ + + L+ + ++N
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--N 57
Query: 493 PSSLVSLKDLREIDLSQNNL-SGKIPISLERLP-LEYLNLSFNDLEG 537
+ +L L+E+ L N L L P L LNL N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.4 bits (86), Expect = 0.001
Identities = 24/124 (19%), Positives = 46/124 (37%), Gaps = 4/124 (3%)
Query: 131 KELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPS--SLGQLKELKSLGLGGTIP 188
+ L + +LT + L + + + L++N L P+ +L L+ L++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 189 PSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQS 248
+ NL L + NRL S ++ L L + N + A L S
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 249 LEIL 252
+ +
Sbjct: 119 VSSI 122
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 13/78 (16%), Positives = 25/78 (32%)
Query: 336 IEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVI 395
+ ++ N + + Q + +N L F S V L + + +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 396 PSSLGNLKQLALLHLFQN 413
L NLK+L +
Sbjct: 218 SYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 31/213 (14%), Positives = 59/213 (27%), Gaps = 30/213 (14%)
Query: 347 IPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNN----------------- 389
IP ++ R N L +L +F L K+ + N
Sbjct: 23 IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 390 ---------NLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
NL + P + NL L L + + + ++
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 441 VGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIP-SSLVSL 499
L + + + N EI + + L E+ +++N +P
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 500 KDLREIDLSQNNLSGKIPISLERLP-LEYLNLS 531
+D+S+ + LE L L +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 45/322 (13%), Positives = 96/322 (29%), Gaps = 27/322 (8%)
Query: 129 NLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGN----IPSSLGQLKELKSLGLG 184
+LK AI + + L S++ I L+ N++G + ++ K+L+
Sbjct: 9 SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 185 GTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSN-------LQLFQISNNFFSGSFP 237
+ + A + + L ++ L+ + + +S +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 238 LAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANC 297
L + +I ++ + L + N L +G E + +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ--SH 185
Query: 298 SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNL 357
L + +V N + ++ + V + + + NL
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245
Query: 358 QFLNMRHNQLSGEIPS------SFGNLSSLVKLILGNNNLSGVIPSSL-----GNLKQLA 406
+ L + LS + S L L L N + +L + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 407 LLHLFQNDLS--GAIPEEIFNI 426
L L N S + +EI +
Sbjct: 306 FLELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 39/333 (11%), Positives = 84/333 (25%), Gaps = 18/333 (5%)
Query: 221 NLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNF----FGKLSVNFGDMKSLAYLNVA 276
+L+L I+ S +++ + + GN LS N K L +
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 277 INNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLI 336
G + + + L A + I +L
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 337 EMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIP 396
++ + LQ L N N +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 397 SSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRM 456
+ Q + L + + N + ++ + + LR
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 457 FVVSSNNLSGEIPSEIGSCFY------LQEIYMAENFFRGSIPSSLVS-----LKDLREI 505
++ LS + + F LQ + + N +L + + DL +
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 506 DLSQNNLS--GKIPISLERLPLEYLNLSFNDLE 536
+L+ N S + + + ++L+
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 37/308 (12%), Positives = 88/308 (28%), Gaps = 23/308 (7%)
Query: 119 SIPSEFVSLYNLKELAIQENNLTG----GIPHFLGNITSLEAISLAYNS---LGGNIPSS 171
S+ + + ++KE+ + N + + + + LE + + IP +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 172 LGQLKEL-KSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNN 230
L L + T+ S A + + + L L + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 231 FFSGSFPLAFSNASNLQSLEIL--GNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEM 288
+ A N L + G N S+ K+ +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-WAKTFQSHRLLHTVKMVQNGIRP 200
Query: 289 SFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIP 348
I L L + + S ++ + +L + ++ +
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260
Query: 349 EEMSR------LQNLQFLNMRHNQLSGEIPSS-----FGNLSSLVKLILGNNNLSGVIPS 397
+ LQ L +++N++ + + + L+ L L N S
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDD 319
Query: 398 SLGNLKQL 405
+ ++++
Sbjct: 320 VVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 38/321 (11%), Positives = 89/321 (27%), Gaps = 32/321 (9%)
Query: 240 FSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSN 299
FS L+ + + + S+ + ++ N +G+ + +S ++A+ +
Sbjct: 3 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLS--ENIASKKD 60
Query: 300 LSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQF 359
L V IP + L+ L + Q
Sbjct: 61 LEIAEFSDIFTG------RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 114
Query: 360 LNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAI 419
+ + + L + + N L + +N L
Sbjct: 115 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 174
Query: 420 PEEIFNISHMSDSLNFARN------------HLVGSIPPKIGNLKVLRMFVVSSNNLSGE 467
+E L+ + L+ + + ++ S
Sbjct: 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234
Query: 468 IPSEIGSCFYLQEIYMAENFFRGSIPSSLV------SLKDLREIDLSQNNLSGKIPISL- 520
+ + S L+E+ + + +++V L+ + L N + +L
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294
Query: 521 ----ERLP-LEYLNLSFNDLE 536
E++P L +L L+ N
Sbjct: 295 TVIDEKMPDLLFLELNGNRFS 315
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 7/137 (5%)
Query: 49 SPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIG 108
+ Q N RE+ L I I L + +A+ S N + RL
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 109 LYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTG----GIPHFLGNITSLEAISLAYNSL 164
L + N++ +L +L EL + N+L L ++T L + +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 165 GGNIPSSLGQLKELKSL 181
+ ++ +++ L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 7e-05
Identities = 29/189 (15%), Positives = 68/189 (35%), Gaps = 8/189 (4%)
Query: 219 LSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278
L+ + + ++ ++ + +L+ K + +L +N + N
Sbjct: 17 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 72
Query: 279 NL-GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIE 337
L ++ + + +N ++ + I L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 338 MDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGV-IP 396
++ + +S L +LQ LN NQ++ P NL++L +L + +N +S + +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVL 190
Query: 397 SSLGNLKQL 405
+ L NL+ L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 23/189 (12%), Positives = 50/189 (26%), Gaps = 20/189 (10%)
Query: 354 LQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413
L + ++ + + +L + L + + + L L ++ N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 414 DLSGAIP-------------EEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMFVVS 460
L+ P +L + + + +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 461 SNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISL 520
S I + + + + L +L L +D+S N +S L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 521 ERLP-LEYL 528
+L LE L
Sbjct: 191 AKLTNLESL 199
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 37/175 (21%), Positives = 70/175 (40%), Gaps = 8/175 (4%)
Query: 322 SIPSEIGK-LVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSS 380
IP +I L L D+ RL +L L ++ NQL+G P++F S
Sbjct: 22 EIPRDIPLHTTELLL--NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 381 LVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHL 440
+ +L LG N + + L QL L+L+ N +S +P +++ ++ ++
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS--LNLASNP 137
Query: 441 VGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSS 495
+ LR ++ PS++ +Q + + F+ S +S
Sbjct: 138 FNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFKCSSENS 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 825 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.96 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.96 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.96 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.94 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.94 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.48 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.34 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.62 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.55 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.87 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.9e-38 Score=334.91 Aligned_cols=169 Identities=31% Similarity=0.610 Sum_probs=139.4
Q ss_pred CCcccccCCCCCCCCc--eeeceeecCCC--CcEEEEECCCCCCcc--ccCcCCCCCCCCCEEEcCC-CcccccCCcccc
Q 003368 5 YPEGVLNSWNDSHHFC--DWEGITCSPRH--RRVTVLDLKSKGLIG--SLSPQIGNLSFLREIHLSN-NTIQGKIPGEIG 77 (825)
Q Consensus 5 ~~~~~~~~w~~~~~~C--~~~g~~c~~~~--~~l~~l~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~ 77 (825)
|| +.+++|..++||| .|.||+|+... .||+.|||+++++.+ .+|++|++|++|++|+|++ |+++|.+|.+|+
T Consensus 20 ~~-~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~ 98 (313)
T d1ogqa_ 20 NP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98 (313)
T ss_dssp CC-GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGG
T ss_pred CC-CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccc
Confidence 55 4699999889999 49999998754 489999999999988 5788999999999999986 889888999999
Q ss_pred CCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCC-CE
Q 003368 78 RLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL-EA 156 (825)
Q Consensus 78 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~ 156 (825)
++++|++|+|++|+|++..+..+..+..|+.+++++|++.+.+|..|.++++|+.+++++|.+++.+|..+..+.++ +.
T Consensus 99 ~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~ 178 (313)
T d1ogqa_ 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred cccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccc
Confidence 99999999999998888888888888888888888888888888888888888888888888887777777777665 67
Q ss_pred EEcccCcCcccCCccccc
Q 003368 157 ISLAYNSLGGNIPSSLGQ 174 (825)
Q Consensus 157 L~Ls~N~l~~~~p~~~~~ 174 (825)
++++.|++++..|..+..
T Consensus 179 l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 179 MTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp EECCSSEEEEECCGGGGG
T ss_pred cccccccccccccccccc
Confidence 777777777665554433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1e-32 Score=293.51 Aligned_cols=261 Identities=32% Similarity=0.518 Sum_probs=238.5
Q ss_pred CCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEccc-CcccccCCccccCCCCCCEEEccccccccccCccccC
Q 003368 299 NLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDH-NQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSSFGN 377 (825)
Q Consensus 299 ~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 377 (825)
+++.|+|++|.++|. ..+|+.++++++|++|+|++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..
T Consensus 51 ~v~~L~L~~~~l~g~-------~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~ 123 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKP-------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123 (313)
T ss_dssp CEEEEEEECCCCSSC-------EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG
T ss_pred EEEEEECCCCCCCCC-------CCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccc
Confidence 588899999988862 25889999999999999986 8999999999999999999999999999999999999
Q ss_pred CCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCCCccccCCCccccccccccEE
Q 003368 378 LSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFARNHLVGSIPPKIGNLKVLRMF 457 (825)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~N~l~~~~p~~~~~l~~L~~L 457 (825)
+.+|+++++++|++.+.+|..+++++.|+.+++++|.++|.+|..++.+..+...+++++|++++..|..++.+..+ .+
T Consensus 124 ~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l 202 (313)
T d1ogqa_ 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FV 202 (313)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EE
T ss_pred hhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cc
Confidence 99999999999999999999999999999999999999999999999988887889999999999999999888765 69
Q ss_pred eecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCCccccccCcccccc-cCceeeCCCCcce
Q 003368 458 VVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQNNLSGKIPISLERL-PLEYLNLSFNDLE 536 (825)
Q Consensus 458 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l-~L~~l~ls~N~l~ 536 (825)
++++|.+.|.+|..++.+..++.+++++|.+++.+| .++.+++|+.|||++|+++|.+|..+..+ .|++|+|++|+|+
T Consensus 203 ~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 999999999999999999999999999999998765 68899999999999999999999999998 5999999999999
Q ss_pred ecCCCCCccCccccccccCCCCCCCCCCCCcCCCCCC
Q 003368 537 GQVPTKGIFANASAISVSGNSNRLCGGIPELQLPKCP 573 (825)
Q Consensus 537 g~~p~~~~~~~~~~~~~~~n~~~lc~~~~~~~~~~~~ 573 (825)
|.+|..+.+.++...++.||. .+||.+ .|+|.
T Consensus 282 g~iP~~~~L~~L~~l~l~~N~-~l~g~p----lp~c~ 313 (313)
T d1ogqa_ 282 GEIPQGGNLQRFDVSAYANNK-CLCGSP----LPACT 313 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSS-EEESTT----SSCCC
T ss_pred ccCCCcccCCCCCHHHhCCCc-cccCCC----CCCCC
Confidence 999988888889999999997 899964 35663
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-32 Score=284.90 Aligned_cols=161 Identities=26% Similarity=0.368 Sum_probs=143.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||+||+|+.+.+|+.||||+++.......+.+.+|++++++++|||||++++++ .+++..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence 4699999999999999999999999999999999876655667899999999999999999999985 44678999
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++.. ..+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+||+
T Consensus 95 vmEy~~gg~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~ 158 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT 158 (293)
T ss_dssp EEECCTTCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred EEEecCCCcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeec
Confidence 9999999999988742 3588999999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||+|+............+||+
T Consensus 159 DFG~a~~~~~~~~~~~~~~gt~ 180 (293)
T d1yhwa1 159 DFGFCAQITPEQSKRSTMVGTP 180 (293)
T ss_dssp CCTTCEECCSTTCCBCCCCSCG
T ss_pred cchhheeeccccccccccccCC
Confidence 9999998866555566777886
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=282.61 Aligned_cols=163 Identities=22% Similarity=0.364 Sum_probs=139.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++ .+++..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence 3579999999999999999999999999999999976532 3346789999999999999999999985 446789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||||+++|+|.+++... ..+++.++..|+.|+++||+|||+. +||||||||+|||+++++.+|
T Consensus 79 ~ivmEy~~gg~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~K 143 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK 143 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred EEEEeccCCCcHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEE
Confidence 9999999999999998532 3689999999999999999999986 899999999999999999999
Q ss_pred EcccCcccccccCC--CCCccccccC
Q 003368 801 VGDFGLARLRQEVP--NNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~--~~~~~~~gt~ 824 (825)
|+|||+|+...... ...++.+||+
T Consensus 144 L~DFG~a~~~~~~~~~~~~~~~~GT~ 169 (271)
T d1nvra_ 144 ISDFGLATVFRYNNRERLLNKMCGTL 169 (271)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCG
T ss_pred EccchhheeeccCCccccccceeeCc
Confidence 99999999875443 2345567886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=282.34 Aligned_cols=172 Identities=26% Similarity=0.395 Sum_probs=130.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||.+.... ....+.|.+|++++++++|||||++++++.. +....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 367999999999999999999999999999999997653 2335678999999999999999999998642 23456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCC
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC--QEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~--~~~ivHrdlk~~NILl~~~~ 797 (825)
.|+||||+++|+|.+++... ......+++.++..|+.|++.||+|||+.. ..+||||||||+|||++.++
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~--------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKG--------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHH--------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEEEEecCCCCcHHHHHHhc--------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 79999999999999998521 123457999999999999999999999852 13599999999999999999
Q ss_pred cEEEcccCcccccccCCCCCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
.+||+|||+|+..........+.+||+
T Consensus 152 ~vkl~DFG~a~~~~~~~~~~~~~~gt~ 178 (269)
T d2java1 152 NVKLGDFGLARILNHDTSFAKAFVGTP 178 (269)
T ss_dssp CEEECCHHHHHHC-----------CCC
T ss_pred cEEEeeccceeecccCCCccccCCCCc
Confidence 999999999999876655556677886
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2.2e-32 Score=285.43 Aligned_cols=158 Identities=27% Similarity=0.462 Sum_probs=138.3
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++...++|...+.||+|+||+||+|+++.+|+.||||+++... ...++|.+|++++++++|||||+++++|. ++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eC
Confidence 3334567888999999999999999998899999999997653 34578999999999999999999999964 35
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|+|.+++... ....++|..+..|+.|||+||+|||+. +||||||||+|||+++++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~----------~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~ 152 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLREC----------NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENH 152 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS----------CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred CeeEEEeecccCcchHHHhhhc----------cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCC
Confidence 6789999999999999998532 224689999999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccccCC
Q 003368 798 TAHVGDFGLARLRQEVP 814 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~ 814 (825)
.+||+|||+|+......
T Consensus 153 ~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 153 LVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CEEECCCCCTTTCCSSS
T ss_pred cEEEccccceeecCCCC
Confidence 99999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=285.48 Aligned_cols=163 Identities=23% Similarity=0.352 Sum_probs=141.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.|.+|++++++++|||||++++++. +++..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 45888999999999999999999999999999998766666678999999999999999999999854 4678899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++.. ....+++.++..|+.|+++||+|||+. +||||||||+|||++.++.+||+
T Consensus 87 vmEy~~~g~L~~~~~~-----------~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~ 152 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE-----------LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLA 152 (288)
T ss_dssp EEECCTTEEHHHHHHH-----------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHHh-----------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEE
Confidence 9999999999998742 234689999999999999999999986 99999999999999999999999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||+|+..........+.+||+
T Consensus 153 DFG~a~~~~~~~~~~~~~~Gt~ 174 (288)
T d2jfla1 153 DFGVSAKNTRTIQRRDSFIGTP 174 (288)
T ss_dssp CCTTCEECHHHHHHHTCCCSCC
T ss_pred echhhhccCCCccccccccccc
Confidence 9999987654333334556665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=274.38 Aligned_cols=160 Identities=25% Similarity=0.418 Sum_probs=140.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++|||||++++++ .+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 57999999999999999999999999999999997542 23456789999999999999999999985 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++.. ...+++.++..|+.|+++||+|||+. +||||||||+|||++.++.+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~------------~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~ 145 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQK------------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 145 (263)
T ss_dssp EEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred EEEEEeecCCCcHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCE
Confidence 9999999999999999842 24689999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+..... .....+||+
T Consensus 146 kl~DFG~a~~~~~~--~~~~~~Gt~ 168 (263)
T d2j4za1 146 KIADFGWSVHAPSS--RRTTLCGTL 168 (263)
T ss_dssp EECCCCSCSCCCCC--CCEETTEEG
T ss_pred eecccceeeecCCC--cccccCCCC
Confidence 99999999876543 345556775
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=277.17 Aligned_cols=163 Identities=27% Similarity=0.481 Sum_probs=137.6
Q ss_pred hcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
..++|+..+.||+|+||+||+|++ .+++.||||+++... ...++|.+|++++++++|||||+++|+|. ++..
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~ 82 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI 82 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCe
Confidence 346788899999999999999998 478899999997543 34578999999999999999999999864 2356
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+++|+|.+++.. .....++|.++++|+.|||+||+|||+. +|+||||||+|||+++++.+|
T Consensus 83 ~iv~Ey~~~g~L~~~~~~----------~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~K 149 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKT----------PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCK 149 (272)
T ss_dssp EEEEECCTTCBHHHHTTS----------HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred EEEEEeCCCCcHHHHHhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeeccccee
Confidence 899999999999998753 2334699999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccCCC-CCccccccC
Q 003368 801 VGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
|+|||+|+...+... ......||+
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~ 174 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPI 174 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCT
T ss_pred eccccceEEccCCccccccccCCcc
Confidence 999999998865432 223345554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.1e-32 Score=286.06 Aligned_cols=162 Identities=23% Similarity=0.344 Sum_probs=139.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.++|+..+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||+++++| .+++..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 5789999999999999999999999999999999976533 3456799999999999999999999985 346789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. .+||||||||+|||+++++.+|
T Consensus 80 ~iVmEy~~gg~L~~~l~~------------~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp EEEEECCTTEEHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEE
T ss_pred EEEEEcCCCCcHHHHHhh------------cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEE
Confidence 999999999999999842 24689999999999999999999973 2799999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+...+. ..++.+||+
T Consensus 146 l~DFGla~~~~~~--~~~~~~GT~ 167 (322)
T d1s9ja_ 146 LCDFGVSGQLIDS--MANSFVGTR 167 (322)
T ss_dssp ECCCCCCHHHHHH--TC---CCSS
T ss_pred EeeCCCccccCCC--ccccccCCc
Confidence 9999999977543 245668886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1.4e-31 Score=281.17 Aligned_cols=152 Identities=27% Similarity=0.498 Sum_probs=122.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe---EEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT---IVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~---~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..++||+|+||+||+|+++.+|+ .||||++..... ...+.|.+|++++++++|||||+++|+|.. ++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence 345567899999999999999876654 689999875533 345689999999999999999999999643 56
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..++|||||++|+|.+++... ...++|.++..|+.|||+||+|||+. +||||||||+|||++.++.
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~-----------~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~ 166 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQN-----------DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLV 166 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTT-----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred EEEEEEEecCCCcceeeeccc-----------cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCc
Confidence 789999999999999988532 24689999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 167 ~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 167 CKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCC---------
T ss_pred EEECCcccceEccCC
Confidence 999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4e-31 Score=281.35 Aligned_cols=163 Identities=26% Similarity=0.362 Sum_probs=144.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||++++.. ....+.+.+|++++++++|||||+++++ +++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----ecccc
Confidence 467999999999999999999999999999999997542 2345778999999999999999999998 45678
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+|||||++|+|.+++.. ...+++.++..++.|++.||+|||+. +||||||||+|||+++++.
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~------------~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~ 143 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSR------------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH 143 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred ccccceeccCCCchhhhhhc------------ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCC
Confidence 89999999999999998842 34688899999999999999999996 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+..........+.+||+
T Consensus 144 vkl~DFG~a~~~~~~~~~~~~~~GT~ 169 (337)
T d1o6la_ 144 IKITDFGLCKEGISDGATMKTFCGTP 169 (337)
T ss_dssp EEECCCTTCBCSCCTTCCBCCCEECG
T ss_pred EEEeecccccccccCCcccccceeCH
Confidence 99999999998766555667778886
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-31 Score=273.37 Aligned_cols=161 Identities=24% Similarity=0.400 Sum_probs=127.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||+||+|++ .+++.||||+++... ...++|.+|++++++++|||||+++|+|.. ++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEE-TTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEE
Confidence 5688899999999999999998 478899999997643 345789999999999999999999999753 567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|+|.+++... ...++|..+..|+.|+|+||+|||+. +|+||||||+|||+|+++.+||+
T Consensus 78 v~E~~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~ 143 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-----------RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS 143 (263)
T ss_dssp EEECCTTCBHHHHHHTT-----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEEC
T ss_pred EEEecCCCcHHHHhhcc-----------ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEec
Confidence 99999999999998532 24688999999999999999999985 89999999999999999999999
Q ss_pred ccCcccccccCCCC-CccccccC
Q 003368 803 DFGLARLRQEVPNN-QSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~-~~~~~gt~ 824 (825)
|||+|+........ .....||+
T Consensus 144 DFGla~~~~~~~~~~~~~~~gt~ 166 (263)
T d1sm2a_ 144 DFGMTRFVLDDQYTSSTGTKFPV 166 (263)
T ss_dssp SCC------------------CT
T ss_pred ccchheeccCCCceeecceecCc
Confidence 99999987654332 22334554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.5e-31 Score=275.82 Aligned_cols=162 Identities=25% Similarity=0.381 Sum_probs=138.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..++||+|+||+||+|+.+.+|+.||||++.... ....+.+.+|++++++++|||||++++++ ++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 67999999999999999999998999999999997542 23456799999999999999999999984 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++. ....+++.++..++.|++.||+|||+. +||||||||+|||+++++.+
T Consensus 83 ~~ivmEy~~gg~L~~~~~------------~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIR------------KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp EEEEECCCTTEEHHHHHH------------HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred EEEEEEccCCCCHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceE
Confidence 999999999999999884 234789999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCC--CCccccccC
Q 003368 800 HVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
||+|||+|+.+..... ...+.+||+
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTA 174 (288)
T ss_dssp EECCCTTCEECC----------CCCCG
T ss_pred EecccccceecccCCcccccccccCCc
Confidence 9999999998754332 344567886
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-30 Score=269.66 Aligned_cols=163 Identities=28% Similarity=0.428 Sum_probs=136.2
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
+..+.||+|+||+||+|++..+++.||||.+.... ....+.|.+|++++++++|||||++++++... ..+....|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence 45568999999999999999999999999987543 23456799999999999999999999986431 2335568999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCcEEEc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD-NNLTAHVG 802 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~-~~~~~ki~ 802 (825)
|||+++|+|.+++.. ...+++.++..++.|+++||+|||+. .++||||||||+|||++ +++.+||+
T Consensus 91 mE~~~~g~L~~~l~~------------~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EeCCCCCcHHHHHhc------------cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEe
Confidence 999999999999842 24689999999999999999999986 23599999999999996 57899999
Q ss_pred ccCcccccccCCCCCccccccC
Q 003368 803 DFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|||+|+..... ...+.+||+
T Consensus 158 DFGla~~~~~~--~~~~~~GT~ 177 (270)
T d1t4ha_ 158 DLGLATLKRAS--FAKAVIGTP 177 (270)
T ss_dssp CTTGGGGCCTT--SBEESCSSC
T ss_pred ecCcceeccCC--ccCCcccCc
Confidence 99999975432 345668886
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=276.13 Aligned_cols=160 Identities=34% Similarity=0.522 Sum_probs=130.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|...+.||+|+||+||+|+++ ..||||+++... ....+.|.+|++++++++|||||+++++|. ++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccE
Confidence 467888999999999999999873 259999997543 344678999999999999999999999864 245
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+++|+|.++++.. ...++|.++..|+.|||+||+|||+. +||||||||+|||++.++.+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~ 143 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII-----------ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTV 143 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS-----------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSE
T ss_pred EEEEEecCCCCCHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCE
Confidence 79999999999999999532 13589999999999999999999985 89999999999999999999
Q ss_pred EEcccCcccccccCCC--CCccccccC
Q 003368 800 HVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
||+|||+|+....... ...+..||+
T Consensus 144 Kl~DFGla~~~~~~~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 144 KIGDFGLATVKSRWSGSHQFEQLSGSI 170 (276)
T ss_dssp EECCCCCSCC------------CCCCG
T ss_pred EEccccceeeccccCCcccccccccCc
Confidence 9999999998765432 234446665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3.1e-29 Score=274.29 Aligned_cols=356 Identities=24% Similarity=0.331 Sum_probs=206.8
Q ss_pred ECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCC
Q 003368 38 DLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 38 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+++.+++.+.++. ..+.+|++|++++|.|+. + +.|+.+++|++|||++|+|++..| |+++++|++|++++|+|+
T Consensus 28 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEECH--HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccCH--HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccc
Confidence 4555666655543 467788999999998884 3 357788899999999999986543 888899999999999988
Q ss_pred CCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCC
Q 003368 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLL 197 (825)
Q Consensus 118 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l 197 (825)
+.. .+.++++|+.|++++|.+++..+ ......+..+....|.+....+.....................+.
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 172 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA----- 172 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGT-----
T ss_pred ccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhc-----
Confidence 643 37888899999999888885543 345567778888888776444333322222222211111111111
Q ss_pred ceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEccc
Q 003368 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAI 277 (825)
Q Consensus 198 ~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~ 277 (825)
..+.........|... ....+..+++++.+++++|.+.+..+ +.
T Consensus 173 --------------------~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~------------ 216 (384)
T d2omza2 173 --------------------NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LG------------ 216 (384)
T ss_dssp --------------------TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GG------------
T ss_pred --------------------cccccccccccccccc--cccccccccccceeeccCCccCCCCc--cc------------
Confidence 2333344444444432 23445566666666666666554332 12
Q ss_pred ccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCC
Q 003368 278 NNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNL 357 (825)
Q Consensus 278 N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 357 (825)
.+++|+.|++++|+++ .+| .+..+++|+.+++++|.+++..+ ++.+++|
T Consensus 217 ------------------~~~~L~~L~l~~n~l~----------~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L 265 (384)
T d2omza2 217 ------------------ILTNLDELSLNGNQLK----------DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKL 265 (384)
T ss_dssp ------------------GCTTCCEEECCSSCCC----------CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred ------------------ccCCCCEEECCCCCCC----------Ccc-hhhcccccchhccccCccCCCCc--ccccccC
Confidence 2334444444444443 111 23444555555555555553322 4555666
Q ss_pred CEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccchhhhcccccccccccCC
Q 003368 358 QFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPEEIFNISHMSDSLNFAR 437 (825)
Q Consensus 358 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~~~~~~~~l~~~l~l~~ 437 (825)
++|++++|++.+.. .+..++.++.++++.|.+++. ..+..+++++.|++++|++++. +
T Consensus 266 ~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~----------------- 323 (384)
T d2omza2 266 TELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S----------------- 323 (384)
T ss_dssp SEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-----------------
T ss_pred CEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC-c-----------------
Confidence 66666666665332 244556666666666666542 2355556666666666655421 1
Q ss_pred CccccCCCccccccccccEEeecCceecccCCccccCCCCCCEEEccCCcCCCCCCccccCCCCCCEEECCCC
Q 003368 438 NHLVGSIPPKIGNLKVLRMFVVSSNNLSGEIPSEIGSCFYLQEIYMAENFFRGSIPSSLVSLKDLREIDLSQN 510 (825)
Q Consensus 438 N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~Ldls~N 510 (825)
.+..+++|+.|++++|++++ +| .++.+++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 324 ---------~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 ---------PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ---------GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ---------ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 12334555666666666653 33 46666666666666666665433 666777777777776
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.3e-30 Score=274.42 Aligned_cols=157 Identities=29% Similarity=0.373 Sum_probs=136.0
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
.|+..+.||+|+||+||+|+...+|+.||||++..... ...+.|.+|++++++++|||||++++++. +++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence 48889999999999999999999999999999976532 23457899999999999999999999854 36789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+|||||++|++..++. ....++|.++..|+.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 91 ~iv~E~~~~g~l~~~~~------------~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV------------HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp EEEEECCSEEHHHHHHH------------HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred EEEEEecCCCchHHHHH------------hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEE
Confidence 99999999999976653 224689999999999999999999986 899999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+..... .+.+||+
T Consensus 156 l~DFG~a~~~~~~----~~~~GT~ 175 (309)
T d1u5ra_ 156 LGDFGSASIMAPA----NSFVGTP 175 (309)
T ss_dssp ECCCTTCBSSSSB----CCCCSCG
T ss_pred EeecccccccCCC----CccccCc
Confidence 9999999976543 3445665
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.96 E-value=2.5e-30 Score=277.21 Aligned_cols=163 Identities=18% Similarity=0.304 Sum_probs=140.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||+++.......+.+.+|++++++++|||||++++++ .+++..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35689999999999999999999899999999999876555567889999999999999999999984 4577899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD--NNLTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~--~~~~~ 799 (825)
+||||+++|+|.+++... ...+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+
T Consensus 103 ivmE~~~gg~L~~~~~~~-----------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~v 168 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-----------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 168 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-----------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCE
T ss_pred EEEEcCCCChHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeE
Confidence 999999999999887432 23589999999999999999999985 999999999999998 57899
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... ...+..||+
T Consensus 169 kL~DFGla~~~~~~~-~~~~~~gt~ 192 (352)
T d1koba_ 169 KIIDFGLATKLNPDE-IVKVTTATA 192 (352)
T ss_dssp EECCCTTCEECCTTS-CEEEECSSG
T ss_pred EEeecccceecCCCC-ceeeccCcc
Confidence 999999999876542 334455654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.96 E-value=1.9e-30 Score=277.84 Aligned_cols=163 Identities=21% Similarity=0.339 Sum_probs=141.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||+||+|+.+.+|+.||||++........+.+.+|++++++++|||||++++++ .+++..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 35799999999999999999999999999999999876656667899999999999999999999984 4467899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD--NNLTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~--~~~~~ 799 (825)
+|||||++|+|.+++... ...+++.++..|+.||+.||+|||+. +||||||||+|||++ .++.+
T Consensus 100 ivmE~~~gg~L~~~l~~~-----------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~v 165 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADE-----------HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 165 (350)
T ss_dssp EEECCCCSCBHHHHHTCT-----------TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCE
T ss_pred EEEEcCCCCCHHHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeE
Confidence 999999999999998532 23689999999999999999999986 999999999999995 46789
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+..... ....+..||+
T Consensus 166 kL~DFG~a~~~~~~-~~~~~~~gT~ 189 (350)
T d1koaa2 166 KLIDFGLTAHLDPK-QSVKVTTGTA 189 (350)
T ss_dssp EECCCTTCEECCTT-SCEEEECSCT
T ss_pred EEeecchheecccc-cccceecCcc
Confidence 99999999987554 2345567775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=3.5e-30 Score=272.21 Aligned_cols=159 Identities=28% Similarity=0.372 Sum_probs=139.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|++++++++|||||++++++ .+++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 57999999999999999999999999999999997542 23457799999999999999999999984 45778
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||++||++..++.. ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~------------~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~v 143 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRK------------SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI 143 (316)
T ss_dssp EEEEECCCCSCBHHHHHHH------------TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred eeeEeeecCCccccccccc------------cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCE
Confidence 9999999999999988743 24678888899999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...+. ..+.+||+
T Consensus 144 kL~DFG~a~~~~~~---~~~~~Gt~ 165 (316)
T d1fota_ 144 KITDFGFAKYVPDV---TYTLCGTP 165 (316)
T ss_dssp EECCCSSCEECSSC---BCCCCSCT
T ss_pred EEecCccceEeccc---cccccCcc
Confidence 99999999987543 35567876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.3e-30 Score=262.73 Aligned_cols=161 Identities=26% Similarity=0.417 Sum_probs=138.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|+..+.||+|+||+||+|++ .+++.||||.++.... ..++|.+|++++++++|||||+++|+|. +++..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEE
Confidence 6788999999999999999998 5889999999986543 4578999999999999999999999964 3567899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEc
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVG 802 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~ 802 (825)
||||+++|++.+++.. ....++|..+.+|+.|+|+||+|||+. +|+||||||+||++++++.+||+
T Consensus 77 v~Ey~~~g~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~ 142 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLRE-----------MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS 142 (258)
T ss_dssp EEECCTTEEHHHHHHS-----------GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEccCCCcHHHhhhc-----------cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEEC
Confidence 9999999999999743 234689999999999999999999985 99999999999999999999999
Q ss_pred ccCcccccccCCCCC-ccccccC
Q 003368 803 DFGLARLRQEVPNNQ-SSSVGDL 824 (825)
Q Consensus 803 DFGla~~~~~~~~~~-~~~~gt~ 824 (825)
|||+|+...+..... ....||+
T Consensus 143 DfG~a~~~~~~~~~~~~~~~~t~ 165 (258)
T d1k2pa_ 143 DFGLSRYVLDDEYTSSVGSKFPV 165 (258)
T ss_dssp CCSSCCBCSSSSCCCCCCSCCCG
T ss_pred cchhheeccCCCceeecccCCCC
Confidence 999999876554322 2334553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=5.8e-30 Score=265.16 Aligned_cols=161 Identities=23% Similarity=0.359 Sum_probs=139.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---------hhHHHHHHHHHHhhcCC-CCCceeEeeccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---------GASKSFAAECRALRNIR-HRNLVRVITSCSSI 712 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 712 (825)
++|+..+.||+|+||+||+|+...+|+.||||+++.... ...+.+.+|++++++++ |||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 578999999999999999999989999999999976431 12346889999999997 99999999984
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.+++..|+||||+++|+|.+++.. ...+++.++..++.||++||+|||+. +||||||||+|||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~------------~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nil 142 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE------------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL 142 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEE
Confidence 457889999999999999999942 24789999999999999999999985 9999999999999
Q ss_pred ecCCCcEEEcccCcccccccCCCCCccccccC
Q 003368 793 LDNNLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 793 l~~~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.++.+||+|||+|+...+.. ..+..+||+
T Consensus 143 l~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~ 173 (277)
T d1phka_ 143 LDDDMNIKLTDFGFSCQLDPGE-KLREVCGTP 173 (277)
T ss_dssp ECTTCCEEECCCTTCEECCTTC-CBCCCCSCG
T ss_pred EcCCCCeEEccchheeEccCCC-ceeeeeccC
Confidence 9999999999999999876543 334456664
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1.8e-30 Score=273.28 Aligned_cols=161 Identities=26% Similarity=0.386 Sum_probs=122.8
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
+.|+..++||+|+||+||+|+++.+|+.||||++..... ...+.+.+|++++++++|||||++++++ .+++..|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 558899999999999999999999999999999976542 3345688999999999999999999984 4577899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCc
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD---NNLT 798 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~---~~~~ 798 (825)
+||||++||+|.+++... ..+++.++..|+.|++.||+|||+. +||||||||+|||+. +++.
T Consensus 84 lvmE~~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK------------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp EEECCCCSCBHHHHHHTC------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEeccCCCcHHHhhhcc------------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence 999999999999999532 4689999999999999999999985 999999999999994 5789
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+...... ...+.+||+
T Consensus 149 vkl~DFG~a~~~~~~~-~~~~~~GT~ 173 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS-VLSTACGTP 173 (307)
T ss_dssp EEECCC-------------------C
T ss_pred EEEeccceeEEccCCC-eeeeeeeCc
Confidence 9999999999765442 345567886
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.8e-30 Score=267.75 Aligned_cols=151 Identities=26% Similarity=0.432 Sum_probs=129.2
Q ss_pred ccccccce-eccCCeeEEEEEEEcC--CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHL-IGIGSFGSVYKGTFDR--DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~-ig~G~~g~Vy~~~~~~--~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...+. ||+|+||+||+|.++. ++..||||+++.... ...++|.+|++++++++|||||+++|+|. .+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------cC
Confidence 45666664 9999999999998753 456899999976543 34578999999999999999999999863 23
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++... ...++|.++..|+.|||+||+|||+. +||||||||+|||++.++.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~ 147 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-----------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHY 147 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-----------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTE
T ss_pred eEEEEEEeCCCCcHHHHhhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCc
Confidence 579999999999999998532 23689999999999999999999985 9999999999999999999
Q ss_pred EEEcccCcccccccC
Q 003368 799 AHVGDFGLARLRQEV 813 (825)
Q Consensus 799 ~ki~DFGla~~~~~~ 813 (825)
+||+|||+|+.....
T Consensus 148 ~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 148 AKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCCTTCEECTTC
T ss_pred eeeccchhhhccccc
Confidence 999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=268.09 Aligned_cols=154 Identities=29% Similarity=0.525 Sum_probs=126.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC----eEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG----TIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
.+.|+..++||+|+||+||+|+++.++ ..||||+++.... ...++|.+|++++++++|||||+++|+|..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----- 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----- 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----
Confidence 356888999999999999999986554 4799999976543 334579999999999999999999999643
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
.+..++||||+.+|++.+++.. ....++|.++.+|+.|||+|++|||+. +|+||||||+|||++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLRE-----------KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN 146 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH-----------TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred CCceEEEEEecccCcchhhhhc-----------ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC
Confidence 5678999999999999988742 234689999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccccCC
Q 003368 797 LTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~ 814 (825)
+.+||+|||+|+.+....
T Consensus 147 ~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp CCEEECCCCC--------
T ss_pred CeEEEcccchhhcccCCC
Confidence 999999999999876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.2e-30 Score=269.30 Aligned_cols=162 Identities=30% Similarity=0.501 Sum_probs=130.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|+|. ++..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeE
Confidence 467889999999999999999994 56789999997543 34578999999999999999999999863 23478
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|++.+++.. .....++|.++..|+.|||+||+|||+. +|+||||||+|||+|+++.+||
T Consensus 88 lv~Ey~~~g~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKG----------ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp EEECCCTTCBHHHHHSH----------HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEecCCCchhhhhhh----------cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEE
Confidence 99999999999988852 2334699999999999999999999985 8999999999999999999999
Q ss_pred cccCcccccccCCC-CCccccccC
Q 003368 802 GDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
+|||+|+...+... ......||+
T Consensus 155 ~DfGla~~~~~~~~~~~~~~~gt~ 178 (285)
T d1fmka3 155 ADFGLARLIEDNEYTARQGAKFPI 178 (285)
T ss_dssp CCCCTTC--------------CCG
T ss_pred cccchhhhccCCCceeeccccccc
Confidence 99999998755432 223344553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-29 Score=265.18 Aligned_cols=161 Identities=24% Similarity=0.311 Sum_probs=138.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------hhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
+.|+..+.||+|+||+||+|+++.+|+.||||++++... ...+.|.+|++++++++|||||++++++ .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 568999999999999999999999999999999975421 2357899999999999999999999984 45
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
++..|+|||||++|+|.+++.. ...+++.++..++.|++.||+|||+. +||||||||+|||++.+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~------------~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAE------------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR 149 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCS
T ss_pred CCEEEEEEEcCCCccccchhcc------------ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecC
Confidence 7789999999999999999842 24689999999999999999999986 99999999999999877
Q ss_pred C----cEEEcccCcccccccCCCCCccccccC
Q 003368 797 L----TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~----~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+ .+|++|||+|+...... ...+..||+
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~-~~~~~~~t~ 180 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTP 180 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSC-BCSCCCCCG
T ss_pred CCcccceEecchhhhhhcCCCc-cccccCCCC
Confidence 6 59999999999875542 234445654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.3e-28 Score=263.27 Aligned_cols=337 Identities=23% Similarity=0.315 Sum_probs=242.6
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|+++++++... +.+..+++|++|||++|+|++. | .|+++++|++|++++|+|++..| ++.+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccccc--cccccccccccc
Confidence 5799999999999753 4688999999999999999964 4 39999999999999999996543 899999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcC---cCC
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGG---TIP 188 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~---~~p 188 (825)
++|.+++..+ ......+..+....|.+....+..................+ ..+...+......... ...
T Consensus 118 ~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 190 (384)
T d2omza2 118 FNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVSDI 190 (384)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCCCC
T ss_pred cccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccccccc
Confidence 9999986543 45667889999999998765554444333333333322222 2233333333333222 233
Q ss_pred ccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCC
Q 003368 189 PSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMK 268 (825)
Q Consensus 189 ~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 268 (825)
.....++.+..+++++|.+++..|. ...++|+.|++++|+++.. ..+..+++|+.|++++|.+.+..+ +..++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~ 263 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITPL---GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 263 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGGG---GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred cccccccccceeeccCCccCCCCcc---cccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccc
Confidence 4556667777778888888754332 2567888888888888753 357788888888888888876553 67778
Q ss_pred CCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCC
Q 003368 269 SLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIP 348 (825)
Q Consensus 269 ~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p 348 (825)
+|+.|+++.|.+... ..+..++.++.+++..|.+++ + ..+..+++++.|++++|++++..
T Consensus 264 ~L~~L~l~~~~l~~~--------~~~~~~~~l~~l~~~~n~l~~----------~-~~~~~~~~l~~L~ls~n~l~~l~- 323 (384)
T d2omza2 264 KLTELKLGANQISNI--------SPLAGLTALTNLELNENQLED----------I-SPISNLKNLTYLTLYFNNISDIS- 323 (384)
T ss_dssp TCSEEECCSSCCCCC--------GGGTTCTTCSEEECCSSCCSC----------C-GGGGGCTTCSEEECCSSCCSCCG-
T ss_pred cCCEeeccCcccCCC--------Ccccccccccccccccccccc----------c-cccchhcccCeEECCCCCCCCCc-
Confidence 888888888777642 235667778888888887763 2 24667777888888888887643
Q ss_pred ccccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCC
Q 003368 349 EEMSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQN 413 (825)
Q Consensus 349 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 413 (825)
.+..+++|++|++++|+|++ ++ .+.++++|++|++++|++++.+| +.++++|+.|+|++|
T Consensus 324 -~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 324 -PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp -GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred -ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 27778888888888888874 33 57778888888888888886654 777888888888776
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=263.06 Aligned_cols=145 Identities=26% Similarity=0.433 Sum_probs=124.3
Q ss_pred ceeccCCeeEEEEEEEc--CCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEEE
Q 003368 649 HLIGIGSFGSVYKGTFD--RDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALVY 724 (825)
Q Consensus 649 ~~ig~G~~g~Vy~~~~~--~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~ 724 (825)
+.||+|+||+||+|.++ .+++.||||+++... ....++|.+|++++++++|||||+++|+|. .+..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEE
Confidence 57999999999999874 345789999997543 233568999999999999999999999863 23468999
Q ss_pred EccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEccc
Q 003368 725 QYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGDF 804 (825)
Q Consensus 725 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~DF 804 (825)
||+++|+|.++++. ...++|.++..|+.|||+||+|||+. +||||||||+|||++.++.+||+||
T Consensus 87 E~~~~g~L~~~l~~------------~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DF 151 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 151 (277)
T ss_dssp ECCTTEEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred EcCCCCcHHHHHhh------------ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccch
Confidence 99999999999853 24689999999999999999999985 8999999999999999999999999
Q ss_pred CcccccccCC
Q 003368 805 GLARLRQEVP 814 (825)
Q Consensus 805 Gla~~~~~~~ 814 (825)
|+|+......
T Consensus 152 Gla~~~~~~~ 161 (277)
T d1xbba_ 152 GLSKALRADE 161 (277)
T ss_dssp TTCEECCTTC
T ss_pred hhhhhccccc
Confidence 9999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=269.17 Aligned_cols=175 Identities=23% Similarity=0.410 Sum_probs=135.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC-----eEEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG-----TIVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.++|+..++||+|+||+||+|++..++ ..||||.+.... ....+.|.+|+++++++ +|||||+++++|.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~---- 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---- 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence 467889999999999999999986544 369999986543 33456799999999998 8999999999964
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCc-----------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTD-----------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIH 783 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivH 783 (825)
+.+..++||||+++|+|.++++........ ........++|.+++.|+.|||+||+|||+. +|||
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 466789999999999999999754321110 0011234689999999999999999999985 9999
Q ss_pred cCCCCCCeeecCCCcEEEcccCcccccccCCCC--CccccccC
Q 003368 784 CDLKPSNILLDNNLTAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 784 rdlk~~NILl~~~~~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
|||||+|||++.++.+||+|||+|+........ ..+..||+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 999999999999999999999999987665432 23344554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-29 Score=266.33 Aligned_cols=162 Identities=23% Similarity=0.380 Sum_probs=139.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhh-cCCCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALR-NIRHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|...++||+|+||+||+|+.+.+|+.||||++++.. ....+.+.+|+.++. .++|||||++++++ .+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 67899999999999999999999999999999997542 233456777777765 68999999999984 4577
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +||||||||+|||+++++.
T Consensus 77 ~~yivmEy~~~g~L~~~i~~------------~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~ 141 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS------------CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGH 141 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH------------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred ceeEEEeecCCCcHHHHhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCc
Confidence 89999999999999999842 24688899999999999999999986 8999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+||+|||+|+.........+...||+
T Consensus 142 ~kl~DFG~a~~~~~~~~~~~~~~gt~ 167 (320)
T d1xjda_ 142 IKIADFGMCKENMLGDAKTNTFCGTP 167 (320)
T ss_dssp EEECCCTTCBCCCCTTCCBCCCCSCG
T ss_pred eeccccchhhhcccccccccccCCCC
Confidence 99999999998766555566667875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=2.2e-29 Score=269.83 Aligned_cols=159 Identities=27% Similarity=0.352 Sum_probs=139.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++++.++|||||++++++ .+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence 57999999999999999999999999999999997542 23356789999999999999999999984 45678
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++||||+.+|+|.+++.. ...+++.++..|+.|+++||+|||+. +||||||||+|||++.++.+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~------------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~i 180 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRR------------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred cccccccccccchhhhHhh------------cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCE
Confidence 8999999999999999842 24689999999999999999999986 89999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+..... ..+.+||+
T Consensus 181 kL~DFG~a~~~~~~---~~~~~Gt~ 202 (350)
T d1rdqe_ 181 QVTDFGFAKRVKGR---TWTLCGTP 202 (350)
T ss_dssp EECCCTTCEECSSC---BCCCEECG
T ss_pred Eeeeceeeeecccc---cccccCcc
Confidence 99999999986543 34566775
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=2.9e-29 Score=270.35 Aligned_cols=161 Identities=23% Similarity=0.281 Sum_probs=135.4
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHH---HHHHHhhcCCCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFA---AECRALRNIRHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~ 715 (825)
.++|+..++||+|+||+||+|+...+|+.||||++..... .....+. +|+++++.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 3679999999999999999999999999999999975321 2223333 457778888999999999984 4
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
+++..|+||||+++|+|.+++.. ...+++.++..|+.||+.||+|||+. +||||||||+|||+++
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~------------~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~ 142 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ------------HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE 142 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH------------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECS
T ss_pred ECCEEEEEEEecCCCcHHHHHHh------------cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcC
Confidence 56789999999999999999842 24678999999999999999999985 9999999999999999
Q ss_pred CCcEEEcccCcccccccCCCCCccccccC
Q 003368 796 NLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.+||+|||+|+..... .....+||+
T Consensus 143 ~g~iKl~DFGla~~~~~~--~~~~~~GT~ 169 (364)
T d1omwa3 143 HGHVRISDLGLACDFSKK--KPHASVGTH 169 (364)
T ss_dssp SSCEEECCCTTCEECSSS--CCCSCCSCG
T ss_pred CCcEEEeeeceeeecCCC--ccccccccc
Confidence 999999999999977554 234556775
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.7e-29 Score=265.66 Aligned_cols=163 Identities=25% Similarity=0.463 Sum_probs=136.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||++++++ ++++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 689999999999999999999999999999999965432 2356899999999999999999999985 456789
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
|+||||+.++ +.+++.. .....+++.++..++.|++.||+|||+. +||||||||+|||++.++.+|
T Consensus 77 ~iv~e~~~~~-~~~~~~~----------~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 77 YLVFEFLHQD-LKKFMDA----------SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp EEEEECCSEE-HHHHHHH----------TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred eEEEeecCCc-hhhhhhh----------hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcce
Confidence 9999999765 4444421 1234689999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+............+||+
T Consensus 143 l~DFG~a~~~~~~~~~~~~~~gt~ 166 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRTYTHEVVTL 166 (298)
T ss_dssp ECSTTHHHHHCCCSBCTTCCBCCC
T ss_pred eccCCcceeccCCcccceeecccc
Confidence 999999998866555555567775
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-29 Score=265.30 Aligned_cols=162 Identities=20% Similarity=0.286 Sum_probs=137.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|...+.||+|+||+||+|+++.+|+.||||.++.... ....+.+|++++++++|||||+++++ +++++..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-----FESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence 4678899999999999999999999999999999976532 34568899999999999999999998 45577899
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--CcE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN--LTA 799 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~--~~~ 799 (825)
+|||||++|+|.+++... ...+++.++..|+.|+++||+|||+. +|+||||||+|||++.+ ..+
T Consensus 78 lvmE~~~gg~L~~~i~~~-----------~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~i 143 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-----------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI 143 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-----------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred EEEecCCCCcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEE
Confidence 999999999999999532 13589999999999999999999985 99999999999999854 589
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
||+|||+|+...... ...+..||+
T Consensus 144 kl~DFG~~~~~~~~~-~~~~~~~t~ 167 (321)
T d1tkia_ 144 KIIEFGQARQLKPGD-NFRLLFTAP 167 (321)
T ss_dssp EECCCTTCEECCTTC-EEEEEESCG
T ss_pred EEcccchhhccccCC-ccccccccc
Confidence 999999999875432 234445554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.6e-29 Score=264.58 Aligned_cols=169 Identities=25% Similarity=0.418 Sum_probs=137.6
Q ss_pred HHHhhcccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccch-hHHHHHHHHHHhhcCCCCCceeEeeccc
Q 003368 637 SLLKATDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQG-ASKSFAAECRALRNIRHRNLVRVITSCS 710 (825)
Q Consensus 637 ~~~~~~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~ 710 (825)
+++...++|+..+.||+|+||+||+|+++ .+++.||||+++..... ..++|.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34456678999999999999999999974 35689999999765433 3567999999999999999999999964
Q ss_pred ccccCCCCeeeEEEEccCCCChhhhccCCCCCCC------------cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003368 711 SIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQT------------DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQ 778 (825)
Q Consensus 711 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~ 778 (825)
. .+..++||||+++|+|.++++....... .........++|.++..|+.|+|.||+|||+.
T Consensus 87 ~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 87 V-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred c-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 3 5678999999999999999964321000 00112234689999999999999999999985
Q ss_pred CCeeecCCCCCCeeecCCCcEEEcccCcccccccC
Q 003368 779 EPTIHCDLKPSNILLDNNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 779 ~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~~~~ 813 (825)
+||||||||+|||+|.++.+||+|||+|+.+.+.
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~ 193 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCC
Confidence 9999999999999999999999999999977554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-29 Score=262.30 Aligned_cols=165 Identities=28% Similarity=0.372 Sum_probs=130.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
++|...+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++++|.... ......++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 3567788999999999999997 689999999865422 2223345566667889999999999986521 22236799
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCC
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC-----QEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~-----~~~ivHrdlk~~NILl~~~~ 797 (825)
|||||++|+|.++++. ..++|.++.+++.|+|.||+|+|+.+ .++||||||||+|||++.++
T Consensus 79 v~Ey~~~g~L~~~l~~-------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred EEecccCCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 9999999999999953 25899999999999999999999741 36899999999999999999
Q ss_pred cEEEcccCcccccccCCC----CCccccccC
Q 003368 798 TAHVGDFGLARLRQEVPN----NQSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~----~~~~~~gt~ 824 (825)
.+||+|||+|+....... .....+||+
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~ 176 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCG
T ss_pred CeEEEecCccccccCCCcceeccccceeccc
Confidence 999999999998865432 223446665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.9e-29 Score=264.34 Aligned_cols=158 Identities=26% Similarity=0.369 Sum_probs=131.6
Q ss_pred ccceeccCCeeEEEEEEEcCCCeEEEEEEeecccch-----hHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 647 STHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQG-----ASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 647 ~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
..++||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|++++++++|||||++++++ ..++..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 357899999999999999899999999999754321 134688999999999999999999985 4467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|++..+.... ..+++.++..++.|++.||+|||+. +||||||||+|||+++++.+||
T Consensus 77 ivmE~~~~~~~~~~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL 141 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS------------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKL 141 (299)
T ss_dssp EEEECCSEEHHHHHTTCC------------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred ehhhhhcchHHhhhhhcc------------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccc
Confidence 999999998877665322 3577788999999999999999985 9999999999999999999999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||+|+...+......+.+||+
T Consensus 142 ~DFG~a~~~~~~~~~~~~~~gt~ 164 (299)
T d1ua2a_ 142 ADFGLAKSFGSPNRAYTHQVVTR 164 (299)
T ss_dssp CCCGGGSTTTSCCCCCCCSCCCC
T ss_pred ccCccccccCCCcccccceecCh
Confidence 99999998776655555667776
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.1e-29 Score=264.23 Aligned_cols=162 Identities=25% Similarity=0.442 Sum_probs=131.1
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe----EEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT----IVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
++|+..++||+|+||+||+|++..+|+ .||||+++... ....++|.+|++++++++|||||+++|+|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------ 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 469999999999999999999987776 58888886443 3456789999999999999999999999753
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++|+||+.+|+|.+++.. ....++|..+.+|+.|||+||+|||+. +||||||||+|||++.++
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~ 148 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVRE-----------HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 148 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHH-----------TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred CCeeEEEEeccCCcccccccc-----------cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCC
Confidence 346889999999999988742 234689999999999999999999985 899999999999999999
Q ss_pred cEEEcccCcccccccCCCC--CccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNN--QSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~--~~~~~gt~ 824 (825)
.+||+|||+|+........ ....+||+
T Consensus 149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 149 HVKITDFGLAKLLGAEEKEYHAEGGKVPI 177 (317)
T ss_dssp EEEECCCSHHHHTTTTCC--------CCT
T ss_pred CeEeeccccceecccccccccccccccCc
Confidence 9999999999987655433 22335664
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.9e-29 Score=255.29 Aligned_cols=151 Identities=28% Similarity=0.466 Sum_probs=125.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
.++|+..+.||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.. +.+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 45688889999999999999998 5789999999754 345789999999999999999999998743 345579
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHV 801 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki 801 (825)
+||||+++|+|.++++. .....++|..+++|+.|||.||+|||+. +||||||||+|||++.++.+|+
T Consensus 78 lv~ey~~~g~L~~~l~~----------~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl 144 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRS----------RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 144 (262)
T ss_dssp EEECCCTTEEHHHHHHH----------HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred EEEeccCCCCHHHHHHh----------cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEee
Confidence 99999999999999952 2234689999999999999999999985 9999999999999999999999
Q ss_pred cccCcccccccC
Q 003368 802 GDFGLARLRQEV 813 (825)
Q Consensus 802 ~DFGla~~~~~~ 813 (825)
+|||+++.....
T Consensus 145 ~dfg~s~~~~~~ 156 (262)
T d1byga_ 145 SDFGLTKEASST 156 (262)
T ss_dssp CCCCC-------
T ss_pred cccccceecCCC
Confidence 999999976543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-28 Score=259.27 Aligned_cols=178 Identities=25% Similarity=0.343 Sum_probs=130.1
Q ss_pred hhcccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 640 KATDGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 640 ~~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
...++|+..+.||+|+||+||+|++.. +++.||||+++.... ...+.+.+|++.+.++ +|+|||+++++|..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~- 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-
Confidence 344679999999999999999999743 457899999975433 3456788888888877 68999999998643
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCC----cccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQT----DEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
.+...++|||||++|+|.++++....... .........++|.++..|+.|||+||+|||+. +||||||||
T Consensus 89 ---~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 89 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ---TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred ---CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 34568999999999999999964321000 00011234689999999999999999999985 899999999
Q ss_pred CCeeecCCCcEEEcccCcccccccCCC--CCccccccC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEVPN--NQSSSVGDL 824 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~~~--~~~~~~gt~ 824 (825)
+|||+++++.+||+|||+|+....... ...+.+||+
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 999999999999999999998765443 234456775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-28 Score=257.96 Aligned_cols=149 Identities=30% Similarity=0.508 Sum_probs=127.1
Q ss_pred cceeccCCeeEEEEEEEcCCC---eEEEEEEeecc-cchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeEE
Q 003368 648 THLIGIGSFGSVYKGTFDRDG---TIVAIKVLNLQ-LQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKALV 723 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv 723 (825)
.++||+|+||+||+|++..++ ..||||+++.. .....++|.+|++++++++|||||+++|+|.. .+...++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence 478999999999999985533 46999999754 33445789999999999999999999999753 34578999
Q ss_pred EEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEEEcc
Q 003368 724 YQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAHVGD 803 (825)
Q Consensus 724 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ki~D 803 (825)
||||++|+|.++++.. ....+|.++++++.|+|+||.|+|+. +|+||||||+|||+|+++.+||+|
T Consensus 108 ~E~~~~g~l~~~~~~~-----------~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~D 173 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-----------THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVAD 173 (311)
T ss_dssp EECCTTCBHHHHHHCT-----------TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred EEEeecCchhhhhccc-----------cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEec
Confidence 9999999999998533 23577889999999999999999985 899999999999999999999999
Q ss_pred cCcccccccCC
Q 003368 804 FGLARLRQEVP 814 (825)
Q Consensus 804 FGla~~~~~~~ 814 (825)
||+|+......
T Consensus 174 FG~~~~~~~~~ 184 (311)
T d1r0pa_ 174 FGLARDMYDKE 184 (311)
T ss_dssp SGGGCCTTTTT
T ss_pred ccchhhccccc
Confidence 99999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.8e-28 Score=254.39 Aligned_cols=163 Identities=24% Similarity=0.374 Sum_probs=124.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCC---CeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD---GTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~ 717 (825)
.++|+..+.||+|+||+||+|++..+ +..||||.++.... ...+.|.+|++++++++|||||+++++|. +
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 45788999999999999999998543 45799999865433 34567999999999999999999999863 3
Q ss_pred CeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 003368 718 DFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL 797 (825)
Q Consensus 718 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~ 797 (825)
+..++||||+++|++.+++.. ....++|.++..++.|+++||+|||+. +||||||||+||++++++
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~-----------~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQV-----------RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 145 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHH-----------TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred CeEEEEEEeccCCcHHhhhhc-----------cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCC
Confidence 467999999999999998742 224689999999999999999999995 999999999999999999
Q ss_pred cEEEcccCcccccccCCCC-CccccccC
Q 003368 798 TAHVGDFGLARLRQEVPNN-QSSSVGDL 824 (825)
Q Consensus 798 ~~ki~DFGla~~~~~~~~~-~~~~~gt~ 824 (825)
.+||+|||+|+........ .+...||+
T Consensus 146 ~~Kl~DfG~a~~~~~~~~~~~~~~~gt~ 173 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDSTYYKASKGKLPI 173 (273)
T ss_dssp EEEECC-------------------CCG
T ss_pred cEEEccchhheeccCCcceeccceecCc
Confidence 9999999999987654332 33334553
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=3.3e-28 Score=253.02 Aligned_cols=166 Identities=24% Similarity=0.363 Sum_probs=133.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc---hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ---GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
++|+..+.||+|+||+||+|++..+|+.||||+++.... ...+.|.+|++++++++|||||++++++... ......
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~-~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE-TPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-CSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec-cCCCce
Confidence 569999999999999999999989999999999975432 3345799999999999999999999986541 112235
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+++|+|.+++. ....++|.++..|+.|++.||+|||+. +||||||||+|||++.++.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~------------~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH------------TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEEEEECCCEEEHHHHHH------------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCE
T ss_pred EEEEEECCCCCEehhhhc------------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccc
Confidence 789999999999998873 234789999999999999999999985 99999999999999999999
Q ss_pred EEcccCcccccccCCC---CCccccccC
Q 003368 800 HVGDFGLARLRQEVPN---NQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~---~~~~~~gt~ 824 (825)
+++|||.++....... ...+.+||+
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTA 178 (277)
T ss_dssp EECCCTTCEECC----------------
T ss_pred eeehhhhhhhhccccccccccccccCcc
Confidence 9999999987644332 234456775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.3e-28 Score=259.64 Aligned_cols=165 Identities=25% Similarity=0.405 Sum_probs=134.8
Q ss_pred hcccccccceeccCCeeEEEEEEEcC-----CCeEEEEEEeecccc-hhHHHHHHHHHHhhcCCCCCceeEeeccccccc
Q 003368 641 ATDGFSSTHLIGIGSFGSVYKGTFDR-----DGTIVAIKVLNLQLQ-GASKSFAAECRALRNIRHRNLVRVITSCSSIDF 714 (825)
Q Consensus 641 ~~~~f~~~~~ig~G~~g~Vy~~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 714 (825)
..++|...+.||+|+||+||+|+++. +++.||||+++.... .....|.+|++++++++|||||+++++|.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~---- 93 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 93 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe----
Confidence 34678889999999999999999842 357899999975433 33457999999999999999999999964
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
.++..++||||+++|+|.++++..... .........++|.++.+|+.|+|+||+|||+. +||||||||+|||+|
T Consensus 94 -~~~~~~lv~e~~~~g~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 94 -QGQPTLVIMELMTRGDLKSYLRSLRPA--MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167 (308)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHHHHH--HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred -cCCceeEEEeecCCCCHHHHHHhcccc--cccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeec
Confidence 356789999999999999998532000 00001123579999999999999999999985 899999999999999
Q ss_pred CCCcEEEcccCcccccccCCC
Q 003368 795 NNLTAHVGDFGLARLRQEVPN 815 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~~~ 815 (825)
+++.+||+|||+|+...+...
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDY 188 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGC
T ss_pred CCceEEEeecccceeccCCcc
Confidence 999999999999998766543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=2.2e-28 Score=255.91 Aligned_cols=161 Identities=23% Similarity=0.368 Sum_probs=132.5
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||+||+|++ .+|+.||||+++.... ...+.+.+|+.++++++|||||++++++ ..++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 5789999999999999999998 5889999999976432 2357899999999999999999999985 446778
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++||||+.++.+..+... ...+++.++..|+.||+.||+|||+. +||||||||+|||++.++.+|
T Consensus 76 ~i~~e~~~~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~k 140 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK 140 (286)
T ss_dssp EEEEECCSEEHHHHHHTS------------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred eEEEEeehhhhHHHHHhh------------cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEE
Confidence 999999988777666532 24689999999999999999999985 899999999999999999999
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++|||.|.............+||+
T Consensus 141 l~DfG~a~~~~~~~~~~~~~~~~~ 164 (286)
T d1ob3a_ 141 IADFGLARAFGIPVRKYTHEIVTL 164 (286)
T ss_dssp ECCTTHHHHHCC---------CCC
T ss_pred ecccccceecccCccccceecccc
Confidence 999999998766544444445554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3e-28 Score=257.22 Aligned_cols=163 Identities=31% Similarity=0.532 Sum_probs=132.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCe--EEEEEEeeccc-chhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGT--IVAIKVLNLQL-QGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGND 718 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~ 718 (825)
++|+..++||+|+||+||+|+++.+|. .||||+++... ....++|.+|+++++++ +|||||+++|+|.. ++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence 568889999999999999999987876 47788876443 33456799999999998 79999999999753 66
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD 794 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~ 794 (825)
..++||||+++|+|.++++........ ........++|.++.+++.|||+|+.|+|+. +||||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 789999999999999999653110000 0012235799999999999999999999985 999999999999999
Q ss_pred CCCcEEEcccCcccccccC
Q 003368 795 NNLTAHVGDFGLARLRQEV 813 (825)
Q Consensus 795 ~~~~~ki~DFGla~~~~~~ 813 (825)
.++.+||+|||+|+.....
T Consensus 162 ~~~~~kl~DfG~a~~~~~~ 180 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY 180 (309)
T ss_dssp GGGCEEECCTTCEESSCEE
T ss_pred CCCceEEcccccccccccc
Confidence 9999999999999876544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.2e-28 Score=258.27 Aligned_cols=163 Identities=21% Similarity=0.319 Sum_probs=133.7
Q ss_pred ccccccc-ceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcC-CCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSST-HLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNI-RHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~-~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|... ++||+|+||+||+|++..+|+.||||+++.. +.+.+|++++.++ +|||||++++++... +..+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 3578765 5699999999999999999999999998643 4577899987654 899999999985321 223456
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---C
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN---N 796 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~---~ 796 (825)
.|+|||||+||+|.+++... ....+++.++..|+.|++.||+|||+. +|+||||||+|||+++ +
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~----------~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC----------SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTT
T ss_pred EEEEEECCCCCcHHHHHHhc----------CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccc
Confidence 89999999999999999532 124689999999999999999999985 9999999999999975 5
Q ss_pred CcEEEcccCcccccccCCCCCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+.+||+|||+|+...... ...+.+||+
T Consensus 151 ~~~Kl~DFG~a~~~~~~~-~~~~~~gt~ 177 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSHN-SLTTPCYTP 177 (335)
T ss_dssp CCEEECCCTTCEECCCCC-CCCCCSCCC
T ss_pred ccccccccceeeeccCCC-ccccccCCc
Confidence 679999999999876543 345567776
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=251.70 Aligned_cols=153 Identities=31% Similarity=0.450 Sum_probs=123.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCC-C--eEEEEEEeeccc---chhHHHHHHHHHHhhcCCCCCceeEeecccccccCC
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRD-G--TIVAIKVLNLQL---QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~-g--~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 716 (825)
++|+..+.||+|+||+||+|++..+ + ..||||++.... ....++|.+|++++++++|||||+++|+|..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 5688899999999999999987433 2 479999987542 3345689999999999999999999998742
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
...++||||+++|++.+++. .....++|.+++.++.|+|+||+|||+. +|+||||||+||+++.+
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~-----------~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~ 147 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLR-----------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR 147 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHH-----------HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET
T ss_pred -cchheeeeeecCcchhhhhh-----------cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccc
Confidence 34689999999999998874 2335699999999999999999999985 89999999999999999
Q ss_pred CcEEEcccCcccccccCCC
Q 003368 797 LTAHVGDFGLARLRQEVPN 815 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~ 815 (825)
+.+||+|||+|+.......
T Consensus 148 ~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp TEEEECCCTTCEECCC-CC
T ss_pred cceeeccchhhhhcccCCC
Confidence 9999999999998765543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=1.8e-26 Score=243.89 Aligned_cols=199 Identities=22% Similarity=0.341 Sum_probs=131.0
Q ss_pred ceeeceeecCCCCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcC
Q 003368 20 CDWEGITCSPRHRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGN 99 (825)
Q Consensus 20 C~~~g~~c~~~~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 99 (825)
|.|+++.|.. +++. .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|.++...|..
T Consensus 10 c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 6677777753 4444 5566653 67899999999998666678999999999999999999888888
Q ss_pred CCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcc--cCCcccccccc
Q 003368 100 LSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGG--NIPSSLGQLKE 177 (825)
Q Consensus 100 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~ 177 (825)
|.++++|+.|++++|+|+. +|..+ ...|+.|++++|.+.+..+..+.....++.++...|.... ..+..|..+++
T Consensus 75 f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~ 151 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151 (305)
T ss_dssp TTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT
T ss_pred hhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccc
Confidence 9999999999999999885 44432 3467888888888887766677777778888887776532 22333444444
Q ss_pred cceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 178 LKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 178 L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
|+.+ ++++|.++ .+|... .++|+.|++++|.+++..+..|..++.++.|++++|.+.
T Consensus 152 L~~l-------------------~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~ 208 (305)
T d1xkua_ 152 LSYI-------------------RIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208 (305)
T ss_dssp CCEE-------------------ECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred cCcc-------------------ccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccc
Confidence 4333 44444443 333332 345555555555555555555555555555555555444
Q ss_pred Cc
Q 003368 258 GK 259 (825)
Q Consensus 258 ~~ 259 (825)
+.
T Consensus 209 ~~ 210 (305)
T d1xkua_ 209 AV 210 (305)
T ss_dssp EE
T ss_pred cc
Confidence 33
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4.7e-26 Score=240.59 Aligned_cols=113 Identities=27% Similarity=0.389 Sum_probs=73.8
Q ss_pred ccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEEEccccccccccCcc
Q 003368 295 ANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFLNMRHNQLSGEIPSS 374 (825)
Q Consensus 295 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 374 (825)
..+++|+.+++++|.++ .+|..+ .++|+.|++++|.+++..+..|.+++.+++|++++|.+.+..+.+
T Consensus 147 ~~l~~L~~l~l~~n~l~----------~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~ 214 (305)
T d1xkua_ 147 QGMKKLSYIRIADTNIT----------TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214 (305)
T ss_dssp GGCTTCCEEECCSSCCC----------SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccccccCccccccCCcc----------ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccc
Confidence 34445555555555554 233222 345666677777776666777777777777777777777666777
Q ss_pred ccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccch
Q 003368 375 FGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIPE 421 (825)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip~ 421 (825)
|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+++ .++.
T Consensus 215 ~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~ 259 (305)
T d1xkua_ 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 259 (305)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCT
T ss_pred ccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccCh
Confidence 777777777777777776 45667777777777777777776 4444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.6e-28 Score=250.36 Aligned_cols=160 Identities=24% Similarity=0.274 Sum_probs=133.3
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------hhHHHHHHHHHHhhcCC--CCCceeEeeccccccc
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------GASKSFAAECRALRNIR--HRNLVRVITSCSSIDF 714 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 714 (825)
++|+..++||+|+||+||+|+...+|+.||||+++.... ...+.+.+|++++++++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 468889999999999999999999999999999975421 11234678999999987 89999999984
Q ss_pred CCCCeeeEEEEccCC-CChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 715 QGNDFKALVYQYMPN-GSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.+++..++||||+.+ +++.+++. ....+++.++..++.|+++||+|||+. +||||||||+|||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~------------~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll 143 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFIT------------ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILI 143 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH------------HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred eeCCeEEEEEEeccCcchHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEE
Confidence 456789999999986 57777763 234689999999999999999999985 99999999999999
Q ss_pred cC-CCcEEEcccCcccccccCCCCCccccccC
Q 003368 794 DN-NLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 794 ~~-~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+. ++.+||+|||+|+..... ..++.+||+
T Consensus 144 ~~~~~~vkl~DFG~a~~~~~~--~~~~~~GT~ 173 (273)
T d1xwsa_ 144 DLNRGELKLIDFGSGALLKDT--VYTDFDGTR 173 (273)
T ss_dssp ETTTTEEEECCCTTCEECCSS--CBCCCCSCG
T ss_pred ecCCCeEEECccccceecccc--cccccccCC
Confidence 85 479999999999976543 345567775
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.6e-27 Score=251.85 Aligned_cols=175 Identities=25% Similarity=0.352 Sum_probs=139.3
Q ss_pred cccccccceeccCCeeEEEEEEEc-----CCCeEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFD-----RDGTIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSIDF 714 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 714 (825)
.++|+..++||+|+||.||+|+++ .+++.||||+++.... ....+|.+|+++++++ +|||||+++++|..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 467888999999999999999863 4668999999976543 3456799999999999 69999999999743
Q ss_pred CCCCeeeEEEEccCCCChhhhccCCCCCCCc------ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 715 QGNDFKALVYQYMPNGSLENWLHPDAIPQTD------EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 715 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
++..++||||+++|+|.++++........ ........++|.++..|+.|||+|++|||+. +||||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 56789999999999999999754211100 0112334699999999999999999999986 899999999
Q ss_pred CCeeecCCCcEEEcccCcccccccCCCCC--ccccccC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEVPNNQ--SSSVGDL 824 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~~~~~--~~~~gt~ 824 (825)
+||+++.++.+|++|||+|+......... ....||+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 99999999999999999999886654332 2235554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=255.23 Aligned_cols=166 Identities=22% Similarity=0.284 Sum_probs=133.5
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-chhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-QGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++.|...+.||+|+||+||+|+...+|+.||||+++... ....+.+.+|++++++++|||||+++++|....+.....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~- 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD- 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC-
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce-
Confidence 456899999999999999999998999999999997543 334567899999999999999999999986543333333
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
+++++|+.+|+|.+++.. ..+++.++..++.|++.||+|||+. +||||||||+|||++.++.+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~-------------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~k 149 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 149 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEEeecCCchhhhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEE
Confidence 444566779999999842 2589999999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCC---CCccccccC
Q 003368 801 VGDFGLARLRQEVPN---NQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~---~~~~~~gt~ 824 (825)
|+|||+|+....... .....+||+
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~gt~ 176 (345)
T d1pmea_ 150 ICDFGLARVADPDHDHTGFLTEYVATR 176 (345)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCG
T ss_pred EcccCceeeccCCCccceeeccccccc
Confidence 999999997654422 123445554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2e-27 Score=255.65 Aligned_cols=164 Identities=26% Similarity=0.355 Sum_probs=130.6
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCCeeeE
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGNDFKAL 722 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~~l 722 (825)
+|+..++||+|+||+||+|++..+|+.||||++..... .+.+|++++++++|||||++++++.... ..+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 47888999999999999999999999999999976532 2347999999999999999999875421 133456789
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cEEE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TAHV 801 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~ki 801 (825)
||||+++|.+....+. ......+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+||
T Consensus 97 v~Ey~~~~~~~~l~~~---------~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHY---------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp EEECCSEEHHHHHHHH---------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEE
T ss_pred EEeccCCccHHHHHhh---------hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeE
Confidence 9999987644433321 12234689999999999999999999985 999999999999999775 8999
Q ss_pred cccCcccccccCCCCCccccccC
Q 003368 802 GDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 802 ~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|||+|+...... ...+.+||+
T Consensus 165 ~DFG~a~~~~~~~-~~~~~~gt~ 186 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE-PNVSYICSR 186 (350)
T ss_dssp CCCTTCEECCTTS-CCCSCCSCT
T ss_pred ecccchhhccCCc-ccccccccc
Confidence 9999999875543 234455654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=5.2e-27 Score=250.45 Aligned_cols=157 Identities=22% Similarity=0.354 Sum_probs=132.9
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||+||+|+...+|+.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ......+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence 5799999999999999999999999999999998753 3467889999999996 9999999998642 2345689
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-cEE
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNL-TAH 800 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~-~~k 800 (825)
+||||+++|+|..+. +.+++.++..|+.||+.||+|||+. +||||||||+|||++.++ .+|
T Consensus 109 ~v~e~~~~~~L~~~~---------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vk 170 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLR 170 (328)
T ss_dssp EEEECCCSCBGGGTT---------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEEeecCCCcHHHHh---------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeee
Confidence 999999999997664 2578899999999999999999986 999999999999998655 699
Q ss_pred EcccCcccccccCCCCCccccccC
Q 003368 801 VGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 801 i~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|+|||+|+...... .....+||+
T Consensus 171 l~DFG~a~~~~~~~-~~~~~~~t~ 193 (328)
T d3bqca1 171 LIDWGLAEFYHPGQ-EYNVRVASR 193 (328)
T ss_dssp ECCGGGCEECCTTC-CCCSCCSCG
T ss_pred ecccccceeccCCC-cccccccCc
Confidence 99999999876543 234445553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.6e-27 Score=246.80 Aligned_cols=154 Identities=24% Similarity=0.363 Sum_probs=135.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFK 720 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~ 720 (825)
++|+..+.||+|+||+||+|++..+|+.||||+++.... ...+++.+|++++++++|||||+++++|. +.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 578999999999999999999999999999999975432 34578999999999999999999999854 46788
Q ss_pred eEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcEE
Q 003368 721 ALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTAH 800 (825)
Q Consensus 721 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~k 800 (825)
++|+||+.++++..++.. .+.+++..+..++.|+++||+|||+. +||||||||+|||++.++.+|
T Consensus 77 ~iv~~~~~~~~l~~~~~~------------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSC------------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEEECCSEEHHHHHHHT------------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred eEEeeecccccccccccc------------ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCcee
Confidence 999999999999887743 24678899999999999999999986 999999999999999999999
Q ss_pred EcccCcccccccCCCC
Q 003368 801 VGDFGLARLRQEVPNN 816 (825)
Q Consensus 801 i~DFGla~~~~~~~~~ 816 (825)
|+|||.|+........
T Consensus 142 l~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 142 LANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCCTTCEECCSCCSC
T ss_pred eeecchhhcccCCCcc
Confidence 9999999987665443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.9e-27 Score=246.60 Aligned_cols=165 Identities=24% Similarity=0.419 Sum_probs=129.7
Q ss_pred cccccccceeccCCeeEEEEEEEcCCC-------eEEEEEEeecccc-hhHHHHHHHHHHhhcC-CCCCceeEeeccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDG-------TIVAIKVLNLQLQ-GASKSFAAECRALRNI-RHRNLVRVITSCSSI 712 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g-------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 712 (825)
.++|...+.||+|+||.||+|+...++ ..||||+++.... ....++.+|+..+.++ +|||||+++++|..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 357888999999999999999975443 4799999976554 3457889999999888 79999999999743
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCc----ccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTD----EENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKP 788 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~ 788 (825)
++..++||||+++|+|.+++......... ........++|.+++.++.|+|+||+|||+. +||||||||
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 56789999999999999999754321100 0112235689999999999999999999996 999999999
Q ss_pred CCeeecCCCcEEEcccCcccccccCC
Q 003368 789 SNILLDNNLTAHVGDFGLARLRQEVP 814 (825)
Q Consensus 789 ~NILl~~~~~~ki~DFGla~~~~~~~ 814 (825)
+|||++.++.+||+|||+++......
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~ 189 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHID 189 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCC
T ss_pred cceeecCCCCeEeccchhhccccccc
Confidence 99999999999999999999886654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.3e-27 Score=246.30 Aligned_cols=168 Identities=26% Similarity=0.386 Sum_probs=134.3
Q ss_pred cccccccceeccCCeeEEEEEEEcCC-CeEEEEEEeecccc--hhHHHHHHHHHHhhcC---CCCCceeEeecccccccC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRD-GTIVAIKVLNLQLQ--GASKSFAAECRALRNI---RHRNLVRVITSCSSIDFQ 715 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~-g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~ 715 (825)
.++|+..+.||+|+||+||+|++..+ ++.||||+++.... .....+.+|+++++.+ +|||||+++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46799999999999999999998655 67899999975432 2233566777776665 799999999997654344
Q ss_pred CCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 003368 716 GNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN 795 (825)
Q Consensus 716 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~ 795 (825)
.....++||||+.+|.+...... ....+++..+..++.|++.||+|||+. +||||||||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-----------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS 151 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-----------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred cCceEEEEEEeccCCchhhhhhc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcC
Confidence 55678999999998877654422 224688999999999999999999986 8999999999999999
Q ss_pred CCcEEEcccCcccccccCCCCCccccccC
Q 003368 796 NLTAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 796 ~~~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.+||+|||+++..... ....+.+||+
T Consensus 152 ~~~~kl~dfg~~~~~~~~-~~~~~~~gT~ 179 (305)
T d1blxa_ 152 SGQIKLADFGLARIYSFQ-MALTSVVVTL 179 (305)
T ss_dssp TCCEEECSCCSCCCCCGG-GGGCCCCCCC
T ss_pred CCCeeecchhhhhhhccc-ccCCCcccCh
Confidence 999999999999976543 2345567776
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.2e-26 Score=249.30 Aligned_cols=163 Identities=24% Similarity=0.333 Sum_probs=128.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc-cCCCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID-FQGND 718 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~ 718 (825)
.+.|+..+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.... .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467899999999999999999998999999999997543 233567899999999999999999999875422 12233
Q ss_pred eeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 003368 719 FKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLT 798 (825)
Q Consensus 719 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~ 798 (825)
..|+||||+ +++|..+.. ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-------------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-------------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-------------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred eEEEEEecc-cccHHHHHH-------------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccc
Confidence 579999999 556766652 23689999999999999999999986 9999999999999999999
Q ss_pred EEEcccCcccccccCCCCCccccccC
Q 003368 799 AHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 799 ~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
+|++|||+|+..... .+..+||+
T Consensus 160 ~kl~Dfg~a~~~~~~---~~~~~~t~ 182 (346)
T d1cm8a_ 160 LKILDFGLARQADSE---MTGYVVTR 182 (346)
T ss_dssp EEECCCTTCEECCSS---CCSSCSCG
T ss_pred cccccccceeccCCc---cccccccc
Confidence 999999999986543 23445553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.9e-26 Score=237.72 Aligned_cols=221 Identities=22% Similarity=0.249 Sum_probs=169.0
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC-CCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG-RNK 115 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~ 115 (825)
++.++.++. .+|..+. +.+++|+|++|+|+.+.+.+|.++++|++||+++|+|..+.+..+..+..++.++.. .|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 456666665 5566553 578999999999997777889999999999999999999999999999999998765 777
Q ss_pred CCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCC
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLS 195 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~ 195 (825)
++.+.|..|.++++|++|++++|.+....+..+...++|+.+++++|+|++..+..|..+++|+.|
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L-------------- 158 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL-------------- 158 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE--------------
T ss_pred cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhc--------------
Confidence 887778899999999999999999987788888899999999999999987666777666666666
Q ss_pred CCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEc
Q 003368 196 LLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNV 275 (825)
Q Consensus 196 ~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 275 (825)
++++|+++ .+|+..+..+++|+++++++|+++++.|..|.++++|++|++++|++.+..+..|+.+++|+++++
T Consensus 159 -----~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l 232 (284)
T d1ozna_ 159 -----FLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (284)
T ss_dssp -----ECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred -----ccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEe
Confidence 56666666 344444446777777777777777766777777777777777777776665555555555554444
Q ss_pred ccccC
Q 003368 276 AINNL 280 (825)
Q Consensus 276 s~N~l 280 (825)
++|.+
T Consensus 233 ~~N~l 237 (284)
T d1ozna_ 233 NDNPW 237 (284)
T ss_dssp CSSCE
T ss_pred cCCCC
Confidence 44444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.5e-26 Score=242.87 Aligned_cols=156 Identities=24% Similarity=0.385 Sum_probs=127.6
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeecccccc---cCC
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSID---FQG 716 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~ 716 (825)
.++|+..+.||+|+||+||+|++..+|+.||||++.... ....+++.+|++++++++||||+++++++.... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367999999999999999999998999999999986542 234567899999999999999999999875421 122
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNN 796 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~ 796 (825)
+...++||||++++.+..+... ...++..++..|+.|++.||+|||+. +||||||||+|||++++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~------------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~ 153 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV------------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRD 153 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT------------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred CceEEEEEeccCCCccchhhhc------------ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCC
Confidence 4567999999998877655432 23578888999999999999999985 99999999999999999
Q ss_pred CcEEEcccCccccccc
Q 003368 797 LTAHVGDFGLARLRQE 812 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~ 812 (825)
+.+||+|||+|+....
T Consensus 154 ~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 154 GVLKLADFGLARAFSL 169 (318)
T ss_dssp SCEEECCCTTCEECCC
T ss_pred CcEEeeecceeeeccc
Confidence 9999999999987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-26 Score=246.11 Aligned_cols=163 Identities=25% Similarity=0.320 Sum_probs=135.2
Q ss_pred cccccccceeccCCeeEEEEEEE---cCCCeEEEEEEeeccc----chhHHHHHHHHHHhhcCCC-CCceeEeecccccc
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTF---DRDGTIVAIKVLNLQL----QGASKSFAAECRALRNIRH-RNLVRVITSCSSID 713 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~---~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~ 713 (825)
.++|+..+.||+|+||+||+|+. +.+|+.||||+++... ....+.+.+|++++++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~---- 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF---- 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE----
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee----
Confidence 36799999999999999999987 4468999999986542 1234568899999999977 8999999884
Q ss_pred cCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 003368 714 FQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILL 793 (825)
Q Consensus 714 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl 793 (825)
.+....++||||+.+|+|.+++.. ...++......++.|++.|++|+|+. +||||||||+|||+
T Consensus 99 -~~~~~~~~v~e~~~~~~L~~~i~~------------~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill 162 (322)
T d1vzoa_ 99 -QTETKLHLILDYINGGELFTHLSQ------------RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILL 162 (322)
T ss_dssp -EETTEEEEEECCCCSCBHHHHHHH------------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred -ccCCceeeeeecccccHHHHHHHh------------cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceee
Confidence 446789999999999999999842 24567788899999999999999985 89999999999999
Q ss_pred cCCCcEEEcccCcccccccCCC-CCccccccC
Q 003368 794 DNNLTAHVGDFGLARLRQEVPN-NQSSSVGDL 824 (825)
Q Consensus 794 ~~~~~~ki~DFGla~~~~~~~~-~~~~~~gt~ 824 (825)
+.++.+||+|||+|+.+..... ...+..||+
T Consensus 163 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~ 194 (322)
T d1vzoa_ 163 DSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194 (322)
T ss_dssp CTTSCEEESCSSEEEECCGGGGGGGCGGGSCC
T ss_pred cCCCCEEEeeccchhhhccccccccccccccc
Confidence 9999999999999997754332 334455654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.5e-26 Score=247.34 Aligned_cols=155 Identities=24% Similarity=0.353 Sum_probs=128.8
Q ss_pred cccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc--hhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCe
Q 003368 642 TDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ--GASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDF 719 (825)
Q Consensus 642 ~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~ 719 (825)
.++|+..+.||+|+||+||+|+...+|+.||||+++.... ...+.+.+|++++++++|||||++++++......+...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5679999999999999999999989999999999975532 33457889999999999999999999865322222334
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.++|+||+.+|+|.+++.. ..+++.++..|+.|++.||+|||+. +||||||||+|||++.++.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-------------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred eEEEEEeecCCchhhhccc-------------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccc
Confidence 5677888899999999843 2589999999999999999999986 99999999999999999999
Q ss_pred EEcccCccccccc
Q 003368 800 HVGDFGLARLRQE 812 (825)
Q Consensus 800 ki~DFGla~~~~~ 812 (825)
|++|||+|.....
T Consensus 161 kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 161 KILDFGLARHTDD 173 (348)
T ss_dssp EECCC----CCTG
T ss_pred cccccchhcccCc
Confidence 9999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.92 E-value=2e-25 Score=233.54 Aligned_cols=160 Identities=23% Similarity=0.286 Sum_probs=131.7
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCC-CCceeEeecccccccCCCCeee
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRH-RNLVRVITSCSSIDFQGNDFKA 721 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~~~~ 721 (825)
++|+..+.||+|+||+||+|++..+|+.||||+++.... .+.+.+|++.++.++| +|++.+++++ ..+...+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccE
Confidence 468899999999999999999988999999998865432 2456788889988875 8999998874 3467789
Q ss_pred EEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----C
Q 003368 722 LVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDN-----N 796 (825)
Q Consensus 722 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~-----~ 796 (825)
+||||+ +|+|.+++... ...+++.++..++.|++.||+|||+. +||||||||+|||++. +
T Consensus 78 ~vme~~-~~~l~~~~~~~-----------~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~ 142 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-----------GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA 142 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred EEEEec-CCCHHHHHHhh-----------ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccC
Confidence 999998 78999887422 24689999999999999999999985 9999999999999974 5
Q ss_pred CcEEEcccCcccccccCCC-------CCccccccC
Q 003368 797 LTAHVGDFGLARLRQEVPN-------NQSSSVGDL 824 (825)
Q Consensus 797 ~~~ki~DFGla~~~~~~~~-------~~~~~~gt~ 824 (825)
+.+||+|||+|+...+... ...+.+||+
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred CceEEcccceeEEcccCccccceeecccCceEEch
Confidence 7899999999998765422 123456876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=2.1e-25 Score=234.51 Aligned_cols=151 Identities=26% Similarity=0.424 Sum_probs=125.0
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCceeEeecccccccCCCCeeeE
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNLVRVITSCSSIDFQGNDFKAL 722 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l 722 (825)
+.|+..+.||+|+||+||+|++..+|+.||||++..... .+++.+|+++++.++|+|+|..++.|. .+.+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEE
Confidence 468999999999999999999989999999999875432 345789999999999888777766653 34677899
Q ss_pred EEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCcE
Q 003368 723 VYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLD---NNLTA 799 (825)
Q Consensus 723 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~---~~~~~ 799 (825)
||||+ +|++.+.+.. ....+++.++..++.|++.||+|||+. +||||||||+|||++ .+..+
T Consensus 81 vme~~-~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~v 145 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNF-----------CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV 145 (299)
T ss_dssp EEECC-CCBHHHHHHH-----------TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred EEEEc-CCchhhhhhh-----------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCcee
Confidence 99999 4566665531 224689999999999999999999995 999999999999975 45679
Q ss_pred EEcccCcccccccCC
Q 003368 800 HVGDFGLARLRQEVP 814 (825)
Q Consensus 800 ki~DFGla~~~~~~~ 814 (825)
|++|||+|+...+..
T Consensus 146 kl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 146 YIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCSSCEECBCTT
T ss_pred eeeccCcceeccccc
Confidence 999999999886543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.8e-25 Score=240.76 Aligned_cols=163 Identities=23% Similarity=0.241 Sum_probs=124.4
Q ss_pred ccccccceeccCCeeEEEEEEEcCCCeEEEEEEeeccc--chhHHHHHHHHHHhhcCCCCCceeEeeccccccc-CCCCe
Q 003368 643 DGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL--QGASKSFAAECRALRNIRHRNLVRVITSCSSIDF-QGNDF 719 (825)
Q Consensus 643 ~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~ 719 (825)
++|+..++||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++|||||++++++..... .....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999998899999999997543 2334578899999999999999999998754221 24467
Q ss_pred eeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCcE
Q 003368 720 KALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNILLDNNLTA 799 (825)
Q Consensus 720 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NILl~~~~~~ 799 (825)
.|+||||+.++.+. .+. ..+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 97 ~~iv~Ey~~~~l~~-~~~--------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp EEEEEECCSEEHHH-HHT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred eEEEEeccchHHHH-hhh--------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccce
Confidence 89999999766554 332 2578899999999999999999996 99999999999999999999
Q ss_pred EEcccCcccccccCCCCCccccccC
Q 003368 800 HVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 800 ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
|++|||+++...... ..+..+||+
T Consensus 159 kl~df~~~~~~~~~~-~~~~~~~t~ 182 (355)
T d2b1pa1 159 KILDFGLARTAGTSF-MMTPYVVTR 182 (355)
T ss_dssp EECCCCC----------------CC
T ss_pred eeechhhhhcccccc-ccccccccc
Confidence 999999998765532 334445554
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-24 Score=227.51 Aligned_cols=222 Identities=21% Similarity=0.194 Sum_probs=200.0
Q ss_pred CceeeceeecCC--CCcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECC-CCcCCCC
Q 003368 19 FCDWEGITCSPR--HRRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLS-HNSLVGE 95 (825)
Q Consensus 19 ~C~~~g~~c~~~--~~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~ 95 (825)
.|++.+++-+|. ...++.|||++|++.+..+.+|.++++|++|++++|++..+.+..+..+..++.++.+ .|.++..
T Consensus 17 ~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l 96 (284)
T d1ozna_ 17 SCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96 (284)
T ss_dssp ECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCC
T ss_pred EcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence 466777776654 2578999999999987777889999999999999999999999999999999999875 6678888
Q ss_pred CCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccc
Q 003368 96 IPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQL 175 (825)
Q Consensus 96 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 175 (825)
.|..|.++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|..+++|+.|+|++|++++..+.+|.++
T Consensus 97 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l 176 (284)
T d1ozna_ 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176 (284)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred cchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccc
Confidence 89999999999999999999998888899999999999999999998888999999999999999999998888999999
Q ss_pred cccceecCcCcCCccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccc
Q 003368 176 KELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNN 255 (825)
Q Consensus 176 ~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 255 (825)
++|+++ ++++|++++..|..+. .+++|++|++++|++++..|..|.++++|++|+|++|+
T Consensus 177 ~~L~~l-------------------~l~~N~l~~i~~~~f~-~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~ 236 (284)
T d1ozna_ 177 HSLDRL-------------------LLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236 (284)
T ss_dssp TTCCEE-------------------ECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred cccchh-------------------hhhhccccccChhHhh-hhhhcccccccccccccccccccccccccCEEEecCCC
Confidence 888888 7888999876666655 89999999999999999988999999999999999999
Q ss_pred ccCcc
Q 003368 256 FFGKL 260 (825)
Q Consensus 256 l~~~~ 260 (825)
+.+..
T Consensus 237 l~C~C 241 (284)
T d1ozna_ 237 WVCDC 241 (284)
T ss_dssp EECSG
T ss_pred CCCCc
Confidence 97654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3e-23 Score=213.95 Aligned_cols=196 Identities=24% Similarity=0.231 Sum_probs=138.9
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
..+|.++++++ .+|+.+. ++|++|||++|+|+++.+.+|.++++|++|+|++|+|+.. | .+..+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccccc
Confidence 33588888887 4676664 5788999999999877778888899999999999988844 3 3577888888888888
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNL 194 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l 194 (825)
+++. .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..|..+++|+.+
T Consensus 88 ~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l------------- 153 (266)
T d1p9ag_ 88 QLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL------------- 153 (266)
T ss_dssp CCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE-------------
T ss_pred cccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc-------------
Confidence 8884 56678888888888888888887777888888888888888888876655555555555555
Q ss_pred CCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 195 SLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 195 ~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
++++|++++ +|...+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 154 ------~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 154 ------SLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp ------ECTTSCCSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ------ccccccccc-cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 555555552 33333335566666666666665 34444555555555555555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.5e-23 Score=213.46 Aligned_cols=202 Identities=22% Similarity=0.252 Sum_probs=166.9
Q ss_pred CCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccccee
Q 003368 54 NLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133 (825)
Q Consensus 54 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 133 (825)
+.+.+.+.|.++++++ .+|+.+. ++|++|||++|+|++..+..|.++++|++|+|++|+|+.+ | .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 4566778899999999 5787765 5799999999999988888999999999999999999853 3 46789999999
Q ss_pred eccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCc
Q 003368 134 AIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPP 213 (825)
Q Consensus 134 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~ 213 (825)
+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++| ++++|.++ .+|+
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L-------------------~l~~n~l~-~l~~ 141 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL-------------------YLKGNELK-TLPP 141 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE-------------------ECTTSCCC-CCCT
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccc-------------------cccccccc-eecc
Confidence 99999998 457788999999999999999987777777777777766 67777777 5666
Q ss_pred hhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccCCC
Q 003368 214 SLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNLGS 282 (825)
Q Consensus 214 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 282 (825)
..+..+++|+.|++++|++++..+..|..+++|++|+|++|++. .+|..+..+++|++|++++|.+..
T Consensus 142 ~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 66667888999999999998888888888899999999998887 566666777888888888877654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=3.4e-20 Score=198.99 Aligned_cols=302 Identities=26% Similarity=0.303 Sum_probs=166.9
Q ss_pred cEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 33 RVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
+++.|||++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++. ++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---cccccccccc
Confidence 5778888888875 46643 467888888888887 567653 467888888888773 2321 1357777888
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCcccc
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIY 192 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~ 192 (825)
+|+|+. +|. ++.+++|+.|++++|.++.. +. ....+..+.+..+... .+..+..++.++.+
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L----------- 167 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAI----------- 167 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEE-----------
T ss_pred cccccc-ccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccccccccceec-----------
Confidence 777774 443 56677777777777777632 22 2345566666655543 23344555555555
Q ss_pred CCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcE
Q 003368 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAY 272 (825)
Q Consensus 193 ~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 272 (825)
.++.|.+. .++. .....+.+..+++.+.. ++ .+..++.|+.+++++|...... ..+.++..
T Consensus 168 --------~l~~n~~~-~~~~----~~~~~~~l~~~~~~~~~-~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~~l~~ 228 (353)
T d1jl5a_ 168 --------YADNNSLK-KLPD----LPLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKTLP----DLPPSLEA 228 (353)
T ss_dssp --------ECCSSCCS-SCCC----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCC----SCCTTCCE
T ss_pred --------cccccccc-cccc----ccccccccccccccccc-cc-cccccccccccccccccccccc----cccccccc
Confidence 44444443 1221 11233445555444432 22 2445666666666666543221 23344555
Q ss_pred EEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcccc
Q 003368 273 LNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMS 352 (825)
Q Consensus 273 L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 352 (825)
+.+..+.+.... .....+...++..+.+.+ ++. -.......++..+.+.+. ..
T Consensus 229 ~~~~~~~~~~~~----------~~~~~l~~~~~~~~~~~~----------l~~---l~~~~~~~~~~~~~~~~~----~~ 281 (353)
T d1jl5a_ 229 LNVRDNYLTDLP----------ELPQSLTFLDVSENIFSG----------LSE---LPPNLYYLNASSNEIRSL----CD 281 (353)
T ss_dssp EECCSSCCSCCC----------CCCTTCCEEECCSSCCSE----------ESC---CCTTCCEEECCSSCCSEE----CC
T ss_pred cccccccccccc----------cccccccccccccccccc----------ccc---ccchhcccccccCccccc----cc
Confidence 555555543221 112345555555555442 110 012234455555555432 22
Q ss_pred CCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCCCCCccccc
Q 003368 353 RLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQNDLSGAIP 420 (825)
Q Consensus 353 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ip 420 (825)
.+++|++|+|++|+|. .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+++ .+|
T Consensus 282 ~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp 340 (353)
T d1jl5a_ 282 LPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFP 340 (353)
T ss_dssp CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCC
T ss_pred cCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCC
Confidence 3566777777777776 45543 456777777777776 34532 345666677777665 444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.9e-19 Score=193.06 Aligned_cols=293 Identities=25% Similarity=0.266 Sum_probs=194.8
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEc
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYL 111 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 111 (825)
.+++.|+|++|++. .+|+.+ .+|+.|++++|+++ .++.- .+.|++||+++|.|+ .+|. +..+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeecc
Confidence 68999999999997 667654 67999999999998 44432 246999999999998 4554 688999999999
Q ss_pred CCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccc
Q 003368 112 GRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSI 191 (825)
Q Consensus 112 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i 191 (825)
++|.+... +.. ...+..|.+..+... .+..+..++.++.|+++.|.+.. ++..... .+.+
T Consensus 128 ~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-~~~~~~~---~~~l---------- 187 (353)
T d1jl5a_ 128 DNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDLPLS---LESI---------- 187 (353)
T ss_dssp CSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-CCCCCTT---CCEE----------
T ss_pred cccccccc-ccc---cccccchhhcccccc--ccccccccccceecccccccccc-ccccccc---cccc----------
Confidence 99999854 332 456777887776654 34568889999999999999874 3322211 1222
Q ss_pred cCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 192 YNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 192 ~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
....+.+. .+|.. ..++.|+.+++++|.... .| ....++..+.+.+|.+.... .....+.
T Consensus 188 ---------~~~~~~~~-~~~~~--~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~~----~~~~~l~ 247 (353)
T d1jl5a_ 188 ---------VAGNNILE-ELPEL--QNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDLP----ELPQSLT 247 (353)
T ss_dssp ---------ECCSSCCS-SCCCC--TTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCCC----CCCTTCC
T ss_pred ---------cccccccc-ccccc--cccccccccccccccccc-cc---cccccccccccccccccccc----ccccccc
Confidence 22222222 23321 156677777777776653 22 23455666777776654322 2234555
Q ss_pred EEEcccccCCCCCCCccccccccccC-CCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCcc
Q 003368 272 YLNVAINNLGSGESDEMSFIHSLANC-SNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEE 350 (825)
Q Consensus 272 ~L~ls~N~l~~~~~~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~ 350 (825)
..++..+.+... ..+ ......++..+.+.+ ++ ..+++|+.|++++|+++ .+|.
T Consensus 248 ~~~~~~~~~~~l-----------~~l~~~~~~~~~~~~~~~~----------~~---~~~~~L~~L~Ls~N~l~-~lp~- 301 (353)
T d1jl5a_ 248 FLDVSENIFSGL-----------SELPPNLYYLNASSNEIRS----------LC---DLPPSLEELNVSNNKLI-ELPA- 301 (353)
T ss_dssp EEECCSSCCSEE-----------SCCCTTCCEEECCSSCCSE----------EC---CCCTTCCEEECCSSCCS-CCCC-
T ss_pred cccccccccccc-----------ccccchhcccccccCcccc----------cc---ccCCCCCEEECCCCccC-cccc-
Confidence 556555444321 111 244566777776652 22 23568899999999998 5664
Q ss_pred ccCCCCCCEEEccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeec
Q 003368 351 MSRLQNLQFLNMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHL 410 (825)
Q Consensus 351 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 410 (825)
.+++|+.|+|++|+|+ .+|.. +++|++|++++|+++ .+|.... .|+.|.+
T Consensus 302 --~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~---~L~~L~~ 351 (353)
T d1jl5a_ 302 --LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM 351 (353)
T ss_dssp --CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT---TCCEEEC
T ss_pred --ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc---ccCeeEC
Confidence 3678999999999998 56653 468999999999998 5676544 3455544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.5e-21 Score=190.28 Aligned_cols=133 Identities=17% Similarity=0.147 Sum_probs=104.8
Q ss_pred cccceeccCCeeEEEEEEEcCCCeEEEEEEeecccc------------------hhHHHHHHHHHHhhcCCCCCceeEee
Q 003368 646 SSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQ------------------GASKSFAAECRALRNIRHRNLVRVIT 707 (825)
Q Consensus 646 ~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~ 707 (825)
...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|.+.+.+++|+++++.++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3468999999999999998 6899999998753210 01234567899999999999998876
Q ss_pred cccccccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 003368 708 SCSSIDFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLK 787 (825)
Q Consensus 708 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk 787 (825)
+. ..++||||++++.+.+ +++.....++.|+++|++|||+. +|+|||||
T Consensus 82 ~~---------~~~lvme~~~~~~~~~-------------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiK 130 (191)
T d1zara2 82 WE---------GNAVLMELIDAKELYR-------------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLS 130 (191)
T ss_dssp EE---------TTEEEEECCCCEEGGG-------------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred ec---------CCEEEEEeeccccccc-------------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCC
Confidence 52 1379999998865533 22233457899999999999986 99999999
Q ss_pred CCCeeecCCCcEEEcccCcccccc
Q 003368 788 PSNILLDNNLTAHVGDFGLARLRQ 811 (825)
Q Consensus 788 ~~NILl~~~~~~ki~DFGla~~~~ 811 (825)
|+|||++++ .++++|||.|+...
T Consensus 131 P~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 131 QYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp TTSEEEETT-EEEECCCTTCEETT
T ss_pred hhheeeeCC-CEEEEECCCcccCC
Confidence 999999975 58999999998754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=4.3e-21 Score=207.29 Aligned_cols=163 Identities=20% Similarity=0.276 Sum_probs=124.4
Q ss_pred cccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-----------CCCceeEeeccccc
Q 003368 644 GFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-----------HRNLVRVITSCSSI 712 (825)
Q Consensus 644 ~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~ 712 (825)
.|+..++||+|+||+||+|+...+|+.||||+++... ...+.+.+|+.++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~- 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH- 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence 3888999999999999999998999999999997643 23467788998888775 5778888887542
Q ss_pred ccCCCCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 003368 713 DFQGNDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHCQEPTIHCDLKPSNIL 792 (825)
Q Consensus 713 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~~~~ivHrdlk~~NIL 792 (825)
.+....++||+++..+........ ......+++..+..++.||++|++|||+. .+|+||||||+|||
T Consensus 92 --~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 92 --KGPNGVHVVMVFEVLGENLLALIK---------KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL 158 (362)
T ss_dssp --EETTEEEEEEEECCCCEEHHHHHH---------HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred --ccccceeeeeeecccccccccccc---------cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHee
Confidence 334566778877766544333211 12234678889999999999999999984 38999999999999
Q ss_pred ecCCC------cEEEcccCcccccccCCCCCccccccC
Q 003368 793 LDNNL------TAHVGDFGLARLRQEVPNNQSSSVGDL 824 (825)
Q Consensus 793 l~~~~------~~ki~DFGla~~~~~~~~~~~~~~gt~ 824 (825)
++.++ .+|++|||.|+..... ....+||+
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~ 193 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTR 193 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCG
T ss_pred eeccCcccccceeeEeecccccccccc---cccccccc
Confidence 98654 4999999999865443 23445553
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=8.4e-20 Score=177.82 Aligned_cols=130 Identities=28% Similarity=0.403 Sum_probs=115.5
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccc-cCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQG-KIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
.+|.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|++|+|++|+++...++.|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4677788886 5676653 689999999999986 44677899999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNI 168 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 168 (825)
+|+.+.|.+|.++++|++|+|++|+|+++.|.+|..+++|++|+|++|.+....
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 999988999999999999999999999888999999999999999999987543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2e-19 Score=182.23 Aligned_cols=215 Identities=15% Similarity=0.083 Sum_probs=156.9
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC-CCcCCCCCCCCCEEEcC-CC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE-IPGNLSYCSRLIGLYLG-RN 114 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls-~N 114 (825)
++.+++++. .+|+.+. +++++|||++|+|+.+.+.+|.++++|++|+|++|.+... .+..|..++++++|++. .|
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 444455665 5666553 5789999999999977777899999999999999988764 45678899999999876 47
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCc-cCCCCCCCCEEEcccCcCcccCCccccccc-ccceecCcCcCCcccc
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPH-FLGNITSLEAISLAYNSLGGNIPSSLGQLK-ELKSLGLGGTIPPSIY 192 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~~~p~~i~ 192 (825)
++....+..|.++++|++|++++|+++...+. .+..++.++.+..+++++....+..|.+++ .++.|
T Consensus 90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L----------- 158 (242)
T d1xwdc1 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL----------- 158 (242)
T ss_dssp TCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE-----------
T ss_pred cccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceee-----------
Confidence 88888888899999999999999998754332 344566777777788888766666666553 44444
Q ss_pred CCCCCceeecCCccccccCCchhhhcCCCCcEE-EcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCc
Q 003368 193 NLSLLANFSVPENRLHGSLPPSLGLTLSNLQLF-QISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLA 271 (825)
Q Consensus 193 ~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 271 (825)
++++|+++ .++...+ ...+++.+ ++++|+++.+.+..|.++++|++|+|++|++....+..|.++++|+
T Consensus 159 --------~l~~n~l~-~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 159 --------WLNKNGIQ-EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 228 (242)
T ss_dssp --------ECCSSCCC-EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEE
T ss_pred --------eccccccc-ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccc
Confidence 66677776 4555555 45555444 5677788866666788888888888888888766666666666666
Q ss_pred EEEc
Q 003368 272 YLNV 275 (825)
Q Consensus 272 ~L~l 275 (825)
.+++
T Consensus 229 ~l~~ 232 (242)
T d1xwdc1 229 ARST 232 (242)
T ss_dssp SSSE
T ss_pred cCcC
Confidence 5544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=2.2e-19 Score=174.80 Aligned_cols=124 Identities=25% Similarity=0.377 Sum_probs=111.5
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCC-CCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVG-EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQ 136 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 136 (825)
.+.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 357999999999 6787664 689999999999986 457778999999999999999999999999999999999999
Q ss_pred ccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCc
Q 003368 137 ENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLG 184 (825)
Q Consensus 137 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 184 (825)
+|+|+++.|.+|.++++|++|+|++|+|++..|.+|..+++|++|+|+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~ 134 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECT
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccc
Confidence 999999889999999999999999999998888889888888888443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=8.5e-19 Score=177.56 Aligned_cols=203 Identities=15% Similarity=0.082 Sum_probs=166.3
Q ss_pred CcEEEEECCCCCCccccCcCCCCCCCCCEEEcCCCccccc-CCccccCCCCCCEEECC-CCcCCCCCCcCCCCCCCCCEE
Q 003368 32 RRVTVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGK-IPGEIGRLFRLEALYLS-HNSLVGEIPGNLSYCSRLIGL 109 (825)
Q Consensus 32 ~~l~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L 109 (825)
.+++.|||++|.+....+.+|.++++|++|+|++|.+... .+.+|.+++++++|+++ .|++....+..|.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 5799999999999876667899999999999999998764 45689999999999976 478988899999999999999
Q ss_pred EcCCCCCCCCCCh-hhhcccccceeeccccccccccCccCCCCC-CCCEEEcccCcCcccCCcccccccccceecCcCcC
Q 003368 110 YLGRNKLEGSIPS-EFVSLYNLKELAIQENNLTGGIPHFLGNIT-SLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTI 187 (825)
Q Consensus 110 ~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~ 187 (825)
++++|++....+. .+..+..|..+..+++.+....+..|.+++ .++.|++++|+++...+..|. ..+++.+
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~------ 181 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDEL------ 181 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEE------
T ss_pred ccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhcc------
Confidence 9999999854443 345677788888888999877788888875 899999999999865554443 3443333
Q ss_pred CccccCCCCCceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecc
Q 003368 188 PPSIYNLSLLANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGN 254 (825)
Q Consensus 188 p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 254 (825)
+++++|+++ .+|...+..+++|++|+|++|+|+.+.+..|.++++|+.|++.+.
T Consensus 182 ------------~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 182 ------------NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235 (242)
T ss_dssp ------------ECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEESS
T ss_pred ------------ccccccccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCCC
Confidence 256677787 788887778999999999999999877778999999988887543
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.1e-18 Score=169.90 Aligned_cols=121 Identities=18% Similarity=0.268 Sum_probs=72.9
Q ss_pred EEEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCC
Q 003368 35 TVLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 35 ~~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 114 (825)
..++++.+++.+.+ .+.++.+|++|++++|.|+. ++ .|..+++|++|++++|+|++..| |..+++|++|++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33455555555433 33456667777777777763 33 46667777777777777765433 666667777777777
Q ss_pred CCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCc
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
.++. + ..+.++++|+.|+++++...+.. .+...+.++.+.++.+.+.
T Consensus 96 ~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~ 142 (227)
T d1h6ua2 96 PLKN-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQIT 142 (227)
T ss_dssp CCSC-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccc-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhc
Confidence 6663 2 24566666666666666655332 2445566666666666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.9e-17 Score=165.58 Aligned_cols=79 Identities=19% Similarity=0.214 Sum_probs=44.5
Q ss_pred CCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcc
Q 003368 81 RLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLA 160 (825)
Q Consensus 81 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 160 (825)
++..++++.+++++.. .+..+.+|+.|++++|+|+. ++ .+..+++|++|++++|++++..| |..+++|++++++
T Consensus 20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~ 93 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93 (227)
T ss_dssp HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccc
Confidence 3344556666665433 33455566666666666663 22 35666666666666666654332 5566666666666
Q ss_pred cCcCc
Q 003368 161 YNSLG 165 (825)
Q Consensus 161 ~N~l~ 165 (825)
+|.++
T Consensus 94 ~n~~~ 98 (227)
T d1h6ua2 94 GNPLK 98 (227)
T ss_dssp SCCCS
T ss_pred ccccc
Confidence 66554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.6e-17 Score=163.91 Aligned_cols=118 Identities=25% Similarity=0.373 Sum_probs=70.0
Q ss_pred ECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCC
Q 003368 38 DLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 38 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+++.+.+.+.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|+.|++++|+|+
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc
Confidence 3444444444432 2455667777777776632 2 2566667777777777766433 2556666777777766666
Q ss_pred CCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCc
Q 003368 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 118 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
+ +| .+.++++|+.|++++|.+.. + ..+..+++|+.+++++|.++
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~ 147 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT 147 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC
T ss_pred c-cc-cccccccccccccccccccc-c-cccccccccccccccccccc
Confidence 3 33 46666666666666666652 2 24556666666666666665
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=3.5e-20 Score=206.32 Aligned_cols=363 Identities=18% Similarity=0.158 Sum_probs=187.0
Q ss_pred cEEEEECCCCCCcccc-CcCCCCCCCCCEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCC----CCcCCC-C
Q 003368 33 RVTVLDLKSKGLIGSL-SPQIGNLSFLREIHLSNNTIQG----KIPGEIGRLFRLEALYLSHNSLVGE----IPGNLS-Y 102 (825)
Q Consensus 33 ~l~~l~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 102 (825)
+|+.||++++++++.- .+-+..+++++.|+|++|+|+. .++..+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5778888888886532 3334556777788888887762 3345566777788888888777521 222232 2
Q ss_pred CCCCCEEEcCCCCCCCC----CChhhhcccccceeeccccccccccCccC-----CCCCCCCEEEcccCcCcccCCcccc
Q 003368 103 CSRLIGLYLGRNKLEGS----IPSEFVSLYNLKELAIQENNLTGGIPHFL-----GNITSLEAISLAYNSLGGNIPSSLG 173 (825)
Q Consensus 103 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~~~~ 173 (825)
..+|++|+|++|+|+.. ++.++..+++|++|+|++|.++......+ ...............+....-..+
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~- 161 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL- 161 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH-
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc-
Confidence 34677777777777642 34455566677777777776653211111 111222333333332221000000
Q ss_pred cccccceecCcCcCCccccCCCCCceeecCCcccccc----CCchhhhcCCCCcEEEcccccCCCCC----CccccCCCC
Q 003368 174 QLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGS----LPPSLGLTLSNLQLFQISNNFFSGSF----PLAFSNASN 245 (825)
Q Consensus 174 ~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~----lp~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~ 245 (825)
-..+.....++.++++.+..... +...+.........+++..+.+.... ...+...+.
T Consensus 162 --------------~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~ 227 (460)
T d1z7xw1 162 --------------ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 227 (460)
T ss_dssp --------------HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTT
T ss_pred --------------ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccccccc
Confidence 00111223334444444443211 11111112334556666666554221 112345566
Q ss_pred ccEEEeecccccC-----ccccCcCCCCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCccc
Q 003368 246 LQSLEILGNNFFG-----KLSVNFGDMKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVS 320 (825)
Q Consensus 246 L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 320 (825)
++.+++.+|.+.. .....+.....++.++++.|.+..... ......+...+.++.+++++|.++.....
T Consensus 228 ~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~--~~~~~~l~~~~~l~~l~l~~n~i~~~~~~---- 301 (460)
T d1z7xw1 228 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC--GDLCRVLRAKESLKELSLAGNELGDEGAR---- 301 (460)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH--HHHHHHHHHCTTCCEEECTTCCCHHHHHH----
T ss_pred ccccchhhccccccccchhhccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc----
Confidence 7777777776532 222334445667777777666542111 11123344566777777777766531000
Q ss_pred ccCCccc-cCCCCcCEEEcccCcccccCCc----cccCCCCCCEEEccccccccc----cCcccc-CCCCCcEEEcccCc
Q 003368 321 GSIPSEI-GKLVSLYLIEMDHNQFEGKIPE----EMSRLQNLQFLNMRHNQLSGE----IPSSFG-NLSSLVKLILGNNN 390 (825)
Q Consensus 321 ~~ip~~l-~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~ 390 (825)
.+...+ .....|+.+++++|.++..... .+...++|++|+|++|++.+. ++..+. ..+.|++|+|++|.
T Consensus 302 -~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~ 380 (460)
T d1z7xw1 302 -LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 380 (460)
T ss_dssp -HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred -hhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCC
Confidence 010111 1234677777777777644322 234456777777777777532 222332 34567777777777
Q ss_pred cccc----cCCCCCCCCccceeecCCCCCcc
Q 003368 391 LSGV----IPSSLGNLKQLALLHLFQNDLSG 417 (825)
Q Consensus 391 l~~~----~p~~~~~l~~L~~L~L~~N~l~g 417 (825)
|+.. ++..+..+++|++|+|++|+++.
T Consensus 381 i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred CChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 7532 33344556777777777777763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.7e-17 Score=159.74 Aligned_cols=176 Identities=26% Similarity=0.409 Sum_probs=104.9
Q ss_pred ECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCC
Q 003368 38 DLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 38 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+++.+++.+.++. ..+.+|++|++++|.|+. ++ .+..+++|++|+|++|+|++..| |.++++|++|++++|.+.
T Consensus 24 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEECH--HHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccCH--HHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 4555555544332 356677778888777773 33 36677777777777777775443 777777777777777776
Q ss_pred CCCChhhhcccccceeeccccccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCC
Q 003368 118 GSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLL 197 (825)
Q Consensus 118 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l 197 (825)
. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|++|
T Consensus 98 ~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L---------------- 155 (199)
T d2omxa2 98 D-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQL---------------- 155 (199)
T ss_dssp C-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEE----------------
T ss_pred c-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-ccccccccccc----------------
Confidence 3 33 367777777777777777643 246677777777777777752 22 34444444444
Q ss_pred ceeecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEE
Q 003368 198 ANFSVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSL 249 (825)
Q Consensus 198 ~~l~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 249 (825)
++.+|++++ +++ +. .+++|++|++++|+++++ + .++.+++|++|
T Consensus 156 ---~l~~n~l~~-l~~-l~-~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 156 ---NFSSNQVTD-LKP-LA-NLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp ---ECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred ---ccccccccC-Ccc-cc-CCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 444455442 221 22 455555555555555542 1 34455555443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.5e-20 Score=209.28 Aligned_cols=403 Identities=17% Similarity=0.124 Sum_probs=208.0
Q ss_pred CCCEEEcCCCcccccC-CccccCCCCCCEEECCCCcCCC----CCCcCCCCCCCCCEEEcCCCCCCCCCChhhh-----c
Q 003368 57 FLREIHLSNNTIQGKI-PGEIGRLFRLEALYLSHNSLVG----EIPGNLSYCSRLIGLYLGRNKLEGSIPSEFV-----S 126 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~ 126 (825)
+|++||++.|+|+... ..-+..++++++|+|++|.|+. .++..+..+++|++|||++|+|+...-..+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5789999999998532 3445668889999999998873 3345677888999999999988632111221 2
Q ss_pred ccccceeeccccccccc----cCccCCCCCCCCEEEcccCcCcccCCccccc-ccccceecCcCcCCccccCCCCCceee
Q 003368 127 LYNLKELAIQENNLTGG----IPHFLGNITSLEAISLAYNSLGGNIPSSLGQ-LKELKSLGLGGTIPPSIYNLSLLANFS 201 (825)
Q Consensus 127 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~~~p~~i~~l~~l~~l~ 201 (825)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+.. +..... ......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~---------------~~~~~~ 147 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC---------------RLEKLQ 147 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC---------------CCCEEE
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccc---------------cccccc
Confidence 24799999999988743 3556778889999999999887432222211 000000 000111
Q ss_pred cCCccccccCC---chhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccc
Q 003368 202 VPENRLHGSLP---PSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAIN 278 (825)
Q Consensus 202 l~~N~l~~~lp---~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N 278 (825)
.....+...-- .........++.++++++.+....-..+. ......-.....+++..+
T Consensus 148 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~-------------------~~l~~~~~~~~~l~~~~~ 208 (460)
T d1z7xw1 148 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC-------------------QGLKDSPCQLEALKLESC 208 (460)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH-------------------HHHHHSCCCCCEEECTTS
T ss_pred ccccccchhhhcccccccccccccccccccccccccccccccc-------------------cccccccccccccccccc
Confidence 11111110000 00111344556666655543211000000 000000112223333333
Q ss_pred cCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccC----CccccCC
Q 003368 279 NLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKI----PEEMSRL 354 (825)
Q Consensus 279 ~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l 354 (825)
.+.... ...+...+...+.++.++++.|.+.... +...++........++.+++++|.+.... ...+...
T Consensus 209 ~~~~~~--~~~~~~~l~~~~~~~~l~~~~n~~~~~~----~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~ 282 (460)
T d1z7xw1 209 GVTSDN--CRDLCGIVASKASLRELALGSNKLGDVG----MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 282 (460)
T ss_dssp CCBTTH--HHHHHHHHHHCTTCCEEECCSSBCHHHH----HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred cccchh--hhcccccccccccccccchhhccccccc----cchhhccccccccccccccccccccccccccccccccccc
Confidence 222110 0111223344566677777766553200 00011122334556677777777665322 2234456
Q ss_pred CCCCEEEccccccccccCccc-----cCCCCCcEEEcccCccccccCC----CCCCCCccceeecCCCCCccccchhhhc
Q 003368 355 QNLQFLNMRHNQLSGEIPSSF-----GNLSSLVKLILGNNNLSGVIPS----SLGNLKQLALLHLFQNDLSGAIPEEIFN 425 (825)
Q Consensus 355 ~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~g~ip~~~~~ 425 (825)
+.++.+++++|.+.......+ .....|+.+++++|.++..... .+...++|+.|+|++|+++..-...
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~--- 359 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE--- 359 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH---
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccch---
Confidence 667777777777653221111 1234566667766666533211 1223445666666666664311111
Q ss_pred ccccccccccCCCccccCCCcccc-ccccccEEeecCceeccc----CCccccCCCCCCEEEccCCcCCCCCCcc----c
Q 003368 426 ISHMSDSLNFARNHLVGSIPPKIG-NLKVLRMFVVSSNNLSGE----IPSEIGSCFYLQEIYMAENFFRGSIPSS----L 496 (825)
Q Consensus 426 ~~~l~~~l~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~----~ 496 (825)
++..+. ..+.|+.|+|++|+|+.. ++..+..+++|++|++++|+++...... +
T Consensus 360 ------------------l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l 421 (460)
T d1z7xw1 360 ------------------LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421 (460)
T ss_dssp ------------------HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHH
T ss_pred ------------------hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHH
Confidence 111111 234567777777777632 3444556677888888888776422222 2
Q ss_pred c-CCCCCCEEECCCCccccccCccc
Q 003368 497 V-SLKDLREIDLSQNNLSGKIPISL 520 (825)
Q Consensus 497 ~-~l~~L~~Ldls~N~l~~~~p~~~ 520 (825)
. +...|+.|++++|.+....+..+
T Consensus 422 ~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp TSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HhCCCccCEEECCCCCCCHHHHHHH
Confidence 2 33468999999998886555444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=6.8e-17 Score=159.30 Aligned_cols=180 Identities=23% Similarity=0.333 Sum_probs=132.6
Q ss_pred ecCCccccccCCchhhhcCCCCcEEEcccccCCCCCCccccCCCCccEEEeecccccCccccCcCCCCCCcEEEcccccC
Q 003368 201 SVPENRLHGSLPPSLGLTLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFFGKLSVNFGDMKSLAYLNVAINNL 280 (825)
Q Consensus 201 ~l~~N~l~~~lp~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 280 (825)
.+..+.+++.++.. .+.+|+.|++++|.++... .+..+++|++|+|++|++.+..+ ++.+++|++|++++|++
T Consensus 30 ~l~~~~~~~~~~~~---~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECHH---HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCHH---HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccc
Confidence 45555565555432 4567888888888887543 36778888888888888876543 56788888888888877
Q ss_pred CCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCcccccCCccccCCCCCCEE
Q 003368 281 GSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGKIPEEMSRLQNLQFL 360 (825)
Q Consensus 281 ~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 360 (825)
+.. ..+..+++|+.|++++|.+. .+ ..+..++.++.+++++|.+++ +..+..+++|+++
T Consensus 103 ~~l--------~~l~~l~~L~~L~l~~~~~~----------~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 103 KDL--------SSLKDLKKLKSLSLEHNGIS----------DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp CCG--------GGGTTCTTCCEEECTTSCCC----------CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred ccc--------cccccccccccccccccccc----------cc-ccccccccccccccccccccc--ccccccccccccc
Confidence 642 24677888888888888775 33 357778888888888888874 3457778888888
Q ss_pred EccccccccccCccccCCCCCcEEEcccCccccccCCCCCCCCccceeecCC
Q 003368 361 NMRHNQLSGEIPSSFGNLSSLVKLILGNNNLSGVIPSSLGNLKQLALLHLFQ 412 (825)
Q Consensus 361 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 412 (825)
++++|++.+. ++ +.++++|+.|+|++|+++. +| .+.++++|++|+|++
T Consensus 162 ~l~~n~l~~i-~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 162 SLEDNQISDI-VP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccccc-cc-ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 9988888753 32 7788888889998888875 44 488888888888763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=7.1e-17 Score=157.74 Aligned_cols=166 Identities=20% Similarity=0.312 Sum_probs=100.6
Q ss_pred CCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccc
Q 003368 58 LREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 58 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 137 (825)
...+.++.+.+++.++. ..+.++++|++++|.|+.. +.++.+++|++|+|++|+|++..| |.++++|++|++++
T Consensus 20 ~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~ 93 (199)
T d2omxa2 20 KMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 93 (199)
T ss_dssp HHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred HHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccc
Confidence 33456677777754432 3567788888888888743 246777888888888888875432 77778888888888
Q ss_pred cccccccCccCCCCCCCCEEEcccCcCcccCCcccccccccceecCcCcCCccccCCCCCceeecCCccccccCCchhhh
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYNSLGGNIPSSLGQLKELKSLGLGGTIPPSIYNLSLLANFSVPENRLHGSLPPSLGL 217 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~~~p~~i~~l~~l~~l~l~~N~l~~~lp~~~~~ 217 (825)
|.+... + .++++++|+.|++++|.+... ..+..+++|+.| ++++|++. .++ .+.
T Consensus 94 n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L-------------------~l~~n~l~-~~~-~l~- 147 (199)
T d2omxa2 94 NQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRL-------------------ELSSNTIS-DIS-ALS- 147 (199)
T ss_dssp SCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEE-------------------ECCSSCCC-CCG-GGT-
T ss_pred cccccc-c-ccccccccccccccccccccc--cccchhhhhHHh-------------------hhhhhhhc-ccc-ccc-
Confidence 877643 2 367777788888877777632 123444444444 44455544 222 222
Q ss_pred cCCCCcEEEcccccCCCCCCccccCCCCccEEEeeccccc
Q 003368 218 TLSNLQLFQISNNFFSGSFPLAFSNASNLQSLEILGNNFF 257 (825)
Q Consensus 218 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 257 (825)
.+++|+.|++++|++++.. .|+++++|++|++++|+++
T Consensus 148 ~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 148 GLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp TCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred ccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence 4555666666666555432 2555555555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.6e-16 Score=146.63 Aligned_cols=129 Identities=20% Similarity=0.165 Sum_probs=109.3
Q ss_pred CCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccc
Q 003368 51 QIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNL 130 (825)
Q Consensus 51 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 130 (825)
.+.+...|++|||++|+|+ .+|..+..+++|+.||||+|+|+.. + .|..+++|++|++++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4567888999999999999 5677778899999999999999954 3 58999999999999999998777788899999
Q ss_pred ceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccC---Ccccccccccceec
Q 003368 131 KELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNI---PSSLGQLKELKSLG 182 (825)
Q Consensus 131 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 182 (825)
+.|++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999999985432 46889999999999999997432 23577888888885
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=2.5e-15 Score=133.81 Aligned_cols=102 Identities=28% Similarity=0.327 Sum_probs=61.1
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeecccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 138 (825)
|.|||++|+|+ .++ .++.+++|++||+++|+|+ .+|..|+.+++|+.|++++|+|+. +| .|..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 35666666665 333 3566666666666666665 345556666666666666666663 23 3666666666666666
Q ss_pred ccccccC-ccCCCCCCCCEEEcccCcCc
Q 003368 139 NLTGGIP-HFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 139 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 165 (825)
+|+.... ..+..+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 6664322 34566666666666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=8.7e-15 Score=130.24 Aligned_cols=117 Identities=29% Similarity=0.352 Sum_probs=98.2
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
.|||++|+++ .++ .+..+++|++||+++|+|+ .+|+.|+.+++|+.|++++|+|+.. | .|..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 6899999997 444 5899999999999999999 6788899999999999999999954 4 49999999999999999
Q ss_pred CCCCC-Chhhhcccccceeecccccccccc---CccCCCCCCCCEE
Q 003368 116 LEGSI-PSEFVSLYNLKELAIQENNLTGGI---PHFLGNITSLEAI 157 (825)
Q Consensus 116 l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L 157 (825)
|+... ...+..+++|++|++++|+++... ...+..+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 99654 367899999999999999998432 2233446676665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=9.9e-15 Score=136.61 Aligned_cols=88 Identities=18% Similarity=0.117 Sum_probs=67.1
Q ss_pred cccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceeeccccccccccCccCCCCCCC
Q 003368 75 EIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELAIQENNLTGGIPHFLGNITSL 154 (825)
Q Consensus 75 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 154 (825)
.|.+..+|++|||++|+|+. +|+.+..+++|+.|||++|+|+.. + .|..+++|++|++++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 45677788888888888874 466667788888888888888743 3 47778888888888888886666666778888
Q ss_pred CEEEcccCcCc
Q 003368 155 EAISLAYNSLG 165 (825)
Q Consensus 155 ~~L~Ls~N~l~ 165 (825)
+.|+|++|+|+
T Consensus 90 ~~L~L~~N~i~ 100 (162)
T d1a9na_ 90 TELILTNNSLV 100 (162)
T ss_dssp CEEECCSCCCC
T ss_pred ccceecccccc
Confidence 88888888876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=5.1e-15 Score=152.84 Aligned_cols=125 Identities=21% Similarity=0.284 Sum_probs=74.0
Q ss_pred EEECCCCCCccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCC-CCcCCCCCCCCCEEEcCCC
Q 003368 36 VLDLKSKGLIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGE-IPGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 36 ~l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N 114 (825)
.+||+++.+.......+.. ..+..+.++...+...+. ......+|++|||+++.++.. ++..+..+++|++|+|+++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5677777664332222211 234566666666553322 233455777777777776643 3444667777777777777
Q ss_pred CCCCCCChhhhcccccceeecccc-ccccc-cCccCCCCCCCCEEEcccC
Q 003368 115 KLEGSIPSEFVSLYNLKELAIQEN-NLTGG-IPHFLGNITSLEAISLAYN 162 (825)
Q Consensus 115 ~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N 162 (825)
.++...+..+..+++|++|+|+++ .++.. +...+.++++|++|+++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 777666667777777777777773 45421 1222345677777777764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.3e-14 Score=149.67 Aligned_cols=102 Identities=14% Similarity=0.153 Sum_probs=61.2
Q ss_pred CEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCC-CChhhhcccccceeeccc
Q 003368 59 REIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGS-IPSEFVSLYNLKELAIQE 137 (825)
Q Consensus 59 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~ 137 (825)
+.|||+++.+.......+.. ..+..+.++...+..... ......+|++|||+++.++.. ++..+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 46788887775322222211 235566776666553322 233445777777777776643 234456677777777777
Q ss_pred cccccccCccCCCCCCCCEEEcccC
Q 003368 138 NNLTGGIPHFLGNITSLEAISLAYN 162 (825)
Q Consensus 138 N~l~~~~p~~~~~l~~L~~L~Ls~N 162 (825)
+.+++..+..++.+++|++|+|+++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred cCCCcHHHHHHhcCCCCcCcccccc
Confidence 7776666666666777777777663
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=2.5e-15 Score=145.95 Aligned_cols=144 Identities=24% Similarity=0.288 Sum_probs=111.5
Q ss_pred EEEEECCCCC-CccccCcCCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcC
Q 003368 34 VTVLDLKSKG-LIGSLSPQIGNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLG 112 (825)
Q Consensus 34 l~~l~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 112 (825)
.+.+++.++- -...+|.++..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|+++
T Consensus 25 ~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~ 101 (198)
T d1m9la_ 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS 101 (198)
T ss_dssp CSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECS
T ss_pred cceeeeecccCchhhhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccc
Confidence 3344554331 123456778999999999999999994 54 5899999999999999998 556666666789999999
Q ss_pred CCCCCCCCChhhhcccccceeeccccccccccC-ccCCCCCCCCEEEcccCcCcccCCcc----------ccccccccee
Q 003368 113 RNKLEGSIPSEFVSLYNLKELAIQENNLTGGIP-HFLGNITSLEAISLAYNSLGGNIPSS----------LGQLKELKSL 181 (825)
Q Consensus 113 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L 181 (825)
+|+|+.+ ..+..+++|+.|++++|+|+.... ..|..+++|+.|+|++|.+....+.. +..+++|+.|
T Consensus 102 ~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~L 179 (198)
T d1m9la_ 102 YNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179 (198)
T ss_dssp EEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEE
T ss_pred ccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEe
Confidence 9999953 468899999999999999985432 46899999999999999987554432 3456666666
Q ss_pred c
Q 003368 182 G 182 (825)
Q Consensus 182 ~ 182 (825)
|
T Consensus 180 D 180 (198)
T d1m9la_ 180 D 180 (198)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=8.3e-15 Score=156.06 Aligned_cols=117 Identities=21% Similarity=0.119 Sum_probs=65.9
Q ss_pred CcCCCCCCCCCEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCCC----------CcCCCCCCCCCEEEcCCC
Q 003368 49 SPQIGNLSFLREIHLSNNTIQG----KIPGEIGRLFRLEALYLSHNSLVGEI----------PGNLSYCSRLIGLYLGRN 114 (825)
Q Consensus 49 ~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----------p~~~~~l~~L~~L~Ls~N 114 (825)
...+...+.|++|+|++|.|.. .+...+...++|+.|+++++.+.... ...+..+++|++|+|++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 3345556777777777777743 23344556677777777776543211 122445667777777777
Q ss_pred CCCCC----CChhhhcccccceeeccccccccccCcc-------------CCCCCCCCEEEcccCcCc
Q 003368 115 KLEGS----IPSEFVSLYNLKELAIQENNLTGGIPHF-------------LGNITSLEAISLAYNSLG 165 (825)
Q Consensus 115 ~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~ 165 (825)
.++.. +...+...++|++|++++|.+....... ....+.|+.+++++|+++
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~ 171 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 171 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCT
T ss_pred ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccc
Confidence 76643 2233445566777777776654211100 123456666666666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=3.1e-13 Score=125.32 Aligned_cols=103 Identities=23% Similarity=0.244 Sum_probs=75.8
Q ss_pred EECCCCCCccccCcCCCCCCCCCEEEcCCC-cccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCC
Q 003368 37 LDLKSKGLIGSLSPQIGNLSFLREIHLSNN-TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNK 115 (825)
Q Consensus 37 l~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 115 (825)
++.+++++. ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|++|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 334444554 45666778888888888655 5887777778888888888888888887778888888888888888888
Q ss_pred CCCCCChhhhcccccceeeccccccc
Q 003368 116 LEGSIPSEFVSLYNLKELAIQENNLT 141 (825)
Q Consensus 116 l~~~~p~~~~~l~~L~~L~L~~N~l~ 141 (825)
|+.+.+..|..+ +|+.|+|++|.+.
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CcccChhhhccc-cccccccCCCccc
Confidence 886555555544 5778888888764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.2e-12 Score=121.31 Aligned_cols=108 Identities=18% Similarity=0.102 Sum_probs=94.5
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCCEEECCCC-cCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhcccccceee
Q 003368 56 SFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHN-SLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKELA 134 (825)
Q Consensus 56 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 134 (825)
...+.++.+++.+. ..|..|..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34567899999998 67888999999999999866 59988888999999999999999999998899999999999999
Q ss_pred ccccccccccCccCCCCCCCCEEEcccCcCc
Q 003368 135 IQENNLTGGIPHFLGNITSLEAISLAYNSLG 165 (825)
Q Consensus 135 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 165 (825)
|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 99999996666667655 6999999999985
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.36 E-value=3.1e-14 Score=151.51 Aligned_cols=144 Identities=17% Similarity=0.210 Sum_probs=78.6
Q ss_pred CCCCcEEEcccccCCCCCCCccccccccccCCCCCEEEcccccccccCCCCcccccCCccccCCCCcCEEEcccCccccc
Q 003368 267 MKSLAYLNVAINNLGSGESDEMSFIHSLANCSNLSFLNLVANQFKGALPHSIVSGSIPSEIGKLVSLYLIEMDHNQFEGK 346 (825)
Q Consensus 267 l~~L~~L~ls~N~l~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~ 346 (825)
.+.|+.++++.|.+.... ...+...+..++.|+.|+|++|+++.... ...+...+...++|+.|+|++|.++..
T Consensus 157 ~~~L~~l~l~~n~i~~~~--~~~l~~~l~~~~~L~~L~L~~n~i~~~g~----~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 230 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGS--MKEWAKTFQSHRLLHTVKMVQNGIRPEGI----EHLLLEGLAYCQELKVLDLQDNTFTHL 230 (344)
T ss_dssp CCCCCEEECCSSCCTGGG--HHHHHHHHHHCTTCCEEECCSSCCCHHHH----HHHHHTTGGGCTTCCEEECCSSCCHHH
T ss_pred Ccccceeecccccccccc--cccccchhhhhhhhccccccccccccccc----ccchhhhhcchhhhccccccccccccc
Confidence 445556666655543211 11223344556677777777777652100 001223355667777777777776532
Q ss_pred ----CCccccCCCCCCEEEccccccccccCcc----cc--CCCCCcEEEcccCccccc----cCCCC-CCCCccceeecC
Q 003368 347 ----IPEEMSRLQNLQFLNMRHNQLSGEIPSS----FG--NLSSLVKLILGNNNLSGV----IPSSL-GNLKQLALLHLF 411 (825)
Q Consensus 347 ----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~----~p~~~-~~l~~L~~L~L~ 411 (825)
+...+..+++|++|+|++|.|.+.-... +. ..+.|++|++++|+|+.. +...+ .++++|+.|+|+
T Consensus 231 g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~ 310 (344)
T d2ca6a1 231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 310 (344)
T ss_dssp HHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECT
T ss_pred ccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECC
Confidence 3345566777777777777776432222 21 235677777777776532 11122 145567777777
Q ss_pred CCCCc
Q 003368 412 QNDLS 416 (825)
Q Consensus 412 ~N~l~ 416 (825)
+|++.
T Consensus 311 ~N~~~ 315 (344)
T d2ca6a1 311 GNRFS 315 (344)
T ss_dssp TSBSC
T ss_pred CCcCC
Confidence 77765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.34 E-value=1.8e-14 Score=139.68 Aligned_cols=120 Identities=23% Similarity=0.234 Sum_probs=87.7
Q ss_pred CCCCEEEcCCC--cccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCCChhhhccccccee
Q 003368 56 SFLREIHLSNN--TIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNLKEL 133 (825)
Q Consensus 56 ~~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 133 (825)
..++.++++++ .++ .+|.+|..+++|++|+|++|+|+.. + .|..+++|++|+|++|+|+ .+|..+..+++|+.|
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L 98 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccc
Confidence 34556666654 344 5667888899999999999999844 4 4888889999999999988 456666777789999
Q ss_pred eccccccccccCccCCCCCCCCEEEcccCcCcccCC-ccccccccccee
Q 003368 134 AIQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIP-SSLGQLKELKSL 181 (825)
Q Consensus 134 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 181 (825)
++++|+|+.. +.+..+++|++|+|++|+|+.... ..|..+++|+.|
T Consensus 99 ~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T d1m9la_ 99 WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp ECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred cccccccccc--ccccccccccccccccchhccccccccccCCCcccee
Confidence 9999988853 247778888999999888874321 334555555555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=5.5e-10 Score=103.78 Aligned_cols=89 Identities=18% Similarity=0.087 Sum_probs=45.7
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCC--CcCCCCCCCCCEEEcCCCCCCCCCChhhhccccc
Q 003368 53 GNLSFLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEI--PGNLSYCSRLIGLYLGRNKLEGSIPSEFVSLYNL 130 (825)
Q Consensus 53 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 130 (825)
..+..+..|+..+|.+. .++..+..+++|++|+||+|+|+... +..+..+++|+.|||++|+|+...+-.+....+|
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L 117 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence 33444444444444333 34444455666666666666666432 2334455666666666666654333333344455
Q ss_pred ceeecccccccc
Q 003368 131 KELAIQENNLTG 142 (825)
Q Consensus 131 ~~L~L~~N~l~~ 142 (825)
+.|++++|.++.
T Consensus 118 ~~L~L~~Npl~~ 129 (162)
T d1koha1 118 EELWLDGNSLSD 129 (162)
T ss_dssp SSCCCTTSTTSS
T ss_pred ceeecCCCCcCc
Confidence 666666665553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=6.9e-10 Score=103.06 Aligned_cols=121 Identities=18% Similarity=0.034 Sum_probs=86.1
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCCEEECCCCcCCCCCCcCCCCCCCCCEEEcCCCCCCCCC--Chhhhcccccceee
Q 003368 57 FLREIHLSNNTIQGKIPGEIGRLFRLEALYLSHNSLVGEIPGNLSYCSRLIGLYLGRNKLEGSI--PSEFVSLYNLKELA 134 (825)
Q Consensus 57 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~ 134 (825)
..+.||++++... ..+..+..+..|+.++|.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455677665432 23445555666666665544 44556678899999999999999653 45688899999999
Q ss_pred ccccccccccCccCCCCCCCCEEEcccCcCcccCCc-------ccccccccceec
Q 003368 135 IQENNLTGGIPHFLGNITSLEAISLAYNSLGGNIPS-------SLGQLKELKSLG 182 (825)
Q Consensus 135 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~ 182 (825)
|++|+|+...+-.+....+|+.|++++|.++..... .+..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 999999965543444556799999999999865442 255678888774
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=2.5e-06 Score=85.22 Aligned_cols=149 Identities=15% Similarity=0.088 Sum_probs=93.0
Q ss_pred HHhhcccccccceeccCCeeEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCC-CCCceeEeecccccccCC
Q 003368 638 LLKATDGFSSTHLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIR-HRNLVRVITSCSSIDFQG 716 (825)
Q Consensus 638 ~~~~~~~f~~~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 716 (825)
+.+..+.|...+..+-++.+.||+... ++..+.||+...........+.+|.+.+..++ +--+.+++.++ ..
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~ 81 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RH 81 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ec
Confidence 333344555444433344568998874 56677889876554444445678888877664 32344555543 23
Q ss_pred CCeeeEEEEccCCCChhhhccCCCCCCCcccchhcccCCHHHHHHHHHHHHHHHHHHHhcC-------------------
Q 003368 717 NDFKALVYQYMPNGSLENWLHPDAIPQTDEENDEIRNLTLLERISIAIDVASAVDYLHHHC------------------- 777 (825)
Q Consensus 717 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~va~~l~yLH~~~------------------- 777 (825)
++..++||++++|..+.+..... .....++.++++.++.||+..
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~-----------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE-----------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC-----------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCceEEEEEeccccccccccccc-----------------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHH
Confidence 45679999999998876543211 012234455555555555321
Q ss_pred -------------------------------------CCCeeecCCCCCCeeecCCCcEEEcccCccccc
Q 003368 778 -------------------------------------QEPTIHCDLKPSNILLDNNLTAHVGDFGLARLR 810 (825)
Q Consensus 778 -------------------------------------~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~~ 810 (825)
.+.++|+|+.|.||+++++..+-|.||+.+...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 112789999999999998777789999987764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.64 E-value=4.9e-06 Score=76.69 Aligned_cols=85 Identities=12% Similarity=0.106 Sum_probs=38.5
Q ss_pred CCCCCEEEcCCC-ccccc----CCccccCCCCCCEEECCCCcCCCCC----CcCCCCCCCCCEEEcCCCCCCCCC----C
Q 003368 55 LSFLREIHLSNN-TIQGK----IPGEIGRLFRLEALYLSHNSLVGEI----PGNLSYCSRLIGLYLGRNKLEGSI----P 121 (825)
Q Consensus 55 l~~L~~L~Ls~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~----p 121 (825)
.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.+.... ...+...+.|++|+|++|.|+..- -
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355666666543 34321 2223444555666666666554221 122333445555555555554211 1
Q ss_pred hhhhcccccceeeccccc
Q 003368 122 SEFVSLYNLKELAIQENN 139 (825)
Q Consensus 122 ~~~~~l~~L~~L~L~~N~ 139 (825)
.++...+.|++|+|++|.
T Consensus 94 ~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp HHTTTTCCCSEEECCCCS
T ss_pred HHHHhCCcCCEEECCCCc
Confidence 123333445555555444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.47 E-value=0.00015 Score=71.36 Aligned_cols=77 Identities=13% Similarity=0.111 Sum_probs=49.1
Q ss_pred ceeccCCe-eEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCC--ceeEeecccccccCCCCeeeEEEE
Q 003368 649 HLIGIGSF-GSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRN--LVRVITSCSSIDFQGNDFKALVYQ 725 (825)
Q Consensus 649 ~~ig~G~~-g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~~~~lv~e 725 (825)
+.+..|.. +.||+... .+|..+.+|.-..... ..+.+|++.++.+.... +.++++++. .++..++|||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~ 86 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLG 86 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEE
Confidence 34555554 67999987 5677788897654322 34567777777664322 445665532 2456799999
Q ss_pred ccCCCChhh
Q 003368 726 YMPNGSLEN 734 (825)
Q Consensus 726 ~~~~gsL~~ 734 (825)
|++|.++.+
T Consensus 87 ~i~G~~~~~ 95 (255)
T d1nd4a_ 87 EVPGQDLLS 95 (255)
T ss_dssp CCSSEETTT
T ss_pred eeecccccc
Confidence 999866543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=2.1e-05 Score=72.26 Aligned_cols=108 Identities=12% Similarity=0.065 Sum_probs=77.0
Q ss_pred CCcEEEEECCCC-CCccc----cCcCCCCCCCCCEEEcCCCcccc----cCCccccCCCCCCEEECCCCcCCCC----CC
Q 003368 31 HRRVTVLDLKSK-GLIGS----LSPQIGNLSFLREIHLSNNTIQG----KIPGEIGRLFRLEALYLSHNSLVGE----IP 97 (825)
Q Consensus 31 ~~~l~~l~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p 97 (825)
...++.|+|+++ .+... +-..+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 367999999874 45432 44467788999999999999974 2334566678899999999999853 23
Q ss_pred cCCCCCCCCCEEEcCCCCCCCCC-------Chhhhcccccceeecccc
Q 003368 98 GNLSYCSRLIGLYLGRNKLEGSI-------PSEFVSLYNLKELAIQEN 138 (825)
Q Consensus 98 ~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~L~~N 138 (825)
..+...++|++|+|++|++...- ...+...+.|+.|+++.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 45778899999999999876432 223334455555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00021 Score=75.24 Aligned_cols=77 Identities=17% Similarity=0.061 Sum_probs=48.0
Q ss_pred cceeccCCeeEEEEEEEcCCCeEEEEEEeeccc-------chhHHHHHHHHHHhhcCC---CCCceeEeecccccccCCC
Q 003368 648 THLIGIGSFGSVYKGTFDRDGTIVAIKVLNLQL-------QGASKSFAAECRALRNIR---HRNLVRVITSCSSIDFQGN 717 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~~g~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~ 717 (825)
.+.||.|....||+.....+|+.|+||...... .........|.+.++.+. ...+.+++.++ +
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------C
Confidence 456899999999999886667889999764321 111223456777776553 23455666553 3
Q ss_pred CeeeEEEEccCCCC
Q 003368 718 DFKALVYQYMPNGS 731 (825)
Q Consensus 718 ~~~~lv~e~~~~gs 731 (825)
+..++||||+++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 34579999998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.00 E-value=4.8e-05 Score=69.75 Aligned_cols=112 Identities=21% Similarity=0.190 Sum_probs=59.4
Q ss_pred CCCCCCCEEEcCC-Ccccc----cCCccccCCCCCCEEECCCCcCCCCC----CcCCCCCCCCCEEEcCCCCCCCC----
Q 003368 53 GNLSFLREIHLSN-NTIQG----KIPGEIGRLFRLEALYLSHNSLVGEI----PGNLSYCSRLIGLYLGRNKLEGS---- 119 (825)
Q Consensus 53 ~~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~---- 119 (825)
.+.+.|++|+|++ +.|+. .+-.++...++|++|+|++|.++... ...+...+.++.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777776 34542 12334456666777777777665331 22344556667777776666532
Q ss_pred CChhhhcccccceeec--ccccccc----ccCccCCCCCCCCEEEcccCcC
Q 003368 120 IPSEFVSLYNLKELAI--QENNLTG----GIPHFLGNITSLEAISLAYNSL 164 (825)
Q Consensus 120 ~p~~~~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l 164 (825)
+-.++...++|+.++| ++|.+.. .+.+.+...++|+.|+++.+..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 1234445555665333 4455532 1223344556666666655543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.86 E-value=0.00086 Score=68.41 Aligned_cols=72 Identities=10% Similarity=0.059 Sum_probs=45.8
Q ss_pred eEEEEEEEcCCCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc--eeEeecccccccCCCCeeeEEEEccCCC
Q 003368 657 GSVYKGTFDRDGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL--VRVITSCSSIDFQGNDFKALVYQYMPNG 730 (825)
Q Consensus 657 g~Vy~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~g 730 (825)
-.||+++. ++|+.|++|+.+... ...+++..|.+.+..+....+ +..+...-...+...+..+.|++|++|.
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 37999998 689999999986543 234667788888877653222 1222211111123456678999999874
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.55 E-value=0.00041 Score=63.22 Aligned_cols=40 Identities=10% Similarity=-0.001 Sum_probs=19.2
Q ss_pred CCCCCCEEECCC-CcCCCC----CCcCCCCCCCCCEEEcCCCCCC
Q 003368 78 RLFRLEALYLSH-NSLVGE----IPGNLSYCSRLIGLYLGRNKLE 117 (825)
Q Consensus 78 ~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 117 (825)
+.++|++|+|++ +.|+.. +-..+...++|++|+|++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 445666666665 334321 1222334455555555555554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.21 E-value=0.039 Score=57.20 Aligned_cols=74 Identities=16% Similarity=0.218 Sum_probs=47.5
Q ss_pred cceeccCCeeEEEEEEEcC-------CCeEEEEEEeecccchhHHHHHHHHHHhhcCCCCCc-eeEeecccccccCCCCe
Q 003368 648 THLIGIGSFGSVYKGTFDR-------DGTIVAIKVLNLQLQGASKSFAAECRALRNIRHRNL-VRVITSCSSIDFQGNDF 719 (825)
Q Consensus 648 ~~~ig~G~~g~Vy~~~~~~-------~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~ 719 (825)
.+.|+-|-.-.+|+..... ..+.|.+++.... . ..-...+|.++++.+.-.++ .+++++|. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~-------~- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFS-------G- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEET-------T-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC-------C-
Confidence 4568888888999998742 2355777765422 2 22344578888887753344 47777642 1
Q ss_pred eeEEEEccCCCCh
Q 003368 720 KALVYQYMPNGSL 732 (825)
Q Consensus 720 ~~lv~e~~~~gsL 732 (825)
.+||||++|..+
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.87 E-value=0.1 Score=51.86 Aligned_cols=32 Identities=25% Similarity=0.248 Sum_probs=27.7
Q ss_pred CCCeeecCCCCCCeeecCCCcEEEcccCcccc
Q 003368 778 QEPTIHCDLKPSNILLDNNLTAHVGDFGLARL 809 (825)
Q Consensus 778 ~~~ivHrdlk~~NILl~~~~~~ki~DFGla~~ 809 (825)
..++||+|+.+.||+++.+...-|.||+.|..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34799999999999999987778999998653
|